<SEC-DOCUMENT>0001178913-24-000490.txt : 20240213
<SEC-HEADER>0001178913-24-000490.hdr.sgml : 20240213
<ACCEPTANCE-DATETIME>20240213070305
ACCESSION NUMBER:		0001178913-24-000490
CONFORMED SUBMISSION TYPE:	20-F
PUBLIC DOCUMENT COUNT:		110
CONFORMED PERIOD OF REPORT:	20231231
FILED AS OF DATE:		20240213
DATE AS OF CHANGE:		20240213

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			InMode Ltd.
		CENTRAL INDEX KEY:			0001742692
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		20-F
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39016
		FILM NUMBER:		24622562

	BUSINESS ADDRESS:	
		STREET 1:		TAVOR BUILDING, SHA?AR YOKNEAM
		STREET 2:		POB 533
		CITY:			YOKNEAM
		STATE:			L3
		ZIP:			2069200
		BUSINESS PHONE:		972-4-9097470

	MAIL ADDRESS:	
		STREET 1:		TAVOR BUILDING, SHA?AR YOKNEAM
		STREET 2:		POB 533
		CITY:			YOKNEAM
		STATE:			L3
		ZIP:			2069200
</SEC-HEADER>
<DOCUMENT>
<TYPE>20-F
<SEQUENCE>1
<FILENAME>zk2430873.htm
<DESCRIPTION>20-F
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:currency="http://xbrl.sec.gov/currency/2023" xmlns:exch="http://xbrl.sec.gov/exch/2023" xmlns:naics="http://xbrl.sec.gov/naics/2023" xmlns:sic="http://xbrl.sec.gov/sic/2023" xmlns:stpr="http://xbrl.sec.gov/stpr/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:inmd="http://inmodemd.com/20231231" xmlns:ecd="http://xbrl.sec.gov/ecd/2023"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/><title>InMode Ltd. - 1742692 - 2024</title></head><body><div style="font-size: 10pt;"><div style="font-size: 10pt;"><div style="font-size: 10pt;">
        <div style="display:none">
        <ix:header><ix:hidden><ix:nonNumeric name="us-gaap:AccountsPayableRelatedAndNonrelatedPartyStatusExtensibleEnumeration" contextRef="C_20231231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdHimalayaFamilyOfficeConsultingLtdMember" id="Fxbrl_20240208173003815">http://fasb.org/us-gaap/2023#AccountsPayableCurrent</ix:nonNumeric><ix:nonNumeric name="us-gaap:AccountsPayableRelatedAndNonrelatedPartyStatusExtensibleEnumeration" contextRef="C_20221231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdHimalayaFamilyOfficeConsultingLtdMember" id="Fxbrl_20240208192704302">http://fasb.org/us-gaap/2023#AccountsPayableCurrent</ix:nonNumeric><ix:nonNumeric name="us-gaap:AccountsPayableRelatedAndNonrelatedPartyStatusExtensibleEnumeration" contextRef="C_20231231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdHomeSkinnovationsLtdMember" id="Fxbrl_20240208181011420">http://fasb.org/us-gaap/2023#AccountsPayableCurrent</ix:nonNumeric><ix:nonNumeric name="us-gaap:AccountsPayableRelatedAndNonrelatedPartyStatusExtensibleEnumeration" contextRef="C_20221231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdHomeSkinnovationsLtdMember" id="Fxbrl_20240208192647081">http://fasb.org/us-gaap/2023#AccountsPayableCurrent</ix:nonNumeric><ix:nonNumeric name="us-gaap:AccountsReceivableAfterAllowanceForCreditLossRelatedAndNonrelatedPartyStatusExtensibleEnumeration" contextRef="C_20231231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdSubsidiaryOfHomeSkinnovationsLtdMember" id="Fxbrl_20240208190452680">http://fasb.org/us-gaap/2023#AccountsReceivableNetCurrent</ix:nonNumeric><ix:nonNumeric name="us-gaap:AccountsReceivableAfterAllowanceForCreditLossRelatedAndNonrelatedPartyStatusExtensibleEnumeration" contextRef="C_20221231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdSubsidiaryOfHomeSkinnovationsLtdMember" id="Fxbrl_20240208192657231">http://fasb.org/us-gaap/2023#AccountsReceivableNetCurrent</ix:nonNumeric><ix:footnote id="FN20240205164156889" xml:lang="en-US">Including, for 2022, payments amounting $12 million for Amendment to the Investments Law and settlements with the Israeli tax authority. See note 13a(2)(b).</ix:footnote>
<ix:nonNumeric name="us-gaap:LesseeOperatingLeaseTermOfContract" contextRef="C_20200831_srtMortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_srtOfficeBuildingMember_usgaapTypeOfArrangementAxis_inmdLeaseAgreementMember" id="Fxbrl_20240205133500283">P7Y4M</ix:nonNumeric><ix:footnote id="FN20240205142459908" xml:lang="en-US">As of December 31, 2023 and 2022, consists of $0 and $1,502 non-U.S. government bonds, respectively.</ix:footnote>
<ix:nonNumeric name="dei:AmendmentFlag" contextRef="C_20230101to20231231" id="FFact_1054">false</ix:nonNumeric><ix:nonNumeric name="dei:DocumentFiscalPeriodFocus" contextRef="C_20230101to20231231" id="FFact_1055">FY</ix:nonNumeric><ix:nonNumeric name="dei:DocumentFiscalYearFocus" contextRef="C_20230101to20231231" id="FFact_1056">2023</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="C_20230101to20231231" id="FFact_1057">0001742692</ix:nonNumeric><ix:footnote id="FN20240205114132415" xml:lang="en-US">Revenues are attributed to geographic areas based on the location of customer. No single customer accounted for 10% or more of Company&#8217;s total revenues, or Company&#8217;s net accounts receivable, in any fiscal year presented.</ix:footnote>
<ix:footnote id="FN20230120225247000" xml:lang="en-US">As of December 31, 2022, noncurrent deferred revenue is estimated to be recognized as following: 83% in year 2024 and the rest in year 2025-2026.</ix:footnote>
<ix:footnote id="FN20240205164435993" xml:lang="en-US">Consists of non-current accounts receivable, net and other investments</ix:footnote>
<ix:footnote id="FN20240205135838393" xml:lang="en-US">The above number of Ordinary Shares outstanding does not include a total of 1,975,003 Ordinary Shares held at December 31, 2023, as treasury shares, all of which were repurchased by InMode Ltd.</ix:footnote>
<ix:footnote id="FN20230131142645552" xml:lang="en-US">In U.S. dollars per Ordinary Share</ix:footnote>
<ix:footnote id="FN20240205110132274" xml:lang="en-US">As of December 31, 2023, 275,249 RSUs were vested and were settled by issuance of respective shares at the beginning of January 2024.</ix:footnote>
</ix:hidden>
<ix:references>
        <link:schemaRef xlink:type="simple" xlink:href="inmd-20231231.xsd"/>
        </ix:references><ix:resources><xbrli:context id="C_20230101to20231231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdHomeSkinnovationsLtdMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inmd:HomeSkinnovationsLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdHomeSkinnovationsLtdMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inmd:HomeSkinnovationsLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdHomeSkinnovationsLtdMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inmd:HomeSkinnovationsLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_usgaapIncomeStatementLocationAxis_inmdExpensesIncomeMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdSubsidiaryOfHomeSkinnovationsLtdMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">inmd:ExpensesIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inmd:SubsidiaryOfHomeSkinnovationsLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapIncomeStatementLocationAxis_inmdExpensesIncomeMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdSubsidiaryOfHomeSkinnovationsLtdMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">inmd:ExpensesIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inmd:SubsidiaryOfHomeSkinnovationsLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_usgaapIncomeStatementLocationAxis_inmdExpensesIncomeMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdSubsidiaryOfHomeSkinnovationsLtdMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">inmd:ExpensesIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inmd:SubsidiaryOfHomeSkinnovationsLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdSpaMedicalInternationalLsrlMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inmd:SpaMedicalInternationalLsrlMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdSpaMedicalInternationalLsrlMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inmd:SpaMedicalInternationalLsrlMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdSpaMedicalInternationalLsrlMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inmd:SpaMedicalInternationalLsrlMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdHimalayaFamilyOfficeConsultingLtdMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inmd:HimalayaFamilyOfficeConsultingLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdHimalayaFamilyOfficeConsultingLtdMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inmd:HimalayaFamilyOfficeConsultingLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdHimalayaFamilyOfficeConsultingLtdMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inmd:HimalayaFamilyOfficeConsultingLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdHomeSkinnovationsLtdMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inmd:HomeSkinnovationsLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdHomeSkinnovationsLtdMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inmd:HomeSkinnovationsLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdHimalayaFamilyOfficeConsultingLtdMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inmd:HimalayaFamilyOfficeConsultingLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdHimalayaFamilyOfficeConsultingLtdMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inmd:HimalayaFamilyOfficeConsultingLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdSubsidiaryOfHomeSkinnovationsLtdMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inmd:SubsidiaryOfHomeSkinnovationsLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdSubsidiaryOfHomeSkinnovationsLtdMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inmd:SubsidiaryOfHomeSkinnovationsLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200331"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-03-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_usgaapIncomeTaxAuthorityNameAxis_inmdInmodeLtdAndIsreaeliSubsidiariesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">inmd:InmodeLtdAndIsreaeliSubsidiariesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapIncomeTaxAuthorityNameAxis_inmdInmodeLtdAndIsreaeliSubsidiariesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">inmd:InmodeLtdAndIsreaeliSubsidiariesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_usgaapIncomeTaxAuthorityNameAxis_inmdInmodeLtdAndIsreaeliSubsidiariesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">inmd:InmodeLtdAndIsreaeliSubsidiariesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_usgaapIncomeTaxAuthorityNameAxis_inmdSubsidiariesOutsideIsraelMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">inmd:SubsidiariesOutsideIsraelMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapIncomeTaxAuthorityNameAxis_inmdSubsidiariesOutsideIsraelMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">inmd:SubsidiariesOutsideIsraelMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_usgaapIncomeTaxAuthorityNameAxis_inmdSubsidiariesOutsideIsraelMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">inmd:SubsidiariesOutsideIsraelMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_usgaapIncomeTaxAuthorityNameAxis_countryIL"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">country:IL</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapIncomeTaxAuthorityNameAxis_countryIL"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">country:IL</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_usgaapIncomeTaxAuthorityNameAxis_countryIL"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">country:IL</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_usgaapIncomeTaxAuthorityAxis_inmdRegulationsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">inmd:RegulationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211115"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-11-15</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211115_srtCumulativeEffectPeriodOfAdoptionAxis_inmdAmendmentAdvantageExemptionMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">inmd:AmendmentAdvantageExemptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-11-15</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapIncomeTaxAuthorityNameAxis_inmdIsraeliTaxAuthorityMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">inmd:IsraeliTaxAuthorityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_srtRangeAxis_srtMinimumMember_usgaapIncomeTaxAuthorityNameAxis_inmdSubsidiariesOutsideIsraelMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">inmd:SubsidiariesOutsideIsraelMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_srtRangeAxis_srtMaximumMember_usgaapIncomeTaxAuthorityNameAxis_inmdSubsidiariesOutsideIsraelMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">inmd:SubsidiariesOutsideIsraelMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20191130_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_inmdMedimorMember_usgaapTypeOfArrangementAxis_inmdSharePurchaseAndShareholdersAgreementMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inmd:MedimorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">inmd:SharePurchaseAndShareholdersAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2019-11-30</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20191130_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_inmdMedimorMember_usgaapInvestmentTypeAxis_inmdFullyDilutedBasisMember_usgaapTypeOfArrangementAxis_inmdSharePurchaseAndShareholdersAgreementMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inmd:MedimorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">inmd:FullyDilutedBasisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">inmd:SharePurchaseAndShareholdersAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2019-11-30</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231130_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_inmdMedimorMember_usgaapTypeOfArrangementAxis_inmdSharePurchaseAndShareholdersAgreementMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inmd:MedimorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">inmd:SharePurchaseAndShareholdersAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-11-30</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_inmdMedimorMember_usgaapTypeOfArrangementAxis_inmdTwoPurchaseAndShareholdersAgreementsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inmd:MedimorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">inmd:TwoPurchaseAndShareholdersAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_inmdMedimorMember_usgaapInvestmentTypeAxis_inmdFullyDilutedBasisMember_usgaapTypeOfArrangementAxis_inmdTwoPurchaseAndShareholdersAgreementsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inmd:MedimorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">inmd:FullyDilutedBasisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">inmd:TwoPurchaseAndShareholdersAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20180501to20180531_usgaapTypeOfArrangementAxis_inmdLeaseAgreementMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">inmd:LeaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2018-05-01</xbrli:startDate>
        <xbrli:endDate>2018-05-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_srtRangeAxis_srtMinimumMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_srtRangeAxis_srtMaximumMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_srtRangeAxis_srtMinimumMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_srtRangeAxis_srtMaximumMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20180501to20180531_srtMortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_srtWarehouseMember_usgaapTypeOfArrangementAxis_inmdLeaseAgreementMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:WarehouseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">inmd:LeaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2018-05-01</xbrli:startDate>
        <xbrli:endDate>2018-05-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200801to20200831_srtMortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_srtOfficeBuildingMember_usgaapTypeOfArrangementAxis_inmdLeaseAgreementMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OfficeBuildingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">inmd:LeaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-08-01</xbrli:startDate>
        <xbrli:endDate>2020-08-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220701to20220731_srtMortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_srtOfficeBuildingMember_usgaapTypeOfArrangementAxis_inmdLeaseAgreementMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OfficeBuildingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">inmd:LeaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2022-07-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20180531_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapVehiclesMember_usgaapTypeOfArrangementAxis_inmdLeaseAgreementMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">inmd:LeaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2018-05-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200831_srtMortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_srtOfficeBuildingMember_usgaapTypeOfArrangementAxis_inmdLeaseAgreementMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OfficeBuildingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">inmd:LeaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-08-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220701_srtMortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_srtOfficeBuildingMember_usgaapTypeOfArrangementAxis_inmdLeaseAgreementMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OfficeBuildingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">inmd:LeaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-07-01</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapComputerEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapComputerEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapOfficeEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapOfficeEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapToolsDiesAndMoldsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ToolsDiesAndMoldsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapToolsDiesAndMoldsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ToolsDiesAndMoldsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdImprovementsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdImprovementsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_usgaapFinancialInstrumentAxis_usgaapUSGovernmentAgenciesDebtSecuritiesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapFinancialInstrumentAxis_usgaapUSGovernmentAgenciesDebtSecuritiesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_usgaapFinancialInstrumentAxis_usgaapMunicipalBondsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_usgaapFinancialInstrumentAxis_usgaapCorporateDebtSecuritiesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapFinancialInstrumentAxis_usgaapCorporateDebtSecuritiesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_usgaapFinancialInstrumentAxis_usgaapCertificatesOfDepositMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapFinancialInstrumentAxis_usgaapCertificatesOfDepositMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_usgaapFinancialInstrumentAxis_inmdNonUsGovernmentAgenciesDebtSecuritiesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inmd:NonUsGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapFinancialInstrumentAxis_inmdNonUsGovernmentAgenciesDebtSecuritiesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inmd:NonUsGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapUSGovernmentAgenciesDebtSecuritiesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapMunicipalBondsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapCorporateDebtSecuritiesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapCertificatesOfDepositMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapUSGovernmentAgenciesDebtSecuritiesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapCorporateDebtSecuritiesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapCertificatesOfDepositMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapFinancialInstrumentAxis_usgaapMunicipalBondsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapCommercialPaperMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapMunicipalBondsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_usgaapFinancialInstrumentAxis_usgaapCommercialPaperMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapFinancialInstrumentAxis_usgaapCommercialPaperMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_srtStatementGeographicalAxis_countryUS"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_srtStatementGeographicalAxis_countryUS"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_srtStatementGeographicalAxis_countryUS"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_srtStatementGeographicalAxis_inmdOtherCountryMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">inmd:OtherCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_srtStatementGeographicalAxis_inmdOtherCountryMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">inmd:OtherCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_srtStatementGeographicalAxis_inmdOtherCountryMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">inmd:OtherCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_usgaapConcentrationRiskByTypeAxis_inmdMinimalInvasiveMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">inmd:MinimalInvasiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapConcentrationRiskByTypeAxis_inmdMinimalInvasiveMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">inmd:MinimalInvasiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_usgaapConcentrationRiskByTypeAxis_inmdMinimalInvasiveMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">inmd:MinimalInvasiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_usgaapConcentrationRiskByTypeAxis_inmdHandsFreeMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">inmd:HandsFreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapConcentrationRiskByTypeAxis_inmdHandsFreeMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">inmd:HandsFreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_usgaapConcentrationRiskByTypeAxis_inmdHandsFreeMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">inmd:HandsFreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_usgaapConcentrationRiskByTypeAxis_inmdNonInvasiveMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">inmd:NonInvasiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapConcentrationRiskByTypeAxis_inmdNonInvasiveMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">inmd:NonInvasiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_usgaapConcentrationRiskByTypeAxis_inmdNonInvasiveMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">inmd:NonInvasiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_srtStatementGeographicalAxis_countryIL"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_srtStatementGeographicalAxis_countryIL"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_srtStatementGeographicalAxis_countryUS"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_srtStatementGeographicalAxis_countryUS"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_srtStatementGeographicalAxis_inmdOtherCountryMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">inmd:OtherCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_srtStatementGeographicalAxis_inmdOtherCountryMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">inmd:OtherCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_srtStatementGeographicalAxis_srtEuropeMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_srtStatementGeographicalAxis_srtEuropeMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_srtStatementGeographicalAxis_srtEuropeMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_srtProductOrServiceAxis_inmdCapitalEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inmd:CapitalEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_srtProductOrServiceAxis_inmdCapitalEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inmd:CapitalEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_srtProductOrServiceAxis_inmdCapitalEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inmd:CapitalEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_srtProductOrServiceAxis_inmdConsumablesAndServiceRevenuesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inmd:ConsumablesAndServiceRevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_srtProductOrServiceAxis_inmdConsumablesAndServiceRevenuesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inmd:ConsumablesAndServiceRevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_srtProductOrServiceAxis_inmdConsumablesAndServiceRevenuesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inmd:ConsumablesAndServiceRevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_srtRangeAxis_srtMinimumMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_srtRangeAxis_srtMaximumMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_srtRangeAxis_srtMinimumMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_srtRangeAxis_srtMaximumMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20240101to20241231_srtStatementScenarioAxis_srtScenarioForecastMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_srtRangeAxis_srtMinimumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapComputerEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_srtRangeAxis_srtMaximumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapComputerEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_srtRangeAxis_srtMinimumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapToolsDiesAndMoldsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ToolsDiesAndMoldsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_srtRangeAxis_srtMinimumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_srtRangeAxis_srtMaximumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapToolsDiesAndMoldsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ToolsDiesAndMoldsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_srtRangeAxis_srtMaximumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_usgaapPlanNameAxis_inmdTwoThousandsEighteenIncentivePlanMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">inmd:TwoThousandsEighteenIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeOneMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">inmd:ExercisePriceRangeOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeOneMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">inmd:ExercisePriceRangeOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeTwoMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">inmd:ExercisePriceRangeTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeTwoMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">inmd:ExercisePriceRangeTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeThreeMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">inmd:ExercisePriceRangeThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeThreeMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">inmd:ExercisePriceRangeThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeFourMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">inmd:ExercisePriceRangeFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeFourMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">inmd:ExercisePriceRangeFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeFiveMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">inmd:ExercisePriceRangeFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeFiveMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">inmd:ExercisePriceRangeFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeSixMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">inmd:ExercisePriceRangeSixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeSixMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">inmd:ExercisePriceRangeSixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeSevenMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">inmd:ExercisePriceRangeSevenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeSevenMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">inmd:ExercisePriceRangeSevenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeEightMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">inmd:ExercisePriceRangeEightMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeEightMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">inmd:ExercisePriceRangeEightMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeNineMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">inmd:ExercisePriceRangeNineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeNineMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">inmd:ExercisePriceRangeNineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_usgaapIncomeStatementLocationAxis_usgaapCostOfSalesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapIncomeStatementLocationAxis_usgaapCostOfSalesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_usgaapIncomeStatementLocationAxis_usgaapCostOfSalesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_usgaapIncomeStatementLocationAxis_usgaapSellingAndMarketingExpenseMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapIncomeStatementLocationAxis_usgaapSellingAndMarketingExpenseMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_usgaapIncomeStatementLocationAxis_usgaapSellingAndMarketingExpenseMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_usgaapIncomeStatementLocationAxis_usgaapGeneralAndAdministrativeExpenseMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapIncomeStatementLocationAxis_usgaapGeneralAndAdministrativeExpenseMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_usgaapIncomeStatementLocationAxis_usgaapGeneralAndAdministrativeExpenseMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_srtTitleOfIndividualAxis_inmdEmployeesMember_usgaapPlanNameAxis_inmdTwoThousandsEighteenIncentivePlanMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">inmd:EmployeesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">inmd:TwoThousandsEighteenIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_srtTitleOfIndividualAxis_inmdEmployeesMember_usgaapPlanNameAxis_inmdTwoThousandsEighteenIncentivePlanMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">inmd:EmployeesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">inmd:TwoThousandsEighteenIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_srtTitleOfIndividualAxis_inmdEmployeesMember_usgaapPlanNameAxis_inmdTwoThousandsEighteenIncentivePlanMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">inmd:EmployeesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">inmd:TwoThousandsEighteenIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_usgaapPlanNameAxis_inmdTwoThousandsEighteenIncentivePlanMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">inmd:TwoThousandsEighteenIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210523"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-05-23</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210423_srtConsolidatedEntitiesAxis_srtSubsidiariesMember_usgaapBusinessAcquisitionAxis_inmdDilazarLimitedMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">inmd:DilazarLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-04-23</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210423_srtConsolidatedEntitiesAxis_srtSubsidiariesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-04-23</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_usgaapPlanNameAxis_inmdShareRepurchaseProgramMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">inmd:ShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200901to20200930_usgaapSubsidiarySaleOfStockAxis_usgaapIPOMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001742692</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-09-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:unit id="ILS_per_Share"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:ILS</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit>
<xbrli:unit id="Pure"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit>
<xbrli:unit id="Segment"><xbrli:measure>inmd:Segment</xbrli:measure></xbrli:unit>
<xbrli:unit id="Shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit>
<xbrli:unit id="USD"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit>
<xbrli:unit id="USD_Per_Share"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit>
<xbrli:unit id="ils"><xbrli:measure>iso4217:ILS</xbrli:measure></xbrli:unit>
<ix:relationship fromRefs="FFact_370" toRefs="FN20240205164156889"></ix:relationship><ix:relationship fromRefs="FFact_371" toRefs="FN20240205164156889"></ix:relationship><ix:relationship fromRefs="FFact_372" toRefs="FN20240205164156889"></ix:relationship><ix:relationship fromRefs="FFact_444" toRefs="FN20240205142459908"></ix:relationship><ix:relationship fromRefs="FFact_445" toRefs="FN20240205142459908"></ix:relationship><ix:relationship fromRefs="FFact_998" toRefs="FN20240205114132415"></ix:relationship><ix:relationship fromRefs="FFact_999" toRefs="FN20240205114132415"></ix:relationship><ix:relationship fromRefs="FFact_1000" toRefs="FN20240205114132415"></ix:relationship><ix:relationship fromRefs="FFact_1023" toRefs="FN20230120225247000"></ix:relationship><ix:relationship fromRefs="FFact_1024" toRefs="FN20230120225247000"></ix:relationship><ix:relationship fromRefs="Fxbrl_20240205132505564_Fact_1036" toRefs="FN20240205164435993"></ix:relationship><ix:relationship fromRefs="Fxbrl_20240205132505564_Fact_1035" toRefs="FN20240205164435993"></ix:relationship><ix:relationship fromRefs="Fxbrl_20230120221255665" toRefs="FN20240205135838393"></ix:relationship><ix:relationship fromRefs="FFact_696" toRefs="FN20230131142645552"></ix:relationship><ix:relationship fromRefs="FFact_708" toRefs="FN20230131142645552"></ix:relationship><ix:relationship fromRefs="FFact_712" toRefs="FN20230131142645552"></ix:relationship><ix:relationship fromRefs="FFact_720" toRefs="FN20230131142645552"></ix:relationship><ix:relationship fromRefs="FFact_724" toRefs="FN20230131142645552"></ix:relationship><ix:relationship fromRefs="FFact_760" toRefs="FN20230131142645552"></ix:relationship><ix:relationship fromRefs="FFact_765" toRefs="FN20230131142645552"></ix:relationship><ix:relationship fromRefs="FFact_770" toRefs="FN20230131142645552"></ix:relationship><ix:relationship fromRefs="FFact_775" toRefs="FN20230131142645552"></ix:relationship><ix:relationship fromRefs="FFact_780" toRefs="FN20230131142645552"></ix:relationship><ix:relationship fromRefs="FFact_785" toRefs="FN20230131142645552"></ix:relationship><ix:relationship fromRefs="FFact_790" toRefs="FN20230131142645552"></ix:relationship><ix:relationship fromRefs="FFact_795" toRefs="FN20230131142645552"></ix:relationship><ix:relationship fromRefs="FFact_800" toRefs="FN20230131142645552"></ix:relationship><ix:relationship fromRefs="Fxbrl_20230120062219955" toRefs="FN20230131142645552"></ix:relationship><ix:relationship fromRefs="Fxbrl_20230120063922997" toRefs="FN20240205110132274"></ix:relationship><ix:relationship fromRefs="Fxbrl_20230120063944773" toRefs="FN20240205110132274"></ix:relationship><ix:relationship fromRefs="Fxbrl_20230120101707941" toRefs="FN20230131142645552"></ix:relationship></ix:resources></ix:header></div><div><div style="">
  <div>
    <div>
      <hr style="border:none;border-bottom:1px solid black;border-top:4px solid black;height:10px;color:#ffffff;background-color:#ffffff;text-align:center;margin-left:auto;margin-right:auto;text-align:center;margin-bottom:5pt"/>
    </div>
    <p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left">&#160;</p>
    <div>
      <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-size:14pt;font-weight:bold;margin-top:0pt;margin-bottom:0pt"><span style="font-size:14pt"><span style="font-family:Times New Roman,Times,serif"><span>UNITED STATES</span></span></span></div>
      <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-size:14pt;font-weight:bold"><span style="font-size:14pt"><span style="font-family:Times New Roman,Times,serif"><span>SECURITIES AND EXCHANGE COMMISSION</span></span></span></div>
      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>WASHINGTON, D.C. 20549</span></span></span></div>
      <div style="text-align:center;line-height:1.25;font-weight:bold">
        <hr style="height:1px;width:30%;color:#000000;background-color:#000000;margin-left:auto;margin-right:auto;border:none;text-align:center;margin-bottom:4pt"/>
      </div>
      <div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt">&#160;</div>
      <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-size:14pt;font-weight:bold"><span style="font-size:14pt"><span style="font-family:Times New Roman,Times,serif"><span>FORM <ix:nonNumeric id="F20230120134654274_0" name="dei:DocumentType" contextRef="C_20230101to20231231">20-F</ix:nonNumeric></span></span></span></div>
      <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-size:14pt;font-weight:bold">
        <hr style="height:1px;width:30%;color:#000000;background-color:#000000;margin-left:auto;margin-right:auto;border:none;text-align:center;margin-bottom:4pt"/>
      </div>
      <div style="line-height:1.25">&#160;</div>
      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(Mark One)</span></span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-indent:-36pt;margin-left:72pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonNumeric id="F20230120134654277_1" name="dei:DocumentRegistrationStatement" contextRef="C_20230101to20231231" format="ixt:fixed-false">&#9744;</ix:nonNumeric>&#160; &#160; &#160; &#160; &#160; REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934&#8201;&#8201;</span></span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>OR</span></span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-indent:-36pt;margin-left:72pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonNumeric id="F20230120134654278_2" name="dei:DocumentAnnualReport" contextRef="C_20230101to20231231" format="ixt:fixed-true">&#9746;</ix:nonNumeric>&#160; &#160; &#160; &#160; &#160; ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934&#8201;&#8201;</span></span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>For the fiscal year ended <ix:nonNumeric id="F20230120134654282_3" name="dei:DocumentPeriodEndDate" contextRef="C_20230101to20231231" format="ixt:date-monthname-day-year-en"><ix:nonNumeric id="F20230120134654283_4" name="dei:CurrentFiscalYearEndDate" contextRef="C_20230101to20231231" format="ixt:date-monthname-day-en">December 31</ix:nonNumeric>, 2023</ix:nonNumeric></span></span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>OR</span></span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-indent:-36pt;margin-left:72pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonNumeric id="F20230120134654283_5" name="dei:DocumentTransitionReport" contextRef="C_20230101to20231231" format="ixt:fixed-false">&#9744;</ix:nonNumeric>&#160; &#160; &#160; &#160; &#160; TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934&#8201;&#8201;</span></span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>OR</span></span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-indent:-36pt;margin-left:72pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonNumeric id="F20230120134654284_6" name="dei:DocumentShellCompanyReport" contextRef="C_20230101to20231231" format="ixt:fixed-false">&#9744;</ix:nonNumeric>&#160; &#160; &#160; &#160; &#160; SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934&#8201;&#8201;</span></span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Date of event requiring this shell company report</span></span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>For the transition period from __________ to __________</span></span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Commission file number <ix:nonNumeric id="F20230120134654284_7" name="dei:EntityFileNumber" contextRef="C_20230101to20231231">001-39016</ix:nonNumeric></span></span></span></div>
      <div style="line-height:1.25">
        <hr style="height:1px;width:30%;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center;margin-bottom:0pt"/>
      </div>
      <div style="text-align:center;line-height:1.25;font-family:Times New Roman, Times, serif;font-size:16pt;font-weight:bold;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt">&#160;</span></span></span></span></div>
      <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-size:16pt;font-weight:bold"><span style="font-size:16pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonNumeric id="F20230120134654286_8" name="dei:EntityRegistrantName" contextRef="C_20230101to20231231">InMode Ltd.</ix:nonNumeric></span></span></span></div>
      <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(Exact name of Registrant as specified in its charter)</span></span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>N/A</span></span></span></div>
      <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(Translation of Registrant&#8217;s name into English)</span></span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonNumeric id="Fxbrl_20230120195503335" name="dei:EntityIncorporationStateCountryCode" contextRef="C_20230101to20231231" format="ixt-sec:edgarprovcountryen">Israel</ix:nonNumeric></span></span></span></div>
      <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(Jurisdiction of incorporation or organization)</span></span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonNumeric id="F20230120134654274_01" name="dei:EntityAddressAddressLine1" contextRef="C_20230101to20231231">Tavor Building</ix:nonNumeric>, <ix:nonNumeric id="F20230120134654274_02" name="dei:EntityAddressAddressLine2" contextRef="C_20230101to20231231">Sha&#8217;ar Yokneam</ix:nonNumeric>, <ix:nonNumeric id="F20230120134654274_03" name="dei:EntityAddressAddressLine3" contextRef="C_20230101to20231231">P.O. Box 533</ix:nonNumeric></span></span></span></div>
      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonNumeric id="F20230120134654274_04" name="dei:EntityAddressCityOrTown" contextRef="C_20230101to20231231">Yokneam</ix:nonNumeric>, <ix:nonNumeric id="F20230120134654274_05" name="dei:EntityAddressPostalZipCode" contextRef="C_20230101to20231231">2069206</ix:nonNumeric>, <ix:nonNumeric id="F20230120134654274_06" name="dei:EntityAddressCountry" contextRef="C_20230101to20231231" format="ixt-sec:countrynameen">Israel</ix:nonNumeric></span></span></span></div>
      <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(Address of principal executive offices)</span></span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonNumeric id="F20230120134654274_07" name="dei:ContactPersonnelName" contextRef="C_20230101to20231231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember">Moshe Mizrahy</ix:nonNumeric></span></span></span></div>
      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>+<ix:nonNumeric id="Fxbrl_20230120195755807" name="dei:CityAreaCode" contextRef="C_20230101to20231231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember">972</ix:nonNumeric>-<ix:nonNumeric id="F20230120134654274_09" name="dei:LocalPhoneNumber" contextRef="C_20230101to20231231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember">4-9096313</ix:nonNumeric></span></span></span></div>
      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonNumeric id="F20230120134654277_10" name="dei:EntityAddressAddressLine1" contextRef="C_20230101to20231231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember">Tavor Building</ix:nonNumeric>, <ix:nonNumeric id="F20230120134654277_11" name="dei:EntityAddressAddressLine2" contextRef="C_20230101to20231231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember">Sha&#8217;ar Yokneam</ix:nonNumeric>, <ix:nonNumeric id="F20230120134654277_12" name="dei:EntityAddressAddressLine3" contextRef="C_20230101to20231231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember">P.O. Box 533</ix:nonNumeric></span></span></span></div>
      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonNumeric id="F20230120134654277_13" name="dei:EntityAddressCityOrTown" contextRef="C_20230101to20231231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember">Yokneam</ix:nonNumeric>, <ix:nonNumeric id="F20230120134654277_14" name="dei:EntityAddressPostalZipCode" contextRef="C_20230101to20231231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember">2069206</ix:nonNumeric>, <ix:nonNumeric id="F20230120134654277_15" name="dei:EntityAddressCountry" contextRef="C_20230101to20231231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember" format="ixt-sec:countrynameen">Israel</ix:nonNumeric></span></span></span></div>
      <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(Name, Telephone, E-mail and/or Facsimile number and Address of Company Contact Person)</span></span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="clear:both;margin-top:10pt;margin-bottom:10pt">
        <div style="page-break-after:always">
          <hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000"/>
        </div>
      </div>
      <div style="line-height:1.25">&#160;</div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Securities registered or to be registered pursuant to Section 12(b) of the Act:</span></span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

          <tr>
            <td style="width:40.04%;vertical-align:bottom;border-bottom:#000000 2px solid">
              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Title of each class</span></span></span></div>
            </td>
            <td style="width:1.99%;vertical-align:bottom">&#160;</td>
            <td style="width:15.94%;vertical-align:bottom;border-bottom:#000000 2px solid">
              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Trading Symbol(s)</span></span></span></div>
            </td>
            <td style="width:1.99%;vertical-align:bottom">&#160;</td>
            <td style="width:40.03%;vertical-align:bottom;border-bottom:#000000 2px solid">
              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Name of each exchange on which registered</span></span></span></div>
            </td>
          </tr>
          <tr>
            <td style="width:40.04%;vertical-align:top">
              <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonNumeric id="F20230120134654277_16" name="dei:Security12bTitle" contextRef="C_20230101to20231231">Ordinary shares, par value NIS 0.01 per ordinary share</ix:nonNumeric></span></span></span></div>
            </td>
            <td style="width:1.99%;vertical-align:top">&#160;</td>
            <td style="width:15.94%;vertical-align:top">
              <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonNumeric id="F20230120134654277_17" name="dei:TradingSymbol" contextRef="C_20230101to20231231">INMD</ix:nonNumeric></span></span></span></div>
            </td>
            <td style="width:1.99%;vertical-align:top">&#160;</td>
            <td style="width:40.03%;vertical-align:top">
              <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonNumeric id="F20230120134654277_18" name="dei:SecurityExchangeName" contextRef="C_20230101to20231231" format="ixt-sec:exchnameen">Nasdaq</ix:nonNumeric> Global Select Market</span></span></span></div>
            </td>
          </tr>

      </table>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Securities registered or to be registered pursuant to Section 12(g) of the Act.</span></span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="text-decoration:underline">None</span></span></span></span></div>
      <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(Title of Class)</span></span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act.</span></span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="text-decoration:underline">None</span></span></span></span></div>
      <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(Title of Class)</span></span></span></div>
      <div>
        <hr style="height:1px;width:20%;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center"/>
      </div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-indent:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Indicate the number of outstanding shares of each of the issuer&#8217;s classes of capital or common stock as of the close of the period covered by the annual report: <ix:nonFraction id="Fxbrl_20230120221255665" name="dei:EntityCommonStockSharesOutstanding" contextRef="C_20231231" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">83,982,462</ix:nonFraction> Ordinary Shares, par value NIS 0.01 per share<sup style="vertical-align:text-top;line-height:1;font-size:smaller">1</sup>.</span></span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-indent:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.</span></span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonNumeric id="F20230120134654278_20" name="dei:EntityWellKnownSeasonedIssuer" contextRef="C_20230101to20231231">Yes</ix:nonNumeric> &#9746; No &#9744;</span></span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-indent:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.</span></span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Yes &#9744; <ix:nonNumeric id="F20230120134654278_21" name="dei:EntityVoluntaryFilers" contextRef="C_20230101to20231231">No</ix:nonNumeric> &#9746;</span></span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Note &#8212; Checking the box above will not relieve any registrant required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 from their obligations under those Sections.</span></span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-indent:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.</span></span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonNumeric id="F20230120134654278_22" name="dei:EntityCurrentReportingStatus" contextRef="C_20230101to20231231">Yes</ix:nonNumeric> &#9746; No &#9744;</span></span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-indent:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</span></span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonNumeric id="F20230120134654278_23" name="dei:EntityInteractiveDataCurrent" contextRef="C_20230101to20231231">Yes</ix:nonNumeric> &#9746; No &#9744;</span></span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-indent:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or an emerging growth company. See definition of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

          <tr>
            <td style="width:33.38%;vertical-align:top">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonNumeric id="F20230120134654278_24" name="dei:EntityFilerCategory" contextRef="C_20230101to20231231" format="ixt-sec:entityfilercategoryen">Large accelerated filer</ix:nonNumeric>&#160;&#9746;</span></span></span></div>
            </td>
            <td style="width:33.23%;vertical-align:top">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Accelerated filer &#9744;</span></span></span></div>
            </td>
            <td style="width:33.39%;vertical-align:top">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Non-accelerated filer &#9744;</span></span></span></div>
            </td>
          </tr>
          <tr>
            <td style="width:33.38%;vertical-align:top">&#160;</td>
            <td style="width:33.23%;vertical-align:top">&#160;</td>
            <td style="width:33.39%;vertical-align:top">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Emerging growth company <ix:nonNumeric id="F20230120134654278_25" name="dei:EntityEmergingGrowthCompany" contextRef="C_20230101to20231231" format="ixt:fixed-false">&#9744;</ix:nonNumeric></span></span></span></div>
            </td>
          </tr>

      </table>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-indent:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></span></span></div>
      <div style="text-indent:36pt;line-height:1.25">&#160;</div>
      <div style="line-height:1.25">
        <hr style="height:1px;width:20%;color:#000000;background-color:#000000;margin-left:0px;margin-right:auto;border:none;text-align:left"/>
      </div>
      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><sup style="vertical-align:text-top;line-height:1;font-size:smaller">1</sup>The above number of Ordinary Shares outstanding does not include a total of 1,975,003 Ordinary Shares held at December 31, 2023, as treasury shares, all of which were repurchased by InMode Ltd.</span></span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="clear:both;margin-top:10pt;margin-bottom:10pt">
        <div style="page-break-after:always">
          <hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000"/>
        </div>
      </div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-indent:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>&#8224; The term &#8220;new or revised financial accounting standard&#8221; refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards Codification after April 5, 2012.</span></span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-indent:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. <ix:nonNumeric id="F20230120134654278_26" name="dei:IcfrAuditorAttestationFlag" contextRef="C_20230101to20231231" format="ixt:fixed-true">&#9746;</ix:nonNumeric></span></span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-indent:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. <ix:nonNumeric id="Fxbrl_20240205164757032" name="dei:DocumentFinStmtErrorCorrectionFlag" contextRef="C_20230101to20231231" format="ixt:fixed-false">&#9744;</ix:nonNumeric></span></span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-indent:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive based compensation received by any of the registrant&#8217;s executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b). &#9744;</span></span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-indent:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Indicate by check mark which basis of accounting the registrant has used to prepare the financial statements included in this filing:</span></span></span></div>
      <div style="text-indent:36pt;line-height:1.25">&#160;</div>
      <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

          <tr>
            <td style="width:25.08%;vertical-align:top">
              <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonNumeric id="F20230120134654278_27" name="dei:DocumentAccountingStandard" contextRef="C_20230101to20231231">U.S. GAAP</ix:nonNumeric> &#9746;</span></span></span></div>
            </td>
            <td style="width:44.85%;vertical-align:top">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>International Financial Reporting Standards as</span></span></span></div>
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>issued by the International Accounting Standards Board &#9744;</span></span></span></div>
            </td>
            <td style="width:30.07%;vertical-align:top">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>&#160; &#160; &#160; &#160; Other &#9744;</span></span></span></div>
            </td>
          </tr>

      </table>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-indent:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>If &#8220;Other&#8221; has been checked in response to the previous question, indicate by check mark which financial statement item the registrant has elected to follow. N/A</span></span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>&#9744; Item 17 &#9744; Item 18</span></span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-indent:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>If this is an annual report, indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).</span></span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Yes &#9744; No <ix:nonNumeric id="F20230120134654278_28" name="dei:EntityShellCompany" contextRef="C_20230101to20231231" format="ixt:fixed-false">&#9746;</ix:nonNumeric></span></span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY PROCEEDINGS DURING THE PAST FIVE YEARS)</span></span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-indent:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Indicate by check mark whether the registrant has filed all documents and reports required to be filed by Sections 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court.</span></span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Yes &#9744; No &#9744;</span></span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="clear:both;margin-top:10pt;margin-bottom:10pt">
        <div style="page-break-after:always">
          <hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000"/>
        </div>
      </div>
      <div><!-- Field: Include-Text; File: PF\body.htm; Date: 2024%2D02%2D12T20:18:24; Size: 0x00126ED1; Options: XMLPreprocess -->
<div><br/>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: center; line-height: 1.25; font-weight: bold">TABLE OF CONTENTS</div>

<div style="line-height: 1.25"><br/> </div>

<div class="BRPFPageFooter">

<div style="line-height: 1.25">

<table cellspacing="0" cellpadding="0" border="0" id="z66c08e2c053b4ace9a5dacbff05e59ce" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td colspan="2" style="vertical-align: top">
        <div style="line-height: 1.25"><a href="#PARTI">PART I</a></div> </td>
    <td style="width: 5%; vertical-align: bottom">
        <div style="text-align: right; line-height: 1.25">1</div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="margin-left: 8.65pt; line-height: 1.25">&#160;</div> </td>
    <td style="width: 87%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 5%; vertical-align: bottom">&#160;</td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="margin-left: 8.65pt; line-height: 1.25"><a href="#ITEM1">ITEM 1.</a></div> </td>
    <td style="width: 87%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#ITEM1">IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS</a></div> </td>
    <td style="width: 5%; vertical-align: bottom">
        <div style="text-align: right; line-height: 1.25">1</div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="margin-left: 8.65pt; line-height: 1.25"><a href="#ITEM2">ITEM 2.</a></div> </td>
    <td style="width: 87%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#ITEM2">OFFER STATISTICS AND EXPECTED TIMETABLE</a></div> </td>
    <td style="width: 5%; vertical-align: bottom">
        <div style="text-align: right; line-height: 1.25">1</div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="margin-left: 8.65pt; line-height: 1.25"><a href="#ITEM3">ITEM 3.</a></div> </td>
    <td style="width: 87%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#ITEM3">KEY INFORMATION</a></div> </td>
    <td style="width: 5%; vertical-align: bottom">
        <div style="text-align: right; line-height: 1.25">1</div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="margin-left: 8.65pt; line-height: 1.25"><a href="#ITEM4">ITEM 4.</a></div> </td>
    <td style="width: 87%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#ITEM4">INFORMATION ON THE COMPANY</a></div> </td>
    <td style="width: 5%; vertical-align: bottom">
        <div style="text-align: right; line-height: 1.25">31</div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="margin-left: 8.65pt; line-height: 1.25"><a href="#ITEM4A">ITEM 4A.</a></div> </td>
    <td style="width: 87%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#ITEM4A">UNRESOLVED STAFF COMMENTS</a></div> </td>
    <td style="width: 5%; vertical-align: bottom">
        <div style="text-align: right; line-height: 1.25">67</div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="margin-left: 8.65pt; line-height: 1.25"><a href="#ITEM5">ITEM 5.</a></div> </td>
    <td style="width: 87%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#ITEM5">OPERATING AND FINANCIAL REVIEW AND PROSPECTS</a></div> </td>
    <td style="width: 5%; vertical-align: bottom">
        <div style="text-align: right; line-height: 1.25">67</div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="margin-left: 8.65pt; line-height: 1.25"><a href="#ITEM6">ITEM 6.</a></div> </td>
    <td style="width: 87%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#ITEM6">DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES</a></div> </td>
    <td style="width: 5%; vertical-align: bottom; text-align: right">74</td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="margin-left: 8.65pt; line-height: 1.25"><a href="#ITEM7">ITEM 7.</a></div> </td>
    <td style="width: 87%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#ITEM7">MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS</a></div> </td>
    <td style="width: 5%; vertical-align: bottom; text-align: right">93</td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="margin-left: 8.65pt; line-height: 1.25"><a href="#ITEM8">ITEM 8.</a></div> </td>
    <td style="width: 87%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#ITEM8">FINANCIAL INFORMATION</a></div> </td>
    <td style="width: 5%; vertical-align: bottom; text-align: right">94</td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="margin-left: 8.65pt; line-height: 1.25"><a href="#ITEM9">ITEM 9.</a></div> </td>
    <td style="width: 87%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#ITEM9">THE OFFER AND LISTING</a></div> </td>
    <td style="width: 5%; vertical-align: bottom; text-align: right">95</td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="margin-left: 8.65pt; line-height: 1.25"><a href="#ITEM10">ITEM 10.</a></div> </td>
    <td style="width: 87%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#ITEM10">ADDITIONAL INFORMATION</a></div> </td>
    <td style="width: 5%; vertical-align: bottom; text-align: right">95</td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="margin-left: 8.65pt; line-height: 1.25"><a href="#ITEM11">ITEM 11.</a></div> </td>
    <td style="width: 87%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#ITEM11">QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</a></div> </td>
    <td style="width: 5%; vertical-align: bottom; text-align: right">106</td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="margin-left: 8.65pt; line-height: 1.25"><a href="#ITEM12">ITEM 12.</a></div> </td>
    <td style="width: 87%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#ITEM12">DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES</a></div> </td>
    <td style="width: 5%; vertical-align: bottom; text-align: right">107</td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="margin-left: 8.65pt; line-height: 1.25">&#160;</div> </td>
    <td style="width: 87%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 5%; vertical-align: bottom; text-align: right">&#160;</td> </tr>
  <tr>
    <td colspan="2" style="vertical-align: top">
        <div style="line-height: 1.25"><a href="#PARTII">PART II</a></div> </td>
    <td style="width: 5%; vertical-align: bottom; text-align: right">108</td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="margin-left: 8.65pt; line-height: 1.25">&#160;</div> </td>
    <td style="width: 87%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 5%; vertical-align: bottom; text-align: right">&#160;</td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="margin-left: 8.65pt; line-height: 1.25"><a href="#ITEM13">ITEM 13.</a></div> </td>
    <td style="width: 87%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#ITEM13">DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES</a></div> </td>
    <td style="width: 5%; vertical-align: bottom; text-align: right">108</td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="margin-left: 8.65pt; line-height: 1.25"><a href="#ITEM14">ITEM 14.</a></div> </td>
    <td style="width: 87%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#ITEM14">MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS AND USE OF PROCEEDS</a></div>
        </td>
    <td style="width: 5%; vertical-align: bottom">
        <div style="text-align: right; line-height: 1.25">108</div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="margin-left: 8.65pt; line-height: 1.25"><a href="#ITEM15">ITEM 15.</a></div> </td>
    <td style="width: 87%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#ITEM15">CONTROLS AND PROCEDURES</a></div> </td>
    <td style="width: 5%; vertical-align: bottom">
        <div style="text-align: right; line-height: 1.25">108</div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="margin-left: 8.65pt; line-height: 1.25"><a href="#ITEM16">ITEM 16.</a></div> </td>
    <td style="width: 87%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#ITEM16">[RESERVED]</a></div> </td>
    <td style="width: 5%; vertical-align: bottom">
        <div style="text-align: right; line-height: 1.25">109</div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="margin-left: 8.65pt; line-height: 1.25"><a href="#ITEM16A">ITEM 16A.</a></div> </td>
    <td style="width: 87%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#ITEM16A">AUDIT COMMITTEE FINANCIAL EXPERT</a></div> </td>
    <td style="width: 5%; vertical-align: bottom">
        <div style="text-align: right; line-height: 1.25">109</div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="margin-left: 8.65pt; line-height: 1.25"><a href="#ITEM16B">ITEM 16B.</a></div> </td>
    <td style="width: 87%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#ITEM16B">CODE OF ETHICS</a></div> </td>
    <td style="width: 5%; vertical-align: bottom">
        <div style="text-align: right; line-height: 1.25">109</div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="margin-left: 8.65pt; line-height: 1.25"><a href="#ITEM16C">ITEM 16C.</a></div> </td>
    <td style="width: 87%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#ITEM16C">PRINCIPAL ACCOUNTANT FEES AND SERVICES</a></div> </td>
    <td style="width: 5%; vertical-align: bottom">
        <div style="text-align: right; line-height: 1.25">109</div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="margin-left: 8.65pt; line-height: 1.25"><a href="#ITEM16D">ITEM 16D.</a></div> </td>
    <td style="width: 87%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#ITEM16D">EXEMPTIONS FROM THE LISTING STANDARDS FOR AUDIT COMMITTEES</a></div> </td>
    <td style="width: 5%; vertical-align: bottom">
        <div style="text-align: right; line-height: 1.25">110</div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="margin-left: 8.65pt; line-height: 1.25"><a href="#ITEM16E">ITEM 16E.</a></div> </td>
    <td style="width: 87%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#ITEM16E">PURCHASES OF EQUITY SECURITIES BY THE ISSUER AND AFFILIATED PURCHASERS</a></div> </td>
    <td style="width: 5%; vertical-align: bottom">
        <div style="text-align: right; line-height: 1.25">110</div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="margin-left: 8.65pt; line-height: 1.25"><a href="#ITEM16F">ITEM 16F.</a></div> </td>
    <td style="width: 87%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#ITEM16F">CHANGE IN REGISTRANT&#8217;S CERTIFYING ACCOUNTANT</a></div> </td>
    <td style="width: 5%; vertical-align: bottom">
        <div style="text-align: right; line-height: 1.25">110</div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="margin-left: 8.65pt; line-height: 1.25"><a href="#ITEM16G">ITEM 16G.</a></div> </td>
    <td style="width: 87%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#ITEM16G">CORPORATE GOVERNANCE</a></div> </td>
    <td style="width: 5%; vertical-align: bottom; text-align: right">110</td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="margin-left: 8.65pt; line-height: 1.25"><a href="#ITEM16H">ITEM 16H.</a></div> </td>
    <td style="width: 87%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#ITEM16H">MINE SAFETY DISCLOSURE</a></div> </td>
    <td style="width: 5%; vertical-align: bottom">
        <div style="text-align: right; line-height: 1.25">111</div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="margin-left: 8.65pt; line-height: 1.25"><a href="#ITEM16I">ITEM 16I.</a></div> </td>
    <td style="width: 87%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#ITEM16I">DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS</a></div> </td>
    <td style="width: 5%; vertical-align: bottom">
        <div style="text-align: right; line-height: 1.25">111</div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="margin-left: 8.65pt; line-height: 1.25"><a href="#ITEM16K">ITEM 16K.</a></div> </td>
    <td style="width: 87%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#ITEM16K">CYBERSECURITY</a></div> </td>
    <td style="width: 5%; vertical-align: bottom">
        <div style="text-align: right; line-height: 1.25">112</div> </td> </tr>
  <tr>
    <td rowspan="1" colspan="2" style="vertical-align: top">&#160;</td>
    <td rowspan="1" style="width: 5%; vertical-align: bottom; text-align: right">&#160;</td> </tr>
  <tr>
    <td colspan="2" style="vertical-align: top">
        <div style="line-height: 1.25"><a href="#PARTIII">PART III</a><br/> </div> </td>
    <td style="width: 5%; vertical-align: bottom; text-align: right">112</td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="margin-left: 8.65pt; line-height: 1.25">&#160;</div> </td>
    <td style="width: 87%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 5%; vertical-align: bottom; text-align: right">&#160;</td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="margin-left: 8.65pt; line-height: 1.25"><a href="#ITEM17">ITEM 17.</a></div> </td>
    <td style="width: 87%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#ITEM17">FINANCIAL STATEMENTS</a></div> </td>
    <td style="width: 5%; vertical-align: bottom">
        <div style="text-align: right; line-height: 1.25">112</div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="margin-left: 8.65pt; line-height: 1.25"><a href="#ITEM18">ITEM 18.</a></div> </td>
    <td style="width: 87%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#ITEM18">FINANCIAL STATEMENTS</a></div> </td>
    <td style="width: 5%; vertical-align: bottom; text-align: right">112</td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="margin-left: 8.65pt; line-height: 1.25"><a href="#ITEM19">ITEM 19.</a></div> </td>
    <td style="width: 87%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#ITEM19">EXHIBITS</a></div> </td>
    <td style="width: 5%; vertical-align: bottom; text-align: right">113</td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="margin-left: 8.65pt; line-height: 1.25">&#160;</div> </td>
    <td style="width: 87%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 5%; vertical-align: bottom; text-align: right">&#160;</td> </tr>
  <tr>
    <td colspan="2" style="vertical-align: top">
        <div style="line-height: 1.25"><a href="#SIGNATURES">SIGNATURES</a></div> </td>
    <td style="width: 5%; vertical-align: bottom; text-align: right">114</td> </tr>
  </table> </div> </div>

<div style="line-height: 1.25; font-weight: bold"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25; font-weight: bold"> <br/> </div>

<div style="line-height: 1.25; font-weight: bold">Certain Definitions</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">In this Annual Report on Form 20-F, unless the context otherwise requires:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="za159bd5fba714bb386d0af339745b198" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>references to &#8220;InMode,&#8221; the &#8220;Company,&#8221; &#8220;us,&#8221; &#8220;we&#8221; and &#8220;our&#8221; refer to
        InMode Ltd., an Israeli company, and its consolidated subsidiaries;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z03e8289327c64f3eaec79d2f6e019bc2" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>references to &#8220;ordinary shares,&#8221; &#8220;our shares&#8221; and similar expressions refer to the Company&#8217;s ordinary
        shares;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zb19533a2fd754ad3a8ea1454274b0bfb" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>references to &#8220;dollars,&#8221; &#8220;U.S. dollars&#8221; and &#8220;$&#8221; are to U.S. Dollars;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zda823183f07141a1aa3ba267e80f9ca3" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>references to &#8220;shekels&#8221; and &#8220;NIS&#8221; are to New Israeli Shekels, the Israeli currency;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zb15ebe75fbb541df9860ff3f33407ef8" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>references to the &#8220;Companies Law&#8221; are to Israel&#8217;s Companies Law, 5759-1999, as amended;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="za14225b29aa74730ad4662f67e2721b0" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>references to the &#8220;SEC&#8221; are to the U.S. Securities and Exchange Commission; and</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zbd8a8b36b889491c8b5462bdc2507610" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>references to &#8220;U.S. GAAP&#8221; are to U.S. generally accepted accounting principles.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Forward-Looking Statements</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The sections entitled &#8220;Item 3. Key Information - D. Risk Factors&#8221; &#8220;Item
4. Information on the Company&#8221; and &#8220;Item 5. Operating and Financial Review and Prospects&#8221; and elsewhere in this Annual
Report on Form 20-F contain forward-looking statements that are subject to substantial risks and uncertainties. All statements, other
than statements of historical facts, included in this Annual Report on Form 20-F regarding our strategy, future operations, future financial
position, future revenues, projected costs, prospects, plans, objectives of management and expected market growth are forward-looking
statements. The words &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221;
&#8220;may,&#8221; &#8220;plan,&#8221; &#8220;predict,&#8221; &#8220;project,&#8221; &#8220;will,&#8221; &#8220;would&#8221; and similar
expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying
words. Unless otherwise indicated in this Annual Report on Form 20-F, the basis for any statements regarding our competitive position
is based on our own assessment and knowledge of the market in which we operate</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">These forward-looking statements include, among other things, statements about:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z4a0ff65587f243d39de49ca5b5eaa930" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>our ability to identify and penetrate new markets for our products and technology;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z39c75ec7d5414544bf29dd8c2f992cdd" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>our ability to innovate, develop and commercialize our existing and new products and to expand beyond our traditional customer base;</div>
        </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z0ef57c83543040619b25f7a9ed150abd" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>our ability to obtain and maintain regulatory clearances;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z14434d4a232a48f4a64b9fb4d90d28a2" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>the impact of the political, economic and military instability in Israel and the latest Israel-Hamas war on our ability to operate
        and develop, manufacture and deliver products and components;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zb20c80736cdc42be9d821677cb602055" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>our expectation regarding the safety and efficacy of our products;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zfdc5d6687b8b4fab902e4b4bb27596cd" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>the commercial experience of our management team;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="ze5758a9556bd4890b180a7e14d75eb00" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>our commercialization, marketing and manufacturing capabilities and strategy;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z5c5ec5ad22ec47a2a696c4fdfc4bfe27" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>our estimates regarding the potential market opportunity for our products;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z09e906de1d4943fc9dfdd022e1060a21" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>developments and projections relating to our competitors or our industry;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zd48f9f71469e4c09b1d4722187332ef9" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>our ability to differentiate and distinguish our products from those of our competitors;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zb2de2e39c6324082893d7826bb8c7258" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>our estimates regarding expenses, future revenue, capital requirements and needs for additional financing;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zf4349bc25a004800b97310cdc0cad7c1" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>our sales and marketing capabilities and strategy in the United States and internationally;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="za82273dadc684f13a1fc95947bc64106" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>the implementation of our business model, strategic plans for our business, products and technology;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zf7355966199d4fa5a029baa8f1225cb9" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>our ability to attract or retain key personnel;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z618e5d64810b47149298d8180acba8d5" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>the impact of climate-related events and increasing regulatory requirements and security on our operating costs and business operations;</div>
        </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z973180e8bbc74820875327e73922a57f" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>our intellectual property portfolio and position and our ability to protect our intellectual property rights; and</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z4f86c92ea9074a76b83d7a62fe8f8641" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>our assessment of the impact to us of any third-party litigation claiming patent infringement.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We may not actually achieve the plans, intentions or expectations disclosed in our forward-looking
statements, and you should not place undue reliance on our forward-looking statements. Forward-looking statements are based on our management&#8217;s
current expectations, estimates, forecasts and projections about our business and the industry in which we operate and our management&#8217;s
beliefs and assumptions, are not guarantees of future performance or development, and involve known and unknown risks, uncertainties and
other factors that are in some cases beyond our control. Actual results or events could differ materially from the plans, intentions and
expectations disclosed in the forward-looking statements we make. We have included important factors in the cautionary statements included
in this Annual Report on Form 20-F, particularly in the section entitled &#8220;Item 3. Key Information - D. Risk Factors,&#8221; which
could cause actual results or events to differ materially from the forward-looking statements that we make. You should not put undue reliance
on any forward-looking statements. Unless we are required to do so under U.S. federal securities laws or other applicable laws, we do
not intend to update or revise any forward-looking statements. Readers are encouraged to consult the Company&#8217;s reports made on Form
6-K, which are periodically filed with or furnished to the SEC.</div>

<div class="BRPFPageFooter">

<div style="line-height: 1.25"><br/> </div>

<div style="line-height: 1.25; text-align: center">ii<br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div> </div>

<div style="text-align: center; line-height: 1.25; font-weight: bold"><span id="PARTI"><!--Anchor--></span>PART I</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold"><span id="ITEM1"><!--Anchor--></span>ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT
AND ADVISERS</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Not applicable.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold"><span id="ITEM2"><!--Anchor--></span>ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Not applicable.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold"><span id="ITEM3"><!--Anchor--></span>ITEM 3. KEY INFORMATION</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z8fa6760abe5d4fa8b95164697ba75dbe" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt; vertical-align: top; font-weight: bold">A.</td>
    <td style="width: auto; vertical-align: top">
        <div style="font-weight: bold">[Reserved]</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="ze8f101784fb045b1ad6f96821048b339" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt; vertical-align: top; font-weight: bold">B.</td>
    <td style="width: auto; vertical-align: top">
        <div style="font-weight: bold">Capitalization and Indebtedness</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Not applicable.</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z93307f98d5c442a9aa6c17e0e9aff353" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt; vertical-align: top; font-weight: bold">C.</td>
    <td style="width: auto; vertical-align: top">
        <div style="font-weight: bold">Reasons for the Offer and Use of Proceeds</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Not applicable.</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zd6e1c665640140df88c7d4f7fc569322" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt; vertical-align: top; font-weight: bold">D.</td>
    <td style="width: auto; vertical-align: top">
        <div style="font-weight: bold">Risk Factors</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25; font-style: italic">Our business faces significant risks. You should carefully consider
all of the information set forth in this Annual Report on Form 20-F and in our other filings with the SEC, including the following risk
factors that we face and that are faced by our industry. Our business, financial condition or results of operations could be materially
and adversely affected by any of these risks. Additional risks and uncertainties not presently known to us or that we currently deem immaterial
also may have similar adverse effects on us. This report also contains forward-looking statements that involve risks and uncertainties.
Our results could materially differ from those anticipated in these forward-looking statements, as a result of certain factors, including
the risks described below and elsewhere in this Annual Report on Form 20-F and our other SEC filings. See &#8220;Forward-Looking Statements&#8221;
above.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Summary Risk Factors</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our business is subject to a number of risks of which you should be aware of before
making an investment decision. These risks are discussed more fully in the &#8220;Risk Factors&#8221; section of this annual report. These
risks include, but are not limited to, the following:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z5aca96f549c54d288798d6f03a86d960" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 38.15pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>our success depends upon market acceptance of our products;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zefa6326310dc480981b26b9b077179ab" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 38.15pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>if there is not sufficient demand for the procedures performed with our products, practitioner demand for our products could decline,
        resulting in unfavorable operating results;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zb6541d0e7b934bd69f330c27e6898b79" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 38.15pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>the success and continued development of our products depends, in part, upon maintaining strong relationships with physicians and
        other healthcare professionals;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z567a5448a220442d896a2b389979ec18" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 38.15pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>the impact of the political, economic and military instability in Israel and the latest Israel-Hamas war could impede our ability
        to operate and develop, manufacture and deliver products and components and harm our financial results;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z8679ff6a05594f0db1052973e820bd41" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 38.15pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>we rely heavily on our sales professionals to market and sell our products worldwide. If we are unable to hire, effectively train,
        manage, improve the productivity of and retain our sales professionals, our business will be harmed, which would impair our future revenue
        and profitability;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="za8e7090134dd491283691ff277e15610" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 38.15pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>the failure to attract and retain key personnel could adversely affect our business;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="ze79dca900f0043c0a3e6c0f353bcdba7" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 38.15pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>our products and operations are subject to extensive and continuing regulatory compliance obligations in the United States and other
        countries, and failure to meet those obligations could adversely harm our business;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>
<!--PROfilePageNumberReset%Num%2%%%-->

<table cellspacing="0" cellpadding="0" id="zaf9040cd21264c7a9e41b37f32208f32" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 38.15pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>if we do not continue to develop and commercialize new products and identify new markets for our products and technologies, we may
        not remain competitive or expand beyond our traditional customer base, and our revenues and operating results could suffer;</div> </td>
        </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z1b7b3d0dfe064d619ff3fa7c3f741575" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 38.15pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>product liability suits could be brought against us due to defective material or design or misuse of our products and could result
        in expensive and time-consuming litigation, payment of substantial damages and an increase in our insurance rates;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z151d7c5bbb22427caac6a977fa0f2f1f" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 38.15pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>we outsource almost all of the manufacturing of our products to a small number of manufacturing subcontractors. If our subcontractors&#8217;
        operations are interrupted or if our orders exceed our subcontractors&#8217; manufacturing capacity, we may not be able to deliver our
        products on time;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z149ee9517d2b44668ece23d3cb35e7ab" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 38.15pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>if we are unable to protect our intellectual property rights, our competitive position could be harmed. Our success and ability to
        compete depends in large part upon our ability to protect our proprietary technology;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z1b9ef99326c34285a01cc0e9baf3c8f7" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 38.15pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>third parties have commenced and may in the future commence litigation against us claiming that our products infringe upon their
        patents or other intellectual property rights;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z736578c498764ceb9a970795734bad80" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 38.15pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>our operating costs and business operations could be adversely affected by climate-related events and increasing regulatory requirements
        and security;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z5badfecb480e415c9cf6ef9b9de97323" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 38.15pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>if we fail to obtain and maintain necessary FDA clearances for our products, if clearances for future products and proposed indications
        are delayed or not issued, if we or any of our third-party suppliers or manufacturers fail to comply with applicable regulatory requirements,
        or if there are regulatory changes, our commercial operations could be harmed; and</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zdb8c526496784c64977f226dd39b165a" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 38.15pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>as a foreign private issuer, we are exempt from a number of rules under the U.S. securities laws and Nasdaq corporate governance
        rules and are permitted to file less information with the SEC than U.S. domestic public companies, which may limit the information available
        to holders of our ordinary shares.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Risks Related to Our Business and Industry</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Our success depends upon market acceptance of our products.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We design, develop, manufacture and commercialize innovative, minimally invasive and
non-invasive surgical/medical products. We have developed products that apply our minimally invasive technology in plastic surgery, dermatology,
gynecology and ophthalmology. We were established in 2008 and have expanded our product offerings to include 12 product platforms: <span style="font-style: italic">BodyTite,
Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke,</span>&#160;<span style="font-style: italic">Morpheus8</span>, <span style="font-style: italic">EmpowerRF</span>,
<span style="font-style: italic">Define</span> and <span style="font-style: italic">Envision.</span> We introduced two additional product
platforms in 2021, the <span style="font-style: italic">EmpowerRF</span> and <span style="font-style: italic">EvolveX, </span>which replaced
our <span style="font-style: italic">Evolve</span> platform. In 2023 we introduced two new platforms, the <span style="font-style: italic">Define</span>
and <span style="font-style: italic">Envision</span>. If we fail to significantly penetrate current or new markets with our products or
fail to properly manage the manufacturing and distribution of multiple products, our business, financial condition and results of operations
could be negatively impacted. The success of our products depends on adoption and acceptance of our technology by user doctors. The rate
of adoption and acceptance may be affected adversely by perceived issues relating to quality and safety, doctors&#8217; reluctance to
invest in new technologies, the cost of competitive treatments and widespread acceptance of other technologies. Our business strategy
is based, in part, on our expectation that we will continue to make novel product introductions and upgrades that we can sell to new and
existing users of our products and that we will be able to identify new markets for our existing technologies.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">To increase our revenues, we must:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z89f66bdbf34b4a1c89c2168264b2883c" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 50.4pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>continue to further penetrate our existing, traditional customer base, including plastic and facial surgeons, aesthetic surgeons,
        dermatologists and obstetricians/gynecologists, or OB/GYNs, and drive recurring revenues by demonstrating to our customers that our products
        or product upgrades would be an attractive revenue-generating addition to their practices;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z5dcb56ffa9384502b8ff09f9effe6bff" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 50.4pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>expand our customer base to include non-traditional customers, such as ear, nose and throat physicians, or ENTs, ophthalmologists,
        general practitioners and aesthetic clinicians;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">2</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<table cellspacing="0" cellpadding="0" id="ze47f27d2d3314bbf96e8aebf3373898c" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 50.4pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>leverage our existing technology to expand into new minimally invasive and non-invasive applications that either add to or significantly
        improve our current products;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z868991f76a304f89bdeeceeed7cff342" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 50.4pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>increase our sales presence to target and expand our market globally;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z3194b4a97cc04b40b78ca17bddd97de7" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 50.4pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>actively pursue business development opportunities, including potential acquisitions and strategic partnerships to augment our product
        and technology portfolio; and</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z2a5848dd289a4a81a17d32e6a10ddace" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 50.4pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>expand and maintain our intellectual property and patent portfolio.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">In addition, the surgical aesthetic solutions market is highly competitive and dynamic
and marked by rapid and substantial technological development and product innovations. Demand for our products could be diminished by
equivalent or superior products and technologies offered by competitors.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">If there is not sufficient demand for the procedures performed with
our products, practitioner demand for our products could decline, resulting in unfavorable operating results.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Continued expansion of the global market for energy-based aesthetic procedures is a
material assumption of our business strategy. Most procedures performed using our products are not reimbursable through government or
private health insurance and are therefore elective procedures, the cost of which must be borne by the patient. The decision to utilize
our products may therefore be influenced by a number of factors, including:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z39f63d16f491407fbd40677fe06061cf" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 50.4pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>consumer disposable income and access to consumer credit;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="ze19d56ec318a4cf8bdb9a24e0608f11b" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 50.4pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>the cost of procedures performed using our products;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z829175a3665d499180ed13773c52f3cf" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 50.4pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>the cost, safety and effectiveness of alternative treatments, including treatments which are not based upon laser or other energy-based
        technologies and treatments which use pharmaceutical products;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z67b546c4867e43339571901d26627280" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 50.4pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>the success of our sales and marketing efforts;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z3a9d37f0586c43ea8175af94da399c2d" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 50.4pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>the education of our customers and patients on the benefits and uses of our products compared to competitors&#8217; products and
        technologies; and</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zd3bda23eea104197848800fe3e33f629" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 50.4pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>consumer confidence, which may be impacted by economic and political conditions.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">If, as a result of these factors, there is not sufficient demand for the procedures
performed with our products, practitioner demand for our products could decline, which could have a material adverse effect on our results
of operations.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">The success and continued development of our products depends, in
part, upon maintaining strong relationships with physicians and other healthcare professionals.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">If we fail to maintain our working relationships with physicians and other ancillary
healthcare professionals, our products may not be developed and marketed in line with the needs and expectations of the professionals
who use and support our products. If we are unable to maintain these strong relationships or form new relationships with physicians and
other healthcare professionals beyond our traditional customer base, the development and marketing of our products could suffer, which
could have a material adverse effect on our business, financial condition and results of operations.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">We rely heavily on our sales professionals to market and sell our
products worldwide. If we are unable to hire, effectively train, manage, improve the productivity of and retain our sales professionals,
our business will be harmed, which would impair our future revenue and profitability.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our success largely depends on our ability to hire, train, manage and improve the productivity
levels of our sales professionals worldwide. We train our existing and recently recruited sales professionals to better understand our
existing and new product technologies and how they can be positioned against our competitors&#8217; products and increase the revenue
of our customers. It may take time for the sales professionals to become productive, and there can be no assurance that recently recruited
sales professionals will be adequately trained in a timely manner, that our direct sales productivity will improve or that we will not
experience significant levels of attrition in the future.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">3</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Product liability suits could be brought against us due to defective
material or design or misuse of our products and could result in expensive and time-consuming litigation, payment of substantial damages
and an increase in our insurance rates.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our systems are inherently complex in design and require ongoing scheduled maintenance.
Our products may malfunction when used by our customers. Additionally, if our products are alleged to be defectively designed, manufactured
or labeled, contain defective components, or are misused, we may become subject to substantial and costly litigation by our customers
or their patients. Misusing our products or failing to adhere to operating guidelines could cause burns, scarring and tissue irregularities.
In addition, if our operating guidelines are found to be inadequate, we may be subject to liability. Furthermore, our products are sold
in jurisdictions that vary as to the specific qualifications or training required for purchasers or operators of the products. There is
a risk that our products may be purchased or operated by physicians with varying levels of training and, in some cases, by practitioners,
such as nurses, chiropractors and technicians, who may not be adequately trained. The purchase and use of our products by non-physicians
or persons who lack adequate training may result in the misuse of our products, which could give rise to adverse treatment outcomes. If
we are unable to prevent product malfunctions or misuse, or if we fail to do so in a timely manner, we could also experience, among other
things, delays in the recognition of revenues or loss of revenues, particularly in the case of new products; legal actions by customers,
patients and other third parties, which could result in substantial judgments against us or settlement costs; action by regulatory bodies;
and diversion of development, engineering and management resources.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Product liability claims could divert management&#8217;s attention from our core business,
be expensive to defend and result in sizable damage awards against us. In addition, such potential adverse effects may cause a significant
increase in the premiums under our insurance policies. Further, the coverage limits of our product liability insurance policies may not
be adequate to cover future claims. A successful claim brought against us in excess of, or outside of, our insurance coverage could have
a material adverse effect on our business, financial condition and results of operations. Even if unsuccessful, such a claim could nevertheless
have an adverse impact on us, due to damage to our reputation and diversion of management resources.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">We may have difficulty managing our growth, which could limit our
ability to increase sales and cash flow.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We have experienced significant growth in our operations, and the number of our employees
has significantly increased since inception. This growth has placed significant demands on our management, as well as our financial and
operational resources. In order to achieve our business objectives, we will need to continue to grow our business. Continued growth would
increase the challenges involved in:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zdb92666202d540c2b1a7cd4445fba8eb" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>implementing appropriate operational and financial systems;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zb5129a5d5d8f43c5af2f9dc02e0c8404" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>expanding our sales and marketing infrastructure and capabilities;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zc5ba70542dcb4eeda6f30b6eca499bca" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>ensuring compliance with applicable Food and Drug Administration, or FDA, and other regulatory requirements;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z31785f64934542efafc465463133559b" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>providing adequate training and supervision to maintain high quality standards; and</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zcda1a7ba7b7c465eb53013ee8577fafd" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>preserving our culture and values.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">If our growth continues, it will require that we continue to develop and improve our
operational, financial and other internal controls. If we cannot scale and manage our business appropriately, we will not realize our
projected growth and our financial results will suffer.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">The failure to attract and retain key personnel could adversely
affect our business.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our success also will depend in large part on our ability to continue to attract, retain
and motivate qualified and highly skilled personnel. Competition for highly skilled employees is intense. We may be unable to continue
to attract and retain sufficient numbers of highly skilled employees. Our inability to attract and retain additional key employees or
the loss of one or more of our current key employees could adversely affect our business, financial condition and results of operations.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">4</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Our financial results may fluctuate from quarter to quarter.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We base our production, inventory and operating expenditure levels on anticipated orders.
If orders are not received when expected in any given quarter, expenditure levels could be disproportionately high in relation to sales
for that quarter. A number of additional factors, over which we have limited control, may contribute to fluctuations in our financial
results, including:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z63d19b8cce7c4d68b483d880e025d407" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>customer adoption of our products;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z623b3ff4d3da438bbc6169d6e4093e02" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>the willingness of individuals to pay directly for aesthetic medical procedures in light of the lack of reimbursement by third-party
        payors;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zb2a5c2c180f44c44b45f02248dfbe7e4" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>continued availability of attractive equipment leasing terms for our customers, which may be negatively influenced by interest rate
        increases;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z2240aeb0ea8b4971a828967077ee56e3" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>the impact of the political, economic and military instability in Israel and the latest Israel-Hamas war;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="ze7d2c50151a44ac781078cb0f0d05b64" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>changes in our ability to obtain and maintain regulatory approvals and maintain compliance with applicable regulatory requirements;</div>
        </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z8356c6c0f48246fda1297a8a2718ef1b" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>actual or perceived breaches of, or failures relating to, privacy, data protection or data security;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zf6674e8524b9414ca728963f14fd77b1" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>positive or negative coverage in the media or clinical publications of our products or products of our competitors or industry;</div>
        </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z9951a5122f184293a2c88e12e07126f1" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>increases in the length of our sales cycle;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z62821548f69a4ace8bec817836c2b48f" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>performance of our independent distributors;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zec704b1746534d8d97608a96fd3f0ab8" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>delays in, or failure of, product and component deliveries by our subcontractors and suppliers;&#8226;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z94fbe5e08b364a7db25a336eb4f51b9e" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>the impact on our operating costs and business operations by climate-related events and increasing regulatory requirements and security;
        and</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z186aa8412f1a44a6bb0231f135fc96a9" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>the impact of global health crises on our business and general economic conditions.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">We rely on a limited number of suppliers, contract manufacturers,
and logistics partners for our products. A loss of any of these partners or delays at transition points such as harbors, straights, and
ports could negatively affect our business.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We rely on a limited number of contract manufacturers, suppliers and logistics providers
to manufacture and transport our products. Our reliance on a limited number of contract manufacturers for our products increases our risks,
since we do not currently have alternative or replacement contract manufacturers beyond these key parties. In the event of interruption
from any of our contract manufacturers or suppliers, we may not be able to increase capacity from other sources or develop alternate or
secondary sources without incurring material additional costs and substantial delays. Furthermore, our primary facilities are located
in Israel. Thus, our business could be affected if one or more of our suppliers, manufacturers or logistics partners are impacted by a
natural disaster, an epidemic, revived hostilities in Israel, the latest Israel-Hamas war, or other interruption at a particular location.
Interruptions in the development, manufacturing, and shipment of our products, could adversely impact our revenue, gross margins, and
operating results. Such interruptions may be due to, among other things, temporary closures of the facilities our contract manufacturers,
and other vendors in our&#160;supply&#160;chain; restrictions or delays on transport or the import/export of goods and services from certain
ports and harbors that we and our logistics partners use; and local quarantines or work stoppages.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">5</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Competition among providers of energy-based devices for the medical
aesthetics market is characterized by rapid innovation. If we do not continue to develop and commercialize new products and identify new
markets for our products and technologies and expand beyond our traditional customer base, we may not remain competitive, and our revenues
and operating results could suffer.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The industry in which we operate is subject to continuous technological development
and product innovation. If we do not continue to be innovative in the development of new products and applications, our competitive position
will likely deteriorate as other companies successfully design and commercialize new products and applications. While we attempt to protect
our products through patents and other intellectual property, there are few barriers to entry that would prevent new entrants or existing
competitors from developing products that compete directly with ours. We expect that any competitive advantage we may enjoy from our current
and future innovations may diminish over time, as companies successfully respond to our, or create their own, innovations. Accordingly,
our success depends in part on developing new and innovative applications of laser and other energy-based technology and identifying new
markets for and applications of existing products to new customers and technology. Our future growth also depends, in part, on our ability
to expand beyond our traditional customer base to ENTs, ophthalmologists, general practitioners and aesthetic clinicians. If we are unable
to develop and commercialize new products and identify and penetrate new markets for our products and technology, our products and technology
could become obsolete and our revenues and operating results could be adversely affected.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Our long-term growth depends on our ability to enhance our products,
expand our indications, and develop and commercialize additional products.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">It is important to our business that we continue to enhance our products and develop
and introduce new products. Developing products is expensive and time-consuming. The success of any new product offering or product enhancement
to our current products will depend on several factors, including our ability to:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z10b69cb6898a4aa192a047fbabdcbc4c" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>properly identify and anticipate physician and patient needs;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z497d975fcf214db9a411209b17869cf0" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>develop and introduce new products and product enhancements in a timely manner;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zc7bc868ee4e14359b8805203001fdca0" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>avoid infringing upon the intellectual property rights of third parties;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z0775131d8c8949718a0de5fac94af61e" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>demonstrate, if required, the safety and efficacy of new products with data from preclinical studies and clinical trials;</div> </td>
        </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="za35ef20ac63548bb8fcf570b9799507a" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>obtain the necessary regulatory clearances or approvals for expanded indications, new products or product modifications; and</div>
        </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z16aa7a84f5b141ff8aeda75e9a12f6ea" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>be fully FDA-compliant with marketing of new devices or modified products.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">If we are not successful in expanding our indications and developing and commercializing
new products and product enhancements, our ability to increase our revenue may be impaired, which could have a material adverse effect
on our business, financial condition and results of operations.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Our inability to compete effectively with our competitors may prevent
us from achieving significant market penetration or improving our operating results.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our products compete against products offered by public companies, including Allergan
plc, Cutera, Inc., Apyx Medical Corporation, Venus Concept Inc., Sisram Medical Ltd and Viveve Medical, Inc., as well as by private companies,
such as Cynosure LLC, Lumenis Ltd., BTL Aesthetics, Inc. and Candela Medical Inc. Competition with these companies could result in reduced
prices and profit margins and loss of market share, any of which could harm our business, financial condition and results of operations.
We also face competition from medical aesthetic products, including Botox, hyaluronic acid injections and collagen injections, and aesthetic
procedures, such as face lifts, liposuction, sclerotherapy, electrolysis, chemical peels and laser procedures, which may offer a broader
range of medical and non-medical products and technologies that are more readily available to customers at a lower cost. Our ability to
compete effectively depends upon our ability to distinguish the Company and our products from our competitors and their products and includes
the following factors:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z1e665cfa7baf4eb3b9d4e03fe0360f63" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>product performance;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zf66629e8fa8f46d9a4124c591f2fb695" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>product pricing;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z356e40f40a614e018f96cd07545a99ab" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>product safety;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z8c1f7f6395d34dbf99d4d5e6216fb8fc" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>intellectual property protection;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z671282214d8346d18a0934659a03a975" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>quality of customer support;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z59190352f2a34969860f62b38010df9a" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>success and timing of new product development and introductions; and</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="ze300173cc1cf4564a30ad00c95db6849" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>development of successful distribution channels.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">6</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25">Furthermore, potential customers also may need to recoup the cost of expensive products
that they already have purchased from our competitors and may decide not to purchase our products or to delay such purchases. If we are
unable to achieve continued market penetration, we will be unable to compete effectively, and our business will be harmed.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">The introduction of disruptive technological breakthroughs, whether
pharmaceutical or other newer therapeutic solutions, may present an additional threat to our success in our target markets.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The medical technology industry is intensely competitive. Pharmaceutical alternative
treatments compete vigorously with traditional laser and other energy-based procedures, such as those carried out with our products. Some
pharmaceutical companies, academic and research institutions or others may develop new, non-invasive or minimally invasive therapies that
are more effective, more convenient or less expensive than our current or future products. The introduction of new technologies, along
with these potential new therapies, could result in increased competition or make our products obsolete. Moreover, we could expand our
business to include new, non-invasive or minimally invasive therapies which may compete with our current product offerings. We may not
be able to respond effectively to technological changes and emerging industry standards or to successfully identify, develop or support
new technologies or enhancements to existing products in a timely and cost-effective manner. Any such developments could have a material
adverse effect on our business, financial condition and results of operations.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Our markets are characterized by evolving technological standards
and changes in customer requirements, and we may not be able to react to such changes and introduce new products in a timely manner.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The aesthetics market is characterized by extensive research and development, technological
change, frequent modifications and enhancements, innovations, new applications, evolving industry standards, and changes in customer requirements.
Our future growth depends, in part, on our ability to introduce new products on a timely basis, as well as to introduce other product
enhancements that address the evolving customer needs. This requires us to design, develop, manufacture, assemble, test, market and support
these new products or product enhancements on a timely and cost-effective basis. It also requires continued substantial investment in
research and development.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">During each stage of the research and development process, we may encounter obstacles
that could delay development and consequently increase our expenses. This may ultimately force us to abandon a potential product in which
we have already invested substantial time and resources. Technologies in development could prove to be more complex than initially understood
or not scientifically or commercially viable. Even if we develop new products and technologies ahead of our competitors, we will still
need to obtain the requisite regulatory approvals for such products, including from public agencies, such as the FDA, before we can commercially
distribute them. We cannot assure you that we will successfully identify new technological opportunities, develop and bring new or enhanced
products to market, obtain sufficient patent or other intellectual property protection for such new or enhanced products, or obtain the
necessary regulatory approvals in a timely and cost-effective manner, or, if such products are introduced, that those products will achieve
market acceptance. Our failure to do so, or to address the technological changes and challenges in our markets, could have a material
adverse effect on our business, financial condition and results of operations.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">We rely on our own direct sales force to sell our products in certain
territories, which may result in higher fixed costs than our competitors and may slow our ability to reduce costs in the face of a sudden
decline in demand for our products.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We rely on our own direct sales force to market and sell our products in certain territories.
Some of our competitors rely predominantly on independent sales agents and third-party distributors. A direct sales force may subject
us to higher fixed costs than those of companies that market competing products through independent third parties, due to the costs that
we will bear associated with employee benefits, and training and managing sales personnel. As a result, we could be at a competitive disadvantage.
Additionally, these fixed costs may slow our ability to reduce costs in the face of a sudden decline in demand for our products, which
could have a material adverse effect on our business, financial condition and results of operations.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">To successfully market and sell our products internationally, we
must address many issues with which we have little or no experience.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">International (non-U.S.) sales accounted for approximately 37% of our total revenue
for the year ended December 31, 2023. We believe that an increasing percentage of our future revenue will come from international sales
as we continue to expand our operations and develop opportunities in additional international territories. We currently depend on third-party
distributors and a direct sales team in certain regions to sell our products internationally. If these distributors or direct sales personnel
underperform, we may be unable to increase or maintain our level of international revenue. We will need to attract additional distributors
to grow our business and expand the territories in which we sell our products. Distributors may not commit the necessary resources to
market and sell our products to the level of our expectations. If current or future distributors do not perform adequately, or we are
unable to locate distributors in particular geographic areas, we may not realize expected international revenue growth. Additionally,
we expect to expand our direct sales force in the United States, Canada, Europe and Asia. If we are unable to do so successfully, our
revenue and revenue growth from international operations will be adversely affected.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">7</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25">International sales are subject to a number of risks, including:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z1f92b29ca16f4e55a40862ae3412580c" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>difficulties in staffing and managing our foreign operations;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z35c453eda96643e393fa1b6d76712468" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>difficulties in penetrating markets in which our competitors&#8217; products are more established;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zeda8ebc952d44a4e898fa2c62819c2f5" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>reduced protection for intellectual property rights in some countries;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z94f6bc60fbe8483980e1fd4fe4390105" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>export restrictions, trade regulations and foreign tax laws;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z77c5331bbe1142dcbca133adaee33e6e" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>fluctuating foreign currency exchange rates;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z31ef4469716c469fb256d7f72ed8dbd6" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>obtaining and maintaining foreign certification and compliance with other regulatory requirements;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z2d2ea3fa687a40a291727b2f6c710021" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>customs clearance and shipping delays; and</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z1e59b68e4d604adcb1c7250f99dfa52b" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>political and economic instability.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">If one or more of these risks were realized, it could require us to dedicate significant
resources to remedy the situation, and if we are unsuccessful at finding a solution, our revenue may decline.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">The impact of the latest Israel-Hamas war could impede our ability
to operate and develop, manufacture and deliver products and components and harm our business and financial results.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">In October of 2023, Israel&#8217;s security cabinet declared war against Hamas. The
ongoing and revived hostilities, could prevent or delay shipments of our products, harm our operations and product development and cause
our sales to decrease. In the event that the hostilities disrupt the ongoing operation of our and our Israeli subcontractors' facilities
or the airports and seaports on which we depend to import and export our supplies and products, our operations may be materially adversely
affected. The conflict could cause situations where applicable foreign regulatory bodies, such as the FDA, could not be able to visit
our third-party manufacturing facilities in Israel in order to review, causing delays. The war could also result in parties with whom
we have agreements involving performance in Israel claiming that they are not obligated to perform their commitments under those agreements
pursuant to force majeure provisions in such agreements.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Further, there have been travel advisories imposed as related to travel to Israel, and
restriction on travel, or delays and disruptions as related to imports and exports may be imposed in the future. An inability to receive
supplies and materials, shortages of materials or difficulties in procuring our materials, among others, may adversely impact our ability
to commercialize and manufacture our product candidates and products in a timely manner. This could cause a number of delays and/or issues
for our operations, including delay of the review of our product candidates by regulatory agencies, which in turn would have a material
adverse impact on our ability to commercialize our product candidates. Although the resulting sanctions and any related market disruptions
are impossible to predict, they could be substantial, particularly if current or new sanctions continue for an extended period of time
or if geopolitical tensions result in expanded military operations on a global scale.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">We have limited business in Russia which pose some degree of sanctions
risk that cannot be entirely eliminated.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18.9pt; line-height: 1.25">We have a long-standing distribution contract with a Russian distributer which distributes
our products in the country and other neighboring countries. Given the nature of our products and our end customers in Russia (typically
physicians), our Russia-related business falls within a category of activities with respect to which the sanctions regimes have been historically
more permissive and with respect to which there is a relatively lower incidence of sanctions exposure. Furthermore, we are committed,
and take measures, to ensure compliance with any applicable Sanctions. However, the sanctions against Russia across various key jurisdictions,
including the United States, are extremely dynamic and complex and usually apply on a strict liability basis and sometimes may expose
non US parties to liability or imposition of market restrictions even in the absence of jurisdictional grounds or touchpoints with the
country of the governmental authority imposing the sanctions. Accordingly, in the current environment, Russia-related dealings may entail
some degree of exposure to sanctions risks that cannot be entirely eliminated.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">8</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">We outsource almost all of the manufacturing of our products to
a small number of manufacturing subcontractors. If our subcontractors&#8217; operations are interrupted or if our orders exceed our subcontractors&#8217;
manufacturing capacity, we may not be able to deliver our products on time.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We outsource almost all of the manufacturing of our products to three subcontractors
located in Israel, two of which we are substantially dependent on, while we manufacture our laser and intense pulsed light, or IPL, handpieces
in-house in Israel. These subcontractors have limited manufacturing capacity that may be inadequate if our customers place orders for
unexpectedly large quantities of our products. In addition, because our subcontractors are located in Israel, they on occasion may feel
the impact of potential economic or political instability in the region, including the latest Israel-Hamas war. If the operations of one
or more of our subcontractors were halted or limited, even temporarily, or if they were unable or unwilling to fulfill large orders, we
could experience business interruption, increased costs, damage to our reputation and loss of our customers. In addition, finding new
subcontractors that meet our manufacturing requirements, comply with regulatory requirements, and are ISO certified could take several
months.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Components used in our products are complex in design, and defects
may not be discovered prior to shipment to customers, which could result in warranty obligations, reducing our revenue and increasing
our costs.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">In manufacturing our products, we and our subcontractors depend upon third-party suppliers
for various components. Many of these components require a significant degree of technical expertise to produce. If our suppliers fail
to produce components to specification, or if the suppliers, our subcontractors, or we, use defective materials or workmanship in the
manufacturing process, the reliability and performance of our products will be compromised.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">If our products contain defects that cannot be repaired easily and inexpensively, we
may experience:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zbcc287a608fe4cf9946786d20648dff8" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>loss of customer orders and delay in order fulfillment;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z075b09eadee347768d9db305836d82ef" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>damage to our brand reputation;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z1f007be733f8414e907c8190874b42d6" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>increased cost of our warranty program due to product repair or replacement;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="ze0975ffb09e1494d97d57e35dde1263d" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>inability to attract new customers;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z87a4f75c81794240b6762f638e05e1a2" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>diversion of resources from our manufacturing and research and development departments into our service department;&#8201;&#8201;</div>
        </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zb1ccdb66641a4731966b776f17381c51" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>product recalls; and</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z454096cb2c2b413093df91a1680782c6" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>legal action.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The occurrence of any one or more of the foregoing could materially harm our business,
financial condition and results of operations.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">We and our manufacturing subcontractors depend upon third-party
suppliers, making us vulnerable to supply shortages, price fluctuations or other degradations in performance of these suppliers, which
could harm our business and financial condition.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Many of the components that comprise our products are currently manufactured by a limited
number of suppliers. Although each of our components can be obtained from more than one supplier, we do not have the ability to manufacture
the components we outsource. Additionally, our subcontractors rely on a limited number of suppliers, or in some cases, one supplier, for
some of the materials and components used in our products. If our subcontractors were to lose such suppliers, there can be no assurance
that they will be able to identify or enter into agreements with alternative suppliers on a timely basis on acceptable terms, if at all,
which could cause interruptions in their operations. If any of these third-party suppliers fails to adequately perform, our revenue and
profitability could be adversely affected. A supply interruption or an increase in demand beyond current suppliers&#8217; capabilities
could harm our ability to manufacture our products until we identify and qualify a new source of supply, which could take several months.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">There is a risk that our suppliers will not always act consistent with our best interests,
and may not always supply goods that meet our requirements. Any interruption in the supply of components or materials, or our inability
to obtain substitute components or materials from alternate sources at acceptable prices in a timely manner, could impair our ability
to meet the demand of our customers, which would have an adverse effect on our business, financial condition and results of operations.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">9</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25">Transitioning to a new supplier could be time-consuming and expensive, may result in
interruptions in our operations and product delivery, could affect the performance specifications of our products or could require that
we modify the design of certain product systems. If a change in manufacturer results in a significant change to any product, a new 510(k)
clearance from the FDA or similar international regulatory authorization may be necessary before we implement the change, which could
cause substantial delays.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Disruptions or interruptions to our suppliers could occur for many reasons, including
fire, floods, hurricanes, typhoons, droughts, tsunamis, volcanoes, earthquakes, disease or other similar natural disasters, unplanned
maintenance or other manufacturing problems, labor shortages, power outages or shortages, telecommunications failures, strikes, transportation
interruption, government regulation, economic or political instability, terrorism or other extraordinary events, including epidemics and
related travel restrictions. Such disruptions may continue over a sustained period and could cause direct injury or damage to our supplier&#8217;s
employees and property with significant indirect consequences to us. Alternative facilities with sufficient capacity or capabilities may
not be available, may cost substantially more or may take a significant time to start manufacturing, each of which could negatively affect
our ability to fill customer orders and our business and financial performance.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">There exists potential for misuse of our products, over which we
have very little to no control, which could harm our reputation and our business.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">In the United States, federal regulations allow us to sell our products to or on the
order of &#8220;licensed practitioners&#8221;. The definition of &#8220;licensed practitioners&#8221; varies from state to state. As a
result, depending on state law, our products may be purchased or operated by physicians or other licensed practitioners, including nurse
practitioners, chiropractors and technicians. Outside the United States, many jurisdictions do not require specific qualifications or
training for purchasers or operators of our products. Although we offer training on the use of our products, we do not supervise the treatments
performed. Purchase and use of our products by non-physicians may result in product misuse. The potential misuse of our products by physicians
and non-physicians may result in adverse treatment outcomes, which could harm our reputation and expose us to costly product liability
litigation.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Our products include a limited time warranty which could result
in substantial additional costs to us should we fail to monitor product quality effectively.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We generally provide a 12-month warranty on our products. After the warranty period,
maintenance and support is provided on a service contract basis. If our products malfunction, warranty claims may become significant,
which could cause a significant drain on our resources and materially adversely affect our results of operations.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">We forecast sales to determine requirements for our products and
if our forecasts are incorrect, we may experience either shipment delays or increased costs.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our subcontractors keep limited materials and components on hand. To help them manage
their manufacturing operations and minimize inventory costs, we forecast anticipated product orders to predict our inventory needs up
to six months in advance and enter into purchase orders on the basis of these forecasts. If our business expands, our demand would increase
and our suppliers may be unable to meet our demand. If we overestimate our requirements, our subcontractors will have excess inventory,
and may transfer to us any increase in costs. If we underestimate our requirements, our subcontractors may have inadequate components
and materials inventory, which could interrupt, delay or prevent delivery of our products to our customers. Any of these occurrences would
negatively affect our financial performance and the level of satisfaction our customers have with our business.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Under applicable employment laws, we may not be able to enforce
covenants not to compete and therefore may be unable to prevent our competitors from benefiting from the expertise of some of our former
employees.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We generally enter into non-competition agreements with our professional employees,
in most cases within the framework of their employment agreements. These agreements prohibit our employees, if they cease working for
us, from competing directly with us or working for our competitors for a limited period. Under applicable employment laws, we may be unable
to enforce these agreements, in whole or in part, and it may be difficult for us to restrict our competitors from gaining the expertise
our former employees gained while working for us. For example, Israeli courts have required employers seeking to enforce non-compete undertakings
of a former employee to demonstrate that the competitive activities of the former employee will harm one of a limited number of material
interests of the employer which have been recognized by the courts, such as the secrecy of a company&#8217;s confidential commercial information
or its intellectual property. If we cannot demonstrate that harm would be caused to us, we may be unable to prevent our competitors from
benefiting from the expertise of our former employees, which could materially adversely affect our business, results of operations and
ability to capitalize on our proprietary information.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">10</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">The expense and potential unavailability of insurance coverage for
our customers and the Company could adversely affect our ability to sell our products and our financial condition.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Some of our customers and prospective customers are required to maintain liability insurance
to cover their operations and use of our products. Medical malpractice carriers are withdrawing coverage in certain states or substantially
increasing premiums. If this trend continues or worsens, our customers may discontinue using our products and, industry-wide, potential
customers may opt against purchasing light, laser or radio frequency-based products due to the cost or inability to procure insurance
coverage.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Outbreaks of contagious disease or similar public health threats
could materially and adversely affect our business, financial condition and results of operations.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Outbreaks of contagious disease or other adverse public health developments worldwide
could have a material adverse effect on our business, financial condition and results of operations. Outbreaks of contagious disease or
other adverse public health developments could affect our business in a number of ways, including but not limited to</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zc330101341894af2966abdf7d4f66559" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>Disruptions or restrictions on our employees&#8217; ability to work effectively due to illness.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="za20281bfeb8f434284600995d1018fce" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>Temporary closures or disruptions at our facilities or the facilities of our customers or suppliers could reduce demand for our products
        or affect our ability to timely meet our customer&#8217;s orders and negatively impact our supply chain.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zd3fb9590a6d6437f8dc820c0e595d068" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>Outbreaks of contagious disease could cause delays or disruptions in our supply chain</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="ze9640ecbb9a443ae803fe43503348c88" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>The failure of third parties on which we rely to meet their respective obligations to us, or significant disruptions in their ability
        to do so, which may be caused by their own financial or operational difficulties, could have an adverse impact on our business, financial
        condition or results of operations.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zf767773709da4f499beb325ef4e1ee55" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>The impact of contagious disease or other adverse public health developments could also exacerbate other risks discussed elsewhere
        in this section of this report, any of which could have a material adverse effect on us.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Global economic and social conditions may adversely affect our business,
financial condition and results of operations.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Any negative conditions in the national and global economic environments may adversely
affect our business, financial condition and results of operations. Recently, such negative conditions materialized in the ongoing war
in Ukraine and the rising interest rates worldwide. During uncertain economic times and in tight credit markets, many of our customers
may experience financial difficulties or be unable or unwilling to borrow money to fund their operations, including obtaining credit lines
for purchasing our products, and may delay or reduce purchases or reduce the extent of their operations. The market for aesthetic procedures
and the market for our premium products can be particularly vulnerable to economic uncertainty, since the end-users of our products may
decrease the demand for our products when they have less discretionary income or determine not to spend their discretionary income on
aesthetic procedures. In addition, in many instances, the ability of our customers to purchase our products depends in part upon the availability
of obtaining financing at acceptable interest rates.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">These factors could result in reductions in revenues from sales of our products, longer
sales cycles, difficulties in collection of accounts receivable, slower adoption of new technologies and increased price competition.
Payment by our customers of our receivables is dependent upon the financial stability of the economies of certain countries. In light
of the current economic state of many countries outside of the United States, we continue to monitor the creditworthiness of our customers
because weakness in the end-user market could negatively affect the cash flows of our customers who could, in turn, delay paying their
obligations to us. This would increase our credit risk exposure and cause delays in our recognition of revenues on current and future
sales to these customers.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">11</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Exchange rate fluctuations may decrease our earnings if we are not
able to hedge our currency exchange risks successfully.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">A majority of our revenues and a substantial portion of our expenses are denominated
in U.S. dollars. However, a portion of our revenues and a portion of our costs, including personnel and some marketing and facilities
expenses, are incurred in NIS, Canadian dollars and Euros. Inflation in Israel or Europe may have the effect of increasing the U.S. dollar
cost of our operations in that country. If the U.S. dollar declines in value in relation to one or more of these currencies, it will become
more expensive for us to fund our operations in the countries that use those other currencies. To date, we have not found it necessary
to hedge the risks associated with fluctuations in currency exchange rates. In the future, if we do not successfully engage in hedging
transactions, our results of operations may be subject to losses from fluctuations in foreign currency exchange rates.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Cyber-attacks as well as improper disclosure or control of personal
information could result in liability and harm our reputation, which could adversely affect our business and results of operations. We
may face liability if we breach our obligations related to the protection, security, nondisclosure of confidential customer information
or disclosure of sensitive data or fail or are perceived to fail to comply with applicable data protection laws and regulations, or consumer
protection laws, regulations and standards.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our business is heavily dependent on the security of our IT networks. Internal or external
attacks on any of those could disrupt the normal operations of our engagements and impede our ability to provide services to our customers,
thereby subjecting us to liability under our contracts. Additionally, our business involves the use, storage and transmission of information
about our employees, our customers and clients of our customers. Attacks upon information technology systems are increasing in their frequency,
levels of persistence, sophistication and intensity, and are being conducted by sophisticated and organized groups and individuals with
a wide range of motives and expertise. Furthermore, because the techniques used to obtain unauthorized access to, or to sabotage, systems
change frequently and often are not recognized until launched against a target, we may be unable to anticipate these techniques or implement
adequate preventative measures. We may also experience security breaches that may remain undetected for an extended period. While we take
measures to protect the security of, and unauthorized access to, our systems, as well as the privacy of personal and proprietary information,
it is possible that our security controls of our systems, as well as other security practices we follow or those systems of our customers
which we rely upon, may not prevent the improper access to or disclosure of personally identifiable or proprietary information. Such disclosure
could harm our reputation and subject us to liability under our contracts and laws that protect personal data, resulting in increased
costs or loss of revenue.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Further, the global data protection landscape is rapidly evolving, and we are or may
become subject to numerous state, federal and foreign laws, requirements and regulations governing the collection, use, disclosure, retention,
and security of personal data, such as information that we may collect about individuals in the U.S. and abroad. Implementation standards
and enforcement practices are likely to remain uncertain for the foreseeable future, and we cannot yet determine the impact future laws,
regulations, standards, or perception of their requirements may have on our business. This evolution may create uncertainty in our business,
affect our ability to operate in certain jurisdictions or to collect, store, transfer use and share personal information, necessitate
the acceptance of more onerous obligations in our contracts, result in liability or impose additional costs on us. The cost of compliance
with these laws, regulations and standards is high and is likely to increase in the future. Any failure or perceived failure by us to
comply with federal, state or foreign laws or regulation, our internal policies and procedures or our contracts governing our processing
of personal information could result in negative publicity, government investigations and enforcement actions, claims by third parties
and damage to our reputation, any of which could have a material adverse effect on our operations, financial performance and business.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">As our operations and business grow, we may become subject to or affected by new or
additional data protection laws and regulations and face increased scrutiny or attention from regulatory authorities. We are subject to
U.S. federal and state laws regarding data privacy and security including Section 5 of the Federal Trade Commission Act, or FTC Act, the
California Consumer Privacy Act, or the CCPA and the California Privacy Rights Act, or the CPRA. Further, the Health Insurance Portability
and Accountability Act of 1996, as amended, and regulations implemented thereunder, or HIPAA, imposes, among other things, certain standards
relating to the privacy, security, transmission and breach reporting of individually identifiable health information. Even when HIPAA
does not apply, according to the FTC, failing to take appropriate steps to keep consumers&#8217; personal information secure may constitute
unfair acts or practices in or affecting commerce in violation of the Federal Trade Commission Act. The FTC expects a company&#8217;s
data security measures to be reasonable and appropriate in light of the sensitivity and volume of consumer information it holds, the size
and complexity of its business, and the cost of available tools to improve security and reduce vulnerabilities. Federal and state consumer
protection laws are increasingly being applied by the FTC, and states&#8217; attorneys general to regulate the collection, use, storage
and disclosure of personal or personally identifiable information, through websites or otherwise, and to regulate the presentation of
website content.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">12</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25">Certain states have also adopted comparable privacy and security laws and regulations,
some of which may be more stringent than HIPAA. In addition, the CCPA went into effect on January 1, 2020. The CCPA creates individual
privacy rights for California consumers and increases the privacy and security obligations of entities handling certain personal information.
The CCPA provides for civil penalties for violations, as well as a private right of action for data breaches that is expected to increase
data breach litigation. The CCPA may increase our compliance costs and potential liability, and many similar laws have been proposed at
the federal level and in other states. Further, the CPRA, recently passed in California. The CPRA will impose additional data protection
obligations on covered businesses, including additional consumer rights processes, limitations on data uses, new audit requirements for
higher risk data, and opt outs for certain uses of sensitive data. It will also create a new California data protection agency authorized
to issue substantive regulations and could result in increased privacy and information security enforcement. The majority of the provisions
will go into effect on January 1, 2023, and additional compliance investment and potential business process changes may be required. In
the event that we are subject to or affected by HIPAA, the CCPA, the CPRA or other domestic privacy and data protection laws, any liability
from failure to comply with the requirements of these laws could adversely affect our financial condition.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We are also subject to foreign data privacy and security laws, including the Israeli
Protection of Privacy Law of 1981 and the Privacy Protection Regulations (Data Security) 5777-2017 and the General Data Protection Regulation,
or GDPR. The GDPR went into effect in May 2018 and imposes strict requirements for processing the personal data of individuals within
the European Economic Area, or the EEA. Companies that must comply with the GDPR face increased compliance obligations and risk, including
more robust regulatory enforcement of data protection requirements and significant penalties for non-compliance, including potential fines
for noncompliance of up to &#8364;20 million or 4% of the annual global revenues of the noncompliant company, whichever is greater. Since
January 1, 2021, we have been subject to the GDPR and also the United Kingdom GDPR, which, together with the amended United Kingdom Data
Protection Act 2018, retains the GDPR in UK national law. The UK GDPR mirrors the fines under the GDPR, e.g., fines up to the greater
of &#8364;20 million (&#163;17.5 million) or 4% of global turnover. The relationship between the United Kingdom and the European Union
in relation to certain aspects of data protection law remains unclear, and it is unclear how United Kingdom data protection laws and regulations
will develop in the medium to longer term, and how data transfers to and from the United Kingdom will be regulated in the long term. It
is not clear whether (and when) an adequate decision may be granted by the European Commission enabling data transfers from European Union
member states to the United Kingdom long term without additional measures. These changes will lead to additional costs and increase our
overall risk exposure.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Legal developments in Europe have created complexity and uncertainty regarding transfers
of personal data from the EEA and the United Kingdom to the United States. On July 16, 2020, the Court of Justice of the European Union,
or the CJEU, invalidated the EU-US Privacy Shield Framework, or the Privacy Shield, under which personal data could be transferred from
the EEA to US entities who had self-certified under the Privacy Shield scheme. While the CJEU upheld the adequacy of the standard contractual
clauses (a standard form of contract approved by the European Commission as an adequate personal data transfer mechanism, and potential
alternative to the Privacy Shield), it made clear that reliance on them alone may not necessarily be sufficient in all circumstances.
Use of the standard contractual clauses must now be assessed on a case-by-case basis taking into account the legal regime applicable in
the destination country, in particular applicable surveillance laws and rights of individuals and additional measures and/or contractual
provisions may need to be put in place, however, the nature of these additional measures is currently uncertain. The CJEU went on to state
that if a competent supervisory authority believes that the standard contractual clauses cannot be complied with in the destination country
and the required level of protection cannot be secured by other means, such supervisory authority is under an obligation to suspend or
prohibit that transfer.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">These recent developments may require us to review and amend the legal mechanisms by
which we make and/or receive personal data transfers to/in the United States.&#160; As supervisory authorities issue further guidance
on personal data export mechanisms, including circumstances where the standard contractual clauses cannot be used, and/or start taking
enforcement action, we could suffer additional costs, complaints and/or regulatory investigations or fines, and/or if we are otherwise
unable to transfer personal data between and among countries and regions in which we operate, it could affect the manner in which we provide
our services, the geographical location or segregation of our relevant systems and operations, and could adversely affect our financial
results.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our failure to adhere to or successfully implement processes in response to changing
regulatory requirements in this area could result in legal liability or impairment to our reputation in the marketplace, which could have
a material adverse effect on our business, financial condition and results of operations.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">13</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25">In the course of providing services to our customers, we may have access to confidential
customer information, including nonpublic personal data. We are bound by certain agreements to use and disclose this information in a
manner consistent with the privacy standards under regulations applicable to our customers and are subject to numerous U.S. and foreign
jurisdiction laws and regulations designed to protect this information, such as the GDPR and various U.S. federal and state laws governing
the protection of health or other individually identifiable information. If any person, including a team member of ours, misappropriates
customer confidential information, or if customer confidential information is inappropriately disclosed due to a security breach of our
computer systems, system failures or otherwise, we may have substantial liabilities to our customers or our customers&#8217; clients and
may incur substantial liability and penalties in connection with any violation of applicable privacy laws and/or criminal prosecution.
In addition, in the event of any breach or alleged breach of our confidentiality agreements with our customers, these customers may terminate
their engagements with us or sue us for breach of contract, resulting in the associated loss of revenue and increased costs and damaged
reputation. We may also be subject to civil or criminal liability if we are deemed to have violated applicable regulations. We cannot
assure you that we will adequately address the risks created by the regulations to which we may be contractually obligated to abide.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Although we work to comply with applicable laws, regulations and standards, our contractual
obligations and other legal obligations, these requirements are evolving and may be modified, interpreted and applied in an inconsistent
manner from one jurisdiction to another, and may conflict with one another or other legal obligations with which we must comply. Any failure
or perceived failure by us or our employees, representatives, contractors, consultants, collaborators, or other third parties to comply
with such requirements or adequately address privacy and security concerns, even if unfounded, could result in additional cost and liability
to us, damage our reputation, and adversely affect our business and results of operations.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">We may become subject to numerous foreign, federal, and state healthcare
statutes and regulations and our failure to comply could result in a material adverse effect to our business and operations.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Although none of our products or procedures using our products are currently covered
by any state or federal government healthcare programs, or any private commercial payor, we may become subject to foreign, federal, and
state laws intended to prevent healthcare fraud and abuse, including those that apply to all payors. These laws could include state anti-kickback
and false claims laws, which may extend to services reimbursable by any payor, as well as state consumer protection laws. Although we
currently are not subject to transparency laws, we may become subject to such laws in the future. Such laws could include requirements
to disclose payments to certain healthcare professionals and healthcare entities or disclosures related to sales and marketing, or that
could require healthcare professionals to provide notice to their patients of ownership or financial arrangements with manufacturers.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Efforts to ensure that our internal operations and business arrangements with third
parties comply with future applicable healthcare laws and regulations may involve substantial costs. These laws and regulations, among
other things, could constrain our business, marketing and other promotional activities by limiting the kinds of financial arrangements,
including financing programs, we may have with physicians or other potential purchasers of our products. It is possible that governmental
authorities may conclude that our business practices, including our arrangements with physicians, some of whom received stock options
as compensation for services provided, as well as fees for marketing to other physicians, are subject to and do not comply with current
or future statutes, regulations, agency guidance or case law involving applicable healthcare laws. If our current or future operations
are found to be in violation of any of these laws or any other governmental regulations that may apply to us, we may be subject to significant
civil, criminal and administrative penalties which could adversely affect our ability to operate our business and pursue our strategy.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">We are subject to anti-bribery, and corruption and anti-money laundering
laws, including the U.S. Foreign Corrupt Practices Act, as well as export control laws, customs laws, sanctions laws and other laws governing
our operations. If we fail to comply with these laws, we could be subject to civil or criminal penalties, other remedial measures and
legal expenses, which could adversely affect our business, results of operations and financial condition.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">As we continue to grow our international presence and global operations, we will be
increasingly exposed to trade and economic sanctions and other restrictions imposed by the United States, the European Union, the State
of Israel and other governments and organizations. The U.S. Departments of Justice, Commerce, State and Treasury and other federal agencies
and authorities have a broad range of civil and criminal penalties they may seek to impose against corporations and individuals for violations
of economic sanctions laws, export control laws, the U.S. Foreign Corrupt Practices Act, or the FCPA, and other federal statutes and regulations,
including those established by the Office of Foreign Assets Control, or OFAC. In addition, the U.K. Bribery Act of 2010, or the Bribery
Act, prohibits both domestic and international bribery, as well as bribery across both private and public sectors. An organization that
&#8220;fails to prevent bribery&#8221; by anyone associated with the organization can be charged under the Bribery Act unless the organization
can establish the defense of having implemented &#8220;adequate procedures&#8221; to prevent bribery. Under these laws and regulations,
as well as other anti-corruption laws, anti-money laundering laws, export control laws, customs laws, sanctions laws and other laws governing
our operations, various government agencies may require export licenses, may seek to impose modifications to business practices, including
cessation of business activities in sanctioned countries or with sanctioned persons or entities and modifications to compliance programs,
which may increase compliance costs, and may subject us to fines, penalties and other sanctions. A violation of these laws or regulations
would negatively affect our business, financial condition and results of operations.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">14</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25">We have implemented policies and procedures designed to ensure compliance by us and
our directors, officers, employees, representatives, consultants and agents with the FCPA, OFAC restrictions, the Bribery Act and other
export control, anti-corruption, anti-money-laundering and anti-terrorism laws and regulations. We cannot assure you, however, that our
policies and procedures are or will be sufficient or that directors, officers, employees, representatives, consultants and agents have
not engaged and will not engage in conduct for which we may be held responsible, nor can we assure you that our business partners have
not engaged and will not engage in conduct that could materially affect their ability to perform their contractual obligations to us or
even result in our being held liable for such conduct. Violations of the FCPA, OFAC restrictions, the Bribery Act or other export control,
anti-corruption, anti-money laundering and anti-terrorism laws or regulations may result in severe criminal or civil sanctions, and we
may be subject to other liabilities, which could have a material adverse effect on our business, financial condition and results of operations.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Our operating costs and business operations could be adversely affected
by climate-related events and increasing regulatory requirements and security.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 36pt; line-height: 1.25">The effects of climate change (such as drought, flooding, heat waves, wildfires, increased
storm severity, and sea level rise, etc.) could affect our ability to continue our operations and cause delays in our product development,
manufacturing and shipment, all of which could cause reputational harm or otherwise have an adverse effect on our business and operating
results. In addition, the impacts of climate change on the global economy and our industry are rapidly evolving. Changing market dynamics,
global policy developments and the increasing frequency and impact of extreme weather events on critical infrastructure across different
countries could have the potential to disrupt our business, the business of our third-party suppliers and the business of our customers,
and may cause us to experience higher attrition, losses and additional costs to maintain or resume operations. We also expect to face
increasing regulatory requirements and regulatory scrutiny related to climate matters, resulting in higher associated compliance costs.
Failure to uphold, meet or make timely forward progress against our public commitments and goals related to climate action could adversely
affect our reputation with suppliers and customers, financial performance or the ability to recruit and retain talent.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Risks Related to Our Intellectual Property</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">If we are unable to protect our intellectual property rights, our
competitive position could be harmed. Our success and ability to compete depends in large part upon our ability to protect our proprietary
technology.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our success and ability to compete depends in large part upon our ability to protect
our proprietary technology. We rely primarily upon a combination of patents and trademarks, as well as nondisclosure, confidentiality
and other contractual agreements to protect the intellectual property related to our brands, products and other proprietary technologies.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We generally apply for patents only in those countries where we intend to make, have
made, use, offer for sale, or sell products. To date, we have issued patents in the United States, which we consider to be our main target
market, and one issued patent in South Korea. Most of our revenues for the years ended December 31, 2023, 2022 and 2021 were derived from
the United States where we have patent protection. We do not seek protection in all countries where we sell products and we may not accurately
predict all the countries where patent protection would ultimately be desirable. At this time, the countries in which we have not sought
patent protection, but intend to offer our products for sale, are not our main target markets. We acknowledge that competitors may use
our technologies in jurisdictions where we have not obtained patent protection to develop their own products and, further, may export
otherwise infringing products to territories in which we do not have patent protection. Such activity may prevent us from protecting our
proprietary technology, and thus, may harm our competitive position.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">15</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25">Our patent portfolio consists of 10 issued U.S. patents, one issued Korean patent and
seven pending patent applications in the United States relating to our technology and products. Out of those applications, one was filed
also under The Patent Cooperation Treaty and one in Europe. Our pending and future patent applications may not issue as patents or, even
if issued, may not issue in a form that will be advantageous to us. Any issued patents may be challenged, invalidated or legally circumvented
by third parties. We cannot be certain that our patents will be upheld as valid, proven enforceable or prevent the development of competitive
products. Other companies may also design around technologies we have patented. Third parties may have blocking patents that could prevent
us from marketing our products or practicing our own patented technology. In addition, competitors could purchase one of our products
and attempt to replicate some or all of the competitive advantages we derive from our development efforts, design around our protected
technology, or develop their own competitive technologies that fall outside of our intellectual property rights. If our intellectual property
is not adequately protected against competitors&#8217; products and methods, our competitive position could be adversely affected, as
could our business and financial results.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The U.S. Supreme Court and the U.S. Court of Appeals for the Federal Circuit have made,
and will likely continue to make, changes in how the patent laws of the United States are interpreted. Similarly, foreign courts have
made, and will likely continue to make, changes in how the patent laws in their respective jurisdictions are interpreted. We cannot predict
future changes in the interpretation of patent laws or changes to patent laws that might be enacted into law by U.S. and foreign legislative
bodies.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We rely on a combination of patent and other intellectual property laws and confidentiality,
non-disclosure and assignment of inventions agreements, as appropriate, with our employees and consultants, to protect and otherwise seek
to control access to, and distribution of, our proprietary information. These measures may not be adequate to protect our technology from
unauthorized disclosure, third-party infringement or misappropriation. Parties may breach these agreements, and we may not have adequate
remedies for any breach. Also, the laws of certain countries in which we develop, manufacture or sell our products may not protect our
intellectual property rights to the same extent as the laws of the United States or Israel.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The aesthetics industry is highly competitive and marked by frequent litigation. New
patent applications may be pending or may be filed in the future by third parties covering technology that we currently use or may ultimately
use. Third parties have claimed, and may in the future claim, that our current or future products infringe their patent or other intellectual
property rights and may seek to prevent, limit or interfere with our ability to make, use, sell or import our products. Moreover, if such
a claim were to be decided adversely to us or if we settled such a claim on adverse terms, we could be forced to pay substantial damages,
to license the technology in question at high rates or to redesign or modify our products so as to avoid any infringement. Any of those
results could adversely affect our sales, margins and results of operations.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">If it appears necessary or desirable, we may try to obtain licenses for those patents
or intellectual property rights that we are allegedly infringing, may infringe, or desire to use. Although holders of these types of intellectual
property rights commonly offer these licenses, we cannot assure you that licenses will be offered or that the terms of any offered licenses
will be acceptable to us. Our failure to obtain a license for key intellectual property rights from a third party for technology used
by us could cause us to incur substantial liabilities and to suspend the manufacturing and selling of products utilizing the technology.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Alternatively, we could be required to expend significant resources to develop non-infringing
technology. We cannot assure you that we would be successful in developing non-infringing technology.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Third parties have and may in the future commence litigation against
us claiming that our products infringe upon their patents or other intellectual property rights.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">From time to time, we may be party to, or threatened with, litigation or other proceedings
with third parties, including non-practicing entities, who allege that our products, components of our products, services, and/or proprietary
technologies infringe, misappropriate or otherwise violate their intellectual property rights. The types of situations in which we may
become a party to such litigation or proceedings include:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z27678549d9c8482db3c00c1248541ba3" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>we or our collaborators may initiate litigation or other proceedings against third parties seeking to invalidate the patents held
        by those third parties or to obtain a judgment that our products or processes do not infringe those third parties&#8217; patents;</div>
        </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">16</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<table cellspacing="0" cellpadding="0" id="z9585331935b9409f81866d60a7de8626" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>we or our collaborators may participate at substantial cost in International Trade Commission proceedings to abate importation of
        products that would compete unfairly with our products;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z5f70c40fe8f54af683acff82f782f620" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>if our competitors file patent applications that claim technology also claimed by us, we may be required to participate in interference,
        derivation or opposition proceedings to determine the priority of invention, which could jeopardize our patent rights and potentially
        provide a third party with a dominant patent position;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zf08c61b3032a4957ade26456cc348d4b" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>if third parties initiate litigation claiming that our processes or products infringe their patent or other intellectual property
        rights, we and our collaborators will need to defend against such proceedings;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z872c072d057f410f88cecd138b6f6a36" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>if third parties initiate litigation or other proceedings seeking to invalidate patents owned by or licensed to us or to obtain a
        declaratory judgment that their product, service, or technology does not infringe our patents or patents licensed to us, we will need
        to defend against such proceedings;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z339504872970499883377aa11a2aa5ae" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>we may be subject to ownership disputes relating to intellectual property, including disputes arising from conflicting obligations
        of consultants or others who are involved in developing our products; and</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zc5120de20c4e49cc9598e8fdc6ff806b" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>if a license to necessary technology is terminated, the licensor may initiate litigation claiming that our processes or products
        infringe or misappropriate its patent or other intellectual property rights and/or that we breached our obligations under the license
        agreement, and we and our collaborators would need to defend against such proceedings.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">These lawsuits and proceedings, regardless of merit, are time-consuming and expensive
to initiate, maintain, defend or settle, and could divert the time and attention of managerial and technical personnel, which could materially
adversely affect our business. Any such claim could also force us to do one or more of the following:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z8be2a3806b534c65b5b9c61bd01f5776" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>incur substantial monetary liability for infringement or other violations of intellectual property rights, which we may have to pay
        if a court decides that the product, service, or technology at issue infringes or violates the third party&#8217;s rights, and if the
        court finds that the infringement was willful, we could be ordered to pay treble damages and the third party&#8217;s attorneys&#8217;
        fees;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="za2c9a8b31b184064a08a9f2654392904" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>pay substantial damages to our customers or end users to discontinue use or replace infringing technology with non-infringing technology;</div>
        </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z0ab2f5ae92914efd9bdc4d055bc8a91e" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>stop manufacturing, offering for sale, selling, using, importing, exporting or licensing the product or technology incorporating
        the allegedly infringing technology or stop incorporating the allegedly infringing technology into such product, service, or technology;</div>
        </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zf4528f979fd04949931dbe824492dd47" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>obtain from the owner of the infringed intellectual property right a license, which may require us to pay substantial upfront fees
        or royalties to sell or use the relevant technology and which may not be available on commercially reasonable terms, or at all;</div>
        </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z648d1c04c69b4419bc8d3cc111df2df8" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>redesign our products, services, and technology so they do not infringe or violate the third party&#8217;s intellectual property
        rights, which may not be possible or may require substantial monetary expenditures and time;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z941b2ad7cd2548f7aefb169f2860a6d3" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>enter into cross-licenses with our competitors, which could weaken our overall intellectual property position;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z07bf40d5024e42c8a3f7fefe96a59775" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>lose the opportunity to license our technology to others or to collect royalty payments based upon successful protection and assertion
        of our intellectual property against others;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z50fa79a5b7e2462a8069240af9e19842" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>find alternative suppliers for non-infringing products and technologies, which could be costly and create significant delay; or</div>
        </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="za83ca6d9725e4aca8af85bbe21745a12" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>relinquish rights associated with one or more of our patent claims, if our claims are held invalid or otherwise unenforceable.</div>
        </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">17</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25">Although we may try to resolve any potential future claims or actions, we may not be
able to do so on reasonable terms, if at all. Infringement and other intellectual property claims, with or without merit, can be expensive
and time-consuming to litigate, and could divert management&#8217;s attention from our core business. If we lose this kind of litigation,
a court could require us to pay substantial damages and could prohibit us from using technologies essential to our products, either of
which would have a material adverse effect on our business, results of operations and financial condition.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We may become involved in litigation to protect the trademark rights associated with
the Company name or the names of our products. If we have to change the name of the Company or products, we may experience a loss in goodwill
associated with our brand name, customer confusion and a reduction in sales.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Some of our competitors may be able to sustain the costs of complex intellectual property
litigation more effectively than we can because they have substantially greater resources. In addition, intellectual property litigation,
regardless of its outcome, may cause negative publicity, adversely impact prospective customers, cause product shipment delays, or prohibit
us from manufacturing, marketing or otherwise commercializing our products, services and technology. Any uncertainties resulting from
the initiation and continuation of any litigation could have a material adverse effect on our ability to raise additional funds or otherwise
have a material adverse effect on our business, results of operation, financial condition or cash flows.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">In addition, we may indemnify our customers and distributors against claims relating
to the infringement of intellectual property rights of third parties related to our products. Third parties may assert infringement claims
against our customers or distributors. These claims may require us to initiate or defend protracted and costly litigation on behalf of
our customers or distributors, regardless of the merits of these claims. If any of these claims succeed, we may be forced to pay damages
on behalf of our customers, suppliers or distributors, or may be required to obtain licenses for the products or services they use. If
we cannot obtain all necessary licenses on commercially reasonable terms, our customers may be forced to stop using our products or services.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Furthermore, because of the substantial amount of discovery required in connection with
intellectual property litigation, there is a risk that some of our confidential information could be compromised by disclosure during
this type of litigation. There could also be public announcements of the results of hearings, motions or other interim proceedings or
developments, which could have a material adverse effect on the price of our ordinary shares. If securities analysts or investors perceive
these results to be negative, it could have a material adverse effect on the price of our ordinary shares.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">If our trademarks and trade names are not adequately protected,
then we may not be able to build name recognition in our markets of interest and our business may be adversely affected.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our registered or unregistered trademarks or trade names may be challenged, infringed,
circumvented, declared generic or determined to be infringing on other marks. We may not be able to protect our rights in these trademarks
and trade names, which we need in order to build name recognition with potential partners or customers in our markets of interest. If
we are unable to establish name recognition based on our trademarks and trade names, then we may not be able to compete effectively and
our business may be adversely affected.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">We may be subject to claims that our employees, consultants or independent
contractors have wrongfully used or disclosed confidential information of their former employers or other third parties.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We do and may employ individuals who were previously employed at universities or other
pharmaceutical or medical device companies, including our competitors or potential competitors. Although we try to ensure that our employees,
consultants and independent contractors do not use the proprietary information or know-how of others in their work for us, and we are
not currently subject to any significant claims that our employees, consultants or independent contractors have wrongfully used or disclosed
confidential information of third parties, we may in the future be subject to such claims. Litigation may be necessary to defend against
these claims. If we fail in defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property
rights or personnel. Even if we are successful in defending against such claims, litigation could result in substantial costs and be a
distraction to management and other employees.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">18</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Intellectual property rights do not necessarily address all potential
threats to our business.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The degree of future protection afforded by our intellectual property rights is uncertain
because even granted intellectual property rights have limitations, and may not adequately protect our business, provide a barrier to
entry against our competitors or potential competitors or permit us to maintain our competitive advantage. Moreover, if a third party
has intellectual property rights that cover the practice of our technology, we may not be able to fully exercise or extract value from
our intellectual property rights. The following examples are illustrative:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="ze225129c502d4c60bc9132317aeb094c" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>others may be able to develop and/or practice technology that is similar to our technology or aspects of our technology, but that
        are not covered by the claims of the patents that we own or control, assuming such patents have issued or do issue;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z29a54be577754770b2b85cf0fba42711" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>we or any future strategic partners might not have been the first to conceive or reduce to practice the inventions covered by the
        issued patent or pending patent application that we own or have exclusively licensed;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="za618d8e8ea9a46e3b6cd315dba981587" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>we or any future strategic partners might not have been the first to file patent applications covering certain of our inventions;</div>
        </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zd0663ce88cc445c28bf69fce31614b37" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>others may independently develop similar or alternative technologies or duplicate any of our technologies without infringing our
        intellectual property rights;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z5fabe3b022e4497c96c5aa1b80b937bd" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>it is possible that our pending patent applications will not lead to issued patents;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z29404f57d3c540658e1814b8c64100a5" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>issued patents that we own may not provide us with any competitive advantage, or may be held invalid or unenforceable, as a result
        of legal challenges by our competitors;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z016b2df50e604d2d9f3fba60f001c735" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>our competitors might conduct research and development activities in countries where we do not have patent rights and then use the
        information learned from such activities to develop competitive products for sale in our major commercial markets;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z84aec250683944d1994e4fd81a7311e3" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>third parties performing manufacturing or testing for us using our products or technologies could use the intellectual property of
        others without obtaining a proper license;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z79fd4d7b002c4bbf871b80e8aae909e3" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>parties may assert an ownership interest in our intellectual property and, if successful, such disputes may preclude us from exercising
        exclusive rights over that intellectual property;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zfcb7b3b809e14234950ee53d43e723fe" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>we may not develop or in-license additional proprietary technologies that are patentable;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z2d8e117c92134f53b49ac39f9f7fd44f" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>we may not be able to obtain and maintain necessary licenses on commercially reasonable terms, or at all; and</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zbf9262a5c67e427fae8025116e1784a1" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>the patents of others may have an adverse effect on our business.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Should any of these events occur, they could significantly harm our business and results
of operations.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Risks Related to Government Regulation</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25"><span style="font-weight: bold; font-style: italic">Our business is subject to extensive and continuing
regulatory compliance obligations.</span>&#160;<span style="font-weight: bold; font-style: italic">If we fail to obtain and maintain necessary
FDA clearances for our products, if clearances for future products and proposed indications are delayed or not issued, if we or any of
our third-party suppliers or manufacturers fail to comply with applicable regulatory requirements, or if there are regulatory changes,
our commercial operations could be harmed.</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our products are medical devices subject to extensive regulation by the applicable regulatory
authorities where our products are or will be sold prior to their marketing for commercial use. In the United States, our products are
subject to extensive regulation by the FDA for developing, testing, manufacturing, labeling, sale, marketing, advertising, promotion,
distribution, import, export, shipping, establishment registration and device listing, inspections and audits, record keeping, recalls
and field safety corrective actions and post-market surveillance, including reporting of certain events.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Before a new medical device, or a new use of, or claim for, an existing product can
be marketed in the United States, it must first receive marketing authorization from the FDA unless it is exempt. The FDA marketing authorizations
include a 510(k) clearance or premarket approval. A relatively small number of devices may be exempt from 510(k) clearance or may receive
marketing authorization through the de novo classification pathway. These processes can be expensive and lengthy. The FDA&#8217;s 510(k)
clearance process usually takes from 3 to 12 months, but it can last longer. The process of obtaining premarket approval is much more
costly and uncertain than the 510(k) clearance process and it generally takes from one to three years, or even longer, from the time the
application is filed with the FDA. Our future products and enhancements or changes to products may require new 510(k) clearance or premarket
approval from the FDA. All products that we currently market in the United States that require an FDA marketing authorization have received
510(k) clearance for the uses for which they are marketed.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">19</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25">Medical devices may be marketed only for the indications for which they are approved
or cleared. We have obtained 510(k) clearance for the current treatments for which we offer our products. However, our clearances can
be revoked under certain circumstances. If the FDA disagrees with us concerning the scope or applicability of a clearance or exemption
with respect to a device, we may be required to change our promotional and/or labeling materials and/or stop marketing that device. Changes
or modifications to an FDA-cleared device that could significantly affect its safety or effectiveness or that constitute a major change
or modification in its intended use would require a new 510(k) clearance or possibly premarket approval. We may not be able to obtain
additional 510(k) clearances or premarket approvals for new products or for modifications to, or additional indications for, our existing
products in a timely fashion, or at all. Delays in obtaining future clearances or approvals would adversely affect our ability to introduce
new or enhanced products in a timely manner, which in turn would harm our revenue and future profitability.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We have made modifications to our devices in the past and may make additional modifications
in the future that we believe do not or will not require additional clearances or approvals. If the FDA disagrees, and requires new clearances
or approvals for the modifications, we may be required to recall and to stop marketing the modified devices. We also are subject to the
FDA&#8217;s Medical Device Reporting regulations, which require us to report to the FDA if our products cause or contribute to a death
or serious injury, or malfunction in a way that would likely cause or contribute to a death or serious injury.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The FDA or the applicable foreign regulatory bodies can delay, limit or deny clearance
or approval of a device for many reasons, including:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z2d345aafb5f74cadad6e754fe0c5df0d" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>our inability to demonstrate to the satisfaction of the FDA or the applicable foreign regulatory bodies that our products are safe
        or effective for their intended uses;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="ze43c27ff40c1442e8b407f05132d138d" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>the disagreement of the FDA or the applicable foreign regulatory bodies with the design or implementation of our clinical trials
        or the interpretation of data from pre-clinical studies or clinical trials;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z32112a2ddd1743f29a80a062be9c9187" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>serious and unexpected adverse device effects experienced by participants in our clinical trials;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="za3dacec30d354305a8e4e0a5e65c3e9b" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>the data from our pre-clinical studies and clinical trials may be insufficient to support clearance or approval, where required;</div>
        </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z11aa9218f844488eaeb785b2717bb39b" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>our inability to demonstrate that the clinical and other benefits of the device outweigh the risks;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z595a15b0b83a4a409d9653f8d4691428" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>the manufacturing process or facilities we use may not meet applicable requirements; and</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zebc364e7d488426aae35a9a56727c7f1" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>the potential for approval policies or regulations of the FDA or applicable foreign regulatory bodies to change significantly in
        a manner rendering our clinical data or regulatory filings insufficient for clearance or approval.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">In addition, the FDA or applicable foreign regulatory bodies may change their clearance
and approval policies, adopt additional regulations or revise existing regulations, or take other actions, which may prevent or delay
approval or clearance of our future products under development or impact our ability to modify our currently cleared products on a timely
basis. Such policy or regulatory changes could impose additional requirements upon us that could delay our ability to obtain new clearances,
increase the costs of compliance or restrict our ability to maintain our current clearances. For example, in November 2018, FDA officials
announced forthcoming steps that the FDA intends to take to modernize the premarket notification pathway under Section 510(k) of the FDCA.
Among other things, the FDA announced that it plans to develop proposals to drive manufacturers utilizing the 510(k) pathway toward the
use of newer predicates. These proposals include possible plans to sunset certain older devices that were used as predicates under the
510(k) clearance pathway, and to publish a list of devices that have been cleared on the basis of demonstrated substantial equivalence
to predicate devices that are more than 10 years old. The FDA also announced that it intends to finalize guidance to establish a premarket
review pathway for &#8220;manufacturers of certain well-understood device types&#8221; as an alternative to the 510(k) clearance pathway
and that such premarket review pathway would allow manufacturers to rely on objective safety and performance criteria recognized by the
FDA to demonstrate substantial equivalence, obviating the need for manufacturers to compare the safety and performance of their medical
devices to specific predicate devices in the clearance process. These proposals have not yet been finalized or adopted, and the FDA announced
that it would seek public feedback prior to publication of any such proposals, and may work with Congress to implement such proposals
through legislation. Accordingly, it is unclear the extent to which any proposals, if adopted, could impose additional regulatory requirements
on us that could delay our ability to obtain new 510(k) clearances, increase the costs of compliance, or restrict our ability to maintain
our current clearances, or otherwise create competition that may negatively affect our business.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">20</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25">Additionally regulatory clearances or approvals to market a product can contain limitations
on the indicated uses for such product. Product clearances and approvals can be withdrawn due to failure to comply with regulatory standards
or the occurrence of unforeseen problems following initial clearance or approval. FDA regulations depend heavily on administrative interpretation,
and there can be no assurance that future interpretations made by the FDA or other regulatory bodies will not adversely affect our operations.
We and our manufacturers may be inspected by the FDA from time to time to determine whether we or our manufacturers are in compliance
with applicable laws, including the cGMP regulations set forth in the FDA&#8217;s Quality System Regulation/Medical Device Current Good
Manufacturing Practices, or QSR, including those relating to specifications, development, documentation, validation, testing, quality
control and product labeling. A determination that we are in violation of FDA or other applicable foreign regulations or any of our product
clearances or approvals could lead to imposition of civil penalties, including fines, product recalls or product seizures and, in certain
cases, criminal sanctions.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">The use, misuse or off-label use of our products may harm our reputation
in the marketplace, result in injuries that lead to product liability suits or result in costly investigations, fines or sanctions by
regulatory bodies if we are deemed to have engaged in the promotion of these uses, any of which could be costly to our business.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The use, misuse or off-label use of our products may harm our reputation or the image
of our products in the marketplace, result in injuries that lead to product liability suits, which could be costly to our business, or
result in legal sanctions if we are deemed or alleged to have engaged in off-label promotion.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">A medical device may be authorized by the FDA for marketing through several regulatory
mechanisms. The FDA classifies medical devices as Class I, Class II, or Class III, in increasing order of risk. Most of our products are
Class I or Class II medical devices. As such, they are either exempt from premarketing authorization requirements or are subject to the
510(k) clearance process, and all are listed with the FDA pursuant to FDA&#8217;s medical device listing requirements.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Under FDA regulations, for each of our products we must only use labeling, including
advertising and promotional materials, that is consistent with the specific indication(s) for use included in the FDA exemption regulation,
clearance, or approval, that is applicable to the specific product. If the FDA or other authorities determine that our promotional or
training materials constitute the unlawful promotion of an off-label use, they could request that we modify our training or promotional
materials and/or subject us to regulatory or enforcement actions, including the issuance of an untitled letter, a warning letter, civil
money penalties, seizure, injunction or criminal fines and penalties. For example, on July 30, 2018, we received a letter, dated July
24, 2018, from the FDA seeking information as to the regulatory bases for marketing of our <span style="font-style: italic">FormaV </span>and
<span style="font-style: italic">FractoraV </span>handpieces based on our promotion and labeling of these devices for use in certain women&#8217;s
health conditions and procedures. We informed the FDA that the <span style="font-style: italic">FormaV </span>had received 510(k) clearance
for the temporary relief of minor muscle aches and pain, temporary relief of muscle spasm, and temporary improvement of local blood circulation
and that we had determined that the device also fell within a Class II premarketing exemption enabling marketing of the device for therapeutic
use in the treatment of sexual dysfunction or as an adjunct to Kegel&#8217;s exercise (tightening of the muscles of the pelvic floor to
increase muscle tone) without the need to obtain a 510(k) clearance. We also informed the FDA that the <span style="font-style: italic">FractoraV
</span>has received 510(k) clearance for use in dermatologic and general surgical procedures for electrocoagulation and hemostasis. In
addition, we advised the FDA that we have modified our promotional and labeling materials to remove statements using the terms &#8220;sexual
dysfunction,&#8221; &#8220;vaginal rejuvenation&#8221; or &#8220;urinary stress incontinence,&#8221; which were the subject of the agency&#8217;s
letter to us. The FDA responded in September 2018 by stating that the agency had reviewed our response letter and verified the changes
in terminology made to our website. Moreover, the FDA further responded in November 2018 and confirmed we addressed all items raised by
the agency in its letter, and that the FDA continued to expect us to conduct a review of our marketing and promotional materials to make
appropriate changes and remove materials containing uncleared claims regarding this matter. We have received no further communications
from the agency regarding this matter. We cannot be certain whether any further information may be requested by the FDA in the future
and/or any further action may be required on our part, and we cannot guarantee that the FDA will continue to deem our response and actions
to have addressed all items raised by the agency in this matter. If the FDA issues a further communication finding that some or all of
our modifications to our marketing and labeling materials are insufficient, or otherwise takes the position that our products are being
marketed for off-label uses, we could be subject to further discussions with and/or action by the agency, including the possibility of
a warning letter or other enforcement activity. Other federal, state or foreign governmental authorities might also take action if they
consider our promotion or training materials to constitute promotion of an uncleared or unapproved use, which could result in significant
fines or penalties under other statutory authorities, such as laws prohibiting false claims for reimbursement, or exclusion from participation
in federal health programs. In each event, our reputation could be damaged and the use of our products in the marketplace could be impaired,
or our business could face significant hardship. While no third-party claims have been brought against us to date, it is possible that
the FDA letter may lead to private litigation by third parties, potentially including purchasers of <span style="font-style: italic">FormaV
</span>and <span style="font-style: italic">FractoraV </span>handpieces or patients who were treated using those handpieces.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">21</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25">In addition, there may be increased risk of injury if physicians or others attempt to
use our products off-label. The FDA does not restrict or regulate a physician&#8217;s use of a medical product within the practice of
medicine, and we cannot prevent a physician from using our products for an off-label use. The use of our products for indications other
than those for which our products have been approved or cleared by the FDA may not effectively treat the conditions not referenced in
product indications, which could harm our reputation in the marketplace among physicians and patients. Physicians may also misuse our
products or use improper techniques if they are not adequately trained in the particular use, potentially leading to injury and an increased
risk of product liability. Product liability claims are expensive to defend and could divert management&#8217;s attention from our primary
business and result in substantial damage awards against us. Any of these events could harm our business, results of operations and financial
condition.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">We are subject to ongoing regulatory obligations and a failure to
comply with post-marketing regulatory requirements could subject us to enforcement actions, including substantial penalties, and might
require us to recall or withdraw a product from the market.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Even after we have obtained the proper regulatory clearance or approval to market a
product, we have ongoing responsibilities under FDA regulations and applicable foreign laws and regulations. The FDA, state and foreign
regulatory authorities have broad enforcement powers. The regulations to which we are subject are complex and have become more stringent
over time. Regulatory changes could result in restrictions on our ability to continue or expand our operations, higher than anticipated
costs, or lower than anticipated sales.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our products and/or their use are also subject to state regulations and additional regulations
in other foreign jurisdictions outside of the United States, which may change at any time. We cannot predict the impact or effect of future
legislation or regulations and any changes in regulations may impede sales.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Furthermore, the FDA and state authorities have broad enforcement powers. Our failure
to comply with applicable regulatory requirements could result in enforcement action by the FDA or state agencies, which may include any
of the following sanctions:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zb548b916b9d54ea9b39b28cf815ed605" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>warning letters or untitled letters, fines, injunctions, consent decrees and civil penalties;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z2745d030ffc845c18c0b4e8179d5aa20" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>repair, replacement, refunds, recalls, termination of distribution, administrative detention or seizure of our products;</div> </td>
        </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z480c1cd32e544a19b700a2c1ec3f1ea1" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>operating restrictions or partial suspension or total shutdown of production;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z2a2b9d273ef14dbb86b2c7779dfbe389" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>refusing our requests for 510(k) clearance or premarket approval of new products, new intended uses, or modifications to existing
        products;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z9e7a2b136bba4b47b43b4d1c954a060a" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>withdrawing 510(k) clearances or premarket approvals or foreign regulatory approvals that have already been granted, resulting in
        prohibitions on sales of our products; and</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zd4dc3dcbdbbb4ec4bf4aa19d92a7ca11" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>criminal prosecution.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The occurrence of any of these events could harm our business, financial condition and
results of operations.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">If we or our subcontractors fail to comply with federal and state
regulation, including the FDA&#8217;s Quality System Regulation/Medical Device Good Manufacturing Practices and performance standards,
our or our subcontractors&#8217; manufacturing operations could be halted, and our business would suffer.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We and our subcontractors currently are required to demonstrate and maintain compliance
with the QSR. The QSR is a complex regulatory scheme that covers the methods and documentation of the design, testing, control, manufacturing,
labeling, quality assurance, packaging, storage and shipping of our products. Because our products use optical energy, including lasers,
our products also are covered by a performance standard for lasers set forth in FDA regulations. The laser performance standard imposes
specific record-keeping, reporting, product testing and product labeling requirements. These requirements include affixing warning labels
to laser products, as well as incorporating certain safety features in the design of laser products. The FDA enforces the QSR and laser
performance standards through periodic announced or unannounced inspections. We and our subcontractors are subject to such inspections.
Although we place our own quality control employee at each of our subcontractor&#8217;s facilities, we do not have complete control over
our subcontractor&#8217;s compliance with these standards.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">22</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25">Any failure by us or our subcontractors to take satisfactory corrective action in response
to an adverse QSR inspection or to comply with applicable laser performance standards could result in enforcement actions against us or
our subcontractors, including warning letters or untitled letters; fines, injunctions or civil penalties; suspension or withdrawal of
approvals or clearances; seizures or recalls of our products; total or partial suspension of production or distribution; administrative
or judicially imposed sanctions; the FDA&#8217;s refusal to grant pending or future clearances or approvals for our products; clinical
holds; refusal to permit the import or export of our products; and criminal prosecution of us or our employees. Any of these actions could
significantly and negatively impact the supply of our products, and could cause our sales and business to suffer. In addition, we are
subject to standards imposed on our activities outside of the United States, such as obtaining CE mark certification in Europe (by our
notified body DEKRA) and the Standards Institution of Israel (imposed on our activities in Israel), and failure to comply with such standards
could adversely impact our business.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Our products may cause or contribute to adverse medical events or
other undesirable side effects that we are required to report to the FDA, and if we fail to do so, we would be subject to sanctions that
could harm our reputation, business, financial condition and results of operations. The discovery of serious safety issues with our products,
or a recall of our products either voluntarily or at the direction of the FDA or another governmental authority, could have a negative
impact on us.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We are subject to the FDA&#8217;s medical device reporting regulations and similar foreign
regulations, which require us to report to the FDA when we receive or become aware of information that reasonably suggests that one or
more of our products may have caused or contributed to a death or serious injury or malfunctioned in a way that, if the malfunction were
to recur, it could cause or contribute to a death or serious injury. The timing of our obligation to report is triggered by the date we
become aware of the adverse event as well as the nature of the event. We may fail to report adverse events of which we become aware within
the prescribed timeframe. We may also fail to recognize that we have become aware of a reportable adverse event, especially if it is not
reported to us as an adverse event or if it is an adverse event that is unexpected or removed in time from the use of the product. If
we fail to comply with our reporting obligations, the FDA could take action, including warning letters, untitled letters, administrative
actions, criminal prosecution, imposition of civil monetary penalties, revocation of our device clearance, seizure of our products or
delay in clearance of future products.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The FDA and foreign regulatory bodies have the authority to require the recall of commercialized
products in the event of material deficiencies or defects in design or manufacture of a product or in the event that a product poses an
unacceptable risk to health. We may also choose to voluntarily recall a product if any material deficiency is found. A government-mandated
or voluntary recall by us could occur as a result of an unacceptable risk to health, component failures, malfunctions, manufacturing defects,
labeling or design deficiencies, packaging defects or other deficiencies or failures to comply with applicable regulations. Product defects
or other errors may occur in the future. Depending on the corrective action we take to redress a product&#8217;s deficiencies or defects,
the FDA may require, or we may decide, that we will need to obtain new approvals or clearances for the product before we may market or
distribute the corrected product. Seeking such approvals or clearances may delay our ability to replace the recalled products in a timely
manner. Moreover, if we do not adequately address problems associated with our products, we may face additional regulatory enforcement
action, including FDA warning letters, product seizure, injunctions, administrative penalties or civil or criminal fines.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Companies are required to maintain certain records of recalls and corrections, even
if they are not reportable to the FDA. We may initiate voluntary withdrawals or corrections for our products in the future that we determine
do not require notification of the FDA. If the FDA disagrees with our determinations, it could require us to report those actions as recalls
and we may be subject to enforcement action. A future recall announcement could harm our reputation with customers, potentially lead to
product liability claims against us and negatively affect our sales.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">23</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">We may be unable to obtain or maintain international regulatory
qualifications or approvals for our current or future products and indications, which could harm our business. Additionally, obtaining
and maintaining regulatory approval in one jurisdiction does not mean we will be successful in obtaining regulatory approvals for our
products in other jurisdictions.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Sales of our products outside the United States are subject to foreign regulatory requirements
that vary widely from country to country, including some regulatory requirements that we may not be fully aware of, or that may change
in ways that affect our ability to sell our products in those jurisdictions. Complying with international regulatory requirements can
be an expensive and time-consuming process and approval is not certain. The regulatory process in foreign jurisdictions includes all the
risks associated with obtaining FDA clearance, as well as additional risks not present in the FDA process. For example, the time required
to obtain foreign clearance or approvals may be longer than that required for FDA clearance or approvals, and requirements for such clearances
or approvals may significantly differ from FDA requirements, adding costs and variability. Foreign regulatory authorities may not approve
our product for the same uses cleared by the FDA. Although we have obtained regulatory clearances to sell our products in the European
Union and other countries outside the United States, we may be unable to maintain regulatory qualifications, clearances or approvals in
these countries or to obtain approvals in other countries. We also may incur significant costs in attempting to obtain and in maintaining
foreign regulatory approvals, clearances or qualifications.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">If we experience delays in receiving necessary qualifications, clearances or approvals
to market our products outside the United States, or if we fail to receive those qualifications, clearances or approvals, we may be unable
to market some of our products or enhancements in certain international markets effectively, or at all. Since the enactment of the Israeli
Medical Equipment Law, 2012, or the Medical Equipment Law, the manufacturing and marketing of medical and certain aesthetic devices, including
our products, in Israel requires registration with the Israeli Ministry of Health. The Medical Equipment Law offers a fast-track registration
process for devices that received approval from certain non-Israeli regulatory agencies, including FDA clearance or CE marks. We have
taken advantage of such fast-track registration process in the past. If we are unable to obtain and maintain the necessary registration
for any of our products in Israel, we may have to move the manufacturing of such unregistered products to a location outside of Israel
and stop selling these products in Israel until the products are registered. We may also suffer harm to our reputation as a result.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Disruptions at the FDA and other government agencies caused by funding
shortages or global health concerns could hinder their ability to hire and retain key leadership and other personnel, or otherwise prevent
new products and services from being developed or commercialized in a timely manner, which could negatively impact our business.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The ability of the FDA to review and approve new products can be affected by a variety
of factors, including government budget and funding levels, ability to hire and retain key personnel and accept the payment of user fees,
and statutory, regulatory, and policy changes. Average review times at the agency have fluctuated in recent years as a result. In addition,
government funding of other government agencies that fund research and development activities is subject to the political process, which
is inherently fluid and unpredictable.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Disruptions at the FDA and other agencies may also slow the time necessary for new devices
to be reviewed and/or cleared by necessary government agencies, which would adversely affect our business. For example, over the last
several years, including for 35 days beginning on December 22, 2018, the U.S. government has shut down several times and certain regulatory
agencies, such as the FDA, have had to furlough critical FDA employees and stop critical activities.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">New regulations may limit our ability to sell to non-physicians
in the future.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Currently, we sell our products solely to physicians. However, where permitted under
applicable laws, we intend to introduce certain of our products in the developing medical spa market, where aesthetic procedures are being
performed at dedicated facilities by non-physicians under physician supervision. U.S., state and international regulations could change
at any time, disallowing sales of our products to aestheticians, and/or limiting the ability of aestheticians and non-physicians to operate
our products. We cannot predict the impact or effect of changes in U.S., state or international laws or regulations.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">24</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25; font-weight: bold">Risks Related to Our Ordinary Shares</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">The price of our ordinary shares may be volatile, and you may lose
all or part of your investment.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The price of our ordinary shares has fluctuated and is likely to continue to fluctuate.
The market price for our ordinary shares could be highly volatile and may fluctuate substantially as a result of a number of factors,
many of which are beyond our control, including:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z40486e8ac93e442d8f45bd5130ec804d" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>fluctuations in our operating results or the operating results of our competitors;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z5b11770dec9640f5a21d5d8a46a9586c" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>changes in the estimates of the future size and growth rate of our market opportunities;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z18652864e56547d2a07ba1c761d2e6bd" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>changes in the general economic, industry and market conditions;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z10a1136ec4ef4028b0a08e2b9b59bdaf" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>political, economic and military instability in Israel and the impact from the latest Israel-Hamas war;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="ze720f903a9894bb994123c6791d73a76" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>success of competitive technologies and procedures;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z8767952546f54f1b9bef4dbb39bc9407" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>recruitment or departure of key personnel;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zeb488cb048b1482fadd76e838c20f468" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>the announcement of new products or enhancements by us or our competitors;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z9b24af0fd7904d8e907236d126d7a3d4" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>the commencement or outcome of litigation against us, or involving our general industry or both;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z5fea15e27ed2474e9c1f226c0f125e4f" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>new laws or regulations or new interpretations of existing laws or regulations applicable to our business;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zec777cca7e894232a4d2503bcbd8bddc" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>changes in earnings estimates, investors&#8217; perceptions, recommendations by securities analysts or our failure to achieve analysts&#8217;
        earnings estimates;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zbd5e3778f3314e7ea459d519d2c11afd" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>developments in our industry, including the announcement of significant new technologies, procedures or acquisitions by us or our
        competitors;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z5edd17eeef5a45e7b4972a5da8b852db" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>actual or expected sales of our ordinary shares by the holders of our ordinary shares; and</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z4d8af1a3a46b459f82797b2dde6ff30e" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>the trading volume of our ordinary shares.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">In addition, the stock prices of many newly public companies and companies in the medical
device industry have experienced wide fluctuations that often have been unrelated to the operating performance of those companies. These
fluctuations may be attributed, among other reasons, to the general global economic environment and the instability in markets. Prior
to our initial public offering in August 2019, there was no public market for our ordinary shares and an active public trading market
for our ordinary shares may not be sustained. An inactive market may impair our ability to raise capital by selling shares and may impair
our ability to acquire other businesses, applications or technologies using our shares as consideration. These factors and price fluctuations
may materially and adversely affect the market price of our ordinary shares.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Future sales of our ordinary shares could reduce the price of our
ordinary shares.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Sales by shareholders of substantial amounts of our ordinary shares, or the perception
that these sales may occur in the future, could materially and adversely affect the market price of our ordinary shares and could impair
our ability to raise capital through the sale of additional equity securities and our ability to acquire other companies by using our
ordinary shares as consideration.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">As of December 31, 2023, there are 83,982,462 ordinary shares outstanding (not including
a total of 1,975,003 ordinary shares held at that date as treasury shares). Sales of these shares, or the perception that these sales
may occur in the future, into the market could cause the market price of our ordinary shares to drop significantly. In addition, we have
registered all ordinary shares that we may issue under our equity compensation plans, and, as such, these shares can be freely sold in
the public market upon issuance.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">We have not paid dividends in the past and may not pay dividends
in the future, and any return on investment may be limited to the value of our ordinary shares.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We have never declared or paid cash dividends on our ordinary shares and may not distribute
cash or other dividends on our ordinary shares in the foreseeable future. The distribution of dividends on our ordinary shares will depend
on our earnings, financial condition and other business and economic factors affecting us at such time as our board of directors may consider
relevant. We may only distribute dividends out of&#8201; &#8220;profits,&#8221; as defined by the Companies Law and provided that the
distribution is not reasonably expected to impair our ability to fulfill our outstanding and anticipated obligations as they become due.
If we do not distribute dividends, our ordinary shares may be less valuable because a return on your investment will only occur if the
price of our ordinary shares appreciates.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">25</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">We incur significant costs operating as a public company in the
United States, and our management is required to devote substantial time to compliance matters.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">As a public company whose ordinary shares are listed in the United States, we are subject
to an extensive regulatory regime, requiring us, among other things, to maintain various internal controls and facilities and to prepare
and file periodic and current reports and statements. Complying with these requirements is costly and time consuming. In the event that
we are unable to demonstrate ongoing compliance with our obligations as a public company, or are unable to produce timely or accurate
financial statements, we may be subject to sanctions or investigations by regulatory authorities and investors may lose confidence in
our operating results, and the price of our ordinary shares could decline. In addition, we lost our emerging growth company status and
are a &#8220;large accelerated filer&#8221; beginning from December 31, 2020. We have incurred significant management time and cost complying
with the more stringent reporting requirements applicable to &#8220;accelerated filers,&#8221; including complying with auditor attestation
requirements of Section 404(b) of the Sarbanes-Oxley Act of 2002.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">We may be subject to securities litigation, which is expensive to
defend and could divert management&#8217;s attention.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">In the past, following periods of market volatility in the price of a company&#8217;s
securities or the reporting of unfavorable news, security holders have often instituted class action litigation. If the market value of
our securities experience adverse fluctuations and we become involved in this type of litigation, regardless of the outcome, we could
incur substantial legal costs and our management&#8217;s attention could be diverted from the operation of our business, causing our business
to suffer. Any adverse determination in litigation could also subject us to significant liabilities.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">U.S. investors in the Company could suffer adverse tax consequences
if we are characterized as a passive foreign investment company.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We believe that we were not a passive foreign investment company, or PFIC, for U.S.
federal income tax purposes for our taxable year ended December 31, 2023, and we do not expect to be classified as a PFIC for the current
year ending December 31, 2024 or the foreseeable future. However, the determination of whether we are a PFIC is a factual determination
made annually based on all the facts and circumstances and thus is subject to change. The relevant rules for determining whether or not
we are a PFIC as applied to our business are not entirely clear and certain aspects of the relevant tests will be outside our control.
Therefore, no assurance can be given that we will not be a PFIC for any taxable year.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">If we are determined to be a PFIC at any time during which a U.S. Holder (as defined
in &#8220;Item 10E. Additional Information-Taxation-Material U.S. Federal Income Tax Considerations to U.S. Holders&#8221;) holds our
shares, such U.S. Holder may be subject to materially adverse tax consequences, including additional U.S. federal income tax liability
and tax filing obligations. See &#8220;Item 10E. Additional Information-Taxation-Material U.S. Federal Income Tax Considerations to U.S.
Holders-Passive Foreign Investment Company Considerations.&#8221; U.S. Holders are strongly urged to consult their tax advisors as to
whether or not we will be a PFIC.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">If we fail to maintain an effective system of internal control over
financial reporting, we may not be able to accurately report our financial results or prevent fraud. As a result, shareholders could lose
confidence in our financial and other public reporting, which would harm our business and the trading price of our ordinary shares.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Effective internal control over financial reporting is necessary for us to provide reliable
financial reports. As a &#8220;large accelerated filer&#8221; we are responsible for establishing and maintaining internal controls and
procedures that will allow our management to report on, and our independent registered public accounting firm to attest to, our internal
controls over financial reporting under Section 404 of the Sarbanes-Oxley Act of 2002, or Section 404. Although our independent registered
public accounting firm is required to attest to the effectiveness of our internal control over financial reporting pursuant to Section
404(b) of the Sarbanes-Oxley Act of 2002 and our management is required to report on our internal controls over financial reporting under
Section 404, any failure to implement required new or improved controls, or difficulties encountered in their implementation could cause
us to fail to meet our reporting obligations. In addition, any testing by us, as and when required, conducted in connection with Section
404 or any subsequent testing by our independent registered public accounting firm, as and when required, may reveal deficiencies in our
internal controls over financial reporting that are deemed to be material weaknesses or that may require prospective or retroactive changes
to our financial statements or identify other areas for further attention or improvement. Inferior internal controls could also cause
investors to lose confidence in our reported financial information, which could have a negative effect on the trading price of our ordinary
shares.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">26</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">We are a &#8220;foreign private issuer&#8221; and have disclosure
obligations that are different from those of U.S. domestic reporting companies.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We are a foreign private issuer and are not subject to the same requirements that are
imposed upon U.S. domestic issuers by the SEC. Under the Exchange Act, we are subject to reporting obligations that, in certain respects,
are less detailed and less frequent than those of U.S. domestic reporting companies. For example, we are not required to issue quarterly
reports or proxy statements that comply with the requirements applicable to U.S. domestic reporting companies. Furthermore, although under
regulations promulgated under the Companies Law, as an Israeli public company listed on the Nasdaq, we are required to disclose the compensation
of our five most highly compensated officers on an individual basis, this disclosure will not be as extensive as that required of U.S.
domestic reporting companies. We also have four months after the end of each fiscal year to file our annual report with the SEC and are
not required to file current reports as frequently or promptly as U.S. domestic reporting companies. Furthermore, our officers, directors
and principal shareholders are exempt from the requirements to report transactions and short-swing profit recovery required by Section
16 of the Exchange Act. Also, as a &#8220;foreign private issuer,&#8221; we are not subject to the requirements of Regulation FD (Fair
Disclosure) promulgated under the Exchange Act. Even though we have voluntarily elected to comply with Regulation FD, these exemptions
and leniencies reduce the frequency and scope of information and protections available to you in comparison to those applicable to a U.S.
domestic reporting companies.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We would lose our foreign private issuer status if as of June 30 in any calendar year
a majority of our outstanding shares are held of record by U.S. residents and a majority of our directors or executive officers are U.S.
citizens or residents or we fail to meet additional requirements necessary to avoid loss of foreign private issuer status. The regulatory
and compliance costs to us under U.S. securities laws as a U.S. domestic issuer may be significantly higher. If we lose our foreign private
issuer status, we will be required to file periodic reports and registration statements on U.S. domestic issuer forms with the SEC, which
are more detailed and extensive than the forms available to a foreign private issuer. We may also be required to modify certain of our
policies to comply with accepted governance practices associated with U.S. domestic issuers. Such conversion and modifications will involve
additional costs. In addition, we would lose our ability to rely upon exemptions from certain corporate governance requirements on U.S.
stock exchanges that are available to foreign private issuers.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">As a &#8220;foreign private issuer,&#8221; we are permitted to follow
certain home country corporate governance practices instead of otherwise applicable SEC and Nasdaq requirements, which may result in less
protection than is accorded to investors under rules applicable to domestic U.S. issuers.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">As a &#8220;foreign private issuer,&#8221; we are permitted to follow certain home country
corporate governance practices instead of those otherwise required under the listing rules of Nasdaq for domestic U.S. issuers. For instance,
we follow our home country law instead of the listing rules of Nasdaq that require that we obtain shareholder approval for certain dilutive
events, such as the establishment or amendment of certain equity-based compensation plans, an issuance that will result in a change of
control of us, certain transactions other than a public offering involving issuances of a 20% or greater interest in the Company, and
certain acquisitions of the stock or assets of another company. Under the Companies Law as currently applicable to us, there is no requirement
to receive shareholder approval for the issuance of securities for such dilutive events, and under our amended and restated articles of
association our board of directors is authorized to issue securities, including ordinary shares, warrants and convertible notes. Additionally,
under the Companies Law, unless the articles of association otherwise provide, the quorum required for an ordinary meeting of shareholders
must consist of at least two shareholders who hold at least 25% of the voting rights (instead of the 33 and 1/3% required under Nasdaq
rules), and we are not required to have a nominating committee consisting solely of independent directors for the nomination of directors.
See &#8220;Item 16G. Corporate Governance&#8221; for details on the differences between Israeli corporate governance practices and comparable
U.S. requirements and other home country practices we follow instead of the listing rules of Nasdaq. We may in the future elect to follow
home country corporate governance practices in Israel with regard to other matters. Following our home country corporate governance practices
as opposed to the requirements that would otherwise apply to a U.S. company listed on Nasdaq may provide less protection to you than what
is accorded to investors under the listing rules of Nasdaq applicable to domestic U.S. issuers.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Risks Related to Our Operations in Israel</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25"><span style="font-weight: bold; font-style: italic">The impact of</span>&#160;<span style="font-weight: bold; font-style: italic">political,
economic and military conditions in Israel, including the latest Israel-Hamas war, and the surrounding region could directly affect our
business.</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our principal executive offices and research and development facilities as well as our
third-party manufacturers are located in Israel. In addition, all of our subcontractors are located in Israel. Accordingly, political,
economic and military conditions in Israel and the surrounding region could directly affect our business. In recent years, there has been
political instability in Israel, including five national elections since 2019. Since the establishment of the State of Israel in 1948,
a number of armed conflicts have occurred between Israel and its Arab neighbors, Hamas (an Islamist militia and political group in the
Gaza Strip) and Hezbollah (an Islamist militia and political group in Lebanon).</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">27</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25">On October 7, 2023, Hamas terrorists infiltrated Israel&#8217;s southern border from
the Gaza Strip and conducted a series of attacks on civilian and military targets. Hamas also launched extensive rocket attacks on Israeli
population and industrial centers located along Israel&#8217;s border with the Gaza Strip and in other areas within the State of Israel.
These attacks resulted in extensive deaths, injuries and kidnapping of civilians and soldiers. Following the attack, Israel&#8217;s security
cabinet declared war against Hamas and a military campaign against these terrorist organizations. In connection with the Israeli security
cabinet&#8217;s declaration of war against Hamas and possible hostilities with other organizations, several hundred thousand Israeli military
reservists were drafted to perform immediate military service. Certain of our employees in Israel, in addition to employees of our subcontractors
located in Israel, have been called, and additional employees may be called, for service in the current or future wars or other armed
conflicts with Hamas and others, and such persons may be absent for an extended period of time. As a result, our operations may be disrupted
by such absences, which disruption may materially and adversely affect our business and results of operations. Additionally, the absence
of employees of our Israeli subcontractors due to their military service in the current or future wars or other armed conflicts may disrupt
their operations, which in turn may materially and adversely affect our ability to deliver or provide products and services to customers.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Following the attack by Hamas on Israel&#8217;s southern border, Hezbollah in Lebanon
also launched missile, rocket and shooting attacks against Israeli military sites, troops and Israeli towns in northern Israel. In response
to these attacked, the Israeli army has carried out a number of targeted strikes on sites belonging to Hezbollah in southern Lebanon.
It is possible that other terrorist organizations, including Palestinian military organizations in the West Bank, as well as other hostile
countries, such as Iran, will join the hostilities. Such hostilities may include terror and missile attacks. In the event that our facilities
are damaged as a result of hostile actions, or hostilities otherwise disrupt our ongoing operations, our ability to deliver or provide
products and services in a timely manner to meet our contractual obligations towards customers and vendors could be materially and adversely
affected.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The intensity and duration of Israel&#8217;s current war against Hamas is difficult
to predict, as are such war&#8217;s economic implications on our business and operations and on Israel&#8217;s economy in general. These
events may be intertwined with wider macroeconomic indications of a deterioration of Israel&#8217;s economic and political standing, which
may have a material adverse effect on us and our ability to effectively conduct our business and operations.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Moreover, political uprisings and conflicts in various countries in the Middle East
are affecting the political stability of those countries. This instability has raised concerns regarding security in the region and the
potential for armed conflict. In Syria, a country bordering Israel, a civil war is taking place. In addition, there are concerns that
Iran, which has previously threatened to attack Israel, may step up its efforts to achieve nuclear capability. Iran is also believed to
have a strong influence among extremist groups in the region, such as Hamas in Gaza and Hezbollah in Lebanon. Israel has responded with
attacks on Iranian military operations in Syria. The tension between Israel and Iran and/or these groups may escalate in the future and
turn violent, which could affect the Israeli economy in general and us in particular. Any potential future conflict could also include
missile strikes against parts of Israel, including our offices and facilities and the facilities of our Israeli suppliers and subcontractors.
Such instability may lead to deterioration in the political and trade relationships that exist between the State of Israel and certain
other countries. Any armed conflicts, terrorist activities or political instability in the region could adversely affect business conditions,
could harm our results of operations and could make it more difficult for us to raise capital. Parties with whom we do business may be
disinclined to travel to Israel during periods of heightened unrest or tension, forcing us to make alternative arrangements when necessary
in order to meet our business partners face to face. In addition, the political and security situation in Israel may result in parties
with whom we have agreements involving performance in Israel claiming that they are not obligated to perform their commitments under those
agreements pursuant to force majeure provisions in such agreements.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">In addition, the recent escalation of Israel-Hamas conflict could cause disruptions
to our operations, and a delay in the development, production and shipment of our products and the heightened tension in our relations
with various Middle Eastern countries could adversely affect our customer relationships as well as our sales and performance of existing
or future contracts, which in turn could adversely affect our operating results, financial conditions and the expansion of our business.&#160;
Furthermore, the latest Israel-Hamas war and the resulting measures that have been taken, and could be taken in the future, by NATO, the
United States, the United Kingdom, the European Union, Israel and its neighboring states and other countries have created global security
concerns that could have a lasting impact on regional and global economies.&#160; Although the length and impact of this ongoing conflict
are highly unpredictable, they could lead to market disruptions, including significant volatility in commodity prices and supply chain
disruptions.&#160; For more information about the impact of the Israel-Hama war on our operations and financial results, please see &#8220;Item
3. Key Information &#8211; D. Risk Factors-Risks to Our Business and Industry&#8221;.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">28</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-indent: 14.2pt; line-height: 1.25">In addition, prior to the Hamas attack in October 2023, the Israeli government pursued
extensive changes to Israel&#8217;s judicial system, which sparked extensive political debate and unrest. In response to such initiatives,
many individuals, organizations and institutions, both within and outside of Israel, have voiced concerns that the proposed changes may
negatively impact the business environment in Israel including due to reluctance of foreign investors to invest or transact business in
Israel, as well as to increased currency fluctuations, downgrades in credit rating, increased interest rates, increased volatility in
security markets, and other changes in macroeconomic conditions. The risk of such negative developments has increased in light of the
recent Hamas attacks and the war against Hamas declared by Israel, regardless of the proposed changes to the judicial system and the related
debate. To the extent that any of these negative developments do occur, they may have an adverse effect on our business, our results of
operations and our ability to raise additional funds, if deemed necessary by our management and board of directors.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Our commercial insurance may leave us subject to a risk of a loss
if a terrorist attack or act of war occurs.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our insurance does not cover losses that may occur as a result of an event associated
with the security situation in the Middle East or events associated with war and terrorism, such as the latest Israel-Hamas war, or for
any resulting disruption in our operations. Although the Israeli government has in the past covered the reinstatement value of direct
damages that were caused by terrorist attacks or acts of war, we cannot be assured that this government coverage will be maintained or,
if maintained, will be sufficient to compensate us fully for damages incurred and the government may cease providing such coverage or
the coverage might not suffice to cover potential damages. Any losses or damages incurred by us could have a material adverse effect on
our business. Any armed conflicts or political instability in the region would likely negatively affect business conditions generally
and could harm our results of operations.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25"><span style="font-weight: bold; font-style: italic">Boycotts and various Middle Eastern business restrictions
in the region may adversely impact our ability to operate and sell our products</span>.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Several countries, principally in the Middle East, restrict doing business with Israel
and Israeli companies, and additional countries may impose restrictions on doing business with Israel and Israeli companies whether as
a result of the ongoing and revived hostilities in the region, the latest Israel-Hamas war or otherwise. In addition, there have been
increased efforts by activists to cause companies and consumers to boycott Israeli goods based on Israeli government policies. Although
Israel had signed bilateral peace agreements with several Middle Eastern (including Arab) countries for forging new economic ties with
them, the performance of such bilateral peace agreements could be adversely affected by the going and revived hostilities in Israel region,
which has caused a substantial strain on Israel&#8217;s regional relations with a number of Middle Eastern countries, such as Egypt and
Jordan whose relations with Israel had long been cold but worsened since the outbreak of the war.&#160; The restrictive laws and policies
and the actions by boycott activists, if become more widespread and successful, and the fast-moving changes to Israel&#8217;s geopolitical
relations as a result of the war, may seriously limit our ability to sell our products in these countries and may have an adverse impact
on our operating results, financial conditions or the expansion of our business.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">We may become subject to claims for remuneration or royalties for
assigned service invention rights by our employees, which could result in litigation and adversely affect our business.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We have entered into assignment of invention agreements with our employees pursuant
to which such individuals agree to assign to us all rights to any inventions created during their employment or engagement with us. A
significant portion of our intellectual property has been developed by our employees in the course of their employment with us. Under
the Israeli Patent Law, 5727-1967, or the Patent Law, inventions conceived by an employee during the scope of his or her employment with
a company and as a result thereof are regarded as &#8220;service inventions,&#8221; which belong to the employer, absent a specific agreement
between the employee and employer giving the employee service invention rights. The Patent Law also provides that if there is no agreement
between an employer and an employee with respect to the employee&#8217;s right to receive compensation for such &#8220;service inventions,&#8221;
and to what extent and under which conditions, the Israeli Compensation and Royalties Committee, or the Committee, a body constituted
under the Patent Law, shall determine whether the employee is entitled to remuneration for his or her service inventions and the scope
and conditions for such remuneration. The Patent Law further provides criteria for assisting the Committee in making its decisions. Case
law clarifies that the right to receive consideration for &#8220;service inventions&#8221; can be waived by the employee and that in certain
circumstances, such waiver does not necessarily have to be explicit. The Committee will examine, on a case-by-case basis, the general
contractual framework between the parties, applying interpretation rules of the general Israeli contract laws. Further, the Committee
has not yet determined one specific formula for calculating this remuneration, nor the criteria or circumstances under which an employee&#8217;s
waiver of his right to remuneration will be disregarded. Similarly, it remains unclear whether waivers by employees in their employment
agreements of the alleged right to receive consideration for service inventions should be declared as void being a depriving provision
in a standard contract. Although our employees have agreed to assign to us service invention rights and have specifically waived their
right to receive any special remuneration for such service inventions beyond their regular salary and benefits, as a result of uncertainty
under Israeli law with respect to the efficacy of waivers of service invention rights, we may face claims demanding remuneration in consideration
for assigned inventions. As a consequence of such claims, we could be required to pay additional remuneration or royalties to our current
and/or former employees, or be forced to litigate such claims, which could negatively affect our business.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">29</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Our operations may be affected by negative economic conditions or
labor unrest in Israel.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">General strikes or work stoppages, including at Israeli ports, have occurred periodically
or have been threatened in the past by Israeli trade unions due to labor disputes. These general strikes or work stoppages may have an
adverse effect on the Israeli economy and on our business, including our ability to deliver products to our customers and to receive raw
materials from our suppliers in a timely manner and could have a material adverse effect on our results of operations.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">You may have difficulties enforcing a U.S. judgment against us,
our executive officers and directors and Israeli experts named in this Annual Report on Form 20-F in Israel or the United States, asserting
U.S. securities laws claims in Israel or serving process on our officers and directors and these experts in Israel.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We are incorporated in Israel and our corporate headquarters are located in Israel.
Many of our executive officers and directors reside outside of the United States, and a significant portion of our assets and the assets
of certain of our directors and executive officers are located outside the United States. Therefore, a judgment obtained against us or
any of them in the United States, including one based on the civil liability provisions of the U.S. federal securities laws, may not be
collectible in the United States and may not be enforced by an Israeli court. Further, if a foreign judgment is enforced by an Israeli
court, it will be payable in Israeli currency. It also may be difficult for you to effect service of process on these persons in the United
States or to assert U.S. securities law claims in original actions instituted in Israel. Additionally, it may be difficult for an investor,
or any other person or entity, to initiate an action with respect to U.S. securities laws in Israel. Israeli courts may refuse to hear
a claim based on an alleged violation of U.S. securities laws reasoning that Israel is not the most appropriate forum in which to bring
such a claim. In addition, even if an Israeli court agrees to hear a claim, it may determine that Israeli law and not U.S. law is applicable
to the claim. If U.S. law is found to be applicable, the content of applicable U.S. law must be proven as a fact by expert witnesses,
which can be a time consuming and costly process. Certain matters of procedure will also be governed by Israeli law. There is little binding
case law in Israel that addresses the matters described above. As a result of the difficulty associated with enforcing a judgment in Israel,
you may not be able to collect any damages awarded by either a U.S. or foreign court.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Moreover, among other reasons, including but not limited to, fraud or absence of due
process, or the existence of a judgment which is at variance with another judgment that was given in the same matter if a suit in the
same matter between the same parties was pending before a court or tribunal in Israel, an Israeli court will not enforce a foreign judgment
if it was given in a state whose laws do not provide for the enforcement of judgments of Israeli courts (subject to exceptional cases),
or if its enforcement is likely to prejudice the sovereignty or security of the State of Israel.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Provisions of our amended and restated articles of association and
Israeli law may delay, prevent or make difficult a merger with, or an acquisition of, the Company, which could prevent a change of control
even when the terms of such transaction are favorable to us and our shareholders and, therefore, could depress the price of our ordinary
shares.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 21.3pt; line-height: 1.25">As a company incorporated under the laws of the State of Israel, we are subject to
Israeli corporate law. Israeli corporate law regulates mergers, requires tender offers for acquisitions of ordinary shares above specified
thresholds, requires special approvals for transactions involving directors, officers or certain significant shareholders and regulates
other matters that may be relevant to these types of transactions. In addition, our amended and restated articles of association contain
provisions that may make it more difficult to acquire us, such as classified board provisions. Furthermore, Israeli tax considerations
may make potential transactions unappealing to us or to some of our shareholders whose country of residence does not have a tax treaty
with Israel granting tax relief to such shareholders from Israeli tax obligations. With respect to mergers, Israeli tax law allows for
tax deferral in certain circumstances but makes the deferral contingent on the fulfillment of numerous conditions, including, in some
cases, a holding period of two years from the date of the transaction during which certain sales and dispositions of shares of the participating
companies are subject to certain restrictions. See &#8220;Item 10E. Additional Information-Taxation-Israeli Material Tax Considerations&#8221;
for additional information.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">30</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-indent: 21.3pt; line-height: 1.25">In addition, as a corporation incorporated under the laws of the State of Israel,
we are subject to the Israeli Economic Competition Law, 1988, and the regulations promulgated thereunder (formerly known as the Israeli
Antitrust Law, 1988), under which we may be required in certain circumstances to obtain the approval of the Israel Competition Authority
(formerly known as the Israel Antitrust Authority) in order to consummate a merger or a sale of all or substantially all of our assets.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">These provisions of our amended and restated articles of association and Israeli law
may delay, prevent or make difficult an acquisition of us, which could prevent a change of control and therefore depress the price of
our ordinary shares.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Your rights and responsibilities as a holder of our ordinary shares
will be governed by Israeli law, which differs in some material respects from the rights and responsibilities of shareholders of U.S.
companies.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Since we are incorporated under Israeli law, the rights and responsibilities of the
holders of our ordinary shares are governed by our articles of association and by Israeli law, including the Companies Law. These rights
and responsibilities differ in some material respects from the rights and responsibilities of shareholders in typical U.S. corporations.
In particular, pursuant to the Companies Law, a shareholder of an Israeli company has certain duties, including to act in good faith and
fairness and in a customary manner in exercising its rights and performing its obligations towards the company and other shareholders
and to refrain from abusing its power in the company including, among other things, in voting at the general meeting of shareholders on
certain matters, such as an amendment to the company&#8217;s articles of association, an increase of the company&#8217;s authorized share
capital, a merger of the company, and approval of related party transactions that require shareholder approval. A shareholder also has
a general duty to refrain from discriminating against other shareholders. In addition, a controlling shareholder or a shareholder who
knows that it possesses the power to determine the outcome of a shareholders&#8217; vote or to appoint or prevent the appointment of an
officer of the company has a duty to act in fairness towards the company with regard to such vote or appointment. See &#8220;Item 6C.
Directors, Senior Management and Employees-Board Practices-Approval of Related Party Transactions under Israeli Law&#8221; for additional
information. There is limited case law available to assist in understanding the nature of these duties or the implications of these provisions.
These provisions may be interpreted to impose additional obligations on holders of our ordinary shares that are not typically imposed
on shareholders of U.S. corporations.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold"><span id="ITEM4"><!--Anchor--></span>ITEM 4. INFORMATION ON THE COMPANY</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">A. History and Development of the Company</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We were incorporated as a limited liability company in the State of Israel on January
2, 2008 and operate under its laws. In November 2017, our corporate name was changed from Invasix Ltd. to InMode Ltd. Our registered office
is located at Tavor Building, Sha&#8217;ar Yokneam, P.O. Box 533, Yokneam 2069206, Israel. The phone number of our registered office is
+972-4-9096313. Our wholly&#8209;owned subsidiary, Invasix Inc., a Delaware corporation, acts as our agent for service of process in the
United States and is located at 17 Hughes Irvine, California 92618. The phone number for Invasix Inc. is 949-387-5711.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">In August 2019, we completed our initial public offering of 10,000,000 of our ordinary
shares at an initial public offering price of $7.00 per ordinary share. The effective date of the registration statement on Form F-1 (File
No. 333-232615) was August 7, 2019. Also, during August 2019, the underwriters partially exercised their over-allotment option and purchased
an additional 1,000,000 ordinary shares at the same price per share. Our ordinary shares commenced trading on Nasdaq on August 8, 2019,
under the symbol &#8220;INMD&#8221;.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our capital expenditures for the years ended December 31, 2023, 2022 and 2021 amounted
to approximately $0.8 million, $1.6 million and $0.9 million, respectively. Our capital expenditures consist principally of the purchase
of molds for manufacturing. We anticipate our capital expenditures in 2024 to be up to $1 million and to be financed from our existing
cash and cash equivalents.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The SEC maintains an Internet site that contains reports, proxy and information statements,
and other information regarding issuers, including InMode, that file electronically with the SEC. The address of that site is www.sec.gov.
We maintain a corporate website at <span style="text-decoration: underline">www.inmodemd.com</span>. Our periodic filings are available,
free of charge (other than an investor's own Internet access charges), on our website soon as reasonably practicable after we electronically
file or furnish such material with the SEC. The information contained on our website or available through our website is not incorporated
by reference into and should not be considered a part of this Annual Report on Form 20-F, and the reference to our website in this Annual
Report on Form 20-F is an inactive textual reference only.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">31</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25; font-weight: bold">B. Business Overview</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Overview</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We are a leading global provider of innovative, energy-based, minimally invasive surgical
medical treatment solutions. Within the global aesthetics market, our products and solutions are primarily designed to address three energy-based
treatment categories comprised of: (i) face and body contouring; (ii) medical aesthetics; and (iii) women&#8217;s health. We have developed
and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing
adipose tissue remodeling. We believe our RF energy-based proprietary technologies&#8212;(i) Radio Frequency Assisted Lipolysis, or RFAL;
(ii) Deep Subdermal Fractional RF; (iii) Simultaneous Fat Destruction and Skin Tightening; and (iv) Deep Heating Collagen Remodeling for
skin and human natural openings -- represent a paradigm shift in the minimally invasive aesthetic solutions market. These technologies
are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures including liposuction with simultaneous
skin tightening, face and body contouring, ablative skin rejuvenation treatments and treatment of Genitourinary Syndrome of Menopause
(GSM). Our products, developed with our proprietary RF energy-based technologies, overcome many of the shortcomings of other surgical
options by delivering surgical-grade results under local anesthetics while significantly minimizing risks of scarring, downtime, pain
and other complications typically accompanying surgical procedures. In addition to our minimally invasive solutions, we design, develop,
manufacture and market differentiated, non-invasive medical aesthetic products that target a wide array of procedures. These include simultaneous
fat killing and skin tightening, permanent hair reduction through the use of our innovative dual wavelength technology and other treatments
targeting skin appearance and texture through the use of our high power IPL technology. Our products, which we market and sell traditionally
to plastic and facial surgeons, aesthetic surgeons, dermatologists and OB/GYNs may be used on a variety of body parts including the face,
neck, abdomen, upper arms, thighs and intimate feminine regions.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">In addition to the existing group of patients who currently undergo full surgical aesthetic
procedures, we believe our minimally invasive solutions satisfy an unmet market demand in two incremental groups of patients: (i) those
whose skin laxity or other physical attributes have previously precluded them from undergoing surgical aesthetic procedures and (ii) those
who would entertain the idea of surgical or minimally invasive aesthetic procedures, but are averse to the associated costs, downtime
and potential safety risks. We believe these patient populations will continue to represent a significant opportunity for our differentiated
minimally invasive aesthetic solutions.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We believe our products have consistently been at the forefront of technological development
in the aesthetic solutions market. Since 2010, we have launched 12 product platforms: <span style="font-style: italic">BodyTite, Optimas,
Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, Morpheus8, EmpowerRF</span>, <span style="font-style: italic">Define</span> and <span style="font-style: italic">Envision</span>.<span style="font-style: italic">&#160;</span>In
2023, we launched two products: the <span style="font-style: italic">Define</span> and the <span style="font-style: italic">Envision</span>.
Each product consists of the following components: a platform that incorporates multiple energy sources, one or more handpieces or hands-free
applicators, our proprietary software and a simple user interface with touch screen. Our platforms have a small footprint and are lightweight
compared to our competitors&#8217; systems, which are typically larger and heavier. Our products can be upgraded easily by the user in
order to perform additional treatments by adding handpieces, hands-free applicators and/or installing software in the existing platform.
The ease of upgrades enables our customers to meet demand for aesthetic solutions through additional service offerings.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our focus on innovation has resulted in a strong track record of sustained new and next-generation
product development. We believe our ability to bring new products to market and continuously innovate is a distinct competitive advantage.
We launched two new product platforms in 2021, which are based on our existing RF energy-based proprietary technology, with the goal of
further penetrating the market for surgical and medical treatment solutions. The two platforms that were introduced in 2021 are the <span style="font-style: italic">EmpowerRF</span>
which is for women&#8217;s health indications and <span style="font-style: italic">EvolveX</span>&#160;which replaced our <span style="font-style: italic">Evolve</span>
platform.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We expect that the new product platforms will complement our existing portfolio of products,
allowing us to increase our offerings to existing customers and attract new customers. We believe that introducing new product platforms
is important in order to satisfy consumer demand and respond to evolving technological developments.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">32</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25">In response to customers&#8217; desires to enhance and expand their offering of our
aesthetic and wellness office-based procedures, we are developing additional RF energy-based platforms, handpieces and applicators targeted
towards several medical specialties.</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z867343211b194ce19240e3e522ffe348" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>For ENTs, we are in the initial stage of developing a new platform and handpieces that we believe will provide patients with a medical
        treatment solution for snoring and rhinitis. The handpiece for treatment of snoring is based on our Deep Subdermal Fractional RF technology
        and is expected to contract and stiffen the soft palate (located on the back of the roof of the mouth), which blocks the airway, causing
        tissues to vibrate during sleep. This platform and both handpieces are in the concept design phase.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z8c04300b659e4a8abb4c858a2e1038f3" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>For urologists, we are in the early-stages of developing a device using RF energy to treat ED (Erectile Dysfunction). We registered
        a patent application to protect our technological concept, and we believe that our technological concept will work well for this indication
        but much more research and development is needed.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We are focused on establishing and using clinical evidence to support and broaden our
marketing claims and drive customer awareness and acceptance of our products. Traditionally, the aesthetic solutions market has relied
heavily on marketing efforts and &#8220;before-and-after&#8221; pictures in an attempt to distinguish products. We believe our focus on
establishing clinical evidence for the efficacy of our products has been important for adoption by our surgically-trained customers, who
are accustomed to seeing extensive clinical data in their non-aesthetic practices. To date, <sup style="vertical-align: text-top; line-height: 1; font-size: smaller">&#160;</sup>85&#160;
third-party clinical studies have been completed and seven&#160; third-party clinical studies are in the process of being conducted using
our products. We also have a portfolio of 90&#160; peer-reviewed publications. While we did not have any involvement in the clinical studies
mentioned above, such studies provide qualitative results that we believe are meaningful. However, because these were third-party studies,
we do not have access to any raw data to conduct any quantitative analyses.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">To complement our surgical aesthetic and medical treatment solutions, we offer post-sales
training and support services. We provide physicians with training focused on the most beneficial ways to utilize our products, including
safety and instructional videos to expand procedural offerings and hands-on, personalized marketing support. We believe that we provide
one of the most extensive training and ongoing support programs available to physicians throughout the aesthetic solutions market.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our revenue increased to approximately $492.0 million for the year ended December 31,
2023, from approximately $454.3 million for the year ended December 31, 2022 and from $357.6 million for the year ended December 31, 2021.
For the years ended December 31, 2023, 2022 and 2021, we recorded a gross margin of approximately 84%, 84% and 85%, respectively, and
net income of approximately $197.9 million, $161.5 million, and $165.1 million, respectively. Our principal market is in the U.S, where
our revenue increased to approximately $307.8 million for the year ended December 31, 2023, from approximately $298.6 million for the
year ended December 31, 2022 and from $237.3 million for the year ended December 31, 2021. Outside of the U.S, our revenue increased to
approximately $184.2 million for the year ended December 31, 2023, from approximately $155.7 million for the year ended December 31, 2022
and from $120.3 million for the year ended December 31, 2021.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Regarding U.S. revenues for the years ended December 31, 2023, 2022 and 2021, we derived
approximately $264.7 million, or 86%, $253.8 million, or 85%, and $168.5 million, or 71%, respectively, of our total U.S revenues from
the sale of minimally invasive platforms. We derived approximately $33.9 million, or 11%, $35.8 million, or 12%, and $64.1 million, or
27.0%, respectively, of our total U.S revenues from the sale of hands-free platforms, and approximately $9.2 million, or 3%, $8.9 million,
or 3%, and $4.7 million, or 2%, respectively, of our total U.S revenues from the sale of non-invasive platforms.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We have 31 FDA clearances and, in addition to the United States, where we have an installed
base of approximately 10,250 product platforms, we are permitted to sell our products in most countries. As of December 31, 2023, we sell
and market our products in the United States, Canada, United Kingdom, Irland, Spain, Portugal, France, Belgium, Luxembourg, Italy, Germany,
Austria, Japan, Australia and India through a direct sales force (include distributer sales managers) of approximately 263 representatives.
We also sell and market our products through 59 distributors in 82 countries. As of December 31, 2023, we had a global installed base
of approximately 22,900 product platforms capable of running various multi-use applicators and utilizing minimally invasive consumables.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">33</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25; font-weight: bold">Our Solution</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Key benefits of our minimally invasive surgical aesthetic and medical treatment solutions
include:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z79bd8b4f137e47dfbf2007ef761a428a" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>Small to no incisions, which reduces the drawbacks and risks typically associated with surgical procedures such as significant pain,
        local or widespread scarring, infection, perforation and hemorrhage.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zc1b5e9256b4b499c97f786ccd6575379" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>Outpatient procedures that typically do not require general anesthesia, which can decrease patient downtime, discomfort and other
        potential complications and typically reduces cost.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zdc25dfb5dc4e4192b89eb6295388813c" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>Minimally invasive procedures with similar efficacy to surgical procedures that have the ability to expand the addressable patient
        population for aesthetics procedures.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z48e951007b27438e8782d10515acface" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>Effective and long-lasting aesthetic solutions, many of which are supported by compelling clinical data, including 90 peer-reviewed
        publications.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z803bc01b9d134b0fada4d2cade5ce725" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>Differentiated, RF energy-based technology simultaneously kills fat and tightens skin, overcoming the many shortcomings of traditional
        surgical, minimally and non-invasive aesthetic procedures.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z3109ee0a07b04be38e6a6e9a93258faf" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>Innovative dual wavelength laser technology that allows for permanent hair reduction on a wider range of skin types and hair textures
        than other aesthetic solutions currently on the market, reducing the number of treatments required.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z260916dac1b043738af7e70737e22d69" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>Typically less expensive than other aesthetic solutions on the market that provide comparable results as a result of less required
        physician time and training required.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Leader in RF Energy</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We believe we are the leader in using RF energy for both minimally invasive and subdermal
ablative aesthetic purposes. RF energy is different from optical energy because it is not absorbed by the epidermis and is able to be
targeted to penetrate deep into the tissue. The application of RF energy in medicine is a well-established practice. For example, RF energy
is the basis of magnetic resonance imaging, or MRI, and surgical diathermy, used to cauterize blood vessels to prevent excessive bleeding,
both commonplace applications administered regularly in medical practice. RF energy is also used in cardiology for ablative interventions
and in oncology surgery for tumor/metastasis ablation.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">RF energy can be delivered to the skin in a variety of ways, the most common being monopolar
delivery, whereby RF energy is delivered through a single probe placed on the skin with a grounding pad distant to the probe site. Alternatively,
in bipolar delivery, RF energy is delivered from a probe with two electrodes placed over the treatment area. Bipolar delivery has an important
advantage over monopolar delivery: depth of penetration of the RF energy is not dependent on the tissue impedance, or electrical resistance,
which varies from person to person, or the cross-sectional area of the probe. That is not the case with monopolar delivery. Instead, in
bipolar delivery, depth of penetration of the RF energy depends on the distance between the two electrodes on the probe, with increasing
distance resulting in increased depth of penetration. We believe we are the leader in the development, design and commercialization of
bipolar RF energy devices for minimally invasive and subdermal ablative aesthetic purposes.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Radio-Frequency Assisted Lipolysis</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Using our expertise in bipolar RF energy delivery, we developed what we believe is the
next generation of lipolysis and adipose tissue remodeling technology, a new category that delivers a thermal response to the adipose
tissue, skin and subdermal matrix. Our RFAL products deliver directional RF energy into the subcutaneous fat to coagulate, liquefy and
remodel adipose tissue and heat the subcutaneous fibrous septa, or partitions, resulting in substantial collagen contraction of subdermal
space. We believe we are the first company to utilize bipolar radio frequency in a minimally invasive manner. Our RFAL products generate
a higher power and more efficient energy transfer than laser energy systems and allow the treatment of larger volumes of the subcutaneous
tissue with optimal thermal profiles, facilitating the significant tightening of the tissue. The shrinkage of tissue is significant and
can reach double-digit percentages of the heated tissue volume. The thermal energy is delivered by an innovative handpiece comprised of
two electrodes: the internal electrode is inserted into the fat layer while the other larger electrode is applied externally to the skin
surface above the cannula tip. The internal cannula is passed through the subcutaneous fat while the external electrode is moved above
and over the skin&#8217;s surface. The small, conductive tip of the cannula delivers RF energy into the subcutaneous fat, liquefying it
and simultaneously contracting fibrous septa. The liquefied fat can then be removed from the body through a suction cannula. Our RFAL
products also apply gentle uniform heating of the dermis, thereby promoting skin tightening. Figure 1 below shows how the RF energy is
delivered through the handpiece to simultaneously liquefy fat and tighten the skin.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">34</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25">Our <span style="font-style: italic">BodyTite</span> and <span style="font-style: italic">EmbraceRF</span>
platforms and the <span style="font-style: italic">BodyTite</span> and <span style="font-style: italic">FaceTite</span> handpieces rely
on our proprietary RFAL technology. To date, there have been more than 250,000 successful RFAL procedures conducted with positive clinical
results using our <span style="font-style: italic">BodyTite</span> and <span style="font-style: italic">EmbraceRF</span> platforms and
the <span style="font-style: italic">BodyTite</span> and <span style="font-style: italic">FaceTite</span> handpieces.<sup style="vertical-align: text-top; line-height: 1; font-size: smaller">&#160;</sup>We
have demonstrated that RFAL has the potential to elicit three-dimensional soft tissue contraction reliably and predictably to both serve
otherwise non-traditional liposuction candidates, as well as to improve outcomes in patients for whom liposuction is an option.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: center; text-indent: 18pt; line-height: 1.25"><img src="image00001.jpg" alt="" style="width: 275px; height: 165px"/></div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: center; line-height: 1.25; font-weight: bold">Figure 1: RFAL mechanism of action.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Deep Subdermal Fractional RF</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our Deep Subdermal Fractional RF delivers RF energy into the subdermal fat tissue to
depths of up to four millimeters, or mm. Deep Subdermal Fractional RF provides skin tightening and adipose tissue remodeling directly
under the dermal layer. Our Deep Subdermal Fractional RF products deliver RF energy under the dermis through an array of pins producing
localized heat and small micro-lesion dots in the treatment area. The heat generated by the pins in the subdermal tissue promotes collagen
restructuring and tissue reshaping. Physicians can offer a versatile fractional treatment creating a three-dimensional matrix of coagulation
volumes inside the tissue. Deep Subdermal Fractional RF is used for wrinkle reduction, skin tightening and treatment of cellulite appearance.
Our deep subdermal fractional RF can be applied to both face and body. Our <span style="font-style: italic">Morpheus8, Morpheus8 Body
</span>and <span style="font-style: italic">Morpheus8 V </span>handpieces rely on our proprietary Deep Subdermal Fractional RF technology
and are used in conjunction with our <span style="font-style: italic">BodyTite, Embrace RF, Optimas,</span>&#160;<span style="font-style: italic">EmpowerRF,
Envision and Define </span>platforms. Figure 2 below shows how the RF energy is delivered through the coated pins on the handpiece to
reshape tissue under the dermal layer.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: center; text-indent: 18pt; line-height: 1.25"><img src="image1.jpg" alt="" style="width: 185px; height: 161px"/>&#8201;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: center; line-height: 1.25; font-weight: bold">Figure 2: Deep Subdermal Fractional RF mechanism of action.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Simultaneous Fat Destruction and Skin Tightening</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our Simultaneous Fat Destruction and Skin Tightening proprietary technology combines
vacuum and bipolar RF energy with high and low amplitudes to both permanently kill adipose tissue and contract the skin. We believe our
Simultaneous Fat Destruction and Skin Tightening technology is the first and only RF-based, non-invasive body contouring technology that
permanently kills adipose tissue. Our BodyFX handpiece and MiniFX handpiece utilize our Simultaneous Fat Destruction and Skin Tightening
technology to address problematic fatty tissue in larger body areas such as the abdomen, back and thighs.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">35</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Deep Heating Collagen Remodeling for Skin and Human Natural Openings</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our Deep Heating Collagen Remodeling propriety technology delivers heat in a uniform
and volumetric form targeting deep into tissue while providing collagen remodeling with real-time control of the device&#8217;s temperature.
The versatility of this technology allows the operator to provide a customized solution to address a variety of women&#8217;s wellness
concerns that occur due to aging, hormonal stress or physical damage. Our <span style="font-style: italic">Forma,</span>&#160;<span style="font-style: italic">FormaV,
</span>and <span style="font-style: italic">Morpheus8V</span> handpieces utilize Deep Heating Collagen Remodeling technology while harnessing
continuous bipolar RF energy with real-time temperature measurement. RF energy generated heat is delivered uniformly to vaginal tissue
through a consumable applicator to provide vaginal and labia contraction with patients often seeing effects of the procedure immediately.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Pulse/Continuous Bipolar RF</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Continuous Bi-polar RF is electrical energy in the RF spectrum (1 MHz) that results
from the flow of an electric charge between two electrodes. This conducted energy increases ion movement in the tissue and generates kinetic
energy that is transformed to thermal energy (heating). In turn, this thermal energy causes controlled damage to the tissue and triggers
a natural healing mechanism and tissue-renewal resulting in tissue tightening and remodeling. The distance between the electrodes allows
for control of the depth of penetration of the bi-polar RF energy into the tissue. The distance between the electrodes is chosen based
on the particular treatment and according to the tissue to be treated (generally varies between a few millimeters to 3-4 centimeters).
Bi-polar RF can be delivered to the tissue in one of two modes: either pulse or continuous. In pulse mode, pulse duration is pre-determined
and RF energy automatically stops. In continuous mode, the RF energy is delivered uninterrupted into the tissue for as long as the operator
deems appropriate. As part of the design, continuous bi-polar RF energy allows real-time measurement of the patient&#8217;s skin temperature.
This allows our products to provide real-time feedback to the operator throughout the treatment process and enhances overall safety and
efficiency. All of our RF platforms (both existing and expected) and RF handpieces (both minimally and non-invasive) have both pulse bi-polar
RF and continuous bi-polar RF capabilities. Our proprietary RFAL-based products (such as our <span style="font-style: italic">BodyTite
</span>product platform and <span style="font-style: italic">FaceTite </span>handpiece) and Deep Heating Collagen Remodeling based products
(such as our <span style="font-style: italic">Forma </span>handpiece) primarily utilize the continuous bipolar RF feature. Our proprietary
Deep Subdermal Fractional RF based products (such as our <span style="font-style: italic">Morpheus8 </span>handpiece) and Simultaneous
Fat Destruction and Skin Tightening products (such as our BodyFX handpiece) primarily utilize the pulse feature depending on the procedure
and target result. Figure 3 below shows how RF energy is delivered through the handpiece by an electric charge between two electrodes
continuously into the tissue.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: center; line-height: 1.25"><img src="image2.jpg" alt="" style="width: 212px; height: 120px"/>&#8201;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: center; line-height: 1.25; font-weight: bold">Figure 3: Pulse/Continuous Bi-polar RF mechanism of action.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Non-invasive Medical Aesthetic Technologies</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">In addition to our proprietary minimally invasive solutions, we continue to develop
innovative non-invasive medical aesthetic solutions, including:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="za7e72c2fa3d64785b33d4bd41eb16024" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div><span style="font-style: italic">Simultaneous non-invasive fat killing and skin tightening</span>. We believe our technology is the
        first and only RF-based, noninvasive body contouring technology that permanently kills adipose tissue while simultaneously contracting
        the skin. This technology addresses problematic fatty tissue in large body areas such as the abdomen, back and thighs. Customers use this
        technology with the <span style="font-style: italic">Contoura</span> platform and the <span style="font-style: italic">BodyFX</span> and
        <span style="font-style: italic">MiniFX</span> handpieces.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z36cafe9c73704412acf8c347b94d6e39" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div><span style="font-style: italic">Dual wavelength for permanent hair reduction</span>. Our single-pulse, dual wavelength product for
        permanent hair reduction, <span style="font-style: italic">Triton</span>, combines two wavelengths in one platform, overcoming certain
        limitations of standard lasers. This optimal mix of wavelengths allows the highest efficiency and safety. We believe <span style="font-style: italic">Triton</span>
        is the only FDA-cleared, single-pulse, dual wavelength product for permanent hair reduction. Customers use this technology with the <span style="font-style: italic">Triton
        Duo</span>&#160;<span style="font-style: italic">Light</span> and <span style="font-style: italic">Triton Duo</span>&#160;<span style="font-style: italic">Dark</span>
        handpieces.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">36</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<table cellspacing="0" cellpadding="0" id="zb61764a3157d4d42b0491e2fa2a105f4" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div><span style="font-style: italic">High-power Intense Pulsed Light</span>. Our high-power IPL is a breakthrough technology that delivers
        up to three times more energy than typical IPL devices within the 500 to 600 nanometer, or nm, range to improve efficacy for vascular
        and pigmented lesions. It is optimized to treat a variety of skin types and conditions in a single session. Customers use this technology
        with the <span style="font-style: italic">Optimas</span> platform and the <span style="font-style: italic">Lumecca handpiece</span>.</div>
        </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z0ba787d1aa4d403a9bdb35225fb5bfd2" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div><span style="font-style: italic">Controlled continuous RF heating. </span>We believe our controlled continuous RF technology is the
        first auto-adjusting non-invasive thermal skin treating technology for deep and uniform tissue stimulation. This technology uses bipolar
        RF energy delivery that allows uniformity between the electrodes to provide a comfortable thermal effect with immediate and subsequent
        contraction. Customers use this technology with the <span style="font-style: italic">Optimas, Votiva, Contoura, Evoke </span>and <span style="font-style: italic">EvolveX
        hands-free </span>platforms, <span style="font-style: italic">EmpowerRF</span> for women&#8217;s health, <span style="font-style: italic">Envision</span>
        and <span style="font-style: italic">Define</span>.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Differentiated and Comprehensive Post-Sales Support</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">To complement our innovative aesthetic solutions, we offer post-sales support services
focused on the most beneficial ways to utilize our products, including a disciplined focus on safety. Our post-sales and support program
consists of three key components:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z914a40879e4a49e0924d60ee8e15dcac" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 58.5pt"><br/> </td>
    <td style="width: 31.5pt; vertical-align: top">i.</td>
    <td style="width: auto; vertical-align: top">
        <div>A visit by a new physician to one of our many highly qualified plastic surgery facilities for instruction followed by a live patient
        demonstration;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zd378b1d31db34c26a7a7d3dd791bc222" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 58.5pt"><br/> </td>
    <td style="width: 31.5pt; vertical-align: top">ii.</td>
    <td style="width: auto; vertical-align: top">
        <div>A visit to the new physician&#8217;s office by a trained registered nurse or physician&#8217;s assistant to attend the first day
        of treatments to in-service; and</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="za0247f5ba6604ba2a730297a16063bf5" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 58.5pt"><br/> </td>
    <td style="width: 31.5pt; vertical-align: top">iii.</td>
    <td style="width: auto; vertical-align: top">
        <div>Open house workshops organized by us, wherein the new physician invites his or her patient base and we assist him or her in &#8220;kick
        starting&#8221; marketing efforts. These events typically secure significant procedural revenues for the physician.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">In addition, we offer ongoing livestream cases for customers where they can observe
and interact in real-time with both our training staff and highly qualified physician instructors on a regular basis. Advanced training
is also available for physicians who choose to expand their education on highly skilled procedures, including non-excisional breast lifting
or brachioplasty. We are continuing to build a library of on-line instructional videos as both a reference tool and to expand physicians&#8217;
procedural offerings. We also provide support to help customers educate and engage patients about the new minimally invasive procedures
available to them through our In-Practice program. This program provides hands-on, personalized marketing support for customers&#8217;
practices including signage, educational collateral, digital marketing and advertising assets. We believe that we provide one of the most
extensive training and ongoing support programs available to physicians throughout the aesthetics industry.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Our Competitive Strengths</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We attribute the growing commercial success of our various platforms and products to
the following:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zf678efafd8234413a58848e373fdc68a" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div><span style="font-style: italic">Pioneer of the minimally invasive aesthetic solutions market</span>. We believe our proprietary
        technologies represent a paradigm shift in the minimally invasive and surgical aesthetic solutions market. We believe our technologies
        and products demonstrate numerous performance advantages over other aesthetic options and enable physicians and patients to obtain results
        that can generally only be achieved with more expensive and invasive surgical procedures. Our RF proprietary energy-based technology simultaneously
        kills fat and tightens skin, overcoming many of the limitations of other surgical, minimally and non-invasive procedures, positioning
        us to address unmet patient needs and expand the addressable patient population for aesthetic solutions. Although each of our product
        platforms has a primary handpiece or applicator that is either minimally or non-invasive, our platforms are designed to be modular, which
        enables the user to provide complementary treatments using a single platform by attaching different handpieces or applicators.</div> </td>
        </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zf878fd24114341b0b5ee82145510b987" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div><span style="font-style: italic">Strong brand recognition</span>. Our brand is associated with product leadership, significant technological
        advances and extensive clinical data, which has led to strong customer loyalty. Unlike many of our competitors, our technology is not
        exclusively laser-based or limited to superficial treatment of the skin. Instead, we have developed and commercialized products utilizing
        medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. We believe
        our brand is synonymous throughout the physician and patient communities with having the broadest RF energy-based portfolio in the minimally
        invasive aesthetics market for fat destruction and remodeling, face and body contouring and skin tightening.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">37</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<table cellspacing="0" cellpadding="0" id="z26e3306df6524973aaa46768c2262657" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div><span style="font-style: italic">Provide comprehensive solutions for physicians and patients</span>. We have an extensive product
        portfolio that includes solutions for a wide range of both minimally and non-invasive procedures across the aesthetic solutions market.</div>
        </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z76c9427b89de4b7c98d84bcda0417948" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div><span style="font-style: italic">Broad regulatory approvals supported by extensive clinical data. </span>We have 31 FDA clearances
        and in addition to the United States, are permitted to sell in Europe, Argentina, Australia, Brazil, Canada, China, Colombia, the Commonwealth
        of Independent States, Israel, Mexico, Panama, Philippines, Russia, South Korea, Taiwan and Thailand. To date, we also have a portfolio
        of 90 peer-reviewed publications and there are 85 completed and 7 ongoing third-party clinical studies on a number of our products <span style="font-style: italic">(BodyTite,
        FaceTite, NeckTite, Optimas, Fractora, Morpheus8, Forma, Lumecca, DiolazeXL, Votiva, Morpheus8V, FormaV, Contoura, BodyFX, MiniFX, Evoke,
        EvolveX, Morpheus8, Forma I, Lumecca I and</span>&#160;<span style="font-style: italic">AccuTite). </span>While we did not have any involvement
        in the clinical studies mentioned above, such studies provide qualitative results that we believe are significant. However, because these
        were third-party studies, we do not have access to any raw data to conduct any quantitative analyses. We believe our focus on demonstrated
        clinical data and effectiveness differentiates us from our competition and helps to validate our technology with surgically-trained physicians,
        who we believe are typically the most difficult segment of the market to penetrate.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z768a8612b8e748b4936c85243b023d97" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div><span style="font-style: italic">Strong management team with proven track record</span>. Our management team has significant expertise
        in the medical aesthetics industry with a proven track record of successfully developing and commercializing innovative technologies.
        Moshe Mizrahy and Dr. Michael Kreindel, our co-founders, previously founded Syneron Medical Ltd. Our senior executive team has an average
        of over 15 years of medical aesthetics industry experience and has served in various leadership positions at Syneron Medical Ltd. and
        Cynosure, Inc.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Our Growth Strategy</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our objective is to expand our technological leadership in the surgical solutions market
and to leverage our RF proprietary technologies to expand into additional medical solutions markets. We intend to achieve this goal by
implementing the following strategies:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zc44b220f05744d57b9545a0613088c2e" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div><span style="font-style: italic">Increase our sales presence to target and expand our addressable market globally</span>. We plan
        to continue to expand our direct sales organization and our distribution network and seek to recruit and train exceptionally talented
        sales representatives in existing and new markets to help us broaden the adoption of our products, drive further market penetration and
        expand beyond our traditional customer base.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z5352f063cbb64fa6a833783517cc67af" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 90pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div><span style="font-style: italic">United States</span>: We have a direct sales presence in United States and plan to keep expanding
        our direct sales team.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zc8a0696458f2400da8a67790a6f2878b" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 90pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div><span style="font-style: italic">Canada</span>: We have a direct sales presence in Canada and plan to keep expanding our direct sales
        team.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z06bfcf18dca44f7c92a80f349a6ada66" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 90pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div><span style="font-style: italic">Europe</span>: We intend to establish sales and marketing organizations and a network of exclusive
        European distributors (in addition to our subsidiaries network in the United Kingdom, Spain, Italy, France and Germany).</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zd2c100c22d3e4285a3098d44e6f12fe6" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 90pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div><span style="font-style: italic">Latin America</span>: We plan to enhance our network of exclusive distributors in Argentina, Brazil,
        Colombia, Mexico, Panama and Chile.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z1d9ddd2951234086b282f7ba3d3a3d04" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 90pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div><span style="font-style: italic">Asia-Pacific</span>: In addition to our direct sales presence in India and Australia, we may also
        establish direct sales presence in China through our fully-owned subsidiary in Guangzhou, as well as enhance our network of exclusive
        distributors in Japan, Philippines, South Korea, Taiwan and Thailand.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">38</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<table cellspacing="0" cellpadding="0" id="z4883a7033064408baf5e59aaa92f5701" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div><span style="font-style: italic">Continue to further penetrate our existing customer base and drive recurring revenues. </span>We
        believe that there are opportunities for us to generate additional revenue from existing customers who are already familiar with our products.
        Additionally, we have experienced growth in the sales of consumables over the past six years. Since inception, we have sold over 2.6 million
        consumables. We expect that as our customer base grows, the percentage of our revenues attributable to consumables will increase. We also
        expect that certain customers will be candidates for technology upgrades to enhance the capabilities of their existing InMode products.
        In addition, as we continue to grow our support services program, we expect to seek to increase the number of customers that enter into
        extended warranties, which would provide us with additional recurring revenues.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="ze52609c7b079431ab3182bf0fa7f3e6f" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div><span style="font-style: italic">Leverage our existing technology to expand into new minimally and non-invasive applications</span>.
        We have an active research and development pipeline focused on additional solutions targeted to our traditional customer base. Our near-term
        product development portfolio consists of new and second generation solutions for various conditions, including wearable, noninvasive
        face and body reshaping products, cellulite, large area lipolysis, fractional RF treatment of SUI, vaginal laxity pelvic floor muscle
        restoration, labiaplasty procedures, post-partum treatments and other GSM symptoms, snoring and rhinitis treatments, dry eye and eyelid
        treatments, TMJ (Temporomandibular Joint Disorders) and ED (Erectile Dysfunction). We launched two new product platforms in 2021 and one
        of them (<span style="font-style: italic">EvolveX</span>) replaced our <span style="font-style: italic">Evolve</span> platform, which
        we believe will allow us to continue to grow our revenues over the long term and further penetrate the market for aesthetic solutions.
        Each such product is or will be subject to the FDA regulatory framework, specifically, the FDA&#8217;s 510(k) clearance requirements,
        described in this Annual Report on Form 20-F.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z77f58ad9879d408fbd3472ecad9123fa" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div><span style="font-style: italic">Expand our customer base beyond traditional customers</span>. We intend to develop products that
        leverage our minimally and non-invasive technologies to address the unmet market needs of a new customer base, which includes OB/gyns,
        ENTs, ophthalmologists, general practitioners and aesthetic clinicians. We intend to adapt our products to the expertise and skill level
        of these providers, further expanding our addressable market.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z15f78804fca04fd0af17ec5bc2d612c1" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div><span style="font-style: italic">Actively pursue business development opportunities</span>. We may seek to engage in targeted business
        development activities, including acquisitions of technologies and strategic partnerships, in order to augment our product and technology
        portfolio in our existing and potentially adjacent markets. We believe we can leverage our global infrastructure and existing relationships
        to implement a disciplined tuck-in acquisition strategy.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zfae2995d89f24515aa2ba022fd9977d7" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div><span style="font-style: italic">Expand our intellectual properly and patent portfolio</span>. We intend to expand our existing intellectual
        property and patent portfolio as we develop additional applications and continue to aggressively defend against potential infringement
        by our competitors.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Our Products</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We offer a broad portfolio of aesthetic and medical treatment solutions that consist
of a variety of platforms providing minimally and non-invasive applications. The following tables provide information concerning our product
platforms and their applications.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">39</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25; font-weight: bold"><span style="text-decoration: underline">Minimally Invasive and Ablative Platforms</span></div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" border="0" id="zf45700a389e54450b2ce7a13e9472cea" style="font: 10pt Times New Roman,Times,serif; width: 100%; text-align: left; color: rgb(0, 0, 0)">
  <tr>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 11.79%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif; font-weight: bold">Product</div>
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif; font-weight: bold">Platform</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 18.86%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif; font-weight: bold">Energy</div>
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif; font-weight: bold">Source(s)</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 10.82%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif; font-weight: bold">Year</div>
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif; font-weight: bold">Introduced</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 21.56%; vertical-align: bottom; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif; font-weight: bold">Handpiece(s)</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 36.96%; vertical-align: bottom; border-right: rgb(0, 0, 0) 2px solid; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif; font-weight: bold">Primary (not Exclusive)
        Applications*</div> </td> </tr>
  <tr>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 11.79%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif; font-style: italic; font-weight: bold">BodyTite</div>
        </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 18.86%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif">Bipolar RF</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 10.82%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif">2010</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 21.56%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif; font-style: italic">BodyTite</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 36.96%; vertical-align: top; border-right: rgb(0, 0, 0) 2px solid; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif">Body Contouring (MI)</div> </td> </tr>
  <tr>
    <td style="border-left: rgb(0, 0, 0) 2px solid; width: 11.79%; vertical-align: top">&#160;</td>
    <td style="border-left: rgb(0, 0, 0) 2px solid; width: 18.86%; vertical-align: top">&#160;</td>
    <td style="border-left: rgb(0, 0, 0) 2px solid; width: 10.82%; vertical-align: top">&#160;</td>
    <td style="border-left: rgb(0, 0, 0) 2px solid; width: 21.56%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif; font-style: italic">FaceTite</div> </td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 36.96%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif">Face Contouring (MI)</div> </td> </tr>
  <tr>
    <td style="border-left: rgb(0, 0, 0) 2px solid; width: 11.79%; vertical-align: top">&#160;</td>
    <td style="border-left: rgb(0, 0, 0) 2px solid; width: 18.86%; vertical-align: top">&#160;</td>
    <td style="border-left: rgb(0, 0, 0) 2px solid; width: 10.82%; vertical-align: top">&#160;</td>
    <td style="border-left: rgb(0, 0, 0) 2px solid; width: 21.56%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif; font-style: italic">NeckTite</div> </td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 36.96%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif">Neck Contouring (MI)</div> </td> </tr>
  <tr>
    <td style="border-left: rgb(0, 0, 0) 2px solid; width: 11.79%; vertical-align: top">&#160;</td>
    <td style="border-left: rgb(0, 0, 0) 2px solid; width: 18.86%; vertical-align: top">&#160;</td>
    <td style="border-left: rgb(0, 0, 0) 2px solid; width: 10.82%; vertical-align: top">&#160;</td>
    <td style="border-left: rgb(0, 0, 0) 2px solid; width: 21.56%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif; font-style: italic">AccuTite</div> </td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 36.96%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif">Face/Body Contouring (MI)</div> </td> </tr>
  <tr>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 11.79%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif; font-style: italic; font-weight: bold">Optimas</div>
        </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 18.86%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif">Laser Bipolar RF IPL</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 10.82%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif">2016</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 21.56%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif; font-style: italic">Morpheus8</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 36.96%; vertical-align: top; border-right: rgb(0, 0, 0) 2px solid; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif">Skin Rejuvenation (MI)</div> </td> </tr>
  <tr>
    <td style="border-left: rgb(0, 0, 0) 2px solid; width: 11.79%; vertical-align: top">&#160;</td>
    <td style="border-left: rgb(0, 0, 0) 2px solid; width: 18.86%; vertical-align: top">&#160;</td>
    <td style="border-left: rgb(0, 0, 0) 2px solid; width: 10.82%; vertical-align: top">&#160;</td>
    <td style="border-left: rgb(0, 0, 0) 2px solid; width: 21.56%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif; font-style: italic">Forma</div> </td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 36.96%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif">Skin Rejuvenation (NI)</div> </td> </tr>
  <tr>
    <td style="border-left: rgb(0, 0, 0) 2px solid; width: 11.79%; vertical-align: top">&#160;</td>
    <td style="border-left: rgb(0, 0, 0) 2px solid; width: 18.86%; vertical-align: top">&#160;</td>
    <td style="border-left: rgb(0, 0, 0) 2px solid; width: 10.82%; vertical-align: top">&#160;</td>
    <td style="border-left: rgb(0, 0, 0) 2px solid; width: 21.56%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif; font-style: italic">Lumecca</div> </td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 36.96%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif">Skin Rejuvenation &amp; Pigmentation (NI)</div>
        </td> </tr>
  <tr>
    <td style="border-left: rgb(0, 0, 0) 2px solid; width: 11.79%; vertical-align: top">&#160;</td>
    <td style="border-left: rgb(0, 0, 0) 2px solid; width: 18.86%; vertical-align: top">&#160;</td>
    <td style="border-left: rgb(0, 0, 0) 2px solid; width: 10.82%; vertical-align: top">&#160;</td>
    <td style="border-left: rgb(0, 0, 0) 2px solid; width: 21.56%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif; font-style: italic">DiolazeXL</div> </td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 36.96%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif">Hair Removal (NI)</div> </td> </tr>
  <tr>
    <td style="border-left: rgb(0, 0, 0) 2px solid; width: 11.79%; vertical-align: top">&#160;</td>
    <td style="border-left: rgb(0, 0, 0) 2px solid; width: 18.86%; vertical-align: top">&#160;</td>
    <td style="border-left: rgb(0, 0, 0) 2px solid; width: 10.82%; vertical-align: top">&#160;</td>
    <td style="border-left: rgb(0, 0, 0) 2px solid; width: 21.56%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif; font-style: italic">Vasculaze</div> </td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 36.96%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif">Vascular Lesion (NI)</div> </td> </tr>
  <tr>
    <td style="border-left: rgb(0, 0, 0) 2px solid; width: 11.79%; vertical-align: top">&#160;</td>
    <td style="border-left: rgb(0, 0, 0) 2px solid; width: 18.86%; vertical-align: top">&#160;</td>
    <td style="border-left: rgb(0, 0, 0) 2px solid; width: 10.82%; vertical-align: top">&#160;</td>
    <td style="border-left: rgb(0, 0, 0) 2px solid; width: 21.56%; vertical-align: top">&#160;</td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 36.96%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif">Facial Wrinkles and Texture (MI)</div>
        </td> </tr>
  <tr>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 11.79%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif; font-style: italic; font-weight: bold">EmbraceRF</div>
        </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 18.86%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif">Bipolar RF</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 10.82%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif">2018</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 21.56%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif; font-style: italic">FaceTite</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 36.96%; vertical-align: top; border-right: rgb(0, 0, 0) 2px solid; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif">Face Remodeling (MI)</div> </td> </tr>
  <tr>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 11.79%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">&#160;</td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 18.86%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">&#160;</td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 10.82%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">&#160;</td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 21.56%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif; font-style: italic">Morpheus8</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 36.96%; vertical-align: top; border-right: rgb(0, 0, 0) 2px solid; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif">Facial Wrinkles and Texture (MI)</div>
        </td> </tr>
  <tr>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 11.79%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">&#160;</td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 18.86%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">&#160;</td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 10.82%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">&#160;</td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 21.56%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif; font-style: italic">AccuTite</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 36.96%; vertical-align: top; border-right: rgb(0, 0, 0) 2px solid; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif">Face/Body Contouring (MI)</div> </td> </tr>
  <tr>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 11.79%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif; font-style: italic; font-weight: bold">Votiva</div>
        </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 18.86%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif">Bipolar RF</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 10.82%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif">2017</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 21.56%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif; font-style: italic">FormaV</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 36.96%; vertical-align: top; border-right: rgb(0, 0, 0) 2px solid; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif">Women&#8217;s Health (MI)</div> </td> </tr>
  <tr>
    <td style="border-left: rgb(0, 0, 0) 2px solid; width: 11.79%; vertical-align: top">&#160;</td>
    <td style="border-left: rgb(0, 0, 0) 2px solid; width: 18.86%; vertical-align: top">&#160;</td>
    <td style="border-left: rgb(0, 0, 0) 2px solid; width: 10.82%; vertical-align: top">&#160;</td>
    <td style="border-left: rgb(0, 0, 0) 2px solid; width: 21.56%; vertical-align: top">&#160;</td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 36.96%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif">Women&#8217;s Health (NI)</div> </td> </tr>
  <tr>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 11.79%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif; font-style: italic; font-weight: bold">Morpheus8</div>
        </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 18.86%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif">Bipolar RF</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 10.82%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif">2021</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 21.56%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif; font-style: italic">Morpheus8</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 36.96%; vertical-align: top; border-right: rgb(0, 0, 0) 2px solid; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif">Face and body fractional RF treatment (MI)</div>
        </td> </tr>
  <tr>
    <td style="border-left: rgb(0, 0, 0) 2px solid; width: 11.79%; vertical-align: top">&#160;</td>
    <td style="border-left: rgb(0, 0, 0) 2px solid; width: 18.86%; vertical-align: top">&#160;</td>
    <td style="border-left: rgb(0, 0, 0) 2px solid; width: 10.82%; vertical-align: top">&#160;</td>
    <td style="border-left: rgb(0, 0, 0) 2px solid; width: 21.56%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif; font-style: italic">Morpheus8 Body</div>
        </td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 36.96%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">&#160;</td> </tr>
  <tr>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 11.79%; vertical-align: top; border-bottom: rgb(0, 0, 0) 2px solid; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif; font-style: italic; font-weight: bold">EmpowerRF</div>
        </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 18.86%; vertical-align: top; border-bottom: rgb(0, 0, 0) 2px solid; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif">Bipolar RF and EMS</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 10.82%; vertical-align: top; border-bottom: rgb(0, 0, 0) 2px solid; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif">2021</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 21.56%; vertical-align: top; border-bottom: rgb(0, 0, 0) 2px solid; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif; font-style: italic">FormaV, Morpheus8V,
        VTone, Aviva</div> </td>
    <td style="border: rgb(0, 0, 0) 2px solid; width: 36.96%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif">Women&#8217;s health (MI)</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold"><span style="text-decoration: underline">Non-Invasive Platforms</span></div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="1" border="0" id="zab2c5e8d812e4a938178999cde6f0d2a" style="font: 10pt Times New Roman,Times,serif; width: 100%; text-align: left; color: rgb(0, 0, 0)">
  <tr>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 21.56%; vertical-align: bottom; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif; font-weight: bold">Product&#160;Platform</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 17.8%; vertical-align: bottom; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif; font-weight: bold">Energy&#160;Source(s)</div>
        </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 17.2%; vertical-align: bottom; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif; font-weight: bold">Year&#160;Introduced</div>
        </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 16.9%; vertical-align: bottom; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif; font-weight: bold">Handpiece(s)</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 26.54%; vertical-align: bottom; border-right: rgb(0, 0, 0) 2px solid; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif; font-weight: bold">Primary (not Exclusive)
        Applications*</div> </td> </tr>
  <tr>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 21.56%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="margin-left: 7.2pt; line-height: 1.25; font-family: Times New Roman, Times, serif; font-style: italic; font-weight: bold">Contoura</div>
        </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 17.8%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif">Bipolar RF</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 17.2%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif">2017</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 16.9%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif; font-style: italic">BodyFX</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 26.54%; vertical-align: top; border-right: rgb(0, 0, 0) 2px solid; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif">Body Contouring</div> </td> </tr>
  <tr>
    <td style="border-left: rgb(0, 0, 0) 2px solid; width: 21.56%; vertical-align: top">&#160;</td>
    <td style="border-left: rgb(0, 0, 0) 2px solid; width: 17.8%; vertical-align: top">&#160;</td>
    <td style="border-left: rgb(0, 0, 0) 2px solid; width: 17.2%; vertical-align: top">&#160;</td>
    <td style="border-left: rgb(0, 0, 0) 2px solid; width: 16.9%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif; font-style: italic">MiniFX</div> </td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 26.54%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif">Face/Neck Contouring</div> </td> </tr>
  <tr>
    <td style="border-left: rgb(0, 0, 0) 2px solid; width: 21.56%; vertical-align: top">&#160;</td>
    <td style="border-left: rgb(0, 0, 0) 2px solid; width: 17.8%; vertical-align: top">&#160;</td>
    <td style="border-left: rgb(0, 0, 0) 2px solid; width: 17.2%; vertical-align: top">&#160;</td>
    <td style="border-left: rgb(0, 0, 0) 2px solid; width: 16.9%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif; font-style: italic">Plus</div> </td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 26.54%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif">Skin Tightening</div> </td> </tr>
  <tr>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 21.56%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="margin-left: 7.2pt; line-height: 1.25; font-family: Times New Roman, Times, serif; font-style: italic; font-weight: bold">Triton</div>
        </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 17.8%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif">Laser</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 17.2%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif">2018</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 16.9%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif; font-style: italic">Triton Duo Light</div>
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif; font-style: italic">Triton Duo Dark</div>
        </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 26.54%; vertical-align: top; border-right: rgb(0, 0, 0) 2px solid; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif">Hair Removal</div>
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif">Hair Removal</div> </td> </tr>
  <tr>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 21.56%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="margin-left: 7.2pt; line-height: 1.25; font-family: Times New Roman, Times, serif; font-style: italic; font-weight: bold">Envision</div>
        </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 17.8%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif">IPL and Bipolar RF</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 17.2%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif">2023</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 16.9%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif; font-style: italic">Forma I</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 26.54%; vertical-align: top; border-right: rgb(0, 0, 0) 2px solid; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif">Dry eye treatment</div> </td> </tr>
  <tr>
    <td style="border-bottom: rgb(0, 0, 0) 2px solid; width: 21.56%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">&#160;</td>
    <td style="border-bottom: rgb(0, 0, 0) 2px solid; width: 17.8%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">&#160;</td>
    <td style="border-bottom: rgb(0, 0, 0) 2px solid; width: 17.2%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">&#160;</td>
    <td style="border-bottom: rgb(0, 0, 0) 2px solid; width: 16.9%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif; font-style: italic">Lumeca I</div> </td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 26.54%; vertical-align: top; border-bottom: rgb(0, 0, 0) 2px solid; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif">Dry eye treatment</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold"><span style="text-decoration: underline">Hand-Free Platforms</span></div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="1" border="0" id="zac15ca6b44c946dc8eb9be0588e18ed7" style="font: 10pt Times New Roman,Times,serif; width: 100%; text-align: left; color: rgb(0, 0, 0)">
  <tr>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 18.41%; vertical-align: bottom; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif; font-weight: bold">Product&#160;Platform</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 18.4%; vertical-align: bottom; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif; font-weight: bold">Energy&#160;Source(s)</div>
        </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 17.2%; vertical-align: bottom; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif; font-weight: bold">Year&#160;Introduced</div>
        </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 14.18%; vertical-align: bottom; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif; font-weight: bold">Handpiece(s)</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 31.82%; vertical-align: top; border-right: rgb(0, 0, 0) 2px solid; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif; font-weight: bold">Primary (not Exclusive)
        Applications*</div> </td> </tr>
  <tr>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 18.41%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="margin-left: 7.2pt; line-height: 1.25; font-family: Times New Roman, Times, serif; font-style: italic; font-weight: bold">EvolveX</div>
        </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 18.4%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif">Bipolar RF EMS</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 17.2%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif">2021</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 14.18%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif; font-style: italic">Tite (HF)</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 31.82%; vertical-align: top; border-right: rgb(0, 0, 0) 2px solid; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif">Skin Tightening</div> </td> </tr>
  <tr>
    <td style="border-left: rgb(0, 0, 0) 2px solid; width: 18.41%; vertical-align: top">&#160;</td>
    <td style="border-left: rgb(0, 0, 0) 2px solid; width: 18.4%; vertical-align: top">&#160;</td>
    <td style="border-left: rgb(0, 0, 0) 2px solid; width: 17.2%; vertical-align: top">&#160;</td>
    <td style="border-left: rgb(0, 0, 0) 2px solid; width: 14.18%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif; font-style: italic">Transform (HF)</div>
        </td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 31.82%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif">Body Contouring</div> </td> </tr>
  <tr>
    <td style="border-left: rgb(0, 0, 0) 2px solid; width: 18.41%; vertical-align: top">&#160;</td>
    <td style="border-left: rgb(0, 0, 0) 2px solid; width: 18.4%; vertical-align: top">&#160;</td>
    <td style="border-left: rgb(0, 0, 0) 2px solid; width: 17.2%; vertical-align: top">&#160;</td>
    <td style="border-left: rgb(0, 0, 0) 2px solid; width: 14.18%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif; font-style: italic">Tone (HF)</div> </td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 31.82%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif">EMS</div> </td> </tr>
  <tr>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 18.41%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="margin-left: 7.2pt; line-height: 1.25; font-family: Times New Roman, Times, serif; font-style: italic; font-weight: bold">Evoke</div>
        </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 18.4%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif">Bipolar RF</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 17.2%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif">2020</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 14.18%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif; font-style: italic">Cheek (HF)</div>
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif; font-style: italic">Chin (HF)</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 31.82%; vertical-align: top; border-right: rgb(0, 0, 0) 2px solid; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif">Skin Rejuvenation</div>
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif">Skin Rejuvenation</div> </td> </tr>
  <tr>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 18.41%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="margin-left: 7.2pt; line-height: 1.25; font-family: Times New Roman, Times, serif; font-style: italic; font-weight: bold">Define</div>
        </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 18.4%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif">Bipolar RF and Morpheus8</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 17.2%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif">2023</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 14.18%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif; font-style: italic">Cheek (HF)</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 31.82%; vertical-align: top; border-right: rgb(0, 0, 0) 2px solid; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif">Skin Rejuvenation</div> </td> </tr>
  <tr>
    <td style="border-bottom: rgb(0, 0, 0) 2px solid; width: 18.41%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">&#160;</td>
    <td style="border-bottom: rgb(0, 0, 0) 2px solid; width: 18.4%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">&#160;</td>
    <td style="border-bottom: rgb(0, 0, 0) 2px solid; width: 17.2%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">&#160;</td>
    <td style="border-bottom: rgb(0, 0, 0) 2px solid; width: 14.18%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif; font-style: italic">Chin (HF)</div> </td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 31.82%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid; border-bottom: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman, Times, serif">Skin Rejuvenation</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z14c77d70c3a3455484c4dcb204b38d40" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">*</td>
    <td style="width: auto; vertical-align: top">
        <div>&#8220;MI&#8221; = Minimally Invasive, &#8220;NI&#8221; = Non-Invasive, &#8220;HF&#8221; = Hands-free application&#160;&#160;</div>
        </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">In addition to the products described above, prior versions of our products continue
to be used by customers. Outside of the United States, we also offer some alternative versions of our aesthetic treatment solutions, in
some cases under different trademarks, which are tailored to the specific preferences and needs of certain countries and regions.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">40</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25; font-weight: bold">Components of Our Products</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Each of our products consists of the following components:</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 36pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;platform;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 36pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;one or more handpieces
or hands-free applicators; and</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 36pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;our proprietary software.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Platforms</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our platforms are mostly electronic boxes, comprised of RF energy generators and modules
supporting lasers and IPL, as applicable, a 110/220VAC input power supply, controller and a user interface with touch screen. The user
interface allows the physician to select the handpiece and set treatment parameters to meet the requirements of a particular application
and patient. Using the touch screen, the physician can independently adjust the energy level, pulse width and other parameters depending
on application to optimize the treatment&#8217;s safety and effectiveness. The user interface on our multiple energy workstations also
allows the user to change energy sources with the press of a button. The control system communicates the operator&#8217;s settings from
the user interface to the system&#8217;s modules and manages system operation and performance.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Handpieces and Hands-Free Applicators</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our handpieces and hands-free applicators are used to apply the energy to the patient
treatment area. The handpieces and hands-free applicators are designed for specific targeted body areas, type of energy to maximize treatment
safety and efficacy for specific treatment. Certain of our handpieces and hands-free applicators have a contained thermal field that ensures
a controlled and safe treatment through our Acquire, Control and Extend, or ACE, technology. Our ACE technology ensures that no areas
are under- or over-treated using therapeutic temperatures safely and efficiently. Built-in safeguards, including real time measurements
of skin temperature, impedance monitoring, power cut-off and audible feedback, help ensure patient safety throughout the procedure. A
number of our handpieces and hands-free applicators are, or contain, one-time use applicators, or consumables, that must be replaced following
each treatment.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Minimally Invasive</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25"><span style="font-style: italic">BodyTite</span>&#160;&#8211; The minimally invasive,
consumable&#160;<span style="font-style: italic">BodyTite</span>&#160;handpiece, introduced in 2010, utilizes directional RF energy for
RFAL treatments using needle-size cannula and external electrodes to apply RF energy to the subcutaneous adipose tissue. The tissue is
heated to 50&#176;C to 70&#176;C to destroy fat and contract connective tissue, simultaneously remodeling the dermis at external temperatures
of up to 42&#176;C. This handpiece allows tissue treatment using a 17cm cannula that provides treatment depth up to 50mm.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25"><span style="font-style: italic">Facerite/NeckTite</span>&#160;&#8211; The minimally
invasive, consumable&#160;<span style="font-style: italic">FaceTite</span>&#160;and&#160;<span style="font-style: italic">NeckTite</span>&#160;handpieces,
introduced in 2012, utilize directional RF energy for RFAL treatments using cannula with diameters of 1.8mm and 2.2mm and external electrodes
to apply RF energy to the subcutaneous adipose tissue. The tissue is heated to 50&#176;C to 70&#176;C to destroy fat and contract connective
tissue, simultaneously remodeling the dermis at external temperatures up to 42&#176;C. This handpiece allows tissue treatment using a
10cm cannula that provides treatment depth up to 25mm.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25"><span style="font-style: italic">AccuTite</span>&#160;&#8211; The minimally invasive&#160;<span style="font-style: italic">AccuTite&#160;</span>handpiece,
introduced in 2019, utilizes directional RF energy for RFAL treatments using sub-millimeter cannula with diameters of 0.9mm and external
electrodes to apply RF energy to subcutaneous adipose tissue. The tissue is heated to 50&#176;C to 70&#176;C to destroy fat and contract
connective tissue, simultaneously remodeling the dermis at external temperatures of up to 42&#176;C. This handpiece allows tissue treatment
using a 60mm cannula that provides treatment depth up to 25mm. Additionally, in 2019, we began marketing&#160;<span style="font-style: italic">AccuTite&#160;</span>for&#160;<span style="font-style: italic">Aviva,&#160;</span>a
minimally invasive procedure that restores the function and appearance of the vulva by offering a non-excisional alternative to a labiaplasty.&#160;<span style="font-style: italic">Aviva&#160;</span>is
powered by&#160;<span style="font-style: italic">AccuTite&#160;</span>to deliver safe and uniform heat to the entire soft tissue matrix
of the labia minora, labia majora, clitoral hood, vaginal introitus and perineal body.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25"><span style="font-style: italic">Fractora</span>&#160;&#8211; The minimally invasive&#160;<span style="font-style: italic">Fractora</span>&#160;handpiece,
introduced in 2011, uses customizable fractional energy and superficial fractional resurfacing for subdermal adipose tissue remodeling.
The handpiece offers two treatment depths (skin surface and subdermal) and is safe on all skin types including type IV. The consumable
applicator tip contains 24-coated pins with a length of up to 4mm.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25"><span style="font-style: italic">Morpheus8/Morpehus8 Body/Morpheus8V</span>&#160;&#8211;
The minimally invasive&#160;<span style="font-style: italic">Morpheus8 and Morpheus8 Body&#160;</span>handpieces use RF energy for subdermal
adipose tissue remodeling, which is programmable by the user according to treatment area. The handpieces offer treatment depth up to 7mm.
The upper part of the needle and external electrodes are coated with a polymer to prevent skin surface thermal damage while delivering
RF energy into the subdermal space.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Non-Invasive</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25"><span style="font-style: italic">BodyFX/MiniFX</span>&#160;&#8211; The non-invasive&#160;<span style="font-style: italic">BodyFX&#160;</span>and
<span style="font-style: italic">MiniFX</span> handpieces, introduced in 2013, combine vacuum and bipolar RF energy with high and low
amplitudes to both permanently kill adipose tissue and contract the skin. The <span style="font-style: italic">BodyFX</span> handpiece,
intended for use on various parts of the body, comprises a vacuum cavity with a size of 1.36in x 1.2in. The <span style="font-style: italic">MiniFX</span>
handpiece, better suited to address problematic fatty tissue in smaller areas, comprises a vacuum cavity with a size of 1.24in x 0.87in.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">41</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25"><span style="font-style: italic">DiolazeXL (810nm)</span>&#160;&#8211; The non-invasive&#160;<span style="font-style: italic">DiolazeXL
(810nm)</span>&#160;handpiece, introduced in 2017, is a high-speed, gold standard 810nm (diode) laser indicated for permanent hair reduction.&#160;<span style="font-style: italic">DiolazeXL</span>&#8217;s&#160;differentiated
triple contact cooling technology (pre, parallel and post), or 3PC technology, provides for a safe and comfortable patient experience.
The handpiece covers a spot size of 12mm x 26mm to allow for the removal of a variety of hair colors and thickness. This handpiece offers
short and long pulse durations and repetition rates that enable treatment times up to 6cm<sup style="vertical-align: text-top; line-height: 1; font-size: smaller">2</sup>/second.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25"><span style="font-style: italic">Triton Duo Light (755nm &amp; 810nm)&#160;</span>&#8211;
The non-invasive&#160;<span style="font-style: italic">Triton Duo Light&#160;</span>handpiece, introduced in 2017, combines two wavelengths
for optimal treatment of light skin patients. The handpiece utilizes a blend of 755nm (Alexandrite) and 810nm (diode) laser wavelengths
that have been optimized for hair removal on patients with skin types I to IV. We believe the&#160;<span style="font-style: italic">Triton&#160;</span>platform
is the only FDA-cleared device capable of firing two wavelengths in one pulse. The handpiece covers a spot size of 12mm x 26mm and provides
two pulse durations and high repetition rates.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25"><span style="font-style: italic">Triton Duo Dark (810nm &amp; 1064nm)</span>&#160;&#8211;
The non-invasive&#160;<span style="font-style: italic">Triton Duo Dark&#160;</span>handpiece, introduced in 2017, combines two wavelengths
for optimal treatment of dark skin patients. The handpiece utilizes a blend of 810nm (diode) and 1064nm (Nd:YAG) laser wavelengths that
have been optimized for hair removal on patients with skin types Ito IV. We believe the&#160;<span style="font-style: italic">Triton&#160;</span>platform
is the only FDA-cleared device capable of firing two wavelengths in one pulse. The handpiece covers a spot size of 12mm x 26mm and provides
two pulse durations and high repetition rates.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25"><span style="font-style: italic">Forma</span>&#160;&#8211; The non-invasive Forma handpiece,
introduced in 2013, uses our ACE technology to deliver auto-adjusting uniform RF energy-generated heat (up to 43&#176;C) for collagen
remodeling and skin contraction of the face and neck. We believe&#160;<span style="font-style: italic">Forma</span>&#160;is the first
thermal face and neck skin tightening device to have both temperature monitoring and automatic, user programmable, RF on/off control.
This handpiece has an RF energy output power of up to 65 watts and covers a spot size of 22mm x 20mm.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25"><span style="font-style: italic">FormaV</span>&#160;&#8211; The non-invasive&#160;<span style="font-style: italic">FormaV
</span>handpiece, introduced in 2017, uses our ACE technology to deliver auto-adjusting uniform RF energy generated heat (up to 43&#176;C)
to vaginal tissue through a consumable applicator.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25"><span style="font-style: italic">VTone</span>&#160;&#8211; Intervaginal EMS device to
treat SUI and pelvic floor muscle restorations.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25"><span style="font-style: italic">Plus</span>&#160;&#8211; The non-invasive&#160;<span style="font-style: italic">Plus</span>&#160;handpiece,
introduced in 2013, uses our ACE technology to deliver auto-adjusting uniform RF generated heat (up to 43&#176;C) for collagen remodeling
and skin contraction of the body. We believe&#160;<span style="font-style: italic">Plus</span>&#160;is the first thermal body skin tightening
device to have both temperature monitoring and automatic, user programmable, RF on/off control. This handpiece has an RF energy output
of up to 65 watts and covers a spot size of 45mm x 45mm.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25"><span style="font-style: italic">Lumecca</span>&#160;&#8211; The non-invasive&#160;<span style="font-style: italic">Lumecca</span>&#160;handpiece,
introduced in 2015, is an IPL handpiece optimized for both light and dark skin that uses a xenon flash lamp to deliver filtered optical
energy in the 515nm to 1200nm range for light skin treatment and 580nm to 1200nm range for darker skin.&#160;<span style="font-style: italic">Lumecca</span>&#160;is
intended for treatment of superficial vascular and pigmented lesions. The handpiece covers a spot size of 30mm x 10mm with a peak optical
power of 10,000 watts.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25"><span style="font-style: italic">Lumecca I</span> &#8211; a version of <span style="font-style: italic">Lumecca
</span>for treatment of dry eye.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25"><span style="font-style: italic">Vasculaze</span>&#160;&#8211; The non-invasive&#160;<span style="font-style: italic">Vasculaze</span>&#160;handpiece,
introduced in 2018, is a 1064nm wavelength diode laser intended for use in the coagulation and hemostasis of benign vascular legions such
as, but not limited to, reticular leg veins, spider veins, hemangiomas, port wine stains and venous lakes.&#160;<span style="font-style: italic">Vasculaze</span>&#160;is
optimized with high peak power, strong contact cooling and an ergonomic head intended to maximize treatment efficiency. The handpiece
covers a spot size of 3mm x 4mm and has pulse duration of 20 to 100 milliseconds, or msec.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25"><span style="font-style: italic">Forma I</span> &#8211; a non-invasive handpiece that
is based on Bipolar RF for treatment of lower and upper lids in order to improve dry eye.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Hands-Free</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25"><span style="font-style: italic">Transform</span>&#160;&#8211; The non-invasive&#160;<span style="font-style: italic">Transform,&#160;</span>introduced
in 2021, is a set of six hands-free applicators for the&#160;<span style="font-style: italic">EvolveX&#160;</span>platform. The mechanism
of action is a combination of Bipolar RF and EMS. The&#160;<span style="font-style: italic">Transform&#160;</span>is mounted on a belt
and works automatically without the assistance of a physician or&#160;<span style="font-style: italic">technician</span>.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">42</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25"><span style="font-style: italic">Tite</span>&#160;&#8211; The non-invasive&#160;<span style="font-style: italic">Tite</span>,
introduced in 2019, is a set of eight hands-free applicators for the&#160;<span style="font-style: italic">EvolveX</span>&#160;platform.
The mechanism of action is similar to the&#160;<span style="font-style: italic">Plus</span>&#160;handpiece. The&#160;<span style="font-style: italic">Tite</span>&#160;is
mounted on a belt for treatment of different body parts and areas without the assistance of a physician or technician.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25"><span style="font-style: italic">Tone</span>&#160;&#8211; The non-invasive&#160;<span style="font-style: italic">Tone</span>,
introduced in 2019, is a set of four hands-free electro-muscle stimulation applicators. The&#160;<span style="font-style: italic">Tone</span>&#160;is
designed to be used on the&#160;<span style="font-style: italic">EvolveX</span>&#160;platform for muscle stimulation and improving skin
tone.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25"><span style="font-style: italic">Cheek</span>&#160;&#8211; The non-invasive&#160;<span style="font-style: italic">Cheek</span>,
introduced in 2020, is a hands-free device containing eight applicators that is mounted on the face and designed to be used with the&#160;<span style="font-style: italic">Evoke</span>&#160;platform.
The mechanism of action is similar to the&#160;<span style="font-style: italic">Forma</span>&#160;handpiece, but works automatically on
both sides of the face without the assistance of a physician or technician.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25"><span style="font-style: italic">Chin</span>&#160;&#8211; The non-invasive&#160;<span style="font-style: italic">Chin</span>,
introduced in 2020, is a hands-free device containing two applicators that is mounted on the chin and designed to be used with the&#160;<span style="font-style: italic">Evoke</span>&#160;platform.
The mechanism of action is similar to the&#160;<span style="font-style: italic">Forma</span>&#160;handpiece, but works automatically on
the chin without the assistance of a physician or technician.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Proprietary Software</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our software permits the user to define treatment parameters to be communicated to the
electronic modules in the platform and deliver RF or optical energy through the handpiece or hands-free applicator to the patient. In
addition, our software controls and manages proper system performance and automatic temperature control, system self-calibration, system
setup and detection of any malfunction of the system. We believe our software&#8217;s automotive capabilities allow physicians to dedicate
their attention and focus to patient treatment rather than system monitoring. Our users upgrade their products through the purchase of
additional treatment applicators and corresponding software plugs. All of our software complies with applicable medical specifications
and regulations.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Applications and Procedures</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our products provide our customers with a broad range of applications among both traditional
procedures and emerging applications.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Face and Body Contouring</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic">Minimally Invasive</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Generally performed by a physician, RFAL delivers directional RF energy into a patient&#8217;s
subcutaneous fat to coagulate and liquefy adipose tissue and heat the subcutaneous fibrous septa, resulting in substantial collagen contraction
of the subdermal space. RF energy is delivered through an innovative handpiece comprised of two electrodes. The internal electrode is
inserted into the fat layer, while the other larger electrode is applied externally to the skin surface above the cannula tip. The internal
cannula passes through the subcutaneous fat, while the external electrode slides over the skin&#8217;s surface. The small conductive tip
of the cannula concentrates RF energy in the subcutaneous fat, liquefying it and simultaneously contracting the fiber septa. This liquefied
fat can then be removed from the body. Our RFAL technology can be administered on all regions of the body and typical treatments are approximately
30 to 90 minutes each under local anesthesia. We received 510(k) FDA clearance for our RFAL technology in 2016. Users conduct minimally
invasive face and body contouring using RFAL technology with the&#160;<span style="font-style: italic">BodyTite&#160;</span>and<span style="font-style: italic">&#160;Embrace&#160;</span>platforms
and&#160;<span style="font-style: italic">BodyTite, FaceTite&#160;</span>and&#160;<span style="font-style: italic">AccuTite&#160;</span>handpieces.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Generally performed by a physician, Deep Subdermal Fractional RF, delivers RF energy
into the subcutaneous adipose tissue to depths of up to 4mm through an array of coated needles producing localized heat and matrix of
small lesions in the subcutaneous fat. The heat generated by the pins in the subdermal tissue promotes connective tissue restructuring.
As a result, physicians can offer a versatile fractional treatment creating a three-dimensional collagen contraction and subdermal fat
coagulation. The deep fractional remodeling is used when fat layer is not thick enough to use RFAL technology or when patient wants only
superficial result. Deep Subdermal Fractional RF can be used for wrinkle reduction, skin tightening and treatment of cellulite appearance.
In addition to reshaping, Deep Subdermal Fractional RF provides long-term results for inflammatory acne by coagulating enlarged sebaceous
glands. The most common areas of treatment are the face and neck. Patients generally receive between one to three treatments for approximately
30 minutes each. Treatments are typically spaced two to three weeks apart. We received two 510(k) FDA clearances for&#160;<span style="font-style: italic">Fractora</span>&#160;in
2011 and 2016, and 510(k) FDA clearance for the&#160;<span style="font-style: italic">Morpheus8</span>&#160;in 2019. Customers use this
technology with the&#160;<span style="font-style: italic">BodyTite,&#160;Embrace, Votiva&#160;</span>and&#160;<span style="font-style: italic">Optimas&#160;</span>platforms.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">43</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25; font-style: italic">Non-Invasive</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25"><span style="font-style: italic">Handpieces:&#160;</span>Administered by physicians
and other aesthetic practitioners, our differentiated fat reduction solution is based on skin shaping using a vacuum and delivering both
low amplitude bipolar RF energy for gentle deep tissue heating and high amplitude RF energy to simultaneously kill fat and tighten skin.
The handpiece is placed over the desired area of the body and vacuum energy shapes the skin into the cavity for safe and effective RF
energy delivery allowing greater volumes of fat to be treated (up to 2.5cm in depth). Subsequently, temperature-controlled RF energy is
applied to preheat the tissue and fat uniformly to 42&#176;C to 43&#176;C. High amplitude RF energy delivered in ultra-short pulse duration
is then administered via electrodes causing apoptosis of adipose tissue and resulting in simultaneous skin contraction. Our technology
can be administered on all regions of the body. Patients generally receive six treatments for approximately 10 to 20 minutes each. Treatments
are typically spaced one to two weeks apart. We received 510(k) FDA clearance for this technology in 2013. Users conduct non-invasive
face and body contouring with the&#160;<span style="font-style: italic">Contoura&#160;</span>platform using the&#160;<span style="font-style: italic">BodyFX
or&#160;MiniFX </span>handpieces<span style="font-style: italic">.</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic">Hands-Free</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25"><span style="font-style: italic">Hands-Free Applicators</span>: Applied by physicians
and other aesthetic practitioners, our differentiated skin tightening, fat reduction and muscle stimulation solution is based on bipolar
RF and EMS technologies, delivered through a set of hands-free applicators mounted or placed over the body or face. The setup of the parameters
is determined by a doctor. Subsequently, temperature-controlled RF energy is applied to preheat the tissue and fat uniformly to 42&#176;C
to 43&#176;C. High amplitude RF energy delivered in ultra-short pulse duration is then administered via electrodes causing apoptosis of
adipose tissue and resulting in simultaneous skin contraction. Our technology can be administered on all regions of the body and face.
Patients generally receive three to six treatments for approximately 30 minutes each. Treatments are typically spaced one to two weeks
apart. We received 510(k) FDA clearance for the&#160;<span style="font-style: italic">Evoke</span>&#160;and&#160;<span style="font-style: italic">Evolve</span>&#160;in
2019. In 2021 we received 510(k) FDA clearance for the <span style="font-style: italic">EvolveX </span>which replace the<span style="font-style: italic">
Evolve </span>platform<span style="font-style: italic">. </span>Users conduct hands-free face and body contouring with the&#160;<span style="font-style: italic">Evoke/Define</span>&#160;and&#160;<span style="font-style: italic">EvolveX</span>&#160;platforms
using the&#160;<span style="font-style: italic">Transform</span>,&#160;<span style="font-style: italic">Tite</span>&#160;and&#160;<span style="font-style: italic">Tone</span>&#160;hands-free
applicators for the&#160;<span style="font-style: italic">EvolveX</span>, and&#160;<span style="font-style: italic">Cheek</span>&#160;and&#160;<span style="font-style: italic">Chin</span>&#160;hands-free
applicators for the&#160;<span style="font-style: italic">Evoke</span>.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Medical Aesthetics</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic">Skin Rejuvenation/Vascular &amp; Pigmented Lesion Treatment</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Generally performed by a physician or other aesthetic professional, different types
of energy and treatments are provided depending on the handpiece. The application of JPL energy enables the improvement of photo damage,
as well as other pigmented abnormalities and superficial vascular lesions. A 1064nm laser is used for the treatment of larger and deeper
veins. Patients often see results after a single treatment but typically two to three treatments of approximately 15 minutes each are
recommended. Treatments are typically spaced two to four weeks apart. We received 510(k) FDA clearance for superficial vascular and pigmented
lesion treatments in 2013 and for hair removal and permanent hair reduction in 2017 and 2018, respectively. Users rejuvenate the skin
with the&#160;<span style="font-style: italic">Optimas</span>&#160;platform using the&#160;<span style="font-style: italic">Vasculaze</span>&#160;and&#160;<span style="font-style: italic">Lumecca</span>&#160;handpieces.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic">Sub-Necrotic Thermal Tissue Remodeling</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Administered by physicians and other aesthetic practitioners, the application is based
on uniform and deep heating of the skin and subdermal layer using bipolar RF energy. The handpiece is moved over the desired area of the
treatment area, while maintaining the designated temperature for the predetermined time for safe and effective collagen remodeling. Subsequently,
temperature-controlled RF energy is applied automatically to heat tissue uniformly to 42&#176;C to 43&#176;C. The&#160;<span style="font-style: italic">Forma</span>&#160;handpiece
is utilized to target fat and heats the tissue to depths of up to 4.5mm while the&#160;<span style="font-style: italic">Plus</span>&#160;handpiece
is used for larger body areas and provides effect up to 6mm in depth. Patients generally receive six treatments for approximately 10 to
20 minutes each. Treatments are typically spaced one to two weeks apart. We received three 510(k) FDA clearances for this technology in
2014, 2016 and 2017. Users conduct facial treatment with the&#160;<span style="font-style: italic">Optimas</span>&#160;platform using
the&#160;<span style="font-style: italic">Forma</span>&#160;handpiece and body contouring with the <span style="font-style: italic">Contoura</span>
platform using the&#160;<span style="font-style: italic">Plus</span>&#160;handpiece.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic">Permanent Hair Reduction</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Administered by a user, who is not necessarily a physician, our differentiated dual
wavelength technology incorporated in the&#160;<span style="font-style: italic">Triton</span>&#160;platform fires two wavelengths in a
single pulse destroying the hair follicles located in the dermis and subdermal layers. This procedure is continued over the target area
and can last from a few minutes to 90 minutes depending on the size of the treatment area. In general, permanent hair reduction requires
four to six treatments spaced four to eight weeks apart. More sessions may be required for stubborn hairs. Due to our unique dual wavelength
technology, our&#160;<span style="font-style: italic">Triton</span>&#160;platform allows practitioners to address all skin types and tones.
We received 510(k) FDA clearance for our&#160;<span style="font-style: italic">Optimas</span>&#160;and dual wavelength&#160;<span style="font-style: italic">Triton</span>&#160;platforms
for permanent hair reduction treatments in 2016 and 2018, respectively. Users perform permanent hair reduction procedures with our&#160;<span style="font-style: italic">Optimas</span>&#160;and&#160;<span style="font-style: italic">Triton</span>&#160;platforms
using the&#160;<span style="font-style: italic">DiolazeXL</span>&#160;and&#160;<span style="font-style: italic">Triton Duo Light</span>&#160;and&#160;<span style="font-style: italic">Triton
Duo Dark</span>&#160;handpieces, respectively.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">44</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Women&#8217;s Health</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We have two platforms for women&#8217;s health: the <span style="font-style: italic">Votiva</span>
and the <span style="font-style: italic">EmpowerRF</span>. Procedures with these platforms are performed by a physician. Depending on
the handpiece, the administration of bipolar RF energy or subdermal heating is applied to gently warm and massage the internal vaginal
tissue&#160;<span style="font-style: italic">(FormaV),&#160;</span>the external vaginal tissue&#160;<span style="font-style: italic">(Morpheus8V),&#160;</span>or
to deliver uniform heat to the entire soft tissue matrix of the labia minora, labia majora, clitoral hood, vaginal introitus and perineal
body&#160;<span style="font-style: italic">(Aviva&#160;</span>procedure administered by the&#160;<span style="font-style: italic">AccuTite&#160;</span>handpiece),
and pelvic floor muscle restoration (with <span style="font-style: italic">VTone</span>). Depending on the treatment type, patients typically
receive between two to three treatments of approximately 15 minutes each. Treatments are typically spaced two to three weeks apart. We
received 510(k) FDA clearance for&#160;<span style="font-style: italic">FormaV&#160;</span>for certain indications in 2017. In July 2018,
we received a letter from the FDA seeking information as to the regulatory basis for marketing of our&#160;<span style="font-style: italic">FormaV&#160;</span>handpiece
based on our promotion and labeling of this device for use in certain women&#8217;s health conditions and procedures. We timely responded
to the FDA by immediately altering the wording of our promotional and labeling materials, and we submitted a response letter in August
2018 answering the FDA&#8217;s questions and advising the agency that we had modified our promotional and labeling materials to remove
certain statements regarding uses of our products for conditions and procedures that were questioned by the FDA in the agency&#8217;s
informational request letter. The FDA responded in September 2018 by stating that the agency had reviewed our response letter and verified
the changes in terminology made to our website. Moreover, the FDA further responded in November 2018 and confirmed we addressed all items
raised by the agency in its letter, and that the FDA continues to expect us to conduct a review of our marketing and promotional materials
to make appropriate changes and remove materials containing uncleared claims. We have received no further communications from the agency
regarding this matter.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25; font-style: italic; font-weight: bold">Ophthalmology</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">In 2023, we introduced a new platform called <span style="font-style: italic">Envision</span>,
which includes the <span style="font-style: italic">Forma I</span> handpiece and the <span style="font-style: italic">Lumecca I</span>
handpiece for treatment of upper and lower lids and dry eye. This platform also includes the Moprheus8 handpiece for treatment of peri-orbital
wrinkles.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25"></div>

<div style="line-height: 1.25; font-weight: bold">Sales and Marketing</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our primary strategy to increase market penetration relies on selling directly to our
traditional customer base of plastic and facial surgeons, aesthetic surgeons, dermatologists and OB/GYNs. We believe we are the only company
commercializing minimally invasive aesthetic solutions specifically targeting the surgical community and believe our products represent
a significant opportunity for these practitioners to deliver improved patient treatment results and significantly increase their ability
to generate additional revenue. We are also targeting newer market opportunities consisting of OB/GYNs, ENTs, ophthalmologists, general
practitioners and aesthetic clinicians as an incremental growth opportunity.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We target potential customers through office visits, trade shows, professional journals
and various forms of paid and unpaid media. We also conduct clinical workshops featuring recognized expert panelists and key opinion leaders
to promote existing and new treatment techniques using our products. We believe that these workshops enhance customer loyalty and provide
us with new sales opportunities. We plan to continue to offer a large number of workshops spanning from single-day workshops to three-day
workshops. We also use direct mail programs to target specific segments of the market that we seek to access, such as members of medical
societies and attendees at meetings sponsored by medical societies or associations. In addition, we maintain an active public relations
program that has resulted in treatments based on our products being featured in various televised and printed media outlets including&#160;<span style="font-style: italic">InStyle,
Shape,&#160;The Doctors</span>&#160;and&#160;<span style="font-style: italic">Harper&#8217;s Bazaar</span>. In September 2022, international
actress and producer, Eva Longoria, agreed to join us as our brand ambassador to share her positive experience with our&#160;<span style="font-style: italic">EvolveX</span>&#160;and&#160;<span style="font-style: italic">Morpheus8</span>&#160;technologies,
replacing our previous brand ambassador, international pop icon, Paula Abdul.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We currently sell and market our products in the United States, Canada, the United Kingdom,
Ireland, Spain, Portugal, France, Belgium, Luxemburg, Italy, Germany, Austria, Japan, Australia and India, through a direct sales force
of approximately 256 representatives. We also sell and market our products through 59 distributors in 82 countries. Our U.S. sales efforts
are headquartered in Irvine, California. To support the continued roll-out of our products and further penetrate the market, we anticipate
that our direct salesforce in the United States will continue to increase.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">45</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25">In international markets, to complement our direct sales force in Canada, the United
Kingdom, Spain, Portugal, France, Belgium, Luxemburg, Italy, Australia and India we sell our products through a network of distributors.
Our Canadian sales efforts are headquartered in Toronto, Canada. As of December 31, 2023, we had an international sales management team
of seven employees supporting 59&#160; independent distributors. The percentage of our revenues from customers located outside of the
United States for each of the years ended December 31, 2023 and 2022 was 37%, and 34%, respectively. We intend to continue to increase
penetration of our customer base in international markets and expand into attractive new international markets, including within Canada,
the United Kingdom, Ireland, Spain, Portugal, France, Belgium, Luxemburg, Italy, Germany, Austria, Japan, Australia and India, by identifying
and training qualified distributors. In addition, we may opportunistically hire a direct sales force and expand our marketing campaigns
in select international markets. We require our distributors to provide customer training, to invest in equipment and marketing, and to
attend certain exhibitions and industry meetings.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Service and Support</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We support our customers with a range of services including business and practice development
consulting and product service and maintenance.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We service our products in three service centers: (1) the U.S. market is serviced through
our facility in Irvine, California, (2) the Canadian market is serviced through our facility in Toronto, Canada, and (3) the rest of the
world is serviced through our distributors and our facility in Yokneam, Israel. In the event of a technical malfunction, our customers
first contact us (if in the United States or Canada) or our distributors (if outside of the United States or Canada) telephonically. If
a product requires service or repair that cannot be addressed telephonically, we or our distributors ship a temporary &#8220;loaner&#8221;
system to the customer as soon as possible, often overnight. This unique &#8220;loaner&#8221; system reduces any product downtime and
associated lost revenues for the physician. We then arrange for shipment of the defective product to one of our service centers in the
United States or Canada. Outside the United States or Canada, the product is sent to our distributors or our facility in Israel. Either
we or our distributors quickly repair the faulty product and ship it back to the customer. We have designed our products in a light-weight,
modular fashion to enable quick and efficient service and support. Specifically, we build our platforms to be less than 35 kilograms in
weight to ensure acceptance by traditional, commercial third-party logistics providers for next-day delivery of replacement products without
requiring specialized shipping procedures. We believe our depot service and support model provides for more efficient and less costly
operations.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our standard warranty term is 12 months, however, many of our products are sold with
multi-year warranties. Our standard warranty covers parts, labor, participation in our loaner program and a white glove, door-to-door,
shipping service for expedited repair service, and can be extended for an additional charge. We believe that we have a significant opportunity
to increase our recurring customer revenue by increasing the number of our customers that enter into service contracts and extended warranties
for our systems. All of our distributors have a service department and are required by us to maintain a full inventory of spare parts.
All service staff is trained by our service department in Israel.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Manufacturing and Supply</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We rely primarily on outsourced manufacturing to produce our devices while maintaining
control over the production process. Outsourcing allows us to carry lower inventory levels and maintain fixed unit costs without incurring
significant capital expenditures than would be in place if products were self-manufactured. We outsource almost all of the manufacturing
of our products to three subcontractors located in Israel, two of which we are substantially dependent on as part of our business. Through
our strategic arrangement with Flextronics (Israel) Ltd., or Flex, and (BY) Medimor Ltd., or Medimor, we maintain dedicated manufacturing
lines supervised by us in Flex and Medimor&#8217;s medical-grade manufacturing facilities in Migdal Haemek and Poriya, Israel. Within
the Flex and Medimor facilities, all proprietary manufacturing, testing and assembly equipment has been built and is owned by us. We also
use a separate manufacturer in addition to Flex and Medimor to produce our handpieces and disposables.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We believe our outsourced manufacturers&#8217; processes comply with all applicable
U.S. and international quality and safety standards, such as ISO 13485:2016, CE and the FDA quality system regulations. We conduct in-house
prototype development and present detailed manufacturing documents to our subcontractors, who then purchase most of the necessary components
and manufacture the product. These manufacturing subcontractors provide us fully assembled, or &#8220;turn-key,&#8221; services. We control
and monitor the quality of our products by having one of our quality control employees at each of our subcontractor&#8217;s facilities.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">46</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25">The contracts we have with<span style="font-weight: bold; font-style: italic">&#160;</span>our
main manufacturing subcontractors (Flex and Medimor) do not have minimum purchase requirements and allow us to purchase end products entered
into on a purchase order basis. Under these contracts, our manufacturing subcontractors provide manufacturing services pursuant to our
written specifications. These manufacturing services include labor, materials, testing, packaging and delivery, as well as allocating
production and storage space within their facilities for our products. Pricing under these contracts are reviewed between us and the manufacturing
subcontractors every three months. These contracts typically have one-year terms that automatically renew for successive one-year terms
unless either we or the manufacturing subcontractor provide three months written notice prior to the expiration of the term. To date,
we have not experienced any significant manufacturing delays.<sup style="vertical-align: text-top; line-height: 1; font-size: smaller">&#160;</sup>These
contracts can be terminated by either party, without cause, with four to six months prior written notice.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We manufacture all laser and IPL handpieces in our facility in Yokneam, Israel and procure
other major components of our products on behalf of our third-party manufacturers from a limited number of suppliers. We have flexibility
to adjust the number of lasers and other components that we either manufacture or procure as well as the delivery schedules. The forecasts
that we use are based on historical demands and expected future plans. Lead times may vary significantly depending on the size of the
order, time required to fabricate and test the components, specific supplier requirements and current market demand for the components.
We intend to reduce any potential for delays of supply by maintaining relationships with multiple suppliers of major components. To date,
we have not experienced significant delays in obtaining our major components.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">

<div style="text-indent: 18pt; line-height: 1.25">In November 2019, we signed a Share Purchase and Shareholders Agreement, or the SPA,
with Medimor, one of our turnkey manufacturing subcontractors. Pursuant to the SPA, we have invested an aggregate of $600,000, in consideration
for 1,369,863 ordinary shares of Medimor (which reflected a 10.34% ownership interest in Medimor at the signing date, on a fully diluted
basis), at a price per share of $0.438, of which 414,384 ordinary shares were issued upon consummation of the initial closing on December
31, 2019, and the remaining 955,479 ordinary shares were issued in July 2020 following Medimor achieving certain pre-defined milestone
events. In November 2023, we signed an additional Share Purchase and Shareholders Agreement (the &#8220;Purchase Agreement&#8221;) in
which we invested an additional $100,000 in consideration of 117,440 ordinary shares of Medimor.</div> </div>

<div style="text-indent: 18pt; line-height: 1.25"> <br/> </div>

<div style="text-indent: 18pt; line-height: 1.25">As of December 31, 2023, we hold 14.79% ownership interest on an as-issued basis and
11.24% ownership interest on a fully diluted basis of Medimor.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Research and Development</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our research and development activities are conducted internally by a team of 36 research
and development staff based mainly in Israel. Our research and development efforts are focused on the development of new products, as
well as on the extension of our existing products to introduce new applications in the minimally and non-invasive and medical aesthetic
markets. We expect to concentrate our research and development efforts in the coming years on developing procedures and platforms based
on our proprietary technologies: (i) RFAL, (ii) Deep Subdermal Fractional RF, (iii) Simultaneous Fat Destruction and Skin Tightening,
and (iv) Deep Heating Collagen Remodeling, and developing new technologies. We have a number of new projects and products under development,
mainly focusing on additional minimally and non-invasive aesthetic and medical treatments.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our research and development expenditures for the years ended December 31, 2023 and
2022 were approximately $13.4 million and $12.4 million, respectively.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Seasonality</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our business is not significantly impacted by seasonality; however, our fourth quarter
has historically generated slightly stronger operating results. We have historically experienced stronger sales in the fourth quarter
in correlation with our customers&#8217; spending patterns and budget cycles. Most physicians operate on an annual budget cycle with a
fiscal year that begins on January 1. It is not uncommon to experience a higher level of purchasing activity from physicians in the final
months and weeks of their fiscal year. Consequently, our fourth quarter revenues may be greater than other quarters. Our business is also
impacted by general economic conditions, which may impact future seasonal variations.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Intellectual Property</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We rely on a combination of patent, trademark and copyright laws to protect our intellectual
property rights.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">47</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Patents and Patent Applications</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">As of February 13, 2024, we own ten issued U.S. patents and one issued Korean patent.
As of February 13, 2024, we have filed seven patent applications that are pending in the United States Patent and Trademark Office. Out
of those applications, one was filed also under The Patent Cooperation Treaty and one in Europe. Our issued U.S. patents are projected
to expire between 2027 and 2038 (assuming pending U.S. patent applications are approved). These patents and patent applications cover
the technologies described herein, and contribute to the protection of our rights to our proprietary technology. Our patents relate to
radio frequency (RF) based technology that may be used for minimally invasive aesthetic solutions, such as fat destruction, and fractional
skin ablation relating to skin tightening and fat destruction, among others, and cover our existing products. Without these patents, we
cannot guarantee that we can prevent others from manufacturing similar products that are covered by our patent rights. We also rely on
our issued patents to make, use, sell, and distribute our products. The term of the patents depends on the legal term for patents in the
countries in which they are granted. In most countries, including the United States, the patent term is generally 20 years from the earliest
claimed filing date of a non-provisional patent application in the applicable country. We also rely upon trademarks in various jurisdictions
covering the InMode brand and our product lines, as well as upon U.S. copyright law for protection of the software programs associated
with our products.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We cannot assure you that patents will issue from any of our pending applications or
that, if patents issue, they will be of sufficient scope or strength to provide meaningful protection for our technology. Our policy is
to obtain patents and to seek to operate without infringing on the intellectual property rights of third parties. Loss or invalidation
of our patents, or a finding of unenforceability or limitation of scope of our patents, could have a material adverse effect on us. The
patent position of many inventions in the areas related to our business is highly uncertain, involves many complex legal, factual and
technical issues and has recently been the subject of litigation industry-wide. There is no certainty in predicting the breadth of allowable
patent claims or the degree of protection afforded under any issued patents.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Notwithstanding the scope of the patent protection available to us, a competitor could
develop treatment methods or devices that are not covered by our patents. Furthermore, numerous U.S. and foreign issued patents and patent
applications owned by third parties exist in the fields in which we are developing products. Because patent applications can take many
years to issue, there may be applications unknown to us, which applications may later result in issued patents that our existing or future
products or proprietary technologies may be alleged to infringe. Third parties may also obtain patents that we may need to license from
them in order to conduct our business.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">It is possible that patents issued to us will be successfully challenged or that patents
issued to others may preclude us from commercializing our products under development. Litigation to establish or challenge the validity
of patents, to defend against infringement, unenforceability or invalidity claims or to assert infringement, invalidity or unenforceability
claims against others, if required, can be lengthy and expensive, and may result in determinations materially adverse to us. We cannot
assure you that the products currently marketed or under development by us will not be found to infringe patents issued or licensed to
others.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Patent Litigation</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We have received, and we may in the future receive, allegations from third parties contending
that we are infringing their patents. If such third parties were to commence infringement suits against us, and such third-party patents
were found by a court to be valid, enforceable and infringed upon by us, then we could be required to pay damages and/or make royalty
payments, and we could also be enjoined from continuing the infringing activity. Depending on the nature of the patent found to be infringed
upon by us, a court order requiring us to cease such infringement could have a material adverse effect on us. We might be unable to design
around such patents or continue offering the products or services found to be infringing, or we could suffer other adverse consequences.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">On March 16, 2021 we filed a complaint with the United States International Trade Commission
(&#8220;ITC&#8221;) alleging ILOODA&#8217;s fractional radio frequency (&#8220;RF&#8221;) microneedling system, distributed in the United
States by Cutera, Inc., infringes on our U.S. Patent No. 10,799,285. Additionally, we requested that the ITC investigate ILOODA&#8217;s
infringing imports and issue an exclusion order to bar importation of ILOODA&#8217;s microneedling system. On November 22, 2021 we reached
a settlement agreement with ILOODA and, accordingly, filed an agreed motion to terminate the investigation.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">On October 11, 2023 we filed a complaint of patent infringement against BTL Industries
Ltd. (&#8220;BTL&#8221;) in the United States District Court, Central District of California, alleging that BTL infringed our U.S. patent
no. 8961511. This litigation process is in the early stage and BTL has not yet submitted its response to this complaint. We expect the
first BTL response to be submitted to the Court no later than February 2024.</div>

<div style="line-height: 1.25">&#160;</div> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">48</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div>

<div style="text-indent: 18pt; line-height: 1.25">Although we may try to resolve any potential future claims or actions, we may not be
able to do so on reasonable terms, if at all. Infringement and other intellectual property claims, with or without merit, can be expensive
and time-consuming to litigate, and could divert management&#8217;s attention from our core business. If we lose this kind of litigation,
a court could require us to pay substantial damages and could prohibit us from using technologies essential to our products, either of
which would have a material adverse effect on our business, results of operations and financial condition. See &#8220;Item 3. Key Information
&#8211; D. Risk Factors-Risks Related to Our Intellectual Property &#8211; If we are unable to protect our intellectual property rights,
our competitive position could be harmed. Our success and ability to compete depends in large part upon our ability to protect our proprietary
technology.&#8221;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Copyrights, Trademarks and Trade Secrets</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The software programs associated with our products are protected by U.S. copyright law.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We also filed for protection available under trademark law. As of December 31, 2023,
we own 14 registered trademarks in the United States and we own at least 38 registered trademarks in various jurisdictions outside the
United States, including for the marks &#8220;InMode&#8221; and &#8220;RFAL&#8221; and certain key product names, in particular,&#160;
<span style="font-style: italic">BodyTite, Contoura&#160;</span>by&#160;<span style="font-style: italic">InMode, FaceTite, InMode, Optimas&#160;</span>by&#160;<span style="font-style: italic">InMode,
Triton&#160;</span>by&#160;<span style="font-style: italic">InMode, Votiva&#160;</span>by&#160;<span style="font-style: italic">InMode,
Triton&#160;</span>by&#160;<span style="font-style: italic">InMode, AccuTite, Morpheus, BodyFX, Diolaze, Fractora&#160;</span>and&#160;<span style="font-style: italic">Lumecca.&#160;</span>We
also have at least nine pending foreign trademark applications. We also have six pending trademark applications in the United States.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We also rely upon know-how and continuing technological innovation, and may pursue licensing
opportunities in the future, to develop and maintain our competitive position. We seek to protect our proprietary rights through a variety
of methods, including confidentiality agreements and proprietary information agreements with suppliers, employees, consultants and others
who may have access to proprietary information, under which they are bound to assign to us inventions made during the term of their employment
or term of service.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">All professional employees and technical consultants are required to execute confidentiality
agreements in connection with their employment and consulting relationships with us. We also require them to agree to disclose and assign
to us all inventions conceived in connection with their services to us. However, there can be no assurance that these confidentiality
and invention assignment agreements will be enforceable or that they will provide us with adequate protection.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Competition</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our industry is subject to intense competition, subject to rapid change and highly sensitive
to the introduction of new products or other market activities of industry participants. We compete against products offered by public
companies, including Allergan plc, Cutera, Inc., Apyx Medical Corporation, Venus Concept Inc., and Sisram Medical Ltd.., as well as by
private companies, such as Cynosure LLC (formerly Cynosure Inc.), Lumenis Ltd., BTL Aesthetics, Inc. and Candela Medical Inc. In the past
few years, several large pharmaceutical and medical device companies have also entered the aesthetic device market, including Bausch Health.
and Merz Pharma Group. Our products compete against conventional medical products, including Botox, hyaluronic acid injections and collagen
injections, and aesthetic procedures, such as face lifts, liposuction, sclerotherapy, electrolysis, chemical peels and microdermabrasion,
that are unrelated to laser, light and RF-based technologies. Our products also compete against laser and other light and radio frequency-based
products.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Competition among providers of laser and other light and radio frequency-based products
for the aesthetic medical market is characterized by extensive research efforts and rapid technological progress. While we attempt to
protect our products through patents and other intellectual property rights, there are few barriers to entry that would prevent new entrants
or existing competitors from developing products that would compete directly with ours. There are many companies, both public and private,
that are developing innovative devices that use laser and other energy-based and alternative technologies. Many of these competitors have
significantly greater financial and human resources than we do and have established reputations, greater brand name recognition, broader
product lines, and larger customer bases, as well as worldwide distribution channels that are more effective than ours. Additional competitors
may enter the market, and we are likely to compete with new companies in the future. Any business combinations or mergers among our competitors
that result in larger competitors with greater resources or distribution networks, or the acquisition of a competitor by a major medical
or technology corporation seeking to enter this business, could further result in increased competition.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">49</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25">To compete effectively, we have to demonstrate that our products are attractive alternatives
to other devices and treatments by differentiating our products on the basis of performance, brand name, reputation and price. We have
encountered and expect to continue to encounter potential customers who, due to existing relationships with our competitors, are committed
to, or prefer the products offered by, these competitors. We expect that competitive pressures may over time result in price reductions
and reduced margins for our products.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Other medical companies, academic and research institutions, or others, may develop
new technologies or therapies, including medical devices, surgical procedures or pharmacological treatments and obtain regulatory approval
for products utilizing such techniques that are more effective in treating the conditions that we target or are less expensive than our
current or future products. Our technologies and products could be rendered obsolete by such developments.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Government Regulation</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our products and operations are subject to extensive and rigorous regulation by the
relevant governmental authorities in the countries where we market and sell or products. These governmental authorities include the FDA,
which enforces, the FDCA as well as other similar laws, and regulatory bodies worldwide. In addition, the Federal Trade Commission, or
FTC, regulates the advertising of our products in the United States. Further, we are subject to laws directed at preventing fraud and
abuse, which subject our sales and marketing, training and other practices to government scrutiny.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">In some jurisdictions, such as the United States, Canada, South Korea and Israel, we
must complete an application process with the relevant regulator, which includes submitting the results of clinical trials for their review.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">In addition to the requirements regarding product clearance, many countries also impose
product standards, packaging requirements, environmental requirements, labeling requirements and import and export restrictions on our
devices. Each country also has its own tariff regulations, duties and tax requirements. Failure to comply with applicable regulatory requirements
may result in fines, suspension or withdrawal of regulatory approvals, product recalls, seizure of products, operating restrictions, criminal
prosecution, or other consequences.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">In the United States, the FDCA and its implementing regulations govern the following
activities that we perform and will continue to perform to help ensure that medical products distributed within the United States are
safe and effective for their intended uses:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z7b58dd6e561d493991a854af693b45e6" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>product design and development;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="ze89b34de1b3349b18e2d392e3b0935f5" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>product testing;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z154fe3bcc4a4444a973cad5fdc51e419" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>product manufacturing;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="ze82c4ffe640d4b78b84d4d10a9ef5029" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>product safety;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zf832cd848d0e489ca22510b535ca83f0" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>product labeling;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z8a2aebb67e6b43669418f845029c0204" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>product storage;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z526eadb973b740169aabe8bf6264710c" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>record-keeping;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zf0fc7fd022254ba4ab7b8720c3449a8f" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>premarket clearance or approval;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zc33f6298c43449df9aa21bcf95d87c48" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>advertising and promotion;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z9deb93358a214fdaba512f407db58ca7" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>manufacturing and production;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zb6472f127dd248cf9a086f329644e8bd" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>product sales and distribution;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z08e31a80c25e48978c6b2446266aca76" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>import, export and shipping;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z509e606aa16047c5af293391bdd6864c" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>establishment registration and device listing; and</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zf1bffdb98f1a4f6eb6ce3488a23b1738" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>recalls, field-safety corrective actions and post-market surveillance.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Each of our currently marketed products has received 510(k) clearance for the uses for
which they are being marketed.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">50</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">FDA&#8217;s Premarket Clearance and Approval Requirements</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Unless an exemption applies, each medical device we wish to commercially distribute
in the United States requires 510(k) clearance or premarket approval. The FDA classifies medical devices into one of three classes --
Class I, Class II or Class III --depending on the degree of risk associated with each medical device and the extent of manufacturer and
regulatory control needed to ensure safety and effectiveness. Class I includes devices with the lowest risk to the patient and are those
for which safety and effectiveness can be assured by adherence to the FDA&#8217;s General Controls for medical devices, which include
compliance with the applicable portions of the QSR, facility registration and product listing, reporting of adverse medical events, and
truthful and non-misleading labeling, advertising, and promotional materials. Class II devices are subject to the FDA&#8217;s General
Controls, and special controls as deemed necessary by the FDA to ensure the safety and effectiveness of the device. These special controls
can include performance standards, post-market surveillance, patient registries and FDA guidance documents. While most Class I devices
are exempt from the 510(k) premarket notification requirement, manufacturers of most Class II devices are required to submit to the FDA
a premarket notification under Section 510(k) of the FDCA requesting permission to commercially distribute the device. The FDA&#8217;s
permission to commercially distribute a device subject to a 510(k) premarket notification is generally known as 510(k) clearance. All
of our current products are Class II devices subject to the 510(k) clearance requirements.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Devices deemed by the FDA to pose the greatest risks, such as life-sustaining, life-supporting
or some implantable devices, or devices that have a new intended use, or use advanced technology that is not substantially equivalent
to that of a legally marketed device, are placed in Class III, requiring approval of a premarket approval application, or PMA. Some pre-amendment
devices are unclassified, but are subject to the FDA&#8217;s premarket notification and clearance process in order to be commercially
distributed.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">510(k) Clearance Pathway</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">When a 510(k) clearance is required, we must submit a premarket notification demonstrating
that our proposed device is &#8220;substantially equivalent,&#8221; as defined in the statute, to a previously cleared 510(k) device or
a device that was in commercial distribution in the United States before May 28, 1976, the date upon which the Medical Device Amendments
of 1976 were enacted, for which the FDA has not yet called for the submission of premarket approval applications.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">After a 510(k) premarket notification is submitted, the FDA determines whether to accept
it for substantive review. If it lacks necessary information for substantive review, the FDA will refuse to accept the 510(k) notification.
If it is accepted for filing, the FDA begins a substantive review. By statute, the FDA is required to complete its review of a 510(k)
notification within 90 days of receiving the 510(k) notification. As a practical matter, if the FDA requires additional information, clearance
often takes far longer, and clearance is never assured. Although most 510(k) premarket notifications are cleared without clinical data,
the FDA may require further information, including clinical data, to make a determination regarding substantial equivalence, which may
significantly prolong the review process. If the FDA agrees that the device is substantially equivalent, it will grant clearance to commercially
market the device.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">If the FDA determines that the device is not &#8220;substantially equivalent&#8221;
to a predicate device, or if the device is automatically classified into Class III, the device sponsor must then fulfill the much more
rigorous premarketing requirements of the PMA approval process, or seek reclassification of the device through the de novo process. A
manufacturer can also submit a petition for direct de novo review if the manufacturer is unable to identify an appropriate predicate device
and the new device or new use of the device presents a moderate or low risk.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">After a device receives 510(k) clearance, any modification that could significantly
affect its safety or effectiveness, or that would constitute a new or major change in its intended use, will require a new 510(k) clearance
or, depending on the modification, could require a PMA application or&#160;<span style="font-style: italic">de novo</span>&#160;classification.
The FDA requires each manufacturer to determine whether the proposed change requires submission of a 510(k) or a PMA in the first instance,
but the FDA can review any such decision and disagree with a manufacturer&#8217;s determination. Many minor modifications are accomplished
by a letter-to-file in which the manufacture documents the change in an internal letter-to-file. The letter-to-file is in lieu of submitting
a new 510(k) to obtain clearance for such change. The FDA can always review these letters to file in an inspection. If the FDA disagrees
with a manufacturer&#8217;s determination regarding whether a new premarket submission is required for the modification of an existing
device, the FDA can require the manufacturer to cease marketing and/or recall the modified device until 510(k) clearance or approval of
a PMA is obtained. In addition, in these circumstances, the FDA can impose significant regulatory fines or penalties for failure to submit
the requisite PMA(s).</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">51</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25">Over the last several years, the FDA has proposed reforms to its 510(k) clearance process,
and such proposals could include increased requirements for clinical data and a longer review period, or could make it more difficult
for manufacturers to utilize the 510(k) clearance process for their products. For example, in November 2018, FDA officials announced forthcoming
steps that the FDA intends to take to modernize the premarket notification pathway under Section 510(k) of the FFDCA. Among other things,
the FDA announced that it planned to develop proposals to drive manufacturers utilizing the 510(k) pathway toward the use of newer predicates.
These proposals included plans to potentially sunset certain older devices that were used as predicates under the 510(k) clearance pathway
and to potentially publish a list of devices that have been cleared on the basis of demonstrated substantial equivalence to predicate
devices that are more than 10 years old. In May 2019, the FDA solicited public feedback on these proposals. These proposals have not yet
been finalized or adopted, and the FDA may work with Congress to implement such proposals through legislation.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">In September 2019, the FDA finalized guidance describing an optional &#8220;safety and
performance based&#8221; premarket review pathway for manufacturers of &#8220;certain, well-understood device types&#8221; to demonstrate
substantial equivalence under the 510(k) clearance pathway by showing that such device meets objective safety and performance criteria
established by the FDA, thereby obviating the need for manufacturers to compare the safety and performance of their medical devices to
specific predicate devices in the clearance process. The FDA maintains a list of device types appropriate for the &#8220;safety and performance
based&#8221; pathway and will continue to develop product-specific guidance documents that identify the performance criteria for each
such device type, as well as the testing methods recommended in the guidance documents, where feasible.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Laser devices used for aesthetic procedures, such as hair removal, have generally qualified
for clearance under 510(k) procedures.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The table below presents the specific FDA 510(k) clearances, dates and summary of cleared
indications for our&#160;<span style="font-style: italic">BodyTite (Inmode&#160;RF), Optimas, Votiva, Contoura, Triton, EmbraceRF, Morpheus8,
EvolveX</span>,&#160;<span style="font-style: italic">Evoke,&#160;</span>platforms:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="2" border="0" id="zb933d75886dd42509dea7118ca355cd7" style="font: 10pt Times New Roman,Times,serif; width: 100%; text-align: left; color: rgb(0, 0, 0)">
  <tr>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 28.2%; vertical-align: middle; border-left: rgb(0, 0, 0) 2px solid">
        <div style="margin-left: 3.6pt; line-height: 1.25; font-weight: bold">Product Platform</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 16.52%; vertical-align: middle; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Energy Source</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 18.88%; vertical-align: middle; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Handpiece</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 36.4%; vertical-align: middle; border-right: rgb(0, 0, 0) 2px solid; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">FDA 510(k) Clearance and Cleared Indications</div> </td> </tr>
  <tr>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 28.2%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="margin-left: 3.6pt; line-height: 1.25; font-style: italic">Evolve system with the Transform applicator</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 16.52%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="margin-left: 3.6pt; line-height: 1.25">Sequential RF/EMS</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 18.88%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="margin-left: 3.6pt; line-height: 1.25; font-style: italic">&#160;Transform</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 36.4%; vertical-align: top; border-right: rgb(0, 0, 0) 2px solid; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25">K231495 (10/13/2023)</div>
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">The Evolve System with the Transform Applicator employs RF technology and EMS-TENS technology for the treatment
        of selected medical conditions.</div>
        <div style="line-height: 1.25">The Transform Applicator in RF mode is intended for the temporary relief of minor muscle aches and pain,
        temporary relief of muscle spasm, and temporary improvement of local blood circulation.</div>
        <div style="line-height: 1.25">The Transform Applicator in EMS mode is intended for:</div>
        <div style="text-indent: -14.4pt; margin-left: 28.8pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Relaxation
        of muscle spasms</div>
        <div style="text-indent: -14.4pt; margin-left: 28.8pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Prevention
        or retardation of disuse atrophy</div>
        <div style="text-indent: -14.4pt; margin-left: 28.8pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Increasing
        local blood circulation</div>
        <div style="text-indent: -14.4pt; margin-left: 28.8pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Muscle
        re-education</div>
        <div style="text-indent: -14.4pt; margin-left: 28.8pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Maintaining
        or increasing range of motion</div>
        <div style="text-indent: -32.4pt; margin-left: 46.8pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Immediate
        postsurgical stimulation of calf muscles to prevent venous thrombosis</div>
        <div style="line-height: 1.25">The Transform Applicator in TENS mode is intended for:</div>
        <div style="text-indent: -32.4pt; margin-left: 46.8pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Symptomatic
        relief and management of chronic, intractable pain</div>
        <div style="text-indent: -14.4pt; margin-left: 28.8pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Post-surgical
        acute pain</div>
        <div style="text-indent: -14.4pt; margin-left: 28.8pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Post-trauma
        acute pain</div>
        <div style="line-height: 1.25">Additionally, the Transform Applicator in sequential RF/EMS mode is intended for:</div>
        <div style="text-indent: -23.4pt; margin-left: 37.8pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Non-invasive
        lipolysis (breakdown of fat) of the abdomen.</div>
        <div style="text-indent: -23.4pt; margin-left: 37.8pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Reduction
        in circumference of the abdomen</div>
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div> </td> </tr>
  <tr>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 28.2%; vertical-align: top; border-bottom: rgb(0, 0, 0) 2px solid; border-left: rgb(0, 0, 0) 2px solid">
        <div style="margin-left: 3.6pt; line-height: 1.25; font-style: italic">InMode system with Morpheus8 applicators (coagulation/contraction
        of software tissue)</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 16.52%; vertical-align: top; border-bottom: rgb(0, 0, 0) 2px solid; border-left: rgb(0, 0, 0) 2px solid">
        <div style="margin-left: 3.6pt; line-height: 1.25">Radiofrequency (RF)</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 18.88%; vertical-align: top; border-bottom: rgb(0, 0, 0) 2px solid; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-indent: -27pt; margin-left: 27pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-style: italic">The
        standard Morpheus 8 Applicator is limited to use with the 12, 24 &amp; T tip heads.</span></div>
        <div style="text-indent: -27pt; margin-left: 27pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-style: italic">The
        Morpheus 8 Body Applicator is limited to use with the 40-tip head.</span></div> </td>
    <td style="border: rgb(0, 0, 0) 2px solid; width: 36.4%; vertical-align: top">
        <div style="line-height: 1.25">K231790 (07/20/2023)</div>
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">The InMode System with the Morpheus8 Applicators is intended for use in dermatological procedures where
        coagulation/contraction of soft tissue or hemostasis is needed. At higher energy levels greater than 62 mJ/pin, the use of the Morpheus8
        Applicator is limited to Skin Types I-IV.</div> </td> </tr>
  </table>

<div><br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">52</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div><br/> </div>

<table cellspacing="0" cellpadding="2" border="0" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td rowspan="1" style="border-top: rgb(0, 0, 0) 2px solid; width: 28.2%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="margin-left: 3.6pt; line-height: 1.25; font-weight: bold">Product Platform</div> </td>
    <td rowspan="1" style="border-top: rgb(0, 0, 0) 2px solid; width: 16.52%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Energy Source</div> </td>
    <td rowspan="1" style="border-top: rgb(0, 0, 0) 2px solid; width: 18.88%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Handpiece</div> </td>
    <td rowspan="1" style="border-top: rgb(0, 0, 0) 2px solid; width: 36.4%; vertical-align: top; border-right: rgb(0, 0, 0) 2px solid; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">FDA 510(k) Clearance and Cleared Indications</div> </td> </tr>
  <tr>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 28.2%; vertical-align: top; border-bottom: rgb(0, 0, 0) 2px solid; border-left: rgb(0, 0, 0) 2px solid">
        <div style="margin-left: 3.6pt; line-height: 1.25; font-style: italic">InMode Multi System (interface screen was slightly enlarged from
        10 inch to 12 inch)</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 16.52%; vertical-align: top; border-bottom: rgb(0, 0, 0) 2px solid; border-left: rgb(0, 0, 0) 2px solid">
        <div style="margin-left: 3.6pt; line-height: 1.25">Radiofrequency (RF), Laser, IPL</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 18.88%; vertical-align: top; border-bottom: rgb(0, 0, 0) 2px solid; border-left: rgb(0, 0, 0) 2px solid">
        <div style="margin-left: 3.6pt; line-height: 1.25; font-style: italic">Laser Applicators:</div>
        <div style="text-indent: -18pt; margin-left: 18pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-style: italic">Diolaze
        XL 810nm</span></div>
        <div style="text-indent: -18pt; margin-left: 18pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-style: italic">Diolaze
        XL 755/810nm</span></div>
        <div style="text-indent: -18pt; margin-left: 18pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-style: italic">Diolaze
        XL 810/1064nm</span></div>
        <div style="text-indent: -18pt; margin-left: 18pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-style: italic">VLaze
        (Vasculaze)</span></div>
        <div style="text-indent: -18pt; margin-left: 18pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-style: italic">IPL
        Applicator:</span></div>
        <div style="text-indent: -27pt; margin-left: 27pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-style: italic">SR
        IPL (Lumecca 580, Lumecca 515)</span></div>
        <div style="margin-left: 3.6pt; line-height: 1.25; font-style: italic">Non-Invasive RF Applicators:</div>
        <div style="text-indent: -18pt; margin-left: 18pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-style: italic">Forma
        (Plus)</span></div>
        <div style="text-indent: -18pt; margin-left: 18pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-style: italic">Plus
        (Plus Plus)</span></div>
        <div style="text-indent: -18pt; margin-left: 18pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-style: italic">Plus90</span></div>
        <div style="text-indent: -18pt; margin-left: 18pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-style: italic">i-Forma</span></div>
        <div style="text-indent: -18pt; margin-left: 18pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-style: italic">BodyFX&#8482;
        (WMBody)</span></div>
        <div style="text-indent: -18pt; margin-left: 18pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-style: italic">MiniFX&#8482;</span></div>
        <div style="text-indent: -18pt; margin-left: 18pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-style: italic">WMFace</span></div>
        <div style="margin-left: 3.6pt; line-height: 1.25; font-style: italic">Fractional RF Applicators:</div>
        <div style="margin-left: 3.6pt; line-height: 1.25; font-style: italic">Fractora</div>
        <div style="text-indent: -18pt; margin-left: 18pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-style: italic">24
        pins tip (FRF)</span></div>
        <div style="text-indent: -18pt; margin-left: 18pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-style: italic">60
        pins tip</span></div>
        <div style="text-indent: -18pt; margin-left: 18pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-style: italic">Morpheus8&#8482;</span></div>
        <div style="text-indent: -18pt; margin-left: 18pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-style: italic">12
        pins tip (Prime Tip)</span></div>
        <div style="text-indent: -18pt; margin-left: 18pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-style: italic">24
        pins tip )Fractora 3D</span>)</div>
        <div style="text-indent: -18pt; margin-left: 18pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-style: italic">40
        pins tip (Body Tip)</span></div>
        <div style="text-indent: -18pt; margin-left: 18pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-style: italic">T
        tip</span></div> </td>
    <td style="border: rgb(0, 0, 0) 2px solid; width: 36.4%; vertical-align: top">
        <div style="line-height: 1.25">K221571 (05/26/2022)</div>
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">The InMode Multi System with the Diode laser Applicators is indicated for:</div>
        <div style="text-indent: -27pt; margin-left: 38.45pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Diolaze
        XL 810nm Applicator is intended for hair removal and permanent hair reduction defined as the stable, long-term reduction in hair counts
        at 6, 9, or 12 months following a treatment regime.</div>
        <div style="text-indent: -27pt; margin-left: 38.45pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Diolaze
        XL 755/810nm &amp; 810/1064nm Applicators are intended for hair removal.</div>
        <div style="text-indent: -27pt; margin-left: 38.45pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;VLaze
        Applicator is intended for the treatment of vascular lesions, including angiomas, hemangiomas, telangiectasia, port wine stains, leg veins
        and other benign vascular lesions.</div>
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">The InMode Multi System with the IPL Applicator is indicated for:</div>
        <div style="text-indent: -27pt; margin-left: 38.45pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;IPL
        Applicator with wavelengths (515-l200nm) is indicated for use for the following treatments: The treatment of benign pigmented epidermal
        lesions, including dyschromia, hyperpigmentation, melasma, ephelides (freckles); The treatment of benign cutaneous vascular lesions, including
        port wine stains, facial, truncal and leg telangiectasias, rosacea, erythema of rosacea, angiomas and spider angiomas, poikiloderma of
        Civatte, superficial leg veins and venlous malformations.</div>
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">The InMode Multi System with the non-invasive RF Applicators is indicated for:</div>
        <div style="text-indent: -27pt; margin-left: 38.45pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;BodyFX
        (WMBody) and MiniFX Applicators are intended for the treatment of the following medical conditions: Relief of minor muscle aches and pains,
        relief of muscle spasm, temporary improvement of local blood circulation; and temporary reduction in the appearance of cellulite.</div>
        <div style="text-indent: -27pt; margin-left: 38.45pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;PLUS/
        PLUS90/PLUS-PLUS (FORMA) and i-Forma Applicators are indicated for the temporary relief of minor muscle aches and pain, temporary relief
        of muscle spasm, and temporary improvement of local blood circulation.</div>
        <div style="text-indent: -27pt; margin-left: 38.45pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;FaceFX
        (WMFace) Applicator is intended for use in dermatologic procedures, for noninvasive treatment of mild to moderate facial wrinkles and
        rhytids</div>
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">The InMode Multi System with the Fractional RF Applicators is indicated for:</div>
        <div style="text-indent: -27pt; margin-left: 38.45pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;FRACTORA
        60 pin Applicator is intended for use in dermatological procedures requiring ablation and resurfacing of the skin.</div>
        <div style="text-indent: -27pt; margin-left: 38.45pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;FRF
        24 pin Applicator is intended for use in dermatologic and general surgical procedures for electrocoagulation and hemostasis.</div>
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25">Fractora3D and Morpheus8 Applicators are intended for use in dermatologic and general surgical procedures
        for electrocoagulation and hemostasis. At higher energy levels greater than 62 mJ/pin, use is limited to Skin Types I-IV.</div> </td>
        </tr>
  </table>

<div><br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">53</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div><br/> </div>

<table cellspacing="0" cellpadding="2" border="0" style="font: 10pt Times New Roman,Times,serif; width: 100%; text-align: left; color: rgb(0, 0, 0)">
  <tr>
    <td rowspan="1" style="border: rgb(0, 0, 0) 2px solid; width: 28.2%; vertical-align: top">
        <div style="margin-left: 3.6pt; line-height: 1.25; font-weight: bold">Product Platform</div> </td>
    <td rowspan="1" style="border-top: rgb(0, 0, 0) 2px solid; width: 16.52%; vertical-align: top; border-bottom: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Energy Source</div> </td>
    <td rowspan="1" style="border: rgb(0, 0, 0) 2px solid; width: 18.88%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Handpiece</div> </td>
    <td rowspan="1" style="border-top: rgb(0, 0, 0) 2px solid; width: 36.4%; vertical-align: top; border-right: rgb(0, 0, 0) 2px solid; border-bottom: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">FDA 510(k) Clearance and Cleared Indications</div> </td> </tr>
  <tr>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 28.2%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="margin-left: 3.6pt; line-height: 1.25; font-style: italic">InMode RF Multi&#160;Platform &#8211; Contoura</div> </td>
    <td style="width: 16.52%; vertical-align: top">
        <div style="margin-left: 3.6pt; line-height: 1.25">Radiofrequency (RF)</div> </td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 18.88%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="margin-left: 3.6pt; line-height: 1.25; font-style: italic">Forma(Plus), Plus90,&#160;</div> </td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 36.4%; vertical-align: top">
        <div style="line-height: 1.25">K201150 (07/21/2020)</div> </td> </tr>
  <tr>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 28.2%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">&#160;</td>
    <td style="width: 16.52%; vertical-align: top">&#160;</td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 18.88%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="margin-left: 3.6pt; line-height: 1.25; font-style: italic">Plus(Plus-Plus)</div> </td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 36.4%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 28.2%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">&#160;</td>
    <td style="width: 16.52%; vertical-align: top">&#160;</td>
    <td colspan="1" rowspan="3" style="border-right: rgb(0, 0, 0) 2px solid; width: 18.88%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="margin-left: 3.6pt; line-height: 1.25; font-style: italic">BodyFX,<br/> MiniFX,<br/> Wmface,</div>
        <div style="margin-left: 3.6pt; line-height: 1.25; font-style: italic">Fractora 24 pins tip<br/> Fractora 60 pins tip<br/> Morpheus8
        24 Pin<br/> Applicator<br/> Morpheus8 40<br/> Pin&#160;treatment tip</div>
        <div style="text-indent: -27pt; margin-left: 27pt; line-height: 1.25">&#160; &#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <span style="font-style: italic">Morpheus8
        12 Pin treatment tip</span></div>
        <div style="text-indent: -27pt; margin-left: 27pt; line-height: 1.25">&#160; &#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <span style="font-style: italic">Morpheus8
        T Pin treatment tip</span></div> </td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 36.4%; vertical-align: top">
        <div style="line-height: 1.25">The InMode RF Multi-System with the Non-invasive RF Applicators employs RF energy for various applications:</div>
        </td> </tr>
  <tr>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 28.2%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">&#160;</td>
    <td style="width: 16.52%; vertical-align: top">&#160; <br/> </td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 36.4%; vertical-align: top">
        <div style="text-indent: -27pt; margin-left: 38.45pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Forma
        (Plus), Plus (Plus Plus) and Plus90 for relief of minor muscle aches and pain, relief of muscle spasm, and temporary improvement of local
        blood circulation.</div>
        <div style="text-indent: -27pt; margin-left: 38.45pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;WMface
        is intended for use in dermatologic procedures for non-invasive treatment of mild to moderate facial wrinkles and rhytids.</div>
        <div style="text-indent: -27pt; margin-left: 38.45pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;BodyFX&#8482;
        (WMBody)/MiniFX&#8482; for relief of minor muscle aches and pain, relief of muscle spasm, temporary improvement of local blood circulation
        and temporary reduction in the appearance of cellulite.</div> </td> </tr>
  <tr>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 28.2%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">&#160;</td>
    <td style="width: 16.52%; vertical-align: top">&#160;</td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 36.4%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 28.2%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">&#160;</td>
    <td style="width: 16.52%; vertical-align: top">&#160;</td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 18.88%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">&#160;</td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 36.4%; vertical-align: top">
        <div style="line-height: 1.25">The InMode RF Multi-System with the Fractional Applicators employs RF energy for various applications:</div>
        </td> </tr>
  <tr>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 28.2%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">&#160;</td>
    <td style="width: 16.52%; vertical-align: top">&#160;</td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 18.88%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">&#160;</td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 36.4%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 28.2%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">&#160;</td>
    <td style="width: 16.52%; vertical-align: top">&#160;</td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 18.88%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">&#160;</td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 36.4%; vertical-align: top">
        <div style="text-indent: -27pt; margin-left: 38.45pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Fractora
        Applicator with 60 pins tip is designed for use in dermatological procedures requiring ablation and resurfacing of the skin.</div> </td>
        </tr>
  <tr>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 28.2%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">&#160;</td>
    <td style="width: 16.52%; vertical-align: top">&#160;</td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 18.88%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">&#160;</td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 36.4%; vertical-align: top">
        <div style="text-indent: -27pt; margin-left: 38.45pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Fractora
        Applicator with 24 pins tip is intended for use in dermatological and general surgical procedures for electrocoagulation and hemostasis.
        At higher energy levels greater than 62mJ/pin, use of the applicator is limited to skin types I-IV.</div> </td> </tr>
  <tr>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 28.2%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">&#160;</td>
    <td style="width: 16.52%; vertical-align: top">&#160;</td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 18.88%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">&#160;</td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 36.4%; vertical-align: top">
        <div style="text-indent: -27pt; margin-left: 38.45pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Morpheus8&#8482;
        for dermatological and general surgical procedures for electrocoagulation and hemostasis. At higher energy levels greater than 62mJ/pin,
        use of the applicator is limited to skin types I-IV.</div> </td> </tr>
  <tr>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 28.2%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid; border-right: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25; font-style: italic">Inmode</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 16.52%; vertical-align: top">
        <div style="margin-left: 3.6pt; line-height: 1.25">Powered muscle</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 18.88%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid; border-right: rgb(0, 0, 0) 2px solid">
        <div style="margin-left: 3.6pt; line-height: 1.25; font-style: italic">Tone</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 36.4%; vertical-align: top; border-right: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25">K192249 (12/17/2019)</div> </td> </tr>
  <tr>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 28.2%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 16.52%; vertical-align: top">
        <div style="margin-left: 3.6pt; line-height: 1.25">stimulator</div> </td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 18.88%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">&#160;</td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 36.4%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 28.2%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">&#160;</td>
    <td style="width: 16.52%; vertical-align: top">&#160;</td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 18.88%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">&#160;</td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 36.4%; vertical-align: top">
        <div style="line-height: 1.25">The&#160;<span style="font-style: italic">Evolve</span>&#160;platform is used in EMS mode for:</div> </td>
        </tr>
  <tr>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 28.2%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 16.52%; vertical-align: top">&#160;</td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 18.88%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">&#160;</td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 36.4%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 28.2%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">&#160;</td>
    <td style="width: 16.52%; vertical-align: top">&#160;</td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 18.88%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">&#160;</td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 36.4%; vertical-align: top">
        <div style="text-indent: -27pt; margin-left: 38.45pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;prevention
        or retardation of disuse atrophy;</div>
        <div style="text-indent: -27pt; margin-left: 38.45pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;maintaining
        or increasing range of motion;</div>
        <div style="text-indent: -27pt; margin-left: 38.45pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;muscle
        re-education;</div>
        <div style="text-indent: -27pt; margin-left: 38.45pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;relaxation
        of muscle spasms;</div>
        <div style="text-indent: -27pt; margin-left: 38.45pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;increasing
        local blood circulation; and</div>
        <div style="text-indent: -27pt; margin-left: 38.45pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;immediate
        postsurgical stimulation of calf muscles to prevent venous thrombosis.</div> </td> </tr>
  <tr>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 28.2%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 16.52%; vertical-align: top">&#160;</td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 18.88%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">&#160;</td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 36.4%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 28.2%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">&#160;</td>
    <td style="width: 16.52%; vertical-align: top">&#160;</td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 18.88%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">&#160;</td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 36.4%; vertical-align: top">
        <div style="line-height: 1.25">And in TENS mode for:</div> </td> </tr>
  <tr>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 28.2%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 16.52%; vertical-align: top">&#160;</td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 18.88%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">&#160;</td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 36.4%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 28.2%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid; border-bottom: rgb(0, 0, 0) 2px solid">&#160;</td>
    <td style="border-bottom: rgb(0, 0, 0) 2px solid; width: 16.52%; vertical-align: top">&#160;</td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 18.88%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid; border-bottom: rgb(0, 0, 0) 2px solid">&#160;</td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 36.4%; vertical-align: top; border-bottom: rgb(0, 0, 0) 2px solid">
        <div style="text-indent: -27pt; margin-left: 38.45pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;symptomatic
        relief and management of chronic, intractable pain;</div>
        <div style="text-indent: -27pt; margin-left: 38.45pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;post-surgical
        acute pain; and</div>
        <div style="text-indent: -27pt; margin-left: 38.45pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;post-traumatic
        acute pain.</div> </td> </tr>
  </table>

<div style="line-height: 1.25"><br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">54</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="2" border="0" id="zb18030d3052c4a6598f5387e4e26ca79" style="font: 10pt Times New Roman,Times,serif; width: 100%; text-align: left; color: rgb(0, 0, 0)">
  <tr>
    <td style="border: rgb(0, 0, 0) 2px solid; width: 28.16%; vertical-align: middle">
        <div style="margin-left: 3.6pt; line-height: 1.25; font-weight: bold">Product Platform</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 16.7%; vertical-align: middle; border-bottom: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Energy Source</div> </td>
    <td style="border: rgb(0, 0, 0) 2px solid; width: 18.82%; vertical-align: middle">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Handpiece</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 36.32%; vertical-align: middle; border-right: rgb(0, 0, 0) 2px solid; border-bottom: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">FDA 510(k) Clearance and Cleared Indications</div> </td> </tr>
  <tr>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 28.16%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="margin-left: 3.6pt; line-height: 1.25; font-style: italic">InMode</div> </td>
    <td style="width: 16.7%; vertical-align: top">
        <div style="line-height: 1.25">Powered muscle stimulator</div> </td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 18.82%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25; font-style: italic">vTone</div> </td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 36.32%; vertical-align: top">
        <div style="line-height: 1.25">K200293 (05/05/2020)</div> </td> </tr>
  <tr>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 28.16%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">&#160;</td>
    <td style="width: 16.7%; vertical-align: top">&#160;</td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 18.82%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">&#160;</td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 36.32%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 28.16%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">&#160;</td>
    <td style="width: 16.7%; vertical-align: top">&#160;</td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 18.82%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">&#160;</td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 36.32%; vertical-align: top">
        <div style="line-height: 1.25">The InMode System with the vTone Applicator is intended to provide electrical stimulation and neuromuscular
        re-education for the purpose of rehabilitation of weak pelvic floor muscles for the treatment of stress, urge, and mixed urinary incontinence
        in women.</div> </td> </tr>
  <tr>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 28.16%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid; border-right: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25; font-style: italic">EmFace (Evoke)</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 16.7%; vertical-align: top">
        <div style="line-height: 1.25">Radiofrequency (RF)</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 18.82%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid; border-right: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25; font-style: italic">Cheek</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 36.32%; vertical-align: top; border-right: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25">K191855 (10/29/2019)</div> </td> </tr>
  <tr>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 28.16%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">&#160;</td>
    <td style="width: 16.7%; vertical-align: top">&#160;</td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 18.82%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25; font-style: italic">Chin</div> </td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 36.32%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 28.16%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">&#160;</td>
    <td style="width: 16.7%; vertical-align: top">&#160;</td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 18.82%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">&#160;</td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 36.32%; vertical-align: top">
        <div style="line-height: 1.25">The&#160;<span style="font-style: italic">EmFace</span>&#160;(<span style="font-style: italic">Evoke</span>)
        device with the&#160;<span style="font-style: italic">Cheek</span>&#160;and&#160;<span style="font-style: italic">Chin</span>&#160;applicators
        is indicated for the temporary relief of minor muscle aches and pain, temporary relief of muscle spasm, and temporary improvement of local
        blood circulation.</div> </td> </tr>
  <tr>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 28.16%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid; border-right: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25; font-style: italic">EmBody (Evolve)</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 16.7%; vertical-align: top">
        <div style="line-height: 1.25">Radiofrequency (RF)</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 18.82%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid; border-right: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25; font-style: italic">EMBodyPlus &#8211; Tite</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 36.32%; vertical-align: top; border-right: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25">K183450 (06/20/2019)</div> </td> </tr>
  <tr>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 28.16%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">&#160;</td>
    <td style="width: 16.7%; vertical-align: top">&#160;</td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 18.82%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25; font-style: italic">EmBodyFX &#8211; Trim</div> </td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 36.32%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 28.16%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">&#160;</td>
    <td style="width: 16.7%; vertical-align: top">&#160;</td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 18.82%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">&#160;</td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 36.32%; vertical-align: top">
        <div style="line-height: 1.25">The&#160;<span style="font-style: italic">EmBody (Evolve)</span>&#160;platform with its designated applicators
        is intended for the treatment of the following medical conditions:</div> </td> </tr>
  <tr>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 28.16%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">&#160;</td>
    <td style="width: 16.7%; vertical-align: top">&#160;</td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 18.82%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">&#160;</td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 36.32%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 28.16%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">&#160;</td>
    <td style="width: 16.7%; vertical-align: top">&#160;</td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 18.82%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">&#160;</td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 36.32%; vertical-align: top">
        <div style="line-height: 1.25">The&#160;<span style="font-style: italic">EmBodyPlus (Tite)</span>&#160;hands-fee applicator is intended
        for the temporary relief of minor muscle aches and pain, temporary relief of muscle spasm, and temporary improvement of local blood circulation.</div>
        </td> </tr>
  <tr>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 28.16%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">&#160;</td>
    <td style="width: 16.7%; vertical-align: top">&#160;</td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 18.82%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">&#160;</td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 36.32%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 28.16%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">&#160;</td>
    <td style="width: 16.7%; vertical-align: top">&#160;</td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 18.82%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">&#160;</td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 36.32%; vertical-align: top">
        <div style="line-height: 1.25">The&#160;<span style="font-style: italic">EmBodyFX(Tite)</span>&#160;hands-free applicator is intended
        for the treatment of the following medical conditions using RF combined with massage:</div> </td> </tr>
  <tr>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 28.16%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">&#160;</td>
    <td style="width: 16.7%; vertical-align: top">&#160;</td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 18.82%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">&#160;</td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 36.32%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 28.16%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">&#160;</td>
    <td style="width: 16.7%; vertical-align: top">&#160;</td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 18.82%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">&#160;</td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 36.32%; vertical-align: top">
        <div style="text-indent: -27pt; margin-left: 38.45pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;relief
        of minor muscle aches and pain, relief of muscle spasm, and temporary improvement of local blood circulation; and</div>
        <div style="text-indent: -27pt; margin-left: 38.45pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;temporary
        reduction in the appearance of cellulite.</div> </td> </tr>
  <tr>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 28.16%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid; border-right: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25; font-style: italic">InMode RF /&#160;BodyTite&#160;/&#160;EmbraceRF</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 16.7%; vertical-align: top">
        <div style="line-height: 1.25">Radiofrequency (RF)</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 18.82%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid; border-right: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25"><span style="font-style: italic">Bodyrite</span>&#160;minimally invasive handpiece for thick body areas
        (&gt;20mm)</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 36.32%; vertical-align: top; border-right: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25">K171593 (10/10/2017)</div> </td> </tr>
  <tr>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 28.16%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid; border-bottom: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="border-bottom: rgb(0, 0, 0) 2px solid; width: 16.7%; vertical-align: top">&#160;</td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 18.82%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid; border-bottom: rgb(0, 0, 0) 2px solid">&#160;</td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 36.32%; vertical-align: top; border-bottom: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25">The&#160;<span style="font-style: italic">InMode RFIBodyTitel EmbraceRF&#160;</span>platform with the minimally
        invasive&#160;<span style="font-style: italic">Bodyrite&#160;</span>handpiece for thick body areas is indicated for use in dermatological
        and general surgical procedures for electrocoagulation and hemostasis.</div> </td> </tr>
  </table>

<div style="line-height: 1.25"><br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">55</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25"><br/> </div>

<table cellspacing="0" cellpadding="2" border="0" id="z7ddd7bd1f5e14404a22c8aee91b39f75" style="font: 10pt Times New Roman,Times,serif; width: 100%; text-align: left; color: rgb(0, 0, 0)">
  <tr>
    <td style="border: rgb(0, 0, 0) 2px solid; width: 28.19%; vertical-align: middle">
        <div style="line-height: 1.25; font-weight: bold">Product Platform</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 16.82%; vertical-align: middle; border-bottom: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Energy Source</div> </td>
    <td style="border: rgb(0, 0, 0) 2px solid; width: 19%; vertical-align: middle">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Handpiece</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 36%; vertical-align: middle; border-right: rgb(0, 0, 0) 2px solid; border-bottom: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">FDA 510(k) Clearance and Cleared Indications</div> </td> </tr>
  <tr>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 28.19%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25; font-style: italic">InMode RF&#160;/&#160;Bodyrite&#160;/&#160;EmbraceRF</div> </td>
    <td style="width: 16.82%; vertical-align: top">
        <div style="line-height: 1.25">Radiofrequency (RF)</div> </td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 19%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25"><span style="font-style: italic">Bodyrite</span>&#160;minimally invasive handpiece for thin body areas
        (&lt;20mm) or for large specialty areas</div> </td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 36%; vertical-align: top">
        <div style="line-height: 1.25">K163190 (12/12/2016)</div> </td> </tr>
  <tr>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 28.19%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 16.82%; vertical-align: top">&#160;</td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 19%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">&#160;</td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 36%; vertical-align: top">
        <div style="line-height: 1.25">The&#160;<span style="font-style: italic">InMode RFIBodyTitel EmbraceRF&#160;</span>platform with the minimally
        invasive <span style="font-style: italic">Bodyrite </span>handpiece for thin body and large specialty areas is indicated for use in dermatological
        and general surgical procedures for electrocoagulation and hemostasis.</div> </td> </tr>
  <tr>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 28.19%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid; border-right: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25; font-style: italic">InMode RF&#160;/&#160;EmbraceRF</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 16.82%; vertical-align: top">
        <div style="line-height: 1.25">Radiofrequency (RF)</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 19%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid; border-right: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25; font-style: italic">FaceTite</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 36%; vertical-align: top; border-right: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25">K151793 (02/19/2016)</div> </td> </tr>
  <tr>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 28.19%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">&#160;</td>
    <td style="width: 16.82%; vertical-align: top">&#160;</td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 19%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">&#160;</td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 36%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 28.19%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">&#160;</td>
    <td style="width: 16.82%; vertical-align: top">&#160;</td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 19%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">&#160;</td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 36%; vertical-align: top">
        <div style="line-height: 1.25">The&#160;<span style="font-style: italic">InMode RF/EmbraceRF&#160;</span>platform with the&#160;<span style="font-style: italic">FaceTite</span>&#160;handpiece
        is indicated for use in dermatological and general surgical procedures for electrocoagulation and hemostasis.</div> </td> </tr>
  <tr>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 28.19%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid; border-right: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25; font-style: italic">Optimas / InMode RF</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 16.82%; vertical-align: top">
        <div style="line-height: 1.25">Radiofrequency (RF)</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 19%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid; border-right: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25"><span style="font-style: italic">Fractora</span>&#160;(60 pin tip)</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 36%; vertical-align: top; border-right: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25">K102461 (06/02/2011)</div> </td> </tr>
  <tr>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 28.19%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 16.82%; vertical-align: top">&#160;</td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 19%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">&#160;</td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 36%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 28.19%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">&#160;</td>
    <td style="width: 16.82%; vertical-align: top">&#160;</td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 19%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">&#160;</td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 36%; vertical-align: top">
        <div style="line-height: 1.25">The&#160;<span style="font-style: italic">Optimas/InMode</span>&#160;RF platform with the&#160;<span style="font-style: italic">Fractora</span>&#160;60
        pin tip handpiece is indicated for use in dermatological procedures requiring ablation and resurfacing of the skin.</div> </td> </tr>
  <tr>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 28.19%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid; border-right: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25; font-style: italic">Optimas&#160;/&#160;InMode RF&#160;/&#160;EmbraceRF</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 16.82%; vertical-align: top">
        <div style="line-height: 1.25">Radiofrequency (RF)</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 19%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid; border-right: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25"><span style="font-style: italic">Fractora</span>&#160;(24 pin tip)&#160;<span style="font-style: italic">FractoraV</span></div>
        </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 36%; vertical-align: top; border-right: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25">K151273 (01/04/2016)</div> </td> </tr>
  <tr>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 28.19%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 16.82%; vertical-align: top">&#160;</td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 19%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">&#160;</td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 36%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 28.19%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">&#160;</td>
    <td style="width: 16.82%; vertical-align: top">&#160;</td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 19%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">&#160;</td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 36%; vertical-align: top">
        <div style="line-height: 1.25">The&#160;<span style="font-style: italic">OptimaslInMode RFI EmbraceRF&#160;</span>platform with the&#160;<span style="font-style: italic">Fractora&#160;</span>24
        pin tip handpiece is indicated for use in dermatologic and general surgical procedures for electrocoagulation and hemostasis.</div> </td>
        </tr>
  <tr>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 28.19%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid; border-right: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25; font-style: italic">Optimas</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 16.82%; vertical-align: top">
        <div style="line-height: 1.25">Radiofrequency (RF)</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 19%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid; border-right: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25; font-style: italic">Morpheus8</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 36%; vertical-align: top; border-right: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25">K180189 (06/01/2018)</div> </td> </tr>
  <tr>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 28.19%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 16.82%; vertical-align: top">&#160;</td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 19%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">&#160;</td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 36%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 28.19%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">&#160;</td>
    <td style="width: 16.82%; vertical-align: top">&#160;</td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 19%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">&#160;</td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 36%; vertical-align: top">
        <div style="line-height: 1.25">The&#160;<span style="font-style: italic">Optimas</span>&#160;platform with the&#160;<span style="font-style: italic">Morpheus8</span>&#160;handpiece
        is indicated for use in dermatological and general surgical procedures for electrocoagulation and homeostasis.</div> </td> </tr>
  <tr>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 28.19%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid; border-right: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25; font-style: italic">InMode RF</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 16.82%; vertical-align: top">
        <div style="line-height: 1.25">Radiofrequency (RF)</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 19%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid; border-right: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25; font-style: italic">Morpheus8 24 Pin&#160;Applicator</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 36%; vertical-align: top; border-right: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25">K192695 (12/27/2019)</div>
        <div style="line-height: 1.25"> <br/> </div> </td> </tr>
  <tr>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 28.19%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">&#160;</td>
    <td style="width: 16.82%; vertical-align: top">&#160;</td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 19%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25; font-style: italic">Morpheus8 40 Pin&#160;treatment tip (New tip)</div>
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25; font-style: italic">&#8226; Morpheus8 12 Pin&#160;treatment tip (New tip)</div>
        <div style="line-height: 1.25; font-style: italic">&#8226; Morpheus8 T Pin&#160;treatment tip (New tip)</div>
        <div style="line-height: 1.25; font-style: italic">(maximal treatment&#160;depth 4.00 mm)</div> </td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 36%; vertical-align: top">
        <div style="line-height: 1.25">The InMode System with the Morpheus8&#160;<span style="font-style: italic">(Fractora)</span>&#160;Applicators
        is intended for use in dermatological procedures for electrocoagulation and hemostasis. At higher energy levels greater than 62 mJ/pin,
        use of the Morpheus8 (Fractora) Applicator is limited to Skin Types I-IV.</div> </td> </tr>
  <tr>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 28.19%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid; border-right: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25; font-style: italic">InMode</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 16.82%; vertical-align: top">
        <div style="line-height: 1.25">Radiofrequency (RF)</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 19%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid; border-right: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25; font-style: italic">Morpheus8 24 Pin&#160;Applicator</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 36%; vertical-align: top; border-right: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25">K200947 (06/12/2020)</div>
        <div style="line-height: 1.25"> <br/> </div> </td> </tr>
  <tr>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 28.19%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid; border-bottom: rgb(0, 0, 0) 2px solid">&#160;</td>
    <td style="border-bottom: rgb(0, 0, 0) 2px solid; width: 16.82%; vertical-align: top">&#160;</td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 19%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid; border-bottom: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25; font-style: italic">Morpheus8 40 Pin&#160;treatment tip (New tip)</div>
        <div style="line-height: 1.25; font-style: italic">&#8226; Morpheus8 12 Pin&#160;treatment tip (New tip)</div>
        <div style="line-height: 1.25; font-style: italic">&#8226; Morpheus8 T Pin&#160;treatment tip (New tip)</div>
        <div style="line-height: 1.25; font-style: italic">maximal treatment depth&#160;7.00 mm)</div> </td>
    <td style="border-right: rgb(0, 0, 0) 2px solid; width: 36%; vertical-align: top; border-bottom: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25">The InMode System with the Morpheus8 Applicators is intended for use in dermatological procedures for electrocoagulation
        and hemostasis. At higher energy levels greater than 62 mJ/pin, use of the Morpheus8 (Fractora) Applicator is limited to Skin Types I-IV.</div>
        </td> </tr>
  </table>

<div><br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">56</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div><br/> </div>

<table cellspacing="0" cellpadding="2" border="0" style="font: 10pt Times New Roman,Times,serif; width: 100%; text-align: left; color: rgb(0, 0, 0)">
  <tr>
    <td rowspan="1" style="border-top: rgb(0, 0, 0) 2px solid; width: 28.19%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25; font-weight: bold">Product Platform</div> </td>
    <td rowspan="1" style="border-top: rgb(0, 0, 0) 2px solid; width: 16.82%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Energy Source</div> </td>
    <td rowspan="1" style="border-top: rgb(0, 0, 0) 2px solid; width: 19%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Handpiece</div> </td>
    <td rowspan="1" style="border-top: rgb(0, 0, 0) 2px solid; width: 36%; vertical-align: top; border-right: rgb(0, 0, 0) 2px solid; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">FDA 510(k) Clearance and Cleared Indications</div> </td> </tr>
  <tr>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 28.19%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25; font-style: italic">EmBody (Evolve)</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 16.82%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25">Radiofrequency (RF)</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 19%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25; font-style: italic">Tone</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 36%; vertical-align: top; border-right: rgb(0, 0, 0) 2px solid; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25">K201285 (03/05/2021)</div>
        <div style="line-height: 1.25"> <br/> </div>
        <div style="line-height: 1.25">The&#160;EmBody (Evolve)&#160;platform with its designated applicators is intended for the treatment of
        the following medical conditions:&#160;</div>
        <div style="line-height: 1.25"> <br/> </div>
        <div style="line-height: 1.25">The EmBody (Evolve) System with Tone Applicator is designed to operate in two modes &#8211; EMS and TENS.
        In EMS mode it is used for:</div>
        <div style="text-indent: -27pt; margin-left: 38.45pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Relaxation
        of muscle spasms</div>
        <div style="text-indent: -27pt; margin-left: 38.45pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Prevention
        or retardation of disuse atrophy</div>
        <div style="text-indent: -27pt; margin-left: 38.45pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Increasing
        local blood circulation</div>
        <div style="text-indent: -27pt; margin-left: 38.45pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Muscle
        re-education</div>
        <div style="text-indent: -27pt; margin-left: 38.45pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Maintaining
        or increasing range of motion</div>
        <div style="text-indent: -27pt; margin-left: 38.45pt; line-height: 1.25"><span style="font-style: italic">&#8226;</span>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Immediate
        postsurgical stimulation of calf muscles to prevent venous thrombosis</div>
        <div style="text-indent: -14.4pt; margin-left: 14.4pt; line-height: 1.25">And in TENS mode is intended for:</div>
        <div style="text-indent: -27pt; margin-left: 38.45pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Symptomatic
        relief and management of chronic, intractable pain</div>
        <div style="text-indent: -27pt; margin-left: 38.45pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Post-surgical
        acute pain</div>
        <div style="text-indent: -27pt; margin-left: 38.45pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Post-trauma
        acute pain</div> </td> </tr>
  <tr>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 28.19%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25; font-style: italic">EmBody (Evolve)</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 16.82%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25">Radiofrequency (RF)</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 19%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25; font-style: italic">EMBodyPlus &#8211; Tite</div>
        <div style="line-height: 1.25; font-style: italic">&#160;T3-Transform</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 36%; vertical-align: top; border-right: rgb(0, 0, 0) 2px solid; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25">K210877 (07/19/2021)</div>
        <div style="line-height: 1.25"> <br/> </div>
        <div style="line-height: 1.25">The EvolveX System with the T3 Applicator employs RF technology or EMS-TENS technology for the treatment
        of selected medical conditions.</div>
        <div style="line-height: 1.25">The T3 Applicator in RF mode is intended for the temporary relief of minor muscle aches and pain, temporary
        relief of muscle spasm, and temporary improvement of local blood circulation.</div>
        <div style="line-height: 1.25">The T3 Applicator in EMS mode is intended for:</div>
        <div style="text-indent: -27pt; margin-left: 38.45pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Relaxation
        of muscle spasms</div>
        <div style="text-indent: -27pt; margin-left: 38.45pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Prevention
        or retardation of disuse atrophy</div>
        <div style="text-indent: -27pt; margin-left: 38.45pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Increasing
        local blood circulation</div>
        <div style="text-indent: -27pt; margin-left: 38.45pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Muscle
        re-education</div>
        <div style="text-indent: -27pt; margin-left: 38.45pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Maintaining
        or increasing range of motion</div>
        <div style="text-indent: -27pt; margin-left: 38.45pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Immediate
        postsurgical stimulation of calf muscles to prevent venous thrombosis</div>
        <div style="line-height: 1.25">The T3 Applicator in TENS mode is intended for:</div>
        <div style="text-indent: -27pt; margin-left: 38.45pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Symptomatic
        relief and management of chronic, intractable pain</div>
        <div style="text-indent: -27pt; margin-left: 38.45pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Post-surgical
        acute pain</div>
        <div style="text-indent: -27pt; margin-left: 38.45pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Post-trauma
        acute pain</div>
        <div style="line-height: 1.25">The RF treatment mode and EMS/TENS mode should not be used in combination or sequentially.</div> </td>
        </tr>
  <tr>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 28.19%; vertical-align: top; border-bottom: rgb(0, 0, 0) 2px solid; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25; font-style: italic">InMode RF Pro&#160;Platform &#8211; Empower</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 16.82%; vertical-align: top; border-bottom: rgb(0, 0, 0) 2px solid; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25">Radiofrequency (RF)</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 19%; vertical-align: top; border-bottom: rgb(0, 0, 0) 2px solid; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25; font-style: italic">i-Forma</div>
        <div style="line-height: 1.25; font-style: italic">Forma(Plus), Plus90,&#160;</div>
        <div style="line-height: 1.25; font-style: italic">Plus(Plus-Plus)</div>
        <div style="line-height: 1.25; font-style: italic">BodyFX,</div>
        <div style="line-height: 1.25; font-style: italic">MiniFX,</div>
        <div style="line-height: 1.25; font-style: italic">Wmface,</div>
        <div style="line-height: 1.25; font-style: italic">Fractora 24 pins tip</div>
        <div style="line-height: 1.25; font-style: italic">Fractora 60 pins tip</div>
        <div style="line-height: 1.25; font-style: italic">Morpheus8 24 Pin</div>
        <div style="line-height: 1.25; font-style: italic">&#160;Applicator</div>
        <div style="line-height: 1.25; font-style: italic">Morpheus8 40</div>
        <div style="line-height: 1.25; font-style: italic">&#160;Pin&#160;treatment tip</div>
        <div style="line-height: 1.25; font-style: italic">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-style: italic">Morpheus8
        12 Pin</span> treatment tip</div>
        <div style="line-height: 1.25; font-style: italic">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-style: italic">Morpheus8
        T Pin</span> treatment tip</div> </td>
    <td style="border: rgb(0, 0, 0) 2px solid; width: 36%; vertical-align: top">
        <div style="line-height: 1.25">K201150 (07/21/2021)</div>
        <div style="line-height: 1.25"> <br/> </div>
        <div style="line-height: 1.25">The InMode RF&#160;Pro System with the Non-invasive RF Applicators employs RF energy for various applications:</div>
        <div style="text-indent: -27pt; margin-left: 38.45pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;i-Forma,
        Forma (Plus), Plus (Plus Plus) and Plus90 for relief of minor muscle aches and pain, relief of muscle spasm, and temporary improvement
        of local blood circulation.</div>
        <div style="text-indent: -27pt; margin-left: 38.45pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;WMface
        is intended for use in dermatologic procedures for non-invasive treatment of mild to moderate facial wrinkles and rhytids.</div>
        <div style="text-indent: -27pt; margin-left: 38.45pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;BodyFX&#8482;
        (WMBody)/MiniFX&#8482; for relief of minor muscle aches and pain, relief of muscle spasm, temporary improvement of local blood circulation
        and temporary reduction in the appearance of cellulite.</div>
        <div style="line-height: 1.25">The InMode RF Multi-System with the Fractional Applicators employs RF energy for various applications:</div>
        <div style="text-indent: -27pt; margin-left: 38.45pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Fractora
        Applicator with 60 pins tip is designed for use in dermatological procedures requiring ablation and resurfacing of the skin.</div>
        <div style="text-indent: -27pt; margin-left: 38.45pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Fractora
        Applicator with 24 pins tip is intended for use in dermatological and general surgical procedures for electrocoagulation and hemostasis.
        At higher energy levels greater than 62mJ/pin, use of the applicator is limited to skin types I-IV.</div>
        <div style="text-indent: -27pt; margin-left: 38.45pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Morpheus8&#8482;
        for dermatological and general surgical procedures for electrocoagulation and hemostasis. At higher energy levels greater than 62mJ/pin,
        use of the applicator is limited to skin types I-IV.</div> </td> </tr>
  </table>

<div style="line-height: 1.25"><br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">57</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="2" border="0" id="z196798258f644d0a9f1cfa47f8ef77dc" style="font: 10pt Times New Roman,Times,serif; width: 100%; text-align: left; color: rgb(0, 0, 0)">
  <tr>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 28.35%; vertical-align: bottom; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25; font-weight: bold">Product Platform</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 16.78%; vertical-align: bottom; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Energy Source</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 18.85%; vertical-align: bottom; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Handpiece</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 36.02%; vertical-align: top; border-right: rgb(0, 0, 0) 2px solid; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">FDA 510(k) Clearance and Cleared Indications</div> </td> </tr>
  <tr>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 28.35%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25; font-style: italic">InMode RF&#160;/&#160;EmbraceRF</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 16.78%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25">Radiofrequency (RF)</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 18.85%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25; font-style: italic">AccuTite</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 36.02%; vertical-align: top; border-right: rgb(0, 0, 0) 2px solid; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25">K182325 (08/27/2018)</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="line-height: 1.25">The&#160;<span style="font-style: italic">InMode RFI EmbraceRF</span>&#160;platform with the AccuTite handpiece
        is indicated for use in dermatological and general surgical procedures for electrocoagulation and hemostasis.</div> </td> </tr>
  <tr>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 28.35%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25; font-style: italic">Contoura / Optimas</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 16.78%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25">Radiofrequency (RF)</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 18.85%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25; font-style: italic">Plus</div>
        <div style="line-height: 1.25; font-style: italic">Plus90</div>
        <div style="line-height: 1.25; font-style: italic">Plus-Plus</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 36.02%; vertical-align: top; border-right: rgb(0, 0, 0) 2px solid; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25">K172302 (12/08/2017)</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="line-height: 1.25">The&#160;<span style="font-style: italic">Contoura/Optimas</span>&#160;platform with the&#160;<span style="font-style: italic">Forma</span>&#160;<span style="font-style: italic">Plus</span>,&#160;<span style="font-style: italic">Plus90</span>,&#160;<span style="font-style: italic">Plus-Plus</span>&#160;handpieces
        is indicated for the temporary relief of minor muscle aches and pain, temporary relief of muscle spasm, and temporary improvement of local
        blood circulation.</div> </td> </tr>
  <tr>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 28.35%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25; font-style: italic">Optimas</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 16.78%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25">Intense Pulsed Light (IPL)</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 18.85%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25; font-style: italic">Lumecca 515</div>
        <div style="line-height: 1.25; font-style: italic">Lumecca 580</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 36.02%; vertical-align: top; border-right: rgb(0, 0, 0) 2px solid; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25">K123860 (04/02/2013)</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="line-height: 1.25">The&#160;<span style="font-style: italic">Optimas</span>&#160;platform with the&#160;<span style="font-style: italic">Lumecca
        515</span>&#160;and&#160;<span style="font-style: italic">Lumecca 580</span>&#160;handpieces is indicated for:</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-indent: -27pt; margin-left: 38.45pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the
        treatment of benign pigmented epidermal lesions, including dyschrornia, hyperpigmentation, melasma, ephelides (freckles); and</div>
        <div style="text-indent: -27pt; margin-left: 38.45pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the
        treatment of benign cutaneous vascular lesions, including port wine stains, facial truncal and leg telangiectasias, rosacea, erythema
        of rosacea, angiomas and spider angiomas, poikilodenna of civatte, superficial leg veins and venous malformations.</div> </td> </tr>
  <tr>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 28.35%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25; font-style: italic">Triton / Optimas</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 16.78%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25">Laser</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 18.85%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25; font-style: italic">DiolazeXL</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 36.02%; vertical-align: top; border-right: rgb(0, 0, 0) 2px solid; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25">K170738 (08/07/2017)</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="line-height: 1.25">The&#160;<span style="font-style: italic">Triton/Optimas</span>&#160;platform with the&#160;<span style="font-style: italic">DiolazeXL</span>&#160;handpiece
        is indicated for hair removal and permanent hair reduction defined as stable, long-term reduction in hair counts at six, nine or 12 months
        following a treatment regime.</div> </td> </tr>
  <tr>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 28.35%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25; font-style: italic">Triton / Optimas</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 16.78%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25">Powered Laser</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 18.85%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25; font-style: italic">Vasculaze</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 36.02%; vertical-align: top; border-right: rgb(0, 0, 0) 2px solid; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25">K173677 (02/23/2018)</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="line-height: 1.25">The&#160;<span style="font-style: italic">Triton/Optimas</span>&#160;platform with the&#160;<span style="font-style: italic">Vasculaze</span>&#160;handpiece
        is indicated for the treatment of vascular lesions, including angiomas, hemangiomas, telangiectasia, port wine stains, leg veins and other
        benign vascular lesions.</div> </td> </tr>
  <tr>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 28.35%; vertical-align: top; border-bottom: rgb(0, 0, 0) 2px solid; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25; font-style: italic">Votiva</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 16.78%; vertical-align: top; border-bottom: rgb(0, 0, 0) 2px solid; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25">Radiofrequency (RF)</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 18.85%; vertical-align: top; border-bottom: rgb(0, 0, 0) 2px solid; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25; font-style: italic">FormaV</div> </td>
    <td style="border: rgb(0, 0, 0) 2px solid; width: 36.02%; vertical-align: top">
        <div style="line-height: 1.25">f (07/12/2016)*</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="line-height: 1.25">The&#160;<span style="font-style: italic">InMode Plus90 (Votiva)</span>&#160;platform with the&#160;<span style="font-style: italic">Forma</span>&#160;Vhandpiece
        is indicated for the temporary relief of minor muscle aches and pain, temporary relief of muscle spasm, and temporary improvement of local
        blood circulation.</div> </td> </tr>
  </table>

<div style="line-height: 1.25"><br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">58</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25"><br/> </div>

<table cellspacing="0" cellpadding="2" border="0" id="z5fd4f5921e3743d1ab93ac8409afa6ec" style="font: 10pt Times New Roman,Times,serif; width: 100%; text-align: left; color: rgb(0, 0, 0)">
  <tr>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 28.44%; vertical-align: bottom; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25; font-weight: bold">Product Platform</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 16.56%; vertical-align: bottom; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Energy Source</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 19.18%; vertical-align: bottom; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Handpiece</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 35.82%; vertical-align: top; border-right: rgb(0, 0, 0) 2px solid; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">FDA 510(k) Clearance and Cleared Indications</div> </td> </tr>
  <tr>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 28.44%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25; font-style: italic">Contoura / Optimas</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 16.56%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25">Radiofrequency (RF)</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 19.18%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25; font-style: italic">BodyFX</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 35.82%; vertical-align: top; border-right: rgb(0, 0, 0) 2px solid; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25">K131362 (10/08/2013)</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="line-height: 1.25">The&#160;<span style="font-style: italic">Contoura/Optimas</span>&#160;platform with the&#160;<span style="font-style: italic">BodyFX</span>&#160;handpiece
        is indicated for the treatment of:</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-indent: -27pt; margin-left: 38.45pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;relief
        of minor muscle aches and pains, muscle spasms and temporary improvement of blood circulation; and</div>
        <div style="text-indent: -27pt; margin-left: 38.45pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
        temporary reduction in the appearance of cellulite.</div> </td> </tr>
  <tr>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 28.44%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25; font-style: italic">Contoura / Optimas</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 16.56%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25">Radiofrequency (RF)</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 19.18%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25; font-style: italic">MiniFX</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 35.82%; vertical-align: top; border-right: rgb(0, 0, 0) 2px solid; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25">K160329 (08/19/2016)</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="line-height: 1.25">The&#160;<span style="font-style: italic">Contoura/Optimas</span>&#160;platform with the&#160;<span style="font-style: italic">MiniFX</span>&#160;handpiece
        is indicated for the treatment of:</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-indent: -27pt; margin-left: 38.45pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;relief
        of minor muscle aches and pain, muscle spasms, and temporary improvement of local blood circulation; and</div>
        <div style="text-indent: -27pt; margin-left: 38.45pt; line-height: 1.25">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
        temporary reduction in the appearance of cellulite.</div> </td> </tr>
  <tr>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 28.44%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25; font-style: italic">Triton / Optimas</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 16.56%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25">Laser</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 19.18%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25"><span style="font-style: italic">Triton Duo Light/</span>&#160;<span style="font-style: italic">Triton&#160;Duo
        Dark</span>&#160;<span style="font-style: italic">InMode&#160;Diolaze XL</span>&#160;755/810nm&#160;<span style="font-style: italic">InMode
        Diolaze XL</span>&#160;810/1064nm&#160;<span style="font-style: italic">InMode Diolaze&#160;XL</span>&#160;810<span style="font-style: italic">nm</span></div>
        </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 35.82%; vertical-align: top; border-right: rgb(0, 0, 0) 2px solid; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25">K180719 (06/14/2018)</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="line-height: 1.25">The&#160;<span style="font-style: italic">Triton</span>/<span style="font-style: italic">Optimas</span>&#160;platform
        with the&#160;<span style="font-style: italic">Triton Duo&#160;Light</span>&#160;and&#160;<span style="font-style: italic">Triton Duo
        Dark</span>&#160;handpieces is indicated for hair removal and permanent hair reduction.</div> </td> </tr>
  <tr>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 28.44%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25; font-style: italic">InMode</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 16.56%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25">Laser</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 19.18%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25; font-style: italic">Diolaze</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 35.82%; vertical-align: top; border-right: rgb(0, 0, 0) 2px solid; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25">K142952 (11/24/2014)</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="line-height: 1.25">The InMode Diolaze device is indicated for use for hair removal and for permanent reduction in hair regrowth,
        defined as the long-term, stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion
        of a treatment regime</div> </td> </tr>
  <tr>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 28.44%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25; font-style: italic">InMode</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 16.56%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25">Laser</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 19.18%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25; font-style: italic">Diolaze</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 35.82%; vertical-align: top; border-right: rgb(0, 0, 0) 2px solid; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25">K123682 (27/02/2013)</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="line-height: 1.25">The InMode Diolaze device is indicated for use for hair removal</div> </td> </tr>
  <tr>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 28.44%; vertical-align: top; border-bottom: rgb(0, 0, 0) 2px solid; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25; font-style: italic">InMode</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 16.56%; vertical-align: top; border-bottom: rgb(0, 0, 0) 2px solid; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25">Radiofrequency (RF)</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 19.18%; vertical-align: top; border-bottom: rgb(0, 0, 0) 2px solid; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25; font-style: italic">WMface</div> </td>
    <td style="border: rgb(0, 0, 0) 2px solid; width: 35.82%; vertical-align: top">
        <div style="line-height: 1.25">k140926 (12/03/2014)</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="line-height: 1.25">The InMode WMface device is intended for use in dermatologic procedures for noninvasive treatment of mild
        to moderate facial wrinkles and rhytids.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z51ef508c81e7463aa295a2f9fc399dc1" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt; vertical-align: top">*</td>
    <td style="width: auto; vertical-align: top">
        <div>In addition to the 510(k) clearance, we also market the&#160;<span style="font-style: italic">FormaV</span>&#160;for use with the&#160;<span style="font-style: italic">Votiva</span>&#160;platform
        pursuant to a classification regulation for &#8220;genital vibrators for therapeutic use&#8221; under 21 C.F.R. 884.5960, which permits
        &#8220;electronically operated devices intended and labeled for therapeutic use in the treatment of sexual dysfunction or as an adjunct
        to Kegel&#8217;s exercise (tightening of the muscles of the pelvic floor to increase muscle tone)&#8221; to be marketed without a 510(k)
        clearance.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">59</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Premarket Approval Pathway</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">A PMA must be submitted to the FDA if the device cannot be cleared through the 510(k)
process. A PMA must be supported by extensive data, including, but not limited to, technical, preclinical, clinical trials, manufacturing
and labeling, to demonstrate the safety and effectiveness of the device to the FDA&#8217;s satisfaction.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">No device that we have developed has required premarket approval, nor do we currently
expect that any future device or indication will require premarket approval.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Pervasive and Continuing Regulation</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">After the FDA permits a device to enter commercial distribution, numerous regulatory
requirements apply. These include:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z74122c64c2864ff6b6bd20fbfbea7488" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>QSR, which require manufacturers, including third-party manufacturers, to follow stringent design, testing, control, documentation
        and other quality assurance procedures during all aspects of the manufacturing process;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z955a5470577f410ab8ae502a1bc737b8" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>clearance or approval of product modifications to 510(k)-cleared or PMA-approved devices that could affect safety or effectiveness;</div>
        </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zed8fcd57723b4c9288a54cee2f9fa1c0" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>labeling regulations and FDA prohibitions against the promotion of products for uncleared, unapproved or &#8220;off-label&#8221;
        uses;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zad0fc259577046d3969a901dfd060438" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>advertising and promotion requirements;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z0d1977a7532a4c1da00846aca80ac7e2" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>medical device reporting regulations, which require that manufacturers report to the FDA if their devices may have caused or contributed
        to deaths or serious injuries or malfunctioned in ways that would likely cause or contribute to deaths or serious injuries if the malfunctions
        were to recur;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z565a15cd99514da2bc62e70fb0d32280" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>medical device correction and removal reporting regulations, which require the manufacturers to report to the FDA corrections and
        removals if undertaken to reduce a risk to health posed by the device or to remedy a violation of the FDCA that may present a risk to
        health; and</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z997cf82ff35147e286de89496b2f2dc3" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>post-market surveillance regulations, which apply when necessary to protect the public health or to provide additional safety and
        effectiveness data for the devices.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We may be subject to similar foreign laws that may include applicable post-marketing
requirements such as safety surveillance. Our manufacturing processes are required to comply with the applicable portions of the QSR,
which cover the methods and the facilities and controls for the design, manufacture, testing, production, processes, controls, quality
assurance, labeling, packaging, distribution, installation and servicing of finished devices intended for human use. The QSR also requires,
among other things, maintenance of a device master file, device history file, and complaint files. As a manufacturer, our facilities,
records and manufacturing processes are subject to periodic scheduled or unscheduled inspections by the FDA. Our failure to maintain compliance
with the QSR or other applicable regulatory requirements could result in the shut-down of, or restrictions on, our manufacturing operations
and the recall or seizure of our products. The discovery of previously unknown problems with any of our products, including unanticipated
adverse events or adverse events of increasing severity or frequency, whether resulting from the use of the device within the scope of
its clearance or off-label by a physician in the practice of medicine, could result in restrictions on the device, including the removal
of the product from the market or voluntary or mandatory device recalls.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The FDA has broad post-market and regulatory enforcement powers. We are subject to unannounced
inspections by the FDA to determine our compliance with the QSR and other regulations, and these inspections may include the facilities
of our manufacturing subcontractors.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We also are regulated under the Radiation Control for Health and Safety Act, which requires
laser products to comply with performance standards, including design and operation requirements, and manufacturers to certify in product
labeling and in reports to the FDA that their products comply with all such standards. The law also requires laser manufacturers to file
new product and annual reports, maintain manufacturing, testing and sales records, and report product defects. Various warning labels
must be affixed and certain protective devices installed, depending on the class of the product.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">60</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25">Failure to comply with applicable regulatory requirements can result in enforcement
action by the FDA, which may include any of the following sanctions:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z6378efd52e654a7a804f05dd3f4286f7" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>warning or untitled letters, fines, injunctions, consent decrees and civil penalties;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z049fd58b52894a30825ead2082ba71fa" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>unanticipated expenditures, repair, replacement, refunds, recalls, administrative detention or seizure of products;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z3ee44b1dcd3945258795e64896ef6d92" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>operating restrictions, partial suspension or total shutdown of production;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zb88257216f0d4e9ea4340a0c0dae697c" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>refusing requests for 510(k) clearance or PMAs of new products or new intended uses;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z8bf797f151064e5eaf5ca1262183e9a4" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>withdrawing 510(k) clearance or PMAs that have already been granted; and</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z6085e2fc4ba0488a8fa8cddd402c9012" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>criminal prosecution.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The FDA also has the authority to require us to repair, replace or refund the cost of
any medical device that we have manufactured or distributed. If any of these events were to occur, they could have a material adverse
effect on our business.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We are also subject to a wide range of federal, state and local laws and regulations,
including those related to the environment, health and safety, land use, and quality assurance. We believe that we are in compliance with
these laws and regulations as currently in effect, and our compliance with such laws will not have a material adverse effect on our capital
expenditures, earnings, and competitive and financial position.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Other Healthcare Laws</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Although none of our products or procedures using our products are currently covered
by any state or federal government healthcare programs, or any private commercial payor, we may be subject to a number of foreign, federal,
and state laws and regulations that may restrict our business practices, including, without limitation, anti-kickback, false claims, physician
payment transparency and data privacy and security laws. The government has interpreted these laws broadly as they apply to the marketing
and sales activities of manufacturers and distributors. Companies targeted in such prosecutions and in civil litigation have paid substantial
fines, penalties, and settlements in the hundreds of millions of dollars or more, have been forced to implement extensive corrective action
plans, can be excluded from federal health care programs, and have often become subject to consent decrees, settlement agreements or corporate
integrity agreements severely restricting the manner in which they conduct their business. Many U.S. states and countries outside the
United States have similar fraud and abuse statutes or regulations that may be broader in scope than the U.S. federal laws, and may apply
regardless of payor, in addition to items and services reimbursed under government programs.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">International Regulations</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">International manufacturing and sales of medical devices are subject to foreign governmental
regulations, which vary substantially from country to country. The time required to obtain clearance or approval by a foreign country
may be longer or shorter than that required for FDA clearance or approval, and the requirements may be different.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The primary regulatory environment in Europe is that of the European Union or EU, which
consists of 27 countries encompassing most of the major countries in Europe. The European Union has adopted numerous specific directives
regulating the design, manufacture, clinical investigations, conformity assessment, labeling and adverse event reporting for medical devices.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Devices that comply with the essential requirements of the EU Medical Devices Directive
(Directive 93/42/EEC) will be entitled to bear CE conformity marking, indicating that the device conforms with the essential requirements
of the EU Medical Devices Directive and, accordingly, can be commercially distributed throughout the member states of the European Union,
the member states of the European Economic Area, or EEA (which is comprised of the 27 EU countries, plus Norway, Liechtenstein, and Iceland),
and countries that have entered into a Mutual Recognition Agreement. The method of assessing conformity varies depending on the type and
(risk) class of the product but normally involves a combination of self-assessment by the manufacturer and a third-party assessment by
a notified body, an independent organization designed by an EU country to conduct the conformity assessment. This third-party assessment
may consist of an audit of the manufacturer&#8217;s quality system and specific testing of the manufacturer&#8217;s device. An assessment
by a notified body in one member state of the European Union, the EEA or a country that has entered into a Mutual Recognition Agreement
is required in order for a manufacturer to commercially distribute the product throughout these countries. European Standardization Committees
and the International Organization for Standardization, or ISO, have promulgated voluntary harmonized standards. Compliance with applicable
standards establishes the presumption of conformity with the essential requirements for a CE Marking.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">61</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25">As a general rule, demonstration of conformity of medical devices and their manufacturers
with the essential requirements must be based, among other things, on the evaluation of clinical data supporting the safety and performance
of the products during normal conditions of use. Specifically, a manufacturer must demonstrate that the device achieves its intended performance
during normal conditions of use, that the known and foreseeable risks, and any adverse events, are minimized and acceptable when weighed
against the benefits of its intended performance, and that any claims made about the performance and safety of the device are supported
by suitable evidence. All manufacturers placing medical devices into the market in the EEA must comply with the EU Medical Device Vigilance
System. Under this system, incidents must be reported to the relevant authorities of the Member States of the EEA, and manufacturers are
required to take Field Safety Corrective Actions, or FSCAs, to reduce a risk of death or serious deterioration in the state of health
associated with the use of a medical device that is already placed on the market. An incident is defined as any malfunction or deterioration
in the characteristics and/or performance of a device, as well as any inadequacy in the labeling or the instructions for use which, directly
or indirectly, might lead to or might have led to the death of a patient or user or of other persons or to a serious deterioration in
their state of health. An FSCA may include the recall, modification, exchange, destruction or retrofitting of the device. FSCAs must be
communicated by the manufacturer or its legal representative to its customers and/or to the end users of the device through Field Safety
Notices.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">On May 25, 2017, the EU passed the Medical Devices Regulation (Regulation 2017/745)
(&#8220;MDR&#8221;) entered into force, which repeals and replaces the EU Medical Devices Directive. Unlike directives, which must be
implemented into the national laws of the EEA member states, regulations are directly applicable (i.e., without the need for adoption
of EEA member state laws implementing them) in all EEA member states and are intended to eliminate current differences in the regulation
of medical devices among EEA member states. The MDR, among other things, is intended to establish a uniform, transparent, predictable
and sustainable regulatory framework across the EEA for medical devices and ensure a high level of safety and health while supporting
innovation.</div>

<div style="text-indent: 18pt; line-height: 1.25"> <br/> </div>

<div style="text-align: justify; text-indent: 21.3pt; line-height: 1.25">The MDR was however originally intended to become applicable
three years after publication and, in April 2020, such transition period was extended by the European Parliament and the Council of the
EU.</div>

<div style="text-align: justify; text-indent: 21.3pt; line-height: 1.25"> <br/> </div>

<div style="text-align: justify; text-indent: 21.3pt; line-height: 1.25">Following the signing of a written agreement with the notify
body, under MDR, by the date of MDD certificates expiry, The notify body confirms the extension of our MDD certificates until December
31, 2028,</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-indent: 18pt; line-height: 1.25"></div>

<div style="text-indent: 18pt; line-height: 1.25">These modifications may have an impact on the way we design and manufacture products
and the way we conduct our business in the EEA.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Following the end of the &#8220;Brexit&#8221; Transition Period, since January 1, 2021,
the Medicines and Healthcare Products Regulatory Agency (&#8220;MHRA&#8221;) has been responsible for the UK medical device market. The
new regulations require medical devices to be registered with the MHRA (but manufacturers will be given a grace period of four to 12 months
to comply with the new registration process). Manufacturers based outside the UK will need to appoint a UK Responsible Person to register
devices with the MHRA in line with the grace periods. By July 1, 2023, in the UK (England, Scotland, and Wales), all medical devices will
require a UKCA (UK Conformity Assessed) mark but CE marks issued by EU notified bodies will remain valid until this time. However, UKCA
marking alone will not be recognized in the EU. The rules for placing medical devices on the Northern Ireland market will differ from
those in the UK. All of our platforms and applicators require UKCA marking.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Several member states of the EEA have voluntarily adopted laws and regulations that
mirror those of the European Union with respect to medical devices. Other countries, such as Switzerland, have entered into Mutual Recognition
Agreements and allow the marketing of medical devices that meet European Union requirements.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">In Israel, the Medical Equipment Law generally governs the regulatory process and authorizations
required for the manufacture, marketing and use of medical and certain aesthetic products in Israel. Under the Medical Equipment Law,
we are required to register our products with the Israeli Ministry of Health. The Medical Equipment Law offers a fast-track approval process
for devices that received approval from certain non-Israeli regulatory agencies, including FDA clearance or CE marks. The registration
process under this fast-track process involves submitting an application to the Israeli Ministry of Health which includes, among other
things, documentation confirming receipt of the necessary regulatory approvals, such as 510(k) clearance or CE mark certification. In
addition, we must provide details regarding the approval, including the period for which the applicable device was authorized for marketing
in the applicable country, registration terms, any limitations, and any instructions given with respect to the labeling and packaging
of such device. If approved, the registration of the device in Israel will be valid for the same period that such device was authorized
to be marketed in the applicable non-Israeli country (but in any event not more than five years from the date of registration in Israel),
and the device will be subject to the terms and conditions imposed by the relevant non-Israeli regulatory agency, if any. We have taken
advantage of such fast-track approval in the past. All of our products that we currently sell in Israel are registered with the Israeli
Ministry of Health, with registrations that expired on January 31, 2021. We applied for extensions as required to maintain active registrations,
and such registrations now expire on January 31, 2023.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">62</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Federal Communications Commission and other governmental agencies
governing the use of radio frequency energy</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our products generate and use radio frequency energy and therefore may be subject to
technical equipment authorization and other regulatory requirements in the countries and regions where they are marketed or distributed.
In the United States, our products are subject to the Federal Communications Commission&#8217;s equipment verification procedures, under
which the manufacturer is required to determine or verify that the equipment complies with the applicable technical standards and to keep
a record of test measurements demonstrating compliance before the equipment can be marketed or sold in the United States. Any modifications
to our products may require reverification before we are permitted to market and distribute the modified devices.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We obtain regulatory approvals in countries requiring advance clearance of our products
before they are marketed or distributed in those countries. Our failure to comply with the technical, equipment authorization or other
regulatory requirements of a specific country or region could impair our ability to commercially market and distribute our products in
that country or region.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Data Protection</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our business involves the use, storage and transmission of information about our employees,
our customers and, to a certain extent, clients of our customers. In the course of our operations, we may gain access to confidential
customer information, including nonpublic personal data. We are bound by certain agreements to use and disclose this information in a
manner consistent with the privacy standards under regulations applicable to our customers and are subject to numerous U.S. and foreign
jurisdiction laws and regulations designed to protect this information. With the recent increase in publicity regarding data breaches
resulting in improper dissemination of consumer information, many states have passed laws regulating the actions that a business must
take if it experiences a data breach, such as prompt disclosure to affected customers, governmental entities, and the media. In addition
to data breach notification laws, some states have enacted statutes and rules requiring businesses to protect certain types of personal
information they hold or to otherwise comply with certain specified data security requirements for personal information. We intend to
protect all personal information and to comply with all applicable laws regarding the protection of such information.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">As an Israeli headquartered company, we are subject to the Israeli Protection of Privacy
Law of 1981 and the Privacy Protection Regulations (Data Security) 5777-2017. Further, in the U.S., numerous federal and state laws and
regulations, including data breach notification laws, health information privacy laws and consumer protection and advertising laws (e.g.,
Section 5 of the Federal Trade Commission Act), that govern the collection, use, disclosure and protection of health-related and other
personal information could apply to our operations or the operations of our collaborators and third-party providers. For example, the
CCPA, which became effective on January 1, 2020, gives California residents expanded rights to access and delete their personal information,
opt out of certain personal information sharing and receive detailed information about how their personal information is used. The CCPA
provides for civil penalties for violations, as well as a private right of action for data breaches that is expected to increase data
breach litigation. Further, the CPRA recently passed in California. The CPRA will impose additional data protection obligations on covered
businesses, including additional consumer rights processes, limitations on data uses, new audit requirements for higher risk data, and
opt outs for certain uses of sensitive data. It will also create a new California data protection agency authorized to issue substantive
regulations and could result in increased privacy and information security enforcement. The majority of the provisions went into effect
on January 1, 2023, and additional compliance investment and potential business process changes required.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">In the European Union and the EEA, the GDPR imposes several stringent requirements for
controllers and processors of personal data, including, for example, higher standards for obtaining consent from individuals to process
their personal data, more robust disclosures to individuals and a strengthened individual data rights regime, shortened timelines for
data breach notifications, limitations on retention and secondary use of information, increased requirements pertaining to health data
and pseudonymised (<span style="font-style: italic">i.e.</span>, key-coded) data and additional obligations when we contract third-party
processors in connection with the processing of the personal data. The GDPR provides that EU and EEA member states may make their own
further laws and regulations limiting the processing of genetic, biometric or health data, which could limit our ability to use and share
personal data or could cause our costs to increase, and harm our business and financial condition. Failure to comply with the requirements
of GDPR and the applicable national data protection laws of the EU and EEA member states may result in fines of up to &#8364;20 million
or up to 4% of the total worldwide annual turnover of the preceding financial year, whichever is higher, and other administrative penalties.
To comply with the new data protection rules imposed by GDPR, we may be required to put in place additional mechanisms ensuring compliance.
Further, since January 1, 2021, we are subject to the GDPR and also the UK GDPR, which, together with the amended UK Data Protection Act
2018, retains the GDPR in UK national law. The UK GDPR mirrors the fines under the GDPR, e.g. fines up to the greater of &#8364;20 million
or 4% of global turnover. The relationship between the United Kingdom and the European Union in relation to certain aspects of data protection
law remains unclear, and it is unclear how UK data protection laws and regulations will develop in the medium to longer term, and how
data transfers to and from the United Kingdom will be regulated in the long term. It is not clear whether (and when) an adequate decision
may be granted by the European Commission enabling data transfers from European Union member states to the United Kingdom long-term without
additional measures. These changes will lead to additional costs and increase our overall risk exposure.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">63</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25">Recent legal developments in Europe have created complexity and uncertainty regarding
transfers of personal data from the EEA and the United Kingdom to the United States. Most recently, on July 16, 2020, the CJEU invalidated
the Privacy Shield under which personal data could be transferred from the EEA to US entities who had self-certified under the Privacy
Shield scheme. While the CJEU upheld the adequacy of the standard contractual clauses (a standard form of contract approved by the European
Commission as an adequate personal data transfer mechanism, and potential alternative to the Privacy Shield), it made clear that reliance
on them alone may not necessarily be sufficient in all circumstances. Use of the standard contractual clauses must now be assessed on
a case-by-case basis taking into account the legal regime applicable in the destination country, in particular applicable surveillance
laws and rights of individuals and additional measures and/or contractual provisions may need to be put in place, however, the nature
of these additional measures is currently uncertain. The CJEU went on to state that if a competent supervisory authority believes that
the standard contractual clauses cannot be complied with in the destination country and the required level of protection cannot be secured
by other means, such supervisory authority is under an obligation to suspend or prohibit that transfer. We rely on a mixture of mechanisms
to transfer personal data from the EEA to the United States, and could be impacted by these recent developments, which may require us
to review and amend the legal mechanisms by which we make and/or receive personal data transfers to/in the U.S.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Corporate and Social Responsibility</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our management continues to participate in Corporate Social Responsibility (&#8220;CSR&#8221;)
Reporting on our website to respond to increased awareness of the importance of environmental and sustainability topics and non-material
company activities towards the long-term success of the company. As a manufacturer of medical devices, we already adhere to strict quality
and safety requirements dictated by regulatory bodies such as the FDA, CE, Health Canada, TGA (Australia), Brazil, Japan, Chinese NMPA
(previously Chinese FDA), ISO, as well as international GMP standards. We successfully completed all audits conducted by the regulatory
bodies in 2023, including a physical audit of our facilities and the facilities of our Tier 1 subcontractors-Medimor, Flex, and Resonetics.&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our mission is to develop and produce innovative, life-changing technologies to enable
patients to become their &#8216;best possible self&#8217;, in the safest and most effective manner. Our commitment to CSR topics complements
InMode&#8217;s core values to provide the ultimate in customer care and support.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Management Discussion</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">In 2023, we completed reporting on all six topics defined by The SASB (Sustainability
Accounting Standards Board) Sustainability Accounting Standard for Medical Equipment and Supplies. These topics were: Affordability &amp;
Pricing, Ethical Marketing, Product Design &amp; Lifecycle Management, Business Ethics, Product Safety and Supply Chain Management.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic">MSCI Ratings</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">MSCI is one of the leading organizations to rank a company&#8217;s ESG compliance. MSCI
has ranked InMode as &#8220;BB-Average rank&#8221;, based on a more in-depth review of the company&#8217;s ESG compliance activities.
InMode&#8217;s ranking is above the industry&#8217;s average.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">64</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25">The CSR Reporting also highlights our impact on the local economies in government-designated
development areas in the periphery where we work with contract suppliers and subcontractors (<span style="text-decoration: underline">https://inmodemd.com/investors/corporate-social-responsibility/</span>).</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The CSR Reporting specifically focuses on our primary assembly and manufacturing facilities
in Israel, the location of the Company&#8217;s headquarters. Further information on our corporate social responsibility efforts and SASB
data reporting is available on our website. The information contained on our website or available through our website is not incorporated
by reference into and should not be considered a part of this Annual Report on Form 20-F, and the reference to our website in this Annual
Report on Form 20-F is an inactive textual reference only.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Environment</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic">Carbon Emissions</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our products do not require any fossil fuels for manufacture, and we do not have any
active carbon emissions from our headquarters. We are aware of the importance of reducing carbon emissions and have made a management
decision to eliminate almost all air shipments to and from the United States and Canada, our largest markets. In addition we have forced
a company policy for &#8220;slow boat&#8221; shipment for domestics shipments to reduce air shipments courier.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic">Industrial and Electronic Waste&#160;Disposal</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We focused our efforts on setting baseline metrics for many of our activities. One of
our priorities was to manage industrial and electronic waste disposal at our R&amp;D facility. As a result, we entered into a new agreement
with a government-approved industrial waste removal company. We designated an electronic waste depository in the warehouse and expected
to manage the disposal every quarter.<sup style="vertical-align: text-top; line-height: 1; font-size: smaller">&#160;</sup>We assured
that all our subcontractors full turnkey manufactures are fully meeting disposable local environmental regulations.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25"></div>

<div style="line-height: 1.25; font-style: italic">Printing</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Annually, we sell hundreds of thousands of our consumables in boxes with colorful printed
sleeves. We have established a technology to eliminate the sleeves and validate colorful boxes with no need for the colorful sleeves which
will save printing and papers. This process has been started in 2023 and be implemented during on most products during 2024.</div>

<div style="text-indent: 18pt; line-height: 1.25"> <br/> </div>

<div style="text-align: justify; text-indent: 21.3pt; line-height: 1.25">We have added manuals to a disk on key instead of printing where
is applicable.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25"></div>

<div style="line-height: 1.25; font-weight: bold">Social</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">As previously reported, we have started baseline metrics for many of our activities.
This also holds true for many of our social and community involvement activities.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Employees</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We continue to expand our staff around the world, by 101 employees, in 2023. We currently
have a total of 581 employees of which 341 are male and 240 female.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We have 16 Vice Presidents in our Senior Management, of which four are female and 12
are male &#8211; representing a 33.3% ratio.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic">Training &amp; Development</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">At InMode we carry out two types of training courses: Internal technical and sales training
on all of InMode&#8217;s products, as well a professional development courses offered by third-party contractors. All new employees receive
a full-day training in all of InModes platforms and handpieces. Additionally, with the introduction of each new product or technology,
all clinical, marketing and sales personnel undergo product training. All team members employed in the production and testing lines receive
advance technical training for manufacturing and maintenance of the new products.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">65</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25; font-style: italic">Corporate Culture</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">InMode encourages an informal corporate culture, and the company organization encourages
direct communication with managers and management, creating an atmosphere where every employee feels integral to the company's success.
In 2023, this phenomenon manifested in many types of employee activities: company trips, Halloween celebrations, holiday festivities,
summer picnics, spontaneous birthday parties, and more.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Community Involvement in the Periphery</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic">Robotics Mentoring in Dimona</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Since 2017, Moshe Mizrahy and InMode engineers have been involved with the FIRST Robotics
Group at Amit Zinman High School in Dimona. Dimona is located in southern Israel and is an area in the lower rungs of the socioeconomic
scale.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">InMode supports the robotics team of Amit Zinman High School with more than just financial
resources. Our engineers provide ongoing mentoring and opportunities to design electromechanical devices. One of the program's goals is
to introduce STEM subjects into the community through projects and our outreach programs and activities for kindergartens and elementary
schools. We continue to support the Robotics team with mentoring, resources, and funds and will continue in 2024.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic">Technology Project at ORT Maale Tiberias High School</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">InMode, together with Medimor, our Tier 1 supplier, has established a partnership with
ORT Maale Tiberias school to create a sustainable technology project. We have earmarked one hundred thousand dollars to this educational
project. Tiberias is in&#160;an economically depressed area of Israel and there have been few industry or business partnerships with Tiberias.
We are proud to sponsor such an exciting and impactful project.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">C. Organizational Structure</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">

<div style="margin-left: 18pt; line-height: 1.25">Our direct subsidiaries, the countries of their incorporation/residence and proportion
of ownership interest are as follows:</div> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin-left: 18pt">

<table cellspacing="0" cellpadding="2" border="0" id="za94486be01ea425b936f48fe122639e4" style="font: 10pt Times New Roman, Times, serif; width: 90%; color: #000000; text-align: left">
  <tr>
    <td style="width: 46.41%; vertical-align: top">
        <div style="line-height: 1.25"><span style="text-decoration: underline">Name</span></div> </td>
    <td style="width: 29.76%; vertical-align: top">
        <div style="margin-left: 3.6pt; line-height: 1.25"><span style="text-decoration: underline">Jurisdiction of Incorporation</span></div>
        </td>
    <td style="width: 23.82%; vertical-align: top">
        <div style="line-height: 1.25; text-align: center"><span style="text-decoration: underline">Percentage Ownership</span></div> </td> </tr>
  <tr>
    <td style="width: 46.41%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Invasix Inc.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div> </td>
    <td style="width: 29.76%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="margin-left: 3.6pt; line-height: 1.25">Delaware, USA</div> </td>
    <td style="width: 23.82%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">100%</div> </td> </tr>
  <tr>
    <td style="width: 46.41%; vertical-align: top">
        <div style="line-height: 1.25">Invasix Corp.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div> </td>
    <td style="width: 29.76%; vertical-align: top">
        <div style="margin-left: 3.6pt; line-height: 1.25">Canada</div> </td>
    <td style="width: 23.82%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">100%</div> </td> </tr>
  <tr>
    <td style="width: 46.41%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">InMode M.D. Ltd.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div> </td>
    <td style="width: 29.76%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="margin-left: 3.6pt; line-height: 1.25">Israel</div> </td>
    <td style="width: 23.82%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">100%</div> </td> </tr>
  <tr>
    <td style="width: 46.41%; vertical-align: top">
        <div style="line-height: 1.25">Invasix UK Ltd.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div> </td>
    <td style="width: 29.76%; vertical-align: top">
        <div style="margin-left: 3.6pt; line-height: 1.25">United Kingdom</div> </td>
    <td style="width: 23.82%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">100%</div> </td> </tr>
  <tr>
    <td style="width: 46.41%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">InMode Japan KK&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div> </td>
    <td style="width: 29.76%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="margin-left: 3.6pt; line-height: 1.25">Japan</div> </td>
    <td style="width: 23.82%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">100%</div> </td> </tr>
  <tr>
    <td style="width: 46.41%; vertical-align: top">
        <div style="line-height: 1.25">Invasix Iberia S.L.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div> </td>
    <td style="width: 29.76%; vertical-align: top">
        <div style="margin-left: 3.6pt; line-height: 1.25">Spain</div> </td>
    <td style="width: 23.82%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">100%</div> </td> </tr>
  <tr>
    <td style="width: 46.41%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Guangzhou InMode Medical Technology Ltd.</div> </td>
    <td style="width: 29.76%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="margin-left: 3.6pt; line-height: 1.25">China</div> </td>
    <td style="width: 23.82%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">100%</div> </td> </tr>
  <tr>
    <td style="width: 46.41%; vertical-align: top">
        <div style="line-height: 1.25">InMode Asia Limited.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div> </td>
    <td style="width: 29.76%; vertical-align: top">
        <div style="margin-left: 3.6pt; line-height: 1.25">Hong Kong</div> </td>
    <td style="width: 23.82%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">100%</div> </td> </tr>
  <tr>
    <td style="width: 46.41%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">InMode India Private Limited&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div> </td>
    <td style="width: 29.76%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="margin-left: 3.6pt; line-height: 1.25">India</div> </td>
    <td style="width: 23.82%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">100%</div> </td> </tr>
  <tr>
    <td style="width: 46.41%; vertical-align: top">
        <div style="line-height: 1.25">InMode Australia Pty Ltd&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div> </td>
    <td style="width: 29.76%; vertical-align: top">
        <div style="margin-left: 3.6pt; line-height: 1.25">Australia</div> </td>
    <td style="width: 23.82%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">100%</div> </td> </tr>
  <tr>
    <td style="width: 46.41%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">IMD France EURL&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div> </td>
    <td style="width: 29.76%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="margin-left: 3.6pt; line-height: 1.25">France</div> </td>
    <td style="width: 23.82%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">100%</div> </td> </tr>
  <tr>
    <td style="width: 46.41%; vertical-align: top">
        <div style="line-height: 1.25">InMode Innovations Ltd.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div> </td>
    <td style="width: 29.76%; vertical-align: top">
        <div style="margin-left: 3.6pt; line-height: 1.25">Israel</div> </td>
    <td style="width: 23.82%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">100%</div> </td> </tr>
  <tr>
    <td style="width: 46.41%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">InMode Italy S.r.l&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div> </td>
    <td style="width: 29.76%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="margin-left: 3.6pt; line-height: 1.25">Italy</div> </td>
    <td style="width: 23.82%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">100%</div> </td> </tr>
  <tr>
    <td style="width: 46.41%; vertical-align: top">
        <div style="line-height: 1.25">InMode Germany GmbH&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div> </td>
    <td style="width: 29.76%; vertical-align: top">
        <div style="margin-left: 3.6pt; line-height: 1.25">Germany</div> </td>
    <td style="width: 23.82%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">100%</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">66</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25; font-weight: bold">D. Property, Plants and Equipment</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We lease our main office, manufacturing and research and development facilities, located
in the Industrial Zone in Yokneam, Israel, pursuant to a lease that expires in December 2027. The original agreement was signed in May
2018. In January 2019, February 2020, March 2021, March 2023 and May 2023, we signed supplemental lease agreements, further expanding
our headquarters in Israel.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We currently lease approximately 35.6 thousand square feet in the Israeli facility.
Our current monthly rent payment is approximately $64.5 thousand.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">In August of 2020, our U.S. subsidiary, signed a new leasing agreement, for an approximately
24-thousand-square-foot facility located in Orange County, California, to support our expanding operations in the U.S. The new lease agreement
is for seven years and four months and occupation of the new facility commenced in the middle of April of 2021. The current monthly rent
payment is approximately $27 thousand.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our Canadian subsidiary has signed a new lease agreement in April 2022 for an approximately
12-thousand-square-foot facility in Richmond Hill, Ontario. The new lease agreement is for three years which began in July 2022. The current
monthly rent payment is approximately $17 thousand.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">From time to time, we also lease small properties, mainly for offices for subsidiaries
around the world which range for periods of up to three years.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We believe our current office space is sufficient to meet our anticipated needs for
the foreseeable future and is suitable for the conduct of our business.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold"><span id="ITEM4A"><!--Anchor--></span>ITEM 4A. UNRESOLVED STAFF COMMENTS</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">None.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25"><span style="font-weight: bold"><span id="ITEM5"><!--Anchor--></span>ITEM 5.</span>&#160;<span style="font-weight: bold">OPERATING
AND FINANCIAL REVIEW AND PROSPECTS</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic">The following discussion should be read in conjunction with our consolidated financial
statements and related notes for the years ended December&#160;31, 2023, 2022 and 2021, which are included elsewhere in this 2023 Annual
Report. A discussion of the year ended December&#160;31, 2021 can be found in the Annual Report on Form 20-F filed with the SEC on February
14, 2023.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Overview</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We design, develop, manufacture and commercialize innovative, energy-based, non-invasive,
minimally invasive surgical aesthetic and medical treatment solutions. Since 2010, we have launched 12 product platforms&#160;<span style="font-style: italic">(BodyTite,
Optimas, Votiva, Contoura, Triton,&#160;EmbraceRF, EvolveX, Evoke,&#160;Morpheus8, EmpowerRF, Define </span>and<span style="font-style: italic">
Envision</span>)<span style="font-style: italic">&#160;</span>that we market and sell traditionally to plastic and facial surgeons, aesthetic
surgeons, medical spas, dermatologists and OB/GYNs.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">As of December 31, 2023, we had a global installed base of approximately 22,900 product
platforms capable of running various multi-use applicators and minimally invasive consumables.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We anticipate that our quarterly results of operations may fluctuate from quarter to
quarter due to several factors, including seasonality, unexpected delays in the introduction and market acceptance of our products, unexpected
delays in our manufacturing operations, introduction of new and improved products by our competitors and the performance of our direct
sales organization.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Components of Our Operating Results</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Revenues</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We generate our revenues primarily from the sale of energy-based medical aesthetic products,
which consist of platforms and non-consumable handpieces and hands-free applicators. To a lesser extent, we generate revenue from the
sale of consumables and from the sale of extended warranties. For the year ended December 31, 2023, we derived approximately 84% of our
revenues from the sale of medical aesthetic products and approximately 16% of our revenues from the sale of consumables and extended warranties.
We expect our revenues from the sale of consumables and extended warranties to increase over time as our installed base continues to grow.
We have experienced growth in sales of consumables in the past six years.<sup style="vertical-align: text-top; line-height: 1; font-size: smaller">&#160;</sup>Recent
revenue growth has been driven by, and we expect continued growth as a result of, increased patient and physician awareness of our medical
aesthetic products and additional sales representatives. We have expanded our sales and marketing organization as well as our number of
platforms, to help us drive and support revenue growth and intend to continue this expansion.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">67</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25">For the years ended December 31, 2023 and 2022 we derived approximately $406.6 million,
or 83% and $369.0 million, or 81%, respectively, of our total revenues from the sale of minimally invasive platforms, and we derived approximately
$43.1 million, or 8% and $45.2 million, or 10%, respectively, of our total revenues from the sale of hands-free platforms and approximately
$42.4 million, or 9% and $40.1 million, or 9%, respectively, of our total revenues from the sale of non-invasive platforms. This resulted
in the year ended December 31, 2023 in growth of approximately $37.6 million, or 10% and $2.3 million, or 6% in revenues from the sale
of minimally invasive platforms and non-invasive platforms respectively, and a decrease of approximately $2.1 million, or 5% in hands-free
platforms. In the future, we expect that revenues from the sale of minimally invasive platforms and hands-free platforms will continue
to be a major contributor to our revenues. Results for the year ended December 31, 2021 are provided in the consolidated financial statements
and notes filed with this report on Form 20-F beginning on page [F-1].</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We sell our products directly in the United States, Canada, United Kingdom, Ireland,
Spain, Portugal, France, Belgium, Luxemburg, Italy, Germany, Austria, Japan Australia and India, and indirectly through third-party distributors
in other countries.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The following table provides information regarding the breakdown of our revenue by geographic
region for the years ended December 31, 2023 and 2022:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zf672c3d6cc2445438c09fee004e00eea" class="cfttable" style="font: 10pt Times New Roman, Times, serif; text-align: left; color: #000000; width: 100%">
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td colspan="6" style="vertical-align: bottom; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Years Ended December 31,</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
        <div style="line-height: 1.25; font-weight: bold">Geographic region*</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">2023</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="line-height: 1.25">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">2022</div> </div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">United States&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">63</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">%</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">66</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">%</div> </td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%">
        <div style="line-height: 1.25">Europe&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">13</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">%</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">11</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">%</div> </td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">International&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">24</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">%</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">23</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">%</div> </td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%">
        <div style="line-height: 1.25">Total&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">100</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">%</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">100</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">%</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">*Revenues are attributed to geographic areas based on the location of customer</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We believe that there are opportunities for us to generate additional revenue from existing
customers who are already familiar with our products. We intend to continue to invest in research and development activities, increase
the number of sales representatives in our sales and marketing organization and introduce innovative next-generation pipeline products
to our customers. As a result, we expect that certain existing customers will be candidates for technology upgrades to enhance the capabilities
of their existing InMode products. In addition, as we continue to grow our support services program, we expect to increase the number
of customers that enter into service contracts and extended warranties with us, which would result in additional recurring revenues. We
also plan to expand our current product line in order to reach non-traditional customers, such as ENTs (ear, nose, and throat), ophthalmologists,
general practitioners and aesthetic clinicians, and generate additional revenue.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Cost of Revenues</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our cost of revenues consists primarily of the expenses we incur to have our products
manufactured and assembled by third parties and the direct costs we incur in order to obtain the materials, labor and overhead that are
needed to manufacture and assemble our products.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our cost of revenues also includes shipping, handling, service and warranty expenses,
as well as salaries and personnel-related expenses, including share-based compensation expenses, for our operations management team, which
is comprised of subcontractor supervisors and purchasing and quality control employees. We expect our cost of revenues to increase in
absolute dollars primarily as, and to the extent, our revenue grows.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our cost of revenues as a percentage of revenues has been, and we expect it to continue
to be, affected by a variety of factors, including manufacturing costs, the average selling price of our products, the maturity of our
existing products, promotional prices being offered to existing customers for our new products, and to a lesser extent the sales mix between
the United States and the rest of the world as our average selling price in the United States tends to be higher than in the rest of the
world. We expect our gross margin to be maintained at current levels over time to the extent we are successful in offsetting increased
material and shipping costs with reducing manufacturing costs as our sales volume increases, as well as, maintaining our average selling
prices. However, our gross margin may fluctuate from period to period.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">68</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Research and Development Expenses</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our research and development expenses consist of salaries and personnel-related expenses,
including share-based compensation expenses, for our employees that are primarily engaged in research, development and engineering activities.
Our research and development expenses also include regulatory-related costs and expenses, external engineering fees, materials used and
other overhead expenses that are incurred in connection with the design and development of our products. For further details with respect
to government regulations we are subject to, see &#8220;Item 4B. Information on the Company-Business Overview-Government Regulations.&#8221;
We expense all of our research and development costs as incurred. While we do not track our research and development spending by technology,
product or application, we do expect that our overall research and development costs will increase in absolute dollars in the future as
we develop more products and technologies. We expect research and development expenses as a percentage of our total revenue to vary over
time depending on the level and timing of initiating new product development efforts.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Sales and Marketing Expenses</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our sales and marketing expenses consist primarily of salaries, commissions and personnel-related
expenses, including share-based compensation expenses, for our employees that are engaged in sales and marketing activities, which include
marketing and public support of our products, participation in trade shows and industry events, promotional and public relations activities,
and administrative functions in support of sales and marketing. We expect sales and marketing expenses to continue to increase in absolute
dollars as we continue to expand our marketing organization to both drive and support our planned growth in revenue.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">General and Administrative Expenses</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our general and administrative expenses consist primarily of salaries and personnel-related
expenses, including share-based compensation expenses, for executive, accounting and administrative personnel, professional fees and other
general corporate expenses. We expect general and administrative expenses to grow at a steady state as our operations will continue to
expand. However, general and administrative expenses may vary over time, due to increasing legal and insurance premium costs and involvement
in IP related litigations.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Income Taxes</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We are subject to income taxes in Israel, the United States and numerous foreign jurisdictions.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our facilities in Israel were previously granted the status of &#8220;Benefited Enterprise&#8221;
which provided us with a ten-year corporate tax exemption for undistributed income from 2012 to 2021. From 2022, the corporate tax rate
of the Company under the Encouragement of Capital Investments Regulations (Preferred Technology Income and Capital Profits for a Technological
Enterprise 2017), and its Israeli subsidiary is expected to be approximately 7.5%.See &#8220;Item 10E. Additional Information-Taxation.&#8221;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Critical Accounting Policies and Estimates</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">For a description of our significant accounting policies, see Note 2b to our consolidated
financial statements included in Item 18 of this annual report.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 18pt; line-height: 1.25">The preparation of our consolidated financial statements in conformity
with U.S. GAAP requires us to make estimates and assumptions in certain circumstances that affect the reported amount of assets, liabilities,
sales and expenses and related disclosure of contingent assets and liabilities. We base our estimates on historical experience and various
other assumptions that we believe to be reasonable under the circumstances. On a periodic basis, we evaluate our estimates. Because of
the uncertainty inherent in these matters, actual results could differ from those estimates.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 18pt; line-height: 1.25">The following are our critical accounting policies and estimates
affecting the application of those policies in our consolidated financial statements.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">69</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Revenue Recognition</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25; font-style: italic">Product revenue, net</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 18pt; line-height: 1.25">Revenues from product sales are recognized when the customer obtains
control over our product, typically upon shipment to the customer. Taxes collected from customers relating to product sales and remitted
to governmental authorities are excluded from revenues.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 18pt; line-height: 1.25">Variable consideration includes price concessions related to installment
sales contracts. We estimate variable consideration using the most likely outcome amount. Amounts included in the transaction price are
recognized only when it is probable that a significant reversal of cumulative revenues will not occur.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 18pt; line-height: 1.25">We do not grant any right of return, refund, cancelation or termination.
From time to time, we participate in our customers&#8217; marketing activities and deduct costs related to such activities from revenue.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25; font-style: italic">Service Revenue</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 18pt; line-height: 1.25">We also generate revenues from long-term maintenance contracts,
or Extended Warranties. Revenue from Extended Warranties is recognized ratably, on a straight-line basis, over the period of the applicable
service contract. Revenue from repairs performed in the absence of Extended Warranties is recognized when the related services are performed.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 18pt; line-height: 1.25">More information regarding revenue recognition is discussed in
Note 2q in our consolidated financial statements.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Income Taxes</div>

<div style="line-height: 1.25">

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; text-indent: 15pt; line-height: 1.25">The provision for income tax is calculated based on our assumptions
as to our entitlement to various benefits under the applicable tax laws in the jurisdictions in which we operate. The entitlement to such
benefits depends upon our compliance with the terms and conditions set out in these laws. We are subject to income taxes in Israel, the
U.S. and other foreign jurisdictions.&#160;Our effective tax rate is primarily impacted by the geographical mix of taxable income and
loss. We record a tax provision for the anticipated tax consequences of our reported operating results. Changes in tax laws, regulations,
agreements and treaties, currency exchange restrictions or the Company&#8217;s level of operations or profitability in each taxing jurisdiction
could have an impact upon the amount of current and deferred tax balances and hence the Company&#8217;s net income.</div> </div>

<div style="line-height: 1.25">

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; text-indent: 15pt; line-height: 1.25">We estimate the degree to which deferred tax assets will result
in a benefit, after consideration of all positive and negative evidence, and provide a valuation allowance for deferred tax assets that
we believe more likely than not will not be realized. In situations in which we are able to determine that our deferred tax assets will
be realized, that determination generally relies on future reversals of taxable temporary differences and expected future taxable income.
Significant judgment required in determining any valuation allowance recorded against deferred tax assets. In assessing the need for a
valuation allowance, we considered all available evidence, including past operating results, the most recent projections for taxable income,
and prudent and feasible tax planning strategies. We reassess our valuation allowance periodically and if future evidence allows for a
partial or full release of the valuation allowance, we reverse the related valuation allowance. The tax valuation allowance totaled $64.4
million at December&#160;31, 2023 (see Note 13 to our consolidated financial statements for additional information). Should our actual
future taxable income by tax jurisdiction vary from estimates, additional allowances or reversals thereof may be necessary.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; text-indent: 15pt; line-height: 1.25">Significant judgment is required in evaluating our uncertain tax
positions. In evaluating the exposure associated with our various tax filing positions, we record reserves for uncertain tax positions
in accordance with US GAAP, based on the technical support for the positions and our past audit experience with similar positions. For
those tax positions where it is more likely than not that a tax benefit will be sustained, we record the largest amount of tax benefit
with a greater than 50 percent likelihood of being realized upon ultimate settlement with a taxing authority that has full knowledge of
all relevant information. We believe our tax positions comply with applicable tax laws and we intend to defend our positions, no assurance
can be given that the final tax outcome of these matters will not be different from that which is reflected in our historical income tax
reserves and accruals. To the extent that the final tax outcome of these matters is different than the amounts recorded, such differences
will impact the provision for income taxes in the period in which such determination is made. The provision for income taxes includes
the impact of reserve provisions and changes to reserves that are considered appropriate. The Company&#8217;s liability for these unrecognized
tax benefits totaled $1.4 million on December&#160;31,&#160;2023&#160;(see Note 13&#160;to our consolidated financial statements&#160;for
additional information).</div> </div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">70</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25; font-weight: bold">Operating Results</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The following table summarizes the results of our operations for the periods presented:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zbda94a0d9cf841aaa7b3446d7072172f" class="cfttable" style="font: 10pt Times New Roman, Times, serif; text-align: left; color: #000000; width: 100%">
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="14" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Years Ended December 31,</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold"> 2023</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="line-height: 1.25">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">2022</div> </div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="line-height: 1.25">
        <div style="text-align: center; line-height: 1.25">($)</div> </div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="line-height: 1.25">
        <div style="text-align: center; line-height: 1.25"><span style="font-weight: bold">(% of Revenues</span>)</div> </div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="line-height: 1.25">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">($)</div> </div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="line-height: 1.25">
        <div style="text-align: center; line-height: 1.25"><span style="font-weight: bold">(% of Revenues</span>)</div> </div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="14" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="line-height: 1.25">
        <div style="text-align: center; line-height: 1.25"><span style="font-weight: bold">(in thousands</span>)</div> </div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Revenues&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">492,048</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">100</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">454,271</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">100</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 52%; padding-bottom: 2px">
        <div style="line-height: 1.25">Cost of revenues&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">80,708</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">16</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">73,485</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">16</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Gross profit&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">411,340</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">84</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">380,786</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">84</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 52%">
        <div style="line-height: 1.25">Operating expenses:</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255)">
        <div style="text-indent: -8.65pt; margin-left: 17.3pt; line-height: 1.25">Research and development&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
        </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">13,410</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">3</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">12,425</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">3</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 52%">
        <div style="text-indent: -8.65pt; margin-left: 17.3pt; line-height: 1.25">Sales and marketing&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
        </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">193,042</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">39</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">160,576</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">35</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 52%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">General and administrative&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">9,228</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">2</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">9,931</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">2</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 52%; padding-bottom: 2px">
        <div style="line-height: 1.25">Total operating expenses&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">215,680</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">44</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">182,932</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">40</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Income from operations&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">195,660</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">40</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">197,854</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">44</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 52%; padding-bottom: 2px">
        <div style="line-height: 1.25">Finance income, net&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">21,607</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">4</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">3,612</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">1</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Income before taxes&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">217,267</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">44</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">201,466</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">45</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 52%; padding-bottom: 2px">
        <div style="line-height: 1.25">Income taxes&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">19,348</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">4</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">39,946</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">9</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Net income&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">197,919</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">40</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">161,520</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">36</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Comparison of the Year Ended December 31, 2023 to the Year Ended December 31, 2022</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25; font-style: italic; font-weight: bold">Revenues</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our revenues increased by approximately $37.8 million, or 8%, to approximately $492.0
million for the year ended December 31, 2023, compared to approximately $454.3 million for the year ended December 31, 2022. This increase
was attributable to an increase in sales of our minimal invasive platforms worldwide in the amount of $37.6 million and increase in sales
of our non-invasive platforms worldwide in the amount of $2.3 million, offset by a decrease in the sales of our hand free platforms worldwide
in the amount of $2.1 million.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our revenues in the United States increased by approximately $9.2 million, or 3%, to
approximately $307.8 million for the year ended December 31, 2023, compared to approximately $$298.6 million for the year ended December
31, 2022. This increase was primarily attributable to an increase in sales of our minimal invasive platforms in the U.S. in the amount
of $10.9 million, additional sales representatives worldwide, the growth of consumable sales, offset by a decrease in the sales of hand
free platforms in the U.S. in the amount of $2.0 million.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our revenues outside of the United States increased by approximately $28.6, or 18%,
to approximately $184.2 million for the year ended December 31, 2023, compared to approximately $155.7 million for the year ended December
31, 2022. This increase was primarily driven by an increase in revenues in Europe of $13.2 million as result of an increase in sales representatives
in this region and opening another subsidiary in the region, an increase of $5.9 million in Canada due to an increase in sales representatives
in this region and an increase in patient and physicians awareness in the region, and an increase of $11.3 million in the Asia region
as result of an increase in sales representatives in this region and opening another subsidiary in the region.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our revenues from the sale of consumables and extended warranties for the year ended
December 31, 2023, increased by approximately 33% compared to the year ended December 31, 2022. This increase was primarily attributable
to the growth in our installed platform base by 5,900 platforms, as well as patients and physicians becoming more familiar with our products.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25; font-style: italic; font-weight: bold">Cost of revenues</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our cost of revenues increased by approximately $7.2 million, or 10%, to approximately
$80.7 million for the year ended December 31, 2023, compared to approximately $73.5 million for the year ended December 31, 2022. This
increase was primarily due to increased in sales and higher costs to purchase manufactured products to support the higher sales volume
in the amount of $6.8 million. Our gross margin for the year ended December 31, 2023, and for the year ended December 31, 2022 was 84%
without change.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">71</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25; font-style: italic; font-weight: bold">Research and development expenses</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our research and development expenses increased to approximately $13.4 million for the
year ended December 31, 2023, compared to approximately $12.4 million for the year ended December 31, 2022. This increase was primarily
attributable to an increase in research and development team expenses in the amount of $0.9 million due to of the addition of R&amp;D
employees and increase in salaries.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25; font-style: italic; font-weight: bold">Sales and marketing expenses</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our sales and marketing expenses increased by approximately $32.5 million, or 20%, to
approximately $193.0 million for the year ended December 31, 2023, compared to approximately $160.6 million for the year ended December
31, 2022. This increase was primarily attributable to increase in salary and related expenses in the amount of $19.8 million and an increase
in marketing expenses in the amount of $9.7 million relating to increase in volume of sales in 2023.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25; font-style: italic; font-weight: bold">General and administrative expenses</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our general and administrative expenses decreased by approximately $0.7 million, or
7%, to approximately $9.2 million for the year ended December 31, 2023, compared to approximately $9.9 million for the year ended December
31, 2022. This decrease was primarily attributable to the decrease in salary and related expenses in the amount of $0.5 million.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25; font-style: italic; font-weight: bold">Finance income, net</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our finance income, net was approximately $21.6 million for the year ended December
31, 2023, compared to approximately $3.6 million for the year ended December 31, 2022. This increase in finance income, net was primarily
attributable to higher interest rate in 2023 compared to 2022 from our portfolio of investments in bonds and corporate debt securities
and short-term bank deposits in the amount of $16.0 million and changes in exchange rate in the amount of $2.0.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25; font-style: italic; font-weight: bold">Income taxes</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our income taxes decreased by approximately $20.6 million, or 52%, to approximately
$19.3 million for the year ended December 31, 2023, compared to approximately $39.9 million for the year ended December 31, 2022. This
decrease was primarily attributable to one-time payment in 2022 of the Company to the Israeli tax authority of approximately $12 million
for undistributed exempt income for years 2012 until 2020, and an additional one-time payment of the Company to the Israeli tax authority
of approximately $14.3 million for the tax year of 2021. The additional increase is due to an increase in income before tax and an increase
in financial income which are subject to higher tax rates. See &#8220;Item 10E. Additional Information-Taxation&#8221;.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Liquidity and Capital Resources</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Historically, we have funded our operations primarily from cash flows from operations,
from private placements of our ordinary shares, from our initial public offering in August 2019 and from exercise of options. Since inception
in January 2008, we have not received any debt financing from banks or issued any preferred or debt securities. We have received aggregate
net proceeds of approximately $107.2 million from issuances of our ordinary shares, including approximately $69.8 million from our initial
public offering.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">In September 2020, we approved a share repurchase program of up to 2 million ordinary
shares, to be purchased out of our cash reserve and to be paid solely from our IPO proceeds. In February 2022, the board approved that
the share repurchase program could also be funded from the proceeds of exercised options. In March 2022, we approved an additional repurchase
program of up to one million ordinary shares, to be purchased out of our cash reserve and to be paid from our remaining IPO proceeds and
from the proceeds of exercised options. As of December 31, 2023, we purchased 2,557,829 shares in the amount of $95.2 million under these
repurchase programs.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">As of December 31, 2023, we had working capital of approximately $781.2 million, and
our primary source of liquidity was approximately $741.6&#160; million in cash and cash equivalents, marketable securities and bank deposits.
Our major cash requirements are obligations to support our ongoing operations which consist primarily of salary and commissions expenses
for employees, and contractual obligations for our subcontractors and lease agreements. We expect our working capital to be sufficient
for the Company&#8217;s present requirements.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">72</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25">If existing cash and cash generated from operations are insufficient to satisfy our
liquidity requirements, we may seek to sell equity or debt securities or obtain a credit facility. If we raise funds by issuing equity
securities, our shareholders would experience dilution. Debt financing, if available, may involve covenants restricting our operations
or our ability to incur additional debt. Any debt financing or equity that we raise may contain terms that are not favorable to us or
our shareholders. Financing may not be available at all, or in amounts or on terms unacceptable to us. If we are unable to obtain financing,
we may be required to delay the development, commercialization and marketing of our aesthetic medical products.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25"></div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Cash Flows</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The following table represents a summary of our cash flow for the periods indicated</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" border="0" id="zd3d66255e01d465bb0501d76d0240de5" class="cfttable" style="font: 10pt Times New Roman, Times, serif; margin-left: auto; width: 90%; color: #000000; text-align: left; margin-right: auto">
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Years ended December 31,</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold"> 2023</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="line-height: 1.25">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">2022</div> </div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Net cash provided by (used in):</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="6" style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">(in thousands)</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%">
        <div style="text-indent: -8.65pt; margin-left: 25.9pt; line-height: 1.25">Operating activities&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
        </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">176,826</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">181,578</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255)">
        <div style="text-indent: -8.65pt; margin-left: 25.9pt; line-height: 1.25">Investing activities&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
        </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">(136,064</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">)</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">(109,474</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">)</div> </td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%">
        <div style="text-indent: -8.65pt; margin-left: 25.9pt; line-height: 1.25">Financing activities&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
        </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">5,504</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">(41,085</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">)</div> </td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Effects of exchange rate changes on cash&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
        </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">605</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">(1,615</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">)</div> </td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 4px">
        <div style="line-height: 1.25">Net increase in cash and cash equivalents&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
        </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 4px double; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 4px double; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">46,871</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 4px double; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 4px double; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">29,404</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Net Cash Provided by Operating Activities</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">For the year ended December 31, 2023, our net cash provided by operating activities
was $176.8 million. The primary reason for net cash provided by operating activities was the net profit of $197.9 million. The outflow
from operating assets and liabilities in the amount of $41.4 million was primarily due to an increase of $16.1 million in accounts receivable
due to an increase in sales through distributors, and an increase in other liabilities of $12.6 million, primarily in income tax due to
one-time payments of the Company to the Israeli tax authority discussed above, and an increase of $5.2 million in inventories to meet
growth in anticipated sales.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Additionally, our net profit for the year ended December 31, 2023, included $23.6 million
in non-cash expenses primarily comprised of share-based compensation expense.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">For the year ended December 31, 2022, our net cash provided by operating activities
was $181.6 million. The primary reason for net cash provided by operating activities was the net profit of $161.5 million. The outflow
from operating assets and liabilities in the amount of $4.5 million was primarily due to an increase of $18.9 million in inventories to
meet growth in anticipated sales and an increase of $10.4 million in accounts receivable due to an increase in sales through distributors,
offset by an increase in other liabilities of $17.9 million, primarily in income tax due to one-time payments of the Company to the Israeli
tax authority discussed above, and that the Company started paying corporate tax status in Israel in 2022.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">As we expect our revenues to continue to grow, we anticipate our accounts receivables,
inventory and accounts payable will similarly continue to grow, including our available working capital.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">73</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Net Cash Used in Investing Activities</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">For the year ended December 31, 2023, net cash used in investing activities was $136.1
million, which primarily related to short-term bank deposits and marketable securities of $478.6 million. These outflows were partially
offset by inflows of $343.3 million related to proceeds from short-term bank deposits and marketable securities.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">For the year ended December 31, 2022, net cash used in investing activities was $109.5
million, which primarily related to short-term bank deposits and marketable securities of $262.4 million, and capital expenditures of
$1.6 million. These outflows were partially offset by inflows of $154.5 million related to proceeds from short-term bank deposits and
marketable securities.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Net Cash Used in Financing Activities</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">For the year ended December 31, 2023, net cash used in financing activities was $5.5
million, which consisted of&#160; proceeds from the exercise of options.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">For the year ended December 31, 2022, net cash used in financing activities was $41.1
million, which consisted of $42.6 million outflow as part of our share repurchase programs. This outflow was partially offset by inflow
of $1.6 million related to proceeds from the exercise of options.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Research and Development, Patents and Licenses, etc.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">For a description of the Company&#8217;s research and development policies, see &#8220;Item
4B. Information on the Company-Business Overview-Intellectual Property&#8221;.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Trend Information</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Other than as disclosed elsewhere in this Annual Report on Form 20-F, we are not aware
of any trends, uncertainties, demands, commitments or events for the year ended December 31, 2023 that are reasonably likely to have a
material effect on our net revenues, income, profitability, liquidity or capital resources, or that would cause the disclosed financial
information to be not necessarily indicative of future results of operations or financial condition.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Recently Issued Accounting Pronouncements</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Certain recently issued accounting pronouncements are discussed in Note 2 in our consolidated
financial statements.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold"><span id="ITEM6"><!--Anchor--></span>ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">A. Directors and Senior Management</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The following table sets forth the name, age and position of each of our executive officers
and directors as of the date of this Annual Report on Form 20-F.</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="2" border="0" id="zdfc82cd22e354199a2156633230b334a" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="border-bottom: #000000 2px solid; width: 29.97%; vertical-align: top">
        <div style="line-height: 1.25; font-weight: bold">Name</div> </td>
    <td style="width: 1%; vertical-align: top">&#160;</td>
    <td style="border-bottom: #000000 2px solid; width: 18%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Age</div> </td>
    <td style="width: 1%; vertical-align: top">&#160;</td>
    <td style="border-bottom: #000000 2px solid; width: 50.02%; vertical-align: top">
        <div style="line-height: 1.25; font-weight: bold">Position</div> </td> </tr>
  <tr>
    <td style="width: 29.97%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Moshe Mizrahy&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div> </td>
    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 18%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">71</div> </td>
    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 50.02%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Chief Executive Officer and Chairman of Board of Directors</div> </td> </tr>
  <tr>
    <td style="width: 29.97%; vertical-align: top">
        <div style="line-height: 1.25">Yair Malca&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div> </td>
    <td style="width: 1%; vertical-align: top">&#160;</td>
    <td style="width: 18%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">46</div> </td>
    <td style="width: 1%; vertical-align: top">&#160;</td>
    <td style="width: 50.02%; vertical-align: top">
        <div style="line-height: 1.25">Chief Financial Officer</div> </td> </tr>
  <tr>
    <td style="width: 29.97%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Dr. Michael Kreindel&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div> </td>
    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 18%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">57</div> </td>
    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 50.02%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Chief Technology Officer and Director</div> </td> </tr>
  <tr>
    <td style="width: 29.97%; vertical-align: top">
        <div style="line-height: 1.25">Shakil Lakhani&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div> </td>
    <td style="width: 1%; vertical-align: top">&#160;</td>
    <td style="width: 18%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">41</div> </td>
    <td style="width: 1%; vertical-align: top">&#160;</td>
    <td style="width: 50.02%; vertical-align: top">
        <div style="line-height: 1.25">President, North America</div> </td> </tr>
  <tr>
    <td style="width: 29.97%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Dr. Hadar Ron, M.D.<sup style="vertical-align: text-top; line-height: 1; font-size: smaller">(1)(2)</sup>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
        </td>
    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 18%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">65</div> </td>
    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 50.02%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Director</div> </td> </tr>
  <tr>
    <td style="width: 29.97%; vertical-align: top">
        <div style="line-height: 1.25">Bruce Mann<sup style="vertical-align: text-top; line-height: 1; font-size: smaller">(1)(2)</sup>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
        </td>
    <td style="width: 1%; vertical-align: top">&#160;</td>
    <td style="width: 18%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">89</div> </td>
    <td style="width: 1%; vertical-align: top">&#160;</td>
    <td style="width: 50.02%; vertical-align: top">
        <div style="line-height: 1.25">Director (Chairman of the Compensation Committee)</div> </td> </tr>
  <tr>
    <td style="width: 29.97%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Dr. Michael Anghel<sup style="vertical-align: text-top; line-height: 1; font-size: smaller">(1)(2)</sup>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
        </td>
    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 18%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">85</div> </td>
    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 50.02%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Director&#160; (Chairman of the Audit &amp; Investment Committee)</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">(1)&#160;&#160;&#160;Member of Audit &amp; Investment Committee</div>

<div style="line-height: 1.25">(2)&#160;&#160;&#160;Member of Compensation, Nominating and Corporate Governance Committee</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">74</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25">A brief biography of each person who serves as an executive officer and/or director
of the Company is set forth below:</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25"><span style="font-weight: bold; font-style: italic">Moshe Mizrahy.</span> Moshe Mizrahy
co-founded the Company in 2008 and has been our Chief Executive Officer and Chairman of the board of directors since inception. Prior
to that, Mr. Mizrahy was co-founder and chief executive officer of Syneron Medical Ltd., a medical aesthetic device company based in Israel.
Mr. Mizrahy was also the former chief executive officer of Home Skinovations Ltd., an international medical aesthetic consumer devices
company active in the home use market, and is currently the chairman of its board since 2007. In addition to Home Skinovations Ltd., Mr.
Mizrahy currently sits on the board of directors of the following companies: SipNose Ltd., Pet Novations Ltd., Peri-Ness Technologies
Ltd., Urifer Ltd., Escape Rescue Systems Ltd., New Forest Wood Products (2012) Ltd., Med Smart Hub Ltd., Ivy Next Ltd., M.N. Business
Strategy Ltd. and Himalaya Family Office Advising Ltd. Mr. Mizrahy has a B.S. in Engineering from the Tel Aviv University and an MBA from
Pace University, New York.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25"><span style="font-weight: bold; font-style: italic">Yair Malca.</span> Yair Malca has
served as our Chief Financial Officer since 2017. In his previous role, Mr. Malca was the Director of Finance for Jazz Semiconductor,
Inc., a developer of integrated circuits and semiconductors, from 2013 to 2017. Before that, he served as the controller of Syneron from
2008 to 2013, as assistant controller of EZchip Semiconductor, a provider of network processors, from 2007 to 2008, as subsidiary controller
of Bermad, a provider of hydraulic control valves, from 2005 to 2007, and began his career in public accounting at Ernst &amp; Young from
2002 to 2005. Mr. Malca holds a B.A. in Accounting and Economics from Haifa University and an MBA from Tel Aviv University, and is a Certified
Public Accountant in Israel.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25"><span style="font-weight: bold; font-style: italic">Dr. Michael Kreindel.</span> Dr.
Michael Kreindel co-founded the Company in 2008 and has served as our Chief Technology Officer since inception. Dr. Kreindel became a
director for the Company in August 2019. He previously was a co-founder of, and served as CTO of, Syneron Medical Ltd. from 2001 to 2007.
Dr. Kreindel has a Ph.D. in physics and mathematics, and also graduated as an engineer and physicist in experimental and theoretical nuclear
physics from Ural Politechnical Institute, Russia.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25"><span style="font-weight: bold; font-style: italic">Shakil Lakhani.</span> Shakil Lakhani
has served as the President of InMode&#8217;s North America division since 2017. Prior to becoming the President of North America for
the Company in August 2017, Mr. Lakhani was previously the Executive Vice President of Sales for North America since February 2017, where
he managed all sales operations and established a new distribution strategy. Mr. Lakhani previously held multiple roles at various levels
at Cynosure, including Director of Sales from September 2013 through January 2017. Mr. Lakhani graduated with a B.A. from the University
of Waterloo.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25"><span style="font-weight: bold; font-style: italic">Dr. Hadar Ron, M.D. L.L.B.</span>
Dr. Hadar Ron became a director of the Company in August 2019. Since 2000, Dr. Ron has been the founding and managing partner of Israel
Healthcare Ventures, an Israeli life science venture capital fund. Dr. Ron is also the chief executive officer of the management company
for Israel Healthcare Ventures 2 LP Incorporated, or IHCV2, an Israeli life sciences venture capital fund. Dr. Ron serves as chairperson
of G.I. View Ltd., a medical device company specializing in colorectal screenings, and CyTwist Ltd., an information technology start-up
company, and as a board member of the following companies: Home Skinovations Ltd., SipNose Ltd., Pet Novations Ltd., Peri-Ness Technologies
Ltd., Viroblock Ltd., O.G.D.H. Ltd., OrSense Ltd., and NanoPass Technologies Ltd. In addition, Dr. Ron serves as an external director
of Together Pharma Ltd. In addition, Dr. Ron serves as a member of the advisory board of the Momentum Fund Tech Transfer of Tel Aviv University,
a board member of BIRAD Ltd., the tech transfer company of Bar Ilan University, and is the chairperson of the scientific advisory board
of Social Finance Israel&#8217;s Social Impact Bond for the prevention of diabetes and colon cancer. Dr. Ron is a physician and attorney
by education. She holds M.D. and L.L.B. degrees from Tel Aviv University and has studied at the School of Business Administration at Tel
Aviv University.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25"><span style="font-weight: bold; font-style: italic">Bruce Mann.</span> Mr. Bruce Mann
became a director of the Company in August 2019. Bruce Mann is an independent advisor and consultant on corporate governance, corporate
law, and capital markets matters, primarily for emerging technology companies. He was a senior partner, partner, or senior of counsel
of Morrison &amp; Foerster LLP for 30 years prior to his retirement in 2017. Mr. Mann has been a Governor-at-Large of the National Association
of Securities Dealers (NASD) and a member of the New York Stock Exchange Legal Advisory Committee. He has held numerous positions in the
American Bar Association, including chairing the Senior Lawyers Division, the Federal Regulation of Securities Committee and the Venture
Capital and Private Equity Committee of the ABA Business Law Section. Mr. Mann holds a BBA from the University of Wisconsin and a JD from
the University of Wisconsin Law School.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25"><span style="font-weight: bold; font-style: italic">Dr. Michael Anghel.</span> Dr. Michael
Anghel became a director of the Company in August 2019. Dr. Anghel has served on the board of directors of BiolineRx Ltd. (Nasdaq: BLRX)
since 2010 and on Bioline&#8217;s Investment Monitoring Committee since 2010. From 1977 to 1999, Dr. Anghel led the Discount Investment
Corporation Ltd. (of the IDB Group) activities in the fields of technology and communications. In 1999, he founded CAP Ventures, an advanced
technology investment company. From 2004 to 2005, Dr. Anghel served as CEO of DCM, the investment banking arm of the Israel Discount Bank
(TASE: DSCT). He currently serves on the board of directors of BiolineRx Ltd. (Nasdaq: BLRX) and as the Chairman of the Audit Committee
and the Chairman of the Remuneration Committee of Ellomay Capital Ltd. {NYSE, TASE : ELLO). Dr. Anghel previously served as the chairman
of the Center for Educational Technology and as the Chairman of the board of directors of Lahav Ltd (Tel-Aviv University Executive Program).
Prior to launching his business career, Dr. Anghel served as a full-time member of the Graduate School of Business Administration of the
Tel Aviv University, where he taught finance and corporate strategy. Dr. Anghel holds a B.A. in Economics from the Hebrew University in
Jerusalem and an M.B.A. and Ph.D. in Finance from Columbia University, New York.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">75</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25; font-weight: bold">Board Diversity</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 21.3pt; line-height: 1.25">The table below provides certain information regarding the diversity
of our board of directors as of the date of this annual report.</div>

<div style="line-height: 1.25"><br/> </div>

<table cellspacing="0" cellpadding="2" border="0" id="zed5191f1af004fd8a3f5b9d19e9d3c29" style="font: 10pt Times New Roman,Times,serif; width: 100%; text-align: left; color: rgb(0, 0, 0)">
  <tr>
    <td colspan="5" style="border-top: rgb(0, 0, 0) 2px solid; width: 100%; vertical-align: top; border-right: rgb(0, 0, 0) 2px solid; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Board Diversity Matrix</div> </td> </tr>
  <tr>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 41.63%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25">Country of Principal Executive Offices:</div> </td>
    <td colspan="4" style="border-top: rgb(0, 0, 0) 2px solid; width: 58.37%; vertical-align: top; border-right: rgb(0, 0, 0) 2px solid; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25">Israel</div> </td> </tr>
  <tr>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 41.63%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25">Foreign Private Issuer</div> </td>
    <td colspan="4" style="border-top: rgb(0, 0, 0) 2px solid; width: 58.37%; vertical-align: top; border-right: rgb(0, 0, 0) 2px solid; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25">Yes</div> </td> </tr>
  <tr>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 41.63%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25">Disclosure Prohibited under Home Country Law</div> </td>
    <td colspan="4" style="border-top: rgb(0, 0, 0) 2px solid; width: 58.37%; vertical-align: top; border-right: rgb(0, 0, 0) 2px solid; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25">No</div> </td> </tr>
  <tr>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 41.63%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25">Total Number of Directors</div> </td>
    <td colspan="4" style="border-top: rgb(0, 0, 0) 2px solid; width: 58.37%; vertical-align: top; border-right: rgb(0, 0, 0) 2px solid; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25">5</div> </td> </tr>
  <tr>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 41.63%; vertical-align: top; background-color: rgb(217, 217, 217); border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 14.56%; vertical-align: top; background-color: rgb(217, 217, 217); border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Female</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 14.56%; vertical-align: top; background-color: rgb(217, 217, 217); border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Male</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 12.32%; vertical-align: top; background-color: rgb(217, 217, 217); border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Non-</div>
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Binary</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 16.94%; vertical-align: top; background-color: rgb(217, 217, 217); border-right: rgb(0, 0, 0) 2px solid; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Did Not<br/> Disclose<br/> Gender</div> </td> </tr>
  <tr>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 41.63%; vertical-align: top; background-color: rgb(217, 217, 217); border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25; font-weight: bold">Part I: Gender Identity</div> </td>
    <td colspan="4" style="border-top: rgb(0, 0, 0) 2px solid; width: 58.37%; vertical-align: top; background-color: rgb(217, 217, 217); border-right: rgb(0, 0, 0) 2px solid; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 41.63%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25">Directors</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 14.56%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25">[1]</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 14.56%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25">[4]</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 12.32%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25">[0]</div> </td>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 16.94%; vertical-align: top; border-right: rgb(0, 0, 0) 2px solid; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25">[0]</div> </td> </tr>
  <tr>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 41.63%; vertical-align: top; background-color: rgb(217, 217, 217); border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25; font-weight: bold">Part II: Demographic Background</div> </td>
    <td colspan="4" style="border-top: rgb(0, 0, 0) 2px solid; width: 58.37%; vertical-align: top; background-color: rgb(217, 217, 217); border-right: rgb(0, 0, 0) 2px solid; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 41.63%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25">Underrepresented Individual in Home Country Jurisdiction</div> </td>
    <td colspan="4" style="border-top: rgb(0, 0, 0) 2px solid; width: 58.37%; vertical-align: top; border-right: rgb(0, 0, 0) 2px solid; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25">[0]</div> </td> </tr>
  <tr>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 41.63%; vertical-align: top; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25">LGBTQ+</div> </td>
    <td colspan="4" style="border-top: rgb(0, 0, 0) 2px solid; width: 58.37%; vertical-align: top; border-right: rgb(0, 0, 0) 2px solid; border-left: rgb(0, 0, 0) 2px solid">
        <div style="text-align: center; line-height: 1.25">[0]</div> </td> </tr>
  <tr>
    <td style="border-top: rgb(0, 0, 0) 2px solid; width: 41.63%; vertical-align: top; border-bottom: rgb(0, 0, 0) 2px solid; border-left: rgb(0, 0, 0) 2px solid">
        <div style="line-height: 1.25">Did Not Disclose Demographic Background</div> </td>
    <td colspan="4" style="border: rgb(0, 0, 0) 2px solid; width: 58.37%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">[0]</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Family Relationships</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">There are no family relationships among any of our directors or officers.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Special Arrangements</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">There are no special arrangements or understandings with major shareholders, customers,
suppliers or others, pursuant to which any person referred to above was selected as a director or member of senior management.</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z2ff679e7912344f8bf688ac077206ed0" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt; vertical-align: top; font-weight: bold">B.</td>
    <td style="width: auto; vertical-align: top">
        <div style="font-weight: bold">Compensation</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Employment and Consulting Agreements</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We have entered into employment or consulting agreements with all of our executive officers
and key employees. These agreements contain standard provisions for a company in our industry regarding non-solicitation, confidentiality
of information, non-competition and assignment of inventions. Our executive officers will not receive benefits upon the termination of
their respective employment with us, other than mandatory severance payments and payment of salary and benefits (and limited accrual of
vacation days) during the required notice period for termination of their employment, which varies for each individual. The agreements
are terminable by us at will, subject to prior notice, which varies for each individual.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">76</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25; font-weight: bold">Compensation of Individual Covered Executives</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The table and summary below outlines the compensation granted to our five most highly
compensated officeholders (as defined in the Companies Law) with respect to the year ended December 31, 2023. We refer to the five individuals
for whom disclosure is provided herein as our Covered Executives. For purposes of the table and the summary below, &#8220;compensation&#8221;
includes amounts accrued or paid in connection with salary costs, consulting fees, bonuses, equity-based compensation, retirement or termination
payments, benefits and perquisites such as car, phone and social benefits and any undertaking to provide such compensation. All amounts
reported in the table are in terms of cost to the Company, as recognized in our consolidated financial statements for the year ended December
31, 2023, plus compensation paid to such officers following the end of the year in respect of services provided during the year.</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z6d660d5d958740f79997732eba05bd1b" class="cfttable" style="font: 10pt Times New Roman, Times, serif; text-align: left; color: #000000; width: 100%">
  <tr>
    <td style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="line-height: 1.25; font-weight: bold">Name and Principal Position</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Salary (1)</div>
        <div style="text-align: center; line-height: 1.25; font-weight: bold">(USD in thousands)</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Bonus (USD in thousands)</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Equity-Based<br/> Compensation (2) (USD in thousands)</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Total<br/> (USD in thousands)</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Shakil Lakhani<br/> <span style="font-style: italic">President, North America (3)</span>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
        </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">1,105</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">2,386</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">1,750</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">5,241</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 52%">
        <div style="line-height: 1.25">Yair Malca<br/> <span style="font-style: italic">Chief Financial Officer (4)</span>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
        </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">448</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">133</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">1,324</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">1,905</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Alon Yaari<br/> <span style="font-style: italic">VP Operations (5)</span>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
        </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">269</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">15</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">459</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">743</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 52%">
        <div style="line-height: 1.25">Nava Tal-Launer<br/> <span style="font-style: italic">Chief Information Officer (6)</span>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
        </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">174</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">11</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">136</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">321</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Dr. Michael Kreindel<br/> <span style="font-style: italic">Chief Technology Officer and Director</span>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
        </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">266</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">-</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">-</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">266</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z3c379e42d8f747f7b5146699a96291e5" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">(1)</td>
    <td style="width: auto; vertical-align: top">
        <div>Salary includes Covered Executives&#8217; gross salary plus payment of social benefits made by us on behalf of such Covered Executive.
        Such benefits may include, to the extent applicable to the Covered Executive, payments, pension, car expenses, medical and other insurances,
        401K company contribution, payments for social security and tax gross-up payments, vacation and other benefits consistent with our policies.</div>
        </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zee4861d739554337a4ee8a008798337f" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">(2)</td>
    <td style="width: auto; vertical-align: top">
        <div>Represents the share-based compensation expenses recorded in our consolidated financial statements for the year ended December 31,
        2023, based on the Share-based Compensation fair value, calculated in accordance with accounting guidance for share-based compensation.
        For a discussion of the assumptions used in reaching this valuation, see Note 12 to our consolidated financial statements.</div> </td>
        </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z27865ca6c6c241db81d09ad69bb90283" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">(3)</td>
    <td style="width: auto; vertical-align: top">
        <div>On February 13, 2023, Mr. Lakhani was granted 40,000 RSUs under our 2018 Incentive Plan, none of which are vested as of December
        31, 2023. On May 1, 2023, Mr. Lakhani was further granted 10,000 RSUs under our 2018 Incentive Plan, none of which are vested as of December
        31, 2023.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z119b18c0146a4b939a19d118687bab33" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">(4)</td>
    <td style="width: auto; vertical-align: top">
        <div>On February 13, 2023, Mr. Malca was granted 34,000 RSUs under our 2018 Incentive Plan, none of which are vested as of December 31,
        2023.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z3b6712a20c094097864c2bb3a149b56a" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">(5)</td>
    <td style="width: auto; vertical-align: top">
        <div>On February 13, 2023, Mr. Yaari was granted 12,000 RSUs under our 2018 Incentive Plan, none of which are vested as of December 31,
        2023. On July 26, 2023, Mr. Yaari was further granted 2,000 RSUs under our 2018 Incentive Plan, none of which are vested as of December
        31, 2023.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zf0da8bcc4a8d4a0fa90e14a05b43d94c" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">(6)</td>
    <td style="width: auto; vertical-align: top">
        <div>On February 13, 2023, Ms. Tal-Launer was granted 3,500 RSUs under our 2018 Incentive Plan, none of which are vested as of December
        31, 2023.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Compensation of Directors as a Group</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The aggregate compensation paid by us to our directors for the year ended December 31,
2023, was approximately $417 thousand, including share-based compensation expenses of approximately $243 thousand. This amount does not
include reimbursements or coverage of expenses.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We do not have any written agreement with any director providing for benefits upon the
termination of such director's relationship with our Company, other than our consultancy agreement with our Chief Executive Officer and
our employment agreement with our Chief Medical Officer.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">77</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25; font-weight: bold">Employee Benefit Plans</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">2008 Plans</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">On January 30, 2008, our board of directors adopted the 2008 Israeli Option Plan, or
2008 Israeli Plan, pursuant to the Companies Law and Section 102 of the Israeli Income Tax Ordinance, 1961, or the Tax Ordinance, allowing
us to grant options to purchase our ordinary shares to our and our current and future affiliates&#8217; Israeli employees, officers, directors,
consultants, and service providers. Under Israeli law, no shareholder approval was required to approve the 2008 Israeli Plan.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">On January 30, 2008, concurrently with the adoption of the 2008 Israeli Plan, our board
of directors also adopted the 2008 Rest of the World Options Plan, or 2008 ROW Plan, allowing us to grant options to purchase our ordinary
shares to our and our current and future affiliates&#8217; non-Israeli employees, consultants and service providers. The 2008 ROW Plan
was approved by our shareholders on March 16, 2008.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Options granted under the 2008 Israeli Plan and 2008 ROW Plan generally vest over a
period of three years, but shorter or longer vesting schedules have been set. Any option that is cancelled or forfeited before expiration
of its vesting period was available for future grants until the expiration of these plans in January 2018. Since that date, shares underlying
any option that is cancelled or forfeited under these plans return to the authorized and un-issued share capital of the company. Additionally,
options under the 2008 Israeli Plan and 2008 ROW Plan generally expire seven years after the initial grant date, unless extended by the
board of directors. Our board of directors has previously extended the expiration period of certain options prior to their original expiration
date. Under the 2008 Israeli Plan, as of December 31, 2023, we have granted options to purchase a total of 4,182,684 ordinary shares,
of which 3,707,755 ordinary shares have been issued upon the exercise of such options and 443,672 options have been expired and forfeited.
Under the 2008 ROW Plan, as of December 31, 2023, we have granted options to purchase a total of 19,204,710 ordinary shares, of which
14,608,542 ordinary shares have been issued upon the exercise of such options and 4,061,994 options have been expired and forfeited. As
of December 31, 2023, 565,431 options are exercisable under the 2008 Israeli Plan and the 2008 ROW Plan in the aggregate.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">For more information, see Note 12 to our consolidated financial statements included
elsewhere in this Annual Report on Form 20-F.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Israeli tax law allows us to choose from among three alternative sets of tax treatment
for our 2008 Israeli Plan and for future plans. In approving the 2008 Israeli Plan, our board of directors selected the capital gains
tax treatment under Section 102 of the Tax Ordinance described below for grants to Israeli employees and other office holders, including
directors. In accordance with the capital gains tax treatment under Section 102 of the Tax Ordinance, the 2008 Israeli Plan allowed for
beneficial tax treatment for options issued through a trustee to Israeli employees and other office holders, including directors, provided
that options granted thereunder or, upon their exercise, the underlying ordinary shares, are held by a trustee for at least two years
following the date of the option grant. Under Section 102 of the Tax Ordinance, Israeli employees and other office holders, including
directors, are (i) entitled to defer any taxable event with respect to the options until the underlying ordinary shares are sold or withdrawn
from the trust, and (ii) subject to capital gains tax of 25% on the sale of the underlying ordinary shares. In addition, we may not recognize
expenses pertaining to the options for Israeli tax purposes.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Under the 2008 ROW Plan, we were able to grant our non-Israeli employees, officers,
directors, consultants and service providers options to purchase our ordinary shares. The 2008 ROW Plan did not allow favorable tax treatment
for our U.S., Canadian and other non-Israeli directors, officers, employees and consultants.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The 2008 Israeli Plan and the 2008 ROW Plan expired in January 2018 and additional grants
may not be made thereunder; however, options granted under such plans prior to their expiration remain valid following such expiration.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">2018 Incentive Plan</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">On June 17, 2018, our board of directors adopted a new Incentive Plan, or the 2018 Incentive
Plan, allowing us to grant shares, options to purchase our ordinary shares, restricted shares and restricted share units to our and our
current and future affiliates&#8217; Israeli and other non-U.S. employees, officers, directors, consultants and service providers. In
approving the 2018 Incentive Plan, our board of directors selected the capital gains tax treatment described above for grants to Israeli
employees and other office holders, including directors, under the 2018 Incentive Plan. The 2018 Incentive Plan also includes as an appendix
a sub-plan, or the U.S. Sub-Plan, allowing us to grant shares, options to purchase our ordinary shares, restricted shares and restricted
share units to our and our current and future affiliates&#8217; U.S. employees, officers, directors, consultants, and service providers.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">78</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25">Under the 2018 Incentive Plan, as of December 31, 2023, we have granted restricted share
units and options to purchase ordinary shares in a total of 7,036,785, of which 4,466,456 ordinary shares have been issued upon exercise
of such options and 561,216 options and restricted share units have been forfeited and returned to the reserved authorized and unissued
ordinary shares of the company under the 2018 Incentive Plan. The grant above does not include 2,533,300&#160;options, which we granted
during January and February 2020, of which 2,518,300 were cancelled and regranted, in March 2020, following repricing of exercise price,
and 15,000 were forfeited prior to the repricing of those options.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">As of December 31, 2023, 1,073,064 options are exercisable and 936,049 restricted share
units are vested during 2023 and 275,249 restricted share units are vested and were settled by issuance of respective shares at the beginning
of January 2024.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">As of December 31, 2023, up to 8,378,000 of our authorized and unissued ordinary shares
may be issued pursuant to awards under the 2018 Incentive Plan. Upon adoption of the 2018 Incentive Plan, our board of directors resolved
that the number of reserved authorized and unissued ordinary shares of the company for issuance of awards pursuant to the 2018 Incentive
Plan, shall automatically increase on an annual basis in such manner that on the first business day of each calendar year beginning in
2019 such number of reserved ordinary shares equal to the lesser of (i) 800,000 ordinary shares, (ii) three percent (3%) of the number
of ordinary shares outstanding as of such date, or (iii) a lesser number of ordinary shares determined by the board of directors, will
be added to the reserved authorized and unissued ordinary shares of the company for issuance of awards pursuant to the 2018 Incentive
Plan. Accordingly, in January 2023, the number of reserved authorized and unissued ordinary shares of the company for issuance of awards
pursuant to the 2018 Incentive Plan was last increased by an additional 800,000 ordinary shares to 8,378,000. Awards are made pursuant
to agreements and are subject to vesting and other restrictions as determined by the board of directors or the compensation committee.
In January 2024 the board of directors approved that no increase is required this year under the Evergreen mechanism.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The following paragraphs summarize the terms of the 2018 Incentive Plan:</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25"><span style="font-style: italic">Plan Administration.</span> Our board of directors
or the compensation committee acts as the plan administrator.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25"><span style="font-style: italic">Types of Awards.</span> The 2018 Incentive Plan permits
grants of options to purchase ordinary shares, ordinary shares, restricted shares, or restricted share units.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25"><span style="font-style: italic">Exercise Period.</span> Options granted under the 2018
Incentive Plan are exercisable for a period of seven years following the date of grant, unless otherwise determined by our board of directors
or our compensation committee.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25"><span style="font-style: italic">Exercise Price.</span> Our board of directors or compensation
committee has discretion in determining the exercise price of awards, subject to certain limitations. The 2018 Incentive Plan provides
procedures for the cashless exercise of options.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25"><span style="font-style: italic">Transactions.</span> The 2018 Incentive Plan provides
that in the event of a &#8220;Transaction&#8221; (which is defined as (i) a merger, acquisition or consolidation of the Company with one
or more other entities in which the Company is not the surviving entity; or (ii) a sale or other disposition of all or substantially all,
as determined by our board of directors in its discretion, of the outstanding ordinary shares of the Company; or (iii) a sale or other
disposition of all or substantially all, as determined by our board of directors in its discretion, of the consolidated assets of the
Company and its affiliates), if the unexercised awards then outstanding under the 2018 Incentive Plan are assumed or substituted for securities
of the successor company pursuant to the Transaction, then the board of directors or compensation committee, in their sole discretion
and subject to applicable laws, may adjust the exercise price and number and type of shares of such unexercised awards to reflect such
assumption and/or substitution. All other terms and conditions of the award agreements shall remain unchanged, including but not limited
to the vesting period. The 2018 Incentive Plan further provides that our board of directors shall have full power and authority to determine
that all outstanding awards shall terminate and cease to be outstanding, except to the extent assumed or substituted as aforesaid. In
the event that awards are not assumed or substituted by the successor company, our board of directors may provide the participant the
right to exercise the vested awards under such terms and conditions as our board of directors shall determine prior to the Transaction.
In addition, our 2018 Incentive Plan further provides that, subject to any applicable law, our board of directors or our compensation
committee shall have full power and authority to determine that in certain award agreements there shall be a clause providing different
provisions with respect to the vesting period of awards underlying such award agreement or any portion thereof in the event of a Transaction.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">79</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25"><span style="font-style: italic">Termination.</span> The 2018 Incentive Plan provides
that in the event of a participant&#8217;s termination of services as an employee, director, consultant or contractor of the Company and/or
its subsidiaries, other than by reason of such participant&#8217;s death or disability or due to termination for cause, all options which
are vested upon the date of termination shall be exercisable during a period of 90 days from the date of termination, unless otherwise
determined by our board of directors or our compensation committee. All options that are not vested upon the date of termination shall
terminate immediately. The participant shall forfeit any ordinary shares acquired pursuant to an award of restricted stock that remains
unvested as of the date of termination.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25"><span style="font-style: italic">Plan Term.</span> Unless terminated earlier, the 2018
Incentive Plan will continue in effect for a term of ten years from the date of its adoption.</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z4399cc21b62548bba096f7302ba10345" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt; vertical-align: top; font-weight: bold">C.</td>
    <td style="width: auto; vertical-align: top">
        <div style="font-weight: bold">Board Practices</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Board of Directors</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Under the Companies Law, our board of directors is responsible for setting our general
policies and supervising the performance of management. Our board of directors may exercise all powers and may take all actions that are
not specifically granted to our shareholders or to management. Our executive officers are responsible for our day-to-day management and
have individual responsibilities established by our board of directors. Our Chief Executive Officer is appointed by, and serves at the
discretion of, our board of directors, subject to the terms of the consultancy agreement that we have entered into with him. All other
executive officers who are not directors are appointed by our Chief Executive Officer, and are subject to the terms of any applicable
employment or consultancy agreements that we may enter into with each of them.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Under our amended and restated articles of association, our board of directors must
consist of at least three directors and not more than seven directors. Our board of directors consists of five directors. Our directors
are elected in three staggered classes by the vote of a majority of the ordinary shares present, in person or by proxy, at a shareholders&#8217;
meeting (excluding abstentions). Each class of directors consists, as nearly as possible, of one-third of the total number of directors
constituting the entire board of directors (other than the external directors, if applicable). At each annual general meeting of our shareholders,
the election or re-election of directors following the expiration of the term of office of the directors of that class of directors will
be for a term of office that expires on the third annual general meeting following such election or re-election, such that from 2020 and
after, at each annual general meeting the term of office of only one class of directors will expire. Each director holds office until
the third annual general meeting of our shareholders, unless the tenure of such director expires earlier pursuant to the Companies Law
or unless removed from office as described below.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our directors are divided among three classes as follows: the Class I director, consisting
of Dr. Michael Anghel and Mr. Bruce Mann, will hold office until our annual general meeting of shareholders to be held in 2024; the Class
II directors, consisting of Mr. Moshe Mizrahy and Dr. Michael Kreindel, will hold office until our annual general meeting of shareholders
to be held in 2025; and the Class I director, consisting of Dr. Hadar Ron, will hold office until our annual general meeting of shareholders
to be held in 2026.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The provisions of our amended and restated articles of association relating to the number
of directors, staggered board and election and removal of a director from office prior to the lapse of their tenure may be changed only
by a resolution adopted by two-thirds of our ordinary shares voting on the proposed change.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Under the Companies Law, our board of directors is required to employ independent judgment
and discretion when voting, and is prohibited from entering into any voting arrangements with respect to actions taken at meetings of
the board. Further, the Companies Law provides that in the event a director learns about an alleged breach of law or improper conduct
of business relating to a company matter, said director must promptly take action to summon a meeting of the board of directors to address
any such breach.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">In accordance with the exemptions available to foreign private issuers under Nasdaq
rules, we do not intend to follow the requirements of Nasdaq rules with regard to the process of nominating directors. Instead, we intend
to follow Israeli law and practice, in accordance with which our board of directors (or a committee thereof) is authorized to recommend
to our shareholders director nominees for election.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">In addition, our amended and restated articles of association allow our board of directors
to appoint directors to fill vacancies on our board of directors, including filling empty board seats up to the maximum number of directors
permitted under our amended and restated articles of association, for a term of office equal to the remaining period of the term of office
of each director whose office has been vacated. Vacancies on our board of directors may be filled by a vote of a simple majority of the
directors then in office even if they do not constitute a quorum (subject to the limitation on the number of directors and their qualifications).
A director so appointed will hold office until the next applicable annual general meeting of our shareholders in which such director&#8217;s
class is to be replaced.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">80</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25">Directors may be removed from office by a resolution at a general meeting of shareholders
adopted by holders of two-thirds of our ordinary shares voting on the proposed removal, provided that the director being removed from
office is given a reasonable opportunity to state his or her case before the general meeting, or under other circumstances set forth in
our amended and restated articles of association. If a director is removed from office as set forth above, the general meeting will be
entitled, in the same session, to elect another director in his or her place subject to the maximum number of directors permitted as stated
above. Should it fail to do so, the board of directors will be entitled to do so. Any director who is appointed in this manner will serve
in office for the remainder of the removed director&#8217;s term in office, and will be eligible for re-election.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Under the Companies Law, we would be required to include on our board of directors at
least two members, each of whom qualifies as an external director, and as to whom special qualifications, voting requirements and other
provisions would be applicable. We would also be required to include one such external director on each of our board committees.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">However, under regulations promulgated under the Companies Law, Israeli companies whose
shares are traded on stock exchanges such as Nasdaq that do not have a controlling shareholder (as defined therein) and which comply with
the requirements of the jurisdiction where the company&#8217;s shares are traded with respect to the appointment of independent directors
and the composition of an audit committee and compensation committee, may elect not to follow the Companies Law requirements with respect
to the composition of its audit committee and compensation committee and the appointment of external directors (provided that in the event
that upon the appointment of a certain director all members of the board of directors of the company are from one and the same gender
only, a director from the opposite gender will be appointed). As we do not have a controlling shareholder, we have elected to comply with
the requirements of Nasdaq with respect to the composition of our board and such committees, and therefore we are exempt from the Companies
Law requirements with respect thereto, including the appointment of external directors.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Alternate Directors</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 14.2pt; line-height: 1.25">Our amended and restated articles of association provide, as allowed by the Companies
Law, that any director may, by written notice to us, appoint another person to serve as an alternate director at a meeting of the board
of directors. The alternate director will be regarded as a director. Under the Companies Law, a person who is not qualified to be appointed
as a director, a person who is already serving as a director or a person who is already serving as an alternate director for another director,
may not be appointed as an alternate director, unless otherwise permitted by applicable law. Nevertheless, a director who is already serving
as a director may be appointed as an alternate director for a member of a committee of the board of directors so long as he or she is
not already serving as a member of such committee. The term of appointment of an alternate director may be for one meeting of the board
of directors or until notice is given of the cancellation of the appointment.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Leadership Structure of the Board</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">In accordance with the Companies Law and our amended and restated articles of association,
our board of directors is required to appoint one of its members to serve as chairman of the board of directors. Mr. Moshe Mizrahy currently
serves as the Chairman of our board of directors.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Under the Companies Law, the chairman of the board of directors of a public company
or his relatives cannot be vested with the authority of the chief executive officer of such a public company, without the approval of
a special majority of such company&#8217;s shareholders. The shareholders&#8217; approval can be provided for a period of five years following
an initial public offering, and subsequently, for additional periods of up to three years. The shareholders&#8217; special majority consists
of a majority vote of the shares present and voting at a shareholders meeting, provided that either:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z46bbccca6a0f49d1baf33abd8b64d97f" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>such majority includes at least a majority of the shares held by all shareholders who are not controlling shareholders and do not
        have a personal interest in approving such resolution that are voted at the meeting, excluding abstentions; or</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z291ffc14863143968485693592295fac" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>the total number of shares voted by non-controlling shareholders and by shareholders who do not have a personal interest against
        approving such resolution does not exceed 2% of the aggregate voting rights in the company.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">81</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25">In addition, a person who is subordinated, directly or indirectly, to the chief executive
officer may not serve as the chairperson of the board of directors; the chairperson of the board of directors may not be vested with authorities
that are granted to persons who are subordinated to the chief executive officer; and the chairperson of the board of directors may not
serve in any other position in the company or in a controlled subsidiary, but may serve as a director or chairperson of a controlled subsidiary.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our shareholders have duly approved Mr. Moshe Mizrahy serving as both our Chief Executive
Officer and Chairman of our board of directors and such approval will be valid for a period of five years following our initial public
offering.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Committees of the Board of Directors</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Under the Companies Law and our amended and restated articles of association, our board
of directors is permitted to form committees, and to delegate to any such committee powers allotted to the board of directors, subject
to certain exceptions. In general, the board of directors may overturn a resolution adopted by a committee it has formed; however, the
board&#8217;s decision shall not affect the ability of third parties, who were not aware of such decision, to rely on the committee&#8217;s
resolution prior to the time it is overturned. Only members of the board of directors can be members of a board committee, unless the
committee is solely advisory.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Audit and Investment Committee</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our audit and investment committee consists of Dr. Michael Anghel, Dr. Hadar Ron and
Mr. Bruce Mann. Dr. Anghel serves as chairperson of the audit and investment committee.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic">Israeli Companies Law Requirements</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Under the Companies Law, we are required to maintain an audit committee.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic">Nasdaq Listing Requirements</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Under Nasdaq rules, we are required to maintain an audit committee consisting of at
least three independent directors, each of whom is financially literate and one of whom has accounting or related financial management
expertise.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">All members of our audit and investment committee meet the requirements for financial
literacy under the applicable rules and regulations of the SEC and Nasdaq. Our board of directors has determined that Dr. Michael Anghel
is an audit committee financial expert as such term is defined by the SEC rules and has the requisite financial experience as defined
by Nasdaq rules. Each of the members of our audit and investment committee is &#8220;independent&#8221; as such term is defined in Rule
10A-3(b)(1) under the Exchange Act and satisfies the independent director requirements under Nasdaq rules.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic">Audit and Investment Committee Role</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our audit and investment committee charter was amended in February 2021, to include
additional duties and responsibilities of the audit committee to serve also as the Company&#8217;s investment committee. Our audit and
investment committee charter sets forth the responsibilities of the audit and investment committee consistent with the rules and regulations
of the SEC and Nasdaq rules as well as the requirements for such committee under the Companies Law, including the following:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z83fce87550da4a0ba68d9d033ed86346" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>oversight of our independent registered public accounting firm and recommending the engagement, compensation or termination of engagement
        of our independent registered public accounting firm to the board of directors in accordance with Israeli law;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z3112f8f363b743bda8e845e20f4eb3c5" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>recommending the engagement or termination of the person filling the office of our internal auditor; and</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z5dcbd701dbab40dca06e33989cfe47a0" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>recommending the terms of audit and non-audit services provided by the independent registered public accounting firm for pre-approval
        by our board of directors.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our audit and investment committee provides assistance to our board of directors in
fulfilling its legal and fiduciary obligations in matters involving our accounting, auditing, financial reporting, risk assessment and
risk management, internal control and legal compliance functions by pre-approving the services performed by our independent accountants
and reviewing their reports regarding our accounting practices and systems of internal control over financial reporting. Our audit and
investment committee also oversees the audit efforts of our independent accountants and takes those actions that it deems necessary to
satisfy itself that the auditors are independent of management.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">82</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25">Our audit and investment committee also periodically reviews the company's investment
policy and guidelines, the investments made by the company, the company&#8217;s investment strategy and its compliance with the company's
investment policy, and suggest to the board of directors modifications to be made to the company's investment policy.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Under the Companies Law, our audit and investment committee is responsible for:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z418ba499e3bd42e7bb07f7fcedea1f09" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>determining whether there are deficiencies in the business management practices of the Company, including in consultation with our
        internal auditor or the independent auditor, and making recommendations to the board of directors to improve such practices;</div> </td>
        </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z25c056cc82dd45a0a4ccaa40b6890b42" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>determining whether to approve certain related party transactions (including transactions in which an office holder has a personal
        interest and whether such transaction is extraordinary or material under the Companies Law) (see &#8220;&#8212;Approval of Related Party
        Transactions under Israeli Law&#8212;Office Holders&#8221;);</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zec7fd6a2fdd848409f7f886ad615e51e" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>establishing the approval process (including by conducting competitive proceedings) for certain transactions with a controlling shareholder
        or in which a controlling shareholder has a personal interest;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z40f8dcc8b6d045ddad5c612ff136967c" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>where the board of directors approves the working plan of the internal auditor, examining such working plan before its submission
        to the board of directors and proposing amendments thereto;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z806ea2354c0247d791c981555bc74573" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>examining our internal audit controls and internal auditor&#8217;s performance, including whether the internal auditor has sufficient
        resources and tools to fulfill his responsibilities;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z58284f4b6a2a4265ba6c17c7fe0d6f0c" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>examining the scope of our auditor&#8217;s work and compensation and submitting a recommendation with respect thereto to our board
        of directors or shareholders, depending on which of them is considering the appointment of our auditor; and</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z2988e7a9ad3a42a7b1f17648fd137985" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>establishing procedures for the handling of employees&#8217; complaints as to deficiencies in the management of our business and
        the protection to be provided to such employees.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Compensation, Nominating and Governance Committee</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Following our initial public offering, we established a compensation, nominating and
corporate governance committee. The members of this committee are Mr. Bruce Mann, Dr. Michael Anghel and Dr. Hadar Ron. Mr. Mann serves
as chairperson of the committee.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic">Israeli Companies Law Requirements</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Under the Companies Law, the board of directors of a public company must appoint a compensation
committee. The duties of the compensation, nominating and corporate governance committee include the recommendation to our board of directors
of a policy regarding the terms of engagement of office holders (as defined in the Companies Law), to which we refer as a compensation
policy. The term &#8220;office holder&#8221; is defined under the Companies Law as a chief executive officer (referred to in the Companies
Law as the general manager), chief business manager, deputy general manager, vice general manager, any other person assuming the responsibilities
of any of these positions regardless of that person&#8217;s title, a director and any other manager directly subordinate to the general
manager. That policy must be adopted by the board of directors, after considering the recommendations of the compensation, nominating
and corporate governance committee, and needs to be approved by the company&#8217;s shareholders, which approval requires what we refer
to as a Special Majority Approval for Compensation. A Special Majority Approval for Compensation requires shareholder approval by a majority
vote of the ordinary shares present and voting at a meeting of shareholders called for such purpose, provided that either: (i) such majority
includes at least a majority of the ordinary shares held by all shareholders who are not controlling shareholders and do not have a personal
interest in such compensation arrangement, excluding abstentions; or (ii) the total number of ordinary shares of non-controlling shareholders
and shareholders who do not have a personal interest in the compensation arrangement and who vote against the arrangement does not exceed
2% of the company&#8217;s aggregate voting rights.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">83</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25">Even if the shareholders do not approve the compensation policy, the board of directors
may resolve to approve the compensation policy if and to the extent the compensation committee and the board determine, in its judgment
following internal discussions and after reconsidering the compensation policy, that approval of the compensation policy is in the best
interests of the company.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Pursuant to regulations promulgated under the Companies Law, if a company adopts a compensation
policy in advance of its initial public offering and describes it in its prospectus, then the compensation policy shall be deemed a validly
adopted policy and will remain in effect for a term of five years from the date the company becomes a public company. Our compensation
policy has been approved by our shareholders and, in accordance with the regulations promulgated under the Companies Law, will be in effect
for a period of five years from our initial public offering. In light of revisions to our compensation practices and policies, in January
2020, our Compensation Committee and Board of Directors approved an amended and restated compensation policy, or the Revised Compensation
Policy, which was approved by our shareholders at the 2020 Annual General Meeting of the Shareholders.&#160; The compensation policy will
be reviewed from time to time by our compensation committee and our board of directors, according to the requirements of the Companies
Law.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The compensation policy must serve as the basis for decisions concerning the financial
terms of employment or engagement of office holders, including exculpation, insurance, indemnification or any monetary payment or obligation
of payment in respect of employment or engagement. Under the Companies Law, the compensation policy must relate to certain factors, including
advancement of the company&#8217;s long-term objectives, business plan and policies, and creation of appropriate incentives for office
holders. It must also consider, among other things, the company&#8217;s risk management, size and the nature of its operations. The compensation
policy must furthermore consider the following additional factors:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z2528aa036d7c426e85113231d7584913" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>the education, skills, expertise and accomplishments of the relevant office holder;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zb3bbcce10df04209995623c7cd7d1ae0" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>the office holder&#8217;s roles and responsibilities and prior compensation agreements with him or her;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zac53a21e051c4d0baeb9b708342dedf2" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>the ratio between the cost of the terms offered and the cost of the employment of other employees of the company, including those
        employed through outsourcing firms, in particular the ratio between such cost to the average and median salary of such employees of the
        company;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zf3d7eaf49cb34aa58164d931aa959a83" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>the impact of disparities in salary upon work relationships in the company;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z72ced82452824e24889fe0dac9f690ca" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>the possibility of reducing variable compensation at the discretion of the board of directors;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z5edee4c3090d49c38fca0c620b97b16c" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>the possibility of setting a limit on the exercise value of non-cash variable equity-based compensation; and</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z6bed05500b9a44fe8ce8708111eab09e" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>as to severance compensation, the period of service of the office holder, the terms of his or her compensation during such service
        period, the company&#8217;s performance during that period of service, the person&#8217;s contribution towards the company&#8217;s achievement
        of its goals and the maximization of its profits, and the circumstances under which the person is leaving the company.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The compensation policy must also include the following principles:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z4b9594bd8e494fb6a766517f11904380" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>with the exception of office holders who report directly to the chief executive officer, determining the link between variable compensation
        and long-term performance and measurable criteria; however, the company may determine that an immaterial part of the variable components
        of an office holder&#8217;s compensation package shall be awarded based on non-measurable criteria, if such amount is not higher than
        three months&#8217; salary per annum, while taking into account such office holder&#8217;s contribution to the company;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z9360dd5afbdc41ea8b8223d39bd607c4" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>the ratio between variable and fixed compensation, and the ceiling for the value of variable compensation at the time of their payment,
        or in the case of share-based compensation, at the time of grant;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="ze1e379e3253644abba9d210a4a2e52d2" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>the conditions under which an office holder would be required to repay compensation paid to him or her if it was later shown that
        the data upon which such compensation was based was inaccurate and was restated in the company&#8217;s financial statements;</div> </td>
        </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z24d089ab47eb4f009e7b91d2b189c292" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>the minimum holding or vesting period for variable, equity-based compensation while referring to an appropriate long-term perspective
        based incentives; and</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zdafedea5bf654defa7d51ae8f81b8147" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>maximum limits for retirement payments.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">84</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25">Our compensation policy is designed to promote retention and motivation of directors
and executive officers. Additionally, our compensation policy is designed to align the interests of our directors and executive officers
with our long-term performance and serves as a risk management tool. Under our compensation policy, a portion of an executive officer&#8217;s
compensation package is targeted to reflect our short- and long-term goals as well as the executive officer&#8217;s individual performance.
Our compensation policy also includes measures designed to reduce an executive officer&#8217;s incentives to take excessive risks that
may harm us in the long term. Such measures include limits on the value of cash bonuses and equity-based compensation for executive officers,
limits on the ratio between an executive officer&#8217;s variable and total compensation, and minimum vesting periods for equity-based
compensation.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our compensation policy takes into account an executive officer&#8217;s individual characteristics,
such as his or her respective position, educational background, scope of responsibilities and contributions to the attainment of our goals,
as the basis for compensation variation among our executive officers and considers the internal ratios between compensation of our executive
officers and directors and other employees.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Pursuant to our compensation policy, compensation that may be granted to an executive
officer may include base salary, an annual bonus, other cash bonuses (such as a signing bonus or special bonus for special achievements,
such as an outstanding personal achievement, outstanding personal effort or outstanding company performance), equity-based compensation,
benefits and retirement compensation and termination of service arrangements. All cash bonuses are limited to a maximum amount linked
to the executive officer&#8217;s base salary. In addition, the total variable compensation components (cash bonuses and equity-based compensation)
may not exceed 90% of each executive officer&#8217;s total compensation package with respect to any given calendar year.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">An annual cash bonus may be awarded to executive officers upon the attainment of pre-set
periodic objectives and individual targets. The annual cash bonus that may be granted to our executive officers (excluding our chief executive
officer) will be based on performance objectives and a discretionary evaluation of the executive officer&#8217;s overall performance by
our chief executive officer and is subject to minimum thresholds. The annual cash bonus that may be granted to executive officers (excluding
our chief executive officer) may be based entirely on a discretionary evaluation. Furthermore, our chief executive officer will be entitled
to recommend performance objectives, and such performance objectives will be approved by our compensation committee and, if required by
law, by our board of directors.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The performance-measurable objectives of our chief executive officer will be determined
annually by our compensation committee and board of directors. Such objectives will include the weight assigned to each achievement in
the overall evaluation. A less significant portion of the chief executive officer&#8217;s annual cash bonus may be based on a discretionary
evaluation of the chief executive officer&#8217;s overall performance by the compensation committee and the board of directors based on
quantitative and qualitative criteria.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Under our compensation policy, equity-based compensation for executive officers (including
members of our board of directors) is designed in a manner consistent with the underlying objectives in determining such person&#8217;s
annual cash bonus; namely, to enhance the alignment between such person&#8217;s interests with the company&#8217;s long-term interests
and those of our shareholders and to strengthen the retention and motivation of such persons in the medium to long term.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our compensation policy provides for executive officer&#8217;s compensation to be in
the form of share options or other equity-based awards, such as restricted shares and restricted share units, in accordance with our share
incentive plan then in place. All equity-based incentives granted to executive officers shall be subject to vesting periods in order to
promote long-term retention of the awarded executive officers.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Equity-based compensation shall be granted from time to time and will be individually
determined and awarded based on the performance, educational background, prior business experience, qualifications, role and the personal
responsibilities of the executive officer.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">In addition, our compensation policy contains compensation recovery provisions that
allow the company, under certain conditions, to recover bonuses paid in excess. Moreover, the compensation policy enables our chief executive
officer to approve immaterial changes to the terms of an executive officer&#8217;s employment (provided that the changes of the terms
of employment are in accordance our compensation policy) and allows the company to exculpate, indemnify and insure our executive officers
and directors subject to certain limitations.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our compensation policy also provides for compensation for the members of our board
of directors to be determined either (i) in accordance with the amounts set forth in the Companies Regulations (Rules Regarding the Compensation
and Expenses of an External Director) of 2000, as amended by the Companies Regulations (Relief for Public Companies Traded in Stock Exchange
Outside of Israel) of 2000, as such regulations may be amended from time to time, or (ii) in accordance with the amounts determined in
our compensation policy.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">85</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Compensation, Nominating and Corporate Governance Committee Roles</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The compensation, nominating and corporate governance committee is responsible for (i)
recommending the compensation policy to our board of directors for its approval (and subsequent approval by our shareholders) and (ii)
undertaking duties related to the compensation policy and to the compensation of our office holders, including:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z2e241d029e954de08af931cd13e437ef" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>recommending whether a compensation policy should continue in effect, if the then-current policy has a term of greater than five
        years from the company&#8217;s initial public offering, or otherwise three years (approval of either a new compensation policy or the
        continuation of an existing compensation policy must in any case occur five years from the company&#8217;s initial public offering, or
        otherwise every three years);</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z25e2fbf50635422b85583e6fb291a62c" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>recommending to the board of directors periodic updates to the compensation policy;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zf717d0fd51ad47c899a9ac6057d07a2d" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>assessing implementation of the compensation policy;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zab61b7906f574ac8bd6173bd17f1b9a8" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>determining whether to approve the terms of compensation of certain office holders which, according to the Companies Law, require
        the committee&#8217;s approval;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z413d0c13bcdf4ebbb5ebd9d69e8310ee" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>determining whether the compensation terms of a candidate for the position of the chief executive officer of the company needs to
        be brought to approval of the shareholders according to the Companies Law; and</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="ze2de03852aa544d4a0d24deba1c14be8" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>determining, subject to the approval of the board of directors and under special circumstances, whether to override a determination
        of the company's shareholders regarding certain compensation related issues.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our compensation, nominating and corporate governance charter sets forth the responsibilities
of the compensation, nominating and corporate governance committee, which include:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zdd8386ba135141e6b83b5a26613021af" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>the responsibilities set forth in the compensation policy;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zc23d7c70ade34d0eaa9f8ea49a86215c" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>reviewing and approving the granting of options and other incentive awards to the extent such authority is delegated by our board
        of directors; and</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z10ea6e92c37f4b0caef556697cf9c218" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>reviewing, evaluating and making recommendations regarding the compensation and benefits for our non-employee directors.</div> </td>
        </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">In addition, our compensation, nominating and corporate governance committee is responsible
for:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zf51a64246e0a44a89af01d2545ffa9c2" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>overseeing our corporate governance functions on behalf of the board;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z92f2fe77a3774dfa97e8b532f276e039" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>making recommendations to the board regarding corporate governance issues;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z4379f732e14140be9e0f0efe6da51049" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>identifying and evaluating candidates to serve as our directors consistent with the criteria approved by the board;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z8714b732488e498895369fe363294e7f" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>reviewing and evaluating the performance of the board;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z24e42884edbf4c6a8da3fedb77332ea4" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>serving as a focal point for communication between director candidates, non-committee directors and our management;&#8201;&#8201;</div>
        </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zf8ce0eda0d744f749bc02cc938b8357e" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>selecting or recommending to the board for selection candidates to the board; and</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zf5861908d4354c7186976be4fc2cc50c" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>making other recommendations to the board regarding affairs relating to our directors.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Internal Auditor</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Under the Companies Law, the board of directors of an Israeli public company must appoint
an internal auditor recommended by the audit committee. An internal auditor may not be:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z2771a58824fc45089700073a22490bcf" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>a person (or a relative of a person) who holds more than 5% of the company&#8217;s outstanding shares or voting rights;</div> </td>
        </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">86</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<table cellspacing="0" cellpadding="0" id="z802643369fda41269fe65fef2fe3bca6" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>a person (or a relative of a person) who has the power to appoint a director or the general manager of the company (i.e., the chief
        executive officer);</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z207a772ca7b4413d9de5b86ed067268c" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>an office holder (including a director) of the company (or a relative thereof); or</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z315fa904fe9841f1823a28cf0895da95" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>a member of the company&#8217;s independent accounting firm, or anyone on its behalf.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The role of the internal auditor is to examine, among other things, our compliance with
applicable law and orderly business procedures, and to report to the chief executive officer, the chairman of the board and the chairman
of the audit committee. The internal auditor is entitled to receive notice of audit committee meetings and to participate in them. In
addition, the internal auditor may request that the chairman of the audit committee convene a meeting within a reasonable time to discuss
an issue raised by the internal auditor. The internal auditor is responsible for preparing a proposal for an annual or periodical audit
plan and submit such plan to the board of directors or the audit committee for their approval. Following the closing of our initial public
offering we appointed Mr. Oren Grupi, CPA, who serves as partner at KPMG Somech Chaikin, as our internal auditor.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Approval of Related Party Transactions under Israeli Law</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Office Holders</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The Companies Law codifies the fiduciary duties that office holders owe to a company.
Each person listed in the table above under &#8220;Item 6A. Directors, Senior Management and Employees-Directors and Senior Management&#8221;
who is engaged by us is an office holder under the Companies law.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25"><span style="font-style: italic">Fiduciary duties.</span> An office holder&#8217;s fiduciary
duties consist of a duty of loyalty and a duty of care. The duty of loyalty requires the office holder to act in good faith and for the
benefit of the company, and includes, among other things, the duty to avoid any conflict of interest between the office holder&#8217;s
position in the company and personal affairs, and proscribes any competition with the company or the exploitation of any business opportunity
of the company in order to receive personal advantage for himself or herself or others. This duty also requires him or her to reveal to
the company any information or documents relating to the company&#8217;s affairs that the office holder has received due to his or her
position as an office holder. The duty of care requires an office holder, among other things, to act with a level of care that a reasonable
office holder in the same position would employ under the same circumstances. This includes the duty to use reasonable means to obtain
information regarding the advisability of a given action submitted for his or her approval or performed by virtue of his or her position
and all other relevant information pertaining to these actions. We may approve an act specified above which would otherwise constitute
a breach of an office holder&#8217;s duty of loyalty, provided that the office holder acted in good faith, the act or its approval does
not harm the Company, and the office holder discloses his or her personal interest, including any related material information or document,
in a timely manner before the date for discussion of approval of such act. Any such approval is subject to the terms of the Companies
Law, setting forth, among other things, the appropriate parties of the company entitled to provide such approval, and the methods of obtaining
such approval.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25"><span style="font-style: italic">Disclosure of personal interest</span>. The Companies
Law requires that an office holder promptly disclose to the company any personal interest that he or she may have and all related documents
and material information known to him or her, in connection with any existing or proposed transaction by the company. &#8220;Personal
interest,&#8221; as defined by the Companies Law, includes a personal interest of any person in an act or transaction of the company,
including a personal interest of his or her relative or of a corporate body in which that person or a relative of that person is a 5%
or greater shareholder, a holder of 5% or more of the voting rights, a director or chief executive officer, or in which he or she has
the right to appoint at least one director or the chief executive officer. &#8220;Personal interest&#8221; does not apply to a personal
interest stemming merely from one&#8217;s ownership of shares in the company. A personal interest also includes (1) a personal interest
of a person who votes according to a proxy of another person, including in the event that the other person has no personal interest, and
(2) a personal interest of a person who gave a proxy to another person to vote on his or her behalf, regardless of whether or not the
discretion of how to vote lies with the person voting.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The office holder must make the disclosure of his personal interest promptly and no
later than the first meeting of the company&#8217;s board of directors that discusses the particular transaction. This duty to disclose
such information does not apply if the personal interest of the office holder derives solely from the personal interest of a relative
of the office holder in a transaction unless it is an &#8220;extraordinary transaction&#8221;. The Companies Law defines an extraordinary
transaction as a transaction not in the ordinary course of business, not on market terms or that is likely to have a material impact on
the company&#8217;s profitability, assets or liabilities, and defines a relative as a spouse, sibling, parent, grandparent, descendent,
spouse&#8217;s descendant, sibling or parent, and the spouse of any of the foregoing.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">87</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25"><span style="font-style: italic">Approvals of related party transactions. </span>The
Companies Law provides that a transaction with an office holder or a transaction in which an office holder has a personal interest may
not be approved if it is adverse to the company&#8217;s interest. In addition, such a transaction generally requires board approval, unless
the transaction is an extraordinary transaction or the articles of association provide otherwise and provided that the transaction is
in the company&#8217;s interest and is performed by the office holder in good faith. If the transaction is an extraordinary transaction,
first the audit committee and then the board of directors, in that order, must approve the transaction. Under certain circumstances, shareholder
approval may also be required. Generally, a director (and any person in general) who has a personal interest in an extraordinary transaction
that is considered at a meeting of the board of directors or the audit committee may not attend that meeting or vote on that matter, unless
(1) the chairman of the audit committee or board of directors (as applicable) determines that he or she should be present to present the
transaction that is subject to approval, or (2) a majority of the board of directors or the audit committee, as the case may be, also
has a personal interest in the matter then, in such event, all directors may participate in discussions of the audit committee or the
board of directors (as applicable) on such transaction and the voting on approval thereof. If a majority of the board of directors or
the audit committee has a personal interest in the transaction, shareholder approval also would be required for the approval of such transaction.
See &#8220;-Approval of Related Party Transactions under Israeli Law-Office Holders-Approval of office holders&#8217; compensation&#8221;.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25"><span style="font-style: italic">Approval of office holders&#8217; compensation. </span>The
compensation of, or an undertaking to indemnify or insure, an office holder who is not a director generally requires approval first by
our compensation committee, then by our board of directors. If the compensation arrangement or undertaking to indemnify or insure is inconsistent
with our compensation policy, or if the office holder is the chief executive officer (apart from a number of specific exceptions), then
the arrangement is further subject to a Special Majority Approval for Compensation. If the shareholders of a company do not approve the
compensation terms of office holders at a meeting of the shareholders, other than directors, the compensation committee and board of directors
may override the shareholders&#8217; decision, subject to certain conditions. Arrangements regarding the compensation, indemnification
or insurance of a director require the approval of the compensation committee, board of directors and shareholders by simple majority,
in that order, and under certain circumstances, a Special Majority Approval for Compensation.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Controlling Shareholders</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The Companies Law imposes the same disclosure requirements that apply to directors and
office holders, as described above, on a controlling shareholder of a public company. The term &#8220;controlling shareholder&#8221; is
defined in the Companies Law as a shareholder with the ability to direct the activities of the company, other than by virtue of being
an office holder. A shareholder is presumed to be a controlling shareholder if the shareholder holds 50% or more of the voting rights
in a company or has the right to appoint the majority of the directors of the company or its general manager. In the context of a transaction
involving a shareholder of the company, a controlling shareholder is deemed to include any shareholder holding 25% or more of the voting
rights if no other shareholder owns more than 50% of the voting rights in the company. For this purpose, two or more shareholders with
a personal interest in the approval of the same transaction are deemed to be one shareholder.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Approval of the audit committee or the compensation committee (with respect to compensation
arrangements) as the case may be, the board of directors and our shareholders, in that order, is required for:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zbe2a093bc0b24b5881752365d33c95a6" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>extraordinary transactions with a controlling shareholder or in which a controlling shareholder has a personal interest, including
        a private placement in which a controlling shareholder has a personal interest; and</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z8d283e5582634ff28ff8fb9e2d6692ea" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>transactions for the provision of services, whether directly or indirectly, by a controlling shareholder or his or her relative,
        or a company such controlling shareholder controls, and transactions concerning the terms of engagement of a controlling shareholder or
        a controlling shareholder&#8217;s relative, whether as an office holder or an employee.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">88</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25">The shareholder approval must include the majority of shares voted at the meeting. In
addition, either:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zce656a3cf797464faef512d4416f87f5" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>at least a majority of the shares held by the shareholders who have no personal interest in the transaction and are present and voting
        at the meeting must be voted in favor of approving the transaction, excluding abstentions; or</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zea65851fc30b4adea6d5d36672a0e59d" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>the total shareholdings of those who have no personal interest in the transaction and who vote against the transaction must not represent
        more than 2% of the aggregate voting rights in the company.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">In addition, any extraordinary transaction with a controlling shareholder or in which
a controlling shareholder has a personal interest with a term of more than three years, and under certain conditions, five years from
a company&#8217;s initial public offering, requires the abovementioned approval at the end of such period; however, such transactions
not involving the receipt of services or compensation can be approved for a longer term, provided that the audit committee determines
that such longer term is reasonable under the circumstances.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Pursuant to regulations promulgated under the Companies Law, certain transactions with
a controlling shareholder or his or her relative, or with directors or other office holders, that would otherwise require approval of
a company&#8217;s shareholders, may be exempt from shareholder approval upon certain conditions.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Shareholder Duties</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Under the Companies Law, a shareholder has a duty to act in good faith and in a customary
manner towards the company and other shareholders and to refrain from abusing his or her power in the company including, among other things,
when voting in a general meeting of shareholders or in a class meeting on the following matters:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z5cc635f2666a4274b07c5a70cae711ed" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>an amendment to the articles of association;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zcffce493d08940a186037f9e62daf8eb" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>an increase in the company&#8217;s authorized share capital;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z8295c41f63b2433d83ef8df5e1dfdf9a" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>a merger; or</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z0ee6585f275b460ab64271a7d8302e55" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>approval of related party transactions and acts of office holders that require shareholder approval.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">A shareholder also has a general duty to refrain from discriminating against other shareholders.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The remedies generally available upon a breach of contract will also apply to a breach
of the shareholder duties mentioned above, and in the event of discrimination against other shareholders, additional remedies may be available
to the injured shareholder.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">In addition, any controlling shareholder, any shareholder who knows that it possesses
the power to determine the outcome of a shareholder vote and any shareholder who, under the company&#8217;s articles of association, has
the power to appoint or prevent the appointment of an office holder in the company, or has any other power with respect to the company,
is under a duty to act with fairness towards the company. The Companies Law does not describe the substance of this duty of fairness except
to state that the remedies generally available upon a breach of contract will also apply in the event of a breach of the duty to act with
fairness, taking the shareholder&#8217;s position in the company into account. There is limited case law available to assist in understanding
the nature of these duties or the implications of these provisions.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Approval of Private Placements</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 21.3pt; line-height: 1.25">Under the Companies Law and the regulations promulgated thereunder, a private placement
of securities does not require approval at a general meeting of the shareholders of a company; provided however, that in special circumstances,
such as a private placement completed in lieu of a special tender offer (see &#8220;Item 10.-Additional Information-B. Articles of Association&#8221;)
or a private placement which qualifies as a related party transaction (see &#8220;Item 6.-Directors, Senior Management and Employees-C.
Board Practices-Approval of Related Party Transactions under Israeli Law&#8221;), approval at a general meeting of the shareholders of
a company is required.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Exculpation, Indemnification and Insurance of Directors and Officers</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our amended and restated articles of association allow us to indemnify, exculpate and
insure our office holders, either pursuant to an undertaking made in advance of an event or following an event, to the fullest extent
permitted by the Companies Law, the Israeli Securities Law, 5738-1968, or the Securities Law, and the Economic Competition Law, 5748-1988,
or the Economic Competition Law, in respect of liabilities, payments and expenses incurred for acts performed and omissions committed
as an office holder. Our articles of association also allow us to exculpate, insure or indemnify any person who is not an office holder,
including any employee, agent, consultant or contractor who is not an office holder.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">89</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25">Under the Companies Law, the Securities Law and the Economic Competition Law, a company
may indemnify an office holder against the following liabilities, payments and expenses incurred in his or her capacity as an office holder,
either in advance of the act or following the act, provided its articles of association authorize such indemnification:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zccef22666a5d4ba4a3a398cceb6d8abf" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>a monetary liability incurred by or imposed on him or her in favor of another person pursuant to a judgment, including a settlement
        or arbitration award approved by a court. However, if an undertaking to indemnify an office holder with respect to such liability is provided
        in advance, then such an undertaking must be limited to events which, in the opinion of the board of directors, can be foreseen based
        on the company&#8217;s activities when the undertaking to indemnify is given, and to an amount, or according to criteria, determined by
        the board of directors as reasonable under the circumstances. Such undertaking shall detail the foreseen events and amount or criteria
        mentioned above;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z14064aa3c70f4553a0357aadecae07f4" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>reasonable litigation expenses, including reasonable attorneys&#8217; fees, incurred by the office holder (i) as a result of an investigation
        or proceeding instituted against him or her by an authority authorized to conduct such investigation or proceeding, provided that (a)
        no indictment was filed against such office holder as a result of such investigation or proceeding, and (b) no financial liability was
        imposed upon him or her as a substitute for a criminal proceeding against them as a result of such investigation or proceeding or, if
        such financial liability was imposed, it was imposed with respect to an offense that did not require proof of criminal intent; and (ii)
        in connection with a monetary sanction;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z990ecc8b6f7c4f0da16579f87588a26f" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>reasonable litigation expenses, including attorneys&#8217; fees, incurred by the office holder or imposed by a court in proceedings
        instituted against him or her by the company, on its behalf, or by a third party, or in connection with criminal proceedings in which
        the office holder was acquitted, or as a result of a conviction for an offense that does not require proof of criminal intent;</div> </td>
        </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="ze5fe16f93db1446188c59c30b671b6ea" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>expenses incurred by the office holder with respect to proceedings held pursuant to certain provisions of the Economic Competition
        Law;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z164cf70c703d41bba5807637507d59b0" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>a monetary liability imposed on the office holder in favor of a payment for a breach offended at an Administrative Procedure (as
        defined below) as set forth in Section 52(54)(a)(1)(a) of the Securities Law;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zf1fed478e8f04614a86406f0eb7dd882" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>expenses expended by the office holder with respect to an Administrative Procedure under the Securities Law, including reasonable
        litigation expenses and reasonable attorneys&#8217; fees; and</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zd2f3e16ab52b453cac5ddda95eeb2290" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>any other obligation or expense in respect of which it is permitted or will be permitted under applicable law to indemnify an office
        holder, including, without limitation, matters referenced in Section 56H(b)(1) of the Securities law.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">An &#8220;Administrative Procedure&#8221; is defined as a procedure pursuant to Chapters
H3 (Monetary Sanction by the Israeli Securities Authority), H4 (Administrative Enforcement Procedures of the Administrative Enforcement
Committee) or Il (Arrangement to Prevent Procedures or Interruption of Procedures Subject to Conditions) of the Securities Law.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Under the Companies Law, the Securities Law and the Economic Competition Law, a company
may obtain insurance for an office holder against the following liabilities incurred in his or her capacity as an office holder, to the
extent provided in the company&#8217;s articles of association:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z43e71c7616614ee6b4b0221694477491" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>a breach of the duty of loyalty to the company, provided that the office holder acted in good faith and had a reasonable basis to
        believe that the act would not harm the company;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z91872f52129240aaa05d6df8fa1a7831" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>a breach of the duty of care to the company or to a third party, to the extent such a breach arises out of the negligent conduct
        of the office holder;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z8da2e71234a7496ba2d5d1e6ac90871a" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>a financial liability imposed on the office holder in favor of a third party;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="za5788e53e2564da18e8e5b9671fc35e8" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>expenses incurred by the office holder with respect to proceedings held pursuant to certain provisions of the Economic Competition
        Law;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">90</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<table cellspacing="0" cellpadding="0" id="zdfb6bcb6f41d4b6ba6a4af687120501d" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>a monetary liability imposed on the office holder in favor of an injured party at an Administrative Procedure pursuant to Section
        52(54)(a)(1)(a) of the Securities Law; and</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z8017a39b365946b1a58421b5f84621db" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>expenses incurred by an office holder in connection with an Administrative Procedure, including reasonable litigation expenses and
        reasonable attorneys&#8217; fees.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Under the Companies Law, a company may not exculpate an office holder from liability
for a breach of the duty of loyalty. A company may exculpate an office holder in advance from liability to the company, in whole or part,
for damages caused to the company as a result of a breach of the duty of care, but only if a provision authorizing such exculpation is
included in its articles of association. A company may not exculpate in advance a director from liability arising out of a breach of a
duty of care with respect to a distribution.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Under the Companies Law, however, a company may not indemnify, exculpate or insure an
office holder against any of the following:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z0b2ea66c99ea42fe9b5498c2f5b2181d" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>a breach of the duty of loyalty, except for indemnification and insurance for a breach of the duty of loyalty to the company to the
        extent that the office holder acted in good faith and had a reasonable basis to believe that the act would not harm the company;</div>
        </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zf157d0391da546cdbed09c14b80789a6" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>a breach of the duty of care committed intentionally or recklessly, excluding a breach arising out of the negligent conduct of the
        office holder;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z4edede9dc358429da960cfa6dfa2263b" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>an act or omission committed with intent to derive illegal personal benefit; or</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zf67dd8aa07534d0981b7a4e26b6cf644" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>a fine, civil fine, monetary sanction or forfeit levied against the office holder.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The Securities Law and the Economic Competition Law also provide certain limitations
on the ability of a company to indemnify, exculpate and insure office holders.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We have obtained directors&#8217; and officers&#8217; liability insurance for the benefit
of our office holders and intend to continue to maintain such coverage and pay all premiums thereunder to the fullest extent permitted
by applicable law. In addition, we have entered into agreements with each of our directors and executive officers, exculpating them from
a breach of their duty of care to us to the fullest extent permitted by law, and undertaking to indemnify them to the fullest extent permitted
by law. Such indemnification is in addition to any amounts available under our directors&#8217; and office holders&#8217; liability insurance
policy. Each office holder who agreed to receive this letter of indemnification also agreed to give his or her approval to terminate all
previous letters of indemnification that we have provided to him or her, if any. The maximum and aggregate indemnification amount for
all current and future indemnified persons under such agreements is the greater of (i) an amount equal to 25% of our shareholders&#8217;
equity on a consolidated basis, based on our most recent financial statements made publicly available before the date on which the indemnity
payment is made and (ii) $40 million.</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zc3fc44b2118048999472f7d30bfe203b" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt; vertical-align: top; font-weight: bold">D.</td>
    <td style="width: auto; vertical-align: top">
        <div style="font-weight: bold">Employees</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">As of December 31, 2023, we had 581 employees worldwide, across five departments, including
three employees on the executive team, 13 employees in finance, IT and administration, 409 employees in sales and marketing, 37 employees
in research and development and 119 employees in manufacturing and assembly, supply chain and service. As of December 31, 2023, 340 of
our employees are located in the United States and Canada, 109 are located in Israel and the remainder are located in Europe, Asia and
Latin America. We believe our employee relations are good.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Israeli labor laws govern the length of the workday and workweek, minimum wages for
employees, procedures for hiring and dismissing employees, determination of severance pay, annual leave, sick days, advance notice of
termination of employment, equal opportunity and antidiscrimination laws, and other conditions of employment. Subject to certain exceptions,
Israeli law generally requires severance pay upon the retirement, death or dismissal of employees and requires us and our employees to
make payments to the National Insurance Institute, which is similar to the U.S. Social Security Administration. Our Israeli employees
have pension plans that comply with applicable Israeli legal requirements, which also include the mandatory pension payments required
by applicable law and allocation of severance pay.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">91</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25">While none of our Israeli employees work under any collective bargaining agreements,
certain provisions of the collective bargaining agreements between the Histadrut (General Federation of Labor Law in Israel) and the Coordination
Bureau of Economic Organizations (including the Industrialists&#8217; Associations) are applicable to our employees in Israel by extension
orders issued by the Israeli Ministry of Economy and Industry. These provisions primarily affect such matters as length of working hours
and workweek,&#160;recuperation pay, travel expenses and pension rights with respect to our Israeli employees.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">All of our employment and consulting agreements include employees&#8217; and consultants&#8217;
undertakings with respect to confidentiality, noncompetition and assignment to us of intellectual property rights developed in the course
of their employment or engagement with us. However, there can be no assurance that these agreements will be enforceable or that they will
provide us with adequate protection.</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z8bd5a77115244d73ad82f290f966ce76" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt; vertical-align: top; font-weight: bold">E.</td>
    <td style="width: auto; vertical-align: top">
        <div style="font-weight: bold">Share Ownership</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The beneficial ownership of our ordinary shares is determined in accordance with the
rules of the SEC. Under these rules, a person is deemed to be a beneficial owner of a security if that person has or shares voting power,
which includes the power to vote or to direct the voting of the security, or investment power, which includes the power to dispose of
or to direct the disposition of the security. For purposes of the table below, we deem ordinary shares issuable pursuant to options, restricted
share units or warrants that are currently exercisable or exercisable within 60 days of December 31, 2023, if any, to be outstanding and
to be beneficially owned by the person holding the options, restricted share units or warrants for the purposes of computing the percentage
ownership of that person, but we do not treat them as outstanding for the purpose of computing the percentage ownership of any other person.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">All arrangements for involving employees in our capital is discussed in &#8220;Item
6B. Directors, Senior Management and Employees-Compensation-Employee Benefit Plans&#8221; above.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Unless otherwise noted below, each shareholder&#8217;s address is do InMode Ltd., Tavor
Building, Sha&#8217;ar Yokneam, P.O. Box 533, Yokneam 2069200, Israel.</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z0a204b5392b445d6863f9ac2aaf1ba65" class="cfttable" style="font: 10pt Times New Roman, Times, serif; text-align: left; color: #000000; width: 100%">
  <tr>
    <td style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="line-height: 1.25; font-weight: bold">Name of Beneficial Owner:</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Number of<br/> Ordinary<br/> Shares</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Percentage<sup style="vertical-align: text-top; line-height: 1; font-size: smaller">(1)</sup></div>
        </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25; font-weight: bold">Directors and Named Executive Officers</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%">
        <div style="text-indent: -8.65pt; margin-left: 17.3pt; line-height: 1.25">Dr. Michael Kreindel<sup style="vertical-align: text-top; line-height: 1; font-size: smaller">(2)</sup>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
        </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">3,114,762</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">3.7</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">%</div> </td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255)">
        <div style="text-indent: -8.65pt; margin-left: 17.3pt; line-height: 1.25">Moshe Mizrahy<sup style="vertical-align: text-top; line-height: 1; font-size: smaller">(3)</sup>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
        </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">2,005,280</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">2.38</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">%</div> </td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%">
        <div style="text-indent: -8.65pt; margin-left: 17.3pt; line-height: 1.25">Dr. Hadar Ron, M.D.<sup style="vertical-align: text-top; line-height: 1; font-size: smaller">(4)</sup>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
        </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">89,270</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">*</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255)">
        <div style="text-indent: -8.65pt; margin-left: 17.3pt; line-height: 1.25">Bruce Mann<sup style="vertical-align: text-top; line-height: 1; font-size: smaller">(5)</sup>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
        </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">22,270</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">*</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%">
        <div style="text-indent: -8.65pt; margin-left: 17.3pt; line-height: 1.25">Dr. Michael Anghel <sup style="vertical-align: text-top; line-height: 1; font-size: smaller">(6)</sup>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
        </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">16,000</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">*</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255)">
        <div style="text-indent: -8.65pt; margin-left: 17.3pt; line-height: 1.25">Yair Malca<sup style="vertical-align: text-top; line-height: 1; font-size: smaller">(7)</sup>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
        </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">93,314</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">*</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 2px">
        <div style="text-indent: -8.65pt; margin-left: 17.3pt; line-height: 1.25">Shakil Lakhani<sup style="vertical-align: text-top; line-height: 1; font-size: smaller">(8)</sup>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
        </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">42,500</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">*</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Total for all directors and executive officers as a group (7 persons)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
        </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 4px double; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 4px double; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">5,383,396</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 4px double; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 4px double; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">6.4</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">%</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zd1a54ff3a8164dbaba98f6af3a9e3722" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt; vertical-align: top">*</td>
    <td style="width: auto; vertical-align: top">
        <div>Represents less than 1.0%.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z8e062e95be7e4dd3a66cbd798922f71c" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt; vertical-align: top">(1)</td>
    <td style="width: auto; vertical-align: top">
        <div>Percentage ownership is based on 83,982,462 ordinary shares outstanding (excluding treasury shares) as of December 31, 2023, and
        (ii) restricted share units and options to purchase ordinary shares in a total of 152,500 exercisable within 60 days of December 31, 2023,
        of our officers, directors and major shareholders (see &#8220;Item 7A. Major Shareholders and Related Party Transactions-Major Shareholders&#8221;).</div>
        </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z76436074ab4a495994f7fb2d9a6b0a16" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt; vertical-align: top">(2)</td>
    <td style="width: auto; vertical-align: top">
        <div>Consists of 3,114,762 ordinary shares.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z31dc4fecf7a3447fa04a580cd55df0e6" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt; vertical-align: top">(3)</td>
    <td style="width: auto; vertical-align: top">
        <div>Consists of 2,005,280 ordinary shares.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">92</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<table cellspacing="0" cellpadding="0" id="z6c78865d662147238b15edc07e13020f" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt; vertical-align: top">(4)</td>
    <td style="width: auto; vertical-align: top">
        <div>Consists of: (i) 57,270 ordinary shares, (ii) options to purchase 30,000 ordinary shares exercisable within 60 days of December 31,
        2023, with an exercise price of $7. These options expire on August 13, 2026, and (iii) 2,000 restricted share units vested within 60 days
        of December 31, 2023.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zf89cb7f60aa549b29828fc07dd48ab82" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt; vertical-align: top">(5)</td>
    <td style="width: auto; vertical-align: top">
        <div>Consists of: (i) 20,270 ordinary shares, and (ii) 2,000 restricted share units vested within 60 days of December 31, 2023.</div>
        </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zd5b0c4968135408f9b3cd0dafeaa61fa" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt; vertical-align: top">(6)</td>
    <td style="width: auto; vertical-align: top">
        <div>Consists of: (i) 3,000 ordinary shares, (ii) options to purchase 11,000 ordinary shares exercisable within 60 days of December 31,
        2023, with an exercise price of $7 These options expire on August 13, 2026, and (ii) 2,000 restricted share units vested within 60 days
        of December 31, 2023.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zed8e35639f954e4dac15efb76d83944a" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt; vertical-align: top">(7)</td>
    <td style="width: auto; vertical-align: top">
        <div>Consists of: (i) 30,314 ordinary shares, (ii) options to purchase 30,000 ordinary shares exercisable within 60 days of December 31,
        2023, with an exercise price of $9.845. These options expire on March 14, 2027, and (iii) 33,000 restricted share units vested within
        60 days of December 31, 2023.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z300b6a4e0531448ebb4b582cd640a2c5" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt; vertical-align: top">(8)</td>
    <td style="width: auto; vertical-align: top">
        <div>Consists of (i) 42,500 restricted share units vested within 60 days of December 31, 2023.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zbb0663d766784c509a84cc7d30fe6afd" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt; vertical-align: top; font-weight: bold">&#160;F.</td>
    <td style="width: auto; vertical-align: top">
        <div style="font-weight: bold">Disclosure of a Registrant&#8217;s Action to Recover Erroneously Awarded Compensation.</div> </td> </tr>
  </table>

<div style="line-height: 1.25"><br/> </div>

<div style="text-indent: 18pt; line-height: 1.25">We were not required to prepare an accounting restatement, in accordance with the final
clawback rules adopted by the SEC under Section 10D and Rule 10-D1 of the Exchange Act, during the period covered by this Annual Report
on Form 20-F which would require recoupment of any &#160;erroneously awarded incentive compensation.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="line-height: 1.25; font-weight: bold"><span id="ITEM7"><!--Anchor--></span>ITEM 7. MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="za739e742c5a648d68d6b3150b9e7fdce" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt; vertical-align: top; font-weight: bold">A.</td>
    <td style="width: auto; vertical-align: top">
        <div style="font-weight: bold">Major Shareholders</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">As of the date of this Annual Report on Form 20-F, there is no person or entity who
we know beneficially owns 5% or more of the outstanding ordinary shares.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">As of December 22, 2023, we have approximately 83,487 shareholders of record of our
ordinary shares, approximately 77,705 of which are U.S. persons. These U.S. persons hold approximately 57% of our outstanding share capital.
The actual number of beneficial owners is substantially greater than the number of shareholders of record because a large portion of our
ordinary shares are held in street name by brokers and other nominees. This number of shareholders of record also does not include shareholders
whose shares may be held in trust by other entities.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">None of our shareholders has different voting rights from other shareholders. We are
not aware of any arrangement that may, at a subsequent date, result in a change of control of the Company.</div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z78e60a9e9815476b9176825805de11c0" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="text-align: right; vertical-align: top; width: 18pt">
        <div style="line-height: 1.25; text-align: left"><span style="font-weight: bold">B.</span></div> </td>
    <td style="text-align: left; vertical-align: top; width: auto">
        <div style="line-height: 1.25"><span style="font-weight: bold">Related Party Transactions</span></div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Relationship with Home Skinovations Ltd.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Mr. Moshe Mizrahy, our Chief Executive Officer and Chairman of our board of directors,
is a substantial shareholder and board member of Home Skinovations, and Dr. Hadar Ron, one of our directors, serves on the board of directors
of Home Skinovations.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Home Skinovations is involved in the development, manufacture and distribution of home-use
light-based devices for aesthetic applications, which include hair removal, anti-aging, microdermabrasion, cellulite and acne treatments.
Except as detailed below, we have no commitments to, or agreements with, Home Skinovations or any of its subsidiaries, including with
respect to any mutual research and development, indebtedness, financing, debt or credit lines, or any jointly-owned intellectual property
or like arrangements, and we do not share tangible or intangible assets with Home Skinovations or any of its subsidiaries. Any future
agreements with Home Skinovations must be reviewed and approved by our audit committee and board of directors.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25; font-style: italic; font-weight: bold">Service Agreements</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We receive certain services from, and provide certain services to, Home Skinovations.
We do not consider these services to be material. The services include an office sublease in Israel, mobile phone services, use of certain
computer hardware and switchboard infrastructure, certain software licenses and limited personnel services. In relation to these services,
Home Skinovations invoiced us approximately $99 thousand for the year ended December 31, 2023, and the Canadian subsidiary of Home Skinovations
paid our Canadian subsidiary approximately $30 thousand for the year ended December 31, 2023, for these services.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">93</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-indent: 17.3pt; line-height: 1.25; font-style: italic; font-weight: bold">Asset Purchase Agreement</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">In February 2022, following approval by our audit committee and our board of directors,
we have entered into an Asset Purchase Agreement with Home Skinovations, whereby Home Skinovations sold and assigned to us all of Home
Skinovations&#8217; right, title and interest in and to Home Skinovations&#8217; Spa segment assets (including molds, tooling, inventory
and trademarks) and further granted us an exclusive license to certain IP rights of Home Skinovations, all the foregoing in consideration
for an aggregate amount of $497 thousand.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Relationship with Himalaya Family Office Consulting Ltd.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Mr. Moshe Mizrahy, our Chief Executive Officer and Chairman of our board of directors,
is a minor shareholder and board member of Himalaya Family Office Consulting Ltd., a company engaged in providing global investment portfolio
management and risk management &amp; analysis services.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We receive certain investment portfolio management services from Himalaya Family Office
Consulting Ltd., with respect to part of our investment portfolio, and recorded expenses related to those services in the amount of $193
thousand for the year ended December 31, 2023.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Agreements and Arrangements with Directors and Executive Officers</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We have entered into written employment or consulting agreements with each of our executive
officers. See &#8220;Item 6. Directors, Senior Management and Employees &#8211; B. Compensation- Employment and Consulting Agreements&#8221;.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Members of our board of directors are entitled to certain compensation for their services.
See &#8220;Item 6. Directors, Senior Management and Employees &#8211; C. Board Practices &#8211; Committees of the Board of Directors
&#8211; Compensation, Nominating and Governance Committee&#8221;.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Options</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Since our inception, we have granted options to purchase our ordinary shares to our
executive officers and certain of our directors. The options are generally subject to the further terms of the respective option plans,
which we describe under &#8220;Item 6.B. Compensation-Employee Benefit Plans&#8221;.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25"><span style="font-weight: bold">RSUs</span>&#160;<span style="font-weight: bold">(restricted share units)</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Under the 2018 Incentive Plan, we have granted RSUs to our executive officers and certain
of our directors. The RSUs are generally subject to the further terms of the 2018 Incentive Plan, which we describe under &#8220;Item
6.B. Compensation-Employee Benefit Plans-2018 Incentive Plan.&#8221;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Indemnification Agreements</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We have entered into separate indemnification agreements with each of our current directors,
office holders and other executives exculpating them from a breach of their duty of care to us to the fullest extent permitted by law
and undertaking to indemnify them to the fullest extent permitted by law. We have also obtained directors&#8217; and officers&#8217; liability
insurance for each of our executive officers and directors. See &#8220;Item 6C. Directors, Senior Management and Employees-Board Practices-Exculpation,
Indemnification and Insurance of Directors and Officers&#8221; for additional information.</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z4a99b859ef884b909018fa276ffced4a" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt; vertical-align: top; font-weight: bold">C.</td>
    <td style="width: auto; vertical-align: top">
        <div style="font-weight: bold">Interests of Experts and Counsel</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Not applicable.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold"><span id="ITEM8"><!--Anchor--></span>ITEM 8. FINANCIAL INFORMATION</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z86f80ab599354ad4a3002b7fecf77a8b" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt; vertical-align: top; font-weight: bold">A.</td>
    <td style="width: auto; vertical-align: top">
        <div style="font-weight: bold">Consolidated Statements and other Financial Information</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">See &#8220;Item 18. Financial Statements&#8221;.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">94</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25; font-weight: bold">Legal Proceedings</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We may be party from time to time to various other lawsuits, claims and other legal
proceedings that arise in the ordinary course of our business. There can be no assurance that matters that arise in the future, individually
or in aggregate, will not have a material adverse effect on our financial condition or results of operations.</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z02ba492dee404d87b4ae89c18fcbb694" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt; vertical-align: top; font-weight: bold">B.</td>
    <td style="width: auto; vertical-align: top">
        <div style="font-weight: bold">Significant Changes</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Since December 31, 2023, no significant changes have occurred.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold"><span id="ITEM9"><!--Anchor--></span>ITEM 9. THE OFFER AND LISTING</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zbae76c47178b482a8f6a73e13a881608" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt; vertical-align: top; font-weight: bold">A.</td>
    <td style="width: auto; vertical-align: top">
        <div style="font-weight: bold">Offer and Listing Details</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our ordinary shares have been trading on the Nasdaq Global Select Market under the symbol
&#8220;INMD&#8221; since August 8, 2019. Prior to that date, there was no public trading market for our ordinary shares.</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z5fe19ce695b94693b5de3fd865c0efbd" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt; vertical-align: top; font-weight: bold">B.</td>
    <td style="width: auto; vertical-align: top">
        <div style="font-weight: bold">Plan of Distribution</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Not applicable.</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z6215c025b77240aca55efc30465ab399" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt; vertical-align: top; font-weight: bold">C.</td>
    <td style="width: auto; vertical-align: top">
        <div style="font-weight: bold">Markets</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our ordinary shares trade on the Nasdaq Global Select Market under the symbol &#8220;INMD&#8221;.</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zfe905d742d82446d8cf03e91eb1b4ecd" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt; vertical-align: top; font-weight: bold">D.</td>
    <td style="width: auto; vertical-align: top">
        <div style="font-weight: bold">Selling Shareholders</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Not applicable.</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z4633d8bb52e04061a5839404bb126e9c" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt; vertical-align: top; font-weight: bold">E.</td>
    <td style="width: auto; vertical-align: top">
        <div style="font-weight: bold">Dilution</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Not applicable.</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z17fcd7aea6bd41c8a68678d300c007aa" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt; vertical-align: top; font-weight: bold">F.</td>
    <td style="width: auto; vertical-align: top">
        <div style="font-weight: bold">Expenses of the Issue</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Not applicable.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold"><span id="ITEM10"><!--Anchor--></span>ITEM 10. ADDITIONAL INFORMATION</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z7e7dd842d01648239bb3118cceaa4488" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt; vertical-align: top; font-weight: bold">A.</td>
    <td style="width: auto; vertical-align: top">
        <div style="font-weight: bold">Share Capital</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Not applicable.</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z47d1cd76c5f84ada8dc54128d7e830cf" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt; vertical-align: top; font-weight: bold">B.</td>
    <td style="width: auto; vertical-align: top">
        <div style="font-weight: bold">Articles of Association</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The information set forth in our Registration Statement on Form F-1 filed with the SEC
on July 11, 2019 (File No.: 333-232615), under the heading &#8220;Description of Share Capital&#8221; is incorporated herein by reference.</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z6cf6a811643a49ddbffe9e0b431c4b20" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt; vertical-align: top; font-weight: bold">C.</td>
    <td style="width: auto; vertical-align: top">
        <div style="font-weight: bold">Material Contracts</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic">UK Exchange Agreement</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">On April 23, 2021, the Company, Dilazar Limited (&#8220;Dilazar&#8221;), Wigmore and
Invasix UK entered into a share exchange agreement (the &#8220;UK Exchange Agreement&#8221;) whereby, Dilazar (which owned 49% of the
Invasix UK&#8217;s shares immediately prior to the UK Exchange Agreement, which shares were previously transferred to Dilazar from its
wholly-owned subsidiary Wigmore) sold to the Company all of its outstanding share capital in Invasix UK and Wigmore sold to the Company
all of its rights pursuant to the Founders Memorandum of Understanding, dated March 4, 2014, by and between Wigmore and the Company, in
exchange for the issuance at closing to Dilazar by the Company in a private placement of 457,912 of the Company&#8217;s ordinary shares,
par value NIS 0.01. Upon closing, in May 2021, 457,912 of the Company&#8217;s ordinary shares were issued to Dilazar from the Company&#8217;s
treasury shares.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">For a summary of other material contracts, see &#8220;Item 7B. Major Shareholders and
Related Party Transactions-Related Party Transactions&#8221; and &#8220;Item 19. Exhibits&#8221; no &#8211; 4.7, 4.8, 4.10, 4.11, 4.12,
4.13, 4.16 and 4.17.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">95</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<table cellspacing="0" cellpadding="0" id="zc35dbfa72d4b4f5d888bb1638d4f58ee" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt; vertical-align: top; font-weight: bold">D.</td>
    <td style="width: auto; vertical-align: top">
        <div style="font-weight: bold">Exchange Controls</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">There are currently no Israeli government laws, decrees or regulations that restrict
or that affect our export or import of capital or the remittance of dividends, interest or other payments to non-resident holders of our
securities, including the availability of cash and cash equivalents for use by us and our wholly-owned subsidiaries, except under certain
circumstances, for shareholders who are subjects of countries that are, or have been, in a state of war with Israel, and except or otherwise
as set forth under &#8220;Item 10E. Additional Information-Taxation&#8221;.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">However, under current Israeli laws, currency controls may be imposed by administrative
action at any time. Israeli residents also have an obligation to file reports with the Bank of Israel regarding certain transactions.</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zd15cdb363d044f13977986730a97e0e7" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt; vertical-align: top; font-weight: bold">E.</td>
    <td style="width: auto; vertical-align: top">
        <div style="font-weight: bold">Taxation</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25; font-style: italic">The following description is not intended to constitute a complete
analysis of all tax consequences relating to the ownership or disposition of our ordinary shares, both referred to in this Item 10E as
the ordinary shares. You should consult your own tax advisor concerning the tax consequences of your particular situation, as well as
any tax consequences that may arise under the laws of any state, local, foreign, including Israeli, or other taxing jurisdiction.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Material Israeli Tax Considerations</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The following is a summary of the material Israeli tax laws applicable to us, and some
Israeli Government programs benefiting us. This section also contains a discussion of some Israeli tax consequences to persons acquiring
ordinary shares. This summary does not discuss all the acts of Israeli tax law that may be relevant to a particular investor in light
of his or her personal investment circumstances or to some types of investors subject to special treatment under Israeli law. Examples
of this kind of investor include residents of Israel, traders in securities or persons that own, directly or indirectly, 10% or more of
our outstanding voting capital, all of whom are subject to special tax regimes not covered in this discussion. To the extent that the
discussion is based on new tax legislation which has not yet been subject to judicial or administrative interpretation, we cannot assure
you that Israeli governmental and tax authority or the Israeli courts will accept the views expressed below. The discussion below is subject
to amendment under Israeli law or changes to the applicable judicial or administrative interpretations of Israeli law, which could affect
the tax consequences described below. The discussion should not be construed as legal or professional tax advice and does not cover all
possible tax considerations.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 21.3pt; line-height: 1.25">Potential investors are urged to consult their own tax advisors
as to the Israeli or other tax consequences of the purchase, ownership and disposition of our ordinary shares, including, in particular,
the effect of any foreign, state or local taxes.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25; font-style: italic; font-weight: bold">General Corporate Tax Structure in Israel</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Israeli companies are generally subject to tax on their taxable income at the corporate
tax rate of 23% in 2018 and thereafter.&#160; Capital gains derived by an Israeli resident company are subject to tax at the regular corporate
tax rate.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25; font-style: italic; font-weight: bold">Tax Benefits under the Law for the Encouragement
of Capital Investments, 5719-1959</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The Law for the Encouragement of Capital Investments, 5719-1959, or the Investment Law,
provides certain incentives for capital investments in production facilities (or other eligible assets) by &#8220;Industrial Enterprises&#8221;
(as defined under the Investment Law).</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25; font-style: italic">Tax Benefits Under the 2005 Amendment</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">An amendment to the Investment Law, which became effective as of April 1, 2005, or the
2005 Amendment, changed certain provisions of the Investment Law. An eligible investment program under the 2005 Amendment qualifies for
benefits as a &#8220;Benefited Enterprise&#8221;.. According to the 2005 Amendment, investment programs under the Investment Law (&#8220;Approved
Enterprises&#8221;) receiving cash grants require the prior approval of the Investment Center. Rather, a company may claim the tax benefits
offered by the Investment Law directly in its tax returns, provided that its facilities meet the criteria for tax benefits set forth in
the 2005 Amendment. A company that has a Benefited Enterprise may, in its discretion, approach the Israel Tax Authority for a pre-ruling
confirming that it is in compliance with the provisions of the Investment Law.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The duration of the tax benefits for a Benefited Enterprise is limited to the earlier
of seven or ten years, depending on certain circumstances, and allows first for an exemption from corporate tax and before transitioning
to a reduced corporate tax.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">96</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25">In addition, a company that has a Benefited Enterprise program is eligible for further
tax benefits if it qualifies as a Foreign Investors&#8217; Company, or FIC. The level of foreign investment is measured as the percentage
of rights in the company (in the terms of shares, rights to profits, voting and appointment of directors) and of combined share capital
and shareholder loans that are owned, directly or indirectly, by persons who are not residents of Israel.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The 2011 Amendment as described below has eliminated the definition of a FIC. However,
according to the 2011 Amendment&#8217;s transitional provisions, the tax benefits of companies with Benefited Enterprise plans that opt
to remain under the Benefited Enterprise regime in accordance with the Investment Law prior to the 2011 Amendment will be preserved.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">If the company pays a dividend out of income derived from the Benefited Enterprise during
the tax exemption period, such income will be subject to deferred corporate tax with respect to the amount distributed (grossed up to
reflect such pre-tax income that it would have had to earn in order to distribute the dividend) at the corporate tax rate which would
have otherwise been applied. The company is required to withhold tax on such distribution at a rate of 15%, or such lower rate may be
provided in an applicable tax treaty (subject to the receipt in advance of a valid certificate from the Israel Tax Authority allowing
for a reduced tax rate); or</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">(ii) Reduced corporate tax rates for companies with facilities in certain geographical
locations in Israel.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our facilities in Israel were granted Benefited Enterprise status and thereunder we
enjoyed a ten-year tax exemption from corporate tax on our undistributed income derived from the Benefited Enterprise. The first year
in which we were exempted from tax was 2012 and the ten-year eligibility period of tax exemption ended in 2021.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25; font-style: italic">Tax Benefits Under the 2011 Amendment</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">In December 2010, the Israeli Parliament approved amendment 68 to the Investment Law,
or the 2011 Amendment. The 2011 Amendment significantly revised the tax incentive regime in Israel and it commenced on January 1, 2011.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The 2011 Amendment provided for a new and additional status of a &#8220;Preferred Enterprise,&#8221;
which introduced new benefits for income generated by a &#8220;Preferred Company&#8221; through its Preferred Enterprise. The definition
of a Preferred Company, includes, inter alia, a company incorporated in Israel that (1) is not wholly owned by a government entity, (2)
owns a Preferred Enterprise and (3) is controlled and managed from Israel and is subject to further conditions set forth in the Investment
Law. Moreover, a Preferred Company needs to meet certain condition stipulated in the Investment Law such as being an industrial company
(including a minimum threshold of 25% export).</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">A Preferred Company is entitled to a reduced corporate tax rate of 16% with respect
to income attributable to its Preferred Enterprise, unless the Preferred Enterprise is located in a specified development zone, known
as Development Zone &#8220;A,&#8221; in which case the rate is currently 7.5%.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Dividends paid out of income attributed to a Preferred Enterprise are generally subject
to tax at the rate of 20% or such lower rate as may be provided in an applicable tax treaty. Claim of tax benefits afforded by an applicable
tax treaty is subject to the receipt in advance of a valid certificate from the Israel Tax Authority, allowing for a reduced tax rate.
However, if such dividends are paid to an Israeli company, no tax is required to be withheld (although, if the funds are subsequently
distributed to individuals or non-Israeli residents (individuals and corporations), withholding tax would apply when distributing the
dividend to such individuals or non-Israeli residents).</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25; font-style: italic">Tax Benefits Under the 2017 Amendment</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Additional amendments to the Investment Law became effective in January 2017, or the
2017 Amendment. Under the 2017 Amendment, and provided the conditions stipulated therein are met, income derived by Preferred Companies
from &#8220;Preferred Technological Enterprises,&#8221; or PTE (as defined in the 2017 Amendment), would be subject to reduced corporate
tax rates of 7.5% in Development Zone &#8220;A&#8221; and 12% elsewhere in Israel, or 6% in the case of a &#8220;Special Preferred Technological
Enterprise,&#8221; or SPTE (as defined in the 2017 Amendment) regardless of the company&#8217;s geographical location within Israel. A
Preferred Company distributing dividends from income derived from its PTE or SPTE, would subject the recipient to a 20% tax (or lower,
if so provided under an applicable tax treaty). The 2017 Amendment further provides that, in certain circumstances, a dividend distributed
to a corporate shareholder who is not an Israeli resident for tax purposes would be subject to a 4% tax (inter alia, if the amount of
foreign investors in the distributing company exceeds 90%). Such taxes would generally be withheld at source by the distributing company.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">97</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25">On June 14, 2017, the Encouragement of Capital Investments Regulations (Preferred Technology
Income and Capital Profits for a Technological Enterprise), 2017, or the Regulations, were published, which adopted Action 5 under the
base erosion and profit shifting, or BEPS, regulations. The Regulations describe, inter alia, the mechanism used to determine the calculation
of the benefits under the PTE and under the SPTE regimes and determine certain requirements relating to documentation of intellectual
property for the purpose of a PTE. According to these provisions, a company that complies with the terms under the PTE regime may be entitled
to certain tax benefits with respect to income generated during the company&#8217;s regular course of business and derived from the preferred
intangible asset (as determined in the Investment Law), excluding income derived from intangible assets used for marketing and income
attributed to production activity. In the event that intangible assets used for marketing purposes generate over 10% of the PTE&#8217;s
income, the relevant portion, calculated using a transfer pricing study, would be subject to regular corporate income tax. If such income
does not exceed 10%, the PTE will not be required to exclude the marketing income from the PTE&#8217;s total income. The Regulations set
a presumption of direct production expenses plus 10% with respect to income related to production, which can be countered by the results
of a supporting transfer pricing study. Tax rates applicable to such production income expenses will be similar to the tax rates under
the Preferred Enterprise regime, to the extent such income would be considered as eligible. In order to calculate the preferred income,
the PTE is required to take into account the income and the research and development expenses that are attributed to each single preferred
intangible asset. Under the Regulations, our corporate tax rate for the Company is expected to be approximately 7.5%.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Under the transitional provisions of the 2017 Amendment, a company is allowed to continue
to enjoy the tax benefits available under the Investment Law prior to the 2017 Amendment until the end of the period of benefits, as defined
in the Investment Law. In each year during the period of benefit under its Benefited Enterprise status, the Company will be able to opt-in
for application of the 2017 Amendment, thereby making itself available to the tax rates described above. A company&#8217;s decision to
opt-in for application of the 2017 Amendment is irrecoverable.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Pursuant to the amendment to the Investments Law which became effective on November&#160;15,
2021, a company that elects by November&#160;15, 2022 to pay a reduced corporate tax rate as set forth in that amendment (rather than
the regular corporate tax rate applicable to Approved Enterprise income) with respect to undistributed exempt income accumulated by the
company until December&#160;31, 2020 will be entitled to distribute a dividend from such income or to be used for any other reason found
by the Company, without being required to pay additional corporate tax. A company that has so elected must make certain qualified investments
in Israel over the five-year period commencing on the year of which the Company has elected to pay the reduced corporate tax rate. A company
that has elected to apply the amendment cannot withdraw from its election. The Company elected to take advantage of the amendment, and
has paid NIS 42.5 million (approximately $12 million) as a one-time payment, and as a result NIS 591 million (approximately $165.7 million)
of the Company&#8217;s undistributed exempt income for years 2012 until 2020 will be entitled to be distributed as dividend or to be used
for any other reason found by the Company without being required to pay additional corporate tax. As a result, the Company is required
to invest NIS 32 million (approximately $9 million) in its industrial enterprises in Israel over a five year period. Such investment may
be in the form of the acquisition of industrial assets (excluding real estate assets), investment in R&amp;D in Israel, or payroll payments
to new employees to be hired by the enterprise.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">In February 2022, the Company settled the 2017-2020 income tax assessment with the Israeli
tax authority, paying $1.3 million. In addition, the Company reached an agreement of tax assessment with the Israeli tax authority under
which the Company paid during January 2023 NIS 50.2 million (approximately $14.3 million). As a result, tax assessments of the Israeli
Company through tax year 2021 are considered final.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25; font-style: italic; font-weight: bold">Law for the Encouragement of Industry (Taxes),
5729-1969</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We believe that we currently qualify as an &#8220;Industrial Company&#8221; within the
meaning of the Law for the Encouragement of Industry (Taxes), 5729-1969, or the Industry Encouragement Law. The Industry Encouragement
Law defines an &#8220;Industrial Company&#8221; as an Israeli-resident company, incorporated in Israel, of which 90% or more of its income
in any tax year, other than of income from defense loans, capital gains, interest and dividends, is derived from an &#8220;Industrial
Enterprise&#8221; owned by it and located in Israel or in the &#8220;Area,&#8221; in accordance with the definition in section 3a of the
Tax Ordinance. An &#8220;Industrial Enterprise&#8221; is defined as an enterprise which is held by an Industrial Company whose principal
activity in a given tax year is industrial production.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The following tax benefits, among others, are available to Industrial Companies:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zc24d01beddfa4e08b4fabf08d411412b" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>amortization of the cost of purchased know-how, patents and certain other intangible property rights (other than goodwill), which
        are used for the development or promotion of the Industrial Enterprise, over an eight-year period for tax purposes, commencing in the
        year where the Industrial Company began to utilize them;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">98</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<table cellspacing="0" cellpadding="0" id="z0306fbb64bae47018aa05be742527511" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>accelerated depreciation rates on equipment and buildings;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z7c3326dd22f649c5834c0d08cd584598" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>under specified conditions, an election to file consolidated tax returns with additional related Israeli Industrial Companies; and</div>
        </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z0191625a5cc14c3caf5a91fa0a1d45de" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>expenses related to a public offering are deductible in equal amounts over three years, beginning from the year of the offering.</div>
        </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Eligibility for the benefits under the Industry Encouragement Law is not subject to
receipt of prior approval from any governmental authority. We cannot assure that we will continue to qualify as an &#8220;Industrial Company&#8221;
or that the benefits described above will be available to us in the future.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25; font-style: italic; font-weight: bold">Capital Gains Taxes Applicable to Israeli Resident
and Non-Israeli Resident Shareholders</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 21.3pt; line-height: 1.25">Capital gains tax is imposed on the sale of capital assets by
an Israeli resident and on the sale of such assets by non-Israeli residents if those assets are either: (i) located in Israel, (ii) shares
or rights to shares in Israeli resident companies or (iii) represent, directly or indirectly, rights to assets located in Israel, unless
a specific exemption is available under Israeli tax law or unless a treaty between Israel and the country of the nonresident provides
otherwise. The Tax Ordinance distinguishes between &#8220;Real Capital Gain&#8221; and the &#8220;Inflationary Surplus&#8221;. Real Capital
Gain is the excess of the total capital gain over Inflationary Surplus computed generally on the basis of the increase in the Israeli
Consumer Price Index or, in certain circumstances, a foreign currency exchange rate, between the date of purchase and the date of disposition.
You should consult with your own tax advisor as to the method you should use to determine the Inflationary Surplus. Inflationary Surplus
is not subject to tax in Israel.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Generally, the tax rate applicable to real capital gains derived by individuals on the
sale of our ordinary shares will be taxed at the rate of 25%, unless such shareholder claims a deduction for interest and linkage differences
expenses in connection with such shares, in which case the gain will generally be taxed at a rate of 30%. If the individual shareholder
is a Controlling Shareholder at the time of the sale or at any time during the 12-month period preceding such sale, such gain will be
taxed at the rate of 30%. A &#8220;Controlling Shareholder&#8221; is defined as a person who holds, directly or indirectly, including
together with others, at least 10% of any means of control in the company (including, among other things, the right to receive profits
of the company, voting rights, the right to receive the proceeds upon the company&#8217;s liquidation and the right to appoint a director).</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Real capital gains derived by corporations will be generally subject to the regular
corporate tax rate (23% in 2018 and thereafter). Individual and corporate shareholders dealing in securities are taxed at the tax rates
applicable to business income: 23% for corporations in 2018 and thereafter and a marginal tax rate of up to 47% in 2018 and thereafter
for individuals plus an additional excess tax of 3% as described below.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25; font-style: italic">Non-Israeli Resident Shareholders</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Non-Israeli residents (individuals and corporations) are generally exempt from Israeli
capital gains tax on any gains derived from the sale, exchange or disposition of shares of Israeli companies publicly traded on a recognized
stock exchange outside of Israel, provided, among other things, that such shareholders did not acquire their shares prior to the company&#8217;s
initial public offering and the gains were not derived from a permanent establishment of such shareholders in Israel. However, shareholders
that are non-Israeli entities will not be entitled to such exemption if Israeli residents: (1) have directly or indirectly, alone or together
with another, a controlling interest of more than 25% of any of the means of control in such non-Israeli corporation or (2) are the beneficiaries
of or are entitled to 25% or more of the revenues or profits of such non-Israeli entity, whether directly or indirectly. This exemption
is not applicable to a person whose gains from selling or otherwise disposing of the shares are deemed to be business income.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">In addition, a sale of shares may be exempt from Israeli capital gains tax under the
provisions of an applicable tax treaty and subject to the receipt in advance of a valid certificate from the Israeli tax authority allowing
of such exemption.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">For example, pursuant to the Convention Between the Governments of the United States
and Israel with respect to Taxes of Income, as amended, or the U.S.-Israel Tax Treaty, the sale, exchange or disposition of ordinary shares
by a person who qualifies as a resident of the United States within the meaning of the U.S.-Israel Tax Treaty and who holds the shares
as a capital asset and is entitled to claim the benefits afforded to such person by the U.S.-Israel Tax Treaty generally will not be subject
to the Israeli capital gains tax unless: (i) the capital gain arising from such sale, exchange or disposition is attributed to real estate
located in Israel; (ii) the capital gain arising from such sale, exchange or disposition is attributed to royalties; (iii) such person
holds, directly or indirectly, shares representing 10% or more of our voting power during any part of the 12-month period preceding such
sale, exchange or disposition, subject to certain conditions; (iv) the capital gains arising from such sale, exchange or disposition can
be allocated to a permanent establishment of the shareholder in Israel, under certain terms; or (v) such person is an individual and was
present in Israel for a period or periods of 183 days or more in the aggregate during the relevant tax year. In any such case, the sale,
exchange or disposition of such shares would be subject to Israeli tax, to the extent applicable. Eligibility to benefit from tax treaties
is conditioned upon the shareholder presenting a withholding certificate issued by the Israel Tax Authority prior to the applicable payment.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">99</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25; font-style: italic">Withholding and Reporting</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Either the purchaser, the Israeli stockbrokers or financial institutions through which
the shares are held is obliged to withhold tax on the amount of consideration paid upon the sale of our ordinary shares (or on the capital
gain realized on the sale, if known), at the Israeli corporate tax rate for Israeli companies (23% in 2018 and thereafter). In case the
seller is an individual, the applicable withholding tax rate would be 25% of the amount of consideration paid upon the sale of shares
(or on the capital gain realized on the sale, if known).</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">In some instances where our shareholders may be liable for Israeli tax on the sale of
our ordinary shares, the payment of the consideration may be subject to the withholding of Israeli tax at source. Shareholders, including
non-Israeli resident shareholders, may be required to demonstrate that they are exempt from tax on their capital gains in order to avoid
withholding at source at the time of sale. In transactions involving a sale of all of the securities of an Israeli resident company, in
the form of a merger or otherwise, the Israel Tax Authority may require non-Israeli resident shareholders who are not liable for Israeli
tax to sign a declaration in a form specified by the Israel Tax Authority or obtain a specific exemption from the Israel Tax Authority
to confirm their status as a non-resident of Israel, and, in the absence of such declarations or exemptions, may require the purchaser
of the securities to withhold taxes at source.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The sale of securities traded on a stock exchange, requires that a detailed return,
including a computation of the tax due, be filed and an advanced payment must be paid on January 31 and July 31 of every tax year in respect
of sales of securities made within the previous six months. However, if all tax due was withheld at source according to applicable provisions
of the Tax Ordinance and the regulations promulgated thereunder, then the aforementioned return need not be filed and no advance payment
must be made.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25; font-style: italic; font-weight: bold">Taxation of Dividend Distributions</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">A distribution of dividends from income, which is not attributed to an Approved Enterprise/Benefited
Enterprise/Preferred Enterprise/Technology Enterprises to an Israeli resident individual, will generally be subject to income tax at a
rate of 25%. However, a 30% tax rate will apply if the dividend recipient is a &#8220;Controlling Shareholder&#8221; (as defined above)
at the time of the distribution or at any time during the preceding 12-month period, and a non-Israeli resident individual will be generally
subject to withholding tax at source at the rate of 15% or such lower rate as may be provided in an applicable tax treaty.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The Tax Ordinance generally provides that a non-Israeli resident (either individual
or corporation) is subject to Israeli income tax on the receipt of dividends at the rate of 25% (30% if the dividends recipient is a &#8220;Controlling
Shareholder&#8221; (as defined above), at the time of the distribution or at any time during the preceding 12 months).</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Generally, Israeli resident corporations are not subject to Israeli tax on the receipt
of dividends paid on shares of Israeli corporations, other than with respect to dividends distributed from income that has accrued during
the benefits period and attributed to a Benefited Enterprise as described above.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Payers of dividends on our shares, including the Israeli stockbrokers or the financial
institutions through which the shares are held, are generally required, subject to reduced tax rates and the demonstration of a shareholder
of his, her or its foreign residency, to withhold taxes upon the distribution of dividends at a rate of 25% (whether or not the recipient
is a &#8220;Controlling Shareholder&#8221;) provided that the shares are registered with a nominee company in Israel (for corporations
and individuals), unless a reduced tax rate under the provisions of an applicable double tax treaty (subject to the receipt in advance
of a valid certificate from the Israel Tax Authority allowing for a reduced tax rate) is available.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Dividends paid out of income attributed to a Preferred Technology Enterprises are generally
subject to withholding tax at source at the rate of 20% or such lower rate as may be provided in an applicable tax treaty.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">100</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25">For example, under the U.S.-Israel Tax Treaty, the following rates will apply in respect
of dividends distributed by an Israeli resident company to a U.S. resident (for purposes of the U.S.-Israel Treaty): (i) with regard to
a dividend distributed from income which is not attributed to an Approved Enterprise/Benefited Enterprise/Preferred Enterprise/Preferred
Technology Enterprise or Special Preferred Technology Enterprise, if the U.S. resident is a corporation which holds during that portion
of the taxable year which precedes the date of payment of the dividend and during the whole of its prior taxable year (if any), at least
10% of the outstanding shares of the voting stock of the Israeli resident paying corporation and not more than 25% of the gross income
of the Israeli resident paying corporation for such prior taxable year (if any) consists of certain types of interest or dividends &#8211;
the maximum tax rate of withholding is 12.5% if a certificate for a reduced withholding tax rate would be provided in advance from the
Israel Tax Authority, (ii) with regard to a dividend distributed from income derived from an Approved Enterprise/Benefited Enterprise/Preferred
Enterprise under the Investment Law, if the U.S. resident is a corporation which holds during that portion of the taxable year which precedes
the date of payment of the dividend and during the whole of its prior taxable year (if any), at least 10% of the outstanding shares of
the voting stock of the Israeli resident paying corporation and not more than 25% of the gross income of the Israeli resident paying corporation
for such prior taxable year (if any) consists of certain types of interest or dividends, the tax rate of withholding 15% will be applicable
if a certificate for a reduced withholding tax rate would be provided in advance from the Israel Tax Authority and (iii) in all other
cases, the tax rate is 25%, or the domestic rate (if such is lower). The aforementioned rates under the U.S.-Israel Tax Treaty will not
apply if the dividend income was derived through a permanent establishment of the U.S. resident in Israel.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">If the dividend is attributable partly to income derived from an Approved Enterprise,
Benefited Enterprise or Preferred Enterprise, and partly from other sources of income, the income tax rate will be a blended rate reflecting
the relative portions of the types of income.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">A non-Israeli resident who receives dividend income derived from or accrued from Israel,
from which the full amount of tax was withheld at source, is generally exempt from the obligation to file tax returns in Israel with respect
to such income, provided that (i) such income was not generated from a business conducted in Israel by the taxpayer, and (ii) the taxpayer
has no other taxable sources of income in Israel with respect to which a tax return is required to be filed.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We have never declared or paid cash dividends to our shareholders and currently we do
not intend to distribute cash or other dividends in the foreseeable future. We cannot assure you that, in the event we declare a dividend,
we will designate the profits that are being distributed in a way that will reduce shareholders&#8217; tax liability.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25; font-style: italic; font-weight: bold">Foreign Exchange Regulations</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Non-residents of Israel who hold our ordinary shares are able to receive any dividends,
and any amounts payable upon the dissolution, liquidation and winding up of our affairs, freely repayable in non-Israeli currency at the
rate of exchange prevailing at the time of conversion. However, Israeli income tax is generally required to have been paid or withheld
on these amounts. In addition, the statutory framework for the potential imposition of currency exchange controls has not been eliminated,
and may be restored at any time by administrative action.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25; font-style: italic; font-weight: bold">Excess Tax</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Individuals who are subject to tax in Israel are also subject to an additional tax at
a rate of 3% on annual income exceeding a certain threshold (NIS 698,280 for 2023), which amount is linked to the annual change in the
Israeli consumer price index, including, but not limited to income derived from dividends, interest and capital gains, subject to the
provisions of an applicable tax treaty.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25; font-style: italic; font-weight: bold">Estate and Gift Tax</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Israeli law presently does not impose estate or gift taxes.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Material U.S. Federal Income Tax Considerations to U.S. Holders</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The following discussion is a description of the material U.S. federal income tax considerations
applicable to an investment in our ordinary shares by U.S. Holders who hold the ordinary shares as capital assets for U.S. federal income
tax purposes, (generally, property held for investment). As used in this section, the term &#8220;U.S. Holder&#8221; means a beneficial
owner of an ordinary share who, for U.S. federal income tax purposes, is or is treated as any of the following:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z5035ea08d1da4cc9b9e3e9993413c0a3" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>a citizen or resident of the United States;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z66e3b9b38f334f6ea5bdc352eb61c3cc" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>a corporation created or organized in or under the laws of the United States or any political subdivision thereof, including the
        District of Columbia;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">101</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<table cellspacing="0" cellpadding="0" id="z148cb5094dce4e42ae9e93ad1bf6aa67" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>an estate, the income of which is subject to U.S. federal income taxation regardless of its source; or</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z0b6025ffa3f6409e9fea7c61b5c93ad8" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>a trust if the trust has elected validly to be treated as a United States person for U.S. federal income tax purposes or if a U.S.
        court is able to exercise primary supervision over the trust&#8217;s administration and one or more United States persons have the authority
        to control all of the trust&#8217;s substantial decisions.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; margin-left: 36pt; line-height: 1.25">This description is based on provisions of the U.S. Internal Revenue
Code of 1986, as amended, referred to in this discussion as the Code, existing U.S. Treasury regulations and administrative and judicial
interpretations, each as available and in effect as of the date of this prospectus. These sources may change and are open to differing
interpretations, possibly with retroactive effect in a manner that could adversely affect a U.S. Holder. This description does not discuss
all aspects of U.S. federal income taxation that may be applicable to investors in light of their particular circumstances or to investors
who are subject to special treatment under U.S. federal income tax law, including:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z25f5c91eed904145a963f071b989367a" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>insurance companies;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z2224237444a9402c887abdbf88f21689" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>dealers in stocks, securities or currencies;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zea3f007d11a74257a00c75d432e146eb" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>financial institutions and financial services entities;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z39a2adc16a424689a3fc4a4b9c209d06" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>real estate investment trusts;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z48e08ee02d28488d9b734b194035ead2" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>regulated investment companies;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zd609b72e00554b5b916d65f84ad3b672" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>partnerships and other pass-through entities, and investors in such entities;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zd5bee1a5c5db41099048b05867840f91" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>persons that receive ordinary shares as compensation for the performance of services;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zf445d6e336e14809b0688e72fcb86a71" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>tax-exempt organizations;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z38dfd708ed344528b211ce43650d7ae9" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>persons that hold ordinary shares as a position in a straddle or as part of a hedging, conversion or other integrated instrument
        or persons entering into a constructive sale with respect to the ordinary shares;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="za16574e9ed284272a906342ac78bbdcc" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>persons subject to special tax accounting rules under Section 451(b) of the Code;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zea0f03a4457e4c97b09c4385f9b95a13" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>individual retirement and other tax-deferred accounts;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z341df860a43d4cb191e86ba292a41706" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>expatriates of the United States;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zca1382b3aaec48758ce5c00d49c15f8b" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>persons having a functional currency other than the U.S. dollar; and</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z6182121f1de54b208462f296e60c6673" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>direct, indirect or constructive owners of 10% or more of our ordinary shares and/or other equity by vote or value.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">This discussion does not address any U.S. state or local or non-U.S. tax consequences
or any U.S. federal gift or estate tax or alternative minimum tax considerations.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">If an entity or arrangement treated as a partnership for U.S. federal income tax purposes
holds ordinary shares, the U.S. federal income tax consequences relating to an investment in the ordinary shares will depend in part upon
the status and activities of such entity or arrangement and the particular partner and certain determinations made at the partner level.
Any such entity or arrangement should consult its own tax advisor regarding the U.S. federal income tax consequences applicable to it
and its partners of the purchase, ownership and disposition of ordinary shares.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We urge you to consult with your own tax advisor regarding the tax consequences of investing
in the ordinary shares, including the effects of federal, state, local, foreign and other tax laws.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">102</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25; font-weight: bold">Distributions Paid on the Ordinary Shares</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We have never paid cash dividends on our ordinary shares and we may not distribute cash
or other dividends on our ordinary shares in the foreseeable future. Subject to the discussion below under &#8220;- Passive Foreign Investment
Company Considerations,&#8221; a U.S. Holder generally will be required to include in gross income as ordinary dividend income the amount
of any distributions paid on the ordinary shares, including the amount of any Israeli taxes withheld, to the extent that those distributions
are paid out of our current or accumulated earnings and profits as determined for U.S. federal income tax purposes. Subject to the discussion
below under &#8220;-Passive Foreign Investment Company Considerations,&#8221; distributions in excess of our earnings and profits will
be applied against and will reduce the U.S. Holder&#8217;s tax basis in its ordinary shares and, to the extent they exceed that tax basis,
will be treated as gain from a sale or exchange of those ordinary shares. Our dividends will not qualify for the dividends-received deduction
applicable in some cases to U.S. corporations. Dividends paid in NIS, including the amount of any Israeli taxes withheld, will be includible
in the income of a U.S. Holder in a U.S. dollar amount calculated by reference to the exchange rate in effect on the day they are received
by the U.S. Holder. Any gain or loss resulting from currency exchange fluctuations during the period from the date the dividend is includible
in the income of the U.S. Holder to the date that payment is converted into U.S. dollars generally will be treated as ordinary income
or loss. Because we may not account for our earnings and profits in accordance with U.S. federal income tax principles, U.S. Holders should
expect all distributions to be reported to them as dividends. Distributions on ordinary shares that are treated as dividends generally
will constitute income from sources outside the United States for foreign tax credit purposes and generally will constitute passive category
income. Subject to certain complex conditions and limitations, Israeli taxes withheld on any distributions on ordinary shares may be eligible
for credit against a U.S. Holder&#8217;s federal income tax liability. The rules relating to the determination of the U.S. foreign tax
credit are complex, and U.S. Holders should consult their tax advisors regarding the availability of a foreign tax credit in their particular
circumstances and the possibility of claiming an itemized deduction (in lieu of the foreign tax credit) for any foreign taxes paid or
withheld.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Dividends paid by a &#8220;qualified foreign corporation&#8221; to non-corporate U.S.
Holders are eligible for taxation at a reduced capital gains rate rather than the marginal tax rates generally applicable to ordinary
income provided that certain requirements are met. Each U.S. Holder is advised to consult its tax advisors regarding the availability
of the reduced tax rate on dividends with regard to its particular circumstances. Distributions on ordinary shares that are treated as
dividends generally will not be eligible for the &#8220;dividends received&#8221; deduction generally allowed to corporate shareholders
with respect to dividends received from U.S. corporations.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">A corporation organized outside of the United States, or a non-U.S. corporation (other
than a corporation that is classified as a PFIC for the taxable year in which the dividend is paid or the preceding taxable year) generally
will be considered to be a qualified foreign corporation (a) if it is eligible for the benefits of a comprehensive tax treaty with the
United States which the Secretary of Treasury of the United States determines is satisfactory for purposes of this provision and which
includes an exchange of information provision, or (b) with respect to any dividend it pays on ordinary shares that are readily tradable
on an established securities market in the United States. We believe that we qualify as a resident of Israel for purposes of, and are
eligible for the benefits of, the U.S.-Israel Treaty, although there can be no assurance in this regard. Further, the Internal Revenue
Service, or IRS, has determined that the U.S.-Israel Treaty is satisfactory for purposes of the qualified dividend rules and that it includes
an exchange of information provision. Therefore, subject to the discussion below under &#8220;- Passive Foreign Investment Company Considerations,&#8221;
if the U.S.-Israel Treaty is applicable, such dividends will generally be &#8220;qualified dividend income&#8221; in the hands of individual
U.S. Holders, provided that certain conditions are met, including holding period and the absence of certain risk reduction transaction
requirements. Each U.S. Holder is advised to consult its tax advisors regarding the availability of the reduced tax rate on dividends
with regard to its particular circumstances.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Disposition of Ordinary Shares</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Subject to the discussion below under &#8220;- Passive Foreign Investment Company Considerations,&#8221;
a U.S. Holder generally will recognize capital gain or loss for U.S. federal income tax purposes upon the sale, exchange or other disposition
of ordinary shares in an amount equal to the difference, if any, between the amount realized (i.e., the amount of cash plus the fair market
value of any property received) on the sale, exchange or other disposition and such U.S. Holder&#8217;s adjusted tax basis in the ordinary
shares. Such capital gain or loss generally will be long-term capital gain taxable at a reduced rate for non-corporate U.S. Holders or
long-term capital loss if, on the date of sale, exchange or other disposition, the ordinary shares were held by the U.S. Holder for more
than one year. Any capital gain of a non-corporate U.S. Holder that is not long-term capital gain is taxed at ordinary income rates. The
deductibility of capital losses is subject to limitations. Any gain or loss recognized from the sale or other disposition of ordinary
shares will generally be gain or loss from sources within the United States for U.S. foreign tax credit purposes.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Passive Foreign Investment Company Considerations</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We believe that we were not a PFIC for our taxable year ended December 31, 2023, and
we do not expect to be classified as a PFIC for U.S. federal income tax purposes for the current year ending December 31, 2024, or the
foreseeable future. However, the determination of whether we are a PFIC is a factual determination made annually based on all the facts
and circumstances and thus is subject to change. The relevant rules for determining whether or not we are a PFIC as applied to our business
are not entirely clear and certain aspects of the relevant tests will be outside our control. Therefore, no assurance can be given that
we will not be a PFIC for any taxable year.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">103</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25">In general, a non-U.S. corporation will be treated as a PFIC, for any taxable year in
which either (1) at least 75% of its gross income is &#8220;passive income,&#8221; referred to as the PFIC income test, or (2) on average
at least 50% of its assets, determined on a quarterly basis, are assets that produce passive income or are held for the production of
passive income, referred to as the PFIC asset test. Passive income for this purpose generally includes, among other things, dividends,
interest, royalties, rents, and gains from the sale or exchange of property that gives rise to passive income. Assets that produce or
are held for the production of passive income generally include cash, even if held as working capital or raised in a public offering,
marketable securities, and other assets that may produce passive income. Generally, in determining whether a non-U.S. corporation is a
PFIC, a proportionate share of the income and assets of each corporation in which it owns, directly or indirectly, at least a 25% interest
(by value) is taken into account.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">A separate determination must be made after the close of each taxable year as to whether
we were a PFIC for that year. Because the value of our assets for purposes of the PFIC test will generally be determined by reference
to the market price of our ordinary shares, fluctuations in the market price of our ordinary shares may cause us to become a PFIC. In
addition, changes in the composition of our income or assets may cause us to become a PFIC.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">If we are a PFIC in any taxable year during which a U.S. Holder owns ordinary shares,
the U.S. Holder could be liable for additional taxes and interest charges under the &#8220;PFIC excess distribution regime&#8221; upon
(1) a distribution paid during a taxable year that is greater than 125% of the average annual distributions paid in the three preceding
taxable years, or, if shorter, the U.S. Holder&#8217;s holding period for the ordinary shares, and (2) any gain recognized on a sale,
exchange or other disposition, including, under certain circumstances, a pledge, of the ordinary shares, whether or not we continue to
be a PFIC. Under the PFIC excess distribution regime, the tax on such distribution or gain would be determined by allocating the distribution
or gain ratably over the U.S. Holder&#8217;s holding period for ordinary shares. The amount allocated to the current taxable year (i.e.,
the year in which the distribution occurs or the gain is recognized) and any year prior to the first taxable year in which we are a PFIC
will be taxed as ordinary income earned in the current taxable year. The amount allocated to other taxable years will be taxed at the
highest marginal rates in effect for individuals or corporations, as applicable, to ordinary income for each such taxable year, and an
interest charge, generally applicable to underpayments of tax, will be added to the tax.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">If we are a PFIC for any year during which a U.S. Holder holds ordinary shares, we must
generally continue to be treated as a PFIC by such U.S. Holder for all succeeding years during which such U.S. Holder holds the ordinary
shares, unless we cease to meet the requirements for PFIC status and such U.S. Holder makes a &#8220;deemed sale&#8221; election with
respect to the ordinary shares. If the election is made, the U.S. Holder will be deemed to sell the ordinary shares it holds at their
fair market value on the last day of the last taxable year in which we qualified as a PFIC, and any gain recognized from such deemed sale
would be taxed under the PFIC excess distribution regime. After the deemed sale election, the U.S. Holder&#8217;s ordinary shares would
not be treated as shares of a PFIC unless we subsequently become a PFIC.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">If we are a PFIC for any taxable year during which a U.S. Holder holds ordinary shares
and one of our non-U.S. corporate subsidiaries is also a PFIC (i.e., a lower-tier PFIC), such U.S. Holder would be treated as owning a
proportionate amount (by value) of the shares of the lower-tier PFIC and would be taxed under the PFIC excess distribution regime on distributions
by the lower-tier PFIC and on gain from the disposition of shares of the lower-tier PFIC even though such U.S. Holder would not receive
the proceeds of those distributions or dispositions. Each U.S. Holder is advised to consult its tax advisors regarding the application
of the PFIC rules to our non-U.S. subsidiaries.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">If we are a PFIC, a U.S. Holder will not be subject to tax under the PFIC excess distribution
regime on distributions or gain recognized on ordinary shares if such U.S. Holder makes a valid &#8220;mark-to-market&#8221; election
for our ordinary shares. A mark-to-market election is available to a U.S. Holder only for &#8220;marketable stock.&#8221; Our ordinary
shares will be marketable stock as long as they remain listed on Nasdaq and are regularly traded, other than in <span style="font-style: italic">de
minimis</span> quantities, on at least 15 days during each calendar quarter. There can be no assurance that the ordinary shares will be
&#8220;marketable stock&#8221; for purposes of the mark-to-market election. If a mark-to-market election is in effect, a U.S. Holder generally
would take into account, as ordinary income for each taxable year of the U.S. Holder, the excess of the fair market value of ordinary
shares held at the end of such taxable year over the adjusted tax basis of such ordinary shares. The U.S. Holder would also take into
account, as an ordinary loss each year, the excess of the adjusted tax basis of such ordinary shares over their fair market value at the
end of the taxable year, but only to the extent of the excess of amounts previously included in income over ordinary losses deducted as
a result of the mark-to-market election. The U.S. Holder&#8217;s tax basis in ordinary shares would be adjusted to reflect any income
or loss recognized as a result of the mark-to-market election. Any gain from a sale, exchange or other disposition of ordinary shares
in any taxable year in which we are a PFIC would be treated as ordinary income and any loss from such sale, exchange or other disposition
would be treated first as ordinary loss (to the extent of any net mark-to-market gains previously included in income) and thereafter as
capital loss.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">104</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25">A mark-to-market election will not apply to ordinary shares for any taxable year during
which we are not a PFIC, but will remain in effect with respect to any subsequent taxable year in which we become a PFIC. Such election
will not apply to any non-U.S. subsidiaries that we may organize or acquire in the future. Accordingly, a U.S. Holder may continue to
be subject to tax under the PFIC excess distribution regime with respect to any lower-tier PFICs that we may organize or acquire in the
future notwithstanding the U.S. Holder&#8217;s mark-to-market election for the ordinary shares.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The tax consequences that would apply if we are a PFIC would also be different from
those described above if a U.S. Holder were able to make a valid qualified electing fund, or QEF, election. At this time, we do not expect
to provide U.S. Holders with the information necessary for a U.S. Holder to make a QEF election. Prospective investors should assume that
a QEF election will not be available.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Each U.S. person that is an investor of a PFIC is generally required to file an annual
information return on IRS Form 8621 containing such information as the U.S. Treasury Department may require. The failure to file IRS Form
8621 could result in the imposition of penalties and the extension of the statute of limitations with respect to U.S. federal income tax.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The U.S. federal income tax rules relating to PFICs are very complex. Prospective U.S.
investors are strongly urged to consult their own tax advisors with respect to the impact of PFIC status on the purchase, ownership and
disposition of ordinary shares, the consequences to them of an investment in a PFIC, any elections available with respect to the ordinary
shares and the IRS information reporting obligations with respect to the purchase, ownership and disposition of ordinary shares of a PFIC.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Medicare Tax</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Certain U.S. Holders that are individuals, estates or trusts and whose income exceeds
certain thresholds generally are subject to a 3.8% tax on all or a portion of their net investment income, which may include their gross
dividend income and net gains from the disposition of ordinary shares. If you are a U.S. person that is an individual, estate or trust,
you are encouraged to consult your tax advisors regarding the applicability of this Medicare tax to your income and gains in respect of
your investment in ordinary shares.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Information Reporting and Back-up Withholding</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">U.S. Holders may be required to file certain U.S. information reporting returns with
the IRS with respect to an investment in ordinary shares, including, among others, IRS Form 8938 (Statement of Specified Foreign Financial
Assets). As described above under &#8220;- Passive Foreign Investment Company Considerations,&#8221; each U.S. Holder who is a shareholder
of a PFIC must file an annual report containing certain information. U.S. Holders paying more than $100,000 for ordinary shares may be
required to file IRS Form 926 (Return by a U.S. Transferor of Property to a Foreign Corporation) reporting this payment. Substantial penalties
may be imposed upon a U.S. Holder that fails to comply with the required information reporting.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Dividends on and proceeds from the sale or other disposition of ordinary shares may
be reported to the IRS unless the U.S. Holder establishes a basis for exemption. Backup withholding may apply to amounts subject to reporting
if the holder (1) fails to provide an accurate United States taxpayer identification number or otherwise establish a basis for exemption
(usually on IRS Form W-9), or (2) is described in certain other categories of persons. However, U.S. Holders that are corporations generally
are excluded from these information reporting and backup withholding tax rules. Backup withholding is not an additional tax. Any amounts
withheld under the backup withholding rules generally will be allowed as a refund or a credit against a U.S. Holder&#8217;s U.S. federal
income tax liability if the required information is furnished by the U.S. Holder on a timely basis to the IRS.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">U.S. Holders should consult their own tax advisors regarding the backup withholding
tax and information reporting rules.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25; font-weight: bold">EACH PROSPECTIVE INVESTOR IS URGED TO CONSULT ITS OWN TAX ADVISOR
ABOUT THE TAX CONSEQUENCES TO IT OF AN INVESTMENT IN ORDINARY SHARES IN LIGHT OF THE INVESTOR&#8217;S OWN CIRCUMSTANCES.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">105</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<table cellspacing="0" cellpadding="0" id="z8fb909423fe04f68b83c7fde29f65940" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt; vertical-align: top; font-weight: bold">F.</td>
    <td style="width: auto; vertical-align: top">
        <div style="font-weight: bold">Dividends and Paying Agents</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Not applicable.</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z6ea8e567cd654830b7c96c479a0888d6" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt; vertical-align: top; font-weight: bold">G.</td>
    <td style="width: auto; vertical-align: top">
        <div style="font-weight: bold">Statement by Experts</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Not applicable.</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z268226b2fb354564accdc444ec51b625" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt; vertical-align: top; font-weight: bold">H.</td>
    <td style="width: auto; vertical-align: top">
        <div style="font-weight: bold">Documents on Display</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We are subject to the information reporting requirements of the Securities Exchange
Act of 1934, as amended (the &#8220;Exchange Act&#8221;) applicable to foreign private issuers and under those requirements will file
reports with the SEC. Those reports may be inspected without charge at the locations described below. As a foreign private issuer, we
are exempt from the rules under the Exchange Act related to the furnishing and content of proxy statements, and our officers, directors
and principal shareholders are exempt from the reporting and short swing profit recovery provisions contained in Section 16 of the Exchange
Act. In addition, we are not required under the Exchange Act to file periodic reports and financial statements with the SEC as frequently
or as promptly as U.S. companies whose securities are registered under the Exchange Act. Nevertheless, we will file with the SEC an Annual
Report on Form 20-F containing financial statements that have been examined and reported on, with and opinion expressed by an independent
registered public accounting firm, and we intend to submit quarterly interim consolidated financial data to the SEC under cover of the
SEC&#8217;s Form 6-K.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We maintain a corporate website at <span style="text-decoration: underline">www.inmodemd.com</span>.
We intend to post our Annual Report on Form 20-F on our website promptly following it being filed with the SEC. Information contained
on, or that can be accessed through, our website does not constitute a part of this Annual Report on Form 20-F. We have included our website
address in this Annual Report on Form 20-F solely as an inactive textual reference.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our SEC filings are available to you on the SEC&#8217;s website at <span style="text-decoration: underline">http://www.sec.gov</span>.
This site contains reports, proxy and information statements and other information regarding issuers that file electronically with the
SEC. The information on that website is not part of this Annual Report on Form 20-F.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">With respect to references made in this Annual Report on Form 20-F to any contract or
other document of InMode, such references are not necessarily complete and you should refer to the exhibits attached or incorporated by
reference to this Annual Report on Form 20-F for copies of the actual contract or document.</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z2b7a64bbe643476c9e509a7bb781e5c7" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt; vertical-align: top; font-weight: bold">I.</td>
    <td style="width: auto; vertical-align: top">
        <div style="font-weight: bold">Subsidiary Information</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Not applicable.</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zdb801499104342fe9ff4477c246085e1" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt; vertical-align: top; font-weight: bold">J.</td>
    <td style="width: auto; vertical-align: top">
        <div style="font-weight: bold">Annual Report to Security Holders.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Not applicable.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold"><span id="ITEM11"><!--Anchor--></span>ITEM 11. QUANTITATIVE AND QUALITATIVE DISCLOSURES
ABOUT MARKET RISK</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Foreign Currency Risk</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our consolidated revenues are generated primarily in U.S. dollars. In addition, a substantial
portion of our consolidated costs are incurred in dollars. We believe that the U.S. dollar is the primary currency of the economic environment
we operate in. Thus, the U.S. dollar is our primary functional and reporting currency.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our transactions and balances originally denominated in dollars are presented at their
original amounts. Balances in non-dollar currencies are translated into U.S. dollars using historical and current exchange rates for non-monetary
and monetary balances, respectively. For non-U.S. dollar transactions and other items in the consolidated statements of income (indicated
below), the following exchange rates are used: (i) for transactions, exchange rates at transaction dates or average rates; and (ii) for
other items (derived from non-monetary balance sheet items such as depreciation and amortization), historical exchange rates. Currency
translation gains and losses are presented in finance income or expenses, as appropriate.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">A significant portion of our operations is conducted through operations in countries
other than the United States and Israel. Revenues from our global operations that were recorded in U.S. dollars represented approximately
74%, 76% and 78% for the years ended December 31, 2023, 2022 and 2021, respectively.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">106</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-indent: 18pt; line-height: 1.25">The functional currency of our subsidiaries is the U.S. dollar. For purposes of consolidation,
the financial statements of the Foreign Subsidiaries are translated into U.S. dollars in accordance with ASC No. 830, &#8220;Foreign Currency
Matters&#8221; (&#8220;ASC 830&#8221;).</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Interest Rate Risk</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The primary objective of our investment activities is to preserve principal while maximizing
the interest income we receive from our investments, without increasing risk. Currently, we do not have any outstanding borrowings. We
intend to invest our cash balances primarily in bank deposits and fixed-income securities issued by corporations, the United States and
non-U.S. governments. We are exposed to market risks resulting from changes in interest rates relating primarily to our financial investments
in cash, cash equivalents, deposits and marketable securities. We do not use derivative financial instruments to limit exposure to interest
rate risk. Our interest gains may decline in the future as a result of changes in the financial markets; however, we believe any such
potential loss would be immaterial to us.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold"><span id="ITEM12"><!--Anchor--></span>ITEM 12. DESCRIPTION OF SECURITIES OTHER THAN
EQUITY SECURITIES</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">A.&#160;&#160; Debt Securities</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Not applicable.</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zb4d9f7d91e0b4ab09a118db2511cd2a0" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt; vertical-align: top; font-weight: bold">B.</td>
    <td style="width: auto; vertical-align: top">
        <div style="font-weight: bold">Warrants and Rights</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Not applicable.</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zbfb85addee3c4bdbbb3c271d9022bca9" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt; vertical-align: top; font-weight: bold">C.</td>
    <td style="width: auto; vertical-align: top">
        <div style="font-weight: bold">Other Securities</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Not applicable.</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z98c9d1c7b26f428a9b28191bd96c38b1" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt; vertical-align: top; font-weight: bold">D.</td>
    <td style="width: auto; vertical-align: top">
        <div style="font-weight: bold">American Depositary Shares</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Not applicable.</div>

<div style="line-height: 1.25"><br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">107</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: center; line-height: 1.25; font-weight: bold"><span id="PARTII"><!--Anchor--></span>PART II</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold"><span id="ITEM13"><!--Anchor--></span>ITEM 13. DEFAULTS, DIVIDENDS ARREARAGES AND DELINQUENCIES</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Not applicable.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold"><span id="ITEM14"><!--Anchor--></span>ITEM 14. MATERIAL MODIFICATIONS TO THE RIGHTS
OF SECURITY HOLDERS AND USE OF PROCEEDS</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">In September 2020, we approved a share repurchase program of up to 2 million ordinary
shares, to be purchased out of our cash reserve and to be paid solely from our IPO proceeds. In February 2022, the board approved that
the share repurchase program could also be funded from the proceeds of exercised options. In March 2022, we approved an additional repurchase
program of up to 1 million ordinary shares, to be purchased out of our cash reserve and to be paid from our remaining IPO proceeds and
from the proceeds of exercised options. As of December 31, 2023, we purchased 2,557,829&#160; shares in the amount of $95.2 million under
these repurchase programs.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold"><span id="ITEM15"><!--Anchor--></span>ITEM 15. CONTROLS AND PROCEDURES</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25; font-weight: bold">Evaluation of Disclosure Controls and Procedures</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We have performed an evaluation, under the supervision and with the participation of
management, including our Chief Executive Officer and Chief Financial Officer (our principal executive officer and principal financial
officer, respectively), of the effectiveness of our disclosure controls and procedures that are designed to provide a reasonable level
of assurance that the information required to be disclosed in reports that we file or submit under the Exchange Act is recorded, processed,
summarized and reported within the specified time periods and accumulated and communicated to our management, including our Chief Executive
Officer and our Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Based on our evaluation, our Chief Executive Officer and Chief Financial Officer have
concluded that our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) promulgated under the Exchange Act)
as of the end of the period covered by this report are effective in ensuring that the information required to be disclosed in reports
that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the specified time periods and accumulated
and communicated to our management, including our Chief Executive Officer and our Chief Financial Officer, as appropriate, to allow timely
decisions regarding required disclosure.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Management&#8217;s Annual Report on Internal Control Over Financial Reporting</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our management is responsible for establishing and maintaining adequate internal control
over financial reporting, as such term is defined in Rule 13a-15(f) promulgated under the Exchange Act. Our internal control system was
designed to provide reasonable assurance to our management and board of directors regarding the reliability of financial reporting and
the preparation and fair presentation of published financial statements for external purposes in accordance with generally accepted accounting
principles. All internal control systems, no matter how well designed, have inherent limitations. Therefore, even those systems determined
to be effective can provide only reasonable assurance with respect to financial statement preparation and presentation and may not prevent
or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls
may become inadequate because of changes in conditions, or that the degree of compliance with policies or procedures may deteriorate.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Management has assessed the effectiveness of our internal control over financial reporting
as of December 31, 2023 using criteria described in the Internal Control-Integrated Framework (2013) issued by the Committee of Sponsoring
Organizations of the Treadway Commission.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Based on its assessment, management concluded that the internal control over financial
reporting was effective as of December 31, 2023, based on the criteria established in the Internal Control-Integrated Framework (2013).</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The effectiveness of our internal control over financial reporting as of December&#160;31,
2023 has been audited by Kesselman&#160;&amp; Kesselman, an independent registered public accounting firm in Israel and a member of PricewaterhouseCoopers
International Limited (&#8220;PwC&#8221;), as stated in their report on pages [F-2 to F-4] under &#8220;Item 18. Financial Statements&#8221;
in this Annual Report on Form 20-F.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Changes in Internal Control Over Financial Reporting</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">There were no changes in our internal control over financial reporting that occurred
during the period covered by this Annual Report on Form 20-F that have materially affected, or that are reasonably likely to materially
affect, our internal control over financial reporting.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">108</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25; font-weight: bold"><span id="ITEM16"><!--Anchor--></span>ITEM 16. [RESERVED]</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold"><span id="ITEM16A"><!--Anchor--></span>ITEM 16A. AUDIT COMMITTEE FINANCIAL EXPERT</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our board of directors has determined that all members of our audit committee are financially
literate as determined in accordance with Nasdaq rules and that Dr. Michael Anghel is qualified to serve as an &#8220;audit committee
financial expert&#8221; as defined by SEC rules. Dr. Anghel is independent, as defined by Nasdaq listing standards.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold"><span id="ITEM16B"><!--Anchor--></span>ITEM 16B. CODE OF ETHICS</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We have adopted a Code of Business Conduct and Ethics applicable to all of our directors
and employees, including our Chief Executive Officer, Chief Financial Officer, controller or principal accounting officer, or other persons
performing similar functions. The full text of the Code of Business Conduct and Ethics has been posted on our website at <span style="text-decoration: underline">www.inmodemd.com</span>.
If we make any amendment to the Code of Business Conduct and Ethics or grant any waivers, including any implicit waiver, from a provision
of the code of ethics, we will disclose the nature of such amendment or waiver on our website to the extent required by the rules and
regulations of the SEC.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold"><span id="ITEM16C"><!--Anchor--></span>ITEM 16C. PRINCIPAL ACCOUNTANT FEES AND SERVICES</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Fees Paid to Independent Registered Public Accounting Firm</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The following table sets forth, for each of the years indicated, the fees billed by
Kesselman&#160;&amp; Kesselman, an independent registered public accounting firm in Israel and a member of PricewaterhouseCoopers International
Limited (&#8220;PwC&#8221;), our independent registered public accounting firm.</div>

<div style="text-indent: 18pt; line-height: 1.25"> <br/> </div>

<div style="line-height: 1.25">

<table cellspacing="0" cellpadding="0" id="zf8c3235305724293977bb17e55e37732" class="cfttable" style="font: 10pt Times New Roman, Times, serif; text-align: left; color: #000000; width: 100%">
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Year ended December 31,</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="line-height: 1.25">
        <div style="text-align: center; line-height: 1.25; font-weight: bold"> 2023</div> </div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="line-height: 1.25">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">2022</div> </div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">USD, in thousands</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Audit fees<sup style="vertical-align: text-top; line-height: 1; font-size: smaller">(1)</sup>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
        </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">630</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">564</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%">
        <div style="line-height: 1.25">Audit-related fees<sup style="vertical-align: text-top; line-height: 1; font-size: smaller">(2)</sup>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
        </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">-</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">&#8212;</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Tax fees<sup style="vertical-align: text-top; line-height: 1; font-size: smaller">(3)</sup>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
        </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">116</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">108</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 2px">
        <div style="line-height: 1.25">Other fees&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">-</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">&#8212;</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25; font-weight: bold">Total&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 4px double; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 4px double; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">746</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 4px double; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 4px double; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">672</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  </table> &#160;</div>

<table cellspacing="0" cellpadding="0" id="zdaa3050dfca84a5cbe23c51230b3d648" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt; vertical-align: top">(1)</td>
    <td style="width: auto; vertical-align: top">
        <div>Audit fees consist of fees billed or expected to be billed for the annual audit services engagement and other audit services, which
        are those services that only the external auditor can reasonably provide, and include the Company audit; statutory audits; comfort letters
        and consents; attest services; and assistance with and review of documents filed with the SEC.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zd53fe4859701425382c939ad6029faba" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt; vertical-align: top">(2)</td>
    <td style="width: auto; vertical-align: top">
        <div>Audit-related fees consist of fees billed for assurance and related services that are reasonably related to the performance of the
        audit or review of our financial statements or that are traditionally performed by the external auditor, and include consultations concerning
        financial accounting and reporting standards; internal control reviews of new systems, programs and projects; review of security controls
        and operational effectiveness of systems; review of plans and control for shared service centers, due diligence related to acquisitions;
        accounting assistance and audits in connection with proposed or completed acquisitions; and employee benefit plan audits.</div> </td>
        </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zcd1517ddecf14d71866660120d2037a9" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt; vertical-align: top">(3)</td>
    <td style="width: auto; vertical-align: top">
        <div>Tax fees include fees billed for tax compliance services that were rendered during the most recent fiscal year, including the preparation
        of original and amended tax returns and claims for refund; tax consultations, such as assistance and representation in connection with
        tax audits and appeals, tax advice related to mergers and acquisitions, transfer pricing, and requests for rulings or technical advice
        from taxing authority; tax planning services; and expatriate tax planning and services.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Our Audit and Investment Committee, in accordance with its charter, reviews and pre-approves
all audit services and permitted non-audit services (including the fees and other terms) to be provided by our independent auditors.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">109</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold"><span id="ITEM16D"><!--Anchor--></span>ITEM 16D. EXEMPTIONS FROM THE LISTING STANDARDS
FOR AUDIT COMMITTEES</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Not applicable.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold"><span id="ITEM16E"><!--Anchor--></span>ITEM 16E. PURCHASES OF EQUITY SECURITIES BY THE
ISSUER AND AFFILIATED PURCHASERS</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">In September 2020, we approved a share repurchase program of up to 2 million ordinary
shares, to be purchased out of our cash reserve and to be paid solely from our IPO proceeds. In February 2022, the board approved that
the share repurchase program could also be funded from the proceeds of exercised options. In March 2022, we approved an additional repurchase
program of up to 1 million ordinary shares, to be purchased out of our cash reserve and to be paid from our remaining IPO proceeds and
from the proceeds of exercised options. As of December 31, 2023, we purchased 2,557,829 shares in the amount of $95.2 million. For the
year ended December 31, 2023, we did not purchase any outstanding shares.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold"><span id="ITEM16F"><!--Anchor--></span>ITEM 16F. CHANGE IN REGISTRANT&#8217;S CERTIFYING
ACCOUNTANT</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Not applicable.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold"><span id="ITEM16G"><!--Anchor--></span>ITEM 16G. CORPORATE GOVERNANCE</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Nasdaq Listing Rules and Home Country Practices</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Companies incorporated under the laws of the State of Israel, whose shares are publicly
traded, including companies with shares listed on Nasdaq, are considered public companies under the Companies Law and are required to
comply with various corporate governance requirements under Israeli law relating to such matters as the composition and responsibilities
of the audit committee and the compensation committee (subject to certain exceptions that we intend to utilize), and a requirement to
have an internal auditor. This is the case even if our ordinary shares are not listed on the Tel Aviv Stock Exchange, which our ordinary
shares are not expected to be. These requirements are in addition to the corporate governance requirements imposed by Nasdaq rules and
other applicable provisions of U.S. securities laws to which we are subject (as a foreign private issuer). Under Nasdaq rules, a foreign
private issuer may generally follow its home country rules of corporate governance in lieu of the comparable requirements of Nasdaq rules,
except for certain matters including the composition and responsibilities of the audit committee and the independence of its members within
the meaning of the rules and regulations of the SEC.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">In accordance with Israeli law and practice and subject to the &#8220;home country practice
exemption&#8221; set forth in Rule 5615 of the Nasdaq rules, we currently follow the provisions of the Companies Law, rather than the
Nasdaq requirements, with respect to the following requirements:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z5137210bfdb24f85bf2d318ac35d5b90" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div><span style="font-style: italic">Quorum</span>. As permitted under the Companies Law and pursuant to our amended and restated articles
        of association, the quorum required for an ordinary meeting of shareholders consists of at least two shareholders present in person, by
        proxy or by other voting instrument in accordance with the Companies Law, who hold at least 25% of the voting rights in the Company (and
        in an adjourned meeting, with some exceptions, at least one shareholder holding any number of the voting rights in the Company), instead
        of 33 1/3% of the issued share capital required under Nasdaq rules. A proxy may be deemed to be two (2) or more shareholders pursuant
        to the number of shareholders represented by the proxy holder.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zbf3a03ca0c5441e6b1316622ce0ef1ec" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div><span style="font-style: italic">Nomination of Directors</span>. Our directors are elected through a staggered board mechanism. With
        the exception of directors elected by our Board of Directors due to vacancy, our directors are elected by an annual general meeting of
        our shareholders to hold office until the next annual meeting following three years from his or her election. The nominations for directors,
        which are presented to our shareholders by our board of directors, are generally made by the board of directors itself or a duly authorized
        committee thereof, but nominations may be made by one or more of our shareholders, all in accordance with the provisions of our amended
        and restated articles of association and the Companies Law. Nominations need not be made by a nominating committee of our board of directors
        consisting solely of independent directors, as required under Nasdaq rules.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">110</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<table cellspacing="0" cellpadding="0" id="z387de932022a4df684fbbe8b89654412" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div><span style="font-style: italic">Compensation Committee.</span> Nasdaq rules require a listed company to have a compensation committee
        composed entirely of independent directors that operates pursuant to a written charter addressing its purpose, responsibilities and membership
        qualifications and may receive counselling from independent consultants, after evaluating their independence. The purpose, responsibilities
        and membership qualifications of our compensation committee are governed by the Companies Law, rather than the Nasdaq rules. In addition,
        under the Companies Law, there are no specific independence evaluation requirements for outside consultants<span style="font-style: italic">.</span></div>
        </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zb3d2953a65c644ff98d1affd9d5a96e3" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div><span style="font-style: italic">Compensation of Officers. </span>We comply with the requirements set forth under the Companies Law
        with respect to the approval of officer compensation. For a discussion regarding the approvals required under the Companies Law and the
        regulations promulgated thereunder for the approval of compensation of the chief executive officer, all other executive officers and directors,
        see &#8220;Item 6.C &#8211; Board Practices &#8211;Approval of Related Party Transactions and under Israeli Law&#8221;.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z06c4d0c6aafb40009638706cabff95da" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div><span style="font-style: italic">Proxy Statements</span>. We are not required to and, in reliance on home country practice, we do
        not intend to, comply with certain Nasdaq rules regarding the provision of proxy statements for general meetings of shareholders. Israeli
        corporate law does not have a regulatory regime for the solicitation of proxies. We intend to provide notice convening an annual general
        meeting, including an agenda and other relevant documents.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z320b730d1e6d480e9b68b770ce7b274d" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div><span style="font-style: italic">Shareholder Approval</span>. We are not required to and, in reliance on home country practice, we
        do not intend to comply with certain Nasdaq rules regarding shareholder approval for certain issuances of securities under Nasdaq Rule
        5635. Instead, we will seek our shareholders&#8217; approval for all corporate actions requiring such approval under the requirements
        of the Companies Law. In accordance with the provisions of our amended and restated articles of association and the Companies Law, our
        board of directors is authorized to issue securities, including ordinary shares, warrants and convertible notes.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z38e13a5d8a1d4bdabb7cbab1d66ffaab" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div><span style="font-style: italic">Executive Sessions</span>. We are not required to and, in reliance on home country practice, we
        do not intend to comply with certain Nasdaq rules regarding regularly scheduled meetings at which only independent directors are present.</div>
        </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z69e7f3a748124fe78bad5b82f4a86b1e" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div><span style="font-style: italic">Approval of Related Party Transactions.</span> All related party transactions are approved in accordance
        with the requirements and procedures for approval of interested party acts and transactions, set forth in the Companies Law and the regulations
        promulgated thereunder, which require the approval of the audit committee or the compensation committee, as the case may be, the board
        of directors and shareholders, as may be applicable, for specified transactions, rather than approval by the audit committee or other
        independent body of our Board of Directors as required under the Nasdaq rules.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z32412eadf25b4b5a85d93854c21490ce" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div><span style="font-style: italic">Third Party Director Compensation.</span> We follow Israeli law requirements with respect to disclosure
        of compensation for our directors and executive officers. Israeli law does not require that we disclose information regarding third party
        compensation of our directors or director nominees. As a result, our practice varies from the third-party compensation disclosure requirements
        of Nasdaq.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z2179b8d7187f41e092f0f5124f5ccb5b" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div><span style="font-style: italic">Annual Shareholders Meeting.</span> As opposed to the Nasdaq Rule 5620(a), which mandates that a
        listed company hold its annual shareholders meeting within one year of the company&#8217;s fiscal year-end, we are required, under the
        Companies Law, to hold an annual shareholder meeting each calendar year and within 15 months of the last annual shareholders meeting.</div>
        </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Other than as stated above, we currently intend to take all actions necessary for us
to maintain compliance as a foreign private issuer under the applicable corporate governance requirements of the Sarbanes-Oxley Act of
2002, the rules adopted by the SEC and Nasdaq&#8217;s listing standards.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">We may in the future elect to follow home country corporate governance practices in
Israel with regard to other matters. Following our home country governance practices, as opposed to the requirements that would otherwise
apply to a company listed on Nasdaq, may provide less protection than is accorded to investors under Nasdaq rules applicable to domestic
issuers.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold"><span id="ITEM16H"><!--Anchor--></span>ITEM 16H. MINE SAFETY DISCLOSURE</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Not applicable.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold"><span id="ITEM16I"><!--Anchor--></span>ITEM 16I. DISCLOSURE REGARDING FOREIGN JURISDICTIONS
THAT PREVENT INSPECTIONS</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">Not applicable.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">111</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25; font-weight: bold"><span id="ITEM16K"><!--Anchor--></span>ITEM 16K. CYBERSECURITY </div>

<div style="line-height: 1.25">

<div style="line-height: 1.25"><br/> </div>

<div style="line-height: 1.25">

<div style="line-height: 1.25">The Company has developed and maintained a cybersecurity risk management program, consisting of cybersecurity
policies, procedures, compliance and awareness programs to mitigate risk&#160;and to ensure compliance with security, availability and
confidentiality Trust principles, or SOC 2.&#160;The cybersecurity process has been integrated into the Company&#8217;s overall risk management
system and process, and is solely internally managed. Management is responsible for identifying risks that threaten achievement of the
control activities stated in the management&#8217;s description of the services organizations systems. Management has implemented a process
for identifying relevant risks that could affect the organization&#8217;s ability to provide secure and reliable service to its users.
The risk assessment occurs annually, or as business needs change, and covers identification of risks that could act against the company's
objectives as well as specific risks related to a compromise to the security of data.&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">The level of each identified risk is determined by considering the impact of the risk itself and the likelihood
of the risk materializing and high scoring risks are actioned upon. Risks are analyzed to determine whether the risk meets company risk
acceptance criteria to be accepted or whether a mitigation plan will be applied. Mitigation plans include both the individual or department
responsible for the plan and may include budget considerations.&#160;</div>

<div style="line-height: 1.25"><br/> </div> </div>

<div style="text-align: justify; line-height: 1.25">The oversight of cybersecurity threats is undertaken by Chief Information Officer
(CIO), who holds over 25 years of experience in information technology, and is supported by management. To facilitate its monitoring over
cybersecurity risks, the Company has engaged Chief Information Security Officer (CISO) who holds over 20 years of experience in information
technology in connection with its cybersecurity process.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">Our audit and investment committee is responsible for cybersecurity oversight and monitoring risk. Management
informs the audit and investment committee of such risk by committee meetings.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">As of the date of this report, we are not aware of any material risks from cybersecurity
threats that have materially affected or are reasonably likely to materially affect us, including our business strategy, results of operations
or financial condition.</div> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: center; line-height: 1.25; font-weight: bold"><span id="PARTIII"><!--Anchor--></span>PART III</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold"><span id="ITEM17"><!--Anchor--></span>ITEM 17. FINANCIAL STATEMENTS</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">The Registrant has responded to Item 18 in lieu of responding to this Item.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold"><span id="ITEM18"><!--Anchor--></span>ITEM 18. FINANCIAL STATEMENTS</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 18pt; line-height: 1.25">See the financial statements beginning on page F-1. The following financial statements
are filed as part of this Annual Report on Form 20-F together with the report of the independent registered public accounting firm.</div>

<div style="line-height: 1.25"><br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">112</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold"><span id="ITEM19"><!--Anchor--></span>ITEM 19. EXHIBITS</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" border="0" id="z56babd9a84184a34a79ecce8924b6335" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="border-bottom: rgb(0, 0, 0) 2px solid; width: 8%; vertical-align: top">
        <div style="line-height: 1.25; font-weight: bold">Exhibit No.</div> </td>
    <td style="width: 2%; vertical-align: top"><br/> </td>
    <td style="border-bottom: rgb(0, 0, 0) 2px solid; width: 90%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Description</div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1742692/000114420419039228/tv527433_ex3-1.htm">1.1</a></div>
        </td>
    <td style="width: 2%; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1742692/000114420419039228/tv527433_ex3-1.htm"><br/>
        </a> </td>
    <td style="width: 90%; vertical-align: top">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1742692/000114420419039228/tv527433_ex3-1.htm">Amended
        and Restated Articles of Association of InMode Ltd. (incorporated herein by reference to Exhibit 3.1 to Form 6-K filed with the SEC on
        August 12, 2019).</a></div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1742692/000114420419034453/tv524581-f1.htm">2.1</a></div>
        </td>
    <td style="width: 2%; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1742692/000114420419034453/tv524581-f1.htm"><br/>
        </a> </td>
    <td style="width: 90%; vertical-align: top">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1742692/000114420419034453/tv524581-f1.htm">Description
        of Share Capital (incorporated herein by reference to the Company&#8217;s Registration Statement on Form F-1 (File No. 333-232615) filed
        with the SEC on July 11, 2019).</a></div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1742692/000114420419034453/tv524581_ex10-1.htm">4.1</a></div>
        </td>
    <td style="width: 2%; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1742692/000114420419034453/tv524581_ex10-1.htm"><br/>
        </a> </td>
    <td style="width: 90%; vertical-align: top">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1742692/000114420419034453/tv524581_ex10-1.htm">Invasix
        Ltd. 2008 ROW Option Plan (incorporated herein by reference to Exhibit 10.1 to the Company&#8217;s Registration Statement on Form F-1
        (File No. 333-232615) filed with the SEC on July 11, 2019).</a></div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1742692/000114420419034453/tv524581_ex10-2.htm">4.2</a></div>
        </td>
    <td style="width: 2%; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1742692/000114420419034453/tv524581_ex10-2.htm"><br/>
        </a> </td>
    <td style="width: 90%; vertical-align: top">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1742692/000114420419034453/tv524581_ex10-2.htm">Invasix
        Ltd. 2008 Israeli Option Plan (English translation) (incorporated herein by reference to Exhibit 10.2 to the Company&#8217;s Registration
        Statement on Form F-1 (File No. 333-232615) filed with the SEC on July 11, 2019).</a></div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1742692/000114420419034453/tv524581_ex10-3.htm">4.3</a></div>
        </td>
    <td style="width: 2%; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1742692/000114420419034453/tv524581_ex10-3.htm"><br/>
        </a> </td>
    <td style="width: 90%; vertical-align: top">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1742692/000114420419034453/tv524581_ex10-3.htm">InMode
        Ltd. 2018 Incentive Plan (incorporated herein by reference to Exhibit 10.3 to Amendment No. 1 to the Company&#8217;s Registration Statement
        on Form F-1 (File No. 333-232615) filed with the SEC on July 29, 2019).</a></div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1742692/000117891322000512/exhibit_4-4.htm">4.4</a></div>
        </td>
    <td style="width: 2%; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1742692/000117891322000512/exhibit_4-4.htm"><br/>
        </a> </td>
    <td style="width: 90%; vertical-align: top">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1742692/000117891322000512/exhibit_4-4.htm">InMode Ltd.
        2018 Incentive Plan Form of RSUs Award Grant Notice &amp; RSUs Award Agreement for Israeli Participants (incorporated herein by reference
        to Exhibit 4.5 to the Company&#8217;s Registration Statement on Form F-1 (File No. 001-39016) filed with the SEC on February 14, 2023).</a></div>
        </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1742692/000117891322000512/exhibit_4-5.htm">4.5</a></div>
        </td>
    <td style="width: 2%; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1742692/000117891322000512/exhibit_4-5.htm"><br/>
        </a> </td>
    <td style="width: 90%; vertical-align: top">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1742692/000117891322000512/exhibit_4-5.htm">InMode Ltd.
        2018 Incentive Plan Form of RSUs Award Grant Notice &amp; RSUs Award Agreement for Non-Israeli Participants (incorporated herein by reference
        to Exhibit 4.5 to the Company&#8217;s Registration Statement on Form F-1 (File No. 001-39016) filed with the SEC on February 14, 2023).</a></div>
        </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1742692/000114420419034453/tv524581_ex10-4.htm">4.6</a></div>
        </td>
    <td style="width: 2%; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1742692/000114420419034453/tv524581_ex10-4.htm"><br/>
        </a> </td>
    <td style="width: 90%; vertical-align: top">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1742692/000114420419034453/tv524581_ex10-4.htm">Form of
        Indemnification Agreement (incorporated herein by reference to Exhibit 10.4 to the Company&#8217;s Registration Statement on Form F-1
        (File No. 333-232615) filed with the SEC on July 11, 2019).</a></div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="line-height: 1.25"><a href="exhibit_4-7.htm">4.7</a></div> </td>
    <td style="width: 2%; vertical-align: top"><a href="exhibit_4-7.htm"><br/> </a> </td>
    <td style="width: 90%; vertical-align: top">
        <div style="line-height: 1.25"><a href="exhibit_4-7.htm">Consultancy Agreement, dated August 1, 2018, by and between InMode Ltd. and Mr.
        Moshe Mizrahy (incorporated herein by reference to Exhibit 10.5 to the Company&#8217;s Registration Statement on Form F-1 (File No. 333-232615)
        filed with the SEC on July 11, 2019). First Addendum to Consultancy Agreement, dated January 1, 2023, by and between InMode Ltd. and Mr.
        Moshe Mizrahy (filed herewith).</a></div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="line-height: 1.25"><a href="exhibit_4-8.htm">4.8</a></div> </td>
    <td style="width: 2%; vertical-align: top"><a href="exhibit_4-8.htm"><br/> </a> </td>
    <td style="width: 90%; vertical-align: top">
        <div style="line-height: 1.25"><a href="exhibit_4-8.htm">Employment Agreement, dated July 1, 2017, by and between Invasix Corp. and Dr.
        Michael Kreindel (incorporated herein by reference to Exhibit 10.6 to the Company&#8217;s Registration Statement on Form F-1 (File No.
        333-232615) filed with the SEC on July 11, 2019). First Addendum to Employment Agreement, dated January 1, 2023, by and between Invasix
        Corp. and Dr. Michael Kreindel (filed herewith).</a></div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1742692/000114420419034453/tv524581_ex10-7.htm">4.9</a></div>
        </td>
    <td style="width: 2%; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1742692/000114420419034453/tv524581_ex10-7.htm"><br/>
        </a> </td>
    <td style="width: 90%; vertical-align: top">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1742692/000114420419034453/tv524581_ex10-7.htm">Form of
        Option Award for Israeli Employees, Officers and Directors and Form of Option Award for Consultants, Service Providers and Non-Israeli
        Employees, Officers and Directors (incorporated herein by reference to Exhibit 10.7 to the Company&#8217;s Registration Statement on Form
        F-1 (File No. 333-232615) filed with the SEC on July 11, 2019).</a></div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1742692/000114420419034453/tv524581_ex10-9.htm">4.10</a></div>
        </td>
    <td style="width: 2%; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1742692/000114420419034453/tv524581_ex10-9.htm"><br/>
        </a> </td>
    <td style="width: 90%; vertical-align: top">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1742692/000114420419034453/tv524581_ex10-9.htm">Turn-Key
        Manufacturing Agreement, dated April 1, 2011, by and between Invasix Ltd. and Flextronics Israel Ltd. (incorporated herein by reference
        to Exhibit 10.9 to Amendment No. 1 to the Company&#8217;s Registration Statement on Form F-1 (File No. 333&#172;232615) filed with the
        SEC on July 29, 2019).</a></div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1742692/000114420419034453/tv524581_ex10-10.htm">4.11</a></div>
        </td>
    <td style="width: 2%; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1742692/000114420419034453/tv524581_ex10-10.htm"><br/>
        </a> </td>
    <td style="width: 90%; vertical-align: top">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1742692/000114420419034453/tv524581_ex10-10.htm">Turn-Key
        Manufacturing Agreement, dated November 7, 2013, by and between Invasix Ltd. and STI Laser Industries Ltd. (incorporated herein by reference
        to Exhibit 10.10 to Amendment No. 1 to the Company&#8217;s Registration Statement on Form F-1 (File No. 333-232615) filed with the SEC
        on July 29, 2019).</a></div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1742692/000117891322000512/exhibit_4-12.htm">4.12</a></div>
        </td>
    <td style="width: 2%; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1742692/000117891322000512/exhibit_4-12.htm"><br/>
        </a> </td>
    <td style="width: 90%; vertical-align: top">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1742692/000117891322000512/exhibit_4-12.htm">Turn-Key
        Manufacturing Agreement, dated October 2, 2019, by and between InMode Ltd. and B.Y. Medimor Ltd. (incorporated herein by reference to
        Exhibit 4.12 to the Company&#8217;s Annual Report on Form 20-F (File No. 001-39016) filed with the SEC on February 10, 2022).</a></div>
        </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="line-height: 1.25"><a href="exhibit_4-13.htm">4.13</a></div> </td>
    <td style="width: 2%; vertical-align: top"><a href="exhibit_4-13.htm"><br/> </a> </td>
    <td style="width: 90%; vertical-align: top">
        <div style="line-height: 1.25">
        <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: Times New Roman,serif"><a href="exhibit_4-13.htm">Lease Agreement, dated
        April 16, 2018, by and between Sha&#8217;ar Yokneam Limited Partnership and InMode Ltd. (English translation). Supplemental Lease Agreement,
        dated January 13, 2019, by and between Sha&#8217;ar Yokneam Limited Partnership and InMode Ltd. (English translation) (incorporated herein
        by reference to Exhibit 10.11 to the Company&#8217;s Registration Statement on Form F-1 (File No. 333-232615) filed with the SEC on July
        11, 2019). Second Supplemental Lease Agreement, dated February 16, 2020, by and between Sha&#8217;ar Yokneam Limited Partnership and InMode
        Ltd. (English translation) (incorporated herein by reference to Exhibit 4.10 to the Company&#8217;s Annual Report on Form 20-F (File No.
        001-39016) filed with the SEC on February 10, 2021). Third Supplemental Lease Agreement, dated March 4, 2021, by and between Sha&#8217;ar
        Yokneam Limited Partnership and InMode Ltd. (English translation) (incorporated herein by reference to Exhibit 4.13 to the Company&#8217;s
        Annual Report on Form 20-F (File No. 001-39016) filed with the SEC on February 10, 2022). Fourth Supplemental Lease Agreement, dated March
        9, 2023, by and between Sha&#8217;ar Yokneam Limited Partnership and InMode Ltd. (English translation) (filed herewith). Fifth Supplemental
        Lease Agreement, dated May 8, 2023, by and between Sha&#8217;ar Yokneam Limited Partnership and InMode Ltd. (English translation) (filed
        herewith).</a></div> </div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1742692/000114420419034453/tv524581_ex10-12.htm">4.14</a></div>
        </td>
    <td style="width: 2%; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1742692/000114420419034453/tv524581_ex10-12.htm"><br/>
        </a> </td>
    <td style="width: 90%; vertical-align: top">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1742692/000114420419034453/tv524581_ex10-12.htm">Founders
        Memorandum of Understanding dated March 4, 2014, by and between Invasix Ltd. and Wigmore Medical Limited (incorporated herein by reference
        to Exhibit 10.12 to the Company&#8217;s Registration Statement on Form F-1 (File No. 333-232615) filed with the SEC on July 11, 2019).</a></div>
        </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1742692/000117891321000406/exhibit_4-12.htm">4.15</a></div>
        </td>
    <td style="width: 2%; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1742692/000117891321000406/exhibit_4-12.htm"><br/>
        </a> </td>
    <td style="width: 90%; vertical-align: top">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1742692/000117891321000406/exhibit_4-12.htm">Amended and
        Restated Compensation Policy dated April 2, 2020 (incorporated herein by reference to Exhibit 4.12 to the Company&#8217;s Annual Report
        on Form 20-F (File No. 001-39016) filed with the SEC on February 10, 2021).</a></div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1742692/000117891320003105/exhibit_10-1.htm">4.16</a></div>
        </td>
    <td style="width: 2%; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1742692/000117891320003105/exhibit_10-1.htm"><br/>
        </a> </td>
    <td style="width: 90%; vertical-align: top">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1742692/000117891320003105/exhibit_10-1.htm">Share Exchange
        Agreement, dated November 11, 2020, by and between the Company, Guangzhou Sino-Israel Bio-Industry Investment Fund (LLP) and Guangzhou
        InMode Medical Technology Ltd. (incorporated herein by reference to Exhibit 10.1 to Form 6-K filed with the SEC on November 12, 2020).</a></div>
        </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1742692/000117891321001448/exhibit_10-1.htm">4.17</a></div>
        </td>
    <td style="width: 2%; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1742692/000117891321001448/exhibit_10-1.htm"><br/>
        </a> </td>
    <td style="width: 90%; vertical-align: top">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1742692/000117891321001448/exhibit_10-1.htm">Share Exchange
        Agreement, dated April 23, 2021, by and between the Company, Dilazar Limited, Wigmore Medical Limited and Invasix UK Limited (incorporated
        herein by reference to Exhibit 10.1 to Form 6-K (File No. 001-39016) filed with the SEC on April 26, 2021).</a></div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="line-height: 1.25"><a href="exhibit_8-1.htm">8.1</a></div> </td>
    <td style="width: 2%; vertical-align: top"><a href="exhibit_8-1.htm"><br/> </a> </td>
    <td style="width: 90%; vertical-align: top">
        <div style="line-height: 1.25">
        <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: Times New Roman,serif"><a href="exhibit_8-1.htm">List of Subsidiaries
        (filed herewith).</a></div> </div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="line-height: 1.25"><a href="exhibit_12-1.htm">12.1</a></div> </td>
    <td style="width: 2%; vertical-align: top"><a href="exhibit_12-1.htm"><br/> </a> </td>
    <td style="width: 90%; vertical-align: top">
        <div style="line-height: 1.25"><a href="exhibit_12-1.htm">Certification of the Chief Executive Officer required by Rule 13a-14(a) or Rule
        15d-14(a) of the Securities Exchange Act of 1934, as amended (filed herein).</a></div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="line-height: 1.25"><a href="exhibit_12-2.htm">12.2</a></div> </td>
    <td style="width: 2%; vertical-align: top"><a href="exhibit_12-2.htm"><br/> </a> </td>
    <td style="width: 90%; vertical-align: top">
        <div style="line-height: 1.25"><a href="exhibit_12-2.htm">Certification of the Chief Financial Officer required by Rule 13a-14(a) or Rule
        15d-14(a) of the Securities Exchange Act of 1934, as amended(filed herein). (filed herein).</a></div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="line-height: 1.25"><a href="exhibit_13-1.htm">13.1</a></div> </td>
    <td style="width: 2%; vertical-align: top"><a href="exhibit_13-1.htm"><br/> </a> </td>
    <td style="width: 90%; vertical-align: top">
        <div style="line-height: 1.25"><a href="exhibit_13-1.htm">Certification of the Chief Executive Officer Pursuant to Section 906 of the
        Sarbanes-Oxley Act of 2002 ((filed herein)</a></div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="line-height: 1.25"><a href="exhibit_13-2.htm">13.2</a></div> </td>
    <td style="width: 2%; vertical-align: top"><a href="exhibit_13-2.htm"><br/> </a> </td>
    <td style="width: 90%; vertical-align: top">
        <div style="line-height: 1.25"><a href="exhibit_13-2.htm">Certification of the Chief Financial Officer Pursuant to Section 906 of the
        Sarbanes-Oxley Act of 2002 ((filed herein)).</a></div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="line-height: 1.25"><a href="exhibit_15-1.htm">15.1</a></div> </td>
    <td style="width: 2%; vertical-align: top"><a href="exhibit_15-1.htm"><br/> </a> </td>
    <td style="width: 90%; vertical-align: top">
        <div style="line-height: 1.25"><a href="exhibit_15-1.htm">Consent of Kesselman&#160;&amp; Kesselman, an independent registered public
        accounting firm in Israel and a member of PricewaterhouseCoopers International Limited (&#8220;PwC&#8221;).</a></div> </td> </tr>
  <tr>
    <td rowspan="1" style="width: 8%; vertical-align: top"><a href="exhibit_97.htm">97</a></td>
    <td rowspan="1" style="width: 2%; vertical-align: top"><a href="exhibit_97.htm"><br/> </a> </td>
    <td rowspan="1" style="width: 90%; vertical-align: top">
        <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: Times New Roman,serif"><a href="exhibit_97.htm">InMode Lt. Clawback Policy,
        adopted November 1, 2023.</a></div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-weight: bold">&#160; &#160;
&#160;&#160; </span><br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">113</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: center; line-height: 1.25; font-weight: bold"><span id="SIGNATURES"><!--Anchor--></span>SIGNATURES</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">The Registrant hereby certifies that it meets all of the requirements for filing on Form 20-F and that
it has duly caused and authorized the undersigned to sign this annual report on its behalf.</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zef4ec2f0aada4ca8a7e517a8570b275a" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 50%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td colspan="2" style="vertical-align: top">
        <div style="line-height: 1.25">INMODE LTD.</div> </td>
    <td colspan="1" style="width: 20%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="width: 50%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 27%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td colspan="1" style="width: 20%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="width: 50%; vertical-align: top; padding-bottom: 2px">&#160;</td>
    <td style="width: 3%; vertical-align: top; padding-bottom: 2px">
        <div style="line-height: 1.25">By:</div> </td>
    <td style="border-bottom: rgb(0, 0, 0) 2px solid; width: 27%; vertical-align: top">
        <div style="line-height: 1.25">/s/ Yair Malca</div> </td>
    <td colspan="1" style="width: 20%; vertical-align: top; padding-bottom: 2px">&#160;</td> </tr>
  <tr>
    <td style="width: 50%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 27%; vertical-align: top">
        <div style="line-height: 1.25">Yair Malca</div> </td>
    <td colspan="1" style="width: 20%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="width: 50%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 3%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 27%; vertical-align: top">
        <div style="line-height: 1.25">Chief Financial Officer</div> </td>
    <td colspan="1" style="width: 20%; vertical-align: top">&#160;</td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">Date: February 13, 2024</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">114</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div> <br/> </div> </div> <br/> <br/>
<!-- Field: /Include-Text -->
&#160;</div>
    </div>
  </div>
</div><div style="">
  <div>
    <div>
      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">INMODE LTD.</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CONSOLIDATED FINANCIAL STATEMENTS</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">INDEX TO FINANCIAL STATEMENTS:</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

          <tr>
            <td style="width:91.98%;vertical-align:top">&#160;</td>
            <td style="width:8.02%;vertical-align:top">
              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Page</span></span></div>
            </td>
          </tr>
          <tr>
            <td style="width:91.98%;vertical-align:middle">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="#ReportofIndependentRegist_integixAnchor"><span style="font-weight:bold">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM </span>(PCAOB name: Kesselman &amp; Kesselman C.P.A.s and PCAOB ID <ix:nonNumeric id="Fxbrl_20240205135253296" name="dei:AuditorFirmId" contextRef="C_20230101to20231231">1309</ix:nonNumeric>)</a></span></span></div>
            </td>
            <td style="width:8.02%;vertical-align:top">
              <div style="text-align:center;line-height:1.25"><br/><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">F-2</span></span></div>
            </td>
          </tr>
          <tr>
            <td style="width:91.98%;vertical-align:top">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CONSOLIDATED FINANCIAL STATEMENTS:</span></span></div>
            </td>
            <td style="width:8.02%;vertical-align:top">&#160;</td>
          </tr>
          <tr>
            <td style="width:91.98%;vertical-align:top">
              <div style="text-indent:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="#CONSOLIDATEDBALANCESHEETS_integixAnchor">Consolidated Balance Sheets</a></span></span></div>
            </td>
            <td style="width:8.02%;vertical-align:top">
              <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">F-4</span></span></div>
            </td>
          </tr>
          <tr>
            <td style="width:91.98%;vertical-align:top">
              <div style="text-indent:-14.85pt;margin-left:28.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="#STATEMENTSOFINCOME_integixAnchor">Consolidated Statements of Income</a></span></span></div>
            </td>
            <td style="width:8.02%;vertical-align:top">
              <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">F-5</span></span></div>
            </td>
          </tr>
          <tr>
            <td style="width:91.98%;vertical-align:top">
              <div style="text-indent:-14.85pt;margin-left:28.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="#COMPREHENSIVEINCOME_integixAnchor">Consolidated Statements of Comprehensive Income</a></span></span></div>
            </td>
            <td style="width:8.02%;vertical-align:top">
              <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">F-6</span></span></div>
            </td>
          </tr>
          <tr>
            <td style="width:91.98%;vertical-align:top">
              <div style="text-indent:-14.85pt;margin-left:28.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="#CHANGESINSHAREHOLDERSEQUI_integixAnchor">Consolidated Statements of Changes in Shareholders&#8217; Equity</a></span></span></div>
            </td>
            <td style="width:8.02%;vertical-align:top">
              <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">F-7</span></span></div>
            </td>
          </tr>
          <tr>
            <td style="width:91.98%;vertical-align:top">
              <div style="text-indent:-14.85pt;margin-left:28.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="#CASHFLOWS_integixAnchor">Consolidated Statements of Cash Flows</a></span></span></div>
            </td>
            <td style="width:8.02%;vertical-align:top">
              <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">F-8</span></span></div>
            </td>
          </tr>
          <tr>
            <td style="width:91.98%;vertical-align:top">
              <div style="text-indent:-26.2pt;margin-left:39.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="#NOTESTOCONSOLIDATEDFINANC_integixAnchor">Notes to Consolidated Financial Statements</a></span></span></div>
            </td>
            <td style="width:8.02%;vertical-align:top">
              <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">F-9</span></span></div>
            </td>
          </tr>
          <tr>
            <td style="width:91.98%;vertical-align:top">&#160;</td>
            <td style="width:8.02%;vertical-align:top">&#160;</td>
          </tr>

      </table>
      <div style="line-height:1.25">&#160;</div>
      <div style="clear:both;margin-top:10pt;margin-bottom:10pt">
        <div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000;font-weight:normal;font-style:normal">F-1</span></span></span></div>
        <div style="page-break-after:always">
          <hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000"/>
        </div>
      </div>
      <div>
        <div style="line-height:1.25"><img alt="image0.jpg" src="inmd_img01.jpg" style="width:141px;height:119px"/></div>
      </div>
      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span id="ReportofIndependentRegist_integixAnchor"></span>Report of Independent Registered Public Accounting Firm</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">To the Board of Directors and Shareholders of InMode Ltd.</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Opinions on the Financial Statements and Internal Control over Financial Reporting</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">We have audited the accompanying consolidated balance sheets of InMode Ltd. and its subsidiaries (the &#8220;Company&#8221;) as of December 31, 2023 and 2022, and the related consolidated statements of income, comprehensive income, changes in shareholders&#8217; equity and cash flows for each of the three years in the period ended December 31, 2023, including the related notes (collectively referred to as the &#8220;consolidated financial statements&#8221;). We also have audited the Company's internal control over financial reporting as of December 31, 2023, based on criteria established in <span style="font-style:italic">Internal Control - Integrated Framework</span> (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In our opinion, the consolidated<span style="font-weight:bold">&#160;</span>financial statements referred to above present fairly, in all material respects, the financial position of the Company as of December 31, 2023 and 2022, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2023 in conformity with accounting principles generally accepted in the United States of America. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2023, based on criteria established in <span style="font-style:italic">Internal Control - Integrated Framework</span> (2013) issued by the COSO.</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Basis for Opinions</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company's management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in Management's Annual Report on Internal Control over Financial Reporting appearing under Item 15.<span style="font-weight:bold">&#160;</span>Our responsibility is to express opinions on the Company&#8217;s consolidated<span style="font-weight:bold">&#160;</span>financial statements and on the Company's internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated<span style="font-weight:bold">&#160;</span>financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Our audits of the consolidated<span style="font-weight:bold">&#160;</span>financial statements included performing procedures to assess the risks of material misstatement of the consolidated<span style="font-weight:bold">&#160;</span>financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated<span style="font-weight:bold">&#160;</span>financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated<span style="font-weight:bold">&#160;</span>financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.</span></span></div>
      <div style="text-align:justify;line-height:1.25">&#160;</div>
      <div style="text-align:justify;line-height:1.25">
        <table border="0" cellpadding="0" cellspacing="0" style="border-top:1px dashed;width:100%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt">

            <tr>
              <td style="width:100.00%">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Kesselman &amp; Kesselman, 146 Derech Menachem Begin, Tel-Aviv 6492103, Israel,</span></span>
                  <div style="text-align:left;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">P.O Box 7187 Tel-Aviv 6107120, Telephone: +972 -3- 7954555, Fax:+972 -3- 7954556, www.pwc.com/il</span></span></div>
                </div>
              </td>
            </tr>

        </table>
      </div>
      <div>&#160;<div style="clear:both;margin-top:10pt;margin-bottom:10pt">
          <div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000;font-weight:normal;font-style:normal">F-2</span></span></span></div>
          <div style="page-break-after:always">
            <hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000"/>
          </div>
        </div>
      </div>
      <div>
        <div style="line-height:1.25"><img alt="image0.jpg" src="inmd_img01.jpg" style="width:141px;height:119px"/></div>
      </div>
      <div style="line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Definition and Limitations of Internal Control over Financial Reporting</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Critical Audit Matters</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Critical audit matters are matters arising from the current period audit of the consolidated financial statements that were communicated or required to be communicated to the audit committee and that (i) relate to accounts or disclosures that are material to the consolidated financial statements and (ii) involved our especially challenging, subjective, or complex judgments. We determined there are no critical audit matters.</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

          <tr>
            <td style="width:100%;vertical-align:top">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">/s/<ix:nonNumeric id="Fxbrl_20230214000712999" name="dei:AuditorName" contextRef="C_20230101to20231231">Kesselman &amp; Kesselman</ix:nonNumeric></span></span></div>
            </td>
          </tr>
          <tr>
            <td style="width:100%;vertical-align:top">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Certified Public Accountants (lsr.)</span></span></div>
            </td>
          </tr>
          <tr>
            <td style="width:100%;vertical-align:top">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">A member firm of PricewaterhouseCoopers International Limited</span></span></div>
            </td>
          </tr>

      </table>
      <div style="line-height:1.25">&#160;</div>
      <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

          <tr>
            <td style="width:100%;vertical-align:top">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20220610114750884" name="dei:AuditorLocation" contextRef="C_20230101to20231231">Tel-Aviv, Israel</ix:nonNumeric></span></span></div>
            </td>
          </tr>
          <tr>
            <td style="width:100%;vertical-align:top">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">February 13, 2024</span></span></div>
            </td>
          </tr>

      </table>
      <div style="line-height:1.25">&#160;</div>
      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">We have served as the Company&#8217;s auditor since 2008.</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="clear:both;margin-top:10pt;margin-bottom:10pt">
        <div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000;font-weight:normal;font-style:normal">F-3</span></span></span></div>
        <div style="page-break-after:always">
          <hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000"/>
        </div>
      </div>
      <div>
        <div style="line-height:1.25">&#160;</div>
      </div>
    </div>
  </div>
</div><div style="">
  <div>
    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">INMODE LTD.</span></span></div>
    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span id="CONSOLIDATEDBALANCESHEETS_integixAnchor"></span> CONSOLIDATED BALANCE SHEETS</span></span></div>
    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(U.S. dollars in thousands, except for per share data)</span></span></div>
    <div style="line-height:1.25">&#160;</div>
    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;color:#000000;width:100%">

        <tr>
          <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="6" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
            <div style="line-height:1.25">
              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31</span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
            <div style="line-height:1.25">
              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
            <div style="line-height:1.25">
              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Assets</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">CURRENT ASSETS</span>:</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:top;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="margin-left:13.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash and cash equivalents</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_42" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">144,411</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_43" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">97,540</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
            <div style="margin-left:13.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Marketable securities (amortized cost of $<ix:nonFraction id="FFact_44" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">375,829</ix:nonFraction> and $<ix:nonFraction id="FFact_45" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">384,320</ix:nonFraction>, as of December 31, 2023 and 2022, respectively)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_46" name="us-gaap:MarketableSecuritiesCurrent" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">373,647</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_47" name="us-gaap:MarketableSecuritiesCurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">374,589</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="margin-left:13.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Short-term bank deposits</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_48" name="us-gaap:DepositsAssetsCurrent" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">223,547</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_49" name="us-gaap:DepositsAssetsCurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">75,254</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
            <div style="margin-left:13.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Accounts receivable, net of allowance for credit losses of $<ix:nonFraction id="Fxbrl_20230210021911691" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,538</ix:nonFraction> and $<ix:nonFraction id="Fxbrl_20230210021933434" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">836</ix:nonFraction>, as of December 31, 2023 and 2022, respectively</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_52" name="us-gaap:AccountsReceivableNetCurrent" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">42,362</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_53" name="us-gaap:AccountsReceivableNetCurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">26,997</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="margin-left:13.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Prepaid expense and other receivables</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_54" name="us-gaap:OtherReceivablesNetCurrent" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">16,268</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_55" name="us-gaap:OtherReceivablesNetCurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,094</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:76%;padding-bottom:2px;vertical-align:bottom">
            <div style="margin-left:13.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Inventories</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_56" name="us-gaap:InventoryNet" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">45,095</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_57" name="us-gaap:InventoryNet" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">39,897</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">TOTAL CURRENT ASSETS</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_58" name="us-gaap:AssetsCurrent" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">845,330</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_59" name="us-gaap:AssetsCurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">629,371</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NON-CURRENT ASSETS:</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="margin-left:13.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Accounts receivable net of allowance for credit losses of $<ix:nonFraction id="Fxbrl_20230210023555792" name="us-gaap:AllowanceForDoubtfulAccountsReceivableNoncurrent" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">716</ix:nonFraction> and $<ix:nonFraction id="Fxbrl_20230210023633859" name="us-gaap:AllowanceForDoubtfulAccountsReceivableNoncurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">482</ix:nonFraction> as of December 31, 2023 and 2022, respectively</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_60" name="us-gaap:AccountsReceivableNetNoncurrent" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,670</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_61" name="us-gaap:AccountsReceivableNetNoncurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,973</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:76%;vertical-align:bottom">
            <div style="margin-left:13.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred income tax assets</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_64" name="us-gaap:DeferredIncomeTaxAssetsNet" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,506</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_65" name="us-gaap:DeferredIncomeTaxAssetsNet" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,094</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="margin-left:13.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Operating lease right-of-use assets</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_66" name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,698</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_67" name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,073</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
            <div style="margin-left:13.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Property and equipment, net</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_68" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,382</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_69" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,298</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="margin-left:13.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other investments</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_70" name="us-gaap:OtherInvestments" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">700</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_71" name="us-gaap:OtherInvestments" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">600</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:76%;padding-bottom:2px;vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">TOTAL NON-CURRENT ASSETS</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_72" name="us-gaap:AssetsNoncurrent" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">17,956</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_73" name="us-gaap:AssetsNoncurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,038</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">TOTAL ASSETS</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_74" name="us-gaap:Assets" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">863,286</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_75" name="us-gaap:Assets" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">644,409</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:76%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Liabilities and shareholders&#8217; equity</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:76%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">CURRENT LIABILITIES</span>:</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-indent:-13.65pt;margin-left:28.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Accounts payable</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_76" name="us-gaap:AccountsPayableCurrent" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,966</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_77" name="us-gaap:AccountsPayableCurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">16,242</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:76%;vertical-align:bottom">
            <div style="text-indent:-15.9pt;margin-left:30.1pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Contract liabilities</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_78" name="us-gaap:ContractWithCustomerLiabilityCurrent" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,923</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_79" name="us-gaap:ContractWithCustomerLiabilityCurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,798</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-indent:-15.9pt;margin-left:30.1pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other liabilities</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_80" name="us-gaap:OtherLiabilitiesCurrent" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">39,247</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_81" name="us-gaap:OtherLiabilitiesCurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">51,980</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:76%;vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">TOTAL CURRENT LIABILITIES</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_82" name="us-gaap:LiabilitiesCurrent" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">64,136</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_83" name="us-gaap:LiabilitiesCurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">82,020</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">NON-CURRENT LIABILITIES</span>:</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:76%;vertical-align:bottom">
            <div style="text-indent:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Contract liabilities</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_84" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,766</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_85" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,959</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-indent:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other liabilities</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_86" name="us-gaap:OtherLiabilitiesNoncurrent" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,399</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_87" name="us-gaap:OtherLiabilitiesNoncurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">303</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
            <div style="text-indent:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Operating lease liabilities</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_88" name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,613</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_89" name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,509</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-indent:-15.95pt;margin-left:15.95pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">TOTAL NON-CURRENT LIABILITIES</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_90" name="us-gaap:LiabilitiesNoncurrent" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,778</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_91" name="us-gaap:LiabilitiesNoncurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,771</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
            <div style="text-indent:-15.95pt;margin-left:15.95pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">TOTAL LIABILITIES</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_92" name="us-gaap:Liabilities" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">75,914</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_93" name="us-gaap:Liabilities" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">89,791</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:76%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">COMMITMENTS AND CONTINGENCIES </span>(note 11)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"><ix:nonFraction id="Fxbrl_20240205172103830" name="us-gaap:CommitmentsAndContingencies" contextRef="C_20231231" unitRef="USD" xsi:nil="true"></ix:nonFraction></td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"><ix:nonFraction id="Fxbrl_20240205172223101" name="us-gaap:CommitmentsAndContingencies" contextRef="C_20221231" unitRef="USD" xsi:nil="true"></ix:nonFraction></td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:76%;vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">SHAREHOLDERS&#8217; EQUITY:</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-indent:-21.95pt;margin-left:50.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Ordinary shares, NIS <ix:nonFraction id="Fxbrl_20230120140150676" name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="C_20221231" unitRef="ILS_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20230120140145108" name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="C_20231231" unitRef="ILS_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">0.01</ix:nonFraction></ix:nonFraction> par value, authorized <ix:nonFraction id="Fxbrl_20230119233138679" name="us-gaap:CommonStockSharesAuthorized" contextRef="C_20221231" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="FFact_97" name="us-gaap:CommonStockSharesAuthorized" contextRef="C_20231231" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">100,000,000</ix:nonFraction></ix:nonFraction> shares at December 31, 2023 and 2022 Issued <ix:nonFraction id="FFact_98" name="us-gaap:CommonStockSharesIssued" contextRef="C_20231231" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">85,957,465</ix:nonFraction> and <ix:nonFraction id="FFact_99" name="us-gaap:CommonStockSharesIssued" contextRef="C_20221231" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">84,519,994</ix:nonFraction> shares at December 31, 2023 and 2022, respectively Outstanding <ix:nonFraction id="FFact_100" name="us-gaap:CommonStockSharesOutstanding" contextRef="C_20231231" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">83,982,462</ix:nonFraction> and <ix:nonFraction id="FFact_101" name="us-gaap:CommonStockSharesOutstanding" contextRef="C_20221231" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">82,544,991</ix:nonFraction> shares at December 31, 2023 and 2022, respectively</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_102" name="us-gaap:CommonStockValue" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">245</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_103" name="us-gaap:CommonStockValue" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">241</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:76%;vertical-align:bottom">
            <div style="text-indent:-21.95pt;margin-left:50.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Additional paid-in capital</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_104" name="us-gaap:AdditionalPaidInCapitalCommonStock" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">177,820</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_105" name="us-gaap:AdditionalPaidInCapitalCommonStock" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">148,803</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-indent:-21.95pt;margin-left:50.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Retained earnings</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_106" name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">693,426</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_107" name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">495,507</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:76%;vertical-align:bottom">
            <div style="text-indent:-21.95pt;margin-left:50.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Accumulated other comprehensive loss</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_108" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1,679</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_109" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">7,493</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-indent:-21.95pt;margin-left:50.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Less treasury shares, at cost: <ix:nonFraction id="FFact_110" name="us-gaap:TreasuryStockCommonShares" contextRef="C_20231231" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">1,975,003</ix:nonFraction> and <ix:nonFraction id="FFact_111" name="us-gaap:TreasuryStockCommonShares" contextRef="C_20221231" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">1,975,003</ix:nonFraction> ordinary shares at December 31, 2023 and 2022, respectively</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_112" name="us-gaap:TreasuryStockValue" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">82,440</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_113" name="us-gaap:TreasuryStockValue" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">82,440</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">TOTAL SHAREHOLDERS&#8217; EQUITY</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_118" name="us-gaap:StockholdersEquity" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">787,372</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_119" name="us-gaap:StockholdersEquity" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">554,618</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">TOTAL LIABILITIES AND SHAREHOLDERS&#8217; EQUITY</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_120" name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">863,286</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_121" name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">644,409</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>

    </table>
    <div style="line-height:1.25">&#160;</div>
    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The accompanying notes are an integral part of these consolidated financial statements</span></span></div>
  </div>
  <p style="margin:0pt">&#160;</p>
  <div><p style="margin-top:10pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:107%;color:black">F-4</span></span></span></p></div><hr style="border-top:1.5pt solid #000000;page-break-after:always;margin-top:4pt;margin-bottom:10pt"/><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left">&#160;</p>
</div><div style="">
  <div>
    <div>
      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">INMODE LTD.</span></span></div>
      <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CONSOLIDATED STATEMENTS OF INCOME<span id="STATEMENTSOFINCOME_integixAnchor"></span></span></span></div>
      <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(U.S. dollars in thousands, except for per share data)</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;color:#000000;width:100%">

          <tr>
            <td rowspan="1" style="vertical-align:bottom;width:64%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
            <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
            <td colspan="10" rowspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended December 31</span></span></div>
              </div>
            </td>
            <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          </tr>
          <tr>
            <td rowspan="1" style="vertical-align:bottom;width:64%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
            <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
            <td colspan="2" rowspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
              </div>
            </td>
            <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
            <td colspan="2" rowspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
              </div>
            </td>
            <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
            <td colspan="2" rowspan="1" style="text-align:center;vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;<span style="font-weight:bold">2021 </span></span></span></td>
            <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">REVENUES</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_122" name="us-gaap:Revenues" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">492,048</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_123" name="us-gaap:Revenues" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">454,271</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_124" name="us-gaap:Revenues" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">357,565</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:64%;padding-bottom:2px;vertical-align:bottom">
              <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">COST OF REVENUES</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_125" name="us-gaap:CostOfRevenue" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">80,708</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_126" name="us-gaap:CostOfRevenue" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">73,485</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_127" name="us-gaap:CostOfRevenue" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">53,592</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">GROSS PROFIT</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_128" name="us-gaap:GrossProfit" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">411,340</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_129" name="us-gaap:GrossProfit" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">380,786</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_130" name="us-gaap:GrossProfit" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">303,973</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">OPERATING EXPENSES:</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="text-indent:15.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Research and development</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_131" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,410</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_132" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,425</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_133" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,532</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
              <div style="text-indent:15.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Sales and marketing</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_134" name="us-gaap:SellingAndMarketingExpense" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">193,042</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_135" name="us-gaap:SellingAndMarketingExpense" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">160,576</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_136" name="us-gaap:SellingAndMarketingExpense" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">119,353</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="text-indent:15.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">General and administrative</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_137" name="us-gaap:GeneralAndAdministrativeExpense" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,228</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_138" name="us-gaap:GeneralAndAdministrativeExpense" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,931</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_139" name="us-gaap:GeneralAndAdministrativeExpense" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,411</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:64%;padding-bottom:2px;vertical-align:bottom">
              <div style="text-indent:15.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other income</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_140" name="inmd:OtherOperatingExpenseIncome" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120000300565" name="inmd:OtherOperatingExpenseIncome" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230120000318213" name="inmd:OtherOperatingExpenseIncome" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">800</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">TOTAL OPERATING EXPENSES</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;border-bottom:1.5pt solid black">&#160;</td>
            <td colspan="1" style="text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;border-bottom:1.5pt solid black">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_143" name="us-gaap:OperatingExpenses" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">215,680</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;border-bottom:1.5pt solid black">&#160;</td>
            <td colspan="1" style="text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;border-bottom:1.5pt solid black">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_144" name="us-gaap:OperatingExpenses" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">182,932</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;border-bottom:1.5pt solid black">&#160;</td>
            <td colspan="1" style="text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;border-bottom:1.5pt solid black">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_145" name="us-gaap:OperatingExpenses" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">136,496</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:64%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">OPERATING INCOME</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_146" name="us-gaap:OperatingIncomeLoss" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">195,660</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_147" name="us-gaap:OperatingIncomeLoss" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">197,854</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_148" name="us-gaap:OperatingIncomeLoss" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">167,477</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:64%;padding-bottom:2px;vertical-align:bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Finance income,<span style="font-weight:bold">&#160;</span>net</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_149" name="us-gaap:InvestmentIncomeNet" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">21,607</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_150" name="us-gaap:InvestmentIncomeNet" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,612</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_151" name="us-gaap:InvestmentIncomeNet" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">525</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">INCOME BEFORE INCOME TAXES</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_152" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">217,267</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_153" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">201,466</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_154" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">168,002</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:64%;padding-bottom:2px;vertical-align:bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">INCOME TAXES</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_155" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">19,348</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_156" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">39,946</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_157" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,928</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NET INCOME</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_158" name="us-gaap:ProfitLoss" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">197,919</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_159" name="us-gaap:ProfitLoss" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">161,520</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_160" name="us-gaap:ProfitLoss" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">165,074</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:64%;padding-bottom:2px;vertical-align:bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Add: Net income attributable to non-controlling interests</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_161" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120000407581" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_163" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">103</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
              </div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="text-indent:-15.1pt;margin-left:15.1pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NET INCOME ATTRIBUTABLE TO INMODE LTD</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_164" name="us-gaap:NetIncomeLoss" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">197,919</ix:nonFraction></span></span></strong></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_165" name="us-gaap:NetIncomeLoss" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">161,520</ix:nonFraction></span></span></strong></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240205093752570" name="us-gaap:NetIncomeLoss" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">164,971</ix:nonFraction></span></span></strong></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:64%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="text-indent:-15.1pt;margin-left:15.1pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">EARNINGS PER SHARE:</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">
              <div style="text-indent:15.1pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Basic</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_167" name="us-gaap:EarningsPerShareBasic" contextRef="C_20230101to20231231" unitRef="USD_Per_Share" decimals="INF" format="ixt:num-dot-decimal">2.37</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_168" name="us-gaap:EarningsPerShareBasic" contextRef="C_20220101to20221231" unitRef="USD_Per_Share" decimals="INF" format="ixt:num-dot-decimal">1.96</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_169" name="us-gaap:EarningsPerShareBasic" contextRef="C_20210101to20211231" unitRef="USD_Per_Share" decimals="INF" format="ixt:num-dot-decimal">2.03</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="text-indent:15.1pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Diluted</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_170" name="us-gaap:EarningsPerShareDiluted" contextRef="C_20230101to20231231" unitRef="USD_Per_Share" decimals="INF" format="ixt:num-dot-decimal">2.30</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_171" name="us-gaap:EarningsPerShareDiluted" contextRef="C_20220101to20221231" unitRef="USD_Per_Share" decimals="INF" format="ixt:num-dot-decimal">1.89</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_172" name="us-gaap:EarningsPerShareDiluted" contextRef="C_20210101to20211231" unitRef="USD_Per_Share" decimals="INF" format="ixt:num-dot-decimal">1.92</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="text-indent:-15.1pt;margin-left:15.1pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING USED IN COMPUTATION OF EARNINGS PER SHARE</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">
              <div style="text-indent:15.1pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Basic</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_173" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="C_20230101to20231231" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">83,533,593</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_174" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="C_20220101to20221231" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">82,482,090</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_175" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="C_20210101to20211231" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">81,444,938</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="text-indent:15.1pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Diluted</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_176" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="C_20230101to20231231" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">85,953,581</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_177" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="C_20220101to20221231" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">85,403,714</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_178" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="C_20210101to20211231" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">86,017,203</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          </tr>

      </table>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The accompanying notes are an integral part of these consolidated financial statements.</span></span></div>
    </div>
  </div>
  <p style="margin:0pt">&#160;</p>
  <div><p style="margin-top:10pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:107%;color:black">F-5</span></span></span></p></div><hr style="border-top:1.5pt solid #000000;page-break-after:always;margin-top:4pt;margin-bottom:10pt"/><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left">&#160;</p>
</div><div style="">
  <div>
    <div>
      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">INMODE LTD.</span></span></div>
      <div style="text-align:center;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME<span id="COMPREHENSIVEINCOME_integixAnchor"></span></span></span></div>
      <div style="text-align:center;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(U.S. dollars in thousands, except for per share data)</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;color:#000000;width:100%">

          <tr>
            <td rowspan="1" style="vertical-align:bottom;width:64%;background-color:rgb(255, 255, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
            <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
            <td colspan="10" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Year ended December 31</span></span></div>
              </div>
            </td>
            <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          </tr>
          <tr>
            <td rowspan="1" style="vertical-align:bottom;width:64%;background-color:rgb(255, 255, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
            <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
            <td colspan="2" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">2023</span></span></div>
              </div>
            </td>
            <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
            <td colspan="2" rowspan="1" style="text-align:center;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#160;<span style="font-weight:bold">2022</span></span></span></td>
            <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
            <td colspan="2" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">2021</span></span></div>
              </div>
            </td>
            <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">NET INCOME</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="FFact_179" name="us-gaap:ProfitLoss" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">197,919</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="FFact_180" name="us-gaap:ProfitLoss" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">161,520</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="FFact_181" name="us-gaap:ProfitLoss" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">165,074</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">OTHER COMPREHENSIVE INCOME:</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="text-indent:-14.15pt;margin-left:30.05pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Change in net unrealized gains (loss) of marketable securities, net of tax</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="FFact_185" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,814</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(<ix:nonFraction id="Fxbrl_20230120001613434" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">6,174</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(<ix:nonFraction id="FFact_187" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1,675</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></div>
              </div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
              <div style="text-indent:-50.2pt;margin-left:50.2pt;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">TOTAL COMPREHENSIVE INCOME</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="FFact_188" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">203,733</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="FFact_189" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">155,346</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="FFact_190" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">163,399</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="text-indent:-14.15pt;margin-left:30.05pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Add: Comprehensive income attributable to non-controlling interests</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="FFact_191" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20230120001759442" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(<ix:nonFraction id="FFact_193" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">103</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></div>
              </div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:64%;padding-bottom:4px;vertical-align:bottom">
              <div style="text-indent:-17.7pt;margin-left:17.7pt;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">TOTAL COMPREHENSIVE INCOME ATTRIBUTABLE TO INMODE LTD.</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="FFact_194" name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">203,733</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="FFact_195" name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">155,346</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="FFact_196" name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">163,296</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          </tr>

      </table>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">The accompanying notes are an integral part of these consolidated financial statements.</span></span></div>
    </div>
  </div>
  <p style="margin:0pt">&#160;</p>
  <div><p style="margin-top:10pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:107%;color:black">F-6</span></span></span></p></div><hr style="border-top:1.5pt solid #000000;page-break-after:always;margin-top:4pt;margin-bottom:10pt"/><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left">&#160;</p>
</div><div style="">
  <div>
    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">INMODE LTD.</span></span></div>
    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS&#8217; EQUITY<span id="CHANGESINSHAREHOLDERSEQUI_integixAnchor"></span><br/>(U.S. dollars in thousands, except for per share data)</span></span></div>
    <div style="line-height:1.25">&#160;</div>
    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;color:#000000;width:100%">

        <tr>
          <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="22" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25">
              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">InMode Ltd. Shareholders&#8217; Equity</span></span></div>
            </div>
          </td>
          <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
            <div style="line-height:1.25">
              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Ordinary Shares</span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" rowspan="2" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="2" rowspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25">
              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Additional paid-in capital</span></span></div>
            </div>
          </td>
          <td colspan="1" rowspan="2" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" rowspan="2" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="2" rowspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25">
              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Retained</span></span></div>
              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">earnings</span></span></div>
            </div>
          </td>
          <td colspan="1" rowspan="2" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" rowspan="2" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="2" rowspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25">
              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Accumulated other comprehensive income</span></span></div>
            </div>
          </td>
          <td colspan="1" rowspan="2" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" rowspan="2" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="2" rowspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25">
              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Treasury<br/>shares</span></span></div>
            </div>
          </td>
          <td colspan="1" rowspan="2" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25">
              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-</span></span></div>
              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">controlling</span></span></div>
              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Interests</span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:top;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25">
              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Number of shares outstanding</span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25">
              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Amount</span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25">
              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:20%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">BALANCE AS OF JANUARY 1, 2021</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_197" name="us-gaap:CommonStockSharesOutstanding" contextRef="C_20201231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">75,567,554</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_198" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="C_20201231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">216</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_199" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="C_20201231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">101,593</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_200" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="C_20201231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">169,016</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_201" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="C_20201231_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">356</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230120014100242" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="C_20201231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">17,218</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_202" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="C_20201231_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,512</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_203" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="C_20201231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">255,475</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:20%;vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CHANGES DURING 2021:</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:20%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-indent:-7.05pt;margin-left:22.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net income</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120014141233" name="us-gaap:ProfitLoss" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120014146795" name="us-gaap:ProfitLoss" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_204" name="us-gaap:ProfitLoss" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">164,971</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120014200921" name="us-gaap:ProfitLoss" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120014207753" name="us-gaap:ProfitLoss" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120014122241" name="us-gaap:ProfitLoss" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">103</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_206" name="us-gaap:ProfitLoss" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">165,074</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:20%;vertical-align:bottom">
            <div style="text-indent:-7.05pt;margin-left:22.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other comprehensive loss, net</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120014409521" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120014405384" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120014401640" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_207" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1,675</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120014413889" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230210171619966" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_209" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1,675</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:20%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-indent:-7.05pt;margin-left:22.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based compensation</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120014625593" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_210" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,962</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120014617369" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120014610681" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120014605432" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120014602448" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_211" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,962</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:20%;vertical-align:bottom">
            <div style="text-indent:-7.05pt;margin-left:22.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Acquisition of non-controlling interest in exchange of ordinary shares (see note 12b)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240205100449992" name="inmd:ShareValueOfAcquisitionOfNonControllingInterestInExchangeOfOrdinaryShares" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">582,826</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120014900537" name="inmd:AcquisitionOfNonControllingInterestInExchangeOfOrdinaryShares" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230120013012498" name="inmd:AcquisitionOfNonControllingInterestInExchangeOfOrdinaryShares" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">11,165</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120015037489" name="inmd:AcquisitionOfNonControllingInterestInExchangeOfOrdinaryShares" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120015330833" name="inmd:AcquisitionOfNonControllingInterestInExchangeOfOrdinaryShares" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120015322551" name="inmd:AcquisitionOfNonControllingInterestInExchangeOfOrdinaryShares" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,780</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230120013041324" name="inmd:AcquisitionOfNonControllingInterestInExchangeOfOrdinaryShares" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1,615</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120015103976" name="inmd:AcquisitionOfNonControllingInterestInExchangeOfOrdinaryShares" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:20%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-indent:-7.05pt;margin-left:22.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Repurchase of ordinary shares</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230120015415168" name="inmd:StockRepurchasedOrdinarySharesDuringPeriodShares" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal" sign="-">693,734</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120015635296" name="inmd:StockRepurchasedOrdinarySharesDuringPeriodValue" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120015631911" name="inmd:StockRepurchasedOrdinarySharesDuringPeriodValue" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120015628399" name="inmd:StockRepurchasedOrdinarySharesDuringPeriodValue" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120015624551" name="inmd:StockRepurchasedOrdinarySharesDuringPeriodValue" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230120015442888" name="inmd:StockRepurchasedOrdinarySharesDuringPeriodValue" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">35,365</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120015448736" name="inmd:StockRepurchasedOrdinarySharesDuringPeriodValue" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230120011840595" name="inmd:StockRepurchasedOrdinarySharesDuringPeriodValue" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">35,365</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:20%;padding-bottom:2px;vertical-align:bottom">
            <div style="text-indent:-7.05pt;margin-left:22.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercise of options</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_220" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">7,521,469</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_221" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">23</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_222" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">20,308</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120015811910" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120015808495" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120015805017" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120015747415" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_223" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">20,331</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:20%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">BALANCE AT DECEMBER 31, 2021</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240205110327660" name="us-gaap:CommonStockSharesOutstanding" contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">82,978,115</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_225" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">239</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_226" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">122,698</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_227" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">333,987</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_228" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1,319</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230120015939639" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">39,803</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_229" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_230" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">415,802</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:20%;vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CHANGES DURING 2022:</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:20%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-indent:-7.05pt;margin-left:22.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net income</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120020053357" name="us-gaap:ProfitLoss" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120020031391" name="us-gaap:ProfitLoss" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_231" name="us-gaap:ProfitLoss" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">161,520</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120020026566" name="us-gaap:ProfitLoss" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120020023182" name="us-gaap:ProfitLoss" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_232" name="us-gaap:ProfitLoss" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_233" name="us-gaap:ProfitLoss" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">161,520</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:20%;vertical-align:bottom">
            <div style="text-indent:-7.05pt;margin-left:22.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other comprehensive loss, net</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120020216727" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120020210846" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120020203406" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230120020231054" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">6,174</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120020144286" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120020139912" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230120022444363" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">6,174</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:20%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-indent:-7.05pt;margin-left:22.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based compensation</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120020427958" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_236" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">24,452</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120020424800" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120020421119" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120020418199" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120020408670" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_237" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">24,452</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:20%;vertical-align:bottom">
            <div style="text-indent:-7.05pt;margin-left:22.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Repurchase of ordinary shares</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_240" name="inmd:StockRepurchasedOrdinarySharesDuringPeriodShares" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal" sign="-">1,077,213</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120020841599" name="inmd:StockRepurchasedOrdinarySharesDuringPeriodValue" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120020837238" name="inmd:StockRepurchasedOrdinarySharesDuringPeriodValue" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120020831126" name="inmd:StockRepurchasedOrdinarySharesDuringPeriodValue" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120020825313" name="inmd:StockRepurchasedOrdinarySharesDuringPeriodValue" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_241" name="inmd:StockRepurchasedOrdinarySharesDuringPeriodValue" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">42,637</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120020813735" name="inmd:StockRepurchasedOrdinarySharesDuringPeriodValue" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_242" name="inmd:StockRepurchasedOrdinarySharesDuringPeriodValue" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">42,637</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:20%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-indent:-7.05pt;margin-left:22.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercise of options</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_243" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">644,089</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_244" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_245" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,653</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120021056973" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120021036974" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120021023181" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120021008854" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_246" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,655</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:20%;vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">BALANCE AT DECEMBER 31, 2022</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_247" name="us-gaap:CommonStockSharesOutstanding" contextRef="C_20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">82,544,991</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_248" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="C_20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">241</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_249" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="C_20221231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">148,803</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_250" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="C_20221231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">495,507</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230120022215604" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="C_20221231_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">7,493</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_252" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="C_20221231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">82,440</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_253" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="C_20221231_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_254" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">554,618</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:20%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CHANGES DURING 2023:</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:20%;vertical-align:bottom">
            <div style="text-indent:-7.05pt;margin-left:22.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net income</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120022017693" name="us-gaap:ProfitLoss" contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120022005948" name="us-gaap:ProfitLoss" contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_255" name="us-gaap:ProfitLoss" contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">197,919</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120022129700" name="us-gaap:ProfitLoss" contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120022146284" name="us-gaap:ProfitLoss" contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_256" name="us-gaap:ProfitLoss" contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_257" name="us-gaap:ProfitLoss" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">197,919</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:20%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-indent:-7.05pt;margin-left:22.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other comprehensive loss, net</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120021820981" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120021815325" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120021811246" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_258" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,814</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120021805421" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120021802101" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_259" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,814</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:20%;vertical-align:bottom">
            <div style="text-indent:-7.05pt;margin-left:22.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based compensation</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120021731694" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240205100930808" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">23,600</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120021717053" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120021655621" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120021639134" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120021628245" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_261" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">23,600</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:20%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-indent:-7.05pt;margin-left:22.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercise of options</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_269" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">1,437,471</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_270" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_271" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,417</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120021305510" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120021249174" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120021219749" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120021159981" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_272" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,421</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:20%;padding-bottom:4px;vertical-align:bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">BALANCE AT DECEMBER 31, 2023</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_273" name="us-gaap:CommonStockSharesOutstanding" contextRef="C_20231231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">83,982,462</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_274" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="C_20231231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">245</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_275" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="C_20231231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">177,820</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_276" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="C_20231231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">693,426</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_277" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="C_20231231_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1,679</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_278" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="C_20231231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">82,440</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120021145391" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="C_20231231_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_279" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">787,372</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>

    </table>
    <div style="line-height:1.25">&#160;</div>
    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The accompanying notes are an integral part of these consolidated financial statements.</span></span></div>
  </div>
  <p style="margin:0pt">&#160;</p>
  <div><p style="margin-top:10pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:107%;color:black">F-7</span></span></span></p></div><hr style="border-top:1.5pt solid #000000;page-break-after:always;margin-top:4pt;margin-bottom:10pt"/><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left">&#160;</p>
</div><div style="">
  <div>
    <div>
      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">INMODE LTD.</span></span></div>
      <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CONSOLIDATED STATEMENTS OF CASH FLOWS<span id="CASHFLOWS_integixAnchor"></span></span></span></div>
      <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(U.S. dollars in thousands, except per share data)</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;color:#000000;width:100%">

          <tr>
            <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
            <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended December 31</span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          </tr>
          <tr>
            <td rowspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
            <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
            <td colspan="2" rowspan="1" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
              </div>
            </td>
            <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
            <td colspan="2" rowspan="1" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
              </div>
            </td>
            <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" rowspan="1" style="font-weight:bold;text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
            <td colspan="2" rowspan="1" style="vertical-align:bottom;font-weight:bold;text-align:center;border-bottom:#000000 solid 2px;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></td>
            <td colspan="1" rowspan="1" style="font-weight:bold;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CASH FLOWS FROM OPERATING ACTIVITIES:</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%;vertical-align:bottom">
              <div style="text-indent:13.9pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net income</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_280" name="us-gaap:ProfitLoss" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">197,919</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_281" name="us-gaap:ProfitLoss" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">161,520</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_282" name="us-gaap:ProfitLoss" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">165,074</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="text-indent:-14pt;margin-left:27.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Adjustments required to reconcile net income to net cash provided by operating activities:</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%;vertical-align:bottom">
              <div style="text-indent:31.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciation and amortization</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_283" name="us-gaap:DepreciationDepletionAndAmortization" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">623</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_284" name="us-gaap:DepreciationDepletionAndAmortization" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">680</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_285" name="us-gaap:DepreciationDepletionAndAmortization" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">517</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="text-indent:31.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based compensation expenses</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_286" name="us-gaap:ShareBasedCompensation" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">23,600</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_287" name="us-gaap:ShareBasedCompensation" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">24,452</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_288" name="us-gaap:ShareBasedCompensation" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,962</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%;vertical-align:bottom">
              <div style="text-indent:-9.8pt;margin-left:41pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Change in allowance for credit losses of trade receivable</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_289" name="us-gaap:ProvisionForDoubtfulAccounts" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,020</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_290" name="us-gaap:ProvisionForDoubtfulAccounts" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">449</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_291" name="us-gaap:ProvisionForDoubtfulAccounts" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">516</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="text-indent:-9.8pt;margin-left:41pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss on marketable securities, net</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_292" name="us-gaap:GainLossOnInvestments" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_293" name="us-gaap:GainLossOnInvestments" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">71</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_294" name="us-gaap:GainLossOnInvestments" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">175</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%;vertical-align:bottom">
              <div style="text-indent:-9.8pt;margin-left:41pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Finance expense (income), net</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230120005516002" name="us-gaap:InterestIncomeExpenseNet" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,714</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_296" name="us-gaap:InterestIncomeExpenseNet" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,210</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120005526885" name="us-gaap:InterestIncomeExpenseNet" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1,223</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="text-indent:-9.8pt;margin-left:41pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred income tax assets, net</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_298" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">184</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120005647758" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">84</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_300" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">770</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
              <div style="text-indent:13.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Changes in operating assets and liabilities:</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="text-indent:31.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Increase in accounts receivable</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_301" name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">16,084</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_302" name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,415</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230120005541533" name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,544</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%;vertical-align:bottom">
              <div style="text-indent:31.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Increase in other receivables</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_304" name="us-gaap:IncreaseDecreaseInOtherReceivables" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,224</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_305" name="us-gaap:IncreaseDecreaseInOtherReceivables" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,787</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_306" name="us-gaap:IncreaseDecreaseInOtherReceivables" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,400</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="margin-left:31.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Increase in inventories</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_307" name="us-gaap:IncreaseDecreaseInInventories" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,198</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_308" name="us-gaap:IncreaseDecreaseInInventories" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">18,871</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_309" name="us-gaap:IncreaseDecreaseInInventories" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,043</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%;vertical-align:bottom">
              <div style="text-indent:31.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Increase (decrease) in accounts payable</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_310" name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">2,276</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_311" name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,463</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_312" name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,369</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="text-indent:31.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Increase (decrease) in other liabilities</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_313" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">12,588</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_314" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">17,941</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_315" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,138</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
              <div style="text-indent:31.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Increase (decrease) in contract liabilities</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_316" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">3,068</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_317" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,201</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120005559413" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,668</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="text-indent:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net cash provided by operating activities</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_322" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">176,826</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_323" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">181,578</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_324" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">174,885</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%;vertical-align:bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CASH FLOWS FROM INVESTING ACTIVITIES:</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="text-indent:12.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Investment in short-term deposits</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_325" name="inmd:InvestmentInShortTermDeposit" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">233,241</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_326" name="inmd:InvestmentInShortTermDeposit" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">93,701</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_327" name="inmd:InvestmentInShortTermDeposit" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">73,090</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%;vertical-align:bottom">
              <div style="text-indent:12.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Proceeds from short-term deposits</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_328" name="inmd:ProceedsFromInvestmentInShortTermDeposit" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">85,090</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_329" name="inmd:ProceedsFromInvestmentInShortTermDeposit" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">73,090</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_330" name="inmd:ProceedsFromInvestmentInShortTermDeposit" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">69,180</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="text-indent:12.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Purchase of fixed assets</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_331" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">705</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_332" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,575</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_333" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">939</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%;vertical-align:bottom">
              <div style="text-indent:12.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other investments</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240205101624969" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">100</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240205101650280" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240205101704557" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="text-indent:12.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Purchase of marketable securities</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_337" name="us-gaap:PaymentsToAcquireMarketableSecurities" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">245,337</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_338" name="us-gaap:PaymentsToAcquireMarketableSecurities" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">168,680</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_339" name="us-gaap:PaymentsToAcquireMarketableSecurities" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">273,834</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%;vertical-align:bottom">
              <div style="text-indent:12.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Proceeds from sale of marketable securities</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_340" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,000</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_341" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,303</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_342" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">93,652</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="text-indent:12.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Proceeds from maturity of marketable securities</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230131032211860_Fact_340" name="inmd:ProceedsFromMaturityOfMarketableSecurities" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">253,229</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230131032211860_Fact_341" name="inmd:ProceedsFromMaturityOfMarketableSecurities" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">79,089</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230131032211860_Fact_342" name="inmd:ProceedsFromMaturityOfMarketableSecurities" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">24,925</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
              <div style="text-indent:12.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net cash used in investing activities</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_343" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">136,064</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_344" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">109,474</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_345" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">160,106</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
              </div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CASH FLOWS FROM FINANCING ACTIVITIES:</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%;vertical-align:bottom">
              <div style="text-indent:12.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Repurchase of ordinary shares</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_349" name="us-gaap:PaymentsForRepurchaseOfCommonStock" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_350" name="us-gaap:PaymentsForRepurchaseOfCommonStock" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">42,637</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230120005856887" name="us-gaap:PaymentsForRepurchaseOfCommonStock" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">35,365</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="text-indent:12.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercise of options</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_352" name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,504</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_353" name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,552</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_354" name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">20,343</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
              <div style="text-indent:12.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net cash used in financing activities</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_355" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,504</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_356" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">41,085</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230120010009023" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">15,022</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
              </div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
              <div style="text-indent:-16.1pt;margin-left:16.1pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_358" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">605</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230120142003953" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1,615</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_360" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">559</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
              </div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="text-indent:-16.8pt;margin-left:16.8pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_361" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">46,871</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120005631534" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">29,404</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_363" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">802</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%;vertical-align:bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CASH AND CASH EQUIVALENTS AT</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%;padding-bottom:2px;background-color:rgb(255, 255, 255);vertical-align:bottom">
              <div style="text-indent:1.4pt;margin-left:16.8pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">BEGINNING OF THE YEAR</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(255, 255, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(255, 255, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(255, 255, 255);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_364" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">97,540</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(255, 255, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(255, 255, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(255, 255, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(255, 255, 255);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_365" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">68,136</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(255, 255, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(255, 255, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(255, 255, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(255, 255, 255);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_366" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="C_20201231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">68,938</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(255, 255, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CASH AND CASH EQUIVALENTS AT</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="text-indent:18.9pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">END OF THE YEAR</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_367" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">144,411</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_368" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">97,540</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_369" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">68,136</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
              <div style="text-indent:-14.2pt;margin-left:14.2pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">SUPPLEMENTAL DISCLOSURES OF CASH FLOWS INFORMATION:</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="text-indent:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Income taxes paid *</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_370" name="us-gaap:IncomeTaxesPaidNet" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">31,614</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_371" name="us-gaap:IncomeTaxesPaidNet" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">25,843</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_372" name="us-gaap:IncomeTaxesPaidNet" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,658</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">
              <div style="text-indent:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Interest received</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_373" name="inmd:InterestReceived" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,219</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_374" name="inmd:InterestReceived" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,856</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_375" name="inmd:InterestReceived" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,358</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%;vertical-align:bottom">
              <div style="text-indent:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">NON</span>-<span style="font-weight:bold">CASH ACTIVITIES</span></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Recognition of operating lease right-of-use assets and liabilities</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_376" name="inmd:OperatingLeaseRightOfUseAssests" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,200</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_377" name="inmd:OperatingLeaseRightOfUseAssests" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,342</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_378" name="inmd:OperatingLeaseRightOfUseAssests" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,315</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">
              <div style="margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercise of Options</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240205100151108" name="inmd:ExerciseOfOptions" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">20</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240205100248190" name="inmd:ExerciseOfOptions" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">103</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240205100306825" name="inmd:ExerciseOfOptions" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Acquisition of non-controlling interest in exchange of ordinary shares</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_382" name="inmd:NonCashAcquisitionOfNoncontrollingInterestInExchangeOfOrdinaryShares" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120004200376" name="inmd:NonCashAcquisitionOfNoncontrollingInterestInExchangeOfOrdinaryShares" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120004204888" name="inmd:NonCashAcquisitionOfNoncontrollingInterestInExchangeOfOrdinaryShares" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,780</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          </tr>

      </table>
      <div style="line-height:1.25">&#160;</div>
      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">*Including, for 2022, payments amounting $<ix:nonFraction id="Fxbrl_20240205165813930" name="inmd:PaymentsToTaxAuthorities" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12</ix:nonFraction> million for Amendment to the Investments Law and settlements with the Israeli tax authority. See note 13a(2)(b).</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The accompanying notes are an integral part of these consolidated financial statements.</span></span></div>
    </div>
  </div>
  <p style="margin:0pt">&#160;</p>
  <div><p style="margin-top:10pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:107%;color:black">F-8</span></span></span></p></div><hr style="border-top:1.5pt solid #000000;page-break-after:always;margin-top:4pt;margin-bottom:10pt"/><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left">&#160;</p>
  <div>
    <div>
      <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">
        <div style="text-align:center;line-height:1.25;font-family:Times New Roman, Times, serif;font-weight:bold;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">INMODE LTD.</span></span></span></span></span></span><span style="font-size:10pt;text-align:left;font-weight:400">&#160;</span></div>
        <div style="text-align:center;line-height:1.25;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span id="NOTESTOCONSOLIDATEDFINANC_integixAnchor"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span id="financialstatements_integixAnchor"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTES TO CONSOLIDATED FINANCIAL S</span></span></span><span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">TATEMENTS</span></span></span></span></span></span></span><span style="font-size:10pt;text-align:left">&#160;</span></span></div>
        <div style="text-align:center;line-height:1.25;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(U.S. dollars in thousands, except for share and per amounts)</span></span></span></span></span></span></div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#160;</span></span></span></span>
      </div>
    </div>
  </div>
</div><div style="">
  <div>
    <ix:nonNumeric id="Fxbrl_20240205092101211" name="us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock" contextRef="C_20230101to20231231" escape="true">
      <div>
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 1 - GENERAL:</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%">

              <tr style="vertical-align:top">
                <td style="text-align:right;vertical-align:top;width:9pt">
                  <div style="text-align:left;margin-left:49.65pt;line-height:1.25">&#160;</div>
                </td>
                <td style="text-align:left;vertical-align:top;width:auto">
                  <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">InMode Ltd. (separately and together with its subsidiaries, the &#8220;Company&#8221;) was incorporated on January 2, 2008 and commenced operations shortly thereafter. The Company&#8217;s headquarters are located in Israel. The Company is traded in the Nasdaq Global Select Market (the &#8220;Nasdaq&#8221;) since August 2019.</span></span></div>
                  <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
                  <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company designs, develops, manufactures and markets innovative minimally-invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radio frequency technologies. These technologies are used to remodel subdermal adipose or fatty tissue in a variety of procedures including liposuction with simultaneous skin tightening, body and face contouring and ablative skin rejuvenation treatments, as well as, for use in certain women&#8217;s health conditions and procedures. In addition to the minimally-invasive technologies, the Company designs, develops, manufactures and markets non&#8209;invasive medical aesthetic products that target a wide array of procedures including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture and superficial benign vascular and pigmented lesions. The Company also designs, develops, manufactures and markets hands-free medical aesthetic products that target a wide array of procedures such as skin tightening, fat reduction and muscle stimulation.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company has wholly-owned subsidiaries located in the United States and two subsidiaries in Canada (&#8220;North America&#8221;), Hong Kong, Japan, Spain, two subsidiaries in Israel, India, Australia, China, the United Kingdom (&#8220;UK&#8221;), France, Italy and Germany. The Company&#8217;s subsidiaries are referred to collectively herein as the &#8220;Subsidiaries.&#8221; The Company sells its products primarily through its Subsidiaries. See note 12b for an update regarding change in ownership of the UK subsidiary.</span></span></div>
                  </div>
                </td>
              </tr>

          </table>
        </div>
      </div>
    </ix:nonNumeric>
    <p style="margin-top:0pt;margin-bottom:0pt">&#160;</p>
  </div>
</div><div style="">
  <div>
    <ix:nonNumeric id="Fxbrl_20240205094425028" name="us-gaap:SignificantAccountingPoliciesTextBlock" contextRef="C_20230101to20231231" escape="true">
      <div>
        <div>
          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">NOTE 2 - SIGNIFICANT</span>&#160;<span style="font-weight:bold">ACCOUNTING</span>&#160;<span style="font-weight:bold">POLICIES:</span></span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <ix:nonNumeric id="Fxbrl_20240205094636406" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" contextRef="C_20230101to20231231" escape="true">
            <div>
              <div style="line-height:1.25">
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:48.4pt">&#160;</td>
                      <td style="width:22.5pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">a.</span></span></td>
                      <td style="width:auto;vertical-align:top">
                        <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Basis of presentation</span></span></span></div>
                        <div style="font-weight:bold">&#160;</div>
                        <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">
                          <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company&#8217;s consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (&#8220;U.S. GAAP&#8221;).</span></span></div>
                        </div>
                      </td>
                    </tr>

                </table>
              </div>
            </div>
          </ix:nonNumeric>
          <p style="margin:0pt">&#160;</p>
          <ix:nonNumeric id="Fxbrl_20240205094651732" name="us-gaap:UseOfEstimates" contextRef="C_20230101to20231231" escape="true">
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:48.4pt">&#160;</td>
                  <td style="width:22.5pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">b.</span></span></td>
                  <td style="width:auto;vertical-align:top">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Use of estimates</span></span></div>
                    <div style="font-weight:bold">&#160;</div>
                    <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">
                      <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</span></span></div>
                    </div>
                  </td>
                </tr>

            </table>
          </ix:nonNumeric>
          <div>
            <div style="line-height:1.25">&#160;</div>
          </div>
          <ix:nonNumeric id="Fxbrl_20240205094720859" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" contextRef="C_20230101to20231231" escape="true">
            <div>
              <div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:48.4pt">&#160;</td>
                      <td style="width:22.5pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">c.</span></span></td>
                      <td style="width:auto;vertical-align:top">
                        <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Functional currency</span></span></div>
                        <div style="font-weight:bold">&#160;</div>
                        <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:normal">The U.S. dollar (&#8220;U.S. dollar&#8221; or &#8220;$&#8221;) is the currency of the primary economic environment in which the operations of the Company is conducted. Substantial revenues and a substantial portion of the operational costs are denominated in U.S. dollars. Accordingly, the functional currency of the Company is the U.S. dollar (&#8220;primary currency&#8221;).</span></span></span></div>
                        </div>
                      </td>
                    </tr>
                    <tr>
                      <td style="width:48.4pt">&#160;</td>
                      <td style="width:22.5pt;vertical-align:top;font-weight:bold">&#160;</td>
                      <td style="width:auto;vertical-align:top">&#160;</td>
                    </tr>

                </table>
              </div>
              <div><ix:exclude>
                <div style="line-height:1.25">
                  <div style="font-size:10pt"><div><div><div><p style="margin-top:10pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:107%;color:black">F-9</span></span></span></p></div><hr style="border-top:1.5pt solid #000000;page-break-after:always;margin-top:4pt;margin-bottom:10pt"/><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left">&#160;</p><div style="margin-bottom:0pt"><table cellpadding="0" style="font-size:10pt;border-spacing:0px;border-width:0px;border-style:initial;border-color:initial;width:100%;margin-top:0pt"><tr><td style="width:100%;vertical-align:top"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-weight:bold">INMODE LTD.</span></p></td></tr><tr><td style="width:100%;vertical-align:top"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></td></tr><tr><td style="width:100%;vertical-align:top"><p style="margin-top:0pt;margin-bottom:0px;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif">(U.S. dollars in thousands, except for share and per amounts)</p></td></tr></table></div></div></div></div><div style="margin-top:0px;margin-bottom:0px">&#160;</div>
                </div>
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">NOTE 2 - SIGNIFICANT</span>&#160;<span style="font-weight:bold">ACCOUNTING</span>&#160;<span style="font-weight:bold">POLICIES </span>(continued):</span></span></div>
                <div style="line-height:1.25">&#160;</div>
              </ix:exclude></div>
              <div style="line-height:1.25">
                <div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%">

                      <tr style="vertical-align:top">
                        <td style="text-align:right;vertical-align:top;width:70pt">
                          <div style="text-align:left;margin-left:49.65pt;line-height:1.25">&#160;</div>
                        </td>
                        <td style="text-align:left;vertical-align:top;width:auto">
                          <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Transactions and balances originally denominated in U.S. dollars are presented at their original amounts. Balances in non-U.S. dollar currencies are translated into U.S. dollars using historical and current exchange rates for non-monetary and monetary balances, respectively. For non-U.S. dollar transactions and other items in the statements of income (indicated below), the following exchange rates are used: (i) for transactions &#8211; exchange rates at transaction dates or average exchange rates; and (ii) for other items (derived from non-monetary balance sheet items such as depreciation and amortization) &#8211; historical exchange rates. Currency transaction gains and losses are presented in finance income (expenses), as appropriate.</span></span></div>
                          <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
                          <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The functional currency of each of the Subsidiaries is the U.S. dollar.</span></span></div>
                          </div>
                        </td>
                      </tr>

                  </table>
                </div>
              </div>
            </div>
          </ix:nonNumeric>
          <div style="line-height:1.25">&#160;</div>
          <ix:nonNumeric id="Fxbrl_20240205094726621" name="us-gaap:ConsolidationPolicyTextBlock" contextRef="C_20230101to20231231" escape="true">
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:48.4pt">&#160;</td>
                  <td style="width:22.5pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">d.</span></span></td>
                  <td style="width:auto;vertical-align:top">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Principles of consolidation and presentation</span></span></div>
                    <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">&#160;<div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The consolidated financial statements include the accounts of the Company and its Subsidiaries. Intercompany transactions and balances are eliminated in consolidation.</span></span></div>
                    </div>
                  </td>
                </tr>

            </table>
          </ix:nonNumeric>
          <div style="line-height:1.25">&#160;</div>
          <ix:nonNumeric id="Fxbrl_20240205094731221" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" contextRef="C_20230101to20231231" escape="true">
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:48.4pt">&#160;</td>
                  <td style="width:22.5pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">e.</span></span></td>
                  <td style="width:auto;vertical-align:top">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash and cash equivalents</span></span></div>
                    <div style="font-weight:bold">&#160;</div>
                    <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">
                      <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company considers cash equivalents to be all short-term, highly liquid investments, which include money market instruments, that are not restricted as to withdrawal or use, and short-term bank deposits with original maturities of three months or less from the date of purchase that are not restricted as to withdrawal or use and are readily convertible to known amounts of cash.</span></span></div>
                    </div>
                  </td>
                </tr>

            </table>
          </ix:nonNumeric>
          <div style="line-height:1.25">&#160;</div>
          <ix:nonNumeric id="Fxbrl_20240205094735405" name="inmd:ShortTermBankDepositsPolicyTextBlock" contextRef="C_20230101to20231231" escape="true">
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:48.4pt">&#160;</td>
                  <td style="width:22.5pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">f.</span></span></td>
                  <td style="width:auto;vertical-align:top">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Short-term bank deposits</span></span></div>
                    <div style="font-weight:bold">&#160;</div>
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:normal">Bank deposits with maturities of more than three months but less than one year are included in short-term deposits. Such short-term deposits bear interest at an average annual rate of approximately <ix:nonFraction id="FFact_395" name="inmd:ShortTermDepositsAnnualInterestRate" contextRef="C_20230101to20231231_srtRangeAxis_srtMinimumMember" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">4.10</ix:nonFraction>%-<ix:nonFraction id="FFact_396" name="inmd:ShortTermDepositsAnnualInterestRate" contextRef="C_20230101to20231231_srtRangeAxis_srtMaximumMember" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">7.01</ix:nonFraction>% in 2023 and <ix:nonFraction id="FFact_397" name="inmd:ShortTermDepositsAnnualInterestRate" contextRef="C_20220101to20221231_srtRangeAxis_srtMinimumMember" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">0.50</ix:nonFraction>%-<ix:nonFraction id="FFact_398" name="inmd:ShortTermDepositsAnnualInterestRate" contextRef="C_20220101to20221231_srtRangeAxis_srtMaximumMember" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">5.73</ix:nonFraction>% in 2022.</span></span></span></div>
                  </td>
                </tr>

            </table>
          </ix:nonNumeric>
          <div style="line-height:1.25">&#160;</div>
          <ix:nonNumeric id="Fxbrl_20240205094742982" name="us-gaap:MarketableSecuritiesPolicy" contextRef="C_20230101to20231231" escape="true">
            <div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:48.4pt">&#160;</td>
                    <td style="width:22.5pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">g.</span></span></td>
                    <td style="width:auto;vertical-align:top">
                      <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Marketable securities</span></span></div>
                      <div style="font-weight:bold">&#160;</div>
                      <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">
                        <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">AFS Securities</span></span></span></div>
                        <div style="line-height:1.25;font-weight:normal">&#160;</div>
                        <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Marketable securities consist of government bonds, municipal bonds, and corporate debt securities (together &#8220;Debt Securities&#8221;), and certificates of deposit measured at fair value in each reporting period. The fair value of quoted securities is based on current market value.</span></span></div>
                        <div style="line-height:1.25;font-weight:normal">&#160;</div>
                        <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Debt Securities and certificates of deposit are classified as available-for-sale (together &#8220;AFS Securities&#8221;) under current assets in the consolidated balance sheet as they represent the investment of funds available for the Company&#8217;s current operations. Changes in fair value, excluding credit losses and impairments, net of taxes (if applicable), are reflected in other comprehensive income or loss. Realized gains and losses on sales of Debt Securities and certificates of deposit as well as premium or discount amortization are included in the consolidated statements of income as finance income (expenses), net. Fair value is calculated based on publicly available market information. When the estimated fair value of a Debt Security is below its amortized cost, the Debt Security is assessed using the Current Expected Credit Losses model (in accordance with ASU 2016-13) in order to determine what portion of that difference, if any, is caused by expected credit losses. The amortized cost of the Debt Security will be reduced to its fair value if it is more likely than not that the Company is required to sell the impaired security before recovery of its amortized cost basis, or it has the intention to sell the security. If neither of these conditions are met, the Company determines whether the impairment is due to credit losses by comparing the present value of the expected cash flows of the security with its amortized cost basis. The amount of impairment recognized is limited to the excess of the amortized cost over the fair value of the security. An allowance for credit losses for the excess of amortized cost over the expected cash flows is recognized in finance income (expenses), net on the consolidated statements income. </span></span></div>
                      </div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <div style="line-height:1.25">
                <div><ix:exclude>
                  <div style="font-size:10pt"><div><div><div><p style="margin-top:10pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:107%;color:black">F-10</span></span></span></p></div><hr style="border-top:1.5pt solid #000000;page-break-after:always;margin-top:4pt;margin-bottom:10pt"/><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left">&#160;</p><div style="margin-bottom:0pt"><table cellpadding="0" style="font-size:10pt;border-spacing:0px;border-width:0px;border-style:initial;border-color:initial;width:100%;margin-top:0pt"><tr><td style="width:100%;vertical-align:top"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-weight:bold">INMODE LTD.</span></p></td></tr><tr><td style="width:100%;vertical-align:top"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></td></tr><tr><td style="width:100%;vertical-align:top"><p style="margin-top:0pt;margin-bottom:0px;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif">(U.S. dollars in thousands, except for share and per amounts)</p></td></tr></table></div></div></div></div><div style="margin-top:0px;margin-bottom:0px">&#160;</div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">NOTE 2 - SIGNIFICANT</span>&#160;<span style="font-weight:bold">ACCOUNTING</span>&#160;<span style="font-weight:bold">POLICIES </span>(continued):</span></span>
                  <p style="margin:0pt">&#160;</p>
                </ix:exclude></div>
              </div>
              <div style="line-height:1.25">
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%">

                    <tr style="vertical-align:top">
                      <td style="text-align:right;vertical-align:top;width:70pt">
                        <div style="text-align:left;margin-left:49.65pt;line-height:1.25">&#160;</div>
                      </td>
                      <td style="text-align:left;vertical-align:top;width:auto">
                        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company classifies investments that are readily convertible to known amounts of cash and have stated maturities of three months or less from the date of purchase as cash equivalents and those with stated maturities of greater than three months as marketable securities.</span></span></div>
                        <div style="line-height:1.25">&#160;</div>
                        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company determines the appropriate classification of its investments in marketable securities at the time of purchase.</span></span></div>
                      </td>
                    </tr>

                </table>
              </div>
            </div>
          </ix:nonNumeric>&#160;<ix:nonNumeric id="Fxbrl_20240205094750582" name="us-gaap:InvestmentPolicyTextBlock" contextRef="C_20230101to20231231" escape="true">
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:48.4pt">&#160;</td>
                  <td style="width:22.5pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">h.</span></span></td>
                  <td style="width:auto;vertical-align:top">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other Investments</span></span></div>
                    <div style="font-weight:bold">&#160;</div>
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:normal">The Company applies the measurement alternative upon the adoption of ASU 2016-01, and elected to record equity investments without readily determinable fair values at cost for other investments, less impairment, adjusted for subsequent observable price changes. In this measurement alternative method, changes in the carrying value of the equity investments are reflected in current earnings. Changes in the carrying value of the equity investment are required to be made whenever there are observable price changes in orderly transactions for the identical or similar investment of the same issuer.</span></span></span></div>
                  </td>
                </tr>

            </table>
          </ix:nonNumeric>
          <div style="line-height:1.25">&#160;</div>
          <div style="line-height:1.25">
            <ix:nonNumeric id="Fxbrl_20240205094757029" name="us-gaap:InventoryPolicyTextBlock" contextRef="C_20230101to20231231" escape="true">
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:48.4pt">&#160;</td>
                    <td style="width:22.5pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">i.</span></span></td>
                    <td style="width:auto;vertical-align:top">
                      <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Inventories</span></span></span></div>
                        <div style="line-height:1.25">&#160;</div>
                        <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Inventories include raw materials and finished products and are valued at the lower of cost or net realizable value. During the year ended December 31, 2022, the Company changed the cost determination method of raw materials from first in, first out (&#8220;FIFO&#8221;) method to a &#8220;moving average&#8221; method. This voluntary change in accounting method was implemented and considered preferable because the Company's ERP system supports automatic calculation of inventory according to the &#8220;moving average&#8221; method and it allows consistency of the cost determination method among the different components of inventory. The change in method was immaterial to all periods presented. The Company regularly evaluates its ability to realize the value of inventory based on a combination of factors including the following: historical usage rates, forecasted sales or usage, estimated current and future market values and new product introductions.</span></span></div>
                      </div>
                    </td>
                  </tr>

              </table>
            </ix:nonNumeric>
          </div>
          <ix:nonNumeric id="Fxbrl_20240205094801432" name="us-gaap:LesseeLeasesPolicyTextBlock" contextRef="C_20230101to20231231" escape="true">
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:48.4pt">&#160;</td>
                  <td style="width:22.5pt;vertical-align:top;font-weight:bold">&#160;</td>
                  <td style="width:auto;vertical-align:top">&#160;</td>
                </tr>
                <tr>
                  <td style="width:48.4pt">&#160;</td>
                  <td style="width:22.5pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">j.</span></span></td>
                  <td style="width:auto;vertical-align:top">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Leases</span></span></div>
                    <div style="font-weight:bold">&#160;</div>
                    <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">
                      <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company determines if an arrangement is a lease at inception. Balances related to operating leases are included in operating lease right-of-use (&#8220;ROU&#8221;) assets, other current liabilities, and operating lease liabilities in the consolidated balance sheets.</span></span></div>
                      <div style="line-height:1.25;font-weight:normal">&#160;</div>
                      <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company also elected to combine lease and non-lease components and to keep leases with an initial term of 12 months or less off the balance sheet and recognize the associated lease payments in the consolidated statements of income on a straight-line basis over the lease term.</span></span></div>
                      <div style="line-height:1.25;font-weight:normal">&#160;</div>
                      <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">ROU assets represent the Company&#8217;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#8217;s obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized as of the commencement date based on the present value of lease payments over the lease term. The Company&#8217;s lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. The discount rate for the lease is the rate implicit in the lease unless that rate cannot be readily determined. As the Company&#8217;s leases do not provide an implicit rate, the Company&#8217;s uses its estimated incremental borrowing rate based on the information available at the commencement date in determining the present value of lease payments. Lease expense for lease payments is recognized on a straight-line basis over the lease term (see also note 9).</span></span></div>
                    </div>
                  </td>
                </tr>
                <tr>
                  <td style="width:48.4pt">&#160;</td>
                  <td style="width:22.5pt;vertical-align:top;font-weight:bold">&#160;</td>
                  <td style="width:auto;vertical-align:top">&#160;</td>
                </tr>

            </table>
          </ix:nonNumeric>
          <div><ix:exclude>
            <div style="line-height:1.25">
              <div style="font-size:10pt"><div><div><div><p style="margin-top:10pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:107%;color:black">F-11</span></span></span></p></div><hr style="border-top:1.5pt solid #000000;page-break-after:always;margin-top:4pt;margin-bottom:10pt"/><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left">&#160;</p><div style="margin-bottom:0pt"><table cellpadding="0" style="font-size:10pt;border-spacing:0px;border-width:0px;border-style:initial;border-color:initial;width:100%;margin-top:0pt"><tr><td style="width:100%;vertical-align:top"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-weight:bold">INMODE LTD.</span></p></td></tr><tr><td style="width:100%;vertical-align:top"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></td></tr><tr><td style="width:100%;vertical-align:top"><p style="margin-top:0pt;margin-bottom:0px;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif">(U.S. dollars in thousands, except for share and per amounts)</p></td></tr></table></div></div></div></div><div style="margin-top:0px;margin-bottom:0px">&#160;</div>
            </div>
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">NOTE 2 - SIGNIFICANT</span>&#160;<span style="font-weight:bold">ACCOUNTING</span>&#160;<span style="font-weight:bold">POLICIES </span>(continued):</span></span>
              <p style="margin:0pt">&#160;</p>
            </div>
          </ix:exclude></div>
          <ix:nonNumeric id="Fxbrl_20240205094808566" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" contextRef="C_20230101to20231231" escape="true">
            <div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:48.4pt">&#160;</td>
                    <td style="width:22.5pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">k.</span></span></td>
                    <td style="width:auto;vertical-align:top">
                      <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Property and equipment</span></span></div>
                      <div style="font-weight:bold">&#160;</div>
                    </td>
                  </tr>

              </table>
              <ix:nonNumeric id="Fxbrl_20240205125323201" name="inmd:ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock" contextRef="C_20230101to20231231" escape="true">
                <div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                      <tr>
                        <td style="vertical-align:top;width:70pt">&#160;</td>
                        <td style="vertical-align:top;width:auto">
                          <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:normal">Property and equipment is stated at cost, net of accumulated depreciation and amortization. Depreciation is calculated on a straight-line basis over the following estimated useful lives:</span></span></span></div>
                          </div>
                        </td>
                      </tr>

                  </table>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="margin-left:81pt">
                    <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                        <tr>
                          <td style="vertical-align:top;background-color:rgb(204, 238, 255)">
                            <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Computers</span></span></div>
                          </td>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)">
                            <div style="text-align:center;margin-right:20.45pt;margin-left:13.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20240205125741538" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" contextRef="C_20231231_srtRangeAxis_srtMinimumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapComputerEquipmentMember" format="ixt-sec:duryear">3</ix:nonNumeric> &#8211; <ix:nonNumeric id="Fxbrl_20240205125814667" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" contextRef="C_20231231_srtRangeAxis_srtMaximumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapComputerEquipmentMember" format="ixt-sec:duryear">4</ix:nonNumeric> years</span></span></div>
                          </td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom">
                            <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Molds</span></span></div>
                          </td>
                          <td style="vertical-align:bottom">
                            <div style="text-align:center;margin-right:20.45pt;margin-left:13.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20240205125836674" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" contextRef="C_20231231_srtRangeAxis_srtMinimumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapToolsDiesAndMoldsMember" format="ixt-sec:duryear">4</ix:nonNumeric> &#8211; <ix:nonNumeric id="Fxbrl_20240205125850370" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" contextRef="C_20231231_srtRangeAxis_srtMaximumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapToolsDiesAndMoldsMember" format="ixt-sec:duryear">10</ix:nonNumeric> years</span></span></div>
                          </td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)">
                            <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Equipment and furniture</span></span></div>
                          </td>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)">
                            <div style="text-align:center;margin-right:20.45pt;margin-left:13.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20240205125840699" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" contextRef="C_20231231_srtRangeAxis_srtMinimumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapEquipmentMember" format="ixt-sec:duryear">10</ix:nonNumeric> &#8211; <ix:nonNumeric id="Fxbrl_20240205125854844" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" contextRef="C_20231231_srtRangeAxis_srtMaximumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapEquipmentMember" format="ixt-sec:duryear">17</ix:nonNumeric> years</span></span></div>
                          </td>
                        </tr>

                    </table>
                  </div>
                </div>
              </ix:nonNumeric>
              <div style="line-height:1.25">&#160;</div>
              <div style="line-height:1.25">
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:48.4pt">&#160;</td>
                      <td style="width:22.5pt;vertical-align:top;font-weight:bold">&#160;</td>
                      <td style="width:auto;vertical-align:top;font-weight:normal">
                        <div style="font-family:'Times New Roman',Times,serif">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Leasehold improvements are depreciated using the straight-line method over the shorter of the term of the lease or the estimated useful lives of the improvements.</span></span></div>
                        </div>
                      </td>
                    </tr>

                </table>
              </div>
            </div>
          </ix:nonNumeric>
          <ix:nonNumeric id="Fxbrl_20240205094813029" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" contextRef="C_20230101to20231231" escape="true">
            <table cellpadding="0" cellspacing="0" style="color:#000000;font-family:'Times New Roman',Times,serif;font-size:10pt;text-align:left;width:100%">

                <tr>
                  <td style="width:48.4pt">&#160;</td>
                  <td style="width:22.5pt;vertical-align:top;font-weight:bold">&#160;</td>
                  <td style="width:auto;vertical-align:top">&#160;</td>
                </tr>
                <tr>
                  <td style="width:48.4pt">&#160;</td>
                  <td style="width:22.5pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">l.</span></span></td>
                  <td style="width:auto;vertical-align:top">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Impairment of long-lived assets</span></span></div>
                    <div style="font-weight:bold">&#160;</div>
                    <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:normal">The Company tests long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may no longer be recoverable. Recoverability of long-lived assets is measured by comparing the carrying amount of the long-lived asset to the estimated undiscounted future cash flows expected to be generated by the asset. If the sum of the expected undiscounted cash flow is less than the carrying amount of the asset, the Company recognizes an impairment loss, which is the excess of the carrying amount over the fair value of the asset, using the expected future discounted cash flows.</span></span></span></div>
                      <div style="line-height:1.25">&#160;</div>
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:normal">During the years ended December 31, 2023, 2022 and 2021, the Company did not recognize an impairment loss on its long-lived assets.</span></span></span></div>
                    </div>
                  </td>
                </tr>

            </table>
          </ix:nonNumeric>
          <div style="line-height:1.25">&#160;</div>
          <ix:nonNumeric id="Fxbrl_20240205094822105" name="us-gaap:CommitmentsAndContingenciesPolicyTextBlock" contextRef="C_20230101to20231231" escape="true">
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:48.4pt">&#160;</td>
                  <td style="width:22.5pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">m.</span></span></td>
                  <td style="width:auto;vertical-align:top">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Legal and other contingencies</span></span></div>
                    <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">&#160;<div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Certain conditions may exist as of the date of the consolidated financial statements, which may result in a loss to the Company but which will only be resolved when one or more future events occur or fail to occur. The Company&#8217;s management assesses such contingent liabilities, if any, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the Company or unasserted claims that may result in such proceedings, the Company&#8217;s management evaluates the perceived merits of any legal proceedings or unasserted claims as well as the perceived merits of the amount of relief sought or expected to be sought.</span></span></div>
                      <div style="line-height:1.25;font-weight:normal">&#160;</div>
                      <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Management applies the guidance in ASC 450-20, &#8220;Loss Contingencies&#8221; when assessing losses resulting from contingencies. If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be reasonable estimated, then the estimated liability is recorded as accrued expenses in the Company&#8217;s consolidated financial statements.</span></span></div>
                      <div style="margin-left:72pt;line-height:1.25;font-weight:normal">&#160;</div>
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:normal">Legal costs incurred in connection with loss contingencies are expensed as incurred.</span></span></span></div>
                    </div>
                  </td>
                </tr>

            </table>
          </ix:nonNumeric><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;</span></span>
          <ix:nonNumeric id="Fxbrl_20240205094831103" name="us-gaap:IncomeTaxPolicyTextBlock" contextRef="C_20230101to20231231" escape="true">
            <div>
              <div style="line-height:1.25">
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:48.4pt">&#160;</td>
                      <td style="width:22.5pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">n.</span></span></td>
                      <td style="width:auto;vertical-align:top">
                        <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Income taxes:</span></span></div>
                      </td>
                    </tr>
                    <tr>
                      <td style="width:48.4pt">&#160;</td>
                      <td style="width:22.5pt;vertical-align:top;font-weight:bold">&#160;</td>
                      <td style="width:auto;vertical-align:top">&#160;</td>
                    </tr>

                </table>
              </div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:72pt">&#160;</td>
                    <td style="width:26.7pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1)</span></span></td>
                    <td style="width:auto;vertical-align:top">
                      <div style="font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company accounts for income taxes in accordance with ASC 740, &#8220;Income Taxes&#8221; (&#8220;ASC 740&#8221;). ASC 740 prescribes the use of the liability method whereby deferred tax asset and liability account balances are determined based on differences between the financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company provides a valuation allowance, if necessary, to reduce deferred tax assets to their estimated realizable value if it is more likely than not that a portion or all of the deferred tax assets will not be realized, based on the weight of available positive and negative evidence. Deferred tax liabilities and assets are classified as non-current in accordance with ASU 2015&#8209;17.</span></span></div>
                    </td>
                  </tr>
                  <tr>
                    <td style="width:72pt">&#160;</td>
                    <td style="width:26.7pt;vertical-align:top">&#160;</td>
                    <td style="width:auto;vertical-align:top">&#160;</td>
                  </tr>

              </table>
              <div><ix:exclude>
                <div style="line-height:1.25">
                  <div style="font-size:10pt"><div><div><div><p style="margin-top:10pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:107%;color:black">F-12</span></span></span></p></div><hr style="border-top:1.5pt solid #000000;page-break-after:always;margin-top:4pt;margin-bottom:10pt"/><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left">&#160;</p><div style="margin-bottom:0pt"><table cellpadding="0" style="font-size:10pt;border-spacing:0px;border-width:0px;border-style:initial;border-color:initial;width:100%;margin-top:0pt"><tr><td style="width:100%;vertical-align:top"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-weight:bold">INMODE LTD.</span></p></td></tr><tr><td style="width:100%;vertical-align:top"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></td></tr><tr><td style="width:100%;vertical-align:top"><p style="margin-top:0pt;margin-bottom:0px;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif">(U.S. dollars in thousands, except for share and per amounts)</p></td></tr></table></div></div></div></div><div style="margin-top:0px;margin-bottom:0px">&#160;</div>
                </div>
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">NOTE 2 - SIGNIFICANT</span>&#160;<span style="font-weight:bold">ACCOUNTING</span>&#160;<span style="font-weight:bold">POLICIES </span>(continued):</span></span>
                  <p style="margin:0pt">&#160;</p>
                </div>
              </ix:exclude></div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:72pt">&#160;</td>
                    <td style="width:26.7pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2)</span></span></td>
                    <td style="width:auto;vertical-align:top">
                      <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company may incur an additional tax liability in the event of an inter-company dividend distribution from Subsidiaries outside of Israel; no additional deferred income tax assets have been provided, since the Company does not expect to distribute inter-company dividends in the foreseeable future that may result in additional tax liability.</span></span></div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:72pt">&#160;</td>
                    <td style="width:26.7pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3)</span></span></td>
                    <td style="width:auto;vertical-align:top">
                      <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Taxes that would apply in the event of disposal of investments in Subsidiaries have not been taken into account in computing the deferred income tax assets, as it is the Company&#8217;s intent and ability to hold these investments.</span></span></div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:72pt">&#160;</td>
                    <td style="width:26.7pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4)</span></span></td>
                    <td style="width:auto;vertical-align:top">
                      <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company accounts for uncertain tax positions in accordance with ASC 740-10. ASC 740&#8209;10 contains a two-step approach to recognizing and measuring uncertain tax positions. The first step is to evaluate the tax position taken or expected to be taken in a tax return by determining if the weight of available evidence indicates that it is more likely than not that, on an evaluation of the technical merits, the tax position will be sustained on audit, including resolution of any related appeals or litigation processes. The second step is to measure the tax benefit of the largest amount that is more than 50% (cumulative probability) likely to be realized upon ultimate settlement.</span></span></div>
                    </td>
                  </tr>

              </table>
            </div>
          </ix:nonNumeric>
          <div style="line-height:1.25">&#160;</div>
          <ix:nonNumeric id="Fxbrl_20240205094845770" name="us-gaap:AdvertisingCostsPolicyTextBlock" contextRef="C_20230101to20231231" escape="true">
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:48.4pt">&#160;</td>
                  <td style="width:22.5pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">o.</span></span></td>
                  <td style="width:auto;vertical-align:top">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Advertising expenses</span></span></div>
                    <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">&#160;<div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Advertising expenses are charged to sales and marketing on the consolidated statement of income as incurred. Advertising expenses for the years ended December 31, 2023, 2022 and 2021 amounted to $<ix:nonFraction id="Fxbrl_20230214001207012" name="us-gaap:AdvertisingExpense" contextRef="C_20230101to20231231" unitRef="USD" scale="6" decimals="-6" format="ixt:num-dot-decimal">15</ix:nonFraction> million, $<ix:nonFraction id="Fxbrl_20230214001212815" name="us-gaap:AdvertisingExpense" contextRef="C_20220101to20221231" unitRef="USD" scale="6" decimals="-6" format="ixt:num-dot-decimal">10</ix:nonFraction> million, and $<ix:nonFraction id="Fxbrl_20230214001219487" name="us-gaap:AdvertisingExpense" contextRef="C_20210101to20211231" unitRef="USD" scale="6" decimals="-6" format="ixt:num-dot-decimal">4</ix:nonFraction> million, respectively.</span></span></div>
                    </div>
                  </td>
                </tr>

            </table>
          </ix:nonNumeric>
          <div style="line-height:1.25">&#160;</div>
          <ix:nonNumeric id="Fxbrl_20240205094856192" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" contextRef="C_20230101to20231231" escape="true">
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:48.4pt">&#160;</td>
                  <td style="width:22.5pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">p.</span></span></td>
                  <td style="width:auto;vertical-align:top">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based compensation</span></span></div>
                    <div style="font-weight:bold">&#160;</div>
                    <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">
                      <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company grants share options and restricted share units (&#8220;RSU&#8221;) (together &#8220;Share-Based Compensation&#8221;) to its employees, officers, directors and non-employees in consideration for services rendered and for acquiring goods. See note 12(a)(2) for details on outstanding share capital.</span></span></div>
                      <div style="line-height:1.25;font-weight:normal">&#160;</div>
                      <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company accounts for Share-Based Compensation awards classified as equity awards using the grant-date fair value method. The fair value at grant-date of the issued equity award is recognized as an expense on a straight-line basis over the requisite service period. The fair value of each share option granted is estimated using the Binomial Model, and for each RSU granted is based on the Company&#8217;s share price at the close of the last trading day prior to the date of the grant. The Company estimates forfeitures based on historical experience and anticipated future conditions at the time of grant and revises such estimates in subsequent periods if actual forfeitures differ from those estimates.</span></span></div>
                      <div style="line-height:1.25;font-weight:normal">&#160;</div>
                      <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company elected to recognize Share-Based Compensation cost for awards with only service conditions that have a graded vesting schedule using the straight-line method based on the multiple-option award approach. Performance-based Share-Based Compensation expenses are calculated based on the valuation at the grant date, and recognized based on the probability of achieving those targets. The Company assess at what scale can the performance targets be reached at each balance sheet date, and expenses are recognized accordingly.</span></span></div>
                      <div style="line-height:1.25;font-weight:normal">&#160;</div>
                      <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company issues new shares upon option exercise or RSU vesting.</span></span></div>
                    </div>
                  </td>
                </tr>

            </table>
          </ix:nonNumeric>
        </div>&#160;<div><ix:exclude>
          <div>
            <div>
              <div style="font-size:10pt"><div><div><div><p style="margin-top:10pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:107%;color:black">F-13</span></span></span></p></div><hr style="border-top:1.5pt solid #000000;page-break-after:always;margin-top:4pt;margin-bottom:10pt"/><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left">&#160;</p><div style="margin-bottom:0pt"><table cellpadding="0" style="font-size:10pt;border-spacing:0px;border-width:0px;border-style:initial;border-color:initial;width:100%;margin-top:0pt"><tr><td style="width:100%;vertical-align:top"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-weight:bold">INMODE LTD.</span></p></td></tr><tr><td style="width:100%;vertical-align:top"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></td></tr><tr><td style="width:100%;vertical-align:top"><p style="margin-top:0pt;margin-bottom:0px;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif">(U.S. dollars in thousands, except for share and per amounts)</p></td></tr></table></div></div></div></div><div style="margin-top:0px;margin-bottom:0px">&#160;</div>
            </div>
          </div>
          <div>
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">NOTE 2 - SIGNIFICANT</span>&#160;<span style="font-weight:bold">ACCOUNTING</span>&#160;<span style="font-weight:bold">POLICIES </span>(continued):</span></span>
              <p style="margin:0pt">&#160;</p>
            </div>
          </div>
        </ix:exclude></div>
        <div>
          <ix:nonNumeric id="Fxbrl_20240205094933327" name="us-gaap:RevenueRecognitionPolicyTextBlock" contextRef="C_20230101to20231231" escape="true">
            <div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="vertical-align:top;font-weight:bold;width:48pt">&#160;</td>
                    <td style="vertical-align:top;font-weight:bold;width:22pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">q.</span></span></td>
                    <td style="vertical-align:top;width:auto">
                      <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenue recognition</span></span></div>
                      <div style="font-weight:bold">&#160;</div>
                      <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">
                        <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company applies ASC 606, &#8220;Revenue from Contracts with Customers&#8221; (&#8220;ASC 606&#8221;). Under ASC 606, an entity recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration that the entity expects to receive in exchange for those goods or services. To determine revenue recognition for arrangements that an entity determines are within the scope of ASC 606, the entity performs the following five steps:</span></span></div>
                      </div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:72pt">&#160;</td>
                    <td style="width:38.05pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(i)</span></span></td>
                    <td style="width:auto;vertical-align:top">
                      <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Identify the contract(s) with a customer;</span></span></div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:72pt">&#160;</td>
                    <td style="width:38.05pt;vertical-align:top;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(ii)</span></span></td>
                    <td style="width:auto;vertical-align:top">
                      <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Identify the performance obligations in the contract. The Company determined that its arrangements are generally comprised of the following elements that are recognized as separate performance obligations: products, consumables and extended warranties;</span></span></div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:72pt">&#160;</td>
                    <td style="width:38.05pt;vertical-align:top;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(iii)</span></span></td>
                    <td style="width:auto;vertical-align:top">
                      <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Determine the transaction price;</span></span></div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:72pt">&#160;</td>
                    <td style="width:38.05pt;vertical-align:top;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(iv)</span></span></td>
                    <td style="width:auto;vertical-align:top">
                      <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Allocate the transaction price to the performance obligations in the contract;</span></span></div>
                      <div style="font-family:'Times New Roman',Times,serif">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company estimates the standalone selling prices of the services to be provided based on actual sales transactions of service contract purchased on a standalone basis and uses the residual approach to estimate the selling price of the products; and</span></span></div>
                      </div>
                    </td>
                  </tr>

              </table>
              <div style="margin-left:106.9pt;line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:72pt">&#160;</td>
                    <td style="width:38.05pt;vertical-align:top;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(v)</span></span></td>
                    <td style="width:auto;vertical-align:top">
                      <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Recognize revenue when (or as) the performance obligation is satisfied. </span></span></div>
                      <div>&#160;</div>
                      <div style="font-family:'Times New Roman',Times,serif">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company only applies the five-step model to contracts when it is probable that the entity will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer, after considering any price concession expected to be provided to the customer, when applicable. At contract inception, the Company assesses the goods or services promised within each contract and determines those that are performance obligations and assesses whether each promised good or service is distinct. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied. </span></span></div>
                        <div style="line-height:1.25">&#160;</div>
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company uses the following practical expedients that are permitted under the rules:</span></span></div>
                        </div>
                      </div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:111pt">&#160;</td>
                    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td>
                    <td style="width:auto;vertical-align:top">
                      <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company recognizes the incremental costs of obtaining contracts as an expense when incurred if the amortization period of the assets that the Company otherwise would have recognized is one year or less. These costs are included in sales and marketing expenses.</span></span></div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:111pt">&#160;</td>
                    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td>
                    <td style="width:auto;vertical-align:top">
                      <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company does not disclose the value of unsatisfied performance obligations for contracts with an original expected length of one year or less.</span></span></div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <div style="line-height:1.25">
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="vertical-align:top;font-weight:bold;width:72pt">&#160;</td>
                      <td style="vertical-align:top;width:auto">
                        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The following is a description of the principal activities from which the Company generates its revenue.</span></span></div>
                        <div style="line-height:1.25">&#160;</div>
                        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Product Revenue, Net</span></span></div>
                        <div style="line-height:1.25">&#160;</div>
                        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenues from product sales are recognized when the customer obtains control over the Company&#8217;s product, typically upon shipment to the customer. Revenues from shipping and handling activities that occur after the customer has obtained control of a good are recognized according to an accounting policy election as a fulfilment cost rather than as an additional promised service. Taxes collected from customers relating to product sales and remitted to governmental authorities are excluded from revenues.</span></span></div>
                      </td>
                    </tr>

                </table>
              </div>
              <p style="margin:0pt">&#160;</p>
              <div><ix:exclude>
                <div style="font-size:10pt"><div><div><div><p style="margin-top:10pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:107%;color:black">F-14</span></span></span></p></div><hr style="border-top:1.5pt solid #000000;page-break-after:always;margin-top:4pt;margin-bottom:10pt"/><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left">&#160;</p><div style="margin-bottom:0pt"><table cellpadding="0" style="font-size:10pt;border-spacing:0px;border-width:0px;border-style:initial;border-color:initial;width:100%;margin-top:0pt"><tr><td style="width:100%;vertical-align:top"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-weight:bold">INMODE LTD.</span></p></td></tr><tr><td style="width:100%;vertical-align:top"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></td></tr><tr><td style="width:100%;vertical-align:top"><p style="margin-top:0pt;margin-bottom:0px;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif">(U.S. dollars in thousands, except for share and per amounts)</p></td></tr></table></div></div></div></div><div style="margin-top:0px;margin-bottom:0px">&#160;</div>
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">NOTE 2 - SIGNIFICANT</span>&#160;<span style="font-weight:bold">ACCOUNTING</span>&#160;<span style="font-weight:bold">POLICIES </span>(continued):</span></span>
                  <p style="margin:0pt">&#160;</p>
                </div>
              </ix:exclude></div>
              <div style="line-height:1.25">
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="vertical-align:top;font-weight:bold;width:70pt">&#160;</td>
                      <td style="vertical-align:top;width:auto">
                        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Payment terms and conditions vary by customer. The Company&#8217;s standard terms for end users usually require of payment upon delivery and for distributors require a down payment and payments made within several month from the invoice date. </span></span></div>
                        <div style="line-height:1.25">&#160;</div>
                        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company may enter into installment sales contracts with end users in North America that provide them with long-term (generally up to 60 months) financing for the purchase of the Company&#8217;s products. The interest rate used in these contracts reflects the credit characteristics of the party receiving financing in the contract, as well as any collateral or security provided by the customer. Interest income on these receivables is recognized as finance income and earned over the terms of the contract.</span></span></div>
                        <div style="line-height:1.25">&#160;</div>
                        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Variable consideration includes price concessions related to installment sales contracts. The Company estimates variable consideration using the most likely outcome amount. Amounts included in the transaction price are recognized only when it is probable that a significant reversal of cumulative revenues will not occur.</span></span></div>
                        <div style="line-height:1.25">&#160;</div>
                        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company does not grant a right of return, refund, cancelation or termination. From time to time, the Company participates in its customers&#8217; marketing activities and deducts such amounts from revenue.</span></span></div>
                        <div style="line-height:1.25">&#160;</div>
                        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Service Revenue</span></span></div>
                        <div style="line-height:1.25">&#160;</div>
                        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company also generates revenues from long-term maintenance contracts (&#8220;Extended Warranty&#8221;). Revenue from Extended Warranty is recognized ratably, on a straight-line basis, over the period of the applicable service contract. These maintenance agreements are included in contract liabilities. Revenue from repairs performed in the absence of Extended Warranty is recognized when the related services are performed.</span></span></div>
                        <div style="line-height:1.25">&#160;</div>
                        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company classifies the portion of contract liabilities not expected to be earned in the subsequent 12 months as long-term.</span></span></div>
                      </td>
                    </tr>

                </table>
              </div>
            </div>
          </ix:nonNumeric><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;</span></span>
          <ix:nonNumeric id="Fxbrl_20240205094945087" name="us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" contextRef="C_20230101to20231231" escape="true">
            <div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="vertical-align:top;font-weight:bold;width:48pt">&#160;</td>
                    <td style="vertical-align:top;width:22pt">
                      <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><strong><span style="font-size:10pt;font-family:Times New Roman, Times, serif">r.</span></strong></p>
                    </td>
                    <td style="vertical-align:top;width:auto">
                      <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Allowance for doubtful accounts and financial instruments &#8211; credit loss</span></span></div>
                      <div style="font-weight:bold">&#160;</div>
                      <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">
                        <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company maintains the allowance for doubtful account resulting from the inability of the Company&#8217;s customers to make required payments.</span></span></div>
                        <div style="line-height:1.25;font-weight:normal">&#160;</div>
                        <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The allowance represents the current estimate of lifetime expected credit losses over the remaining duration of existing accounts receivable. This information includes among other the historic experience, the extent and amount of the account and future expectations.</span></span></div>
                        <div style="line-height:1.25;font-weight:normal">&#160;</div>
                        <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Allowance for credit losses due to the Company&#8217;s accounts receivable amounted to $<ix:nonFraction id="Fxbrl_20240205102249294" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,254</ix:nonFraction> and $<ix:nonFraction id="Fxbrl_20240205102257538" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,318</ix:nonFraction> as of December 31, 2023 and 2022 respectively. Changes in the allowance for credit losses are recognized in general and administrative expenses. Accounts receivable are written-off against the allowance for credit losses when management deems the accounts are no longer collectible.</span></span></div>
                        <div style="line-height:1.25;font-weight:normal">&#160;</div>
                      </div>
                    </td>
                  </tr>

              </table>
              <ix:nonNumeric id="Fxbrl_20240205125408201" name="us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock" contextRef="C_20230101to20231231" escape="true">
                <div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                      <tr>
                        <td style="vertical-align:top;width:48pt">&#160;</td>
                        <td style="vertical-align:top;width:22pt">&#160;</td>
                        <td style="vertical-align:top;width:auto">
                          <div style="font-family:'Times New Roman',Times,serif">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:normal">The following table sets forth activity in the Company&#8217;s allowance for credit losses for</span> each of the years ended December 31, 2023, 2022 and 2021, respectively:</span></span></div>
                          </div>
                        </td>
                      </tr>

                  </table>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="margin-left:81pt">
                    <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                        <tr>
                          <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:middle;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="text-indent:15.85pt;margin-right:7.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at beginning of year</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240205101847644_13" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,318</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240205101847644_17" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,107</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240205101847644_111" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="C_20201231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">672</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:middle;width:64%;vertical-align:bottom">
                            <div style="text-indent:15.85pt;margin-right:7.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Current-period provision</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240205101847644_23" name="us-gaap:ProvisionForDoubtfulAccounts" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,020</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240205101847644_27" name="us-gaap:ProvisionForDoubtfulAccounts" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">449</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240205101847644_211" name="us-gaap:ProvisionForDoubtfulAccounts" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">516</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:middle;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="text-indent:15.85pt;margin-right:7.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Write-offs charged against the</span></span></div>
                            <div style="text-indent:15.85pt;margin-right:7.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">allowance</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240205101847644_33" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">84</ix:nonFraction></span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240205101847644_37" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">238</ix:nonFraction></span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240205101847644_311" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">81</ix:nonFraction></span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                            </div>
                          </td>
                        </tr>
                        <tr>
                          <td style="vertical-align:middle;width:64%;padding-bottom:4px;vertical-align:bottom">
                            <div style="text-indent:15.85pt;margin-right:7.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at end of year</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240205101847644_43" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,254</ix:nonFraction></span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240205101847644_47" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,318</ix:nonFraction></span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240205101847644_411" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,107</ix:nonFraction></span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>

                    </table>
                  </div>
                </div>
              </ix:nonNumeric>
            </div>
          </ix:nonNumeric>
          <div style="line-height:1.25">&#160;</div>
          <div><ix:exclude>
            <div style="clear:both;margin-top:0pt;margin-bottom:0pt">
              <div style="width:100%;margin-top:0pt;margin-bottom:0pt">
                <div style="font-size:10pt"><div><div><div><p style="margin-top:10pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:107%;color:black">F-15</span></span></span></p></div><hr style="border-top:1.5pt solid #000000;page-break-after:always;margin-top:4pt;margin-bottom:10pt"/><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left">&#160;</p><div style="margin-bottom:0pt"><table cellpadding="0" style="font-size:10pt;border-spacing:0px;border-width:0px;border-style:initial;border-color:initial;width:100%;margin-top:0pt"><tr><td style="width:100%;vertical-align:top"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-weight:bold">INMODE LTD.</span></p></td></tr><tr><td style="width:100%;vertical-align:top"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></td></tr><tr><td style="width:100%;vertical-align:top"><p style="margin-top:0pt;margin-bottom:0px;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif">(U.S. dollars in thousands, except for share and per amounts)</p></td></tr></table></div></div></div></div><div style="margin-top:0px;margin-bottom:0px">&#160;</div>
              </div>
            </div>
            <div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold;margin-top:0pt;margin-bottom:0pt">NOTE 2 - SIGNIFICANT</span>&#160;<span style="font-weight:bold;margin-top:0pt;margin-bottom:0pt">ACCOUNTING</span>&#160;<span style="font-weight:bold;margin-top:0pt;margin-bottom:0pt">POLICIES </span>(continued):</span></span>
              <p style="margin:0pt">&#160;</p>
            </div>
          </ix:exclude></div>
          <ix:nonNumeric id="Fxbrl_20240205095022165" name="us-gaap:StandardProductWarrantyPolicy" contextRef="C_20230101to20231231" escape="true">
            <div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:48pt">&#160;</td>
                    <td style="vertical-align:top;font-weight:bold;width:22pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">s.</span></span></td>
                    <td style="vertical-align:top;width:auto">
                      <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Warranty reserve</span></span></div>
                      <div style="font-weight:bold">&#160;</div>
                      <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">
                        <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company provides a one-year standard warranty for its products. The Company records a provision for the estimated cost to repair or replace products under warranty at the time of sale. Factors that affect the Company&#8217;s warranty reserve include the number of units sold, historical and anticipated rates of warranty repairs, the cost per repair and shipping cost. The Company periodically assesses the adequacy of its recorded warranty liabilities and adjusts the amounts as necessary.</span></span></div>
                        <div style="line-height:1.25;font-weight:normal">&#160;</div>
                      </div>
                    </td>
                  </tr>

              </table>
              <ix:nonNumeric id="Fxbrl_20240205125448187" name="us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock" contextRef="C_20230101to20231231" escape="true">
                <div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                      <tr>
                        <td style="vertical-align:top;width:48pt">&#160;</td>
                        <td style="vertical-align:top;width:22pt">&#160;</td>
                        <td style="vertical-align:top;width:auto">
                          <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">
                            <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The following table sets forth activity in the Company&#8217;s accrued warranty account for each of the years ended December 31, 2023, 2022 and 2021, respectively:</span></span></div>
                          </div>
                        </td>
                      </tr>

                  </table>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="margin-left:81pt">
                    <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                        <tr>
                          <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:middle;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="text-indent:15.85pt;margin-right:7.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at beginning of year</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_415" name="us-gaap:StandardProductWarrantyAccrual" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,418</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_416" name="us-gaap:StandardProductWarrantyAccrual" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,248</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_417" name="us-gaap:StandardProductWarrantyAccrual" contextRef="C_20201231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">705</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:middle;width:64%;vertical-align:bottom">
                            <div style="text-indent:15.85pt;margin-right:7.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cost incurred</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_418" name="us-gaap:StandardProductWarrantyAccrualPayments" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,304</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_419" name="us-gaap:StandardProductWarrantyAccrualPayments" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,099</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_420" name="us-gaap:StandardProductWarrantyAccrualPayments" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,453</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                        </tr>
                        <tr>
                          <td style="vertical-align:middle;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="text-indent:15.85pt;margin-right:7.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Expense recognized</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_421" name="us-gaap:StandardProductWarrantyAccrualWarrantiesIssued" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,362</ix:nonFraction></span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_422" name="us-gaap:StandardProductWarrantyAccrualWarrantiesIssued" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,269</ix:nonFraction></span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_423" name="us-gaap:StandardProductWarrantyAccrualWarrantiesIssued" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,996</ix:nonFraction></span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:middle;width:64%;padding-bottom:4px;vertical-align:bottom">
                            <div style="text-indent:15.85pt;margin-right:7.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at end of year</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_424" name="us-gaap:StandardProductWarrantyAccrual" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,476</ix:nonFraction></span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_425" name="us-gaap:StandardProductWarrantyAccrual" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,418</ix:nonFraction></span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_426" name="us-gaap:StandardProductWarrantyAccrual" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,248</ix:nonFraction></span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>

                    </table>
                  </div>
                </div>
              </ix:nonNumeric>
            </div>
          </ix:nonNumeric>
          <div style="line-height:1.25">&#160;</div>
          <ix:nonNumeric id="Fxbrl_20240205095032023" name="us-gaap:CostOfSalesPolicyTextBlock" contextRef="C_20230101to20231231" escape="true">
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:48.4pt">&#160;</td>
                  <td style="width:22.5pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">t.</span></span></td>
                  <td style="width:auto;vertical-align:top">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cost of revenues</span></span></div>
                    <div style="font-weight:bold">&#160;</div>
                    <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">
                      <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cost of revenue consists of products purchased from turnkey sub-contractors which are responsible for the production of most of the Company&#8217;s products under the Company&#8217;s directions and supervision, raw materials for in-house assembly line, shipping and handling costs to customers and to subsidiaries, salary, employee-related expenses and overhead expenses of internal assembly line and service costs associate with warranty.</span></span></div>
                    </div>
                  </td>
                </tr>

            </table>
          </ix:nonNumeric>
          <div style="line-height:1.25">&#160;</div>
          <ix:nonNumeric id="Fxbrl_20240205095035523" name="us-gaap:ResearchAndDevelopmentExpensePolicy" contextRef="C_20230101to20231231" escape="true">
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:48.4pt">&#160;</td>
                  <td style="width:22.5pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">u.</span></span></td>
                  <td style="width:auto;vertical-align:top">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Research and development costs</span></span></div>
                    <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">&#160;<div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Research and development costs are expensed as incurred and includes salaries and employee-related expenses, overhead expenses, material and third-party contractor&#8217;s charges related to product development, regulatory affairs and clinical studies.</span></span></div>
                    </div>
                  </td>
                </tr>

            </table>
          </ix:nonNumeric>
          <div style="line-height:1.25">&#160;</div>
          <ix:nonNumeric id="Fxbrl_20240205095042783" name="us-gaap:EarningsPerSharePolicyTextBlock" contextRef="C_20230101to20231231" escape="true">
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:48.4pt">&#160;</td>
                  <td style="width:22.5pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">v.</span></span></td>
                  <td style="width:auto;vertical-align:top">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Net earnings</span>&#160;<span style="font-weight:bold">per share</span></span></span></div>
                    <div>&#160;</div>
                    <div style="font-family:'Times New Roman',Times,serif">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Basic earnings per share are computed by dividing net income </span></span>attributed to the shareholders of InMode Ltd. by the weighted average number of the Company&#8217;s ordinary shares, par value NIS 0.01 per share (including vested RSUs),<span><span> outstanding for each period, net of treasury shares.</span></span></span></span></div>
                      <div style="line-height:1.25">&#160;</div>
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For the diluted earnings per share calculation, the weighted average number of shares outstanding during the year is adjusted for the average number of shares that are potentially issuable in connection with employee share-based payment, using the treasury stock method.</span></span></div>
                    </div>
                  </td>
                </tr>

            </table>
          </ix:nonNumeric>
          <div style="line-height:1.25">&#160;</div>
          <ix:nonNumeric id="Fxbrl_20240205095052796" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" contextRef="C_20230101to20231231" escape="true">
            <div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:48.4pt">&#160;</td>
                    <td style="width:22.5pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">w.</span></span></td>
                    <td style="width:auto;vertical-align:top">
                      <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair value measurement</span></span></div>
                      <div style="font-weight:bold">&#160;</div>
                      <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">
                        <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company measures fair value and discloses fair value measurements for financial assets and liabilities. Fair value is based on the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. In the absence of active markets for identical assets or liabilities, such measurements involve developing assumptions based on market observable data and, in the absence of such data,</span></span></div>
                        <div style="line-height:1.25;font-weight:normal">&#160;</div>
                        <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">internal information that is consistent with what market participants would use in a hypothetical transaction that occurs at the measurement date. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect the Company&#8217;s market assumptions.</span></span></div>
                      </div>
                    </td>
                  </tr>

              </table><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;</span></span>
              <div><ix:exclude>
                <div style="font-size:10pt"><div><div><div><p style="margin-top:10pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:107%;color:black">F-16</span></span></span></p></div><hr style="border-top:1.5pt solid #000000;page-break-after:always;margin-top:4pt;margin-bottom:10pt"/><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left">&#160;</p><div style="margin-bottom:0pt"><table cellpadding="0" style="font-size:10pt;border-spacing:0px;border-width:0px;border-style:initial;border-color:initial;width:100%;margin-top:0pt"><tr><td style="width:100%;vertical-align:top"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-weight:bold">INMODE LTD.</span></p></td></tr><tr><td style="width:100%;vertical-align:top"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></td></tr><tr><td style="width:100%;vertical-align:top"><p style="margin-top:0pt;margin-bottom:0px;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif">(U.S. dollars in thousands, except for share and per amounts)</p></td></tr></table></div></div></div></div><div style="margin-top:0px;margin-bottom:0px">&#160;</div>
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">NOTE 2 - SIGNIFICANT</span>&#160;<span style="font-weight:bold">ACCOUNTING</span>&#160;<span style="font-weight:bold">POLICIES </span>(continued):</span></span>
                  <p style="margin:0pt">&#160;</p>
                </div>
              </ix:exclude></div>
              <div style="line-height:1.25">
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:48.4pt">&#160;</td>
                      <td style="width:22.5pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">w.</span></span></td>
                      <td style="width:auto;vertical-align:top;font-weight:normal">
                        <div style="font-family:'Times New Roman',Times,serif">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The three levels of inputs that may be used to measure fair value are as follows:</span></span></div>
                        </div>
                      </td>
                    </tr>

                </table>
              </div>
              <div>&#160;</div>
              <div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="vertical-align:top;width:106pt;font-weight:bold">&#160;</td>
                      <td style="width:auto;vertical-align:top">
                        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Level 1 &#8211; Quoted prices (unadjusted) in active markets that are accessible at the measurement date for identical assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs.</span></span></div>
                          <div style="line-height:1.25">&#160;</div>
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Level 2 &#8211; Observable prices that are based on identical or similar instruments not quoted on active markets, but corroborated by observable market data, or quoted prices for similar instruments in active markets.</span></span></div>
                          <div style="line-height:1.25">&#160;</div>
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Level 3 &#8211; Unobservable inputs are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level 3 inputs.</span></span></div>
                        </div>
                      </td>
                    </tr>

                </table>
              </div>
              <div>&#160;</div>
              <div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:48.4pt">&#160;</td>
                      <td style="width:22.5pt;vertical-align:top;font-weight:bold">&#160;</td>
                      <td style="width:auto;vertical-align:top;font-weight:normal">
                        <div style="font-family:'Times New Roman',Times,serif">
                          <div style="line-height:1.25">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company maintains policies and procedures to determine the fair value of financial assets and liabilities using what it considers to be the most relevant and reliable market data available.</span></span></div>
                            <div style="line-height:1.25">&#160;</div>
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of December 31, 2023, and 2022, the fair values of the Company's cash, cash equivalents, short term bank deposits, accounts receivable, accounts payable, approximated the carrying values of these instruments presented in the Company's consolidated balance sheets because of their nature.</span></span></div>
                          </div>
                        </div>
                      </td>
                    </tr>

                </table>
              </div>
            </div>
          </ix:nonNumeric>
          <div>&#160;</div>
          <ix:nonNumeric id="Fxbrl_20240205095119671" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" contextRef="C_20230101to20231231" escape="true">
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:48.4pt">&#160;</td>
                  <td style="width:22.5pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">x.</span></span></td>
                  <td style="width:auto;vertical-align:top">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Segments</span></span></div>
                    <div style="font-family:'Times New Roman',Times,serif;font-weight:normal">&#160;<div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company operates in <ix:nonFraction id="Fxbrl_20240205102757575" name="us-gaap:NumberOfOperatingSegments" contextRef="C_20230101to20231231" unitRef="Segment" scale="0" decimals="0" format="ixt-sec:numwordsen">one</ix:nonFraction> segment. Management does not segregate its business for internal reporting. The Company&#8217;s chief operating decision-maker evaluates the performance of its business based on financial data consistent with the presentation in the accompanying financial statements. The Company concluded that its unified business is conducted globally and accordingly represents one operating segment.</span></span></div>
                      <div style="line-height:1.25">&#160;</div>
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Entity-wide disclosures on revenue and long-lived assets are presented in note 14.</span></span></div>
                    </div>
                  </td>
                </tr>

            </table>
          </ix:nonNumeric>
          <div style="line-height:1.25">&#160;</div>
          <ix:nonNumeric id="Fxbrl_20240205095124323" name="inmd:EmployeeSeveranceBenefitsPolicyTextBlock" contextRef="C_20230101to20231231" escape="true">
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:48.4pt">&#160;</td>
                  <td style="width:22.5pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">y.</span></span></td>
                  <td style="width:auto;vertical-align:top">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Employee severance benefits</span></span></div>
                    <div style="font-weight:bold">&#160;</div>
                    <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">
                      <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company is required to make severance payments upon dismissal of an Israeli employee or upon termination of employment in certain circumstances.</span></span></div>
                      <div style="line-height:1.25;font-weight:normal">&#160;</div>
                      <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In accordance with the current employment terms with all of its employees (Section 14 of the Israeli Severance Pay Law, 1963) located in Israel, the Company makes regular deposits with certain insurance companies for accounts controlled by each applicable employee in order to secure the employee&#8217;s full retirement benefit and severance obligation. The Company is relieved from any severance pay liability with respect to each such employee after it makes the payments on behalf of the employee. The liability accrued in respect of these employees and the amounts funded, as of the respective agreement dates, are not reflected on the Company&#8217;s consolidated balance sheet, as the amounts funded are not under the control and management of the Company and the pension or severance pay risks have been irrevocably transferred to the applicable insurance companies.</span></span></div>
                      <div style="line-height:1.25;font-weight:normal">&#160;</div>
                      <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The amounts of severance payment expenses were $<ix:nonFraction id="FFact_435" name="us-gaap:SeveranceCosts1" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">522</ix:nonFraction>, $<ix:nonFraction id="FFact_436" name="us-gaap:SeveranceCosts1" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">431</ix:nonFraction> and $<ix:nonFraction id="FFact_437" name="us-gaap:SeveranceCosts1" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">405</ix:nonFraction> and for the years ended December 31, 2023, 2022 and 2021, respectively.</span></span></div>
                      <div style="line-height:1.25;font-weight:normal">&#160;</div>
                      <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company expects to contribute approximately $<ix:nonFraction id="FFact_438" name="us-gaap:SeveranceCosts1" contextRef="C_20240101to20241231_srtStatementScenarioAxis_srtScenarioForecastMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">533</ix:nonFraction> in the year ending December 31, 2024 to insurance companies in connection with its expected severance liabilities for the year.</span></span></div>
                    </div>
                  </td>
                </tr>

            </table>
          </ix:nonNumeric>
          <div style="line-height:1.25">&#160;</div>
          <ix:nonNumeric id="Fxbrl_20240205095130567" name="inmd:TreasurySharesPolicyTextBlock" contextRef="C_20230101to20231231" escape="true">
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:48.4pt">&#160;</td>
                  <td style="width:22.5pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">z.</span></span></td>
                  <td style="width:auto;vertical-align:top">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Treasury Shares</span></span></div>
                    <div style="font-weight:bold">&#160;</div>
                    <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">
                      <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Treasury shares are presented as a reduction of equity, at their cost to the Company.</span></span></div>
                    </div>
                  </td>
                </tr>

            </table>
          </ix:nonNumeric>&#160;<div><ix:exclude>
            <div style="line-height:1.25">
              <div style="font-size:10pt"><div><div><div><p style="margin-top:10pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:107%;color:black">F-17</span></span></span></p></div><hr style="border-top:1.5pt solid #000000;page-break-after:always;margin-top:4pt;margin-bottom:10pt"/><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left">&#160;</p><div style="margin-bottom:0pt"><table cellpadding="0" style="font-size:10pt;border-spacing:0px;border-width:0px;border-style:initial;border-color:initial;width:100%;margin-top:0pt"><tr><td style="width:100%;vertical-align:top"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-weight:bold">INMODE LTD.</span></p></td></tr><tr><td style="width:100%;vertical-align:top"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></td></tr><tr><td style="width:100%;vertical-align:top"><p style="margin-top:0pt;margin-bottom:0px;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif">(U.S. dollars in thousands, except for share and per amounts)</p></td></tr></table></div></div></div></div><div style="margin-top:0px;margin-bottom:0px">&#160;</div>
            </div>
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">NOTE 2 - SIGNIFICANT</span>&#160;<span style="font-weight:bold">ACCOUNTING</span>&#160;<span style="font-weight:bold">POLICIES </span>(continued):</span></span>
              <p style="margin:0pt">&#160;</p>
            </div>
          </ix:exclude></div>
          <ix:nonNumeric id="Fxbrl_20240205095137883" name="us-gaap:ConcentrationRiskCreditRisk" contextRef="C_20230101to20231231" escape="true">
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:48.4pt">&#160;</td>
                  <td style="width:22.5pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">aa.</span></span></td>
                  <td style="width:auto;vertical-align:top">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Concentration of credit risks</span></span></div>
                    <div style="font-weight:bold">&#160;</div>
                    <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:normal">Most of the cash and cash equivalents were deposited with U.S., European and Israeli banks and financial institutions and were comprised mainly of money market fund. The U.S. market constituted approximately 63% of the revenues in 2023.</span></span></span></div>
                      <div style="line-height:1.25">&#160;</div>
                      <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The exposure of credit risks relating to other trade receivables outside the U.S. is limited, due to the relatively large number of group customers and their wide geographic distribution. The Company performs ongoing credit evaluations of its customers for the purpose of determining the appropriate allowance for Credit Losses and generally does not require collateral and from time to time the Company may choose to purchase trade credit insurance.</span></span></div>
                    </div>
                  </td>
                </tr>

            </table>
          </ix:nonNumeric>
          <div style="line-height:1.25">&#160;</div>
          <ix:nonNumeric id="Fxbrl_20240205095148046" name="inmd:WarRiskSituationInIsraelPolicyTextBlock" contextRef="C_20230101to20231231" escape="true">
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:48.4pt">&#160;</td>
                  <td style="width:22.5pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">ab.</span></span></td>
                  <td style="width:auto;vertical-align:top">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">War risk situation in Israel</span></span></div>
                    <div style="font-weight:bold">&#160;</div>
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:normal">In October 2023, Israel was attacked by a terrorist organization and entered a state of war. As of the date of these consolidated financial statements, the war is ongoing and continues to evolve. The Company's headquarter, its R&amp;D operations, and certain manufacturing facilities are located in Israel. Currently, such activities in Israel remain largely unaffected. During the year ended December 31, 2023, the impact of this war on the Company&#8217;s results of operations and financial condition was immaterial, but such impact may increase, which could be material, as a result of the continuation, escalation or expansion of such war.</span></span></span></div>
                  </td>
                </tr>

            </table>
          </ix:nonNumeric>
          <div style="line-height:1.25">&#160;<div>
              <ix:nonNumeric id="Fxbrl_20240205095154190" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" contextRef="C_20230101to20231231" escape="true">
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:48.4pt">&#160;</td>
                      <td style="width:22.5pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">ac.</span></span></td>
                      <td style="width:auto;vertical-align:top">
                        <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">
                          <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Newly issued accounting pronouncements, not yet adopted</span></span></div>
                          <div style="line-height:1.25;font-weight:bold">&#160;</div>
                        </div>
                        <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">
                          <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In December 2023, the FASB issued ASU 2023-09 &#8220;Income Taxes (Topic 740): Improvements to Income Tax Disclosures&#8221;. This guidance is intended to enhance the transparency and decision-usefulness of income tax disclosures. The amendments in ASU 2023-09 address investor requests for enhanced income tax information primarily through changes to disclosure regarding rate reconciliation and income taxes paid both in the U.S. and in foreign jurisdictions. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024 on a prospective basis. Early adoption is permitted, with the option to apply the standard retrospectively. The Company is currently evaluating this guidance to determine the impact it may have on its consolidated financial statements disclosures.</span></span></div>
                          <div style="line-height:1.25;font-weight:normal">&#160;</div>
                          <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In November 2023, the FASB issued ASU 2023-07 &#8220;Segment Reporting: Improvements to Reportable Segment Disclosures&#8221;. This guidance expands public entities&#8217; segment disclosures primarily by requiring disclosure of significant segment expenses that are regularly provided to the chief operating decision maker and included within each reported measure of segment profit or loss, an amount and description of its composition for other segment items, and interim disclosures of a reportable.</span></span></div>
                        </div>
                      </td>
                    </tr>

                </table>
              </ix:nonNumeric>
            </div>
          </div>
        </div>
      </div>
    </ix:nonNumeric>
    <p style="margin-top:0pt;margin-bottom:0pt">&#160;</p>
  </div>
</div><div style="">
  <div>
    <ix:nonNumeric id="Fxbrl_20240205112729720" name="inmd:MarketableSecuritiesAndFairValueMeasurements" contextRef="C_20230101to20231231" escape="true">
      <div>
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 3 - MARKETABLE SECURITIES AND FAIR VALUE MEASUREMENTS:</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="line-height:1.25">
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:49pt;vertical-align:top;font-weight:bold">&#160;</td>
                <td style="width:auto;vertical-align:top">
                  <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">
                    <div style="line-height:1.25;font-weight:normal">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">AFS securities as of December 31, 2023 and 2022, consisted of government bonds, municipal bonds, corporate debt securities, commercial paper and certificates of deposit. These marketable securities are recorded at fair value.</span></span></div>
                    </div>
                  </div>
                </td>
              </tr>

          </table>
        </div>&#160;<div><ix:exclude>
          <div style="clear:both;margin-top:0pt;margin-bottom:0pt">
            <div style="width:100%;margin-top:0pt;margin-bottom:0pt">
              <div style="font-size:10pt"><div><div><div><p style="margin-top:10pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:107%;color:black">F-18</span></span></span></p></div><hr style="border-top:1.5pt solid #000000;page-break-after:always;margin-top:4pt;margin-bottom:10pt"/><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left">&#160;</p><div style="margin-bottom:0pt"><table cellpadding="0" style="font-size:10pt;border-spacing:0px;border-width:0px;border-style:initial;border-color:initial;width:100%;margin-top:0pt"><tr><td style="width:100%;vertical-align:top"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-weight:bold">INMODE LTD.</span></p></td></tr><tr><td style="width:100%;vertical-align:top"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></td></tr><tr><td style="width:100%;vertical-align:top"><p style="margin-top:0pt;margin-bottom:0px;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif">(U.S. dollars in thousands, except for share and per amounts)</p></td></tr></table></div></div></div></div><div style="margin-top:0px;margin-bottom:0px">&#160;</div>
            </div>
          </div>
          <div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold;margin-top:0pt;margin-bottom:0pt">NOTE 3 - MARKETABLE SECURITIES AND FAIR VALUE MEASUREMENTS </span>(continued):</span></span>
            <p style="margin:0pt">&#160;</p>
          </div>
        </ix:exclude></div>
        <ix:nonNumeric id="Fxbrl_20240205112634685" name="us-gaap:MarketableSecuritiesTextBlock" contextRef="C_20230101to20231231" escape="true">
          <div>
            <div style="line-height:1.25">
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="vertical-align:top;width:49pt">&#160;</td>
                    <td style="vertical-align:top;width:auto">
                      <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">
                        <div style="line-height:1.25;font-weight:normal">
                          <div style="line-height:1.25">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The following table sets forth the Company&#8217;s marketable securities for the periods indicated:</span></span></div>
                          </div>
                        </div>
                      </div>
                    </td>
                  </tr>

              </table>
            </div>
            <div style="margin-left:49.65pt;line-height:1.25">&#160;</div>
            <div style="margin-left:54pt">
              <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td colspan="1" style="vertical-align:bottom;padding-left:9pt;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:top;padding-left:9pt;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:middle;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Government bonds *</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_444" name="us-gaap:MarketableSecuritiesCurrent" contextRef="C_20231231_usgaapFinancialInstrumentAxis_usgaapUSGovernmentAgenciesDebtSecuritiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">353,414</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_445" name="us-gaap:MarketableSecuritiesCurrent" contextRef="C_20221231_usgaapFinancialInstrumentAxis_usgaapUSGovernmentAgenciesDebtSecuritiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">339,684</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:middle;width:76%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Municipal bonds</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_446" name="us-gaap:MarketableSecuritiesCurrent" contextRef="C_20231231_usgaapFinancialInstrumentAxis_usgaapMunicipalBondsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,319</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120021708616" name="us-gaap:MarketableSecuritiesCurrent" contextRef="C_20221231_usgaapFinancialInstrumentAxis_usgaapMunicipalBondsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,551</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:middle;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Corporate debt securities</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_448" name="us-gaap:MarketableSecuritiesCurrent" contextRef="C_20231231_usgaapFinancialInstrumentAxis_usgaapCorporateDebtSecuritiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,234</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_449" name="us-gaap:MarketableSecuritiesCurrent" contextRef="C_20221231_usgaapFinancialInstrumentAxis_usgaapCorporateDebtSecuritiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">21,252</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:middle;width:76%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Commercial paper</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120032254671" name="us-gaap:MarketableSecuritiesCurrent" contextRef="C_20231231_usgaapFinancialInstrumentAxis_usgaapCommercialPaperMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120032335072" name="us-gaap:MarketableSecuritiesCurrent" contextRef="C_20221231_usgaapFinancialInstrumentAxis_usgaapCommercialPaperMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,195</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:middle;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Certificates of deposit</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_450" name="us-gaap:MarketableSecuritiesCurrent" contextRef="C_20231231_usgaapFinancialInstrumentAxis_usgaapCertificatesOfDepositMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,680</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_451" name="us-gaap:MarketableSecuritiesCurrent" contextRef="C_20221231_usgaapFinancialInstrumentAxis_usgaapCertificatesOfDepositMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,907</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:middle;width:76%;padding-bottom:4px;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_452" name="us-gaap:MarketableSecuritiesCurrent" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">373,647</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_453" name="us-gaap:MarketableSecuritiesCurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">374,589</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>

              </table>
            </div>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:49pt;vertical-align:top;font-family:'Times New Roman',Times,serif;text-align:center">&#160;</td>
                  <td style="width:auto;vertical-align:top">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">* As of December 31, 2023 and 2022, consists of $<ix:nonFraction id="FFact_454" name="us-gaap:MarketableSecuritiesCurrent" contextRef="C_20231231_usgaapFinancialInstrumentAxis_inmdNonUsGovernmentAgenciesDebtSecuritiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">0</ix:nonFraction> and $<ix:nonFraction id="FFact_455" name="us-gaap:MarketableSecuritiesCurrent" contextRef="C_20221231_usgaapFinancialInstrumentAxis_inmdNonUsGovernmentAgenciesDebtSecuritiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,502</ix:nonFraction> non-U.S. government bonds, respectively.</span></span></div>
                  </td>
                </tr>

            </table>
          </div>
        </ix:nonNumeric>
        <div style="line-height:1.25">&#160;</div>
        <div style="line-height:1.25">
          <div style="line-height:1.25">
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:49pt;vertical-align:top;font-weight:bold">&#160;</td>
                  <td style="width:auto;vertical-align:top">
                    <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">
                      <div style="line-height:1.25;font-weight:normal">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company classifies AFS securities within Level 2 because it uses alternative pricing sources and models utilizing market observable inputs to determine their fair value. See also note 2(w).</span></span></div>
                            <div style="line-height:1.25">&#160;</div>
                          </div>
                        </div>
                      </div>
                    </div>
                  </td>
                </tr>

            </table>
          </div>
          <ix:nonNumeric id="Fxbrl_20240205112651050" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock" contextRef="C_20230101to20231231" escape="true">
            <div>
              <div style="line-height:1.25">
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="vertical-align:top;width:49pt">&#160;</td>
                      <td style="vertical-align:top;width:auto">
                        <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">
                          <div style="line-height:1.25;font-weight:normal">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The following table sets forth the Company&#8217;s financial assets as of December 31, 2023 and 2022, that are measured at fair value on a recurring basis during the period:</span></span></div>
                              </div>
                            </div>
                          </div>
                        </div>
                      </td>
                    </tr>

                </table>
              </div>
              <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;<div style="line-height:1.25">
                  <div>
                    <div style="margin-left:54pt">
                      <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                          <tr>
                            <td rowspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                            <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                            <td colspan="14" rowspan="1" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                              <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">December 31, 2023&#160;</span></span></span></strong></div>
                            </td>
                            <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                              <div style="line-height:1.25">
                                <div style="line-height:1.25;font-weight:bold;text-align:center"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Fair</span></span></span></span></strong></div>
                                <div style="line-height:1.25;font-weight:bold;text-align:center"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>value</span></span></span></span></strong></div>
                              </div>
                            </td>
                            <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;text-align:center">&#160;</td>
                            <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;text-align:center">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                              <div style="line-height:1.25;font-weight:bold;text-align:center"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Cost or</span></span></span></span></strong></div>
                              <div style="line-height:1.25;font-weight:bold;text-align:center"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>amortized</span></span></span></span></strong></div>
                              <div style="line-height:1.25;font-weight:bold;text-align:center"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>cost</span></span></span></span></strong></div>
                            </td>
                            <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;text-align:center">&#160;</td>
                            <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;text-align:center">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                              <div style="line-height:1.25;font-weight:bold;text-align:center"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Gross</span></span></span></span></strong></div>
                              <div style="line-height:1.25;font-weight:bold;text-align:center"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>unrealized</span></span></span></span></strong></div>
                              <div style="line-height:1.25;font-weight:bold;text-align:center"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>holding loss</span></span></span></span></strong></div>
                            </td>
                            <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;text-align:center">&#160;</td>
                            <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;text-align:center">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                              <div style="line-height:1.25;font-weight:bold;text-align:center">
                                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Gross</span></span></strong></p>
                                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">unrealized</span></span></strong></p>
                                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">holding</span></span></strong></p>
                                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">gains</span></span></strong></p>
                              </div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;background-color:rgb(204, 238, 255);vertical-align:bottom">
                              <div style="margin-left:7.1pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Level 2 securities:</span></span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:52%;vertical-align:bottom">
                              <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;margin-left:27pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Government bonds</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_457" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_20231231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapUSGovernmentAgenciesDebtSecuritiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">353,414</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_458" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="C_20231231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapUSGovernmentAgenciesDebtSecuritiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">355,382</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_459" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" contextRef="C_20231231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapUSGovernmentAgenciesDebtSecuritiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,139</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_460" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" contextRef="C_20231231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapUSGovernmentAgenciesDebtSecuritiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">171</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                              <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;margin-left:27pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Municipal bonds</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_461" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_20231231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapMunicipalBondsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,319</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_462" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="C_20231231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapMunicipalBondsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,363</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_463" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" contextRef="C_20231231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapMunicipalBondsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">44</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240205143326095" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" contextRef="C_20231231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapMunicipalBondsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:52%;vertical-align:bottom">
                              <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;margin-left:27pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Corporate debt securities</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_465" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_20231231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapCorporateDebtSecuritiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,234</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_466" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="C_20231231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapCorporateDebtSecuritiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,404</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_467" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" contextRef="C_20231231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapCorporateDebtSecuritiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">170</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_468" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" contextRef="C_20231231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapCorporateDebtSecuritiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:52%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                              <div style="line-height:1.25">
                                <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;margin-left:27pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Certificates of deposit</span></span></div>
                              </div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                              <div style="line-height:1.25">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_469" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_20231231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapCertificatesOfDepositMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,680</ix:nonFraction></span></span></div>
                              </div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_470" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="C_20231231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapCertificatesOfDepositMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,680</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_471" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" contextRef="C_20231231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapCertificatesOfDepositMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_472" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" contextRef="C_20231231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapCertificatesOfDepositMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;width:52%;padding-bottom:4px;vertical-align:bottom">
                              <div style="line-height:1.25">
                                <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
                              </div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                              <div style="line-height:1.25">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_473" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_20231231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">373,647</ix:nonFraction></span></span></div>
                              </div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_474" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="C_20231231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">375,829</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_475" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" contextRef="C_20231231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,353</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_476" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" contextRef="C_20231231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">171</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          </tr>

                      </table>
                    </div>
                    <div>&#160;<div style="margin-left:54pt">
                        <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                            <tr>
                              <td rowspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                              <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                              <td colspan="14" rowspan="1" style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span><span><span style="font-weight:bold">December 31, 2022</span></span></span></strong></span></span></td>
                              <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                                <div style="line-height:1.25">
                                  <div style="line-height:1.25;font-weight:bold;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span><span>Fair</span></span></strong></span></span></div>
                                  <div style="line-height:1.25;font-weight:bold;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span><span>value</span></span></strong></span></span></div>
                                </div>
                              </td>
                              <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;text-align:center">&#160;</td>
                              <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;text-align:center">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                                <div style="line-height:1.25;font-weight:bold;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span><span>Cost or </span></span></strong></span></span></div>
                                <div style="line-height:1.25;font-weight:bold;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span><span>amortized </span></span></strong></span></span></div>
                                <div style="line-height:1.25;font-weight:bold;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span><span>cost</span></span></strong></span></span></div>
                              </td>
                              <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;text-align:center">&#160;</td>
                              <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;text-align:center">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                                <div style="line-height:1.25;font-weight:bold;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span><span>Gross </span></span></strong></span></span></div>
                                <div style="line-height:1.25;font-weight:bold;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span><span>unrealized</span></span></strong></span></span></div>
                                <div style="line-height:1.25;font-weight:bold;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span><span>holding loss</span></span></strong></span></span></div>
                              </td>
                              <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;text-align:center">&#160;</td>
                              <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;text-align:center">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                                <div style="line-height:1.25;font-weight:bold;text-align:center">
                                  <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Gross<br/>unrealized<br/>holding<br/>gains</span></span></p>
                                </div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:middle;background-color:rgb(204, 238, 255);vertical-align:bottom">
                                <div style="margin-left:7.1pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Level 2 securities:</span></span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:middle;width:52%;vertical-align:bottom">
                                <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;margin-left:27pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Government bonds</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_477" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_20221231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapUSGovernmentAgenciesDebtSecuritiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">339,684</ix:nonFraction></span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_478" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="C_20221231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapUSGovernmentAgenciesDebtSecuritiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">348,687</ix:nonFraction></span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_479" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" contextRef="C_20221231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapUSGovernmentAgenciesDebtSecuritiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,003</ix:nonFraction></span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_480" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" contextRef="C_20221231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapUSGovernmentAgenciesDebtSecuritiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:middle;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                                <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;margin-left:27pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Municipal bonds</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120031549545" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_20221231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapMunicipalBondsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,551</ix:nonFraction></span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120031616068" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="C_20221231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapMunicipalBondsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,674</ix:nonFraction></span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230120031655473" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" contextRef="C_20221231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapMunicipalBondsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">123</ix:nonFraction></span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120031731450" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" contextRef="C_20221231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapMunicipalBondsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:middle;width:52%;vertical-align:bottom">
                                <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;margin-left:27pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Corporate debt securities</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_481" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_20221231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapCorporateDebtSecuritiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">21,252</ix:nonFraction></span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_482" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="C_20221231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapCorporateDebtSecuritiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">21,850</ix:nonFraction></span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_483" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" contextRef="C_20221231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapCorporateDebtSecuritiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">612</ix:nonFraction></span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_484" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" contextRef="C_20221231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapCorporateDebtSecuritiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14</ix:nonFraction></span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:middle;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                                <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;margin-left:27pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Commercial paper</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120031159247" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_20221231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapCommercialPaperMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,195</ix:nonFraction></span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120031250775" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="C_20221231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapCommercialPaperMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,195</ix:nonFraction></span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120031416602" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" contextRef="C_20221231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapCommercialPaperMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120031449159" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" contextRef="C_20221231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapCommercialPaperMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:middle;width:52%;padding-bottom:2px;vertical-align:bottom">
                                <div style="line-height:1.25">
                                  <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;margin-left:27pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Certificates of deposit</span></span></div>
                                </div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                                <div style="line-height:1.25">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_485" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_20221231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapCertificatesOfDepositMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,907</ix:nonFraction></span></span></div>
                                </div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_486" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="C_20221231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapCertificatesOfDepositMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,914</ix:nonFraction></span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230120204142744" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" contextRef="C_20221231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapCertificatesOfDepositMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7</ix:nonFraction></span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_488" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" contextRef="C_20221231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapCertificatesOfDepositMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:top;width:52%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                                <div style="line-height:1.25">
                                  <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
                                </div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                                <div style="line-height:1.25">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_489" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_20221231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">374,589</ix:nonFraction></span></span></div>
                                </div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_490" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="C_20221231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">384,320</ix:nonFraction></span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_491" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" contextRef="C_20221231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,745</ix:nonFraction></span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_492" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" contextRef="C_20221231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14</ix:nonFraction></span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                            </tr>

                        </table>
                      </div>
                    </div>
                  </div>
                </div>
              </div>
            </div>
          </ix:nonNumeric>
        </div>
        <div style="line-height:1.25">
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:49pt;vertical-align:top;font-family:'Times New Roman',Times,serif;text-align:center">&#160;</td>
                <td style="width:auto;vertical-align:top">&#160;</td>
              </tr>
              <tr>
                <td style="width:49pt;vertical-align:top;font-family:'Times New Roman',Times,serif;text-align:center">&#160;</td>
                <td style="width:auto;vertical-align:top">
                  <div style="font-family:'Times New Roman',Times,serif">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of December 31, 2023 and 2022, the Company considered, based on its evaluation, that the decreases in market value on relevant marketable securities were temporarily impaired and primarily attributable to changes in interest rates, and therefore did not result in an impairment charge in finance income (expenses), net.</span></span></div>
                  </div>
                </td>
              </tr>

          </table>
        </div>&#160;<div style="margin-top:0pt;margin-bottom:0pt"><ix:exclude>
          <div style="clear:both;margin-top:0pt;margin-bottom:0pt">
            <div style="text-align:center;margin-top:0pt;margin-bottom:0pt">
              <div style="font-size:10pt"><div><div><div><p style="margin-top:10pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:107%;color:black">F-19</span></span></span></p></div><hr style="border-top:1.5pt solid #000000;page-break-after:always;margin-top:4pt;margin-bottom:10pt"/><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left">&#160;</p><div style="margin-bottom:0pt"><table cellpadding="0" style="font-size:10pt;border-spacing:0px;border-width:0px;border-style:initial;border-color:initial;width:100%;margin-top:0pt"><tr><td style="width:100%;vertical-align:top"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-weight:bold">INMODE LTD.</span></p></td></tr><tr><td style="width:100%;vertical-align:top"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></td></tr><tr><td style="width:100%;vertical-align:top"><p style="margin-top:0pt;margin-bottom:0px;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif">(U.S. dollars in thousands, except for share and per amounts)</p></td></tr></table></div></div></div></div><div style="margin-top:0px;margin-bottom:0px">&#160;</div>
              <p style="margin:0pt;text-align:left"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold;margin-top:0pt;margin-bottom:0pt">NOTE 3 - MARKETABLE SECURITIES AND FAIR VALUE MEASUREMENTS </span>(continued):</span></span></p>
              <p style="margin:0pt">&#160;</p>
            </div>
          </div>
        </ix:exclude></div>
        <ix:nonNumeric id="Fxbrl_20240205112710072" name="us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock" contextRef="C_20230101to20231231" escape="true">
          <div>
            <div style="line-height:1.25">
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="vertical-align:top;width:49pt">&#160;</td>
                    <td style="vertical-align:top;width:auto">
                      <div style="font-family:'Times New Roman',Times,serif">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of December 31, 2023 and 2022, the Company&#8217;s debt securities and certificates of deposit had the following maturity dates:</span></span></div>
                        </div>
                      </div>
                    </td>
                  </tr>

              </table>
            </div>
            <div style="margin-left:49.65pt;line-height:1.25">&#160;</div>
            <div style="margin-left:54pt">
              <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:middle;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Due within one year</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_494" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">308,671</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_495" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">243,094</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:middle;width:76%;vertical-align:bottom">
                      <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1 to 2 years</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_496" name="inmd:AvailableForSaleSecuritiesDebtMaturitiesWithInOneToTwoYearsFairValue" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">49,259</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_497" name="inmd:AvailableForSaleSecuritiesDebtMaturitiesWithInOneToTwoYearsFairValue" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">124,037</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:middle;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 to 3 years</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_498" name="inmd:AvailableForSaleSecuritiesDebtMaturitiesWithInTwoToThreeYearsFairValue" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,717</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_499" name="inmd:AvailableForSaleSecuritiesDebtMaturitiesWithInTwoToThreeYearsFairValue" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,458</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:middle;width:76%;padding-bottom:4px;vertical-align:bottom">
                      <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_500" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">373,647</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_501" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">374,589</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>

              </table>
            </div>
          </div>
        </ix:nonNumeric>
      </div>
    </ix:nonNumeric>
    <p style="margin-top:0pt;margin-bottom:0pt">&#160;</p>
  </div>
</div><div style="">
  <div>
    <ix:nonNumeric id="Fxbrl_20240205111114115" name="us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" contextRef="C_20230101to20231231" escape="true">
      <div>
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 4 - ACCOUNTS RECEIVABLE:</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <ix:nonNumeric id="Fxbrl_20240205111100218" name="us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" contextRef="C_20230101to20231231" escape="true">
          <div>
            <div style="line-height:1.25">
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="vertical-align:top;width:49pt">&#160;</td>
                    <td style="vertical-align:top;width:auto">
                      <div style="font-family:'Times New Roman',Times,serif">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Accounts receivable consist of the following:</span></span></div>
                          </div>
                        </div>
                      </div>
                    </td>
                  </tr>

              </table>
            </div>
            <div style="margin-right:1.95pt;margin-left:49.65pt;line-height:1.25">&#160;</div>
            <div style="margin-left:54pt">
              <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td rowspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="6" rowspan="1" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td rowspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" rowspan="1" style="text-align:center;font-weight:bold;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" rowspan="1" style="vertical-align:top;text-align:center;font-weight:bold;border-bottom:#000000 solid 2px;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></td>
                    <td colspan="1" rowspan="1" style="font-weight:bold;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" rowspan="1" style="text-align:center;font-weight:bold;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" rowspan="1" style="vertical-align:top;text-align:center;font-weight:bold;border-bottom:#000000 solid 2px;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></td>
                    <td colspan="1" rowspan="1" style="font-weight:bold;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_504" name="us-gaap:AccountsReceivableGross" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">46,646</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_505" name="us-gaap:AccountsReceivableGross" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">29,859</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Notes receivable</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_506" name="us-gaap:NotesReceivableGross" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,640</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_507" name="us-gaap:NotesReceivableGross" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,429</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Less - allowance for credit losses</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_508" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,254</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_509" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,318</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </div>
                    </td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_510" name="us-gaap:AccountsAndNotesReceivableNet" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">46,032</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_511" name="us-gaap:AccountsAndNotesReceivableNet" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">30,970</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Less - non-current accounts receivable, net</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_512" name="us-gaap:AccountsReceivableNetNoncurrent" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,670</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_513" name="us-gaap:AccountsReceivableNetNoncurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,973</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </div>
                    </td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total current accounts receivable, net</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_514" name="us-gaap:AccountsReceivableNetCurrent" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">42,362</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_515" name="us-gaap:AccountsReceivableNetCurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">26,997</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>

              </table>
            </div>
          </div>
        </ix:nonNumeric>
      </div>
    </ix:nonNumeric>
    <p style="margin-top:0pt;margin-bottom:0pt">&#160;</p>
  </div>
</div><div style="">
  <div>
    <ix:nonNumeric id="Fxbrl_20240205111947187" name="inmd:PrepaidExpensesAndOtherCurrentReceivablesTextBlock" contextRef="C_20230101to20231231" escape="true">
      <div>
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 5 - PREPAID EXPENSES AND OTHER CURRENT RECEIVABLES:</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <ix:nonNumeric id="Fxbrl_20240205111933156" name="inmd:ScheduleOfPrepaidExpensesAndOtherCurrentRecivablesTableTextBlock" contextRef="C_20230101to20231231" escape="true">
          <div>
            <div style="line-height:1.25">
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="vertical-align:top;width:49pt">&#160;</td>
                    <td style="vertical-align:top;width:auto">
                      <div style="font-family:'Times New Roman',Times,serif">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Prepaid expenses and other current receivables consist of the following:</span></span></div>
                            </div>
                          </div>
                        </div>
                      </div>
                    </td>
                  </tr>

              </table>
            </div>
            <div style="line-height:1.25">&#160;</div>
            <div style="margin-left:54pt">
              <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="6" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Advances to suppliers</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_518" name="inmd:OtherAdvancesToSuppliersCurrent" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,960</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_519" name="inmd:OtherAdvancesToSuppliersCurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,898</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Prepaid expenses</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_520" name="inmd:OtherPrepaidExpensesReceivablesCurrent" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,041</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_521" name="inmd:OtherPrepaidExpensesReceivablesCurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,928</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Government institutions</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_522" name="inmd:OtherGovernmentInstitutionsReceivablesCurrent" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">948</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_523" name="inmd:OtherGovernmentInstitutionsReceivablesCurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">879</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Income tax</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_524" name="inmd:OtherIncomeTaxReceivablesCurrent" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">66</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_525" name="inmd:OtherIncomeTaxReceivablesCurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">44</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_526" name="us-gaap:OtherReceivablesGrossCurrent" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">253</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_527" name="us-gaap:OtherReceivablesGrossCurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">345</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total other current receivables</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_528" name="us-gaap:OtherReceivablesNetCurrent" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">16,268</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_529" name="us-gaap:OtherReceivablesNetCurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,094</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>

              </table>
            </div>
          </div>
        </ix:nonNumeric>
      </div>
    </ix:nonNumeric>
    <p style="margin-top:0pt;margin-bottom:0pt">&#160;</p>
  </div>
</div><div style="">
  <ix:nonNumeric id="FFact_539" name="us-gaap:InventoryDisclosureTextBlock" contextRef="C_20230101to20231231" escape="true">
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0px;margin-bottom:0pt"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 6 - INVENTORIES:</span></span></strong></p>
    <div>
      <div>
        <div style="line-height:1.25">&#160;</div>
        <ix:nonNumeric id="Fxbrl_20240205113625734" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" contextRef="C_20230101to20231231" escape="true">
          <div>
            <div style="line-height:1.25">
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="vertical-align:top;width:49pt">&#160;</td>
                    <td style="vertical-align:top;width:auto">
                      <div style="font-family:'Times New Roman',Times,serif">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Inventories consist of the following:</span></span></div>
                              </div>
                            </div>
                          </div>
                        </div>
                      </div>
                    </td>
                  </tr>

              </table>
            </div>
            <div style="margin-right:1.95pt;margin-left:49.65pt;line-height:1.25">&#160;</div>
            <div style="margin-left:54pt">
              <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td rowspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="6" rowspan="1" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td rowspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" rowspan="1" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" rowspan="1" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Raw materials</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_532" name="us-gaap:InventoryRawMaterials" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,080</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_533" name="us-gaap:InventoryRawMaterials" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,686</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Finished products</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_534" name="us-gaap:InventoryFinishedGoods" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">33,015</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_535" name="us-gaap:InventoryFinishedGoods" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">26,211</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total inventories</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_536" name="us-gaap:InventoryNet" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">45,095</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_537" name="us-gaap:InventoryNet" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">39,897</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>

              </table>
            </div>
          </div>
        </ix:nonNumeric>
      </div>
    </div>
  </ix:nonNumeric>
  <p style="margin:0pt">&#160;</p>
  <div style="font-size:10pt"><div><div><div><p style="margin-top:10pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:107%;color:black">F-20</span></span></span></p></div><hr style="border-top:1.5pt solid #000000;page-break-after:always;margin-top:4pt;margin-bottom:10pt"/><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left">&#160;</p><div style="margin-bottom:0pt"><table cellpadding="0" style="font-size:10pt;border-spacing:0px;border-width:0px;border-style:initial;border-color:initial;width:100%;margin-top:0pt"><tr><td style="width:100%;vertical-align:top"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-weight:bold">INMODE LTD.</span></p></td></tr><tr><td style="width:100%;vertical-align:top"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></td></tr><tr><td style="width:100%;vertical-align:top"><p style="margin-top:0pt;margin-bottom:0px;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif">(U.S. dollars in thousands, except for share and per amounts)</p></td></tr></table></div></div></div></div><div style="margin-top:0px;margin-bottom:0px">&#160;</div>
</div><div style="">
  <div>
    <ix:nonNumeric id="Fxbrl_20240205113706519" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" contextRef="C_20230101to20231231" escape="true">
      <div>
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 7 - PROPERTY AND EQUIPMENT, NET:</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <ix:nonNumeric id="Fxbrl_20240205113728326" name="us-gaap:PropertyPlantAndEquipmentTextBlock" contextRef="C_20230101to20231231" escape="true">
          <div>
            <div style="line-height:1.25">
              <div style="line-height:1.25">
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:49pt;vertical-align:top;font-family:'Times New Roman',Times,serif;text-align:center">&#160;</td>
                      <td style="width:auto;vertical-align:top">
                        <div style="font-family:'Times New Roman',Times,serif">
                          <div style="line-height:1.25">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25">
                                <div style="line-height:1.25">
                                  <div style="line-height:1.25">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Composition of property and equipment grouped by major classifications is as follows:</span></span></div>
                                  </div>
                                </div>
                              </div>
                            </div>
                          </div>
                        </div>
                      </td>
                    </tr>

                </table>
              </div>
            </div>
            <div style="line-height:1.25">&#160;</div>
            <div style="margin-left:54pt">
              <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td rowspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="6" rowspan="1" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td rowspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" rowspan="1" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" rowspan="1" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="margin-right:7.2pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Computers</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_540" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_20231231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapComputerEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,334</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_541" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapComputerEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,191</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;vertical-align:bottom">
                      <div style="margin-right:7.2pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Office furniture and equipment</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_542" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_20231231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapOfficeEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">670</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_543" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapOfficeEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">562</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="margin-right:7.2pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Molds</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_544" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_20231231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapToolsDiesAndMoldsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,592</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_545" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapToolsDiesAndMoldsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,550</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
                      <div style="margin-right:7.2pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Leasehold improvements</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_546" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_20231231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdImprovementsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,243</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_547" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdImprovementsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">829</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240205113856622" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,839</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240205113909598" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,132</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;padding-bottom:2px;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Less: accumulated depreciation</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_550" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,457</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_551" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,834</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </div>
                    </td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="margin-right:7.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total property and equipment, net</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_552" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,382</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_553" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,298</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>

              </table>
            </div>
          </div>
        </ix:nonNumeric>
        <div style="line-height:1.25">&#160;</div>
        <div style="line-height:1.25">
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:49pt;vertical-align:top;font-family:'Times New Roman',Times,serif;text-align:center">&#160;</td>
                <td style="width:auto;vertical-align:top">
                  <div style="font-family:'Times New Roman',Times,serif">
                    <div style="line-height:1.25">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total depreciation and amortization in respect of property and equipment were $<ix:nonFraction id="FFact_555" name="us-gaap:DepreciationDepletionAndAmortization" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">623</ix:nonFraction>, $<ix:nonFraction id="FFact_556" name="us-gaap:DepreciationDepletionAndAmortization" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">680</ix:nonFraction> and $<ix:nonFraction id="FFact_557" name="us-gaap:DepreciationDepletionAndAmortization" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">517</ix:nonFraction> for the years ended December 31, 2023, 2022 and 2021, respectively.</span></span></div>
                              </div>
                            </div>
                          </div>
                        </div>
                      </div>
                    </div>
                  </div>
                </td>
              </tr>

          </table>
        </div>
      </div>
    </ix:nonNumeric>
  </div>
  <p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left">&#160;</p>
</div><div style="">
  <ix:nonNumeric id="FFact_565" name="us-gaap:InvestmentTextBlock" contextRef="C_20230101to20231231" escape="true">
    <div>
      <div>
        <div style="line-height:1.25;font-weight:bold">
          <p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">NOTE 8 - OTHER INVESTMENTS:</span></span></p>
          <p style="margin:0pt">&#160;</p>
        </div>
        <div style="line-height:1.25;margin-top:0pt">
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%">

              <tr style="vertical-align:top">
                <td style="text-align:right;vertical-align:top;width:9pt">
                  <div style="margin-left:49.65pt;line-height:1.25;text-align:justify">&#160;</div>
                </td>
                <td style="text-align:left;vertical-align:top;width:auto">
                  <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">
                    <div>
                      <div style="line-height:1.25">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25">
                                <div style="line-height:1.25">
                                  <div style="line-height:1.25">
                                    <div style="line-height:1.25">
                                      <p><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>In November 2019, the Company signed a Share Purchase and Shareholders Agreement (the &#8220;SPA&#8221;) with (BY) Medimor Ltd., one of the Company&#8217;s turnkey manufacturing subcontractors (&#8220;Medimor&#8221;). Pursuant to the SPA, the Company has invested (in December 2019 and July 2020) an aggregate amount of $<ix:nonFraction id="Fxbrl_20240208193843203" name="us-gaap:Investments" contextRef="C_20191130_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_inmdMedimorMember_usgaapTypeOfArrangementAxis_inmdSharePurchaseAndShareholdersAgreementMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">600</ix:nonFraction> in consideration for <ix:nonFraction id="Fxbrl_20240208193850619" name="us-gaap:SharesIssued" contextRef="C_20191130_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_inmdMedimorMember_usgaapTypeOfArrangementAxis_inmdSharePurchaseAndShareholdersAgreementMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">1,369,863</ix:nonFraction> ordinary shares of Medimor (which reflected at the signing date a <ix:nonFraction id="Fxbrl_20240208193856514" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="C_20191130_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_inmdMedimorMember_usgaapTypeOfArrangementAxis_inmdSharePurchaseAndShareholdersAgreementMember" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">14.78</ix:nonFraction>% ownership interest on an as-issued basis and <ix:nonFraction id="Fxbrl_20240208193906181" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="C_20191130_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_inmdMedimorMember_usgaapInvestmentTypeAxis_inmdFullyDilutedBasisMember_usgaapTypeOfArrangementAxis_inmdSharePurchaseAndShareholdersAgreementMember" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">10.34</ix:nonFraction>% ownership interest on a fully diluted basis.</span></span></span></span></p>
                                    </div>
                                    <div style="line-height:1.25">&#160;<p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>In November 2023, the Company signed an additional SPA with Medimor and invested $<ix:nonFraction id="Fxbrl_20240208193935557" name="us-gaap:Investments" contextRef="C_20231130_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_inmdMedimorMember_usgaapTypeOfArrangementAxis_inmdSharePurchaseAndShareholdersAgreementMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">100</ix:nonFraction> in consideration for <ix:nonFraction id="Fxbrl_20240208193943493" name="us-gaap:SharesIssued" contextRef="C_20231130_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_inmdMedimorMember_usgaapTypeOfArrangementAxis_inmdSharePurchaseAndShareholdersAgreementMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">117,440</ix:nonFraction> ordinary shares of Medimor.</span></span></span></span></p>
                                    </div>
                                    <div style="line-height:1.25">&#160;</div>
                                    <div style="line-height:1.25">
                                      <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The SPAs together reflected as of December 31, 2023 a <ix:nonFraction id="Fxbrl_20240208194001093" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="C_20231231_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_inmdMedimorMember_usgaapTypeOfArrangementAxis_inmdTwoPurchaseAndShareholdersAgreementsMember" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">14.78</ix:nonFraction>% ownership interest on an as-issued basis and <ix:nonFraction id="Fxbrl_20240208194018300" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="C_20231231_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_inmdMedimorMember_usgaapInvestmentTypeAxis_inmdFullyDilutedBasisMember_usgaapTypeOfArrangementAxis_inmdTwoPurchaseAndShareholdersAgreementsMember" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">11.23</ix:nonFraction>% ownership interest on a fully diluted basis.</span></span></span></span></p>
                                    </div>
                                    <div style="line-height:1.25">&#160;</div>
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>The Company&#8217;s investment in Medimor is measured at cost, less impairment and adjusted for subsequent observable price changes if any. As of December 31, 2023, 2022 and 2021, the Company did not recognize an impairment or adjustment on its other investments.</span></span></span></span></span></span></div>
                                  </div>
                                </div>
                              </div>
                            </div>
                          </div>
                        </div>
                      </div>
                    </div>
                  </div>
                </td>
              </tr>

          </table>
        </div>
      </div>
    </div>
  </ix:nonNumeric>
  <p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
</div><div style="">
  <ix:nonNumeric id="FFact_602" name="us-gaap:LesseeOperatingLeasesTextBlock" contextRef="C_20230101to20231231" escape="true">
    <div>
      <div>
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 9 - LEASES:</span></span></div>
        <div>
          <div>
            <div style="line-height:1.25">&#160;</div>
            <div style="line-height:1.25">
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%">

                  <tr style="vertical-align:top">
                    <td style="text-align:right;vertical-align:top;width:49pt">
                      <div style="text-align:left;line-height:1.25">&#160;</div>
                    </td>
                    <td style="text-align:left;vertical-align:top;width:auto">
                      <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">
                        <div>
                          <div style="line-height:1.25">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25">
                                <div style="line-height:1.25">
                                  <div style="line-height:1.25">
                                    <div style="line-height:1.25">
                                      <div style="line-height:1.25">
                                        <div style="line-height:1.25">
                                          <div>
                                            <div style="line-height:1.25">
                                              <div style="line-height:1.25">
                                                <div style="line-height:1.25">
                                                  <div style="line-height:1.25">
                                                    <div style="line-height:1.25">
                                                      <div style="line-height:1.25">
                                                        <div style="line-height:1.25">
                                                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company&#8217;s main leasing properties are located in Israel, USA and Canada as detailed below:</span></span></div>
                                                        </div>
                                                      </div>
                                                    </div>
                                                  </div>
                                                </div>
                                              </div>
                                            </div>
                                          </div>
                                        </div>
                                      </div>
                                    </div>
                                  </div>
                                </div>
                              </div>
                            </div>
                          </div>
                        </div>
                      </div>
                    </td>
                  </tr>

              </table>
            </div>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:49.65pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">a.</span></span></td>
                  <td style="width:auto;vertical-align:top">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In May 2018, the Company signed a lease agreement for its headquarters in Israel. In January 2019, February 2020, March 2021, March 2023 and May 2023 the Company signed supplement lease agreements, further expanding its headquarters in Israel (collectively, the &#8220;Lease Agreement&#8221;). The Lease Agreement will expire in <ix:nonNumeric id="FFact_566" name="inmd:LeaseExpires" contextRef="C_20180501to20180531_usgaapTypeOfArrangementAxis_inmdLeaseAgreementMember">December 2027</ix:nonNumeric>. The current monthly rent payment under the Lease Agreement is approximately $<ix:nonFraction id="FFact_567" name="inmd:CurrentMonthlyRentPayment" contextRef="C_20180501to20180531_usgaapTypeOfArrangementAxis_inmdLeaseAgreementMember" unitRef="USD" scale="3" decimals="-2" format="ixt:num-dot-decimal">64.5</ix:nonFraction>.</span></span></div>
                    <div>&#160;</div>
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The costs under the Lease Agreement in Israel are linked to the Israeli Consumer Price Index. For purposes of ensuring the Company&#8217;s obligation towards the lessor, the Company has provided the lessor with a bank guarantee of NIS <ix:nonFraction id="FFact_568" name="inmd:BankGuarantee" contextRef="C_20180501to20180531_usgaapTypeOfArrangementAxis_inmdLeaseAgreementMember" unitRef="ils" scale="3" decimals="-3" format="ixt:num-dot-decimal">966</ix:nonFraction> thousand (approximately $<ix:nonFraction id="FFact_569" name="inmd:BankGuarantee" contextRef="C_20180501to20180531_usgaapTypeOfArrangementAxis_inmdLeaseAgreementMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">266</ix:nonFraction>).</span></span></div>
                  </td>
                </tr>

            </table>
            <p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left">&#160;</p>
            <div><ix:exclude>
              <div style="line-height:1.25">
                <div style="font-size:10pt"><div><div><div><p style="margin-top:10pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:107%;color:black">F-21</span></span></span></p></div><hr style="border-top:1.5pt solid #000000;page-break-after:always;margin-top:4pt;margin-bottom:10pt"/><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left">&#160;</p><div style="margin-bottom:0pt"><table cellpadding="0" style="font-size:10pt;border-spacing:0px;border-width:0px;border-style:initial;border-color:initial;width:100%;margin-top:0pt"><tr><td style="width:100%;vertical-align:top"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-weight:bold">INMODE LTD.</span></p></td></tr><tr><td style="width:100%;vertical-align:top"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></td></tr><tr><td style="width:100%;vertical-align:top"><p style="margin-top:0pt;margin-bottom:0px;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif">(U.S. dollars in thousands, except for share and per amounts)</p></td></tr></table></div></div></div></div><div style="margin-top:0px;margin-bottom:0px">&#160;</div>
              </div>
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">NOTE 9 - LEASES </span>(continued):</span></span></div>
              <div style="line-height:1.25">&#160;</div>
            </ix:exclude></div>
            <div style="line-height:1.25">
              <div style="line-height:1.25">
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:48.4pt">&#160;</td>
                      <td style="width:22.5pt;vertical-align:top;font-family:'Times New Roman',Times,serif;text-align:center">&#160;</td>
                      <td style="width:auto;vertical-align:top">
                        <div style="font-family:'Times New Roman',Times,serif">
                          <div style="line-height:1.25">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25">
                                <div style="line-height:1.25">
                                  <div style="line-height:1.25">
                                    <div style="line-height:1.25">
                                      <div style="line-height:1.25">
                                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company also leases warehouse outside the company's offices. The Lease Agreement will expire in <ix:nonNumeric id="Fxbrl_20230131042821333" name="inmd:LeaseExpires" contextRef="C_20180501to20180531_srtMortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_srtWarehouseMember_usgaapTypeOfArrangementAxis_inmdLeaseAgreementMember">august 2027</ix:nonNumeric>. The current monthly rent payment under the Lease Agreement is approximately $<ix:nonFraction id="Fxbrl_20240205132710680" name="inmd:CurrentMonthlyRentPayment" contextRef="C_20180501to20180531_srtMortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_srtWarehouseMember_usgaapTypeOfArrangementAxis_inmdLeaseAgreementMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7</ix:nonFraction>.</span></span></div>
                                        <div style="line-height:1.25">&#160;</div>
                                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company also leases vehicles for several employees in Israel for a period of <ix:nonNumeric id="Fxbrl_20240205133417664" name="us-gaap:LesseeOperatingLeaseTermOfContract" contextRef="C_20180531_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapVehiclesMember_usgaapTypeOfArrangementAxis_inmdLeaseAgreementMember" format="ixt-sec:durwordsen">three years</ix:nonNumeric>.</span></span></div>
                                      </div>
                                    </div>
                                  </div>
                                </div>
                              </div>
                            </div>
                          </div>
                        </div>
                      </td>
                    </tr>

                </table>
              </div>
              <div style="line-height:1.25">&#160;</div>
            </div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:48.4pt">&#160;</td>
                  <td style="width:22.5pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">b.</span></span></td>
                  <td style="width:auto;vertical-align:top">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In August 2020, the Company&#8217;s U.S. subsidiary, has signed a new lease agreement, for additional lease agreement of property and for its offices (&#8220;U.S Lease&#8221;). The U.S. Lease is for <span style="-sec-ix-hidden:Fxbrl_20240205133500283">7 years and 4 months</span> which began in the middle of April of 2021. The current monthly rent payment is approximately $<ix:nonFraction id="Fxbrl_20230131042856469" name="inmd:CurrentMonthlyRentPayment" contextRef="C_20200801to20200831_srtMortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_srtOfficeBuildingMember_usgaapTypeOfArrangementAxis_inmdLeaseAgreementMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">27</ix:nonFraction>.</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:48.4pt">&#160;</td>
                  <td style="width:22.5pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">c.</span></span></td>
                  <td style="width:auto;vertical-align:top">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company&#8217;s Canadian subsidiary has signed a new lease agreement in April 2022 for property and for its offices (&#8220;Canadian Lease&#8221;). The Canadian Lease is for <ix:nonNumeric id="Fxbrl_20240205135622575" name="us-gaap:LesseeOperatingLeaseTermOfContract" contextRef="C_20220701_srtMortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_srtOfficeBuildingMember_usgaapTypeOfArrangementAxis_inmdLeaseAgreementMember" format="ixt-sec:duryear">3</ix:nonNumeric> years which began in July 2022. The current monthly rent payment is approximately $<ix:nonFraction id="Fxbrl_20230131044202294" name="inmd:CurrentMonthlyRentPayment" contextRef="C_20220701to20220731_srtMortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_srtOfficeBuildingMember_usgaapTypeOfArrangementAxis_inmdLeaseAgreementMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">17</ix:nonFraction>.</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="width:48.4pt">&#160;</td>
                  <td style="width:22.5pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold">&#160;</td>
                  <td style="width:auto;vertical-align:top">&#160;</td>
                </tr>
                <tr>
                  <td style="width:48.4pt">&#160;</td>
                  <td style="width:22.5pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold">&#160;</td>
                  <td style="width:auto;vertical-align:top">
                    <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">From time to time the Company also leases small properties, mainly for offices for Subsidiaries around the world which range for periods of up to 3 years.</span></p>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
          </div>
        </div>
      </div>
    </div>
    <div>
      <div>
        <ix:nonNumeric id="Fxbrl_20240205122007603" name="us-gaap:LeaseCostTableTextBlock" contextRef="C_20230101to20231231" escape="true">
          <div>
            <div style="line-height:1.25">
              <div style="line-height:1.25">
                <table cellpadding="0" cellspacing="0" style="width:100%">

                    <tr>
                      <td style="vertical-align:top;width:auto">
                        <div style="font-family:'Times New Roman',Times,serif">
                          <div style="line-height:1.25;margin-left:70pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The lease cost was as follows:</span></span></div>
                        </div>
                      </td>
                    </tr>

                </table>
                <p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left">&#160;</p>
              </div>
            </div>
            <div style="margin-left:81pt">
              <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td colspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td style="padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="10" rowspan="1" style="padding-bottom:2px;vertical-align:bottom;border-bottom:2px solid black">
                      <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:1pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended</span></span></div>
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td style="padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" rowspan="1" style="padding-bottom:2px;vertical-align:bottom;border-bottom:2px solid black">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="2" rowspan="1" style="padding-bottom:2px;vertical-align:bottom;border-bottom:2px solid black">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="2" rowspan="1" style="padding-bottom:2px;vertical-align:bottom;border-bottom:2px solid black">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:top;padding-left:9pt;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Operating lease cost</span></span></div>
                    </td>
                    <td style="width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240205095310852" name="us-gaap:OperatingLeaseCost" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,348</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_574" name="us-gaap:OperatingLeaseCost" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,628</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_575" name="us-gaap:OperatingLeaseCost" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,297</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>

              </table>
            </div>
          </div>
        </ix:nonNumeric>
        <div style="line-height:1.25">&#160;</div>
        <ix:nonNumeric id="Fxbrl_20240205122018185" name="inmd:ScheduleOfSupplementalCashFlowInformationRelatedToLeases" contextRef="C_20230101to20231231" escape="true">
          <div>
            <div style="line-height:1.25">
              <div style="line-height:1.25">
                <div style="line-height:1.25">
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                      <tr>
                        <td style="vertical-align:top;margin-top:0pt;margin-bottom:0pt;width:auto">
                          <div style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">
                            <div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt">
                              <div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt;margin-left:70pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Supplemental cash flow information related to leases was as follows:</span></span></div>
                            </div>
                          </div>
                        </td>
                      </tr>

                  </table>
                </div>
              </div>
            </div>
            <p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left">&#160;</p>
            <div>
              <div>
                <div style="margin-left:81pt">
                  <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                      <tr>
                        <td colspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="10" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:1pt">Year ended</div>
                          <div style="line-height:1.25">
                            <div style="text-align:center;line-height:1.25;font-weight:bold">December 31</div>
                          </div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td colspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                          <div style="line-height:1.25">
                            <div style="text-align:center;line-height:1.25;font-weight:bold">2023</div>
                          </div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                          <div style="line-height:1.25">
                            <div style="text-align:center;line-height:1.25;font-weight:bold">2022</div>
                          </div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                          <div style="line-height:1.25">
                            <div style="text-align:center;line-height:1.25;font-weight:bold">2021</div>
                          </div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td colspan="1" style="vertical-align:top;padding-left:9pt;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25">Operating cash flows from operating leases</div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25">
                            <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20240205124932194_xbrl_20240205095310852" name="us-gaap:OperatingLeasePayments" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,530</ix:nonFraction></div>
                          </div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25">
                            <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20240205124932194_Fact_574" name="us-gaap:OperatingLeasePayments" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,881</ix:nonFraction></div>
                          </div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25">
                            <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20240205124932194_Fact_575" name="us-gaap:OperatingLeasePayments" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,328</ix:nonFraction></div>
                          </div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>

                  </table>
                </div>
              </div>
            </div>
          </div>
        </ix:nonNumeric>
        <p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left">&#160;</p>
        <ix:nonNumeric id="Fxbrl_20240205122027420" name="inmd:ScheduleOfSupplementalBalanceSheetInformationRelatedToLeases" contextRef="C_20230101to20231231" escape="true">
          <div>
            <div style="line-height:1.25">
              <div style="line-height:1.25">
                <div style="line-height:1.25">
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                      <tr>
                        <td style="vertical-align:top;width:auto">
                          <div style="font-family:'Times New Roman',Times,serif">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25;margin-left:70pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Supplemental balance sheet information related to leases was as follows:</span></span></div>
                            </div>
                          </div>
                        </td>
                      </tr>

                  </table>
                </div>
              </div>
            </div>
            <p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left">&#160;</p>
            <div style="margin-left:81pt">
              <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="6" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:1pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:1pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:1pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Operating Leases</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;padding-bottom:2px;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Operating lease right-of-use assets</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_580" name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,698</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_581" name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,073</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other current liabilities</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_582" name="inmd:OtherCurrentLeaseLiabilities" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,404</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_583" name="inmd:OtherCurrentLeaseLiabilities" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,453</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;padding-bottom:2px;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Operating lease liabilities</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_584" name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,613</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_585" name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,509</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total operating lease liabilities</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_586" name="us-gaap:OperatingLeaseLiability" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,017</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_587" name="us-gaap:OperatingLeaseLiability" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,962</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted Average Remaining Lease Term</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Operating leases</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="FFact_588" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" contextRef="C_20231231" format="ixt-sec:duryear">2.90</ix:nonNumeric> years</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="FFact_589" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" contextRef="C_20221231" format="ixt-sec:duryear">4.30</ix:nonNumeric> years</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted Average Discount Rate</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Operating leases</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_590" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" contextRef="C_20231231_srtRangeAxis_srtMinimumMember" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">2.00</ix:nonFraction>%-<ix:nonFraction id="FFact_591" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" contextRef="C_20231231_srtRangeAxis_srtMaximumMember" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">7.84</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120042952079" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" contextRef="C_20221231_srtRangeAxis_srtMinimumMember" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">2.00</ix:nonFraction>%-<ix:nonFraction id="Fxbrl_20230120043000440" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" contextRef="C_20221231_srtRangeAxis_srtMaximumMember" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">5.80</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                      </div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </ix:nonNumeric>
        <div style="line-height:1.25">&#160;</div>
        <div><ix:exclude>
          <div style="clear:both;margin-top:0pt;margin-bottom:0pt">
            <div style="width:100%">
              <div style="font-size:10pt"><div><div><div><p style="margin-top:10pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:107%;color:black">F-22</span></span></span></p></div><hr style="border-top:1.5pt solid #000000;page-break-after:always;margin-top:4pt;margin-bottom:10pt"/><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left">&#160;</p><div style="margin-bottom:0pt"><table cellpadding="0" style="font-size:10pt;border-spacing:0px;border-width:0px;border-style:initial;border-color:initial;width:100%;margin-top:0pt"><tr><td style="width:100%;vertical-align:top"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-weight:bold">INMODE LTD.</span></p></td></tr><tr><td style="width:100%;vertical-align:top"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></td></tr><tr><td style="width:100%;vertical-align:top"><p style="margin-top:0pt;margin-bottom:0px;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif">(U.S. dollars in thousands, except for share and per amounts)</p></td></tr></table></div></div></div></div><div style="margin-top:0px;margin-bottom:0px">&#160;</div>
            </div>
          </div>
          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">NOTE 9 - LEASES </span>(continued):</span></span></div>
          <div style="line-height:1.25">&#160;</div>
        </ix:exclude></div>
        <ix:nonNumeric id="Fxbrl_20240205122038009" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" contextRef="C_20230101to20231231" escape="true">
          <div>
            <div style="line-height:1.25">
              <div style="line-height:1.25">
                <div style="line-height:1.25">
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                      <tr>
                        <td style="vertical-align:top;width:auto">
                          <div style="font-family:'Times New Roman',Times,serif">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25">
                                <div style="line-height:1.25;margin-left:70pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of December 31, 2023, the maturities of lease liabilities were as follows:</span></span></div>
                              </div>
                            </div>
                          </div>
                        </td>
                      </tr>

                  </table>
                </div>
              </div>
              <div style="margin-left:49.65pt;line-height:1.25">&#160;</div>
            </div>
            <div style="margin-left:81pt">
              <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;</span></span></td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" rowspan="1" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:1pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Operating Leases</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year Ending December 31,</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:88%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_594" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,745</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2025</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_595" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,491</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:88%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2026</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_596" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,001</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2027</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240205101509151" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,733</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:88%;padding-bottom:2px;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2028 and beyond</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240205101515348" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">902</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total lease payments</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_598" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,872</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:88%;padding-bottom:2px;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Less imputed interests</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_599" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">855</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </div>
                    </td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:88%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_600" name="us-gaap:OperatingLeaseLiability" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,017</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>

              </table>
            </div>
          </div>
        </ix:nonNumeric>
      </div>
    </div>
  </ix:nonNumeric>
  <p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
</div><div style="">
  <ix:nonNumeric id="FFact_618" name="us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" contextRef="C_20230101to20231231" escape="true">
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">NOTE 10 -</span><span>&#160;</span><span style="font-weight:bold">OTHER CURRENT LIABILITIES:</span></p>
    <ix:nonNumeric id="FFact_617" name="us-gaap:OtherCurrentLiabilitiesTableTextBlock" contextRef="C_20230101to20231231" escape="true">
      <div>
        <div>
          <div style="line-height:1.25">&#160;</div>
          <div style="line-height:1.25">
            <div style="line-height:1.25">
              <div style="line-height:1.25">
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="vertical-align:top;width:49pt;font-weight:bold">&#160;</td>
                      <td style="width:auto;vertical-align:top">
                        <div style="font-family:'Times New Roman',Times,serif">
                          <div style="line-height:1.25">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other current liabilities consist of the following:</span></span></div>
                              </div>
                            </div>
                          </div>
                        </div>
                      </td>
                    </tr>

                </table>
              </div>
            </div>
            <div style="margin-left:49.65pt;line-height:1.25">&#160;</div>
          </div>
          <div style="margin-left:54pt">
            <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                <tr>
                  <td colspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="6" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                    <div style="line-height:1.25">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31</span></span></div>
                    </div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                    <div style="line-height:1.25">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                    </div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="2" rowspan="1" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                    <div style="line-height:1.25">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                    </div>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Employees and related expenses</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_603" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">21,040</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_604" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">19,439</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:top;width:76%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Government institutions</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_605" name="inmd:GovernmentInstitutions" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,932</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_606" name="inmd:GovernmentInstitutions" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,052</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Income tax payable</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_607" name="us-gaap:AccruedIncomeTaxesCurrent" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,918</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_608" name="us-gaap:AccruedIncomeTaxesCurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">19,241</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:top;width:76%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Warranty reserve</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_609" name="inmd:WarrantyReserveLiabilityCurrent" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,476</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_610" name="inmd:WarrantyReserveLiabilityCurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,418</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Operating lease liabilities</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_611" name="inmd:OtherCurrentLeaseLiabilities" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,404</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_612" name="inmd:OtherCurrentLeaseLiabilities" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,453</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:top;width:76%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Contractor liability</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240205112207940_Fact_611" name="inmd:ContractorLiability" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,656</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240205112207940_Fact_612" name="inmd:ContractorLiability" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,003</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_613" name="us-gaap:OtherAccruedLiabilitiesCurrent" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,821</ix:nonFraction></span></span></div>
                    </div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_614" name="us-gaap:OtherAccruedLiabilitiesCurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,374</ix:nonFraction></span></span></div>
                    </div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total other current liabilities</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_615" name="us-gaap:OtherLiabilitiesCurrent" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">39,247</ix:nonFraction></span></span></div>
                    </div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_616" name="us-gaap:OtherLiabilitiesCurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">51,980</ix:nonFraction></span></span></div>
                    </div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>

            </table>
          </div>
        </div>
      </div>
    </ix:nonNumeric>
  </ix:nonNumeric>
  <p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
</div><div style="">
  <ix:nonNumeric id="FFact_620" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" contextRef="C_20230101to20231231" escape="true">
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">NOTE 11 -</span><span style="padding-left:0pt">&#160;</span><span style="font-weight:bold">COMMITMENTS AND CONTINGENCIES:</span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt;margin-left:49.65pt">&#160;</p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt;margin-left:49.65pt"><span style="font-weight:bold">Subcontracting Agreements</span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt;margin-left:49.65pt">&#160;</p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt;margin-left:49.65pt"><span style="font-size:10pt;font-family:Times New Roman, serif">The Company has an existing turnkey manufacturing agreements with three of its major subcontractors in Israel in connection with manufacturing and assembling the Company&#8217;s products.</span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt;margin-left:49.65pt">&#160;</p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt;margin-left:49.65pt"><span style="font-size:10pt;font-family:Times New Roman, serif">The Company has agreements with two of the subcontractors which are renewed automatically every year for an additional one-year period, unless either the Company or the turnkey manufacturer gives written notice three months prior to the expiration of the term of its decision not to renew the agreement. Additionally, the Company or the turnkey manufacturer has the ability to terminate the contract at any time and for any reason with a prior written notice of four months.</span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt;margin-left:49.65pt">&#160;</p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt;margin-left:49.65pt"><span style="font-size:10pt;font-family:Times New Roman, serif">In addition, </span>in October 2019, the Company entered into a turnkey manufacturing agreement with another of its major subcontractors in Israel, Medimor (See also note 8). The agreement is for three years and renewed automatically every year afterwards for an additional one-year period, unless either the Company or Medimor gives written notice three months prior to the expiration of the term of its decision not to renew the agreement. Additionally, the Company or Medimor has the ability to terminate the agreement at any time and for any reason with a prior written notice of six months.</p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt;margin-left:49.65pt">&#160;</p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt;margin-left:49.65pt"><span style="font-size:10pt;font-family:Times New Roman, serif">According to the agreements above, the Company does not have a minimum order obligation, but the Company provides the subcontractors a six-month rolling forecast with the projected demand for products. In case of termination of the agreement with each subcontractor, the Company has to compensate that subcontractor for non-returnable inventory, materials in orders that cannot be cancelled and finished products inventory. As of December 31, 2023, the subcontractors&#8217; finished goods inventory, raw materials and open orders amounted to approximately $<ix:nonFraction id="Fxbrl_20240205134443827" name="us-gaap:SignificantSupplyCommitmentRemainingMinimumAmountCommitted" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">41,561</ix:nonFraction>. In order to secure these obligations, the Company gave its subcontractors advances in the amount of $<ix:nonFraction id="Fxbrl_20230120012921515" name="us-gaap:PaymentsForAdvanceToAffiliate" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,914</ix:nonFraction>.</span></p>
  </ix:nonNumeric>
  <div>
    <div style="width:100%;clear:both">
      <p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left">&#160;</p>
      <div style="font-size:10pt"><div><div><div><p style="margin-top:10pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:107%;color:black">F-23</span></span></span></p></div><hr style="border-top:1.5pt solid #000000;page-break-after:always;margin-top:4pt;margin-bottom:10pt"/><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left">&#160;</p><div style="margin-bottom:0pt"><table cellpadding="0" style="font-size:10pt;border-spacing:0px;border-width:0px;border-style:initial;border-color:initial;width:100%;margin-top:0pt"><tr><td style="width:100%;vertical-align:top"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-weight:bold">INMODE LTD.</span></p></td></tr><tr><td style="width:100%;vertical-align:top"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></td></tr><tr><td style="width:100%;vertical-align:top"><p style="margin-top:0pt;margin-bottom:0px;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif">(U.S. dollars in thousands, except for share and per amounts)</p></td></tr></table></div></div></div></div><div style="margin-top:0px;margin-bottom:0px">&#160;</div>
    </div>
  </div>
</div><div style="">
  <ix:nonNumeric id="Fxbrl_20220609132952308" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" contextRef="C_20230101to20231231" escape="true">
    <div>
      <div>
        <div>
          <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 12 - SHAREHOLDERS&#8217; EQUITY:</span></span></div>
        </div>
      </div>
      <div>
        <div>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:49pt">&#160;</td>
                <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:18pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">a.</span></span></td>
                <td style="vertical-align:top;text-align:justify;width:auto">
                  <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share Capital:</span></span></div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:49pt">&#160;</td>
                <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:18pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1)</span></span></td>
                <td style="vertical-align:top;text-align:justify;width:auto">
                  <div style="text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Ordinary shares</span></span></div>
                  <div>&#160;</div>
                  <div>
                    <div style="line-height:1.25;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Each holder of the Company&#8217;s ordinary shares is entitled to one vote. The holders of ordinary shares are also entitled to receive dividends whenever funds are legally available, when and if declared by the Company&#8217;s Board of Directors. Since inception, the Company has not declared any dividends.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="line-height:1.25;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In September 2020, the Company approved a share repurchase program of up to <ix:nonFraction id="Fxbrl_20230210152949131" name="us-gaap:StockRepurchasedDuringPeriodShares" contextRef="C_20200901to20200930_usgaapSubsidiarySaleOfStockAxis_usgaapIPOMember" unitRef="Shares" decimals="INF" format="ixt-sec:numwordsen">two</ix:nonFraction> million ordinary shares, to be purchased out of the Company&#8217;s cash reserve and to be paid solely from the Company&#8217;s IPO proceeds. In February 2022, the Company approved that the share repurchase program could also be funded from the proceeds of exercised options. In March 2022, the Company approved an additional repurchase program of up to one million ordinary shares, to be purchased out of its cash reserve and to be paid from the Company&#8217;s remaining IPO proceeds and from the proceeds of exercised options.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="line-height:1.25;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">During 2021, the Company purchased <ix:nonFraction id="Fxbrl_20230120042241251" name="us-gaap:StockRepurchasedDuringPeriodShares" contextRef="C_20210101to20211231" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">693,734 </ix:nonFraction>shares in the amount of $<ix:nonFraction id="Fxbrl_20230120042257792" name="inmd:StockRepurchasedDuringPeriodValueOne" contextRef="C_20210101to20211231" unitRef="USD" scale="6" decimals="-4" format="ixt:num-dot-decimal">35.4 </ix:nonFraction>million. In addition, during 2022, the Company purchased <ix:nonFraction id="Fxbrl_20230120042143068" name="us-gaap:StockRepurchasedDuringPeriodShares" contextRef="C_20220101to20221231" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">1,077,213 </ix:nonFraction>shares in the amount of $<ix:nonFraction id="Fxbrl_20230120042202495" name="inmd:StockRepurchasedDuringPeriodValueOne" contextRef="C_20220101to20221231" unitRef="USD" scale="6" decimals="-4" format="ixt:num-dot-decimal">42.6 </ix:nonFraction>million. During 2023 the company did not purchase any shares. As of December 31, 2023, the Company purchased <ix:nonFraction id="Fxbrl_20230210121053657" name="us-gaap:StockRepurchasedDuringPeriodShares" contextRef="C_20230101to20231231_usgaapPlanNameAxis_inmdShareRepurchaseProgramMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">2,557,829 </ix:nonFraction>shares in the amount of $<ix:nonFraction id="Fxbrl_20230210121101407" name="inmd:StockRepurchasedDuringPeriodValueOne" contextRef="C_20230101to20231231_usgaapPlanNameAxis_inmdShareRepurchaseProgramMember" unitRef="USD" scale="6" decimals="-4" format="ixt:num-dot-decimal">95.2 </ix:nonFraction>million under these repurchase programs.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="line-height:1.25;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On September 30, 2021, the Company executed a <ix:nonNumeric id="Fxbrl_20230131051015427" name="us-gaap:StockholdersEquityNoteStockSplit" contextRef="C_20230101to20231231">1-for-2 share split</ix:nonNumeric> (&#8220;2021 Share Split&#8221;) of the Company&#8217;s shares by way of an issuance of bonus shares. Upon the effectiveness of the 2021 Share Split, (i) one bonus share was issued for each outstanding share, (ii) the number of ordinary shares into&#160;</span></span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">which each outstanding option to purchase ordinary shares is exercisable was adjusted through proportional increase, (iii) the exercise price of each exercisable share under such outstanding options to purchase ordinary shares was adjusted through proportional decrease, (iv) the number of outstanding RSUs was adjusted through proportional increase, and (v) the number of shares reserved under the Company&#8217;s options plans was proportionally adjusted to accommodate the adjustment to the number of exercisable options under the Company&#8217;s respective option plans.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="line-height:1.25;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Unless otherwise indicated, and except for authorized capital, all of the share numbers, number of RSUs, number of options to purchase ordinary shares, net income per share amounts, share prices and option exercise prices in these financial statements have been adjusted, on a retroactive basis, to reflect the 2021 Share Split.</span></span></div>
                  </div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:49pt">&#160;</td>
                <td style="vertical-align:top;width:18pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2)</span></span></td>
                <td style="vertical-align:top;text-align:justify;width:auto">
                  <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based compensation</span></span></div>
                  <div>&#160;</div>
                  <div>
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On January 30, 2008, the Company&#8217;s Board of Directors adopted two share option plans as follows (collectively, the &#8220;2008 Plans&#8221;):</span></span></div>
                  </div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:67pt">&#160;</td>
                <td style="vertical-align:top;width:22pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">a)</span></span></td>
                <td style="vertical-align:top;width:auto">
                  <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2008 Israeli Option Plan (&#8220;2008 Israeli Plan&#8221;) allowing the Company to grant ordinary shares and options to purchase ordinary shares to Israeli employees, officers, directors, consultants and service providers. Each option under the 2008 Israeli Plan grants the right to exercise such option into one ordinary share of the Company.</span></span></div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:67pt">&#160;</td>
                <td style="vertical-align:top;width:21pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">b)</span></span></td>
                <td style="vertical-align:top;width:auto">
                  <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2008 ROW Option Plan (&#8220;2008 ROW Plan&#8221;) allowing the Company to grant ordinary shares and options to purchase ordinary shares to non-Israeli employees, officers, directors, consultants and service providers. Each option under the 2008 ROW Plan grants the right to exercise such option into one ordinary share of the Company.</span></span></div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <div style="clear:both;margin-top:0pt;margin-bottom:0pt">
            <div style="width:100%">
              <div><ix:exclude>
                <div style="font-size:10pt"><div><div><div><p style="margin-top:10pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:107%;color:black">F-24</span></span></span></p></div><hr style="border-top:1.5pt solid #000000;page-break-after:always;margin-top:4pt;margin-bottom:10pt"/><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left">&#160;</p><div style="margin-bottom:0pt"><table cellpadding="0" style="font-size:10pt;border-spacing:0px;border-width:0px;border-style:initial;border-color:initial;width:100%;margin-top:0pt"><tr><td style="width:100%;vertical-align:top"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-weight:bold">INMODE LTD.</span></p></td></tr><tr><td style="width:100%;vertical-align:top"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></td></tr><tr><td style="width:100%;vertical-align:top"><p style="margin-top:0pt;margin-bottom:0px;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif">(U.S. dollars in thousands, except for share and per amounts)</p></td></tr></table></div></div></div></div><div style="margin-top:0px;margin-bottom:0px">&#160;</div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">NOTE 12 - SHAREHOLDERS&#8217; EQUITY </span>(continued):</span></span>
                <div style="line-height:1.25">&#160;</div>
              </ix:exclude></div>
            </div>
          </div>
          <div style="line-height:1.25">
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:67pt">&#160;</td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div>
                      <div style="line-height:1.25;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In June 2018, the Company&#8217;s Board of Directors adopted a new incentive plan (&#8220;2018 Incentive Plan&#8221;), allowing the Company to grant ordinary shares, options to purchase ordinary shares, restricted shares and restricted share unit (&#8220;RSUs&#8221;) (together, &#8220;Awards&#8221;) to Israeli and other non-U.S. employees, officers, directors, consultants and service providers of the Company and its Subsidiaries. The 2018 Incentive Plan also includes as an appendix a sub-plan allowing the Company to grant awards to U.S. employees, officers, consultants and service providers of the Company and its Subsidiaries. Each option award under 2018 Incentive Plan grants the right to exercise such option into one ordinary share of the Company. The Company&#8217;s subsidiary in U.S. may recognize under U.S. corporate tax laws, a tax benefit for RSU and options exercised for U.S. employees and U.S. service providers for tax purposes.</span></span></div>
                      <div style="line-height:1.25">&#160;</div>
                      <div style="line-height:1.25;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The grant of awards to Israeli employees, officers and directors under the 2008 Israeli Plan and the 2018 Incentive Plan is subject to the terms stipulated by Sections 102 and 102A of the Israeli Income Tax Ordinance. Each award grant is subject to the track chosen by the Company, either Section 102 or Section 102A of the Israeli Income Tax Ordinance, and pursuant to the terms thereof, the Company is not allowed to claim as an expense for tax purposes the amounts credited to employees as benefits, including amounts recorded as salary benefits in the Company&#8217;s accounts, in respect of options granted to employees under the 2008 Israeli Plan, with the exception of the work-income benefit component, if any, determined on grant date. For consultants and service providers, grants under the 2008 Israeli Plan and the 2018 Incentive Plan are subject to Section 3(i) of the Israeli Income Tax Ordinance.</span></span></div>
                      <div style="line-height:1.25">&#160;</div>
                      <div style="line-height:1.25;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Upon the adoption of the 2018 Incentive Plan, the then-current pool of awards available for future grants under the 2008 Plans was canceled and returned to the Company&#8217;s authorized and un-issued share capital. In addition, any shares returning to the free pool of options under the 2008 Plans, due to options expirations or otherwise, are automatically returning to the Company&#8217;s authorized and un-issued share capital.</span></span></div>
                      <div style="line-height:1.25">&#160;</div>
                      <div style="line-height:1.25;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Upon adoption of the 2018 Incentive Plan, the Board and the shareholders resolved to approve an evergreen mechanism with respect to the 2018 Incentive Plan, under which the number of reserved, authorized and unissued ordinary shares of the Company available for issuance of awards pursuant to&#160;</span></span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">the 2018 Incentive Plan shall automatically increase on an annual basis, by such number of ordinary shares as follows: on the first business day of each calendar year beginning in 2019, the number of awards equal to the lesser of (i) <ix:nonFraction id="Fxbrl_20230131051259236" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="C_20230101to20231231_usgaapPlanNameAxis_inmdTwoThousandsEighteenIncentivePlanMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">800,000 </ix:nonFraction>ordinary shares, (ii) three percent of the number of shares outstanding as of such date or (iii) a lesser number of ordinary shares as shall be determined by the Company&#8217;s board of directors. </span></span></div>
                      <div style="line-height:1.25;text-align:left">&#160;</div>
                      <div style="line-height:1.25;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As</span></span>&#160;of December 31, 2023, the total awards under 2018 Incentive Plan that have been authorized to be issued as ordinary shares were <ix:nonFraction id="Fxbrl_20240208201751065" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" contextRef="C_20231231_usgaapPlanNameAxis_inmdTwoThousandsEighteenIncentivePlanMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">8,378,000</ix:nonFraction> of which&#160;1,902,431 awards were available for grant under the 2018 Incentive Plan.</div>
                    </div>
                  </td>
                </tr>

            </table>
          </div>
          <div style="line-height:1.25">&#160;</div>
          <div style="clear:both;margin-top:0pt;margin-bottom:0pt">
            <div style="width:100%">
              <div><ix:exclude>
                <div style="font-size:10pt"><div><div><div><p style="margin-top:10pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:107%;color:black">F-25</span></span></span></p></div><hr style="border-top:1.5pt solid #000000;page-break-after:always;margin-top:4pt;margin-bottom:10pt"/><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left">&#160;</p><div style="margin-bottom:0pt"><table cellpadding="0" style="font-size:10pt;border-spacing:0px;border-width:0px;border-style:initial;border-color:initial;width:100%;margin-top:0pt"><tr><td style="width:100%;vertical-align:top"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-weight:bold">INMODE LTD.</span></p></td></tr><tr><td style="width:100%;vertical-align:top"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></td></tr><tr><td style="width:100%;vertical-align:top"><p style="margin-top:0pt;margin-bottom:0px;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif">(U.S. dollars in thousands, except for share and per amounts)</p></td></tr></table></div></div></div></div><div style="margin-top:0px;margin-bottom:0px">&#160;</div>
                <p style="margin:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">NOTE 12 &#8211; SHAREHOLDERS&#8217; EQUITY </span>(continued):</span></span></p>
                <div style="line-height:1.25">&#160;</div>
              </ix:exclude></div>
            </div>
          </div>
        </div>
        <div style="line-height:1.25">
          <div>
            <table cellpadding="0" cellspacing="0" style="color:#000000;font-family:'Times New Roman',Times,serif;font-size:10pt;text-align:left;width:100%">

                <tr>
                  <td style="width:58.5pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top;font-family:'Times New Roman',Times,serif">&#160;</td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div>
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of December 31, 2023, <ix:nonFraction id="FFact_642" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" contextRef="C_20231231_usgaapPlanNameAxis_inmdTwoThousandsEighteenIncentivePlanMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">1,902,431</ix:nonFraction> awards were available for grant under the 2018 Incentive Plan.</span></span></div>
                        <div style="line-height:1.25">&#160;</div>
                        <div style="line-height:1.25"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Share Options</span></span></span></strong></div>
                        <div style="line-height:1.25;font-weight:bold">&#160;</div>
                      </div>
                    </div>
                  </td>
                </tr>

            </table>
          </div>
          <ix:nonNumeric id="Fxbrl_20240205105026367" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" contextRef="C_20230101to20231231" escape="true">
            <div>
              <div style="line-height:1.25">
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:auto;vertical-align:top;text-align:justify">
                        <div>
                          <div style="line-height:1.25">
                            <div style="line-height:1.25;margin-left:75.5pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The following tables is a summary of stock option activity for the year ended on December 31, 2023<span style="font-weight:bold">&#160;</span>:</span></span></div>
                          </div>
                        </div>
                      </td>
                    </tr>

                </table>
              </div>
              <div style="line-height:1.25">&#160;</div>
              <div style="margin-left:81pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="6" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year&#160;ended&#160;December&#160;31</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="6" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Number</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Average</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">of</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercise</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Price*</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Outstanding at beginning of year</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_695" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="C_20221231" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">2,553,640</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_696" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="C_20221231" unitRef="USD_Per_Share" decimals="INF" format="ixt:num-dot-decimal">5.30</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Changes during the year:</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="margin-left:8.8pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Granted</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120101724042" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" contextRef="C_20230101to20231231" unitRef="Shares" decimals="INF" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120101707941" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="C_20230101to20231231" unitRef="USD_Per_Share" decimals="INF" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;vertical-align:bottom">
                        <div style="margin-left:8.8pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercised</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_707" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="C_20230101to20231231" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">915,145</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_708" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="C_20230101to20231231" unitRef="USD_Per_Share" decimals="INF" format="ixt:num-dot-decimal">5.92</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="margin-left:8.8pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Forfeited</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_711" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" contextRef="C_20230101to20231231" unitRef="Shares" decimals="INF" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_712" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" contextRef="C_20230101to20231231" unitRef="USD_Per_Share" decimals="INF" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom">
                        <div style="margin-left:8.8pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Expired</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120062156531" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="C_20230101to20231231" unitRef="Shares" decimals="INF" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120062219955" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" contextRef="C_20230101to20231231" unitRef="USD_Per_Share" decimals="INF" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Outstanding at end of year</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_719" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="C_20231231" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">1,638,495</ix:nonFraction></span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_720" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="C_20231231" unitRef="USD_Per_Share" decimals="INF" format="ixt:num-dot-decimal">4.96</ix:nonFraction></span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercisable at end of year</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_723" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="C_20231231" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">1,638,495</ix:nonFraction></span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_724" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextRef="C_20231231" unitRef="USD_Per_Share" decimals="INF" format="ixt:num-dot-decimal">4.96</ix:nonFraction></span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="width:76%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="8" style="vertical-align:top;vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">* In U.S. dollars per Ordinary Share</span></span></div>
                      </td>
                    </tr>

                </table>
              </div>
            </div>
          </ix:nonNumeric>
          <div style="line-height:1.25">&#160;</div>
          <div style="line-height:1.25">
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:58.5pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top;font-family:'Times New Roman',Times,serif">&#160;</td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div>
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of December 31, 2023, the weighted-average remaining contractual life of exercisable options were <ix:nonNumeric id="Fxbrl_20230120053845922" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" contextRef="C_20230101to20231231_srtTitleOfIndividualAxis_inmdEmployeesMember_usgaapPlanNameAxis_inmdTwoThousandsEighteenIncentivePlanMember" format="ixt-sec:duryear">1.90 </ix:nonNumeric>years. The total intrinsic value of options exercised during 2023, 2022 and 2021 were approximately $<ix:nonFraction id="Fxbrl_20230120053852098" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" contextRef="C_20230101to20231231_srtTitleOfIndividualAxis_inmdEmployeesMember_usgaapPlanNameAxis_inmdTwoThousandsEighteenIncentivePlanMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">24,819</ix:nonFraction>, $<ix:nonFraction id="Fxbrl_20230120053858497" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" contextRef="C_20220101to20221231_srtTitleOfIndividualAxis_inmdEmployeesMember_usgaapPlanNameAxis_inmdTwoThousandsEighteenIncentivePlanMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,549 </ix:nonFraction>and $<ix:nonFraction id="Fxbrl_20230120053906154" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" contextRef="C_20210101to20211231_srtTitleOfIndividualAxis_inmdEmployeesMember_usgaapPlanNameAxis_inmdTwoThousandsEighteenIncentivePlanMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">277,978</ix:nonFraction>, respectively.</span></span></div>
                        <div style="line-height:1.25">&#160;</div>
                      </div>
                    </div>
                  </td>
                </tr>

            </table>
          </div>
          <ix:nonNumeric id="Fxbrl_20240205105125046" name="us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" contextRef="C_20230101to20231231" escape="true">
            <div>
              <div style="line-height:1.25">
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:auto;vertical-align:top;text-align:justify">
                        <div>
                          <div style="line-height:1.25">
                            <div style="line-height:1.25;margin-left:75.5pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The following tables summarize information concerning outstanding and exercisable options as of December 31, 2023:</span></span></div>
                          </div>
                        </div>
                      </td>
                    </tr>

                </table>
              </div>&#160;<div style="margin-left:81pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td colspan="10" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25;text-align:center"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options outstanding and exercisable</span></span></strong></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="2" rowspan="5" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercise</span></span></div>
                        <div style="line-height:1.25">
                          <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Prices *</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center">&#160;</td>
                      <td colspan="2" rowspan="5" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Number of</span></span></div>
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">options</span></span></div>
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Outstanding and exercisable</span></span></div>
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">at end of</span></span></div>
                        <div style="line-height:1.25">
                          <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">year</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
                      <td colspan="1" rowspan="5" style="vertical-align:bottom;padding-bottom:2px;text-align:center">&#160;</td>
                      <td colspan="2" rowspan="5" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted</span></span></div>
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">average</span></span></div>
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">remaining</span></span></div>
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">contractual</span></span></div>
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">life</span></span></div>
                      </td>
                      <td colspan="1" rowspan="5" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_760" name="inmd:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice" contextRef="C_20230101to20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeOneMember" unitRef="USD_Per_Share" decimals="INF" format="ixt:num-dot-decimal">0.28</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_761" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" contextRef="C_20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeOneMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">361,993</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="FFact_762" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" contextRef="C_20230101to20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeOneMember" format="ixt-sec:duryear">0.42</ix:nonNumeric></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_765" name="inmd:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice" contextRef="C_20230101to20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeTwoMember" unitRef="USD_Per_Share" decimals="INF" format="ixt:num-dot-decimal">0.29</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_766" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" contextRef="C_20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeTwoMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">203,438</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="FFact_767" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" contextRef="C_20230101to20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeTwoMember" format="ixt-sec:duryear">0.42</ix:nonNumeric></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_770" name="inmd:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice" contextRef="C_20230101to20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeThreeMember" unitRef="USD_Per_Share" decimals="INF" format="ixt:num-dot-decimal">3.16</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_771" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" contextRef="C_20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeThreeMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">149,948</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="FFact_772" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" contextRef="C_20230101to20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeThreeMember" format="ixt-sec:duryear">1.71</ix:nonNumeric></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_775" name="inmd:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice" contextRef="C_20230101to20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeFourMember" unitRef="USD_Per_Share" decimals="INF" format="ixt:num-dot-decimal">3.75</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_776" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" contextRef="C_20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeFourMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">211,173</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="FFact_777" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" contextRef="C_20230101to20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeFourMember" format="ixt-sec:duryear">2.02</ix:nonNumeric></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_780" name="inmd:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice" contextRef="C_20230101to20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeFiveMember" unitRef="USD_Per_Share" decimals="INF" format="ixt:num-dot-decimal">5.11</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_781" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" contextRef="C_20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeFiveMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">70,756</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="FFact_782" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" contextRef="C_20230101to20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeFiveMember" format="ixt-sec:duryear">2.26</ix:nonNumeric></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_785" name="inmd:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice" contextRef="C_20230101to20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeSixMember" unitRef="USD_Per_Share" decimals="INF" format="ixt:num-dot-decimal">7.00</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_786" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" contextRef="C_20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeSixMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">41,000</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="FFact_787" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" contextRef="C_20230101to20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeSixMember" format="ixt-sec:duryear">2.61</ix:nonNumeric></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_790" name="inmd:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice" contextRef="C_20230101to20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeSevenMember" unitRef="USD_Per_Share" decimals="INF" format="ixt:num-dot-decimal">9.85</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_791" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" contextRef="C_20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeSevenMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">565,129</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="FFact_792" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" contextRef="C_20230101to20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeSevenMember" format="ixt-sec:duryear">3.18</ix:nonNumeric></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_795" name="inmd:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice" contextRef="C_20230101to20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeEightMember" unitRef="USD_Per_Share" decimals="INF" format="ixt:num-dot-decimal">12.16</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_796" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" contextRef="C_20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeEightMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">28,558</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="FFact_797" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" contextRef="C_20230101to20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeEightMember" format="ixt-sec:duryear">3.35</ix:nonNumeric></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_800" name="inmd:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice" contextRef="C_20230101to20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeNineMember" unitRef="USD_Per_Share" decimals="INF" format="ixt:num-dot-decimal">21.62</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_801" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" contextRef="C_20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeNineMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">6,500</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="FFact_802" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" contextRef="C_20230101to20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeNineMember" format="ixt-sec:duryear">3.86</ix:nonNumeric></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>

                </table>
              </div>
              <div style="line-height:1.25">&#160;</div>
              <div style="line-height:1.25">
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:58.5pt">&#160;</td>
                      <td style="width:18pt;vertical-align:top;font-family:'Times New Roman',Times,serif">&#160;</td>
                      <td style="width:auto;vertical-align:top;text-align:justify">
                        <div>
                          <div style="line-height:1.25">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">* In U.S. dollars per Ordinary Share.</span></span></div>
                            </div>
                          </div>
                        </div>
                      </td>
                    </tr>

                </table>
              </div>
            </div>
          </ix:nonNumeric>
          <div style="line-height:1.25">
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div>
                      <div style="line-height:1.25">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25;margin-left:77pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The aggregate intrinsic value of total exercisable options as of December 31, 2023 is $<ix:nonFraction id="FFact_806" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" contextRef="C_20231231_usgaapPlanNameAxis_inmdTwoThousandsEighteenIncentivePlanMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">28,315</ix:nonFraction>.</span></span></div>
                        </div>
                      </div>
                    </div>
                  </td>
                </tr>

            </table>
          </div>
          <p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left">&#160;</p>
          <div><ix:exclude>
            <div style="line-height:1.25">
              <div style="font-size:10pt"><div><div><div><p style="margin-top:10pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:107%;color:black">F-26</span></span></span></p></div><hr style="border-top:1.5pt solid #000000;page-break-after:always;margin-top:4pt;margin-bottom:10pt"/><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left">&#160;</p><div style="margin-bottom:0pt"><table cellpadding="0" style="font-size:10pt;border-spacing:0px;border-width:0px;border-style:initial;border-color:initial;width:100%;margin-top:0pt"><tr><td style="width:100%;vertical-align:top"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-weight:bold">INMODE LTD.</span></p></td></tr><tr><td style="width:100%;vertical-align:top"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></td></tr><tr><td style="width:100%;vertical-align:top"><p style="margin-top:0pt;margin-bottom:0px;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif">(U.S. dollars in thousands, except for share and per amounts)</p></td></tr></table></div></div></div></div><div style="margin-top:0px;margin-bottom:0px">&#160;</div>
            </div>
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">NOTE 12 - SHAREHOLDERS&#8217; EQUITY </span>(continued):</span></span></div>
            <p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left">&#160;</p>
          </ix:exclude></div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:58.5pt">&#160;</td>
                <td style="width:18pt;vertical-align:top;font-family:'Times New Roman',Times,serif">&#160;</td>
                <td style="width:auto;vertical-align:top;text-align:justify">
                  <div>
                    <div style="line-height:1.25">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Restricted Share Units</span></span></span></div>
                        <div style="line-height:1.25">&#160;</div>
                      </div>
                    </div>
                  </div>
                </td>
              </tr>

          </table>
          <ix:nonNumeric id="Fxbrl_20240205105227621" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" contextRef="C_20230101to20231231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember" escape="true">
            <div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:auto;vertical-align:top;text-align:justify">
                      <div>
                        <div style="line-height:1.25">
                          <div style="line-height:1.25">
                            <div style="line-height:1.25;margin-left:76pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The following tables summarize information concerning RSUs as of December 31, 2023<span style="font-weight:bold">&#160;</span>:</span></span></div>
                          </div>
                        </div>
                      </div>
                    </td>
                  </tr>

              </table><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;</span></span>
              <div style="margin-left:81pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="6" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year&#160;ended&#160;December&#160;31</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="6" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Number</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Average</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">of</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Grant&#160;Date</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">RSUs</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair Value</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Outstanding at beginning of year</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120064100124" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextRef="C_20221231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">804,575</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120064106675" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="C_20221231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember" unitRef="USD_Per_Share" decimals="INF" format="ixt:num-dot-decimal">45.74</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Changes during the year:</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="margin-left:8.8pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Granted</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120063737867" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" contextRef="C_20230101to20231231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">706,560</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120063858688" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="C_20230101to20231231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember" unitRef="USD_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">34.44</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;vertical-align:bottom">
                        <div style="margin-left:8.8pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Vested</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230120063912503" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" contextRef="C_20230101to20231231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">522,326</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120064001573" name="inmd:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue" contextRef="C_20230101to20231231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember" unitRef="USD_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">43.33</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="margin-left:8.8pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Forfeited</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230120063751848" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" contextRef="C_20230101to20231231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">52,760</ix:nonFraction></span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120063958765" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" contextRef="C_20230101to20231231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember" unitRef="USD_Per_Share" decimals="INF" format="ixt:num-dot-decimal">37.21</ix:nonFraction></span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Outstanding at end of year *</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120063922997" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextRef="C_20231231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">936,049</ix:nonFraction></span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120063944773" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="C_20231231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember" unitRef="USD_Per_Share" decimals="INF" format="ixt:num-dot-decimal">39.04</ix:nonFraction></span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>

                </table>
              </div>
              <div style="line-height:1.25">&#160;</div>
              <div style="line-height:1.25">
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:58.5pt">&#160;</td>
                      <td style="width:18pt;vertical-align:top;font-family:'Times New Roman',Times,serif">&#160;</td>
                      <td style="width:auto;vertical-align:top;text-align:justify">
                        <div>
                          <div style="line-height:1.25">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">* As of December 31, 2023, <ix:nonFraction id="FFact_815" name="inmd:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonVestedVested" contextRef="C_20231231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">275,249 </ix:nonFraction>RSUs were vested and were settled by issuance of respective shares at the beginning of January 2024.</span></span></div>
                            </div>
                          </div>
                        </div>
                      </td>
                    </tr>

                </table>
              </div>
            </div>
          </ix:nonNumeric>
          <div style="margin-left:113.4pt;line-height:1.25">&#160;</div>
          <div style="line-height:1.25">
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%">

                <tr style="vertical-align:top">
                  <td style="text-align:right;vertical-align:top;width:58pt">&#160;</td>
                  <td style="text-align:right;vertical-align:top;width:18pt">
                    <div style="text-align:left;line-height:1.25">&#160;</div>
                  </td>
                  <td style="text-align:left;vertical-align:top;width:auto">
                    <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">
                      <div>
                        <div style="line-height:1.25">
                          <div style="line-height:1.25">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25">
                                <div style="line-height:1.25">
                                  <div style="line-height:1.25">
                                    <div style="line-height:1.25">
                                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Each RSU represents the right to receive one ordinary share of the Company upon the vesting thereof. The fair value of an RSU is identical to the value of the underlying share at the close of the last trading day prior to the day of grant. The weighted average fair value of each RSU granted in 2023 was <ix:nonFraction id="Fxbrl_20230120050330070" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue" contextRef="C_20230101to20231231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember" unitRef="USD_Per_Share" decimals="INF" format="ixt:num-dot-decimal">34.44</ix:nonFraction>, and in 2022 was <ix:nonFraction id="Fxbrl_20230120050336934" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue" contextRef="C_20220101to20221231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember" unitRef="USD_Per_Share" decimals="INF" format="ixt:num-dot-decimal">49.35 </ix:nonFraction>and in 2021 <ix:nonFraction id="Fxbrl_20230120050358608" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue" contextRef="C_20210101to20211231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember" unitRef="USD_Per_Share" decimals="INF" format="ixt:num-dot-decimal">35.44 </ix:nonFraction>based on the Company&#8217;s share price at closing of trading day prior to the day of grant.</span></span></div>
                                      <div style="line-height:1.25">&#160;</div>
                                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The total fair value of RSUs granted during the year ended December 31, 2023, 2022 and 2021, was $<ix:nonFraction id="Fxbrl_20230210121250399" name="inmd:FairValueOfRestrictedOptionsGranted" contextRef="C_20230101to20231231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">24,334</ix:nonFraction>, $<ix:nonFraction id="Fxbrl_20230210121257313" name="inmd:FairValueOfRestrictedOptionsGranted" contextRef="C_20220101to20221231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">30,817</ix:nonFraction>, and $<ix:nonFraction id="Fxbrl_20240205101856695" name="inmd:FairValueOfRestrictedOptionsGranted" contextRef="C_20210101to20211231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">19,279</ix:nonFraction> respectively.</span></span></div>
                                      <div style="line-height:1.25">&#160;</div>
                                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of December 31, 2023, the Company had <ix:nonFraction id="Fxbrl_20230120050220206" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" contextRef="C_20231231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">660,800 </ix:nonFraction>unvested RSUs. The total unrecognized compensation cost of employee RSUs as of December 31, 2023 is $<ix:nonFraction id="Fxbrl_20230120050228579" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" contextRef="C_20231231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,517</ix:nonFraction>, which is expected to be recognized over a weighted average period of <ix:nonNumeric id="Fxbrl_20230120050234748" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" contextRef="C_20230101to20231231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember" format="ixt-sec:duryear">1.10 </ix:nonNumeric>years.</span></span></div>
                                      <div style="line-height:1.25">&#160;</div>
                                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The total vesting-date value of equity classified RSUs vested during, 2023 is $<ix:nonFraction id="Fxbrl_20240205102630753" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" contextRef="C_20230101to20231231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,122</ix:nonFraction>.&#160;</span></span><span style="font-size:10pt;font-family:Times New Roman, Times, serif">The following table illustrates the effect of share-based compensation on the consolidated statements of income:</span></div>
                                      <div style="line-height:1.25">&#160;</div>
                                    </div>
                                  </div>
                                </div>
                              </div>
                            </div>
                          </div>
                        </div>
                      </div>
                    </div>
                  </td>
                </tr>

            </table>
          </div>
          <ix:nonNumeric id="Fxbrl_20240205105323519" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" contextRef="C_20230101to20231231" escape="true">
            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;</span></span>
              <div style="margin-left:76pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="10" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended December 31</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cost of sales</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_825" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_20230101to20231231_usgaapIncomeStatementLocationAxis_usgaapCostOfSalesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,046</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_826" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_20220101to20221231_usgaapIncomeStatementLocationAxis_usgaapCostOfSalesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,917</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_827" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_20210101to20211231_usgaapIncomeStatementLocationAxis_usgaapCostOfSalesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,108</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                        <div style="text-indent:-12.6pt;margin-left:12.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Research and development expenses</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_828" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_20230101to20231231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,652</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_829" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_20220101to20221231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,166</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_830" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_20210101to20211231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,554</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-12.6pt;margin-left:12.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Selling and marketing expenses</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_831" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_20230101to20231231_usgaapIncomeStatementLocationAxis_usgaapSellingAndMarketingExpenseMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">17,167</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_832" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_20220101to20221231_usgaapIncomeStatementLocationAxis_usgaapSellingAndMarketingExpenseMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">17,302</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_833" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_20210101to20211231_usgaapIncomeStatementLocationAxis_usgaapSellingAndMarketingExpenseMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,274</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;padding-bottom:2px;vertical-align:bottom">
                        <div style="text-indent:-12.6pt;margin-left:12.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">General and administrative expenses</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_834" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_20230101to20231231_usgaapIncomeStatementLocationAxis_usgaapGeneralAndAdministrativeExpenseMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,735</ix:nonFraction></span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_835" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_20220101to20221231_usgaapIncomeStatementLocationAxis_usgaapGeneralAndAdministrativeExpenseMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,067</ix:nonFraction></span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_836" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_20210101to20211231_usgaapIncomeStatementLocationAxis_usgaapGeneralAndAdministrativeExpenseMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,026</ix:nonFraction></span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_837" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">23,600</ix:nonFraction></span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_838" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">24,452</ix:nonFraction></span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_839" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,962</ix:nonFraction></span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>

                </table>
              </div>
            </div>
          </ix:nonNumeric>
          <div style="line-height:1.25">&#160;</div>
          <div style="clear:both;margin-top:0pt;margin-bottom:0pt">
            <div style="width:100%">
              <div><ix:exclude>
                <div style="font-size:10pt"><div><div><div><p style="margin-top:10pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:107%;color:black">F-27</span></span></span></p></div><hr style="border-top:1.5pt solid #000000;page-break-after:always;margin-top:4pt;margin-bottom:10pt"/><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left">&#160;</p><div style="margin-bottom:0pt"><table cellpadding="0" style="font-size:10pt;border-spacing:0px;border-width:0px;border-style:initial;border-color:initial;width:100%;margin-top:0pt"><tr><td style="width:100%;vertical-align:top"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-weight:bold">INMODE LTD.</span></p></td></tr><tr><td style="width:100%;vertical-align:top"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></td></tr><tr><td style="width:100%;vertical-align:top"><p style="margin-top:0pt;margin-bottom:0px;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif">(U.S. dollars in thousands, except for share and per amounts)</p></td></tr></table></div></div></div></div><div style="margin-top:0px;margin-bottom:0px">&#160;</div>
                <p style="margin:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">NOTE 12 - SHAREHOLDERS&#8217; EQUITY </span>(continued):</span></span></p>
                <p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left">&#160;</p>
              </ix:exclude></div>
            </div>
          </div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:49pt">&#160;</td>
                <td style="vertical-align:top;font-weight:bold;width:18pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">b.</span></span></td>
                <td style="vertical-align:top;text-align:justify;width:auto">
                  <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-Controlling Interests:</span></span></div>
                  <div style="font-weight:bold">&#160;</div>
                  <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:normal">On April 23, 2021, the Company, Dilazar Limited (&#8220;Dilazar&#8221;), Wigmore and Invasix UK (the UK subsidiary) entered into a share exchange agreement (the &#8220;UK Exchange Agreement&#8221;) whereby, Dilazar (which owned <ix:nonFraction id="Fxbrl_20230131055505729" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" contextRef="C_20210423_srtConsolidatedEntitiesAxis_srtSubsidiariesMember_usgaapBusinessAcquisitionAxis_inmdDilazarLimitedMember" unitRef="Pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">49</ix:nonFraction>% of the Invasix UK&#8217;s shares immediately prior to the UK Exchange Agreement, which shares were previously transferred to Dilazar from its wholly-owned subsidiary Wigmore) sold to the Company all of its outstanding share capital in Invasix UK and Wigmore sold to the Company all of its rights pursuant to the Founders Memorandum of Understanding, dated March 4, 2014, by and between Wigmore and the Company, in exchange for the issuance at closing to Dilazar by the Company in a private placement of <ix:nonFraction id="Fxbrl_20230131055523443" name="us-gaap:SharesIssued" contextRef="C_20210423_srtConsolidatedEntitiesAxis_srtSubsidiariesMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">457,912 </ix:nonFraction>of the Company&#8217;s ordinary shares, par value NIS <ix:nonFraction id="Fxbrl_20230131054917619" name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="C_20210523" unitRef="ILS_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">0.01</ix:nonFraction>. Upon closing, in May 2021, <ix:nonFraction id="Fxbrl_20230131055634764" name="us-gaap:SharesIssued" contextRef="C_20210423_srtConsolidatedEntitiesAxis_srtSubsidiariesMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">457,912</ix:nonFraction> of the Company&#8217;s ordinary shares were issued to Dilazar from the Company&#8217;s treasury shares.</span></span></span></div>
                </td>
              </tr>

          </table>
        </div>
      </div>
    </div>
  </ix:nonNumeric>
  <p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left">&#160;</p>
</div><div style="">
  <div>
    <ix:nonNumeric id="Fxbrl_20240205110851898" name="us-gaap:IncomeTaxDisclosureTextBlock" contextRef="C_20230101to20231231" escape="true">
      <div>
        <div>
          <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 13 - INCOME TAXES:</span></span></div>
          <div style="line-height:1.25;font-weight:bold">&#160;</div>
          <div style="line-height:1.25">
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:49pt">&#160;</td>
                  <td style="vertical-align:top;font-weight:bold;width:18pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">a.</span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">InMode Ltd.</span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company is taxed according to Israeli tax laws:</span></span></div>
                  </td>
                </tr>

            </table>
          </div>
        </div>
        <div>&#160;<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:67pt">&#160;</td>
                <td style="vertical-align:top;width:21pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1)</span></span></td>
                <td style="vertical-align:top;width:auto">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Measurement of results for tax purposes</span></span></div>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company as a &#8220;foreign-investment company&#8221; measures its results for tax purposes in dollar based on Income Tax Regulations (Bookkeeping Principles of Foreign Invested Companies and of Certain Partnerships and the Determination of Their Taxable Income), 1986.</span></span></div>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">These consolidated financial statements are presented in U.S. dollars. The changes in the exchange rate of the dollar, both on an annual and a cumulative basis, cause a difference between taxable income and income reflected in these consolidated financial statements. ASC 740-10-25 prohibits the recognition of deferred tax liabilities or assets that arise from differences between the financial reporting and tax bases of assets and liabilities that are re-measured from the local currency into dollars using historical exchange rates, and that result from changes in exchange rates or indexing for tax purposes. Consequently, the above-mentioned differences were not reflected in the computation of deferred tax assets and liabilities.</span></span></div>
                </td>
              </tr>

          </table>&#160;<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:67pt">&#160;</td>
                <td style="vertical-align:top;width:21pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2)</span></span></td>
                <td style="vertical-align:top;width:auto">
                  <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Basis of taxation</span></span></div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:67pt">&#160;</td>
                <td style="vertical-align:top;font-weight:bold;width:21pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">a)</span></span></td>
                <td style="vertical-align:top;width:auto">
                  <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Incentives Applicable until 2020</span></span></div>
                  <div style="font-weight:bold">&#160;</div>
                  <div style="font-weight:bold">
                    <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Under the Encouragement of Capital Investments Law, including Amendment No. 60 thereof as published in April 2005, by virtue of the &#8220;Approved Enterprise&#8221; or &#8220;Benefited Enterprise&#8221; status, the Israeli Company was tax exempt from 2012 to 2020 for income derived from the Benefited Enterprise. See also note 13a(2)(b).</span></span></div>
                  </div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:67pt">&#160;</td>
                <td style="vertical-align:top;font-weight:bold;width:21pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">b)</span></span></td>
                <td style="vertical-align:top;width:auto">
                  <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Incentives Applicable starting 2021 - The New Technological Enterprise and Preferred Enterprise Incentives Regime &#8211; Amendment 73 to the Investment Law</span></span></div>
                  <div style="font-weight:bold">&#160;</div>
                  <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:normal">On June 14, 2017, the Encouragement of Capital Investments Regulations (Preferred Technology Income and Capital Profits for a Technological Enterprise), 2017 (the &#8220;Regulations&#8221;) were published, which adopted Action 5 under the base erosion and profit shifting (&#8220;BEPS&#8221;) regulations. The Regulations describe, inter alia, the mechanism used to determine the calculation of the benefits under the PTE (Preferred technological enterprise) or PE (Preferred enterprise) and under the SPTE (Special Preferred Technology Enterprise) regime and determine certain requirements relating to documentation of intellectual property for the purpose of the PTE or PE. According to these provisions, a company that complies with the terms under the PTE or PE</span> regime may be entitled to certain tax benefits with respect to income generated during the company&#8217;s regular course of business and derived from the preferred intangible asset (as determined in the Investments Law) and income attributed to production activity (different tax rate), Excluding income derived from intangible assets used for marketing.</span></span></div>
                  <div style="font-weight:bold">&#160;</div>
                </td>
              </tr>

          </table>
        </div>
        <div><ix:exclude>
          <div>
            <div style="line-height:1.25">
              <div style="font-size:10pt"><div><div><div><p style="margin-top:10pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:107%;color:black">F-28</span></span></span></p></div><hr style="border-top:1.5pt solid #000000;page-break-after:always;margin-top:4pt;margin-bottom:10pt"/><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left">&#160;</p><div style="margin-bottom:0pt"><table cellpadding="0" style="font-size:10pt;border-spacing:0px;border-width:0px;border-style:initial;border-color:initial;width:100%;margin-top:0pt"><tr><td style="width:100%;vertical-align:top"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-weight:bold">INMODE LTD.</span></p></td></tr><tr><td style="width:100%;vertical-align:top"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></td></tr><tr><td style="width:100%;vertical-align:top"><p style="margin-top:0pt;margin-bottom:0px;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif">(U.S. dollars in thousands, except for share and per amounts)</p></td></tr></table></div></div></div></div><div style="margin-top:0px;margin-bottom:0px">&#160;</div>
            </div>
          </div>
          <div>
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">NOTE 13 - INCOME TAXES</span> (continued):</span></span>
              <p style="margin:0pt">&#160;</p>
            </div>
          </div>
        </ix:exclude></div>
        <div>
          <div style="line-height:1.25">
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:67pt">&#160;</td>
                  <td style="vertical-align:top;font-weight:bold;width:21pt">&#160;</td>
                  <td style="vertical-align:top;width:auto">
                    <div style="font-weight:bold">
                      <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In the event that intangible assets used for marketing purposes generate over 10% of the PTE&#8217;s or PE&#8217;s income, the relevant portion, calculated using a transfer pricing study, would be subject to regular corporate income tax. If such income does not exceed 10%, the PTE or PE will not be required to exclude the marketing income from the PTE&#8217;s or PE&#8217;s total income. The Regulations set a presumption of direct production expenses plus 10% with respect to income related to production, which can be countered by the results of a supporting transfer pricing study. Tax rates applicable to such production income expenses will be similar to the tax rates under the Preferred Enterprise regime, to the extent such income would be considered as eligible. In order to calculate the preferred income, the PTE and PE is required to take into account the income and the research and development expenses that are attributed to each single preferred intangible asset.</span></span></div>
                      <div style="line-height:1.25;font-weight:normal">&#160;</div>
                      <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The company reviews every year whether it meets the conditions of the PTE or PE. The difference for the company is immaterial since it located in development area A.</span></span></div>
                      <div style="line-height:1.25;font-weight:normal">&#160;</div>
                      <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Under the Regulations the Company&#8217;s tax rate is expected to be approximately <ix:nonFraction id="Fxbrl_20230131113531818" name="inmd:CorporateTax" contextRef="C_20230101to20231231_usgaapIncomeTaxAuthorityAxis_inmdRegulationsMember" unitRef="Pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">7.5</ix:nonFraction>%.</span></span></div>
                      <div style="line-height:1.25;font-weight:normal">&#160;</div>
                      <div style="line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Amendment 74 to the Investment Law</span></span></div>
                      <div style="line-height:1.25;font-weight:normal">&#160;</div>
                      <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Pursuant to the amendment to the Investments Law which became effective on November 15, 2021, a company that elects by November 15, 2022 to pay a reduced corporate tax rate as set forth in that amendment (rather than the regular corporate tax rate applicable to Approved Enterprise income) with respect to undistributed exempt income accumulated by the company until December 31, 2020 will be entitled to distribute a dividend from such income or to be used for any other reason found by the company, without being required to pay additional corporate tax.</span></span></div>
                      <div style="line-height:1.25;font-weight:normal">&#160;</div>
                      <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company elected to take advantage of the amendment, and during November 2022 has paid NIS <ix:nonFraction id="Fxbrl_20230131113833491" name="inmd:OneTimePayment" contextRef="C_20211115" unitRef="ils" scale="6" decimals="-5" format="ixt:num-dot-decimal">42.5</ix:nonFraction> million ($<ix:nonFraction id="Fxbrl_20230131113847356" name="inmd:OneTimePayment" contextRef="C_20211115" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">12.0</ix:nonFraction> million) as a one-time payment, and as a result NIS <ix:nonFraction id="Fxbrl_20230131113902097" name="inmd:UndistributedExemptIncome" contextRef="C_20211115" unitRef="ils" scale="6" decimals="-6" format="ixt:num-dot-decimal">591</ix:nonFraction> million (approximately $<ix:nonFraction id="Fxbrl_20230131113913325" name="inmd:UndistributedExemptIncome" contextRef="C_20211115" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">165.7</ix:nonFraction> million) of the Company&#8217;s undistributed exempt income for years 2012 until 2020 are entitled to be distributed as dividend or to be used for any other reason found by the Company without being required to pay additional corporate tax. As a result, the Company is required to invest NIS <ix:nonFraction id="Fxbrl_20230131113931115" name="inmd:OneTimePayment" contextRef="C_20211115_srtCumulativeEffectPeriodOfAdoptionAxis_inmdAmendmentAdvantageExemptionMember" unitRef="ils" scale="6" decimals="-6" format="ixt:num-dot-decimal">32</ix:nonFraction> million (approximately $<ix:nonFraction id="Fxbrl_20230131113943020" name="inmd:OneTimePayment" contextRef="C_20211115_srtCumulativeEffectPeriodOfAdoptionAxis_inmdAmendmentAdvantageExemptionMember" unitRef="USD" scale="6" decimals="-6" format="ixt:num-dot-decimal">9</ix:nonFraction> million) in its industrial enterprises in Israel over a five year period. Such investment may be in the form of the acquisition of industrial assets (excluding real estate assets), investment in R&amp;D in Israel, or payroll payments to new employees to be hired by the enterprise.<sup style="vertical-align:text-top;line-height:1;font-size:smaller">&#160;</sup>All the amount that was required to invest was invested in 2022.</span></span></div>
                    </div>
                  </td>
                </tr>

            </table>
          </div>&#160;<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:67pt">&#160;</td>
                <td style="vertical-align:top;width:21pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3)</span></span></td>
                <td style="vertical-align:top;width:auto">
                  <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Corporate tax rate in Israel</span></span></div>
                  <div>&#160;</div>
                  <div>
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The income of Israeli companies, other than preferred income, is taxed in accordance with Israeli tax laws at the regular corporate tax rates. The corporate tax rate is 23% for 2018 and thereafter. Capital gain is subject to capital gain tax according to the corporate tax rate in the year the assets are sold.</span></span></div>
                  </div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <div style="line-height:1.25">
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:49pt">&#160;</td>
                  <td style="vertical-align:top;font-weight:bold;width:18pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">b.</span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div style="font-weight:bold">
                      <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Subsidiaries outside of Israel</span></span></div>
                    </div>
                    <div style="font-weight:bold">&#160;</div>
                    <div style="font-weight:bold">
                      <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Subsidiaries that are incorporated outside of Israel are assessed for taxes under the tax laws in their countries of residence.</span></span></div>
                      <div style="line-height:1.25;font-weight:normal">&#160;</div>
                      <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The corporate tax rates of Subsidiaries outside of Israel for the year ended on December 31, 2023 is between <ix:nonFraction id="Fxbrl_20240205171331220" name="inmd:CorporateTax" contextRef="C_20230101to20231231_srtRangeAxis_srtMinimumMember_usgaapIncomeTaxAuthorityNameAxis_inmdSubsidiariesOutsideIsraelMember" unitRef="Pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">21</ix:nonFraction>% to <ix:nonFraction id="Fxbrl_20240205171337783" name="inmd:CorporateTax" contextRef="C_20230101to20231231_srtRangeAxis_srtMaximumMember_usgaapIncomeTaxAuthorityNameAxis_inmdSubsidiariesOutsideIsraelMember" unitRef="Pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">26.5</ix:nonFraction>%.</span></span></div>
                    </div>
                  </td>
                </tr>

            </table>
          </div>&#160;<div><ix:exclude>
            <div style="line-height:1.25">
              <div style="font-size:10pt"><div><div><div><p style="margin-top:10pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:107%;color:black">F-29</span></span></span></p></div><hr style="border-top:1.5pt solid #000000;page-break-after:always;margin-top:4pt;margin-bottom:10pt"/><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left">&#160;</p><div style="margin-bottom:0pt"><table cellpadding="0" style="font-size:10pt;border-spacing:0px;border-width:0px;border-style:initial;border-color:initial;width:100%;margin-top:0pt"><tr><td style="width:100%;vertical-align:top"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-weight:bold">INMODE LTD.</span></p></td></tr><tr><td style="width:100%;vertical-align:top"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></td></tr><tr><td style="width:100%;vertical-align:top"><p style="margin-top:0pt;margin-bottom:0px;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif">(U.S. dollars in thousands, except for share and per amounts)</p></td></tr></table></div></div></div></div><div style="margin-top:0px;margin-bottom:0px">&#160;</div>
            </div>
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">NOTE 13 - INCOME TAXES</span> (continued):</span></span>
              <p style="margin:0pt">&#160;</p>
            </div>
          </ix:exclude></div>
          <div style="line-height:1.25">
            <div style="line-height:1.25">
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:49pt">&#160;</td>
                    <td style="vertical-align:top;font-weight:bold;width:18pt">&#160;</td>
                    <td style="vertical-align:top;text-align:justify;width:auto">
                      <div style="font-weight:bold">
                        <div style="font-weight:bold">
                          <div style="line-height:1.25">
                            <div style="line-height:1.25;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:normal">In March 2020, the Coronavirus Aid, Relief, and Economic Security Act (&#8220;CARES Act&#8221;) was enacted in the US, which provides among others, tax relief measures for businesses including a five-year net operating loss (&#8220;NOL&#8221;) carry back. As a result, the Company recognized in its consolidated financial statements a receivable tax asset in the amount of $<ix:nonFraction id="FFact_884" name="us-gaap:IncomeTaxesReceivable" contextRef="C_20200331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,894</ix:nonFraction>, under current other receivables. During 2022, the Company fully received the tax refund as part of the CARES Act.</span></span></span></div>
                            <div style="line-height:1.25;text-align:left">&#160;</div>
                          </div>
                          <div style="line-height:1.25;font-weight:normal;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of December 31, 2023, the Company&#8217;s subsidiary in U.S has an accumulated tax loss carryforward of approximately $<ix:nonFraction id="FFact_885" name="us-gaap:OperatingLossCarryforwards" contextRef="C_20231231" unitRef="USD" scale="6" decimals="-6" format="ixt:num-dot-decimal">217</ix:nonFraction> million derived mainly from exercises of options by employees which provided the Company tax deductions in excess of the actual compensation expenses (recognized in loss), under the Tax Cuts and Jobs Act of 2017 (&#8220;TCJA&#8221;).</span></span></div>
                          <div style="line-height:1.25;font-weight:normal;text-align:left">&#160;</div>
                          <div style="line-height:1.25;font-weight:normal;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Under U.S. tax laws, subject to certain limitations, carryforward tax losses originating in tax years beginning after January 1, 2018, have no expiration date, but they are limited to 80% of the company's<span style="font-weight:normal"> taxable income in any given tax year. However, the 80% limitation was temporarily removed by the CARES Act, for tax years beginning before January 1, 2021. A full valuation allowance was created against the Company&#8217;s subsidiary in the U.S against the deferred tax assets. Management currently believes that it is more likely than not that the deferred taxes generated in U.S will not be realized in the foreseeable future.</span></span></span></div>
                        </div>
                      </div>
                    </td>
                  </tr>
                  <tr>
                    <td style="width:49pt">&#160;</td>
                    <td style="vertical-align:top;font-weight:bold;width:18pt">&#160;</td>
                    <td style="vertical-align:top;text-align:justify;width:auto">&#160;</td>
                  </tr>

              </table>
            </div>
          </div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:49.65pt">&#160;</td>
                <td style="width:18pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">c.</span></span></td>
                <td style="width:auto;vertical-align:top">
                  <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred income tax assets</span></span></div>
                  <div style="font-weight:bold">&#160;</div>
                </td>
              </tr>

          </table>
          <ix:nonNumeric id="Fxbrl_20240205113145487" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" contextRef="C_20230101to20231231" escape="true">
            <div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="vertical-align:top;width:49pt">&#160;</td>
                    <td style="vertical-align:top;width:18pt">&#160;</td>
                    <td style="vertical-align:top;width:auto">
                      <div style="font-weight:bold">
                        <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred income tax assets reflect the net tax effects of loss and credit carryforwards and temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The components of the Company&#8217;s net deferred tax assets (liabilities) at December 31, 2023 and 2022 were as follows:</span></span></div>
                      </div>
                    </td>
                  </tr>

              </table>
              <div style="margin-left:67.5pt;line-height:1.25">&#160;</div>
              <div style="margin-left:72pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="6" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)">
                        <div style="margin-left:0.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred tax assets in respect of:</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="width:76%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                        <div style="text-indent:9pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Subsidiaries carryforward losses</span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_886" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">58,075</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_887" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">60,229</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="width:76%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
                        <div style="text-indent:9pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other temporary differences</span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_888" name="us-gaap:DeferredTaxAssetsOther" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,112</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_889" name="us-gaap:DeferredTaxAssetsOther" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,369</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="width:76%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                        <div style="text-indent:9pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based compensation</span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_890" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,194</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_891" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,073</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="vertical-align:bottom;width:76%;background-color:rgb(255, 255, 255)">
                        <div style="line-height:1.25;margin-left:9pt"><span style="line-height:1.25;text-indent:9pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred</span></span></span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"> tax asset in respect to other comprehensive loss</span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120111952311_Fact_890" name="us-gaap:DeferredTaxAssetsOtherComprehensiveLoss" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">502</ix:nonFraction></span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120111952311_Fact_891" name="us-gaap:DeferredTaxAssetsOtherComprehensiveLoss" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,238</ix:nonFraction></span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="width:76%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                        <div style="text-indent:-12.15pt;margin-left:21.25pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total deferred tax assets before valuation allowance</span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120102325108_Fact_898" name="us-gaap:DeferredTaxAssetsGross" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">65,883</ix:nonFraction></span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120102325108_Fact_899" name="us-gaap:DeferredTaxAssetsGross" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">69,909</ix:nonFraction></span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="width:76%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">
                        <div style="text-indent:9pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Valuation allowance</span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_896" name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">64,377</ix:nonFraction></span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_897" name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">66,815</ix:nonFraction></span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </div>
                      </td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="width:76%;padding-bottom:4px;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total deferred tax assets</span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_898" name="us-gaap:DeferredTaxAssetsNet" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,506</ix:nonFraction></span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_899" name="us-gaap:DeferredTaxAssetsNet" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,094</ix:nonFraction></span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
                    </tr>

                </table>
              </div>
            </div>
          </ix:nonNumeric>
          <div style="line-height:1.25">&#160;</div>
          <div style="line-height:1.25">
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:49.65pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top;font-weight:bold">&#160;</td>
                  <td style="width:auto;vertical-align:top">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred taxes are computed using the tax rates expected to be in effect when those differences reverse.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company records net deferred tax assets to the extent it believes these assets will more likely than not be realized in the foreseeable future. As of each reporting date, management considers new evidence, both positive and negative, that could impact management&#8217;s view with regard to the future realization of deferred tax assets for each jurisdiction.</span></span></div>
                  </td>
                </tr>

            </table>
          </div>&#160;<div><ix:exclude>
            <div style="font-size:10pt"><div><div><div><p style="margin-top:10pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:107%;color:black">F-30</span></span></span></p></div><hr style="border-top:1.5pt solid #000000;page-break-after:always;margin-top:4pt;margin-bottom:10pt"/><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left">&#160;</p><div style="margin-bottom:0pt"><table cellpadding="0" style="font-size:10pt;border-spacing:0px;border-width:0px;border-style:initial;border-color:initial;width:100%;margin-top:0pt"><tr><td style="width:100%;vertical-align:top"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-weight:bold">INMODE LTD.</span></p></td></tr><tr><td style="width:100%;vertical-align:top"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></td></tr><tr><td style="width:100%;vertical-align:top"><p style="margin-top:0pt;margin-bottom:0px;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif">(U.S. dollars in thousands, except for share and per amounts)</p></td></tr></table></div></div></div></div><div style="margin-top:0px;margin-bottom:0px">&#160;</div>
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">NOTE 13 - INCOME TAXES</span> (continued):</span></span></div>
          </ix:exclude></div>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:49.65pt">&#160;</td>
                <td style="width:18pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">d.</span></span></td>
                <td style="width:auto;vertical-align:top">
                  <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Reconciliation of theoretical tax expense to actual tax expense</span></span></div>
                  <div style="font-weight:bold">&#160;</div>
                </td>
              </tr>

          </table>
          <ix:nonNumeric id="Fxbrl_20240205113210208" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" contextRef="C_20230101to20231231" escape="true">
            <div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="vertical-align:top;width:49pt">&#160;</td>
                    <td style="vertical-align:top;width:18pt">&#160;</td>
                    <td style="vertical-align:top;width:auto">
                      <div style="font-weight:bold">
                        <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Following is a reconciliation of the theoretical provision for income tax, assuming all income is taxed at the statutory corporate tax rate applicable to Israeli corporations, and the actual tax on income:</span></span></div>
                      </div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <div style="margin-left:72pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td colspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="10" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended December 31</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="1" style="vertical-align:top;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Income before taxes on income</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><ix:nonFraction id="FFact_907" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">217,267</ix:nonFraction></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><ix:nonFraction id="FFact_908" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">201,466</ix:nonFraction></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><ix:nonFraction id="FFact_909" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">168,002</ix:nonFraction></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="1" style="vertical-align:top;width:64%;vertical-align:bottom">
                        <div style="text-indent:-13.55pt;margin-left:13.55pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>Theoretical tax expenses at the statutory rate of InMode&#160;Ltd.</span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_910" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="C_20230101to20231231" unitRef="Pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">23</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_911" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="C_20220101to20221231" unitRef="Pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">23</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_912" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="C_20210101to20211231" unitRef="Pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">23</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                      </td>
                    </tr>
                    <tr>
                      <td colspan="1" style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_913" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">49,971</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_914" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">46,337</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_915" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">38,640</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="1" style="vertical-align:top;width:64%;vertical-align:bottom">
                        <div style="text-indent:-13.55pt;margin-left:13.55pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Increase (decrease) in taxes on income due to:</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="1" style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:0.75pt;margin-left:13.55pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Benefits to the Benefited Enterprise</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_916" name="inmd:IncomeTaxReconciliationBenefitsToBenefitedEnterprise" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">31,739</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_917" name="inmd:IncomeTaxReconciliationBenefitsToBenefitedEnterprise" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">29,429</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_918" name="inmd:IncomeTaxReconciliationBenefitsToBenefitedEnterprise" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">37,478</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                    </tr>
                    <tr>
                      <td colspan="1" style="vertical-align:top;width:64%;vertical-align:bottom">
                        <div style="text-indent:-7.05pt;margin-left:21.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Different effective tax rates applicable to the Subsidiaries</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_919" name="inmd:IncomeTaxReconciliationDifferentEffectiveTaxRatesApplicableToSubsidiaries" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,956</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230120112420029" name="inmd:IncomeTaxReconciliationDifferentEffectiveTaxRatesApplicableToSubsidiaries" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,453</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230120112427832" name="inmd:IncomeTaxReconciliationDifferentEffectiveTaxRatesApplicableToSubsidiaries" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,033</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                    </tr>
                    <tr>
                      <td colspan="1" style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="margin-left:13.55pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Valuation allowance</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_925" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">126</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_926" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">130</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_927" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">40</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="1" style="vertical-align:top;width:64%;vertical-align:bottom">
                        <div style="margin-left:13.55pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Uncertain tax positions</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120112828521" name="inmd:IncomeTaxReconciliationUncertainTaxPosition" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,096</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_929" name="inmd:IncomeTaxReconciliationUncertainTaxPosition" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">303</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_930" name="inmd:IncomeTaxReconciliationUncertainTaxPosition" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,921</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="1" style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-9.4pt;margin-left:22.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-deductible expenses and other permanent differences, mainly share based compensation expenses</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_931" name="inmd:IncomeTaxReconciliationNonDeductibleExpenses" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,850</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_932" name="inmd:IncomeTaxReconciliationNonDeductibleExpenses" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,842</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_933" name="inmd:IncomeTaxReconciliationNonDeductibleExpenses" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,838</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="1" style="vertical-align:top;padding-left:9pt;width:64%;vertical-align:bottom">
                        <div style="text-indent:-9.4pt;margin-left:22.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Amendment to the Investments Law payment - see also note 13a(2)(b)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230210104355513_xbrl_20230210103120152" name="inmd:IncomeTaxReconciliationAmendmentToInvestmentsLawPayment" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230210104355513_xbrl_20230210103132889" name="inmd:IncomeTaxReconciliationAmendmentToInvestmentsLawPayment" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,017</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230210104355513_xbrl_20230120102708186_Fact_933" name="inmd:IncomeTaxReconciliationAmendmentToInvestmentsLawPayment" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="1" style="vertical-align:top;padding-left:9pt;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="margin-left:13.55pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Settlements with the Israeli tax authority net of decrease of related uncertain tax&#160;provision</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230210104419032_xbrl_20230210104355513_xbrl_20230210103120152" name="inmd:IncomeTaxReconciliationSettlementsWithIsraeliTaxAuthorityNetOfDecreaseOfRelatedUncertainTax" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230210104419032_xbrl_20230210104355513_xbrl_20230210103132889" name="inmd:IncomeTaxReconciliationSettlementsWithIsraeliTaxAuthorityNetOfDecreaseOfRelatedUncertainTax" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,199</ix:nonFraction></span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230210104419032_xbrl_20230210104355513_xbrl_20230120102708186_Fact_933" name="inmd:IncomeTaxReconciliationSettlementsWithIsraeliTaxAuthorityNetOfDecreaseOfRelatedUncertainTax" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="1" style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_937" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">19,348</ix:nonFraction></span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_938" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">39,946</ix:nonFraction></span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_939" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,928</ix:nonFraction></span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>

                </table>
              </div>
            </div>
          </ix:nonNumeric>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:49pt">&#160;</td>
                <td style="vertical-align:top;font-weight:bold;width:18pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">e.</span></span></td>
                <td style="vertical-align:top;width:auto">
                  <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Tax assessments</span></span></div>
                  <div style="font-weight:bold">&#160;</div>
                  <div style="font-weight:bold">
                    <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In February 2022, the Israeli Company settled the 2017-2020 income tax assessment with the Israeli tax authority, paying $<ix:nonFraction id="Fxbrl_20230131150049364" name="us-gaap:TaxAdjustmentsSettlementsAndUnusualProvisions" contextRef="C_20230101to20231231" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.3</ix:nonFraction> million. also see Note 13a(2)(b).</span></span></div>
                    <div style="line-height:1.25;font-weight:normal">&#160;</div>
                    <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In December 2022 the Company reached an agreement with the Israeli Tax Authority under which the Company paid on January 2023 NIS <ix:nonFraction id="Fxbrl_20230210140458012" name="inmd:UndistributedExemptIncome" contextRef="C_20221231_usgaapIncomeTaxAuthorityNameAxis_inmdIsraeliTaxAuthorityMember" unitRef="ils" scale="6" decimals="-5" format="ixt:num-dot-decimal">50.2</ix:nonFraction> million (approximately $<ix:nonFraction id="Fxbrl_20230210140523646" name="inmd:UndistributedExemptIncome" contextRef="C_20221231_usgaapIncomeTaxAuthorityNameAxis_inmdIsraeliTaxAuthorityMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">14.3</ix:nonFraction> million).</span></span></div>
                    <div style="line-height:1.25;font-weight:normal">&#160;</div>
                    <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of December 31, 2023, tax assessments of the Israeli Company through tax year 2021 are considered final. In addition, all tax assessments of one of the Company&#8217;s subsidiaries in Israel through tax year 2018 are considered final. Another Israeli subsidiary was established in 2022 and therefore does not have any tax year that considered final.</span></span></div>
                    <div style="line-height:1.25;font-weight:normal">&#160;</div>
                    <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of December 31, 2023, all tax assessments on the Company&#8217;s subsidiary in the United States, through tax year 2019, are considered final.</span></span></div>
                    <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The </span></span>other Subsidiaries' open tax years range from 2018-2023.</div>
                  </div>
                </td>
              </tr>

          </table>
        </div>&#160;<div><ix:exclude>
          <div>
            <div style="line-height:1.25">
              <div style="font-size:10pt"><div><div><div><p style="margin-top:10pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:107%;color:black">F-31</span></span></span></p></div><hr style="border-top:1.5pt solid #000000;page-break-after:always;margin-top:4pt;margin-bottom:10pt"/><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left">&#160;</p><div style="margin-bottom:0pt"><table cellpadding="0" style="font-size:10pt;border-spacing:0px;border-width:0px;border-style:initial;border-color:initial;width:100%;margin-top:0pt"><tr><td style="width:100%;vertical-align:top"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-weight:bold">INMODE LTD.</span></p></td></tr><tr><td style="width:100%;vertical-align:top"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></td></tr><tr><td style="width:100%;vertical-align:top"><p style="margin-top:0pt;margin-bottom:0px;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif">(U.S. dollars in thousands, except for share and per amounts)</p></td></tr></table></div></div></div></div><div style="margin-top:0px;margin-bottom:0px">&#160;</div>
            </div>
          </div>
          <div>
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">NOTE 13 - INCOME TAXES</span> (continued):</span></span>
              <p style="margin:0pt">&#160;</p>
            </div>
          </div>
        </ix:exclude></div>
        <div>
          <ix:nonNumeric id="Fxbrl_20240205113231928" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" contextRef="C_20230101to20231231" escape="true">
            <div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:49.65pt">&#160;</td>
                    <td style="width:18pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">f.</span></span></td>
                    <td style="width:auto;vertical-align:top">
                      <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Income before income taxes is composed of the following:</span></span></div>
                    </td>
                  </tr>
                  <tr>
                    <td style="width:49.65pt">&#160;</td>
                    <td style="width:18pt;vertical-align:top;font-weight:bold">&#160;</td>
                    <td style="width:auto;vertical-align:top">&#160;</td>
                  </tr>

              </table>
              <div style="margin-left:72pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="10" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended December 31</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">InMode Ltd. and Israeli subsidiaries</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_941" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="C_20230101to20231231_usgaapIncomeTaxAuthorityNameAxis_inmdInmodeLtdAndIsreaeliSubsidiariesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">211,137</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_942" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="C_20220101to20221231_usgaapIncomeTaxAuthorityNameAxis_inmdInmodeLtdAndIsreaeliSubsidiariesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">196,354</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_943" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="C_20210101to20211231_usgaapIncomeTaxAuthorityNameAxis_inmdInmodeLtdAndIsreaeliSubsidiariesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">163,370</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Subsidiaries outside of Israel</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_944" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="C_20230101to20231231_usgaapIncomeTaxAuthorityNameAxis_inmdSubsidiariesOutsideIsraelMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,130</ix:nonFraction></span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_945" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="C_20220101to20221231_usgaapIncomeTaxAuthorityNameAxis_inmdSubsidiariesOutsideIsraelMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,112</ix:nonFraction></span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_946" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="C_20210101to20211231_usgaapIncomeTaxAuthorityNameAxis_inmdSubsidiariesOutsideIsraelMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,632</ix:nonFraction></span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_947" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">217,267</ix:nonFraction></span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_948" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">201,466</ix:nonFraction></span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_949" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">168,002</ix:nonFraction></span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>

                </table>
              </div>
            </div>
          </ix:nonNumeric>
          <div style="line-height:1.25">&#160;</div>
          <ix:nonNumeric id="Fxbrl_20240205113248427" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" contextRef="C_20230101to20231231" escape="true">
            <div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:49.65pt">&#160;</td>
                    <td style="width:18pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">g.</span></span></td>
                    <td style="width:auto;vertical-align:top">
                      <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Tax expenses (tax benefit):</span></span></div>
                    </td>
                  </tr>

              </table>
              <div style="margin-left:72pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="10" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended December 31</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Current:</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;vertical-align:bottom">
                        <div style="margin-left:8.55pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Israel</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_951" name="us-gaap:CurrentIncomeTaxExpenseBenefit" contextRef="C_20230101to20231231_usgaapIncomeTaxAuthorityNameAxis_countryIL" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">17,633</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_952" name="us-gaap:CurrentIncomeTaxExpenseBenefit" contextRef="C_20220101to20221231_usgaapIncomeTaxAuthorityNameAxis_countryIL" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">38,248</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_953" name="us-gaap:CurrentIncomeTaxExpenseBenefit" contextRef="C_20210101to20211231_usgaapIncomeTaxAuthorityNameAxis_countryIL" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,829</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="margin-left:8.55pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Subsidiaries</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120114248879_Fact_957" name="us-gaap:CurrentIncomeTaxExpenseBenefit" contextRef="C_20230101to20231231_usgaapIncomeTaxAuthorityNameAxis_inmdSubsidiariesOutsideIsraelMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,864</ix:nonFraction></span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120114248879_Fact_958" name="us-gaap:CurrentIncomeTaxExpenseBenefit" contextRef="C_20220101to20221231_usgaapIncomeTaxAuthorityNameAxis_inmdSubsidiariesOutsideIsraelMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,614</ix:nonFraction></span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230120114248879_Fact_959" name="us-gaap:CurrentIncomeTaxExpenseBenefit" contextRef="C_20210101to20211231_usgaapIncomeTaxAuthorityNameAxis_inmdSubsidiariesOutsideIsraelMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">131</ix:nonFraction></span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </div>
                      </td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230210105713218_xbrl_20230120114248879_Fact_957" name="us-gaap:CurrentIncomeTaxExpenseBenefit" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">19,497</ix:nonFraction></span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230210105713218_xbrl_20230120114248879_Fact_958" name="us-gaap:CurrentIncomeTaxExpenseBenefit" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">39,862</ix:nonFraction></span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230210105713218_xbrl_20230120114248879_Fact_959" name="us-gaap:CurrentIncomeTaxExpenseBenefit" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,698</ix:nonFraction></span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred:</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;vertical-align:bottom">
                        <div style="margin-left:8.55pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Israel</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230120113838966_Fact_978" name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="C_20230101to20231231_usgaapIncomeTaxAuthorityNameAxis_countryIL" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">149</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120113838966_Fact_979" name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="C_20220101to20221231_usgaapIncomeTaxAuthorityNameAxis_countryIL" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">84</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230120113838966_Fact_980" name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="C_20210101to20211231_usgaapIncomeTaxAuthorityNameAxis_countryIL" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">770</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="margin-left:8.55pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Subsidiaries</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120103603322_xbrl_20230120103544203" name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="C_20230101to20231231_usgaapIncomeTaxAuthorityNameAxis_inmdSubsidiariesOutsideIsraelMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120103603322_Fact_967" name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="C_20220101to20221231_usgaapIncomeTaxAuthorityNameAxis_inmdSubsidiariesOutsideIsraelMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120103603322_Fact_968" name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="C_20210101to20211231_usgaapIncomeTaxAuthorityNameAxis_inmdSubsidiariesOutsideIsraelMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230120113854852_Fact_978" name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">149</ix:nonFraction></span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230120113854852_Fact_979" name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">84</ix:nonFraction></span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230120113854852_Fact_980" name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">770</ix:nonFraction></span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </div>
                      </td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total taxes on income</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_978" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">19,348</ix:nonFraction></span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_979" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">39,946</ix:nonFraction></span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_980" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,928</ix:nonFraction></span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>

                </table>
              </div>
            </div>
          </ix:nonNumeric>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:49.65pt">&#160;</td>
                <td style="width:18pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">h.</span></span></td>
                <td style="width:auto;vertical-align:top">
                  <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Uncertain tax positions:</span></span></div>
                  <div style="font-weight:bold">&#160;</div>
                  <div style="font-weight:bold">
                    <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">ASC No. 740, Income Taxes, requires significant judgment in determining what constitutes an individual tax position as well as assessing the outcome of each tax position. Changes in judgment as to recognition or measurement of tax positions can materially affect the estimate of the effective tax rate and consequently, affect the operating results of the Company. </span></span><br/><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:normal">&#160;</span></span></span></div>
                  </div>
                </td>
              </tr>

          </table>
          <ix:nonNumeric id="Fxbrl_20240205113307909" name="us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" contextRef="C_20230101to20231231" escape="true">
            <div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="vertical-align:top;width:49pt">&#160;</td>
                    <td style="vertical-align:top;width:18pt">&#160;</td>
                    <td style="vertical-align:top;width:auto">
                      <div style="font-weight:bold">
                        <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The following table summarizes the activity of the Company&#8217;s unrecognized tax benefits:</span></span></div>
                      </div>
                    </td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:49pt">&#160;</td>
                    <td style="vertical-align:top;width:18pt">&#160;</td>
                    <td style="vertical-align:top;width:auto">&#160;</td>
                  </tr>

              </table>
              <div style="margin-left:72pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year&#160;ended&#160;December&#160;31</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="margin-left:16.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at January 1</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_982" name="us-gaap:UnrecognizedTaxBenefits" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">303</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_983" name="us-gaap:UnrecognizedTaxBenefits" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,831</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:76%;vertical-align:bottom">
                        <div style="margin-left:16.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Decrease in uncertain tax positions for the previous years</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_984" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230120104011627" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,831</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="margin-left:16.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Increase in uncertain tax positions for the current year, net</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_986" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,096</ix:nonFraction></span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_987" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">303</ix:nonFraction></span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:76%;padding-bottom:4px;vertical-align:bottom">
                        <div style="margin-left:16.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at December 31</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_988" name="us-gaap:UnrecognizedTaxBenefits" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,399</ix:nonFraction></span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_989" name="us-gaap:UnrecognizedTaxBenefits" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">303</ix:nonFraction></span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>

                </table>
              </div>
            </div>
          </ix:nonNumeric>
          <div style="line-height:1.25">&#160;</div>
          <div style="line-height:1.25">
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:49.65pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top;font-weight:bold">&#160;</td>
                  <td style="width:auto;vertical-align:top">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company does not expect uncertain tax positions to change significantly over the next 12 months.</span></span></div>
                  </td>
                </tr>

            </table>
          </div>
        </div>
      </div>
    </ix:nonNumeric>
    <p style="margin:0pt">&#160;</p>
    <div style="font-size:10pt"><div><div><div><p style="margin-top:10pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:107%;color:black">F-32</span></span></span></p></div><hr style="border-top:1.5pt solid #000000;page-break-after:always;margin-top:4pt;margin-bottom:10pt"/><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left">&#160;</p><div style="margin-bottom:0pt"><table cellpadding="0" style="font-size:10pt;border-spacing:0px;border-width:0px;border-style:initial;border-color:initial;width:100%;margin-top:0pt"><tr><td style="width:100%;vertical-align:top"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-weight:bold">INMODE LTD.</span></p></td></tr><tr><td style="width:100%;vertical-align:top"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></td></tr><tr><td style="width:100%;vertical-align:top"><p style="margin-top:0pt;margin-bottom:0px;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif">(U.S. dollars in thousands, except for share and per amounts)</p></td></tr></table></div></div></div></div><div style="margin-top:0px;margin-bottom:0px">&#160;</div>
  </div>
</div><div style="">
  <ix:nonNumeric id="FFact_1038" name="us-gaap:SegmentReportingDisclosureTextBlock" contextRef="C_20230101to20231231" escape="true">
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 14 - ENTITY-WIDE DISCLOSURE:</span></span></strong></p>
    <div>
      <div>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:49.65pt">&#160;</td>
              <td style="width:18pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">a.</span></span></td>
              <td style="width:auto;vertical-align:top">
                <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenue</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <ix:nonNumeric id="Fxbrl_20240205141121811" name="us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock" contextRef="C_20230101to20231231" escape="true">
          <div>
            <div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:67pt">&#160;</td>
                    <td style="vertical-align:top;width:21pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1)</span></span></td>
                    <td style="vertical-align:top;width:auto">
                      <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenues by geographic area were as follows:</span></span></div>
                    </td>
                  </tr>

              </table>
              <p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left">&#160;</p>
              <div style="margin-left:93pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="10" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended December 31</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">United States</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_992" name="us-gaap:Revenues" contextRef="C_20230101to20231231_srtStatementGeographicalAxis_countryUS" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">307,818</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_993" name="us-gaap:Revenues" contextRef="C_20220101to20221231_srtStatementGeographicalAxis_countryUS" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">298,612</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_994" name="us-gaap:Revenues" contextRef="C_20210101to20211231_srtStatementGeographicalAxis_countryUS" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">237,263</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:64%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Europe</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230131122327862_Fact_992" name="us-gaap:Revenues" contextRef="C_20230101to20231231_srtStatementGeographicalAxis_srtEuropeMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">62,532</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230131122327862_Fact_993" name="us-gaap:Revenues" contextRef="C_20220101to20221231_srtStatementGeographicalAxis_srtEuropeMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">49,274</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230131122327862_Fact_994" name="us-gaap:Revenues" contextRef="C_20210101to20211231_srtStatementGeographicalAxis_srtEuropeMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">36,588</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_995" name="us-gaap:Revenues" contextRef="C_20230101to20231231_srtStatementGeographicalAxis_inmdOtherCountryMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">121,698</ix:nonFraction></span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_996" name="us-gaap:Revenues" contextRef="C_20220101to20221231_srtStatementGeographicalAxis_inmdOtherCountryMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">106,385</ix:nonFraction></span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_997" name="us-gaap:Revenues" contextRef="C_20210101to20211231_srtStatementGeographicalAxis_inmdOtherCountryMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">83,714</ix:nonFraction></span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:64%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_998" name="us-gaap:Revenues" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">492,048</ix:nonFraction></span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">*</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_999" name="us-gaap:Revenues" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">454,271</ix:nonFraction></span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">*</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_1000" name="us-gaap:Revenues" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">357,565</ix:nonFraction></span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">*</span></span></div>
                        </div>
                      </td>
                    </tr>

                </table>
              </div>
            </div>
            <div style="line-height:1.25">&#160;</div>
            <div style="line-height:1.25">
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:71pt">&#160;</td>
                    <td style="vertical-align:top;width:18pt">&#160;</td>
                    <td style="vertical-align:top;width:auto">
                      <div>
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">*Revenues are attributed to geographic areas based on the location of customer. No single customer accounted for 10% or more of Company&#8217;s total revenues, or Company&#8217;s net accounts receivable, in any fiscal year presented.</span></span></div>
                      </div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </ix:nonNumeric>
        <p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left">&#160;</p>
        <ix:nonNumeric id="Fxbrl_20240205135644068" name="us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" contextRef="C_20230101to20231231" escape="true">
          <div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:67pt">&#160;</td>
                  <td style="vertical-align:top;width:21pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2)</span></span></td>
                  <td style="vertical-align:top;width:auto">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenues based on products' category were as follows:</span></span></div>
                  </td>
                </tr>

            </table>
            <p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left">&#160;</p>
            <div style="margin-left:93pt">
              <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="10" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended December 31</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:middle;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Capital Equipment revenues</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240205124122989" name="us-gaap:Revenues" contextRef="C_20230101to20231231_srtProductOrServiceAxis_inmdCapitalEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">412,089</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240205124131321" name="us-gaap:Revenues" contextRef="C_20220101to20221231_srtProductOrServiceAxis_inmdCapitalEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">394,212</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240205124134328" name="us-gaap:Revenues" contextRef="C_20210101to20211231_srtProductOrServiceAxis_inmdCapitalEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">319,239</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:middle;width:64%;padding-bottom:2px;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Consumables and service revenues</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240205124304562_xbrl_20240205124122989" name="us-gaap:Revenues" contextRef="C_20230101to20231231_srtProductOrServiceAxis_inmdConsumablesAndServiceRevenuesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">79,959</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240205124304562_xbrl_20240205124131321" name="us-gaap:Revenues" contextRef="C_20220101to20221231_srtProductOrServiceAxis_inmdConsumablesAndServiceRevenuesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">60,059</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240205124304562_xbrl_20240205124134328" name="us-gaap:Revenues" contextRef="C_20210101to20211231_srtProductOrServiceAxis_inmdConsumablesAndServiceRevenuesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">38,326</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:middle;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240205124305915_xbrl_20240205124122989" name="us-gaap:Revenues" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">492,048</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240205124305915_xbrl_20240205124131321" name="us-gaap:Revenues" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">454,271</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240205124305915_xbrl_20240205124134328" name="us-gaap:Revenues" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">357,565</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>

              </table>
            </div>
          </div>
        </ix:nonNumeric>
        <div style="line-height:1.25">&#160;</div>
        <ix:nonNumeric id="Fxbrl_20240205135415381" name="us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" contextRef="C_20230101to20231231" escape="true">
          <div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:67pt">&#160;</td>
                  <td style="vertical-align:top;width:21pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3)</span></span></td>
                  <td style="vertical-align:top;width:auto">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenues based on products' technology were as follows:</span></span></div>
                  </td>
                </tr>

            </table>
            <p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left">&#160;</p>
            <div style="margin-left:93pt">
              <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="10" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended December 31</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="10" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:middle;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Minimal-Invasive</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_1002" name="inmd:PercentageOfNetSalesBasedOnProductsTechnology" contextRef="C_20230101to20231231_usgaapConcentrationRiskByTypeAxis_inmdMinimalInvasiveMember" unitRef="Pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">83</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_1003" name="inmd:PercentageOfNetSalesBasedOnProductsTechnology" contextRef="C_20220101to20221231_usgaapConcentrationRiskByTypeAxis_inmdMinimalInvasiveMember" unitRef="Pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">81</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_1004" name="inmd:PercentageOfNetSalesBasedOnProductsTechnology" contextRef="C_20210101to20211231_usgaapConcentrationRiskByTypeAxis_inmdMinimalInvasiveMember" unitRef="Pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">72</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:middle;width:64%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Hands-Free</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_1005" name="inmd:PercentageOfNetSalesBasedOnProductsTechnology" contextRef="C_20230101to20231231_usgaapConcentrationRiskByTypeAxis_inmdHandsFreeMember" unitRef="Pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">8</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_1006" name="inmd:PercentageOfNetSalesBasedOnProductsTechnology" contextRef="C_20220101to20221231_usgaapConcentrationRiskByTypeAxis_inmdHandsFreeMember" unitRef="Pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">10</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_1007" name="inmd:PercentageOfNetSalesBasedOnProductsTechnology" contextRef="C_20210101to20211231_usgaapConcentrationRiskByTypeAxis_inmdHandsFreeMember" unitRef="Pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">20</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:middle;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-Invasive</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_1008" name="inmd:PercentageOfNetSalesBasedOnProductsTechnology" contextRef="C_20230101to20231231_usgaapConcentrationRiskByTypeAxis_inmdNonInvasiveMember" unitRef="Pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">9</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_1009" name="inmd:PercentageOfNetSalesBasedOnProductsTechnology" contextRef="C_20220101to20221231_usgaapConcentrationRiskByTypeAxis_inmdNonInvasiveMember" unitRef="Pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">9</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_1010" name="inmd:PercentageOfNetSalesBasedOnProductsTechnology" contextRef="C_20210101to20211231_usgaapConcentrationRiskByTypeAxis_inmdNonInvasiveMember" unitRef="Pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">8</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:middle;width:64%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_1011" name="inmd:PercentageOfNetSalesBasedOnProductsTechnology" contextRef="C_20230101to20231231" unitRef="Pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">100</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_1012" name="inmd:PercentageOfNetSalesBasedOnProductsTechnology" contextRef="C_20220101to20221231" unitRef="Pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">100</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_1013" name="inmd:PercentageOfNetSalesBasedOnProductsTechnology" contextRef="C_20210101to20211231" unitRef="Pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">100</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>

              </table>
            </div>
          </div>
        </ix:nonNumeric>
        <div style="line-height:1.25">&#160;</div>
        <ix:nonNumeric id="Fxbrl_20240205141050251" name="us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock" contextRef="C_20230101to20231231" escape="true">
          <div>
            <div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:67pt">&#160;</td>
                    <td style="vertical-align:top;width:21pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4)</span></span></td>
                    <td style="vertical-align:top;width:auto">
                      <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The changes in contract liabilities are as follows:</span></span></div>
                    </td>
                  </tr>

              </table>
              <p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left">&#160;</p>
              <div style="margin-left:93pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td rowspan="1" style="vertical-align:middle;width:76%;background-color:rgb(255, 255, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="6" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year&#160;ended&#160;December&#160;31</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td rowspan="1" style="vertical-align:middle;width:76%;background-color:rgb(255, 255, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" rowspan="1" style="text-align:center;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255);font-weight:bold;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></td>
                      <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-15.95pt;margin-left:15.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of January 1</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_1015" name="us-gaap:ContractWithCustomerLiability" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">17,757</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_1016" name="us-gaap:ContractWithCustomerLiability" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">16,556</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:76%;vertical-align:bottom">
                        <div style="text-indent:-15.95pt;margin-left:15.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Increases due to issuance of new contracts, excluding amounts recognized as revenue during the period</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_1017" name="inmd:IncreasesDueToIssuanceOfNewContractsExcludingAmountsRecognizedAsRevenueDuringPeriod" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,498</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_1018" name="inmd:IncreasesDueToIssuanceOfNewContractsExcludingAmountsRecognizedAsRevenueDuringPeriod" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,987</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-15.95pt;margin-left:15.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenue recognized that was included in the contract liability balance at the beginning of the period</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_1019" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">15,566</ix:nonFraction></span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_1020" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">13,786</ix:nonFraction></span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </div>
                      </td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:76%;padding-bottom:4px;vertical-align:bottom">
                        <div style="text-indent:-15.95pt;margin-left:15.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_1021" name="us-gaap:ContractWithCustomerLiability" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,689</ix:nonFraction></span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_1022" name="us-gaap:ContractWithCustomerLiability" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">17,757</ix:nonFraction></span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-15.95pt;margin-left:15.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Contract liability presented in non-current liabilities (1)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_1023" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,766</ix:nonFraction></span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_1024" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,959</ix:nonFraction></span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:76%;padding-bottom:4px;vertical-align:bottom">
                        <div style="text-indent:-15.95pt;margin-left:15.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Contract liability presented in current liabilities</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_1025" name="us-gaap:ContractWithCustomerLiabilityCurrent" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,923</ix:nonFraction></span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_1026" name="us-gaap:ContractWithCustomerLiabilityCurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,798</ix:nonFraction></span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>

                </table>
              </div>
            </div>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:67pt">&#160;</td>
                  <td style="vertical-align:top;width:21pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1)</span></span></td>
                  <td style="vertical-align:top;width:auto">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of December 31, 2023, non-current deferred revenue is estimated to be recognized as following: <ix:nonFraction id="FFact_1027" name="inmd:PercentageOfNonCurrentDeferredRevenue" contextRef="C_20231231" unitRef="Pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">83</ix:nonFraction>% in year 2025 and the rest in year 2026-2027.</span></span></div>
                  </td>
                </tr>

            </table>
          </div>
        </ix:nonNumeric>
        <div style="line-height:1.25">&#160;</div>
        <div><ix:exclude>
          <div style="clear:both;margin-top:0pt;margin-bottom:0pt">
            <div style="width:100%">
              <div style="font-size:10pt"><div><div><div><p style="margin-top:10pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:107%;color:black">F-33</span></span></span></p></div><hr style="border-top:1.5pt solid #000000;page-break-after:always;margin-top:4pt;margin-bottom:10pt"/><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left">&#160;</p><div style="margin-bottom:0pt"><table cellpadding="0" style="font-size:10pt;border-spacing:0px;border-width:0px;border-style:initial;border-color:initial;width:100%;margin-top:0pt"><tr><td style="width:100%;vertical-align:top"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-weight:bold">INMODE LTD.</span></p></td></tr><tr><td style="width:100%;vertical-align:top"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></td></tr><tr><td style="width:100%;vertical-align:top"><p style="margin-top:0pt;margin-bottom:0px;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif">(U.S. dollars in thousands, except for share and per amounts)</p></td></tr></table></div></div></div></div><div style="margin-top:0px;margin-bottom:0px">&#160;</div>
            </div>
          </div>
          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">NOTE 14 - ENTITY-WIDE DISCLOSURE </span>(continued):</span></span></div>
          <div style="line-height:1.25">&#160;</div>
        </ix:exclude></div>
        <ix:nonNumeric id="Fxbrl_20240205141110581" name="us-gaap:DisclosureOfLongLivedAssetsHeldForSaleTextBlock" contextRef="C_20230101to20231231" escape="true">
          <div>
            <div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:49.65pt">&#160;</td>
                    <td style="width:18pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">b.</span></span></td>
                    <td style="width:auto;vertical-align:top">
                      <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Long-Lived Assets</span></span></div>
                    </td>
                  </tr>

              </table>
              <p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left">&#160;</p>
              <div style="margin-left:72pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="6" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-15.95pt;margin-left:15.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Israel</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_1029" name="inmd:TotalLongLivedAssetsByGeographicalArea" contextRef="C_20231231_srtStatementGeographicalAxis_countryIL" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,704</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_1030" name="inmd:TotalLongLivedAssetsByGeographicalArea" contextRef="C_20221231_srtStatementGeographicalAxis_countryIL" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,263</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:76%;vertical-align:bottom">
                        <div style="text-indent:-15.95pt;margin-left:15.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">United States</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_1031" name="inmd:TotalLongLivedAssetsByGeographicalArea" contextRef="C_20231231_srtStatementGeographicalAxis_countryUS" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,789</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_1032" name="inmd:TotalLongLivedAssetsByGeographicalArea" contextRef="C_20221231_srtStatementGeographicalAxis_countryUS" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,097</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-15.95pt;margin-left:15.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_1033" name="inmd:TotalLongLivedAssetsByGeographicalArea" contextRef="C_20231231_srtStatementGeographicalAxis_inmdOtherCountryMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,587</ix:nonFraction></span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_1034" name="inmd:TotalLongLivedAssetsByGeographicalArea" contextRef="C_20221231_srtStatementGeographicalAxis_inmdOtherCountryMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,011</ix:nonFraction></span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:76%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240205140957808_Fact_1035" name="inmd:TotalLongLivedAssetsByGeographicalArea" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,080</ix:nonFraction></span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240205140957808_Fact_1036" name="inmd:TotalLongLivedAssetsByGeographicalArea" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,371</ix:nonFraction></span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-15.95pt;margin-left:15.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other long-term assets*</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240205132505564_Fact_1035" name="us-gaap:OtherAssetsNoncurrent" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,370</ix:nonFraction></span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240205132505564_Fact_1036" name="us-gaap:OtherAssetsNoncurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,573</ix:nonFraction></span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:76%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_1035" name="us-gaap:NoncurrentAssets" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">16,450</ix:nonFraction></span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_1036" name="us-gaap:NoncurrentAssets" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,944</ix:nonFraction></span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>

                </table>
              </div>
            </div>
            <div style="line-height:1.25">&#160;</div>
            <div style="line-height:1.25">
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:49.65pt">&#160;</td>
                    <td style="width:18pt;vertical-align:top;font-weight:bold">&#160;</td>
                    <td style="width:auto;vertical-align:top">
                      <div style="font-weight:normal">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">*Consists of non-current accounts receivable, net and other investments</span></span></div>
                      </div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </ix:nonNumeric>
      </div>
    </div>
  </ix:nonNumeric>
  <p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left">&#160;</p>
</div><div style="">
  <div>
    <ix:nonNumeric id="Fxbrl_20240208204236302" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" contextRef="C_20230101to20231231" escape="true">
      <div>
        <div>
          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">NOTE 15 - RELATED PARTIES</span>:</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:49.5pt">&#160;</td>
                <td style="width:18pt;font-weight:bold;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">a.</span></span></td>
                <td style="width:auto;vertical-align:top">
                  <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company receives and provides certain services from and to Home Skinovations Ltd., a related party as part of a service agreement between them. The services include an office sublease in Israel, use of certain computer hardware and switchboard infrastructure, certain software licenses, joint purchases of employee&#8217;s welfare products and services from third parties and limited manpower services. The Chairman of the Board and Chief Executive Officer of the Company is also a substantial shareholder and board member of Home Skinovations Ltd. and one of the Company&#8217;s directors, serves on the board of directors of Home Skinovations Ltd. The Company recorded expenses related to services received and provided from Home Skinovations Ltd. of $<ix:nonFraction id="Fxbrl_20230131123034237" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" contextRef="C_20230101to20231231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdHomeSkinnovationsLtdMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">99</ix:nonFraction>, $<ix:nonFraction id="Fxbrl_20230131123041448" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" contextRef="C_20220101to20221231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdHomeSkinnovationsLtdMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">332</ix:nonFraction> and $<ix:nonFraction id="Fxbrl_20230131123046934" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" contextRef="C_20210101to20211231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdHomeSkinnovationsLtdMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">239</ix:nonFraction> for the years ended December 31, 2023, 2022 and 2021, respectively.</span></span></div>
                  <div>&#160;</div>
                  <div>
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In addition, the balance of the <span style="-sec-ix-hidden:Fxbrl_20240208192647081"><span style="-sec-ix-hidden:Fxbrl_20240208181011420">accounts payable</span></span> as of December 31, 2023, 2022 was $<ix:nonFraction id="Fxbrl_20240205122456326" name="us-gaap:AccountsPayableCurrent" contextRef="C_20221231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdHomeSkinnovationsLtdMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20240205122431219" name="us-gaap:AccountsPayableCurrent" contextRef="C_20231231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdHomeSkinnovationsLtdMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">0</ix:nonFraction></ix:nonFraction>.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In February 2022 the Company have entered into an Asset Purchase Agreement with Home Skinovations, whereby Home Skinovations Ltd. sold and assigned to the Company all of Home Skinovations Ltd.&#8217;s right, title and interest in and to Home Skinovations Ltd.&#8217;s Spa segment assets (including molds, tooling, inventory and trademarks) and further granted the Company an exclusive license to certain IP rights of Home Skinovations Ltd., all the foregoing in consideration for an aggregate amount of $<ix:nonFraction id="Fxbrl_20230131123529781" name="inmd:RelatedPartyConsiderationForAggregateAmount" contextRef="C_20230101to20231231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdHomeSkinnovationsLtdMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">497</ix:nonFraction>.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company&#8217;s subsidiary in Canada receives and provides certain services from and to a subsidiary of Home Skinovations Ltd. in Canada as part of a service agreement between them. The services include mobile phone services, an office sublease, use of certain computer hardware and switchboard infrastructure, certain software licenses, joint purchases of employee&#8217;s welfare products and services from third parties and limited manpower services. In relation to these services received and provided, the Company recorded expenses (income) in the amount of $(<ix:nonFraction id="Fxbrl_20230131124342928" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" contextRef="C_20230101to20231231_usgaapIncomeStatementLocationAxis_inmdExpensesIncomeMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdSubsidiaryOfHomeSkinnovationsLtdMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">30</ix:nonFraction>), $<ix:nonFraction id="Fxbrl_20230131124352840" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" contextRef="C_20220101to20221231_usgaapIncomeStatementLocationAxis_inmdExpensesIncomeMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdSubsidiaryOfHomeSkinnovationsLtdMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">123</ix:nonFraction> and $<ix:nonFraction id="Fxbrl_20230131124359791" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" contextRef="C_20210101to20211231_usgaapIncomeStatementLocationAxis_inmdExpensesIncomeMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdSubsidiaryOfHomeSkinnovationsLtdMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">433</ix:nonFraction> for the years ended December 31, 2023, 2022 and 2021, respectively. In addition, the balance of the <span style="-sec-ix-hidden:Fxbrl_20240208192657231"><span style="-sec-ix-hidden:Fxbrl_20240208190452680">accounts receivable</span></span> as of December 31, 2023, 2022 was $<ix:nonFraction id="Fxbrl_20240208190552555" name="us-gaap:AccountsReceivableNet" contextRef="C_20221231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdSubsidiaryOfHomeSkinnovationsLtdMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20240208184557538" name="us-gaap:AccountsReceivableNet" contextRef="C_20231231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdSubsidiaryOfHomeSkinnovationsLtdMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">0</ix:nonFraction></ix:nonFraction>.</span></span></div>
                  </div>
                </td>
              </tr>

          </table>&#160;<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:67.65pt">&#160;</td>
                <td style="width:18pt;vertical-align:top;font-weight:normal">1)</td>
                <td style="width:auto;vertical-align:top">
                  <div>
                    <div style="line-height:1.25">The Company&#8217;s subsidiaries in North America received marketing services from SpaMedica International SRL, which was amalgamated with an affiliate company into the Company&#8217;s major shareholder BoomerangFX International SRL during 2021. Dr. Stephan Mulholland is a beneficiary owner of 100% of the Company's major shareholder BoomerangFX. The Company recorded expenses related to those services in the amount of $<ix:nonFraction id="Fxbrl_20230131124619385" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" contextRef="C_20230101to20231231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdSpaMedicalInternationalLsrlMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">172 </ix:nonFraction>for the year ended December 31, 2021. Starting from 2022 calendar year, Dr. Stephen Mulholland provides the Company and its subsidiaries certain marketing services as an independent contractor. The Company recorded expenses related to those services in the amount of $<ix:nonFraction id="Fxbrl_20230131124631373" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" contextRef="C_20220101to20221231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdSpaMedicalInternationalLsrlMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">636</ix:nonFraction>, $<ix:nonFraction id="Fxbrl_20230131124637719" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" contextRef="C_20210101to20211231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdSpaMedicalInternationalLsrlMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">723 </ix:nonFraction>for the years ended December 31, 2023 and 2022, respectively.</div>
                  </div>
                  <div>&#160;</div>
                  <div>
                    <div style="line-height:1.25">During 2023 Dr. Stephen Mulholland ceased to be a related party.</div>
                  </div>
                </td>
              </tr>

          </table>
        </div>&#160;<div><ix:exclude>
          <div style="clear:both;margin-top:0pt;margin-bottom:0pt">
            <div style="text-align:center">
              <div style="font-size:10pt"><div><div><div><p style="margin-top:10pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:107%;color:black">F-34</span></span></span></p></div><hr style="border-top:1.5pt solid #000000;page-break-after:always;margin-top:4pt;margin-bottom:10pt"/><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left">&#160;</p><div style="margin-bottom:0pt"><table cellpadding="0" style="font-size:10pt;border-spacing:0px;border-width:0px;border-style:initial;border-color:initial;width:100%;margin-top:0pt"><tr><td style="width:100%;vertical-align:top"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-weight:bold">INMODE LTD.</span></p></td></tr><tr><td style="width:100%;vertical-align:top"><p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></td></tr><tr><td style="width:100%;vertical-align:top"><p style="margin-top:0pt;margin-bottom:0px;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif">(U.S. dollars in thousands, except for share and per amounts)</p></td></tr></table></div></div></div></div><div style="margin-top:0px;margin-bottom:0px">&#160;</div>
              <p style="margin:0pt;text-align:left"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold;margin-top:0pt;margin-bottom:0pt">NOTE 15 - RELATED PARTIES </span>(continued):</span></span></p>
              <p style="margin:0pt;text-align:left">&#160;</p>
            </div>
          </div>
        </ix:exclude></div>
        <div>
          <div>
            <div style="line-height:1.25">
              <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;color:rgb(0, 0, 0)">

                  <tr>
                    <td style="width:67.65pt">&#160;</td>
                    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span>2)</span></span></td>
                    <td style="width:auto;vertical-align:top">
                      <div>
                        <div style="line-height:1.25"><span style="font-size:10pt"><span>The Company receives certain investment portfolio management services from Himalaya Family Office Consulting Ltd., with respect to part of its investment portfolio. The Chairman of the Board and Chief Executive Officer of the Company, is a minor shareholder and a board member of Himalaya Family Office Consulting Ltd. In relation to these services, the Company recorded expenses in the amount of $<ix:nonFraction id="Fxbrl_20230131125250358" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" contextRef="C_20230101to20231231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdHimalayaFamilyOfficeConsultingLtdMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">193</ix:nonFraction>, $<ix:nonFraction id="Fxbrl_20230131125300232" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" contextRef="C_20220101to20221231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdHimalayaFamilyOfficeConsultingLtdMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">100</ix:nonFraction> and $<ix:nonFraction id="Fxbrl_20230131125306335" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" contextRef="C_20210101to20211231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdHimalayaFamilyOfficeConsultingLtdMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">90</ix:nonFraction> for the years ended December 31, 2023, 2022 and 2021, respectively.</span></span></div>
                      </div>
                      <div>&#160;</div>
                      <div>
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span>In addition, the balance of the <span style="-sec-ix-hidden:Fxbrl_20240208192704302"><span style="-sec-ix-hidden:Fxbrl_20240208173003815">accounts payable</span></span> as of December 31, 2023, 2022, was $<ix:nonFraction id="Fxbrl_20240205122557345" name="us-gaap:AccountsPayableCurrent" contextRef="C_20231231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdHimalayaFamilyOfficeConsultingLtdMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">86</ix:nonFraction>, $<ix:nonFraction id="Fxbrl_20240205122600617" name="us-gaap:AccountsPayableCurrent" contextRef="C_20221231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdHimalayaFamilyOfficeConsultingLtdMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">28</ix:nonFraction>, respectively.</span></span></div>
                        </div>
                      </div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
      </div>
    </ix:nonNumeric>
  </div>
  <p style="margin:0pt">&#160;</p>
  <p style="margin:10pt 0pt 0pt;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">F-35</span></span></p>
  <hr style="border:none;border-bottom:4px solid black;border-top:1px solid black;height:10px;width:100%;color:#ffffff;background-color:#ffffff;text-align:center;margin-left:auto;margin-right:auto;text-align:center"/>
</div></div></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.7
<SEQUENCE>2
<FILENAME>exhibit_4-7.htm
<DESCRIPTION>FIRST ADDENDUM TO CONSULTANCY AGREEMENT
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: company
         Document created using Broadridge PROfile 23.9.1.5178
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <font style="font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0);">
  </font>
  <div>
    <div style="line-height: 1.25; text-align: right;">
      <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"><font style="font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0);"><u><font style="font-weight: bold;">Exhibit 4.7</font></u><br style="line-height: 1.25;">
      </font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0);">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold; color: rgb(0, 0, 0);"><u>FIRST ADDENDUM TO CONSULTANCY AGREEMENT</u></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0);">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',serif; font-size: 11pt;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0);">This First Addendum (the </font><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);">"Addendum") </font><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0);">is
        made and entered effective as of the 1<sup style="color: rgb(107, 107, 107); vertical-align: text-top; line-height: 1; font-size: smaller;">st</sup>&#160;day of January 2023 (the <font style="font-weight: bold;">"Effective Date"), </font>by and between:</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0);">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; color: rgb(80, 80, 80); font-family: 'Times New Roman',serif; font-size: 11pt;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);">InMode Ltd., </font><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0);">Israeli registration number 514073618, of Tavor Building, Sha'ar Yokne'am Industrial Zone,
        P.O. Box 533, Yoknea'm 20692, Israel (the <font style="font-weight: bold;">"Company"); </font>and</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0);">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',serif; font-size: 11pt;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);">M.N.
        Business Strategy Ltd., </font><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0);">Israeli incorporation number 512297508, of 2 Yatziz St., Tel- Aviv, Israel, via its sole principal </font><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);">Mr. Moshe Mizrahy, </font><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0);">Israeli I.D. number 051825396 (respectively, the </font><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);">"Consultant" </font><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0);">and the </font><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);">"Principal").</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0);">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',serif; font-size: 11pt;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0);">(The Company and the
        Consultant shall be jointly referred to herein as the </font><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);">"Parties").</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0);">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; color: rgb(80, 80, 80); font-family: 'Times New Roman',serif; font-size: 11pt;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);">WHEREAS, </font><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0);">the Company and the Consultant are parties to Consultancy Agreement dated August 1, 2018, pursuant thereto the
        Consultant, through the Principal, serves as the CEO of the Company (the <font style="font-weight: bold;">"Consultancy Agreement", </font>respectively); and</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0);">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; color: rgb(80, 80, 80); font-family: 'Times New Roman',serif; font-size: 11pt;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);">WHEREAS, </font><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0);">the Parties wish to amend certain terms of the Agreement, effective as of the Effective Date, by increasing
        the Consultant's Consulting Fee, as further set out below;</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0);">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;"><font style="color: rgb(0, 0, 0);">NOW THEREFORE, the Parties
        hereby agree as follows:</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0);">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z975ee180957e458abb3f2c01e6db191c" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 6.4pt; font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0);"><br>
          </td>
          <td style="width: 26.2pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: normal; color: rgb(0, 0, 0);">1.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-family: 'Times New Roman',serif;"><font style="font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0);">Capitalized te1ms in this Addendum shall bear the meaning
                ascribed to such terms in the Agreement unless the context otheiwise requires.</font></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0);">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z377d0dc494e94934b1a3e34e06ba4f50" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 6.2pt; font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0);"><br>
          </td>
          <td style="width: 26.05pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0);">2.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-family: 'Times New Roman',serif; font-size: 11pt;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0);">The Parties agree that effective as of the Effective Date,
                Section 3.1 to
                Appendix A to the Consultancy Agreement shall be revised in such manner that the Consultant's gross monthly Consulting Fee shall increase to US $22,000 plus VAT, if applicable.</font></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0);"><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="za5394a4311594dc19d02656993fdb83a" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 6.25pt; font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0);"><br>
          </td>
          <td style="width: 26.4pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0);">3.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0);">
            <div>Except as explicitly amended by this Addendum, the provisions of the Employment Agreement will continue in full force.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0);"><br>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0); text-align: center;">&#160;<img width="659" border="0" height="146" src="image00015.jpg"></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0);">
      <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0);"> <br>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0);"> <br>
    </div>
  </div>
  <font style="font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0);">
  </font>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.8
<SEQUENCE>3
<FILENAME>exhibit_4-8.htm
<DESCRIPTION>FIRST ADDENDUM TO EMPLOYMENT AGREEMENT
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: company
         Document created using Broadridge PROfile 23.9.1.5178
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <font style="font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0);">
  </font>
  <div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0); text-align: right;">
      <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"><u><font style="font-weight: bold;">Exhibit 4.8</font></u><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0);">&#160;</div>
    <div style="text-align: center; margin-left: 2.15pt; line-height: 1.25; font-family: 'Times New Roman', serif; font-size: 10.5pt; font-weight: bold;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0);"><u>FIRST ADDENDUM TO EMPLOYMENT </u><u>AGREEMENT</u></font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0);">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',serif; font-size: 11pt;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0);">This First Addendum (the </font><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);">"Addendum")
      </font><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0);">is made and entered effective as of the 1<sup style="color: rgb(89, 89, 89); vertical-align: text-top; line-height: 1; font-size: smaller;">st</sup> day of January 2023 (the <font style="font-weight: bold;">"Effective Date"), </font>by and between:</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0);">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',serif; font-size: 11pt;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);">Invasix
        Corp., </font><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0);">a company
        incorporated under the laws of Canada, whose head office address is: 100 Leek Crescent, Unit 115, Richmond Hill Ontario, Toronto, Canada (the </font><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);">"Company");
      </font><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0);">and</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0);">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; color: rgb(75, 75, 75); font-family: 'Times New Roman',serif; font-size: 10.5pt;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);">Dr. Michael Kreindel, </font><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0);">Canadian Passport No. HMI74509, of 43 Aubumdale Drive, Thornhill, Canada L4J8w8 (the </font><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);">"Employee").</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0);">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',serif; font-size: 10.5pt;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0);">(The Company and the Employee shall be jointly referred to herein as the </font><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);">"Parties").</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0);">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',serif; font-size: 11pt;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);">WHEREAS,
      </font><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0);">the Company and the Employee are parties to an Employment Agreement dated July 1, 2017, as further amended effective as of August 1, 2018
      (collectively, the </font><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);">"Employment Agreement''); </font><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0);">and</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0);">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',serif; font-size: 11pt;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);">WHEREAS,
      </font><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0);">the Parties wish to amend certain employment terms of the Employment Agreement, effective as of the Effective Date, by increasing the Employees Base Salary, as further
        set out below;</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0);">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',serif; font-size: 10.5pt; font-weight: bold;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0);">NOW THEREFORE, the Parties hereby agree as follows:</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0);">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z8f13c6a0ff514081b6519342aced6dc8" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 11.55pt; font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0);"><br>
          </td>
          <td style="width: 24.85pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">1.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-family: 'Times New Roman', serif; font-size: 11pt;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0);">Capitalized tenns in this Addendum shall bear the meaning ascribed to
                such terms in the Employment Agreement m1less the context otherwise rnquires.</font></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0);">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z7eb66056b9f34de7bf824f0b5f3c5bc4" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 11.15pt; font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0);"><br>
          </td>
          <td style="width: 25.3pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">2.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-family: 'Times New Roman', serif; font-size: 11pt;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0);">The Parties agree that effective as of the Effective Date, Section 4(a) to the Employment Agreement shall be revised
                in such manner that the Employee's gross annual Base Salary shall increase to US $264,000 (i.e., US $22,000 per month).</font></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0);">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z8220070d0a4b4ee08d47d8dff9699370" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 10.95pt; font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0);"><br>
          </td>
          <td style="width: 24.9pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">3.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-family: 'Times New Roman', serif; font-size: 11pt;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0);">Effective as of the Effective Date, all benefits due to the Employee pursuant to
                the provisions of the Employment Agreement or by law, shall be provided on the new Base Salary as amended herein.</font></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0);"><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="zdfbd2b4541b6449d9cbbac9f254718cf" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 10.75pt; font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0);"><br>
          </td>
          <td style="width: 25.35pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">4.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-family: 'Times New Roman', serif; font-size: 11pt;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0);">Except as explicitly amended by this Addendum, the provisions
                of the Employment Agreement will continue in full force.</font></div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <div> <br>
    </div>
    <div style="text-align: center;"> <img width="560" border="0" height="160" src="image00018.jpg"></div>
    <div>
      <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
  </div>
  <font style="font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0);">
  </font>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.13
<SEQUENCE>4
<FILENAME>exhibit_4-13.htm
<DESCRIPTION>EXHIBIT 4.13
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: company
         Document created using Broadridge PROfile 23.9.1.5178
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <!--PROfilePageNumberReset%Num%1%- % -%--><font style="font-family: 'Times New Roman',Times,serif;"> </font>
  <div>
    <div class="BRPFPageHeader">
      <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><u><font style="font-weight: bold;"></font></u>
        <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"><u><font style="font-weight: bold;">Exhibit 4.13</font></u><br>
      </div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u>Fourth Addendum to Unprotected Lease Agreement dated February 28, 2018</u></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">Held and signed in ________ on _9_ of month___3____ 2023</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z50cdcc51c71f4a539754fe0848feebb3">

        <tr>
          <td style="width: 70.9pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">Between:</td>
          <td style="width: auto; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="font-weight: bold;">Shaar Yokneam - Limited Partnership</div>
            <div style="font-weight: bold;">
              <div style="line-height: 1.25; font-weight: bold;">Partnership No.: 550014666</div>
              <div style="line-height: 1.25; font-weight: normal;">"Ofer Shear Yokneam", 28 Hakidama St., Yokneam</div>
              <div style="line-height: 1.25; font-weight: normal;">(hereinafter: "Lessor")</div>
            </div>
          </td>
        </tr>

    </table>
    <br>
    <div style="text-align: right; margin-left: 85.05pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u>Of the first part;</u></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z130a6ff0c3014b0ab93fe62f7fa9a8f9">

        <tr>
          <td style="width: 70.9pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">And:</td>
          <td style="width: auto; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="font-weight: bold;">Inmode Ltd.</div>
            <div style="font-weight: bold;">
              <div style="line-height: 1.25; font-weight: bold;">PC: 514073618</div>
              <div style="text-align: justify; line-height: 1.25; font-weight: normal;">By authorized signatory, Mr. Moshe Mizrahi, ID: 051825396, who is authorized to sign on behalf of the Company and bind it,<br>
                whose address for the purposes of this Addendum is<br>
                "Tavor" building, Shear Yokneam, PO Box 533, Yokneam</div>
              <div style="line-height: 1.25; font-weight: normal;">(hereinafter: "Lessee")</div>
              <font style="font-weight: normal;"> </font></div>
          </td>
        </tr>

    </table>
    <br>
    <div style="text-align: right; margin-left: 85.05pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u>Of the second part;</u></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z193db99b3553404ead50f5463c60444c">

        <tr>
          <td style="width: 70.9pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">WHEREAS</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>on February 28, 2018, an unprotected lease was signed between Lessor and Lessee, with its appendices and attachments (hereinafter: "<font style="font-weight: bold;">original lease</font>"), as extended and/or amended from time to time (the
              original lease together with its addendums, including this Addendum, with all their appendices and attachments, shall be hereinafter referred to collectively: "<font style="font-weight: bold;">Lease</font>"); and</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7423e545599a493ab20dc2f8dd8cf3ef">

        <tr>
          <td style="width: 70.9pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">WHEREAS</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>under the terms of the Lease, Lessee leases from Lessor an area of 866 sqm gross located on the second floor of a building known as "Beit Tavor" (hereinafter: "<font style="font-weight: bold;">area on second floor</font>" and "<font style="font-weight: bold;">building</font>", respectively), an area of 1,432 sqm gross located on the third floor of the building (hereinafter: "<font style="font-weight: bold;">area on third floor</font>"), as well as 37 parking spaces
              (hereinafter: "<font style="font-weight: bold;">parking spaces</font>"), all in a complex known as "Ofer Shear Yokneam" in the city of Yokneam (hereafter: "<font style="font-weight: bold;">complex</font>") (the area on the second floor, the
              area on the third floor and the parking spaces shall be hereinafter referred to collectively: "<font style="font-weight: bold;">existing leasehold</font>" or "<font style="font-weight: bold;">existing leasehold area</font>", as the case may
              be); and</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zdf974434e82140c5972ae07d56c4d91e">

        <tr>
          <td style="width: 70.9pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">WHEREAS</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>Lessee&#8217;s lease term in the existing leasehold according to the Lease will expire on December 31, 2024; and</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z6d0b80569c9442f68b722bca6e7d1e41">

        <tr>
          <td style="width: 70.9pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">WHEREAS</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>Lessee applied to Lessor for extension of the lease term in the existing leasehold by another Lease term as well as for leasing of the additional leasehold, as defined below, in its AS IS state, thus increasing the area of the existing
              leasehold, and this in addition to the existing leasehold, as set forth above; and</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za8c84af9d02c4022b26713475ca11649">

        <tr>
          <td style="width: 70.9pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">WHEREAS</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>Lessor consented to Lessee's applications as mentioned, and all in accordance with and subject to the provisions of the Lease and the terms of this Addendum as set forth below;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">- 1 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"> <br>
    </div>
    <div style="text-align: center; text-indent: -28.35pt; margin-left: 28.35pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">It was therefore agreed, stipulated and declared by the parties as follows:</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zeff1fa2b97924c748c74c651a8b79ba2">

        <tr>
          <td style="width: 28.35pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">1.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div style="font-weight: bold;"><u>Preamble and appendices</u></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z09ac06aa020845fda07e1128ed974987">

        <tr>
          <td style="width: 28.35pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 28.35pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">1.1</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>The preamble to this Agreement as well as its appendices constitute an integral part thereof and are binding as the rest of its terms.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf6105b7a4f56404480061a3303b66835">

        <tr>
          <td style="width: 28.35pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 28.35pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">1.2.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>Section headers are for orientation and convenience purposes only and shall not be used to interpret this Addendum.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd90d663ade104aedae16e7b96306e301">

        <tr>
          <td style="width: 28.35pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 28.35pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">1.3.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>All terms and expressions appearing in this Addendum shall have the meaning assigned thereto in the Lease, unless expressly stated otherwise.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z2a3a78318ff14a089349c20d492b4d5e">

        <tr>
          <td style="width: 28.35pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 28.35pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">1.4.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>This Addendum is an integral part of the Lease.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z158bed2a8dc44d549406beb48a0ca0ed">

        <tr>
          <td style="width: 28.35pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 28.35pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">1.5.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>Previous drafts of this Addendum shall not have any weight in connection with the interpretation of the Lease and/or this Addendum and their stipulations. Such drafts will not be admissible in any judicial or quasi-judicial proceeding.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z75c0a7b4c0614dd9bf3199ebd1265da3">

        <tr>
          <td style="width: 28.35pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">2.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div style="font-weight: bold;"><u>Additional leasehold</u></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z87abfa2fbb43471cbc7a90c972e26f73">

        <tr>
          <td style="width: 28.35pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 28.35pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">2.1.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>Subject to the fulfilment of the terms stipulated in this Addendum below, <font style="font-weight: bold;"><u>as of January 1, 2023</u></font>, an additional area of 256 sqm gross will be added to the existing leasehold area, on the third
              floor of the building in the complex, all as demarcated and indicated in the blueprint attached as <font style="font-weight: bold;"><u>Appendix A</u></font> to this Addendum (hereinafter - "<font style="font-weight: bold;">additional area</font>").</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; margin-left: 56.7pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Moreover, <font style="font-weight: bold;"><u>as of March 1, 2023</u></font>, 4 (four) additional parking spaces will be added on the
      roof of the building (hereinafter: <font style="font-weight: bold;">additional parking spaces</font>").</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; margin-left: 56.7pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">The additional area and the additional parking spaces shall be hereinafter referred to collectively: "<font style="font-weight: bold;">additional
        leasehold</font>".</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; margin-left: 56.7pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">The existing leasehold area together with the additional area shall be hereinafter referred to as: "<font style="font-weight: bold;">leasehold
        area</font>".</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; margin-left: 56.7pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">The existing leasehold together with the additional leasehold shall be hereinafter referred to as: "<font style="font-weight: bold;">Leasehold</font>".</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; margin-left: 56.7pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">The leasehold area (i.e. existing leasehold area together with the additional area) is 2,554 gross sqm.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z304b50fa5b0044768e602e296c198ef4">

        <tr>
          <td style="width: 28.35pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 28.35pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">2.2.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-family: Calibri, sans-serif; font-size: 11pt;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;"><u>As of January 1, 2023</u></font><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;">, the additional area will be added to the existing leasehold and shall be deemed part of the Leasehold area, and all the provisions of the Lease Agreement shall apply thereto for all intents and
                purposes, so that reference in the Lease Agreement to "Leasehold area" and/or "Leasehold" shall imply the existing leasehold area together with the additional area, except in relation to matters with regards to which a different express
                arrangement included in this Addendum.</font></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; margin-left: 56.7pt; line-height: 1.25; font-family: Calibri, sans-serif; font-size: 11pt;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;"><u>As of March 1, 2023</u></font><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;">, the additional parking spaces will be added to the existing leasehold and the additional area, and shall be deemed part of the leasehold and all the provisions of the Lease
        shall apply thereto for all intents and purposes, so that reference in the Lease Agreement to "Leasehold&#8221; shall imply the existing leasehold together with the additional area and the additional parking spaces, except in relation to matters with
        regards to which a different express arrangement included in this Addendum.</font></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">- 2 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z9e7a9758b4a341ce8c6cfec7cd242c4a">

        <tr>
          <td style="width: 28.35pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 28.35pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">2.3.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>For the avoidance of doubt, it is clarified that Lessee leases the additional area solely for the purpose of expanding the existing leasehold area and for the purpose of the Lease, as set forth in the Lease Agreement.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8b3c4af5e0184f2181d97608cb8a8ee0">

        <tr>
          <td style="width: 28.35pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 28.35pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">2.4.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>The additional rental shall be delivered to Lessee in its AS IS condition, and said delivery will constitute a confirmation by Lessee that the additional leasehold has been delivered thereto in accordance with the provisions of the Lease
              and to its complete satisfaction and that it does not and will not have any suits and/or claims and/or demands in connection thereof, against Lessor and/or anyone on its behalf.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zff0cc95db65d4267825ede3ba270e922">

        <tr>
          <td style="width: 28.35pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">3.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div style="font-weight: bold;"><u>Lessee&#8217;s works for the purpose of increasing the existing leasehold area</u></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z70aa14480d80489ab51be10732b20cc5">

        <tr>
          <td style="width: 28.35pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 28.35pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">3.1.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>Lessee hereby assumes a fundamental undertaking, that as of January 1, 2023, it will carry out, at its own responsibility and expense, all the works necessary for the purpose of connecting and adding the additional area to the existing
              leasehold area and adapting the additional area to its objectives and needs, all as approved by Lessor and/or anyone on its behalf, in advance and in writing (above and below: "<font style="font-weight: bold;">Lessee's works</font>").</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8e8eb5d2e00a4558ab3a900c49d882c6">

        <tr>
          <td style="width: 28.35pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 28.35pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">3.2.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>Lessee undertakes that Lessee's works, as set forth in Section 3.1 above, shall be executed and completed pursuant to the provisions of the Lease and the instructions issued to Lessee by Lessor and/or anyone on its behalf, and this no
              later than February 28, 2023 (hereinafter - "d<font style="font-weight: bold;">ate of completion of Lessee&#8217;s works</font>"), without Lessor having any responsibility and/or liability regarding the aforesaid and/or performance of Lessee&#8217;s
              works as stated.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z1ae53f4961834d4bb5c24f9094b1e433">

        <tr>
          <td style="width: 28.35pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">4.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div style="font-weight: bold;"><u>The Lease term in the additional leasehold area</u></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; margin-left: 28.35pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">It is agreed that the Lease term for the <u>additional leasehold area</u> will commence on January 1, 2023 and from that date onward
      shall correspond to the Lease term in the existing leasehold, pursuant to the provisions of this Addendum below, i.e. until December 31, 2027 (hereinafter: "<font style="font-weight: bold;"><u>Lease term in the additional leasehold area</u></font>&#8221;).</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z165cab69e5524678bb14861d5c01678d">

        <tr>
          <td style="width: 28.35pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">5.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div style="font-weight: bold;"><u>The lease term for additional parking spaces</u></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; margin-left: 28.35pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">It is agreed that the lease term for the <u>additional parking spaces</u> will commence March 1, 2023 and from that date onwards
      shall correspond to the Lease term in the existing leasehold, in accordance with the provisions of this Addendum below, i.e. until December 31, 2027 (hereinafter: "<font style="font-weight: bold;"><u>lease term for additional parking spaces</u></font>&#8221;).</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z782851543562462087c70ba0ffabf6a4">

        <tr>
          <td style="width: 28.35pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">6.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div style="font-weight: bold;"><u>Lessee&#8217;s payments for the additional area during the Lease term in the additional leasehold area</u></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8ddebe7c63d947e69dfb0174750705e1">

        <tr>
          <td style="width: 28.35pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 28.35pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">6.1</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div style="font-weight: bold;"><u>The rent for the additional area</u></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zcd1ff5e3a02d4ac6a7a16596ce702ba0">

        <tr>
          <td style="width: 56.7pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 51.3pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">6.1.1.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-family: Calibri, sans-serif; font-size: 11pt;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;">As of January 1, 2023 until December 31, 2024</font><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;">, Lessee undertakes to pay Lessor, for the additional area, a monthly rent of <font style="font-weight: bold;">NIS 56</font> (fifty six new shekels) per gross sqm of the additional space, together
                with linkage differentials linked to the Consumer Price Index (general index) published on or near November 15, 2022, in respect of October 2022 (hereinafter: "<font style="font-weight: bold;">basic index</font>"), plus VAT by law.</font></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z6e0b7d222937441ea22fca5a3cec779f">

        <tr>
          <td style="width: 56.7pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 51.3pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">6.1.2.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-family: Calibri, sans-serif; font-size: 11pt;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;">As of January 1, 2025 until December 31, 2027</font><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;">, Lessee undertakes to pay Lessor for the additional space, a monthly rental fee of <font style="font-weight: bold;">NIS 58</font> (fifty eight new shekels) per gross sqm of the additional space,
                together with linkage differentials to the basic index, plus VAT by law.</font></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">- 3 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd2611642db064284a654ad8d0fc91b72">

        <tr>
          <td style="width: 56.7pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 51.3pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">6.1.3.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>It is clarified that the monthly rent for the additional space shall be paid in the manner and on dates as prescribed in the Lease Agreement regarding payment for the existing leasehold.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z84569052550b4fea9ef6fc8dbd48bcc2">

        <tr>
          <td style="width: 28.35pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 28.35pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">6.2.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div><u>Grace and the "Grace Period"</u></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z1a4509c77c454eb5a751bd0105a1e3eb">

        <tr>
          <td style="width: 56.7pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 42.55pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">6.2.1.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>Notwithstanding the aforesaid, it is clarified and agreed that Lessee will only be exempt from the obligation to pay rent in respect of the additional area, and this for a period of 2 (two) months of rent (at most), commencing January 1,
              2023 and ending two months later (i.e. on February 23, 2023), and this regardless of the duration of Lessee's actual works (hereinafter: "<font style="font-weight: bold;">grace</font>" or "<font style="font-weight: bold;">grace amount</font>"
              and "<font style="font-weight: bold;">grace period</font>", respectively), all subject to the fulfilment of the terms set forth below (in aggregate):</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za33f7936ca3f4d2a98717bfa59f92d88">

        <tr>
          <td style="width: 99.2pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 44.8pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">6.2.1.1.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>Lessee complied with all the provisions of the Lease (including this Addendum), in full and on time, at the discretion of Lessor, including that Lessee furnished Lessor with the collateral, insurance certificates and a letter of
              authorization to debit Lessee's account as stated in the Lease Agreement and this Addendum.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zdf97e6433bf54d21ba532131d525fc2b">

        <tr>
          <td style="width: 99.2pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 44.8pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">6.2.1.2.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>Lessee has completed "Lessee's works" by the "date of completion of Lessee's works" pursuant to the provisions of the Lease Agreement (including this Addendum) and to Lessor&#8217;s satisfaction.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7b13841594024fb2b2869ddeea493bdd">

        <tr>
          <td style="width: 56.7pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 42.55pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">6.2.2.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>For the avoidance of doubt, it is clarified that the above does not detract from Lessee's obligation to pay Lessor, even during the grace period, the other payments applicable thereto under the Lease Agreement, including - but not limited
              to - payment of rent for the existing leasehold, payment of management fees in respect of the Leasehold, payments for electricity supply, property taxes and all mandatory payments of any kind in respect of the use and/or possession of the
              leasehold, as required by the authorities.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z9f3dbc80899240ad8e9b97fd71067585">

        <tr>
          <td style="width: 56.7pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 42.55pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">6.2.3.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>Without deviating from the aforementioned, it is agreed that in any case where Lessee is in fundamental breach of the Lease Agreement and/or this Addendum or of a fundamental provision thereof, Lessee will repay Lessor the grace amount,
              plus linkage differentials to the basic index and plus VAT by law, immediately upon Lessor&#8217;s first demand. If Lessee fails to repay the "grace" amount to Lessor as stated above, Lessor may use the collateral for the purpose of collecting the
              "grace" amount and Lessee waives any claim and/or demand and/or suit against Lessor and/or anyone on its behalf in this regard.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf80ce717b37d4c7e9bf0820f8b3b49e3">

        <tr>
          <td style="width: 28.35pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 28.35pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">6.3.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div style="font-weight: bold;"><u>Management fees for additional area</u></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z32d7f0d3404245428c80beb00204c887">

        <tr>
          <td style="width: 56.7pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 42.55pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">6.3.1.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-family: Calibri, sans-serif; font-size: 11pt;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;">As of January 1, 2023 until December 31, 2024</font><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;">, Lessee undertakes to pay Lessor in respect of the additional space, a monthly management fee of <font style="font-weight: bold;">NIS 12.1</font> (twelve new shekels and ten agorot) per gross sqm
                of the additional space, plus linkage differentials to the basic index, plus VAT by law.</font></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">- 4 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z65eb778222cf49018ab54f2c6295b1d4">

        <tr>
          <td style="width: 56.7pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 42.55pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">6.3.2.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-family: Calibri, sans-serif; font-size: 11pt;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;">As of January 1, 2025 until December 31, 2027</font><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;">, Lessee undertakes to pay Lessor in respect of the additional space, monthly management fees amounting to <font style="font-weight: bold;">NIS 14</font> (fourteen new shekels) per gross sqm of the
                additional space, plus linkage differentials to the basic index, plus VAT by law.</font></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb2758aed3b874f80888b5a4d248c6f93">

        <tr>
          <td style="width: 28.35pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 28.35pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">6.4.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div style="font-weight: bold;"><u>Depreciation fund for additional area</u></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z32d0359b9cae49f68f6669ab49d88f83">

        <tr>
          <td style="width: 56.7pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 42.55pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">6.4.1.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>Without derogating from the provisions of the management agreement, it is agreed that during the lease term of the additional lease, Lessee will pay Lessor a depreciation fund fee amounting to NIS 1.2 (one new shekel and twenty agorot) per
              gross sqm of the additional area, with said amount linked to the basic index, plus VAT by law.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zbe26f942f4f64b2588872c6002d64d95">

        <tr>
          <td style="width: 28.35pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 28.35pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">6.5.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div style="font-weight: bold;"><u>Insurance premiums for the additional area</u></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf8f097c0e652496494d7406b0b0dda7d">

        <tr>
          <td style="width: 56.7pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 42.55pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">6.5.1.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>During the lease term of the additional leasehold, Lessee undertakes to pay Lessor for Lessee's relative share in the insurance premium paid by Lessor to the insurance company, monthly insurance premiums amounting to <font style="font-weight: bold;">NIS 0.5</font> (fifty agorot) per gross sqm of the additional area, plus linkage differentials to the basic index, plus VAT by law.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb0692cbb99ea4fa2964f4f68701d1246">

        <tr>
          <td style="width: 56.7pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 42.55pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">6.5.2.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>Lessee will not have any claim and/or suit and/or demand against Lessor and/or the management company or anyone on their behalf with regard to the insurance premiums (whether the amount is fixed or whether calculated according to another
              mechanism stipulated in the management agreement and/or Lease Agreement).</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7d023cadc20a44e2b6496f73e6bcc4e8">

        <tr>
          <td style="width: 28.35pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">7.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div style="font-weight: bold;"><u>Lessee&#8217;s payments for additional parking spaces during the Lease term in the additional parking spaces</u></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc5cf576782b54482905dd169a278e682">

        <tr>
          <td style="width: 28.35pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 28.35pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">7.1.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div style="font-weight: bold;"><u>Parking fees for the additional parking spaces</u></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; margin-left: 56.7pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">During the Lease term in the additional parking spaces, Lessee undertakes to pay Lessor for the additional parking spaces, monthly
      parking fees amounting to <font style="font-weight: bold;">NIS 320</font> (three hundred and twenty new shekels) for each of the additional parking spaces, with this amount linked to the basic index and plus VAT by law. It is clarified that the
      aforesaid amount does not include the payment of property tax for the additional parking spaces, inasmuch as such applies.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z817c7a62dd534f7792cb8afbd29a31dd">

        <tr>
          <td style="width: 28.35pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">8.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>For the avoidance of doubt, it is clarified that all other obligations and payments applicable to Lessee under the Lease Agreement, including &#8211; but not limited to - property taxes, electricity consumption, water and any payment to any
              third party, shall apply, as of January 1, 2023, also to the additional area, and as of March 1, 2023, also to the additional parking spaces.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za9587769489c4de7bf96d4a1fe794de5">

        <tr>
          <td style="width: 28.35pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">9.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>It is agreed that entry into force of this Addendum is subject to fulfilment of Lessee&#8217;s fundamental charges as follows:</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za74bd68c163e4c68b214b05956ed5046">

        <tr>
          <td style="width: 28.35pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 28.35pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">9.1</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div style="font-weight: bold;"><u>Collateral/guarantees in respect of the additional leasehold</u></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z07a3ee365b9a41d98092fa573eb3c137">

        <tr>
          <td style="width: 56.7pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 42.55pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">9.1.1.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>Notwithstanding what is stated in the Lease Agreement, it is clarified and agreed that, as a guarantee of Lessee&#8217;s fulfilment of its charges and undertakings under this Addendum, Lessee will furnish Lessor, at the signing this Addendum, a
              bank guarantee, in the form attached in <font style="font-weight: bold;"><u>Appendix B</u></font> to this Addendum, for an amount equal to the rent for the additional area, management fees for the additional area and parking fees for the
              additional parking spaces, payable by Lessee for 3 (three) months of rent in relation to the additional leasehold, with said amount linked to the basic index, plus VAT by law, and this <font style="font-weight: bold;"><u>in addition</u></font>
              to existing bank guarantees that have been furnished to Lessor by Lessee pursuant to the provisions of the Lease Agreement (hereinafter: "<font style="font-weight: bold;">additional bank guarantee</font>").</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">- 5 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z4f1675a020b1404394e73db5e3f0c21f">

        <tr>
          <td style="width: 56.7pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 42.55pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">9.1.2.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>It is clarified and agreed that all the provisions of the Lease Agreement regarding the bank guarantee shall also apply to the additional bank guarantee.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z3d223c5eef6546409bf2904a17ffe331">

        <tr>
          <td style="width: 56.7pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 42.55pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">9.1.3.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>The additional bank guarantee shall remain valid for the entire Lease term in the additional leasehold area as well as the Lease term in the additional parking spaces, all under the responsibility of Lessee and at its expense and for the
              purpose of securing all Lessee's undertakings and charges pursuant to the Lease agreement (including this Addendum).</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc2bc6d0983384f4ca2df50a70c85f996">

        <tr>
          <td style="width: 56.7pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 42.55pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">9.1.4.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>Without detracting from the aforementioned, all collateral deposited with Lessor, pursuant to the provisions of the Lease Agreement, will be used by Lessor and/or the management company and/or anyone on their behalf, also to secure the
              complete and precise fulfilment of all Lessee&#8217;s undertakings and charges pursuant to this Addendum.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z82d2002d9c2e4a008c9b30dd576fdf82">

        <tr>
          <td style="width: 28.35pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 28.35pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">9.2.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div style="font-weight: bold;"><u>Direct debit authorization</u></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z376e42e5c5754a7db3a0a4380269b254">

        <tr>
          <td style="width: 56.7pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 42.55pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">9.2.1.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>Lessee undertakes that the authorization to debit an account it furnishes to Lessor pursuant to the provisions of the Lease Agreement will remain in effect during the entire additional lease term in the existing leasehold, as set forth
              below, and will also be used for collection of payments applicable to Lessee in respect of the additional leasehold during the entire lease term in the additional leasehold area as well as the lease term in the additional parking spaces, in
              accordance with the provisions of this Addendum.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z1874e158b6574c858d54200c84c1ee96">

        <tr>
          <td style="width: 28.35pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 28.35pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">9.3.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div style="font-weight: bold;"><u>Insurance</u></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc64c4e0e594f4369911acb2d8326967b">

        <tr>
          <td style="width: 56.7pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 42.55pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">9.3.1.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>Lessee undertakes that the insurances it undertook to arrange under the Lease Agreement shall be extended to apply to the additional leasehold, such that they remain in force and fully covered for the entire lease term in the additional
              leasehold area, the entire Lease term in the additional parking spaces, as well as the entire additional lease term in the existing leasehold.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; margin-left: 99.25pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">It is clarified and agreed that the wording of the <font style="font-weight: bold;">insurance clauses</font> and the wording of the
      <font style="font-weight: bold;">insurance certificates</font> attached as <font style="font-weight: bold;"><u>Appendix C</u></font> to this Appendix will <u>replace</u> the wording of the insurance clause in the Lease Agreement.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8e75229d70c14d418cf15783e9d45493">

        <tr>
          <td style="width: 56.7pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 42.55pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">9.3.2.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>Lessee will present Lessor with the insurance certificates as required in the Lease Agreement (including this Addendum) no later than the date of signing this Addendum. It is clarified that failure to produce the insurance certificates
              does not absolve Lessee from its insurance liability, as detailed in the clauses and appendices of the Lease Agreement.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">- 6 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z34ecb6ab50d44974b8c9b9200a1e5641">

        <tr>
          <td style="width: 56.7pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 42.55pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">9.3.3.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>If, in Lessor's opinion, there is a need to arrange additional and/or supplementary insurances for the additional leasehold, Lessee undertakes to arrange said insurances according to Lessor's request.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8d7507cdfe8c483cac99aafc6993f091">

        <tr>
          <td style="width: 28.35pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">10.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div style="font-weight: bold;"><u>Extension of the Lease term in the existing leasehold</u></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z35bec84e1fcb49b3b9c3098e8a6e7f5c">

        <tr>
          <td style="width: 28.35pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 43.65pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">10.1.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>Lessee declares and undertakes that it has paid the full rent, management fees as well as all amounts, taxes, levies and other payments to which Lessee is liable pursuant to the provisions of the Lease Agreement and/or according to any law
              regarding and in connection with the Lease term in the existing leasehold up to the date of signing this Addendum.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z9356d785c34e45e4ab6b7419558ed012">

        <tr>
          <td style="width: 28.35pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 43.65pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">10.2.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>It is clarified that as of the date of signing this Addendum, Lessee has for a period of time occupied the existing leasehold, and has found and finds the existing leasehold, on all its features, suitable for its purposes and needs, to its
              full satisfaction, and Lessee waives any claim regarding incompatibility and/or deficiency and/or defect in the existing leasehold and/or any demand in relation to the existing leasehold, including in respect of and in connection with the
              Lease term leading to the signing of this Addendum.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z80402665aff54381b786b9f16e064e22">

        <tr>
          <td style="width: 28.35pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 43.65pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">10.3.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>Lessee declares that it hereby irrevocably waives any claim and/or demand and/or suit against Lessor and/or the management company and/or anyone on their behalf in connection with the Lease Agreement, including in connection with the Lease
              term up to the signing of this Addendum and/or in connection with this Addendum and/or in connection with the existing leasehold and/or in relation to all matters connected to and arising therefrom and that all its claims and/or claims of
              anyone on its behalf addressed to Lessor either verbally or in writing (insofar as addressed) are null and void and shall not be raised and/or directed to Lessor in any way.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z1bf3d360841149269d65554331358412">

        <tr>
          <td style="width: 28.35pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 43.65pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">&#160;&#160;10.4</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>Subject to Lessee's declarations and absolute fulfilment of its undertaking under the Lease Agreement (including this Addendum), in full and on time, Lessee's Lease term will be extended in the existing leasehold, by an additional lease
              term of 36 (thirty-six) months, commencing on 1.1.2025 and ending 31.12.2027 (hereinafter: "<font style="font-weight: bold;">additional lease term in existing leasehold</font>").</div>
            <div> <br>
            </div>
            <div>
              <div style="line-height: 1.25;">Subject to the provisions of this Addendum, on December 31, 2027, the additional lease term in the existing leasehold will expire, and the provisions of Lease Agreement regarding the termination of the Lease
                and evacuation of the leasehold will apply. It is clarified and agreed that Lessee will not have any option for early termination and/or an additional option to extend the Lease Agreement.</div>
            </div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z6c0e505bd26940c0bfd73f9f3844723e">

        <tr>
          <td style="width: 28.35pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">11.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div style="font-weight: bold;"><u>Lessee's payments for the existing leasehold during the additional lease term in the existing leasehold</u></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; margin-left: 28.35pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">It is clarified and agreed that Lessee's payments and the terms of the Lease in the existing leasehold during the additional lease
      term in the existing leasehold, shall be in accordance with what is set forth in the Lease Agreement, with the changes detailed below:</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zae22d83e1d974cb6ac3059079a87f42e">

        <tr>
          <td style="width: 28.35pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 43.65pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">11.1.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div style="font-weight: bold;"><u>Rent for existing leasehold area</u></div>
            <div style="font-weight: bold;"><u> <br>
              </u></div>
            <div style="font-weight: bold;">
              <div style="line-height: 1.25; font-weight: normal;">During the additional lease period in the existing leasehold, Lessee undertakes to pay Lessor for the existing leasehold space, a monthly rent of NIS 58 (fifty-eight new shekels) per each
                gross sqm of the existing leasehold area, plus linkage differentials to the basic index and VAT by law.</div>
              <u> </u></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">- 7 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z94759ffa298e4abc970a6ca2fda319fa">

        <tr>
          <td style="width: 28.35pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 43.65pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">11.2.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div style="font-weight: bold;"><u>Management fee for existing leasehold area</u></div>
            <div style="font-weight: bold;"><u> <br>
              </u></div>
            <div style="font-weight: bold;">
              <div style="line-height: 1.25; font-weight: normal;">During the additional lease term in the existing leasehold, the management fee for the existing leasehold shall be NIS 14 (fourteen new shekels) per gross sqm of the existing leasehold
                area, plus linkage differentials to the basic index and VAT by law.</div>
              <u> </u></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7dee16f7793a46cc887e1024bfed2869">

        <tr>
          <td style="width: 28.35pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 43.65pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">11.3.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div style="font-weight: bold;"><u>Depreciation fund for existing leasehold area</u></div>
            <div style="font-weight: bold;"><u> <br>
              </u></div>
            <div style="font-weight: bold;">
              <div style="line-height: 1.25; font-weight: normal;">It is agreed that during the additional lease term in the existing leasehold, Lessee will continue to pay Lessor a monthly depreciation allowance of and under the terms stipulated in the
                Lease Agreement.</div>
              <u> </u></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z5360bb1cfbd84db7973dc43486e63252">

        <tr>
          <td style="width: 28.35pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 43.65pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">11.4.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div style="font-weight: bold;"><u>Insurance premiums for the existing leasehold area</u></div>
            <div style="font-weight: bold;"><u> <br>
              </u></div>
            <div style="font-weight: bold;">
              <div style="line-height: 1.25; font-weight: normal;">It is agreed that during the additional lease term in the existing leasehold, Lessee will continue to pay Lessor monthly insurance premiums of and under the terms stipulated in the Lease
                Agreement.</div>
              <u> </u></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z3e8db93feffc43c5ab43fd5510e72ee3">

        <tr>
          <td style="width: 28.35pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 43.65pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">11.5.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div style="font-weight: bold;"><u>Parking fees for the parking spaces</u></div>
            <div style="font-weight: bold;"><u> <br>
              </u></div>
            <div style="font-weight: bold;">
              <div style="line-height: 1.25; font-weight: normal;">It is agreed that during the additional lease term in the existing leasehold, Lessee will continue to pay Lessor, in respect of parking spaces, monthly parking fees of and under the terms
                stipulated in the Lease Agreement.</div>
              <u> </u></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z634c68ba884c44ca8c7ccbc0829ebfe5">

        <tr>
          <td style="width: 28.35pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 43.65pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">11.6.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>For the avoidance of doubt, it is clarified that Lessee undertakes to continue bearing all payments and obligations during the additional lease term of the existing leasehold, on time and accurately, in accordance with the provisions of
              the Lease Agreement, including - but not limited to - property taxes, electricity consumption, water and any payment to any third party in respect of the existing leasehold.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zebc75ed0c5e841e2b0b129ce3260ee6e">

        <tr>
          <td style="width: 28.35pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">12.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div style="font-weight: bold;"><u>Collateral in respect of the existing leasehold during the additional lease term in the existing leasehold</u></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; margin-left: 28.35pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Lessee undertakes by fundamental undertaking that the collateral given by Lessee to secure its obligations under the Lease Agreement
      will continue to be valid for the entire additional lease term in the existing leasehold, and with no change in their terms, and shall also serve to secure Lessee's obligations and duties under this Addendum, and all under Lessee&#8217;s responsibility and
      at its expense.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7a9cbc9bc03944c48e61818235f0c72d">

        <tr>
          <td style="width: 28.35pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">13.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div style="font-weight: bold;"><u>Lessor's works in the leasehold</u></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; margin-left: 28.35pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Subject to extension of the lease term in the existing leasehold, as set forth in Section 10 above, and absolute fulfilment of
      Lessee's undertakings under the Lease Agreement (including this Addendum), in full and on time, the following provisions shall apply:</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze82e3bc126c849c59142629b1c8e0593">

        <tr>
          <td style="width: 28.35pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 43.65pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">13.1.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>As agreed between the parties, as of the date of signing this Addendum, Lessor has carried out renovations in the common areas leading to the leasehold, on the second and third floors of the building, which included wall repairs, painting
              (including painting the corridors leading to the leasehold), replacing floor cladding, painting doors, painting a freight elevator and painting metal staircase.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">- 8 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0f39551c63314029b40d1cdd536e082b">

        <tr>
          <td style="width: 28.35pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 43.65pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">13.2.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>Notwithstanding what is stated in Section 21.4 of the original Lease Agreement, it is agreed that Lessor will perform maintenance/treatment work on the existing air conditioning system, at its expense, in all the leasehold areas, and for
              the entire lease term in the additional leasehold as well as the additional lease term in the existing leasehold.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zaec130889167476e94de76b1d44ccd01">

        <tr>
          <td style="width: 28.35pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 43.65pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">13.3.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>Lessor will carry out at its expense works related to completion of the fresh air system in missing locations in all areas of the leasehold.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zbcd42735d6644e42bcc013e9e31e4157">

        <tr>
          <td style="width: 28.35pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">14.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div style="font-weight: bold;"><u>General</u></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z487aa410e6e34715b0f5fa8e03954da5">

        <tr>
          <td style="width: 28.35pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 43.65pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">14.1.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>All other provisions of the Lease Agreement, insofar as said have not been expressly amended in this Addendum, shall continue to be in force and binding of the parties, including but without detracting, with regard to the additional area,
              as the case may be and mutatis mutandis, if any.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zaeca91033d484608affdc93e6a8df706">

        <tr>
          <td style="width: 28.35pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 43.65pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">14.2.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>To the extent that any term was stipulated in the Lease Agreement, which granted Lessee any right of exclusivity and/or right of first refusal and/or right of first offer, etc., then any such term shall be null and void as of the signing
              of this Addendum.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z9abb2b1d18ff4e0fb01db9fccbc2dc47">

        <tr>
          <td style="width: 28.35pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 43.65pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">14.3.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>It is clarified that none of what is stated in this Addendum may impose any obligation on Lessor and/or the management company which is not imposed under the provisions of the Lease Agreement and/or by law and that none of the foregoing
              detracts from any of Lessee&#8217;s obligations and/or duties under the Lease Agreement and/or any law.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z1b0ab05661d342e9891e3c1b94a88ec4">

        <tr>
          <td style="width: 28.35pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 43.65pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">14.4.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>It is clarified and agreed upon by the parties, that none of what is stated in this Addendum constitutes a waiver and/or absolution on the part of Lessor and/or the management company of any claim and/or suit and/or demand of any of the
              above against Lessee, including in accordance with the Lease Agreement and/or any law.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0751cd73f2a04dc78ec0800bbcc5145f">

        <tr>
          <td style="width: 28.35pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 43.65pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">14.5.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>Any breach of any of the provisions of this Addendum, shall be deemed a breach of the Lease Agreement, for all intents and purposes, and will afford Lessor with all the remedies available to it under the Lease Agreement and/or by law, in
              respect of such breach.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z45e750a965444e1bbf0b4dc953f01f09">

        <tr>
          <td style="width: 28.35pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 43.65pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">14.6.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>In any case of a contradiction between the provisions of the Lease Agreement (without the Addendum) and the provisions of this Addendum, the provisions of this Addendum shall prevail.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb390005cd6da42bfa4a5684e9cce864e">

        <tr>
          <td style="width: 28.35pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 43.65pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">14.7.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>This Addendum shall only enter into force upon its signing by the parties.</div>
          </td>
        </tr>

    </table>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><img src="image00008.jpg"></div>
    <div style="line-height: 1.25; text-align: center; font-family: 'Times New Roman',Times,serif;">&#160;<img src="image00007.jpg"></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">- 9 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u>Lessor Attorney Certification</u></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">I the undersigned, <font style="font-style: italic;"><u>Sagi Omer</u></font>, Adv., of <font style="font-style: italic;"><u>16 Derech Hayam, Haifa,</u>&#160;</font>hereby
      confirm that Lessee is a valid and going concern and that it has passed all the necessary resolutions for its engagement in this Addendum in accordance with its incorporation documents; That the above signatures are those of <font style="font-style: italic;"><u>Moshe Mizrachi,</u></font> ID: <font style="font-style: italic;"><u>051825396,</u></font> who is authorized to bind Lessee with its signature.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">In witness whereof I have signed:</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
      <table cellspacing="0" cellpadding="0" border="0" id="ze0c011a5396d4ec8b36ef556a91d5712" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

          <tr>
            <td style="width: 50%; text-align: left; vertical-align: top;">
              <div><font style="font-family: 'Times New Roman',Times,serif;">Date: </font><font style="font-family: 'Times New Roman',Times,serif; font-style: italic;"><u>9.3.2023</u></font><font style="font-family: 'Times New Roman',Times,serif;"><br>
                </font></div>
            </td>
            <td style="width: 50%;">
              <div><font style="font-family: 'Times New Roman',Times,serif;"><font style="font-style: italic;">&#160;&#160; <u>Sagi Omer,</u></font> Adv.</font></div>
              <div><img width="127" height="55" src="image00005.jpg">
                <div><font style="font-weight: bold;">Sagi Omer, Adv.<br>
                    LN 57764<br>
                    16 Derech Hayam, Haifa</font></div>
                <font style="font-family: 'Times New Roman',Times,serif;"> </font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"> <br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">- 10 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u>Appendix A</u></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u>Blueprint of Additional Area</u></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-align: center;">&#160;<img src="image00011.jpg"></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
      <div style="text-align: center; line-height: 1.25;"><br>
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">Shaar Yokneam<br>
        <br>
        Limited Partnership</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: 'Times New Roman', Times, serif; color: #000000; font-weight: normal; font-style: normal;">- 11 -</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25;"><br>
      </div>
      <div style="text-align: center; line-height: 1.25;"><img src="image00012.jpg"></div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">Shaar Yokneam<br>
        <br>
        Limited Partnership</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: 'Times New Roman', Times, serif; color: #000000; font-weight: normal; font-style: normal;">- 12 -</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
    </div>
    <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u>Appendix B'</u></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u>Bank Guarantee</u></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zf21dc538228e40dcb08a72682b60f8e6">

        <tr>
          <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="text-align: justify; line-height: 1.25;">To</div>
          </td>
          <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="text-align: justify; line-height: 1.25;">To</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="text-align: justify; line-height: 1.25;">_____________________ Ltd.</div>
          </td>
          <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="text-align: justify; line-height: 1.25;">_____________________ Ltd.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="text-align: justify; line-height: 1.25;">1 Abba Eben Blvd.</div>
          </td>
          <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="text-align: justify; line-height: 1.25;">1 Abba Eben Blvd.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; font-family: Calibri, sans-serif; font-size: 11pt;"><u><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;">Herzliya (&#8220;<font style="font-weight: bold;">Lessor</font>&#8221;)</font></u></div>
          </td>
          <td style="width: 50%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; font-family: Calibri, sans-serif; font-size: 11pt;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><u>Herzliya</u> (&#8220;<font style="font-weight: bold;">Management
                  Company</font>&#8221;)</font></div>
          </td>
        </tr>

    </table>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br>
      Dear Sir/Madam,</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Re.: <font style="font-weight: bold;"><u>Bank Guarantee</u></font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">As per ____________________&#8217;s (hereinafter: "<font style="font-weight: bold;">Applicant</font>") application, we hereby guarantee the discharge of any
      amount demanded of Applicant by yourself, up to the sum of NIS ____________________ (hereinafter: "<font style="font-weight: bold;">Principal amount</font>").</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">The principal amount will be linked to the consumer price index (General Index) as published by the Central Bureau of Statistics and Economic Research or
      by any other official institution replacing it (hereinafter: "<font style="font-weight: bold;">Index</font>").</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">"<font style="font-weight: bold;">Basic Index</font>" will be the index published for the month _______ in the year _____ (__________ points, according to
      the ______ base).</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">"<font style="font-weight: bold;">New Index</font>" for the purpose of calculating linkage differentials shall be the most recently published index prior
      to our payment under this Guarantee.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">If at the time of making a payment under this Guarantee, it becomes clear that the new index has increased compared to the basic index, the principal
      amount will be increased by the rate of increase of the new index compared to the basic index.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">If the new index is lower than the basic index or equal thereto, we will pay you the principal amount in its original amount without any linkage
      differentials.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">"<font style="font-weight: bold;">Guarantee amount</font>" - the principal amount plus linkage differentials as stated above.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">We undertake to pay you any amount you demand within the limit of the guarantee amount immediately upon your first written demand, and no later than two
      business days from the day of such demand, and without requiring you to substantiate or prove your demand and without you being required to first demand said guarantee amount from Applicant.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Each of you will be entitled to demand from us payment of the guarantee amount in full or to demand sums on account of the guarantee amount, from time to
      time, in which case following each payment the guarantee will remain in effect with regards to the balance of the guarantee amount, provided that the sum of all your demands collectively does not exceed the guarantee amount.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">This guarantee shall be in force until ____________ at 12:00 p.m. inclusive, and any demand thereunder must be delivered to us no later than the above
      date.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">This Guarantee is negotiable and/or transferable.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
      <table cellspacing="0" cellpadding="0" border="0" id="z2a9d4d18a4974782886193ff400e5f67" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

          <tr>
            <td style="width: 50.00%;">
              <div>&#160;</div>
            </td>
            <td style="width: 50%;">
              <div>
                <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">______________<br>
                  <font style="font-weight: bold;">Bank</font></div>
              </div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"> <br>
    </div>
    <div style="font-family: 'Times New Roman',Times,serif;" class="BRPFPageFooter">
      <div style="line-height: 1.25;"><img width="119" height="65" src="image5.jpg"></div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: 'Times New Roman', Times, serif; color: #000000; font-weight: normal; font-style: normal;">- 13 -</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
    </div>
    <div class="BRPFPageHeader">
      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br>
      </div>
    </div>
    <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u>Appendix C</u></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u>Insurance Appendix</u></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7f17f433cbe6445e806ea8a120b08349">

        <tr>
          <td style="width: 28.35pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">1.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div style="font-weight: bold;"><u>Insurance</u></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; margin-left: 28.35pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Without detracting from Lessee's responsibility under this Agreement or by law, Lessee undertakes to arrange and maintain insurance
      as required by this Section 1 and the insurance particulars set forth therein.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf05378bbf2f745cfa5c6d15402552da9">

        <tr>
          <td style="width: 28.35pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 28.35pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">1.1.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>With regards to obtaining permission for performance of works in the leasehold, in the event that any work is performed in the leasehold by or for Lessee prior to initial occupancy of the leasehold and/or at any time during the Lease term,
              Lessee undertakes that prior to the start of said works, it will arrange contract work insurance in the name of Lessee, contractors and subcontractors, Lessor and the management company, and this under the terms specified in the insurance
              specification attached to this Agreement and which constitutes an integral part thereof and marked <font style="font-weight: bold;"><u>Appendix C1</u></font> (hereinafter: "<font style="font-weight: bold;">Lessee's works insurance
                specification</font>"), with a legally licensed insurance company in Israel (hereinafter: "<font style="font-weight: bold;">Lessee&#8217;s works insurance</font>").</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zddfa5f28b1794d689860a2f5097ff8aa">

        <tr>
          <td style="width: 28.35pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 28.35pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">1.2.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>Without detracting from Lessee's responsibility under the Lease Agreement or by law, for the entire duration of the lease term, Lessee undertakes to arrange and maintain, through a duly licensed insurance company in Israel, the insurances
              specified in the insurance specification attached to this Agreement and which constitutes an integral part thereof and marked <font style="font-weight: bold;"><u>Appendix C2</u></font> (hereinafter respectively: "<font style="font-weight: bold;">Specification of Lessee&#8217;s permanent insurance</font>" and "<font style="font-weight: bold;">Lessee&#8217;s permanent insurance</font>"); And this with regards to all matters pertaining to the leasehold and Lessee&#8217;s activity therein.</div>
            <div> <br>
            </div>
            <div>
              <div style="line-height: 1.25;">Lessee's works insurance and Lessee's permanent insurance will be hereinafter collectively referred to as "<font style="font-weight: bold;">Lessee&#8217;s insurance</font>".</div>
            </div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z5ffdbafc510749d4a80ef3c49cf8bb86">

        <tr>
          <td style="width: 28.35pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 28.35pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">1.3.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>Without the need for any demand on the part of Lessor or the management company, Lessee undertakes to provide Lessor and the management company, no later than the date of commencement of the works on the leasehold, a certificate regarding
              the existence of insurance for Lessee's works in the form attached to this Agreement and constituting an integral part thereof and marked <font style="font-weight: bold;"><u>Appendix C3</u></font> (hereinafter - "<font style="font-weight: bold;"> Lessee&#8217;s&#160; works insurance certificate</font>"), signed by its insurer. Lessee declares that it is aware that the furnishing of Lessee's work insurance certificate as mentioned is a pre-requisite to the performance of any works in
              the leasehold, and Lessor or the management company will be entitled (but not obligated) to prevent Lessee from performing work in the leasehold, if said certificate was not furnished prior to the start of the works.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z2f0c3eded3bd499a84324dde6e927e27">

        <tr>
          <td style="width: 28.35pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 28.35pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">1.4.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>At the request of Lessor or the management company, Lessee undertakes to furnish Lessor and management company, within 5 days of their request, a certificate attesting to the existence of Lessee's permanent insurance, in the form attached
              to this Agreement and constituting an integral part thereof and marked <font style="font-weight: bold;"><u>Appendix C4</u></font> (hereinafter: "<font style="font-weight: bold;">Lessee&#8217;s permanent insurance</font>") signed by its insurer.</div>
            <div> <br>
            </div>
            <div>
              <div style="line-height: 1.25;">A certificate of Lessee's works insurance and permanent insurance shall be hereinafter referred to collectively: "<font style="font-weight: bold;">Insurance certificates</font>".</div>
            </div>
          </td>
        </tr>

    </table>
    <div style="text-align: justify; margin-left: 56.7pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">- 14 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z9f7c99c9ebaf42e687f54763aee42f6a">

        <tr>
          <td style="width: 28.35pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 28.35pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">1.5.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>It is agreed that Lessee may not arrange consequential loss insurance, in whole or in part, as detailed in Section (4) of Lessee's permanent insurance specification, and Lessee may also not arrange property insurance with cover against the
              risk of broken glass, as specified in Section (1) of Lessee's permanent insurance specification, however the exemption specified in Section below shall apply as though said insurances were arranged in full.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z1400415bf9294e86a7c40b5cd58bd5a2">

        <tr>
          <td style="width: 28.35pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 28.35pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">1.6.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>If in Lessee's opinion there is a need to arrange additional or supplementary insurance to the specification of Lessee's works insurance and/or the specification of Lessee's permanent insurance, Lessee undertakes to arrange and maintain
              the aforementioned additional or supplementary insurance. Lessee undertakes that in any such additional or supplementary insurance, a clause will be included regarding waiver of the right of subrogation towards Lessor, towards the management
              company and towards anyone on their behalf, however, the aforementioned waiver shall not apply in favor of a person who caused the damage maliciously. Lessor also undertakes that in any such additional or supplementary liability insurance,
              insured's name will be extended to include Lessor and the management company, and this is subject to a cross liability clause, according to which the insurance is deemed to have been arranged separately for each individual insured.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8ae46f63d6984516b44f9731e0688f61">

        <tr>
          <td style="width: 28.35pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 28.35pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">1.7</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>Lessee undertakes to update the insurance amounts for the insurances established according to sections (1) and (4) of Lessee's permanent insurance specification, from time to time, to reflect the full value of the subject insured
              thereunder.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za7de90c4af2142faa7971418845d6863">

        <tr>
          <td style="width: 28.35pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 28.35pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">1.8</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>Lessee exempts Lessor, the management company, and anyone on their behalf, as well as the other lessors, tenants, and rights holders in the building (other lessees, tenants and other rights holders shall be hereinafter referred to
              collectively as: "<font style="font-weight: bold;">other rights holders</font>"), where in the Lease agreements of the other rights holders or in any other agreement granting the other rights holders rights in the building, a corresponding
              exemption is included towards Lessee, from liability for damage for which it is entitled to indemnification according to the insurances arranged under Section (1) of the specification of Lessee's works insurance, sections (1) and (4) of the
              specification of Lessee's permanent insurance or for which it would be entitled to indemnification were it not for the deductibles specified in the policies), however the exemption from such liability shall not apply in favor of a person who
              caused the damage maliciously.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z566dc01f163a4cedb1e0b595aeddac58">

        <tr>
          <td style="width: 28.35pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 28.35pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">1.9</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>At the request of Lessor or the management company, Lessee undertakes to furnish Lessor and the management company, within 5 days of their request, a certificate of Lessee's permanent insurance in respect of the extension of its validity
              for another insurance term, on the eve of each extended insurance period and insofar as this Agreement is in effect.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za3e67a48490846a9a77b76887e774a04">

        <tr>
          <td style="width: 28.35pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 28.35pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">1.10</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>Each time Lessee's insurer informs Lessor or the management company of a change or cancellation of any of Lessee's insurances, Lessee undertakes to re-arrange said insurance and reissue a certificate regarding the existence of the
              insurance that was amended or revoked as aforesaid, 30 days prior to the date of said change or revocation.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z5079f47011ca4bf78a681199283d9509">

        <tr>
          <td style="width: 28.35pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 28.35pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">1.11</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>For the avoidance of doubt, it is clarified that failure to furnish the insurance certificates as stated in sections 1.3, 1.4, 1.9 and 1.10 above, will not detract from Lessee's undertakings under this Agreement, including, and without
              prejudice to the generality of the aforementioned, any payment obligation imposed on Lessee, and Lessee undertakes to fulfil all its undertakings under the Agreement. It is expressly agreed that Lessor or the management company shall be
              permitted (but not obligated) to prevent Lessee from performing work on the leasehold or receiving possession thereof and/or introducing assets into the leasehold and/or opening its business in the leasehold and/or initiating its activity in
              the leasehold due to its failure to furnish the aforementioned certificates.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">- 15 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8d0e71d5d0744e289732455070018347">

        <tr>
          <td style="width: 28.35pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 28.35pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">1.12</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>Lessor and/or the management company are entitled to examine the insurance certificates furnished by Lessee as set forth in sections 1.3, 1.4, 1.9 and 1.10 above, and Lessee must make any changes or amendments required of it in order to
              adapt them to Lessee's obligations as set forth in this Agreement. Lessee declares that Lessor and the management company&#8217;s right to inspect the insurance certificates and order their amendment as specified above, does not impose on Lessor or
              the management company or anyone on their behalf any liability whatsoever in connection with said insurance certificates, their nature, the scope and validity of the insurances arranged according to said certificates or their absence, and
              does not detract from any liability imposed on Lessee under this Agreement or by law.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z997bf925a73145bebdb65fa35add307e">

        <tr>
          <td style="width: 28.35pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 28.35pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">1.13</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>Lessee undertakes to comply with the terms of the insurance policies arranged by Lessee, pay the insurance premiums in full and on time, and ensure that Lessee's permanent insurance is renewed from time to time as necessary and is in force
              for the entire lease term.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z174f074691b4411b86b369c80108af9f">

        <tr>
          <td style="width: 28.35pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 28.35pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">1.14</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>For the avoidance of doubt, it is hereby agreed that the scope of insurance coverage including limits of liability as set forth in the specification the insurance certificates are a minimum requirement imposed on Lessee. Lessee declares
              and confirms that it will be prohibited from raising any claim and/or demand towards Lessor or towards the management company or towards anyone on their behalf with regards to the scope of insurance coverage including the limits of liability
              as stated.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zbcc3bf6b52ec407f90171e34aae772d2">

        <tr>
          <td style="width: 28.35pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 28.35pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">1.15</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>Lessee declares that it is aware that Lessor or the management company have not undertaken to maintain security or other security measures in the building or in the Leasehold, and insofar as they do so, such will not create any obligation
              or liability towards Lessee. It is further explicitly agreed that the provisions of the Guardians Law 5727-1967 and its appendices shall not apply to Lessor and the management company.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc95f528e91cb414fb482d040d890da89">

        <tr>
          <td style="width: 28.35pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 28.35pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">1.16</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>It is clarified that the insurance certificates attached to this Agreement, which Lessee is obliged to provide signed by its insurer, are formulated in a concise format only as required by the insurance companies according directives of
              the Commissioner of the Capital Market, Insurance and Savings, where the furnishing of said certificates does not detract from Lessee's duty to comply with which is stated in the above insurance clauses and arrange insurance in accordance
              with the specifications of said insurance, and for this purpose Lessee, if necessary with the help of insurance personnel on its behalf, must study and fully implement said requirements which should be brought to the attention of Lessee's
              insurer. It is also clarified that insofar as changes are made in the directives of the Commissioner of the Capital Market, Insurance and Savings as stated, Lessor will be entitled to replace the insurance certificates attached to this
              Agreement with alternative insurance certificates.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
  </div>
  <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">- 16 -</font></div>
    <div class="BRPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <div class="BRPFPageNumberArea" style="text-align: center;">
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8d8c4eeee9ed42f3905fb430bcbb5fb2">

        <tr>
          <td style="width: 28.35pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 28.35pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">1.17</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>Lessor undertakes to arrange and maintain, whether itself or via the management company, for the duration of the Agreement, the insurances set forth below, with a duly authorized insurance company in Israel.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb925dc75a2924ea1a859d6d012b98d7a">

        <tr>
          <td style="width: 56.7pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 42.55pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">1.17.1.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>Insurance of parts of the building owned by Lessor (including leasehold building), against loss or damage due to common risks in extended fire insurance, including fire, smoke, lightning, explosion, earthquake, storm and gale, flood,
              liquid damage and burst pipes, injury by vehicles, injury by aircraft, riots, strikes, malicious damage as well as burglary damage. The aforementioned insurance will include a clause regarding the waiver of subrogation rights towards Lessee,
              however said waiver shall not apply in favor of a person who caused the damage maliciously. For the avoidance of doubt, it is expressly agreed that the aforementioned insurance shall not include any content and/or addition, improvement or
              extension executed by and/or on behalf of and/or for Lessee and/or the other rights holders and shall not include windshields, windows, glass partitions and glass doors, with regards to which the duty of insurance lies with Lessee as stated
              in Section (1) of Lessee&#8217;s permanent insurance specification.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z99124fd6a3064a05ac1841435fa65a50">

        <tr>
          <td style="width: 56.7pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 42.55pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">1.17.2.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>Consequential loss insurance which insures loss of rent and management fees (if any) due to damage caused to the parts of the building owned by Lessor (including the Leasehold building) due to the risks specified in Section 1.17.1 above
              (with the exception of burglary), for an indemnity period of 24 months. The insurance as aforesaid will include a clause regarding waiver of the right of subrogation in favour of Lessee, but such waiver will not apply in favour of a person
              who caused damage maliciously.</div>
            <div> <br>
            </div>
            <div>
              <div style="line-height: 1.25;">It is agreed that Lessor or the management company are entitled to not arrange consequential insurance for loss of rental and management fees as stated in this Section 1.17.2 above, in full or in part, however
                what is stated in Section 1.19 below will apply as though the aforementioned insurance had been taken out in full.</div>
            </div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z86a0a4992662477a99300d3470b29dcc">

        <tr>
          <td style="width: 28.35pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 28.35pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">1.18</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>It is agreed that Lessor is entitled, at its sole discretion, to arrange additional insurances to those specified in Section 1.17 above. It is expressly agreed that the arranging of insurance as set forth in Section 1.17 above or
              additional insurances as stated, shall not add to the liability of Lessor or the management company beyond what is stated in this Agreement or detract from Lessee's liability under the Agreement or by law (except as expressly specified at the
              end of Section 1.19 below).</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za7a19a645e9d404f8c99f0e5f043874c">

        <tr>
          <td style="width: 28.35pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 28.35pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">1.19</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>Lessor exempts Lessee, in its behalf and on behalf of the management company, from liability in respect of which Lessor or the management company are entitled to indemnification under the insurances arranged in accordance with Sections
              1.17.1 and 1.17.2 above (or would have been entitled to indemnification in its regard were it not for the deductibles specified in the policies), however the exemption from such liability shall not apply to a person who caused the damage
              maliciously.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; margin-left: 56.7pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Notwithstanding the aforesaid, in the event of an insurance incident which is covered under sections 1.17.1 - 1.17.2 above, under
      circumstances for which Lessee is liable under this Agreement and/or by law, Lessee will bear the amount of the damage and/or the loss caused up to the deductible applicable according to the aforementioned policies.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea"><font class="BRPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">- 17 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u>Appendix C1: Insurance specification for Lessee&#8217;s works</u></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Lessee will arrange and maintain contract work insurance in the name of Lessee, contractors, subcontractors, Lessor and the management company, which
      includes the insurance chapters detailed below including all extensions stated in the policy, including an extended maintenance term of 24 months (hereinafter: "<font style="font-weight: bold;">maintenance period</font>"), with the scope of said
      coverage not inferior to "BIT" wording valid at the time the insurance was arranged:</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z31f37f226fb345aebd858997263ac86c">

        <tr>
          <td style="width: 28.35pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">1.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>Chapter 1- Insurance coverage for the works, at their full value (including materials provided by Lessor or the management company) against loss or damage caused during the insurance period and during the maintenance period regarding the
              fulfilment of obligations in connection with the maintenance works (hereinafter: "<font style="font-weight: bold;">maintenance works</font>") or the discovery of damage to the works during the maintenance period caused during the insurance
              period. For the avoidance of doubt, this chapter includes a clause regarding the waiver of the right of subrogation towards Lessor, the management company and anyone on their behalf, as well as towards other lessees, tenants and other rights
              holders in the building (other lessees, tenants and other rights holders shall be hereinafter collectively referred to: &#8220;<font style="font-weight: bold;">other rights holders</font>&#8221;) where in the property insurance of the other rights
              holders, a corresponding clause is included concerning the waiver of the right of subrogation towards Lessee or in an agreement granting the other rights holders rights in the building, an exemption from liability is included in favor of
              Lessee for loss or damage caused to the property of the other rights holders due to common risks associated with insurance of contractual works or in the policy covering extended fire, however, the aforementioned waiver shall not apply in
              favor of a person who caused damage maliciously. The chapter further includes an explicit expansion regarding coverage of adjacent property and the property being worked on, at a cover limited to NIS 350,000.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z4d1c421238b34d81b82a1d37a7e4b789">

        <tr>
          <td style="width: 28.35pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">2.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>Chapter 2 - Liability insurance against a third party that insures liability by law due to damage to the body or property of any person or entity in connection with the works during the insurance period, as well as damage to the body or
              property as stated during the maintenance period, regarding the maintenance works or for a reason originating during the insurance period, within limits of liability as set forth below. The aforementioned chapter includes a cross-liability
              clause according to which the insurance is deemed to have been arranged separately for individual insured. The chapter explicitly states that the leasehold is deemed third party property.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; margin-left: 28.35pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Liability limit: NIS__________________ per incident and cumulatively according to the chapter(*).</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; margin-left: 28.35pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">The aforementioned chapter is expanded to include the following topics:</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; margin-left: 28.35pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">A. Subrogation claims of the National Insurance Institute.</div>
    <div style="text-align: justify; margin-left: 28.35pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">B. Bodily injuries resulting from the use of mechanical engineering equipment which is a motorized vehicle with regards to which no
      mandatory insurance requirement applies.</div>
    <div style="text-align: justify; margin-left: 28.35pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">C. Liability due to damage caused following earthquakes and weakening of foundations, within a liability limit of NIS 1,000,000 NIS
      per incident.</div>
    <div style="text-align: justify; margin-left: 28.35pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">(*) The limit of liability will be an amount equal to NIS 8,000 times the area of the leasehold in sqm, but said amount shall not be
      less than NIS 400,000 and will not exceed NIS 4,000,000 per incident and cumulatively according to the chapter.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z515e73b5ddb84e4588a8d26e4132d42b">

        <tr>
          <td style="width: 28.35pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">3.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>Chapter 3 - Employers' liability insurance insuring liability for bodily injury or occupational illness that may be caused to employees employed in executing the works or maintenance works during and as a result of their work during the
              insurance period as well as during the maintenance period regarding the maintenance work, with a liability limit of NIS 20,000,000 per claimant, per incident and cumulatively according to the chapter. This insurance does not include a
              restriction regarding work at height and at depth, work hours, baits and poisons, contractors, subcontractors and their employees as well as regarding the employment of minors. For the avoidance of doubt, the chapter includes a waiver of the
              right of subrogation towards Lessor, towards the management company and towards anyone on their behalf, however the aforementioned waiver shall not apply in favor of a person who caused the insured incident maliciously.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><u>The insurance will include the following terms:</u></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">The above policy takes precedence over any insurance arranged by Lessor and/or by the management company and the insurer waives any claim and/or demand
      regarding the sharing of Lessor's and/or the management company's insurance. Failure of Lessee and/or anyone on its behalf to comply with the policy's terms and conditions in good faith, will not detract from the rights of Lessor and/or the rights of
      the management company to indemnification under the policy. The aforementioned policy may not be revoked nor adversely changed during the insurance period unless a written notice is delivered to Lessor and the management company by registered mail at
      least 60 days in advance. Lessee alone is responsible for paying the insurance premiums for the aforementioned policy and bears the deductibles applicable according to the aforementioned policy. Gross negligence exception is revoked, but said
      revocation shall not detract from insurer&#8217;s rights and Lessee&#8217;s obligations under the Insurance Contract Law, 5741-1981.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea"><font class="BRPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">- 18 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u>Appendix C2: Lessee&#8217;s permanent insurance specification</u></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Lessee will arrange and maintain insurance policies as detailed below, with the scope of said coverage not inferior to "BIT" wording valid at the time the
      insurance is arranged:</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z2d48ee10d7f442af9a5eb17997cee184">

        <tr>
          <td style="width: 28.35pt; vertical-align: top;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;">1</font><font style="font-family: 'Times New Roman',Times,serif;">.</font></td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div style="font-weight: bold;">"Extended Fire" insurance policy</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; margin-left: 28.35pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Insures the contents of the leasehold, its windows, glass partitions and doors, and any other property brought to the leasehold
      and/or to the building by or on behalf of Lessee (including equipment, furniture, fixtures and supplies), and any change, improvement and addition to the leasehold executed or to be executed by Lessee or on its behalf, in their full value, against
      loss or damage due to acceptable risks in extended fire insurance, including fire, smoke, lightning, explosion, earthquake, storm and gale, flood, liquid damage and burst pipes, broken glass , damage by vehicles, damage by aircraft, riots, strikes,
      malicious damage and burglary. The policy includes a clause according to which the insurer waives the right of subrogation towards Lessor, towards the building&#8217;s management company [if such exists, (hereinafter: "<font style="font-weight: bold;">Management
        company</font>")] and towards anyone on their behalf, as well as towards other lessees, tenants and other rights holders in the building (other lessees, tenants and other rights holders shall be hereinafter collectively referred to: &#8220;<font style="font-weight: bold;">other rights holders</font>&#8221;) where in the property insurance of the other rights holders, a corresponding clause is included concerning the waiver of the right of subrogation towards Lessee or in an agreement granting
      the other rights holders rights in the building, an exemption from liability is included in favor of Lessee for loss or damage caused to the property of the other rights holders due to common risks associated with extended fire insurance; However,
      the aforementioned waiver shall not apply in favor of a person who caused damage maliciously.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zef7c93dd33e048c7b553a6b83d432f72">

        <tr>
          <td style="width: 28.35pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">2.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div style="font-weight: bold;">Liability insurance policy to a third party</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; margin-left: 28.35pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Insuring Lessee's liability by law for bodily injury or damage to property that may be caused to the body or property of any person
      or entity in the leasehold, in the building or in its surroundings, within limits of liability as specified below. The policy is not subject to a restriction regarding liability arising from fire, explosion, panic, lifting, unloading and loading
      devices, defective sanitary facilities, poisoning, anything harmful in food or drink, strike and shutdown, liability for and towards contractors, subcontractors (of any level) and their employees, animals, as well as turnover claims from the National
      Insurance Institute. The policy is extended to indemnify Lessor and the management company in respect of their liability as the owner and managers of the leasehold, as well as for liability that may be imposed on any of them due to an act or omission
      of Lessee or anyone on its behalf, subject to a cross-liability clause according to which the insurance is deemed as having been arranged separately for each individual insured. A liability limit amounting to: NIS __________________ per incident and
      cumulatively according to the policy(*).</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; margin-left: 28.35pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">{*) The limit of liability will be an amount equal to NIS 14,000 times the area of the leasehold in sqm, but no less than NIS
      1,000,000 and no more than NIS 20,000,000 per incident and cumulatively according to the policy.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zfe6b5d85ab0c4443a9120e171d67fe91">

        <tr>
          <td style="width: 28.35pt; vertical-align: top;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;">3</font><font style="font-family: 'Times New Roman',Times,serif;">.</font></td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div style="font-weight: bold;">Employers&#8217; liability insurance policy</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; margin-left: 28.35pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Insures Lessee's liability to its employees for bodily injury or occupational illness that may be caused to any of them during and as
      a result of their work in the leasehold, in the building and its surroundings, with a liability limit of NIS 20,000,000 per claimant, per incident and cumulatively according to the policy. The policy does not include a restriction regarding work at
      height and depth, working hours, baits and poisons as well as regarding the employment of minors. The policy is extended to indemnify Lessor and the management company, upon the alleged occurrence of a work accident or occupational illness of any
      kind, and in the event of a claim relating to Lessor&#8217;s liability as employer to any of Lessee's employees. Also, the policy includes a clause regarding the waiver of the right of subrogation towards Lessor, towards the management company and towards
      anyone on their behalf; However, the aforementioned waiver shall not apply in favor of a person who caused the insurance incident maliciously.</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea"><font class="BRPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">- 19 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zefe79b59af9349409641128792b63fae">

        <tr>
          <td style="width: 28.35pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">4.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div style="font-weight: bold;">Consequential loss insurance policy</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; margin-left: 28.35pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Insurer Lessee&#8217;s gross profit loss due to loss or damage caused to the insured property according to Section 1 above or to the
      leasehold or to the building structure, as a result of one of the risks specified in Section 1 above, and this for an indemnity period of 24 months. The policy includes a clause according to which the insurer waives the right of subrogation towards
      the management company and towards anyone on its behalf, as well as towards the other rights holders, who, in their consequential loss insurance, a corresponding clause is included regarding the waiver of right of subrogation towards Lessee or an
      exemption from liability is included in an agreement granting the other rights holders rights in the building, in favor of Lessee for consequential loss to the other rights holders due to common risks in extended fire insurance, however, the
      aforementioned waiver shall not apply in favor of a person who caused the damage maliciously.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><u>The insurances shall include the following terms:</u></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">The aforementioned policies precede any insurance taken out by Lessor and/or by the management company and the insurer waives any claim and/or demand
      regarding the sharing of Lessor's insurances and/or the management company's insurances. Failure of Lessee and/or anyone on its behalf, to comply with the terms and conditions of the policies, in good faith, shall not detract from Lessor's rights
      and/or the rights of the management company to receive indemnification under the policies. The aforementioned policies may not be revoked nor adversely changed during the insurance period unless a written notice is delivered to Lessor and the
      management company by registered mail at least 60 days in advance. Lessee alone is responsible for paying the insurance premiums for the aforementioned policies and bears the deductibles applicable according to the aforementioned policy. Gross
      negligence exception is revoked, but said revocation shall not detract from insurer&#8217;s rights and Lessee&#8217;s obligations under the Insurance Contract Law, 5741-1981.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea"><font class="BRPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">- 20 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
      <div style="line-height: 1.25; font-weight: bold;"><u>APPENDIX C3</u></div>
      <div style="line-height: 1.25; font-weight: bold;"><u> <br>
        </u></div>
    </div>
    <table cellspacing="0" cellpadding="2" border="0" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" id="z65595713da534cf38425e2645b43947d">

        <tr>
          <td colspan="7" style="width: 57.91%; vertical-align: middle; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; color: rgb(0, 0, 0);">Certificate of Insurance Policies - Contract/Construction work Insurance</div>
          </td>
          <td colspan="4" style="width: 42.09%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">Date of Certificate issuance (DD/MM/YYYY)</div>
          </td>
        </tr>
        <tr>
          <td colspan="11" style="width: 100%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">This insurance certificate is reference to insured&#8217;s valid insurance policy, in accordance with the information specified therein. The information specified in this certificate does not
              include all the terms of the policy and its exclusions. However, in the event of a conflict between the terms specified in this Certificate and the terms set forth in the insurance policy, what is stated in the insurance policy shall prevail,
              except in the&#160; case where a term in this Certificate benefits its applicant.</div>
          </td>
        </tr>
        <tr>
          <td colspan="2" style="width: 23.09%; vertical-align: middle; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; color: rgb(0, 0, 0);">Certificate Applicant*</div>
          </td>
          <td colspan="2" style="width: 14.01%; vertical-align: middle; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; color: rgb(0, 0, 0);">Insured</div>
          </td>
          <td colspan="3" style="width: 20.82%; vertical-align: middle; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; color: rgb(0, 0, 0);">Address of the insured property/Address of execution of the works*</div>
          </td>
          <td colspan="4" style="width: 42.09%; vertical-align: middle; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; color: rgb(0, 0, 0);">Status of Applicant*</div>
          </td>
        </tr>
        <tr>
          <td colspan="2" style="width: 23.09%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">Name</div>
          </td>
          <td colspan="2" rowspan="4" style="width: 14.01%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; color: rgb(0, 0, 0);">Name:</div>
          </td>
          <td colspan="3" rowspan="8" style="width: 20.82%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..</div>
          </td>
          <td colspan="4" style="width: 42.09%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
        </tr>
        <tr>
          <td colspan="2" rowspan="3" style="width: 23.09%; vertical-align: middle; border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0); font-weight: bold;">Shaar Yokneam - Limited Partnership and/or Trade Centers (Azo-Reit) Ltd. and/or Melisron Ltd. and/or parent companies and/or subsidiaries</div>
          </td>
          <td colspan="4" style="width: 42.09%; vertical-align: middle; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: #000000; font-family: Calibri, sans-serif;"><font style="font-family: 'Times New Roman',Times,serif;">&#9744;Contractor</font></div>
          </td>
        </tr>
        <tr>
          <td colspan="4" style="width: 42.09%; vertical-align: middle; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: #000000; font-family: Calibri, sans-serif;"><font style="font-family: 'Times New Roman',Times,serif;">&#9744;Sub-contractor</font></div>
          </td>
        </tr>
        <tr>
          <td colspan="4" style="width: 42.09%; vertical-align: middle; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: #000000; font-family: Calibri, sans-serif;"><font style="font-family: 'Times New Roman',Times,serif;">&#9744;Lessee</font></div>
          </td>
        </tr>
        <tr>
          <td colspan="2" rowspan="2" style="width: 23.09%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">ID/P.C./Partnership No.: 550014666<br>
              520037789<br>
              510758329</div>
          </td>
          <td colspan="2" rowspan="2" style="width: 14.01%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">ID/P.C.:</div>
          </td>
          <td colspan="4" style="width: 42.09%; vertical-align: middle; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: #000000; font-family: Calibri, sans-serif; font-weight: bold;"><font style="font-family: 'Times New Roman',Times,serif;">&#9746;Other: Lessor</font></div>
          </td>
        </tr>
        <tr>
          <td colspan="4" style="width: 42.09%; vertical-align: middle; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
        </tr>
        <tr>
          <td colspan="2" style="width: 23.09%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">Address</div>
          </td>
          <td colspan="2" rowspan="2" style="width: 14.01%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">Address:</div>
          </td>
          <td colspan="4" style="width: 42.09%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
        </tr>
        <tr>
          <td colspan="2" style="width: 23.09%; vertical-align: middle; border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0); font-weight: bold;">1 Abba Eben St., Herzliya</div>
          </td>
          <td colspan="4" style="width: 42.09%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
        </tr>
        <tr>
          <td colspan="11" style="width: 100%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">Covers</div>
          </td>
        </tr>
        <tr>
          <td style="width: 16.86%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">Policy chapters - Division by limits of liability or insurance amounts</div>
          </td>
          <td colspan="2" rowspan="2" style="width: 13.04%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">Policy No.</div>
          </td>
          <td colspan="2" rowspan="2" style="width: 14.14%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">Policy version and edition</div>
          </td>
          <td rowspan="2" style="width: 7.07%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">Start date</div>
          </td>
          <td colspan="2" rowspan="2" style="width: 10.77%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">End date</div>
          </td>
          <td colspan="2" style="width: 19.2%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">Liability limit/Insurance amount/Value of work</div>
          </td>
          <td style="width: 18.94%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">Additional covers in force and revocation of exclusions</div>
          </td>
        </tr>
        <tr>
          <td style="width: 16.86%; vertical-align: top; background-color: rgb(242, 242, 242); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
          <td style="width: 11.67%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">Amount</div>
          </td>
          <td style="width: 7.46%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">Currency</div>
          </td>
          <td style="width: 18.94%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">Cover code must be specified according to Appendix D</div>
          </td>
        </tr>
        <tr>
          <td style="width: 16.86%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">All risks contract work</div>
          </td>
          <td colspan="2" rowspan="2" style="width: 13.04%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;BIT Edition</div>
          </td>
          <td colspan="2" rowspan="2" style="width: 14.14%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td rowspan="2" style="width: 7.07%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
          <td colspan="2" rowspan="2" style="width: 10.77%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
          <td rowspan="2" style="width: 11.67%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
          <td rowspan="2" style="width: 7.46%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
          <td rowspan="7" style="width: 18.94%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0); font-weight: bold;">308 - Waiver in favor of another entity (other tenants subject to reciprocity in favor of tenant)<br>
              309 -Waiver of subrogation</div>
            <div style="line-height: 1.25; color: rgb(0, 0, 0); font-weight: bold;">313 -natural disasters</div>
            <div style="line-height: 1.25; color: rgb(0, 0, 0); font-weight: bold;">314 -burglary and robbery<br>
              316 -Earthquake<br>
              317 -Contractors and subcontractors<br>
              318 -additional insured</div>
            <div style="line-height: 1.25; color: rgb(0, 0, 0); font-weight: bold;">328 -primary</div>
            <div style="line-height: 1.25; color: rgb(0, 0, 0); font-weight: bold;">302 -cross-warranty</div>
            <div style="line-height: 1.25; color: rgb(0, 0, 0); font-weight: bold;">309 -Waiver of subrogation in favor of applicant</div>
            <div style="line-height: 1.25; color: rgb(0, 0, 0); font-weight: bold;">312 -Coverage for damage from the use heavy mechanical equipment)</div>
            <div style="line-height: 1.25; color: rgb(0, 0, 0); font-weight: bold;">315 -Coverage for National Insurance Claims)</div>
            <div style="line-height: 1.25; color: rgb(0, 0, 0); font-weight: bold;">318 -additional insured - applicant)</div>
            <div style="line-height: 1.25; color: rgb(0, 0, 0); font-weight: bold;">322 -Applicant shall be deemed a third party)</div>
            <div style="line-height: 1.25; color: rgb(0, 0, 0); font-weight: bold;">328 -Primary</div>
          </td>
        </tr>
        <tr>
          <td style="width: 16.86%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">Example extensions (can be specified according to the policy chapters):</div>
          </td>
        </tr>
        <tr>
          <td style="width: 16.86%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">Theft and burglary</div>
          </td>
          <td colspan="2" style="width: 13.04%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
          <td colspan="2" style="width: 14.14%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
          <td style="width: 7.07%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
          <td colspan="2" style="width: 10.77%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
          <td style="width: 11.67%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td style="width: 7.46%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 16.86%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">Property worked upon</div>
          </td>
          <td colspan="2" style="width: 13.04%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
          <td colspan="2" style="width: 14.14%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
          <td style="width: 7.07%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
          <td colspan="2" style="width: 10.77%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
          <td style="width: 11.67%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">350,000</div>
          </td>
          <td style="width: 7.46%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">NIS</div>
          </td>
        </tr>
        <tr>
          <td style="width: 16.86%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">Adjacent property</div>
          </td>
          <td colspan="2" style="width: 13.04%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
          <td colspan="2" style="width: 14.14%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
          <td style="width: 7.07%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
          <td colspan="2" style="width: 10.77%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
          <td style="width: 11.67%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">350,000</div>
          </td>
          <td style="width: 7.46%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">NIS</div>
          </td>
        </tr>
        <tr>
          <td style="width: 16.86%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">Property in transfer</div>
          </td>
          <td colspan="2" style="width: 13.04%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
          <td colspan="2" style="width: 14.14%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
          <td style="width: 7.07%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
          <td colspan="2" style="width: 10.77%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
          <td style="width: 11.67%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
          <td style="width: 7.46%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 16.86%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">Removal of rubble</div>
          </td>
          <td colspan="2" style="width: 13.04%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
          <td colspan="2" style="width: 14.14%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
          <td style="width: 7.07%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
          <td colspan="2" style="width: 10.77%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
          <td style="width: 11.67%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td style="width: 7.46%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 16.86%; vertical-align: middle; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">Third party</div>
          </td>
          <td colspan="2" style="width: 13.04%; vertical-align: middle; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;BIT Edition</div>
          </td>
          <td colspan="2" style="width: 14.14%; vertical-align: middle; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td style="width: 7.07%; vertical-align: middle; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
          <td colspan="2" style="width: 10.77%; vertical-align: middle; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
          <td style="width: 11.67%; vertical-align: middle; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td style="width: 7.46%; vertical-align: middle; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">NIS</div>
          </td>
          <td style="width: 18.94%; vertical-align: middle; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: #000000; font-family: Calibri, sans-serif; font-size: 9pt; font-weight: bold;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;">302-cross liability<br>
                312-use of heavy equipment<br>
                315- Coverage for National Insurance Claims)</font></div>
            <div style="line-height: 1.25; color: #000000; font-family: Arial, sans-serif; font-size: 9pt; font-weight: bold;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;">317- Contractors and subcontractors<br>
                318-Additional insured<br>
                328-Primary<br>
                329- Applicant property shall be deemed a third party)</font></div>
          </td>
        </tr>
        <tr>
          <td style="width: 16.86%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">Employer's liability</div>
          </td>
          <td colspan="2" style="width: 13.04%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;BIT Edition</div>
          </td>
          <td colspan="2" style="width: 14.14%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td style="width: 7.07%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
          <td colspan="2" style="width: 10.77%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
          <td style="width: 11.67%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">20,000,000</div>
          </td>
          <td style="width: 7.46%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">NIS</div>
          </td>
          <td style="width: 18.94%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0); font-weight: bold;">302-cross liability</div>
            <div style="line-height: 1.25;"><font style="font-weight: bold; color: rgb(0, 0, 0);">309-waiver of subrogation<br>
                317- Contractors and subcontractors<br>
                318-Additional insured<br>
                328-Primary<br>
              </font></div>
          </td>
        </tr>
        <tr>
          <td style="width: 16.86%; vertical-align: middle; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td colspan="2" style="width: 13.04%; vertical-align: middle; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
          <td colspan="2" style="width: 14.14%; vertical-align: middle; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
          <td style="width: 7.07%; vertical-align: middle; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
          <td colspan="2" style="width: 10.77%; vertical-align: middle; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
          <td style="width: 11.67%; vertical-align: middle; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
          <td style="width: 7.46%; vertical-align: middle; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
          <td style="width: 18.94%; vertical-align: middle; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0); font-weight: bold;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td colspan="11" style="width: 100%; vertical-align: middle; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">Details of the services (subject to the services specified in the agreement between the insured and the applicant, the service code must be indicated from the list in Appendix <font style="font-weight: bold;">C</font>) *:</div>
          </td>
        </tr>
        <tr>
          <td colspan="11" style="width: 100%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;<font style="font-weight: bold;">074-Renovation works in leasehold located at&#8230;&#8230;..</font></div>
          </td>
        </tr>
        <tr>
          <td colspan="11" style="width: 100%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">Revocation/Amendment of policy*</div>
          </td>
        </tr>
        <tr>
          <td colspan="11" rowspan="2" style="width: 100%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">A change to the detriment of applicant or revocation of an insurance policy will only take effect<font style="font-weight: bold;"> 60 days</font> following the dispatch of a notice to the
              applicant regarding the change or revocation.</div>
          </td>
        </tr>
        <tr>
        </tr>
        <tr>
          <td colspan="11" style="width: 100%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">Signed confirmation</div>
          </td>
        </tr>
        <tr>
          <td colspan="11" style="width: 100%; vertical-align: middle; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">Insurer:</div>
          </td>
        </tr>

    </table>
    <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
    <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><font style="font-weight: bold;">*<u>By approval of General Insurance</u></font>, these fields can be marked as invalid.</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea"><font class="BRPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">- 21 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
      <div style="line-height: 1.25; font-weight: bold;"><u>APPENDIX C4</u></div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;
      <div style="text-align: left; line-height: 1.25; font-weight: bold;"><u>8/3/23</u></div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"> </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"> <br>
    </div>
    <table cellspacing="0" cellpadding="2" border="0" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" id="z75bd67d589ec4388881c7b5c4ada6c7a">

        <tr>
          <td colspan="7" style="width: 58.69%; vertical-align: middle; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; color: rgb(0, 0, 0);">Certificate of Insurance</div>
          </td>
          <td colspan="4" style="width: 41.31%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">Date of Certificate issuance <strike>(DD/MM/YYYY)</strike></div>
          </td>
        </tr>
        <tr>
          <td colspan="11" style="width: 100%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">This insurance certificate is reference to insured&#8217;s valid insurance policy, in accordance with the information specified therein. The information specified in this certificate does not
              include all the terms of the policy and its exclusions. However, in the event of a conflict between the terms specified in this Certificate and the terms set forth in the insurance policy, what is stated in the insurance policy shall prevail,
              except in the&#160; case where a term in this Certificate benefits its applicant.</div>
          </td>
        </tr>
        <tr>
          <td colspan="2" style="width: 23.61%; vertical-align: middle; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; color: rgb(0, 0, 0);">Certificate Applicant*</div>
          </td>
          <td colspan="3" style="width: 20.82%; vertical-align: middle; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; color: rgb(0, 0, 0);">Insured</div>
          </td>
          <td colspan="2" style="width: 14.27%; vertical-align: middle; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; color: rgb(0, 0, 0);">Nature of transaction*</div>
          </td>
          <td colspan="4" style="width: 41.31%; vertical-align: middle; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; color: rgb(0, 0, 0);">Status of Applicant*</div>
          </td>
        </tr>
        <tr>
          <td colspan="2" style="width: 23.61%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">Name</div>
          </td>
          <td colspan="3" rowspan="6" style="width: 20.82%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; color: rgb(0, 0, 0);">Name:<br>
              <font style="font-weight: bold;">INMODE LTD.</font></div>
          </td>
          <td colspan="2" style="width: 14.27%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
          <td colspan="4" style="width: 41.31%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: #000000; font-family: Calibri, sans-serif; font-weight: bold;"><font style="font-family: 'Times New Roman',Times,serif;">&#9746; Lessor</font></div>
          </td>
        </tr>
        <tr>
          <td colspan="2" rowspan="5" style="width: 23.61%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0); font-weight: bold;">Shaar Yokneam - Limited Partnership and/or Trade Centres (Azo-Reit) Ltd. and/or Melisron Ltd. and/or parent companies and/or subsidiaries</div>
          </td>
          <td colspan="2" style="width: 14.27%; vertical-align: middle; border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: #000000; font-family: Calibri, sans-serif;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;">&#9746;</font><font style="font-family: 'Times New Roman',Times,serif;"> Real estate</font></div>
          </td>
          <td colspan="4" style="width: 41.31%; vertical-align: middle; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: #000000; font-family: Calibri, sans-serif;"><font style="font-family: 'Times New Roman',Times,serif;">&#9744; Lessee</font></div>
          </td>
        </tr>
        <tr>
          <td colspan="2" style="width: 14.27%; vertical-align: middle; border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: #000000; font-family: Calibri, sans-serif;"><font style="font-family: 'Times New Roman',Times,serif;">&#9744; Services</font></div>
          </td>
          <td colspan="4" style="width: 41.31%; vertical-align: middle; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: #000000; font-family: Calibri, sans-serif;"><font style="font-family: 'Times New Roman',Times,serif;">&#9744; Concessioner</font></div>
          </td>
        </tr>
        <tr>
          <td colspan="2" style="width: 14.27%; vertical-align: middle; border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: #000000; font-family: Calibri, sans-serif;"><font style="font-family: 'Times New Roman',Times,serif;">&#9744; Products supply</font></div>
          </td>
          <td colspan="4" style="width: 41.31%; vertical-align: middle; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: #000000; font-family: Calibri, sans-serif;"><font style="font-family: 'Times New Roman',Times,serif;">&#9744; Subcontractor</font></div>
          </td>
        </tr>
        <tr>
          <td colspan="2" style="width: 14.27%; vertical-align: middle; border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: #000000; font-family: Calibri, sans-serif;"><font style="font-family: 'Times New Roman',Times,serif;">&#9744;</font><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;"> Other:</font></div>
          </td>
          <td colspan="4" style="width: 41.31%; vertical-align: middle; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: #000000; font-family: Calibri, sans-serif;"><font style="font-family: 'Times New Roman',Times,serif;">&#9744; Service procurer</font></div>
          </td>
        </tr>
        <tr>
          <td colspan="2" style="width: 14.27%; vertical-align: middle; border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
          <td colspan="4" style="width: 41.31%; vertical-align: middle; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: #000000; font-family: Calibri, sans-serif;"><font style="font-family: 'Times New Roman',Times,serif;">&#9744; Product procurer</font></div>
          </td>
        </tr>
        <tr>
          <td colspan="2" style="width: 23.61%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">ID/P.C./Partnership No.: 550014666<br>
              520037789<br>
              510758329</div>
          </td>
          <td colspan="3" style="width: 20.82%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; color: rgb(0, 0, 0); font-weight: bold;">ID/P.C.:<br>
              514073618</div>
          </td>
          <td colspan="2" style="width: 14.27%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: right; line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
          <td colspan="4" style="width: 41.31%; vertical-align: middle; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: #000000; font-family: Calibri, sans-serif;"><font style="font-family: 'Times New Roman',Times,serif;">&#9744; Other: ______</font></div>
          </td>
        </tr>
        <tr>
          <td colspan="2" style="width: 23.61%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: right; line-height: 1.25; color: rgb(0, 0, 0);">Address</div>
          </td>
          <td colspan="3" rowspan="2" style="width: 20.82%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0); font-weight: bold;">Address: 1 Arbel<br>
              YOKNEAM ILLIT</div>
          </td>
          <td colspan="2" style="width: 14.27%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: right; line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
          <td colspan="4" style="width: 41.31%; vertical-align: middle; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
        </tr>
        <tr>
          <td colspan="2" style="width: 23.61%; vertical-align: middle; border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0); font-weight: bold;">1 Abba Eben St., Herzliya</div>
          </td>
          <td colspan="2" style="width: 14.27%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: right; line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
          <td colspan="4" style="width: 41.31%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
        </tr>
        <tr>
          <td colspan="11" style="width: 100%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">Covers</div>
          </td>
        </tr>
        <tr>
          <td style="width: 16.99%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">Type of policy</div>
          </td>
          <td colspan="2" rowspan="3" style="width: 13.16%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; color: rgb(0, 0, 0);">Policy No.</div>
          </td>
          <td rowspan="3" style="width: 7.2%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; color: rgb(0, 0, 0);">Policy version and edition</div>
          </td>
          <td colspan="2" rowspan="3" style="width: 14.14%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; color: rgb(0, 0, 0);">Start date</div>
          </td>
          <td colspan="2" rowspan="3" style="width: 13.94%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; color: rgb(0, 0, 0);">End date</div>
          </td>
          <td colspan="2" rowspan="2" style="width: 20.56%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; color: rgb(0, 0, 0);">Limit of liability/Insurance amount</div>
          </td>
          <td style="width: 14.01%; vertical-align: middle; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">Additional covers in force and revocation of exclusions</div>
          </td>
        </tr>
        <tr>
          <td style="width: 16.99%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
          <td style="width: 14.01%; vertical-align: middle; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">Cover code must be specified according to Appendix D</div>
          </td>
        </tr>
        <tr>
          <td style="width: 16.99%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td style="width: 10.57%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; color: rgb(0, 0, 0);">Amount</div>
          </td>
          <td style="width: 9.99%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; color: rgb(0, 0, 0);">Currency</div>
          </td>
          <td style="width: 14.01%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: right; line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
        </tr>
        <tr>
          <td rowspan="2" style="width: 16.99%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">Property</div>
          </td>
          <td colspan="2" rowspan="2" style="width: 13.16%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: right; line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
          <td rowspan="2" style="width: 7.2%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">BIT Edition Eilon 2016</div>
          </td>
          <td colspan="2" rowspan="2" style="width: 14.14%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; color: rgb(0, 0, 0);">31/1/24</div>
          </td>
          <td colspan="2" rowspan="2" style="width: 13.94%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; color: rgb(0, 0, 0);">1/2/23</div>
          </td>
          <td colspan="2" rowspan="2" style="width: 20.56%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; color: rgb(0, 0, 0);">Contents including inventory as set forth in the Policy and up to the sum specified therein</div>
            <div style="text-align: right; line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
          <td rowspan="2" style="width: 14.01%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0); font-weight: bold;">308 -Waiver in favor of another entity (other tenants subject to reciprocity in favor of tenant)</div>
            <div style="line-height: 1.25; color: rgb(0, 0, 0); font-weight: bold;">309 -Waiver of subrogation</div>
            <div style="line-height: 1.25; color: rgb(0, 0, 0); font-weight: bold;">313 -natural disasters</div>
            <div style="line-height: 1.25; color: rgb(0, 0, 0); font-weight: bold;">314 -burglary and robbery<br>
              316 -Earthquake<br>
              328 -Primary</div>
          </td>
        </tr>
        <tr>
        </tr>
        <tr>
          <td style="width: 16.99%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);"><strike>Consequential loss</strike></div>
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">INVALID</div>
          </td>
          <td colspan="2" style="width: 13.16%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td style="width: 7.2%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: right; line-height: 1.25; color: rgb(0, 0, 0);"><strike>BIT Edition</strike></div>
          </td>
          <td colspan="2" style="width: 14.14%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td colspan="2" style="width: 13.94%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td style="width: 10.57%; vertical-align: middle; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td style="width: 9.99%; vertical-align: middle; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td style="width: 14.01%; vertical-align: middle; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">&#160;</td>
        </tr>
        <tr>
          <td style="width: 16.99%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">Third party</div>
            <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">33905424623</div>
          </td>
          <td colspan="2" style="width: 13.16%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: right; line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
          <td style="width: 7.2%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">BIT Edition Eilon 2016</div>
          </td>
          <td colspan="2" style="width: 14.14%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">1.2.23</div>
          </td>
          <td colspan="2" style="width: 13.94%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">31.12.24</div>
          </td>
          <td style="width: 10.57%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">5,000,000</div>
          </td>
          <td style="width: 9.99%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: right; line-height: 1.25; color: rgb(0, 0, 0);">NIS</div>
          </td>
          <td style="width: 14.01%; vertical-align: middle; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0); font-weight: bold;">302-cross liability</div>
            <div style="line-height: 1.25; color: rgb(0, 0, 0); font-weight: bold;">304-Expanded indemnity</div>
            <div style="line-height: 1.25; color: #000000; font-family: Calibri, sans-serif; font-size: 9pt; font-weight: bold;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;">307-Contractors and subcontractors<br>
                315- Coverage for National Insurance Claims)</font></div>
            <div style="line-height: 1.25; color: rgb(0, 0, 0); font-weight: bold;">321-Additional insured due to acts of omissions of insured</div>
            <div style="line-height: 1.25; color: #000000; font-family: Calibri, sans-serif; font-size: 9pt; font-weight: bold;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;">322-Applicant deemed third party<br>
                328-Primary<br>
                329- Applicant property shall be deemed a third party)</font></div>
          </td>
        </tr>
        <tr>
          <td style="width: 16.99%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">Employer liability</div>
          </td>
          <td colspan="2" style="width: 13.16%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: right; line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
          <td style="width: 7.2%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">BIT Edition Eilon 2016</div>
          </td>
          <td colspan="2" style="width: 14.14%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: right; line-height: 1.25; color: rgb(0, 0, 0);">1.2.23</div>
          </td>
          <td colspan="2" style="width: 13.94%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: right; line-height: 1.25; color: rgb(0, 0, 0);">31.12.24</div>
          </td>
          <td style="width: 10.57%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">20,000,000</div>
          </td>
          <td style="width: 9.99%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: right; line-height: 1.25; color: rgb(0, 0, 0);">NIS</div>
          </td>
          <td style="width: 14.01%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0); font-weight: bold;">302-cross liability</div>
            <div style="line-height: 1.25; color: rgb(0, 0, 0); font-weight: bold;">304-Expanded indemnity</div>
            <div style="line-height: 1.25; color: rgb(0, 0, 0); font-weight: bold;">309-waiver of subrogation<br>
              319-deemed employer of Applicant&#8217;s employees</div>
            <div style="line-height: 1.25; color: rgb(0, 0, 0); font-weight: bold;">328-Primary</div>
          </td>
        </tr>
        <tr>
          <td colspan="11" style="width: 100%; vertical-align: middle; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">Details of the services (subject to the services specified in the agreement between the insured and the applicant, the service code must be indicated from the list in Appendix C) *:</div>
          </td>
        </tr>
        <tr>
          <td colspan="11" style="width: 100%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0); font-weight: bold;">096-Lease of property in building_____________</div>
          </td>
        </tr>
        <tr>
          <td colspan="11" style="width: 100%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">Revocation/Amendment of policy*&#160;&#160; 046</div>
          </td>
        </tr>
        <tr>
          <td colspan="11" style="width: 100%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">A change to the detriment of Applicant or revocation of an insurance policy will only take effect<font style="font-weight: bold;"> 60 days</font> following the dispatch of a notice to the
              Applicant regarding the change or revocation.</div>
          </td>
        </tr>
        <tr>
          <td colspan="11" style="width: 100%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">Signed confirmation</div>
          </td>
        </tr>
        <tr>
          <td colspan="11" style="width: 100%; vertical-align: middle; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">Insurer:</div>
          </td>
        </tr>

    </table>
    <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
    <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;<font style="font-weight: bold;">*<u>By approval of General Insurance</u></font>, these fields can be marked as invalid.</div>
    <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"> <br>
    </div>
    <div class="BRPFPageNumberArea"><font class="BRPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">- 22 -</font></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <!--PROfilePageNumberReset%Num%1%%%-->
    <div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25; font-family: Arial, sans-serif;"><br>
        </div>
      </div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u>Addendum No. 5 to the Unprotected Lease Contract dated 28.2.2018</u></div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">Held and signed on the _8__ of __5__,2023</div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

            <tr>
              <td style="width: 72pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;"><font style="font-weight: bold;">Between</font>:</td>
              <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
                <div>
                  <div style="line-height: 1.25;"><font style="font-weight: bold;">Shaar Yokneam - Limited Partnership</font></div>
                  <div style="line-height: 1.25; font-weight: bold;">Partnership No.: 550014666</div>
                  <div style="line-height: 1.25;">"Ofer Shaar Yokneam", 28 Kedma St.,<font style="font-weight: bold;">&#160;</font>Yokneam</div>
                  <div style="line-height: 1.25;">(Hereinafter: "<font style="font-weight: bold;">Lessor</font>") <br>
                  </div>
                </div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25; text-align: right;"> <br>
        </div>
        <div style="line-height: 1.25; text-align: right;">&#160;<font style="font-weight: bold;"><u>Of the first part;</u></font></div>
      </div>
      <div style="text-align: justify; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <br>
        </font></div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

            <tr>
              <td style="width: 72pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">And:</td>
              <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
                <div>
                  <div style="line-height: 1.25;"><font style="font-weight: bold;">InMode Ltd.</font></div>
                  <div style="line-height: 1.25; font-weight: bold;">Pvt. Co.: 514073618</div>
                  <div style="line-height: 1.25;">By authorized signatory Mr. Moshe Mizrahi, ID No.:<font style="font-weight: bold;"> 051825396</font></div>
                  <div style="line-height: 1.25;">Authorized to sign on behalf of the Company and bind it</div>
                  <div style="line-height: 1.25;">Whose address for the purposes of this Addendum is</div>
                  <div style="line-height: 1.25;">"Tavor" Building, Shaar Yokneam, PO Box<font style="font-weight: bold;">&#160;</font>533<font style="font-weight: bold;">, </font>Yokneam</div>
                  <div style="line-height: 1.25;">(Hereinafter: "<font style="font-weight: bold;">Lessee</font>")&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
                </div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25; text-align: right;"> <br>
        </div>
        <div style="line-height: 1.25; text-align: right;">&#160;<font style="font-weight: bold;"><u>Of the second part;</u></font></div>
        <div style="line-height: 1.25;"> <br>
        </div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z36b36708172e4bb695886475fd6df7cc">

          <tr>
            <td style="width: 72pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">WHEREAS</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
              <div>an Unprotected Lease Contract was signed<font style="font-weight: bold;">&#160;</font>between Lessor and Lessee on<font style="font-weight: bold;"> 28.2.2018</font>, with all its appendices and attachments (hereinafter: "<font style="font-weight: bold;">original lease contract</font>"), as extended and/or modified periodically (the original lease contract together with the additions thereto, including this Addendum, with all their appendices and attachments,
                shall be hereinafter referred to collectively: "<font style="font-weight: bold;">Lease Contract</font>");<font style="font-weight: bold;">&#160;</font>and</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0494048725214379baed0e16a7cd9c78">

          <tr>
            <td style="width: 72pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">WHEREAS</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
              <div>by virtue of the Lease Agreement, Lessee leases from Lessor an area of<font style="font-weight: bold;"> 866 </font>square meters gross located on the second floor of the building known as "Beit Tavor" (hereinafter: "<font style="font-weight: bold;">area on second floor</font>" and "<font style="font-weight: bold;">building</font>", respectively), an area of<font style="font-weight: bold;">&#160;</font>1,688 square meters gross located on the third floor of the
                building (hereinafter: "<font style="font-weight: bold;">area on third floor</font>"), as well as<font style="font-weight: bold;"> 41 </font>parking spaces (hereinafter: "<font style="font-weight: bold;">parking spaces</font>"), all in the
                complex known as "Ofer Shaar Yokneam" in the city of Yokneam (hereinafter: "<font style="font-weight: bold;">complex</font>"), (the area on the second floor, the area on the third floor and the parking spaces shall be referred to
                collectively as the "<font style="font-weight: bold;">existing leasehold</font>" or "<font style="font-weight: bold;">existing leasehold area</font>", as applicable); and</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z1551a1765f874f968a9902ad473896e6">

          <tr>
            <td style="width: 72pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">WHEREAS</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
              <div>Lessee approached Lessor requesting to lease the additional leasehold, as defined below, in its present condition ("AS IS"), in addition to the existing leasehold, as defined above; and</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z5227a5b814ed48aeba1a10c09d48e756">

          <tr>
            <td style="width: 72pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">WHEREAS</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
              <div>Lessor acceded to Lessee's request as stated, and all in accordance with and subject to the provisions of the Lease Contract and the terms of this addendum as set forth below;</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea"><font class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">1</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"> <br>
      </div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">It was therefore agreed, stipulated and declared by the parties as follows:</div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;">1.</font><font style="font-family: 'Times New Roman',Times,serif;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;"><u>Preamble
              and appendices</u></font></font></div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z27b69645c93246ed8906e9dfe5c6dec9">

          <tr>
            <td style="width: 36pt; font-family: 'Times New Roman',Times,serif;"><br>
            </td>
            <td style="width: 34.9pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">1.1.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
              <div>The preamble to this Addendum and its appendices constitutes an integral part thereof and are binding as the rest of its terms.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7790289ddcab43c2919756f236455160">

          <tr>
            <td style="width: 36pt; font-family: 'Times New Roman',Times,serif;"><br>
            </td>
            <td style="width: 34.9pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">1.2.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
              <div>The section headings are for orientation and convenience purposes only and may not be used for interpretation of this Addendum.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z1640ef6655134d119ceeec1617a82f18">

          <tr>
            <td style="width: 36pt; font-family: 'Times New Roman',Times,serif;"><br>
            </td>
            <td style="width: 35.25pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">1.3.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
              <div>All terms and expressions contained in this Addendum shall have the meaning ascribed thereto in the Lease Contract, unless expressly stated otherwise.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;">1.4.</font><font style="font-family: 'Times New Roman',Times,serif;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;This Addendum
          constitutes an integral part of the Lease Contract.</font></div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z79290c39875846d2a3ee95dfeac30848">

          <tr>
            <td style="width: 36pt; font-family: 'Times New Roman',Times,serif;"><br>
            </td>
            <td style="width: 35.25pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">1.5.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
              <div>No previous drafts of this Addendum shall not be considered in the interpretation of the Lease Contract and/or this Addendum or any stipulation thereof. Such drafts shall not be admissible in any judicial or quasi-judicial proceeding.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;">2.</font><font style="font-family: 'Times New Roman',Times,serif;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;"><u>Condition
              Precedent</u></font></font></div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zad5905a52e434fe69fadf5727161cbc4">

          <tr>
            <td style="width: 36pt; font-family: 'Times New Roman',Times,serif;"><br>
            </td>
            <td style="width: 35.6pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">2.1.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
              <div>Lessee declares that it is aware that at the date of signing this Addendum, the additional area is not vacant and is occupied by an existing lessee with regards to whom the lease period has not ended (hereinafter: "<font style="font-weight: bold;">current lessee</font>"). It is hereby agreed that the actual evacuation of the current lessee from the additional area <font style="font-weight: bold;"><u>by</u>&#160;</font>30/04/2023, constitutes a condition
                precedent for delivery of possession of the additional area (above and below: "<font style="font-weight: bold;">condition precedent</font>" and "<font style="font-weight: bold;">date for fulfillment of condition precedent</font>,
                respectively).</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze869fae4e6534dbcb2d5a2f05874af28">

          <tr>
            <td style="width: 36pt; font-family: 'Times New Roman',Times,serif;"><br>
            </td>
            <td style="width: 35.6pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">2.2.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
              <div>It is agreed that insofar as the current lessee does not vacate the additional area of any person and object by the date of fulfillment of the condition precedent, for any reason whatsoever, the deadline for fulfillment of the condition
                precedent shall be postponed of its own accord to the date on which the additional area would have been vacated by the actual current lessee, and the other dates specified in this Addendum shall be postponed accordingly as well.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z1dd47ce68c2b43dfaa3b775050c67395">

          <tr>
            <td style="width: 36pt; font-family: 'Times New Roman',Times,serif;"><br>
            </td>
            <td style="width: 35.6pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">2.3.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
              <div>Notwithstanding the foregoing, it is agreed that insofar as the postponement of the condition precedent date shall exceed<font style="font-weight: bold;">&#160;</font>60 (sixty) days, for any reason whatsoever, each party shall be entitled
                (but not obligated) to notify the other of the revocation of this Addendum and all its provisions, as if it had never been signed (hereinafter: "<font style="font-weight: bold;">revocation notice</font>"). If the revocation notice is
                delivered, the parties will be released from all their obligations under this Addendum and the parties will not have and hereby waive any claim and/or demand and/or lawsuit in connection with the postponement of the deadline for the
                fulfillment of the condition precedent and/or in connection with the revocation of this Addendum.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <div style="text-align: justify; margin-left: 72pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">For the avoidance of doubt, in the case stated in this section, Lessee undertakes to continue fulfilling all its obligations and
        liabilities under the Lease Contract (except for this Addendum), in full, on time and precisely, without any change.</div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;">3.</font><font style="font-family: 'Times New Roman',Times,serif;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;"><u>Increasing
              the Leasehold area</u></font></font></div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze741d3a05ff24ccba4a5e6d3fabc3113">

          <tr>
            <td style="width: 36pt; font-family: 'Times New Roman',Times,serif;"><br>
            </td>
            <td style="width: 35.6pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">3.1.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
              <div>Subject to the fulfillment of the conditions set forth in this Addendum below, and to the fulfillment of the condition precedent at its designated<a href="#bookmark7"> date, as<font style="font-weight: bold;">&#160;</font>specified in Section<font style="font-weight: bold;">&#160;</font>2<font style="font-weight: bold;">&#160;</font></a>above,<font style="font-weight: bold;">&#160;<u>as of 1.5.2023</u>&#160;</font>or at a later date<a href="#bookmark10"> under the circumstances as stated in Section<font style="font-weight: bold;">&#160;</font>2.2<font style="font-weight: bold;">&#160;</font></a>above (hereinafter: "<font style="font-weight: bold;">Effective</font>&#160;<font style="font-weight: bold;">date</font>"), an additional gross area of<font style="font-weight: bold;"> 757 </font>square meters will be added to the existing leasehold area, on the third floor of the building in the complex, all as delimited and marked in the blueprint attached<font style="font-weight: bold;">&#160;</font>as
                <font style="font-weight: bold;"><u>Appendix A</u>&#160;</font>to this Addendum (hereinafter: "<font style="font-weight: bold;">Additional area</font>"), as well as<font style="font-weight: bold;">&#160;</font>22<font style="font-weight: bold;">&#160;</font>(twenty-two)
                parking spaces on the roof of the building and<font style="font-weight: bold;">&#160;</font>5<font style="font-weight: bold;">&#160;</font>(five) parking spaces in the parking lot around the building (hereinafter<font style="font-weight: bold;">&#160;</font>collectively:
                <font style="font-weight: bold;">Additional parking spaces</font> ").</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea"><font class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">2</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; margin-left: 72pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">The additional area and the additional parking spaces shall be hereinafter referred to collectively: "<font style="font-weight: bold;">Additional
          Leasehold</font>".</div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <div style="text-align: justify; margin-left: 72pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">The existing leased area together with the additional area shall be hereinafter referred to as: "<font style="font-weight: bold;">Leasehold
          area</font>".</div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <div style="text-align: justify; margin-left: 72pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">The existing leasehold together with the additional leasehold shall be hereinafter referred to as: "<font style="font-weight: bold;">Leasehold</font>".</div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <div style="text-align: justify; margin-left: 72pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">The Leasehold area (i.e. the existing leased area along with the additional area) is<font style="font-weight: bold;"> 3,311 </font>square
        meters gross.</div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zec479aba9ec845c5a1d2ff5d1d27d983">

          <tr>
            <td style="width: 36pt; font-family: 'Times New Roman',Times,serif;"><br>
            </td>
            <td style="width: 35.6pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">3.2.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
              <div>As of the effective date, the Additional Leasehold shall be added to the existing Leasehold, will be deemed part of the Leasehold and all the provisions of the Lease Contract shall apply thereto for all intents and purposes, so that in
                reference in the Lease Contract to "the Leasehold area" and/or "the Leasehold", shall mean the existing Leasehold area along with the additional area and the existing Leasehold together with the additional leasehold, as applicable, except
                with regards to issues where there is another explicit arrangement included in this Addendum.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z9ecebab7c0d24b79b0635aff0f9bc492">

          <tr>
            <td style="width: 36pt; font-family: 'Times New Roman',Times,serif;"><br>
            </td>
            <td style="width: 35.6pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">3.3.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
              <div>It is clarified, for the avoidance of doubt, that Lessee leases the additional area solely for the purpose of expanding the existing Leasehold area and for the purpose of the Lease, as set forth in the Lease Contract.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zaad2cccde3674775b271380616d99b7b">

          <tr>
            <td style="width: 36pt; font-family: 'Times New Roman',Times,serif;"><br>
            </td>
            <td style="width: 35.6pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">3.4.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
              <div>The additional leasehold will be delivered to Lessee in its condition AS IS,<font style="font-weight: bold;">&#160;</font>and its delivery as stated shall constitute confirmation from Lessee that the additional leasehold was delivered to it
                in accordance with the provisions of the Lease Contract and to its absolute satisfaction and that it does not and will not have any suits and/or claims and/or demands in this regard towards Lessor and/or anyone acting on its behalf.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <div style="text-align: left; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;">4.</font><font style="font-family: 'Times New Roman',Times,serif;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;"><u>Lessee's
              works for increasing the existing Leasehold area</u></font></font></div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z759566b9fdfa4b7bb781703fcb265e8e">

          <tr>
            <td style="width: 36pt; font-family: 'Times New Roman',Times,serif;"><br>
            </td>
            <td style="width: 35.15pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">4.1.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
              <div>It is hereby clarified that as of the effective date, Lessee shall perform at its sole responsibility and expense all the works required for connecting and adding the additional area to the existing Leasehold area and adapting the
                additional area to its purposes and needs, all as approved by Lessor and/or anyone acting on its behalf, in advance and in writing (above and below: "<font style="font-weight: bold;">Lessee's works</font>").</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z110abd370340490ca739de9fb4009e92">

          <tr>
            <td style="width: 36pt; font-family: 'Times New Roman',Times,serif;"><br>
            </td>
            <td style="width: 35.15pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">4.2.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
              <div>Lessee undertakes that Lessee's works, as<a href="#bookmark15"> defined in Section 4.1 </a>above, will be executed and completed in accordance with the provisions of the Lease Contract and the instructions given to Lessee by Lessor
                and/or anyone acting on<font style="font-weight: bold;"><u>&#160;</u></font>its behalf, and all this until no later than <font style="font-weight: bold;"><u>31.5.2023</u></font> (hereinafter: "<font style="font-weight: bold;">Date of completion
                  of Lessee's works</font>"), without Lessor bearing any responsibility and/or liability whatsoever regarding the aforesaid and/or the execution of Lessee's works as stated.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea"><font class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">3</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: left; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;">5.</font><font style="font-family: 'Times New Roman',Times,serif;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>The
              lease period in the additional leasehold</u></font></font></div>
      <div style="text-align: left; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif;"><font style="font-weight: bold;"><u> <br>
            </u></font></font></div>
      <div style="text-align: justify; margin-left: 36pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">It is agreed that the Lease term in respect of <u>the additional leasehold</u> will commence on the effective date and from that date
        onwards will align with the Lease term in the existing Leasehold, in accordance with the provisions of the Lease Contract, i.e., until<font style="font-weight: bold;">&#160;</font>31.12.2027<font style="font-weight: bold;">&#160;</font>(above and below: <font style="font-weight: bold;">"Lease term in the additional leasehold").</font></div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;">6.</font><font style="font-family: 'Times New Roman',Times,serif;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;"><u>Lessee's
              payments for the additional leasehold during the Lease term in the additional leasehold</u></font></font></div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;">6.1.</font><font style="font-family: 'Times New Roman',Times,serif;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;"><u>Rent in respect of the additional area</u></font></font></div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z2f5628fbfa2a44cbb20df036c64bef8a">

          <tr>
            <td style="width: 72.3pt; font-family: 'Times New Roman',Times,serif;"><br>
            </td>
            <td style="width: 56.7pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">6.1.1.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', serif; font-size: 11pt;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;">As of the effective date and up to 31.12.2024</font><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;">, Lessee undertakes to pay Lessor for the additional area, monthly rent of <font style="font-weight: bold;">NIS 56</font> (fifty-six NIS) per gross square meter in the additional area,
                  plus linkage differentials to the CPI (General Index) published on 15.11.2022 or near such date, for the month of October 2022 (hereinafter: "<font style="font-weight: bold;">Basic Index</font>"), plus VAT by law.</font></div>
              <div style="font-family: 'Times New Roman', serif; font-size: 11pt;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;"> <br>
                </font></div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb20d074d982b499c92615a7b96483e5d">

          <tr>
            <td style="width: 72.3pt; font-family: 'Times New Roman',Times,serif;"><br>
            </td>
            <td style="width: 56.7pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">6.1.2.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', serif; font-size: 11pt;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;">From 1.1.2025 to 31.12.2027</font><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;">, Lessee undertakes to pay Lessor for the additional area, monthly rent of <font style="font-weight: bold;">NIS 58</font> (fifty-eight new shekels), per gross square meter in the additional area,
                  plus linkage differentials to the basic index, plus VAT by law.</font></div>
              <div style="font-family: 'Times New Roman', serif; font-size: 11pt;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;"> <br>
                </font></div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z3ee48b3ed690464fb8acc68799002a31">

          <tr>
            <td style="width: 72.3pt; font-family: 'Times New Roman',Times,serif;"><br>
            </td>
            <td style="width: 56.7pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">6.1.3.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
              <div>It is clarified that the monthly rent for the additional area shall be paid in a manner and on the dates set in respect of the existing Leasehold, as specified in the Lease Contract.</div>
              <div> <br>
              </div>
            </td>
          </tr>

      </table>
      <div style="text-align: left; text-indent: 36pt; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;">6.2.</font><font style="font-family: 'Times New Roman',Times,serif;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;"><u>Management fees for the additional area</u></font></font></div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z00cacf86272d46efb496d2e3e12ec0e2">

          <tr>
            <td style="width: 70.8pt; font-family: 'Times New Roman',Times,serif;"><br>
            </td>
            <td style="width: 56.7pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">6.2.1.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', serif; font-size: 11pt;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;">As of the effective date and up to 31.12.2024, </font><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;">Lessee undertakes to pay Lessor for<font style="font-weight: bold;">&#160;</font>the additional area, monthly management fees amounting to NIS 12.1 (twelve new shekels and
                  ten agorot) per gross square meter of the additional area, plus linkage differentials to the base index, plus VAT by law.</font></div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc6ac900952ce4593bbc8b619d91aacaa">

          <tr>
            <td style="width: 70.8pt; font-family: 'Times New Roman',Times,serif;"><br>
            </td>
            <td style="width: 56.7pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">6.2.2.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', serif; font-size: 11pt;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;">From 1.1.2025 to 31.12.2027, </font><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;">Lessee undertakes to pay Lessor for<font style="font-weight: bold;">&#160;</font>the additional area, monthly management fees amounting to NIS 14 (fourteen new shekels) per gross square meter of the
                  additional area, plus linkage differentials to the base index, plus VAT by law.</font></div>
              <div style="font-family: 'Times New Roman', serif; font-size: 11pt;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;"> <br>
                </font></div>
            </td>
          </tr>

      </table>
      <div style="text-align: left; text-indent: 36pt; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;">6.3.</font><font style="font-family: 'Times New Roman',Times,serif;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;"><u>Depreciation fund for the additional area</u></font></font></div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z40ade52faed240afbddffe0923cb0cba">

          <tr>
            <td style="width: 72.3pt; font-family: 'Times New Roman',Times,serif;"><br>
            </td>
            <td style="width: 56.7pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">6.3.1.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
              <div>Without derogating from the provisions of the management agreement, it is agreed that during the Lease term in the additional leasehold, Lessee shall pay Lessor depreciation fund fees amounting to<font style="font-weight: bold;"> NIS 1.2
                </font>(one new shekel and twenty agorot) per gross square meter in the additional area, with said amount linked to the base index, plus VAT by law.</div>
              <div> <br>
              </div>
            </td>
          </tr>

      </table>
      <div style="text-align: left; text-indent: 36pt; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;">6.4.</font><font style="font-family: 'Times New Roman',Times,serif;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;"><u>Insurance premiums for the additional area</u></font></font></div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za8244e4c4d2246e4a7e20b916fb156b0">

          <tr>
            <td style="width: 71.3pt; font-family: 'Times New Roman',Times,serif;"><br>
            </td>
            <td style="width: 56.7pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">6.4.1.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
              <div>During the Lease term in the additional leasehold, Lessee undertakes to pay Lessor in respect of Lessee&#8217;s relative share in the insurance premium payment expenses paid to the insurance company by Lessor, monthly insurance premiums
                amounting to <font style="font-weight: bold;">NIS 0.5 </font>(fifty agorot) per gross square meter in the additional area, plus linkage differentials to the basic index, plus VAT by law.</div>
              <div> <br>
              </div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z31475dddf77b428eba3016048f6517e2">

          <tr>
            <td style="width: 71.3pt; font-family: 'Times New Roman',Times,serif;"><br>
            </td>
            <td style="width: 56.7pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">6.4.2.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
              <div>Lessee shall have no claim and/or suit and/or demand against Lessor and/or the management company and/or anyone acting on their behalf with regard to the insurance premiums (including whether the amount is fixed or whether it be
                calculated according to another mechanism set forth in the management agreement and/or in the Lease Contract).</div>
            </td>
          </tr>

      </table>
      <div style="text-align: left; text-indent: 36pt; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;"> <br>
        </font></div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea"><font class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">4</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: left; text-indent: 36pt; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;"> <br>
        </font></div>
      <div style="text-align: left; text-indent: 36pt; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;">6.5.</font><font style="font-family: 'Times New Roman',Times,serif;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;"><u>Parking fees for additional parking spaces</u></font></font></div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <div style="text-align: justify; margin-left: 72pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">During the Lease term in the additional leasehold, Lessee undertakes to pay the Lessor in respect of the additional parking spaces, a
        monthly parking fee of<font style="font-weight: bold;"> NIS 320 NIS (three hundred and twenty NIS</font>) for each of the additional parking spaces, with said amount linked to the base index plus VAT by law. It is clarified that the above amount
        does not include payment of property taxes in respect of the additional parking spaces, if applicable.</div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z4128c025f2cc49a5ba72b039df021f2e">

          <tr>
            <td style="width: 36pt; font-family: 'Times New Roman',Times,serif;"><br>
            </td>
            <td style="width: 35.25pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">6.6.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
              <div>For the avoidance of doubt, it is clarified that all other debts and payments applicable to Lessee under the Lease Contract, including - but not limited to - municipal taxes, electricity consumption, water and any payment to any third
                party, shall apply, as of the effective date, also to the additional leasehold.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <div style="text-align: left; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;">7.</font><font style="font-family: 'Times New Roman',Times,serif;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;It is agreed that additional terms for the
          entry into force of this Addendum are that Lessee meet its fundamental charges</font> as follows: </div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;">7.1.</font><font style="font-family: 'Times New Roman',Times,serif;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;"><u>Collateral/guarantees in respect of the additional leasehold</u></font></font></div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z180c70ad9ece4745849455ee80a7c57f">

          <tr>
            <td style="width: 70.8pt; font-family: 'Times New Roman',Times,serif;"><br>
            </td>
            <td style="width: 56.7pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">7.1.1.</td>
            <td style="width: auto; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
              <div>Notwithstanding the provisions of the Lease Contract, it is clarified and agreed that to ensure the fulfillment of Lessee's obligations and liabilities under this Addendum, Lessee shall provide Lessor at the time of signing this
                Addendum, a bank guarantee, in the form attached as <font style="font-weight: bold;"><u>Appendix B</u>&#160;</font>to this Addendum, for<font style="font-weight: bold;">&#160;</font>an amount equal to the rent for the additional area, the management
                fees for the additional area and the parking fees for the additional parking spaces, payable by Lessee for<font style="font-weight: bold;">&#160;</font>3 (three) months rent in relation to the additional leasehold, with this amount linked to the
                base index, plus VAT by law, in <font style="font-weight: bold;"><u>addition</u>&#160;</font>to the existing bank guarantees provided to Lessor by Lessee in accordance with the provisions of the Lease Contract (hereinafter: "<font style="font-weight: bold;">additional bank guarantee</font>").</div>
              <div> <br>
              </div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z2b82353b7bf84c889c5a5e02031e4dbf">

          <tr>
            <td style="width: 70.8pt; font-family: 'Times New Roman',Times,serif;"><br>
            </td>
            <td style="width: 56.7pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">7.1.2.</td>
            <td style="width: auto; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
              <div>It is clarified and agreed that all the provisions of the Lease Contract in connection with the bank guarantee will also apply to the additional bank guarantee.</div>
              <div> <br>
              </div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z1b81388fbb974f158a4b32120fb1494c">

          <tr>
            <td style="width: 70.8pt; font-family: 'Times New Roman',Times,serif;"><br>
            </td>
            <td style="width: 56.7pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">7.1.3.</td>
            <td style="width: auto; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
              <div>The additional bank guarantee will be valid for the duration of the Lease in the additional leasehold, and all under the responsibility of Lessee and at its expense and to ensure all of Lessee&#8217;s obligations and liabilities under the
                Lease Contract (including this Addendum).</div>
              <div> <br>
              </div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z20ca3f3bb30844619cbe3f6f7ad259ad">

          <tr>
            <td style="width: 70.8pt; font-family: 'Times New Roman',Times,serif;"><br>
            </td>
            <td style="width: 56.7pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">7.1.4.</td>
            <td style="width: auto; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
              <div>Without derogating from the aforesaid, all the collateral deposited with Lessor in accordance with the provisions of the Lease Contract, shall serve Lessor and/or the management company and/or anyone on their behalf, also to ensure the
                full and accurate fulfillment of all of Lessee&#8217;s obligations and liabilities under this Addendum.</div>
            </td>
          </tr>

      </table>
      <div style="text-align: left; text-indent: 36pt; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;"> <br>
        </font></div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea"><font class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">5</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: left; text-indent: 36pt; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;"> <br>
        </font></div>
      <div style="text-align: left; text-indent: 36pt; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;">7.2.</font><font style="font-family: 'Times New Roman',Times,serif;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;"><u>Account billing authorization</u></font></font></div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z423fed3c7539493688ca141a962bc2c8">

          <tr>
            <td style="width: 70.55pt; font-family: 'Times New Roman',Times,serif;"><br>
            </td>
            <td style="width: 57.45pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">7.2.1.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
              <div>Lessee undertakes that the letter of authorization to debit an account provided to Lessor according to the provisions of the Lease Contract, will also be used for collecting the payments applicable to Lessee in respect of the additional
                leasehold during the entire Lease term in the additional leasehold, in accordance with the provisions of this Addendum.</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;"> <br>
        </font></div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;">7.3.</font><font style="font-family: 'Times New Roman',Times,serif;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;"><u>Insurance</u></font></font></div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z33ca18d17f9c4b2f98d7e9d32636ba0e">

          <tr>
            <td style="width: 70.9pt; font-family: 'Times New Roman',Times,serif;"><br>
            </td>
            <td style="width: 57.1pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">7.3.1.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
              <div>Lessee undertakes that the insurances it undertook to prepare under the Lease Contract, will be extended to further apply to the additional leasehold, in a manner that will remain valid and fully covered during the entire Lease term of
                the additional leasehold.</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; margin-left: 128pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">It is clarified and agreed that the wording <font style="font-weight: bold;">of the insurance sections </font>and the wording of
        the <font style="font-weight: bold;">insurance certificates </font>attached as <font style="font-weight: bold;"><u>Appendix C</u>&#160;</font>to this Addendum <u>will replace</u> the wording of the insurance section in the Lease Contract.</div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze8b594b16b31401db2c813dbe989cb47">

          <tr>
            <td style="width: 70.9pt; font-family: 'Times New Roman',Times,serif;"><br>
            </td>
            <td style="width: 57.1pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">7.3.2.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
              <div>Lessee will present to Lessor the insurance certificates as required in the Lease Contract (including this Addendum) no later than the date of signing this Addendum). It is clarified that failure to furnish insurance certificates does
                not exempt Lessee from its insurance liability, which is specified in the insurance sections and appendices of the Lease Contract.</div>
              <div> <br>
              </div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z5a350d2449c4497a9cc959849a59afc8">

          <tr>
            <td style="width: 70.9pt; font-family: 'Times New Roman',Times,serif;"><br>
            </td>
            <td style="width: 57.1pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">7.3.3.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
              <div>If, in the opinion of Lessor, there is a need to prepare additional and/or supplementary insurances for the additional Leasehold, Lessee undertakes to prepare such insurances at Lessor&#8217;s request.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;">8.</font><font style="font-family: 'Times New Roman',Times,serif;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Lessor's
              works in the Leasehold</u></font></font></div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <div style="text-align: justify; margin-left: 36pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Subject to the full fulfillment of Lessee's obligations under the Lease Contract (including this Addendum), in full and on time, the
        following provisions shall apply:</div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze343bc09d8334eb59721608806abd25f">

          <tr>
            <td style="width: 36pt; font-family: 'Times New Roman',Times,serif;"><br>
            </td>
            <td style="width: 35.55pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">8.1.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
              <div>Notwithstanding the provisions of Section<font style="font-weight: bold;"> 21.4 </font>of the original Lease Contract, it is agreed that Lessor will perform maintenance/treatment works at its expense in the existing air conditioning
                system, in all areas of the Leasehold, and for the duration of the Lease in the additional leasehold.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze9270879d6c54ef4b995da5ae0a7c3e0">

          <tr>
            <td style="width: 36pt; font-family: 'Times New Roman',Times,serif;"><br>
            </td>
            <td style="width: 35.55pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">8.2.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
              <div>Lessor will perform at its expense works related to implementing necessary adjustments to the fresh air system to address any deficiencies in all Leasehold areas.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;">9.</font><font style="font-family: 'Times New Roman',Times,serif;">&#160;&#160;&#160;&#160;&#160; &#160; &#160;&#160; <font style="font-weight: bold;"><u>General</u></font></font></div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z55b23c7d8a874ae28c26438bd36a1b85">

          <tr>
            <td style="width: 36pt; font-family: 'Times New Roman',Times,serif;"><br>
            </td>
            <td style="width: 35.55pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">9.1.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
              <div>All other provisions of the Lease Contract, insofar as they have not been explicitly amended in this Addendum, will continue to be valid and binding of the parties, including but not limited to, with regards to the additional area, as
                applicable and mutatis mutandis, if any.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z943db8640e074be0a8fe7aa139ddec3d">

          <tr>
            <td style="width: 36pt; font-family: 'Times New Roman',Times,serif;"><br>
            </td>
            <td style="width: 35.55pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">9.2.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
              <div>Insofar as any term is set out in the Lease Contract, which has granted Lessee any right of exclusivity and/or right of first refusal and/or right of first offer, etc. - then any such term shall be null and void from the date of signing
                this Addendum.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea"><font class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">6</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z9476197d236a44098a0e7d9526377982">

          <tr>
            <td style="width: 36pt; font-family: 'Times New Roman',Times,serif;"><br>
            </td>
            <td style="width: 35.55pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">9.3.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
              <div>It is clarified that the aforesaid in this Addendum does not impose on Lessor and/or the management company any charge that is not imposed on any of them under the provisions of the Lease Contract and/or by law and that the aforesaid
                does not derogate from any obligation and/or liability of Lessee under the Lease Contract and/or under any law.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8775fb55149f4bf3acb145c8478e98d0">

          <tr>
            <td style="width: 36pt; font-family: 'Times New Roman',Times,serif;"><br>
            </td>
            <td style="width: 35.55pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">9.4.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
              <div>It is clarified and agreed by the parties that the aforesaid in this Addendum does not constitute a waiver and/or forgiveness on the part of the Lessor and/or the management company with regards to any claim and/or lawsuit and/or demand
                of any of the above towards Lessee, including under the Lease Contract and/or under any law.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze51773c867ae48bb96d9ddf8709f119f">

          <tr>
            <td style="width: 36pt; font-family: 'Times New Roman',Times,serif;"><br>
            </td>
            <td style="width: 35.55pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">9.5.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
              <div>Any breach of any of the provisions of this Addendum shall be deemed a breach of the Lease Contract, for all intents and purposes, and shall grant Lessor all remedies available thereto under the Lease Contract and/or by law, for such
                breach.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z861eb536b5014bd699f5af554bd65168">

          <tr>
            <td style="width: 36pt; font-family: 'Times New Roman',Times,serif;"><br>
            </td>
            <td style="width: 35.55pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">9.6.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
              <div>In any case of conflict between the provisions of the Lease Contract (without this Addendum) and the provisions of this Addendum, the provisions of this Addendum shall prevail.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z5c53785b8249463094361e15d2e194b2">

          <tr>
            <td style="width: 36pt; font-family: 'Times New Roman',Times,serif;"><br>
            </td>
            <td style="width: 35.55pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">9.7.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
              <div>This Addendum shall enter into force only following the parties&#8217; signing thereof and subject to the fulfillment of the condition precedent by the deadline for its fulfillment.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea"><font class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">7</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-weight: bold;">IN WITNESS WHEREOF the parties have signed:</div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zbd711a2c99714de0b80d0bc907af8a35">

          <tr>
            <td rowspan="1" style="width: 20%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td rowspan="1" style="width: 60%; vertical-align: top; font-family: 'Times New Roman',Times,serif; padding-bottom: 2px;"><br>
            </td>
            <td rowspan="1" style="width: 20%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          </tr>
          <tr>
            <td style="width: 20%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
              <div style="text-align: center; line-height: 1.25; color: rgb(0, 0, 0); font-weight: bold;">Lessor</div>
            </td>
            <td style="width: 60%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">&#160;</td>
            <td style="width: 20%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
              <div style="text-align: center; line-height: 1.25; color: rgb(0, 0, 0); font-weight: bold;">Lessee</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u>Approval of Lessee's Attorney</u></div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">I, the undersigned<u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</u>, Adv., of<u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</u> St.
        hereby confirm that Lessee is an existing and active corporation and that it has passed all the resolutions required for its engagement in this Addendum in accordance to its Articles of Association; that the above signatures are those of Mr.<u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</u>ID:<u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</u>
        and Mr. <u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</u>ID:<u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </u> who are authorized to bind Lessee with their signatures.</div>
      <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"> <br>
      </div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">IN WITNESS WHEREOF I have signed:</div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zddaffa96aec6458ebc927428c6156c75">

          <tr>
            <td style="width: 33.33%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif;">
              <div style="line-height: 1.25;">Date:<u> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</u></div>
            </td>
            <td style="width: 33.33%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif;">&#160;</td>
            <td style="width: 33.33%; vertical-align: bottom;">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', serif; font-size: 11pt;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</u>&#160;, Adv.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea"><font class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">8</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div><br>
      <div style="text-align: right; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u>Appendix A</u></div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u>Additional Area Blueprint</u></div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td rowspan="1" style="width: 20%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
              <td rowspan="1" style="width: 60%; vertical-align: top; font-family: 'Times New Roman',Times,serif; padding-bottom: 2px;"><br>
              </td>
              <td rowspan="1" style="width: 20%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            </tr>
            <tr>
              <td style="width: 20%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
                <div style="text-align: center; line-height: 1.25; color: rgb(0, 0, 0); font-weight: bold;">Lessor</div>
              </td>
              <td style="width: 60%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">&#160;</td>
              <td style="width: 20%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
                <div style="text-align: center; line-height: 1.25; color: rgb(0, 0, 0); font-weight: bold;">Lessee</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageNumberArea"><font class="BRPFPageNumber" style="color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">9</font></div>
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
      </div>
      <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u>Appendix B</u></div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u>Bank Guarantee</u></div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u> <br>
        </u></div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
        <table cellspacing="0" cellpadding="0" border="0" id="z1be832f966e343cab39ac0b17e00a2ce" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td style="width: 50.00%;">
                <div>
                  <div style="text-align: justify; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif;">To&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <br>
                    </font></div>
                  <div style="text-align: justify; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif;"><u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</u> - Limited Partnership&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div>
                  <div style="text-align: justify; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif;">1 Abba Eban Blvd.</font><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;">,</font><font style="font-family: 'Times New Roman',Times,serif;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div>
                  <font style="font-family: 'Times New Roman',Times,serif;"><u>Herzliya</u> ("</font><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;">Lessor</font><font style="font-family: 'Times New Roman',Times,serif;">")</font></div>
              </td>
              <td style="width: 50.00%;">
                <div><font style="font-family: 'Times New Roman',Times,serif;">To</font></div>
                <div><font style="font-family: 'Times New Roman',Times,serif;"><font style="font-size: 11pt;"><u> _____________</u></font>Ltd.</font></div>
                <div><font style="font-family: 'Times New Roman',Times,serif;">1 Abba Eban Blvd.<font style="font-size: 11pt; font-weight: bold;">,</font></font></div>
                <div><font style="font-family: 'Times New Roman',Times,serif;"><font style="font-size: 11pt;"><u>Herzliya</u></font> ("<font style="font-size: 11pt; font-weight: bold;">Management Company</font>")<font style="font-size: 11pt; font-weight: bold;"></font> </font></div>
              </td>
            </tr>

        </table>
      </div>
      <font style="font-family: 'Times New Roman',Times,serif;">&#160;&#160;&#160;&#160;&#160;&#160; <br>
      </font>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Dear Sir/Madam,</div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Re.: <font style="font-weight: bold;"><u>Bank Guarantee</u></font></div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">At the request of (hereinafter: "<font style="font-weight: bold;">Applicant</font>"), we hereby guarantee the settling of any amount you may require of
        Applicant up to a total of NIS (hereinafter: "<font style="font-weight: bold;">Principal Amount</font>").</div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"> <br>
      </div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">The principal amount will be linked to the Consumer Price Index (General Index) as published by the Central Bureau of Statistics and Economic Research or
        by any other official institution replacing it (hereinafter: "<font style="font-weight: bold;">Index</font>").</div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">"<font style="font-weight: bold;">Base index</font>" will be the index published for the month ______in the year___ (&#160;<u>&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;</u>
        points, according to base.</div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">"<font style="font-weight: bold;">New index</font>" for calculating linkage differentials will be the index recently published prior to executing a
        payment by ourselves according to this Letter of Guarantee.</div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">If at the time of payment according to this Letter of Guarantee it becomes clear that the new index has risen relative to the base index, the principal
        amount will be increased as per the rate increase of the new index relative to the base index.</div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"> <br>
      </div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">If the new index is lower than or equal to the base index, we will pay you the original principal amount without any linkage differentials.</div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">"<font style="font-weight: bold;">Guarantee amount</font>" - the amount of the principal plus linkage differentials as aforesaid.</div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">We undertake to promptly paying you any necessary amount up to the guarantee limit upon your initial written request, and within two business days from
        the date of such request, without the need for you to provide evidence or justification for your request, and without requiring you to first seek payment of the guaranteed amount from the Applicant.</div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Each of you will be entitled to demand payment of the guarantee amount from us in full or from time-to-time demand from us on account of the guarantee
        amount, in which case following each payment the guarantee will remain in effect in respect of the balance of the guarantee amount, provided that the total of all your demands collectively does not exceed the guarantee amount.</div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">This guarantee will be valid in full up until at<font style="font-weight: bold;">&#160;</font>12:00<font style="font-weight: bold;">&#160;</font>inclusive, and any
        demand thereunder must be delivered to us no later than on the aforementioned date.</div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">This guarantee is assignable and/or transferable.</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea"><font class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">10</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u>Appendix C</u></div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u>Insurance Appendix</u></div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;">1.</font><font style="font-family: 'Times New Roman',Times,serif;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Insurance</u></font></div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <div style="text-align: justify; text-indent: 1pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Without derogating from Lessee's liability under this Agreement or by law, Lessee undertakes to arrange and maintain
        insurances as required by the provisions of this Section 1 and the insurance specifications mentioned therein.</div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zce452c8a2e014ed8b028a8a4f07c9eed">

          <tr>
            <td style="width: 21.3pt; font-family: 'Times New Roman',Times,serif;"><br>
            </td>
            <td style="width: 42.3pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">1.1.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
              <div>With regard to obtaining permission to carry out works in the Leasehold and if any works are carried out in the Leasehold by Lessee or on its behalf prior to Lessee&#8216;s occupying of the Leasehold for the first time and/or at any time
                during the Lease term, Lessee undertakes, prior to the commencement of the works, to arrange and maintain insurance for contract works in the name of Lessee, contractors and subcontractors, Lessor and the management company, under the terms
                specified in the insurance specification attached to this Agreement and which constitutes an integral part thereof and marked <font style="font-weight: bold;"><u>Appendix</u>&#160;<u>C1</u>&#160;</font>(hereinafter: "<font style="font-weight: bold;">Lessee
                  works insurance specification</font>"), with an insurance company duly licensed in Israel (hereinafter: "<font style="font-weight: bold;">Lessee works insurance</font>").</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z41224ee179b14bde9919b2c7ea876775">

          <tr>
            <td style="width: 21.3pt; font-family: 'Times New Roman',Times,serif;"><br>
            </td>
            <td style="width: 42.05pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">1.2.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
              <div>Without derogating from Lessee's liability under this Agreement or by law, during the entire Lease term, Lessee undertakes to arrange and maintain, through a duly licensed insurance company in Israel, the insurances specified in the
                insurance specifications attached to this Agreement and which constitutes an integral part thereof and marked <font style="font-weight: bold;"><u>Appendix</u></font>&#160;<font style="font-weight: bold;"><u>C2</u>&#160;</font>(respectively,
                hereinafter: "<font style="font-weight: bold;">Lessee's permanent insurance specification" </font>and<font style="font-weight: bold;"> "Lessee's permanent insurance</font>"); and this with regard to the Leasehold and Lessee's activity
                therein.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <div style="text-align: justify; margin-left: 64pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Lessee&#8217;s works insurance and Lessee&#8217;s permanent insurances shall hereinafter be referred to collectively as "<font style="font-weight: bold;">Lessee's insurances</font>".</div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0fcd4d6a3f3a4b489481bb5f461c4139">

          <tr>
            <td style="width: 21.3pt; font-family: 'Times New Roman',Times,serif;"><br>
            </td>
            <td style="width: 42.3pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">1.3.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
              <div>Without the need for any demand from Lessor or the management company, Lessee undertakes to furnish Lessor and the management company, no later than the date of commencement of the works in the Leasehold, confirmation of Lessee's works
                insurance in the form attached to this Agreement and constituting an integral part thereof and marked <font style="font-weight: bold;"><u>Appendix C3</u></font><u>&#160;</u>(hereinafter: "<font style="font-weight: bold;">Lessee's works
                  insurance certificate</font>"), signed by its insurer. Lessee declares that it is aware that the furnishing of its works insurance certificate as stated is a condition precedent and prerequisite for the execution of any works in the
                Leasehold, and Lessor or the management company shall be entitled (but not obligated) to prevent Lessee from executing works in the Leasehold if said certificate was not furnished prior to the date of commencement of the works.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z3bbfc0d034b64605a50a57e61f98415b">

          <tr>
            <td style="width: 21.3pt; font-family: 'Times New Roman',Times,serif;"><br>
            </td>
            <td style="width: 42.35pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">1.4.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
              <div>At the request of Lessor or the Management Company, Lessee undertakes to furnish Lessor and the management company, within<font style="font-weight: bold;">&#160;</font>5<font style="font-weight: bold;">&#160;</font>days from the date of a request,
                confirmation of Lessee's permanent insurance, in the form attached to this Agreement and constituting an integral part thereof and marked <font style="font-weight: bold;"><u>Appendix</u></font>&#160;<font style="font-weight: bold;"><u>C4</u>&#160;</font>(hereinafter:
                "<font style="font-weight: bold;">Lessee's permanent insurance certificate</font>") signed by its<font style="font-weight: bold;">&#160;</font>insurer.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <div style="text-align: justify; margin-left: 64pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Lessee's work insurance certificate and Lessee's permanent insurance certificate shall be hereinafter referred to collectively as: "<font style="font-weight: bold;">Insurance Certificates</font>".</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea"><font class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">11</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z3f087ad9471d4654ba5381dc860caec8">

          <tr>
            <td style="width: 21.3pt; font-family: 'Times New Roman',Times,serif;"><br>
            </td>
            <td style="width: 42.35pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">1.5.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
              <div>It is agreed that Lessee may refrain from arranging consequential loss insurance, in whole or in part, as specified in Section (4)<font style="font-weight: bold;">&#160;</font>of Lessee's permanent insurance specification and Lessee may also
                refrain from arranging property insurance covering the risk of a broken glass, as specified in Section<font style="font-weight: bold;">&#160;</font>(1)<font style="font-weight: bold;">&#160;</font>of Lessee's permanent insurance specification, but
                the exemption specified in Section 1.8<font style="font-weight: bold;">&#160;</font>below shall apply as if said insurances had<font style="font-weight: bold;">&#160;</font>been arranged in full.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zdf207e64bc1d476ea36169c965373965">

          <tr>
            <td style="width: 21.3pt; font-family: 'Times New Roman',Times,serif;"><br>
            </td>
            <td style="width: 42.35pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">1.6.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
              <div>If in Lessee's opinion there is a need to arrange additional or supplementary insurance for Lessee's work insurance specification and/or for Lessee's permanent insurance specification, Lessee undertakes to arrange and maintain such
                additional or supplementary insurance. Lessee undertakes that in any additional or supplementary property insurance as stated, a clause regarding waiver of the right of subrogation against Lessor, the management company and those on their
                behalf shall be included, but such waiver shall not apply to a person who caused the damage maliciously. Lessee also undertakes that in any such additional or supplementary liability insurance, the name of the insured will be expanded to
                include Lessor and the management company, subject to a cross-liability clause, according to which the insurance is deemed to have been arranged separately for each of the insured individuals.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7ac951f7e7394b178e5c62d23ee51406">

          <tr>
            <td style="width: 21.3pt; font-family: 'Times New Roman',Times,serif;"><br>
            </td>
            <td style="width: 42.7pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">1.7.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
              <div>Lessee undertakes to update from time to time the insurance amounts in the insurance policies arranged under sections (1) and (4) of Lessee's permanent insurance specification, so that they always reflect the full value of what is
                insured thereunder.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z2c630ca2eeb9458292ae7c04a37ad30b">

          <tr>
            <td style="width: 21.3pt; font-family: 'Times New Roman',Times,serif;"><br>
            </td>
            <td style="width: 42.7pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">1.8.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
              <div>Lessee exempts Lessor, the management company and anyone on their behalf as well as the other lessees, tenants and other rights holders in the building (the other lessees, tenants and other rights holders as stated shall be hereinafter
                referred to collectively as: "<font style="font-weight: bold;">other rights holders</font>"), whose lease agreements or other agreement granting the other<font style="font-weight: bold;">&#160;</font>rights holders rights in the building, a
                corresponding exemption is included towards Lessee, from liability for damage for which it is entitled to indemnification according to the insurances arranged pursuant to Section<font style="font-weight: bold;">&#160;</font>(1)<font style="font-weight: bold;">&#160;</font>of Lessee's works insurance specification, sections<font style="font-weight: bold;">&#160;</font>(1) and (4)<font style="font-weight: bold;">&#160;</font>of Lessee's permanent insurance specification or
                indemnification it would be entitled to in respect thereof had it not been for the deductibles specified in the policies), however such exemption from liability shall not apply to a person who caused the damage maliciously.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zbed0c858f8794b72bd6051c891677733">

          <tr>
            <td style="width: 21.3pt; font-family: 'Times New Roman',Times,serif;"><br>
            </td>
            <td style="width: 42.7pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">1.9.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
              <div>At the request of Lessor or the Management Company, Lessee undertakes to furnish Lessor and the management company, the management company, within<font style="font-weight: bold;">&#160;</font>5<font style="font-weight: bold;">&#160;</font>days
                from the date of the request, Lessee's permanent insurance certificate extended for an additional insurance term, and so forth for each insurance term and as long as this Agreement is valid.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z4c6bda6885e9483694f29a37476b90c5">

          <tr>
            <td style="width: 19pt; font-family: 'Times New Roman',Times,serif;"><br>
            </td>
            <td style="width: 45pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">1.10.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
              <div>Whenever Lessee's insurer notifies Lessor or the management company that an amendment or cancellation of any of Lessee's insurances is about to take place, Lessee undertakes to re-arrange said insurance and re-furnish a certificate of
                insurance in place of the amended or canceled insurance as stated, 30<font style="font-weight: bold;">&#160;</font>days prior to the date of the amendment or cancellation as stated.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z490f6b6e448b4916b0b29b41d8c6f9b3">

          <tr>
            <td style="width: 19pt; font-family: 'Times New Roman',Times,serif;"><br>
            </td>
            <td style="width: 45pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">1.11.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
              <div>For the avoidance of doubt, it is clarified that failure to provide insurance certificates as stated in sections<font style="font-weight: bold;">&#160;</font>1.3, 1.4, 1.9<font style="font-weight: bold;">&#160;</font>and<font style="font-weight: bold;">&#160;</font>1.10 above, shall not prejudice Lessee's obligations under this Agreement, including, without prejudice to the generality of the aforesaid, any payment undertaking applicable to Lessee, and Lessee undertakes to fulfill all
                its obligations under the Agreement. It is expressly agreed that Lessor or management company shall be entitled (but not obligated) to prevent Lessee from executing works in the Leasehold and/or receiving possession of the Leasehold and/or
                delivering assets into the Leasehold and/or opening its business in the Leasehold and/or its operations in the Leasehold due to its failure to present the aforementioned certificates.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea"><font class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">12</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z1637949d22364e7e964b186c6cd227f1">

          <tr>
            <td style="width: 19pt; font-family: 'Times New Roman',Times,serif;"><br>
            </td>
            <td style="width: 45pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">1.12.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
              <div>Lessor and/or the management company may examine the insurance certificates provided by Lessee as stated in sections<font style="font-weight: bold;">&#160;</font>1.3, 1.4, 1.9<font style="font-weight: bold;">&#160;</font>and<font style="font-weight: bold;">&#160;</font>1.10<font style="font-weight: bold;">&#160;</font>above, and Lessee undertakes to make any changes or amendments required in order to adapt them to Lessee&#8217;s obligations as stated in this Agreement. Lessee
                declares that the right of inspection of Lessor or the Management Company in relation to the insurance certificates and their right to require amendments as specified above, does not impose on Lessor or the management company or anyone
                acting on their behalf any obligation and any liability whatsoever in connection with the aforesaid insurance certificates, the nature, scope and validity of the insurances arranged according to the aforesaid certificates or regarding their
                absence, and does not derogate from any liability imposed on Lessee under this Agreement or by law.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc589f1eba7594ef3a8c385c9b6b12b7c">

          <tr>
            <td style="width: 19pt; font-family: 'Times New Roman',Times,serif;"><br>
            </td>
            <td style="width: 45pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">1.13.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
              <div>Lessee undertakes to comply with the terms of the insurance policies arranged by it, to pay the insurance premiums in full and on time, and to ensure that Lessee's permanent insurance is renewed from time to time as necessary and in
                force for the duration of the Lease.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zef817d9518044b1a9d1c4e9b6394aed7">

          <tr>
            <td style="width: 19pt; font-family: 'Times New Roman',Times,serif;"><br>
            </td>
            <td style="width: 45pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">1.14.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
              <div>For the avoidance of doubt, it is hereby agreed that the scope of the insurance coverage, including the limits of liability required by the provisions of the insurance specifications, are a minimal requirement imposed on Lessee. Lessee
                declares and confirms that it will be prevented from raising any claim and/or demand against Lessor or towards the management company or anyone on their behalf, with regards to the scope of the insurance coverage, including the limits of
                liability as stated.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z44b6baf4324a49018b50762d806eb208">

          <tr>
            <td style="width: 19pt; font-family: 'Times New Roman',Times,serif;"><br>
            </td>
            <td style="width: 45pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">1.15.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
              <div>Lessee declares that it is aware that Lessor or the management company do not undertake to maintain security and other security measures in the building or Leasehold and if they do so, this does not reflect an undertaking or liability
                towards Lessee. It is further explicitly agreed that Lessor and the management company will not be subject to the provisions of the Custodian Law,<font style="font-weight: bold;"> 5727-1967, </font>and its appendices.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z37a9401741df43ef90701f5f86f2e44d">

          <tr>
            <td style="width: 19pt; font-family: 'Times New Roman',Times,serif;"><br>
            </td>
            <td style="width: 45pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">1.16.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
              <div>It is clarified that the insurance certificates attached to this Agreement, which Lessee is obligated to furnish, are signed by its insurer, worded in a concise format only as required of the insurance companies according to the
                provisions of the Commissioner of Capital Markets, Insurance and Savings, and where the furnishing of such certificates does not derogate from Lessee's obligation to comply with all of the provisions of the above insurance sections and
                arrange insurance coverage in accordance with the provisions of the insurance specifications as stated, and for such purpose, Lessee, if necessary with the help of insurance people on its behalf, must study and fully implement said
                requirements which should also be brought to the attention of Lessee's insurer. It is also clarified that insofar as there are changes in the guidelines of the Commissioner of Capital Market, Insurance and Savings as stated, Lessor will be
                entitled to replace the insurance certificates attached to this Agreement with alternative insurance certificates.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zcab9dd725f48496aaee723871654c312">

          <tr>
            <td style="width: 20.95pt; font-family: 'Times New Roman',Times,serif;"><br>
            </td>
            <td style="width: 42.55pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">1.17.</td>
            <td style="width: auto; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
              <div>Lessor undertakes to arrange and maintain, whether itself or through the management company, for the duration of the Agreement, the insurances listed below in this section with duly licensed insurance company in Israel.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z045821b139094fd8a0ee7e0556389c44">

          <tr>
            <td style="width: 64pt; font-family: 'Times New Roman',Times,serif;"><br>
            </td>
            <td style="width: 44.3pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">1.17.1.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
              <div>Insurance of the parts of the building owned by Lessor (including the Leasehold structure), against loss or damage due to risks accepted in extended fire insurance, including fire, smoke, lightning, explosion, earthquake, storm and gale,
                flood, fluid damage and pipe rupture, damage by vehicles, damage by aircraft, riots, strikes, malicious damage as well as burglary damage. Such insurance coverage shall include a clause regarding waiver of subrogation right towards Lessee,
                however such waiver shall not apply to a person who caused the damage maliciously. For the avoidance of doubt, it is expressly agreed that such insurance shall not include any contents and/or addition, improvement or extension made by
                and/or on behalf of and/or for Lessee and/or other rights holders and shall not include windshields, windows, glass partitions and glass doors, the insurance liability of which is imposed on Lessee as stated in Section<font style="font-weight: bold;">&#160;</font>(1)<font style="font-weight: bold;">&#160;</font>of Lessee's permanent insurance specification.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea"><font class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">13</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd23936daa5bf4fc9bead71066af0b799">

          <tr>
            <td style="width: 64pt; font-family: 'Times New Roman',Times,serif;"><br>
            </td>
            <td style="width: 44.3pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">1.17.2.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
              <div>Consequential loss insurance that insures loss of rent and loss of management fees (if any) due to damage caused to parts of the building owned by Lessor (including the Leasehold structure) due to the risks<font style="font-weight: bold;">&#160;</font>specified in Section 1.17.1 above (excluding burglary), and this for an indemnity period of<font style="font-weight: bold;">&#160;</font>24<font style="font-weight: bold;">&#160;</font>months. Such insurance coverage shall include a
                clause regarding waiver of subrogation right towards Lessee, however such waiver shall not apply to a person who caused the damage maliciously.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <div style="text-align: justify; margin-left: 110pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">It is agreed that Lessor or the management company may refrain from arranging consequential loss insurance that insures loss of rent
        and loss of management fees as stated in this Section<font style="font-weight: bold;">&#160;</font>1.17.2 above, in whole or in part, but the provisions of Section 1.19<font style="font-weight: bold;">&#160;</font>below shall apply as if the insurance had
        been prepared in full.</div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb3c3b98e6cc749b9aaf8f2380ec83aac">

          <tr>
            <td style="width: 18pt; font-family: 'Times New Roman',Times,serif;"><br>
            </td>
            <td style="width: 45.85pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">1.18.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
              <div>It is agreed that Lessor may, at its sole discretion, arrange additional insurances to those specified in Section 1.17<font style="font-weight: bold;">&#160;</font>above. It is hereby expressly agreed that the arranging of the insurances
                specified in<font style="font-weight: bold;">&#160;</font>Section 1.17<font style="font-weight: bold;">&#160;</font>above or the additional insurance as aforesaid, will in no way add to the responsibility of Lessor or the management company beyond
                what is set forth in this Agreement or derogate from Lessee liability under the Agreement or by law (except as explicitly stated at the end of Section 1.19 below).</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z665c9f85d1764103bd8569eac78d9813">

          <tr>
            <td style="width: 18pt; font-family: 'Times New Roman',Times,serif;"><br>
            </td>
            <td style="width: 45.85pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">1.19.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
              <div>Lessor exempts Lessee, on its behalf and on behalf of the management company, from liability in respect of damage for which any of them are entitled to indemnification according to the insurances arranged pursuant to sections<font style="font-weight: bold;">&#160;</font>1.17.1 and 1.17.2 above<font style="font-weight: bold;">&#160;</font>(or would have been entitled to indemnification for it had it not been for the deductibles specified in the policies), however said
                exemption from liability shall not apply to a person who caused the damage maliciously.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <div style="text-align: justify; margin-left: 64pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Notwithstanding the foregoing, if an insurance incident is caused by the insured according<font style="font-weight: bold;">&#160;</font>to
        sections 1.17.1 and 1.17.2<font style="font-weight: bold;">&#160;</font>above, in circumstances in which Lessee is liable under this Contract and/or by law, Lessee shall bear the amount of the damage and/or loss caused up to the amount of the
        deductibles applicable under the aforesaid policies.</div>
      <div style="text-align: justify; margin-left: 64pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea"><font class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">14</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; margin-left: 64pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br>
      </div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">&#160;<u>Appendix C1: Specifications of Lessee's works insurance</u></div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Lessee will arrange and maintain contractor works insurance on behalf of Lessee, contractors, subcontractors, Lessor and the management company, which
        includes the insurance chapters set forth below including all extensions included in the policy, including an extended maintenance period of<font style="font-weight: bold;">&#160;</font>24<font style="font-weight: bold;">&#160;</font>months (hereinafter: "<font style="font-weight: bold;">maintenance period</font>"), with the scope of coverage not falling short of the "BIT" format valid on the date of arranging the insurance:</div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z18f9a5f640854f55b8feff440b606add">

          <tr>
            <td style="width: 17.7pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">1.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
              <div>Chapter<font style="font-weight: bold;">&#160;</font>1<font style="font-weight: bold;">&#160;</font>- Insurance that insures the works, to their full value (including materials provided by Lessor or by the management company) against loss or
                damage caused during the insurance period and during the maintenance period concerning the fulfillment of maintenance works obligations (hereinafter: "<font style="font-weight: bold;">maintenance works</font>") or the discovery of damage to
                the works during the maintenance period due to a reason related to the insurance term. For the avoidance of doubt, this chapter includes a clause regarding waiver of the right of subrogation towards Lessor, the management company and anyone
                on their behalf, as well as towards other lessees tenants and other rights holders in the building (the other lessees, tenants and other rights holders as stated shall be hereinafter referred to collectively as: "<font style="font-weight: bold;">other rights holders</font>"), whose property<font style="font-weight: bold;"> i</font>nsurance includes a parallel clause regarding waiver of the right of subrogation towards Lessee or where an agreement granting the other rights
                holders as aforesaid rights in the building includes an exemption from liability in favor of Lessee for loss or damage caused to the property of the other rights holders due to acceptable risks in the insurance of contractual works or the
                extended fire insurance policy, however such waiver shall not apply to a person who caused the damage maliciously. The chapter also includes an explicit extension regarding coverage of adjacent property and property worked on within
                liability limits of NIS <font style="color: rgb(255, 0, 0);">(*).</font></div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z14d69febb12049e394f8ef24d7be8222">

          <tr>
            <td style="width: 17.7pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">2.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
              <div>Chapter 2<font style="font-weight: bold;">&#160;</font>- liability insurance towards a third party, insuring liability under law for bodily injury or property damage of any person or entity in connection with the works executed during the
                insurance period as well as such injury to body or damage to property during the maintenance period, in connection with maintenance works or for a reason that is rooted in the insurance period, within a liability limit as detailed below.
                The aforesaid chapter includes a cross-liability clause, according to which the insurance is deemed to have been arranged separately for each of the insured individuals. For works whose value exceeds<font style="font-weight: bold;">&#160;</font>NIS

                5,000,000, Lessee shall provide Lessor with a reference from the works insurer indicating that Lessor's property including the Leasehold structure is deemed third party property except for damage caused to the property covered in Chapter<font style="font-weight: bold;">&#160;</font>1<font style="font-weight: bold;">&#160;</font>and excluding damage to property that is an integral part of the works.</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; text-indent: 18pt; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif;">Limit of liability: NIS&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; per event and cumulatively according to the chapter<font style="font-size: 11pt; color: rgb(255, 0, 0);"> (*).</font></font></div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <div style="text-align: justify; text-indent: 18pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">The chapter is expanded to include the following items:</div>
      <div style="text-align: justify; text-indent: 18pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 18pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">a. Subrogation claims of the National Insurance Institute.</div>
      <div style="text-align: justify; text-indent: 18pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"> <br>
      </div>
      <div style="text-align: justify; text-indent: -10.35pt; margin-left: 28.35pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">b. Bodily injury arising from the use of mechanical engineering equipment that is a motor vehicle which does
        not require mandatory insurance. C. Liability for damage caused by vibrations and weakening of support at a liability limit of<font style="font-weight: bold;"> NIS 1,000,000</font> per event.</div>
      <div style="text-align: justify; text-indent: -10.35pt; margin-left: 28.35pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 1pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman', serif; font-size: 11pt;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(255, 0, 0);">(*)</font><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;"> Limit of liability in Chapter<font style="font-weight: bold;">&#160;</font>1<font style="font-weight: bold;">&#160;</font>- expansion of adjacent property/ property being worked on and a
          limit of liability in Chapter<font style="font-weight: bold;">&#160;</font>2<font style="font-weight: bold;">&#160;</font>- liability insurance<font style="color: rgb(255, 0, 0);">&#160;</font>towards a third party per event and cumulatively according to the
          chapter.</font></div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" id="z48b88dcc57684d55b9631258bc930b02">

          <tr>
            <td style="width: 24.57%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">Scope of works</div>
            </td>
            <td style="width: 46.18%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">Chapter A - Expansion for adjacent property/ </div>
              <div style="text-align: center; line-height: 1.25;">property being worked on</div>
            </td>
            <td style="width: 29.24%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">Limit of Liability Chapter B</div>
            </td>
          </tr>
          <tr>
            <td style="width: 24.57%; vertical-align: bottom; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; text-indent: 2.4pt; line-height: 1.25;">Up to<font style="font-weight: bold;"> 500,000</font></div>
            </td>
            <td style="width: 46.18%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: right; margin-right: 6.45pt; margin-left: 1pt; line-height: 1.25; font-weight: bold;">&#8362; 350,000</div>
            </td>
            <td style="width: 29.24%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="text-align: right; margin-right: 6.5pt; margin-left: 1pt; line-height: 1.25; font-weight: bold;">&#8362; 1,000,000</div>
            </td>
          </tr>
          <tr>
            <td style="width: 24.57%; vertical-align: bottom; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; text-indent: 2.4pt; line-height: 1.25; font-weight: bold;">500,000-1,000,000</div>
            </td>
            <td style="width: 46.18%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: right; margin-right: 6.45pt; margin-left: 1pt; line-height: 1.25; font-weight: bold;">&#8362; 500,000</div>
            </td>
            <td style="width: 29.24%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="text-align: right; margin-right: 6.5pt; margin-left: 1pt; line-height: 1.25; font-weight: bold;">&#8362; 2,000,000</div>
            </td>
          </tr>
          <tr>
            <td style="width: 24.57%; vertical-align: bottom; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; text-indent: 2.4pt; line-height: 1.25; font-weight: bold;">1,000,000-2,500,000</div>
            </td>
            <td style="width: 46.18%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: right; margin-right: 6.45pt; margin-left: 1pt; line-height: 1.25; font-weight: bold;">&#8362; 600,000</div>
            </td>
            <td style="width: 29.24%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="text-align: right; margin-right: 6.5pt; margin-left: 1pt; line-height: 1.25; font-weight: bold;">&#8362; 4,000,000</div>
            </td>
          </tr>
          <tr>
            <td style="width: 24.57%; vertical-align: bottom; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; text-indent: 2.4pt; line-height: 1.25; font-weight: bold;">2,500,000-5,000,000</div>
            </td>
            <td style="width: 46.18%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: right; margin-right: 6.45pt; margin-left: 1pt; line-height: 1.25; font-weight: bold;">&#8362; 800,000</div>
            </td>
            <td style="width: 29.24%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="text-align: right; margin-right: 6.5pt; margin-left: 1pt; line-height: 1.25; font-weight: bold;">&#8362; 6,000,000</div>
            </td>
          </tr>
          <tr>
            <td style="width: 24.57%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; text-indent: 2.4pt; line-height: 1.25;">Over <font style="font-weight: bold;">5,000,000</font></div>
            </td>
            <td style="width: 46.18%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: right; margin-right: 6.45pt; margin-left: 1pt; line-height: 1.25; font-weight: bold;">&#8362; 1,000,000</div>
            </td>
            <td style="width: 29.24%; vertical-align: middle; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="text-align: right; margin-right: 6.5pt; margin-left: 1pt; line-height: 1.25; font-weight: bold;">&#8362; 10,000,000</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

            <tr>
              <td style="width: 17.7pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">3.</td>
              <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
                <div>Chapter <font style="font-weight: bold;">3 </font>- Employers' liability insurance covering liability for physical injury or professional illness that may be caused to employees employed in the execution of the works or maintenance
                  works during and following their work during the insurance period, as well as during the maintenance period in connection with the maintenance works, with a liability limit of<font style="font-weight: bold;"> NIS 20,000,000 </font>per
                  claimant, per event and cumulatively according to the chapter. This insurance does not include restrictions on work at height and depth, working hours, baits and poisons, contractors, subcontractors and their employees as well as the
                  employment of youth. For the avoidance of doubt, the chapter includes a waiver of the right of subrogation towards Lessor, the management company and those on their behalf, however, such a waiver shall not apply to a person who caused the
                  insurance event maliciously.</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: justify; line-height: 1.25;"><u>The insurance shall include the following stipulations:</u></div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; line-height: 1.25;">The above policy precedes any insurance prepared by Lessor and/or by the management company and the insurer waives any claim and/or demand regarding the sharing of the insurances of Lessor and/or
          the management company. Failure to comply with the terms of the policy and its stipulations in good faith by Lessee and/or anyone on its behalf, shall not derogate from Lessor's and/or the management company&#8217;s rights to receive indemnification
          under the policy. The aforementioned policy shall remain in effect and unchanged throughout the insurance period, unless a written notice is sent to both the Lessor and the management company via registered mail at least 60 days prior. Lessee
          alone is responsible for payment of the insurance premiums for the above policy and bears the deductibles applicable under said policy. Gross negligence exclusion is revoked, but the revocation of said exception does not derogate from the rights
          of the insurer and Lessee&#8216;s liabilities pursuant to the Insurance Contract Law,<font style="font-weight: bold;"> 5741-1981.</font></div>
      </div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea"><font class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">15</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u>Appendix C2: Lessee's Permanent Insurance Specifications</u></div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Lessee will arrange and maintain insurance policies as detailed below, ensuring the coverage meets or exceeds the standards set forth in the current
        "BIT" version at the time of obtaining the insurance.</div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"> <br>
      </div>
      <div style="text-align: justify; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;">1.</font><font style="font-family: 'Times New Roman',Times,serif;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;">"Extended
            Fire" insurance policy</font></font></div>
      <div style="text-align: justify; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif;"><font style="font-weight: bold;"> <br>
          </font></font></div>
      <div style="text-align: justify; text-indent: 1pt; margin-left: 28pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Insuring the contents of the Leasehold, its windows, glass partitions and glass doors, and any other property
        brought to the Leasehold and/or building by or for Lessee (including equipment, furniture, facilities and inventories), and any modification, improvement and addition to the Leasehold made by or for Lessee, at its full value, against loss or damage
        due to the risks accepted in extended fire insurance, including fire, smoke, lightning, explosion, earthquake, storm and gale, flood, fluid damage and rupture of pipes, broken glass, damage by vehicles, damage by aircraft, riots, strikes, malicious
        damage and burglary. The policy includes a clause regarding insurer&#8217;s waiver of the right of subrogation towards Lessor, the building&#8216;s management company [if any (hereinafter: &#8221;<font style="font-weight: bold;">Management Company</font>&#8221;)] and
        anyone on their behalf, as well as towards other lessees, tenants and other rights holders in the building (the other lessees, tenants and other rights holders as stated shall be hereinafter referred to collectively as: "<font style="font-weight: bold;">other rights holders</font>"), whose property<font style="font-weight: bold;">&#160;</font>insurance includes a parallel clause regarding waiver of the right of subrogation towards Lessee or where an agreement granting the other rights holders
        as aforesaid rights in the building includes an exemption from liability in favor of Lessee for loss or damage that may be caused to the property of the other rights holders due to the risks accepted in extended fire insurance; However, the
        aforementioned waiver will not apply to a person who caused the damage maliciously.</div>
      <div style="text-align: justify; text-indent: 1pt; margin-left: 28pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"> <br>
      </div>
      <div style="text-align: justify; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;">2.</font><font style="font-family: 'Times New Roman',Times,serif;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;">Third party
            liability insurance policy</font></font></div>
      <div style="text-align: justify; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif;"><font style="font-weight: bold;"> <br>
          </font></font></div>
      <div style="text-align: justify; text-indent: 1pt; margin-left: 28pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Insuring Lessee's liability under law for bodily injury or damage to property that may be caused to the body or
        property of any person or entity in the Leasehold, building or its surroundings, with a limit of liability as detailed below. The policy is not subject to a limitation of liability arising from fire, explosion, terror, hoisting devices, unloading
        and loading, damaged sanitary facilities, poisoning, anything harmful in food or drink, strike and lockdown, liability for and towards subcontractors (of any rank) and their employees, animals, as well as subrogation claims by the National
        Insurance Institute. The policy is extended to indemnify Lessor and the management company in respect of their liability as the owners and managers of the Leasehold as well as with respect to liability that may be imposed on any of them due to an
        act or omission of Lessee or anyone on its behalf, subject to the cross-liability clause, according to which the insurance is deemed to have been arranged separately for each of the insured individuals. Limit of liability amounting to: NIS per
        event and cumulatively according to the policy (*).</div>
      <div style="text-align: justify; text-indent: 1pt; margin-left: 28pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 1pt; margin-left: 28pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">(*) The limits of liability will equal NIS<font style="font-weight: bold;">&#160;</font>14,000<font style="font-weight: bold;">&#160;</font>multiplied by the Leasehold area in square meters, but not less than<font style="font-weight: bold;">&#160;</font>NIS 1,000,000 and not exceeding<font style="font-weight: bold;">&#160;</font>NIS 20,000,000<font style="font-weight: bold;">&#160;</font>per
        event and cumulatively according to the policy.</div>
      <div style="text-align: justify; text-indent: 1pt; margin-left: 28pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"> <br>
      </div>
      <div style="text-align: justify; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;">3.</font><font style="font-family: 'Times New Roman',Times,serif;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;">Employer
            Liability Insurance Policy</font></font></div>
      <div style="text-align: justify; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif;"><font style="font-weight: bold;"> <br>
          </font></font></div>
      <div style="text-align: justify; text-indent: 1pt; margin-left: 28pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Insuring Lessee's liability towards its employees for bodily injury or professional illness that may be caused to
        any of them during and due to their work in the Leasehold, building and its surroundings, with a liability limit of NIS<font style="font-weight: bold;">&#160;</font>20,000,000<font style="font-weight: bold;">&#160;</font>per claimant, event and cumulatively
        according to the policy. The policy does not include restrictions on work at height and depth, working hours, baits and poisons, as well as on the employment of youth. The policy is extended to indemnify Lessor and the management company in the
        event of a claim in connection with the occurrence of a work accident or any professional illness, alleging that any of them bears any employer's obligations towards any of Lessee's employees. In addition, the policy includes a clause regarding a
        waiver of the right of subrogation towards Lessor, the management company and those on their behalf; However, such a waiver shall not apply to a person who caused the insurance event maliciously.</div>
      <div style="text-align: justify; text-indent: 1pt; margin-left: 28pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"> <br>
      </div>
      <div style="text-align: justify; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;">4.</font><font style="font-family: 'Times New Roman',Times,serif;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;">Consequential
            Loss Insurance Policy</font></font></div>
      <div style="text-align: justify; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif;"><font style="font-weight: bold;"> <br>
          </font></font></div>
      <div style="text-align: justify; text-indent: 1pt; margin-left: 28pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Insuring loss of gross profit to Lessee due to loss or damage caused to the insured property under Section<font style="font-weight: bold;">&#160;</font>1<font style="font-weight: bold;">&#160;</font>above or to the Leasehold or building structure, as a result of one of the risks specified in Section<font style="font-weight: bold;">&#160;</font>1<font style="font-weight: bold;">&#160;</font>above, and this for an indemnity period of<font style="font-weight: bold;">&#160;</font>24 months. The policy includes a clause regarding insurer&#8217;s waiver of the right of subrogation towards the management company and anyone on their
        behalf, as well as towards other rights holders whose consequential loss insurance includes a parallel clause regarding waiver of the right of subrogation towards Lessee or where an agreement granting the other rights holders as aforesaid rights in
        the building includes an exemption from liability in favor of Lessee for consequential loss to the other rights holders due to the risks accepted in extended fire insurance, however the aforementioned waiver will not apply to a person who caused
        damage maliciously.</div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><u>The insurances shall include the following terms:</u></div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">The above policies precede any insurance prepared by Lessor and/or by the management company and the insurer waives any claim and/or demand regarding
        sharing of the insurances of Lessor and/or the management company. Failure to comply with the terms of the policy and its stipulations in good faith by Lessee and/or anyone on its behalf, shall not derogate from Lessor's and/or the management
        company&#8217;s rights to receive indemnification under the policies. The aforementioned policies shall remain in effect and unchanged throughout the insurance period, unless a written notice is sent to both the Lessor and the management company via
        registered mail at least 60 days prior. Lessee alone is responsible for payment of the insurance premiums for the above policies and bears the deductibles applicable under said policies. Gross negligence exclusion is revoked, but the revocation of
        said exception does not derogate from the rights of the insurer and Lessee&#8216;s liabilities pursuant to the Insurance Contract Law,<font style="font-weight: bold;">&#160;</font>5741-1981.</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea"><font class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">16</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u>Appendix C3</u></div>
      <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u> <br>
        </u></div>
      <table cellspacing="0" cellpadding="2" border="0" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" id="zd5de90d24574447eba0a64e3fb8b1cc2">

          <tr>
            <td colspan="4" style="width: 76.99%; vertical-align: top; background-color: rgb(231, 230, 230); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">Certificates of insurance - Insurance of contractor&#8217;s work/ work under construction</div>
            </td>
            <td style="width: 23.01%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">Date of Certificate issuance</div>
              <div style="text-align: center; line-height: 1.25; color: rgb(0, 0, 0);">(DD/MM/YYYY)</div>
            </td>
          </tr>
          <tr>
            <td colspan="5" style="width: 100%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; margin-right: 4.05pt; margin-left: 6.15pt; line-height: 1.25;">This insurance certificate is in reference to the insured holding a valid insurance policy, in accordance with the information specified therein.
                The information specified in this certificate does not include all the terms of the policy and its exclusions. However, in the event of a conflict between the terms specified in this Certificate and the terms set forth in the insurance
                policy, what is stated in the insurance policy shall prevail, except in cases where a term in this Certificate benefits the Applicant.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 26.26%; vertical-align: top; background-color: rgb(231, 230, 230); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">Main Applicant</div>
            </td>
            <td style="width: 13.93%; vertical-align: top; background-color: rgb(231, 230, 230); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">Additional entities related to the Applicant and deemed as Applicant</div>
            </td>
            <td style="width: 17.95%; vertical-align: top; background-color: rgb(231, 230, 230); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">Insured/Insurance Candidate</div>
            </td>
            <td style="width: 18.84%; vertical-align: top; background-color: rgb(231, 230, 230); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">Address of the insured property Address of execution of the works*</div>
            </td>
            <td style="width: 23.01%; vertical-align: top; background-color: rgb(231, 230, 230); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">Status of Applicant*</div>
            </td>
          </tr>
          <tr>
            <td style="width: 26.26%; vertical-align: bottom; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Name:</div>
            </td>
            <td rowspan="3" style="width: 13.93%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Subsidiaries</div>
              <div style="line-height: 1.25;">and/or companies</div>
              <div style="line-height: 1.25;">Related and/or partnerships and/or management company</div>
            </td>
            <td style="width: 17.95%; vertical-align: bottom; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Name:</div>
            </td>
            <td style="width: 18.84%; vertical-align: bottom; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">Leased</div>
            </td>
            <td rowspan="3" style="width: 23.01%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="margin-right: 4.1pt; margin-left: 2.6pt; line-height: 1.25;">&#9633;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Execution Contractor</div>
              <div style="margin-right: 4.1pt; margin-left: 2.6pt; line-height: 1.25;">&#9633;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Subcontractors</div>
              <div style="margin-right: 4.1pt; margin-left: 2.6pt; line-height: 1.25;">&#9633;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Lessee</div>
              <div style="margin-right: 4.1pt; margin-left: 2.6pt; line-height: 1.25;">&#9633;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Other: Lessor / Owner of the property where the works shall be carried out.</div>
            </td>
          </tr>
          <tr>
            <td rowspan="2" style="width: 26.26%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Shaar Yokneam - Limited Partnership and/or Commercial Centers (Ezo-Rit) Ltd. and/or</div>
              <div style="line-height: 1.25;">Melisron Ltd. and/or parent companies and/or subsidiaries</div>
            </td>
            <td style="width: 17.95%; vertical-align: bottom; border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;"><font style="background-color: #FFFF00;">..................</font></div>
            </td>
            <td style="width: 18.84%; vertical-align: bottom; border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">at <font style="background-color: rgb(255, 255, 0);">___________</font></div>
            </td>
          </tr>
          <tr>
            <td style="width: 17.95%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">and/or Contractors and</div>
              <div style="line-height: 1.25;">subcontractors of any rank and type</div>
            </td>
            <td style="width: 18.84%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
          </tr>
          <tr>
            <td style="width: 26.26%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">ID/Pvt. Co./Partnership No.:</div>
              <div style="line-height: 1.25; font-weight: bold;">550014666</div>
              <div style="line-height: 1.25; font-weight: bold;">520037789</div>
              <div style="line-height: 1.25; font-weight: bold;">510758329</div>
            </td>
            <td style="width: 13.93%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 17.95%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">ID/Pvt. Co.:</div>
            </td>
            <td style="width: 18.84%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 23.01%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">&#160;</td>
          </tr>
          <tr>
            <td style="width: 26.26%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Address:</div>
              <div style="line-height: 1.25;">1 Abba Eban St., Herzliya</div>
            </td>
            <td style="width: 13.93%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 17.95%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Address:</div>
            </td>
            <td style="width: 18.84%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 23.01%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          </tr>

      </table>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z9b13ac57f9f24ca787fda1de843599e8">

          <tr>
            <td colspan="10" style="width: 100%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; line-height: 1.25;">Covers</div>
            </td>
          </tr>
          <tr>
            <td rowspan="2" style="width: 10.17%; vertical-align: top; background-color: rgb(231, 230, 230); font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">Policy chapters are divided according to limits of liability or insurance amounts or extensions</div>
            </td>
            <td rowspan="2" style="width: 8.46%; vertical-align: top; background-color: rgb(231, 230, 230); font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">Policy No.</div>
            </td>
            <td rowspan="2" style="width: 9.95%; vertical-align: top; background-color: rgb(231, 230, 230); font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">Policy version and edition</div>
            </td>
            <td rowspan="2" style="width: 7.02%; vertical-align: top; background-color: rgb(231, 230, 230); font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">Start date</div>
            </td>
            <td rowspan="2" style="width: 6.97%; vertical-align: top; background-color: rgb(231, 230, 230); font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">End date</div>
            </td>
            <td colspan="2" style="width: 20.8%; vertical-align: top; background-color: rgb(231, 230, 230); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Limit of liability for insureds&#8217; entire activity/</div>
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Insurance amount/Value of work</div>
            </td>
            <td style="width: 12.33%; vertical-align: top; background-color: rgb(231, 230, 230); font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">Deductible (it is not mandatory to display this data)</div>
            </td>
            <td rowspan="2" style="width: 8.06%; vertical-align: top; background-color: rgb(231, 230, 230); font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">Currency</div>
            </td>
            <td rowspan="2" style="width: 16.24%; vertical-align: top; background-color: rgb(231, 230, 230); font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">Additional covers in force and revocation of exclusions****</div>
            </td>
          </tr>
          <tr>
            <td style="width: 12.69%; vertical-align: top; background-color: rgb(231, 230, 230); font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">For the period</div>
            </td>
            <td style="width: 8.1%; vertical-align: top; background-color: rgb(231, 230, 230); font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">per event*</div>
            </td>
            <td style="width: 12.33%; vertical-align: top; background-color: rgb(231, 230, 230); font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
          </tr>
          <tr>
            <td style="width: 10.17%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">All Risks Contractor&#8217;s Works</div>
            </td>
            <td style="width: 8.46%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 9.95%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">.... BIT edition....</div>
            </td>
            <td style="width: 7.02%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 6.97%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 12.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 8.1%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 12.33%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 8.06%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-indent: 17pt; line-height: 1.25;">&#8362;</div>
            </td>
            <td rowspan="6" style="width: 16.24%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">308-Waiver in&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; favor of other party&#160;&#160; (Other lessees, other tenants, other rights holders subject to reciprocity)</div>
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">309-Waiver of subrogation<br>
                313- Natural damage<br>
                314-Burglary Theft and robbery<br>
                316-Earthquake<br>
                318-Additional Insured<br>
                328-Priority<br>
                334- Maintenance Period 24 months</div>
            </td>
          </tr>
          <tr>
            <td style="width: 10.17%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Theft and burglary</div>
            </td>
            <td style="width: 8.46%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 9.95%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 7.02%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 6.97%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 12.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 8.1%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 12.33%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 8.06%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
          </tr>
          <tr>
            <td style="width: 10.17%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Property being worked on</div>
            </td>
            <td style="width: 8.46%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 9.95%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 7.02%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 6.97%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 12.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25; color: rgb(255, 0, 0);">(The amount must be completed in accordance with the table set forth in the insurance specifications Lessee&#8216;s Works)</div>
            </td>
            <td style="width: 8.1%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 12.33%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 8.06%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
          </tr>
          <tr>
            <td style="width: 10.17%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Nearby property</div>
            </td>
            <td style="width: 8.46%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 9.95%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 7.02%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 6.97%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 12.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25; color: rgb(255, 0, 0);">(The amount must be completed in accordance with the table set forth in the insurance specifications Lessee&#8216;s Works)</div>
            </td>
            <td style="width: 8.1%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 12.33%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 8.06%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
          </tr>
          <tr>
            <td style="width: 10.17%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Property in transfer</div>
            </td>
            <td style="width: 8.46%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 9.95%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 7.02%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 6.97%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 12.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 8.1%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 12.33%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 8.06%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
          </tr>
          <tr>
            <td style="width: 10.17%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Removal of rubble</div>
            </td>
            <td style="width: 8.46%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 9.95%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 7.02%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 6.97%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 12.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 8.1%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 12.33%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 8.06%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
          </tr>
          <tr>
            <td style="width: 10.17%; vertical-align: top; background-color: rgb(231, 230, 230); font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Third party</div>
            </td>
            <td style="width: 8.46%; vertical-align: top; background-color: rgb(231, 230, 230); font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 9.95%; vertical-align: top; background-color: rgb(231, 230, 230); font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">.... BIT edition....</div>
            </td>
            <td style="width: 7.02%; vertical-align: top; background-color: rgb(231, 230, 230); font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 6.97%; vertical-align: top; background-color: rgb(231, 230, 230); font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 12.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25; color: rgb(255, 0, 0);">(The amount must be completed in accordance with the table set forth in the insurance specifications Lessee&#8216;s Works)</div>
            </td>
            <td style="width: 8.1%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 12.33%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 8.06%; vertical-align: top; background-color: rgb(231, 230, 230); font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-indent: 17pt; line-height: 1.25;">&#8362;</div>
            </td>
            <td style="width: 16.24%; vertical-align: bottom; background-color: rgb(231, 230, 230); font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25; font-weight: bold;">302-Cross Liability<br>
                309-Waiver of Subrogation<br>
                312-Use of heavy equipment<br>
                315- NII claims<br>
                318- Additional Insured<br>
                328-Priority<br>
                340-Tremors and deterioration of support</div>
            </td>
          </tr>
          <tr>
            <td style="width: 10.17%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Employer Liability</div>
            </td>
            <td style="width: 8.46%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 9.95%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">.... BIT edition....</div>
            </td>
            <td style="width: 7.02%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 6.97%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 12.69%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; text-indent: 13pt; line-height: 1.25;">20,000,000</div>
            </td>
            <td style="width: 8.1%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 12.33%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 8.06%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-indent: 17pt; line-height: 1.25;">&#8362;</div>
            </td>
            <td style="width: 16.24%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">
              <div style="line-height: 1.25; font-weight: bold;">309-Waiver of subrogation<br>
                318- Additional insured<br>
                328-Priority<br>
                350-Extension of&#160; Liability towards contractors and subcontractors</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="2" border="0" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" id="zf288af0802ab4f46ac36d6b1d33e8968">

          <tr>
            <td style="width: 100%; vertical-align: top; background-color: rgb(231, 230, 230); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; line-height: 1.25;">Details of the services (subject to the services specified in the agreement between the insured and the Applicant, the service code must be indicated from the closed list set forth in
                Appendix C as published by the Capital Market, Insurance and Savings Authority. The text displayed next to the code can also be displayed in the closed list)*:</div>
            </td>
          </tr>
          <tr>
            <td style="width: 100%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; line-height: 1.25;">074- Renovations</div>
            </td>
          </tr>
          <tr>
            <td style="width: 100%; vertical-align: top; background-color: rgb(231, 230, 230); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; line-height: 1.25;">Revocation/change of policy*</div>
            </td>
          </tr>
          <tr>
            <td style="width: 100%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; line-height: 1.25;">A change to the detriment of Applicant or revocation of an insurance policy will only take effect 60 days following the dispatch of a notice to Applicant regarding the change or revocation.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 100%; vertical-align: middle; background-color: rgb(231, 230, 230); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; line-height: 1.25;">Signing of Certificate</div>
            </td>
          </tr>
          <tr>
            <td style="width: 100%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="text-align: justify; line-height: 1.25;">Insurer:</div>
            </td>
          </tr>

      </table>
      <div class="BRPFPageFooter">
        <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
        </div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageNumberArea"><font class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">17</font></div>
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
      </div>
      <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u> <br>
        </u></div>
      <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u>Appendix C4</u></div>
      <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u> <br>
        </u></div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" id="z00da36450c01483691ee270b99cf5bdc">

          <tr>
            <td colspan="12" style="width: 77.66%; vertical-align: top; background-color: rgb(231, 230, 230); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">Insurance Certificate</div>
            </td>
            <td style="width: 22.34%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">Date of Certificate issuance<br>
                (DD/MM/YYYY)</div>
            </td>
          </tr>
          <tr>
            <td colspan="13" style="width: 100%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; margin-right: 4.1pt; margin-left: 6.55pt; line-height: 1.25;">This insurance certificate is in reference to the insured holding a valid insurance policy, in accordance with the information specified therein.
                The information specified in this certificate does not include all the terms of the policy and its exclusions. However, in the event of a conflict between the terms specified in this Certificate and the terms set forth in the insurance
                policy, what is stated in the insurance policy shall prevail, except in cases where a term in this Certificate benefits the Applicant.</div>
            </td>
          </tr>
          <tr>
            <td colspan="3" style="width: 22.81%; vertical-align: top; background-color: rgb(231, 230, 230); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">Main Applicant</div>
            </td>
            <td colspan="3" style="width: 15.22%; vertical-align: top; background-color: rgb(231, 230, 230); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">Additional entities related to the Applicant and deemed as Applicant</div>
            </td>
            <td colspan="3" style="width: 17.85%; vertical-align: top; background-color: rgb(231, 230, 230); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">Insured/Insurance Candidate</div>
            </td>
            <td colspan="3" style="width: 21.78%; vertical-align: top; background-color: rgb(231, 230, 230); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">Nature of the transaction and insured occupation</div>
            </td>
            <td style="width: 22.34%; vertical-align: top; background-color: rgb(231, 230, 230); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">Status of Applicant</div>
            </td>
          </tr>
          <tr>
            <td colspan="3" style="width: 22.81%; vertical-align: bottom; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Name:<br>
                Shaar Yokneam &#8211; Limited Partnership and/or Commercial Centers (Ezo-Rit) Ltd. and/or Melisron Ltd. and/or parent companies and/or subsidiaries</div>
            </td>
            <td colspan="3" rowspan="3" style="width: 15.22%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Subsidiaries and/or related companies</div>
              <div style="line-height: 1.25;">and/or partnerships</div>
              <div style="line-height: 1.25;">and/or the management company</div>
            </td>
            <td colspan="3" style="width: 17.85%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Name:</div>
              <div style="line-height: 1.25;"><font style="background-color: #FFFF00;">...............</font></div>
            </td>
            <td colspan="3" rowspan="3" style="width: 21.78%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="margin-left: 7pt; line-height: 1.25;">Nature of the transaction:</div>
              <div style="margin-left: 7pt; line-height: 1.25; font-family: 'Times New Roman', serif; font-size: 9pt;">&#9746; <font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;">Real Estate &#9633;Services</font></div>
              <div style="text-indent: 7pt; line-height: 1.25;">&#9744; Products supply</div>
              <div style="text-indent: 7pt; line-height: 1.25;">&#9744; Other:&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
              <div style="text-indent: 7pt; line-height: 1.25;">Insured occupation:</div>
              <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
              <div style="text-align: center; line-height: 1.25;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="line-height: 1.25;">&#160;</font></div>
            </td>
            <td rowspan="3" style="width: 22.34%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="text-indent: 7pt; line-height: 1.25; font-family: 'Times New Roman', serif; font-size: 9pt;">&#9746;<font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;"> Lessor</font></div>
              <div style="text-indent: 7pt; line-height: 1.25;">&#9744; Lessee</div>
              <div style="text-indent: 7pt; line-height: 1.25;">&#9744; Franchisee</div>
              <div style="text-indent: 7pt; line-height: 1.25;">&#9744; Subcontractors</div>
              <div style="text-indent: 7pt; line-height: 1.25;">&#9744; Service procurer</div>
              <div style="text-indent: 7pt; line-height: 1.25;">&#9744; Product procurer</div>
              <div style="text-indent: 7pt; line-height: 1.25;">&#9744; <font style="font-size: 9pt;">Other:</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
            </td>
          </tr>
          <tr>
            <td colspan="3" style="width: 22.81%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">ID/Pvt. Co./Partnership No.:</div>
              <div style="line-height: 1.25;">550014666</div>
              <div style="line-height: 1.25;">520037789</div>
              <div style="line-height: 1.25;">510758329</div>
            </td>
            <td colspan="3" style="width: 14.55%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">ID/Pvt. Co.:</div>
              <div style="line-height: 1.25;"><font style="background-color: #FFFF00;">...............</font></div>
            </td>
          </tr>
          <tr>
            <td colspan="3" style="width: 22.81%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Address:</div>
              <div style="line-height: 1.25;">1 Abba Eban St., Herzliya</div>
            </td>
            <td colspan="3" style="width: 14.55%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Address:</div>
              <div style="line-height: 1.25;"><font style="background-color: #FFFF00;">...............</font></div>
            </td>
          </tr>
          <tr>
            <td colspan="13" style="width: 100%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Covers</div>
            </td>
          </tr>
          <tr>
            <td rowspan="2" style="width: 11.81%; vertical-align: top; background-color: rgb(231, 230, 230); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">Type of policy Division according to limits of liability or insurance amounts</div>
            </td>
            <td rowspan="2" style="width: 8.46%; vertical-align: top; background-color: rgb(231, 230, 230); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">Policy No.</div>
            </td>
            <td colspan="2" rowspan="2" style="width: 9.95%; vertical-align: top; background-color: rgb(231, 230, 230); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">Policy version and edition</div>
            </td>
            <td rowspan="2" style="width: 7.59%; vertical-align: top; background-color: rgb(231, 230, 230); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">Start date</div>
            </td>
            <td colspan="2" rowspan="2" style="width: 6.97%; vertical-align: top; background-color: rgb(231, 230, 230); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">End date</div>
            </td>
            <td colspan="3" style="width: 19.14%; vertical-align: top; background-color: rgb(231, 230, 230); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">Limit of liability for insureds&#8217; entire activity/insurance amount</div>
            </td>
            <td rowspan="2" style="width: 9.39%; vertical-align: top; background-color: rgb(231, 230, 230); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">Deductible (it is not mandatory to display this data)</div>
            </td>
            <td rowspan="2" style="width: 4.34%; vertical-align: top; background-color: rgb(231, 230, 230); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">Currency</div>
            </td>
            <td rowspan="2" style="width: 22.34%; vertical-align: top; background-color: rgb(231, 230, 230); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">Additional covers in force and revocation of exclusions****</div>
            </td>
          </tr>
          <tr>
            <td style="width: 0.21%; vertical-align: top; background-color: rgb(231, 230, 230); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">For the period</div>
            </td>
            <td colspan="2" style="width: 17.79%; vertical-align: top; background-color: rgb(231, 230, 230); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">per event*</div>
            </td>
          </tr>
          <tr>
            <td style="width: 11.81%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Property</div>
            </td>
            <td style="width: 8.46%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td colspan="2" style="width: 9.95%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">.... BIT edition....</div>
            </td>
            <td style="width: 7.59%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td colspan="2" style="width: 6.97%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 11.04%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td colspan="2" style="width: 8.1%; vertical-align: top; background-color: rgb(231, 230, 230); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 9.39%; vertical-align: top; background-color: rgb(231, 230, 230); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 4.34%; vertical-align: top; background-color: rgb(231, 230, 230); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-indent: 17pt; line-height: 1.25;">&#8362;</div>
            </td>
            <td rowspan="3" style="width: 22.34%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25; font-weight: bold;">308-Waiver in favor of other entity- (other lessees, other tenants, rights holders, subject to reciprocity)<br>
                309-Waiver of Subrogation<br>
                313- Natural damage<br>
                314-Burglary, theft and robbery<br>
                316-Earthquake<br>
                328-Priority</div>
            </td>
          </tr>
          <tr>
            <td style="width: 11.81%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 8.46%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td colspan="2" style="width: 9.95%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 7.59%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td colspan="2" style="width: 6.97%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 11.04%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td colspan="2" style="width: 8.1%; vertical-align: top; background-color: rgb(231, 230, 230); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 9.39%; vertical-align: top; background-color: rgb(231, 230, 230); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 4.34%; vertical-align: top; background-color: rgb(231, 230, 230); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
          </tr>
          <tr>
            <td style="width: 11.81%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 8.46%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td colspan="2" style="width: 9.95%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 7.59%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td colspan="2" style="width: 6.97%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 11.04%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td colspan="2" style="width: 8.1%; vertical-align: top; background-color: rgb(231, 230, 230); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 9.39%; vertical-align: top; background-color: rgb(231, 230, 230); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 4.34%; vertical-align: top; background-color: rgb(231, 230, 230); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
          </tr>
          <tr>
            <td style="width: 11.81%; vertical-align: top; background-color: rgb(231, 230, 230); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Third party</div>
            </td>
            <td style="width: 8.46%; vertical-align: top; background-color: rgb(231, 230, 230); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td colspan="2" style="width: 9.95%; vertical-align: top; background-color: rgb(231, 230, 230); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">.... BIT edition....</div>
            </td>
            <td style="width: 7.59%; vertical-align: top; background-color: rgb(231, 230, 230); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td colspan="2" style="width: 6.97%; vertical-align: top; background-color: rgb(231, 230, 230); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 11.04%; vertical-align: top; background-color: rgb(231, 230, 230); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25; color: rgb(255, 0, 0);">(The amount must be entered in accordance with the table set forth in Lessee's permanent insurance specifications)</div>
            </td>
            <td colspan="2" style="width: 8.1%; vertical-align: top; background-color: rgb(231, 230, 230); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 9.39%; vertical-align: top; background-color: rgb(231, 230, 230); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 4.34%; vertical-align: top; background-color: rgb(231, 230, 230); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 22.34%; vertical-align: top; background-color: rgb(231, 230, 230); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', serif; font-size: 9pt;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;">302- Cross Liability</font><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><br>
                </font><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;">304-Expansion of indemnity</font><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;">&#160;<font style="font-weight: bold;">Contractors and</font>&#160;<font style="font-weight: bold;">sub-contractors</font><br>
                  <font style="font-weight: bold;">315- NII claims</font><br>
                  <font style="font-weight: bold;">321- additional insured in respect of</font>&#160;<font style="font-weight: bold;">insured-Certificate Applicant&#8217;s acts or omissions</font><br>
                  <font style="font-weight: bold;">322- Applicant defined as third party</font></font></div>
              <div style="line-height: 1.25; font-weight: bold;">328-Priority</div>
            </td>
          </tr>
          <tr>
            <td style="width: 11.81%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Employer Liability</div>
            </td>
            <td style="width: 8.46%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td colspan="2" style="width: 9.95%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">.... BIT edition....</div>
            </td>
            <td style="width: 7.59%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td colspan="2" style="width: 6.97%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 11.04%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: right; line-height: 1.25;">20,000,000</div>
            </td>
            <td colspan="2" style="width: 8.1%; vertical-align: top; background-color: rgb(231, 230, 230); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 9.39%; vertical-align: top; background-color: rgb(231, 230, 230); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 4.34%; vertical-align: top; background-color: rgb(231, 230, 230); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 22.34%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', serif; font-size: 9pt;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;">309-Waiver of Subrogation</font><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><br>
                </font><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;">319- Deemed as</font><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;">&#160;<font style="font-weight: bold;">the
                    employer of Applicant&#8217;s</font>&#160;<font style="font-weight: bold;">employees</font><br>
                  <font style="font-weight: bold;">328-Priority</font></font></div>
            </td>
          </tr>
          <tr>
            <td style="width: 11.81%; vertical-align: top; background-color: rgb(231, 230, 230); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Consequential loss</div>
            </td>
            <td style="width: 8.46%; vertical-align: top; background-color: rgb(231, 230, 230); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td colspan="2" style="width: 9.95%; vertical-align: top; background-color: rgb(231, 230, 230); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">.... BIT edition....</div>
            </td>
            <td style="width: 7.59%; vertical-align: top; background-color: rgb(231, 230, 230); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td colspan="2" style="width: 6.97%; vertical-align: top; background-color: rgb(231, 230, 230); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 11.04%; vertical-align: top; background-color: rgb(231, 230, 230); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td colspan="2" style="width: 8.1%; vertical-align: top; background-color: rgb(231, 230, 230); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 9.39%; vertical-align: top; background-color: rgb(231, 230, 230); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 4.34%; vertical-align: top; background-color: rgb(231, 230, 230); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 22.34%; vertical-align: top; background-color: rgb(231, 230, 230); border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="line-height: 1.25; font-weight: bold;">308-Waiver in favor of other entity- (other lessees, other tenants, rights holders, subject to reciprocity)<br>
                309-Waiver of subrogation in favor of Applicant<br>
                313- Natural damage<br>
                316-Earthquake<br>
                328-Priority</div>
            </td>
          </tr>

      </table>
      <div class="BRPFPageFooter">
        <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
        </div>
      </div>
      <table cellspacing="0" cellpadding="2" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z26dd21e7f5d94acc80ef680d35656b0c">

          <tr>
            <td colspan="10" style="width: 100%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; line-height: 1.25;">Covers</div>
            </td>
          </tr>
          <tr>
            <td style="width: 11.94%; vertical-align: top; background-color: rgb(231, 230, 230); font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 8.47%; vertical-align: top; background-color: rgb(231, 230, 230); font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 9.97%; vertical-align: top; background-color: rgb(231, 230, 230); font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 7.9%; vertical-align: top; background-color: rgb(231, 230, 230); font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 6.92%; vertical-align: top; background-color: rgb(231, 230, 230); font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 10.85%; vertical-align: top; background-color: rgb(231, 230, 230); font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 8.27%; vertical-align: top; background-color: rgb(231, 230, 230); font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 9.1%; vertical-align: top; background-color: rgb(231, 230, 230); font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 6.41%; vertical-align: top; background-color: rgb(231, 230, 230); font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 20.16%; vertical-align: top; background-color: rgb(231, 230, 230); font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25; font-weight: bold;">335- Indemnity standards &#8211; 24 months</div>
            </td>
          </tr>
          <tr>
            <td colspan="10" style="width: 100%; vertical-align: bottom; background-color: rgb(231, 230, 230); font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; line-height: 1.25;">Details of the services (subject to the services specified in the agreement between the insured and the Applicant, the service code must be indicated from the closed list set forth in
                Appendix C as published by the Capital Market, Insurance and Savings Authority. The text displayed next to the code can also be displayed in the closed list)*:</div>
            </td>
          </tr>
          <tr>
            <td colspan="10" style="width: 100%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">096- Rentals and Leases</div>
            </td>
          </tr>
          <tr>
            <td colspan="10" style="width: 100%; vertical-align: top; background-color: rgb(231, 230, 230); font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Revocation/change of policy*</div>
            </td>
          </tr>
          <tr>
            <td colspan="10" style="width: 100%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; line-height: 1.25;">A change to the detriment of Applicant or revocation of an insurance policy will only take effect 60 days following the dispatch of a notice to Applicant regarding the change or revocation.</div>
            </td>
          </tr>
          <tr>
            <td colspan="10" style="width: 100%; vertical-align: top; background-color: rgb(231, 230, 230); font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; line-height: 1.25;">Signing of Certificate</div>
            </td>
          </tr>
          <tr>
            <td colspan="10" style="width: 100%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="text-align: justify; line-height: 1.25;">Insurer:</div>
            </td>
          </tr>

      </table>
      <div class="BRPFPageFooter">
        <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
        </div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageNumberArea"><font class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">18</font></div>
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
      </div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u>Appendix C - Services Appendix</u></div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <table cellspacing="0" cellpadding="2" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zfa026a2701b2446e9737bc9465a39e43">

          <tr>
            <td style="width: 41.69%; vertical-align: top; background-color: rgb(231, 230, 230); font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">Description of the service subject of the Contract</div>
            </td>
            <td style="width: 8.31%; vertical-align: top; background-color: rgb(231, 230, 230); font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">Service Code</div>
            </td>
            <td style="width: 41.59%; vertical-align: top; background-color: rgb(231, 230, 230); font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">Description of the service subject of the Contract</div>
            </td>
            <td style="width: 8.41%; vertical-align: top; background-color: rgb(231, 230, 230); font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">Service Code</div>
            </td>
          </tr>
          <tr>
            <td style="width: 41.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Security</div>
            </td>
            <td style="width: 8.31%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">001</div>
            </td>
            <td style="width: 41.59%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Pharmacy</div>
            </td>
            <td style="width: 8.41%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">071</div>
            </td>
          </tr>
          <tr>
            <td style="width: 41.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Storage/ warehouses (including bonded warehouses and refrigeration)</div>
            </td>
            <td style="width: 8.31%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">002</div>
            </td>
            <td style="width: 41.59%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Vehicle/Garages/Parking/Shuttle</div>
            </td>
            <td style="width: 8.41%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">072</div>
            </td>
          </tr>
          <tr>
            <td style="width: 41.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Gas and Fuel Supply</div>
            </td>
            <td style="width: 8.31%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">003</div>
            </td>
            <td style="width: 41.59%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Complementary medicine</div>
            </td>
            <td style="width: 8.41%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">073</div>
            </td>
          </tr>
          <tr>
            <td style="width: 41.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Garbage and recycling services</div>
            </td>
            <td style="width: 8.31%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">004</div>
            </td>
            <td style="width: 41.59%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Renovations</div>
            </td>
            <td style="width: 8.41%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">074</div>
            </td>
          </tr>
          <tr>
            <td style="width: 41.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Laboratory tests and samples</div>
            </td>
            <td style="width: 8.31%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">005</div>
            </td>
            <td style="width: 41.59%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">National Service</div>
            </td>
            <td style="width: 8.41%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">075</div>
            </td>
          </tr>
          <tr>
            <td style="width: 41.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Clothing/ Textiles/ Fashion</div>
            </td>
            <td style="width: 8.31%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">006</div>
            </td>
            <td style="width: 41.59%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Hospitality services, conferences, advanced education, leisure and hoteliery</div>
            </td>
            <td style="width: 8.41%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">076</div>
            </td>
          </tr>
          <tr>
            <td style="width: 41.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Auditing, accounting and taxation</div>
            </td>
            <td style="width: 8.31%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">007</div>
            </td>
            <td style="width: 41.59%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Audit services</div>
            </td>
            <td style="width: 8.41%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">077</div>
            </td>
          </tr>
          <tr>
            <td style="width: 41.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Slaughterhouse/ Butchers</div>
            </td>
            <td style="width: 8.31%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">008</div>
            </td>
            <td style="width: 41.59%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Archive Services</div>
            </td>
            <td style="width: 8.41%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">078</div>
            </td>
          </tr>
          <tr>
            <td style="width: 41.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Construction - large contract works</div>
            </td>
            <td style="width: 8.31%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">009</div>
            </td>
            <td style="width: 41.59%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Religious Services</div>
            </td>
            <td style="width: 8.41%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">079</div>
            </td>
          </tr>
          <tr>
            <td style="width: 41.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Animals</div>
            </td>
            <td style="width: 8.31%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">010</div>
            </td>
            <td style="width: 41.59%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Laboratory/Repair/Installation/Parts Services</div>
            </td>
            <td style="width: 8.41%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">080</div>
            </td>
          </tr>
          <tr>
            <td style="width: 41.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Control, audit of standards and appraisals</div>
            </td>
            <td style="width: 8.31%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">011</div>
            </td>
            <td style="width: 41.59%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Office Services</div>
            </td>
            <td style="width: 8.41%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">081</div>
            </td>
          </tr>
          <tr>
            <td style="width: 41.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Supervision of educational institutions</div>
            </td>
            <td style="width: 8.31%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">012</div>
            </td>
            <td style="width: 41.59%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Management services</div>
            </td>
            <td style="width: 8.41%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">082</div>
            </td>
          </tr>
          <tr>
            <td style="width: 41.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Mental Health</div>
            </td>
            <td style="width: 8.31%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">013</div>
            </td>
            <td style="width: 41.59%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Monitoring services</div>
            </td>
            <td style="width: 8.41%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">083</div>
            </td>
          </tr>
          <tr>
            <td style="width: 41.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Pool/amusement park and water/ attractions</div>
            </td>
            <td style="width: 8.31%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">014</div>
            </td>
            <td style="width: 41.59%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Supervision and control services</div>
            </td>
            <td style="width: 8.41%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">084</div>
            </td>
          </tr>
          <tr>
            <td style="width: 41.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Retirement homes and dormitories</div>
            </td>
            <td style="width: 8.31%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">015</div>
            </td>
            <td style="width: 41.59%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; margin-left: 185pt; line-height: 1.25;">-</div>
            </td>
            <td style="width: 8.41%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">085</div>
            </td>
          </tr>
          <tr>
            <td style="width: 41.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Collections and Finance</div>
            </td>
            <td style="width: 8.31%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">016</div>
            </td>
            <td style="width: 41.59%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Supervision, planning and control services</div>
            </td>
            <td style="width: 8.41%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">086</div>
            </td>
          </tr>
          <tr>
            <td style="width: 41.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Gardening, pruning and vegetation</div>
            </td>
            <td style="width: 8.31%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">017</div>
            </td>
            <td style="width: 41.59%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Cosmetics services</div>
            </td>
            <td style="width: 8.41%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">087</div>
            </td>
          </tr>
          <tr>
            <td style="width: 41.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Valuables/ Collectibles/ Art</div>
            </td>
            <td style="width: 8.31%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">018</div>
            </td>
            <td style="width: 41.59%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Maintenance and operation services</div>
            </td>
            <td style="width: 8.41%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">088</div>
            </td>
          </tr>
          <tr>
            <td style="width: 41.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Printing, Graphic Design and Arts</div>
            </td>
            <td style="width: 8.31%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">019</div>
            </td>
            <td style="width: 41.59%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; margin-left: 185pt; line-height: 1.25;">-</div>
            </td>
            <td style="width: 8.41%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">089</div>
            </td>
          </tr>
          <tr>
            <td style="width: 41.69%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Special Requirements/Special Needs</div>
            </td>
            <td style="width: 8.31%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">020</div>
            </td>
            <td style="width: 41.59%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Air/maritime services</div>
            </td>
            <td style="width: 8.41%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">090</div>
            </td>
          </tr>
          <tr>
            <td style="width: 41.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Tutorials/ Courses/ Workshops</div>
            </td>
            <td style="width: 8.31%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">021</div>
            </td>
            <td style="width: 41.59%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Services abroad</div>
            </td>
            <td style="width: 8.41%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">091</div>
            </td>
          </tr>
          <tr>
            <td style="width: 41.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Transportation and distribution</div>
            </td>
            <td style="width: 8.31%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">022</div>
            </td>
            <td style="width: 41.59%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Services to the public (including: public bodies, non-profit organizations and community interest company)</div>
            </td>
            <td style="width: 8.41%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">092</div>
            </td>
          </tr>
          <tr>
            <td style="width: 41.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Concerts/ Cinema/Entertainment Services</div>
            </td>
            <td style="width: 8.31%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">023</div>
            </td>
            <td style="width: 41.59%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Legal services</div>
            </td>
            <td style="width: 8.41%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">093</div>
            </td>
          </tr>
          <tr>
            <td style="width: 41.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Preparation of tenders procedures and guidelines</div>
            </td>
            <td style="width: 8.31%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">024</div>
            </td>
            <td style="width: 41.59%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Paramedical services</div>
            </td>
            <td style="width: 8.41%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">094</div>
            </td>
          </tr>
          <tr>
            <td style="width: 41.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Passenger transportation</div>
            </td>
            <td style="width: 8.31%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">025</div>
            </td>
            <td style="width: 41.59%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Medical services</div>
            </td>
            <td style="width: 8.41%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">095</div>
            </td>
          </tr>
          <tr>
            <td style="width: 41.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Event production/banquet halls</div>
            </td>
            <td style="width: 8.31%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">026</div>
            </td>
            <td style="width: 41.59%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Rentals and Leases</div>
            </td>
            <td style="width: 8.41%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">096</div>
            </td>
          </tr>
          <tr>
            <td style="width: 41.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Ruins/Evacuations</div>
            </td>
            <td style="width: 8.31%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">027</div>
            </td>
            <td style="width: 41.59%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; line-height: 1.25;">Water corporations/wastewater treatment plant</div>
            </td>
            <td style="width: 8.41%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">097</div>
            </td>
          </tr>
          <tr>
            <td style="width: 41.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Investments and entrepreneurship</div>
            </td>
            <td style="width: 8.31%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">028</div>
            </td>
            <td style="width: 41.59%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Maintenance of equipment and electrical and communication networks</div>
            </td>
            <td style="width: 8.41%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">098</div>
            </td>
          </tr>
          <tr>
            <td style="width: 41.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Installation and upgrading of systems and building attachments</div>
            </td>
            <td style="width: 8.31%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">029</div>
            </td>
            <td style="width: 41.59%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Jewelry/ Gems</div>
            </td>
            <td style="width: 8.41%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">099</div>
            </td>
          </tr>
          <tr>
            <td style="width: 41.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Management Companies</div>
            </td>
            <td style="width: 8.31%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">030</div>
            </td>
            <td style="width: 41.59%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Equipment Operations</div>
            </td>
            <td style="width: 8.41%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">100</div>
            </td>
          </tr>
          <tr>
            <td style="width: 41.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Gym/ Exercise</div>
            </td>
            <td style="width: 8.31%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">031</div>
            </td>
            <td style="width: 41.59%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Communications and cellular companies</div>
            </td>
            <td style="width: 8.41%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">101</div>
            </td>
          </tr>
          <tr>
            <td style="width: 41.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;"><strike>Gyms &amp; Sports</strike></div>
            </td>
            <td style="width: 8.31%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">032</div>
            </td>
            <td style="width: 41.59%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Amplification/Lighting Services</div>
            </td>
            <td style="width: 8.41%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">102</div>
            </td>
          </tr>
          <tr>
            <td style="width: 41.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Hazardous Materials and Chemicals - Waste, Disposal and Transportation</div>
            </td>
            <td style="width: 8.31%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">033</div>
            </td>
            <td style="width: 41.59%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Hardware and/or software services</div>
            </td>
            <td style="width: 8.41%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">103</div>
            </td>
          </tr>
          <tr>
            <td style="width: 41.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Education/Courses/Workshops</div>
            </td>
            <td style="width: 8.31%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">034</div>
            </td>
            <td style="width: 41.59%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Marketing, advertising and media services</div>
            </td>
            <td style="width: 8.41%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">104</div>
            </td>
          </tr>
          <tr>
            <td style="width: 41.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Investigations</div>
            </td>
            <td style="width: 8.31%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">035</div>
            </td>
            <td style="width: 41.59%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Tama/Conservation/Maintenance/Construction Contractor</div>
            </td>
            <td style="width: 8.41%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">105</div>
            </td>
          </tr>
          <tr>
            <td style="width: 41.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Agriculture - flora/fauna</div>
            </td>
            <td style="width: 8.31%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">036</div>
            </td>
            <td style="width: 41.59%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Mine/Quarry</div>
            </td>
            <td style="width: 8.41%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">106</div>
            </td>
          </tr>
          <tr>
            <td style="width: 41.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Flights</div>
            </td>
            <td style="width: 8.31%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">037</div>
            </td>
            <td style="width: 41.59%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Shooting Range</div>
            </td>
            <td style="width: 8.41%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">107</div>
            </td>
          </tr>
          <tr>
            <td style="width: 41.69%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Consultants/planners</div>
            </td>
            <td style="width: 8.31%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">038</div>
            </td>
            <td style="width: 41.59%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Construction services) a domain name must be specified under the item "Insured occupation")</div>
            </td>
            <td style="width: 8.41%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">108</div>
            </td>
          </tr>
          <tr>
            <td style="width: 41.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Personnel</div>
            </td>
            <td style="width: 8.31%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">039</div>
            </td>
            <td style="width: 41.59%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Pest control services</div>
            </td>
            <td style="width: 8.41%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">109</div>
            </td>
          </tr>
          <tr>
            <td style="width: 41.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Engineer, Architect, Technician</div>
            </td>
            <td style="width: 8.31%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">040</div>
            </td>
            <td style="width: 41.59%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Courier services</div>
            </td>
            <td style="width: 8.41%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">110</div>
            </td>
          </tr>
          <tr>
            <td style="width: 41.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Food/ Catering/Dining Services</div>
            </td>
            <td style="width: 8.31%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">041</div>
            </td>
            <td style="width: 41.59%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 8.41%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">111</div>
            </td>
          </tr>
          <tr>
            <td style="width: 41.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Research and surveys</div>
            </td>
            <td style="width: 8.31%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">042</div>
            </td>
            <td style="width: 41.59%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 8.41%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">112</div>
            </td>
          </tr>
          <tr>
            <td style="width: 41.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Computing</div>
            </td>
            <td style="width: 8.31%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">043</div>
            </td>
            <td style="width: 41.59%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 8.41%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">113</div>
            </td>
          </tr>
          <tr>
            <td style="width: 41.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Information</div>
            </td>
            <td style="width: 8.31%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">044</div>
            </td>
            <td style="width: 41.59%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 8.41%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">114</div>
            </td>
          </tr>
          <tr>
            <td style="width: 41.69%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Mapping</div>
            </td>
            <td style="width: 8.31%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">045</div>
            </td>
            <td style="width: 41.59%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 8.41%; vertical-align: bottom; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; text-align: center;">
              <div style="line-height: 1.25;">115</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea"><font class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">19</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <table cellspacing="0" cellpadding="2" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zfd56f4c6141b47d989e334f4a29286bb">

          <tr>
            <td style="width: 41.69%; vertical-align: top; background-color: rgb(231, 230, 230); font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">Description of the service subject of the Contract</div>
            </td>
            <td style="width: 8.31%; vertical-align: top; background-color: rgb(231, 230, 230); font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">Service Code</div>
            </td>
            <td style="width: 41.59%; vertical-align: top; background-color: rgb(231, 230, 230); font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">Description of the service subject of the Contract</div>
            </td>
            <td style="width: 8.41%; vertical-align: top; background-color: rgb(231, 230, 230); font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">Service Code</div>
            </td>
          </tr>
          <tr>
            <td style="width: 41.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Sale/acquisition/hiring of equipment (under "Insured Occupation", please specify a domain name)</div>
            </td>
            <td style="width: 8.31%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">046</div>
            </td>
            <td style="width: 41.59%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 8.41%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">116</div>
            </td>
          </tr>
          <tr>
            <td style="width: 41.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Safety officers and consultants</div>
            </td>
            <td style="width: 8.31%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">047</div>
            </td>
            <td style="width: 41.59%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 8.41%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">117</div>
            </td>
          </tr>
          <tr>
            <td style="width: 41.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Elevators - Maintenance/ Service/ Spare Parts</div>
            </td>
            <td style="width: 8.31%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">048</div>
            </td>
            <td style="width: 41.59%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 8.41%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">118</div>
            </td>
          </tr>
          <tr>
            <td style="width: 41.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Monitoring and control systems</div>
            </td>
            <td style="width: 8.31%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">049</div>
            </td>
            <td style="width: 41.59%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 8.41%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">119</div>
            </td>
          </tr>
          <tr>
            <td style="width: 41.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Fire detection and extinguishing systems</div>
            </td>
            <td style="width: 8.31%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">050</div>
            </td>
            <td style="width: 41.59%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 8.41%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">120</div>
            </td>
          </tr>
          <tr>
            <td style="width: 41.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Irrigation and water conduction systems</div>
            </td>
            <td style="width: 8.31%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">051</div>
            </td>
            <td style="width: 41.59%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 8.41%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">121</div>
            </td>
          </tr>
          <tr>
            <td style="width: 41.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">PV systems</div>
            </td>
            <td style="width: 8.31%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">052</div>
            </td>
            <td style="width: 41.59%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 8.41%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">122</div>
            </td>
          </tr>
          <tr>
            <td style="width: 41.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Manufacturing plant (under "Insured Occupation", please specify a domain name)</div>
            </td>
            <td style="width: 8.31%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">053</div>
            </td>
            <td style="width: 41.59%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 8.41%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">123</div>
            </td>
          </tr>
          <tr>
            <td style="width: 41.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Real Estate / Investments and Entrepreneurship</div>
            </td>
            <td style="width: 8.31%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">054</div>
            </td>
            <td style="width: 41.59%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 8.41%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">124</div>
            </td>
          </tr>
          <tr>
            <td style="width: 41.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Vacation and excursions (including guides)/summer camps/children&#8217;s activities</div>
            </td>
            <td style="width: 8.31%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">055</div>
            </td>
            <td style="width: 41.59%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 8.41%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">125</div>
            </td>
          </tr>
          <tr>
            <td style="width: 41.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Building Management</div>
            </td>
            <td style="width: 8.31%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">056</div>
            </td>
            <td style="width: 41.59%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 8.41%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">126</div>
            </td>
          </tr>
          <tr>
            <td style="width: 41.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Cleaning Services</div>
            </td>
            <td style="width: 8.31%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">057</div>
            </td>
            <td style="width: 41.59%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 8.41%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">127</div>
            </td>
          </tr>
          <tr>
            <td style="width: 41.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Weapons &amp; Explosives</div>
            </td>
            <td style="width: 8.31%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">058</div>
            </td>
            <td style="width: 41.59%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 8.41%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">128</div>
            </td>
          </tr>
          <tr>
            <td style="width: 41.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Sprinklers</div>
            </td>
            <td style="width: 8.31%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">059</div>
            </td>
            <td style="width: 41.59%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 8.41%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">129</div>
            </td>
          </tr>
          <tr>
            <td style="width: 41.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Metalwork</div>
            </td>
            <td style="width: 8.31%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">060</div>
            </td>
            <td style="width: 41.59%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 8.41%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">130</div>
            </td>
          </tr>
          <tr>
            <td style="width: 41.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Woodwork</div>
            </td>
            <td style="width: 8.31%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">061</div>
            </td>
            <td style="width: 41.59%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 8.41%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">131</div>
            </td>
          </tr>
          <tr>
            <td style="width: 41.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Maintenance and renovation work (electricity/sealing/plumbing)</div>
            </td>
            <td style="width: 8.31%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">062</div>
            </td>
            <td style="width: 41.59%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 8.41%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">132</div>
            </td>
          </tr>
          <tr>
            <td style="width: 41.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Plastic</div>
            </td>
            <td style="width: 8.31%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">063</div>
            </td>
            <td style="width: 41.59%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 8.41%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">133</div>
            </td>
          </tr>
          <tr>
            <td style="width: 41.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Operations abroad</div>
            </td>
            <td style="width: 8.31%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">064</div>
            </td>
            <td style="width: 41.59%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 8.41%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">134</div>
            </td>
          </tr>
          <tr>
            <td style="width: 41.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Lighting and amplification equipment</div>
            </td>
            <td style="width: 8.31%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">065</div>
            </td>
            <td style="width: 41.59%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 8.41%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">135</div>
            </td>
          </tr>
          <tr>
            <td style="width: 41.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Photography/Radio/TV Broadcasting</div>
            </td>
            <td style="width: 8.31%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">066</div>
            </td>
            <td style="width: 41.59%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 8.41%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">136</div>
            </td>
          </tr>
          <tr>
            <td style="width: 41.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Heavy equipment</div>
            </td>
            <td style="width: 8.31%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">067</div>
            </td>
            <td style="width: 41.59%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 8.41%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">137</div>
            </td>
          </tr>
          <tr>
            <td style="width: 41.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Piping and laying water and sewage lines</div>
            </td>
            <td style="width: 8.31%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">068</div>
            </td>
            <td style="width: 41.59%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 8.41%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">138</div>
            </td>
          </tr>
          <tr>
            <td style="width: 41.69%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Civilian Works Contractor (including infrastructures)</div>
            </td>
            <td style="width: 8.31%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">069</div>
            </td>
            <td style="width: 41.59%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 8.41%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">139</div>
            </td>
          </tr>
          <tr>
            <td style="width: 41.69%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Retail (under "Insured Occupation", please specify a domain name)</div>
            </td>
            <td style="width: 8.31%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">070</div>
            </td>
            <td style="width: 41.59%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 8.41%; vertical-align: bottom; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; text-align: center;">
              <div style="line-height: 1.25;">140</div>
            </td>
          </tr>

      </table>
      <div class="BRPFPageFooter">
        <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
        </div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageNumberArea"><font class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">20</font></div>
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
      </div>
      <div style="font-family: 'Times New Roman',Times,serif;" class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br>
        </div>
      </div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u>Appendix D - Additional coverages valid and cancellation of exceptions</u></div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <table cellspacing="0" cellpadding="2" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zdae79a7f89b44191ace7b7d17b73bd72">

          <tr>
            <td style="width: 44.89%; vertical-align: top; background-color: rgb(231, 230, 230); font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-right: 6.55pt; line-height: 1.25;">Additional covers in force</div>
            </td>
            <td style="width: 6.5%; vertical-align: top; background-color: rgb(231, 230, 230); font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">Section code</div>
            </td>
            <td style="width: 40.68%; vertical-align: top; background-color: rgb(231, 230, 230); font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">Additional covers in force</div>
            </td>
            <td style="width: 7.93%; vertical-align: top; background-color: rgb(231, 230, 230); font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">Section code</div>
            </td>
          </tr>
          <tr>
            <td style="width: 44.89%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; margin-right: 6.55pt; line-height: 1.25;">Loss of documents</div>
            </td>
            <td style="width: 6.5%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">301</div>
            </td>
            <td style="width: 40.68%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 7.93%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">371</div>
            </td>
          </tr>
          <tr>
            <td style="width: 44.89%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; margin-right: 6.55pt; line-height: 1.25;">Cross-liability (with the exception of Applicant&#8217;s professional liability)</div>
            </td>
            <td style="width: 6.5%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">302</div>
            </td>
            <td style="width: 40.68%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 7.93%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">372</div>
            </td>
          </tr>
          <tr>
            <td style="width: 44.89%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; margin-right: 6.55pt; line-height: 1.25;">Libel, defamation and slander under professional liability coverage</div>
            </td>
            <td style="width: 6.5%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">303</div>
            </td>
            <td style="width: 40.68%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 7.93%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">373</div>
            </td>
          </tr>
          <tr>
            <td style="width: 44.89%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; margin-right: 6.55pt; line-height: 1.25;">Extension of indemnification for insured acts and omissions/products/works/activities</div>
            </td>
            <td style="width: 6.5%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">304</div>
            </td>
            <td style="width: 40.68%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 7.93%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">374</div>
            </td>
          </tr>
          <tr>
            <td style="width: 44.89%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; margin-right: 6.55pt; line-height: 1.25;">Third party extension or professional liability or employers' liability (depending on the basic coverage to which the code belongs) - legally held firearm</div>
            </td>
            <td style="width: 6.5%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">305</div>
            </td>
            <td style="width: 40.68%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 7.93%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">375</div>
            </td>
          </tr>
          <tr>
            <td style="width: 44.89%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; margin-right: 6.55pt; line-height: 1.25;">Third party extension - damage while temporarily abroad</div>
            </td>
            <td style="width: 6.5%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">306</div>
            </td>
            <td style="width: 40.68%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 7.93%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">376</div>
            </td>
          </tr>
          <tr>
            <td style="width: 44.89%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; margin-right: 6.55pt; line-height: 1.25;">Third Party extension - Liability towards a third party as part of the coverage covered by the policy in respect of contractors and subcontractors</div>
            </td>
            <td style="width: 6.5%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">307</div>
            </td>
            <td style="width: 40.68%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 7.93%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">377</div>
            </td>
          </tr>
          <tr>
            <td style="width: 44.89%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; margin-right: 6.55pt; line-height: 1.25;">Waiver of subrogation in favor of another entity (the details of the entity must be specified by name and address/Pvt. Co. No./ID number/characteristic group),
                excluding those who caused the damage maliciously.</div>
            </td>
            <td style="width: 6.5%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">308</div>
            </td>
            <td style="width: 40.68%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 7.93%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">378</div>
            </td>
          </tr>
          <tr>
            <td style="width: 44.89%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; margin-right: 6.55pt; line-height: 1.25;">Waiver of subrogation in favor of Applicant, excluding those who caused the damage maliciously.</div>
            </td>
            <td style="width: 6.5%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">309</div>
            </td>
            <td style="width: 40.68%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 7.93%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">379</div>
            </td>
          </tr>
          <tr>
            <td style="width: 44.89%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; margin-right: 6.55pt; line-height: 1.25;">Coverage for distributors under product liability</div>
            </td>
            <td style="width: 6.5%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">310</div>
            </td>
            <td style="width: 40.68%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 7.93%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">380</div>
            </td>
          </tr>
          <tr>
            <td style="width: 44.89%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; margin-right: 6.55pt; line-height: 1.25;">Consequential loss coverage for Applicant in respect of property damage</div>
            </td>
            <td style="width: 6.5%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">311</div>
            </td>
            <td style="width: 40.68%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 7.93%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">381</div>
            </td>
          </tr>
          <tr>
            <td style="width: 44.89%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; margin-right: 6.55pt; line-height: 1.25;">Coverage for bodily injury caused by the use of heavy equipment</div>
            </td>
            <td style="width: 6.5%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">312</div>
            </td>
            <td style="width: 40.68%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 7.93%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">382</div>
            </td>
          </tr>
          <tr>
            <td style="width: 44.89%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; margin-right: 6.55pt; line-height: 1.25;">Natural damage coverage</div>
            </td>
            <td style="width: 6.5%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">313</div>
            </td>
            <td style="width: 40.68%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 7.93%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">383</div>
            </td>
          </tr>
          <tr>
            <td style="width: 44.89%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; margin-right: 6.55pt; line-height: 1.25;">Theft, burglary and robbery cover</div>
            </td>
            <td style="width: 6.5%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">314</div>
            </td>
            <td style="width: 40.68%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 7.93%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">384</div>
            </td>
          </tr>
          <tr>
            <td style="width: 44.89%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; margin-right: 6.55pt; line-height: 1.25;">Coverage for NII claims</div>
            </td>
            <td style="width: 6.5%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">315</div>
            </td>
            <td style="width: 40.68%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 7.93%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">385</div>
            </td>
          </tr>
          <tr>
            <td style="width: 44.89%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; margin-right: 6.55pt; line-height: 1.25;">Earthquake coverage</div>
            </td>
            <td style="width: 6.5%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">316</div>
            </td>
            <td style="width: 40.68%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 7.93%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">386</div>
            </td>
          </tr>
          <tr>
            <td style="width: 44.89%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; margin-right: 6.55pt; line-height: 1.25;">Additional policyholder - other) The details of the entity must be specified by name and address/ Pvt. Co. No./ID number/characteristic group),</div>
            </td>
            <td style="width: 6.5%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">317</div>
            </td>
            <td style="width: 40.68%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 7.93%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">387</div>
            </td>
          </tr>
          <tr>
            <td style="width: 44.89%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; margin-right: 6.55pt; line-height: 1.25;">Additional Insured - Applicant</div>
            </td>
            <td style="width: 6.5%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">318</div>
            </td>
            <td style="width: 40.68%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 7.93%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">388</div>
            </td>
          </tr>
          <tr>
            <td style="width: 44.89%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; margin-right: 6.55pt; line-height: 1.25;">Additional insured - if it is deemed the employer of any of insured's employees</div>
            </td>
            <td style="width: 6.5%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">319</div>
            </td>
            <td style="width: 40.68%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 7.93%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">389</div>
            </td>
          </tr>
          <tr>
            <td style="width: 44.89%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; margin-right: 6.55pt; line-height: 1.25;">Additional insured in respect of acts or omissions of insured - other (details of the entity must be specified by name and address/ Pvt. Co. No./ID
                number/characteristic group),</div>
            </td>
            <td style="width: 6.5%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">320</div>
            </td>
            <td style="width: 40.68%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 7.93%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">390</div>
            </td>
          </tr>
          <tr>
            <td style="width: 44.89%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; margin-right: 6.55pt; line-height: 1.25;">Additional insured for acts or omissions of the insured - Applicant</div>
            </td>
            <td style="width: 6.5%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">321</div>
            </td>
            <td style="width: 40.68%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 7.93%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">391</div>
            </td>
          </tr>
          <tr>
            <td style="width: 44.89%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; margin-right: 6.55pt; line-height: 1.25;">Applicant defined as third party in this chapter</div>
            </td>
            <td style="width: 6.5%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">322</div>
            </td>
            <td style="width: 40.68%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 7.93%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">392</div>
            </td>
          </tr>
          <tr>
            <td style="width: 44.89%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="margin-right: 6.55pt; line-height: 1.25;">Beneficiary for insurance benefits - other) specify the beneficiary&#8216;s partciulars)</div>
            </td>
            <td style="width: 6.5%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">323</div>
            </td>
            <td style="width: 40.68%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 7.93%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">393</div>
            </td>
          </tr>
          <tr>
            <td style="width: 44.89%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="margin-right: 6.55pt; line-height: 1.25;">Beneficiary for insurance benefits - Applicant</div>
            </td>
            <td style="width: 6.5%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">324</div>
            </td>
            <td style="width: 40.68%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 7.93%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">394</div>
            </td>
          </tr>
          <tr>
            <td style="width: 44.89%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="margin-right: 6.55pt; line-height: 1.25;">Employee misconduct and deceit</div>
            </td>
            <td style="width: 6.5%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">325</div>
            </td>
            <td style="width: 40.68%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 7.93%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">395</div>
            </td>
          </tr>
          <tr>
            <td style="width: 44.89%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; margin-right: 6.55pt; line-height: 1.25;">Infringement of privacy within the framework of professional liability coverage</div>
            </td>
            <td style="width: 6.5%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">326</div>
            </td>
            <td style="width: 40.68%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 7.93%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">396</div>
            </td>
          </tr>
          <tr>
            <td style="width: 44.89%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; margin-right: 6.55pt; line-height: 1.25;">Delay/deferment due to insurance event</div>
            </td>
            <td style="width: 6.5%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">327</div>
            </td>
            <td style="width: 40.68%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 7.93%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">397</div>
            </td>
          </tr>
          <tr>
            <td style="width: 44.89%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; margin-right: 6.55pt; line-height: 1.25;">Priority (The insurer waives any demand or claim by any of Applicant&#8216;s insurers)</div>
            </td>
            <td style="width: 6.5%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">328</div>
            </td>
            <td style="width: 40.68%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 7.93%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">398</div>
            </td>
          </tr>
          <tr>
            <td style="width: 44.89%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; margin-right: 6.55pt; line-height: 1.25;">The property of the Applicant shall be deemed third party (except for damage caused to the insured property or that could have been insured under the property
                chapter).</div>
            </td>
            <td style="width: 6.5%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">329</div>
            </td>
            <td style="width: 40.68%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 7.93%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">399</div>
            </td>
          </tr>
          <tr>
            <td style="width: 44.89%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; margin-right: 6.55pt; line-height: 1.25;">Lien in favor of another entity (specify the particulars of said entity)</div>
            </td>
            <td style="width: 6.5%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">330</div>
            </td>
            <td style="width: 40.68%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 7.93%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">400</div>
            </td>
          </tr>
          <tr>
            <td style="width: 44.89%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; margin-right: 6.55pt; line-height: 1.25;">Lien in favor of Applicant</div>
            </td>
            <td style="width: 6.5%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">331</div>
            </td>
            <td style="width: 40.68%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 7.93%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">401</div>
            </td>
          </tr>
          <tr>
            <td style="width: 44.89%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; margin-right: 6.55pt; line-height: 1.25;">Disclosure period (specify number of months)</div>
            </td>
            <td style="width: 6.5%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">332</div>
            </td>
            <td style="width: 40.68%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 7.93%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">402</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea"><font class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">21</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div>
        <table cellspacing="0" cellpadding="2" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 44.89%; vertical-align: top; background-color: rgb(231, 230, 230); font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="text-align: center; margin-right: 6.55pt; line-height: 1.25;">Additional covers in force</div>
              </td>
              <td style="width: 6.5%; vertical-align: top; background-color: rgb(231, 230, 230); font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="text-align: center; line-height: 1.25;">Section code</div>
              </td>
              <td style="width: 40.68%; vertical-align: top; background-color: rgb(231, 230, 230); font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="text-align: center; line-height: 1.25;">Additional covers in force</div>
              </td>
              <td style="width: 7.93%; vertical-align: top; background-color: rgb(231, 230, 230); font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
                <div style="text-align: center; line-height: 1.25;">Section code</div>
              </td>
            </tr>

        </table>
      </div>
      <table cellspacing="0" cellpadding="2" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 44.89%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; margin-right: 6.55pt; line-height: 1.25;">Limit of liability in coverage in favor of the contract with the Applicant only.</div>
            </td>
            <td style="width: 6.5%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">333</div>
            </td>
            <td style="width: 40.68%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 7.93%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">403</div>
            </td>
          </tr>
          <tr>
            <td style="width: 44.89%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; margin-right: 6.55pt; line-height: 1.25;">Maintenance period (specify number of months) as part of contractor works policy</div>
            </td>
            <td style="width: 6.5%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">334</div>
            </td>
            <td style="width: 40.68%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 7.93%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">404</div>
            </td>
          </tr>
          <tr>
            <td style="width: 44.89%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; margin-right: 6.55pt; line-height: 1.25;">Indemnity period (specify number of months)</div>
            </td>
            <td style="width: 6.5%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">335</div>
            </td>
            <td style="width: 40.68%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 7.93%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">405</div>
            </td>
          </tr>
          <tr>
            <td style="width: 44.89%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; margin-right: 6.55pt; line-height: 1.25;">Revocation of professional liability exclusion under third party insurance (please specify in respect of: bodily injury or property or body and property)</div>
            </td>
            <td style="width: 6.5%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">336</div>
            </td>
            <td style="width: 40.68%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 7.93%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">406</div>
            </td>
          </tr>
          <tr>
            <td style="width: 44.89%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; margin-right: 6.55pt; line-height: 1.25;">Revocation of product liability exclusion under third party insurance (please specify in respect of: bodily injury or property or body and property)</div>
            </td>
            <td style="width: 6.5%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">337</div>
            </td>
            <td style="width: 40.68%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 7.93%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">407</div>
            </td>
          </tr>
          <tr>
            <td style="width: 44.89%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; margin-right: 6.55pt; line-height: 1.25;">Extension of coverage based on establishing value under a property policy</div>
            </td>
            <td style="width: 6.5%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">338</div>
            </td>
            <td style="width: 40.68%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 7.93%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">408</div>
            </td>
          </tr>
          <tr>
            <td style="width: 44.89%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; margin-right: 6.55pt; line-height: 1.25;">Cybersecurity Risk Extension</div>
            </td>
            <td style="width: 6.5%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">339</div>
            </td>
            <td style="width: 40.68%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 7.93%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">409</div>
            </td>
          </tr>
          <tr>
            <td style="width: 44.89%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; margin-right: 6.55pt; line-height: 1.25;">Extension of tremors and deterioration of support</div>
            </td>
            <td style="width: 6.5%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">340</div>
            </td>
            <td style="width: 40.68%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 7.93%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">410</div>
            </td>
          </tr>
          <tr>
            <td style="width: 44.89%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; margin-right: 6.55pt; line-height: 1.25;">Extension of indirect damage due to damage to underground facilities and cables</div>
            </td>
            <td style="width: 6.5%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">341</div>
            </td>
            <td style="width: 40.68%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 7.93%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">411</div>
            </td>
          </tr>
          <tr>
            <td style="width: 44.89%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; margin-right: 6.55pt; line-height: 1.25;">Employer extension - firearms.</div>
            </td>
            <td style="width: 6.5%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">342</div>
            </td>
            <td style="width: 40.68%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 7.93%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">412</div>
            </td>
          </tr>
          <tr>
            <td style="width: 44.89%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; margin-right: 6.55pt; line-height: 1.25;">Extension of the coverage for damages caused by unloading and/or loading</div>
            </td>
            <td style="width: 6.5%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">343</div>
            </td>
            <td style="width: 40.68%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 7.93%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">413</div>
            </td>
          </tr>
          <tr>
            <td style="width: 44.89%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; margin-right: 6.55pt; line-height: 1.25;">Extension of coverage for work at height</div>
            </td>
            <td style="width: 6.5%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">344</div>
            </td>
            <td style="width: 40.68%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 7.93%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">414</div>
            </td>
          </tr>
          <tr>
            <td style="width: 44.89%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; margin-right: 6.55pt; line-height: 1.25;">Extension oof damage due to riots and strikes</div>
            </td>
            <td style="width: 6.5%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">345</div>
            </td>
            <td style="width: 40.68%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 7.93%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">415</div>
            </td>
          </tr>
          <tr>
            <td style="width: 44.89%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="margin-right: 6.55pt; line-height: 1.25;">Extension of electrical damage to electrical panels, command and transformers</div>
            </td>
            <td style="width: 6.5%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">346</div>
            </td>
            <td style="width: 40.68%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 7.93%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">416</div>
            </td>
          </tr>
          <tr>
            <td style="width: 44.89%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; margin-right: 6.55pt; line-height: 1.25;">Extension of the name of the insured in the product liability insurance in relation to a defect in the products supplied and/or installed and/or marketed and/or
                maintained by the insured and/or anyone on its behalf</div>
            </td>
            <td style="width: 6.5%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">347</div>
            </td>
            <td style="width: 40.68%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 7.93%; vertical-align: bottom; border-top: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; text-align: center;">
              <div style="line-height: 1.25;">417</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="2" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zad677c2cc40647d19fd66e374c60e0fe">

          <tr>
            <td style="width: 44.89%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Revocation of a property exclusion acted directly in third party insurance</div>
            </td>
            <td style="width: 6.5%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">348</div>
            </td>
            <td style="width: 40.68%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 7.93%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">418</div>
            </td>
          </tr>
          <tr>
            <td style="width: 44.89%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Revocation of property exclusion in control, possession and supervision in third party insurance</div>
            </td>
            <td style="width: 6.5%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">349</div>
            </td>
            <td style="width: 40.68%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 7.93%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">419</div>
            </td>
          </tr>
          <tr>
            <td style="width: 44.89%; vertical-align: top; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">Extension of liability towards contractors and subcontractors in employers' liability insurance should the Applicant be deemed their employer</div>
            </td>
            <td style="width: 6.5%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">350</div>
            </td>
            <td style="width: 40.68%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 7.93%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">420</div>
            </td>
          </tr>
          <tr>
            <td style="width: 44.89%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 6.5%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">351</div>
            </td>
            <td style="width: 40.68%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 7.93%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">421</div>
            </td>
          </tr>
          <tr>
            <td style="width: 44.89%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 6.5%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">352</div>
            </td>
            <td style="width: 40.68%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 7.93%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">422</div>
            </td>
          </tr>
          <tr>
            <td style="width: 44.89%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 6.5%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">353</div>
            </td>
            <td style="width: 40.68%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 7.93%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">423</div>
            </td>
          </tr>
          <tr>
            <td style="width: 44.89%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 6.5%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">354</div>
            </td>
            <td style="width: 40.68%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 7.93%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">424</div>
            </td>
          </tr>
          <tr>
            <td style="width: 44.89%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 6.5%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">355</div>
            </td>
            <td style="width: 40.68%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 7.93%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">425</div>
            </td>
          </tr>
          <tr>
            <td style="width: 44.89%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 6.5%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">356</div>
            </td>
            <td style="width: 40.68%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 7.93%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">426</div>
            </td>
          </tr>
          <tr>
            <td style="width: 44.89%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 6.5%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">357</div>
            </td>
            <td style="width: 40.68%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 7.93%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">427</div>
            </td>
          </tr>
          <tr>
            <td style="width: 44.89%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 6.5%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">358</div>
            </td>
            <td style="width: 40.68%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 7.93%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">428</div>
            </td>
          </tr>
          <tr>
            <td style="width: 44.89%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 6.5%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">359</div>
            </td>
            <td style="width: 40.68%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 7.93%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">429</div>
            </td>
          </tr>
          <tr>
            <td style="width: 44.89%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 6.5%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">360</div>
            </td>
            <td style="width: 40.68%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 7.93%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">430</div>
            </td>
          </tr>
          <tr>
            <td style="width: 44.89%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 6.5%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">361</div>
            </td>
            <td style="width: 40.68%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 7.93%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">431</div>
            </td>
          </tr>
          <tr>
            <td style="width: 44.89%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 6.5%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">362</div>
            </td>
            <td style="width: 40.68%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 7.93%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">432</div>
            </td>
          </tr>
          <tr>
            <td style="width: 44.89%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 6.5%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">363</div>
            </td>
            <td style="width: 40.68%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 7.93%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">433</div>
            </td>
          </tr>
          <tr>
            <td style="width: 44.89%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 6.5%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">364</div>
            </td>
            <td style="width: 40.68%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 7.93%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">434</div>
            </td>
          </tr>
          <tr>
            <td style="width: 44.89%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 6.5%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">365</div>
            </td>
            <td style="width: 40.68%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 7.93%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">435</div>
            </td>
          </tr>
          <tr>
            <td style="width: 44.89%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 6.5%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">366</div>
            </td>
            <td style="width: 40.68%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 7.93%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">436</div>
            </td>
          </tr>
          <tr>
            <td style="width: 44.89%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 6.5%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">367</div>
            </td>
            <td style="width: 40.68%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 7.93%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">437</div>
            </td>
          </tr>
          <tr>
            <td style="width: 44.89%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 6.5%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">368</div>
            </td>
            <td style="width: 40.68%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 7.93%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">438</div>
            </td>
          </tr>
          <tr>
            <td style="width: 44.89%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 6.5%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">369</div>
            </td>
            <td style="width: 40.68%; vertical-align: middle; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 7.93%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">439</div>
            </td>
          </tr>
          <tr>
            <td style="width: 44.89%; vertical-align: middle; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 6.5%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); text-align: center;">
              <div style="line-height: 1.25;">370</div>
            </td>
            <td style="width: 40.68%; vertical-align: middle; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 7.93%; vertical-align: bottom; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; text-align: center;">
              <div style="line-height: 1.25;">440</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
      </div>
      <div class="BRPFPageFooter">
        <div style="line-height: 1.25;"><font class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">22</font></div>
      </div>
    </div>
    <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; margin-left: auto; margin-right: auto;"></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-8.1
<SEQUENCE>5
<FILENAME>exhibit_8-1.htm
<DESCRIPTION>EXHIBIT 8.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Z-K GLOBAL
         Document created using Broadridge PROfile 23.12.1.5186
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div class="BRPFPageHeader">
      <div style="line-height: 1.25; text-align: right;">
        <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"><u><font style="font-weight: bold;">Exhibit 8.1</font></u><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="line-height: 1.25">
      <div style="line-height: 1.25; font-weight: bold;">InMode Ltd.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25; font-weight: bold;">List of Subsidiaries</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25;">The following is a list of subsidiaries of the company as of December 31, 2023, omitting some subsidiaries which, considered in the
        aggregate, would be not constitute a significant subsidiary.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25">
        <table cellspacing="0" cellpadding="2" border="0" id="z589c0b5da20941be9545d06df6b83f21" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 50%; vertical-align: top;">
                <div style="line-height: 1.25;"><u>Subsidiary</u></div>
              </td>
              <td style="width: 50%; vertical-align: top;">
                <div style="line-height: 1.25;"><u>Jurisdiction of Incorporation</u></div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top;">
                <div style="line-height: 1.25;">Invasix Inc.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
              </td>
              <td style="width: 50%; vertical-align: top;">
                <div style="line-height: 1.25;">Delaware, USA</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top;">
                <div style="line-height: 1.25;">Invasix Corp.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
              </td>
              <td style="width: 50%; vertical-align: top;">
                <div style="line-height: 1.25;">Canada</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top;">
                <div style="line-height: 1.25;">InMode M.D. Ltd.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
              </td>
              <td style="width: 50%; vertical-align: top;">
                <div style="line-height: 1.25;">Israel</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top;">
                <div style="line-height: 1.25;">InMode Innovations Ltd.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
              </td>
              <td style="width: 50%; vertical-align: top;">
                <div style="line-height: 1.25;">Israel</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top;">
                <div style="line-height: 1.25;">Invasix UK Ltd.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
              </td>
              <td style="width: 50%; vertical-align: top;">
                <div style="line-height: 1.25;">United Kingdom</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top;">
                <div style="line-height: 1.25;">InMode Japan KK&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
              </td>
              <td style="width: 50%; vertical-align: top;">
                <div style="line-height: 1.25;">Japan</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top;">
                <div style="line-height: 1.25;">Invasix Iberia S.L.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
              </td>
              <td style="width: 50%; vertical-align: top;">
                <div style="line-height: 1.25;">Spain</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top;">
                <div style="line-height: 1.25;">Guangzhou InMode Medical Technology Ltd.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
              </td>
              <td style="width: 50%; vertical-align: top;">
                <div style="line-height: 1.25;">China</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top;">
                <div style="line-height: 1.25;">InMode Asia Limited.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
              </td>
              <td style="width: 50%; vertical-align: top;">
                <div style="line-height: 1.25;">Hong Kong</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top;">
                <div style="line-height: 1.25;">InMode India Private Limited.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
              </td>
              <td style="width: 50%; vertical-align: top;">
                <div style="line-height: 1.25;">India</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top;">
                <div style="line-height: 1.25;">InMode Australia Pty Ltd..&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
              </td>
              <td style="width: 50%; vertical-align: top;">
                <div style="line-height: 1.25;">Australia</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top;">
                <div style="line-height: 1.25;">IMD France EURL..&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
              </td>
              <td style="width: 50%; vertical-align: top;">
                <div style="line-height: 1.25;">France</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top;">
                <div style="line-height: 1.25;">InMode Italy S.r.l..&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
              </td>
              <td style="width: 50%; vertical-align: top;">
                <div style="line-height: 1.25;">Italy</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top;">
                <div style="line-height: 1.25;">InMode Germany GmbH..&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
              </td>
              <td style="width: 50%; vertical-align: top;">
                <div style="line-height: 1.25;">Germany</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="line-height: 1.25"> <br>
      </div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25">
      <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-12.1
<SEQUENCE>6
<FILENAME>exhibit_12-1.htm
<DESCRIPTION>EXHIBIT 12.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: company
         Document created using Broadridge PROfile 23.9.1.5178
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
    <div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25; text-align: right;"><u><font style="font-weight: bold;">Exhibit 12.1</font></u><br style="line-height: 1.25;">
        </div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">Certification of the Principal Executive Officer Pursuant to<br>
        Section 302 of the Sarbanes-Oxley Act of 2002</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">I, Moshe Mizrahy, Chief Executive Officer of InMode Ltd. (the &#8220;Company&#8221;), certify that:</div>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z928d6f4a754b452a93543a8938b54dec" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top;">1.</td>
            <td style="width: auto; vertical-align: top;">
              <div>I have reviewed this Annual Report on Form 20-F of the Company;</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zdcf9e982f4a54e81b6bfe7cad3dc1b45" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top;">2.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in
                light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z4a88932322984109993fc385952a46eb" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top;">3.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial
                condition, results of operations and cash flows of the Company as of, and for, the periods presented in this report;</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z3ebc6f01d8e14c8d91b8ec279e5501b6" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top;">4.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The Company&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules
                13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Company and have:</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z426f6baeb8ff430f93cf9dcf6facc9fa" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 72pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top;">(a)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material
                information relating to the Company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z0cf4dcedd2914ea19d55f63209ad9bc3" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 72pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top;">(b)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide
                reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zef01a83b49a94023bf895ff3dd56170a" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 72pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top;">(c)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Evaluated the effectiveness of the Company&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure
                controls and procedures, as of the end of the period covered by this report based on such evaluation; and</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zd261aebc98d945e8a0e32f91f2d6ff43" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 72pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top;">(d)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Disclosed in this report any change in the Company&#8217;s internal control over financial reporting that occurred during the fourth fiscal quarter that has materially
                affected, or is reasonably likely to materially affect, the Company&#8217;s internal control over financial reporting; and</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z8e7375d5fedf4c5797694d2bd7eb4d66" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top;">5.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Company&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Company&#8217;s auditors
                and the audit committee of the Company&#8217;s board of directors (or persons performing the equivalent functions);</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z978fb9c227714e31aad80c95383dfab0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 72pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top;">(a)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely
                affect the Company&#8217;s ability to record, process, summarize and report financial information; and</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zd2403bc2bd044fd3bebbd787410bcf04" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 72pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top;">(b)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Any fraud, whether or not material, that involves management or other employees who have a significant role in the Company&#8217;s internal control over financial
                reporting.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z103f92ab363a422a966c09a5427615c1" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 50%; vertical-align: top; padding-bottom: 2px;">
              <div style="line-height: 1.25;">Dated: February 13, 2024</div>
            </td>
            <td style="width: 25%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">/s/ Moshe Mizrahy</td>
            <td style="width: 25%; vertical-align: top; padding-bottom: 2px;" colspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 25%; vertical-align: top;">
              <div style="line-height: 1.25;">By: Moshe Mizrahy</div>
            </td>
            <td style="width: 25%; vertical-align: top;" colspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 25%; vertical-align: top;">
              <div style="line-height: 1.25;">Title: Chief Executive Officer</div>
            </td>
            <td style="width: 25%; vertical-align: top;" colspan="1">&#160;</td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div class="BRPFPageFooter">
        <div style="line-height: 1.25;">
          <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
      </div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-12.2
<SEQUENCE>7
<FILENAME>exhibit_12-2.htm
<DESCRIPTION>EXHIBIT 12.2
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: company
         Document created using Broadridge PROfile 23.9.1.5178
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
    <div>
      <div class="BRPFPageHeader">
        <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-style: italic;">&#160;<font style="font-style: normal;"><u><font style="font-weight: bold;">Exhibit 12.2</font></u></font><br>
        </div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
      <div style="text-align: center; line-height: 1.25;"><font style="font-weight: bold;">Certification of Principal Financial Officer Pursuant to<br>
          Section 302 of the Sarbanes-Oxley Act of 2002<br>
        </font><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">I, Yair Malca, Chief Financial Officer of InMode Ltd. (the &#8220;Company&#8221;), certify that:</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-indent: 0pt; margin-left: 36pt; line-height: 1.25;">I have reviewed this Annual Report on Form 20-F of the Company;</div>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zab9bc44a839e4083863b803c54444cc4">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top;">2.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not
                misleading with respect to the period covered by this report;</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7d601532703b4863adbc4af0156205a1">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top;">3.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Company as of, and
                for, the periods presented in this report;</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z3997b6fde0e1424c96f418a258a22e0b">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top;">4.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The Company&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as
                defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Company and have:</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z843772c3dcbf4418b104e2d258a00aa7">

          <tr>
            <td style="width: 72pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top;">(a)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Company, including its consolidated
                subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z87c0ff19e41b4195a00b9ae2f0f708b6">

          <tr>
            <td style="width: 72pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top;">(b)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and
                the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z44ae47c6df694281876bc7bd97f25ef5">

          <tr>
            <td style="width: 72pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top;">(c)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Evaluated the effectiveness of the Company&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this
                report based on such evaluation; and</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8b0355ac9e2f429bbe6bf199f3b0f637">

          <tr>
            <td style="width: 72pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top;">(d)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Disclosed in this report any change in the Company&#8217;s internal control over financial reporting that occurred during the fourth fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Company&#8217;s
                internal control over financial reporting; and</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z89c4f025396d4178ae1482ff7cf7db64">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top;">5.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Company&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Company&#8217;s auditors and the audit committee of the Company&#8217;s board of directors (or persons
                performing the equivalent functions);</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z02409b9903664829bb82dd132c3b068a">

          <tr>
            <td style="width: 72pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top;">(a)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Company&#8217;s ability to record, process, summarize and report
                financial information; and</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z53cd027c84f24f26864628ed042d6efc">

          <tr>
            <td style="width: 72pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top;">(b)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Any fraud, whether or not material, that involves management or other employees who have a significant role in the Company&#8217;s internal control over financial reporting.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z92c8f09d7bd54009bfb344124bcbb461">

          <tr>
            <td style="width: 50%; vertical-align: top;">
              <div style="line-height: 1.25;">February 13, 2024</div>
            </td>
            <td style="width: 25%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">/s/ Yair Malca</div>
            </td>
            <td style="width: 25%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 25%; vertical-align: top;">
              <div style="line-height: 1.25;">Yair Malca</div>
            </td>
            <td style="width: 25%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 25%; vertical-align: top;">
              <div style="line-height: 1.25; font-style: italic;">Chief Financial Officer</div>
            </td>
            <td style="width: 25%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 25%; vertical-align: top;">
              <div style="line-height: 1.25;">(principal financial officer)</div>
            </td>
            <td style="width: 25%; vertical-align: top;">&#160;</td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">
        <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
    </div>
    <div> <br>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-13.1
<SEQUENCE>8
<FILENAME>exhibit_13-1.htm
<DESCRIPTION>EXHIBIT 13.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: company
         Document created using Broadridge PROfile 23.9.1.5178
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
    <div>
      <div class="BRPFPageHeader">
        <div style="text-align: right; line-height: 1.25; font-weight: bold;"><u>Exhibit 13.1</u></div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">Certification of Principal Executive Officer Pursuant to<br>
        18 U.S.C. Section 1350 as Adopted Pursuant to<br>
        Section 906 of the Sarbanes-Oxley Act of 2002</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Pursuant to 18 U.S.C. Section &#167;1350, as adopted pursuant to Section &#167; 906 of the Sarbanes-Oxley Act of 2002, I, Moshe Mizrahy, Chief Executive Officer of InMode Ltd. (the
        &#8220;Company&#8221;), hereby certify, to my knowledge, that:</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z1ecd8f81cf474e3c8cc577f5f91cf66a" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top;">1.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The Annual Report on Form 20-F for the year ended December 31, 2023 (the &#8220;Report&#8221;) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" id="z517ea2c78f194d4a8da2824200f39966" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top;">2.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">Date: February 13, 2024</div>
      <table cellspacing="0" cellpadding="0" border="0" id="zc9ed9c66edf54608a58ebd2ac1db2c8b" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 50%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
            <td style="width: 25%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; line-height: 1.25;">/s/ Moshe Mizrahy</div>
            </td>
            <td style="width: 25%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 25%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">Moshe Mizrahy</div>
            </td>
            <td style="width: 25%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 25%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-style: italic;">Chief Executive Officer and Chairman of the Board</div>
            </td>
            <td style="width: 25%; vertical-align: top;">&#160;</td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">
        <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
      <div class="BRPFPageFooter">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-13.2
<SEQUENCE>9
<FILENAME>exhibit_13-2.htm
<DESCRIPTION>EXHIBIT 13.2
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: company
         Document created using Broadridge PROfile 23.9.1.5178
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
    <div>
      <div class="BRPFPageHeader">
        <div style="text-align: right; line-height: 1.25; font-weight: bold;"><u>Exhibit 13.2</u></div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">Certification of Principal Financial Officer Pursuant to<br>
        18 U.S.C. Section 1350 as Adopted Pursuant to<br>
        Section 906 of the Sarbanes-Oxley Act of 2002</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I, Yair Malca, Chief Financial Officer of InMode Ltd. (the &#8220;Company&#8221;),
        hereby certify, to my knowledge, that:</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd03ddce09e7742eb85c8ee0d0504c3f2">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top;">1.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The Annual Report on Form 20-F for the year ended December 31, 2023 (the &#8220;Report&#8221;) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc2b9717ba2964aeba10c9af28bbd3456">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top;">2.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">Date: February 13, 2024</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zd83cba51a0b24a51a0a4319bc0199d73">

          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 25%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; line-height: 1.25;">/s/ Yair Malca</div>
            </td>
            <td style="width: 25%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 25%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">Yair Malca</div>
            </td>
            <td style="width: 25%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 25%; vertical-align: top;">
              <div style="text-align: justify; text-indent: -22.5pt; margin-left: 22.5pt; line-height: 1.25; font-style: italic;">Chief Financial Officer</div>
            </td>
            <td style="width: 25%; vertical-align: top;">&#160;</td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div class="BRPFPageFooter">
        <div style="line-height: 1.25;">
          <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"> </div>
      </div>
    </div>
    <div> <br>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-15.1
<SEQUENCE>10
<FILENAME>exhibit_15-1.htm
<DESCRIPTION>EXHIBIT 15.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: company
         Document created using Broadridge PROfile 23.9.1.5178
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div class="BRPFPageHeader">
      <div style="line-height: 1.25;">
        <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
      <div style="line-height: 1.25; text-align: right;"><u><font style="font-weight: bold;">Exhibit 15.1</font></u><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25;">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-233873, 333-236477, 333-252935, 333-262617 and 333-269749) of InMode Ltd. of our report dated
      February 13, 2024 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 20-F.</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z50edab5879424917b42b37bab400fb25">

        <tr>
          <td style="width: 100%; vertical-align: top;">
            <div style="line-height: 1.25;">/s/ Kesselman &amp; Kesselman</div>
          </td>
        </tr>
        <tr>
          <td style="width: 100%; vertical-align: top;">
            <div style="line-height: 1.25;">Certified Public Accountants (lsr.)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 100%; vertical-align: top;">
            <div style="line-height: 1.25;">A member firm of PricewaterhouseCoopers International Limited</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z215e6d2193fe40d0be14f262c9f67b3e">

        <tr>
          <td style="width: 100%; vertical-align: top;">
            <div style="line-height: 1.25;">Tel-Aviv, Israel</div>
          </td>
        </tr>
        <tr>
          <td style="width: 100%; vertical-align: top;">
            <div style="line-height: 1.25;">February 13, 2024</div>
          </td>
        </tr>
        <tr>
          <td style="width: 100%; vertical-align: top;">&#160;</td>
        </tr>

    </table>
    <div> <br>
    </div>
    <div>
      <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"> </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div class="BRPFPageFooter"><br>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-97.CLAWBACKPOLICY
<SEQUENCE>11
<FILENAME>exhibit_97.htm
<DESCRIPTION>CLAWBACK POLICY
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: company
         Document created using Broadridge PROfile 23.9.1.5178
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <font style="font-family: 'Times New Roman',Times,serif;">
  </font>
  <div>
    <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u> </u>
      <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"><u>Exhibit
            97</u><br>
      </div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;"> <br>
      </div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">INMODE LTD.</div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">CLAWBACK POLICY</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">Adopted on November 1, 2023</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">The following clawback policy (the &#8220;<u>Policy</u>&#8221;) of InMode Ltd., an Israeli limited liability company&#160;
      (the &#8220;<u>Company</u>&#8221;), requires the recovery of erroneously awarded compensation in order to satisfy the requirements of the Nasdaq Stock Market LLC (&#8220;<u>Nasdaq</u>&#8221;) Listing Rule 5608 (the &#8220;<u>Listing Standards</u>&#8221;) and to satisfy the requirements
      of Rule 10D-1 (&#8220;<u>Rule 10D-1</u>&#8221;), as adopted by the Securities and Exchange Commission&#160; (the &#8220;<u>SEC</u>&#8221;) pursuant to the Securities Exchange Act of 1934, as amended (the &#8220;<u>Exchange Act</u>&#8221;) to implement Section 954 of the Dodd-Frank Wall
      Street Reform and Consumer Protection Act of 2010.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z2e0bd5c87999442b8d311fe4dd10cf44" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 72pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">Section 1.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-family: 'Times New Roman', serif; font-size: 12pt;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;"><u>Definitions</u></font><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;">. As used in this Policy, the following definitions shall apply:</font></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;<u>Applicable
          Period</u>&#8221; means, with respect to any Restatement, the three completed fiscal years prior to the earlier of (i) the date the Company&#8217;s board of directors, a board committee, or officer(s) authorized to take such action if board action is not
        required, concludes, or reasonably should have concluded, that the Company is required to prepare a Restatement or (ii) the date a court, regulator, or other legally authorized body directs the Company to prepare a Restatement.&#160; In addition <font style="color: rgb(0, 0, 0);">to the last three completed fiscal years described in the preceding sentence, the Applicable Period includes any transition period (that results from a change in the Company&#8217;s fiscal year) within or immediately
          following those three completed fiscal years; provided, however, a transition period between the last day of the Company&#8217;s previous fiscal year end and the first day of its new fiscal year that comprises a period of nine to 12 months would be
          deemed a completed fiscal year for purposes of the Applicable Period.</font></font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;<u>Committee</u>&#8221;
        means the compensation committee of the Board of Directors of the Company.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;<u>Covered
          Executive</u>&#8221; means all of the Company&#8217;s current and former executive officers, as determined by the Committee, in accordance with the Listing Standards and Rule 10D-1 and the definition of executive officer as defined in Rule 10D-1(d). For the
        avoidance of doubt, the identification of an executive officer as a Covered Executive for the purposes of this Policy shall include each executive officer who is identified pursuant to Item 6.A of Form 20-F.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;">&#8220;</font><u>Erroneously Awarded Compensation</u>&#8221; means, with respect to each Covered Executive in connection with a Restatement, the amount of Incentive-Based Compensation received by the Covered Executive that exceeds
        the amount of Incentive-Based Compensation that otherwise would have been received had it been determined based on the restated financial statements.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;<u>Incentive-Based
          Compensation</u>&#8221; means all compensation (including cash bonuses or other cash incentive awards (including any deferred element thereof), and vested and unvested equity awards, including options, restricted shares and restricted share units,
        performance share unit awards and performance share awards) from the Company or a subsidiary of the Company that is granted, earned, or vested based wholly or in part upon the attainment of a Financial Reporting Measure.&#160; For the avoidance of
        doubt, Incentive-Based Compensation does not include annual salary, compensation awarded based on completion of a specified period of service, or compensation awarded based on subjective standards, strategic measures, or operational measures,
        unless also based on attainment of a Financial Reporting Measure.</font></div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <!--PROfilePageNumberReset%Num%2%%%-->
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif;">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;<u>Financial
          Reporting Measures</u>&#8221; are measures that are determined and presented in accordance with the accounting principles used in preparing the Company&#8217;s financial statements, and any measures that are derived wholly or in part from such measures,
        including share price and total shareholder return. For the avoidance of doubt, a Financial Reporting Measure need not be presented in the Company's financial statements or included in a filing with the SEC.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif;">(g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;<u>Restatement</u>&#8221;
        means an accounting restatement of the Company&#8217;s financial statements due to material noncompliance with any financial reporting requirement under the federal securities laws, including any required accounting restatement to correct an error in
        previously issued financial statements that is material to the previously issued financial statements, or that would result in a material misstatement if the error were corrected in the current period or left uncorrected in the current period.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;">Section 2.</font><font style="font-family: 'Times New Roman',Times,serif;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;"><u>Recovery Event</u></font>. If the Company is required to prepare a Restatement, then, as determined by the Committee, the Covered Executive&#8217;s unsettled
        Incentive-Based Compensation will be subject to forfeiture, and the Covered Executive&#8217;s settled Incentive-Based Compensation will be subject to recoupment, subject to the following:</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The
        forfeiture or recoupment of the Incentive-Based Compensation will apply to a recipient of Incentive-Based Compensation if the recipient of the Incentive-Based Compensation was a Covered Executive at any time during the performance period for such
        Incentive-Based Compensation.&#160; This Policy applies to Incentive-Based Compensation received by a Covered Executive after beginning services as a Covered Executive, and any subsequent changes in a Covered Executive&#8217;s employment status, including
        retirement or termination of employment, do not affect the Company&#8217;s rights to recover Erroneously Awarded Compensation pursuant to this Policy.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The
        amount to be forfeited or recouped will equal the Erroneously Awarded Compensation, as determined by the Committee. The Committee will take actions necessary to recover the Erroneously Awarded Compensation reasonably promptly following a
        Restatement. Where the amount of Erroneously Awarded Compensation is not subject to mathematical recalculation directly from the information in the Restatement, the amount must be based on a reasonable estimate of the effect of the Restatement on
        the Company's share price or total shareholder return upon which the Incentive-Based Compensation was granted, vested, paid or settled.&#160; The Company will maintain documentation of the determination of that reasonable estimate and provide such
        documentation to Nasdaq.&#160; The amount of the Erroneously Awarded Compensation shall not be reduced based on, or otherwise calculated with regard to, any taxes paid by the Covered Executive with respect to such amounts.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;This
        Policy shall only apply to Incentive-Based Compensations that was received (or would have been settled in the absence of an elective deferral of payment by the individual) during, or in respect of, the Applicable Period and that was received (or
        would have been settled in the absence of an elective deferral of payment by the individual) during the period while the Company <font style="color: rgb(0, 0, 0);">has a class of securities listed on a national securities exchange or a national
          securities association</font>.&#160; For purposes of this Policy, Incentive-Based Compensation shall be deemed to have been received during the fiscal period in which the financial reporting measure specified in the applicable Incentive-Based
        Compensation is attained, even if such Incentive-Based Compensation is paid or granted after the end of such fiscal period.<font style="color: rgb(0, 0, 0);"> The Company&#8217;s obligation to recover erroneously awarded compensation is not dependent on
          if or when the restated financial statements are filed.</font></font></div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">2</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;">Section 3.</font><font style="font-family: 'Times New Roman',Times,serif;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;"><u>Impracticability</u></font>.&#160; The Company shall recover any Erroneously Awarded Compensation unless any of the conditions set forth in clauses (a), (b) or (c)
        of the following sentence are met, and such recovery would be impracticable, as determined by the Committee in accordance with Rule 10D-1 and the Listing Standards.&#160; No recovery shall be required if:</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the
        direct expense paid to a third party to assist in enforcing this Policy would exceed the amount to be recovered; <font style="font-style: italic;">provided </font>that before concluding that it would be impractical to recover any amount of
        Erroneously Awarded Compensation based on this clause (a), the Company shall make a reasonable attempt to recover such Erroneously Awarded Compensation, document such reasonable attempt(s) and provide such documentation to Nasdaq;</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;recovery
        would violate home country law where that law was adopted prior to November 28, 2022; <font style="font-style: italic;">provided </font>that before concluding that it would be impractical to recover any amount of Erroneously Awarded Compensation
        based on this clause (b), the Company shall obtain an opinion of home country counsel, acceptable to Nasdaq, that recovery would result in such violation, and shall provide such opinion to Nasdaq; or</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;recovery
        would likely cause an otherwise tax-qualified retirement plan, under which benefits are broadly available to employees of the Company or a subsidiary, to fail to meet the requirements of Section 401(a)(13) or Section 411(a) of the Internal Revenue
        Code of 1986, as amended, and regulations thereunder (the &#8220;<u>Code</u>&#8221;).</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;">Section 4.</font><font style="font-family: 'Times New Roman',Times,serif;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;"><u>Method of Clawback</u></font>. The Committee shall determine, in its sole discretion, the method of recovering any Erroneously Awarded Compensation pursuant to
        this Policy, which may include, without limitation:</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;requiring
        reimbursement of cash Erroneously Awarded Compensation previously paid;</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;seeking
        recovery of any gain realized on the vesting, exercise, settlement, sale, transfer, or other disposition of any equity-based awards;</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;offsetting
        the recouped amount from any compensation otherwise owed by the Company or any subsidiary to the Covered Executive;</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;cancelling
        outstanding vested or unvested equity awards; and/or</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;taking
        any other remedial and recovery action, as determined by the Committee; provided, however that any such action pursuant to subsections (a) through (e) shall be subject to applicable law and shall be subject to compliance with Section 409A of the
        Code.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zbe7121a6b57544f28f0e425a1b6e2e04" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 72pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">Section 5.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-family: 'Times New Roman', serif; font-size: 12pt;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;"><u>Suspension of Outstanding Incentive-Based Compensation</u></font><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;">.</font></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;After
        a determination by the Committee that a Restatement may have occurred, the Committee may suspend all Incentive-Based Compensation that the Committee determines may be forfeited under this Policy or otherwise subject to offset pursuant to Section 4,
        in which case and subject to the terms of this Section, Incentive-Based Compensation subject to the suspension: (i) if unvested, will not vest, and (ii) otherwise will not be distributed or permitted to be exercised or otherwise settled.&#160; In the
        event the term of an option award will expire during a period of suspension, the Covered Executive will be permitted to exercise the option before it expires; however settlement of the option award following such exercise will remain suspended and
        the securities otherwise deliverable upon settlement shall remain subject to forfeiture under the terms of this Policy. For avoidance of doubt, the Company shall be entitled to provide instructions to its awards administrator for the purpose of
        enforcing this Policy.</font></div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">3</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Following
        suspension of Incentive-Based Compensation under subsection (a) of this Section 5, the Committee will determine as promptly as practicable whether the suspended Incentive-Based Compensation is to be forfeited or whether the suspension of the
        Incentive-Based Compensation is to be ended.&#160; For Incentive-Based Compensation that are ultimately not forfeited, the following provisions will apply upon the Committee&#8217;s determination to lift the suspension:</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Unvested
        awards that would not otherwise have vested during the suspension by their original terms will be thereafter subject to vesting under their original terms;</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Unvested
        awards that otherwise would have vested during the suspension will vest as soon as practicable and otherwise consistent with their original terms<font style="font-style: italic;">;</font></font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Cash awards such as annual bonus withheld during the suspension will be immediately payable;</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif;">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In
        no event will distribution of cash or shares be made to a Covered Executive with respect to Incentive-Based Compensation if, by reason of termination of employment or otherwise, the Covered Executive would have forfeited the Incentive-Based
        Compensation if the Incentive-Based Compensation had not been suspended; and</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif;">(v)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Distribution
        or settlement of Incentive-Based Compensation will be made no later than the latest date on which such distribution or settlement would be required to avoid additional tax by reason of Section 409A of the Code; provided, however, that if such
        distribution or settlement occurs during a period when such Incentive-Based Compensation remains suspended pursuant to this Section 5, then the after-tax proceeds of such distribution or settlement shall be held in escrow until such time as such
        Incentive-Based Compensation is no longer subject to a suspension or such amounts are determined to have been forfeited by the Committee.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;">Section 6.</font><font style="font-family: 'Times New Roman',Times,serif;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;"><u>Committee Administration and Discretion</u></font>.&#160; The authority to interpret, manage the operation and administration of this Policy and make all
        determinations necessary, appropriate, or advisable for the administration of this Policy and for the Company's compliance with the Nasdaq rules, Section 10D, Rule 10D-1 and any other applicable law, regulation, rule or interpretation of the SEC or
        Nasdaq promulgated or issued in connection therewith, is vested in the Committee.&#160; This authority includes the obligation to determine (i) whether a Restatement has occurred for the purposes of this Policy, Rule 10D-1 and the Listing Standards and
        (ii) the amount of Erroneously Awarded Compensation. The Committee may retain and rely upon the advice and determinations of legal counsel, accountants and other relevant experts to operate and administer this Policy.&#160; Any interpretation of this
        Policy by the Committee and any decision made by it with respect to this Policy will be final, binding and conclusive on all persons.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;">Section 7.</font><font style="font-family: 'Times New Roman',Times,serif;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;"><u>No Indemnification</u></font>. The Company shall not indemnify any current or former Covered Executive against the loss of Erroneously Awarded Compensation,
        and shall not pay, or reimburse any Covered Executives for premiums, for any insurance policy to fund such executive&#8217;s potential repayment obligations.</font></div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">4</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;">Section 8.</font><font style="font-family: 'Times New Roman',Times,serif;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;"><u>Notice</u></font>. Before the Committee determines to seek recovery pursuant to this Policy, it shall provide the Covered Executive with written notice and the
        opportunity to be heard at a meeting of the Committee or the Board (either in person or via telephone or virtual conference).</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;">Section 9.</font><font style="font-family: 'Times New Roman',Times,serif;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;"><u>Effective Date</u></font>.&#160; This Policy is effective as of November 1, 2023 (the &#8220;<u>Effective Date</u>&#8221;).&#160; The terms of this Policy shall apply to any
        Incentive-Based Compensation that is received by a Covered Executive on or after October 2, 2023, even if such Incentive-Based Compensation was approved, awarded or granted to the Covered Executive prior to October 2, 2023.&#160; Subject to applicable
        law, the Committee may effect forfeiture or recoupment under this Policy from any amount of compensation approved, awarded, granted, payable or paid to the Covered Executive prior to, on or after the Effective Date.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;">Section 10.</font><font style="font-family: 'Times New Roman',Times,serif;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;"><u>Amendment and Interpretation</u></font>. The Committee may amend this Policy from time to time in its discretion, and shall amend this Policy as it deems
        necessary, appropriate or advisable to reflect the regulations adopted by the SEC and to comply with any rules or standards adopted by a national securities exchange on which the Company&#8217;s securities are then listed. The Committee is authorized to
        interpret and construe this Policy and to make all determinations necessary, appropriate, or advisable for the administration of this Policy.&#160; It is intended that this Policy be interpreted in a manner that is consistent with the requirements of
        Rule 10D-1 and any applicable rules or standards adopted by the SEC and any national securities exchange on which the Company&#8217;s securities are then listed.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;">Section 11.</font><font style="font-family: 'Times New Roman',Times,serif;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;"><u>Other Recoupment Rights</u></font>. The Committee intends that this Policy will be applied to the fullest extent required by applicable law or guidance from
        the SEC or Nasdaq. Any employment and or/consulting agreement, equity award agreement, compensatory plan or any other similar agreement or arrangement with a Covered Executive shall be deemed to include, as a condition to the grant of any benefit
        thereunder, an agreement by the Covered Executive to abide by the terms of this Policy and the application of this Policy to any award made prior to the Effective Date. Any right of recoupment under this Policy is in addition to, and not in lieu
        of, any other remedies or rights of recoupment that may be available to the Company pursuant to the terms of any other recoupment or recoupment policy, any similar policy in any employment and/or consulting agreement, equity award agreement, or
        similar agreement and any other legal remedies available to the Company.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;">Section 12.</font><font style="font-family: 'Times New Roman',Times,serif;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;"><u>Successors</u></font>. This Policy shall be binding and enforceable against all Covered Executives and their beneficiaries, heirs, executors, administrators or
        other legal representatives.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;">Section 13.</font><font style="font-family: 'Times New Roman',Times,serif;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;"><u>Disclosure Obligations</u></font>. The Company shall file all disclosures with respect to this Policy required by applicable SEC filings and rules.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;">Section 14.</font><font style="font-family: 'Times New Roman',Times,serif;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold; color: rgb(0, 0, 0);"><u>Entire Agreement</u>. </font><font style="color: rgb(0, 0, 0);">To the
          extent inconsistent with this Policy, this Policy supersedes all prior contracts, agreements and understandings, written or oral, with any Covered Executive. In the event any contract, agreement or understanding with any Covered Executive is
          inconsistent with the terms of this Policy, the terms of this Policy shall govern.</font></font></div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">5</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u>Appendix A</u></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">Acknowledgement of Clawback Policy for the Recovery of Erroneously Awarded Compensation</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-style: italic;">[Date]</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-style: italic;">[Covered Executive name]</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Dear <font style="font-style: italic;">[Covered Executive name]:</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Please sign and return to me this letter acknowledging that you have received a copy of the InMode Ltd. Clawback Policy (the &#8220;<u>Policy</u>&#8221;)
      and that you agree to its application to you as a Covered Executive. Your receipt of grants of equity or incentive compensation on or after the effective date of the Policy is conditioned on your agreeing to the terms of the Policy.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">By signing this letter, you agree that the Policy, as it may be amended from time to time, applies to your Incentive-Based
      Compensation (as defined in the Policy), regardless of whether it is granted on, before, or after the date on which this Policy was adopted by the Company or the date that you sign this letter.&#160; Additionally, you agree and acknowledge that any
      employment and or/consulting agreement, equity award agreement, compensatory plan or any other similar agreement or arrangement previously entered with you shall be deemed to include, as a condition to the grant of any benefit thereunder, an
      agreement by you to abide by the terms of this Policy and the application of this Policy to any award made prior to the Effective Date, and that the Policy supersedes any prior <font style="color: rgb(0, 0, 0);">contract, agreement and
        understanding, written or oral, </font>between you and the Company and that, in the event any contract, agreement or understanding with you is inconsistent with the Policy, the terms of the Policy shall govern.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">You also agree and acknowledge that the Incentive-Based Compensation subject to the Policy are voluntary programs, that you have
      chosen to accept such Incentive-Based Compensation understanding that such Incentive-Based Compensation are subject to forfeiture and recoupment as set forth in the Policy, and that you specifically agree to such forfeiture and recoupment. If you do
      not wish to accept any future Incentive-Based Compensation subject to the Policy or to otherwise agree to the terms of the Policy, you must notify in writing HR Department within 10 days after receiving notice of a grant of Incentive-Based
      Compensation that you are rejecting such grant.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">If you have any questions about the Policy, please contact me.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Very truly yours,</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-style: italic;">Moshe Mizrahy</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-style: italic;">CEO and Chairman of the Board</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Acknowledged and agreed:</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;__________________________ &#160;&#160;&#160;&#160; <br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-style: italic;">[Covered Executive&#160; name]</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif;">Date:&#160;
        _____________________ &#160;&#160;&#160;&#160;&#160;&#160; <br>
      </font></div>
    <div style="line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif;"> <br>
      </font></div>
    <div style="line-height: 1.25;">
      <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"><font style="font-family: 'Times New Roman',Times,serif;"> </font></div>
  </div>
  <font style="font-family: 'Times New Roman',Times,serif;">
  </font>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>12
<FILENAME>inmd-20231231.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<schema xmlns:inmd="http://inmodemd.com/20231231" xmlns="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:currency="http://xbrl.sec.gov/currency/2023" xmlns:exch="http://xbrl.sec.gov/exch/2023" xmlns:naics="http://xbrl.sec.gov/naics/2023" xmlns:sic="http://xbrl.sec.gov/sic/2023" xmlns:stpr="http://xbrl.sec.gov/stpr/2023" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:ecd="http://xbrl.sec.gov/ecd/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" targetNamespace="http://inmodemd.com/20231231" elementFormDefault="qualified">
  <!-- INTEGIX by Ez-XBRL -->
  <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>
  <import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd"/>
  <import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd"/>
  <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
  <import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd"/>
  <import namespace="http://xbrl.sec.gov/currency/2023" schemaLocation="https://xbrl.sec.gov/currency/2023/currency-2023.xsd"/>
  <import namespace="http://xbrl.sec.gov/exch/2023" schemaLocation="https://xbrl.sec.gov/exch/2023/exch-2023.xsd"/>
  <import namespace="http://xbrl.sec.gov/naics/2023" schemaLocation="https://xbrl.sec.gov/naics/2023/naics-2023.xsd"/>
  <import namespace="http://xbrl.sec.gov/sic/2023" schemaLocation="https://xbrl.sec.gov/sic/2023/sic-2023.xsd"/>
  <import namespace="http://xbrl.sec.gov/stpr/2023" schemaLocation="https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd"/>
  <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd"/>
  <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd"/>
  <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd"/>
  <import namespace="http://xbrl.org/2020/extensible-enumerations-2.0" schemaLocation="https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd"/>
  <import namespace="http://xbrl.sec.gov/ecd/2023" schemaLocation="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd"/>
  <import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd"/>
  <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd"/>
  <annotation>
    <appinfo>
      <link:roleType roleURI="http://inmodemd.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>0001 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://inmodemd.com/role/ConsolidatedBalanceSheets" id="ConsolidatedBalanceSheets">
        <link:definition>0002 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://inmodemd.com/role/ConsolidatedBalanceSheetsParenthetical" id="ConsolidatedBalanceSheetsParenthetical">
        <link:definition>0003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://inmodemd.com/role/CONSOLIDATEDBALANCESHEETSParentheticals2" id="CONSOLIDATEDBALANCESHEETSParentheticals2">
        <link:definition>0004 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical 2)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://inmodemd.com/role/ConsolidatedStatementsOfIncome" id="ConsolidatedStatementsOfIncome">
        <link:definition>0005 - Statement - CONSOLIDATED STATEMENTS OF INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://inmodemd.com/role/ConsolidatedStatementsOfComprehensiveIncome" id="ConsolidatedStatementsOfComprehensiveIncome">
        <link:definition>0006 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://inmodemd.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity" id="ConsolidatedStatementsOfChangesInShareholdersEquity">
        <link:definition>0007 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://inmodemd.com/role/ConsolidatedStatementsOfCashFlows" id="ConsolidatedStatementsOfCashFlows">
        <link:definition>0008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://inmodemd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParentheticals" id="CONSOLIDATEDSTATEMENTSOFCASHFLOWSParentheticals">
        <link:definition>0009 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://inmodemd.com/role/General" id="General">
        <link:definition>0010 - Disclosure - GENERAL</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://inmodemd.com/role/SignificantAccountingPolicies" id="SignificantAccountingPolicies">
        <link:definition>0011 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurements" id="MarketableSecuritiesAndFairValueMeasurements">
        <link:definition>0012 - Disclosure - MARKETABLE SECURITIES AND FAIR VALUE MEASUREMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://inmodemd.com/role/AccountsReceivable" id="AccountsReceivable">
        <link:definition>0013 - Disclosure - ACCOUNTS RECEIVABLE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://inmodemd.com/role/OtherCurrentReceivables" id="OtherCurrentReceivables">
        <link:definition>0014 - Disclosure - PREPAID EXPENSES AND OTHER CURRENT RECEIVABLES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://inmodemd.com/role/Inventories" id="Inventories">
        <link:definition>0015 - Disclosure - INVENTORIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://inmodemd.com/role/PropertyAndEquipmentNet" id="PropertyAndEquipmentNet">
        <link:definition>0016 - Disclosure - PROPERTY AND EQUIPMENT, NET</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://inmodemd.com/role/OtherInvestments" id="OtherInvestments">
        <link:definition>0017 - Disclosure - OTHER INVESTMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://inmodemd.com/role/Leases" id="Leases">
        <link:definition>0018 - Disclosure - LEASES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://inmodemd.com/role/OtherCurrentLiabilities" id="OtherCurrentLiabilities">
        <link:definition>0019 - Disclosure - OTHER CURRENT LIABILITIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://inmodemd.com/role/CommitmentsAndContingentLiabilities" id="CommitmentsAndContingentLiabilities">
        <link:definition>0020 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://inmodemd.com/role/ShareholdersEquity" id="ShareholdersEquity">
        <link:definition>0021 - Disclosure - SHAREHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://inmodemd.com/role/TaxesOnIncome" id="TaxesOnIncome">
        <link:definition>0022 - Disclosure - INCOME TAXES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://inmodemd.com/role/Entity-wideDisclosure" id="Entity-wideDisclosure">
        <link:definition>0023 - Disclosure - ENTITY-WIDE DISCLOSURE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://inmodemd.com/role/RelatedParties" id="RelatedParties">
        <link:definition>0024 - Disclosure - RELATED PARTIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://inmodemd.com/role/SignificantAccountingPoliciesPolicies" id="SignificantAccountingPoliciesPolicies">
        <link:definition>0025 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://inmodemd.com/role/SignificantAccountingPoliciesTables" id="SignificantAccountingPoliciesTables">
        <link:definition>0026 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsTables" id="MarketableSecuritiesAndFairValueMeasurementsTables">
        <link:definition>0027 - Disclosure - MARKETABLE SECURITIES AND FAIR VALUE MEASUREMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://inmodemd.com/role/AccountsReceivableTables" id="AccountsReceivableTables">
        <link:definition>0028 - Disclosure - ACCOUNTS RECEIVABLE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://inmodemd.com/role/OtherCurrentReceivablesTables" id="OtherCurrentReceivablesTables">
        <link:definition>0029 - Disclosure - PREPAID EXPENSES AND OTHER CURRENT RECEIVABLES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://inmodemd.com/role/InventoriesTables" id="InventoriesTables">
        <link:definition>0030 - Disclosure - INVENTORIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://inmodemd.com/role/PropertyAndEquipmentNetTables" id="PropertyAndEquipmentNetTables">
        <link:definition>0031 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://inmodemd.com/role/LeasesTables" id="LeasesTables">
        <link:definition>0032 - Disclosure - LEASES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://inmodemd.com/role/OtherCurrentLiabilitiesTables" id="OtherCurrentLiabilitiesTables">
        <link:definition>0033 - Disclosure - OTHER CURRENT LIABILITIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://inmodemd.com/role/ShareholdersEquityTables" id="ShareholdersEquityTables">
        <link:definition>0034 - Disclosure - SHAREHOLDERS' EQUITY (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://inmodemd.com/role/TaxesOnIncomeTables" id="TaxesOnIncomeTables">
        <link:definition>0035 - Disclosure - INCOME TAXES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://inmodemd.com/role/Entity-wideDisclosureTables" id="Entity-wideDisclosureTables">
        <link:definition>0036 - Disclosure - ENTITY-WIDE DISCLOSURE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://inmodemd.com/role/SignificantAccountingPoliciesNarrativeDetails" id="SignificantAccountingPoliciesNarrativeDetails">
        <link:definition>0037 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://inmodemd.com/role/SignificantAccountingPoliciesScheduleOfPropertyAndEquipmentEstimatedUsefulLivesDetails" id="SignificantAccountingPoliciesScheduleOfPropertyAndEquipmentEstimatedUsefulLivesDetails">
        <link:definition>0038 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Schedule of Property and Equipment Estimated Useful Lives) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://inmodemd.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleOfAllowanceForCreditLossesDetails" id="SIGNIFICANTACCOUNTINGPOLICIESScheduleOfAllowanceForCreditLossesDetails">
        <link:definition>0039 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Schedule of Allowance For Credit Losses) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://inmodemd.com/role/SignificantAccountingPoliciesScheduleOfAccruedWarrantyDetails" id="SignificantAccountingPoliciesScheduleOfAccruedWarrantyDetails">
        <link:definition>0040 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Schedule of Accrued Warranty) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsNarrativeDetails" id="MarketableSecuritiesAndFairValueMeasurementsNarrativeDetails">
        <link:definition>0041 - Disclosure - MARKETABLE SECURITIES AND FAIR VALUE MEASUREMENTS (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsScheduleOfMarketableSecuritiesDetails" id="MarketableSecuritiesAndFairValueMeasurementsScheduleOfMarketableSecuritiesDetails">
        <link:definition>0042 - Disclosure - MARKETABLE SECURITIES AND FAIR VALUE MEASUREMENTS (Schedule Of Marketable Securities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsScheduleOfFinancialAssetsMeasuredAtFairValueDetails" id="MarketableSecuritiesAndFairValueMeasurementsScheduleOfFinancialAssetsMeasuredAtFairValueDetails">
        <link:definition>0043 - Disclosure - MARKETABLE SECURITIES AND FAIR VALUE MEASUREMENTS (Schedule of Financial Assets Measured at Fair Value) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsScheduleOfDebtSecuritiesOnMaturityDetails" id="MarketableSecuritiesAndFairValueMeasurementsScheduleOfDebtSecuritiesOnMaturityDetails">
        <link:definition>0044 - Disclosure - MARKETABLE SECURITIES AND FAIR VALUE MEASUREMENTS (Schedule of Debt Securities on Maturity) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://inmodemd.com/role/AccountsReceivableScheduleOfAccountsReceivableDetails" id="AccountsReceivableScheduleOfAccountsReceivableDetails">
        <link:definition>0045 - Disclosure - ACCOUNTS RECEIVABLE (Schedule of Accounts Receivable) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://inmodemd.com/role/OtherCurrentReceivablesScheduleOfOtherCurrentReceivablesDetails" id="OtherCurrentReceivablesScheduleOfOtherCurrentReceivablesDetails">
        <link:definition>0046 - Disclosure - PREPAID EXPENSES AND OTHER CURRENT RECEIVABLES (Schedule of Prepaid expenses and other current receivables) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://inmodemd.com/role/InventoriesScheduleOfInventoriesDetails" id="InventoriesScheduleOfInventoriesDetails">
        <link:definition>0047 - Disclosure - INVENTORIES (Schedule of Inventories) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://inmodemd.com/role/PropertyAndEquipmentNetScheduleOfPropertyAndEquipmentDetails" id="PropertyAndEquipmentNetScheduleOfPropertyAndEquipmentDetails">
        <link:definition>0048 - Disclosure - PROPERTY AND EQUIPMENT, NET (Schedule of Property and Equipment) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://inmodemd.com/role/OtherInvestmentsDetails" id="OtherInvestmentsDetails">
        <link:definition>0049 - Disclosure - OTHER INVESTMENTS (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://inmodemd.com/role/LeasesNarrativeDetails" id="LeasesNarrativeDetails">
        <link:definition>0050 - Disclosure - LEASES (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://inmodemd.com/role/LeasesScheduleOfLeaseExpenseDetails" id="LeasesScheduleOfLeaseExpenseDetails">
        <link:definition>0051 - Disclosure - LEASES (Schedule of Lease Expense) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://inmodemd.com/role/LeasesScheduleOfSupplementalCashFlowInformationRelatedToLeasesDetails" id="LeasesScheduleOfSupplementalCashFlowInformationRelatedToLeasesDetails">
        <link:definition>0052 - Disclosure - LEASES (Schedule of Supplemental Cash Flow Information Related to Leases) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://inmodemd.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails" id="LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails">
        <link:definition>0053 - Disclosure - LEASES (Schedule of Supplemental Balance Sheet Information Related to Leases) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://inmodemd.com/role/LeasesScheduleOfMaturitiesOfLeaseLiabilitiesDetails" id="LeasesScheduleOfMaturitiesOfLeaseLiabilitiesDetails">
        <link:definition>0054 - Disclosure - LEASES (Schedule of Maturities of Lease Liabilities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://inmodemd.com/role/OtherCurrentLiabilitiesScheduleOfOtherLiabilitiesDetails" id="OtherCurrentLiabilitiesScheduleOfOtherLiabilitiesDetails">
        <link:definition>0055 - Disclosure - OTHER CURRENT LIABILITIES (Schedule Of Other Liabilities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://inmodemd.com/role/CommitmentsAndContingentLiabilitiesDetails" id="CommitmentsAndContingentLiabilitiesDetails">
        <link:definition>0056 - Disclosure - COMMITMENTS AND CONTINGENCIES (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://inmodemd.com/role/ShareholdersEquityNarrativeDetails" id="ShareholdersEquityNarrativeDetails">
        <link:definition>0057 - Disclosure - SHAREHOLDERS' EQUITY (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://inmodemd.com/role/ShareholdersEquityScheduleOfOptionsGrantedDetails" id="ShareholdersEquityScheduleOfOptionsGrantedDetails">
        <link:definition>0059 - Disclosure - SHAREHOLDERS' EQUITY (Schedule Of Options Granted) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://inmodemd.com/role/ShareholdersEquityScheduleOfOutstandingAndExercisableOptionsDetails" id="ShareholdersEquityScheduleOfOutstandingAndExercisableOptionsDetails">
        <link:definition>0060 - Disclosure - SHAREHOLDERS' EQUITY (Schedule Of Outstanding and Exercisable Options) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://inmodemd.com/role/ShareholdersEquityScheduleOfOptionsGrantedRestictedShareUnitDetails" id="ShareholdersEquityScheduleOfOptionsGrantedRestictedShareUnitDetails">
        <link:definition>0061 - Disclosure - SHAREHOLDERS' EQUITY (Schedule of Options Granted Resticted Share Unit) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://inmodemd.com/role/ShareholdersEquityScheduleOfShareBasedCompensationExpenseDetails" id="ShareholdersEquityScheduleOfShareBasedCompensationExpenseDetails">
        <link:definition>0062 - Disclosure - SHAREHOLDERS' EQUITY (Schedule Of Share Based Compensation Expense) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://inmodemd.com/role/TaxesOnIncomeNarrativeDetails" id="TaxesOnIncomeNarrativeDetails">
        <link:definition>0063 - Disclosure - INCOME TAXES (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://inmodemd.com/role/TaxesOnIncomeScheduleOfDeferredTaxAssetsLiabilitiesDetails" id="TaxesOnIncomeScheduleOfDeferredTaxAssetsLiabilitiesDetails">
        <link:definition>0064 - Disclosure - INCOME TAXES (Schedule of Deferred Tax Assets (liabilities)) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://inmodemd.com/role/TaxesOnIncomeScheduleOfReconciliationOfTheoreticalProvisionForIncomeTaxDetails" id="TaxesOnIncomeScheduleOfReconciliationOfTheoreticalProvisionForIncomeTaxDetails">
        <link:definition>0065 - Disclosure - INCOME TAXES (Schedule of Reconciliation of Theoretical Provision For Income Tax) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://inmodemd.com/role/TaxesOnIncomeScheduleOfIncomeBeforeIncomeTaxesDetails" id="TaxesOnIncomeScheduleOfIncomeBeforeIncomeTaxesDetails">
        <link:definition>0066 - Disclosure - INCOME TAXES (Schedule of Income Before Income Taxes) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://inmodemd.com/role/TaxesOnIncomeScheduleOfTaxExpensesTaxBenefitDetails" id="TaxesOnIncomeScheduleOfTaxExpensesTaxBenefitDetails">
        <link:definition>0067 - Disclosure - INCOME TAXES (Schedule of Tax Expenses (Tax Benefit)) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://inmodemd.com/role/TaxesOnIncomeScheduleOfUnrecognizedTaxBenefitsDetails" id="TaxesOnIncomeScheduleOfUnrecognizedTaxBenefitsDetails">
        <link:definition>0068 - Disclosure - INCOME TAXES (Schedule of Unrecognized Tax Benefits) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://inmodemd.com/role/Entity-wideDisclosureNarrativeDetails" id="Entity-wideDisclosureNarrativeDetails">
        <link:definition>0069 - Disclosure - ENTITY-WIDE DISCLOSURE (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://inmodemd.com/role/Entity-wideDisclosureScheduleOfNetSalesByGeographicalAreaDetails" id="Entity-wideDisclosureScheduleOfNetSalesByGeographicalAreaDetails">
        <link:definition>0070 - Disclosure - ENTITY-WIDE DISCLOSURE (Schedule Of Net Sales By Geographical Area) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://inmodemd.com/role/ENTITYWIDEDISCLOSUREDisclosureOfRevenuesBasedOnProductsCategory" id="ENTITYWIDEDISCLOSUREDisclosureOfRevenuesBasedOnProductsCategory">
        <link:definition>0071 - Disclosure - ENTITY-WIDE DISCLOSURE (Schedule of revenues based on products' category) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://inmodemd.com/role/Entity-wideDisclosureScheduleOfNetSalesByTechonologyDetails" id="Entity-wideDisclosureScheduleOfNetSalesByTechonologyDetails">
        <link:definition>0072 - Disclosure - ENTITY-WIDE DISCLOSURE (Schedule of Net Sales by Techonology) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://inmodemd.com/role/Entity-wideDisclosureScheduleOfChangesInContractLiabilitiesDetails" id="Entity-wideDisclosureScheduleOfChangesInContractLiabilitiesDetails">
        <link:definition>0073 - Disclosure - ENTITY-WIDE DISCLOSURE (Schedule Of Changes In Contract Liabilities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://inmodemd.com/role/Entity-wideDisclosureScheduleOfLong-livedAssetsDetails" id="Entity-wideDisclosureScheduleOfLong-livedAssetsDetails">
        <link:definition>0074 - Disclosure - ENTITY-WIDE DISCLOSURE (Schedule Of Long-Lived Assets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://inmodemd.com/role/RelatedPartiesDetails" id="RelatedPartiesDetails">
        <link:definition>0075 - Disclosure - RELATED PARTIES (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:type="simple" xlink:href="inmd-20231231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="inmd-20231231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="inmd-20231231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="inmd-20231231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
    </appinfo>
  </annotation>
  <element name="AccountingPoliciesLineItems" id="inmd_AccountingPoliciesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AccountingPoliciesTable" id="inmd_AccountingPoliciesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" nillable="true"/>
  <element name="AcquisitionOfNonControllingInterestInExchangeOfOrdinaryShares" id="inmd_AcquisitionOfNonControllingInterestInExchangeOfOrdinaryShares" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AdjustmentToRedemptionValueOfRedeemableNonControllingInterest" id="inmd_AdjustmentToRedemptionValueOfRedeemableNonControllingInterest" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AmendmentAdvantageExemptionMember" id="inmd_AmendmentAdvantageExemptionMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AmountOfInvestment" id="inmd_AmountOfInvestment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AmountPaidToUndistributedExemptIncome" id="inmd_AmountPaidToUndistributedExemptIncome" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AutomaticIncreaseApprovedByBoardCompanyIn" id="inmd_AutomaticIncreaseApprovedByBoardCompanyIn" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AvailableForSaleSecuritiesDebtMaturitiesMoreThanFiveYearsFairValue" id="inmd_AvailableForSaleSecuritiesDebtMaturitiesMoreThanFiveYearsFairValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AvailableForSaleSecuritiesDebtMaturitiesWithInFourToFiveYearsFairValue" id="inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInFourToFiveYearsFairValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AvailableForSaleSecuritiesDebtMaturitiesWithInOneToTwoYearsFairValue" id="inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInOneToTwoYearsFairValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AvailableForSaleSecuritiesDebtMaturitiesWithInThreeToFourYearsFairValue" id="inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInThreeToFourYearsFairValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AvailableForSaleSecuritiesDebtMaturitiesWithInTwoToThreeYearsFairValue" id="inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInTwoToThreeYearsFairValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="BankGuarantee" id="inmd_BankGuarantee" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="BonusShareIssuesPerOutstandingShare" id="inmd_BonusShareIssuesPerOutstandingShare" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="BusinessDescriptionLineItems" id="inmd_BusinessDescriptionLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="BusinessDescriptionTable" id="inmd_BusinessDescriptionTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" nillable="true"/>
  <element name="CapitalEquipmentMember" id="inmd_CapitalEquipmentMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ConsumablesAndServiceRevenuesMember" id="inmd_ConsumablesAndServiceRevenuesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ContractorLiability" id="inmd_ContractorLiability" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="CorporateTax" id="inmd_CorporateTax" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CovidNinteenAbstract" id="inmd_CovidNinteenAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CovidNinteenTextBlock" id="inmd_CovidNinteenTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CurrentMonthlyRentPayment" id="inmd_CurrentMonthlyRentPayment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="DevelopmentZoneAMember" id="inmd_DevelopmentZoneAMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DilazarLimitedMember" id="inmd_DilazarLimitedMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EffectiveIncomeTaxRateReconciliationDeductionsDividendsForNonIsraeliResidents" id="inmd_EffectiveIncomeTaxRateReconciliationDeductionsDividendsForNonIsraeliResidents" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ElsewhereMember" id="inmd_ElsewhereMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EmployeeRelatedSeveranceLiabilities" id="inmd_EmployeeRelatedSeveranceLiabilities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="EmployeeSeveranceBenefitsPolicyTextBlock" id="inmd_EmployeeSeveranceBenefitsPolicyTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EmployeesMember" id="inmd_EmployeesMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EmployeesOfficersDirectorsServiceProvidersAndConsultantsMember" id="inmd_EmployeesOfficersDirectorsServiceProvidersAndConsultantsMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExerciseOfOptions" id="inmd_ExerciseOfOptions" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ExercisePriceRangeEightMember" id="inmd_ExercisePriceRangeEightMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceRangeFiveMember" id="inmd_ExercisePriceRangeFiveMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceRangeFourMember" id="inmd_ExercisePriceRangeFourMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceRangeNineMember" id="inmd_ExercisePriceRangeNineMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceRangeOneMember" id="inmd_ExercisePriceRangeOneMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceRangeSevenMember" id="inmd_ExercisePriceRangeSevenMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceRangeSixMember" id="inmd_ExercisePriceRangeSixMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceRangeThreeMember" id="inmd_ExercisePriceRangeThreeMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceRangeTwoMember" id="inmd_ExercisePriceRangeTwoMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExpensesIncomeMember" id="inmd_ExpensesIncomeMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FairValueOfOneOrdinaryShare" id="inmd_FairValueOfOneOrdinaryShare" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FairValueOfOptionsGranted" id="inmd_FairValueOfOptionsGranted" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="FairValueOfRestrictedOptionsGranted" id="inmd_FairValueOfRestrictedOptionsGranted" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FebruaryNineTwoThousandsTwentyOneMember" id="inmd_FebruaryNineTwoThousandsTwentyOneMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FebruaryNineTwoZeroTwoTwoMember" id="inmd_FebruaryNineTwoZeroTwoTwoMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FebruarySeventeenTwoThousandsTwentyMember" id="inmd_FebruarySeventeenTwoThousandsTwentyMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FifteenMarchTwoThousandsTwentyMember" id="inmd_FifteenMarchTwoThousandsTwentyMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FinanceIncome" id="inmd_FinanceIncome" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="FullyDilutedBasisMember" id="inmd_FullyDilutedBasisMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="GeneralAbstract" id="inmd_GeneralAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="GIBFAndJVCMember" id="inmd_GIBFAndJVCMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="GovernmentInstitutions" id="inmd_GovernmentInstitutions" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="HandsFreeMember" id="inmd_HandsFreeMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="HimalayaFamilyOfficeConsultingLtdMember" id="inmd_HimalayaFamilyOfficeConsultingLtdMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="HomeSkinnovationsLtdMember" id="inmd_HomeSkinnovationsLtdMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IncomeTaxNoteLineItems" id="inmd_IncomeTaxNoteLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IncomeTaxNoteTable" id="inmd_IncomeTaxNoteTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" nillable="true"/>
  <element name="IncomeTaxReconciliationAmendmentToInvestmentsLawPayment" id="inmd_IncomeTaxReconciliationAmendmentToInvestmentsLawPayment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="IncomeTaxReconciliationBenefitsToBenefitedEnterprise" id="inmd_IncomeTaxReconciliationBenefitsToBenefitedEnterprise" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="IncomeTaxReconciliationDifferentEffectiveTaxRatesApplicableToOperatingLoss" id="inmd_IncomeTaxReconciliationDifferentEffectiveTaxRatesApplicableToOperatingLoss" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="IncomeTaxReconciliationDifferentEffectiveTaxRatesApplicableToSubsidiaries" id="inmd_IncomeTaxReconciliationDifferentEffectiveTaxRatesApplicableToSubsidiaries" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="IncomeTaxReconciliationNonDeductibleExpenses" id="inmd_IncomeTaxReconciliationNonDeductibleExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="IncomeTaxReconciliationSettlementsWithIsraeliTaxAuthorityNetOfDecreaseOfRelatedUncertainTax" id="inmd_IncomeTaxReconciliationSettlementsWithIsraeliTaxAuthorityNetOfDecreaseOfRelatedUncertainTax" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="IncomeTaxReconciliationUncertainTaxPosition" id="inmd_IncomeTaxReconciliationUncertainTaxPosition" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="IncreasesDueToIssuanceOfNewContractsExcludingAmountsRecognizedAsRevenueDuringPeriod" id="inmd_IncreasesDueToIssuanceOfNewContractsExcludingAmountsRecognizedAsRevenueDuringPeriod" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="InmodeInnovationMember" id="inmd_InmodeInnovationMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="InmodeLtdAndIsreaeliSubsidiariesMember" id="inmd_InmodeLtdAndIsreaeliSubsidiariesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="InterestReceived" id="inmd_InterestReceived" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="InvestmentInShortTermDeposit" id="inmd_InvestmentInShortTermDeposit" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="IsraeliTaxAuthorityMember" id="inmd_IsraeliTaxAuthorityMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="JanuarySevenTwoThousandsTwentyMember" id="inmd_JanuarySevenTwoThousandsTwentyMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="JointVentureAgreementMember" id="inmd_JointVentureAgreementMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="JulyTwentySevenTwoThousandsTwentyOneMember" id="inmd_JulyTwentySevenTwoThousandsTwentyOneMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="JulyTwoSevenTwoZeroTwoTwoMember" id="inmd_JulyTwoSevenTwoZeroTwoTwoMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="LeaseAgreementMember" id="inmd_LeaseAgreementMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="LeaseExpires" id="inmd_LeaseExpires" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="LeasesLineItems" id="inmd_LeasesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="LeasesTable" id="inmd_LeasesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" nillable="true"/>
  <element name="MarketableSecuritiesAndFairValueMeasurementAbstract" id="inmd_MarketableSecuritiesAndFairValueMeasurementAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="MarketableSecuritiesAndFairValueMeasurements" id="inmd_MarketableSecuritiesAndFairValueMeasurements" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="MayFiveTwoThousandsTwentyMember" id="inmd_MayFiveTwoThousandsTwentyMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="MayOneTwoZeroTwoTwoMember" id="inmd_MayOneTwoZeroTwoTwoMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="MaySixTwoThousandsTwentyOneMember" id="inmd_MaySixTwoThousandsTwentyOneMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="MedimorMember" id="inmd_MedimorMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="MinimalInvasiveMember" id="inmd_MinimalInvasiveMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="MinorityInterestDecreaseFromRedemptionsOne" id="inmd_MinorityInterestDecreaseFromRedemptionsOne" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="NoAmendmentMember" id="inmd_NoAmendmentMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NonCashAcquisitionOfNoncontrollingInterestInExchangeOfOrdinaryShares" id="inmd_NonCashAcquisitionOfNoncontrollingInterestInExchangeOfOrdinaryShares" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="NonInvasiveMember" id="inmd_NonInvasiveMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NonIsraeliPlanMember" id="inmd_NonIsraeliPlanMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NonUsGovernmentAgenciesDebtSecuritiesMember" id="inmd_NonUsGovernmentAgenciesDebtSecuritiesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NovemberElevenTwoThousandsTwentyMember" id="inmd_NovemberElevenTwoThousandsTwentyMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfOrdinarySharesConsideration" id="inmd_NumberOfOrdinarySharesConsideration" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfShareholder" id="inmd_NumberOfShareholder" type="xbrli:integerItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OctoberTwoSixTwoZeroTwoTwoMember" id="inmd_OctoberTwoSixTwoZeroTwoTwoMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OneTimePayment" id="inmd_OneTimePayment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="OperatingLeaseRightOfUseAssests" id="inmd_OperatingLeaseRightOfUseAssests" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="OptionsChangesDuringYear" id="inmd_OptionsChangesDuringYear" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OtherAdvancesToSuppliersCurrent" id="inmd_OtherAdvancesToSuppliersCurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="OtherCountryMember" id="inmd_OtherCountryMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OtherCurrentLeaseLiabilities" id="inmd_OtherCurrentLeaseLiabilities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="OtherCurrentLiabilitiesLineItems" id="inmd_OtherCurrentLiabilitiesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OtherCurrentLiabilitiesTable" id="inmd_OtherCurrentLiabilitiesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" nillable="true"/>
  <element name="OtherCurrentReceivables" id="inmd_OtherCurrentReceivables" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OtherGovernmentInstitutionsReceivablesCurrent" id="inmd_OtherGovernmentInstitutionsReceivablesCurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="OtherIncomeTaxReceivablesCurrent" id="inmd_OtherIncomeTaxReceivablesCurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="OtherOperatingExpenseIncome" id="inmd_OtherOperatingExpenseIncome" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="OtherPrepaidExpensesReceivablesCurrent" id="inmd_OtherPrepaidExpensesReceivablesCurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="OtherReceivablesNonCurrent" id="inmd_OtherReceivablesNonCurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="OwnershipInterestExchange" id="inmd_OwnershipInterestExchange" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PaymentsToTaxAuthorities" id="inmd_PaymentsToTaxAuthorities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="PercentageOfNetSalesBasedOnProductsTechnology" id="inmd_PercentageOfNetSalesBasedOnProductsTechnology" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PercentageOfNonCurrentDeferredRevenue" id="inmd_PercentageOfNonCurrentDeferredRevenue" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PrepaidExpensesAndOtherCurrentReceivablesTextBlock" id="inmd_PrepaidExpensesAndOtherCurrentReceivablesTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PreviousYearIncomeTaxExpenseBenefit" id="inmd_PreviousYearIncomeTaxExpenseBenefit" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ProceedsFromInvestmentInShortTermDeposit" id="inmd_ProceedsFromInvestmentInShortTermDeposit" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ProceedsFromMaturityOfMarketableSecurities" id="inmd_ProceedsFromMaturityOfMarketableSecurities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="RegulationsMember" id="inmd_RegulationsMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RelatedPartyConsiderationForAggregateAmount" id="inmd_RelatedPartyConsiderationForAggregateAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ScheduleOfOtherReceivablesCurrentTableTextBlock" id="inmd_ScheduleOfOtherReceivablesCurrentTableTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ScheduleOfPrepaidExpensesAndOtherCurrentRecivablesTableTextBlock" id="inmd_ScheduleOfPrepaidExpensesAndOtherCurrentRecivablesTableTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock" id="inmd_ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ScheduleOfSupplementalBalanceSheetInformationRelatedToLeases" id="inmd_ScheduleOfSupplementalBalanceSheetInformationRelatedToLeases" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ScheduleOfSupplementalCashFlowInformationRelatedToLeases" id="inmd_ScheduleOfSupplementalCashFlowInformationRelatedToLeases" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonVestedVested" id="inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonVestedVested" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue" id="inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsEarlyExerciseMultiple" id="inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsEarlyExerciseMultiple" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedFour" id="inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedFour" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedOne" id="inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedOne" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedThree" id="inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedThree" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedTwo" id="inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedTwo" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedUponAdoption" id="inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedUponAdoption" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriod" id="inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriod" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAwardAmount" id="inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAwardAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionCancelledInPeriodWeightedAverageExercisePrice" id="inmd_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionCancelledInPeriodWeightedAverageExercisePrice" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ShareBasedCompensationAwardTrancheFourMember" id="inmd_ShareBasedCompensationAwardTrancheFourMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice" id="inmd_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SharePurchaseAndShareholdersAgreementMember" id="inmd_SharePurchaseAndShareholdersAgreementMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ShareRepurchaseProgramMember" id="inmd_ShareRepurchaseProgramMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SharesAuthorizedAmount" id="inmd_SharesAuthorizedAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ShareValueOfAcquisitionOfNonControllingInterestInExchangeOfOrdinaryShares" id="inmd_ShareValueOfAcquisitionOfNonControllingInterestInExchangeOfOrdinaryShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ShortTermBankDepositsPolicyTextBlock" id="inmd_ShortTermBankDepositsPolicyTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ShortTermDepositsAnnualInterestRate" id="inmd_ShortTermDepositsAnnualInterestRate" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SpaMedicalInternationalLsrlMember" id="inmd_SpaMedicalInternationalLsrlMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SpecialPreferredEnterpriseMember" id="inmd_SpecialPreferredEnterpriseMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="StockRepurchasedDuringPeriodValueOne" id="inmd_StockRepurchasedDuringPeriodValueOne" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="StockRepurchasedOrdinarySharesDuringPeriodShares" id="inmd_StockRepurchasedOrdinarySharesDuringPeriodShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="StockRepurchasedOrdinarySharesDuringPeriodValue" id="inmd_StockRepurchasedOrdinarySharesDuringPeriodValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="SubsidiariesFourMember" id="inmd_SubsidiariesFourMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SubsidiariesOutsideIsraelMember" id="inmd_SubsidiariesOutsideIsraelMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SubsidiariesThreeMember" id="inmd_SubsidiariesThreeMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SubsidiaryOfHomeSkinnovationsLtdMember" id="inmd_SubsidiaryOfHomeSkinnovationsLtdMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TaxBenefitYear" id="inmd_TaxBenefitYear" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TaxRateForRecipientForDividendsDistributedByPreferredCompany" id="inmd_TaxRateForRecipientForDividendsDistributedByPreferredCompany" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TotalLongLivedAssetsByGeographicalArea" id="inmd_TotalLongLivedAssetsByGeographicalArea" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="TreasurySharesPolicyTextBlock" id="inmd_TreasurySharesPolicyTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TwoPurchaseAndShareholdersAgreementsMember" id="inmd_TwoPurchaseAndShareholdersAgreementsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TwoThousandsEighteenIncentivePlanMember" id="inmd_TwoThousandsEighteenIncentivePlanMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="UnderwritersAllotmentOptionMember" id="inmd_UnderwritersAllotmentOptionMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="UndistributedExemptIncome" id="inmd_UndistributedExemptIncome" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="UnitsChangesDuringYearAbstract" id="inmd_UnitsChangesDuringYearAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantyReserveLiabilityCurrent" id="inmd_WarrantyReserveLiabilityCurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="WarRiskSituationInIsraelPolicyTextBlock" id="inmd_WarRiskSituationInIsraelPolicyTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WeightedAverageExercisePriceChangesDuringYearAbstract" id="inmd_WeightedAverageExercisePriceChangesDuringYearAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WeightedAverageGrantDateChangesDuringYearAbstract" id="inmd_WeightedAverageGrantDateChangesDuringYearAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WeightedAverageNumberOfSharesOutStandingUsedInComputationOfNetIncomePerShareAbstract" id="inmd_WeightedAverageNumberOfSharesOutStandingUsedInComputationOfNetIncomePerShareAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>13
<FILENAME>inmd-20231231_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <!-- INTEGIX by Ez-XBRL -->
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#ConsolidatedBalanceSheets" roleURI="http://inmodemd.com/role/ConsolidatedBalanceSheets"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#ConsolidatedStatementsOfIncome" roleURI="http://inmodemd.com/role/ConsolidatedStatementsOfIncome"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#ConsolidatedStatementsOfComprehensiveIncome" roleURI="http://inmodemd.com/role/ConsolidatedStatementsOfComprehensiveIncome"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#ConsolidatedStatementsOfCashFlows" roleURI="http://inmodemd.com/role/ConsolidatedStatementsOfCashFlows"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#MarketableSecuritiesAndFairValueMeasurementsScheduleOfDebtSecuritiesOnMaturityDetails" roleURI="http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsScheduleOfDebtSecuritiesOnMaturityDetails"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#AccountsReceivableScheduleOfAccountsReceivableDetails" roleURI="http://inmodemd.com/role/AccountsReceivableScheduleOfAccountsReceivableDetails"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#OtherCurrentReceivablesScheduleOfOtherCurrentReceivablesDetails" roleURI="http://inmodemd.com/role/OtherCurrentReceivablesScheduleOfOtherCurrentReceivablesDetails"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#InventoriesScheduleOfInventoriesDetails" roleURI="http://inmodemd.com/role/InventoriesScheduleOfInventoriesDetails"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#PropertyAndEquipmentNetScheduleOfPropertyAndEquipmentDetails" roleURI="http://inmodemd.com/role/PropertyAndEquipmentNetScheduleOfPropertyAndEquipmentDetails"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails" roleURI="http://inmodemd.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#LeasesScheduleOfMaturitiesOfLeaseLiabilitiesDetails" roleURI="http://inmodemd.com/role/LeasesScheduleOfMaturitiesOfLeaseLiabilitiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#OtherCurrentLiabilitiesScheduleOfOtherLiabilitiesDetails" roleURI="http://inmodemd.com/role/OtherCurrentLiabilitiesScheduleOfOtherLiabilitiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#TaxesOnIncomeScheduleOfDeferredTaxAssetsLiabilitiesDetails" roleURI="http://inmodemd.com/role/TaxesOnIncomeScheduleOfDeferredTaxAssetsLiabilitiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#TaxesOnIncomeScheduleOfReconciliationOfTheoreticalProvisionForIncomeTaxDetails" roleURI="http://inmodemd.com/role/TaxesOnIncomeScheduleOfReconciliationOfTheoreticalProvisionForIncomeTaxDetails"/>
  <calculationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/ConsolidatedBalanceSheets">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepositsAssetsCurrent" xlink:label="loc_us-gaap_DepositsAssetsCurrent_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaap_AssetsNoncurrent_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetNoncurrent" xlink:label="loc_us-gaap_AccountsReceivableNetNoncurrent_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxAssetsNet" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherInvestments" xlink:label="loc_us-gaap_OtherInvestments_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaap_TreasuryStockValue_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaap_CommitmentsAndContingencies_30"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_0" xlink:to="loc_us-gaap_AssetsCurrent_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_1" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_1" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_1" xlink:to="loc_us-gaap_DepositsAssetsCurrent_3" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_1" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_4" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_1" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_5" order="40" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_1" xlink:to="loc_us-gaap_InventoryNet_6" order="50" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_0" xlink:to="loc_us-gaap_AssetsNoncurrent_8" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_8" xlink:to="loc_us-gaap_AccountsReceivableNetNoncurrent_8" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_8" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_9" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_10" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_8" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_11" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_8" xlink:to="loc_us-gaap_OtherInvestments_12" order="40" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_14" xlink:to="loc_us-gaap_StockholdersEquity_15" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_15" xlink:to="loc_us-gaap_CommonStockValue_15" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_15" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_16" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_15" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_17" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_15" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_18" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_15" xlink:to="loc_us-gaap_TreasuryStockValue_19" order="40" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_14" xlink:to="loc_us-gaap_Liabilities_21" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_21" xlink:to="loc_us-gaap_LiabilitiesCurrent_21" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_21" xlink:to="loc_us-gaap_AccountsPayableCurrent_21" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_21" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_22" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_21" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_23" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_21" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_25" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_25" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_25" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_25" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_26" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_25" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_27" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_14" xlink:to="loc_us-gaap_CommitmentsAndContingencies_30" order="20" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/ConsolidatedStatementsOfIncome">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaap_GrossProfit_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaap_CostOfRevenue_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaap_SellingAndMarketingExpense_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_6"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_OtherOperatingExpenseIncome" xlink:label="loc_inmd_OtherOperatingExpenseIncome_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeNet" xlink:label="loc_us-gaap_InvestmentIncomeNet_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_14"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_0" xlink:to="loc_us-gaap_ProfitLoss_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_1" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1" xlink:to="loc_us-gaap_OperatingIncomeLoss_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_1" xlink:to="loc_us-gaap_GrossProfit_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_1" xlink:to="loc_us-gaap_Revenues_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_1" xlink:to="loc_us-gaap_CostOfRevenue_2" order="10" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_1" xlink:to="loc_us-gaap_OperatingExpenses_4" order="10" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_4" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_4" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_4" xlink:to="loc_us-gaap_SellingAndMarketingExpense_5" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_4" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_6" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_4" xlink:to="loc_inmd_OtherOperatingExpenseIncome_7" order="30" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1" xlink:to="loc_us-gaap_InvestmentIncomeNet_10" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_1" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_12" order="10" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_0" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_14" order="10" use="optional" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/ConsolidatedStatementsOfComprehensiveIncome">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_5"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_0" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1" xlink:to="loc_us-gaap_ProfitLoss_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_0" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_5" order="10" use="optional" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/ConsolidatedStatementsOfCashFlows">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnInvestments" xlink:label="loc_us-gaap_GainLossOnInvestments_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeExpenseNet" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherReceivables" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherReceivables_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_16"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_InvestmentInShortTermDeposit" xlink:label="loc_inmd_InvestmentInShortTermDeposit_16"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ProceedsFromInvestmentInShortTermDeposit" xlink:label="loc_inmd_ProceedsFromInvestmentInShortTermDeposit_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireMarketableSecurities" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_21"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ProceedsFromMaturityOfMarketableSecurities" xlink:label="loc_inmd_ProceedsFromMaturityOfMarketableSecurities_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_27"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1" xlink:to="loc_us-gaap_ProfitLoss_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1" xlink:to="loc_us-gaap_ShareBasedCompensation_3" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_4" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1" xlink:to="loc_us-gaap_GainLossOnInvestments_5" order="40" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_6" order="50" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_7" order="60" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_8" order="70" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherReceivables_9" order="80" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_10" order="90" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_11" order="100" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_12" order="110" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_13" order="120" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_14" order="130" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_16" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_16" xlink:to="loc_inmd_InvestmentInShortTermDeposit_16" order="0" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_16" xlink:to="loc_inmd_ProceedsFromInvestmentInShortTermDeposit_17" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_16" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_18" order="20" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_16" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_19" order="30" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_16" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_20" order="40" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_16" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_21" order="50" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_16" xlink:to="loc_inmd_ProceedsFromMaturityOfMarketableSecurities_22" order="60" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_24" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_24" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_24" order="0" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_24" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_25" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_27" order="30" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsScheduleOfDebtSecuritiesOnMaturityDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_1"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInOneToTwoYearsFairValue" xlink:label="loc_inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInOneToTwoYearsFairValue_2"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInTwoToThreeYearsFairValue" xlink:label="loc_inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInTwoToThreeYearsFairValue_3"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInThreeToFourYearsFairValue" xlink:label="loc_inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInThreeToFourYearsFairValue_4"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInFourToFiveYearsFairValue" xlink:label="loc_inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInFourToFiveYearsFairValue_5"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_AvailableForSaleSecuritiesDebtMaturitiesMoreThanFiveYearsFairValue" xlink:label="loc_inmd_AvailableForSaleSecuritiesDebtMaturitiesMoreThanFiveYearsFairValue_6"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_0" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_0" xlink:to="loc_inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInOneToTwoYearsFairValue_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_0" xlink:to="loc_inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInTwoToThreeYearsFairValue_3" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_0" xlink:to="loc_inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInThreeToFourYearsFairValue_4" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_0" xlink:to="loc_inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInFourToFiveYearsFairValue_5" order="40" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_0" xlink:to="loc_inmd_AvailableForSaleSecuritiesDebtMaturitiesMoreThanFiveYearsFairValue_6" order="50" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/AccountsReceivableScheduleOfAccountsReceivableDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsAndNotesReceivableNet" xlink:label="loc_us-gaap_AccountsAndNotesReceivableNet_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableGross" xlink:label="loc_us-gaap_AccountsReceivableGross_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesReceivableGross" xlink:label="loc_us-gaap_NotesReceivableGross_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_3"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsAndNotesReceivableNet_0" xlink:to="loc_us-gaap_AccountsReceivableGross_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsAndNotesReceivableNet_0" xlink:to="loc_us-gaap_NotesReceivableGross_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsAndNotesReceivableNet_0" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_3" order="20" use="optional" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/OtherCurrentReceivablesScheduleOfOtherCurrentReceivablesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_0"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_OtherAdvancesToSuppliersCurrent" xlink:label="loc_inmd_OtherAdvancesToSuppliersCurrent_1"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_OtherPrepaidExpensesReceivablesCurrent" xlink:label="loc_inmd_OtherPrepaidExpensesReceivablesCurrent_2"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_OtherGovernmentInstitutionsReceivablesCurrent" xlink:label="loc_inmd_OtherGovernmentInstitutionsReceivablesCurrent_3"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_OtherIncomeTaxReceivablesCurrent" xlink:label="loc_inmd_OtherIncomeTaxReceivablesCurrent_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivablesGrossCurrent" xlink:label="loc_us-gaap_OtherReceivablesGrossCurrent_5"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherReceivablesNetCurrent_0" xlink:to="loc_inmd_OtherAdvancesToSuppliersCurrent_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherReceivablesNetCurrent_0" xlink:to="loc_inmd_OtherPrepaidExpensesReceivablesCurrent_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherReceivablesNetCurrent_0" xlink:to="loc_inmd_OtherGovernmentInstitutionsReceivablesCurrent_3" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherReceivablesNetCurrent_0" xlink:to="loc_inmd_OtherIncomeTaxReceivablesCurrent_4" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherReceivablesNetCurrent_0" xlink:to="loc_us-gaap_OtherReceivablesGrossCurrent_5" order="40" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/InventoriesScheduleOfInventoriesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryRawMaterials" xlink:label="loc_us-gaap_InventoryRawMaterials_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoods" xlink:label="loc_us-gaap_InventoryFinishedGoods_2"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_0" xlink:to="loc_us-gaap_InventoryRawMaterials_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_0" xlink:to="loc_us-gaap_InventoryFinishedGoods_2" order="10" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/PropertyAndEquipmentNetScheduleOfPropertyAndEquipmentDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_0" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2" order="10" use="optional" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_1"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_OtherCurrentLeaseLiabilities" xlink:label="loc_inmd_OtherCurrentLeaseLiabilities_2"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_0" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_0" xlink:to="loc_inmd_OtherCurrentLeaseLiabilities_2" order="10" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/LeasesScheduleOfMaturitiesOfLeaseLiabilitiesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_5"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_3" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_4" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_5" order="40" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/OtherCurrentLiabilitiesScheduleOfOtherLiabilitiesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_1"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_GovernmentInstitutions" xlink:label="loc_inmd_GovernmentInstitutions_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedIncomeTaxesCurrent" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_3"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_WarrantyReserveLiabilityCurrent" xlink:label="loc_inmd_WarrantyReserveLiabilityCurrent_4"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_OtherCurrentLeaseLiabilities" xlink:label="loc_inmd_OtherCurrentLeaseLiabilities_5"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ContractorLiability" xlink:label="loc_inmd_ContractorLiability_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_7"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_0" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_0" xlink:to="loc_inmd_GovernmentInstitutions_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_0" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_3" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_0" xlink:to="loc_inmd_WarrantyReserveLiabilityCurrent_4" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_0" xlink:to="loc_inmd_OtherCurrentLeaseLiabilities_5" order="40" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_0" xlink:to="loc_inmd_ContractorLiability_6" order="50" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_0" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_7" order="60" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/TaxesOnIncomeScheduleOfDeferredTaxAssetsLiabilitiesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOtherComprehensiveLoss" xlink:label="loc_us-gaap_DeferredTaxAssetsOtherComprehensiveLoss_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_6"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_0" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_1" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_1" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_1" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_3" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_1" xlink:to="loc_us-gaap_DeferredTaxAssetsOtherComprehensiveLoss_4" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_0" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_6" order="10" use="optional" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/TaxesOnIncomeScheduleOfReconciliationOfTheoreticalProvisionForIncomeTaxDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_1"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_IncomeTaxReconciliationBenefitsToBenefitedEnterprise" xlink:label="loc_inmd_IncomeTaxReconciliationBenefitsToBenefitedEnterprise_2"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_IncomeTaxReconciliationDifferentEffectiveTaxRatesApplicableToSubsidiaries" xlink:label="loc_inmd_IncomeTaxReconciliationDifferentEffectiveTaxRatesApplicableToSubsidiaries_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_4"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_IncomeTaxReconciliationUncertainTaxPosition" xlink:label="loc_inmd_IncomeTaxReconciliationUncertainTaxPosition_5"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_IncomeTaxReconciliationNonDeductibleExpenses" xlink:label="loc_inmd_IncomeTaxReconciliationNonDeductibleExpenses_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:label="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_7"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_IncomeTaxReconciliationAmendmentToInvestmentsLawPayment" xlink:label="loc_inmd_IncomeTaxReconciliationAmendmentToInvestmentsLawPayment_8"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_IncomeTaxReconciliationSettlementsWithIsraeliTaxAuthorityNetOfDecreaseOfRelatedUncertainTax" xlink:label="loc_inmd_IncomeTaxReconciliationSettlementsWithIsraeliTaxAuthorityNetOfDecreaseOfRelatedUncertainTax_9"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_IncomeTaxReconciliationDifferentEffectiveTaxRatesApplicableToOperatingLoss" xlink:label="loc_inmd_IncomeTaxReconciliationDifferentEffectiveTaxRatesApplicableToOperatingLoss_10"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_0" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_0" xlink:to="loc_inmd_IncomeTaxReconciliationBenefitsToBenefitedEnterprise_2" order="10" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_0" xlink:to="loc_inmd_IncomeTaxReconciliationDifferentEffectiveTaxRatesApplicableToSubsidiaries_3" order="20" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_0" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_4" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_0" xlink:to="loc_inmd_IncomeTaxReconciliationUncertainTaxPosition_5" order="40" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_0" xlink:to="loc_inmd_IncomeTaxReconciliationNonDeductibleExpenses_6" order="50" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_0" xlink:to="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_7" order="60" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_0" xlink:to="loc_inmd_IncomeTaxReconciliationAmendmentToInvestmentsLawPayment_8" order="70" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_0" xlink:to="loc_inmd_IncomeTaxReconciliationSettlementsWithIsraeliTaxAuthorityNetOfDecreaseOfRelatedUncertainTax_9" order="80" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_0" xlink:to="loc_inmd_IncomeTaxReconciliationDifferentEffectiveTaxRatesApplicableToOperatingLoss_10" order="90" use="optional" weight="1"/>
  </calculationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>14
<FILENAME>inmd-20231231_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <!-- INTEGIX by Ez-XBRL -->
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#DocumentAndEntityInformation" roleURI="http://inmodemd.com/role/DocumentAndEntityInformation"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#ConsolidatedStatementsOfChangesInShareholdersEquity" roleURI="http://inmodemd.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#ShareholdersEquityTables" roleURI="http://inmodemd.com/role/ShareholdersEquityTables"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#SignificantAccountingPoliciesNarrativeDetails" roleURI="http://inmodemd.com/role/SignificantAccountingPoliciesNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#SignificantAccountingPoliciesScheduleOfPropertyAndEquipmentEstimatedUsefulLivesDetails" roleURI="http://inmodemd.com/role/SignificantAccountingPoliciesScheduleOfPropertyAndEquipmentEstimatedUsefulLivesDetails"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#MarketableSecuritiesAndFairValueMeasurementsNarrativeDetails" roleURI="http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#MarketableSecuritiesAndFairValueMeasurementsScheduleOfMarketableSecuritiesDetails" roleURI="http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsScheduleOfMarketableSecuritiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#MarketableSecuritiesAndFairValueMeasurementsScheduleOfFinancialAssetsMeasuredAtFairValueDetails" roleURI="http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsScheduleOfFinancialAssetsMeasuredAtFairValueDetails"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#PropertyAndEquipmentNetScheduleOfPropertyAndEquipmentDetails" roleURI="http://inmodemd.com/role/PropertyAndEquipmentNetScheduleOfPropertyAndEquipmentDetails"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#OtherInvestmentsDetails" roleURI="http://inmodemd.com/role/OtherInvestmentsDetails"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#LeasesNarrativeDetails" roleURI="http://inmodemd.com/role/LeasesNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails" roleURI="http://inmodemd.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#OtherCurrentLiabilitiesScheduleOfOtherLiabilitiesDetails" roleURI="http://inmodemd.com/role/OtherCurrentLiabilitiesScheduleOfOtherLiabilitiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#ShareholdersEquityNarrativeDetails" roleURI="http://inmodemd.com/role/ShareholdersEquityNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#ShareholdersEquityScheduleOfOptionsGrantedDetails" roleURI="http://inmodemd.com/role/ShareholdersEquityScheduleOfOptionsGrantedDetails"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#ShareholdersEquityScheduleOfOutstandingAndExercisableOptionsDetails" roleURI="http://inmodemd.com/role/ShareholdersEquityScheduleOfOutstandingAndExercisableOptionsDetails"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#ShareholdersEquityScheduleOfOptionsGrantedRestictedShareUnitDetails" roleURI="http://inmodemd.com/role/ShareholdersEquityScheduleOfOptionsGrantedRestictedShareUnitDetails"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#ShareholdersEquityScheduleOfShareBasedCompensationExpenseDetails" roleURI="http://inmodemd.com/role/ShareholdersEquityScheduleOfShareBasedCompensationExpenseDetails"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#TaxesOnIncomeNarrativeDetails" roleURI="http://inmodemd.com/role/TaxesOnIncomeNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#TaxesOnIncomeScheduleOfIncomeBeforeIncomeTaxesDetails" roleURI="http://inmodemd.com/role/TaxesOnIncomeScheduleOfIncomeBeforeIncomeTaxesDetails"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#TaxesOnIncomeScheduleOfTaxExpensesTaxBenefitDetails" roleURI="http://inmodemd.com/role/TaxesOnIncomeScheduleOfTaxExpensesTaxBenefitDetails"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#Entity-wideDisclosureNarrativeDetails" roleURI="http://inmodemd.com/role/Entity-wideDisclosureNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#Entity-wideDisclosureScheduleOfNetSalesByGeographicalAreaDetails" roleURI="http://inmodemd.com/role/Entity-wideDisclosureScheduleOfNetSalesByGeographicalAreaDetails"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#Entity-wideDisclosureScheduleOfNetSalesByTechonologyDetails" roleURI="http://inmodemd.com/role/Entity-wideDisclosureScheduleOfNetSalesByTechonologyDetails"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#Entity-wideDisclosureScheduleOfLong-livedAssetsDetails" roleURI="http://inmodemd.com/role/Entity-wideDisclosureScheduleOfLong-livedAssetsDetails"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#RelatedPartiesDetails" roleURI="http://inmodemd.com/role/RelatedPartiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#ENTITYWIDEDISCLOSUREDisclosureOfRevenuesBasedOnProductsCategory" roleURI="http://inmodemd.com/role/ENTITYWIDEDISCLOSUREDisclosureOfRevenuesBasedOnProductsCategory"/>
  <roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd#eedm"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll"/>
  <definitionLink xlink:type="extended" xlink:role="http://inmodemd.com/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="loc_dei_EntityAddressesAddressTypeAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AddressTypeDomain" xlink:label="loc_dei_AddressTypeDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_BusinessContactMember" xlink:label="loc_dei_BusinessContactMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AddressTypeDomain" xlink:label="loc_dei_AddressTypeDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_dei_DocumentRegistrationStatement_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_dei_DocumentAnnualReport_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_dei_DocumentTransitionReport_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_dei_DocumentShellCompanyReport_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_dei_EntityFileNumber_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_ContactPersonnelName" xlink:label="loc_dei_ContactPersonnelName_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_dei_EntityAddressAddressLine2_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_dei_EntityAddressAddressLine3_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_dei_EntityAddressCountry_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_ContactPersonnelFaxNumber" xlink:label="loc_dei_ContactPersonnelFaxNumber_29"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_ContactPersonnelEmailAddress" xlink:label="loc_dei_ContactPersonnelEmailAddress_30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_dei_Security12bTitle_31"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_32"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_dei_SecurityExchangeName_33"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_dei_Security12gTitle_34"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_dei_SecurityReportingObligation_35"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_36"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_37"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_dei_EntityVoluntaryFilers_38"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_dei_EntityCurrentReportingStatus_39"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_dei_EntityInteractiveDataCurrent_40"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_41"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_42"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_dei_EntityExTransitionPeriod_43"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_dei_DocumentAccountingStandard_44"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_dei_OtherReportingStandardItemNumber_45"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_dei_EntityShellCompany_46"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="loc_dei_IcfrAuditorAttestationFlag_47"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorName" xlink:label="loc_dei_AuditorName_48"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorLocation" xlink:label="loc_dei_AuditorLocation_49"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorFirmId" xlink:label="loc_dei_AuditorFirmId_50"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="loc_dei_DocumentFinStmtErrorCorrectionFlag_51"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StatementTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_dei_EntityAddressesAddressTypeAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_1" xlink:to="loc_dei_AddressTypeDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_AddressTypeDomain_1" xlink:to="loc_dei_BusinessContactMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_1" xlink:to="loc_dei_AddressTypeDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_EntityRegistrantName_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_EntityCentralIndexKey_7" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_DocumentType_8" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_DocumentPeriodEndDate_9" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_CurrentFiscalYearEndDate_10" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_DocumentFiscalYearFocus_11" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_DocumentFiscalPeriodFocus_12" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_AmendmentFlag_13" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_DocumentRegistrationStatement_14" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_DocumentAnnualReport_15" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_DocumentTransitionReport_16" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_DocumentShellCompanyReport_17" order="120" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_EntityFileNumber_18" order="130" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_ContactPersonnelName_19" order="140" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_EntityIncorporationStateCountryCode_20" order="150" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_EntityAddressAddressLine1_21" order="160" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_EntityAddressAddressLine2_22" order="170" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_EntityAddressAddressLine3_23" order="180" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_EntityAddressCityOrTown_24" order="190" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_EntityAddressPostalZipCode_25" order="200" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_EntityAddressCountry_26" order="210" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_CityAreaCode_27" order="220" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_LocalPhoneNumber_28" order="230" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_ContactPersonnelFaxNumber_29" order="240" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_ContactPersonnelEmailAddress_30" order="250" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_Security12bTitle_31" order="260" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_TradingSymbol_32" order="270" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_SecurityExchangeName_33" order="280" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_Security12gTitle_34" order="290" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_SecurityReportingObligation_35" order="300" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_36" order="310" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_37" order="320" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_EntityVoluntaryFilers_38" order="330" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_EntityCurrentReportingStatus_39" order="340" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_EntityInteractiveDataCurrent_40" order="350" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_EntityFilerCategory_41" order="360" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_EntityEmergingGrowthCompany_42" order="370" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_EntityExTransitionPeriod_43" order="380" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_DocumentAccountingStandard_44" order="390" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_OtherReportingStandardItemNumber_45" order="400" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_EntityShellCompany_46" order="410" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_IcfrAuditorAttestationFlag_47" order="420" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_AuditorName_48" order="430" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_AuditorLocation_49" order="440" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_AuditorFirmId_50" order="450" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_DocumentFinStmtErrorCorrectionFlag_51" order="460" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://inmodemd.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonMember" xlink:label="loc_us-gaap_TreasuryStockCommonMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaap_NoncontrollingInterestMember_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_15"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_AcquisitionOfNonControllingInterestInExchangeOfOrdinaryShares" xlink:label="loc_inmd_AcquisitionOfNonControllingInterestInExchangeOfOrdinaryShares_16"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ShareValueOfAcquisitionOfNonControllingInterestInExchangeOfOrdinaryShares" xlink:label="loc_inmd_ShareValueOfAcquisitionOfNonControllingInterestInExchangeOfOrdinaryShares_17"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_StockRepurchasedOrdinarySharesDuringPeriodValue" xlink:label="loc_inmd_StockRepurchasedOrdinarySharesDuringPeriodValue_18"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_StockRepurchasedOrdinarySharesDuringPeriodShares" xlink:label="loc_inmd_StockRepurchasedOrdinarySharesDuringPeriodShares_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_21"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StatementTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1" xlink:to="loc_us-gaap_EquityComponentDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1" xlink:to="loc_us-gaap_CommonStockMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1" xlink:to="loc_us-gaap_RetainedEarningsMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1" xlink:to="loc_us-gaap_TreasuryStockCommonMember_5" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1" xlink:to="loc_us-gaap_NoncontrollingInterestMember_6" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1" xlink:to="loc_us-gaap_EquityComponentDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_11" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_12" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_ProfitLoss_13" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_14" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_15" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_inmd_AcquisitionOfNonControllingInterestInExchangeOfOrdinaryShares_16" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_inmd_ShareValueOfAcquisitionOfNonControllingInterestInExchangeOfOrdinaryShares_17" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_inmd_StockRepurchasedOrdinarySharesDuringPeriodValue_18" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_inmd_StockRepurchasedOrdinarySharesDuringPeriodShares_19" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_20" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_21" order="110" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://inmodemd.com/role/ShareholdersEquityTables">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:label="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GranteeStatusAxis" xlink:label="loc_us-gaap_GranteeStatusAxis_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GranteeStatusDomain" xlink:label="loc_us-gaap_GranteeStatusDomain_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:label="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GranteeStatusDomain" xlink:label="loc_us-gaap_GranteeStatusDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_Default"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_5" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6" order="50" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6" xlink:to="loc_us-gaap_GranteeStatusAxis_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_GranteeStatusAxis_6" xlink:to="loc_us-gaap_GranteeStatusDomain_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GranteeStatusDomain_6" xlink:to="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_GranteeStatusAxis_6" xlink:to="loc_us-gaap_GranteeStatusDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6" xlink:to="loc_us-gaap_AwardTypeAxis_10" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_10" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_10" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_10" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_Default" order="10" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://inmodemd.com/role/SignificantAccountingPoliciesNarrativeDetails">
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_AccountingPoliciesLineItems" xlink:label="loc_inmd_AccountingPoliciesLineItems_0"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_AccountingPoliciesTable" xlink:label="loc_inmd_AccountingPoliciesTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis" xlink:label="loc_srt_StatementScenarioAxis_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srt_ScenarioUnspecifiedDomain_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioForecastMember" xlink:label="loc_srt_ScenarioForecastMember_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srt_ScenarioUnspecifiedDomain_Default"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ShortTermDepositsAnnualInterestRate" xlink:label="loc_inmd_ShortTermDepositsAnnualInterestRate_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdvertisingExpense" xlink:label="loc_us-gaap_AdvertisingExpense_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeveranceCosts1" xlink:label="loc_us-gaap_SeveranceCosts1_14"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_EmployeeRelatedSeveranceLiabilities" xlink:label="loc_inmd_EmployeeRelatedSeveranceLiabilities_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="loc_us-gaap_NumberOfOperatingSegments_17"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_inmd_AccountingPoliciesLineItems_0" xlink:to="loc_inmd_AccountingPoliciesTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_inmd_AccountingPoliciesTable_1" xlink:to="loc_srt_RangeAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_1" xlink:to="loc_srt_RangeMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1" xlink:to="loc_srt_MinimumMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1" xlink:to="loc_srt_MaximumMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_1" xlink:to="loc_srt_RangeMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_inmd_AccountingPoliciesTable_1" xlink:to="loc_srt_StatementScenarioAxis_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_6" xlink:to="loc_srt_ScenarioUnspecifiedDomain_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_6" xlink:to="loc_srt_ScenarioForecastMember_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_6" xlink:to="loc_srt_ScenarioUnspecifiedDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_inmd_AccountingPoliciesLineItems_0" xlink:to="loc_inmd_ShortTermDepositsAnnualInterestRate_11" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_inmd_AccountingPoliciesLineItems_0" xlink:to="loc_us-gaap_AdvertisingExpense_12" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_inmd_AccountingPoliciesLineItems_0" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_13" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_inmd_AccountingPoliciesLineItems_0" xlink:to="loc_us-gaap_SeveranceCosts1_14" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_inmd_AccountingPoliciesLineItems_0" xlink:to="loc_inmd_EmployeeRelatedSeveranceLiabilities_15" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_inmd_AccountingPoliciesLineItems_0" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_16" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_inmd_AccountingPoliciesLineItems_0" xlink:to="loc_us-gaap_NumberOfOperatingSegments_17" order="70" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://inmodemd.com/role/SignificantAccountingPoliciesScheduleOfPropertyAndEquipmentEstimatedUsefulLivesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaap_ComputerEquipmentMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ToolsDiesAndMoldsMember" xlink:label="loc_us-gaap_ToolsDiesAndMoldsMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquipmentMember" xlink:label="loc_us-gaap_EquipmentMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_13"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1" xlink:to="loc_us-gaap_ComputerEquipmentMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1" xlink:to="loc_us-gaap_ToolsDiesAndMoldsMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1" xlink:to="loc_us-gaap_EquipmentMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_srt_RangeAxis_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_7" xlink:to="loc_srt_RangeMember_7" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_7" xlink:to="loc_srt_MinimumMember_7" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_7" xlink:to="loc_srt_MaximumMember_8" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_7" xlink:to="loc_srt_RangeMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_13" order="10" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsNarrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesLineItems" xlink:label="loc_us-gaap_MarketableSecuritiesLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesTable" xlink:label="loc_us-gaap_MarketableSecuritiesTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaap_FinancialInstrumentAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_NonUsGovernmentAgenciesDebtSecuritiesMember" xlink:label="loc_inmd_NonUsGovernmentAgenciesDebtSecuritiesMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BondsMember" xlink:label="loc_us-gaap_BondsMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_7"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_0" xlink:to="loc_us-gaap_MarketableSecuritiesTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_MarketableSecuritiesTable_1" xlink:to="loc_us-gaap_FinancialInstrumentAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_1" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1" xlink:to="loc_inmd_NonUsGovernmentAgenciesDebtSecuritiesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1" xlink:to="loc_us-gaap_BondsMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_1" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_0" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_7" order="10" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsScheduleOfMarketableSecuritiesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesLineItems" xlink:label="loc_us-gaap_MarketableSecuritiesLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesTable" xlink:label="loc_us-gaap_MarketableSecuritiesTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaap_FinancialInstrumentAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MunicipalBondsMember" xlink:label="loc_us-gaap_MunicipalBondsMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommercialPaperMember" xlink:label="loc_us-gaap_CommercialPaperMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CertificatesOfDepositMember" xlink:label="loc_us-gaap_CertificatesOfDepositMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_10"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_0" xlink:to="loc_us-gaap_MarketableSecuritiesTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_MarketableSecuritiesTable_1" xlink:to="loc_us-gaap_FinancialInstrumentAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_1" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1" xlink:to="loc_us-gaap_MunicipalBondsMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1" xlink:to="loc_us-gaap_CommercialPaperMember_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1" xlink:to="loc_us-gaap_CertificatesOfDepositMember_5" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_1" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_0" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_10" order="10" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsScheduleOfFinancialAssetsMeasuredAtFairValueDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesLineItems" xlink:label="loc_us-gaap_MarketableSecuritiesLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesTable" xlink:label="loc_us-gaap_MarketableSecuritiesTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaap_FinancialInstrumentAxis_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MunicipalBondsMember" xlink:label="loc_us-gaap_MunicipalBondsMember_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommercialPaperMember" xlink:label="loc_us-gaap_CommercialPaperMember_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CertificatesOfDepositMember" xlink:label="loc_us-gaap_CertificatesOfDepositMember_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_17"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_0" xlink:to="loc_us-gaap_MarketableSecuritiesTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_MarketableSecuritiesTable_1" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_MarketableSecuritiesTable_1" xlink:to="loc_us-gaap_FinancialInstrumentAxis_5" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_5" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5" xlink:to="loc_us-gaap_MunicipalBondsMember_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_7" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5" xlink:to="loc_us-gaap_CommercialPaperMember_8" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5" xlink:to="loc_us-gaap_CertificatesOfDepositMember_9" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_5" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_0" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_14" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_0" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_15" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_0" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_16" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_0" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_17" order="40" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://inmodemd.com/role/PropertyAndEquipmentNetScheduleOfPropertyAndEquipmentDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaap_ComputerEquipmentMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OfficeEquipmentMember" xlink:label="loc_us-gaap_OfficeEquipmentMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ToolsDiesAndMoldsMember" xlink:label="loc_us-gaap_ToolsDiesAndMoldsMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_12"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1" xlink:to="loc_us-gaap_ComputerEquipmentMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1" xlink:to="loc_us-gaap_OfficeEquipmentMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1" xlink:to="loc_us-gaap_ToolsDiesAndMoldsMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_9" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_10" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_11" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_12" order="40" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://inmodemd.com/role/OtherInvestmentsDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems" xlink:label="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" xlink:label="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaap_TypeOfArrangementAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_1"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_SharePurchaseAndShareholdersAgreementMember" xlink:label="loc_inmd_SharePurchaseAndShareholdersAgreementMember_1"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_TwoPurchaseAndShareholdersAgreementsMember" xlink:label="loc_inmd_TwoPurchaseAndShareholdersAgreementsMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_6"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_MedimorMember" xlink:label="loc_inmd_MedimorMember_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTypeAxis" xlink:label="loc_us-gaap_InvestmentTypeAxis_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_10"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_FullyDilutedBasisMember" xlink:label="loc_inmd_FullyDilutedBasisMember_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Investments" xlink:label="loc_us-gaap_Investments_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesIssued" xlink:label="loc_us-gaap_SharesIssued_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_17"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_0" xlink:to="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_1" xlink:to="loc_us-gaap_TypeOfArrangementAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_1" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_1" xlink:to="loc_inmd_SharePurchaseAndShareholdersAgreementMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_1" xlink:to="loc_inmd_TwoPurchaseAndShareholdersAgreementsMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_1" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_1" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_6" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_6" xlink:to="loc_inmd_MedimorMember_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_6" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_1" xlink:to="loc_us-gaap_InvestmentTypeAxis_10" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_10" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_10" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_10" xlink:to="loc_inmd_FullyDilutedBasisMember_10" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_10" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_0" xlink:to="loc_us-gaap_Investments_15" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_0" xlink:to="loc_us-gaap_SharesIssued_16" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_0" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_17" order="30" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://inmodemd.com/role/LeasesNarrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaap_TypeOfArrangementAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_1"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_LeaseAgreementMember" xlink:label="loc_inmd_LeaseAgreementMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_WarehouseMember" xlink:label="loc_srt_WarehouseMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OfficeBuildingMember" xlink:label="loc_srt_OfficeBuildingMember_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VehiclesMember" xlink:label="loc_us-gaap_VehiclesMember_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_Default"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_LeaseExpires" xlink:label="loc_inmd_LeaseExpires_15"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_BankGuarantee" xlink:label="loc_inmd_BankGuarantee_16"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_CurrentMonthlyRentPayment" xlink:label="loc_inmd_CurrentMonthlyRentPayment_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_18"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StatementTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_TypeOfArrangementAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_1" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_1" xlink:to="loc_inmd_LeaseAgreementMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_1" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_5" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_5" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_5" xlink:to="loc_srt_WarehouseMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_5" xlink:to="loc_srt_OfficeBuildingMember_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_5" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_10" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_10" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_10" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_10" xlink:to="loc_us-gaap_VehiclesMember_10" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_10" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_inmd_LeaseExpires_15" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_inmd_BankGuarantee_16" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_inmd_CurrentMonthlyRentPayment_17" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_18" order="40" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://inmodemd.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails">
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_LeasesLineItems" xlink:label="loc_inmd_LeasesLineItems_0"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_LeasesTable" xlink:label="loc_inmd_LeasesTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesOperatingAbstract" xlink:label="loc_us-gaap_LeasesOperatingAbstract_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_7"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_OtherCurrentLeaseLiabilities" xlink:label="loc_inmd_OtherCurrentLeaseLiabilities_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_13"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_inmd_LeasesLineItems_0" xlink:to="loc_inmd_LeasesTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_inmd_LeasesTable_1" xlink:to="loc_srt_RangeAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_1" xlink:to="loc_srt_RangeMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1" xlink:to="loc_srt_MinimumMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1" xlink:to="loc_srt_MaximumMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_1" xlink:to="loc_srt_RangeMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_inmd_LeasesLineItems_0" xlink:to="loc_us-gaap_LeasesOperatingAbstract_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LeasesOperatingAbstract_7" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_7" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LeasesOperatingAbstract_7" xlink:to="loc_inmd_OtherCurrentLeaseLiabilities_8" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LeasesOperatingAbstract_7" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_9" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LeasesOperatingAbstract_7" xlink:to="loc_us-gaap_OperatingLeaseLiability_10" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_inmd_LeasesLineItems_0" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_12" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_inmd_LeasesLineItems_0" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_13" order="30" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://inmodemd.com/role/OtherCurrentLiabilitiesScheduleOfOtherLiabilitiesDetails">
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_OtherCurrentLiabilitiesLineItems" xlink:label="loc_inmd_OtherCurrentLiabilitiesLineItems_0"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_OtherCurrentLiabilitiesTable" xlink:label="loc_inmd_OtherCurrentLiabilitiesTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCurrentLiabilitiesMember" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_6"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_GovernmentInstitutions" xlink:label="loc_inmd_GovernmentInstitutions_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedIncomeTaxesCurrent" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_8"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_WarrantyReserveLiabilityCurrent" xlink:label="loc_inmd_WarrantyReserveLiabilityCurrent_9"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_OtherCurrentLeaseLiabilities" xlink:label="loc_inmd_OtherCurrentLeaseLiabilities_10"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ContractorLiability" xlink:label="loc_inmd_ContractorLiability_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_13"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_inmd_OtherCurrentLiabilitiesLineItems_0" xlink:to="loc_inmd_OtherCurrentLiabilitiesTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_inmd_OtherCurrentLiabilitiesTable_1" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_1" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_1" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_1" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_inmd_OtherCurrentLiabilitiesLineItems_0" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_inmd_OtherCurrentLiabilitiesLineItems_0" xlink:to="loc_inmd_GovernmentInstitutions_7" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_inmd_OtherCurrentLiabilitiesLineItems_0" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_8" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_inmd_OtherCurrentLiabilitiesLineItems_0" xlink:to="loc_inmd_WarrantyReserveLiabilityCurrent_9" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_inmd_OtherCurrentLiabilitiesLineItems_0" xlink:to="loc_inmd_OtherCurrentLeaseLiabilities_10" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_inmd_OtherCurrentLiabilitiesLineItems_0" xlink:to="loc_inmd_ContractorLiability_11" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_inmd_OtherCurrentLiabilitiesLineItems_0" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_12" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_inmd_OtherCurrentLiabilitiesLineItems_0" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_13" order="80" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://inmodemd.com/role/ShareholdersEquityNarrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaap_IPOMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_9"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_TwoThousandsEighteenIncentivePlanMember" xlink:label="loc_inmd_TwoThousandsEighteenIncentivePlanMember_9"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_NonIsraeliPlanMember" xlink:label="loc_inmd_NonIsraeliPlanMember_10"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ShareRepurchaseProgramMember" xlink:label="loc_inmd_ShareRepurchaseProgramMember_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srt_TitleOfIndividualAxis_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_15"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_EmployeesMember" xlink:label="loc_inmd_EmployeesMember_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_BoardOfDirectorsChairmanMember" xlink:label="loc_srt_BoardOfDirectorsChairmanMember_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="loc_srt_ConsolidatedEntitiesAxis_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="loc_srt_ConsolidatedEntitiesDomain_20"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_JointVentureAgreementMember" xlink:label="loc_inmd_JointVentureAgreementMember_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SubsidiariesMember" xlink:label="loc_srt_SubsidiariesMember_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="loc_srt_ConsolidatedEntitiesDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_25"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_GIBFAndJVCMember" xlink:label="loc_inmd_GIBFAndJVCMember_25"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_JointVentureAgreementMember" xlink:label="loc_inmd_JointVentureAgreementMember_26"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_DilazarLimitedMember" xlink:label="loc_inmd_DilazarLimitedMember_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_31"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_31"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_31"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingAxis" xlink:label="loc_us-gaap_VestingAxis_35"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingDomain" xlink:label="loc_us-gaap_VestingDomain_35"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_35"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_36"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_37"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ShareBasedCompensationAwardTrancheFourMember" xlink:label="loc_inmd_ShareBasedCompensationAwardTrancheFourMember_38"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingDomain" xlink:label="loc_us-gaap_VestingDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_43"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesIssued" xlink:label="loc_us-gaap_SharesIssued_44"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice" xlink:label="loc_inmd_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice_45"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteStockSplit" xlink:label="loc_us-gaap_StockholdersEquityNoteStockSplit_46"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_BonusShareIssuesPerOutstandingShare" xlink:label="loc_inmd_BonusShareIssuesPerOutstandingShare_47"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_48"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_49"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_50"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_51"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_SharesAuthorizedAmount" xlink:label="loc_inmd_SharesAuthorizedAmount_52"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_StockRepurchasedDuringPeriodValueOne" xlink:label="loc_inmd_StockRepurchasedDuringPeriodValueOne_53"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_54"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_55"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_56"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_FairValueOfRestrictedOptionsGranted" xlink:label="loc_inmd_FairValueOfRestrictedOptionsGranted_57"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_FairValueOfOptionsGranted" xlink:label="loc_inmd_FairValueOfOptionsGranted_58"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_59"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_60"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_61"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_62"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_63"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_64"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_65"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_66"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_67"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_OwnershipInterestExchange" xlink:label="loc_inmd_OwnershipInterestExchange_68"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_MinorityInterestDecreaseFromRedemptionsOne" xlink:label="loc_inmd_MinorityInterestDecreaseFromRedemptionsOne_69"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_70"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue_71"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonVestedVested" xlink:label="loc_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonVestedVested_72"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_73"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_srt_RangeAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_1" xlink:to="loc_srt_RangeMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1" xlink:to="loc_srt_MinimumMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_1" xlink:to="loc_srt_RangeMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_5" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_5" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_5" xlink:to="loc_us-gaap_IPOMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_5" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_PlanNameAxis_9" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_9" xlink:to="loc_us-gaap_PlanNameDomain_9" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_9" xlink:to="loc_inmd_TwoThousandsEighteenIncentivePlanMember_9" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_9" xlink:to="loc_inmd_NonIsraeliPlanMember_10" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_9" xlink:to="loc_inmd_ShareRepurchaseProgramMember_11" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_9" xlink:to="loc_us-gaap_PlanNameDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_srt_TitleOfIndividualAxis_15" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_15" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_15" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_15" xlink:to="loc_inmd_EmployeesMember_15" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_15" xlink:to="loc_srt_BoardOfDirectorsChairmanMember_16" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_15" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_srt_ConsolidatedEntitiesAxis_20" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_20" xlink:to="loc_srt_ConsolidatedEntitiesDomain_20" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_20" xlink:to="loc_inmd_JointVentureAgreementMember_20" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_20" xlink:to="loc_srt_SubsidiariesMember_21" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_20" xlink:to="loc_srt_ConsolidatedEntitiesDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_25" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_25" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_25" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_25" xlink:to="loc_inmd_GIBFAndJVCMember_25" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_25" xlink:to="loc_inmd_JointVentureAgreementMember_26" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_25" xlink:to="loc_inmd_DilazarLimitedMember_27" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_25" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_AwardTypeAxis_31" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_31" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_31" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_31" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_31" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_31" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_VestingAxis_35" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VestingAxis_35" xlink:to="loc_us-gaap_VestingDomain_35" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_35" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_35" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_35" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_36" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_35" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_37" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_35" xlink:to="loc_inmd_ShareBasedCompensationAwardTrancheFourMember_38" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VestingAxis_35" xlink:to="loc_us-gaap_VestingDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_43" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_SharesIssued_44" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_inmd_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice_45" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_StockholdersEquityNoteStockSplit_46" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_inmd_BonusShareIssuesPerOutstandingShare_47" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_48" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_49" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_50" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_51" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_inmd_SharesAuthorizedAmount_52" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_inmd_StockRepurchasedDuringPeriodValueOne_53" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_54" order="120" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_55" order="130" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_56" order="140" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_inmd_FairValueOfRestrictedOptionsGranted_57" order="150" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_inmd_FairValueOfOptionsGranted_58" order="160" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_59" order="170" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_60" order="180" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_61" order="190" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_62" order="200" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_63" order="210" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_64" order="220" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_65" order="230" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_66" order="240" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_67" order="250" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_inmd_OwnershipInterestExchange_68" order="260" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_inmd_MinorityInterestDecreaseFromRedemptionsOne_69" order="270" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_70" order="280" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue_71" order="290" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonVestedVested_72" order="300" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_73" order="310" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://inmodemd.com/role/ShareholdersEquityScheduleOfOptionsGrantedDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GranteeStatusAxis" xlink:label="loc_us-gaap_GranteeStatusAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GranteeStatusDomain" xlink:label="loc_us-gaap_GranteeStatusDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:label="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GranteeStatusDomain" xlink:label="loc_us-gaap_GranteeStatusDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_OptionsChangesDuringYear" xlink:label="loc_inmd_OptionsChangesDuringYear_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_14"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_WeightedAverageExercisePriceChangesDuringYearAbstract" xlink:label="loc_inmd_WeightedAverageExercisePriceChangesDuringYearAbstract_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_19"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_GranteeStatusAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_GranteeStatusAxis_1" xlink:to="loc_us-gaap_GranteeStatusDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GranteeStatusDomain_1" xlink:to="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_GranteeStatusAxis_1" xlink:to="loc_us-gaap_GranteeStatusDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6" xlink:to="loc_inmd_OptionsChangesDuringYear_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_inmd_OptionsChangesDuringYear_7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_7" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_inmd_OptionsChangesDuringYear_7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_8" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_inmd_OptionsChangesDuringYear_7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_9" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_inmd_OptionsChangesDuringYear_7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_10" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_inmd_OptionsChangesDuringYear_7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_11" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_14" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_14" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_14" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_14" xlink:to="loc_inmd_WeightedAverageExercisePriceChangesDuringYearAbstract_15" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_inmd_WeightedAverageExercisePriceChangesDuringYearAbstract_15" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_15" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_inmd_WeightedAverageExercisePriceChangesDuringYearAbstract_15" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_16" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_inmd_WeightedAverageExercisePriceChangesDuringYearAbstract_15" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_17" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_inmd_WeightedAverageExercisePriceChangesDuringYearAbstract_15" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_18" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_inmd_WeightedAverageExercisePriceChangesDuringYearAbstract_15" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_19" order="40" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://inmodemd.com/role/ShareholdersEquityScheduleOfOutstandingAndExercisableOptionsDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_1"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ExercisePriceRangeOneMember" xlink:label="loc_inmd_ExercisePriceRangeOneMember_1"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ExercisePriceRangeTwoMember" xlink:label="loc_inmd_ExercisePriceRangeTwoMember_2"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ExercisePriceRangeThreeMember" xlink:label="loc_inmd_ExercisePriceRangeThreeMember_3"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ExercisePriceRangeFourMember" xlink:label="loc_inmd_ExercisePriceRangeFourMember_4"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ExercisePriceRangeFiveMember" xlink:label="loc_inmd_ExercisePriceRangeFiveMember_5"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ExercisePriceRangeSixMember" xlink:label="loc_inmd_ExercisePriceRangeSixMember_6"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ExercisePriceRangeSevenMember" xlink:label="loc_inmd_ExercisePriceRangeSevenMember_7"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ExercisePriceRangeEightMember" xlink:label="loc_inmd_ExercisePriceRangeEightMember_8"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ExercisePriceRangeNineMember" xlink:label="loc_inmd_ExercisePriceRangeNineMember_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_Default"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice" xlink:label="loc_inmd_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_18"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_1" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_1" xlink:to="loc_inmd_ExercisePriceRangeOneMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_1" xlink:to="loc_inmd_ExercisePriceRangeTwoMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_1" xlink:to="loc_inmd_ExercisePriceRangeThreeMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_1" xlink:to="loc_inmd_ExercisePriceRangeFourMember_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_1" xlink:to="loc_inmd_ExercisePriceRangeFiveMember_5" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_1" xlink:to="loc_inmd_ExercisePriceRangeSixMember_6" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_1" xlink:to="loc_inmd_ExercisePriceRangeSevenMember_7" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_1" xlink:to="loc_inmd_ExercisePriceRangeEightMember_8" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_1" xlink:to="loc_inmd_ExercisePriceRangeNineMember_9" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_1" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_inmd_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice_14" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_15" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_16" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_17" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_18" order="50" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://inmodemd.com/role/ShareholdersEquityScheduleOfOptionsGrantedRestictedShareUnitDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_6"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_UnitsChangesDuringYearAbstract" xlink:label="loc_inmd_UnitsChangesDuringYearAbstract_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_12"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_WeightedAverageGrantDateChangesDuringYearAbstract" xlink:label="loc_inmd_WeightedAverageGrantDateChangesDuringYearAbstract_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_14"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="loc_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_16"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_AwardTypeAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_6" xlink:to="loc_inmd_UnitsChangesDuringYearAbstract_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_inmd_UnitsChangesDuringYearAbstract_7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_7" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_inmd_UnitsChangesDuringYearAbstract_7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_8" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_inmd_UnitsChangesDuringYearAbstract_7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_9" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_12" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_12" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_12" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_12" xlink:to="loc_inmd_WeightedAverageGrantDateChangesDuringYearAbstract_13" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_12" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_14" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_12" xlink:to="loc_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue_15" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_12" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_16" order="40" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://inmodemd.com/role/ShareholdersEquityScheduleOfShareBasedCompensationExpenseDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfSalesMember" xlink:label="loc_us-gaap_CostOfSalesMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpenseMember" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_Default"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2" order="10" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_2" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_2" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_2" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2" xlink:to="loc_us-gaap_CostOfSalesMember_2" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_3" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2" xlink:to="loc_us-gaap_SellingAndMarketingExpenseMember_4" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_5" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_2" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_Default" order="10" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://inmodemd.com/role/TaxesOnIncomeNarrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxContingencyLineItems" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxContingencyTable" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_1"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_DevelopmentZoneAMember" xlink:label="loc_inmd_DevelopmentZoneAMember_1"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ElsewhereMember" xlink:label="loc_inmd_ElsewhereMember_2"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_RegulationsMember" xlink:label="loc_inmd_RegulationsMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameAxis" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_7"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_SpecialPreferredEnterpriseMember" xlink:label="loc_inmd_SpecialPreferredEnterpriseMember_7"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_IsraeliTaxAuthorityMember" xlink:label="loc_inmd_IsraeliTaxAuthorityMember_8"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_SubsidiariesOutsideIsraelMember" xlink:label="loc_inmd_SubsidiariesOutsideIsraelMember_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CurrencyAxis" xlink:label="loc_srt_CurrencyAxis_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currency_AllCurrenciesDomain_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_ILS" xlink:label="loc_currency_ILS_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currency_AllCurrenciesDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_22"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_AmendmentAdvantageExemptionMember" xlink:label="loc_inmd_AmendmentAdvantageExemptionMember_22"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_NoAmendmentMember" xlink:label="loc_inmd_NoAmendmentMember_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_Default"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_TaxBenefitYear" xlink:label="loc_inmd_TaxBenefitYear_28"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_CorporateTax" xlink:label="loc_inmd_CorporateTax_29"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_TaxRateForRecipientForDividendsDistributedByPreferredCompany" xlink:label="loc_inmd_TaxRateForRecipientForDividendsDistributedByPreferredCompany_30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsDividends" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsDividends_31"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_EffectiveIncomeTaxRateReconciliationDeductionsDividendsForNonIsraeliResidents" xlink:label="loc_inmd_EffectiveIncomeTaxRateReconciliationDeductionsDividendsForNonIsraeliResidents_32"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_33"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesReceivable" xlink:label="loc_us-gaap_IncomeTaxesReceivable_34"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaap_OperatingLossCarryforwards_35"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_OneTimePayment" xlink:label="loc_inmd_OneTimePayment_36"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_UndistributedExemptIncome" xlink:label="loc_inmd_UndistributedExemptIncome_37"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions" xlink:label="loc_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions_38"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_0" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_1" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_1" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_1" xlink:to="loc_inmd_DevelopmentZoneAMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_1" xlink:to="loc_inmd_ElsewhereMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_1" xlink:to="loc_inmd_RegulationsMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_1" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_1" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_7" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_7" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_7" xlink:to="loc_inmd_SpecialPreferredEnterpriseMember_7" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_7" xlink:to="loc_inmd_IsraeliTaxAuthorityMember_8" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_7" xlink:to="loc_inmd_SubsidiariesOutsideIsraelMember_9" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_7" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_1" xlink:to="loc_srt_RangeAxis_13" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_13" xlink:to="loc_srt_RangeMember_13" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_13" xlink:to="loc_srt_MinimumMember_13" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_13" xlink:to="loc_srt_MaximumMember_14" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_13" xlink:to="loc_srt_RangeMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_1" xlink:to="loc_srt_CurrencyAxis_18" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CurrencyAxis_18" xlink:to="loc_currency_AllCurrenciesDomain_18" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_18" xlink:to="loc_currency_ILS_18" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CurrencyAxis_18" xlink:to="loc_currency_AllCurrenciesDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_1" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_22" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_22" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_22" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_22" xlink:to="loc_inmd_AmendmentAdvantageExemptionMember_22" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_22" xlink:to="loc_inmd_NoAmendmentMember_23" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_22" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_0" xlink:to="loc_inmd_TaxBenefitYear_28" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_0" xlink:to="loc_inmd_CorporateTax_29" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_0" xlink:to="loc_inmd_TaxRateForRecipientForDividendsDistributedByPreferredCompany_30" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_0" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsDividends_31" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_0" xlink:to="loc_inmd_EffectiveIncomeTaxRateReconciliationDeductionsDividendsForNonIsraeliResidents_32" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_0" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_33" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_0" xlink:to="loc_us-gaap_IncomeTaxesReceivable_34" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_0" xlink:to="loc_us-gaap_OperatingLossCarryforwards_35" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_0" xlink:to="loc_inmd_OneTimePayment_36" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_0" xlink:to="loc_inmd_UndistributedExemptIncome_37" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_0" xlink:to="loc_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions_38" order="110" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://inmodemd.com/role/TaxesOnIncomeScheduleOfIncomeBeforeIncomeTaxesDetails">
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_IncomeTaxNoteLineItems" xlink:label="loc_inmd_IncomeTaxNoteLineItems_0"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_IncomeTaxNoteTable" xlink:label="loc_inmd_IncomeTaxNoteTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameAxis" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_1"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_InmodeLtdAndIsreaeliSubsidiariesMember" xlink:label="loc_inmd_InmodeLtdAndIsreaeliSubsidiariesMember_1"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_SubsidiariesOutsideIsraelMember" xlink:label="loc_inmd_SubsidiariesOutsideIsraelMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_7"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_inmd_IncomeTaxNoteLineItems_0" xlink:to="loc_inmd_IncomeTaxNoteTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_inmd_IncomeTaxNoteTable_1" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_1" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_1" xlink:to="loc_inmd_InmodeLtdAndIsreaeliSubsidiariesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_1" xlink:to="loc_inmd_SubsidiariesOutsideIsraelMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_1" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_inmd_IncomeTaxNoteLineItems_0" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_7" order="10" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://inmodemd.com/role/TaxesOnIncomeScheduleOfTaxExpensesTaxBenefitDetails">
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_IncomeTaxNoteLineItems" xlink:label="loc_inmd_IncomeTaxNoteLineItems_0"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_IncomeTaxNoteTable" xlink:label="loc_inmd_IncomeTaxNoteTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameAxis" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_IL" xlink:label="loc_country_IL_1"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_SubsidiariesOutsideIsraelMember" xlink:label="loc_inmd_SubsidiariesOutsideIsraelMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_9"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_inmd_IncomeTaxNoteLineItems_0" xlink:to="loc_inmd_IncomeTaxNoteTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_inmd_IncomeTaxNoteTable_1" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_1" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_1" xlink:to="loc_country_IL_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_1" xlink:to="loc_inmd_SubsidiariesOutsideIsraelMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_1" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_inmd_IncomeTaxNoteLineItems_0" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_inmd_IncomeTaxNoteLineItems_0" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_8" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_inmd_IncomeTaxNoteLineItems_0" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_9" order="30" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://inmodemd.com/role/Entity-wideDisclosureNarrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:label="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_0"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_PercentageOfNonCurrentDeferredRevenue" xlink:label="loc_inmd_PercentageOfNonCurrentDeferredRevenue_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_Default"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_0" xlink:to="loc_inmd_PercentageOfNonCurrentDeferredRevenue_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_0" xlink:to="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_2" order="10" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_2" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_2" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_2" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_2" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_2" xlink:to="loc_us-gaap_SubsequentEventMember_2" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_2" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_Default" order="10" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://inmodemd.com/role/Entity-wideDisclosureScheduleOfNetSalesByGeographicalAreaDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:label="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srt_StatementGeographicalAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US" xlink:label="loc_country_US_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EuropeMember" xlink:label="loc_srt_EuropeMember_2"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_OtherCountryMember" xlink:label="loc_inmd_OtherCountryMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_8"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_0" xlink:to="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_1" xlink:to="loc_srt_StatementGeographicalAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_1" xlink:to="loc_srt_SegmentGeographicalDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_1" xlink:to="loc_country_US_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_1" xlink:to="loc_srt_EuropeMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_1" xlink:to="loc_inmd_OtherCountryMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_1" xlink:to="loc_srt_SegmentGeographicalDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_0" xlink:to="loc_us-gaap_Revenues_8" order="10" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://inmodemd.com/role/Entity-wideDisclosureScheduleOfNetSalesByTechonologyDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTable" xlink:label="loc_us-gaap_ConcentrationRiskTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_1"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_MinimalInvasiveMember" xlink:label="loc_inmd_MinimalInvasiveMember_1"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_HandsFreeMember" xlink:label="loc_inmd_HandsFreeMember_2"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_NonInvasiveMember" xlink:label="loc_inmd_NonInvasiveMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_Default"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_PercentageOfNetSalesBasedOnProductsTechnology" xlink:label="loc_inmd_PercentageOfNetSalesBasedOnProductsTechnology_8"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_0" xlink:to="loc_us-gaap_ConcentrationRiskTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_1" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_1" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_1" xlink:to="loc_inmd_MinimalInvasiveMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_1" xlink:to="loc_inmd_HandsFreeMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_1" xlink:to="loc_inmd_NonInvasiveMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_1" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_0" xlink:to="loc_inmd_PercentageOfNetSalesBasedOnProductsTechnology_8" order="10" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://inmodemd.com/role/Entity-wideDisclosureScheduleOfLong-livedAssetsDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srt_StatementGeographicalAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_IL" xlink:label="loc_country_IL_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US" xlink:label="loc_country_US_2"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_OtherCountryMember" xlink:label="loc_inmd_OtherCountryMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_Default"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_TotalLongLivedAssetsByGeographicalArea" xlink:label="loc_inmd_TotalLongLivedAssetsByGeographicalArea_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncurrentAssets" xlink:label="loc_us-gaap_NoncurrentAssets_10"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_0" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_1" xlink:to="loc_srt_StatementGeographicalAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_1" xlink:to="loc_srt_SegmentGeographicalDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_1" xlink:to="loc_country_IL_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_1" xlink:to="loc_country_US_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_1" xlink:to="loc_inmd_OtherCountryMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_1" xlink:to="loc_srt_SegmentGeographicalDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_0" xlink:to="loc_inmd_TotalLongLivedAssetsByGeographicalArea_8" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_0" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_9" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_0" xlink:to="loc_us-gaap_NoncurrentAssets_10" order="30" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://inmodemd.com/role/RelatedPartiesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_1"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_HomeSkinnovationsLtdMember" xlink:label="loc_inmd_HomeSkinnovationsLtdMember_1"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_SubsidiaryOfHomeSkinnovationsLtdMember" xlink:label="loc_inmd_SubsidiaryOfHomeSkinnovationsLtdMember_2"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_SpaMedicalInternationalLsrlMember" xlink:label="loc_inmd_SpaMedicalInternationalLsrlMember_3"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_HimalayaFamilyOfficeConsultingLtdMember" xlink:label="loc_inmd_HimalayaFamilyOfficeConsultingLtdMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_8"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ExpensesIncomeMember" xlink:label="loc_inmd_ExpensesIncomeMember_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNet" xlink:label="loc_us-gaap_AccountsReceivableNet_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableAfterAllowanceForCreditLossRelatedAndNonrelatedPartyStatusExtensibleEnumeration" xlink:label="loc_us-gaap_AccountsReceivableAfterAllowanceForCreditLossRelatedAndNonrelatedPartyStatusExtensibleEnumeration_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:label="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_15"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_RelatedPartyConsiderationForAggregateAmount" xlink:label="loc_inmd_RelatedPartyConsiderationForAggregateAmount_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableRelatedAndNonrelatedPartyStatusExtensibleEnumeration" xlink:label="loc_us-gaap_AccountsPayableRelatedAndNonrelatedPartyStatusExtensibleEnumeration_18"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_0" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1" xlink:to="loc_us-gaap_RelatedPartyDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_1" xlink:to="loc_inmd_HomeSkinnovationsLtdMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_1" xlink:to="loc_inmd_SubsidiaryOfHomeSkinnovationsLtdMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_1" xlink:to="loc_inmd_SpaMedicalInternationalLsrlMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_1" xlink:to="loc_inmd_HimalayaFamilyOfficeConsultingLtdMember_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1" xlink:to="loc_us-gaap_RelatedPartyDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_8" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_8" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_8" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8" xlink:to="loc_inmd_ExpensesIncomeMember_8" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_8" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_0" xlink:to="loc_us-gaap_AccountsReceivableNet_13" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_0" xlink:to="loc_us-gaap_AccountsReceivableAfterAllowanceForCreditLossRelatedAndNonrelatedPartyStatusExtensibleEnumeration_14" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_0" xlink:to="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_15" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_0" xlink:to="loc_inmd_RelatedPartyConsiderationForAggregateAmount_16" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_0" xlink:to="loc_us-gaap_AccountsPayableCurrent_17" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_0" xlink:to="loc_us-gaap_AccountsPayableRelatedAndNonrelatedPartyStatusExtensibleEnumeration_18" order="60" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://inmodemd.com/role/ENTITYWIDEDISCLOSUREDisclosureOfRevenuesBasedOnProductsCategory">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_1"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_CapitalEquipmentMember" xlink:label="loc_inmd_CapitalEquipmentMember_1"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ConsumablesAndServiceRevenuesMember" xlink:label="loc_inmd_ConsumablesAndServiceRevenuesMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_7"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1" xlink:to="loc_srt_ProductOrServiceAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_1" xlink:to="loc_srt_ProductsAndServicesDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_1" xlink:to="loc_inmd_CapitalEquipmentMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_1" xlink:to="loc_inmd_ConsumablesAndServiceRevenuesMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_1" xlink:to="loc_srt_ProductsAndServicesDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0" xlink:to="loc_us-gaap_Revenues_7" order="10" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedAndNonrelatedPartyStatusDomain" xlink:label="loc_us-gaap_RelatedAndNonrelatedPartyStatusDomain_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_0"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedAndNonrelatedPartyStatusDomain_0" xlink:to="loc_us-gaap_AccountsPayableCurrent_0" order="1" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedAndNonrelatedPartyStatusDomain_0" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_0" order="2" use="optional"/>
  </definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>15
<FILENAME>inmd-20231231_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <!-- INTEGIX by Ez-XBRL -->
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel"/>
  <labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_IL" xlink:label="loc_country_IL_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US" xlink:label="loc_country_US_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currency_AllCurrenciesDomain_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_ILS" xlink:label="loc_currency_ILS_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorFirmId" xlink:label="loc_dei_AuditorFirmId_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorLocation" xlink:label="loc_dei_AuditorLocation_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorName" xlink:label="loc_dei_AuditorName_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_BusinessContactMember" xlink:label="loc_dei_BusinessContactMember_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_ContactPersonnelEmailAddress" xlink:label="loc_dei_ContactPersonnelEmailAddress_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_ContactPersonnelFaxNumber" xlink:label="loc_dei_ContactPersonnelFaxNumber_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_ContactPersonnelName" xlink:label="loc_dei_ContactPersonnelName_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_dei_DocumentAccountingStandard_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_dei_DocumentAnnualReport_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="loc_dei_DocumentFinStmtErrorCorrectionFlag_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_dei_DocumentRegistrationStatement_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_dei_DocumentShellCompanyReport_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_dei_DocumentTransitionReport_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_dei_EntityAddressAddressLine2_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_dei_EntityAddressAddressLine3_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_dei_EntityAddressCountry_29"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="loc_dei_EntityAddressesAddressTypeAxis_30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode_31"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_32"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_33"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_dei_EntityCurrentReportingStatus_34"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_35"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_dei_EntityExTransitionPeriod_36"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_dei_EntityFileNumber_37"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_38"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode_39"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_dei_EntityInteractiveDataCurrent_40"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_41"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_dei_EntityShellCompany_42"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_dei_EntityVoluntaryFilers_43"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_44"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="loc_dei_IcfrAuditorAttestationFlag_45"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber_46"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_dei_OtherReportingStandardItemNumber_47"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_dei_Security12bTitle_48"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_dei_Security12gTitle_49"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_dei_SecurityExchangeName_50"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_dei_SecurityReportingObligation_51"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_52"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_AccountingPoliciesLineItems" xlink:label="loc_inmd_AccountingPoliciesLineItems_53"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_AccountingPoliciesLineItems" xlink:label="loc_inmd_AccountingPoliciesLineItems_54"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_AccountingPoliciesTable" xlink:label="loc_inmd_AccountingPoliciesTable_55"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_AccountingPoliciesTable" xlink:label="loc_inmd_AccountingPoliciesTable_56"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_AcquisitionOfNonControllingInterestInExchangeOfOrdinaryShares" xlink:label="loc_inmd_AcquisitionOfNonControllingInterestInExchangeOfOrdinaryShares_57"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_AcquisitionOfNonControllingInterestInExchangeOfOrdinaryShares" xlink:label="loc_inmd_AcquisitionOfNonControllingInterestInExchangeOfOrdinaryShares_58"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_AcquisitionOfNonControllingInterestInExchangeOfOrdinaryShares" xlink:label="loc_inmd_AcquisitionOfNonControllingInterestInExchangeOfOrdinaryShares_59"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_AdjustmentToRedemptionValueOfRedeemableNonControllingInterest" xlink:label="loc_inmd_AdjustmentToRedemptionValueOfRedeemableNonControllingInterest_60"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_AdjustmentToRedemptionValueOfRedeemableNonControllingInterest" xlink:label="loc_inmd_AdjustmentToRedemptionValueOfRedeemableNonControllingInterest_61"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_AmendmentAdvantageExemptionMember" xlink:label="loc_inmd_AmendmentAdvantageExemptionMember_62"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_AmendmentAdvantageExemptionMember" xlink:label="loc_inmd_AmendmentAdvantageExemptionMember_63"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_AmountOfInvestment" xlink:label="loc_inmd_AmountOfInvestment_64"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_AmountOfInvestment" xlink:label="loc_inmd_AmountOfInvestment_65"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_AmountOfInvestment" xlink:label="loc_inmd_AmountOfInvestment_66"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_AmountPaidToUndistributedExemptIncome" xlink:label="loc_inmd_AmountPaidToUndistributedExemptIncome_67"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_AmountPaidToUndistributedExemptIncome" xlink:label="loc_inmd_AmountPaidToUndistributedExemptIncome_68"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_AmountPaidToUndistributedExemptIncome" xlink:label="loc_inmd_AmountPaidToUndistributedExemptIncome_69"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_AutomaticIncreaseApprovedByBoardCompanyIn" xlink:label="loc_inmd_AutomaticIncreaseApprovedByBoardCompanyIn_70"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_AutomaticIncreaseApprovedByBoardCompanyIn" xlink:label="loc_inmd_AutomaticIncreaseApprovedByBoardCompanyIn_71"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_AvailableForSaleSecuritiesDebtMaturitiesMoreThanFiveYearsFairValue" xlink:label="loc_inmd_AvailableForSaleSecuritiesDebtMaturitiesMoreThanFiveYearsFairValue_72"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_AvailableForSaleSecuritiesDebtMaturitiesMoreThanFiveYearsFairValue" xlink:label="loc_inmd_AvailableForSaleSecuritiesDebtMaturitiesMoreThanFiveYearsFairValue_73"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_AvailableForSaleSecuritiesDebtMaturitiesMoreThanFiveYearsFairValue" xlink:label="loc_inmd_AvailableForSaleSecuritiesDebtMaturitiesMoreThanFiveYearsFairValue_74"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInFourToFiveYearsFairValue" xlink:label="loc_inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInFourToFiveYearsFairValue_75"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInFourToFiveYearsFairValue" xlink:label="loc_inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInFourToFiveYearsFairValue_76"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInFourToFiveYearsFairValue" xlink:label="loc_inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInFourToFiveYearsFairValue_77"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInOneToTwoYearsFairValue" xlink:label="loc_inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInOneToTwoYearsFairValue_78"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInOneToTwoYearsFairValue" xlink:label="loc_inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInOneToTwoYearsFairValue_79"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInOneToTwoYearsFairValue" xlink:label="loc_inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInOneToTwoYearsFairValue_80"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInThreeToFourYearsFairValue" xlink:label="loc_inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInThreeToFourYearsFairValue_81"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInThreeToFourYearsFairValue" xlink:label="loc_inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInThreeToFourYearsFairValue_82"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInThreeToFourYearsFairValue" xlink:label="loc_inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInThreeToFourYearsFairValue_83"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInTwoToThreeYearsFairValue" xlink:label="loc_inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInTwoToThreeYearsFairValue_84"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInTwoToThreeYearsFairValue" xlink:label="loc_inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInTwoToThreeYearsFairValue_85"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInTwoToThreeYearsFairValue" xlink:label="loc_inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInTwoToThreeYearsFairValue_86"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_BankGuarantee" xlink:label="loc_inmd_BankGuarantee_87"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_BankGuarantee" xlink:label="loc_inmd_BankGuarantee_88"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_BonusShareIssuesPerOutstandingShare" xlink:label="loc_inmd_BonusShareIssuesPerOutstandingShare_89"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_BonusShareIssuesPerOutstandingShare" xlink:label="loc_inmd_BonusShareIssuesPerOutstandingShare_90"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_BusinessDescriptionLineItems" xlink:label="loc_inmd_BusinessDescriptionLineItems_91"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_BusinessDescriptionLineItems" xlink:label="loc_inmd_BusinessDescriptionLineItems_92"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_BusinessDescriptionTable" xlink:label="loc_inmd_BusinessDescriptionTable_93"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_BusinessDescriptionTable" xlink:label="loc_inmd_BusinessDescriptionTable_94"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_CapitalEquipmentMember" xlink:label="loc_inmd_CapitalEquipmentMember_95"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_CapitalEquipmentMember" xlink:label="loc_inmd_CapitalEquipmentMember_96"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ConsumablesAndServiceRevenuesMember" xlink:label="loc_inmd_ConsumablesAndServiceRevenuesMember_97"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ConsumablesAndServiceRevenuesMember" xlink:label="loc_inmd_ConsumablesAndServiceRevenuesMember_98"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ContractorLiability" xlink:label="loc_inmd_ContractorLiability_99"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ContractorLiability" xlink:label="loc_inmd_ContractorLiability_100"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_CorporateTax" xlink:label="loc_inmd_CorporateTax_101"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_CorporateTax" xlink:label="loc_inmd_CorporateTax_102"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_CovidNinteenAbstract" xlink:label="loc_inmd_CovidNinteenAbstract_103"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_CovidNinteenAbstract" xlink:label="loc_inmd_CovidNinteenAbstract_104"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_CovidNinteenTextBlock" xlink:label="loc_inmd_CovidNinteenTextBlock_105"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_CovidNinteenTextBlock" xlink:label="loc_inmd_CovidNinteenTextBlock_106"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_CovidNinteenTextBlock" xlink:label="loc_inmd_CovidNinteenTextBlock_107"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_CurrentMonthlyRentPayment" xlink:label="loc_inmd_CurrentMonthlyRentPayment_108"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_CurrentMonthlyRentPayment" xlink:label="loc_inmd_CurrentMonthlyRentPayment_109"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_DevelopmentZoneAMember" xlink:label="loc_inmd_DevelopmentZoneAMember_110"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_DevelopmentZoneAMember" xlink:label="loc_inmd_DevelopmentZoneAMember_111"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_DilazarLimitedMember" xlink:label="loc_inmd_DilazarLimitedMember_112"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_DilazarLimitedMember" xlink:label="loc_inmd_DilazarLimitedMember_113"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_EffectiveIncomeTaxRateReconciliationDeductionsDividendsForNonIsraeliResidents" xlink:label="loc_inmd_EffectiveIncomeTaxRateReconciliationDeductionsDividendsForNonIsraeliResidents_114"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_EffectiveIncomeTaxRateReconciliationDeductionsDividendsForNonIsraeliResidents" xlink:label="loc_inmd_EffectiveIncomeTaxRateReconciliationDeductionsDividendsForNonIsraeliResidents_115"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ElsewhereMember" xlink:label="loc_inmd_ElsewhereMember_116"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ElsewhereMember" xlink:label="loc_inmd_ElsewhereMember_117"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_EmployeeRelatedSeveranceLiabilities" xlink:label="loc_inmd_EmployeeRelatedSeveranceLiabilities_118"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_EmployeeRelatedSeveranceLiabilities" xlink:label="loc_inmd_EmployeeRelatedSeveranceLiabilities_119"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_EmployeeSeveranceBenefitsPolicyTextBlock" xlink:label="loc_inmd_EmployeeSeveranceBenefitsPolicyTextBlock_120"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_EmployeeSeveranceBenefitsPolicyTextBlock" xlink:label="loc_inmd_EmployeeSeveranceBenefitsPolicyTextBlock_121"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_EmployeeSeveranceBenefitsPolicyTextBlock" xlink:label="loc_inmd_EmployeeSeveranceBenefitsPolicyTextBlock_122"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_EmployeesMember" xlink:label="loc_inmd_EmployeesMember_123"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_EmployeesMember" xlink:label="loc_inmd_EmployeesMember_124"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_EmployeesOfficersDirectorsServiceProvidersAndConsultantsMember" xlink:label="loc_inmd_EmployeesOfficersDirectorsServiceProvidersAndConsultantsMember_125"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_EmployeesOfficersDirectorsServiceProvidersAndConsultantsMember" xlink:label="loc_inmd_EmployeesOfficersDirectorsServiceProvidersAndConsultantsMember_126"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ExerciseOfOptions" xlink:label="loc_inmd_ExerciseOfOptions_127"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ExerciseOfOptions" xlink:label="loc_inmd_ExerciseOfOptions_128"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ExercisePriceRangeEightMember" xlink:label="loc_inmd_ExercisePriceRangeEightMember_129"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ExercisePriceRangeEightMember" xlink:label="loc_inmd_ExercisePriceRangeEightMember_130"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ExercisePriceRangeEightMember" xlink:label="loc_inmd_ExercisePriceRangeEightMember_131"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ExercisePriceRangeFiveMember" xlink:label="loc_inmd_ExercisePriceRangeFiveMember_132"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ExercisePriceRangeFiveMember" xlink:label="loc_inmd_ExercisePriceRangeFiveMember_133"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ExercisePriceRangeFiveMember" xlink:label="loc_inmd_ExercisePriceRangeFiveMember_134"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ExercisePriceRangeFourMember" xlink:label="loc_inmd_ExercisePriceRangeFourMember_135"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ExercisePriceRangeFourMember" xlink:label="loc_inmd_ExercisePriceRangeFourMember_136"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ExercisePriceRangeFourMember" xlink:label="loc_inmd_ExercisePriceRangeFourMember_137"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ExercisePriceRangeNineMember" xlink:label="loc_inmd_ExercisePriceRangeNineMember_138"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ExercisePriceRangeNineMember" xlink:label="loc_inmd_ExercisePriceRangeNineMember_139"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ExercisePriceRangeNineMember" xlink:label="loc_inmd_ExercisePriceRangeNineMember_140"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ExercisePriceRangeOneMember" xlink:label="loc_inmd_ExercisePriceRangeOneMember_141"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ExercisePriceRangeOneMember" xlink:label="loc_inmd_ExercisePriceRangeOneMember_142"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ExercisePriceRangeOneMember" xlink:label="loc_inmd_ExercisePriceRangeOneMember_143"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ExercisePriceRangeSevenMember" xlink:label="loc_inmd_ExercisePriceRangeSevenMember_144"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ExercisePriceRangeSevenMember" xlink:label="loc_inmd_ExercisePriceRangeSevenMember_145"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ExercisePriceRangeSevenMember" xlink:label="loc_inmd_ExercisePriceRangeSevenMember_146"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ExercisePriceRangeSixMember" xlink:label="loc_inmd_ExercisePriceRangeSixMember_147"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ExercisePriceRangeSixMember" xlink:label="loc_inmd_ExercisePriceRangeSixMember_148"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ExercisePriceRangeSixMember" xlink:label="loc_inmd_ExercisePriceRangeSixMember_149"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ExercisePriceRangeThreeMember" xlink:label="loc_inmd_ExercisePriceRangeThreeMember_150"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ExercisePriceRangeThreeMember" xlink:label="loc_inmd_ExercisePriceRangeThreeMember_151"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ExercisePriceRangeThreeMember" xlink:label="loc_inmd_ExercisePriceRangeThreeMember_152"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ExercisePriceRangeTwoMember" xlink:label="loc_inmd_ExercisePriceRangeTwoMember_153"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ExercisePriceRangeTwoMember" xlink:label="loc_inmd_ExercisePriceRangeTwoMember_154"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ExercisePriceRangeTwoMember" xlink:label="loc_inmd_ExercisePriceRangeTwoMember_155"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ExpensesIncomeMember" xlink:label="loc_inmd_ExpensesIncomeMember_156"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_FairValueOfOneOrdinaryShare" xlink:label="loc_inmd_FairValueOfOneOrdinaryShare_157"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_FairValueOfOneOrdinaryShare" xlink:label="loc_inmd_FairValueOfOneOrdinaryShare_158"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_FairValueOfOptionsGranted" xlink:label="loc_inmd_FairValueOfOptionsGranted_159"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_FairValueOfOptionsGranted" xlink:label="loc_inmd_FairValueOfOptionsGranted_160"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_FairValueOfRestrictedOptionsGranted" xlink:label="loc_inmd_FairValueOfRestrictedOptionsGranted_161"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_FairValueOfRestrictedOptionsGranted" xlink:label="loc_inmd_FairValueOfRestrictedOptionsGranted_162"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_FairValueOfRestrictedOptionsGranted" xlink:label="loc_inmd_FairValueOfRestrictedOptionsGranted_163"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_FebruaryNineTwoThousandsTwentyOneMember" xlink:label="loc_inmd_FebruaryNineTwoThousandsTwentyOneMember_164"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_FebruaryNineTwoThousandsTwentyOneMember" xlink:label="loc_inmd_FebruaryNineTwoThousandsTwentyOneMember_165"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_FebruaryNineTwoThousandsTwentyOneMember" xlink:label="loc_inmd_FebruaryNineTwoThousandsTwentyOneMember_166"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_FebruaryNineTwoZeroTwoTwoMember" xlink:label="loc_inmd_FebruaryNineTwoZeroTwoTwoMember_167"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_FebruaryNineTwoZeroTwoTwoMember" xlink:label="loc_inmd_FebruaryNineTwoZeroTwoTwoMember_168"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_FebruaryNineTwoZeroTwoTwoMember" xlink:label="loc_inmd_FebruaryNineTwoZeroTwoTwoMember_169"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_FebruarySeventeenTwoThousandsTwentyMember" xlink:label="loc_inmd_FebruarySeventeenTwoThousandsTwentyMember_170"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_FebruarySeventeenTwoThousandsTwentyMember" xlink:label="loc_inmd_FebruarySeventeenTwoThousandsTwentyMember_171"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_FifteenMarchTwoThousandsTwentyMember" xlink:label="loc_inmd_FifteenMarchTwoThousandsTwentyMember_172"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_FifteenMarchTwoThousandsTwentyMember" xlink:label="loc_inmd_FifteenMarchTwoThousandsTwentyMember_173"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_FinanceIncome" xlink:label="loc_inmd_FinanceIncome_174"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_FinanceIncome" xlink:label="loc_inmd_FinanceIncome_175"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_FinanceIncome" xlink:label="loc_inmd_FinanceIncome_176"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_FullyDilutedBasisMember" xlink:label="loc_inmd_FullyDilutedBasisMember_177"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_FullyDilutedBasisMember" xlink:label="loc_inmd_FullyDilutedBasisMember_178"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_GeneralAbstract" xlink:label="loc_inmd_GeneralAbstract_179"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_GIBFAndJVCMember" xlink:label="loc_inmd_GIBFAndJVCMember_180"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_GIBFAndJVCMember" xlink:label="loc_inmd_GIBFAndJVCMember_181"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_GIBFAndJVCMember" xlink:label="loc_inmd_GIBFAndJVCMember_182"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_GovernmentInstitutions" xlink:label="loc_inmd_GovernmentInstitutions_183"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_GovernmentInstitutions" xlink:label="loc_inmd_GovernmentInstitutions_184"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_GovernmentInstitutions" xlink:label="loc_inmd_GovernmentInstitutions_185"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_HandsFreeMember" xlink:label="loc_inmd_HandsFreeMember_186"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_HandsFreeMember" xlink:label="loc_inmd_HandsFreeMember_187"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_HimalayaFamilyOfficeConsultingLtdMember" xlink:label="loc_inmd_HimalayaFamilyOfficeConsultingLtdMember_188"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_HimalayaFamilyOfficeConsultingLtdMember" xlink:label="loc_inmd_HimalayaFamilyOfficeConsultingLtdMember_189"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_HomeSkinnovationsLtdMember" xlink:label="loc_inmd_HomeSkinnovationsLtdMember_190"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_HomeSkinnovationsLtdMember" xlink:label="loc_inmd_HomeSkinnovationsLtdMember_191"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_IncomeTaxNoteLineItems" xlink:label="loc_inmd_IncomeTaxNoteLineItems_192"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_IncomeTaxNoteLineItems" xlink:label="loc_inmd_IncomeTaxNoteLineItems_193"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_IncomeTaxNoteTable" xlink:label="loc_inmd_IncomeTaxNoteTable_194"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_IncomeTaxNoteTable" xlink:label="loc_inmd_IncomeTaxNoteTable_195"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_IncomeTaxReconciliationAmendmentToInvestmentsLawPayment" xlink:label="loc_inmd_IncomeTaxReconciliationAmendmentToInvestmentsLawPayment_196"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_IncomeTaxReconciliationAmendmentToInvestmentsLawPayment" xlink:label="loc_inmd_IncomeTaxReconciliationAmendmentToInvestmentsLawPayment_197"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_IncomeTaxReconciliationAmendmentToInvestmentsLawPayment" xlink:label="loc_inmd_IncomeTaxReconciliationAmendmentToInvestmentsLawPayment_198"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_IncomeTaxReconciliationBenefitsToBenefitedEnterprise" xlink:label="loc_inmd_IncomeTaxReconciliationBenefitsToBenefitedEnterprise_199"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_IncomeTaxReconciliationBenefitsToBenefitedEnterprise" xlink:label="loc_inmd_IncomeTaxReconciliationBenefitsToBenefitedEnterprise_200"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_IncomeTaxReconciliationBenefitsToBenefitedEnterprise" xlink:label="loc_inmd_IncomeTaxReconciliationBenefitsToBenefitedEnterprise_201"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_IncomeTaxReconciliationBenefitsToBenefitedEnterprise" xlink:label="loc_inmd_IncomeTaxReconciliationBenefitsToBenefitedEnterprise_202"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_IncomeTaxReconciliationDifferentEffectiveTaxRatesApplicableToOperatingLoss" xlink:label="loc_inmd_IncomeTaxReconciliationDifferentEffectiveTaxRatesApplicableToOperatingLoss_203"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_IncomeTaxReconciliationDifferentEffectiveTaxRatesApplicableToOperatingLoss" xlink:label="loc_inmd_IncomeTaxReconciliationDifferentEffectiveTaxRatesApplicableToOperatingLoss_204"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_IncomeTaxReconciliationDifferentEffectiveTaxRatesApplicableToOperatingLoss" xlink:label="loc_inmd_IncomeTaxReconciliationDifferentEffectiveTaxRatesApplicableToOperatingLoss_205"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_IncomeTaxReconciliationDifferentEffectiveTaxRatesApplicableToSubsidiaries" xlink:label="loc_inmd_IncomeTaxReconciliationDifferentEffectiveTaxRatesApplicableToSubsidiaries_206"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_IncomeTaxReconciliationDifferentEffectiveTaxRatesApplicableToSubsidiaries" xlink:label="loc_inmd_IncomeTaxReconciliationDifferentEffectiveTaxRatesApplicableToSubsidiaries_207"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_IncomeTaxReconciliationDifferentEffectiveTaxRatesApplicableToSubsidiaries" xlink:label="loc_inmd_IncomeTaxReconciliationDifferentEffectiveTaxRatesApplicableToSubsidiaries_208"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_IncomeTaxReconciliationDifferentEffectiveTaxRatesApplicableToSubsidiaries" xlink:label="loc_inmd_IncomeTaxReconciliationDifferentEffectiveTaxRatesApplicableToSubsidiaries_209"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_IncomeTaxReconciliationNonDeductibleExpenses" xlink:label="loc_inmd_IncomeTaxReconciliationNonDeductibleExpenses_210"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_IncomeTaxReconciliationNonDeductibleExpenses" xlink:label="loc_inmd_IncomeTaxReconciliationNonDeductibleExpenses_211"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_IncomeTaxReconciliationNonDeductibleExpenses" xlink:label="loc_inmd_IncomeTaxReconciliationNonDeductibleExpenses_212"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_IncomeTaxReconciliationSettlementsWithIsraeliTaxAuthorityNetOfDecreaseOfRelatedUncertainTax" xlink:label="loc_inmd_IncomeTaxReconciliationSettlementsWithIsraeliTaxAuthorityNetOfDecreaseOfRelatedUncertainTax_213"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_IncomeTaxReconciliationSettlementsWithIsraeliTaxAuthorityNetOfDecreaseOfRelatedUncertainTax" xlink:label="loc_inmd_IncomeTaxReconciliationSettlementsWithIsraeliTaxAuthorityNetOfDecreaseOfRelatedUncertainTax_214"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_IncomeTaxReconciliationSettlementsWithIsraeliTaxAuthorityNetOfDecreaseOfRelatedUncertainTax" xlink:label="loc_inmd_IncomeTaxReconciliationSettlementsWithIsraeliTaxAuthorityNetOfDecreaseOfRelatedUncertainTax_215"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_IncomeTaxReconciliationUncertainTaxPosition" xlink:label="loc_inmd_IncomeTaxReconciliationUncertainTaxPosition_216"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_IncomeTaxReconciliationUncertainTaxPosition" xlink:label="loc_inmd_IncomeTaxReconciliationUncertainTaxPosition_217"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_IncomeTaxReconciliationUncertainTaxPosition" xlink:label="loc_inmd_IncomeTaxReconciliationUncertainTaxPosition_218"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_IncreasesDueToIssuanceOfNewContractsExcludingAmountsRecognizedAsRevenueDuringPeriod" xlink:label="loc_inmd_IncreasesDueToIssuanceOfNewContractsExcludingAmountsRecognizedAsRevenueDuringPeriod_219"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_IncreasesDueToIssuanceOfNewContractsExcludingAmountsRecognizedAsRevenueDuringPeriod" xlink:label="loc_inmd_IncreasesDueToIssuanceOfNewContractsExcludingAmountsRecognizedAsRevenueDuringPeriod_220"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_InmodeInnovationMember" xlink:label="loc_inmd_InmodeInnovationMember_221"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_InmodeInnovationMember" xlink:label="loc_inmd_InmodeInnovationMember_222"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_InmodeLtdAndIsreaeliSubsidiariesMember" xlink:label="loc_inmd_InmodeLtdAndIsreaeliSubsidiariesMember_223"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_InmodeLtdAndIsreaeliSubsidiariesMember" xlink:label="loc_inmd_InmodeLtdAndIsreaeliSubsidiariesMember_224"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_InmodeLtdAndIsreaeliSubsidiariesMember" xlink:label="loc_inmd_InmodeLtdAndIsreaeliSubsidiariesMember_225"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_InterestReceived" xlink:label="loc_inmd_InterestReceived_226"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_InterestReceived" xlink:label="loc_inmd_InterestReceived_227"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_InvestmentInShortTermDeposit" xlink:label="loc_inmd_InvestmentInShortTermDeposit_228"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_InvestmentInShortTermDeposit" xlink:label="loc_inmd_InvestmentInShortTermDeposit_229"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_InvestmentInShortTermDeposit" xlink:label="loc_inmd_InvestmentInShortTermDeposit_230"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_IsraeliTaxAuthorityMember" xlink:label="loc_inmd_IsraeliTaxAuthorityMember_231"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_IsraeliTaxAuthorityMember" xlink:label="loc_inmd_IsraeliTaxAuthorityMember_232"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_JanuarySevenTwoThousandsTwentyMember" xlink:label="loc_inmd_JanuarySevenTwoThousandsTwentyMember_233"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_JanuarySevenTwoThousandsTwentyMember" xlink:label="loc_inmd_JanuarySevenTwoThousandsTwentyMember_234"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_JointVentureAgreementMember" xlink:label="loc_inmd_JointVentureAgreementMember_235"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_JointVentureAgreementMember" xlink:label="loc_inmd_JointVentureAgreementMember_236"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_JulyTwentySevenTwoThousandsTwentyOneMember" xlink:label="loc_inmd_JulyTwentySevenTwoThousandsTwentyOneMember_237"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_JulyTwentySevenTwoThousandsTwentyOneMember" xlink:label="loc_inmd_JulyTwentySevenTwoThousandsTwentyOneMember_238"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_JulyTwentySevenTwoThousandsTwentyOneMember" xlink:label="loc_inmd_JulyTwentySevenTwoThousandsTwentyOneMember_239"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_JulyTwoSevenTwoZeroTwoTwoMember" xlink:label="loc_inmd_JulyTwoSevenTwoZeroTwoTwoMember_240"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_JulyTwoSevenTwoZeroTwoTwoMember" xlink:label="loc_inmd_JulyTwoSevenTwoZeroTwoTwoMember_241"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_JulyTwoSevenTwoZeroTwoTwoMember" xlink:label="loc_inmd_JulyTwoSevenTwoZeroTwoTwoMember_242"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_LeaseAgreementMember" xlink:label="loc_inmd_LeaseAgreementMember_243"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_LeaseAgreementMember" xlink:label="loc_inmd_LeaseAgreementMember_244"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_LeaseAgreementMember" xlink:label="loc_inmd_LeaseAgreementMember_245"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_LeaseExpires" xlink:label="loc_inmd_LeaseExpires_246"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_LeaseExpires" xlink:label="loc_inmd_LeaseExpires_247"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_LeaseExpires" xlink:label="loc_inmd_LeaseExpires_248"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_LeasesLineItems" xlink:label="loc_inmd_LeasesLineItems_249"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_LeasesLineItems" xlink:label="loc_inmd_LeasesLineItems_250"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_LeasesTable" xlink:label="loc_inmd_LeasesTable_251"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_LeasesTable" xlink:label="loc_inmd_LeasesTable_252"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_MarketableSecuritiesAndFairValueMeasurementAbstract" xlink:label="loc_inmd_MarketableSecuritiesAndFairValueMeasurementAbstract_253"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_MarketableSecuritiesAndFairValueMeasurementAbstract" xlink:label="loc_inmd_MarketableSecuritiesAndFairValueMeasurementAbstract_254"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_MarketableSecuritiesAndFairValueMeasurementAbstract" xlink:label="loc_inmd_MarketableSecuritiesAndFairValueMeasurementAbstract_255"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_MarketableSecuritiesAndFairValueMeasurements" xlink:label="loc_inmd_MarketableSecuritiesAndFairValueMeasurements_256"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_MarketableSecuritiesAndFairValueMeasurements" xlink:label="loc_inmd_MarketableSecuritiesAndFairValueMeasurements_257"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_MarketableSecuritiesAndFairValueMeasurements" xlink:label="loc_inmd_MarketableSecuritiesAndFairValueMeasurements_258"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_MayFiveTwoThousandsTwentyMember" xlink:label="loc_inmd_MayFiveTwoThousandsTwentyMember_259"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_MayFiveTwoThousandsTwentyMember" xlink:label="loc_inmd_MayFiveTwoThousandsTwentyMember_260"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_MayOneTwoZeroTwoTwoMember" xlink:label="loc_inmd_MayOneTwoZeroTwoTwoMember_261"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_MayOneTwoZeroTwoTwoMember" xlink:label="loc_inmd_MayOneTwoZeroTwoTwoMember_262"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_MayOneTwoZeroTwoTwoMember" xlink:label="loc_inmd_MayOneTwoZeroTwoTwoMember_263"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_MaySixTwoThousandsTwentyOneMember" xlink:label="loc_inmd_MaySixTwoThousandsTwentyOneMember_264"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_MaySixTwoThousandsTwentyOneMember" xlink:label="loc_inmd_MaySixTwoThousandsTwentyOneMember_265"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_MaySixTwoThousandsTwentyOneMember" xlink:label="loc_inmd_MaySixTwoThousandsTwentyOneMember_266"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_MedimorMember" xlink:label="loc_inmd_MedimorMember_267"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_MedimorMember" xlink:label="loc_inmd_MedimorMember_268"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_MinimalInvasiveMember" xlink:label="loc_inmd_MinimalInvasiveMember_269"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_MinimalInvasiveMember" xlink:label="loc_inmd_MinimalInvasiveMember_270"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_MinorityInterestDecreaseFromRedemptionsOne" xlink:label="loc_inmd_MinorityInterestDecreaseFromRedemptionsOne_271"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_MinorityInterestDecreaseFromRedemptionsOne" xlink:label="loc_inmd_MinorityInterestDecreaseFromRedemptionsOne_272"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_MinorityInterestDecreaseFromRedemptionsOne" xlink:label="loc_inmd_MinorityInterestDecreaseFromRedemptionsOne_273"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_NoAmendmentMember" xlink:label="loc_inmd_NoAmendmentMember_274"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_NoAmendmentMember" xlink:label="loc_inmd_NoAmendmentMember_275"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_NonCashAcquisitionOfNoncontrollingInterestInExchangeOfOrdinaryShares" xlink:label="loc_inmd_NonCashAcquisitionOfNoncontrollingInterestInExchangeOfOrdinaryShares_276"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_NonCashAcquisitionOfNoncontrollingInterestInExchangeOfOrdinaryShares" xlink:label="loc_inmd_NonCashAcquisitionOfNoncontrollingInterestInExchangeOfOrdinaryShares_277"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_NonCashAcquisitionOfNoncontrollingInterestInExchangeOfOrdinaryShares" xlink:label="loc_inmd_NonCashAcquisitionOfNoncontrollingInterestInExchangeOfOrdinaryShares_278"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_NonInvasiveMember" xlink:label="loc_inmd_NonInvasiveMember_279"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_NonInvasiveMember" xlink:label="loc_inmd_NonInvasiveMember_280"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_NonIsraeliPlanMember" xlink:label="loc_inmd_NonIsraeliPlanMember_281"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_NonIsraeliPlanMember" xlink:label="loc_inmd_NonIsraeliPlanMember_282"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_NonUsGovernmentAgenciesDebtSecuritiesMember" xlink:label="loc_inmd_NonUsGovernmentAgenciesDebtSecuritiesMember_283"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_NonUsGovernmentAgenciesDebtSecuritiesMember" xlink:label="loc_inmd_NonUsGovernmentAgenciesDebtSecuritiesMember_284"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_NovemberElevenTwoThousandsTwentyMember" xlink:label="loc_inmd_NovemberElevenTwoThousandsTwentyMember_285"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_NovemberElevenTwoThousandsTwentyMember" xlink:label="loc_inmd_NovemberElevenTwoThousandsTwentyMember_286"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_NumberOfOrdinarySharesConsideration" xlink:label="loc_inmd_NumberOfOrdinarySharesConsideration_287"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_NumberOfOrdinarySharesConsideration" xlink:label="loc_inmd_NumberOfOrdinarySharesConsideration_288"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_NumberOfOrdinarySharesConsideration" xlink:label="loc_inmd_NumberOfOrdinarySharesConsideration_289"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_NumberOfShareholder" xlink:label="loc_inmd_NumberOfShareholder_290"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_NumberOfShareholder" xlink:label="loc_inmd_NumberOfShareholder_291"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_NumberOfShareholder" xlink:label="loc_inmd_NumberOfShareholder_292"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_OctoberTwoSixTwoZeroTwoTwoMember" xlink:label="loc_inmd_OctoberTwoSixTwoZeroTwoTwoMember_293"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_OctoberTwoSixTwoZeroTwoTwoMember" xlink:label="loc_inmd_OctoberTwoSixTwoZeroTwoTwoMember_294"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_OctoberTwoSixTwoZeroTwoTwoMember" xlink:label="loc_inmd_OctoberTwoSixTwoZeroTwoTwoMember_295"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_OneTimePayment" xlink:label="loc_inmd_OneTimePayment_296"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_OneTimePayment" xlink:label="loc_inmd_OneTimePayment_297"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_OneTimePayment" xlink:label="loc_inmd_OneTimePayment_298"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_OperatingLeaseRightOfUseAssests" xlink:label="loc_inmd_OperatingLeaseRightOfUseAssests_299"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_OperatingLeaseRightOfUseAssests" xlink:label="loc_inmd_OperatingLeaseRightOfUseAssests_300"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_OperatingLeaseRightOfUseAssests" xlink:label="loc_inmd_OperatingLeaseRightOfUseAssests_301"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_OptionsChangesDuringYear" xlink:label="loc_inmd_OptionsChangesDuringYear_302"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_OptionsChangesDuringYear" xlink:label="loc_inmd_OptionsChangesDuringYear_303"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_OtherAdvancesToSuppliersCurrent" xlink:label="loc_inmd_OtherAdvancesToSuppliersCurrent_304"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_OtherAdvancesToSuppliersCurrent" xlink:label="loc_inmd_OtherAdvancesToSuppliersCurrent_305"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_OtherAdvancesToSuppliersCurrent" xlink:label="loc_inmd_OtherAdvancesToSuppliersCurrent_306"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_OtherCountryMember" xlink:label="loc_inmd_OtherCountryMember_307"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_OtherCountryMember" xlink:label="loc_inmd_OtherCountryMember_308"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_OtherCountryMember" xlink:label="loc_inmd_OtherCountryMember_309"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_OtherCurrentLeaseLiabilities" xlink:label="loc_inmd_OtherCurrentLeaseLiabilities_310"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_OtherCurrentLeaseLiabilities" xlink:label="loc_inmd_OtherCurrentLeaseLiabilities_311"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_OtherCurrentLeaseLiabilities" xlink:label="loc_inmd_OtherCurrentLeaseLiabilities_312"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_OtherCurrentLiabilitiesLineItems" xlink:label="loc_inmd_OtherCurrentLiabilitiesLineItems_313"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_OtherCurrentLiabilitiesLineItems" xlink:label="loc_inmd_OtherCurrentLiabilitiesLineItems_314"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_OtherCurrentLiabilitiesTable" xlink:label="loc_inmd_OtherCurrentLiabilitiesTable_315"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_OtherCurrentLiabilitiesTable" xlink:label="loc_inmd_OtherCurrentLiabilitiesTable_316"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_OtherCurrentReceivables" xlink:label="loc_inmd_OtherCurrentReceivables_317"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_OtherCurrentReceivables" xlink:label="loc_inmd_OtherCurrentReceivables_318"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_OtherCurrentReceivables" xlink:label="loc_inmd_OtherCurrentReceivables_319"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_OtherGovernmentInstitutionsReceivablesCurrent" xlink:label="loc_inmd_OtherGovernmentInstitutionsReceivablesCurrent_320"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_OtherGovernmentInstitutionsReceivablesCurrent" xlink:label="loc_inmd_OtherGovernmentInstitutionsReceivablesCurrent_321"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_OtherGovernmentInstitutionsReceivablesCurrent" xlink:label="loc_inmd_OtherGovernmentInstitutionsReceivablesCurrent_322"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_OtherIncomeTaxReceivablesCurrent" xlink:label="loc_inmd_OtherIncomeTaxReceivablesCurrent_323"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_OtherIncomeTaxReceivablesCurrent" xlink:label="loc_inmd_OtherIncomeTaxReceivablesCurrent_324"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_OtherIncomeTaxReceivablesCurrent" xlink:label="loc_inmd_OtherIncomeTaxReceivablesCurrent_325"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_OtherOperatingExpenseIncome" xlink:label="loc_inmd_OtherOperatingExpenseIncome_326"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_OtherOperatingExpenseIncome" xlink:label="loc_inmd_OtherOperatingExpenseIncome_327"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_OtherOperatingExpenseIncome" xlink:label="loc_inmd_OtherOperatingExpenseIncome_328"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_OtherPrepaidExpensesReceivablesCurrent" xlink:label="loc_inmd_OtherPrepaidExpensesReceivablesCurrent_329"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_OtherPrepaidExpensesReceivablesCurrent" xlink:label="loc_inmd_OtherPrepaidExpensesReceivablesCurrent_330"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_OtherPrepaidExpensesReceivablesCurrent" xlink:label="loc_inmd_OtherPrepaidExpensesReceivablesCurrent_331"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_OtherReceivablesNonCurrent" xlink:label="loc_inmd_OtherReceivablesNonCurrent_332"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_OtherReceivablesNonCurrent" xlink:label="loc_inmd_OtherReceivablesNonCurrent_333"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_OtherReceivablesNonCurrent" xlink:label="loc_inmd_OtherReceivablesNonCurrent_334"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_OwnershipInterestExchange" xlink:label="loc_inmd_OwnershipInterestExchange_335"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_OwnershipInterestExchange" xlink:label="loc_inmd_OwnershipInterestExchange_336"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_PaymentsToTaxAuthorities" xlink:label="loc_inmd_PaymentsToTaxAuthorities_337"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_PaymentsToTaxAuthorities" xlink:label="loc_inmd_PaymentsToTaxAuthorities_338"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_PaymentsToTaxAuthorities" xlink:label="loc_inmd_PaymentsToTaxAuthorities_339"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_PercentageOfNetSalesBasedOnProductsTechnology" xlink:label="loc_inmd_PercentageOfNetSalesBasedOnProductsTechnology_340"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_PercentageOfNetSalesBasedOnProductsTechnology" xlink:label="loc_inmd_PercentageOfNetSalesBasedOnProductsTechnology_341"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_PercentageOfNonCurrentDeferredRevenue" xlink:label="loc_inmd_PercentageOfNonCurrentDeferredRevenue_342"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_PercentageOfNonCurrentDeferredRevenue" xlink:label="loc_inmd_PercentageOfNonCurrentDeferredRevenue_343"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_PrepaidExpensesAndOtherCurrentReceivablesTextBlock" xlink:label="loc_inmd_PrepaidExpensesAndOtherCurrentReceivablesTextBlock_344"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_PrepaidExpensesAndOtherCurrentReceivablesTextBlock" xlink:label="loc_inmd_PrepaidExpensesAndOtherCurrentReceivablesTextBlock_345"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_PrepaidExpensesAndOtherCurrentReceivablesTextBlock" xlink:label="loc_inmd_PrepaidExpensesAndOtherCurrentReceivablesTextBlock_346"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_PreviousYearIncomeTaxExpenseBenefit" xlink:label="loc_inmd_PreviousYearIncomeTaxExpenseBenefit_347"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_PreviousYearIncomeTaxExpenseBenefit" xlink:label="loc_inmd_PreviousYearIncomeTaxExpenseBenefit_348"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_PreviousYearIncomeTaxExpenseBenefit" xlink:label="loc_inmd_PreviousYearIncomeTaxExpenseBenefit_349"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ProceedsFromInvestmentInShortTermDeposit" xlink:label="loc_inmd_ProceedsFromInvestmentInShortTermDeposit_350"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ProceedsFromInvestmentInShortTermDeposit" xlink:label="loc_inmd_ProceedsFromInvestmentInShortTermDeposit_351"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ProceedsFromInvestmentInShortTermDeposit" xlink:label="loc_inmd_ProceedsFromInvestmentInShortTermDeposit_352"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ProceedsFromMaturityOfMarketableSecurities" xlink:label="loc_inmd_ProceedsFromMaturityOfMarketableSecurities_353"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ProceedsFromMaturityOfMarketableSecurities" xlink:label="loc_inmd_ProceedsFromMaturityOfMarketableSecurities_354"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ProceedsFromMaturityOfMarketableSecurities" xlink:label="loc_inmd_ProceedsFromMaturityOfMarketableSecurities_355"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_RegulationsMember" xlink:label="loc_inmd_RegulationsMember_356"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_RegulationsMember" xlink:label="loc_inmd_RegulationsMember_357"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_RelatedPartyConsiderationForAggregateAmount" xlink:label="loc_inmd_RelatedPartyConsiderationForAggregateAmount_358"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_RelatedPartyConsiderationForAggregateAmount" xlink:label="loc_inmd_RelatedPartyConsiderationForAggregateAmount_359"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_RelatedPartyConsiderationForAggregateAmount" xlink:label="loc_inmd_RelatedPartyConsiderationForAggregateAmount_360"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ScheduleOfOtherReceivablesCurrentTableTextBlock" xlink:label="loc_inmd_ScheduleOfOtherReceivablesCurrentTableTextBlock_361"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ScheduleOfOtherReceivablesCurrentTableTextBlock" xlink:label="loc_inmd_ScheduleOfOtherReceivablesCurrentTableTextBlock_362"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ScheduleOfPrepaidExpensesAndOtherCurrentRecivablesTableTextBlock" xlink:label="loc_inmd_ScheduleOfPrepaidExpensesAndOtherCurrentRecivablesTableTextBlock_363"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ScheduleOfPrepaidExpensesAndOtherCurrentRecivablesTableTextBlock" xlink:label="loc_inmd_ScheduleOfPrepaidExpensesAndOtherCurrentRecivablesTableTextBlock_364"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ScheduleOfPrepaidExpensesAndOtherCurrentRecivablesTableTextBlock" xlink:label="loc_inmd_ScheduleOfPrepaidExpensesAndOtherCurrentRecivablesTableTextBlock_365"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ScheduleOfPrepaidExpensesAndOtherCurrentRecivablesTableTextBlock" xlink:label="loc_inmd_ScheduleOfPrepaidExpensesAndOtherCurrentRecivablesTableTextBlock_366"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock" xlink:label="loc_inmd_ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock_367"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock" xlink:label="loc_inmd_ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock_368"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock" xlink:label="loc_inmd_ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock_369"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ScheduleOfSupplementalBalanceSheetInformationRelatedToLeases" xlink:label="loc_inmd_ScheduleOfSupplementalBalanceSheetInformationRelatedToLeases_370"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ScheduleOfSupplementalBalanceSheetInformationRelatedToLeases" xlink:label="loc_inmd_ScheduleOfSupplementalBalanceSheetInformationRelatedToLeases_371"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ScheduleOfSupplementalCashFlowInformationRelatedToLeases" xlink:label="loc_inmd_ScheduleOfSupplementalCashFlowInformationRelatedToLeases_372"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ScheduleOfSupplementalCashFlowInformationRelatedToLeases" xlink:label="loc_inmd_ScheduleOfSupplementalCashFlowInformationRelatedToLeases_373"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonVestedVested" xlink:label="loc_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonVestedVested_374"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonVestedVested" xlink:label="loc_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonVestedVested_375"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonVestedVested" xlink:label="loc_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonVestedVested_376"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="loc_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue_377"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="loc_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue_378"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="loc_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue_379"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsEarlyExerciseMultiple" xlink:label="loc_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsEarlyExerciseMultiple_380"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsEarlyExerciseMultiple" xlink:label="loc_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsEarlyExerciseMultiple_381"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsEarlyExerciseMultiple" xlink:label="loc_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsEarlyExerciseMultiple_382"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedFour" xlink:label="loc_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedFour_383"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedFour" xlink:label="loc_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedFour_384"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedFour" xlink:label="loc_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedFour_385"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedOne" xlink:label="loc_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedOne_386"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedOne" xlink:label="loc_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedOne_387"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedOne" xlink:label="loc_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedOne_388"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedThree" xlink:label="loc_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedThree_389"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedThree" xlink:label="loc_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedThree_390"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedThree" xlink:label="loc_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedThree_391"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedTwo" xlink:label="loc_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedTwo_392"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedTwo" xlink:label="loc_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedTwo_393"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedTwo" xlink:label="loc_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedTwo_394"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedUponAdoption" xlink:label="loc_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedUponAdoption_395"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedUponAdoption" xlink:label="loc_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedUponAdoption_396"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedUponAdoption" xlink:label="loc_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedUponAdoption_397"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriod" xlink:label="loc_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriod_398"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriod" xlink:label="loc_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriod_399"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriod" xlink:label="loc_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriod_400"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAwardAmount" xlink:label="loc_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAwardAmount_401"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAwardAmount" xlink:label="loc_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAwardAmount_402"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAwardAmount" xlink:label="loc_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAwardAmount_403"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionCancelledInPeriodWeightedAverageExercisePrice" xlink:label="loc_inmd_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionCancelledInPeriodWeightedAverageExercisePrice_404"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionCancelledInPeriodWeightedAverageExercisePrice" xlink:label="loc_inmd_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionCancelledInPeriodWeightedAverageExercisePrice_405"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionCancelledInPeriodWeightedAverageExercisePrice" xlink:label="loc_inmd_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionCancelledInPeriodWeightedAverageExercisePrice_406"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ShareBasedCompensationAwardTrancheFourMember" xlink:label="loc_inmd_ShareBasedCompensationAwardTrancheFourMember_407"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ShareBasedCompensationAwardTrancheFourMember" xlink:label="loc_inmd_ShareBasedCompensationAwardTrancheFourMember_408"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice" xlink:label="loc_inmd_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice_409"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice" xlink:label="loc_inmd_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice_410"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice" xlink:label="loc_inmd_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice_411"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_SharePurchaseAndShareholdersAgreementMember" xlink:label="loc_inmd_SharePurchaseAndShareholdersAgreementMember_412"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_SharePurchaseAndShareholdersAgreementMember" xlink:label="loc_inmd_SharePurchaseAndShareholdersAgreementMember_413"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_SharePurchaseAndShareholdersAgreementMember" xlink:label="loc_inmd_SharePurchaseAndShareholdersAgreementMember_414"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ShareRepurchaseProgramMember" xlink:label="loc_inmd_ShareRepurchaseProgramMember_415"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_SharesAuthorizedAmount" xlink:label="loc_inmd_SharesAuthorizedAmount_416"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_SharesAuthorizedAmount" xlink:label="loc_inmd_SharesAuthorizedAmount_417"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ShareValueOfAcquisitionOfNonControllingInterestInExchangeOfOrdinaryShares" xlink:label="loc_inmd_ShareValueOfAcquisitionOfNonControllingInterestInExchangeOfOrdinaryShares_418"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ShareValueOfAcquisitionOfNonControllingInterestInExchangeOfOrdinaryShares" xlink:label="loc_inmd_ShareValueOfAcquisitionOfNonControllingInterestInExchangeOfOrdinaryShares_419"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ShareValueOfAcquisitionOfNonControllingInterestInExchangeOfOrdinaryShares" xlink:label="loc_inmd_ShareValueOfAcquisitionOfNonControllingInterestInExchangeOfOrdinaryShares_420"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ShortTermBankDepositsPolicyTextBlock" xlink:label="loc_inmd_ShortTermBankDepositsPolicyTextBlock_421"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ShortTermBankDepositsPolicyTextBlock" xlink:label="loc_inmd_ShortTermBankDepositsPolicyTextBlock_422"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ShortTermBankDepositsPolicyTextBlock" xlink:label="loc_inmd_ShortTermBankDepositsPolicyTextBlock_423"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ShortTermDepositsAnnualInterestRate" xlink:label="loc_inmd_ShortTermDepositsAnnualInterestRate_424"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ShortTermDepositsAnnualInterestRate" xlink:label="loc_inmd_ShortTermDepositsAnnualInterestRate_425"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_SpaMedicalInternationalLsrlMember" xlink:label="loc_inmd_SpaMedicalInternationalLsrlMember_426"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_SpaMedicalInternationalLsrlMember" xlink:label="loc_inmd_SpaMedicalInternationalLsrlMember_427"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_SpecialPreferredEnterpriseMember" xlink:label="loc_inmd_SpecialPreferredEnterpriseMember_428"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_SpecialPreferredEnterpriseMember" xlink:label="loc_inmd_SpecialPreferredEnterpriseMember_429"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_StockRepurchasedDuringPeriodValueOne" xlink:label="loc_inmd_StockRepurchasedDuringPeriodValueOne_430"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_StockRepurchasedDuringPeriodValueOne" xlink:label="loc_inmd_StockRepurchasedDuringPeriodValueOne_431"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_StockRepurchasedDuringPeriodValueOne" xlink:label="loc_inmd_StockRepurchasedDuringPeriodValueOne_432"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_StockRepurchasedOrdinarySharesDuringPeriodShares" xlink:label="loc_inmd_StockRepurchasedOrdinarySharesDuringPeriodShares_433"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_StockRepurchasedOrdinarySharesDuringPeriodShares" xlink:label="loc_inmd_StockRepurchasedOrdinarySharesDuringPeriodShares_434"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_StockRepurchasedOrdinarySharesDuringPeriodShares" xlink:label="loc_inmd_StockRepurchasedOrdinarySharesDuringPeriodShares_435"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_StockRepurchasedOrdinarySharesDuringPeriodValue" xlink:label="loc_inmd_StockRepurchasedOrdinarySharesDuringPeriodValue_436"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_StockRepurchasedOrdinarySharesDuringPeriodValue" xlink:label="loc_inmd_StockRepurchasedOrdinarySharesDuringPeriodValue_437"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_StockRepurchasedOrdinarySharesDuringPeriodValue" xlink:label="loc_inmd_StockRepurchasedOrdinarySharesDuringPeriodValue_438"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_SubsidiariesFourMember" xlink:label="loc_inmd_SubsidiariesFourMember_439"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_SubsidiariesFourMember" xlink:label="loc_inmd_SubsidiariesFourMember_440"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_SubsidiariesOutsideIsraelMember" xlink:label="loc_inmd_SubsidiariesOutsideIsraelMember_441"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_SubsidiariesOutsideIsraelMember" xlink:label="loc_inmd_SubsidiariesOutsideIsraelMember_442"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_SubsidiariesOutsideIsraelMember" xlink:label="loc_inmd_SubsidiariesOutsideIsraelMember_443"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_SubsidiariesThreeMember" xlink:label="loc_inmd_SubsidiariesThreeMember_444"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_SubsidiariesThreeMember" xlink:label="loc_inmd_SubsidiariesThreeMember_445"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_SubsidiaryOfHomeSkinnovationsLtdMember" xlink:label="loc_inmd_SubsidiaryOfHomeSkinnovationsLtdMember_446"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_SubsidiaryOfHomeSkinnovationsLtdMember" xlink:label="loc_inmd_SubsidiaryOfHomeSkinnovationsLtdMember_447"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_TaxBenefitYear" xlink:label="loc_inmd_TaxBenefitYear_448"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_TaxBenefitYear" xlink:label="loc_inmd_TaxBenefitYear_449"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_TaxRateForRecipientForDividendsDistributedByPreferredCompany" xlink:label="loc_inmd_TaxRateForRecipientForDividendsDistributedByPreferredCompany_450"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_TaxRateForRecipientForDividendsDistributedByPreferredCompany" xlink:label="loc_inmd_TaxRateForRecipientForDividendsDistributedByPreferredCompany_451"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_TotalLongLivedAssetsByGeographicalArea" xlink:label="loc_inmd_TotalLongLivedAssetsByGeographicalArea_452"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_TotalLongLivedAssetsByGeographicalArea" xlink:label="loc_inmd_TotalLongLivedAssetsByGeographicalArea_453"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_TotalLongLivedAssetsByGeographicalArea" xlink:label="loc_inmd_TotalLongLivedAssetsByGeographicalArea_454"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_TreasurySharesPolicyTextBlock" xlink:label="loc_inmd_TreasurySharesPolicyTextBlock_455"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_TreasurySharesPolicyTextBlock" xlink:label="loc_inmd_TreasurySharesPolicyTextBlock_456"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_TreasurySharesPolicyTextBlock" xlink:label="loc_inmd_TreasurySharesPolicyTextBlock_457"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_TwoPurchaseAndShareholdersAgreementsMember" xlink:label="loc_inmd_TwoPurchaseAndShareholdersAgreementsMember_458"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_TwoPurchaseAndShareholdersAgreementsMember" xlink:label="loc_inmd_TwoPurchaseAndShareholdersAgreementsMember_459"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_TwoPurchaseAndShareholdersAgreementsMember" xlink:label="loc_inmd_TwoPurchaseAndShareholdersAgreementsMember_460"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_TwoThousandsEighteenIncentivePlanMember" xlink:label="loc_inmd_TwoThousandsEighteenIncentivePlanMember_461"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_TwoThousandsEighteenIncentivePlanMember" xlink:label="loc_inmd_TwoThousandsEighteenIncentivePlanMember_462"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_TwoThousandsEighteenIncentivePlanMember" xlink:label="loc_inmd_TwoThousandsEighteenIncentivePlanMember_463"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_UnderwritersAllotmentOptionMember" xlink:label="loc_inmd_UnderwritersAllotmentOptionMember_464"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_UnderwritersAllotmentOptionMember" xlink:label="loc_inmd_UnderwritersAllotmentOptionMember_465"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_UndistributedExemptIncome" xlink:label="loc_inmd_UndistributedExemptIncome_466"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_UndistributedExemptIncome" xlink:label="loc_inmd_UndistributedExemptIncome_467"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_UnitsChangesDuringYearAbstract" xlink:label="loc_inmd_UnitsChangesDuringYearAbstract_468"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_WarrantyReserveLiabilityCurrent" xlink:label="loc_inmd_WarrantyReserveLiabilityCurrent_469"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_WarrantyReserveLiabilityCurrent" xlink:label="loc_inmd_WarrantyReserveLiabilityCurrent_470"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_WarrantyReserveLiabilityCurrent" xlink:label="loc_inmd_WarrantyReserveLiabilityCurrent_471"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_WarRiskSituationInIsraelPolicyTextBlock" xlink:label="loc_inmd_WarRiskSituationInIsraelPolicyTextBlock_472"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_WarRiskSituationInIsraelPolicyTextBlock" xlink:label="loc_inmd_WarRiskSituationInIsraelPolicyTextBlock_473"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_WarRiskSituationInIsraelPolicyTextBlock" xlink:label="loc_inmd_WarRiskSituationInIsraelPolicyTextBlock_474"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_WeightedAverageExercisePriceChangesDuringYearAbstract" xlink:label="loc_inmd_WeightedAverageExercisePriceChangesDuringYearAbstract_475"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_WeightedAverageExercisePriceChangesDuringYearAbstract" xlink:label="loc_inmd_WeightedAverageExercisePriceChangesDuringYearAbstract_476"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_WeightedAverageGrantDateChangesDuringYearAbstract" xlink:label="loc_inmd_WeightedAverageGrantDateChangesDuringYearAbstract_477"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_WeightedAverageNumberOfSharesOutStandingUsedInComputationOfNetIncomePerShareAbstract" xlink:label="loc_inmd_WeightedAverageNumberOfSharesOutStandingUsedInComputationOfNetIncomePerShareAbstract_478"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_WeightedAverageNumberOfSharesOutStandingUsedInComputationOfNetIncomePerShareAbstract" xlink:label="loc_inmd_WeightedAverageNumberOfSharesOutStandingUsedInComputationOfNetIncomePerShareAbstract_479"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_BoardOfDirectorsChairmanMember" xlink:label="loc_srt_BoardOfDirectorsChairmanMember_480"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="loc_srt_ConsolidatedEntitiesAxis_481"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_482"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CurrencyAxis" xlink:label="loc_srt_CurrencyAxis_483"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_484"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EuropeMember" xlink:label="loc_srt_EuropeMember_485"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EuropeMember" xlink:label="loc_srt_EuropeMember_486"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_487"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_488"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_489"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_490"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_491"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_492"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OfficeBuildingMember" xlink:label="loc_srt_OfficeBuildingMember_493"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipAxis" xlink:label="loc_srt_OwnershipAxis_494"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_495"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_496"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_497"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_498"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioForecastMember" xlink:label="loc_srt_ScenarioForecastMember_499"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_500"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_501"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srt_StatementGeographicalAxis_502"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis" xlink:label="loc_srt_StatementScenarioAxis_503"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SubsidiariesMember" xlink:label="loc_srt_SubsidiariesMember_504"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srt_TitleOfIndividualAxis_505"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_506"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_WarehouseMember" xlink:label="loc_srt_WarehouseMember_507"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_508"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsAndNotesReceivableNet" xlink:label="loc_us-gaap_AccountsAndNotesReceivableNet_509"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsAndNotesReceivableNet" xlink:label="loc_us-gaap_AccountsAndNotesReceivableNet_510"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:label="loc_us-gaap_AccountsAndOtherReceivablesNetCurrent_511"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:label="loc_us-gaap_AccountsAndOtherReceivablesNetCurrent_512"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableGrossAllowanceAndNetAbstract" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableGrossAllowanceAndNetAbstract_513"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:label="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_514"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_515"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_516"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_517"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_518"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_519"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_520"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrentAndNoncurrent" xlink:label="loc_us-gaap_AccountsPayableCurrentAndNoncurrent_521"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableRelatedAndNonrelatedPartyStatusExtensibleEnumeration" xlink:label="loc_us-gaap_AccountsPayableRelatedAndNonrelatedPartyStatusExtensibleEnumeration_522"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableAfterAllowanceForCreditLossRelatedAndNonrelatedPartyStatusExtensibleEnumeration" xlink:label="loc_us-gaap_AccountsReceivableAfterAllowanceForCreditLossRelatedAndNonrelatedPartyStatusExtensibleEnumeration_523"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:label="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_524"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:label="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_525"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableGross" xlink:label="loc_us-gaap_AccountsReceivableGross_526"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNet" xlink:label="loc_us-gaap_AccountsReceivableNet_527"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNet" xlink:label="loc_us-gaap_AccountsReceivableNet_528"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNet" xlink:label="loc_us-gaap_AccountsReceivableNet_529"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_530"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_531"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_532"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_533"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_534"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_535"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetNoncurrent" xlink:label="loc_us-gaap_AccountsReceivableNetNoncurrent_536"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetNoncurrent" xlink:label="loc_us-gaap_AccountsReceivableNetNoncurrent_537"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetNoncurrent" xlink:label="loc_us-gaap_AccountsReceivableNetNoncurrent_538"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetNoncurrent" xlink:label="loc_us-gaap_AccountsReceivableNetNoncurrent_539"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNoncurrentNonaccrual" xlink:label="loc_us-gaap_AccountsReceivableNoncurrentNonaccrual_540"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedIncomeTaxesCurrent" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_541"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedIncomeTaxesCurrent" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_542"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_543"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_544"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_545"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_546"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_547"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_548"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_549"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_550"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_551"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_552"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_553"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_554"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_555"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_556"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdvertisingCostsPolicyTextBlock" xlink:label="loc_us-gaap_AdvertisingCostsPolicyTextBlock_557"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdvertisingCostsPolicyTextBlock" xlink:label="loc_us-gaap_AdvertisingCostsPolicyTextBlock_558"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdvertisingExpense" xlink:label="loc_us-gaap_AdvertisingExpense_559"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdvertisingExpense" xlink:label="loc_us-gaap_AdvertisingExpense_560"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_561"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_562"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" xlink:label="loc_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_563"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" xlink:label="loc_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_564"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_565"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_566"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_567"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_568"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_569"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_570"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableNoncurrent" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableNoncurrent_571"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableNoncurrent" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableNoncurrent_572"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_573"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_574"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_575"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_576"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_577"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_578"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract_579"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_580"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_581"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaap_AssetsCurrentAbstract_582"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaap_AssetsNoncurrent_583"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaap_AssetsNoncurrent_584"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:label="loc_us-gaap_AssetsNoncurrentAbstract_585"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:label="loc_us-gaap_AssetsNoncurrentAbstract_586"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_587"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_588"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_589"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_590"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_591"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_592"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_593"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_594"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_595"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardDateAxis" xlink:label="loc_us-gaap_AwardDateAxis_596"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_597"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_598"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_599"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BondsMember" xlink:label="loc_us-gaap_BondsMember_600"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_601"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_602"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_603"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_604"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:label="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_605"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_606"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_607"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_608"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_609"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_610"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_611"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_612"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_613"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_614"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_615"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_616"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CertificatesOfDepositMember" xlink:label="loc_us-gaap_CertificatesOfDepositMember_617"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommercialPaperMember" xlink:label="loc_us-gaap_CommercialPaperMember_618"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaap_CommitmentsAndContingencies_619"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaap_CommitmentsAndContingencies_620"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_621"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_622"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_623"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_624"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_625"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_626"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_627"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_628"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_629"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_630"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_631"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_632"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_633"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_634"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_635"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_636"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_637"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_638"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_639"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_640"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_641"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_642"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_643"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaap_ComputerEquipmentMember_644"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_645"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_646"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_647"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_648"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTable" xlink:label="loc_us-gaap_ConcentrationRiskTable_649"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_650"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_651"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_652"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiability" xlink:label="loc_us-gaap_ContractWithCustomerLiability_653"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiability" xlink:label="loc_us-gaap_ContractWithCustomerLiability_654"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiability" xlink:label="loc_us-gaap_ContractWithCustomerLiability_655"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_656"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_657"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_658"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_659"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_660"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_661"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaap_CostOfRevenue_662"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaap_CostOfRevenue_663"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfSalesMember" xlink:label="loc_us-gaap_CostOfSalesMember_664"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfSalesPolicyTextBlock" xlink:label="loc_us-gaap_CostOfSalesPolicyTextBlock_665"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_666"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_667"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxAssetsNet" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_668"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxAssetsNet" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_669"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_670"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_671"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_672"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_673"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_674"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_675"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_676"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsNetAbstract" xlink:label="loc_us-gaap_DeferredTaxAssetsNetAbstract_677"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_678"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_679"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOtherComprehensiveLoss" xlink:label="loc_us-gaap_DeferredTaxAssetsOtherComprehensiveLoss_680"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_681"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_682"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_683"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_684"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepositsAssetsCurrent" xlink:label="loc_us-gaap_DepositsAssetsCurrent_685"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_686"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_687"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfLongLivedAssetsHeldForSaleTextBlock" xlink:label="loc_us-gaap_DisclosureOfLongLivedAssetsHeldForSaleTextBlock_688"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:label="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_689"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_690"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_691"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic_692"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic_693"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted_694"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted_695"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_696"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_697"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_698"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_699"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsDividends" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsDividends_700"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_701"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_702"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_703"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_704"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_705"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_706"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquipmentMember" xlink:label="loc_us-gaap_EquipmentMember_707"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_708"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_709"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_710"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_711"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_712"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_713"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_714"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaap_FinancialInstrumentAxis_715"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_716"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnInvestments" xlink:label="loc_us-gaap_GainLossOnInvestments_717"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnInvestments" xlink:label="loc_us-gaap_GainLossOnInvestments_718"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_719"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_720"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_721"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GranteeStatusAxis" xlink:label="loc_us-gaap_GranteeStatusAxis_722"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaap_GrossProfit_723"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaap_GrossProfit_724"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_725"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_726"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_727"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaap_IncomeStatementAbstract_728"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_729"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_730"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_731"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_732"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameAxis" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_733"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxContingencyLineItems" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_734"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxContingencyTable" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_735"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_736"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_737"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_738"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_739"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_740"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesReceivable" xlink:label="loc_us-gaap_IncomeTaxesReceivable_741"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_742"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_743"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_744"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_745"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_746"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_747"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_748"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_749"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_750"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:label="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_751"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:label="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_752"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_753"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_754"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_755"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_756"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_757"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_758"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_759"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_760"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_761"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_762"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_763"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherReceivables" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherReceivables_764"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherReceivables" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherReceivables_765"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeExpenseNet" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_766"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeExpenseNet" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_767"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeExpenseNet" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_768"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_769"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock_770"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoods" xlink:label="loc_us-gaap_InventoryFinishedGoods_771"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet_772"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet_773"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_774"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_775"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryRawMaterials" xlink:label="loc_us-gaap_InventoryRawMaterials_776"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeNet" xlink:label="loc_us-gaap_InvestmentIncomeNet_777"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeNet" xlink:label="loc_us-gaap_InvestmentIncomeNet_778"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentPolicyTextBlock" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock_779"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentPolicyTextBlock" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock_780"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Investments" xlink:label="loc_us-gaap_Investments_781"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Investments" xlink:label="loc_us-gaap_Investments_782"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsAbstract" xlink:label="loc_us-gaap_InvestmentsAbstract_783"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTextBlock" xlink:label="loc_us-gaap_InvestmentTextBlock_784"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTypeAxis" xlink:label="loc_us-gaap_InvestmentTypeAxis_785"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_786"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaap_IPOMember_787"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseContractualTermDomain" xlink:label="loc_us-gaap_LeaseContractualTermDomain_788"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_789"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_790"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_791"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesOperatingAbstract" xlink:label="loc_us-gaap_LeasesOperatingAbstract_792"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_793"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_794"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_795"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_796"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_797"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_798"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_799"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_800"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_801"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_802"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_803"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_804"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_805"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_806"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_807"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_808"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_809"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_810"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_811"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_812"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_813"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_814"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_815"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_816"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_817"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_818"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_819"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_820"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_821"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_822"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_823"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_824"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract_825"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract_826"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:label="loc_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_827"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_828"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_829"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_830"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_831"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesLineItems" xlink:label="loc_us-gaap_MarketableSecuritiesLineItems_832"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesPolicy" xlink:label="loc_us-gaap_MarketableSecuritiesPolicy_833"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesTable" xlink:label="loc_us-gaap_MarketableSecuritiesTable_834"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesTextBlock" xlink:label="loc_us-gaap_MarketableSecuritiesTextBlock_835"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_836"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MunicipalBondsMember" xlink:label="loc_us-gaap_MunicipalBondsMember_837"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_838"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_839"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_840"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_841"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_842"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_843"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_844"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_845"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_846"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_847"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_848"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_849"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_850"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_851"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_852"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_853"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_854"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_855"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaap_NoncontrollingInterestMember_856"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncurrentAssets" xlink:label="loc_us-gaap_NoncurrentAssets_857"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncurrentAssets" xlink:label="loc_us-gaap_NoncurrentAssets_858"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesReceivableGross" xlink:label="loc_us-gaap_NotesReceivableGross_859"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="loc_us-gaap_NumberOfOperatingSegments_860"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="loc_us-gaap_NumberOfOperatingSegments_861"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OfficeEquipmentMember" xlink:label="loc_us-gaap_OfficeEquipmentMember_862"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses_863"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses_864"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaap_OperatingExpensesAbstract_865"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaap_OperatingExpensesAbstract_866"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_867"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_868"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseCost" xlink:label="loc_us-gaap_OperatingLeaseCost_869"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_870"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_871"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_872"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_873"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_874"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeasePayments" xlink:label="loc_us-gaap_OperatingLeasePayments_875"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_876"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_877"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_878"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_879"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_880"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_881"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaap_OperatingLossCarryforwards_882"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_883"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_884"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_885"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_886"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_887"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_888"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_889"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_890"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCurrentLiabilitiesMember" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_891"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock_892"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherInvestments" xlink:label="loc_us-gaap_OtherInvestments_893"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherInvestments" xlink:label="loc_us-gaap_OtherInvestments_894"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_895"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_896"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_897"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_898"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_899"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivablesGrossCurrent" xlink:label="loc_us-gaap_OtherReceivablesGrossCurrent_900"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivablesGrossCurrent" xlink:label="loc_us-gaap_OtherReceivablesGrossCurrent_901"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_902"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_903"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_904"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivablesNetCurrentAbstract" xlink:label="loc_us-gaap_OtherReceivablesNetCurrentAbstract_905"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_906"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForAdvanceToAffiliate" xlink:label="loc_us-gaap_PaymentsForAdvanceToAffiliate_907"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForAdvanceToAffiliate" xlink:label="loc_us-gaap_PaymentsForAdvanceToAffiliate_908"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_909"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_910"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_911"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_912"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_913"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_914"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireMarketableSecurities" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_915"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireMarketableSecurities" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_916"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_917"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_918"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_919"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_920"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_921"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_922"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_923"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_924"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_925"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_926"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_927"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_928"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_929"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_930"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_931"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_932"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_933"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_934"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_935"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_936"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_937"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_938"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_939"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_940"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_941"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_942"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_943"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_944"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_945"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_946"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_947"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:label="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_948"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_949"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:label="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_950"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_951"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_952"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_953"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_954"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_955"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_956"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_957"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_958"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_959"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_960"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_961"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_962"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_963"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock_964"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_965"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_966"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_967"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_968"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_969"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_970"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_971"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_972"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_973"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_974"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_975"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_976"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_977"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems" xlink:label="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_978"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" xlink:label="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_979"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_980"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_981"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_982"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_983"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_984"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_985"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_986"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_987"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_988"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_989"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:label="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_990"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_991"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_992"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_993"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_994"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:label="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_995"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaap_SellingAndMarketingExpense_996"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaap_SellingAndMarketingExpense_997"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpenseMember" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_998"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeveranceCosts1" xlink:label="loc_us-gaap_SeveranceCosts1_999"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_1000"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_1001"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_1002"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_1003"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_1004"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_1005"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_1006"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_1007"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_1008"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_1009"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1010"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1011"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue_1012"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue_1013"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1014"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1015"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_1016"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_1017"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_1018"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_1019"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_1020"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_1021"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_1022"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_1023"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_1024"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_1025"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_1026"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_1027"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_1028"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1029"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_1030"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1031"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1032"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1033"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_1034"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_1035"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_1036"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_1037"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_1038"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_1039"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_1040"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_1041"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_1042"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_1043"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1044"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_1045"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_1046"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_1047"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_1048"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_1049"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_1050"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_1051"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1052"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1053"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1054"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1055"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1056"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1057"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1058"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_1059"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_1060"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_1061"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_1062"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1063"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_1064"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_1065"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1066"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_1067"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_1068"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_1069"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_1070"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_1071"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_1072"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_1073"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_1074"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_1075"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_1076"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:label="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember_1077"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesIssued" xlink:label="loc_us-gaap_SharesIssued_1078"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesIssued" xlink:label="loc_us-gaap_SharesIssued_1079"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_1080"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_1081"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantSupplyCommitmentRemainingMinimumAmountCommitted" xlink:label="loc_us-gaap_SignificantSupplyCommitmentRemainingMinimumAmountCommitted_1082"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StandardProductWarrantyAccrual" xlink:label="loc_us-gaap_StandardProductWarrantyAccrual_1083"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StandardProductWarrantyAccrual" xlink:label="loc_us-gaap_StandardProductWarrantyAccrual_1084"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StandardProductWarrantyAccrual" xlink:label="loc_us-gaap_StandardProductWarrantyAccrual_1085"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StandardProductWarrantyAccrualPayments" xlink:label="loc_us-gaap_StandardProductWarrantyAccrualPayments_1086"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StandardProductWarrantyAccrualPayments" xlink:label="loc_us-gaap_StandardProductWarrantyAccrualPayments_1087"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StandardProductWarrantyAccrualWarrantiesIssued" xlink:label="loc_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued_1088"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StandardProductWarrantyPolicy" xlink:label="loc_us-gaap_StandardProductWarrantyPolicy_1089"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_1090"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1091"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_1092"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_1093"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_1094"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1095"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_1096"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_1097"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaap_StockholdersEquityAbstract_1098"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaap_StockholdersEquityAbstract_1099"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1100"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1101"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1102"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1103"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_1104"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_1105"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteStockSplit" xlink:label="loc_us-gaap_StockholdersEquityNoteStockSplit_1106"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_1107"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_1108"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1109"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1110"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1111"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_1112"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_1113"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_1114"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_1115"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaap_SubsequentEventLineItems_1116"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_1117"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaap_SubsequentEventsAbstract_1118"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_1119"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaap_SubsequentEventTable_1120"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_1121"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_1122"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowElementsAbstract" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_1123"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions" xlink:label="loc_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions_1124"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions" xlink:label="loc_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions_1125"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ToolsDiesAndMoldsMember" xlink:label="loc_us-gaap_ToolsDiesAndMoldsMember_1126"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1127"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonMember" xlink:label="loc_us-gaap_TreasuryStockCommonMember_1128"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares" xlink:label="loc_us-gaap_TreasuryStockCommonShares_1129"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaap_TreasuryStockValue_1130"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaap_TreasuryStockValue_1131"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaap_TypeOfArrangementAxis_1132"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_1133"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_1134"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_1135"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_1136"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_1137"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_1138"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_1139"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaap_UseOfEstimates_1140"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_1141"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VehiclesMember" xlink:label="loc_us-gaap_VehiclesMember_1142"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingAxis" xlink:label="loc_us-gaap_VestingAxis_1143"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1144"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1145"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1146"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1147"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_country_IL_0" xml:lang="en-US">Israel [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_country_US_0" xml:lang="en-US">United States [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_currency_AllCurrenciesDomain_0" xml:lang="en-US">All Currencies [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_currency_ILS_0" xml:lang="en-US">NIS [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_AmendmentFlag_0" xml:lang="en-US">Amendment Flag</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_AuditorFirmId_0" xml:lang="en-US">Auditor Firm Id</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_AuditorLocation_0" xml:lang="en-US">Auditor Location</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_AuditorName_0" xml:lang="en-US">Auditor Name</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_BusinessContactMember_0" xml:lang="en-US">Business Contact [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_CityAreaCode_0" xml:lang="en-US">City Area Code</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_ContactPersonnelEmailAddress_0" xml:lang="en-US">Contact Personnel Email Address</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_ContactPersonnelFaxNumber_0" xml:lang="en-US">Contact Personnel Fax Number</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_ContactPersonnelName_0" xml:lang="en-US">Contact Personnel Name</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_CurrentFiscalYearEndDate_0" xml:lang="en-US">Current Fiscal Year End Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentAccountingStandard_0" xml:lang="en-US">Document Accounting Standard</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentAnnualReport_0" xml:lang="en-US">Document Annual Report</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentFinStmtErrorCorrectionFlag_0" xml:lang="en-US">Document Financial Statement Error Correction [Flag]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentFiscalPeriodFocus_0" xml:lang="en-US">Document Fiscal Period Focus</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentFiscalYearFocus_0" xml:lang="en-US">Document Fiscal Year Focus</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentPeriodEndDate_0" xml:lang="en-US">Document Period End Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentRegistrationStatement_0" xml:lang="en-US">Document Registration Statement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentShellCompanyReport_0" xml:lang="en-US">Document Shell Company Report</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentTransitionReport_0" xml:lang="en-US">Document Transition Report</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentType_0" xml:lang="en-US">Document Type</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressAddressLine1_0" xml:lang="en-US">Entity Address, Address Line One</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressAddressLine2_0" xml:lang="en-US">Entity Address, Address Line Two</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressAddressLine3_0" xml:lang="en-US">Entity Address, Address Line Three</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressCityOrTown_0" xml:lang="en-US">Entity Address, City or Town</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressCountry_0" xml:lang="en-US">Entity Address Country</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressesAddressTypeAxis_0" xml:lang="en-US">Entity Addresses, Address Type [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressPostalZipCode_0" xml:lang="en-US">Entity Address, Postal Zip Code</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityCentralIndexKey_0" xml:lang="en-US">Entity Central Index Key</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityCommonStockSharesOutstanding_0" xml:lang="en-US">Entity Common Stock, Shares Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityCurrentReportingStatus_0" xml:lang="en-US">Entity Current Reporting Status</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityEmergingGrowthCompany_0" xml:lang="en-US">Entity Emerging Growth Company</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityExTransitionPeriod_0" xml:lang="en-US">Entity Ex Transition Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityFileNumber_0" xml:lang="en-US">Entity File Number</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityFilerCategory_0" xml:lang="en-US">Entity Filer Category</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityIncorporationStateCountryCode_0" xml:lang="en-US">Entity Incorporation, State or Country Code</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityInteractiveDataCurrent_0" xml:lang="en-US">Entity Interactive Data Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityRegistrantName_0" xml:lang="en-US">Entity Registrant Name</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityShellCompany_0" xml:lang="en-US">Entity Shell Company</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityVoluntaryFilers_0" xml:lang="en-US">Entity Voluntary Filers</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer_0" xml:lang="en-US">Entity Well-known Seasoned Issuer</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_IcfrAuditorAttestationFlag_0" xml:lang="en-US">Auditor Attestation Flag</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_LocalPhoneNumber_0" xml:lang="en-US">Local Phone Number</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_OtherReportingStandardItemNumber_0" xml:lang="en-US">Other Reporting Standard Item Number</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_Security12bTitle_0" xml:lang="en-US">Title of 12(b) Security</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_Security12gTitle_0" xml:lang="en-US">Security 12g Title</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_SecurityExchangeName_0" xml:lang="en-US">Name of Exchange on which Security is Registered</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_SecurityReportingObligation_0" xml:lang="en-US">Security Reporting Obligation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_TradingSymbol_0" xml:lang="en-US">Trading Symbol</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_AccountingPoliciesLineItems_0" xml:lang="en-US">Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_AccountingPoliciesLineItems_1" xml:lang="en-US">Accounting Policies [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_AccountingPoliciesTable_0" xml:lang="en-US">Table of accounting policies.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_AccountingPoliciesTable_1" xml:lang="en-US">Accounting Policies [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_AcquisitionOfNonControllingInterestInExchangeOfOrdinaryShares_0" xml:lang="en-US">It represents acquisition of non controlling interest in exchange of ordinary shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_AcquisitionOfNonControllingInterestInExchangeOfOrdinaryShares_1" xml:lang="en-US">Acquisition Of Non Controlling Interest In Exchange Of Ordinary Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_inmd_AcquisitionOfNonControllingInterestInExchangeOfOrdinaryShares_2" xml:lang="en-US">Acquisition of non-controlling interest in exchange of ordinary shares (see note 12b)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_AdjustmentToRedemptionValueOfRedeemableNonControllingInterest_0" xml:lang="en-US">Adjustment to redemption value of redeemable non-controlling interest.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_AdjustmentToRedemptionValueOfRedeemableNonControllingInterest_1" xml:lang="en-US">Adjustment To Redemption Value Of Redeemable Non Controlling Interest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_AmendmentAdvantageExemptionMember_0" xml:lang="en-US">Amendment Advantage Exemption [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_AmendmentAdvantageExemptionMember_1" xml:lang="en-US">Amendment Advantage Exemption [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_AmountOfInvestment_0" xml:lang="en-US">Represents the amount of investment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_AmountOfInvestment_1" xml:lang="en-US">Amount Of Investment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_inmd_AmountOfInvestment_2" xml:lang="en-US">Amount of investment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_AmountPaidToUndistributedExemptIncome_0" xml:lang="en-US">It represents amount paid to undistributed exempt income.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_AmountPaidToUndistributedExemptIncome_1" xml:lang="en-US">Amount Paid To Undistributed Exempt Income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_inmd_AmountPaidToUndistributedExemptIncome_2" xml:lang="en-US">Amount paid to undistributed exempt income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_AutomaticIncreaseApprovedByBoardCompanyIn_0" xml:lang="en-US">Automatic Increase Approved By Board Company In</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_inmd_AutomaticIncreaseApprovedByBoardCompanyIn_1" xml:lang="en-US">Automatic increase approved by the Board of the Company in:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_AvailableForSaleSecuritiesDebtMaturitiesMoreThanFiveYearsFairValue_0" xml:lang="en-US">Debt securities, available for sale maturity, more than five years, fair value.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_AvailableForSaleSecuritiesDebtMaturitiesMoreThanFiveYearsFairValue_1" xml:lang="en-US">Available For Sale Securities Debt Maturities More Than Five Years Fair Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_inmd_AvailableForSaleSecuritiesDebtMaturitiesMoreThanFiveYearsFairValue_2" xml:lang="en-US">More than 5 years</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInFourToFiveYearsFairValue_0" xml:lang="en-US">Debt securities, available for sale maturity, within four to five years, fair value.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInFourToFiveYearsFairValue_1" xml:lang="en-US">Available For Sale Securities Debt Maturities With In Four To Five Years Fair Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInFourToFiveYearsFairValue_2" xml:lang="en-US">4 to 5 years</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInOneToTwoYearsFairValue_0" xml:lang="en-US">Debt securities, available for sale maturity, within one to two years, fair value.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInOneToTwoYearsFairValue_1" xml:lang="en-US">Available For Sale Securities Debt Maturities With In One To Two Years Fair Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInOneToTwoYearsFairValue_2" xml:lang="en-US">1 to 2 years</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInThreeToFourYearsFairValue_0" xml:lang="en-US">Debt securities, available for sale maturity, within three to four years, fair value.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInThreeToFourYearsFairValue_1" xml:lang="en-US">Available For Sale Securities Debt Maturities With In Three To Four Years Fair Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInThreeToFourYearsFairValue_2" xml:lang="en-US">3 to 4 years</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInTwoToThreeYearsFairValue_0" xml:lang="en-US">Debt securities, available for sale maturity, within two to three years, fair value.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInTwoToThreeYearsFairValue_1" xml:lang="en-US">Available For Sale Securities Debt Maturities With In Two To Three Years Fair Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInTwoToThreeYearsFairValue_2" xml:lang="en-US">2 to 3 years</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_BankGuarantee_0" xml:lang="en-US">Bank guarantee.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_BankGuarantee_1" xml:lang="en-US">Bank guarantee</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_BonusShareIssuesPerOutstandingShare_0" xml:lang="en-US">Bonus share issues per outstanding share.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_BonusShareIssuesPerOutstandingShare_1" xml:lang="en-US">Bonus Share Issues Per Outstanding Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_BusinessDescriptionLineItems_0" xml:lang="en-US">Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_BusinessDescriptionLineItems_1" xml:lang="en-US">Business Description [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_BusinessDescriptionTable_0" xml:lang="en-US">Table of business description.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_BusinessDescriptionTable_1" xml:lang="en-US">Business Description [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_CapitalEquipmentMember_0" xml:lang="en-US">This member is stand for capital equipment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_CapitalEquipmentMember_1" xml:lang="en-US">Capital Equipment [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_ConsumablesAndServiceRevenuesMember_0" xml:lang="en-US">This member stand for consumables and service revenues.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_ConsumablesAndServiceRevenuesMember_1" xml:lang="en-US">Consumables And Service Revenues [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_ContractorLiability_0" xml:lang="en-US">Represents the amount of contractor liability.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_ContractorLiability_1" xml:lang="en-US">Contractor Liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_CorporateTax_0" xml:lang="en-US">Corporate tax rate.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_CorporateTax_1" xml:lang="en-US">Corporate tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_CovidNinteenAbstract_0" xml:lang="en-US">Covid Ninteen Abstract</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_inmd_CovidNinteenAbstract_1" xml:lang="en-US">Covid Nineteen [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_CovidNinteenTextBlock_0" xml:lang="en-US">The entire dislosure for COVID-19.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_CovidNinteenTextBlock_1" xml:lang="en-US">Covid Ninteen Text Block</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_inmd_CovidNinteenTextBlock_2" xml:lang="en-US">COVID-19</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_CurrentMonthlyRentPayment_0" xml:lang="en-US">Current monthly rent payment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_CurrentMonthlyRentPayment_1" xml:lang="en-US">Current monthly rent payment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_DevelopmentZoneAMember_0" xml:lang="en-US">Development Zone A [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_DevelopmentZoneAMember_1" xml:lang="en-US">Development Zone A [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_DilazarLimitedMember_0" xml:lang="en-US">Dilazar Limited [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_DilazarLimitedMember_1" xml:lang="en-US">Dilazar Limited [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_EffectiveIncomeTaxRateReconciliationDeductionsDividendsForNonIsraeliResidents_0" xml:lang="en-US">Tax rate for dividend distributed to a corporate shareholder who is not an Israeli resident.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_EffectiveIncomeTaxRateReconciliationDeductionsDividendsForNonIsraeliResidents_1" xml:lang="en-US">Effective Income Tax Rate Reconciliation Deductions Dividends For Non Israeli Residents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_ElsewhereMember_0" xml:lang="en-US">Elsewhere [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_ElsewhereMember_1" xml:lang="en-US">Elsewhere [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_EmployeeRelatedSeveranceLiabilities_0" xml:lang="en-US">Employee Related Severance Liabilities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_EmployeeRelatedSeveranceLiabilities_1" xml:lang="en-US">Employee Related Severance Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_EmployeeSeveranceBenefitsPolicyTextBlock_0" xml:lang="en-US">Employee severance benefits.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_EmployeeSeveranceBenefitsPolicyTextBlock_1" xml:lang="en-US">Employee Severance Benefits Policy Text Block</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_inmd_EmployeeSeveranceBenefitsPolicyTextBlock_2" xml:lang="en-US">Employee severance benefits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_EmployeesMember_0" xml:lang="en-US">Employees [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_EmployeesMember_1" xml:lang="en-US">Employees [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_EmployeesOfficersDirectorsServiceProvidersAndConsultantsMember_0" xml:lang="en-US">Employees, officers, directors, service providers and consultants [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_EmployeesOfficersDirectorsServiceProvidersAndConsultantsMember_1" xml:lang="en-US">Employees, officers, directors, service providers and consultants [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_ExerciseOfOptions_0" xml:lang="en-US">Exercise of Options.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_ExerciseOfOptions_1" xml:lang="en-US">Exercise of Options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_ExercisePriceRangeEightMember_0" xml:lang="en-US">$12.16 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_ExercisePriceRangeEightMember_1" xml:lang="en-US">Exercise Price Range Eight [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_inmd_ExercisePriceRangeEightMember_2" xml:lang="en-US">$12.16 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_ExercisePriceRangeFiveMember_0" xml:lang="en-US">$5.11 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_ExercisePriceRangeFiveMember_1" xml:lang="en-US">Exercise Price Range Five [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_inmd_ExercisePriceRangeFiveMember_2" xml:lang="en-US">$5.11 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_ExercisePriceRangeFourMember_0" xml:lang="en-US">$3.75 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_ExercisePriceRangeFourMember_1" xml:lang="en-US">Exercise Price Range Four [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_inmd_ExercisePriceRangeFourMember_2" xml:lang="en-US">$3.75 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_ExercisePriceRangeNineMember_0" xml:lang="en-US">$21.62 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_ExercisePriceRangeNineMember_1" xml:lang="en-US">Exercise Price Range Nine [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_inmd_ExercisePriceRangeNineMember_2" xml:lang="en-US">$21.62 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_ExercisePriceRangeOneMember_0" xml:lang="en-US">$0.28 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_ExercisePriceRangeOneMember_1" xml:lang="en-US">Exercise Price Range One Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_inmd_ExercisePriceRangeOneMember_2" xml:lang="en-US">$0.28 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_ExercisePriceRangeSevenMember_0" xml:lang="en-US">$9.85 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_ExercisePriceRangeSevenMember_1" xml:lang="en-US">Exercise Price Range Seven [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_inmd_ExercisePriceRangeSevenMember_2" xml:lang="en-US">$9.85 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_ExercisePriceRangeSixMember_0" xml:lang="en-US">$7.00 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_ExercisePriceRangeSixMember_1" xml:lang="en-US">Exercise Price Range Six [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_inmd_ExercisePriceRangeSixMember_2" xml:lang="en-US">$7.00 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_ExercisePriceRangeThreeMember_0" xml:lang="en-US">$3.16 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_ExercisePriceRangeThreeMember_1" xml:lang="en-US">Exercise Price Range Three [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_inmd_ExercisePriceRangeThreeMember_2" xml:lang="en-US">$3.16 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_ExercisePriceRangeTwoMember_0" xml:lang="en-US">$0.29 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_ExercisePriceRangeTwoMember_1" xml:lang="en-US">Exercise Price Range Two [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_inmd_ExercisePriceRangeTwoMember_2" xml:lang="en-US">$0.29 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_ExpensesIncomeMember_0" xml:lang="en-US">Expenses (Income) [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_FairValueOfOneOrdinaryShare_0" xml:lang="en-US">Fair value of one ordinary share.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_FairValueOfOneOrdinaryShare_1" xml:lang="en-US">Fair value of one ordinary share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_FairValueOfOptionsGranted_0" xml:lang="en-US">Fair value of options granted.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_FairValueOfOptionsGranted_1" xml:lang="en-US">Fair value of options granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_FairValueOfRestrictedOptionsGranted_0" xml:lang="en-US">Fair value of restricted options granted.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_FairValueOfRestrictedOptionsGranted_1" xml:lang="en-US">Fair Value Of Restricted Options Granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_inmd_FairValueOfRestrictedOptionsGranted_2" xml:lang="en-US">Fair value of RSUs granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_FebruaryNineTwoThousandsTwentyOneMember_0" xml:lang="en-US">February 9, 2021 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_FebruaryNineTwoThousandsTwentyOneMember_1" xml:lang="en-US">February Nine Two Thousands Twenty One [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_inmd_FebruaryNineTwoThousandsTwentyOneMember_2" xml:lang="en-US">February 9, 2021 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_FebruaryNineTwoZeroTwoTwoMember_0" xml:lang="en-US">February9 , 2022 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_FebruaryNineTwoZeroTwoTwoMember_1" xml:lang="en-US">February Nine Two Zero Two Two [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_inmd_FebruaryNineTwoZeroTwoTwoMember_2" xml:lang="en-US">February 9 , 2022 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_FebruarySeventeenTwoThousandsTwentyMember_0" xml:lang="en-US">February 17, 2020 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_FebruarySeventeenTwoThousandsTwentyMember_1" xml:lang="en-US">February Seventeen Two Thousands Twenty [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_FifteenMarchTwoThousandsTwentyMember_0" xml:lang="en-US">March 15, 2020 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_FifteenMarchTwoThousandsTwentyMember_1" xml:lang="en-US">Fifteen March Two Thousands Twenty [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_FinanceIncome_0" xml:lang="en-US">Finance income.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_inmd_FinanceIncome_1" xml:lang="en-US">Finance expense (income), net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_FinanceIncome_2" xml:lang="en-US">Finance Income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_FullyDilutedBasisMember_0" xml:lang="en-US">Fully diluted basis [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_FullyDilutedBasisMember_1" xml:lang="en-US">Fully diluted basis [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_GeneralAbstract_0" xml:lang="en-US">General Abstract</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_GIBFAndJVCMember_0" xml:lang="en-US">GIBF and JVC [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_GIBFAndJVCMember_1" xml:lang="en-US">G I B F And J V C [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_inmd_GIBFAndJVCMember_2" xml:lang="en-US">GIBF and JVC [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_GovernmentInstitutions_0" xml:lang="en-US">Government institutions.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_GovernmentInstitutions_1" xml:lang="en-US">Government Institutions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_inmd_GovernmentInstitutions_2" xml:lang="en-US">Government institutions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_HandsFreeMember_0" xml:lang="en-US">Hands-Free [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_HandsFreeMember_1" xml:lang="en-US">Hands-Free [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_HimalayaFamilyOfficeConsultingLtdMember_0" xml:lang="en-US">Himalaya Family Office Consulting Ltd. [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_HimalayaFamilyOfficeConsultingLtdMember_1" xml:lang="en-US">Himalaya Family Office Consulting Ltd. [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_HomeSkinnovationsLtdMember_0" xml:lang="en-US">Home Skinnovations Ltd [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_HomeSkinnovationsLtdMember_1" xml:lang="en-US">Home Skinnovations Ltd [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_IncomeTaxNoteLineItems_0" xml:lang="en-US">Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_IncomeTaxNoteLineItems_1" xml:lang="en-US">Income Tax Note [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_IncomeTaxNoteTable_0" xml:lang="en-US">Table of income taxes.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_IncomeTaxNoteTable_1" xml:lang="en-US">Income Tax Note [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_IncomeTaxReconciliationAmendmentToInvestmentsLawPayment_0" xml:lang="en-US">Represents the amount of income tax reconciliation amendment to the investments law payment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_IncomeTaxReconciliationAmendmentToInvestmentsLawPayment_1" xml:lang="en-US">Income Tax Reconciliation Amendment To Investments Law Payment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_inmd_IncomeTaxReconciliationAmendmentToInvestmentsLawPayment_2" xml:lang="en-US">Amendment to the Investments Law payment - see also note 13a(2)(b)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_IncomeTaxReconciliationBenefitsToBenefitedEnterprise_0" xml:lang="en-US">Benefits to the Benefited Enterprise.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_IncomeTaxReconciliationBenefitsToBenefitedEnterprise_1" xml:lang="en-US">Income Tax Reconciliation Benefits To Benefited Enterprise</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_inmd_IncomeTaxReconciliationBenefitsToBenefitedEnterprise_2" xml:lang="en-US">Benefits to the Benefited Enterprise</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_inmd_IncomeTaxReconciliationBenefitsToBenefitedEnterprise_3" xml:lang="en-US">Benefits to the Benefited Enterprise</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_IncomeTaxReconciliationDifferentEffectiveTaxRatesApplicableToOperatingLoss_0" xml:lang="en-US">Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by operating losses.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_IncomeTaxReconciliationDifferentEffectiveTaxRatesApplicableToOperatingLoss_1" xml:lang="en-US">Income Tax Reconciliation Different Effective Tax Rates Applicable To Operating Loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_inmd_IncomeTaxReconciliationDifferentEffectiveTaxRatesApplicableToOperatingLoss_2" xml:lang="en-US">NOL carry back as part of the CARES Act relief</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_IncomeTaxReconciliationDifferentEffectiveTaxRatesApplicableToSubsidiaries_0" xml:lang="en-US">Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to Different effective tax rates applicable to the subsidiaries.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_IncomeTaxReconciliationDifferentEffectiveTaxRatesApplicableToSubsidiaries_1" xml:lang="en-US">Income Tax Reconciliation Different Effective Tax Rates Applicable To Subsidiaries</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_inmd_IncomeTaxReconciliationDifferentEffectiveTaxRatesApplicableToSubsidiaries_2" xml:lang="en-US">Different effective tax rates applicable to the Subsidiaries</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_inmd_IncomeTaxReconciliationDifferentEffectiveTaxRatesApplicableToSubsidiaries_3" xml:lang="en-US">Different effective tax rates applicable to the Subsidiaries</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_IncomeTaxReconciliationNonDeductibleExpenses_0" xml:lang="en-US">Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to Non-deductible expenses.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_IncomeTaxReconciliationNonDeductibleExpenses_1" xml:lang="en-US">Income Tax Reconciliation Non Deductible Expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_inmd_IncomeTaxReconciliationNonDeductibleExpenses_2" xml:lang="en-US">Non-deductible expenses and other permanent differences, mainly share based compensation expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_IncomeTaxReconciliationSettlementsWithIsraeliTaxAuthorityNetOfDecreaseOfRelatedUncertainTax_0" xml:lang="en-US">Represents the amount of Income tax reconciliation settlements with israeli tax authority net of decrease of related uncertain tax.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_IncomeTaxReconciliationSettlementsWithIsraeliTaxAuthorityNetOfDecreaseOfRelatedUncertainTax_1" xml:lang="en-US">Income Tax Reconciliation Settlements With Israeli Tax Authority Net Of Decrease Of Related Uncertain Tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_inmd_IncomeTaxReconciliationSettlementsWithIsraeliTaxAuthorityNetOfDecreaseOfRelatedUncertainTax_2" xml:lang="en-US">Settlements with the Israeli tax authority net of decrease of related uncertain tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_IncomeTaxReconciliationUncertainTaxPosition_0" xml:lang="en-US">Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to uncertain tax position.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_IncomeTaxReconciliationUncertainTaxPosition_1" xml:lang="en-US">Income Tax Reconciliation Uncertain Tax Position</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_inmd_IncomeTaxReconciliationUncertainTaxPosition_2" xml:lang="en-US">Uncertain tax positions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_IncreasesDueToIssuanceOfNewContractsExcludingAmountsRecognizedAsRevenueDuringPeriod_0" xml:lang="en-US">Increases due to issuance of new contracts, excluding amounts recognized as revenue during the period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_IncreasesDueToIssuanceOfNewContractsExcludingAmountsRecognizedAsRevenueDuringPeriod_1" xml:lang="en-US">Increases due to issuance of new contracts, excluding amounts recognized as revenue during the period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_InmodeInnovationMember_0" xml:lang="en-US">This member is stand for Inmode Innovation.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_InmodeInnovationMember_1" xml:lang="en-US">Inmode Innovation [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_InmodeLtdAndIsreaeliSubsidiariesMember_0" xml:lang="en-US">InMode Ltd. and Isreaeli subsidiaries[member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_InmodeLtdAndIsreaeliSubsidiariesMember_1" xml:lang="en-US">Inmode Ltd And Isreaeli Subsidiaries [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_inmd_InmodeLtdAndIsreaeliSubsidiariesMember_2" xml:lang="en-US">InMode Ltd. and Israeli subsidiaries [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_InterestReceived_0" xml:lang="en-US">Interest received.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_InterestReceived_1" xml:lang="en-US">Interest received</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_InvestmentInShortTermDeposit_0" xml:lang="en-US">Investment in short-term deposit.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_inmd_InvestmentInShortTermDeposit_1" xml:lang="en-US">Investment in short-term deposits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_InvestmentInShortTermDeposit_2" xml:lang="en-US">Investment In Short Term Deposit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_IsraeliTaxAuthorityMember_0" xml:lang="en-US">This member is stand for Israeli Tax Authority.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_IsraeliTaxAuthorityMember_1" xml:lang="en-US">Israeli Tax Authority [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_JanuarySevenTwoThousandsTwentyMember_0" xml:lang="en-US">January 7, 2020 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_JanuarySevenTwoThousandsTwentyMember_1" xml:lang="en-US">January Seven Two Thousands Twenty [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_JointVentureAgreementMember_0" xml:lang="en-US">Guangzhou Sino Israel Bio Industry Investment Fund LLP [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_JointVentureAgreementMember_1" xml:lang="en-US">Joint Venture Agreement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_JulyTwentySevenTwoThousandsTwentyOneMember_0" xml:lang="en-US">July 27, 2021 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_JulyTwentySevenTwoThousandsTwentyOneMember_1" xml:lang="en-US">July Twenty Seven Two Thousands Twenty One [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_inmd_JulyTwentySevenTwoThousandsTwentyOneMember_2" xml:lang="en-US">July 27, 2021 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_JulyTwoSevenTwoZeroTwoTwoMember_0" xml:lang="en-US">July 27, 2022 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_JulyTwoSevenTwoZeroTwoTwoMember_1" xml:lang="en-US">July Two Seven Two Zero Two Two [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_inmd_JulyTwoSevenTwoZeroTwoTwoMember_2" xml:lang="en-US">July 27, 2022 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_LeaseAgreementMember_0" xml:lang="en-US">Lease agreement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_LeaseAgreementMember_1" xml:lang="en-US">Lease Agreement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_inmd_LeaseAgreementMember_2" xml:lang="en-US">Lease agreement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_LeaseExpires_0" xml:lang="en-US">Lease expires period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_LeaseExpires_1" xml:lang="en-US">Lease expires</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_inmd_LeaseExpires_2" xml:lang="en-US">Lease expiration date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_LeasesLineItems_0" xml:lang="en-US">Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_LeasesLineItems_1" xml:lang="en-US">Leases [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_LeasesTable_0" xml:lang="en-US">Table of leases.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_LeasesTable_1" xml:lang="en-US">Leases [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_MarketableSecuritiesAndFairValueMeasurementAbstract_0" xml:lang="en-US">Marketable Securities and Fair Value Measurement [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_inmd_MarketableSecuritiesAndFairValueMeasurementAbstract_1" xml:lang="en-US">Marketable Securities And Fair Value Measurements Schedule Of Debt Securities On Maturity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_inmd_MarketableSecuritiesAndFairValueMeasurementAbstract_2" xml:lang="en-US">Marketable Securities And Fair Value Measurements</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_MarketableSecuritiesAndFairValueMeasurements_0" xml:lang="en-US">The entire dislosure for marketable securities and fair value measurements.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_MarketableSecuritiesAndFairValueMeasurements_1" xml:lang="en-US">Marketable Securities And Fair Value Measurements</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_inmd_MarketableSecuritiesAndFairValueMeasurements_2" xml:lang="en-US">MARKETABLE SECURITIES AND FAIR VALUE MEASUREMENTS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_MayFiveTwoThousandsTwentyMember_0" xml:lang="en-US">May 5, 2020 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_MayFiveTwoThousandsTwentyMember_1" xml:lang="en-US">May Five Two Thousands Twenty [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_MayOneTwoZeroTwoTwoMember_0" xml:lang="en-US">May 1, 2022 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_MayOneTwoZeroTwoTwoMember_1" xml:lang="en-US">May One Two Zero Two Two [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_inmd_MayOneTwoZeroTwoTwoMember_2" xml:lang="en-US">May 1, 2022 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_MaySixTwoThousandsTwentyOneMember_0" xml:lang="en-US">May 6, 2021 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_MaySixTwoThousandsTwentyOneMember_1" xml:lang="en-US">May Six Two Thousands Twenty One [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_inmd_MaySixTwoThousandsTwentyOneMember_2" xml:lang="en-US">May 6, 2021 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_MedimorMember_0" xml:lang="en-US">Medimor [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_MedimorMember_1" xml:lang="en-US">Medimor [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_MinimalInvasiveMember_0" xml:lang="en-US">Minimal-Invasive [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_MinimalInvasiveMember_1" xml:lang="en-US">Minimal-Invasive [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_MinorityInterestDecreaseFromRedemptionsOne_0" xml:lang="en-US">Waiver of redeemable non controlling interest.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_MinorityInterestDecreaseFromRedemptionsOne_1" xml:lang="en-US">Minority Interest Decrease From Redemptions One</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_inmd_MinorityInterestDecreaseFromRedemptionsOne_2" xml:lang="en-US">Waiver of redeemable non controlling interest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_NoAmendmentMember_0" xml:lang="en-US">No Amendment [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_NoAmendmentMember_1" xml:lang="en-US">No Amendment [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_NonCashAcquisitionOfNoncontrollingInterestInExchangeOfOrdinaryShares_0" xml:lang="en-US">Represents the amount of non cash Acquisition of noncontrolling interest in exchange of ordinary shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_NonCashAcquisitionOfNoncontrollingInterestInExchangeOfOrdinaryShares_1" xml:lang="en-US">Non Cash Acquisition Of Noncontrolling Interest In Exchange Of Ordinary Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_inmd_NonCashAcquisitionOfNoncontrollingInterestInExchangeOfOrdinaryShares_2" xml:lang="en-US">Acquisition of non-controlling interest in exchange of ordinary shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_NonInvasiveMember_0" xml:lang="en-US">Non-Invasive [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_NonInvasiveMember_1" xml:lang="en-US">Non-Invasive [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_NonIsraeliPlanMember_0" xml:lang="en-US">Non-Israeli [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_NonIsraeliPlanMember_1" xml:lang="en-US">Non Israeli Plan [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_NonUsGovernmentAgenciesDebtSecuritiesMember_0" xml:lang="en-US">Non US Government Securities [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_NonUsGovernmentAgenciesDebtSecuritiesMember_1" xml:lang="en-US">Non Us Government Agencies Debt Securities [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_NovemberElevenTwoThousandsTwentyMember_0" xml:lang="en-US">November 11, 2020 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_NovemberElevenTwoThousandsTwentyMember_1" xml:lang="en-US">November Eleven Two Thousands Twenty [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_NumberOfOrdinarySharesConsideration_0" xml:lang="en-US">Number Of Ordinary Shares Consideration</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_NumberOfOrdinarySharesConsideration_1" xml:lang="en-US">Number Of Ordinary Shares Consideration</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_inmd_NumberOfOrdinarySharesConsideration_2" xml:lang="en-US">Number of ordinary shares consideration</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_NumberOfShareholder_0" xml:lang="en-US">Represents the number of shareholder.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_NumberOfShareholder_1" xml:lang="en-US">Number Of Shareholder</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_inmd_NumberOfShareholder_2" xml:lang="en-US">Number for shareholder</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_OctoberTwoSixTwoZeroTwoTwoMember_0" xml:lang="en-US">October 26, 2022 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_OctoberTwoSixTwoZeroTwoTwoMember_1" xml:lang="en-US">October Two Six Two Zero Two Two [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_inmd_OctoberTwoSixTwoZeroTwoTwoMember_2" xml:lang="en-US">October 26, 2022 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_OneTimePayment_0" xml:lang="en-US">One-time payment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_OneTimePayment_1" xml:lang="en-US">One Time Payment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_inmd_OneTimePayment_2" xml:lang="en-US">One-time payment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_OperatingLeaseRightOfUseAssests_0" xml:lang="en-US">Operating lease right-of-use assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_OperatingLeaseRightOfUseAssests_1" xml:lang="en-US">Operating Lease Right Of Use Assests</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_inmd_OperatingLeaseRightOfUseAssests_2" xml:lang="en-US">Recognition of operating lease right-of-use assets and liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_OptionsChangesDuringYear_0" xml:lang="en-US">Options Changes During Year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_inmd_OptionsChangesDuringYear_1" xml:lang="en-US">Changes during the year:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_OtherAdvancesToSuppliersCurrent_0" xml:lang="en-US">Amount, advances to suppliers of receivables classified as other, due within one year or the operating cycle, if longer.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_OtherAdvancesToSuppliersCurrent_1" xml:lang="en-US">Other Advances To Suppliers Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_inmd_OtherAdvancesToSuppliersCurrent_2" xml:lang="en-US">Advances to suppliers</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_OtherCountryMember_0" xml:lang="en-US">Other [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_OtherCountryMember_1" xml:lang="en-US">Other Country [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_inmd_OtherCountryMember_2" xml:lang="en-US">Other [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_OtherCurrentLeaseLiabilities_0" xml:lang="en-US">Other lease liabilities classified as current.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_OtherCurrentLeaseLiabilities_1" xml:lang="en-US">Other Current Lease Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_inmd_OtherCurrentLeaseLiabilities_2" xml:lang="en-US">Other current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_OtherCurrentLiabilitiesLineItems_0" xml:lang="en-US">Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_OtherCurrentLiabilitiesLineItems_1" xml:lang="en-US">Other Current Liabilities [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_OtherCurrentLiabilitiesTable_0" xml:lang="en-US">Table of other current liabilities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_OtherCurrentLiabilitiesTable_1" xml:lang="en-US">Other Current Liabilities [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_OtherCurrentReceivables_0" xml:lang="en-US">The entire disclosure for other current receivables.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_OtherCurrentReceivables_1" xml:lang="en-US">Other Current Receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_inmd_OtherCurrentReceivables_2" xml:lang="en-US">OTHER CURRENT RECIVABLES</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_OtherGovernmentInstitutionsReceivablesCurrent_0" xml:lang="en-US">Amount, government institution of receivables classified as other, due within one year or the operating cycle, if longer.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_OtherGovernmentInstitutionsReceivablesCurrent_1" xml:lang="en-US">Other Government Institutions Receivables Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_inmd_OtherGovernmentInstitutionsReceivablesCurrent_2" xml:lang="en-US">Government institutions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_OtherIncomeTaxReceivablesCurrent_0" xml:lang="en-US">Amount, income tax of receivables classified as other, due within one year or the operating cycle, if longer.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_OtherIncomeTaxReceivablesCurrent_1" xml:lang="en-US">Other Income Tax Receivables Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_inmd_OtherIncomeTaxReceivablesCurrent_2" xml:lang="en-US">Income tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_OtherOperatingExpenseIncome_0" xml:lang="en-US">Other operating income.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_inmd_OtherOperatingExpenseIncome_1" xml:lang="en-US">Other income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_OtherOperatingExpenseIncome_2" xml:lang="en-US">Other Operating Expense Income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_OtherPrepaidExpensesReceivablesCurrent_0" xml:lang="en-US">Amount, prepaid expenses of receivables classified as other, due within one year or the operating cycle, if longer.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_OtherPrepaidExpensesReceivablesCurrent_1" xml:lang="en-US">Other Prepaid Expenses Receivables Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_inmd_OtherPrepaidExpensesReceivablesCurrent_2" xml:lang="en-US">Prepaid expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_OtherReceivablesNonCurrent_0" xml:lang="en-US">Amount, after allowance, of receivables classified as other, due after more than one year.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_OtherReceivablesNonCurrent_1" xml:lang="en-US">Other Receivables Non Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_inmd_OtherReceivablesNonCurrent_2" xml:lang="en-US">Other receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_OwnershipInterestExchange_0" xml:lang="en-US">Ownership interest exchange for voting interest acquired.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_OwnershipInterestExchange_1" xml:lang="en-US">Ownership interest exchange</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_PaymentsToTaxAuthorities_0" xml:lang="en-US">Payments to tax authorities for Amendment to the Investments Law and settlements.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_PaymentsToTaxAuthorities_1" xml:lang="en-US">Payments To Tax Authorities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_inmd_PaymentsToTaxAuthorities_2" xml:lang="en-US">Payments to tax authorities for Amendment to Investments Law and settlements</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_PercentageOfNetSalesBasedOnProductsTechnology_0" xml:lang="en-US">Percentage of net sales based on products technology.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_PercentageOfNetSalesBasedOnProductsTechnology_1" xml:lang="en-US">Percentage of net sales based on products technology</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_PercentageOfNonCurrentDeferredRevenue_0" xml:lang="en-US">Percentage of non- current deferred revenue.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_PercentageOfNonCurrentDeferredRevenue_1" xml:lang="en-US">Percentage of non- current deferred revenue</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_PrepaidExpensesAndOtherCurrentReceivablesTextBlock_0" xml:lang="en-US">The entire disclosure for prepaid expenses and other current receivables.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_PrepaidExpensesAndOtherCurrentReceivablesTextBlock_1" xml:lang="en-US">Prepaid Expenses And Other Current Receivables [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_inmd_PrepaidExpensesAndOtherCurrentReceivablesTextBlock_2" xml:lang="en-US">PREPAID EXPENSES AND OTHER CURRENT RECIVABLES</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_PreviousYearIncomeTaxExpenseBenefit_0" xml:lang="en-US">Amount of previous year income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_PreviousYearIncomeTaxExpenseBenefit_1" xml:lang="en-US">Previous Year Income Tax Expense Benefit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_inmd_PreviousYearIncomeTaxExpenseBenefit_2" xml:lang="en-US">Previous year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_ProceedsFromInvestmentInShortTermDeposit_0" xml:lang="en-US">Proceeds from short-term deposit.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_ProceedsFromInvestmentInShortTermDeposit_1" xml:lang="en-US">Proceeds From Investment In Short Term Deposit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_inmd_ProceedsFromInvestmentInShortTermDeposit_2" xml:lang="en-US">Proceeds from short-term deposits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_ProceedsFromMaturityOfMarketableSecurities_0" xml:lang="en-US">Represent the amount of Proceeds from maturity of marketable securities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_ProceedsFromMaturityOfMarketableSecurities_1" xml:lang="en-US">Proceeds From Maturity Of Marketable Securities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_inmd_ProceedsFromMaturityOfMarketableSecurities_2" xml:lang="en-US">Proceeds from maturity of marketable securities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_RegulationsMember_0" xml:lang="en-US">Regulations [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_RegulationsMember_1" xml:lang="en-US">Regulations [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_RelatedPartyConsiderationForAggregateAmount_0" xml:lang="en-US">It represents related party consideration for aggregate amount.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_RelatedPartyConsiderationForAggregateAmount_1" xml:lang="en-US">Related Party Consideration For Aggregate Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_inmd_RelatedPartyConsiderationForAggregateAmount_2" xml:lang="en-US">Related party consideration for aggregate amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_ScheduleOfOtherReceivablesCurrentTableTextBlock_0" xml:lang="en-US">Tabular disclosure of other current receivables.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_ScheduleOfOtherReceivablesCurrentTableTextBlock_1" xml:lang="en-US">Schedule Of Other Receivables Current [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_ScheduleOfPrepaidExpensesAndOtherCurrentRecivablesTableTextBlock_0" xml:lang="en-US">Tabular disclosure of prepaid expenses and other current receivables.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_ScheduleOfPrepaidExpensesAndOtherCurrentRecivablesTableTextBlock_1" xml:lang="en-US">Schedule Of Prepaid Expenses And Other Current Recivables [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_inmd_ScheduleOfPrepaidExpensesAndOtherCurrentRecivablesTableTextBlock_2" xml:lang="en-US">Schedule of prepaid expenses and other current receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_inmd_ScheduleOfPrepaidExpensesAndOtherCurrentRecivablesTableTextBlock_3" xml:lang="en-US">Schedule Of Prepaid Expenses And Other Current Receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock_0" xml:lang="en-US">Tabular disclosure of property and equipment estimated useful lives.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock_1" xml:lang="en-US">Schedule Of Property And Equipment Estimated Useful Lives [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_inmd_ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock_2" xml:lang="en-US">Schedule of Property and Equipment Estimated Useful Lives</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_ScheduleOfSupplementalBalanceSheetInformationRelatedToLeases_0" xml:lang="en-US">Tabular disclosure of supplemental balance sheet information related to leases.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_ScheduleOfSupplementalBalanceSheetInformationRelatedToLeases_1" xml:lang="en-US">Schedule of Supplemental Balance Sheet Information Related to Leases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_ScheduleOfSupplementalCashFlowInformationRelatedToLeases_0" xml:lang="en-US">Tabular disclosure of supplemental cash flow information related to leases.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_ScheduleOfSupplementalCashFlowInformationRelatedToLeases_1" xml:lang="en-US">Schedule of Supplemental Cash Flow Information Related to Leases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonVestedVested_0" xml:lang="en-US">The number of restricted stock units vested at the end of the year.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonVestedVested_1" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Non Vested Vested</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonVestedVested_2" xml:lang="en-US">Number of RSUs vested</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue_0" xml:lang="en-US">Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were vested.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue_1" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award, Equity Instruments Other Than Options, Vested, Weighted Average Grant Date Fair Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue_2" xml:lang="en-US">Vested</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsEarlyExerciseMultiple_0" xml:lang="en-US">The early exercise multiple assumption.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsEarlyExerciseMultiple_1" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Early Exercise Multiple</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsEarlyExerciseMultiple_2" xml:lang="en-US">Early exercise multiple (&#8220;EEM&#8221;)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedFour_0" xml:lang="en-US">Number of awards authorized to be issued in third year.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedFour_1" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized Four</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedFour_2" xml:lang="en-US">January 2023</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedOne_0" xml:lang="en-US">Number of awards authorized to be issued in year one.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedOne_1" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized One</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedOne_2" xml:lang="en-US">January 2020</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedThree_0" xml:lang="en-US">Number of awards authorized to be issued in third year.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedThree_1" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized Three</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedThree_2" xml:lang="en-US">January 2022</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedTwo_0" xml:lang="en-US">Number of awards authorized to be issued in year two.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedTwo_1" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized Two</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedTwo_2" xml:lang="en-US">January 2021</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedUponAdoption_0" xml:lang="en-US">Number of awards authorized to be issued upon adoption of the 2018 Incentive Plan.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedUponAdoption_1" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized Upon Adoption</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedUponAdoption_2" xml:lang="en-US">Upon adoption of the 2018 Incentive Plan</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriod_0" xml:lang="en-US">The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriod_1" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Options Cancelled In Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriod_2" xml:lang="en-US">Cancelled</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAwardAmount_0" xml:lang="en-US">Amount of award under share-based payment arrangement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAwardAmount_1" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Terms Of Award Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAwardAmount_2" xml:lang="en-US">Award amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionCancelledInPeriodWeightedAverageExercisePrice_0" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Canceled in Period, Weighted Average Exercise Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionCancelledInPeriodWeightedAverageExercisePrice_1" xml:lang="en-US">Share Based Compensation Arrangements By Share Based Payment Award Option Cancelled In Period Weighted Average Exercise Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_inmd_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionCancelledInPeriodWeightedAverageExercisePrice_2" xml:lang="en-US">Cancelled</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_ShareBasedCompensationAwardTrancheFourMember_0" xml:lang="en-US">Third portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_ShareBasedCompensationAwardTrancheFourMember_1" xml:lang="en-US">Share Based Compensation Award Tranche Four [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice_0" xml:lang="en-US">The floor of a range of exercise prices for purposes of disclosing shares potentially issuable under outstanding and exercisable stock option awards on all stock option plans and other required information pertaining to awards in the range.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice_1" xml:lang="en-US">Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_inmd_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice_2" xml:lang="en-US">Exercise prices</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_SharePurchaseAndShareholdersAgreementMember_0" xml:lang="en-US">Share Purchase and Shareholders Agreement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_SharePurchaseAndShareholdersAgreementMember_1" xml:lang="en-US">Share Purchase And Shareholders Agreement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_inmd_SharePurchaseAndShareholdersAgreementMember_2" xml:lang="en-US">Share purchase and shareholders agreement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_ShareRepurchaseProgramMember_0" xml:lang="en-US">Share Repurchase Program [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_SharesAuthorizedAmount_0" xml:lang="en-US">Shares authorized amount.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_SharesAuthorizedAmount_1" xml:lang="en-US">Shares authorized amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_ShareValueOfAcquisitionOfNonControllingInterestInExchangeOfOrdinaryShares_0" xml:lang="en-US">Shares of acquisition of non-controlling interest in exchange of ordinary shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_ShareValueOfAcquisitionOfNonControllingInterestInExchangeOfOrdinaryShares_1" xml:lang="en-US">Share Value Of Acquisition Of Non Controlling Interest In Exchange Of Ordinary Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_inmd_ShareValueOfAcquisitionOfNonControllingInterestInExchangeOfOrdinaryShares_2" xml:lang="en-US">Acquisition of non-controlling interest in exchange of ordinary shares (see note 12b) (Shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_ShortTermBankDepositsPolicyTextBlock_0" xml:lang="en-US">Disclosure of accounting policy for short-term bank deposits.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_ShortTermBankDepositsPolicyTextBlock_1" xml:lang="en-US">Short Term Bank Deposits Policy Text Block</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_inmd_ShortTermBankDepositsPolicyTextBlock_2" xml:lang="en-US">Short-term bank deposits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_ShortTermDepositsAnnualInterestRate_0" xml:lang="en-US">Short-term deposits annual interest rate.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_ShortTermDepositsAnnualInterestRate_1" xml:lang="en-US">Short Term Deposits Annual Interest Rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_SpaMedicalInternationalLsrlMember_0" xml:lang="en-US">Spa MedicaI International SRL [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_SpaMedicalInternationalLsrlMember_1" xml:lang="en-US">Spa Medical International Lsrl [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_SpecialPreferredEnterpriseMember_0" xml:lang="en-US">Special Preferred Enterprise [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_SpecialPreferredEnterpriseMember_1" xml:lang="en-US">Special Preferred Enterprise [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_StockRepurchasedDuringPeriodValueOne_0" xml:lang="en-US">Repurchase of ordinary shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_StockRepurchasedDuringPeriodValueOne_1" xml:lang="en-US">Stock Repurchased During Period Value One</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_inmd_StockRepurchasedDuringPeriodValueOne_2" xml:lang="en-US">Repurchase of ordinary shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_StockRepurchasedOrdinarySharesDuringPeriodShares_0" xml:lang="en-US">Repurchase of ordinary shares, shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_StockRepurchasedOrdinarySharesDuringPeriodShares_1" xml:lang="en-US">Stock Repurchased Ordinary Shares During Period Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_inmd_StockRepurchasedOrdinarySharesDuringPeriodShares_2" xml:lang="en-US">Repurchase of ordinary shares (Shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_StockRepurchasedOrdinarySharesDuringPeriodValue_0" xml:lang="en-US">Repurchase of ordinary shares value.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_StockRepurchasedOrdinarySharesDuringPeriodValue_1" xml:lang="en-US">Stock Repurchased Ordinary Shares During Period Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_inmd_StockRepurchasedOrdinarySharesDuringPeriodValue_2" xml:lang="en-US">Repurchase of ordinary shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_SubsidiariesFourMember_0" xml:lang="en-US">Canadian Subsidiary [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_SubsidiariesFourMember_1" xml:lang="en-US">Subsidiaries Four [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_SubsidiariesOutsideIsraelMember_0" xml:lang="en-US">Subsidiaries outside Israel [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_SubsidiariesOutsideIsraelMember_1" xml:lang="en-US">Subsidiaries outside Israel [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_inmd_SubsidiariesOutsideIsraelMember_2" xml:lang="en-US">Subsidiaries outside of Israel [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_SubsidiariesThreeMember_0" xml:lang="en-US">U.S Subsidiary [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_SubsidiariesThreeMember_1" xml:lang="en-US">Subsidiaries Three [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_SubsidiaryOfHomeSkinnovationsLtdMember_0" xml:lang="en-US">Subsidiary Of Home Skinnovations Ltd [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_SubsidiaryOfHomeSkinnovationsLtdMember_1" xml:lang="en-US">Subsidiary of Home Skinnovations Ltd [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_TaxBenefitYear_0" xml:lang="en-US">Tax benefit in years.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_TaxBenefitYear_1" xml:lang="en-US">Tax benefit year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_TaxRateForRecipientForDividendsDistributedByPreferredCompany_0" xml:lang="en-US">Tax rate for recipient for dividends distributed by Preferred Company from income derived from its PTE or SPTE.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_TaxRateForRecipientForDividendsDistributedByPreferredCompany_1" xml:lang="en-US">Tax Rate For Recipient For Dividends Distributed By Preferred Company</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_TotalLongLivedAssetsByGeographicalArea_0" xml:lang="en-US">Represents the amount of long lived assets by geographical area.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_TotalLongLivedAssetsByGeographicalArea_1" xml:lang="en-US">Total Long Lived Assets By Geographical Area</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_inmd_TotalLongLivedAssetsByGeographicalArea_2" xml:lang="en-US">Total long-lived assets by geographical area</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_TreasurySharesPolicyTextBlock_0" xml:lang="en-US">Disclosure of accounting policy treasury shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_TreasurySharesPolicyTextBlock_1" xml:lang="en-US">Treasury Shares Policy Text Block</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_inmd_TreasurySharesPolicyTextBlock_2" xml:lang="en-US">Treasury Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_TwoPurchaseAndShareholdersAgreementsMember_0" xml:lang="en-US">Two Purchase And Shareholders Agreements [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_TwoPurchaseAndShareholdersAgreementsMember_1" xml:lang="en-US">Two Purchase And Shareholders Agreements [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_inmd_TwoPurchaseAndShareholdersAgreementsMember_2" xml:lang="en-US">Two purchase and shareholders agreements [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_TwoThousandsEighteenIncentivePlanMember_0" xml:lang="en-US">2018 Incentive Plan [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_TwoThousandsEighteenIncentivePlanMember_1" xml:lang="en-US">Two Thousands Eighteen Incentive Plan [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_inmd_TwoThousandsEighteenIncentivePlanMember_2" xml:lang="en-US">2018 Incentive Plan [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_UnderwritersAllotmentOptionMember_0" xml:lang="en-US">Underwriters Allotment Option [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_UnderwritersAllotmentOptionMember_1" xml:lang="en-US">Underwriters Allotment Option [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_UndistributedExemptIncome_0" xml:lang="en-US">Undistributed exempt income.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_UndistributedExemptIncome_1" xml:lang="en-US">Undistributed exempt income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_inmd_UnitsChangesDuringYearAbstract_0" xml:lang="en-US">Changes during the year:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_WarrantyReserveLiabilityCurrent_0" xml:lang="en-US">Warranty reserve liability current.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_WarrantyReserveLiabilityCurrent_1" xml:lang="en-US">Warranty Reserve Liability Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_inmd_WarrantyReserveLiabilityCurrent_2" xml:lang="en-US">Warranty reserve</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_inmd_WarRiskSituationInIsraelPolicyTextBlock_0" xml:lang="en-US">Disclosure of accounting policy for war risk situation in Israel.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_WarRiskSituationInIsraelPolicyTextBlock_1" xml:lang="en-US">War Risk Situation In Israel [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_inmd_WarRiskSituationInIsraelPolicyTextBlock_2" xml:lang="en-US">War risk situation in Israel</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_WeightedAverageExercisePriceChangesDuringYearAbstract_0" xml:lang="en-US">Weighted Average Exercise Price Changes During Year Abstract</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_inmd_WeightedAverageExercisePriceChangesDuringYearAbstract_1" xml:lang="en-US">Changes during the year:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_inmd_WeightedAverageGrantDateChangesDuringYearAbstract_0" xml:lang="en-US">Changes during the year:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_inmd_WeightedAverageNumberOfSharesOutStandingUsedInComputationOfNetIncomePerShareAbstract_0" xml:lang="en-US">Weighted Average Number Of Shares Out Standing Used In Computation Of Net Income Per Share Abstract</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_inmd_WeightedAverageNumberOfSharesOutStandingUsedInComputationOfNetIncomePerShareAbstract_1" xml:lang="en-US">WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING USED IN COMPUTATION OF EARNINGS PER SHARE</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_BoardOfDirectorsChairmanMember_0" xml:lang="en-US">Board of Director [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_ConsolidatedEntitiesAxis_0" xml:lang="en-US">Consolidated Entities [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_0" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_CurrencyAxis_0" xml:lang="en-US">Currency [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_EquityMethodInvesteeNameDomain_0" xml:lang="en-US">Investment, Name [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_EuropeMember_0" xml:lang="en-US">Europe [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_srt_EuropeMember_1" xml:lang="en-US">Europe [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_MaximumMember_0" xml:lang="en-US">Maximum [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_srt_MaximumMember_1" xml:lang="en-US">Maximum [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_MinimumMember_0" xml:lang="en-US">Minimum [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_srt_MinimumMember_1" xml:lang="en-US">Minimum [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_0" xml:lang="en-US">Real Estate, Type of Property [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_0" xml:lang="en-US">Real Estate [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_OfficeBuildingMember_0" xml:lang="en-US">Office Building [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_OwnershipAxis_0" xml:lang="en-US">Ownership [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_ProductOrServiceAxis_0" xml:lang="en-US">Product and Service [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_ProductsAndServicesDomain_0" xml:lang="en-US">Product and Service [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_RangeAxis_0" xml:lang="en-US">Statistical Measurement [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_RangeMember_0" xml:lang="en-US">Statistical Measurement [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_ScenarioForecastMember_0" xml:lang="en-US">Forecast [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_0" xml:lang="en-US">Investment, Name [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_SegmentGeographicalDomain_0" xml:lang="en-US">Geographical [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_StatementGeographicalAxis_0" xml:lang="en-US">Geographical [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_StatementScenarioAxis_0" xml:lang="en-US">Scenario [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_SubsidiariesMember_0" xml:lang="en-US">Invasix UK [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_TitleOfIndividualAxis_0" xml:lang="en-US">Title of Individual [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_0" xml:lang="en-US">Title of Individual [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_WarehouseMember_0" xml:lang="en-US">Warehouse [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccountingPoliciesAbstract_0" xml:lang="en-US">Accounting Policies [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccountsAndNotesReceivableNet_0" xml:lang="en-US">Accounts and Financing Receivable, after Allowance for Credit Loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_AccountsAndNotesReceivableNet_1" xml:lang="en-US">Notes And Loans Receivable Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccountsAndOtherReceivablesNetCurrent_0" xml:lang="en-US">Accounts and Other Receivables, Net, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AccountsAndOtherReceivablesNetCurrent_1" xml:lang="en-US">Accounts receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableGrossAllowanceAndNetAbstract_0" xml:lang="en-US">Accounts, Notes, Loans and Financing Receivable, Gross, Allowance, and Net [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_0" xml:lang="en-US">OTHER CURRENT LIABILITIES</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccountsPayableCurrent_0" xml:lang="en-US">Accounts Payable, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AccountsPayableCurrent_1" xml:lang="en-US">Accounts payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_AccountsPayableCurrent_2" xml:lang="en-US">Accounts Payable, Current, Total</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:label="lab_us-gaap_AccountsPayableCurrent_3" xml:lang="en-US">Accounts receivable, net of allowance for credit losses of $1,538 and $836, as of December 31, 2023 and 2022, respectively</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_AccountsPayableCurrent_4" xml:lang="en-US">Accounts receivable, net of allowance for credit losses of $836 and $1,107, as of December 31, 2022 and 2021, respectively</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveTerseLabel" xlink:label="lab_us-gaap_AccountsPayableCurrent_5" xml:lang="en-US">Accounts paybale</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccountsPayableCurrentAndNoncurrent_0" xml:lang="en-US">Accounts Payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccountsPayableRelatedAndNonrelatedPartyStatusExtensibleEnumeration_0" xml:lang="en-US">Accounts Payable, Related and Nonrelated Party Status [Extensible Enumeration]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccountsReceivableAfterAllowanceForCreditLossRelatedAndNonrelatedPartyStatusExtensibleEnumeration_0" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Related and Nonrelated Party Status [Extensible Enumeration]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_0" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_1" xml:lang="en-US">Schedule Of Allowance For Credit Losses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccountsReceivableGross_0" xml:lang="en-US">Trade</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccountsReceivableNet_0" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_AccountsReceivableNet_1" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Total</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AccountsReceivableNet_2" xml:lang="en-US">Accounts receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent_0" xml:lang="en-US">Accounts receivable, net of allowance for credit losses of $1,538 and $836, as of December 31, 2023 and 2022, respectively</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent_1" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent_2" xml:lang="en-US">Total current accounts receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent_3" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current, Total</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent_4" xml:lang="en-US">Accounts receivable, net of allowance for credit losses of $836 and $1,107, as of December 31, 2022 and 2021, respectively</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveTerseLabel" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent_5" xml:lang="en-US">Accounts paybale</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_AccountsReceivableNetNoncurrent_0" xml:lang="en-US">Less - non-current accounts receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccountsReceivableNetNoncurrent_1" xml:lang="en-US">Accounts receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AccountsReceivableNetNoncurrent_2" xml:lang="en-US">Accounts receivable net of allowance for credit losses of $482 and $0 as of December 31, 2022 and 2021, respectively</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_AccountsReceivableNetNoncurrent_3" xml:lang="en-US">Accounts receivable net of allowance for credit losses of $716 and $482 as of December 31, 2023 and 2022, respectively</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccountsReceivableNoncurrentNonaccrual_0" xml:lang="en-US">Accounts Receivable, Noncurrent, Nonaccrual</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent_0" xml:lang="en-US">Accrued Income Taxes, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent_1" xml:lang="en-US">Income tax payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0" xml:lang="en-US">Less: accumulated depreciation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_1" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_0" xml:lang="en-US">Accumulated other comprehensive income (loss)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_1" xml:lang="en-US">Accumulated other comprehensive loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_0" xml:lang="en-US">Accumulated other comprehensive income [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock_0" xml:lang="en-US">Additional paid-in capital</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock_1" xml:lang="en-US">Additional paid-in capital</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember_0" xml:lang="en-US">Additional paid-in capital [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_0" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1" xml:lang="en-US">Share-based compensation expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition, Total</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_3" xml:lang="en-US">Share-based compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0" xml:lang="en-US">Adjustments required to reconcile net income to net cash provided by operating activities:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1" xml:lang="en-US">Adjustments required to reconcile net income to net cash provided by operating activities:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AdvertisingCostsPolicyTextBlock_0" xml:lang="en-US">Advertising Cost [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AdvertisingCostsPolicyTextBlock_1" xml:lang="en-US">Advertising expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AdvertisingExpense_0" xml:lang="en-US">Advertising Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AdvertisingExpense_1" xml:lang="en-US">Advertising expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense_0" xml:lang="en-US">Share-based Payment Arrangement, Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense_1" xml:lang="en-US">Equity-based compensation income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_0" xml:lang="en-US">Financing Receivable, Allowance for Credit Loss [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_1" xml:lang="en-US">Schedule of allowance for credit losses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_0" xml:lang="en-US">Less - allowance for credit losses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_1" xml:lang="en-US">Balance at end of year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_2" xml:lang="en-US">Balance at beginning of year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_3" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_4" xml:lang="en-US">Allowance for credit losses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_0" xml:lang="en-US">Accounts receivable, allowance for doubtful accounts</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableNoncurrent_0" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Noncurrent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableNoncurrent_1" xml:lang="en-US">Accounts receivable net of allowance for credit losses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_0" xml:lang="en-US">Write-offs charged against the allowance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_1" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Writeoff</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_2" xml:lang="en-US">Write-offs charged against the allowance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_0" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_Assets_0" xml:lang="en-US">Assets [Default Label]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_Assets_1" xml:lang="en-US">TOTAL ASSETS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AssetsAbstract_0" xml:lang="en-US">Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AssetsCurrent_0" xml:lang="en-US">Assets, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_AssetsCurrent_1" xml:lang="en-US">TOTAL CURRENT ASSETS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AssetsCurrentAbstract_0" xml:lang="en-US">CURRENT ASSETS:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AssetsNoncurrent_0" xml:lang="en-US">Assets, Noncurrent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_AssetsNoncurrent_1" xml:lang="en-US">TOTAL NON-CURRENT ASSETS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AssetsNoncurrentAbstract_0" xml:lang="en-US">NON-CURRENT ASSETS:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AssetsNoncurrentAbstract_1" xml:lang="en-US">NON-CURRENT ASSETS:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0" xml:lang="en-US">Gross unrealized holding gains</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0" xml:lang="en-US">Gross unrealized holding loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_1" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_0" xml:lang="en-US">Marketable securities, amortization</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_1" xml:lang="en-US">Cost or amortized cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_0" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_1" xml:lang="en-US">Total</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0" xml:lang="en-US">Due within one year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_0" xml:lang="en-US">Fair Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AwardDateAxis_0" xml:lang="en-US">Award Date [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AwardTypeAxis_0" xml:lang="en-US">Award Type [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BalanceSheetLocationAxis_0" xml:lang="en-US">Balance Sheet Location [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_0" xml:lang="en-US">Basis of presentation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BondsMember_0" xml:lang="en-US">US Government Bonds [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BusinessAcquisitionAxis_0" xml:lang="en-US">Business Acquisition [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_0" xml:lang="en-US">Business Acquisition, Percentage of Voting Interests Acquired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_1" xml:lang="en-US">Ownership interest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1_0" xml:lang="en-US">Purchase consideration</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_0" xml:lang="en-US">GENERAL</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_0" xml:lang="en-US">CASH AND CASH EQUIVALENTS AT END OF THE YEAR</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_1" xml:lang="en-US">CASH AND CASH EQUIVALENTS AT BEGINNING OF THE YEAR</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_2" xml:lang="en-US">Cash and cash equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_0" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_1" xml:lang="en-US">Cash and cash equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0" xml:lang="en-US">CASH AND CASH EQUIVALENTS AT END OF THE YEAR</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1" xml:lang="en-US">CASH AND CASH EQUIVALENTS AT BEGINNING OF THE YEAR</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Total</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1" xml:lang="en-US">NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CertificatesOfDepositMember_0" xml:lang="en-US">Certificates of deposit [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommercialPaperMember_0" xml:lang="en-US">Commercial Paper [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommitmentsAndContingencies_0" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES (note 12)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CommitmentsAndContingencies_1" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_0" xml:lang="en-US">COMMITMENTS AND CONTINGENT LIABILITIES</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_1" xml:lang="en-US">COMMITMENTS AND CONTINGECIES</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_0" xml:lang="en-US">Legal and other contingencies</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockMember_0" xml:lang="en-US">Ordinary Shares [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare_0" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare_1" xml:lang="en-US">Ordinary shares, par value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockSharesAuthorized_0" xml:lang="en-US">Ordinary shares, shares authorized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_CommonStockSharesAuthorized_1" xml:lang="en-US">Shares authorized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockSharesIssued_0" xml:lang="en-US">Ordinary shares, issued shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_CommonStockSharesOutstanding_0" xml:lang="en-US">Ending Balance, shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_CommonStockSharesOutstanding_1" xml:lang="en-US">Begining Balance, Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockSharesOutstanding_2" xml:lang="en-US">Ordinary shares, outstanding shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockValue_0" xml:lang="en-US">Common Stock, Value, Issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CommonStockValue_1" xml:lang="en-US">Ordinary shares, NIS 0.01 par value, authorized 100,000,000 shares at December 31, 2023 and 2022 Issued 85,957,465 and 84,519,994 shares at December 31, 2023 and 2022, respectively Outstanding 83,982,462 and 82,544,991 shares at December 31, 2023 and 2022, respectively</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_CommonStockValue_2" xml:lang="en-US">Ordinary shares, NIS 0.01 par value, authorized 100,000,000 shares at December 31, 2022 and 2021. Issued 84,519,994 and 83,875,905 shares at December 31, 2022 and 2021, respectively. Outstanding 82,544,991 and 82,978,115 shares at December 31, 2022 and 2021, respectively.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax_0" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax_1" xml:lang="en-US">TOTAL COMPREHENSIVE INCOME ATTRIBUTABLE TO INMODE LTD.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_0" xml:lang="en-US">OTHER COMPREHENSIVE INCOME:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_0" xml:lang="en-US">Add: Comprehensive income attributable to non-controlling interests</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_1" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_0" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1" xml:lang="en-US">TOTAL COMPREHENSIVE INCOME</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ComputerEquipmentMember_0" xml:lang="en-US">Computers [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis_0" xml:lang="en-US">Concentration Risk Type [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk_0" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk_1" xml:lang="en-US">Concentration of credit risks</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ConcentrationRiskLineItems_0" xml:lang="en-US">Concentration Risk [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ConcentrationRiskTable_0" xml:lang="en-US">Concentration Risk [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain_0" xml:lang="en-US">Concentration Risk Type [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock_0" xml:lang="en-US">Principles of consolidation and presentation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_0" xml:lang="en-US">Schedule of Changes in Contract Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_ContractWithCustomerLiability_0" xml:lang="en-US">Balance as of December 31</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_ContractWithCustomerLiability_1" xml:lang="en-US">Balance as of January 1</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ContractWithCustomerLiability_2" xml:lang="en-US">Contract with Customer, Liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent_0" xml:lang="en-US">Contract liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent_1" xml:lang="en-US">Contract liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_0" xml:lang="en-US">Contract liability presented in non-current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_1" xml:lang="en-US">Contract liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_0" xml:lang="en-US">Revenue recognized that was included in the contract liability balance at the beginning of the period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember_0" xml:lang="en-US">Corporate debt securities [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CostOfRevenue_0" xml:lang="en-US">COST OF REVENUES</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_CostOfRevenue_1" xml:lang="en-US">COST OF REVENUES</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CostOfSalesMember_0" xml:lang="en-US">Cost of Sales [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CostOfSalesPolicyTextBlock_0" xml:lang="en-US">Cost of revenues</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_0" xml:lang="en-US">Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_0" xml:lang="en-US">Schedule of Debt Securities on Maturity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet_0" xml:lang="en-US">Deferred income taxes, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet_1" xml:lang="en-US">Deferred income tax assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits_0" xml:lang="en-US">Deferred Income Taxes and Tax Credits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits_1" xml:lang="en-US">Deferred income tax assets, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_0" xml:lang="en-US">Deferred</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredTaxAssetsGross_0" xml:lang="en-US">Deferred Tax Assets, Gross</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_DeferredTaxAssetsGross_1" xml:lang="en-US">Total deferred tax assets before valuation allowance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredTaxAssetsNet_0" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_DeferredTaxAssetsNet_1" xml:lang="en-US">Total deferred tax assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredTaxAssetsNetAbstract_0" xml:lang="en-US">Deferred tax assets in respect of:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_0" xml:lang="en-US">Subsidiaries carryforward losses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredTaxAssetsOther_0" xml:lang="en-US">Other temporary differences</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredTaxAssetsOtherComprehensiveLoss_0" xml:lang="en-US">Deferred tax asset in respect to other comprehensive loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_0" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_1" xml:lang="en-US">Share-based compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance_0" xml:lang="en-US">Valuation allowance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance_1" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DepositsAssetsCurrent_0" xml:lang="en-US">Short-term bank deposits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization_0" xml:lang="en-US">Depreciation and amortization</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization_1" xml:lang="en-US">Depreciation and amortization</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DisclosureOfLongLivedAssetsHeldForSaleTextBlock_0" xml:lang="en-US">Schedule of Long-Lived Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_0" xml:lang="en-US">Schedule of Awards Authorized to be Issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EarningsPerShareAbstract_0" xml:lang="en-US">NET INCOME PER SHARE:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_EarningsPerShareAbstract_1" xml:lang="en-US">EARNINGS PER SHARE:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EarningsPerShareBasic_0" xml:lang="en-US">Basic</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_EarningsPerShareBasic_1" xml:lang="en-US">Basic</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EarningsPerShareDiluted_0" xml:lang="en-US">Diluted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_EarningsPerShareDiluted_1" xml:lang="en-US">Diluted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock_0" xml:lang="en-US">Net income per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock_1" xml:lang="en-US">Net earnings per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_0" xml:lang="en-US">Statutory rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_1" xml:lang="en-US">Theoretical tax expenses at the statutory rate of InMode Ltd.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsDividends_0" xml:lang="en-US">Tax rate after divdend</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0" xml:lang="en-US">Effect of Exchange Rate on Cash and Cash Equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_1" xml:lang="en-US">EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2" xml:lang="en-US">Effect of Exchange Rate on Cash and Cash Equivalents, Total</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_0" xml:lang="en-US">Employees and related expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_0" xml:lang="en-US">Unrecognized compensation cost, recognition period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0" xml:lang="en-US">Unrecognized compensation expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EquipmentMember_0" xml:lang="en-US">Equipment and furniture [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_0" xml:lang="en-US">Ownership interest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_1" xml:lang="en-US">Ownership interest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_0" xml:lang="en-US">Schedule of Financial Assets Measured at Fair Value on Recurring Basis</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_0" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueInputsLevel2Member_0" xml:lang="en-US">Level 2 Securities [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_0" xml:lang="en-US">Fair value measurement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FinancialInstrumentAxis_0" xml:lang="en-US">Financial Instrument [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_0" xml:lang="en-US">Functional currency</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_GainLossOnInvestments_0" xml:lang="en-US">Loss on marketable securities, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_GainLossOnInvestments_1" xml:lang="en-US">Gain (Loss) on Investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense_0" xml:lang="en-US">General and administrative</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense_1" xml:lang="en-US">General and administrative</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember_0" xml:lang="en-US">General and Administrative Expenses [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_GranteeStatusAxis_0" xml:lang="en-US">Grantee Status [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_GrossProfit_0" xml:lang="en-US">Gross Profit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_GrossProfit_1" xml:lang="en-US">GROSS PROFIT</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_0" xml:lang="en-US">Impairment of long-lived assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0" xml:lang="en-US">Income before taxes on income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1" xml:lang="en-US">INCOME BEFORE INCOME TAXES</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeStatementAbstract_0" xml:lang="en-US">Income Statement [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeStatementLocationAxis_0" xml:lang="en-US">Income Statement Location [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeStatementLocationDomain_0" xml:lang="en-US">Income Statement Location [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis_0" xml:lang="en-US">Income Tax Authority [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis_1" xml:lang="en-US">Income Tax Authority, Name [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis_0" xml:lang="en-US">Income Tax Authority, Name [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems_0" xml:lang="en-US">Income Tax Contingency [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeTaxContingencyTable_0" xml:lang="en-US">Income Tax Contingency [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract_0" xml:lang="en-US">Income Tax Disclosure [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock_0" xml:lang="en-US">TAXES ON INCOME</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock_1" xml:lang="en-US">INCOME TAXES</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeTaxesPaidNet_0" xml:lang="en-US">Income taxes paid</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_IncomeTaxesPaidNet_1" xml:lang="en-US">Income taxes paid *</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeTaxesReceivable_0" xml:lang="en-US">Tax asset</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit_0" xml:lang="en-US">INCOME TAXES</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit_1" xml:lang="en-US">Total taxes on income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit_2" xml:lang="en-US">Total taxes on income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit_3" xml:lang="en-US">INCOME TAXES</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_0" xml:lang="en-US">Increase (decrease) in taxes on income due to:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock_0" xml:lang="en-US">Income taxes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_0" xml:lang="en-US">Valuation allowance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_1" xml:lang="en-US">Valuation allowance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_0" xml:lang="en-US">Theoretical tax benefit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_0" xml:lang="en-US">Previous years</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_1" xml:lang="en-US">Previous year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable_0" xml:lang="en-US">Increase in accounts payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable_1" xml:lang="en-US">Increase (decrease) in accounts payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_0" xml:lang="en-US">Increase in accounts receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_1" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_0" xml:lang="en-US">Increase (decrease) in contract liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_1" xml:lang="en-US">Increase (decrease) in contract liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories_0" xml:lang="en-US">Increase in inventories</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories_1" xml:lang="en-US">Increase (Decrease) in Inventories</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_0" xml:lang="en-US">Changes in operating assets and liabilities:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_0" xml:lang="en-US">Increase in other liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_1" xml:lang="en-US">Increase (decrease) in other liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherReceivables_0" xml:lang="en-US">Increase in other receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherReceivables_1" xml:lang="en-US">Increase (Decrease) in Other Receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_InterestIncomeExpenseNet_0" xml:lang="en-US">Interest Income (Expense), Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_InterestIncomeExpenseNet_1" xml:lang="en-US">Interest Income (Expense), Net, Total</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_InterestIncomeExpenseNet_2" xml:lang="en-US">Finance expense (income), net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_InventoryDisclosureAbstract_0" xml:lang="en-US">Inventory Disclosure [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock_0" xml:lang="en-US">INVENTORIES</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_InventoryFinishedGoods_0" xml:lang="en-US">Finished products</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_InventoryNet_0" xml:lang="en-US">Inventories</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_InventoryNet_1" xml:lang="en-US">Total inventories</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_InventoryPolicyTextBlock_0" xml:lang="en-US">Inventory, Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_InventoryPolicyTextBlock_1" xml:lang="en-US">Inventories</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_InventoryRawMaterials_0" xml:lang="en-US">Raw materials</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_InvestmentIncomeNet_0" xml:lang="en-US">Finance income, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_InvestmentIncomeNet_1" xml:lang="en-US">Finance income, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock_0" xml:lang="en-US">Investment, Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock_1" xml:lang="en-US">Other Investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_Investments_0" xml:lang="en-US">Investment Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_Investments_1" xml:lang="en-US">Investment Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_InvestmentsAbstract_0" xml:lang="en-US">Investments [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_InvestmentTextBlock_0" xml:lang="en-US">OTHER INVESTMENTS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_InvestmentTypeAxis_0" xml:lang="en-US">Investment Type [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember_0" xml:lang="en-US">Investments [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IPOMember_0" xml:lang="en-US">IPO [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LeaseContractualTermDomain_0" xml:lang="en-US">Lease Contractual Term [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LeaseCostTableTextBlock_0" xml:lang="en-US">Schedule of Lease Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LeaseholdImprovementsMember_0" xml:lang="en-US">Leasehold Improvements [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LeasesAbstract_0" xml:lang="en-US">Leases [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LeasesOperatingAbstract_0" xml:lang="en-US">Operating Leases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock_0" xml:lang="en-US">Leases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_0" xml:lang="en-US">Schedule of Maturities of Lease Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1" xml:lang="en-US">Total lease payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_1" xml:lang="en-US">2028 and beyond</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_1" xml:lang="en-US">2024</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_1" xml:lang="en-US">2027</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_1" xml:lang="en-US">2026</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_1" xml:lang="en-US">2025</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0" xml:lang="en-US">Less imputed interests</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_1" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_2" xml:lang="en-US">Less imputed interests</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock_0" xml:lang="en-US">LEASES</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract_0" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract_1" xml:lang="en-US">Term of contract</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_Liabilities_0" xml:lang="en-US">Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_Liabilities_1" xml:lang="en-US">TOTAL LIABILITIES</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity_0" xml:lang="en-US">Liabilities and Equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity_1" xml:lang="en-US">TOTAL LIABILITIES AND SHAREHOLDERS&#8217; EQUITY</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0" xml:lang="en-US">Liabilities and shareholders' equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1" xml:lang="en-US">Liabilities and shareholders&#8217; equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesCurrent_0" xml:lang="en-US">Liabilities, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_LiabilitiesCurrent_1" xml:lang="en-US">TOTAL CURRENT LIABILITIES</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract_0" xml:lang="en-US">CURRENT LIABILITIES:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract_1" xml:lang="en-US">CURRENT LIABILITIES:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesNoncurrent_0" xml:lang="en-US">Liabilities, Noncurrent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_LiabilitiesNoncurrent_1" xml:lang="en-US">TOTAL NON-CURRENT LIABILITIES</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract_0" xml:lang="en-US">NON-CURRENT LIABILITIES:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract_1" xml:lang="en-US">NON-CURRENT LIABILITIES:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_0" xml:lang="en-US">ACCOUNTS RECEIVABLE</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent_0" xml:lang="en-US">Marketable securities (amortized cost of $375,829 and $384,320, as of December 31, 2023 and 2022, respectively)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent_1" xml:lang="en-US">Marketable Securities, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent_2" xml:lang="en-US">Marketable securities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent_3" xml:lang="en-US">Marketable securities (amortized cost of $384,320 and $296,243, as of December 31, 2022 and 2021, respectively)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_MarketableSecuritiesLineItems_0" xml:lang="en-US">Marketable Securities [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_MarketableSecuritiesPolicy_0" xml:lang="en-US">Marketable securities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_MarketableSecuritiesTable_0" xml:lang="en-US">Marketable Securities [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_MarketableSecuritiesTextBlock_0" xml:lang="en-US">Schedule of Marketable Securities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByParent_0" xml:lang="en-US">Percentage of interest in subsidiaries</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_MunicipalBondsMember_0" xml:lang="en-US">Municipal bonds [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_0" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_1" xml:lang="en-US">Net cash used in financing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0" xml:lang="en-US">CASH FLOWS FROM FINANCING ACTIVITIES:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1" xml:lang="en-US">CASH FLOWS FROM FINANCING ACTIVITIES:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_0" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_1" xml:lang="en-US">Net cash used in investing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0" xml:lang="en-US">CASH FLOWS FROM INVESTING ACTIVITIES:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1" xml:lang="en-US">CASH FLOWS FROM INVESTING ACTIVITIES:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_0" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_1" xml:lang="en-US">Net cash provided by operating activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_0" xml:lang="en-US">CASH FLOWS FROM OPERATING ACTIVITIES:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetIncomeLoss_0" xml:lang="en-US">Net Income (Loss) Attributable to Parent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_NetIncomeLoss_1" xml:lang="en-US">NET INCOME ATTRIBUTABLE TO INMODE LTD</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_0" xml:lang="en-US">Add: Net income attributable to non-controlling interests</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_1" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_0" xml:lang="en-US">Newly issued and recently adopted accounting pronouncements</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_1" xml:lang="en-US">Newly issued accounting pronouncements, not yet adopted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_0" xml:lang="en-US">NON-CASH ACTIVITIES</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NoncontrollingInterestMember_0" xml:lang="en-US">Non-controlling Interest [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NoncurrentAssets_0" xml:lang="en-US">Noncurrent Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_NoncurrentAssets_1" xml:lang="en-US">Total Long-Lived Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NotesReceivableGross_0" xml:lang="en-US">Notes receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NumberOfOperatingSegments_0" xml:lang="en-US">Number of Operating Segments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_NumberOfOperatingSegments_1" xml:lang="en-US">Number of operating segment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OfficeEquipmentMember_0" xml:lang="en-US">Office furniture and equipment [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingExpenses_0" xml:lang="en-US">Operating Expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_OperatingExpenses_1" xml:lang="en-US">TOTAL OPERATING EXPENSES</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingExpensesAbstract_0" xml:lang="en-US">OPERATING EXPENSES:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_OperatingExpensesAbstract_1" xml:lang="en-US">OPERATING EXPENSES:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingIncomeLoss_0" xml:lang="en-US">Operating Income (Loss)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_OperatingIncomeLoss_1" xml:lang="en-US">OPERATING INCOME</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingLeaseCost_0" xml:lang="en-US">Operating lease cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingLeaseLiability_0" xml:lang="en-US">Operating Lease, Liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OperatingLeaseLiability_1" xml:lang="en-US">Total operating lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_OperatingLeaseLiability_2" xml:lang="en-US">Total operating lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_0" xml:lang="en-US">Operating lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_1" xml:lang="en-US">Operating lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingLeasePayments_0" xml:lang="en-US">Operating cash flows from operating leases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset_0" xml:lang="en-US">Operating lease right-of-use assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset_1" xml:lang="en-US">Operating lease right-of-use assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_0" xml:lang="en-US">Weighted Average Discount Rate Operating leases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_1" xml:lang="en-US">Weighted Average Discount Rate, Operating leases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_0" xml:lang="en-US">Weighted Average Remaining Lease Term Operating leases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_1" xml:lang="en-US">Weighted Average Remaining Lease Term, Operating leases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingLossCarryforwards_0" xml:lang="en-US">Accumulated tax loss carryforward</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent_0" xml:lang="en-US">Other Accrued Liabilities, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent_1" xml:lang="en-US">Other</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherAssetsNoncurrent_0" xml:lang="en-US">Other Assets, Noncurrent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_OtherAssetsNoncurrent_1" xml:lang="en-US">Other long-term assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_0" xml:lang="en-US">Other comprehensive income (loss), net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_1" xml:lang="en-US">Other comprehensive income, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2" xml:lang="en-US">Other comprehensive loss, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_0" xml:lang="en-US">Change in net unrealized gains (loss) of marketable securities, net of tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember_0" xml:lang="en-US">Other Current Liabilities [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock_0" xml:lang="en-US">Schedule of Other Current Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherInvestments_0" xml:lang="en-US">Other Investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OtherInvestments_1" xml:lang="en-US">Other investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent_0" xml:lang="en-US">Other liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent_1" xml:lang="en-US">Other liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent_2" xml:lang="en-US">Total other current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent_0" xml:lang="en-US">Other Liabilities, Noncurrent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent_1" xml:lang="en-US">Other liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherReceivablesGrossCurrent_0" xml:lang="en-US">Other</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OtherReceivablesGrossCurrent_1" xml:lang="en-US">Other</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent_0" xml:lang="en-US">Other receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent_1" xml:lang="en-US">Prepaid expense and other receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent_2" xml:lang="en-US">Total other current receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherReceivablesNetCurrentAbstract_0" xml:lang="en-US">Other Receivables, Net, Current [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract_0" xml:lang="en-US">Payables and Accruals [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PaymentsForAdvanceToAffiliate_0" xml:lang="en-US">Payments for Advance to Affiliate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_PaymentsForAdvanceToAffiliate_1" xml:lang="en-US">Subcontractors advances</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_0" xml:lang="en-US">Other investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_1" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_0" xml:lang="en-US">Repurchase of ordinary shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_1" xml:lang="en-US">Payments for Repurchase of Common Stock</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts_0" xml:lang="en-US">IPO expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross_0" xml:lang="en-US">Payment to purchase licence</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities_0" xml:lang="en-US">Purchase of marketable securities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities_1" xml:lang="en-US">Payments to Acquire Marketable Securities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0" xml:lang="en-US">Purchase of fixed assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PlanNameAxis_0" xml:lang="en-US">Plan Name [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering_0" xml:lang="en-US">Proceeds from initial public offering of ordinary shares, net of offering costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering_1" xml:lang="en-US">Proceeds from initial public offering</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_0" xml:lang="en-US">Proceeds from sale of marketable securities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_1" xml:lang="en-US">Proceeds from sale of marketable securities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised_0" xml:lang="en-US">Proceeds from Stock Options Exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised_1" xml:lang="en-US">Exercise of options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProfitLoss_0" xml:lang="en-US">NET INCOME</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ProfitLoss_1" xml:lang="en-US">Net income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_ProfitLoss_2" xml:lang="en-US">NET INCOME</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ProfitLoss_3" xml:lang="en-US">NET INCOME</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract_0" xml:lang="en-US">Property, Plant and Equipment [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_0" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_0" xml:lang="en-US">PROPERTY AND EQUIPMENT, NET</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross_0" xml:lang="en-US">Property plant and equipment gross</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross_1" xml:lang="en-US">Property, plant and equipment, gross</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems_0" xml:lang="en-US">Property, Plant and Equipment [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet_0" xml:lang="en-US">Property and equipment, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet_1" xml:lang="en-US">Property and equipment, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet_2" xml:lang="en-US">Total property and equipment, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_0" xml:lang="en-US">Property and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_0" xml:lang="en-US">Schedule of Property and Equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_0" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_0" xml:lang="en-US">Property, Plant and Equipment, Useful Life</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_1" xml:lang="en-US">Estimated useful lives</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts_0" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts_1" xml:lang="en-US">Change in allowance for credit losses of trade receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts_2" xml:lang="en-US">Current-period provision</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_0" xml:lang="en-US">Allowance for doubtful accounts and financial instruments - credit loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_0" xml:lang="en-US">Reconciliation of Revenue from Segments to Consolidated [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RelatedPartyTransactionAmountsOfTransaction_0" xml:lang="en-US">Payment for services received</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems_0" xml:lang="en-US">Related Party Transaction [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract_0" xml:lang="en-US">Related Party Transactions [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_0" xml:lang="en-US">Related Party [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_0" xml:lang="en-US">RELATED PARTIES</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense_0" xml:lang="en-US">Research and development</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense_1" xml:lang="en-US">Research and development</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember_0" xml:lang="en-US">Research and Development Expenses [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_0" xml:lang="en-US">Research and development costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember_0" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit_0" xml:lang="en-US">Retained earnings</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit_1" xml:lang="en-US">Retained earnings</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RetainedEarningsMember_0" xml:lang="en-US">Retained earnings [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_0" xml:lang="en-US">Schedule of Net Sales by Geographic Area</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock_0" xml:lang="en-US">Revenue recognition</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_Revenues_0" xml:lang="en-US">Revenues</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_Revenues_1" xml:lang="en-US">REVENUES</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_0" xml:lang="en-US">Revenues from External Customers and Long-Lived Assets [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_0" xml:lang="en-US">Schedule of Accounts Receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_0" xml:lang="en-US">Schedule of Tax Expenses (Tax Benefit)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_0" xml:lang="en-US">Schedule of Deferred Tax Assets (liabilities)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_0" xml:lang="en-US">Schedule of Reconciliation of Theoretical Provision For Income Tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_0" xml:lang="en-US">Schedule of Share Based Compensation Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_0" xml:lang="en-US">Revenue from External Customers by Products and Services [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_1" xml:lang="en-US">Revenue from External Customers by Products and Services</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_2" xml:lang="en-US">Schedule of revenues based on products' category</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_0" xml:lang="en-US">Schedule of Income Before Income Taxes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_0" xml:lang="en-US">Schedule of Inventories</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_0" xml:lang="en-US">Net Investment Income [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_0" xml:lang="en-US">Investment Income [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_0" xml:lang="en-US">Schedule of Accrued Warranty</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0" xml:lang="en-US">Property, Plant and Equipment [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_0" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_0" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_0" xml:lang="en-US">Schedule of Outstanding and Exercisable Options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_0" xml:lang="en-US">Schedule of Options Granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_0" xml:lang="en-US">Schedule of Assumptions Used to Calculate Fair Value of Options Granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_0" xml:lang="en-US">Schedule of Unrecognized Tax Benefits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_0" xml:lang="en-US">Schedule of Net Sales by Technology</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SegmentReportingAbstract_0" xml:lang="en-US">Segment Reporting [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock_0" xml:lang="en-US">ENTITY-WIDE DISCLOSURE</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems_0" xml:lang="en-US">Segment Reporting Information [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_0" xml:lang="en-US">Segments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_0" xml:lang="en-US">Segment Reporting, Revenue Reconciling Item [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SellingAndMarketingExpense_0" xml:lang="en-US">Sales and marketing</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SellingAndMarketingExpense_1" xml:lang="en-US">Sales and marketing</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SellingAndMarketingExpenseMember_0" xml:lang="en-US">Selling and Marketing Expenses [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SeveranceCosts1_0" xml:lang="en-US">Amounts of severance payment expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensation_0" xml:lang="en-US">Share-based compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ShareBasedCompensation_1" xml:lang="en-US">Share-based compensation expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ShareBasedCompensation_2" xml:lang="en-US">Share-based compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_0" xml:lang="en-US">Vesting period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_1" xml:lang="en-US">Fair value of RSUs granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_0" xml:lang="en-US">Forfeited</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_1" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_0" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_1" xml:lang="en-US">Forfeited</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_0" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1" xml:lang="en-US">Granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue_0" xml:lang="en-US">Fair value of RSU granted, per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue_1" xml:lang="en-US">Fair value of RSU granted, per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_0" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1" xml:lang="en-US">Granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0" xml:lang="en-US">Outstanding at end of year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_1" xml:lang="en-US">Outstanding at beginning of year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_3" xml:lang="en-US">Unvested RSUs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_0" xml:lang="en-US">Outstanding at end of year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_1" xml:lang="en-US">Outstanding at beginning of year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0" xml:lang="en-US">Weighted Average Grant Date Fair Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_0" xml:lang="en-US">Vested</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_1" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_1" xml:lang="en-US">Fair value of RSUs granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_0" xml:lang="en-US">Expiration</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_0" xml:lang="en-US">Dividend yield</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_0" xml:lang="en-US">Contractual term</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_0" xml:lang="en-US">Expected volatility</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_0" xml:lang="en-US">Risk-free interest rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_0" xml:lang="en-US">Number of RSUs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_1" xml:lang="en-US">Total</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_2" xml:lang="en-US">Number of shares authorized to be issued as ordinary shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_0" xml:lang="en-US">Number of options available for grant</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0" xml:lang="en-US">Exercisable at end of year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_1" xml:lang="en-US">Exercisable at end of year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_0" xml:lang="en-US">Weighted average remaining contractual life</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_1" xml:lang="en-US">Weighted average remaining contractual life of exercisable options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_0" xml:lang="en-US">Total intrinsic value of options exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_0" xml:lang="en-US">Expired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_1" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_0" xml:lang="en-US">Forfeited</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_1" xml:lang="en-US">Stock options cancelled</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_0" xml:lang="en-US">Stock options granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_1" xml:lang="en-US">Granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_0" xml:lang="en-US">Unvested options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0" xml:lang="en-US">Outstanding at end of year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1" xml:lang="en-US">Outstanding at beginning of year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_0" xml:lang="en-US">Number of options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0" xml:lang="en-US">Outstanding at end of year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1" xml:lang="en-US">Outstanding at beginning of year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_0" xml:lang="en-US">Weighted average exercise price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_0" xml:lang="en-US">Weighted average remaining contractual life of outstanding options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_0" xml:lang="en-US">Aggregate intrinsic value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_0" xml:lang="en-US">Vested options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_0" xml:lang="en-US">Exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_0" xml:lang="en-US">Expired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_0" xml:lang="en-US">Forfeited</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_0" xml:lang="en-US">Granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember_0" xml:lang="en-US">Share-based Payment Arrangement, Tranche One [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_0" xml:lang="en-US">Share-based Payment Arrangement, Tranche Three [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_0" xml:lang="en-US">Share-based Payment Arrangement, Tranche Two [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_0" xml:lang="en-US">Share-based Payment Arrangement [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_1" xml:lang="en-US">Share-based compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_0" xml:lang="en-US">Exercise Price Range [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_0" xml:lang="en-US">Number of options exercisable at end of year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_0" xml:lang="en-US">Number of options Outstanding and exercisable at end of year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_0" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_1" xml:lang="en-US">Exercise price range</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedPaymentArrangementEmployeeMember_0" xml:lang="en-US">Employees, officers and directors [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharesIssued_0" xml:lang="en-US">Ordinary shares of Medimor</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_SharesIssued_1" xml:lang="en-US">Ordinary shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharesIssuedPricePerShare_0" xml:lang="en-US">Price per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock_0" xml:lang="en-US">SIGNIFICANT ACCOUNTING POLICIES</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SignificantSupplyCommitmentRemainingMinimumAmountCommitted_0" xml:lang="en-US">Supply and open orders commitment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_StandardProductWarrantyAccrual_0" xml:lang="en-US">Balance at end of year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_StandardProductWarrantyAccrual_1" xml:lang="en-US">Balance at beginning of year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StandardProductWarrantyAccrual_2" xml:lang="en-US">Standard Product Warranty Accrual</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_StandardProductWarrantyAccrualPayments_0" xml:lang="en-US">Cost incurred</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StandardProductWarrantyAccrualPayments_1" xml:lang="en-US">Standard Product Warranty Accrual, Decrease for Payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued_0" xml:lang="en-US">Expense recognized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StandardProductWarrantyPolicy_0" xml:lang="en-US">Warranty reserve</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementEquityComponentsAxis_0" xml:lang="en-US">Equity Components [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementLineItems_0" xml:lang="en-US">Statement [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract_0" xml:lang="en-US">Statement of Cash Flows [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract_0" xml:lang="en-US">Statement of Financial Position [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_0" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementTable_0" xml:lang="en-US">Statement [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockholdersEquity_0" xml:lang="en-US">Stockholders' Equity Attributable to Parent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_StockholdersEquity_1" xml:lang="en-US">TOTAL SHAREHOLDERS&#8217; EQUITY</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockholdersEquityAbstract_0" xml:lang="en-US">InMode Ltd. shareholders' equity:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_StockholdersEquityAbstract_1" xml:lang="en-US">SHAREHOLDERS&#8217; EQUITY:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0" xml:lang="en-US">Ending Balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1" xml:lang="en-US">Begining Balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3" xml:lang="en-US">TOTAL SHAREHOLDERS' EQUITY</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract_0" xml:lang="en-US">Stockholders' Equity Note [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_0" xml:lang="en-US">SHAREHOLDERS' EQUITY</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockholdersEquityNoteStockSplit_0" xml:lang="en-US">Stock split</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_0" xml:lang="en-US">Initial public offering of ordinary shares, net of offering costs, shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_1" xml:lang="en-US">Issuance of shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_0" xml:lang="en-US">Exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1" xml:lang="en-US">Exercise of options, shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2" xml:lang="en-US">Exercise of options (Shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_0" xml:lang="en-US">Exercise of options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_1" xml:lang="en-US">Exercise of options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares_0" xml:lang="en-US">Stock Repurchased During Period, Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares_1" xml:lang="en-US">Repurchase of ordinary shares, shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsequentEventLineItems_0" xml:lang="en-US">Subsequent Event [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsequentEventMember_0" xml:lang="en-US">Subsequent Event [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsequentEventsAbstract_0" xml:lang="en-US">Subsequent Events [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsequentEventsTextBlock_0" xml:lang="en-US">SUBSEQUENT EVENTS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsequentEventTable_0" xml:lang="en-US">Subsequent Event [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsequentEventTypeAxis_0" xml:lang="en-US">Subsequent Event Type [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis_0" xml:lang="en-US">Sale of Stock [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SupplementalCashFlowElementsAbstract_0" xml:lang="en-US">SUPPLEMENTAL DISCLOSURES OF CASH FLOWS INFORMATION:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions_0" xml:lang="en-US">Tax Adjustments, Settlements, and Unusual Provisions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions_1" xml:lang="en-US">Payment of income tax assessment with tax authorities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ToolsDiesAndMoldsMember_0" xml:lang="en-US">Molds [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0" xml:lang="en-US">Financial Instruments [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_TreasuryStockCommonMember_0" xml:lang="en-US">Treasury shares [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_TreasuryStockCommonShares_0" xml:lang="en-US">Treasury shares, ordinary shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_TreasuryStockValue_0" xml:lang="en-US">Less treasury shares, at cost: 1,975,003 and 1,975,003 ordinary shares at December 31, 2023 and 2022, respectively</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_TreasuryStockValue_1" xml:lang="en-US">Treasury Stock, Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_TypeOfArrangementAxis_0" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits_0" xml:lang="en-US">Balance at December 31</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits_1" xml:lang="en-US">Balance at January 1</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits_2" xml:lang="en-US">Unrecognized Tax Benefits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_0" xml:lang="en-US">Decrease in uncertain tax positions for the previous years</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_1" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_0" xml:lang="en-US">Increase in uncertain tax positions for the current year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_1" xml:lang="en-US">Increase in uncertain tax positions for the current year, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_UseOfEstimates_0" xml:lang="en-US">Use of estimates</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_0" xml:lang="en-US">Government bonds [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_VehiclesMember_0" xml:lang="en-US">Vehicles [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_VestingAxis_0" xml:lang="en-US">Vesting [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1" xml:lang="en-US">Diluted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1" xml:lang="en-US">Basic</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_IL_1" xlink:to="lab_country_IL_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US_2" xlink:to="lab_country_US_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_AllCurrenciesDomain_3" xlink:to="lab_currency_AllCurrenciesDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_ILS_4" xlink:to="lab_currency_ILS_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag_5" xlink:to="lab_dei_AmendmentFlag_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorFirmId_6" xlink:to="lab_dei_AuditorFirmId_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLocation_7" xlink:to="lab_dei_AuditorLocation_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorName_8" xlink:to="lab_dei_AuditorName_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_BusinessContactMember_9" xlink:to="lab_dei_BusinessContactMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode_10" xlink:to="lab_dei_CityAreaCode_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_ContactPersonnelEmailAddress_11" xlink:to="lab_dei_ContactPersonnelEmailAddress_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_ContactPersonnelFaxNumber_12" xlink:to="lab_dei_ContactPersonnelFaxNumber_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_ContactPersonnelName_13" xlink:to="lab_dei_ContactPersonnelName_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate_14" xlink:to="lab_dei_CurrentFiscalYearEndDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAccountingStandard_15" xlink:to="lab_dei_DocumentAccountingStandard_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport_16" xlink:to="lab_dei_DocumentAnnualReport_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFinStmtErrorCorrectionFlag_17" xlink:to="lab_dei_DocumentFinStmtErrorCorrectionFlag_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus_18" xlink:to="lab_dei_DocumentFiscalPeriodFocus_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus_19" xlink:to="lab_dei_DocumentFiscalYearFocus_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate_20" xlink:to="lab_dei_DocumentPeriodEndDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentRegistrationStatement_21" xlink:to="lab_dei_DocumentRegistrationStatement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentShellCompanyReport_22" xlink:to="lab_dei_DocumentShellCompanyReport_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport_23" xlink:to="lab_dei_DocumentTransitionReport_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType_24" xlink:to="lab_dei_DocumentType_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1_25" xlink:to="lab_dei_EntityAddressAddressLine1_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2_26" xlink:to="lab_dei_EntityAddressAddressLine2_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine3_27" xlink:to="lab_dei_EntityAddressAddressLine3_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown_28" xlink:to="lab_dei_EntityAddressCityOrTown_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCountry_29" xlink:to="lab_dei_EntityAddressCountry_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_30" xlink:to="lab_dei_EntityAddressesAddressTypeAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode_31" xlink:to="lab_dei_EntityAddressPostalZipCode_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey_32" xlink:to="lab_dei_EntityCentralIndexKey_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding_33" xlink:to="lab_dei_EntityCommonStockSharesOutstanding_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus_34" xlink:to="lab_dei_EntityCurrentReportingStatus_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany_35" xlink:to="lab_dei_EntityEmergingGrowthCompany_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityExTransitionPeriod_36" xlink:to="lab_dei_EntityExTransitionPeriod_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber_37" xlink:to="lab_dei_EntityFileNumber_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory_38" xlink:to="lab_dei_EntityFilerCategory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode_39" xlink:to="lab_dei_EntityIncorporationStateCountryCode_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent_40" xlink:to="lab_dei_EntityInteractiveDataCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName_41" xlink:to="lab_dei_EntityRegistrantName_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany_42" xlink:to="lab_dei_EntityShellCompany_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers_43" xlink:to="lab_dei_EntityVoluntaryFilers_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer_44" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag_45" xlink:to="lab_dei_IcfrAuditorAttestationFlag_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber_46" xlink:to="lab_dei_LocalPhoneNumber_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_OtherReportingStandardItemNumber_47" xlink:to="lab_dei_OtherReportingStandardItemNumber_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle_48" xlink:to="lab_dei_Security12bTitle_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12gTitle_49" xlink:to="lab_dei_Security12gTitle_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName_50" xlink:to="lab_dei_SecurityExchangeName_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityReportingObligation_51" xlink:to="lab_dei_SecurityReportingObligation_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol_52" xlink:to="lab_dei_TradingSymbol_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_AccountingPoliciesLineItems_53" xlink:to="lab_inmd_AccountingPoliciesLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_AccountingPoliciesLineItems_54" xlink:to="lab_inmd_AccountingPoliciesLineItems_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_AccountingPoliciesTable_55" xlink:to="lab_inmd_AccountingPoliciesTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_AccountingPoliciesTable_56" xlink:to="lab_inmd_AccountingPoliciesTable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_AcquisitionOfNonControllingInterestInExchangeOfOrdinaryShares_57" xlink:to="lab_inmd_AcquisitionOfNonControllingInterestInExchangeOfOrdinaryShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_AcquisitionOfNonControllingInterestInExchangeOfOrdinaryShares_58" xlink:to="lab_inmd_AcquisitionOfNonControllingInterestInExchangeOfOrdinaryShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_AcquisitionOfNonControllingInterestInExchangeOfOrdinaryShares_59" xlink:to="lab_inmd_AcquisitionOfNonControllingInterestInExchangeOfOrdinaryShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_AdjustmentToRedemptionValueOfRedeemableNonControllingInterest_60" xlink:to="lab_inmd_AdjustmentToRedemptionValueOfRedeemableNonControllingInterest_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_AdjustmentToRedemptionValueOfRedeemableNonControllingInterest_61" xlink:to="lab_inmd_AdjustmentToRedemptionValueOfRedeemableNonControllingInterest_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_AmendmentAdvantageExemptionMember_62" xlink:to="lab_inmd_AmendmentAdvantageExemptionMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_AmendmentAdvantageExemptionMember_63" xlink:to="lab_inmd_AmendmentAdvantageExemptionMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_AmountOfInvestment_64" xlink:to="lab_inmd_AmountOfInvestment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_AmountOfInvestment_65" xlink:to="lab_inmd_AmountOfInvestment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_AmountOfInvestment_66" xlink:to="lab_inmd_AmountOfInvestment_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_AmountPaidToUndistributedExemptIncome_67" xlink:to="lab_inmd_AmountPaidToUndistributedExemptIncome_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_AmountPaidToUndistributedExemptIncome_68" xlink:to="lab_inmd_AmountPaidToUndistributedExemptIncome_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_AmountPaidToUndistributedExemptIncome_69" xlink:to="lab_inmd_AmountPaidToUndistributedExemptIncome_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_AutomaticIncreaseApprovedByBoardCompanyIn_70" xlink:to="lab_inmd_AutomaticIncreaseApprovedByBoardCompanyIn_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_AutomaticIncreaseApprovedByBoardCompanyIn_71" xlink:to="lab_inmd_AutomaticIncreaseApprovedByBoardCompanyIn_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_AvailableForSaleSecuritiesDebtMaturitiesMoreThanFiveYearsFairValue_72" xlink:to="lab_inmd_AvailableForSaleSecuritiesDebtMaturitiesMoreThanFiveYearsFairValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_AvailableForSaleSecuritiesDebtMaturitiesMoreThanFiveYearsFairValue_73" xlink:to="lab_inmd_AvailableForSaleSecuritiesDebtMaturitiesMoreThanFiveYearsFairValue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_AvailableForSaleSecuritiesDebtMaturitiesMoreThanFiveYearsFairValue_74" xlink:to="lab_inmd_AvailableForSaleSecuritiesDebtMaturitiesMoreThanFiveYearsFairValue_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInFourToFiveYearsFairValue_75" xlink:to="lab_inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInFourToFiveYearsFairValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInFourToFiveYearsFairValue_76" xlink:to="lab_inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInFourToFiveYearsFairValue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInFourToFiveYearsFairValue_77" xlink:to="lab_inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInFourToFiveYearsFairValue_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInOneToTwoYearsFairValue_78" xlink:to="lab_inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInOneToTwoYearsFairValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInOneToTwoYearsFairValue_79" xlink:to="lab_inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInOneToTwoYearsFairValue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInOneToTwoYearsFairValue_80" xlink:to="lab_inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInOneToTwoYearsFairValue_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInThreeToFourYearsFairValue_81" xlink:to="lab_inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInThreeToFourYearsFairValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInThreeToFourYearsFairValue_82" xlink:to="lab_inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInThreeToFourYearsFairValue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInThreeToFourYearsFairValue_83" xlink:to="lab_inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInThreeToFourYearsFairValue_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInTwoToThreeYearsFairValue_84" xlink:to="lab_inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInTwoToThreeYearsFairValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInTwoToThreeYearsFairValue_85" xlink:to="lab_inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInTwoToThreeYearsFairValue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInTwoToThreeYearsFairValue_86" xlink:to="lab_inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInTwoToThreeYearsFairValue_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_BankGuarantee_87" xlink:to="lab_inmd_BankGuarantee_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_BankGuarantee_88" xlink:to="lab_inmd_BankGuarantee_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_BonusShareIssuesPerOutstandingShare_89" xlink:to="lab_inmd_BonusShareIssuesPerOutstandingShare_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_BonusShareIssuesPerOutstandingShare_90" xlink:to="lab_inmd_BonusShareIssuesPerOutstandingShare_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_BusinessDescriptionLineItems_91" xlink:to="lab_inmd_BusinessDescriptionLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_BusinessDescriptionLineItems_92" xlink:to="lab_inmd_BusinessDescriptionLineItems_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_BusinessDescriptionTable_93" xlink:to="lab_inmd_BusinessDescriptionTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_BusinessDescriptionTable_94" xlink:to="lab_inmd_BusinessDescriptionTable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_CapitalEquipmentMember_95" xlink:to="lab_inmd_CapitalEquipmentMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_CapitalEquipmentMember_96" xlink:to="lab_inmd_CapitalEquipmentMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ConsumablesAndServiceRevenuesMember_97" xlink:to="lab_inmd_ConsumablesAndServiceRevenuesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ConsumablesAndServiceRevenuesMember_98" xlink:to="lab_inmd_ConsumablesAndServiceRevenuesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ContractorLiability_99" xlink:to="lab_inmd_ContractorLiability_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ContractorLiability_100" xlink:to="lab_inmd_ContractorLiability_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_CorporateTax_101" xlink:to="lab_inmd_CorporateTax_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_CorporateTax_102" xlink:to="lab_inmd_CorporateTax_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_CovidNinteenAbstract_103" xlink:to="lab_inmd_CovidNinteenAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_CovidNinteenAbstract_104" xlink:to="lab_inmd_CovidNinteenAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_CovidNinteenTextBlock_105" xlink:to="lab_inmd_CovidNinteenTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_CovidNinteenTextBlock_106" xlink:to="lab_inmd_CovidNinteenTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_CovidNinteenTextBlock_107" xlink:to="lab_inmd_CovidNinteenTextBlock_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_CurrentMonthlyRentPayment_108" xlink:to="lab_inmd_CurrentMonthlyRentPayment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_CurrentMonthlyRentPayment_109" xlink:to="lab_inmd_CurrentMonthlyRentPayment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_DevelopmentZoneAMember_110" xlink:to="lab_inmd_DevelopmentZoneAMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_DevelopmentZoneAMember_111" xlink:to="lab_inmd_DevelopmentZoneAMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_DilazarLimitedMember_112" xlink:to="lab_inmd_DilazarLimitedMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_DilazarLimitedMember_113" xlink:to="lab_inmd_DilazarLimitedMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_EffectiveIncomeTaxRateReconciliationDeductionsDividendsForNonIsraeliResidents_114" xlink:to="lab_inmd_EffectiveIncomeTaxRateReconciliationDeductionsDividendsForNonIsraeliResidents_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_EffectiveIncomeTaxRateReconciliationDeductionsDividendsForNonIsraeliResidents_115" xlink:to="lab_inmd_EffectiveIncomeTaxRateReconciliationDeductionsDividendsForNonIsraeliResidents_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ElsewhereMember_116" xlink:to="lab_inmd_ElsewhereMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ElsewhereMember_117" xlink:to="lab_inmd_ElsewhereMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_EmployeeRelatedSeveranceLiabilities_118" xlink:to="lab_inmd_EmployeeRelatedSeveranceLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_EmployeeRelatedSeveranceLiabilities_119" xlink:to="lab_inmd_EmployeeRelatedSeveranceLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_EmployeeSeveranceBenefitsPolicyTextBlock_120" xlink:to="lab_inmd_EmployeeSeveranceBenefitsPolicyTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_EmployeeSeveranceBenefitsPolicyTextBlock_121" xlink:to="lab_inmd_EmployeeSeveranceBenefitsPolicyTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_EmployeeSeveranceBenefitsPolicyTextBlock_122" xlink:to="lab_inmd_EmployeeSeveranceBenefitsPolicyTextBlock_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_EmployeesMember_123" xlink:to="lab_inmd_EmployeesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_EmployeesMember_124" xlink:to="lab_inmd_EmployeesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_EmployeesOfficersDirectorsServiceProvidersAndConsultantsMember_125" xlink:to="lab_inmd_EmployeesOfficersDirectorsServiceProvidersAndConsultantsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_EmployeesOfficersDirectorsServiceProvidersAndConsultantsMember_126" xlink:to="lab_inmd_EmployeesOfficersDirectorsServiceProvidersAndConsultantsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ExerciseOfOptions_127" xlink:to="lab_inmd_ExerciseOfOptions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ExerciseOfOptions_128" xlink:to="lab_inmd_ExerciseOfOptions_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ExercisePriceRangeEightMember_129" xlink:to="lab_inmd_ExercisePriceRangeEightMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ExercisePriceRangeEightMember_130" xlink:to="lab_inmd_ExercisePriceRangeEightMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ExercisePriceRangeEightMember_131" xlink:to="lab_inmd_ExercisePriceRangeEightMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ExercisePriceRangeFiveMember_132" xlink:to="lab_inmd_ExercisePriceRangeFiveMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ExercisePriceRangeFiveMember_133" xlink:to="lab_inmd_ExercisePriceRangeFiveMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ExercisePriceRangeFiveMember_134" xlink:to="lab_inmd_ExercisePriceRangeFiveMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ExercisePriceRangeFourMember_135" xlink:to="lab_inmd_ExercisePriceRangeFourMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ExercisePriceRangeFourMember_136" xlink:to="lab_inmd_ExercisePriceRangeFourMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ExercisePriceRangeFourMember_137" xlink:to="lab_inmd_ExercisePriceRangeFourMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ExercisePriceRangeNineMember_138" xlink:to="lab_inmd_ExercisePriceRangeNineMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ExercisePriceRangeNineMember_139" xlink:to="lab_inmd_ExercisePriceRangeNineMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ExercisePriceRangeNineMember_140" xlink:to="lab_inmd_ExercisePriceRangeNineMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ExercisePriceRangeOneMember_141" xlink:to="lab_inmd_ExercisePriceRangeOneMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ExercisePriceRangeOneMember_142" xlink:to="lab_inmd_ExercisePriceRangeOneMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ExercisePriceRangeOneMember_143" xlink:to="lab_inmd_ExercisePriceRangeOneMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ExercisePriceRangeSevenMember_144" xlink:to="lab_inmd_ExercisePriceRangeSevenMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ExercisePriceRangeSevenMember_145" xlink:to="lab_inmd_ExercisePriceRangeSevenMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ExercisePriceRangeSevenMember_146" xlink:to="lab_inmd_ExercisePriceRangeSevenMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ExercisePriceRangeSixMember_147" xlink:to="lab_inmd_ExercisePriceRangeSixMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ExercisePriceRangeSixMember_148" xlink:to="lab_inmd_ExercisePriceRangeSixMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ExercisePriceRangeSixMember_149" xlink:to="lab_inmd_ExercisePriceRangeSixMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ExercisePriceRangeThreeMember_150" xlink:to="lab_inmd_ExercisePriceRangeThreeMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ExercisePriceRangeThreeMember_151" xlink:to="lab_inmd_ExercisePriceRangeThreeMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ExercisePriceRangeThreeMember_152" xlink:to="lab_inmd_ExercisePriceRangeThreeMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ExercisePriceRangeTwoMember_153" xlink:to="lab_inmd_ExercisePriceRangeTwoMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ExercisePriceRangeTwoMember_154" xlink:to="lab_inmd_ExercisePriceRangeTwoMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ExercisePriceRangeTwoMember_155" xlink:to="lab_inmd_ExercisePriceRangeTwoMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ExpensesIncomeMember_156" xlink:to="lab_inmd_ExpensesIncomeMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_FairValueOfOneOrdinaryShare_157" xlink:to="lab_inmd_FairValueOfOneOrdinaryShare_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_FairValueOfOneOrdinaryShare_158" xlink:to="lab_inmd_FairValueOfOneOrdinaryShare_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_FairValueOfOptionsGranted_159" xlink:to="lab_inmd_FairValueOfOptionsGranted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_FairValueOfOptionsGranted_160" xlink:to="lab_inmd_FairValueOfOptionsGranted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_FairValueOfRestrictedOptionsGranted_161" xlink:to="lab_inmd_FairValueOfRestrictedOptionsGranted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_FairValueOfRestrictedOptionsGranted_162" xlink:to="lab_inmd_FairValueOfRestrictedOptionsGranted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_FairValueOfRestrictedOptionsGranted_163" xlink:to="lab_inmd_FairValueOfRestrictedOptionsGranted_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_FebruaryNineTwoThousandsTwentyOneMember_164" xlink:to="lab_inmd_FebruaryNineTwoThousandsTwentyOneMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_FebruaryNineTwoThousandsTwentyOneMember_165" xlink:to="lab_inmd_FebruaryNineTwoThousandsTwentyOneMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_FebruaryNineTwoThousandsTwentyOneMember_166" xlink:to="lab_inmd_FebruaryNineTwoThousandsTwentyOneMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_FebruaryNineTwoZeroTwoTwoMember_167" xlink:to="lab_inmd_FebruaryNineTwoZeroTwoTwoMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_FebruaryNineTwoZeroTwoTwoMember_168" xlink:to="lab_inmd_FebruaryNineTwoZeroTwoTwoMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_FebruaryNineTwoZeroTwoTwoMember_169" xlink:to="lab_inmd_FebruaryNineTwoZeroTwoTwoMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_FebruarySeventeenTwoThousandsTwentyMember_170" xlink:to="lab_inmd_FebruarySeventeenTwoThousandsTwentyMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_FebruarySeventeenTwoThousandsTwentyMember_171" xlink:to="lab_inmd_FebruarySeventeenTwoThousandsTwentyMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_FifteenMarchTwoThousandsTwentyMember_172" xlink:to="lab_inmd_FifteenMarchTwoThousandsTwentyMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_FifteenMarchTwoThousandsTwentyMember_173" xlink:to="lab_inmd_FifteenMarchTwoThousandsTwentyMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_FinanceIncome_174" xlink:to="lab_inmd_FinanceIncome_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_FinanceIncome_175" xlink:to="lab_inmd_FinanceIncome_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_FinanceIncome_176" xlink:to="lab_inmd_FinanceIncome_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_FullyDilutedBasisMember_177" xlink:to="lab_inmd_FullyDilutedBasisMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_FullyDilutedBasisMember_178" xlink:to="lab_inmd_FullyDilutedBasisMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_GeneralAbstract_179" xlink:to="lab_inmd_GeneralAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_GIBFAndJVCMember_180" xlink:to="lab_inmd_GIBFAndJVCMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_GIBFAndJVCMember_181" xlink:to="lab_inmd_GIBFAndJVCMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_GIBFAndJVCMember_182" xlink:to="lab_inmd_GIBFAndJVCMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_GovernmentInstitutions_183" xlink:to="lab_inmd_GovernmentInstitutions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_GovernmentInstitutions_184" xlink:to="lab_inmd_GovernmentInstitutions_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_GovernmentInstitutions_185" xlink:to="lab_inmd_GovernmentInstitutions_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_HandsFreeMember_186" xlink:to="lab_inmd_HandsFreeMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_HandsFreeMember_187" xlink:to="lab_inmd_HandsFreeMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_HimalayaFamilyOfficeConsultingLtdMember_188" xlink:to="lab_inmd_HimalayaFamilyOfficeConsultingLtdMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_HimalayaFamilyOfficeConsultingLtdMember_189" xlink:to="lab_inmd_HimalayaFamilyOfficeConsultingLtdMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_HomeSkinnovationsLtdMember_190" xlink:to="lab_inmd_HomeSkinnovationsLtdMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_HomeSkinnovationsLtdMember_191" xlink:to="lab_inmd_HomeSkinnovationsLtdMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_IncomeTaxNoteLineItems_192" xlink:to="lab_inmd_IncomeTaxNoteLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_IncomeTaxNoteLineItems_193" xlink:to="lab_inmd_IncomeTaxNoteLineItems_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_IncomeTaxNoteTable_194" xlink:to="lab_inmd_IncomeTaxNoteTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_IncomeTaxNoteTable_195" xlink:to="lab_inmd_IncomeTaxNoteTable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_IncomeTaxReconciliationAmendmentToInvestmentsLawPayment_196" xlink:to="lab_inmd_IncomeTaxReconciliationAmendmentToInvestmentsLawPayment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_IncomeTaxReconciliationAmendmentToInvestmentsLawPayment_197" xlink:to="lab_inmd_IncomeTaxReconciliationAmendmentToInvestmentsLawPayment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_IncomeTaxReconciliationAmendmentToInvestmentsLawPayment_198" xlink:to="lab_inmd_IncomeTaxReconciliationAmendmentToInvestmentsLawPayment_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_IncomeTaxReconciliationBenefitsToBenefitedEnterprise_199" xlink:to="lab_inmd_IncomeTaxReconciliationBenefitsToBenefitedEnterprise_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_IncomeTaxReconciliationBenefitsToBenefitedEnterprise_200" xlink:to="lab_inmd_IncomeTaxReconciliationBenefitsToBenefitedEnterprise_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_IncomeTaxReconciliationBenefitsToBenefitedEnterprise_201" xlink:to="lab_inmd_IncomeTaxReconciliationBenefitsToBenefitedEnterprise_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_IncomeTaxReconciliationBenefitsToBenefitedEnterprise_202" xlink:to="lab_inmd_IncomeTaxReconciliationBenefitsToBenefitedEnterprise_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_IncomeTaxReconciliationDifferentEffectiveTaxRatesApplicableToOperatingLoss_203" xlink:to="lab_inmd_IncomeTaxReconciliationDifferentEffectiveTaxRatesApplicableToOperatingLoss_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_IncomeTaxReconciliationDifferentEffectiveTaxRatesApplicableToOperatingLoss_204" xlink:to="lab_inmd_IncomeTaxReconciliationDifferentEffectiveTaxRatesApplicableToOperatingLoss_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_IncomeTaxReconciliationDifferentEffectiveTaxRatesApplicableToOperatingLoss_205" xlink:to="lab_inmd_IncomeTaxReconciliationDifferentEffectiveTaxRatesApplicableToOperatingLoss_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_IncomeTaxReconciliationDifferentEffectiveTaxRatesApplicableToSubsidiaries_206" xlink:to="lab_inmd_IncomeTaxReconciliationDifferentEffectiveTaxRatesApplicableToSubsidiaries_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_IncomeTaxReconciliationDifferentEffectiveTaxRatesApplicableToSubsidiaries_207" xlink:to="lab_inmd_IncomeTaxReconciliationDifferentEffectiveTaxRatesApplicableToSubsidiaries_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_IncomeTaxReconciliationDifferentEffectiveTaxRatesApplicableToSubsidiaries_208" xlink:to="lab_inmd_IncomeTaxReconciliationDifferentEffectiveTaxRatesApplicableToSubsidiaries_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_IncomeTaxReconciliationDifferentEffectiveTaxRatesApplicableToSubsidiaries_209" xlink:to="lab_inmd_IncomeTaxReconciliationDifferentEffectiveTaxRatesApplicableToSubsidiaries_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_IncomeTaxReconciliationNonDeductibleExpenses_210" xlink:to="lab_inmd_IncomeTaxReconciliationNonDeductibleExpenses_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_IncomeTaxReconciliationNonDeductibleExpenses_211" xlink:to="lab_inmd_IncomeTaxReconciliationNonDeductibleExpenses_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_IncomeTaxReconciliationNonDeductibleExpenses_212" xlink:to="lab_inmd_IncomeTaxReconciliationNonDeductibleExpenses_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_IncomeTaxReconciliationSettlementsWithIsraeliTaxAuthorityNetOfDecreaseOfRelatedUncertainTax_213" xlink:to="lab_inmd_IncomeTaxReconciliationSettlementsWithIsraeliTaxAuthorityNetOfDecreaseOfRelatedUncertainTax_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_IncomeTaxReconciliationSettlementsWithIsraeliTaxAuthorityNetOfDecreaseOfRelatedUncertainTax_214" xlink:to="lab_inmd_IncomeTaxReconciliationSettlementsWithIsraeliTaxAuthorityNetOfDecreaseOfRelatedUncertainTax_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_IncomeTaxReconciliationSettlementsWithIsraeliTaxAuthorityNetOfDecreaseOfRelatedUncertainTax_215" xlink:to="lab_inmd_IncomeTaxReconciliationSettlementsWithIsraeliTaxAuthorityNetOfDecreaseOfRelatedUncertainTax_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_IncomeTaxReconciliationUncertainTaxPosition_216" xlink:to="lab_inmd_IncomeTaxReconciliationUncertainTaxPosition_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_IncomeTaxReconciliationUncertainTaxPosition_217" xlink:to="lab_inmd_IncomeTaxReconciliationUncertainTaxPosition_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_IncomeTaxReconciliationUncertainTaxPosition_218" xlink:to="lab_inmd_IncomeTaxReconciliationUncertainTaxPosition_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_IncreasesDueToIssuanceOfNewContractsExcludingAmountsRecognizedAsRevenueDuringPeriod_219" xlink:to="lab_inmd_IncreasesDueToIssuanceOfNewContractsExcludingAmountsRecognizedAsRevenueDuringPeriod_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_IncreasesDueToIssuanceOfNewContractsExcludingAmountsRecognizedAsRevenueDuringPeriod_220" xlink:to="lab_inmd_IncreasesDueToIssuanceOfNewContractsExcludingAmountsRecognizedAsRevenueDuringPeriod_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_InmodeInnovationMember_221" xlink:to="lab_inmd_InmodeInnovationMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_InmodeInnovationMember_222" xlink:to="lab_inmd_InmodeInnovationMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_InmodeLtdAndIsreaeliSubsidiariesMember_223" xlink:to="lab_inmd_InmodeLtdAndIsreaeliSubsidiariesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_InmodeLtdAndIsreaeliSubsidiariesMember_224" xlink:to="lab_inmd_InmodeLtdAndIsreaeliSubsidiariesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_InmodeLtdAndIsreaeliSubsidiariesMember_225" xlink:to="lab_inmd_InmodeLtdAndIsreaeliSubsidiariesMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_InterestReceived_226" xlink:to="lab_inmd_InterestReceived_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_InterestReceived_227" xlink:to="lab_inmd_InterestReceived_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_InvestmentInShortTermDeposit_228" xlink:to="lab_inmd_InvestmentInShortTermDeposit_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_InvestmentInShortTermDeposit_229" xlink:to="lab_inmd_InvestmentInShortTermDeposit_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_InvestmentInShortTermDeposit_230" xlink:to="lab_inmd_InvestmentInShortTermDeposit_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_IsraeliTaxAuthorityMember_231" xlink:to="lab_inmd_IsraeliTaxAuthorityMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_IsraeliTaxAuthorityMember_232" xlink:to="lab_inmd_IsraeliTaxAuthorityMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_JanuarySevenTwoThousandsTwentyMember_233" xlink:to="lab_inmd_JanuarySevenTwoThousandsTwentyMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_JanuarySevenTwoThousandsTwentyMember_234" xlink:to="lab_inmd_JanuarySevenTwoThousandsTwentyMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_JointVentureAgreementMember_235" xlink:to="lab_inmd_JointVentureAgreementMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_JointVentureAgreementMember_236" xlink:to="lab_inmd_JointVentureAgreementMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_JulyTwentySevenTwoThousandsTwentyOneMember_237" xlink:to="lab_inmd_JulyTwentySevenTwoThousandsTwentyOneMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_JulyTwentySevenTwoThousandsTwentyOneMember_238" xlink:to="lab_inmd_JulyTwentySevenTwoThousandsTwentyOneMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_JulyTwentySevenTwoThousandsTwentyOneMember_239" xlink:to="lab_inmd_JulyTwentySevenTwoThousandsTwentyOneMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_JulyTwoSevenTwoZeroTwoTwoMember_240" xlink:to="lab_inmd_JulyTwoSevenTwoZeroTwoTwoMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_JulyTwoSevenTwoZeroTwoTwoMember_241" xlink:to="lab_inmd_JulyTwoSevenTwoZeroTwoTwoMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_JulyTwoSevenTwoZeroTwoTwoMember_242" xlink:to="lab_inmd_JulyTwoSevenTwoZeroTwoTwoMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_LeaseAgreementMember_243" xlink:to="lab_inmd_LeaseAgreementMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_LeaseAgreementMember_244" xlink:to="lab_inmd_LeaseAgreementMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_LeaseAgreementMember_245" xlink:to="lab_inmd_LeaseAgreementMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_LeaseExpires_246" xlink:to="lab_inmd_LeaseExpires_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_LeaseExpires_247" xlink:to="lab_inmd_LeaseExpires_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_LeaseExpires_248" xlink:to="lab_inmd_LeaseExpires_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_LeasesLineItems_249" xlink:to="lab_inmd_LeasesLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_LeasesLineItems_250" xlink:to="lab_inmd_LeasesLineItems_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_LeasesTable_251" xlink:to="lab_inmd_LeasesTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_LeasesTable_252" xlink:to="lab_inmd_LeasesTable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_MarketableSecuritiesAndFairValueMeasurementAbstract_253" xlink:to="lab_inmd_MarketableSecuritiesAndFairValueMeasurementAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_MarketableSecuritiesAndFairValueMeasurementAbstract_254" xlink:to="lab_inmd_MarketableSecuritiesAndFairValueMeasurementAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_MarketableSecuritiesAndFairValueMeasurementAbstract_255" xlink:to="lab_inmd_MarketableSecuritiesAndFairValueMeasurementAbstract_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_MarketableSecuritiesAndFairValueMeasurements_256" xlink:to="lab_inmd_MarketableSecuritiesAndFairValueMeasurements_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_MarketableSecuritiesAndFairValueMeasurements_257" xlink:to="lab_inmd_MarketableSecuritiesAndFairValueMeasurements_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_MarketableSecuritiesAndFairValueMeasurements_258" xlink:to="lab_inmd_MarketableSecuritiesAndFairValueMeasurements_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_MayFiveTwoThousandsTwentyMember_259" xlink:to="lab_inmd_MayFiveTwoThousandsTwentyMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_MayFiveTwoThousandsTwentyMember_260" xlink:to="lab_inmd_MayFiveTwoThousandsTwentyMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_MayOneTwoZeroTwoTwoMember_261" xlink:to="lab_inmd_MayOneTwoZeroTwoTwoMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_MayOneTwoZeroTwoTwoMember_262" xlink:to="lab_inmd_MayOneTwoZeroTwoTwoMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_MayOneTwoZeroTwoTwoMember_263" xlink:to="lab_inmd_MayOneTwoZeroTwoTwoMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_MaySixTwoThousandsTwentyOneMember_264" xlink:to="lab_inmd_MaySixTwoThousandsTwentyOneMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_MaySixTwoThousandsTwentyOneMember_265" xlink:to="lab_inmd_MaySixTwoThousandsTwentyOneMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_MaySixTwoThousandsTwentyOneMember_266" xlink:to="lab_inmd_MaySixTwoThousandsTwentyOneMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_MedimorMember_267" xlink:to="lab_inmd_MedimorMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_MedimorMember_268" xlink:to="lab_inmd_MedimorMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_MinimalInvasiveMember_269" xlink:to="lab_inmd_MinimalInvasiveMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_MinimalInvasiveMember_270" xlink:to="lab_inmd_MinimalInvasiveMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_MinorityInterestDecreaseFromRedemptionsOne_271" xlink:to="lab_inmd_MinorityInterestDecreaseFromRedemptionsOne_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_MinorityInterestDecreaseFromRedemptionsOne_272" xlink:to="lab_inmd_MinorityInterestDecreaseFromRedemptionsOne_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_MinorityInterestDecreaseFromRedemptionsOne_273" xlink:to="lab_inmd_MinorityInterestDecreaseFromRedemptionsOne_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_NoAmendmentMember_274" xlink:to="lab_inmd_NoAmendmentMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_NoAmendmentMember_275" xlink:to="lab_inmd_NoAmendmentMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_NonCashAcquisitionOfNoncontrollingInterestInExchangeOfOrdinaryShares_276" xlink:to="lab_inmd_NonCashAcquisitionOfNoncontrollingInterestInExchangeOfOrdinaryShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_NonCashAcquisitionOfNoncontrollingInterestInExchangeOfOrdinaryShares_277" xlink:to="lab_inmd_NonCashAcquisitionOfNoncontrollingInterestInExchangeOfOrdinaryShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_NonCashAcquisitionOfNoncontrollingInterestInExchangeOfOrdinaryShares_278" xlink:to="lab_inmd_NonCashAcquisitionOfNoncontrollingInterestInExchangeOfOrdinaryShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_NonInvasiveMember_279" xlink:to="lab_inmd_NonInvasiveMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_NonInvasiveMember_280" xlink:to="lab_inmd_NonInvasiveMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_NonIsraeliPlanMember_281" xlink:to="lab_inmd_NonIsraeliPlanMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_NonIsraeliPlanMember_282" xlink:to="lab_inmd_NonIsraeliPlanMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_NonUsGovernmentAgenciesDebtSecuritiesMember_283" xlink:to="lab_inmd_NonUsGovernmentAgenciesDebtSecuritiesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_NonUsGovernmentAgenciesDebtSecuritiesMember_284" xlink:to="lab_inmd_NonUsGovernmentAgenciesDebtSecuritiesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_NovemberElevenTwoThousandsTwentyMember_285" xlink:to="lab_inmd_NovemberElevenTwoThousandsTwentyMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_NovemberElevenTwoThousandsTwentyMember_286" xlink:to="lab_inmd_NovemberElevenTwoThousandsTwentyMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_NumberOfOrdinarySharesConsideration_287" xlink:to="lab_inmd_NumberOfOrdinarySharesConsideration_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_NumberOfOrdinarySharesConsideration_288" xlink:to="lab_inmd_NumberOfOrdinarySharesConsideration_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_NumberOfOrdinarySharesConsideration_289" xlink:to="lab_inmd_NumberOfOrdinarySharesConsideration_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_NumberOfShareholder_290" xlink:to="lab_inmd_NumberOfShareholder_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_NumberOfShareholder_291" xlink:to="lab_inmd_NumberOfShareholder_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_NumberOfShareholder_292" xlink:to="lab_inmd_NumberOfShareholder_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_OctoberTwoSixTwoZeroTwoTwoMember_293" xlink:to="lab_inmd_OctoberTwoSixTwoZeroTwoTwoMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_OctoberTwoSixTwoZeroTwoTwoMember_294" xlink:to="lab_inmd_OctoberTwoSixTwoZeroTwoTwoMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_OctoberTwoSixTwoZeroTwoTwoMember_295" xlink:to="lab_inmd_OctoberTwoSixTwoZeroTwoTwoMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_OneTimePayment_296" xlink:to="lab_inmd_OneTimePayment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_OneTimePayment_297" xlink:to="lab_inmd_OneTimePayment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_OneTimePayment_298" xlink:to="lab_inmd_OneTimePayment_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_OperatingLeaseRightOfUseAssests_299" xlink:to="lab_inmd_OperatingLeaseRightOfUseAssests_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_OperatingLeaseRightOfUseAssests_300" xlink:to="lab_inmd_OperatingLeaseRightOfUseAssests_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_OperatingLeaseRightOfUseAssests_301" xlink:to="lab_inmd_OperatingLeaseRightOfUseAssests_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_OptionsChangesDuringYear_302" xlink:to="lab_inmd_OptionsChangesDuringYear_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_OptionsChangesDuringYear_303" xlink:to="lab_inmd_OptionsChangesDuringYear_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_OtherAdvancesToSuppliersCurrent_304" xlink:to="lab_inmd_OtherAdvancesToSuppliersCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_OtherAdvancesToSuppliersCurrent_305" xlink:to="lab_inmd_OtherAdvancesToSuppliersCurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_OtherAdvancesToSuppliersCurrent_306" xlink:to="lab_inmd_OtherAdvancesToSuppliersCurrent_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_OtherCountryMember_307" xlink:to="lab_inmd_OtherCountryMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_OtherCountryMember_308" xlink:to="lab_inmd_OtherCountryMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_OtherCountryMember_309" xlink:to="lab_inmd_OtherCountryMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_OtherCurrentLeaseLiabilities_310" xlink:to="lab_inmd_OtherCurrentLeaseLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_OtherCurrentLeaseLiabilities_311" xlink:to="lab_inmd_OtherCurrentLeaseLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_OtherCurrentLeaseLiabilities_312" xlink:to="lab_inmd_OtherCurrentLeaseLiabilities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_OtherCurrentLiabilitiesLineItems_313" xlink:to="lab_inmd_OtherCurrentLiabilitiesLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_OtherCurrentLiabilitiesLineItems_314" xlink:to="lab_inmd_OtherCurrentLiabilitiesLineItems_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_OtherCurrentLiabilitiesTable_315" xlink:to="lab_inmd_OtherCurrentLiabilitiesTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_OtherCurrentLiabilitiesTable_316" xlink:to="lab_inmd_OtherCurrentLiabilitiesTable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_OtherCurrentReceivables_317" xlink:to="lab_inmd_OtherCurrentReceivables_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_OtherCurrentReceivables_318" xlink:to="lab_inmd_OtherCurrentReceivables_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_OtherCurrentReceivables_319" xlink:to="lab_inmd_OtherCurrentReceivables_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_OtherGovernmentInstitutionsReceivablesCurrent_320" xlink:to="lab_inmd_OtherGovernmentInstitutionsReceivablesCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_OtherGovernmentInstitutionsReceivablesCurrent_321" xlink:to="lab_inmd_OtherGovernmentInstitutionsReceivablesCurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_OtherGovernmentInstitutionsReceivablesCurrent_322" xlink:to="lab_inmd_OtherGovernmentInstitutionsReceivablesCurrent_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_OtherIncomeTaxReceivablesCurrent_323" xlink:to="lab_inmd_OtherIncomeTaxReceivablesCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_OtherIncomeTaxReceivablesCurrent_324" xlink:to="lab_inmd_OtherIncomeTaxReceivablesCurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_OtherIncomeTaxReceivablesCurrent_325" xlink:to="lab_inmd_OtherIncomeTaxReceivablesCurrent_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_OtherOperatingExpenseIncome_326" xlink:to="lab_inmd_OtherOperatingExpenseIncome_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_OtherOperatingExpenseIncome_327" xlink:to="lab_inmd_OtherOperatingExpenseIncome_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_OtherOperatingExpenseIncome_328" xlink:to="lab_inmd_OtherOperatingExpenseIncome_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_OtherPrepaidExpensesReceivablesCurrent_329" xlink:to="lab_inmd_OtherPrepaidExpensesReceivablesCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_OtherPrepaidExpensesReceivablesCurrent_330" xlink:to="lab_inmd_OtherPrepaidExpensesReceivablesCurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_OtherPrepaidExpensesReceivablesCurrent_331" xlink:to="lab_inmd_OtherPrepaidExpensesReceivablesCurrent_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_OtherReceivablesNonCurrent_332" xlink:to="lab_inmd_OtherReceivablesNonCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_OtherReceivablesNonCurrent_333" xlink:to="lab_inmd_OtherReceivablesNonCurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_OtherReceivablesNonCurrent_334" xlink:to="lab_inmd_OtherReceivablesNonCurrent_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_OwnershipInterestExchange_335" xlink:to="lab_inmd_OwnershipInterestExchange_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_OwnershipInterestExchange_336" xlink:to="lab_inmd_OwnershipInterestExchange_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_PaymentsToTaxAuthorities_337" xlink:to="lab_inmd_PaymentsToTaxAuthorities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_PaymentsToTaxAuthorities_338" xlink:to="lab_inmd_PaymentsToTaxAuthorities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_PaymentsToTaxAuthorities_339" xlink:to="lab_inmd_PaymentsToTaxAuthorities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_PercentageOfNetSalesBasedOnProductsTechnology_340" xlink:to="lab_inmd_PercentageOfNetSalesBasedOnProductsTechnology_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_PercentageOfNetSalesBasedOnProductsTechnology_341" xlink:to="lab_inmd_PercentageOfNetSalesBasedOnProductsTechnology_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_PercentageOfNonCurrentDeferredRevenue_342" xlink:to="lab_inmd_PercentageOfNonCurrentDeferredRevenue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_PercentageOfNonCurrentDeferredRevenue_343" xlink:to="lab_inmd_PercentageOfNonCurrentDeferredRevenue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_PrepaidExpensesAndOtherCurrentReceivablesTextBlock_344" xlink:to="lab_inmd_PrepaidExpensesAndOtherCurrentReceivablesTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_PrepaidExpensesAndOtherCurrentReceivablesTextBlock_345" xlink:to="lab_inmd_PrepaidExpensesAndOtherCurrentReceivablesTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_PrepaidExpensesAndOtherCurrentReceivablesTextBlock_346" xlink:to="lab_inmd_PrepaidExpensesAndOtherCurrentReceivablesTextBlock_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_PreviousYearIncomeTaxExpenseBenefit_347" xlink:to="lab_inmd_PreviousYearIncomeTaxExpenseBenefit_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_PreviousYearIncomeTaxExpenseBenefit_348" xlink:to="lab_inmd_PreviousYearIncomeTaxExpenseBenefit_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_PreviousYearIncomeTaxExpenseBenefit_349" xlink:to="lab_inmd_PreviousYearIncomeTaxExpenseBenefit_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ProceedsFromInvestmentInShortTermDeposit_350" xlink:to="lab_inmd_ProceedsFromInvestmentInShortTermDeposit_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ProceedsFromInvestmentInShortTermDeposit_351" xlink:to="lab_inmd_ProceedsFromInvestmentInShortTermDeposit_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ProceedsFromInvestmentInShortTermDeposit_352" xlink:to="lab_inmd_ProceedsFromInvestmentInShortTermDeposit_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ProceedsFromMaturityOfMarketableSecurities_353" xlink:to="lab_inmd_ProceedsFromMaturityOfMarketableSecurities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ProceedsFromMaturityOfMarketableSecurities_354" xlink:to="lab_inmd_ProceedsFromMaturityOfMarketableSecurities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ProceedsFromMaturityOfMarketableSecurities_355" xlink:to="lab_inmd_ProceedsFromMaturityOfMarketableSecurities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_RegulationsMember_356" xlink:to="lab_inmd_RegulationsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_RegulationsMember_357" xlink:to="lab_inmd_RegulationsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_RelatedPartyConsiderationForAggregateAmount_358" xlink:to="lab_inmd_RelatedPartyConsiderationForAggregateAmount_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_RelatedPartyConsiderationForAggregateAmount_359" xlink:to="lab_inmd_RelatedPartyConsiderationForAggregateAmount_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_RelatedPartyConsiderationForAggregateAmount_360" xlink:to="lab_inmd_RelatedPartyConsiderationForAggregateAmount_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ScheduleOfOtherReceivablesCurrentTableTextBlock_361" xlink:to="lab_inmd_ScheduleOfOtherReceivablesCurrentTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ScheduleOfOtherReceivablesCurrentTableTextBlock_362" xlink:to="lab_inmd_ScheduleOfOtherReceivablesCurrentTableTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ScheduleOfPrepaidExpensesAndOtherCurrentRecivablesTableTextBlock_363" xlink:to="lab_inmd_ScheduleOfPrepaidExpensesAndOtherCurrentRecivablesTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ScheduleOfPrepaidExpensesAndOtherCurrentRecivablesTableTextBlock_364" xlink:to="lab_inmd_ScheduleOfPrepaidExpensesAndOtherCurrentRecivablesTableTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ScheduleOfPrepaidExpensesAndOtherCurrentRecivablesTableTextBlock_365" xlink:to="lab_inmd_ScheduleOfPrepaidExpensesAndOtherCurrentRecivablesTableTextBlock_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ScheduleOfPrepaidExpensesAndOtherCurrentRecivablesTableTextBlock_366" xlink:to="lab_inmd_ScheduleOfPrepaidExpensesAndOtherCurrentRecivablesTableTextBlock_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock_367" xlink:to="lab_inmd_ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock_368" xlink:to="lab_inmd_ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock_369" xlink:to="lab_inmd_ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ScheduleOfSupplementalBalanceSheetInformationRelatedToLeases_370" xlink:to="lab_inmd_ScheduleOfSupplementalBalanceSheetInformationRelatedToLeases_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ScheduleOfSupplementalBalanceSheetInformationRelatedToLeases_371" xlink:to="lab_inmd_ScheduleOfSupplementalBalanceSheetInformationRelatedToLeases_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ScheduleOfSupplementalCashFlowInformationRelatedToLeases_372" xlink:to="lab_inmd_ScheduleOfSupplementalCashFlowInformationRelatedToLeases_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ScheduleOfSupplementalCashFlowInformationRelatedToLeases_373" xlink:to="lab_inmd_ScheduleOfSupplementalCashFlowInformationRelatedToLeases_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonVestedVested_374" xlink:to="lab_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonVestedVested_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonVestedVested_375" xlink:to="lab_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonVestedVested_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonVestedVested_376" xlink:to="lab_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonVestedVested_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue_377" xlink:to="lab_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue_378" xlink:to="lab_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue_379" xlink:to="lab_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsEarlyExerciseMultiple_380" xlink:to="lab_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsEarlyExerciseMultiple_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsEarlyExerciseMultiple_381" xlink:to="lab_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsEarlyExerciseMultiple_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsEarlyExerciseMultiple_382" xlink:to="lab_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsEarlyExerciseMultiple_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedFour_383" xlink:to="lab_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedFour_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedFour_384" xlink:to="lab_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedFour_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedFour_385" xlink:to="lab_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedFour_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedOne_386" xlink:to="lab_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedOne_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedOne_387" xlink:to="lab_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedOne_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedOne_388" xlink:to="lab_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedOne_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedThree_389" xlink:to="lab_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedThree_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedThree_390" xlink:to="lab_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedThree_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedThree_391" xlink:to="lab_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedThree_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedTwo_392" xlink:to="lab_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedTwo_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedTwo_393" xlink:to="lab_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedTwo_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedTwo_394" xlink:to="lab_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedTwo_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedUponAdoption_395" xlink:to="lab_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedUponAdoption_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedUponAdoption_396" xlink:to="lab_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedUponAdoption_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedUponAdoption_397" xlink:to="lab_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedUponAdoption_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriod_398" xlink:to="lab_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriod_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriod_399" xlink:to="lab_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriod_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriod_400" xlink:to="lab_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriod_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAwardAmount_401" xlink:to="lab_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAwardAmount_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAwardAmount_402" xlink:to="lab_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAwardAmount_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAwardAmount_403" xlink:to="lab_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAwardAmount_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionCancelledInPeriodWeightedAverageExercisePrice_404" xlink:to="lab_inmd_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionCancelledInPeriodWeightedAverageExercisePrice_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionCancelledInPeriodWeightedAverageExercisePrice_405" xlink:to="lab_inmd_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionCancelledInPeriodWeightedAverageExercisePrice_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionCancelledInPeriodWeightedAverageExercisePrice_406" xlink:to="lab_inmd_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionCancelledInPeriodWeightedAverageExercisePrice_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ShareBasedCompensationAwardTrancheFourMember_407" xlink:to="lab_inmd_ShareBasedCompensationAwardTrancheFourMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ShareBasedCompensationAwardTrancheFourMember_408" xlink:to="lab_inmd_ShareBasedCompensationAwardTrancheFourMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice_409" xlink:to="lab_inmd_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice_410" xlink:to="lab_inmd_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice_411" xlink:to="lab_inmd_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_SharePurchaseAndShareholdersAgreementMember_412" xlink:to="lab_inmd_SharePurchaseAndShareholdersAgreementMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_SharePurchaseAndShareholdersAgreementMember_413" xlink:to="lab_inmd_SharePurchaseAndShareholdersAgreementMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_SharePurchaseAndShareholdersAgreementMember_414" xlink:to="lab_inmd_SharePurchaseAndShareholdersAgreementMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ShareRepurchaseProgramMember_415" xlink:to="lab_inmd_ShareRepurchaseProgramMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_SharesAuthorizedAmount_416" xlink:to="lab_inmd_SharesAuthorizedAmount_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_SharesAuthorizedAmount_417" xlink:to="lab_inmd_SharesAuthorizedAmount_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ShareValueOfAcquisitionOfNonControllingInterestInExchangeOfOrdinaryShares_418" xlink:to="lab_inmd_ShareValueOfAcquisitionOfNonControllingInterestInExchangeOfOrdinaryShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ShareValueOfAcquisitionOfNonControllingInterestInExchangeOfOrdinaryShares_419" xlink:to="lab_inmd_ShareValueOfAcquisitionOfNonControllingInterestInExchangeOfOrdinaryShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ShareValueOfAcquisitionOfNonControllingInterestInExchangeOfOrdinaryShares_420" xlink:to="lab_inmd_ShareValueOfAcquisitionOfNonControllingInterestInExchangeOfOrdinaryShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ShortTermBankDepositsPolicyTextBlock_421" xlink:to="lab_inmd_ShortTermBankDepositsPolicyTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ShortTermBankDepositsPolicyTextBlock_422" xlink:to="lab_inmd_ShortTermBankDepositsPolicyTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ShortTermBankDepositsPolicyTextBlock_423" xlink:to="lab_inmd_ShortTermBankDepositsPolicyTextBlock_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ShortTermDepositsAnnualInterestRate_424" xlink:to="lab_inmd_ShortTermDepositsAnnualInterestRate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_ShortTermDepositsAnnualInterestRate_425" xlink:to="lab_inmd_ShortTermDepositsAnnualInterestRate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_SpaMedicalInternationalLsrlMember_426" xlink:to="lab_inmd_SpaMedicalInternationalLsrlMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_SpaMedicalInternationalLsrlMember_427" xlink:to="lab_inmd_SpaMedicalInternationalLsrlMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_SpecialPreferredEnterpriseMember_428" xlink:to="lab_inmd_SpecialPreferredEnterpriseMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_SpecialPreferredEnterpriseMember_429" xlink:to="lab_inmd_SpecialPreferredEnterpriseMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_StockRepurchasedDuringPeriodValueOne_430" xlink:to="lab_inmd_StockRepurchasedDuringPeriodValueOne_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_StockRepurchasedDuringPeriodValueOne_431" xlink:to="lab_inmd_StockRepurchasedDuringPeriodValueOne_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_StockRepurchasedDuringPeriodValueOne_432" xlink:to="lab_inmd_StockRepurchasedDuringPeriodValueOne_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_StockRepurchasedOrdinarySharesDuringPeriodShares_433" xlink:to="lab_inmd_StockRepurchasedOrdinarySharesDuringPeriodShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_StockRepurchasedOrdinarySharesDuringPeriodShares_434" xlink:to="lab_inmd_StockRepurchasedOrdinarySharesDuringPeriodShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_StockRepurchasedOrdinarySharesDuringPeriodShares_435" xlink:to="lab_inmd_StockRepurchasedOrdinarySharesDuringPeriodShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_StockRepurchasedOrdinarySharesDuringPeriodValue_436" xlink:to="lab_inmd_StockRepurchasedOrdinarySharesDuringPeriodValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_StockRepurchasedOrdinarySharesDuringPeriodValue_437" xlink:to="lab_inmd_StockRepurchasedOrdinarySharesDuringPeriodValue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_StockRepurchasedOrdinarySharesDuringPeriodValue_438" xlink:to="lab_inmd_StockRepurchasedOrdinarySharesDuringPeriodValue_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_SubsidiariesFourMember_439" xlink:to="lab_inmd_SubsidiariesFourMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_SubsidiariesFourMember_440" xlink:to="lab_inmd_SubsidiariesFourMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_SubsidiariesOutsideIsraelMember_441" xlink:to="lab_inmd_SubsidiariesOutsideIsraelMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_SubsidiariesOutsideIsraelMember_442" xlink:to="lab_inmd_SubsidiariesOutsideIsraelMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_SubsidiariesOutsideIsraelMember_443" xlink:to="lab_inmd_SubsidiariesOutsideIsraelMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_SubsidiariesThreeMember_444" xlink:to="lab_inmd_SubsidiariesThreeMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_SubsidiariesThreeMember_445" xlink:to="lab_inmd_SubsidiariesThreeMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_SubsidiaryOfHomeSkinnovationsLtdMember_446" xlink:to="lab_inmd_SubsidiaryOfHomeSkinnovationsLtdMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_SubsidiaryOfHomeSkinnovationsLtdMember_447" xlink:to="lab_inmd_SubsidiaryOfHomeSkinnovationsLtdMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_TaxBenefitYear_448" xlink:to="lab_inmd_TaxBenefitYear_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_TaxBenefitYear_449" xlink:to="lab_inmd_TaxBenefitYear_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_TaxRateForRecipientForDividendsDistributedByPreferredCompany_450" xlink:to="lab_inmd_TaxRateForRecipientForDividendsDistributedByPreferredCompany_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_TaxRateForRecipientForDividendsDistributedByPreferredCompany_451" xlink:to="lab_inmd_TaxRateForRecipientForDividendsDistributedByPreferredCompany_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_TotalLongLivedAssetsByGeographicalArea_452" xlink:to="lab_inmd_TotalLongLivedAssetsByGeographicalArea_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_TotalLongLivedAssetsByGeographicalArea_453" xlink:to="lab_inmd_TotalLongLivedAssetsByGeographicalArea_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_TotalLongLivedAssetsByGeographicalArea_454" xlink:to="lab_inmd_TotalLongLivedAssetsByGeographicalArea_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_TreasurySharesPolicyTextBlock_455" xlink:to="lab_inmd_TreasurySharesPolicyTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_TreasurySharesPolicyTextBlock_456" xlink:to="lab_inmd_TreasurySharesPolicyTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_TreasurySharesPolicyTextBlock_457" xlink:to="lab_inmd_TreasurySharesPolicyTextBlock_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_TwoPurchaseAndShareholdersAgreementsMember_458" xlink:to="lab_inmd_TwoPurchaseAndShareholdersAgreementsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_TwoPurchaseAndShareholdersAgreementsMember_459" xlink:to="lab_inmd_TwoPurchaseAndShareholdersAgreementsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_TwoPurchaseAndShareholdersAgreementsMember_460" xlink:to="lab_inmd_TwoPurchaseAndShareholdersAgreementsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_TwoThousandsEighteenIncentivePlanMember_461" xlink:to="lab_inmd_TwoThousandsEighteenIncentivePlanMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_TwoThousandsEighteenIncentivePlanMember_462" xlink:to="lab_inmd_TwoThousandsEighteenIncentivePlanMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_TwoThousandsEighteenIncentivePlanMember_463" xlink:to="lab_inmd_TwoThousandsEighteenIncentivePlanMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_UnderwritersAllotmentOptionMember_464" xlink:to="lab_inmd_UnderwritersAllotmentOptionMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_UnderwritersAllotmentOptionMember_465" xlink:to="lab_inmd_UnderwritersAllotmentOptionMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_UndistributedExemptIncome_466" xlink:to="lab_inmd_UndistributedExemptIncome_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_UndistributedExemptIncome_467" xlink:to="lab_inmd_UndistributedExemptIncome_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_UnitsChangesDuringYearAbstract_468" xlink:to="lab_inmd_UnitsChangesDuringYearAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_WarrantyReserveLiabilityCurrent_469" xlink:to="lab_inmd_WarrantyReserveLiabilityCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_WarrantyReserveLiabilityCurrent_470" xlink:to="lab_inmd_WarrantyReserveLiabilityCurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_WarrantyReserveLiabilityCurrent_471" xlink:to="lab_inmd_WarrantyReserveLiabilityCurrent_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_WarRiskSituationInIsraelPolicyTextBlock_472" xlink:to="lab_inmd_WarRiskSituationInIsraelPolicyTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_WarRiskSituationInIsraelPolicyTextBlock_473" xlink:to="lab_inmd_WarRiskSituationInIsraelPolicyTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_WarRiskSituationInIsraelPolicyTextBlock_474" xlink:to="lab_inmd_WarRiskSituationInIsraelPolicyTextBlock_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_WeightedAverageExercisePriceChangesDuringYearAbstract_475" xlink:to="lab_inmd_WeightedAverageExercisePriceChangesDuringYearAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_WeightedAverageExercisePriceChangesDuringYearAbstract_476" xlink:to="lab_inmd_WeightedAverageExercisePriceChangesDuringYearAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_WeightedAverageGrantDateChangesDuringYearAbstract_477" xlink:to="lab_inmd_WeightedAverageGrantDateChangesDuringYearAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_WeightedAverageNumberOfSharesOutStandingUsedInComputationOfNetIncomePerShareAbstract_478" xlink:to="lab_inmd_WeightedAverageNumberOfSharesOutStandingUsedInComputationOfNetIncomePerShareAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_inmd_WeightedAverageNumberOfSharesOutStandingUsedInComputationOfNetIncomePerShareAbstract_479" xlink:to="lab_inmd_WeightedAverageNumberOfSharesOutStandingUsedInComputationOfNetIncomePerShareAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_BoardOfDirectorsChairmanMember_480" xlink:to="lab_srt_BoardOfDirectorsChairmanMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesAxis_481" xlink:to="lab_srt_ConsolidatedEntitiesAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_482" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CurrencyAxis_483" xlink:to="lab_srt_CurrencyAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_484" xlink:to="lab_srt_EquityMethodInvesteeNameDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EuropeMember_485" xlink:to="lab_srt_EuropeMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EuropeMember_486" xlink:to="lab_srt_EuropeMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember_487" xlink:to="lab_srt_MaximumMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember_488" xlink:to="lab_srt_MaximumMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember_489" xlink:to="lab_srt_MinimumMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember_490" xlink:to="lab_srt_MinimumMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_491" xlink:to="lab_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_492" xlink:to="lab_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OfficeBuildingMember_493" xlink:to="lab_srt_OfficeBuildingMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipAxis_494" xlink:to="lab_srt_OwnershipAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis_495" xlink:to="lab_srt_ProductOrServiceAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain_496" xlink:to="lab_srt_ProductsAndServicesDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis_497" xlink:to="lab_srt_RangeAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember_498" xlink:to="lab_srt_RangeMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioForecastMember_499" xlink:to="lab_srt_ScenarioForecastMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_500" xlink:to="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain_501" xlink:to="lab_srt_SegmentGeographicalDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis_502" xlink:to="lab_srt_StatementGeographicalAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis_503" xlink:to="lab_srt_StatementScenarioAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SubsidiariesMember_504" xlink:to="lab_srt_SubsidiariesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis_505" xlink:to="lab_srt_TitleOfIndividualAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_506" xlink:to="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_WarehouseMember_507" xlink:to="lab_srt_WarehouseMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_508" xlink:to="lab_us-gaap_AccountingPoliciesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsAndNotesReceivableNet_509" xlink:to="lab_us-gaap_AccountsAndNotesReceivableNet_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsAndNotesReceivableNet_510" xlink:to="lab_us-gaap_AccountsAndNotesReceivableNet_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsAndOtherReceivablesNetCurrent_511" xlink:to="lab_us-gaap_AccountsAndOtherReceivablesNetCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsAndOtherReceivablesNetCurrent_512" xlink:to="lab_us-gaap_AccountsAndOtherReceivablesNetCurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableGrossAllowanceAndNetAbstract_513" xlink:to="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableGrossAllowanceAndNetAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_514" xlink:to="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent_515" xlink:to="lab_us-gaap_AccountsPayableCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent_516" xlink:to="lab_us-gaap_AccountsPayableCurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent_517" xlink:to="lab_us-gaap_AccountsPayableCurrent_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent_518" xlink:to="lab_us-gaap_AccountsPayableCurrent_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent_519" xlink:to="lab_us-gaap_AccountsPayableCurrent_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent_520" xlink:to="lab_us-gaap_AccountsPayableCurrent_5"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrentAndNoncurrent_521" xlink:to="lab_us-gaap_AccountsPayableCurrentAndNoncurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableRelatedAndNonrelatedPartyStatusExtensibleEnumeration_522" xlink:to="lab_us-gaap_AccountsPayableRelatedAndNonrelatedPartyStatusExtensibleEnumeration_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableAfterAllowanceForCreditLossRelatedAndNonrelatedPartyStatusExtensibleEnumeration_523" xlink:to="lab_us-gaap_AccountsReceivableAfterAllowanceForCreditLossRelatedAndNonrelatedPartyStatusExtensibleEnumeration_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_524" xlink:to="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_525" xlink:to="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableGross_526" xlink:to="lab_us-gaap_AccountsReceivableGross_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNet_527" xlink:to="lab_us-gaap_AccountsReceivableNet_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNet_528" xlink:to="lab_us-gaap_AccountsReceivableNet_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNet_529" xlink:to="lab_us-gaap_AccountsReceivableNet_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent_530" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent_531" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent_532" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent_533" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent_534" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent_535" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent_5"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetNoncurrent_536" xlink:to="lab_us-gaap_AccountsReceivableNetNoncurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetNoncurrent_537" xlink:to="lab_us-gaap_AccountsReceivableNetNoncurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetNoncurrent_538" xlink:to="lab_us-gaap_AccountsReceivableNetNoncurrent_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetNoncurrent_539" xlink:to="lab_us-gaap_AccountsReceivableNetNoncurrent_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNoncurrentNonaccrual_540" xlink:to="lab_us-gaap_AccountsReceivableNoncurrentNonaccrual_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesCurrent_541" xlink:to="lab_us-gaap_AccruedIncomeTaxesCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesCurrent_542" xlink:to="lab_us-gaap_AccruedIncomeTaxesCurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_543" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_544" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_545" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_546" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_547" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock_548" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock_549" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember_550" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_551" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_552" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_553" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_554" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_555" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_556" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvertisingCostsPolicyTextBlock_557" xlink:to="lab_us-gaap_AdvertisingCostsPolicyTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvertisingCostsPolicyTextBlock_558" xlink:to="lab_us-gaap_AdvertisingCostsPolicyTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvertisingExpense_559" xlink:to="lab_us-gaap_AdvertisingExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvertisingExpense_560" xlink:to="lab_us-gaap_AdvertisingExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense_561" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense_562" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_563" xlink:to="lab_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_564" xlink:to="lab_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_565" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_566" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_567" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_568" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_569" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_570" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableNoncurrent_571" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableNoncurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableNoncurrent_572" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableNoncurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_573" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_574" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_575" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_576" xlink:to="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets_577" xlink:to="lab_us-gaap_Assets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets_578" xlink:to="lab_us-gaap_Assets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract_579" xlink:to="lab_us-gaap_AssetsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent_580" xlink:to="lab_us-gaap_AssetsCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent_581" xlink:to="lab_us-gaap_AssetsCurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract_582" xlink:to="lab_us-gaap_AssetsCurrentAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsNoncurrent_583" xlink:to="lab_us-gaap_AssetsNoncurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsNoncurrent_584" xlink:to="lab_us-gaap_AssetsNoncurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_585" xlink:to="lab_us-gaap_AssetsNoncurrentAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_586" xlink:to="lab_us-gaap_AssetsNoncurrentAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_587" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_588" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_589" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_590" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_591" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_592" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_593" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_594" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_595" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardDateAxis_596" xlink:to="lab_us-gaap_AwardDateAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis_597" xlink:to="lab_us-gaap_AwardTypeAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_598" xlink:to="lab_us-gaap_BalanceSheetLocationAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_599" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BondsMember_600" xlink:to="lab_us-gaap_BondsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_601" xlink:to="lab_us-gaap_BusinessAcquisitionAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_602" xlink:to="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_603" xlink:to="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1_604" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_605" xlink:to="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_606" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_607" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_608" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_609" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_610" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_611" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_612" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_613" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_614" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_615" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_616" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CertificatesOfDepositMember_617" xlink:to="lab_us-gaap_CertificatesOfDepositMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember_618" xlink:to="lab_us-gaap_CommercialPaperMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies_619" xlink:to="lab_us-gaap_CommitmentsAndContingencies_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies_620" xlink:to="lab_us-gaap_CommitmentsAndContingencies_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_621" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_622" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_623" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_624" xlink:to="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember_625" xlink:to="lab_us-gaap_CommonStockMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare_626" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare_627" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized_628" xlink:to="lab_us-gaap_CommonStockSharesAuthorized_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized_629" xlink:to="lab_us-gaap_CommonStockSharesAuthorized_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued_630" xlink:to="lab_us-gaap_CommonStockSharesIssued_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding_631" xlink:to="lab_us-gaap_CommonStockSharesOutstanding_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding_632" xlink:to="lab_us-gaap_CommonStockSharesOutstanding_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding_633" xlink:to="lab_us-gaap_CommonStockSharesOutstanding_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue_634" xlink:to="lab_us-gaap_CommonStockValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue_635" xlink:to="lab_us-gaap_CommonStockValue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue_636" xlink:to="lab_us-gaap_CommonStockValue_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_637" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_638" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_639" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_640" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_641" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_642" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_643" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComputerEquipmentMember_644" xlink:to="lab_us-gaap_ComputerEquipmentMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_645" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk_646" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk_647" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_648" xlink:to="lab_us-gaap_ConcentrationRiskLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTable_649" xlink:to="lab_us-gaap_ConcentrationRiskTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_650" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock_651" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_652" xlink:to="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability_653" xlink:to="lab_us-gaap_ContractWithCustomerLiability_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability_654" xlink:to="lab_us-gaap_ContractWithCustomerLiability_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability_655" xlink:to="lab_us-gaap_ContractWithCustomerLiability_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent_656" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent_657" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_658" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_659" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_660" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateDebtSecuritiesMember_661" xlink:to="lab_us-gaap_CorporateDebtSecuritiesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenue_662" xlink:to="lab_us-gaap_CostOfRevenue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenue_663" xlink:to="lab_us-gaap_CostOfRevenue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember_664" xlink:to="lab_us-gaap_CostOfSalesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesPolicyTextBlock_665" xlink:to="lab_us-gaap_CostOfSalesPolicyTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_666" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_667" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet_668" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet_669" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_670" xlink:to="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_671" xlink:to="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_672" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_673" xlink:to="lab_us-gaap_DeferredTaxAssetsGross_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_674" xlink:to="lab_us-gaap_DeferredTaxAssetsGross_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_675" xlink:to="lab_us-gaap_DeferredTaxAssetsNet_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_676" xlink:to="lab_us-gaap_DeferredTaxAssetsNet_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_677" xlink:to="lab_us-gaap_DeferredTaxAssetsNetAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_678" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOther_679" xlink:to="lab_us-gaap_DeferredTaxAssetsOther_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOtherComprehensiveLoss_680" xlink:to="lab_us-gaap_DeferredTaxAssetsOtherComprehensiveLoss_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_681" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_682" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance_683" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance_684" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepositsAssetsCurrent_685" xlink:to="lab_us-gaap_DepositsAssetsCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization_686" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization_687" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfLongLivedAssetsHeldForSaleTextBlock_688" xlink:to="lab_us-gaap_DisclosureOfLongLivedAssetsHeldForSaleTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_689" xlink:to="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract_690" xlink:to="lab_us-gaap_EarningsPerShareAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract_691" xlink:to="lab_us-gaap_EarningsPerShareAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic_692" xlink:to="lab_us-gaap_EarningsPerShareBasic_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic_693" xlink:to="lab_us-gaap_EarningsPerShareBasic_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted_694" xlink:to="lab_us-gaap_EarningsPerShareDiluted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted_695" xlink:to="lab_us-gaap_EarningsPerShareDiluted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock_696" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock_697" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_698" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_699" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsDividends_700" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsDividends_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_701" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_702" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_703" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_704" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_705" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_706" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquipmentMember_707" xlink:to="lab_us-gaap_EquipmentMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_708" xlink:to="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_709" xlink:to="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_710" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_711" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member_712" xlink:to="lab_us-gaap_FairValueInputsLevel2Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_713" xlink:to="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_714" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis_715" xlink:to="lab_us-gaap_FinancialInstrumentAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_716" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnInvestments_717" xlink:to="lab_us-gaap_GainLossOnInvestments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnInvestments_718" xlink:to="lab_us-gaap_GainLossOnInvestments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense_719" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense_720" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember_721" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GranteeStatusAxis_722" xlink:to="lab_us-gaap_GranteeStatusAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit_723" xlink:to="lab_us-gaap_GrossProfit_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit_724" xlink:to="lab_us-gaap_GrossProfit_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_725" xlink:to="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_726" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_727" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract_728" xlink:to="lab_us-gaap_IncomeStatementAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_729" xlink:to="lab_us-gaap_IncomeStatementLocationAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_730" xlink:to="lab_us-gaap_IncomeStatementLocationDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_731" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_732" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_733" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_734" xlink:to="lab_us-gaap_IncomeTaxContingencyLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_735" xlink:to="lab_us-gaap_IncomeTaxContingencyTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_736" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock_737" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock_738" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet_739" xlink:to="lab_us-gaap_IncomeTaxesPaidNet_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet_740" xlink:to="lab_us-gaap_IncomeTaxesPaidNet_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesReceivable_741" xlink:to="lab_us-gaap_IncomeTaxesReceivable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_742" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_743" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_744" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_745" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_746" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock_747" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_748" xlink:to="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_749" xlink:to="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_750" xlink:to="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_751" xlink:to="lab_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_752" xlink:to="lab_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable_753" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable_754" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_755" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_756" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_757" xlink:to="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_758" xlink:to="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories_759" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories_760" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_761" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_762" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_763" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherReceivables_764" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherReceivables_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherReceivables_765" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherReceivables_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeExpenseNet_766" xlink:to="lab_us-gaap_InterestIncomeExpenseNet_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeExpenseNet_767" xlink:to="lab_us-gaap_InterestIncomeExpenseNet_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeExpenseNet_768" xlink:to="lab_us-gaap_InterestIncomeExpenseNet_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_769" xlink:to="lab_us-gaap_InventoryDisclosureAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureTextBlock_770" xlink:to="lab_us-gaap_InventoryDisclosureTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoods_771" xlink:to="lab_us-gaap_InventoryFinishedGoods_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet_772" xlink:to="lab_us-gaap_InventoryNet_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet_773" xlink:to="lab_us-gaap_InventoryNet_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock_774" xlink:to="lab_us-gaap_InventoryPolicyTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock_775" xlink:to="lab_us-gaap_InventoryPolicyTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterials_776" xlink:to="lab_us-gaap_InventoryRawMaterials_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeNet_777" xlink:to="lab_us-gaap_InvestmentIncomeNet_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeNet_778" xlink:to="lab_us-gaap_InvestmentIncomeNet_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentPolicyTextBlock_779" xlink:to="lab_us-gaap_InvestmentPolicyTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentPolicyTextBlock_780" xlink:to="lab_us-gaap_InvestmentPolicyTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Investments_781" xlink:to="lab_us-gaap_Investments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Investments_782" xlink:to="lab_us-gaap_Investments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsAbstract_783" xlink:to="lab_us-gaap_InvestmentsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTextBlock_784" xlink:to="lab_us-gaap_InvestmentTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeAxis_785" xlink:to="lab_us-gaap_InvestmentTypeAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_786" xlink:to="lab_us-gaap_InvestmentTypeCategorizationMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IPOMember_787" xlink:to="lab_us-gaap_IPOMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseContractualTermDomain_788" xlink:to="lab_us-gaap_LeaseContractualTermDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock_789" xlink:to="lab_us-gaap_LeaseCostTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember_790" xlink:to="lab_us-gaap_LeaseholdImprovementsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract_791" xlink:to="lab_us-gaap_LeasesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesOperatingAbstract_792" xlink:to="lab_us-gaap_LeasesOperatingAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock_793" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_794" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_795" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_796" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_797" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_798" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_799" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_800" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_801" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_802" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_803" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_804" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_805" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_806" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_807" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_808" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_809" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock_810" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract_811" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract_812" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities_813" xlink:to="lab_us-gaap_Liabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities_814" xlink:to="lab_us-gaap_Liabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_815" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_816" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_817" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_818" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent_819" xlink:to="lab_us-gaap_LiabilitiesCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent_820" xlink:to="lab_us-gaap_LiabilitiesCurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_821" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_822" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_823" xlink:to="lab_us-gaap_LiabilitiesNoncurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_824" xlink:to="lab_us-gaap_LiabilitiesNoncurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_825" xlink:to="lab_us-gaap_LiabilitiesNoncurrentAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_826" xlink:to="lab_us-gaap_LiabilitiesNoncurrentAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_827" xlink:to="lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesCurrent_828" xlink:to="lab_us-gaap_MarketableSecuritiesCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesCurrent_829" xlink:to="lab_us-gaap_MarketableSecuritiesCurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesCurrent_830" xlink:to="lab_us-gaap_MarketableSecuritiesCurrent_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesCurrent_831" xlink:to="lab_us-gaap_MarketableSecuritiesCurrent_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_832" xlink:to="lab_us-gaap_MarketableSecuritiesLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesPolicy_833" xlink:to="lab_us-gaap_MarketableSecuritiesPolicy_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesTable_834" xlink:to="lab_us-gaap_MarketableSecuritiesTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesTextBlock_835" xlink:to="lab_us-gaap_MarketableSecuritiesTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_836" xlink:to="lab_us-gaap_MinorityInterestOwnershipPercentageByParent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MunicipalBondsMember_837" xlink:to="lab_us-gaap_MunicipalBondsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_838" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_839" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_840" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_841" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_842" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_843" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_844" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_845" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_846" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_847" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_848" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss_849" xlink:to="lab_us-gaap_NetIncomeLoss_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss_850" xlink:to="lab_us-gaap_NetIncomeLoss_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_851" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_852" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_853" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_854" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_855" xlink:to="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember_856" xlink:to="lab_us-gaap_NoncontrollingInterestMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncurrentAssets_857" xlink:to="lab_us-gaap_NoncurrentAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncurrentAssets_858" xlink:to="lab_us-gaap_NoncurrentAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesReceivableGross_859" xlink:to="lab_us-gaap_NotesReceivableGross_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments_860" xlink:to="lab_us-gaap_NumberOfOperatingSegments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments_861" xlink:to="lab_us-gaap_NumberOfOperatingSegments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OfficeEquipmentMember_862" xlink:to="lab_us-gaap_OfficeEquipmentMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses_863" xlink:to="lab_us-gaap_OperatingExpenses_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses_864" xlink:to="lab_us-gaap_OperatingExpenses_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract_865" xlink:to="lab_us-gaap_OperatingExpensesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract_866" xlink:to="lab_us-gaap_OperatingExpensesAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss_867" xlink:to="lab_us-gaap_OperatingIncomeLoss_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss_868" xlink:to="lab_us-gaap_OperatingIncomeLoss_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost_869" xlink:to="lab_us-gaap_OperatingLeaseCost_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability_870" xlink:to="lab_us-gaap_OperatingLeaseLiability_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability_871" xlink:to="lab_us-gaap_OperatingLeaseLiability_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability_872" xlink:to="lab_us-gaap_OperatingLeaseLiability_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_873" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_874" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments_875" xlink:to="lab_us-gaap_OperatingLeasePayments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset_876" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset_877" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_878" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_879" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_880" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_881" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards_882" xlink:to="lab_us-gaap_OperatingLossCarryforwards_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent_883" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent_884" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_885" xlink:to="lab_us-gaap_OtherAssetsNoncurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_886" xlink:to="lab_us-gaap_OtherAssetsNoncurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_887" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_888" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_889" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_890" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentLiabilitiesMember_891" xlink:to="lab_us-gaap_OtherCurrentLiabilitiesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock_892" xlink:to="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherInvestments_893" xlink:to="lab_us-gaap_OtherInvestments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherInvestments_894" xlink:to="lab_us-gaap_OtherInvestments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_895" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_896" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_897" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_898" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_899" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherReceivablesGrossCurrent_900" xlink:to="lab_us-gaap_OtherReceivablesGrossCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherReceivablesGrossCurrent_901" xlink:to="lab_us-gaap_OtherReceivablesGrossCurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherReceivablesNetCurrent_902" xlink:to="lab_us-gaap_OtherReceivablesNetCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherReceivablesNetCurrent_903" xlink:to="lab_us-gaap_OtherReceivablesNetCurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherReceivablesNetCurrent_904" xlink:to="lab_us-gaap_OtherReceivablesNetCurrent_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherReceivablesNetCurrentAbstract_905" xlink:to="lab_us-gaap_OtherReceivablesNetCurrentAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_906" xlink:to="lab_us-gaap_PayablesAndAccrualsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForAdvanceToAffiliate_907" xlink:to="lab_us-gaap_PaymentsForAdvanceToAffiliate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForAdvanceToAffiliate_908" xlink:to="lab_us-gaap_PaymentsForAdvanceToAffiliate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_909" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_910" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_911" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_912" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfStockIssuanceCosts_913" xlink:to="lab_us-gaap_PaymentsOfStockIssuanceCosts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross_914" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireMarketableSecurities_915" xlink:to="lab_us-gaap_PaymentsToAcquireMarketableSecurities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireMarketableSecurities_916" xlink:to="lab_us-gaap_PaymentsToAcquireMarketableSecurities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_917" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_918" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis_919" xlink:to="lab_us-gaap_PlanNameAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_920" xlink:to="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_921" xlink:to="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_922" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_923" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised_924" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised_925" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss_926" xlink:to="lab_us-gaap_ProfitLoss_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss_927" xlink:to="lab_us-gaap_ProfitLoss_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss_928" xlink:to="lab_us-gaap_ProfitLoss_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss_929" xlink:to="lab_us-gaap_ProfitLoss_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_930" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_931" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_932" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_933" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_934" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_935" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_936" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_937" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_938" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_939" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_940" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_941" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_942" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_943" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_944" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts_945" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts_946" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts_947" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_948" xlink:to="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_949" xlink:to="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_950" xlink:to="lab_us-gaap_RelatedPartyTransactionAmountsOfTransaction_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_951" xlink:to="lab_us-gaap_RelatedPartyTransactionLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_952" xlink:to="lab_us-gaap_RelatedPartyTransactionsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_953" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_954" xlink:to="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense_955" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense_956" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember_957" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_958" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember_959" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit_960" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit_961" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember_962" xlink:to="lab_us-gaap_RetainedEarningsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_963" xlink:to="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRecognitionPolicyTextBlock_964" xlink:to="lab_us-gaap_RevenueRecognitionPolicyTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues_965" xlink:to="lab_us-gaap_Revenues_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues_966" xlink:to="lab_us-gaap_Revenues_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_967" xlink:to="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_968" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_969" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_970" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_971" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_972" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_973" xlink:to="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_974" xlink:to="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_975" xlink:to="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_976" xlink:to="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_977" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_978" xlink:to="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_979" xlink:to="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_980" xlink:to="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_981" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_982" xlink:to="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_983" xlink:to="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_984" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_985" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_986" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_987" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_988" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_989" xlink:to="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_990" xlink:to="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract_991" xlink:to="lab_us-gaap_SegmentReportingAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock_992" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_993" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_994" xlink:to="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_995" xlink:to="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpense_996" xlink:to="lab_us-gaap_SellingAndMarketingExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpense_997" xlink:to="lab_us-gaap_SellingAndMarketingExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpenseMember_998" xlink:to="lab_us-gaap_SellingAndMarketingExpenseMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeveranceCosts1_999" xlink:to="lab_us-gaap_SeveranceCosts1_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation_1000" xlink:to="lab_us-gaap_ShareBasedCompensation_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation_1001" xlink:to="lab_us-gaap_ShareBasedCompensation_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation_1002" xlink:to="lab_us-gaap_ShareBasedCompensation_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_1003" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_1004" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_1005" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_1006" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_1007" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_1008" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_1009" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1010" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1011" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue_1012" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue_1013" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1014" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1015" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_1016" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_1017" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_1018" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_1019" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_1020" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_1021" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_1022" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_1023" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_1024" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_1025" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_1026" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_1027" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_1028" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1029" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_1030" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1031" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1032" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1033" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_1034" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_1035" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_1036" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_1037" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_1038" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_1039" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_1040" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_1041" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_1042" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_1043" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1044" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_1045" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_1046" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_1047" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_1048" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_1049" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_1050" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_1051" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1052" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1053" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1054" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1055" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1056" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1057" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1058" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_1059" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_1060" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_1061" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_1062" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1063" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_1064" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_1065" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1066" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_1067" xlink:to="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_1068" xlink:to="lab_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_1069" xlink:to="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_1070" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_1071" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_1072" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_1073" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_1074" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_1075" xlink:to="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_1076" xlink:to="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember_1077" xlink:to="lab_us-gaap_ShareBasedPaymentArrangementEmployeeMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssued_1078" xlink:to="lab_us-gaap_SharesIssued_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssued_1079" xlink:to="lab_us-gaap_SharesIssued_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssuedPricePerShare_1080" xlink:to="lab_us-gaap_SharesIssuedPricePerShare_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock_1081" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantSupplyCommitmentRemainingMinimumAmountCommitted_1082" xlink:to="lab_us-gaap_SignificantSupplyCommitmentRemainingMinimumAmountCommitted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandardProductWarrantyAccrual_1083" xlink:to="lab_us-gaap_StandardProductWarrantyAccrual_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandardProductWarrantyAccrual_1084" xlink:to="lab_us-gaap_StandardProductWarrantyAccrual_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandardProductWarrantyAccrual_1085" xlink:to="lab_us-gaap_StandardProductWarrantyAccrual_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandardProductWarrantyAccrualPayments_1086" xlink:to="lab_us-gaap_StandardProductWarrantyAccrualPayments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandardProductWarrantyAccrualPayments_1087" xlink:to="lab_us-gaap_StandardProductWarrantyAccrualPayments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued_1088" xlink:to="lab_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandardProductWarrantyPolicy_1089" xlink:to="lab_us-gaap_StandardProductWarrantyPolicy_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1090" xlink:to="lab_us-gaap_StatementEquityComponentsAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems_1091" xlink:to="lab_us-gaap_StatementLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1092" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_1093" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_1094" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable_1095" xlink:to="lab_us-gaap_StatementTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity_1096" xlink:to="lab_us-gaap_StockholdersEquity_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity_1097" xlink:to="lab_us-gaap_StockholdersEquity_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract_1098" xlink:to="lab_us-gaap_StockholdersEquityAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract_1099" xlink:to="lab_us-gaap_StockholdersEquityAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1100" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1101" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1102" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1103" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_1104" xlink:to="lab_us-gaap_StockholdersEquityNoteAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_1105" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteStockSplit_1106" xlink:to="lab_us-gaap_StockholdersEquityNoteStockSplit_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_1107" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_1108" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1109" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1110" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1111" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_1112" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_1113" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodShares_1114" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodShares_1115" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems_1116" xlink:to="lab_us-gaap_SubsequentEventLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember_1117" xlink:to="lab_us-gaap_SubsequentEventMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract_1118" xlink:to="lab_us-gaap_SubsequentEventsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock_1119" xlink:to="lab_us-gaap_SubsequentEventsTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable_1120" xlink:to="lab_us-gaap_SubsequentEventTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_1121" xlink:to="lab_us-gaap_SubsequentEventTypeAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_1122" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_1123" xlink:to="lab_us-gaap_SupplementalCashFlowElementsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions_1124" xlink:to="lab_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions_1125" xlink:to="lab_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ToolsDiesAndMoldsMember_1126" xlink:to="lab_us-gaap_ToolsDiesAndMoldsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1127" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonMember_1128" xlink:to="lab_us-gaap_TreasuryStockCommonMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonShares_1129" xlink:to="lab_us-gaap_TreasuryStockCommonShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue_1130" xlink:to="lab_us-gaap_TreasuryStockValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue_1131" xlink:to="lab_us-gaap_TreasuryStockValue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfArrangementAxis_1132" xlink:to="lab_us-gaap_TypeOfArrangementAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits_1133" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits_1134" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits_1135" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_1136" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_1137" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_1138" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_1139" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates_1140" xlink:to="lab_us-gaap_UseOfEstimates_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_1141" xlink:to="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VehiclesMember_1142" xlink:to="lab_us-gaap_VehiclesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingAxis_1143" xlink:to="lab_us-gaap_VestingAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1144" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1145" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1146" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1147" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1"/>
  </labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>16
<FILENAME>inmd-20231231_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <!-- INTEGIX by Ez-XBRL -->
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#DocumentAndEntityInformation" roleURI="http://inmodemd.com/role/DocumentAndEntityInformation"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#ConsolidatedBalanceSheets" roleURI="http://inmodemd.com/role/ConsolidatedBalanceSheets"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#ConsolidatedBalanceSheetsParenthetical" roleURI="http://inmodemd.com/role/ConsolidatedBalanceSheetsParenthetical"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#ConsolidatedStatementsOfIncome" roleURI="http://inmodemd.com/role/ConsolidatedStatementsOfIncome"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#ConsolidatedStatementsOfComprehensiveIncome" roleURI="http://inmodemd.com/role/ConsolidatedStatementsOfComprehensiveIncome"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#ConsolidatedStatementsOfChangesInShareholdersEquity" roleURI="http://inmodemd.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#ConsolidatedStatementsOfCashFlows" roleURI="http://inmodemd.com/role/ConsolidatedStatementsOfCashFlows"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#General" roleURI="http://inmodemd.com/role/General"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#SignificantAccountingPolicies" roleURI="http://inmodemd.com/role/SignificantAccountingPolicies"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#MarketableSecuritiesAndFairValueMeasurements" roleURI="http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurements"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#AccountsReceivable" roleURI="http://inmodemd.com/role/AccountsReceivable"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#OtherCurrentReceivables" roleURI="http://inmodemd.com/role/OtherCurrentReceivables"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#Inventories" roleURI="http://inmodemd.com/role/Inventories"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#PropertyAndEquipmentNet" roleURI="http://inmodemd.com/role/PropertyAndEquipmentNet"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#OtherInvestments" roleURI="http://inmodemd.com/role/OtherInvestments"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#Leases" roleURI="http://inmodemd.com/role/Leases"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#OtherCurrentLiabilities" roleURI="http://inmodemd.com/role/OtherCurrentLiabilities"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#CommitmentsAndContingentLiabilities" roleURI="http://inmodemd.com/role/CommitmentsAndContingentLiabilities"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#ShareholdersEquity" roleURI="http://inmodemd.com/role/ShareholdersEquity"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#TaxesOnIncome" roleURI="http://inmodemd.com/role/TaxesOnIncome"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#Entity-wideDisclosure" roleURI="http://inmodemd.com/role/Entity-wideDisclosure"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#RelatedParties" roleURI="http://inmodemd.com/role/RelatedParties"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#SignificantAccountingPoliciesPolicies" roleURI="http://inmodemd.com/role/SignificantAccountingPoliciesPolicies"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#SignificantAccountingPoliciesTables" roleURI="http://inmodemd.com/role/SignificantAccountingPoliciesTables"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#MarketableSecuritiesAndFairValueMeasurementsTables" roleURI="http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsTables"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#AccountsReceivableTables" roleURI="http://inmodemd.com/role/AccountsReceivableTables"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#OtherCurrentReceivablesTables" roleURI="http://inmodemd.com/role/OtherCurrentReceivablesTables"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#InventoriesTables" roleURI="http://inmodemd.com/role/InventoriesTables"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#PropertyAndEquipmentNetTables" roleURI="http://inmodemd.com/role/PropertyAndEquipmentNetTables"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#LeasesTables" roleURI="http://inmodemd.com/role/LeasesTables"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#OtherCurrentLiabilitiesTables" roleURI="http://inmodemd.com/role/OtherCurrentLiabilitiesTables"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#ShareholdersEquityTables" roleURI="http://inmodemd.com/role/ShareholdersEquityTables"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#TaxesOnIncomeTables" roleURI="http://inmodemd.com/role/TaxesOnIncomeTables"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#Entity-wideDisclosureTables" roleURI="http://inmodemd.com/role/Entity-wideDisclosureTables"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#SignificantAccountingPoliciesNarrativeDetails" roleURI="http://inmodemd.com/role/SignificantAccountingPoliciesNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#SignificantAccountingPoliciesScheduleOfPropertyAndEquipmentEstimatedUsefulLivesDetails" roleURI="http://inmodemd.com/role/SignificantAccountingPoliciesScheduleOfPropertyAndEquipmentEstimatedUsefulLivesDetails"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#SignificantAccountingPoliciesScheduleOfAccruedWarrantyDetails" roleURI="http://inmodemd.com/role/SignificantAccountingPoliciesScheduleOfAccruedWarrantyDetails"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#MarketableSecuritiesAndFairValueMeasurementsNarrativeDetails" roleURI="http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#MarketableSecuritiesAndFairValueMeasurementsScheduleOfMarketableSecuritiesDetails" roleURI="http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsScheduleOfMarketableSecuritiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#MarketableSecuritiesAndFairValueMeasurementsScheduleOfFinancialAssetsMeasuredAtFairValueDetails" roleURI="http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsScheduleOfFinancialAssetsMeasuredAtFairValueDetails"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#MarketableSecuritiesAndFairValueMeasurementsScheduleOfDebtSecuritiesOnMaturityDetails" roleURI="http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsScheduleOfDebtSecuritiesOnMaturityDetails"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#AccountsReceivableScheduleOfAccountsReceivableDetails" roleURI="http://inmodemd.com/role/AccountsReceivableScheduleOfAccountsReceivableDetails"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#OtherCurrentReceivablesScheduleOfOtherCurrentReceivablesDetails" roleURI="http://inmodemd.com/role/OtherCurrentReceivablesScheduleOfOtherCurrentReceivablesDetails"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#InventoriesScheduleOfInventoriesDetails" roleURI="http://inmodemd.com/role/InventoriesScheduleOfInventoriesDetails"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#PropertyAndEquipmentNetScheduleOfPropertyAndEquipmentDetails" roleURI="http://inmodemd.com/role/PropertyAndEquipmentNetScheduleOfPropertyAndEquipmentDetails"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#OtherInvestmentsDetails" roleURI="http://inmodemd.com/role/OtherInvestmentsDetails"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#LeasesNarrativeDetails" roleURI="http://inmodemd.com/role/LeasesNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#LeasesScheduleOfLeaseExpenseDetails" roleURI="http://inmodemd.com/role/LeasesScheduleOfLeaseExpenseDetails"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#LeasesScheduleOfSupplementalCashFlowInformationRelatedToLeasesDetails" roleURI="http://inmodemd.com/role/LeasesScheduleOfSupplementalCashFlowInformationRelatedToLeasesDetails"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails" roleURI="http://inmodemd.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#LeasesScheduleOfMaturitiesOfLeaseLiabilitiesDetails" roleURI="http://inmodemd.com/role/LeasesScheduleOfMaturitiesOfLeaseLiabilitiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#OtherCurrentLiabilitiesScheduleOfOtherLiabilitiesDetails" roleURI="http://inmodemd.com/role/OtherCurrentLiabilitiesScheduleOfOtherLiabilitiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#CommitmentsAndContingentLiabilitiesDetails" roleURI="http://inmodemd.com/role/CommitmentsAndContingentLiabilitiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#ShareholdersEquityNarrativeDetails" roleURI="http://inmodemd.com/role/ShareholdersEquityNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#ShareholdersEquityScheduleOfOptionsGrantedDetails" roleURI="http://inmodemd.com/role/ShareholdersEquityScheduleOfOptionsGrantedDetails"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#ShareholdersEquityScheduleOfOutstandingAndExercisableOptionsDetails" roleURI="http://inmodemd.com/role/ShareholdersEquityScheduleOfOutstandingAndExercisableOptionsDetails"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#ShareholdersEquityScheduleOfOptionsGrantedRestictedShareUnitDetails" roleURI="http://inmodemd.com/role/ShareholdersEquityScheduleOfOptionsGrantedRestictedShareUnitDetails"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#ShareholdersEquityScheduleOfShareBasedCompensationExpenseDetails" roleURI="http://inmodemd.com/role/ShareholdersEquityScheduleOfShareBasedCompensationExpenseDetails"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#TaxesOnIncomeNarrativeDetails" roleURI="http://inmodemd.com/role/TaxesOnIncomeNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#TaxesOnIncomeScheduleOfDeferredTaxAssetsLiabilitiesDetails" roleURI="http://inmodemd.com/role/TaxesOnIncomeScheduleOfDeferredTaxAssetsLiabilitiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#TaxesOnIncomeScheduleOfReconciliationOfTheoreticalProvisionForIncomeTaxDetails" roleURI="http://inmodemd.com/role/TaxesOnIncomeScheduleOfReconciliationOfTheoreticalProvisionForIncomeTaxDetails"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#TaxesOnIncomeScheduleOfIncomeBeforeIncomeTaxesDetails" roleURI="http://inmodemd.com/role/TaxesOnIncomeScheduleOfIncomeBeforeIncomeTaxesDetails"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#TaxesOnIncomeScheduleOfTaxExpensesTaxBenefitDetails" roleURI="http://inmodemd.com/role/TaxesOnIncomeScheduleOfTaxExpensesTaxBenefitDetails"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#TaxesOnIncomeScheduleOfUnrecognizedTaxBenefitsDetails" roleURI="http://inmodemd.com/role/TaxesOnIncomeScheduleOfUnrecognizedTaxBenefitsDetails"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#Entity-wideDisclosureNarrativeDetails" roleURI="http://inmodemd.com/role/Entity-wideDisclosureNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#Entity-wideDisclosureScheduleOfNetSalesByGeographicalAreaDetails" roleURI="http://inmodemd.com/role/Entity-wideDisclosureScheduleOfNetSalesByGeographicalAreaDetails"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#Entity-wideDisclosureScheduleOfNetSalesByTechonologyDetails" roleURI="http://inmodemd.com/role/Entity-wideDisclosureScheduleOfNetSalesByTechonologyDetails"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#Entity-wideDisclosureScheduleOfChangesInContractLiabilitiesDetails" roleURI="http://inmodemd.com/role/Entity-wideDisclosureScheduleOfChangesInContractLiabilitiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#Entity-wideDisclosureScheduleOfLong-livedAssetsDetails" roleURI="http://inmodemd.com/role/Entity-wideDisclosureScheduleOfLong-livedAssetsDetails"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#RelatedPartiesDetails" roleURI="http://inmodemd.com/role/RelatedPartiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#CONSOLIDATEDBALANCESHEETSParentheticals2" roleURI="http://inmodemd.com/role/CONSOLIDATEDBALANCESHEETSParentheticals2"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWSParentheticals" roleURI="http://inmodemd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParentheticals"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#SIGNIFICANTACCOUNTINGPOLICIESScheduleOfAllowanceForCreditLossesDetails" roleURI="http://inmodemd.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleOfAllowanceForCreditLossesDetails"/>
  <roleRef xlink:type="simple" xlink:href="inmd-20231231.xsd#ENTITYWIDEDISCLOSUREDisclosureOfRevenuesBasedOnProductsCategory" roleURI="http://inmodemd.com/role/ENTITYWIDEDISCLOSUREDisclosureOfRevenuesBasedOnProductsCategory"/>
  <presentationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_dei_CoverAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="loc_dei_EntityAddressesAddressTypeAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AddressTypeDomain" xlink:label="loc_dei_AddressTypeDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_BusinessContactMember" xlink:label="loc_dei_BusinessContactMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_dei_DocumentRegistrationStatement_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_dei_DocumentAnnualReport_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_dei_DocumentTransitionReport_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_dei_DocumentShellCompanyReport_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_dei_EntityFileNumber_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_ContactPersonnelName" xlink:label="loc_dei_ContactPersonnelName_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_dei_EntityAddressAddressLine2_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_dei_EntityAddressAddressLine3_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_dei_EntityAddressCountry_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_ContactPersonnelFaxNumber" xlink:label="loc_dei_ContactPersonnelFaxNumber_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_ContactPersonnelEmailAddress" xlink:label="loc_dei_ContactPersonnelEmailAddress_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_dei_Security12bTitle_29"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_dei_SecurityExchangeName_31"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_dei_Security12gTitle_32"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_dei_SecurityReportingObligation_33"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_34"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_35"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_dei_EntityVoluntaryFilers_36"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_dei_EntityCurrentReportingStatus_37"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_dei_EntityInteractiveDataCurrent_38"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_39"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_40"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_dei_EntityExTransitionPeriod_41"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_dei_DocumentAccountingStandard_42"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_dei_OtherReportingStandardItemNumber_43"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_dei_EntityShellCompany_44"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="loc_dei_IcfrAuditorAttestationFlag_45"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorName" xlink:label="loc_dei_AuditorName_46"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorLocation" xlink:label="loc_dei_AuditorLocation_47"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorFirmId" xlink:label="loc_dei_AuditorFirmId_48"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="loc_dei_DocumentFinStmtErrorCorrectionFlag_49"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_us-gaap_StatementTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_dei_EntityAddressesAddressTypeAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_1" xlink:to="loc_dei_AddressTypeDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_AddressTypeDomain_1" xlink:to="loc_dei_BusinessContactMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementLineItems_4" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4" xlink:to="loc_dei_EntityRegistrantName_4" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4" xlink:to="loc_dei_EntityCentralIndexKey_5" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4" xlink:to="loc_dei_DocumentType_6" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4" xlink:to="loc_dei_DocumentPeriodEndDate_7" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4" xlink:to="loc_dei_CurrentFiscalYearEndDate_8" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4" xlink:to="loc_dei_DocumentFiscalYearFocus_9" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4" xlink:to="loc_dei_DocumentFiscalPeriodFocus_10" order="60" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4" xlink:to="loc_dei_AmendmentFlag_11" order="70" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4" xlink:to="loc_dei_DocumentRegistrationStatement_12" order="80" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4" xlink:to="loc_dei_DocumentAnnualReport_13" order="90" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4" xlink:to="loc_dei_DocumentTransitionReport_14" order="100" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4" xlink:to="loc_dei_DocumentShellCompanyReport_15" order="110" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4" xlink:to="loc_dei_EntityFileNumber_16" order="120" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4" xlink:to="loc_dei_ContactPersonnelName_17" order="130" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4" xlink:to="loc_dei_EntityIncorporationStateCountryCode_18" order="140" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4" xlink:to="loc_dei_EntityAddressAddressLine1_19" order="150" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4" xlink:to="loc_dei_EntityAddressAddressLine2_20" order="160" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4" xlink:to="loc_dei_EntityAddressAddressLine3_21" order="170" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4" xlink:to="loc_dei_EntityAddressCityOrTown_22" order="180" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4" xlink:to="loc_dei_EntityAddressPostalZipCode_23" order="190" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4" xlink:to="loc_dei_EntityAddressCountry_24" order="200" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4" xlink:to="loc_dei_CityAreaCode_25" order="210" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4" xlink:to="loc_dei_LocalPhoneNumber_26" order="220" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4" xlink:to="loc_dei_ContactPersonnelFaxNumber_27" order="230" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4" xlink:to="loc_dei_ContactPersonnelEmailAddress_28" order="240" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4" xlink:to="loc_dei_Security12bTitle_29" order="250" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4" xlink:to="loc_dei_TradingSymbol_30" order="260" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4" xlink:to="loc_dei_SecurityExchangeName_31" order="270" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4" xlink:to="loc_dei_Security12gTitle_32" order="280" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4" xlink:to="loc_dei_SecurityReportingObligation_33" order="290" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_34" order="300" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_35" order="310" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4" xlink:to="loc_dei_EntityVoluntaryFilers_36" order="320" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4" xlink:to="loc_dei_EntityCurrentReportingStatus_37" order="330" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4" xlink:to="loc_dei_EntityInteractiveDataCurrent_38" order="340" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4" xlink:to="loc_dei_EntityFilerCategory_39" order="350" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4" xlink:to="loc_dei_EntityEmergingGrowthCompany_40" order="360" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4" xlink:to="loc_dei_EntityExTransitionPeriod_41" order="370" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4" xlink:to="loc_dei_DocumentAccountingStandard_42" order="380" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4" xlink:to="loc_dei_OtherReportingStandardItemNumber_43" order="390" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4" xlink:to="loc_dei_EntityShellCompany_44" order="400" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4" xlink:to="loc_dei_IcfrAuditorAttestationFlag_45" order="410" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4" xlink:to="loc_dei_AuditorName_46" order="420" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4" xlink:to="loc_dei_AuditorLocation_47" order="430" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4" xlink:to="loc_dei_AuditorFirmId_48" order="440" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4" xlink:to="loc_dei_DocumentFinStmtErrorCorrectionFlag_49" order="450" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/ConsolidatedBalanceSheets">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaap_AssetsCurrentAbstract_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepositsAssetsCurrent" xlink:label="loc_us-gaap_DepositsAssetsCurrent_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:label="loc_us-gaap_AssetsNoncurrentAbstract_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetNoncurrent" xlink:label="loc_us-gaap_AccountsReceivableNetNoncurrent_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxAssetsNet" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherInvestments" xlink:label="loc_us-gaap_OtherInvestments_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaap_AssetsNoncurrent_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaap_CommitmentsAndContingencies_29"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaap_StockholdersEquityAbstract_30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_31"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_32"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_33"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaap_TreasuryStockValue_34"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_35"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_37"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_AssetsAbstract_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1" xlink:to="loc_us-gaap_AssetsCurrentAbstract_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_1" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_1" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_1" xlink:to="loc_us-gaap_DepositsAssetsCurrent_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_1" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_1" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_1" xlink:to="loc_us-gaap_InventoryNet_6" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_1" xlink:to="loc_us-gaap_AssetsCurrent_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1" xlink:to="loc_us-gaap_AssetsNoncurrentAbstract_9" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_9" xlink:to="loc_us-gaap_AccountsReceivableNetNoncurrent_9" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_9" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_10" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_9" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_11" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_9" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_12" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_9" xlink:to="loc_us-gaap_OtherInvestments_13" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_9" xlink:to="loc_us-gaap_AssetsNoncurrent_14" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_9" xlink:to="loc_us-gaap_Assets_15" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_18" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_18" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_18" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_18" xlink:to="loc_us-gaap_AccountsPayableCurrent_18" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_18" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_19" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_18" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_20" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_18" xlink:to="loc_us-gaap_LiabilitiesCurrent_21" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_18" xlink:to="loc_us-gaap_LiabilitiesNoncurrentAbstract_23" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_23" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_23" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_23" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_24" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_23" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_25" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_23" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_26" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_23" xlink:to="loc_us-gaap_Liabilities_27" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_18" xlink:to="loc_us-gaap_CommitmentsAndContingencies_29" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_18" xlink:to="loc_us-gaap_StockholdersEquityAbstract_30" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_30" xlink:to="loc_us-gaap_CommonStockValue_30" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_30" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_31" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_30" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_32" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_30" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_33" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_30" xlink:to="loc_us-gaap_TreasuryStockValue_34" order="40" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_30" xlink:to="loc_us-gaap_StockholdersEquity_35" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_18" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_37" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/ConsolidatedBalanceSheetsParenthetical">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableNoncurrent" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableNoncurrent_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares" xlink:label="loc_us-gaap_TreasuryStockCommonShares_7"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableNoncurrent_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_CommonStockSharesIssued_5" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_6" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_TreasuryStockCommonShares_7" order="60" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/ConsolidatedStatementsOfIncome">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaap_IncomeStatementAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaap_CostOfRevenue_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaap_GrossProfit_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaap_OperatingExpensesAbstract_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaap_SellingAndMarketingExpense_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_6"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_OtherOperatingExpenseIncome" xlink:label="loc_inmd_OtherOperatingExpenseIncome_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeNet" xlink:label="loc_us-gaap_InvestmentIncomeNet_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted_18"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_WeightedAverageNumberOfSharesOutStandingUsedInComputationOfNetIncomePerShareAbstract" xlink:label="loc_inmd_WeightedAverageNumberOfSharesOutStandingUsedInComputationOfNetIncomePerShareAbstract_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_21"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_Revenues_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_CostOfRevenue_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_GrossProfit_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_OperatingExpensesAbstract_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4" xlink:to="loc_us-gaap_SellingAndMarketingExpense_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4" xlink:to="loc_inmd_OtherOperatingExpenseIncome_7" order="30" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4" xlink:to="loc_us-gaap_OperatingExpenses_8" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_OperatingIncomeLoss_10" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_InvestmentIncomeNet_11" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_12" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_13" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_ProfitLoss_14" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_15" order="90" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_NetIncomeLoss_16" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_EarningsPerShareAbstract_17" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_17" xlink:to="loc_us-gaap_EarningsPerShareBasic_17" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_17" xlink:to="loc_us-gaap_EarningsPerShareDiluted_18" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_inmd_WeightedAverageNumberOfSharesOutStandingUsedInComputationOfNetIncomePerShareAbstract_20" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inmd_WeightedAverageNumberOfSharesOutStandingUsedInComputationOfNetIncomePerShareAbstract_20" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_20" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inmd_WeightedAverageNumberOfSharesOutStandingUsedInComputationOfNetIncomePerShareAbstract_20" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_21" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/ConsolidatedStatementsOfComprehensiveIncome">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_5"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_0" xlink:to="loc_us-gaap_ProfitLoss_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_0" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_2" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_3" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_2" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_4" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_2" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_5" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonMember" xlink:label="loc_us-gaap_TreasuryStockCommonMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaap_NoncontrollingInterestMember_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_13"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_AcquisitionOfNonControllingInterestInExchangeOfOrdinaryShares" xlink:label="loc_inmd_AcquisitionOfNonControllingInterestInExchangeOfOrdinaryShares_14"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ShareValueOfAcquisitionOfNonControllingInterestInExchangeOfOrdinaryShares" xlink:label="loc_inmd_ShareValueOfAcquisitionOfNonControllingInterestInExchangeOfOrdinaryShares_15"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_StockRepurchasedOrdinarySharesDuringPeriodValue" xlink:label="loc_inmd_StockRepurchasedOrdinarySharesDuringPeriodValue_16"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_StockRepurchasedOrdinarySharesDuringPeriodShares" xlink:label="loc_inmd_StockRepurchasedOrdinarySharesDuringPeriodShares_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_21"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_0" xlink:to="loc_us-gaap_StatementTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1" xlink:to="loc_us-gaap_CommonStockMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1" xlink:to="loc_us-gaap_RetainedEarningsMember_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1" xlink:to="loc_us-gaap_TreasuryStockCommonMember_5" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1" xlink:to="loc_us-gaap_NoncontrollingInterestMember_6" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1" xlink:to="loc_us-gaap_EquityComponentDomain_7" order="60" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementLineItems_9" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_10" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9" xlink:to="loc_us-gaap_ProfitLoss_11" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_12" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_13" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9" xlink:to="loc_inmd_AcquisitionOfNonControllingInterestInExchangeOfOrdinaryShares_14" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9" xlink:to="loc_inmd_ShareValueOfAcquisitionOfNonControllingInterestInExchangeOfOrdinaryShares_15" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9" xlink:to="loc_inmd_StockRepurchasedOrdinarySharesDuringPeriodValue_16" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9" xlink:to="loc_inmd_StockRepurchasedOrdinarySharesDuringPeriodShares_17" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_18" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_19" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_20" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_21" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/ConsolidatedStatementsOfCashFlows">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnInvestments" xlink:label="loc_us-gaap_GainLossOnInvestments_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeExpenseNet" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherReceivables" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherReceivables_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_18"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_InvestmentInShortTermDeposit" xlink:label="loc_inmd_InvestmentInShortTermDeposit_18"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ProceedsFromInvestmentInShortTermDeposit" xlink:label="loc_inmd_ProceedsFromInvestmentInShortTermDeposit_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireMarketableSecurities" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_23"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ProceedsFromMaturityOfMarketableSecurities" xlink:label="loc_inmd_ProceedsFromMaturityOfMarketableSecurities_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_29"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_31"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_32"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_33"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_34"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowElementsAbstract" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_35"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_35"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_InterestReceived" xlink:label="loc_inmd_InterestReceived_36"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_37"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_OperatingLeaseRightOfUseAssests" xlink:label="loc_inmd_OperatingLeaseRightOfUseAssests_37"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ExerciseOfOptions" xlink:label="loc_inmd_ExerciseOfOptions_38"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_NonCashAcquisitionOfNoncontrollingInterestInExchangeOfOrdinaryShares" xlink:label="loc_inmd_NonCashAcquisitionOfNoncontrollingInterestInExchangeOfOrdinaryShares_39"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1" xlink:to="loc_us-gaap_ProfitLoss_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2" xlink:to="loc_us-gaap_ShareBasedCompensation_3" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_4" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2" xlink:to="loc_us-gaap_GainLossOnInvestments_5" order="30" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_6" order="40" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_7" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_9" order="0" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherReceivables_10" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_11" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_12" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_13" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_14" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_15" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_18" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_18" xlink:to="loc_inmd_InvestmentInShortTermDeposit_18" order="0" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_18" xlink:to="loc_inmd_ProceedsFromInvestmentInShortTermDeposit_19" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_18" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_20" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_18" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_21" order="30" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_18" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_22" order="40" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_18" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_23" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_18" xlink:to="loc_inmd_ProceedsFromMaturityOfMarketableSecurities_24" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_18" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_25" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_27" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_27" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_27" order="0" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_27" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_28" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_27" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_29" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_31" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_32" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_33" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_34" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_SupplementalCashFlowElementsAbstract_35" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_35" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_35" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_35" xlink:to="loc_inmd_InterestReceived_36" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_35" xlink:to="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_37" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_37" xlink:to="loc_inmd_OperatingLeaseRightOfUseAssests_37" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_37" xlink:to="loc_inmd_ExerciseOfOptions_38" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_37" xlink:to="loc_inmd_NonCashAcquisitionOfNoncontrollingInterestInExchangeOfOrdinaryShares_39" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/General">
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_GeneralAbstract" xlink:label="loc_inmd_GeneralAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:label="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inmd_GeneralAbstract_0" xlink:to="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/SignificantAccountingPolicies">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurements">
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_MarketableSecuritiesAndFairValueMeasurementAbstract" xlink:label="loc_inmd_MarketableSecuritiesAndFairValueMeasurementAbstract_0"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_MarketableSecuritiesAndFairValueMeasurements" xlink:label="loc_inmd_MarketableSecuritiesAndFairValueMeasurements_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inmd_MarketableSecuritiesAndFairValueMeasurementAbstract_0" xlink:to="loc_inmd_MarketableSecuritiesAndFairValueMeasurements_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/AccountsReceivable">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableGrossAllowanceAndNetAbstract" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableGrossAllowanceAndNetAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:label="loc_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableGrossAllowanceAndNetAbstract_0" xlink:to="loc_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/OtherCurrentReceivables">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivablesNetCurrentAbstract" xlink:label="loc_us-gaap_OtherReceivablesNetCurrentAbstract_0"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_PrepaidExpensesAndOtherCurrentReceivablesTextBlock" xlink:label="loc_inmd_PrepaidExpensesAndOtherCurrentReceivablesTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherReceivablesNetCurrentAbstract_0" xlink:to="loc_inmd_PrepaidExpensesAndOtherCurrentReceivablesTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/Inventories">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_0" xlink:to="loc_us-gaap_InventoryDisclosureTextBlock_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/PropertyAndEquipmentNet">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/OtherInvestments">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsAbstract" xlink:label="loc_us-gaap_InvestmentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTextBlock" xlink:label="loc_us-gaap_InvestmentTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_0" xlink:to="loc_us-gaap_InvestmentTextBlock_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/Leases">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/OtherCurrentLiabilities">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:label="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_0" xlink:to="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/CommitmentsAndContingentLiabilities">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/ShareholdersEquity">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_0" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/TaxesOnIncome">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/Entity-wideDisclosure">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_0" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/RelatedParties">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_0" xlink:to="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/SignificantAccountingPoliciesPolicies">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaap_UseOfEstimates_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_5"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ShortTermBankDepositsPolicyTextBlock" xlink:label="loc_inmd_ShortTermBankDepositsPolicyTextBlock_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesPolicy" xlink:label="loc_us-gaap_MarketableSecuritiesPolicy_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentPolicyTextBlock" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdvertisingCostsPolicyTextBlock" xlink:label="loc_us-gaap_AdvertisingCostsPolicyTextBlock_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:label="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StandardProductWarrantyPolicy" xlink:label="loc_us-gaap_StandardProductWarrantyPolicy_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfSalesPolicyTextBlock" xlink:label="loc_us-gaap_CostOfSalesPolicyTextBlock_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_24"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_EmployeeSeveranceBenefitsPolicyTextBlock" xlink:label="loc_inmd_EmployeeSeveranceBenefitsPolicyTextBlock_25"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_TreasurySharesPolicyTextBlock" xlink:label="loc_inmd_TreasurySharesPolicyTextBlock_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_27"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_WarRiskSituationInIsraelPolicyTextBlock" xlink:label="loc_inmd_WarRiskSituationInIsraelPolicyTextBlock_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_29"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_UseOfEstimates_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_inmd_ShortTermBankDepositsPolicyTextBlock_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_MarketableSecuritiesPolicy_7" order="60" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_InvestmentPolicyTextBlock_8" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_9" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_10" order="90" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_11" order="100" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_12" order="110" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_13" order="120" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_14" order="130" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_AdvertisingCostsPolicyTextBlock_15" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_16" order="150" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_RevenueRecognitionPolicyTextBlock_17" order="160" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_18" order="170" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_StandardProductWarrantyPolicy_19" order="180" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_CostOfSalesPolicyTextBlock_20" order="190" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_21" order="200" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_22" order="210" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_23" order="220" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_24" order="230" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_inmd_EmployeeSeveranceBenefitsPolicyTextBlock_25" order="240" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_inmd_TreasurySharesPolicyTextBlock_26" order="250" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_27" order="260" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_inmd_WarRiskSituationInIsraelPolicyTextBlock_28" order="270" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_29" order="280" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/SignificantAccountingPoliciesTables">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock" xlink:label="loc_inmd_ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:label="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_3"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_inmd_ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_3" order="20" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsTables">
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_MarketableSecuritiesAndFairValueMeasurementAbstract" xlink:label="loc_inmd_MarketableSecuritiesAndFairValueMeasurementAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesTextBlock" xlink:label="loc_us-gaap_MarketableSecuritiesTextBlock_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_3"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inmd_MarketableSecuritiesAndFairValueMeasurementAbstract_0" xlink:to="loc_us-gaap_MarketableSecuritiesTextBlock_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inmd_MarketableSecuritiesAndFairValueMeasurementAbstract_0" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inmd_MarketableSecuritiesAndFairValueMeasurementAbstract_0" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_3" order="20" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/AccountsReceivableTables">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableGrossAllowanceAndNetAbstract" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableGrossAllowanceAndNetAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableGrossAllowanceAndNetAbstract_0" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/OtherCurrentReceivablesTables">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivablesNetCurrentAbstract" xlink:label="loc_us-gaap_OtherReceivablesNetCurrentAbstract_0"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ScheduleOfPrepaidExpensesAndOtherCurrentRecivablesTableTextBlock" xlink:label="loc_inmd_ScheduleOfPrepaidExpensesAndOtherCurrentRecivablesTableTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherReceivablesNetCurrentAbstract_0" xlink:to="loc_inmd_ScheduleOfPrepaidExpensesAndOtherCurrentRecivablesTableTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/InventoriesTables">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_0" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/PropertyAndEquipmentNetTables">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/LeasesTables">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_1"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ScheduleOfSupplementalCashFlowInformationRelatedToLeases" xlink:label="loc_inmd_ScheduleOfSupplementalCashFlowInformationRelatedToLeases_2"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ScheduleOfSupplementalBalanceSheetInformationRelatedToLeases" xlink:label="loc_inmd_ScheduleOfSupplementalBalanceSheetInformationRelatedToLeases_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_4"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0" xlink:to="loc_inmd_ScheduleOfSupplementalCashFlowInformationRelatedToLeases_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0" xlink:to="loc_inmd_ScheduleOfSupplementalBalanceSheetInformationRelatedToLeases_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_4" order="30" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/OtherCurrentLiabilitiesTables">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_0" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/ShareholdersEquityTables">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GranteeStatusAxis" xlink:label="loc_us-gaap_GranteeStatusAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GranteeStatusDomain" xlink:label="loc_us-gaap_GranteeStatusDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:label="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:label="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_11"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_GranteeStatusAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GranteeStatusAxis_1" xlink:to="loc_us-gaap_GranteeStatusDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GranteeStatusDomain_1" xlink:to="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_AwardTypeAxis_4" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_4" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7" xlink:to="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_7" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_8" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_9" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_10" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_11" order="40" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/TaxesOnIncomeTables">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_5"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_5" order="40" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/Entity-wideDisclosureTables">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:label="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfLongLivedAssetsHeldForSaleTextBlock" xlink:label="loc_us-gaap_DisclosureOfLongLivedAssetsHeldForSaleTextBlock_5"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_0" xlink:to="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_0" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_0" xlink:to="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_0" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_0" xlink:to="loc_us-gaap_DisclosureOfLongLivedAssetsHeldForSaleTextBlock_5" order="40" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/SignificantAccountingPoliciesNarrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_AccountingPoliciesTable" xlink:label="loc_inmd_AccountingPoliciesTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis" xlink:label="loc_srt_StatementScenarioAxis_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srt_ScenarioUnspecifiedDomain_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioForecastMember" xlink:label="loc_srt_ScenarioForecastMember_5"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_AccountingPoliciesLineItems" xlink:label="loc_inmd_AccountingPoliciesLineItems_8"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ShortTermDepositsAnnualInterestRate" xlink:label="loc_inmd_ShortTermDepositsAnnualInterestRate_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdvertisingExpense" xlink:label="loc_us-gaap_AdvertisingExpense_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeveranceCosts1" xlink:label="loc_us-gaap_SeveranceCosts1_11"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_EmployeeRelatedSeveranceLiabilities" xlink:label="loc_inmd_EmployeeRelatedSeveranceLiabilities_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="loc_us-gaap_NumberOfOperatingSegments_14"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_inmd_AccountingPoliciesTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inmd_AccountingPoliciesTable_1" xlink:to="loc_srt_RangeAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_1" xlink:to="loc_srt_RangeMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1" xlink:to="loc_srt_MinimumMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1" xlink:to="loc_srt_MaximumMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inmd_AccountingPoliciesTable_1" xlink:to="loc_srt_StatementScenarioAxis_5" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_5" xlink:to="loc_srt_ScenarioUnspecifiedDomain_5" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_5" xlink:to="loc_srt_ScenarioForecastMember_5" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inmd_AccountingPoliciesTable_1" xlink:to="loc_inmd_AccountingPoliciesLineItems_8" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inmd_AccountingPoliciesLineItems_8" xlink:to="loc_inmd_ShortTermDepositsAnnualInterestRate_8" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inmd_AccountingPoliciesLineItems_8" xlink:to="loc_us-gaap_AdvertisingExpense_9" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inmd_AccountingPoliciesLineItems_8" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_10" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inmd_AccountingPoliciesLineItems_8" xlink:to="loc_us-gaap_SeveranceCosts1_11" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inmd_AccountingPoliciesLineItems_8" xlink:to="loc_inmd_EmployeeRelatedSeveranceLiabilities_12" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inmd_AccountingPoliciesLineItems_8" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_13" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inmd_AccountingPoliciesLineItems_8" xlink:to="loc_us-gaap_NumberOfOperatingSegments_14" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/SignificantAccountingPoliciesScheduleOfPropertyAndEquipmentEstimatedUsefulLivesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaap_ComputerEquipmentMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ToolsDiesAndMoldsMember" xlink:label="loc_us-gaap_ToolsDiesAndMoldsMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquipmentMember" xlink:label="loc_us-gaap_EquipmentMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_10"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1" xlink:to="loc_us-gaap_ComputerEquipmentMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1" xlink:to="loc_us-gaap_ToolsDiesAndMoldsMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1" xlink:to="loc_us-gaap_EquipmentMember_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_srt_RangeAxis_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_6" xlink:to="loc_srt_RangeMember_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_6" xlink:to="loc_srt_MinimumMember_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_6" xlink:to="loc_srt_MaximumMember_7" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_10" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_10" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_10" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/SignificantAccountingPoliciesScheduleOfAccruedWarrantyDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StandardProductWarrantyAccrual" xlink:label="loc_us-gaap_StandardProductWarrantyAccrual_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StandardProductWarrantyAccrualPayments" xlink:label="loc_us-gaap_StandardProductWarrantyAccrualPayments_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StandardProductWarrantyAccrualWarrantiesIssued" xlink:label="loc_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StandardProductWarrantyAccrual" xlink:label="loc_us-gaap_StandardProductWarrantyAccrual_4"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_StandardProductWarrantyAccrual_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_StandardProductWarrantyAccrualPayments_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_StandardProductWarrantyAccrual_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsNarrativeDetails">
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_MarketableSecuritiesAndFairValueMeasurementAbstract" xlink:label="loc_inmd_MarketableSecuritiesAndFairValueMeasurementAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesTable" xlink:label="loc_us-gaap_MarketableSecuritiesTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaap_FinancialInstrumentAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_NonUsGovernmentAgenciesDebtSecuritiesMember" xlink:label="loc_inmd_NonUsGovernmentAgenciesDebtSecuritiesMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BondsMember" xlink:label="loc_us-gaap_BondsMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesLineItems" xlink:label="loc_us-gaap_MarketableSecuritiesLineItems_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_5"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inmd_MarketableSecuritiesAndFairValueMeasurementAbstract_0" xlink:to="loc_us-gaap_MarketableSecuritiesTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesTable_1" xlink:to="loc_us-gaap_FinancialInstrumentAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_1" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1" xlink:to="loc_inmd_NonUsGovernmentAgenciesDebtSecuritiesMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1" xlink:to="loc_us-gaap_BondsMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesTable_1" xlink:to="loc_us-gaap_MarketableSecuritiesLineItems_5" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_5" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsScheduleOfMarketableSecuritiesDetails">
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_MarketableSecuritiesAndFairValueMeasurementAbstract" xlink:label="loc_inmd_MarketableSecuritiesAndFairValueMeasurementAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesTable" xlink:label="loc_us-gaap_MarketableSecuritiesTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaap_FinancialInstrumentAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MunicipalBondsMember" xlink:label="loc_us-gaap_MunicipalBondsMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommercialPaperMember" xlink:label="loc_us-gaap_CommercialPaperMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CertificatesOfDepositMember" xlink:label="loc_us-gaap_CertificatesOfDepositMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesLineItems" xlink:label="loc_us-gaap_MarketableSecuritiesLineItems_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_8"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inmd_MarketableSecuritiesAndFairValueMeasurementAbstract_0" xlink:to="loc_us-gaap_MarketableSecuritiesTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesTable_1" xlink:to="loc_us-gaap_FinancialInstrumentAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_1" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1" xlink:to="loc_us-gaap_MunicipalBondsMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1" xlink:to="loc_us-gaap_CommercialPaperMember_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1" xlink:to="loc_us-gaap_CertificatesOfDepositMember_5" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesTable_1" xlink:to="loc_us-gaap_MarketableSecuritiesLineItems_8" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_8" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsScheduleOfFinancialAssetsMeasuredAtFairValueDetails">
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_MarketableSecuritiesAndFairValueMeasurementAbstract" xlink:label="loc_inmd_MarketableSecuritiesAndFairValueMeasurementAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesTable" xlink:label="loc_us-gaap_MarketableSecuritiesTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaap_FinancialInstrumentAxis_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MunicipalBondsMember" xlink:label="loc_us-gaap_MunicipalBondsMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommercialPaperMember" xlink:label="loc_us-gaap_CommercialPaperMember_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CertificatesOfDepositMember" xlink:label="loc_us-gaap_CertificatesOfDepositMember_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesLineItems" xlink:label="loc_us-gaap_MarketableSecuritiesLineItems_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_14"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inmd_MarketableSecuritiesAndFairValueMeasurementAbstract_0" xlink:to="loc_us-gaap_MarketableSecuritiesTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesTable_1" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesTable_1" xlink:to="loc_us-gaap_FinancialInstrumentAxis_4" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_4" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_4" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4" xlink:to="loc_us-gaap_MunicipalBondsMember_5" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_6" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4" xlink:to="loc_us-gaap_CommercialPaperMember_7" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4" xlink:to="loc_us-gaap_CertificatesOfDepositMember_8" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesTable_1" xlink:to="loc_us-gaap_MarketableSecuritiesLineItems_11" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_11" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_11" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_11" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_12" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_11" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_13" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_11" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_14" order="30" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsScheduleOfDebtSecuritiesOnMaturityDetails">
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_MarketableSecuritiesAndFairValueMeasurementAbstract" xlink:label="loc_inmd_MarketableSecuritiesAndFairValueMeasurementAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_1"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInOneToTwoYearsFairValue" xlink:label="loc_inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInOneToTwoYearsFairValue_2"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInTwoToThreeYearsFairValue" xlink:label="loc_inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInTwoToThreeYearsFairValue_3"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInThreeToFourYearsFairValue" xlink:label="loc_inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInThreeToFourYearsFairValue_4"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInFourToFiveYearsFairValue" xlink:label="loc_inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInFourToFiveYearsFairValue_5"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_AvailableForSaleSecuritiesDebtMaturitiesMoreThanFiveYearsFairValue" xlink:label="loc_inmd_AvailableForSaleSecuritiesDebtMaturitiesMoreThanFiveYearsFairValue_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_7"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inmd_MarketableSecuritiesAndFairValueMeasurementAbstract_0" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inmd_MarketableSecuritiesAndFairValueMeasurementAbstract_0" xlink:to="loc_inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInOneToTwoYearsFairValue_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inmd_MarketableSecuritiesAndFairValueMeasurementAbstract_0" xlink:to="loc_inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInTwoToThreeYearsFairValue_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inmd_MarketableSecuritiesAndFairValueMeasurementAbstract_0" xlink:to="loc_inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInThreeToFourYearsFairValue_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inmd_MarketableSecuritiesAndFairValueMeasurementAbstract_0" xlink:to="loc_inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInFourToFiveYearsFairValue_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inmd_MarketableSecuritiesAndFairValueMeasurementAbstract_0" xlink:to="loc_inmd_AvailableForSaleSecuritiesDebtMaturitiesMoreThanFiveYearsFairValue_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inmd_MarketableSecuritiesAndFairValueMeasurementAbstract_0" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/AccountsReceivableScheduleOfAccountsReceivableDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableGrossAllowanceAndNetAbstract" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableGrossAllowanceAndNetAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableGross" xlink:label="loc_us-gaap_AccountsReceivableGross_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesReceivableGross" xlink:label="loc_us-gaap_NotesReceivableGross_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsAndNotesReceivableNet" xlink:label="loc_us-gaap_AccountsAndNotesReceivableNet_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetNoncurrent" xlink:label="loc_us-gaap_AccountsReceivableNetNoncurrent_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_6"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableGrossAllowanceAndNetAbstract_0" xlink:to="loc_us-gaap_AccountsReceivableGross_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableGrossAllowanceAndNetAbstract_0" xlink:to="loc_us-gaap_NotesReceivableGross_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableGrossAllowanceAndNetAbstract_0" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableGrossAllowanceAndNetAbstract_0" xlink:to="loc_us-gaap_AccountsAndNotesReceivableNet_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableGrossAllowanceAndNetAbstract_0" xlink:to="loc_us-gaap_AccountsReceivableNetNoncurrent_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableGrossAllowanceAndNetAbstract_0" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/OtherCurrentReceivablesScheduleOfOtherCurrentReceivablesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivablesNetCurrentAbstract" xlink:label="loc_us-gaap_OtherReceivablesNetCurrentAbstract_0"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_OtherAdvancesToSuppliersCurrent" xlink:label="loc_inmd_OtherAdvancesToSuppliersCurrent_1"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_OtherPrepaidExpensesReceivablesCurrent" xlink:label="loc_inmd_OtherPrepaidExpensesReceivablesCurrent_2"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_OtherGovernmentInstitutionsReceivablesCurrent" xlink:label="loc_inmd_OtherGovernmentInstitutionsReceivablesCurrent_3"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_OtherIncomeTaxReceivablesCurrent" xlink:label="loc_inmd_OtherIncomeTaxReceivablesCurrent_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivablesGrossCurrent" xlink:label="loc_us-gaap_OtherReceivablesGrossCurrent_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_6"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherReceivablesNetCurrentAbstract_0" xlink:to="loc_inmd_OtherAdvancesToSuppliersCurrent_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherReceivablesNetCurrentAbstract_0" xlink:to="loc_inmd_OtherPrepaidExpensesReceivablesCurrent_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherReceivablesNetCurrentAbstract_0" xlink:to="loc_inmd_OtherGovernmentInstitutionsReceivablesCurrent_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherReceivablesNetCurrentAbstract_0" xlink:to="loc_inmd_OtherIncomeTaxReceivablesCurrent_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherReceivablesNetCurrentAbstract_0" xlink:to="loc_us-gaap_OtherReceivablesGrossCurrent_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherReceivablesNetCurrentAbstract_0" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/InventoriesScheduleOfInventoriesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryRawMaterials" xlink:label="loc_us-gaap_InventoryRawMaterials_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoods" xlink:label="loc_us-gaap_InventoryFinishedGoods_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet_3"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_0" xlink:to="loc_us-gaap_InventoryRawMaterials_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_0" xlink:to="loc_us-gaap_InventoryFinishedGoods_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_0" xlink:to="loc_us-gaap_InventoryNet_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/PropertyAndEquipmentNetScheduleOfPropertyAndEquipmentDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaap_ComputerEquipmentMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OfficeEquipmentMember" xlink:label="loc_us-gaap_OfficeEquipmentMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ToolsDiesAndMoldsMember" xlink:label="loc_us-gaap_ToolsDiesAndMoldsMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_10"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1" xlink:to="loc_us-gaap_ComputerEquipmentMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1" xlink:to="loc_us-gaap_OfficeEquipmentMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1" xlink:to="loc_us-gaap_ToolsDiesAndMoldsMember_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_8" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_9" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_10" order="30" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/OtherInvestmentsDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsAbstract" xlink:label="loc_us-gaap_InvestmentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" xlink:label="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaap_TypeOfArrangementAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_1"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_SharePurchaseAndShareholdersAgreementMember" xlink:label="loc_inmd_SharePurchaseAndShareholdersAgreementMember_1"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_TwoPurchaseAndShareholdersAgreementsMember" xlink:label="loc_inmd_TwoPurchaseAndShareholdersAgreementsMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_5"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_MedimorMember" xlink:label="loc_inmd_MedimorMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTypeAxis" xlink:label="loc_us-gaap_InvestmentTypeAxis_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_8"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_FullyDilutedBasisMember" xlink:label="loc_inmd_FullyDilutedBasisMember_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems" xlink:label="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Investments" xlink:label="loc_us-gaap_Investments_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesIssued" xlink:label="loc_us-gaap_SharesIssued_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_13"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_0" xlink:to="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_1" xlink:to="loc_us-gaap_TypeOfArrangementAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_1" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_1" xlink:to="loc_inmd_SharePurchaseAndShareholdersAgreementMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_1" xlink:to="loc_inmd_TwoPurchaseAndShareholdersAgreementsMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_1" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_5" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_5" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_5" xlink:to="loc_inmd_MedimorMember_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_1" xlink:to="loc_us-gaap_InvestmentTypeAxis_8" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_8" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_8" xlink:to="loc_inmd_FullyDilutedBasisMember_8" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_1" xlink:to="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_11" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_11" xlink:to="loc_us-gaap_Investments_11" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_11" xlink:to="loc_us-gaap_SharesIssued_12" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_11" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_13" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/LeasesNarrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaap_TypeOfArrangementAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_1"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_LeaseAgreementMember" xlink:label="loc_inmd_LeaseAgreementMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_WarehouseMember" xlink:label="loc_srt_WarehouseMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OfficeBuildingMember" xlink:label="loc_srt_OfficeBuildingMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VehiclesMember" xlink:label="loc_us-gaap_VehiclesMember_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_11"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_LeaseExpires" xlink:label="loc_inmd_LeaseExpires_11"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_BankGuarantee" xlink:label="loc_inmd_BankGuarantee_12"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_CurrentMonthlyRentPayment" xlink:label="loc_inmd_CurrentMonthlyRentPayment_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_14"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0" xlink:to="loc_us-gaap_StatementTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_TypeOfArrangementAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_1" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_1" xlink:to="loc_inmd_LeaseAgreementMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_4" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_4" xlink:to="loc_srt_WarehouseMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_4" xlink:to="loc_srt_OfficeBuildingMember_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_8" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8" xlink:to="loc_us-gaap_VehiclesMember_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementLineItems_11" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_11" xlink:to="loc_inmd_LeaseExpires_11" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_11" xlink:to="loc_inmd_BankGuarantee_12" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_11" xlink:to="loc_inmd_CurrentMonthlyRentPayment_13" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_11" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_14" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/LeasesScheduleOfLeaseExpenseDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseCost" xlink:label="loc_us-gaap_OperatingLeaseCost_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0" xlink:to="loc_us-gaap_OperatingLeaseCost_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/LeasesScheduleOfSupplementalCashFlowInformationRelatedToLeasesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeasePayments" xlink:label="loc_us-gaap_OperatingLeasePayments_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0" xlink:to="loc_us-gaap_OperatingLeasePayments_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_LeasesTable" xlink:label="loc_inmd_LeasesTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_2"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_LeasesLineItems" xlink:label="loc_inmd_LeasesLineItems_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesOperatingAbstract" xlink:label="loc_us-gaap_LeasesOperatingAbstract_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_5"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_OtherCurrentLeaseLiabilities" xlink:label="loc_inmd_OtherCurrentLeaseLiabilities_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_11"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0" xlink:to="loc_inmd_LeasesTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inmd_LeasesTable_1" xlink:to="loc_srt_RangeAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_1" xlink:to="loc_srt_RangeMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1" xlink:to="loc_srt_MinimumMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1" xlink:to="loc_srt_MaximumMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inmd_LeasesTable_1" xlink:to="loc_inmd_LeasesLineItems_5" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inmd_LeasesLineItems_5" xlink:to="loc_us-gaap_LeasesOperatingAbstract_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_5" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_5" xlink:to="loc_inmd_OtherCurrentLeaseLiabilities_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_5" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_7" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_5" xlink:to="loc_us-gaap_OperatingLeaseLiability_8" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inmd_LeasesLineItems_5" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_10" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inmd_LeasesLineItems_5" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_11" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/LeasesScheduleOfMaturitiesOfLeaseLiabilitiesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_8"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0" xlink:to="loc_us-gaap_OperatingLeaseLiability_8" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/OtherCurrentLiabilitiesScheduleOfOtherLiabilitiesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_OtherCurrentLiabilitiesTable" xlink:label="loc_inmd_OtherCurrentLiabilitiesTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCurrentLiabilitiesMember" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_1"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_OtherCurrentLiabilitiesLineItems" xlink:label="loc_inmd_OtherCurrentLiabilitiesLineItems_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_4"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_GovernmentInstitutions" xlink:label="loc_inmd_GovernmentInstitutions_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedIncomeTaxesCurrent" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_6"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_WarrantyReserveLiabilityCurrent" xlink:label="loc_inmd_WarrantyReserveLiabilityCurrent_7"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_OtherCurrentLeaseLiabilities" xlink:label="loc_inmd_OtherCurrentLeaseLiabilities_8"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ContractorLiability" xlink:label="loc_inmd_ContractorLiability_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_11"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_0" xlink:to="loc_inmd_OtherCurrentLiabilitiesTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inmd_OtherCurrentLiabilitiesTable_1" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_1" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_1" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inmd_OtherCurrentLiabilitiesTable_1" xlink:to="loc_inmd_OtherCurrentLiabilitiesLineItems_4" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inmd_OtherCurrentLiabilitiesLineItems_4" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_4" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inmd_OtherCurrentLiabilitiesLineItems_4" xlink:to="loc_inmd_GovernmentInstitutions_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inmd_OtherCurrentLiabilitiesLineItems_4" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inmd_OtherCurrentLiabilitiesLineItems_4" xlink:to="loc_inmd_WarrantyReserveLiabilityCurrent_7" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inmd_OtherCurrentLiabilitiesLineItems_4" xlink:to="loc_inmd_OtherCurrentLeaseLiabilities_8" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inmd_OtherCurrentLiabilitiesLineItems_4" xlink:to="loc_inmd_ContractorLiability_9" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inmd_OtherCurrentLiabilitiesLineItems_4" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_10" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inmd_OtherCurrentLiabilitiesLineItems_4" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_11" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/CommitmentsAndContingentLiabilitiesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantSupplyCommitmentRemainingMinimumAmountCommitted" xlink:label="loc_us-gaap_SignificantSupplyCommitmentRemainingMinimumAmountCommitted_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForAdvanceToAffiliate" xlink:label="loc_us-gaap_PaymentsForAdvanceToAffiliate_2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0" xlink:to="loc_us-gaap_SignificantSupplyCommitmentRemainingMinimumAmountCommitted_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0" xlink:to="loc_us-gaap_PaymentsForAdvanceToAffiliate_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/ShareholdersEquityNarrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaap_IPOMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_7"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_TwoThousandsEighteenIncentivePlanMember" xlink:label="loc_inmd_TwoThousandsEighteenIncentivePlanMember_7"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_NonIsraeliPlanMember" xlink:label="loc_inmd_NonIsraeliPlanMember_8"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ShareRepurchaseProgramMember" xlink:label="loc_inmd_ShareRepurchaseProgramMember_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srt_TitleOfIndividualAxis_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_12"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_EmployeesMember" xlink:label="loc_inmd_EmployeesMember_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_BoardOfDirectorsChairmanMember" xlink:label="loc_srt_BoardOfDirectorsChairmanMember_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="loc_srt_ConsolidatedEntitiesAxis_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="loc_srt_ConsolidatedEntitiesDomain_16"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_JointVentureAgreementMember" xlink:label="loc_inmd_JointVentureAgreementMember_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SubsidiariesMember" xlink:label="loc_srt_SubsidiariesMember_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_20"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_GIBFAndJVCMember" xlink:label="loc_inmd_GIBFAndJVCMember_20"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_JointVentureAgreementMember" xlink:label="loc_inmd_JointVentureAgreementMember_21"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_DilazarLimitedMember" xlink:label="loc_inmd_DilazarLimitedMember_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingAxis" xlink:label="loc_us-gaap_VestingAxis_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingDomain" xlink:label="loc_us-gaap_VestingDomain_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_29"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_30"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ShareBasedCompensationAwardTrancheFourMember" xlink:label="loc_inmd_ShareBasedCompensationAwardTrancheFourMember_31"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_34"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_34"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesIssued" xlink:label="loc_us-gaap_SharesIssued_35"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice" xlink:label="loc_inmd_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice_36"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteStockSplit" xlink:label="loc_us-gaap_StockholdersEquityNoteStockSplit_37"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_BonusShareIssuesPerOutstandingShare" xlink:label="loc_inmd_BonusShareIssuesPerOutstandingShare_38"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_39"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_40"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_41"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_42"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_SharesAuthorizedAmount" xlink:label="loc_inmd_SharesAuthorizedAmount_43"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_StockRepurchasedDuringPeriodValueOne" xlink:label="loc_inmd_StockRepurchasedDuringPeriodValueOne_44"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_45"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_46"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_47"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_FairValueOfRestrictedOptionsGranted" xlink:label="loc_inmd_FairValueOfRestrictedOptionsGranted_48"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_FairValueOfOptionsGranted" xlink:label="loc_inmd_FairValueOfOptionsGranted_49"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_50"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_51"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_52"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_53"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_54"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_55"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_56"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_57"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_58"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_OwnershipInterestExchange" xlink:label="loc_inmd_OwnershipInterestExchange_59"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_MinorityInterestDecreaseFromRedemptionsOne" xlink:label="loc_inmd_MinorityInterestDecreaseFromRedemptionsOne_60"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_61"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue_62"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonVestedVested" xlink:label="loc_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonVestedVested_63"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_64"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_srt_RangeAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_1" xlink:to="loc_srt_RangeMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1" xlink:to="loc_srt_MinimumMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_4" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_4" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_4" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_4" xlink:to="loc_us-gaap_IPOMember_4" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_PlanNameAxis_7" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_7" xlink:to="loc_us-gaap_PlanNameDomain_7" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_7" xlink:to="loc_inmd_TwoThousandsEighteenIncentivePlanMember_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_7" xlink:to="loc_inmd_NonIsraeliPlanMember_8" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_7" xlink:to="loc_inmd_ShareRepurchaseProgramMember_9" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_srt_TitleOfIndividualAxis_12" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_12" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_12" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_12" xlink:to="loc_inmd_EmployeesMember_12" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_12" xlink:to="loc_srt_BoardOfDirectorsChairmanMember_13" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_srt_ConsolidatedEntitiesAxis_16" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_16" xlink:to="loc_srt_ConsolidatedEntitiesDomain_16" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_16" xlink:to="loc_inmd_JointVentureAgreementMember_16" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_16" xlink:to="loc_srt_SubsidiariesMember_17" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_20" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_20" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_20" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_20" xlink:to="loc_inmd_GIBFAndJVCMember_20" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_20" xlink:to="loc_inmd_JointVentureAgreementMember_21" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_20" xlink:to="loc_inmd_DilazarLimitedMember_22" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_AwardTypeAxis_25" order="60" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_25" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_25" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_25" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_25" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_VestingAxis_28" order="70" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingAxis_28" xlink:to="loc_us-gaap_VestingDomain_28" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_28" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_28" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_28" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_29" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_28" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_30" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_28" xlink:to="loc_inmd_ShareBasedCompensationAwardTrancheFourMember_31" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_34" order="80" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_34" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_34" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_34" xlink:to="loc_us-gaap_SharesIssued_35" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_34" xlink:to="loc_inmd_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice_36" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_34" xlink:to="loc_us-gaap_StockholdersEquityNoteStockSplit_37" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_34" xlink:to="loc_inmd_BonusShareIssuesPerOutstandingShare_38" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_34" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_39" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_34" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_40" order="60" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_34" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_41" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_34" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_42" order="80" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_34" xlink:to="loc_inmd_SharesAuthorizedAmount_43" order="90" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_34" xlink:to="loc_inmd_StockRepurchasedDuringPeriodValueOne_44" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_34" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_45" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_34" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_46" order="120" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_34" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_47" order="130" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_34" xlink:to="loc_inmd_FairValueOfRestrictedOptionsGranted_48" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_34" xlink:to="loc_inmd_FairValueOfOptionsGranted_49" order="150" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_34" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_50" order="160" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_34" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_51" order="170" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_34" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_52" order="180" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_34" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_53" order="190" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_34" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_54" order="200" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_34" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_55" order="210" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_34" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_56" order="220" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_34" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_57" order="230" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_34" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_58" order="240" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_34" xlink:to="loc_inmd_OwnershipInterestExchange_59" order="250" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_34" xlink:to="loc_inmd_MinorityInterestDecreaseFromRedemptionsOne_60" order="260" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_34" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_61" order="270" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_34" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue_62" order="280" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_34" xlink:to="loc_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonVestedVested_63" order="290" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_34" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_64" order="300" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/ShareholdersEquityScheduleOfOptionsGrantedDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GranteeStatusAxis" xlink:label="loc_us-gaap_GranteeStatusAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GranteeStatusDomain" xlink:label="loc_us-gaap_GranteeStatusDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:label="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_OptionsChangesDuringYear" xlink:label="loc_inmd_OptionsChangesDuringYear_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_13"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_WeightedAverageExercisePriceChangesDuringYearAbstract" xlink:label="loc_inmd_WeightedAverageExercisePriceChangesDuringYearAbstract_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_19"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_GranteeStatusAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GranteeStatusAxis_1" xlink:to="loc_us-gaap_GranteeStatusDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GranteeStatusDomain_1" xlink:to="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_4" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_4" xlink:to="loc_inmd_OptionsChangesDuringYear_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inmd_OptionsChangesDuringYear_5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inmd_OptionsChangesDuringYear_5" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inmd_OptionsChangesDuringYear_5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_7" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inmd_OptionsChangesDuringYear_5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_8" order="30" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inmd_OptionsChangesDuringYear_5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_9" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inmd_OptionsChangesDuringYear_5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_10" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_13" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_13" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_13" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_13" xlink:to="loc_inmd_WeightedAverageExercisePriceChangesDuringYearAbstract_14" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inmd_WeightedAverageExercisePriceChangesDuringYearAbstract_14" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_14" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inmd_WeightedAverageExercisePriceChangesDuringYearAbstract_14" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_15" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inmd_WeightedAverageExercisePriceChangesDuringYearAbstract_14" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_16" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inmd_WeightedAverageExercisePriceChangesDuringYearAbstract_14" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_17" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inmd_WeightedAverageExercisePriceChangesDuringYearAbstract_14" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_18" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inmd_WeightedAverageExercisePriceChangesDuringYearAbstract_14" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_19" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/ShareholdersEquityScheduleOfOutstandingAndExercisableOptionsDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_1"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ExercisePriceRangeOneMember" xlink:label="loc_inmd_ExercisePriceRangeOneMember_1"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ExercisePriceRangeTwoMember" xlink:label="loc_inmd_ExercisePriceRangeTwoMember_2"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ExercisePriceRangeThreeMember" xlink:label="loc_inmd_ExercisePriceRangeThreeMember_3"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ExercisePriceRangeFourMember" xlink:label="loc_inmd_ExercisePriceRangeFourMember_4"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ExercisePriceRangeFiveMember" xlink:label="loc_inmd_ExercisePriceRangeFiveMember_5"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ExercisePriceRangeSixMember" xlink:label="loc_inmd_ExercisePriceRangeSixMember_6"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ExercisePriceRangeSevenMember" xlink:label="loc_inmd_ExercisePriceRangeSevenMember_7"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ExercisePriceRangeEightMember" xlink:label="loc_inmd_ExercisePriceRangeEightMember_8"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ExercisePriceRangeNineMember" xlink:label="loc_inmd_ExercisePriceRangeNineMember_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_12"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice" xlink:label="loc_inmd_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_16"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_1" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_1" xlink:to="loc_inmd_ExercisePriceRangeOneMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_1" xlink:to="loc_inmd_ExercisePriceRangeTwoMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_1" xlink:to="loc_inmd_ExercisePriceRangeThreeMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_1" xlink:to="loc_inmd_ExercisePriceRangeFourMember_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_1" xlink:to="loc_inmd_ExercisePriceRangeFiveMember_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_1" xlink:to="loc_inmd_ExercisePriceRangeSixMember_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_1" xlink:to="loc_inmd_ExercisePriceRangeSevenMember_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_1" xlink:to="loc_inmd_ExercisePriceRangeEightMember_8" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_1" xlink:to="loc_inmd_ExercisePriceRangeNineMember_9" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_12" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_12" xlink:to="loc_inmd_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice_12" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_12" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_13" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_12" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_14" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_12" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_15" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_12" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_16" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/ShareholdersEquityScheduleOfOptionsGrantedRestictedShareUnitDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_UnitsChangesDuringYearAbstract" xlink:label="loc_inmd_UnitsChangesDuringYearAbstract_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_11"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_WeightedAverageGrantDateChangesDuringYearAbstract" xlink:label="loc_inmd_WeightedAverageGrantDateChangesDuringYearAbstract_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_13"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="loc_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_16"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_AwardTypeAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_4" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_4" xlink:to="loc_inmd_UnitsChangesDuringYearAbstract_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inmd_UnitsChangesDuringYearAbstract_5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inmd_UnitsChangesDuringYearAbstract_5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inmd_UnitsChangesDuringYearAbstract_5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_7" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inmd_UnitsChangesDuringYearAbstract_5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_8" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_11" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_11" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_11" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_11" xlink:to="loc_inmd_WeightedAverageGrantDateChangesDuringYearAbstract_12" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_11" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_13" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_11" xlink:to="loc_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue_14" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_11" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_15" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_11" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_16" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/ShareholdersEquityScheduleOfShareBasedCompensationExpenseDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfSalesMember" xlink:label="loc_us-gaap_CostOfSalesMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpenseMember" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_7"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_1" xlink:to="loc_us-gaap_CostOfSalesMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_1" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_1" xlink:to="loc_us-gaap_SellingAndMarketingExpenseMember_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_1" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/TaxesOnIncomeNarrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxContingencyTable" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_1"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_DevelopmentZoneAMember" xlink:label="loc_inmd_DevelopmentZoneAMember_1"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ElsewhereMember" xlink:label="loc_inmd_ElsewhereMember_2"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_RegulationsMember" xlink:label="loc_inmd_RegulationsMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameAxis" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_6"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_SpecialPreferredEnterpriseMember" xlink:label="loc_inmd_SpecialPreferredEnterpriseMember_6"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_IsraeliTaxAuthorityMember" xlink:label="loc_inmd_IsraeliTaxAuthorityMember_7"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_SubsidiariesOutsideIsraelMember" xlink:label="loc_inmd_SubsidiariesOutsideIsraelMember_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CurrencyAxis" xlink:label="loc_srt_CurrencyAxis_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currency_AllCurrenciesDomain_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_ILS" xlink:label="loc_currency_ILS_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_18"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_AmendmentAdvantageExemptionMember" xlink:label="loc_inmd_AmendmentAdvantageExemptionMember_18"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_NoAmendmentMember" xlink:label="loc_inmd_NoAmendmentMember_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxContingencyLineItems" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_22"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_TaxBenefitYear" xlink:label="loc_inmd_TaxBenefitYear_22"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_CorporateTax" xlink:label="loc_inmd_CorporateTax_23"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_TaxRateForRecipientForDividendsDistributedByPreferredCompany" xlink:label="loc_inmd_TaxRateForRecipientForDividendsDistributedByPreferredCompany_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsDividends" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsDividends_25"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_EffectiveIncomeTaxRateReconciliationDeductionsDividendsForNonIsraeliResidents" xlink:label="loc_inmd_EffectiveIncomeTaxRateReconciliationDeductionsDividendsForNonIsraeliResidents_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesReceivable" xlink:label="loc_us-gaap_IncomeTaxesReceivable_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaap_OperatingLossCarryforwards_29"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_OneTimePayment" xlink:label="loc_inmd_OneTimePayment_30"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_UndistributedExemptIncome" xlink:label="loc_inmd_UndistributedExemptIncome_31"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions" xlink:label="loc_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions_32"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_1" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_1" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_1" xlink:to="loc_inmd_DevelopmentZoneAMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_1" xlink:to="loc_inmd_ElsewhereMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_1" xlink:to="loc_inmd_RegulationsMember_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_1" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_6" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_6" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_6" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_6" xlink:to="loc_inmd_SpecialPreferredEnterpriseMember_6" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_6" xlink:to="loc_inmd_IsraeliTaxAuthorityMember_7" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_6" xlink:to="loc_inmd_SubsidiariesOutsideIsraelMember_8" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_1" xlink:to="loc_srt_RangeAxis_11" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_11" xlink:to="loc_srt_RangeMember_11" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_11" xlink:to="loc_srt_MinimumMember_11" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_11" xlink:to="loc_srt_MaximumMember_12" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_1" xlink:to="loc_srt_CurrencyAxis_15" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CurrencyAxis_15" xlink:to="loc_currency_AllCurrenciesDomain_15" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_15" xlink:to="loc_currency_ILS_15" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_1" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_18" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_18" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_18" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_18" xlink:to="loc_inmd_AmendmentAdvantageExemptionMember_18" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_18" xlink:to="loc_inmd_NoAmendmentMember_19" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_1" xlink:to="loc_us-gaap_IncomeTaxContingencyLineItems_22" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_22" xlink:to="loc_inmd_TaxBenefitYear_22" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_22" xlink:to="loc_inmd_CorporateTax_23" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_22" xlink:to="loc_inmd_TaxRateForRecipientForDividendsDistributedByPreferredCompany_24" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_22" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsDividends_25" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_22" xlink:to="loc_inmd_EffectiveIncomeTaxRateReconciliationDeductionsDividendsForNonIsraeliResidents_26" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_22" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_27" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_22" xlink:to="loc_us-gaap_IncomeTaxesReceivable_28" order="60" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_22" xlink:to="loc_us-gaap_OperatingLossCarryforwards_29" order="70" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_22" xlink:to="loc_inmd_OneTimePayment_30" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_22" xlink:to="loc_inmd_UndistributedExemptIncome_31" order="90" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_22" xlink:to="loc_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions_32" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/TaxesOnIncomeScheduleOfDeferredTaxAssetsLiabilitiesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsNetAbstract" xlink:label="loc_us-gaap_DeferredTaxAssetsNetAbstract_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOtherComprehensiveLoss" xlink:label="loc_us-gaap_DeferredTaxAssetsOtherComprehensiveLoss_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_7"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_us-gaap_DeferredTaxAssetsNetAbstract_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_1" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_1" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_1" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_1" xlink:to="loc_us-gaap_DeferredTaxAssetsOtherComprehensiveLoss_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_1" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_1" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_1" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/TaxesOnIncomeScheduleOfReconciliationOfTheoreticalProvisionForIncomeTaxDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_4"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_IncomeTaxReconciliationBenefitsToBenefitedEnterprise" xlink:label="loc_inmd_IncomeTaxReconciliationBenefitsToBenefitedEnterprise_4"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_IncomeTaxReconciliationDifferentEffectiveTaxRatesApplicableToSubsidiaries" xlink:label="loc_inmd_IncomeTaxReconciliationDifferentEffectiveTaxRatesApplicableToSubsidiaries_5"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_IncomeTaxReconciliationDifferentEffectiveTaxRatesApplicableToOperatingLoss" xlink:label="loc_inmd_IncomeTaxReconciliationDifferentEffectiveTaxRatesApplicableToOperatingLoss_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_7"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_IncomeTaxReconciliationUncertainTaxPosition" xlink:label="loc_inmd_IncomeTaxReconciliationUncertainTaxPosition_8"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_IncomeTaxReconciliationNonDeductibleExpenses" xlink:label="loc_inmd_IncomeTaxReconciliationNonDeductibleExpenses_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:label="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_10"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_IncomeTaxReconciliationAmendmentToInvestmentsLawPayment" xlink:label="loc_inmd_IncomeTaxReconciliationAmendmentToInvestmentsLawPayment_11"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_IncomeTaxReconciliationSettlementsWithIsraeliTaxAuthorityNetOfDecreaseOfRelatedUncertainTax" xlink:label="loc_inmd_IncomeTaxReconciliationSettlementsWithIsraeliTaxAuthorityNetOfDecreaseOfRelatedUncertainTax_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_13"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_4" xlink:to="loc_inmd_IncomeTaxReconciliationBenefitsToBenefitedEnterprise_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_4" xlink:to="loc_inmd_IncomeTaxReconciliationDifferentEffectiveTaxRatesApplicableToSubsidiaries_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_4" xlink:to="loc_inmd_IncomeTaxReconciliationDifferentEffectiveTaxRatesApplicableToOperatingLoss_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_4" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_7" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_4" xlink:to="loc_inmd_IncomeTaxReconciliationUncertainTaxPosition_8" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_4" xlink:to="loc_inmd_IncomeTaxReconciliationNonDeductibleExpenses_9" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_4" xlink:to="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_10" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_4" xlink:to="loc_inmd_IncomeTaxReconciliationAmendmentToInvestmentsLawPayment_11" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_4" xlink:to="loc_inmd_IncomeTaxReconciliationSettlementsWithIsraeliTaxAuthorityNetOfDecreaseOfRelatedUncertainTax_12" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_4" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_13" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/TaxesOnIncomeScheduleOfIncomeBeforeIncomeTaxesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_0"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_IncomeTaxNoteTable" xlink:label="loc_inmd_IncomeTaxNoteTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameAxis" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_1"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_InmodeLtdAndIsreaeliSubsidiariesMember" xlink:label="loc_inmd_InmodeLtdAndIsreaeliSubsidiariesMember_1"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_SubsidiariesOutsideIsraelMember" xlink:label="loc_inmd_SubsidiariesOutsideIsraelMember_2"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_IncomeTaxNoteLineItems" xlink:label="loc_inmd_IncomeTaxNoteLineItems_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_5"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_inmd_IncomeTaxNoteTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inmd_IncomeTaxNoteTable_1" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_1" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_1" xlink:to="loc_inmd_InmodeLtdAndIsreaeliSubsidiariesMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_1" xlink:to="loc_inmd_SubsidiariesOutsideIsraelMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inmd_IncomeTaxNoteTable_1" xlink:to="loc_inmd_IncomeTaxNoteLineItems_5" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inmd_IncomeTaxNoteLineItems_5" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_5" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/TaxesOnIncomeScheduleOfTaxExpensesTaxBenefitDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_0"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_IncomeTaxNoteTable" xlink:label="loc_inmd_IncomeTaxNoteTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameAxis" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_IL" xlink:label="loc_country_IL_1"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_SubsidiariesOutsideIsraelMember" xlink:label="loc_inmd_SubsidiariesOutsideIsraelMember_2"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_IncomeTaxNoteLineItems" xlink:label="loc_inmd_IncomeTaxNoteLineItems_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_7"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_inmd_IncomeTaxNoteTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inmd_IncomeTaxNoteTable_1" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_1" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_1" xlink:to="loc_country_IL_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_1" xlink:to="loc_inmd_SubsidiariesOutsideIsraelMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inmd_IncomeTaxNoteTable_1" xlink:to="loc_inmd_IncomeTaxNoteLineItems_5" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inmd_IncomeTaxNoteLineItems_5" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_5" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inmd_IncomeTaxNoteLineItems_5" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_6" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inmd_IncomeTaxNoteLineItems_5" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_7" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/TaxesOnIncomeScheduleOfUnrecognizedTaxBenefitsDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_4"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/Entity-wideDisclosureNarrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:label="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_4"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_PercentageOfNonCurrentDeferredRevenue" xlink:label="loc_inmd_PercentageOfNonCurrentDeferredRevenue_4"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_0" xlink:to="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_1" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_1" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_1" xlink:to="loc_us-gaap_SubsequentEventMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_1" xlink:to="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_4" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_4" xlink:to="loc_inmd_PercentageOfNonCurrentDeferredRevenue_4" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/Entity-wideDisclosureScheduleOfNetSalesByGeographicalAreaDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srt_StatementGeographicalAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US" xlink:label="loc_country_US_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EuropeMember" xlink:label="loc_srt_EuropeMember_2"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_OtherCountryMember" xlink:label="loc_inmd_OtherCountryMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:label="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_6"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_0" xlink:to="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_1" xlink:to="loc_srt_StatementGeographicalAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_1" xlink:to="loc_srt_SegmentGeographicalDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_1" xlink:to="loc_country_US_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_1" xlink:to="loc_srt_EuropeMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_1" xlink:to="loc_inmd_OtherCountryMember_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_1" xlink:to="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_6" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_6" xlink:to="loc_us-gaap_Revenues_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/Entity-wideDisclosureScheduleOfNetSalesByTechonologyDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTable" xlink:label="loc_us-gaap_ConcentrationRiskTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_1"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_MinimalInvasiveMember" xlink:label="loc_inmd_MinimalInvasiveMember_1"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_HandsFreeMember" xlink:label="loc_inmd_HandsFreeMember_2"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_NonInvasiveMember" xlink:label="loc_inmd_NonInvasiveMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_6"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_PercentageOfNetSalesBasedOnProductsTechnology" xlink:label="loc_inmd_PercentageOfNetSalesBasedOnProductsTechnology_6"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_0" xlink:to="loc_us-gaap_ConcentrationRiskTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_1" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_1" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_1" xlink:to="loc_inmd_MinimalInvasiveMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_1" xlink:to="loc_inmd_HandsFreeMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_1" xlink:to="loc_inmd_NonInvasiveMember_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_1" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_6" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_6" xlink:to="loc_inmd_PercentageOfNetSalesBasedOnProductsTechnology_6" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/Entity-wideDisclosureScheduleOfChangesInContractLiabilitiesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiability" xlink:label="loc_us-gaap_ContractWithCustomerLiability_1"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_IncreasesDueToIssuanceOfNewContractsExcludingAmountsRecognizedAsRevenueDuringPeriod" xlink:label="loc_inmd_IncreasesDueToIssuanceOfNewContractsExcludingAmountsRecognizedAsRevenueDuringPeriod_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiability" xlink:label="loc_us-gaap_ContractWithCustomerLiability_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_6"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_0" xlink:to="loc_us-gaap_ContractWithCustomerLiability_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_0" xlink:to="loc_inmd_IncreasesDueToIssuanceOfNewContractsExcludingAmountsRecognizedAsRevenueDuringPeriod_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_0" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_0" xlink:to="loc_us-gaap_ContractWithCustomerLiability_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_0" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_5" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_0" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/Entity-wideDisclosureScheduleOfLong-livedAssetsDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srt_StatementGeographicalAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_IL" xlink:label="loc_country_IL_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US" xlink:label="loc_country_US_2"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_OtherCountryMember" xlink:label="loc_inmd_OtherCountryMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_6"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_TotalLongLivedAssetsByGeographicalArea" xlink:label="loc_inmd_TotalLongLivedAssetsByGeographicalArea_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncurrentAssets" xlink:label="loc_us-gaap_NoncurrentAssets_8"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_0" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_1" xlink:to="loc_srt_StatementGeographicalAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_1" xlink:to="loc_srt_SegmentGeographicalDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_1" xlink:to="loc_country_IL_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_1" xlink:to="loc_country_US_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_1" xlink:to="loc_inmd_OtherCountryMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_1" xlink:to="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_6" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_6" xlink:to="loc_inmd_TotalLongLivedAssetsByGeographicalArea_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_6" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_7" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_6" xlink:to="loc_us-gaap_NoncurrentAssets_8" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/RelatedPartiesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_1"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_HomeSkinnovationsLtdMember" xlink:label="loc_inmd_HomeSkinnovationsLtdMember_1"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_SubsidiaryOfHomeSkinnovationsLtdMember" xlink:label="loc_inmd_SubsidiaryOfHomeSkinnovationsLtdMember_2"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_SpaMedicalInternationalLsrlMember" xlink:label="loc_inmd_SpaMedicalInternationalLsrlMember_3"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_HimalayaFamilyOfficeConsultingLtdMember" xlink:label="loc_inmd_HimalayaFamilyOfficeConsultingLtdMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_7"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ExpensesIncomeMember" xlink:label="loc_inmd_ExpensesIncomeMember_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNet" xlink:label="loc_us-gaap_AccountsReceivableNet_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableAfterAllowanceForCreditLossRelatedAndNonrelatedPartyStatusExtensibleEnumeration" xlink:label="loc_us-gaap_AccountsReceivableAfterAllowanceForCreditLossRelatedAndNonrelatedPartyStatusExtensibleEnumeration_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:label="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_12"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_RelatedPartyConsiderationForAggregateAmount" xlink:label="loc_inmd_RelatedPartyConsiderationForAggregateAmount_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableRelatedAndNonrelatedPartyStatusExtensibleEnumeration" xlink:label="loc_us-gaap_AccountsPayableRelatedAndNonrelatedPartyStatusExtensibleEnumeration_15"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_0" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1" xlink:to="loc_us-gaap_RelatedPartyDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_1" xlink:to="loc_inmd_HomeSkinnovationsLtdMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_1" xlink:to="loc_inmd_SubsidiaryOfHomeSkinnovationsLtdMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_1" xlink:to="loc_inmd_SpaMedicalInternationalLsrlMember_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_1" xlink:to="loc_inmd_HimalayaFamilyOfficeConsultingLtdMember_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_7" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_7" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7" xlink:to="loc_inmd_ExpensesIncomeMember_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_10" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_10" xlink:to="loc_us-gaap_AccountsReceivableNet_10" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_10" xlink:to="loc_us-gaap_AccountsReceivableAfterAllowanceForCreditLossRelatedAndNonrelatedPartyStatusExtensibleEnumeration_11" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_10" xlink:to="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_12" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_10" xlink:to="loc_inmd_RelatedPartyConsiderationForAggregateAmount_13" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_10" xlink:to="loc_us-gaap_AccountsPayableCurrent_14" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveTerseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_10" xlink:to="loc_us-gaap_AccountsPayableRelatedAndNonrelatedPartyStatusExtensibleEnumeration_15" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/CONSOLIDATEDBALANCESHEETSParentheticals2">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParentheticals">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_PaymentsToTaxAuthorities" xlink:label="loc_inmd_PaymentsToTaxAuthorities_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_inmd_PaymentsToTaxAuthorities_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleOfAllowanceForCreditLossesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_4"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://inmodemd.com/role/ENTITYWIDEDISCLOSUREDisclosureOfRevenuesBasedOnProductsCategory">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_1"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_CapitalEquipmentMember" xlink:label="loc_inmd_CapitalEquipmentMember_1"/>
    <loc xlink:type="locator" xlink:href="inmd-20231231.xsd#inmd_ConsumablesAndServiceRevenuesMember" xlink:label="loc_inmd_ConsumablesAndServiceRevenuesMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_5"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_0" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1" xlink:to="loc_srt_ProductOrServiceAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_1" xlink:to="loc_srt_ProductsAndServicesDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_1" xlink:to="loc_inmd_CapitalEquipmentMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_1" xlink:to="loc_inmd_ConsumablesAndServiceRevenuesMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_5" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5" xlink:to="loc_us-gaap_Revenues_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>inmd_img01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 inmd_img01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" +J W(# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **KWUY'86<ES*K%$QD(.>2!_6L?\
MX3#3_P#GC=?]\K_\56%7$TJ3Y9RLS6%"I45XJYT%%<__ ,)AI_\ SQNO^^5_
M^*H_X3#3_P#GC=?]\K_\56?U[#?SHOZI6_E.@HKG_P#A,-/_ .>-U_WRO_Q5
M'_"8:?\ \\;K_OE?_BJ/KV&_G0?5*W\IT%%<_P#\)AI__/&Z_P"^5_\ BJ/^
M$PT__GC=?]\K_P#%4?7L-_.@^J5OY3H**Y__ (3#3_\ GC=?]\K_ /%4?\)A
MI_\ SQNO^^5_^*H^O8;^=!]4K?RG045S_P#PF&G_ //&Z_[Y7_XJC_A,-/\
M^>-U_P!\K_\ %4?7L-_.@^J5OY3H**Y__A,-/_YXW7_?*_\ Q5'_  F&G_\
M/&Z_[Y7_ .*H^O8;^=!]4K?RG04445UG.%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 97B7_D7[K_@
M'_H8KSZO0?$O_(OW7_ /_0Q7GU?-9S_'7I^K/;RW^$_7]$%%%%>2>B%%%% !
M1110 4444 %%%% !1110!ZM1117W9\F%%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M^>G_ (Z*/MMQ_P ]/_'14%%%@Y8]CTG^V+__ )[_ /CB_P"%']L7_P#SW_\
M'%_PJC17N>VJ?S/[SPO94_Y4;VCW]S=7;I-+N41D@;0.<CTK;KF_#_\ Q_R?
M]<C_ #%=)7IX63E3NV>=B8I5+(****Z3G"BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M-/\ E7W&C_;FH_\ /S_XXO\ A72Z5/)<Z;#-,VZ1LY.,=R*XFNQT/_D#P?\
M O\ T(U[.1XBM4Q#52;:MU;?5')C:<(TTXJVIHT445]2>8%%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% '.>._^1,U#_MG_P"C%KQ>O:/'
M?_(F:A_VS_\ 1BUXO7SF;_QUZ?JSZC)/]W?K^B"BBBO*/8"BBB@ HHHH ***
M* "BBB@ HHHH Z:BBBN,X2[IG_'RW^X?YBM:LG3/^/EO]P_S%:U93W.2M\04
M445!F%%%% !78Z'_ ,@>#_@7_H1KCJ['0_\ D#P?\"_]"->[P_\ [S+_  O\
MT<6/_AKU_P S1HHHKZ\\D**** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_0C7N\/_ .\R_P +_-'%C_X:]?\ ,T:***^O/)"BBB@ HHHH **** "BBB@
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MG_HN2HJSY(.78WPU)5JT:;ZG7_\ "5^'/^@_I7_@9'_C1_PE?AS_ *#^E?\
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M^'?^@!I?_@''_A6O11R1[![:I_,_O,C_ (17P[_T -+_ / ./_"C_A%?#O\
MT -+_P# ./\ PK7HHY(]@]M4_F?WF1_PBOAW_H :7_X!Q_X4?\(KX=_Z &E_
M^ <?^%:]%')'L'MJG\S^\R/^$5\._P#0 TO_ , X_P#"C_A%?#O_ $ -+_\
M ./_  K7HHY(]@]M4_F?WF1_PBOAW_H :7_X!Q_X4?\ "*^'?^@!I?\ X!Q_
MX5KT4<D>P>VJ?S/[S.M?#^BV5PEQ::186\Z9VRQ6R(RY&#@@9Z$BM&BBFDEL
M3*4I.\G<****9(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MN(V_]FK@YHI+>>2&52DD;%'4]00<$5]^5\(:[_R,.I_]?<O_ *&: ,^BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MX'\(V]@RJ;Z;]]>2#^*0CIGT4<#Z$]Z\X_:7_P"09X=_Z[3_ ,DH ^=Z***
M"O;/V;/^1IUG_KR7_P!#%>)U[9^S9_R-.L_]>2_^AB@#Z3HHKRSXS?$@>$M&
M_LC3)@-:OD.&4\V\1X+_ %/('XGM0!Y_\=/B3_:MX_A32)\V-N_^FRH>)9!_
M!_NJ>OJ?I7B=!))))R3U)K6\->'=0\5Z_;:/IL>^>=N6/W8U[LWH * .B^&/
MP^N/'GB$1N'CTJV(>\G'''9%/]YOT&37V#:6EO86<-G:0I#;P((XXT& J@8
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MMQX[\2O<@LFFV^8[. _PKW8C^\W4_@.U<70!)!!+<W$<$$;232L$1$&2S$X
M ]:^NOA1\.HO N@>9=*CZS>*&NI!SY8ZB-3Z#OZGZ"N+^!?PT^QPQ^+M9@_T
MB5<Z?"X^XI_Y:D>I[>W/<8]UH **** "OG3]I33&36-$U4+\LL#V[-[HVX?^
MAG\J^BZ\Z^-GAQO$'PYNWACWW.G,+R, <D+D./\ ODD_A0!\BT444 %%%% '
MM7[.?B%;/Q)J&A3/A;^(2P@_\](\Y ^JDG_@-?2M?!NCZK=:'K%IJED^RYM9
M5EC/;(/0^QZ'ZU]K^$_$]CXO\.6NL6##9,N)(\\Q./O(?<'\Q@]Z -NBBB@
MHHHH **** "BH8;NVN9)HX+B*5X&V2JCABC8SAL=#CM4U !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M.I_]?<O_ *&: ,^BBB@ HHKT+X0^!3XS\6H]U$6TJP(FNB1PY_AC_$CGV!H
M]C^!?@3_ (1WPX==OHMNI:F@9 PYB@ZJ/JWWC_P'TKUJD    & .@%+0 5X1
M^TO_ ,@SP[_UVG_DE>[UX1^TO_R#/#O_ %VG_DE 'SO1110 59@U"[M;2ZM8
M)VCANU59U7_EH%.0#[9P?PJM10 5ZG\&_AJ?%VK_ -K:G"?[%LGY5AQ<2#D)
M_NC@G\N_'*> O!5[XY\21:9;;H[=?GNKC&1%'W/U/0#U_&OLK1](LM"TBVTO
M3H1#:6R!(T'IZGU)ZD^IH N !5"J % P .U+110 4444 %-=%D1D=0R,"&4C
M((]*=10!\8_$SP9+X)\87-DJ-]@G)FLW/0QD_=SZJ>#] >]<=7VE\0O UIX\
M\-O82E8KR+,EI<$?ZM_0_P"R>A_/L*^.]8T>_P! U:XTS4[=H+NW;:Z-^A![
M@]0: *-%%% !77_#_P"(.I^ =7-Q:_O[&8@75HS860>H]&'8UR%% 'VSX2\>
M^'O&=HLNE7R&?;F2TE(6:/ZKW'N,BNFKX#BED@E66&1XY$.5=&((/L177Z=\
M5_'.EQK'!XBNG1> +@+-^K@F@#[-IDLL<$32S2)'&HRSNP  ]R:^09_C3X_G
M38==,8]8[>)3^>VN5U;Q)K>NMNU75KR\]!-,S*/H,X% 'U)XG^-GA#PZ'B@N
MCJMVO BLL,H/N_W?RS]*\/\ %OQL\5>)A);VTPTFQ;CRK1B'8?[4G4_A@>U>
M;T4 ?2_[-Y+>$=89B23J&23W_=K7M%>+?LV_\B?J_P#U_P#_ +36O:: "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MH'^LE(Y_ =!["N&^&GP4E\'^(FUG6;NUO)H4Q:)"&PC'@L=P'(' ^I]J]BH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7-?$+_DG/B/
M_L'3_P#H!KI:YKXA?\DY\1_]@Z?_ - - 'Q+1110 4444 ?5'[/7_)-7_P"O
M^7_T%*]7KRC]GK_DFK_]?\O_ *"E>KT %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
3!1110 4444 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>image00001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image00001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !^ -(# 2(  A$! Q$!_\0
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MP_&7_0MQ?DO_ ,>H_P"%A^,O^A;B_)?_ (]7J]% 'E'_  L/QE_T+<7Y+_\
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MO0]A]>#76:3J=Q<QM']F>!80H D'7C^E/V</,B>$Y5HS)W>*%_Y<[L_2:/\
MQIC7/B5>#8ZAS_=9#_6NJ\VY.,!<?2@R7 7D@?\  :/9Q[LR]@^YRJWOB(];
M+4!]57_&MOP_<:A-+.+V*Y0!05\Y,9^E6R\_&)2/J*EWW*6TSAT+*NY2RY!Q
MU]*J$$I;L/8\NMR]145K*;BTAF(P9$5\>F1FI:Z "BBB@ HHHH **** "O$4
M_P"3EK/_ '9?_1,M>W5X@G_)RUG[K+_Z)EH ]OHHHH \HL/^3B=5_P"O0?\
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M?7(XK&6+0I',F]IXQ*I,8 .T9XY)QZ]Z9+KFNJ8POAN9@Y()6=?E&XC)&/0
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MJG%.Z1$\56J1Y92N@J(VT+2&0Q(7/5MHS^=2T59SB!0.G%*.*** &NP52S$
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MP[_T$M<_\#?_ +&C_A2WAW_H):Y_X&__ &- 'H?VB#_GM'_WT*/M$'_/:/\
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DK0?#VOVVM6MQJ4MW;[MGVBX#K\RE3GY<]&/>@#N**** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>image1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "A +D# 2(  A$! Q$!_\0
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M"I'_ . TG_QRO4:* /+O^$O^(W_0J1_^ [__ !RC_A+_ (C?]"I'_P" S_\
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M)Q=M4]>VJ.3$W7H:U%%%?4G(>?>._P#D>? __7^W_H)KT&O/O'?_ "//@?\
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M1P3B:U%%%?7GGGGWCO\ Y'GP1_U_M_Z":]!KS[QW_P CSX'_ .O]O_037H-
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M_P#T46[_ /!>G_Q5 'H%%>?_ /"#^+_^BBW?_@O3_P"*H_X0?Q?_ -%%N_\
MP7I_\50!Z!17G_\ P@_B_P#Z*+=_^"]/_BJ/^$'\7_\ 11;O_P %Z?\ Q5 '
MH%%>?_\ "#^+_P#HHMW_ ."]/_BJ/^$'\7_]%%N__!>G_P 50!Z!17GW_"#>
M+_\ HHMW_P""]/\ XJE_X0?Q?_T46[_\%Z?_ !5 'H%%>?\ _"#^+_\ HHMW
M_P""]/\ XJC_ (0?Q?\ ]%%N_P#P7I_\50!Z!17G_P#P@_B__HHMW_X+T_\
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04 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>image2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image2.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !Z -0# 2(  A$! Q$!_\0
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M5K_^S+"2Z$0DV*Q*DXSA2>OX5SWBSQH?#$=@XLDN#=*3S*$VXQZ]>M '%_\
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M "BBB@ KROX^?\D_/_785ZI7E?Q\_P"2?G_KL* /5**** .+^*__ "3C4/\
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M5] 2%%%)S0(6ES3#10!M>%/^1PT7_K]A_P#0Q7OS7);2+2//>#C_ ($E?/\
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M*<MJ,*=M^/R!KYC/J#JUJ32V/;RF"E2KM](_YGNNEV\!TFQW0)\L2E04'RG
M/H,'/L*\\^/8'_"OC_UV%=Y8:>L^F:8\LLA:&-67:0H['!&!P,>E<%\>QCX?
MG_KL*@\@]5HHHH XOXL?\DXU#_KO:?\ I3%5+0HDD\$:$'<HNR09"!OXO<5=
M^+'_ "3C4/\ KO:?^E,54-%$?_"#Z"9!D!)."<9^:LZJ3BT]AQT9>6XB2'SF
MG7,60,<*<>U.BNI=06*;SA;H.0&&=_U]!5&6PLMZ7-OI[L ^YPI9U^N#[U9N
MFEF6'[/;%69Q^\="B8]#Q7@QC&,VIJZ1T]-!WVF\FNTAN86MXARLI((?_=_^
MO5EVM[:5<RRL92% +=_PJI>I=W,/D,T40(W"4-NVD>@XYJ*W_LV&*.YFD\^0
M#[\S9Q^'2L7-M<O0+(NRVY) -R5B;.5 R1]#5:6WFGD^RQZAMC"99FC#/Z8X
MQ4L4AFW7%MCRRN =V,_2JP@L9RUP[NET,J2C[<?7UK27O4TW+Y"6Y<AFE;5;
M>TS'Y:E6WDXX!' 'K4'Q>D,/POUF10,A8B/^_J5#H;60OLR3B>[\X*'=L$#(
MP .E2?&'_DE>M?[L7_HU*]7+/ATWN95=SY0-W<3').*LVDC;OF))_*JR1 \D
M_I5J-53G^=?5T5/>3N<KL=/I]Y@*#CZ5TUMJ\D4857&WTK@(IS&V5JXM^PQS
M2Q6 H8M?O$>W@,Y>'AR35T=;=:HTBG>2W/3=_P#6K"O;Y<'Y#_WW_P#6J@U_
MNZFJDT^[W%5AL%1PT;4U86.S>5>/+'1$=PT<A.8F.?\ ;_\ L:H%EBSY2R!O
M=\C^0JR_L?TJ!D]:TDKNYXEV:,'B:]B$0<J6B01HS*,A<YQT^M76UZ:[A>&2
M92LARRE0"2#]/\XKG)(]U0F,A@<=*CFY>ERKLZ.@>]4+>Z&S#.#CC.:MA]PX
MKKBTUH*YM^%,?\)CHG_7]#_Z&*WM/<-K,(&/]81^AKG_  F<^,M$_P"OZ'_T
M,5HZ3.&\20(?^>KC ^C5Q8J',V^R/2P&(5*G47=6/HO3UU Z7IOE^0@$2^:#
MGD<8QP,'&>PK@OCY_P D_/\ UU%=[97LD>GZ:B6TLHDB568*1LQ@9/ X_+I^
M7 _'O_DGW_;85X9QGJM%%% '%_%C_DG&H?\ 7>T_]*8JIZ#<&#P-HGR-(&1P
M5";L_,:N?%?_ ))QJ'_7>T_]*8JIZ#'</X&T-889)/DDW;%SCYJQKPYZ;B5'
M<FLDO%@"S(MODD+N/;\.*5XKMX6V%8P",L6!QSUQ4HM+V53$8+E$/)(0@_AQ
M43Z=J>]8$600L.93&=R_ATS7ESHU**:@KIFRDF0S6:PSPW%S>>?".#&4V 'U
M//-.:^TRSN0\:6\4C#[RJ*MQV=]:OA(YY6Q_K#%R?\*DBL)767S+5X]YYVPC
MGW/%8RPDE!2'S*Y5/F/+]H+HEN1\T8X9O?VJ"74;"T)*QPIYG)94')^M6H],
MU,O(1#N5#\I?*[_H,5#+)?F2)7TRZ95?D&$D<?A16P_+;D3!,FL;J"YN;79'
M!M\Q2,1C).>N?6H_C"#_ ,*LUH#^[%_Z-2I8K*XO-6M&FM)D$<@<R&+'3MFD
M^+-O/=?#/6(;:&2:9UCVI$A9C^\0\ 5[&!DY)75C&IN?)*L<@9[U85\GGK5H
M>'M:_P"@+J(_[='_ ,*F7P]K .1H^H_^ C_X5]'&22W.8KA^.:7S1FK0T+6A
MUT?4/_ 23_"G#0M9_P"@/J'/_3H_^%:^TCW)L5-V1_\ 6IN_#8/-7/[#UKI_
M9&HD?]>DG^%']A:S_P! ?4?_  %D_P */:1[A8IEMWX>E,)]JO\ ]A:QVT?4
M!_VZ2?X4?V#K!_Y@^H_^ C_X4>TCW'8S6'>FXSU%:IT#6"/^0/J/_@*_^%1_
MV!K(/_('U'_P$D_PJ7*/<=F9T,8^T*:V54!>E5O[ UK/_('U'/\ UZ2?X5>M
M=)UETP^D:B,>MJX_I5TJD%I<5C3\) ?\)CHG'_+]#C_OL57T"\#^.((@<G[1
M+Q]%:M3PKI&IQ^+M&>33+U%6]B+,UNX &\<DXXKZ&F\,VHU*.YM++3X54<XM
M4W%CG)SMS^M<N-K\LK1UNBXJZ+]A<06^EZ?'(ZH7B14!&,G ]A7GGQ[_ .2?
MGC_EL*[RPT<V[1"X,$T<2#RU$*J$;.21@?2N#^/G_)/SQ_RV%>0:'JE%%% '
M*?$K2M3UKP#J-AH]L+G4'>!X8BZIN*3(YY8@=%)ZUYE81_&K3+"&SM?#\"0Q
M+M51=P?_ !RO>** /$/M?QR_Z </_@7;_P#Q='VOXY?] .'_ ,"[?_XNO;Z*
M /$/M?QR_P"@'#_X%V__ ,71]K^.7_0#A_\  NW_ /BZ]OHH \0^U_'+_H!0
M_P#@7;\_^/T?:_CE_P! .'_P+M__ (NO;Z* /$/M?QR_Z </_@7;_P#Q='VO
MXY?] .'_ ,"[?_XNO;Z* /$/M?QR_P"@'#_X%V__ ,71]K^.7_0#A_\  NW_
M /BZ]OHH \0^U_'+_H!P_P#@7;__ !='VOXY?] .'_P+M_\ XNO;Z* /$/M?
MQR_Z </_ (%V_P#\71]K^.7_ $ X?_ NW_\ BZ]OHH \0^U_'+_H!P_^!=O_
M /%T?:_CE_T X?\ P+M^?_'Z]OHH \0^U_'(?\P.'_P+M_\ XNC[7\<O^@'#
M_P"!=O\ _%U[?10!XA]K^.7_ $ X3_V]V_\ \71]K^.7_0#A_P# NW_^+KV^
MB@#Q#[7\<O\ H!PG_M[M_P#XNC[7\<O^@'#_ .!=O_\ %U[?10!XA]K^.7_0
L#A_\"[?_ .+K'\2Z+\8?%6D2:;J7AZ%X6(((NX,@CN/WE?0]% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>image00015.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image00015.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" $E!2<# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#ZIHHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** $J.>988GD=MJJ"2?0"I*X#XL:
MM)#I]GHUDX%[J<ZQ@!L$1@_,1^8'XU=&FZDU!"98\,>,9]9\47>GF%$MD4M$
MP!W$#')_.NW'O7FFB62Z=\0+>SMU;;':?.2>>U>E"ML5"$9+DVL$1U% HKF&
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 444F: %HH'-% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MKIX,*YSM,A[]>?2NC"4'7G;IU%)V1Z3X*UZ7Q!HXO)K4VS;RNS.>]="#7/\
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MP3U#[3X6:U<$2VTS*P],GBNVKAZ<:+<=91:O\Q)GHM%%%</J,6BBBF 4444
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MV?Q:^@+'(;E(A*SC[HR,UOJ>A]:J47'<!U%%%( HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_FF \Q-+CV2S'GS;HGYF)]1S],#TKU*N0^&-@UMX>-Y,FVXU"5[MQ_OG(_\
M'=M=?5XB?-.W;0FG&T0HHHK T"BBB@ HHHH **** "BBB@ HHHH **0,"2 >
M1UI: "BBB@ HHHH **** "BBB@ HHHH **;+(L4;22,%1069CT %4=$O)+^T
M-RXQ'(Y:+C!,?\)_$<_C3MI<#0HHHI %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MZUJVM:CJ6L7PE^TO;%X'\KS0G'H>/;VKU;5+N/3M+N;J3Y8X(V<_@,UC_#V
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?\A;1"<_\\&_^)H [NBN$^P_$/\ Z"VB?]^6_P#B:/L/Q"_Z"^B?]^&_^)H
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MYF]2DDE9%+4_A?I$UV;O39)K"X ^4(V4!]?4?@:JMX=\<V$X;3]>M[F/M'<
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M&FL 9_X0G7/^^HO_ (J@^,]8 S_PA.M_]]P__%4 =O17$?\ "9ZP/^9)UO\
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MM%% "8I<444 )CW-*!BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M:3EUEHO3J+J;2+BG8H I:Y+#$P*7%%%, Q28I:* "BBB@ HQ110 8I,"EHH
M,4F*6B@!,"EHHH **** #%%%% !CTHQ110 8I,"EHH 3%<%\:9 /!4L6[:TT
MBH.<9.<X]^E=Z:\T^,DN]= LF"E9K^/()QQG']:Z,(KUD)['>:%"8-)LXFZI
M$H/Y5H5%;C;&@[!0*EK"3NVQH****0!1110 4444 %%%% !1110 4444 %%%
M([;49CV&: .:@A>]\=SW+X,5A;"!/]]SN/Z ?G735SW@^87:ZI>+R)KV0 ^R
M80?^@UT.><5I4O>SZ$PVN%<[X]UC^QO#=S+'S<RX@@0'EG;@8_//X5T+L$4L
MQ 4#))[5YU;7 \=>+XI[5EDT'2'SO'2:?V]EITHIOFELA3;M9'6>"],DTCPQ
MI]E/CSHXQYF/[QY/ZFMJBBLY2<FVRDK*R(;FZ@M@IN)4B#' +MC)IAOK4*6-
MQ%@=3N%4/%6E6.JZ/=QZC:0W*"%\>8@8K\IZ9Z&OFWX):1INH?$..*\LH+A(
M89719(P0#TY]:0SZI5@PR.0>E+6!<^)O#VDW)LKK5;"UEC49A>54*CZ58O?$
MNBV,L,5YJMG!),,QK)* 7'M0!JEP._%)YB?WASTYZU3U+3=/U:V\G4;2VO(#
MSLGC$BG\#7R-KNA2:!!8ZK8'RUFF?R608V,C$ <?2@#['# ]*3>H."16/X4U
MN+Q#X?LM4MONW$8<K_=;NI^AKPOXY32ZQ>'45F<65I<M8P1@861E^^V?][(_
M"@#Z,$BGH0?:G5Y;\!=$TRW\#6.HQV5NM]*\N^X\L>8<2, -W7  Q7<ZAXET
M72[G[/J6JV5K/_SSEE"G\C0!LT$XZU#:W4%W DUM-'+"XRKHV0:KZKJ^GZ5"
M)-2O;>U1N TT@4&@"X9$!P6&>_M1O!_I[U\V?M"V^EW&JZ+J>EK;2"[C<--
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M4+R&V2/=RJLX#.1Z $UUZD;1TZ4 +12%E'4C\Z7(]: "BF[U)P&'YT[(]10
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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ME#!W>Z?"E0#E #A1ST&,]Z[[Q/XONM(^$=GK<#!M0N+:':[<_O&49;^=<?\
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M+'AMB<*(I>G^X:Z,-\3?DQ,]&%+2"EKG&%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !BC%%% "8'H/6EQ110   # '%&*** # ]!
M1@>E%% !BC ]!110 8'I1BBB@ (!Z@&C ]!110 F .@%+THHH *,444 &!Z"
MC ]*** # ]*,#T%%% !@>E&!Z444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M>F\M-(TZ"\)),\5LBR$GK\P&:5-!T>/4FU!-*T];]B6:Y%L@E)/4EL9K2HH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M1@HY)XYJ!GHO6BH/M=N+?SS/$(>OF;QM_/I38-0LYY!'!=V\CD9"I("3^&:
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M\5PGB.RT&Q^%UYI5M NIZW9Q;YK^UBRR2;P2YE.#[<$FO1/B?)>ZC\-]3DT
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M !1110 4444 %%%% !7)_%"-G\$:DR#YHE689&?NL&_I76&J>KVHOM+NK1L
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4V3IZ>].HZT >7:OK/CZZ\0ZAHUEH%M%ISD1Q:D\W"(1RVT<D]>.*[
MWP_I<6C:/::? Q=($P7(P68Y)8_4DG\:T]HI<8H ,4444 %&*** "C ]***
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M*** "BBB@ HHHH ****  #THHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
0B@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>image00018.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image00018.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" % !&$# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH AAB>-Y2TI<.V0"/N^U3444 %%%% !1110 4444
M%%%% "&F0L[!C(H4YP.<\5)BB@ HHHH **** "BBB@ HHHH *"<44-T- "$U
MY?\ &'7[Y&T[PYH$S#4]0F5)!"NZ6./KN'8?4FNI\<>+;/PMIGFRE9;R8^7;
M6V\*99#TR3T7U/2LCX8Z%Y=B-?U6W<:]J"[YGED,C(#T4?*-OT&?J: .A\(Z
M#:Z!I*PVL)B:0^9*&DWY<]3G _D*W@,"DI: "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBD-# "<4"L/QGJW]B>
M'[J]5&>15VHJ]2QZ5SGP6GN+GPJTMU++*6DPK2')X !_4&M%2?LW4Z!?H>@4
M445F 4444 %%%% !1110 4&BB@"-A)YJ[=NS^+/6I*** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MUZT /HHHH **** "BBB@ HHI&.!0 M%,5LM@'/\ .GT %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %9'BJ]&F^']1O2P4PP,XSZ@5KUP'
MQLN?(\#72[L>9)''@=\GFM*4>>I&/F!YC\)+3[5KVEP,FZ-,RMGU45]&+7C_
M ,"]+D3[7J+ -"5$4;>_4XKV!3G-=&.GS5;+H3'86B@T@.:XRA:*** "BBB@
M HI":4&@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH #2 \TI&14,=NJ7#S G>RA3SQQ0!-1110 4
MA-0QW<,L\D,4L;R1XWHK LGU':JUY>6YMK@K?00E/W32%P1$YX&?0Y[&@"\&
M)/\ ]>E%9EA:ZC'<E[O45N(2N!&( F#ZYS6H* "@FBH+FYA@:))IHXWE;:BL
MX4N?09ZF@"93FEJEOM=,MD6>>.*,$(K3.%R3P!D]S5O=ZB@!U%0RW,4+()9(
MT+G"AF W'VJ'5=1@TO3[B^O&V6UNADD;&2%'M0!C>./$UOX;TWS)2QN;@^5;
M(B[B[_0>E,\#Z$]CIXO]6\NXUV\ >ZN0A4MQA1@\KA0!CUS69X3LKK7]4B\4
MZK]HBB:-ULK&=-K1(6/S,/5A@_3%=V* $ P.*1^G%.K,\1ZI%HVD3WLY.V->
M O5CV % &%);#5OB-'-^X>VTFTPPSEEGD.<>Q"J#_P #KK]N#GO7.>!;22VT
M))[E<7=X[W4S$@ERQ^4GZ(%'X5T@.: "BBB@ II8C\ZBNKN"T@>:ZFBAA3EG
MD<*H^I-<5J6I:CXIU1;'PQ=K#I$>?MFJ0.&RPQB*(@_>YY/84 .\3Z_=:I>2
M>'_#!62]DC#RW<4R8MT#J&/7.X ]*R_$D<7@/P%/;65PMUJ6H3+"9KN3:\SR
M,$+$C/0&NUT+0K+1(9$M(R7E?S)9'^9Y&.,DG\!7'Z:?^$L^)-W=3102:=H:
M-;1D3A]TS%2&VCI@*>O]* .L\&Z,FB>';.R"Q>8D8,C1]&;KGWK<"@4B#'\J
M=0 4444 %%%% !2$XH)Q4%Y=P65NUQ>316\"#+R2N$51[D]* )F;'<?G7-7&
MO7-[JZ:?HMJ;F..1!=W60(XT."=I_B;!Z#.*Q[&XUGQD)C%(^EZ,)#&I\O\
M>74?<@G!4'U'X5UVAZ/9:+IT5CIL*PVT8X5?7N3[T 0>&-$AT+2XK2*66X<
M&2>9MSRMW)/K6Q28I: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH ***0,#TH 7->3?M#W)B\.V$0_Y:7&/R&17K&17BGQXNA>:QHFEH<8D$C'T
MSQ75@E>LO(4MCT;X>Z2VC^$].MF"B3R][@#HS<G^==*!38^%%/KFE)RDY/J/
M;0#4:"02R;BNPD; .HXYS4E%( HHHH **** &N"5.W&<<9]:2+?Y8\W&_'.W
MI3\T9^M !1110 4444 &:*AS)YQ7:/+V\-GO4PH **** "BBB@ HHHH **,B
MB@ I"V.QH)K#\8:W'H&AW%](1N1<1IGEW[ 4TG)J* M6^N6-QK5QI<,P>\MT
M5Y$ SM!Z9-:=>=?!J!Y=,OM2G;S)[R=G:3').>1] <C\*]$%76@J<W%=!1=U
M<6BBBLQA1110 55U._@TVQFN[LLL$*[G*J6('T'-6J:Z[A0 RUG2YMHIXL^7
M(@=<C'!&14M-0;5Q3J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "B@G%&<T %!Y%%% $:PJLCN%4,V 2!R<>
MM-:VB8$&-"&;<1CJ<YS4U)D>M %3^T;/^TO[/%Q$;T1^;Y 8;PN<9QUQS5@3
MQF39O&[&[&>WK2E 6S@9Z9I=O.?Z4 0F]M_MGV3S4^T[-_EYY*^N*DD5&96=
M1E3E21TI=@W$X^;UI<'_ !H H:EJ.G64EM%J-S;0-/*$A69@I=\\;<]35W@>
MU#1ACR ><TNW'2@!CQ)*4,B!F0[E)&=IK@+P2^,?&4<(6ZBTK1IV6X##:DTH
MZ ?WAZUM>,-6NHY+?2=*A,U]? @,DBJ84Z%R"<XK8\/:/!H6CVFG6N]HK=-@
M=SEF/=B?4GDT : 7CCIVIX&!0.E% !7G'QKNYGT?3M(M+:[N)M0N5#"UCWLL
M:XW' Z=1S7HK'D'M7C.MPR^./BE/#HLA@&BPI!/?;B&B9B6/EC^\0<9[8H [
M/4?$UOH=U9Z#I%G)>W4<&3%"P8PHH_B&<Y(_F/45H>"?%EIXKTY[JU7R)(W*
M26SRHTL7./G522N2&X.#Q5W0?#]EH=N8[-':1L^9/,V^23DGYF/)Y)_.N=\1
M>!#<ZZ=:T&^DTS4&PTJK_J[AEX4O] 3T]: .XWCKV]:PM>\6Z3HJA;BX\ZZ9
MS%':6RF:9W"[MH1<MG'MQD9KEO\ A$O%NL,P\1^)/L\838!I3/&'!8Y# X!X
MP*Z'P[X(T70+A[FRM3)>.,&YN',DF, 8W'G'RC\J .?72-?\:+:3>("^DZ6L
MID;3N"]PN5*"3'3!&<>]=QI.F6FDV:VNGV\=O;J20B+@9/6KN,44 <M\1_$!
M\-^%;B[C5Y+V5A;6D:*2SS/PH&!G.,G\*;\-/#9\.>'5BF99+NX;SII/*V,Q
M/.&[Y&3UKGM10^(OBM9QQ13[=$7SC,S9B&]64IC^\<J?^ UZ6G&: '@8HHS1
M0 4449H 0MBDW<@>^*QO$WB33/#=B;G5KN.!<'8A/S2'^ZHZDGMBN5O)O$WC
M.UB@L+:Y\/6#N1<37#8G=1V0#D?CB@#9\2>,;73;Z/3-/C.IZU,P1+&W8%TR
M/O/SA5[Y/:LVS\):QJ]]!>>+=46>W53NTN*,"')_O'^+%=#X5\,:9X8T_P"R
M:1 8XV8NSNVYW)[ECR:W%&,_G0!';6\=M D,*A(T4*JCH .@J6BB@ HHHH *
M*** "BC-% !1110 4444 %%%% !1110 4444 %%%% !5/4)I8+222"!YY%&1
M&AP6_&KE)C%)@1R$ $G@8YKYH\233ZCK,NOM^\M9+QHXR3P!GC]*]Z\=:G'I
MGAC4)Y'"GRF53GJ3Q7FVN^'&L_@Q!YZ>7>1LMW(/0EMQ'Y<5Z&":A[SZNQ,C
MV='&T'(IX8>HK)\,WG]H^'=-O#P\UM'(WU*@FO/U\6:I'\7GTR>5ETMR((X>
MH)P,-^>:Y8493<EV*N>KYSTHIHHK&X#J,TWM6=J^L:?I%N)M2NXK:)N TC;<
MTU=NR T\CUHR/6LW1]6L-8M?M&EW45U#G!:-PV#5\].U#NM&,5B._:L31?$V
MF:S>W=KI\_F2VK^7( , &N+\8^*;W6M:/ACPJ&^T'Y;JY'2(=_\ /N*['P=X
M=M?#6D)9V_SR'YII3UD;U-;2I>SA>>[V0DS?!![TM4VOK5+U+5IXUN64LL1;
M#%?7'I5KFL=5N [(]:,CUK%\6W@L/#>I77S#RX&8%3@@XQQ[U2^'T<?_  BM
ME/'YG^D+YK>8Y8DGZ_2J47R<_G8#H)+:.2>.9A^\CSMY]:FR!U(HJ.0A%9F(
M ')). *BX$N1ZT9%><>*/B?IVG7B6.C(=8OVR/*MCO"D>N*H+XM\=78+VWA5
M((P,GSV*G]2*Z5A:C7,]/70GF5['JV:,UXY9>.O$NI:DU@AT&SN@I.R2?<>.
MO?J.OX5Z=X=NKJ]TNVN;ZW^SSR(&>,'.TU-6A*E\0T[FK1116(RK',[7<L)@
MD54P1(1\K?2K0Z"BB@!K'!KQ;XP:@=1N;N-&4VNEJ$X/6=A_0$5ZKXFU2+1M
M'N[^XR4BC)P.I/8"O&I-*DEU/PIHUZA:]NY3J>H>N7;)#?[HX_"NS!QM+G9,
MNQZWX#L&TSPGI5M(NV5;=#(/]HC+?J3704V/IQT[4ZN24N9N3ZE!29 ZD4IZ
M5R_Q&OCI_@S5+A)O)?RL(WN?\FG&+E)174#IDD1QE&5AZ@TZN&^#]DMGX%LG
M7(-RSSL/<G'\E%=R.E.I'DDXKH 4445 !110>E !D>M0&\MA=K:FXB%RR[Q%
MO&XKZXZXYJGKVK6^BZ5<ZA>-B&%<G'4^U>"ZEJ&K1^(=.\87"O;+=7.R%6//
ME>GT-=&'P[K7>W^8I.Q]&Y'J**@MI/-@CD_OJ&_,5/7.,**** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MJOT8HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MBBBBLAA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %&*** "BBB@ HHHH **** "BBB@ HHHH ***3- "T49HH **** "BBB
M@ J&YB,P0"1TVMN^0XS[5-10 @[4M&** "J]U ;B$QB5XR2#N0X(YJQ1C- %
M.XGGAFMHX8#,CMMD?<!Y8P3GWJVO(I-@/7/YTX#% %/5WDCTVZ>%)))%B8JD
M9PS'!P ?6O-?ACJD>D_#G[9=0HMP@?:S1B-KEER0,]SQCFO0O%&?^$?U''7[
M-)R#@CY3WKQ7X31-XGTBRTBXGO+BQMY?M=U*9B/-;.50CJ%Z<4 >H_#G0IM&
MT$-J4TMQJEZQN;N69BS%V[<^@XX]*ZPJ,=*:@QQ3F.%- '(^,KZ6[9/#VF3M
M#J5]&6$D;[6ABZ;_ .?%;?AW2HM$T2RTZW'[NWC6/.<[CCEL^I.361H>W5/$
MVIZC)$I%HWV"WEV]0OWR#USO+*?I754 )GFO//B1*VLZQI7A8),MO=NL]S<1
M/]U 3\A ]<=^*[^>588WD=@J*-Q)[ 5YQ\+[:35]8UGQ7>QHSW4SPVMP%92\
M"L54XS@C '.* /2H46.)4C5411A548"CL *?2*>M+0 44C-@9I@E7>%)&XY(
M'>@"2FYQUIU<O\0?$@\+>&Y+\+OE9UAAXR-['OZ# - '*7?D>-?B0+&YC1K'
M0'\XH&8.9L##'!P1SP,9SGUKU%2?K7*_#C1O[&\-IYG_ !]7DC75PV_?N=N<
MY^F*7QEXOL_#:11R*TMW,0(T' &3@%CV&30!+XT\76?AFS4NK75]*P6"RB.9
M9?7:/8 G\*PO!OA74CK8\0>)+QKF[57^R0[FQ ),;LY.,X '''%2>#O"NHO?
M0:YXMOEOM20-]GC4#R[<-Z$#DXXR?6N]"T "\G/MP:=0!BB@ HHI,T +129I
M: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *0G%+5;4+1;VUDM
MY'E17&"T4A1A]".10!8#9)I<UR/_  @MG_T$]=_\&<__ ,50/ MGWU/7?_!I
M./\ V:GH!UN:"<5R9\"V!SG4-=/_ '%;@?\ L]-/@332,&]UQO7.KW7_ ,<H
MT Z>ZNX[6VEGG.V*)"[$]@!DUYG\&+22_?5?$E\C&YOIV\MV[IGD =N:H_%;
M1=-T/PVPMKK5_M5TXB17U:ZDW GD%6D((QFNGT/X<Z99Z3:P/+JR.D8WB'5K
MI%W=\!9 *Z%^[HM]9?DB;ZG=9XXHS7)?\('IVW OM='_ '%[G_XY1_P@=AC_
M )"&N_\ @VN/_BZY[+N/4ZW/M1FN27P'IXZZAKI_[BUP/Y/0W@/3R<C4-='_
M '%K@_\ L]%EW&=6_(ZXKG_%WA>Q\3::;6^4AU.Z&=3AXF]0154^!;+'&I:Z
M/^XI/_\ %4S_ (0.RP<ZIKQ_[BL__P 53B^5\R=F@.?LE^(>C6ZV*0:?JT<1
MPEU/(5<KZ'GFBXTCQMXH?[-K<]KI&EGB2.R.YYAZ%NH_"M__ (0.QX_XF>O#
MW_M6X_\ BZ&\"61/&K:^,?\ 44F.?S:MO;:\R2OZ"L;OA_1K+0=*@T_38O*M
MHAP,DDGU)/4TSQ%#J<VERIH=S%;7Q^Y)*F]1^'>L0>!K0D@:QK_T_M*7_&E/
M@6(KA-<U]5]!?N?U/-9?:YF]1F';_#3^U9OM?C/4[C5;HGA$=HHE'H%4\<^E
M>@:;I]MIEI':V,20V\8PJ+VKFQX$B '_ !/-?X_Z?WI?^$&AS_R&]?\ _!A)
M_C3J595-&]/P!:%WQQX<7Q+HOV03>3<Q2+/;S;<[)%Z'Z4SPWH=Y:S+>Z[>I
M?ZBL?E(R1[(XU[[5[$]S["JG_""Q'_F-Z_\ ^#"3_&E_X06'C.M:^<?]1"3G
M]:.=J/+<#KNO6FA0.F,]_>N3/@2V/_,8U_\ \&4O^-*O@2V'76->/_<2E_QJ
M++N!U$<$4;NR1HC.<L5&"WU]:DQ[UR)\"6I/_(7U_P#\&4O_ ,51_P (-:=]
M5U\_]Q*;_P"*HL@.NZ=LTH/J*Y'_ (02T(XU;7__  9S?_%4H\"6H_YB^O\
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M^8O_ (FE8+GI>:,BO-/^$"\4\?\ %?ZK_P!^8O\ XFC_ (0'Q/C_ )'[5?\
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M#O5D_,2V%HHHK$84444 %%%% !1110 449STHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ K/US4H=(TN[O[G)B@C+E5ZM@9P/>M#->.?
M&SQ#+,\&B:;%'=X827*(-SJX.47T!) Z@T 9/PDANM;\>7>L7PD$\8>:1I=W
M+,"-BC=A0N?3M7NZ]3UKF/ /AS_A'M&\NZ,<E_<'S+F1!A6;_P"M^M=0N>]
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MYF+'GN:DHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@^T&>6;/;Y%W5OA=*B?;_(3V/1K.,PVT,9Q\J*IQ["K%)BEK 84444 %%%%
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M8$L$LTC(X!'(^48;&<'FI?B#\.O%OBGQ,=3632$CC5!#$9I ?E.2"=A_/]*
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M "$XJAK5_'I>DW=]/DQV\32D#^+ SC\:OM7FOQHU.0Z79:'; FXU.X2,8..
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MT4%RQE5[?FQ/L>H1(L:A5&%48 ]*D%(HY]J=7-U&%(#DFEHI@%%%% !1110
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M!I7SZUX7F\CKYMK*) ![CM^-:^B>/= U555;U;:<]8KCY"#]3P?P-=20#UK
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
7 "BBB@ HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>image00008.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image00008.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" $* F<# 2(  A$! Q$!_\0
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MQ'=QSLL[3B!7SO!W99A@G/<U1\0?!FVUGX5Z+X2DU9H;W28_+M]42WY (*R
MQ[_NLI((W>A[5Z+X6TA= \,:1HR2F==.LX;02E=I<1H$W8[9QG% 'S1X\^(W
MB/5/ '@*[\,:C<K?VVF-K6J&&=D,RP.D+!\'YE+^82#QQ78>+?%.H:_XF\7W
MF@ZK>V^D:'X+DNE6WG9 ;JXA:6)R <9$>"#U!&16]X'^"5CX9N?$_GZH]_9Z
MO:2Z?!;FW\O[';2.[M&#N.[E_0<C..:F\#?!]?#'P_\ $_AV;7'O[O7+=[5[
M]K;88H_(\F-=F\Y"#./F'7'% 'FOQ#@UB/X Z'XXMO&'BNVU9--LHVB@U-T@
ME+, TC@?,7.XY;=V%:OQ&\.^(-#T7PAHWAKQIXI?4-9U!V%U?:FSOO\ L^5C
MW#;^[W*.#GJ37H?B+X7_ -L_!JT\!?VOY/V>"WA^W?9MV[RF4Y\O>.NW^]QG
MO6YXD\&C6M3\)7?VXP?V!=?:=GD[O/\ W93;G<-O7.>: /,-)\>ZAXF^(WPH
M9+JZL_M,6I0:MIZ2LJ?:882&61 <':PR,] 0:Y+]GF\U#Q'>Z#<ZOJGQ4N;Q
MIY'>Y-PSZ,X3<0KLV200NTC^\<5ZV/A):0_&.V\=V>I/ D9EEDTT0Y1YY(C$
M\@?=\N1M)&WDKG/-9OP[^%?BOP3!8:=9_$-I/#]M*SOIXT6)#(K$EE\TNS*2
M2>>U '%?#_6=4M/B%!:_$7Q1XITCQ5+?LB6-P<Z3?1D_*D(Q@$Y #9ZXZDXH
M\+:SJEE\3/(^(?BCQ3HFO2ZH5M+:0YT>]@W#;'&,8!(XW9&,COD5W<7PFU:^
MU?1Y/%OCF_U[2-'NEO+.RELXXG\Q/NF28'=)COD<TV3X1ZOJ>H:9'XH\=ZCK
M6@Z;=)=VUA-9QI(73[OF3CYG]\CG]: )_C]J>I>'++PMXCL+^ZMK/3M8A&HQ
M1S,D<MM(=K>8 <, 0 ,]-U<=)XVUI/VCXY#?7)\(O>MX=\@3-Y(N1 KYV9V[
M_,;&>N!7LWQ \,P>,O!NJ^'[J7R8[Z'RQ+LW^6P(96VY&<, <9'2O/)/@DK_
M  QB\,?\)#*-5CU3^UQK/V7YS<[B=^S?UVG&=WO[4 >=:WXPU_\ X0N#QA#J
MNLRVVJ>.D6TM[.X<L]A&)5$,:A@"&*'*\!B!FNHC^(>H^(_C]X&L[?3_ !7H
M&G/!>"XL=6@:U6Z(AD96\L,0X! Y/0UVNH?"F"?P-X,\-VNI?9X_#E_;7_G?
M9]WVEH@VX;=PV[RY.<G'O6QKW@8:M\3?#/B_^T#$=%AGB^R>3N\[S49<[]PV
MXW9Z'..U 'A/[/-YJ'B.]T&YU?5/BI<WC3R.]R;AGT9PFXA79LD@A=I']XXK
MED\6ZA)%J9TGQWXME^(/]N/;Z?HHN));26(R@#*LNP<%NK8X'&.:]T^&_P +
MO%?@9-.L+/XA>=X?M9C(^G?V+$OFJ6+,OFERPR2>>U/D^"]K-\/M4\-S:LQN
M;C5)-6M-02VVO9RLP(VC?SC!!.1D'M0!P'Q.U34Y?C->:;=7OQ$:SBTJ"86G
M@^5BR2D_,S)G 7KSUSBMZ0:UXL^)$/@.U\3>(='T31-&AN;BXCGV:C=R,$QY
MDN.& 89XZAN.1CI-9^&7B>?QB?$VA^/%TC4YM/AL;IUT>.<3;,%F =R%#,,X
M[=,FIM;^%VJ7>K:?XATGQC<Z5XOBL5L;S4X[&-X[U1@EG@)V@DCL<# ]* /-
M]<UWQ+X/;XD>#9/$>J:G%9:(NJ:=J-Q*?M5OED4J91@D_/U_V>,9-=9^SSJG
MA[4Y7?2O'7BCQ%J_V"-KVRU6YEEAMV.W<4WQJ,ALC(8\?G6M;_!Q#X=\50ZG
MXANM2\1>(X!!=ZO<0+\JK]T)$" %&!QN[#G@5Z3X?T[^R-!TW3?-\[[';1V_
MF;=N_8H7.,G&<=,T >3:SX[\:VO[04/AFQT07.BMIZ2_9_M<*;XS+AKS<5W#
M;\R^5G)VY[UP?PX^).H>!/"FOW4GA2^U#P_!X@N?MNJ)<I&L!DD50%0Y9SDC
M/0 L!GFO9?%'P_N]4^(VD^+](\0S:3=VMLMC<Q"U287-N)#(4!8_(2206 )Z
M8Q6--\'O,^%OB/P:-<Q_;&H-?_;/LF?)S-')LV;_ )O]7C.1USCM0!2^('QT
MM/"_BB^T;3]*@U(Z;&DE[+-JL%GMW+N B63F9MI'"]SBNZU#QK:Q?#&;QI86
M[W-HNFG48H';RV==FX*3@[3V/7\:X+QA\#$UCQ-<ZYI&M6EC<WD<27*7^B6V
MI(QC0(&02_ZO( SCK75>.M"N;;X(:OH=G']MO(M%>U1;2U$7GN(L?)"@PNX\
MA%&!G H P-!^,5W>ZYX:M]8\'WVDZ3XC51INHR722"5R@8 HHRH.1@DY((..
MN*<7QPEB\<6&@ZMX9CLX;Z_73XI4UFWGN%=FVJ9+=,LBYZDGCWJ+X<_"O4Y(
M/ VK^*?$>HW=OHUE!/9Z+<6BQ&SF,*Y5V&&;8> & (V@9ZYH:)^SI'I.M:1=
MP^)4DMM*U.+4+>-M(A6=@DF\I)<*0[YZ DX']WH* --?B[XEUF/Q"OACP)<7
M4.DW%W9S7[:E%'&DD0.T@,OS$@ E>V0,G-</;_$OQGJ7P_\ "5[XET/5(K"Y
MU&!?[>T[6X;5[IS(RA7A2,D(>05P =HY&:]L\"^ H_"^D^)M/EOVO8M;U.YU
M!B(O*,0F55,?WFSC;][C.>E<A9?!>]B\$V?AF[\72W5C8:E!?66[3T7R(XV=
MC%P^6+%S\Q/&!@8XH J>+/V@K#0O$NJ6%OHZ7FGZ3<&VO;EM4@@F#@X816[G
M?* <C(QR#6QJOQA\CX@1^&M*\/2ZA&$MY);G[;%#(4F4,K0PM\TP /.WI@UD
M>)?@,+WQ-JNK:'KMA8KJ=PUU/#J'A^UU(B5CEBCRC*J22=OO6KXT^$%QXJ\0
MP75UXG>+1XI()1IXTZ%FB,2J,0S'YH5.W)5>,D^M %?]J.<VO@31YUCEE,>N
MV;^7$,N^"QPH[DXXJ]HWQ5U*XU'Q!I6L>#KO3-;TRQ_M*&R:^BD^TPD@ [^%
M4Y(SU YYR,5TWQ,\&_\ ";Z/86'V[[#]EU""_P#,\GS=WEDG;C<,9SU[>E8'
MC;X3P^*_%&MZM<ZO+;QZGH@T8P10C='B991)O+<\J!MP.,\T <SH_P >;B^?
M7+63PM"-4T[39-4C@M-:AO(YHXV =6DB4A' R=N">.<9%=)-\7M/%QX8%O9&
M:UU329M:O)A-C^S[:./<69=IWG<&3MR*S?AO\%O^$0\5KKEWK=MJ#_8'L)((
M-(ALHW5F!!Q&<$X!!)!)SUXQ3_A[\$;#PI_PD$5[JTVJVNI63Z9!&\7EFTM'
M9V>(-N;=DOG/'(SCF@"EX'^/5IXE\4:9I=QHL=E;:JS)93QZK!<R$@$@30H=
MT.<=\\G\:Z;XL?$MO EWHUE;:/\ VG>ZHT@B$M]'90J$QD&63Y=QW<+W^N,\
M[X$^"4WA'Q)IU[#KVF76G6+DI;R>'+1;EAM(&;H#S-P)!W=3C%=3\5/ =_XX
MM[>"R\0_V5;JCQW$$MA'>Q3JV.=DG"N,<,.1GB@#F[CQRD7Q-M;F]M]?M43P
M@^L36/VP>2@$C$J;8+\TPP0'W],#'>F^&_C'J>M>(]'TY/"EL+;4K)M26XAU
ME)7AMPN<R1B,;6Y4%<Y!/?%0:]\)YM%TV?4-!O+N_N++PE)X?M[( )+,2682
M"7/!^;A=O8<UP_P-L/&MAXFL-.71KVVT>:T:#59;_P -6^F>3B/">7,AWSG=
M@9;DCDCG( .RT/X[WFH67A[5;OP1?6?AW5KM+#^TC>HZQSLQ7A-H+("#ECMZ
M$8R.6^(OVA].TCQ#J5K#HZW6DZ;=&SNKLZG!%/O4[6,5JQWR*#W''!K;A^#W
ME_"WPYX-.N9_L?4%O_MGV3'G8FDDV;-_R_ZS&<GIG':L36_@$)O$&IZAH>O:
M?90:A<O=RP:AX=M-299'.6"22C<JYZ+VH M_$7XG7EQ+XK\.^&/#-WK,&GZ:
MQU+4([I(1:B6$E"JL,R<<D @\' .*M?!K7;ZR\%_#72+?1+J[L=1T^5KC4HR
M?*LC&I90_P I'SG@9(_&K'B/X27%]XJUG5-"\57FAV6NP);ZM906L<GVA438
M-CM_J_E)' )Y/(S6OX8\ 7V@)X+@M_$MT;'P_;36]Q:1Q&.+4"ZX5G7>0-IY
M&=WX4 =_1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4V1MJDXS3J9.<1,: (_/_V?UI?/X^[^
MM5\DFG?2@"8S'^[^M FS_#^M0_A1GU% $WG?[/ZTOG?[/ZU!^%+[_A0!-YQ_
MN\?6CSO]G]:A7FANG- $PF)_@_6D,^/X?UJ$'_.:0].M $_G\?=_6CS_ /9_
M6J_3KP:4GCF@"?SS_<_6CS_]C]:KY_.E[=: )_/_ -G]:#,1_!^M0]/Q_6D!
M]* )_/.,[/UH\[_9_6JY.!S^5*#0!/YW^S^M!GQ_#^M0YYI 3U[>E $WG\XV
M_K2^?_L_K4!;CM0".,T 3^=C^']:3S_]C]:BHQZ\T 2_:/\ 8_6E\XY^[^M1
M9'6D- $WG<XV_K2^=_L_K4)/('%'44 2F?'5?UH\[C[OZU!_%2]#UH F\[_9
M_6CSO]G]:AX-'?\ I0!*;@C^#]:3[0?[GZU"0.M!Z\&@";[2=V-GZT?:/]C]
M:AH/O0!.;C!Y3]:BN+WR8FDVH%0;F+OM 4=3T/:FYY_D:YOQ]=/:^%[N.W"M
M=7A6RA5NA>4A!G_OHG\*!%WP;XI;Q-HXU---N+.UE8FV:9U)GB_AD '0$=CS
M6[]H.,[/UJG9V\=I:0V\("Q0HL:#T &!4X/% R;SSV0?G2?:&_YYC_OK_P"M
M40_"CM@T 2&X<=(QG_>_^M0UPVWY8P6]"V!_*HQS_P#KHR!GUH =)<S!!Y<,
M;/W#2$#\]II5N7*#,:[^X#Y _'']*C-"C.: )OM#<_(/;YO_ *U117-PRQ^9
M!$K$_.%E)"_3Y1G]*4'&>,TTF@!IN[SSU M;?R2Y!;SSN"X&#C9U)SQGCU/2
MK"W#EFS& O8ALD_I460P[4HZ>G- $WG_ .S^M'G_ .S^M0@D\4HY[\T 2F?'
M\/ZUE^)M=_L/P]J>J?9Q/]BMI+CRS)LW[%)QG!QG'7!JZS5RGQ,._P"'_B)"
M,EK&50/JM5%7DDQ-NQTVEZD][IMK=20")IXDE*!]VW<H.,X&>OI5&Y\1^3XM
MLM$^R;OM%I+=&?S/N;&5=NW'.=W7/:L?POXBBO+L:2MK<1>1;*T4[XV3A#L?
M9SGY6&.1S56^8#XL:42#SI-P ?\ MHA_I5J'O-/S)YM#N!=YZ*#@X/S=*QO#
M7B8ZW<:S']D\A=/OGLPWF[O-V@$MC QUQCGIUK,6^^S?$!]/#96]T_[5C/W6
MC<(3^(<?]\UF_#QQ%XA\<6N1\FK>:!CL\2'_ !I**Y6P;=T>@_:/5/UH^T'^
MY^M5LC_"EQG\:@LL"XR<;?UIWG?[/ZU7''%!/?FD!,9\'[OZT?:.1\O7WJ#/
M--/]>N: ':GJ,>G:?<WDX_=6\32M@]E!/]*;I]_)/IUO<75O]GDDB61XM^[R
MR1DC.!G'TKF_&+O=1:;I:')O[M(Y.?\ EDF9'_1<?C47Q,U.73/ >LSVY(N'
MA,$('4R2$(H'OEJVC3YE&*W;(<K-OL:_@OQ*WB7P]!JILC:I<,_E(9-^Y Y5
M7S@?> SC'>MWS?\ 9_6L'PKI:Z)X<TS2XSE;2WCAR>Y  )_.M>HJ<O.^78<;
MV5R?S?\ 9_6CSO\ 9_6H>AYI>.]042^=_L_K2>=S]W]:CS32>] $_G?[/ZT5
M7W8&0,T4 7:*** "H[C_ %+5)4=Q_J6_#^= %7]:* <C(H)Q0 M&>:3/'-+U
M% "_G03CTI,\\&C/(_44 +]*"31DCK^%-9LJ/6@!6]:3CTI">.U#9/UH .GL
M!2$BD)P/:DSQTI@// ]*,\9%,5^#GI1N&.>*0#R>,DC\:!TS4><]*3=[X-,"
M7CO1TJ-6R?I63J.NI8ZU::>UG<R-<*&,Z >7&-P7YB3GJ1T'<46"YLYI3D?2
ML_7-0&F:/>7P1)/L\32!&?8&QVSCBN6\-^/+6[TK49=6(MK[3V/VF!4.8P6V
MH.X)/ X/IZT)7%=';LRC[Q R>].4Y[UXWJWC-M3U'1[\Z;<6-O&Y>%[I<"?#
MJ" ?X2 6)KV)2#G!S3<;(%*[L2$CKS0>G%-!Q2J<_6I&*!QUH)XI,DBE^M "
M9YYZ4H'X4TYI<D9Z^U !T&!6;X@EFALXFMY&C+7,*.X&<*9 &_3C\:T<@5S/
MQ'\T>!]9DMI#'+;P_:48#O&0^/QVXI@=0#Z4@'ZU%:S"XMXITQB5%<8YX(S4
M@)I +P.E'?IBCK[&FMGZ"@!W44F<8&>?>JMY?6VGQ>=?7,-O'G'F3.$&?J:D
MM[F*YB66VECFC89#HP8$?44P)\URFM*=3\<:-I[*CVMC$^I2^HE_U<7_ *%(
M?JHKJ&R6KE?![O?:QXDU.:,*LE[]D@8#[T4*A<Y_WR] '5@^HIWZ4W..1S[4
MX<^] !C\*4XX'6DS]:!P*0"_Q4@.11T-*3B@!H_E2Y 'UHSQZ4 T "GUZ4OX
MTU6[8I0>QZT +TZ\?A12=:7/I0 <T T=>G-!XZ8H :?>N.^*DNSP%K6S.6A$
M8Q_M,H_K77M[BN*^*Y5O!5W&/O22P1J#W)E3%:TOC7J3+X6.U5OL/C'PFY&%
MFBN+)NPR45Q^J?K46LR>3\4?#62 LUC=Q]>I&P_XT[XDM]FTO3=1QSI^I6\S
M'T4ML;\,/G\*@\7GR_'7@F8$@?:+B(X[[H2?Z5I'5)^3_7_,E]5Z&X_A^!_&
M*>(1<W N%LS9&#(\MD+[LXQG.1ZUB>#&Q\0/'*=_/M7 ^L7_ -:NSW<=,UQ&
MDL+3XN:_".!>Z=;7(^J,R&HC=II]OU0WHT=]WIX.&J%6!84_=ALDBLBR48Z\
M4'/:D)Q1NQ_A0 'BF/R/>E;ENU-D- &$O^F>,)&XV:?:A<8Z22G)_':@_.L'
MQLYU3QGX2T)/FB\]]3NAC(\N$?)G_@;#\JW?"LINK>]O]H'VR[D=#T)1?W:Y
M_!/UKG? N_6/&WBKQ"\H>!)1I-F .!'%RYSWR['\JZX>ZW+^5?B]/S=S%NZM
MW/0EZ^M2 C=CO42L?;ZU*!GTKD-A3UH).3FFL.:7/X4@%S10.E(>3Q0 ''7M
M[44AR%Z"B@"]1110 4R?_5-BGTR?_5-0!4Y]*3'<BG8[]Z3D?2@ QQ1R?2@9
M[4>QH %'I1@YQV[4N/<T=_3ZT 'UIIYI>G0TC'(ZT &<BF$D5Y[XZ\5:GHOB
M_3K-+FTMM+D2&1C)'N>3=<+$XSG@ .O3GD=LU3\4?%VPT>_O=-L=(U74]0M9
MVMRD,.$,B@%OFZX (YQWIH#OM5U2QTM$?4KZUM%;.TSRA V.N,FL_6_%FEZ5
MI-GJ$DKW%M>2+%;?9%\TSLP)4+CKD#K7COQ(\5Z=XG\(Z=KYTM+C^RM2%O=6
M;M'+C>@8?,,C&0OH>HXKA+KQ#-=:'H_@^VDETZ]L-:4VI#@LL$RL5Z<97S",
M>A%4E<39]3:'K$6L:7'?11S0QN6!CN$V/&58J0P['(I]AK%A?S2PV-]:W,L7
M+I#*KE/J!7S"NMZG#\";RSA8 6FN&VN@NYF,3?/R2<G+\5T6N:1H'A?5_!NH
M> =3 U.XGBCDBAE$C7$9 RSJ#QGD'MSTXHL*YUOQ4^)6CQZ7K.BZ;?7O]JVB
MAWEM(W*(RL#L=U(V@_=)!XS5>+XGRZ3\,O"MQ&BWFMZH/LL*SRDJ'5MI9W/)
M_AZ^M<KX>U*+X<77BK0?$NF37D^IS/Y*V\*NUP'#;>3R4.1ZX(-5=!^'FO\
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M&H:7:W45B<VZS)N\OIG&?7 S]*NW.C:?<7$D\]K&\DEJUDQ(ZPL<E,>E4_\
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M1CM1GUYHSGIS0 9^E*3Q3>U+@F@!<\49XR<4G:C.. : #.>E+G-(O!ZTN3C
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MKL0F)?M"*^!NR.HYZDYH ]EHHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M"/\ M#P1=V.BV=M>PW^GW%@ZP6LB1_*'R,;6=05+?>SSDY%<]XC\ ^(SX/\
M'.E>'=&O+6PB\6+?0VB6O$]J$8'RHWPLJ@^60HX.W%?5U% 'R/X<\-Z[;^$O
M'5SIF@ZQ>WMU!:(=.U7PI%IL$H67.^.&.0I(Z@$XVCG'7.*@\'^%?$:Q?$.1
M]!U=(K_PS)%;!] 333-)N V""'*[^#@9W$<XYKZ_HH ^9D^%EC]O^"J_\(A^
MX:SD?7O]";'F^1$P^TG'!\S?P_?(]J]"^!F@W'AW5?']F-,FT[2VUR26QC:
MQQM&5 S'D<KP ,<<<5ZO10 4444 %%%% !1110 4444 %%%% !1110 4444
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/ 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>image00007.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image00007.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" !H H@# 2(  A$! Q$!_\0
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MNU3SDCY>O7C@X\Z_X53XYM?"'A71M,UK2HUT^SFM+Z(W%U$C&20MYB/#L=\
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MYBB13DD[]Q+ @G=BNG\/^"-"T&&)+&RW-%-Y\<D[F5T;9L&&8Y "_*!V%=2
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3(?\ 6+110!:HHHH&%%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>image00005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image00005.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !S 0D# 2(  A$! Q$!_\0
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M>?(.![FBS!R2W.W(XXI1[<D5Q2?%'PZ\:N3=ID<AH>GZTY?B;X;&"9KD$_\
M3!N*?*PYD=D<$\K0"!QV[UQI^)_AP$?O;G!4L3Y)X _S^E)_PLWPV1EIKA0!
MDY@/%+E8<R.S./\ "@<8KC1\3/#1 _TB<9&?]2>*7_A97AO/$\YXR?W)XI\K
M#F5['7LV ,9I<D@\UQ,GQ/\ #L;QC==.&YW"$X ]ZDE^)6A?N#;O-/YW V)C
M:?1L]#3Y7L)R2W.Q#<],4X^]<8/&MYGY/#]W+A&9_*E1]N.W'3^?M36\6ZY<
MV,,MCX7NS+(2&6<[0N#CZ_RHY)"]I'N=J6%(3^=<B=4\9L@*Z#:(2N[FY!QC
MM^/:JBWOQ!:%I6T[3E(;(C)Y[<?>Q2Y1N:6YW#$[A03D#D5Q"7OCED$ES'HU
MIN<*HG<C\!@G/_UJB+^*X[V"SO/$.EVUW<EC#"L18L!SQD=O>FHMDN:O8[T'
M';-+R<5Y<M]K^K:]=:#!XKA6[M>9/+M]F['WE!QU'&?K[&M1/#'C(MO?Q6>"
M 0%ZC\J''S'SKL=X-V[UI2<#GM7)/X5U:7&_Q5>G'3"!?Y$4^?P1%<VP@GUS
M5I(PN"//&#[]*5EW'S>1U7F+_>'3)JO_ &C9\C[7!@'!_>#KZ5@1> ](2$)*
M]Y/\N&=[ALL/0^U2+X#\-H@7^S@P QS(W3\Z=H]Q<TK['0PSQ3@F*5'"G!*L
M#@U)]*YWP[X7A\/:CJ4MO(1;W3J8X<DA ![^^:Z ]*EI="KZ#\\]*7\/UIN>
M.*;AO[X_*D/0?R.O-!R<8I,\\4;L<?E0 H':@XQS2<YR.:0^^: &NBR1M&PW
M*P(((ZBL=O">@LV6TFU.1C_5BMO/\(II_&FFUL)Q4MS$/A+P_NR-+M>G]R@^
M$]!//]E6O/!_=UL]^G:DP<U7/+N3[."=[(RCX8T3RPG]F6FT @#RAQD8-20:
M!I-K$(X].M@H[&('^8K2+8&?2HVQR2>.I)XHYI;7#V<.Q3.BZ5)PVFVAP0?]
M2O'Z4?V'I6,_V=9^_P"Y7_"K> KLPZD8)S4%SJ-I8O"EU<1PM._EQ!VQO;&<
M4N:7<?)'L1-HNE'_ )AUH?;R5_PI!HVE,#NTZT_[\K_A6)XB\>Z1X=F:WG9Y
MKI!EH8ADKG&,GMP<URVM?%NW:VDAT>VF-P4RLTB?*C9'4?3-5:3#ECO8]".B
MZ.O)TVS&.YA7_"LF;6_!VGR#$NG"8$C$, 9@1U'RCBO-+;Q?-XDN#'JLNJ32
M'A;/3T"I)GL3G=@XZ8I?!^M7\4K:;H^AVMS>&=Y5:X(W)'@ +DXZ?7\*KD:>
MK,[QZ+8[VYUS3[JT4:5X3GNWS\BR60C0 _Q;B.A]N:Q-;L+LVES>7GA_1M*L
M@GSR2#>X)^4;=G4_@*R?#2>+[WQ3J\$>HK976[S;I7.] <\*HYX&?R%=5JWA
M!K_2O.\2^(IYH[56D+1HL<:CJ2?7I0GRLGD4EK^7^9R^F>!["XL7U4>)D73X
MU+22VYVE<>OH?KS3K#4$UNRU&;3M?UBV?3HI72&:?<)EP2I!X()QTYQ7'G2-
M0LM-M=9CB,VCW4NZ-2_#@,<*ZCV4\_E7;> =.\)Z[:W"W%G!_:,D[2?968KL
M3L%YY'4_SJN:Y25MKOYG/>'M8U75+V:"[\4W&GE(&:.2><A"0>5.3Z$GOTJI
M/K?B#0]2>>/6FG=FSYD5SYJ..@/<=.Q%=KJ&C>$] UK4+S5%AN#.P\C3;=<E
M1P-V 1COUKF==UGPP;&[T_3/"YAE<\32G#(?7')[].E2BN:5]3/\2:]KFL6]
ME)J>H6MQ;[1) MLPR"0,[P.C=N??%:5YXEAU/QKH.L+,L1BCA2?S!@1%6.X?
M0C)S[TW1I=-UGP;-HL.C2MK$89DEAC#%U!W!BQQ@<[?R]:R='GN#$EG;:':7
M%VQ*B5XV8G)[KG'3VIVTT$Y-,W]"N;+3_BF;LZE$UI-)+.)_,R-KH2 3ZY('
MX5[3;:C8W:(]O=P2+)]TI(#NKSSP?\.;6*QEFUVTCEFF*E8CD&,#.1QBM>7X
M;:(TC26;7=G)@[##+@(?4?\ ZZAV>XTY7U1VH9<]13L+V^M<&GP\NHI \7B7
M4@P.5W-G!_.M+1M)\3Z=JJM>ZQ'?6+ EU=<,#CC;Q]*7*NY2EW1U7?-+VR.!
M29[;:,^OX5!0H(I3CKVIK>OI^E.ZGK0 I^E)CWI:3'L* $R..*7'- ((I"?3
M'X4 +[BDR,=J3=USVKC-9^)&D:-J=S8O'-,\&-SQ$%=W<9SQBFE<#LL>O2ER
M3T%>?3>,]3USPI+?^'[&:*YBNXHLRJ&#JQY*]CV_.H;^;QM#;ZM>V<H_<ZBS
M)$Z AK<+QM'Y'\Z?*]A.26YZ(6([9J)[B-)DC+H)&!*H6Y/KQ7F6O>)M4U'P
M;HWBBPD2)[2X?[5$C$KN!V@$=P?TW5B_9?$OB+Q!H^HO>)YFHPLT6QC&L:)R
MR''*]A[T^32X<QZU=:_I5D9/M.HVT7ED!PT@ROUK@/''BG_A(=,.C>&_.NII
MI )FBC;E%Y(![Y('X4V\\*OI4@O;TZ'8R3R^4'F5Y_-9N1]_.#QUK87PMXG<
M)"/$$=I;@8864(B)]^ .>E-136YESRZ+\SSN;PEXLBT*XU&X,\4**6DC:8AP
MH_BP36IXITW5=1\%:7X@U+4Q(MM$@C@6/!!8A=Q(ZMP.:ZG6_!NK_P!E7[#Q
M%J%[N@*_9I#\KX]LXS[XS6+_ ,(A?M\+V@>VGDU"2</;Q+.P"JS+\Q7.W(&:
MJR>Q2;V_R(O#O@O1[[3TU77=625[I595\X*02>Y/4]!4?@[6M.\&:KKVDZO/
M 8!,&AEB1I=_&,< \8Q^)-98\(KKSV^CV7V.UOK",K=0SYWR2ACE@>=PP%(]
M,UV7@GX=_P!@S7,VK1VER\B!(UV[P.Y.",4FDG8%JK[F3X>U[1-.^(VIR:<L
MG]GW=NI1((6.' !/RXS_ 'NU96N>(]+M_'UIKEC!>0.DG^F0R1;&P."1VY'4
M&O4[7PW86?B*35X88HY&@6&-$C"JF,Y(QW.?TK%TSX<Z7:7LM]?DW]S*YD8R
M#"Y/)RN>?QH35]6)\UM$87AJ[UNZ\1ZEXBL] =AJ00)YDP1%10!Z<DX'-;FL
M-XRU*UGM$T?3X[6>)HW5IP[#(P><C^5=C&%CB1$14C4!5"\!1["I,]L]*4GY
M%)2[GEOA?PQXNMM/DLWNHK:Q:,J(+A5D4<\@+V[UGZ[X&7PPK:T^ILJ*N%$0
MV2-,W "8[9.3[ U["S=!CK7#>-KO3+G4-$M[RYC%K;ZBKW1W<1N!E Y_ASFA
M-W!QT(]!^'&GVUO'=:LIN[Y\2/N/R[OSYKH=,\)Z1I=]->6]H@EE;<"PSY?L
MOI3M-\6:+J]RUO:7T;S!F 0\%L=2/:H;SQIHUK*+>&<7ETYVI#;@N2<9Y(R!
M23?0.1=3-UK3+33/%7ARYT^WAM9)9Y()5BC $B,N3GZ$?^/5V$5M#& (XDCQ
MTVKC%<MI=MJL]Q-XCU*Q+W?$=G9K( 8(C][KQN)ZGVJW=>(]0T]HVO-"N4MR
M3YDL3B78/7"\U6MK(2Y;F^TT,;QQR2(K2':@) +$<X%2 <#/ '-9CVVGZXEA
M?9$R0N+B!U..<?YXK5SD\]JAEZW'CD4%<G.30"<]:7@X]*0P[<TN<#K1SZ\4
MA!(XZT@$.,9QUZTHZ>E'(X_G2Y&?7ZT *,?A1M'J*,C-'/\ =_6@!,]NM(2,
M^] !W<GK2$D#(]*!B]:Q;OP_8I87Z6=C;I<W"R.'9 Q,C \\BML8/7-(#ZYI
MWL*QR/PWCNH/!EM#=)MVNXC]USUKJRH960@%3P:4 <*HVJ!@#'%+P#CD9IMW
M=Q)61P4GA;5]'\)7FC:-]E=KRZ=BTF=L43+C&.YXK2\)^#X= @CDFD^T7RH4
M\S)VHI[*.W2NJ)!/-(=H&[/Y4^=BY%<S-:T.SURVA@O(U=89DF7KP5/]1D5?
M9BH^7%<5/\4O#,=R]NLUQ-A]ADBA)7/Z?I4OBKQNVC:7IT^GV,ETVHQ[XF(P
MJ# .6[YYZ4M;#=D[G7DGKUH)P.O6O,?"_C'Q5X@\3PZ?)%;V\2(TD^;=L[1T
M_B&,\#OUK#\0)X[M].$^KWDD,!F!CVR*"9&/RJ .>YX]J?*[@VD>H:SHVCWE
MM+>782VD4>9]OA81R1\8SO\ IZ\5S5@OB6XBEN/#WBFQU:S0D!;R EMX_A##
M&<C%4O&U\^E_"_2-+EW"[ODBB=&Y<JJ[F_4*/^!5!X,\=VUC/8>&FT22SA$4
MCQR>9DX1"[$@CG)!_,>E%W8BRYC0F^(FI6&L)I%[I5O-?.X4+9W 8;CQM.>^
M>U;DGB#6K<1R3^&+D1DCS2DJN5^@'7]*\??4;.01^)H;C9K,NI/.ULN#M7.X
M$ CUP.37OFEZG!K%A'?6OF""7)3S$VG@XZ53M8K7N<_>^)M1GL;F/3="U$W8
M!6/S8@JCMNY/.#VK@[_4?B-IT,E[=7%Q%!#U)C3:,G&3QSVZUZG9^)=(O]8N
M-)MKU'O8!\\?OWP>^,BJWC6-I/!>KI&"7:V< >^*FZ[!:7<S].OO%>KZ3#<1
M0:=:B2%'CF:0OOSUX'3^E>;W_A/5(/%*:'=:E%')K"M,\BEF1F!+ $'OD#'I
MFNNM;OQ)H7A3PK!86OF1E/\ 224WY#'Y1@<C@YS]/I6[<:!<WWQ(M]9N$"V5
MC:B. XR78[L_3&1^7O56U);NKW/+]5T.PL;/3]1@=FDBN!;7]G)(-R2+UQCG
M#;3S7M&CZ)IFCVR1Z=:10)UX')^IKRZZ^$NM1J;E+R"ZG+;FRQW,<\G)'7\:
MZ_3O'7V:86'B;3Y]-NU (<1DQ.O0$'M_]:ETT$N5O4[<''3MVII)P< 5EV_B
M31;NU6:'4K<HQPI,@&3Z8--G\2Z-;6YFFU6T$8)&1,I.?3@\U)K8SM)E&D^+
M;W1!Q;7$7VRW0+\J=G ]L\_C74IWP>#7$>&4N?$'BNZ\531S0VBQ?9;*.08+
M)_$V.V3_ )XKM_.B$BQF1!(W1=PR?PIR=Q1UV'X^7'M2\],]J,=Z7MGDU)0+
MTX)I>O3G--R?3C&:<,"D(0@@#!_2E&1]:.",\TO!XH 3'S9SUHI>.YIN!ZF@
M!V0:0D>U P.M'% Q"<X H[8)S[T$A<EC2#&/04P#!QU%+V]J;GH<TN=M "'U
MX_*D.-O/\J4D8SZTW/'<>] 'CEQX/UW3_$5_-H^C6%Q:K=&:.6YZ!3\VT L
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MM@FLO0M(\2ZSXDL=4\31QPC34<0F-=I<OCJ/08KO;ZT2]T^XLG)5)XVC8KU
M88ISM<(OJ>=:+'X/C\$1274NFP74MKY<LCL&97*GG'7/TJW\/;>#6?AO-I!D
M(199;>251]X9!R,^H-65^%6@(!E[G< ,_. ,^O2NJTG1[#1;5K:PM_)B9]Y7
M<3STZGZ4-HE1[(YWQ]ILZ> VL=+5HTA>("*('+*&''YX/X5-K6FZCJ7PY-G)
M 9M1DMHMR,>?,!4DD^HQG\*ZL[EYZT8(')Z]J2E8;B^AD>%[&[T_PU86E\!Y
M\4>TA>WH/KBM;/&-H.:<N,')Z4$ ]L8J6[LI::'E/A&QGTWXI:S!#N^S9E9S
MMX^9@PS^)KT35]"L-=M5MM0B\Q%<.O)!4CT-6DMK>&YFN(XHUEEQYCA>6QZU
M-N  VDGUJF[B2WN$,*6T$<4:[8XU"J/84Z.)(\A%"9.3@=31N!'4T]<8QWJ1
MV% S01R""*0+CG-)P.F,^E QW\6,#)ZTAP#@XI<>AYH*YQT-  .!@G-'.>*3
M R0>!2\ ?+0 HP!QQ28-&!WI,CTI &!CVHZC-.^@S0<4 (..?YFFY..0:7*G
M(_2FEN._Y4P.$NO[/LOB39:)_8EA);ZG#+<37$\>]S)SP,\=N1[UF^+T?0OB
M+X;OK&QC>-H_*,,2A">67C QT<?ECBN^GT:SN=8M-3F3=<VJ,L1SP,]35B6V
M@EN(YI(T>2/(1RHRN>N*I,BUME8\OB\1Z=X,\3:Y9:9X<NY9)I@6D$P(D?D@
M!<<#+$=3VJWX*?4=4\<:IK5U:3VJ7, 4H5.W@J!U[_*?SKT46\"S-(((M[')
M8(,DU(3M]:=U;8$I7WT(9+2":UDMF0>3*K(ZCC((P>GUK'\*>&QX8TJ2S\P2
M%YC)GL.P_05O@[@1_2E4#&"/SJ;E6,C3O#]KI^JZEJ:$M<W\@=RW\(  P/;B
MF:IX<L]7U+3+VZ&[^SW:2-?5CC'/H-H_2MHDC@G'TIN#W;\:$Q.*:L1SP0W*
MA9H4D".'4.H.&'0_6I#S_A2@<\\T;2V.:0[">V"..PH.,\ C(IV.W3\*"&*^
M_P"5 QN=I'')&*4 9R!2YYZ8'>EW'.T_@: $*G/<^](0V0>-O?-*O0@G^M.Y
MP.] #=HSSD9HQ[9I1N]J4%L@=N]  1WQ3 ",DBG'=FD.X#GGC@XH 4#GD4_'
M/T%,P>*<.1SVH ,#IFFLN>>U.R.F<'^='7@GM0 G8X/-*=V.*1?0&E;/0$\T
M &W)QC/TI>,8STI "!_6DR/Q% #AV%)N7W_.EY)Y//2FT"'>E Y:BBD-@W2D
M-%%,!& (IIZX[9Q110(7)!P/6DXX.!UHHH & !Z4'[N/:BBD [ %-[X[8HHI
MC \+QZTG\-%% #J7_"BB@!I'S8[8IPZ444@$P-YI!UQ113$*>#Q1CG/M110
M@)Q^-(Q(/XT44#'*3^E /'XT44 +UZ^E+VHHH C/#+]:<Y^[[FBB@&.Z=/6F
4_P 1%%%(!PY)-+G_ #BBB@1__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>image00011.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image00011.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" +7!28# 2(  A$! Q$!_\0
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MV!S_ #H/';)I&R.E #B#MXQ2$<YIP.%--.<^U !CIGIBF\!>!3V]!UIF/E%
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MUI<YZ4[@8IO H 4\4'/.*"1G/?% '- "CMS1C&#0M(W84 +G=^=!I, #GUH
M[&@!P_&C.6QTXHZ"ESSTH 2@<G% ]A0/0_G0 #^M&*4'%-(P,]Z0#AQ@"C'K
M0O84N/>F WG\*44O(Z=.U'J*0#<8YI1PU*IQ1^% "FC/6EVYZTA&*!!V%+VY
MI*7\Z!AZ4&@4&@0#WI6'\J:.&I3W% !Z^M)CCBC&>O2EZ"@ !Q2=L@4'M2$_
M2@!VWU[T=Z!SS1U/% "G SBF\4I]Z",T (U ]S0!@TC4P#(HQ0O'(HS\W I
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ML/KBK55;4YF/TJU2&%%%% '*_;O&_P#T+WAO_P 'T_\ \AT?;O&__0O>&_\
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MG_#[OX"D_P#"+N?_ )&K6\)KX0MM<,&@>'UTC5);9Y 6T&73VDA5D#X9XDW
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M.UMXVW)&H;UQ2T#4K62F69IV!7^[FM$>O4T+@#G\J0G#=_PH;N!!J/\ JUZ
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M>-/"UE::U?:-(FGZC+]HL_OL!)9C:?;YL_@*];KB/$__ "4KPYC_ *!&I?\
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M2#6O^A&\1_\ @1I__P E4 =3GGK3>N*YC_A(-:S_ ,B+XC_\"-/_ /DJG?\
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MI2DTP 'K]*=NZ^N*;G&?I3@?QH 7C\:.M)FC(')STH$*3_C3"><4XFDP,"@
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M\RKBZU=WG*YZ%'!T:/PQ+3.L6,D "F->0K_%GZ5S\S3S !E<9X/M3XK:2,8
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MD)60<]0"*!'TU'J-A(X6._M&+.8E59U)+CJN,]1Z=:M">(L8EEC,@4,R!AN
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MB>O%!!'*]#2XQU/XTQC H*^E.8888IJ^E*5R,F@0 =2.F:'[T]0",9H*CH:
M(V!..?K1D9&.1FEP-Q[\<4$<C'!H&!&!C/-(!TR*-IW<&GH#M]!0  #=\M*?
MR% &?SI2<4 1MPV.W;WIW&T>M*.#DTT\@8H 7%* -IS2=?RHZY].U &!H?\
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MACW%MD:*%49)). !R3FK?<\YH&&VC:!D"ESC\J4#/'2@ Q2$#<1BG\4A'I2
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MX3FH_P#QBNJHH Y7_A/-(_Y\_$G_ (3FH_\ QBC_ (3S2/\ GS\2?^$YJ/\
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M2TL_VC+M+*".$GP\6D6-0H/[^/!P.]>N*>N>E,!5'!-)QSWI ..>:<H4<]:
M!&PN*7()XH'"_+THZ4 &[C%)D'.:7((QBF@YSQ[4 +U4$<TN%R*CZ8IY^]SC
MTH .V,X]::IVGCI2N#QQ0"N<** %'/'>G#CD]*:OUIP8%MIH "<@8IISGOSS
M2^F#TI-QQ[Y_*@!<?-_(4_/7'K3%.?SIY'..II &[ IV[Y*C)_\ KTX-M7I3
M =D9[T;F#>U)O_QI%.[\* )!R*7JO%,5LC!I<XZ=*0"9Y S0V/7'O0QY!QGB
MD;E:8"\'-(Q&.?PH_@( H X]\4@&J./7VI>6:FJ<=/QIXXP:8Q5&,?UH'J:
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MR1QZUTP/XUQFFL4F\,['V[H6!&/O?**[,8[5%7>XZ#TL.7TH)XI.@-+FLCH
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M6!!P0#]0*D#L#CIUJ/[K&LW_ (5QX(_Z$WPW_P""N#_XFC_A7'@C_H3?#?\
MX*X/_B:86--CN'&*3H?6LW_A7'@C_H3?#?\ X*X/_B:/^%<>"/\ H3?#?_@K
M@_\ B: --CN^G:EXZUE_\*X\$?\ 0F^&_P#P5P?_ !-'_"N/!'_0F^&__!7!
M_P#$T :2$%ADXIY;D;:RO^%<>"/^A-\-_P#@K@_^)H_X5QX(_P"A-\-_^"N#
M_P")H TV.W;C%.+<<UE?\*X\$?\ 0F^&_P#P5P?_ !-'_"N/!'_0F^&__!7!
M_P#$T :><9SZTUF8YQP?:L[_ (5QX(_Z$WPW_P""N#_XFO"/C'=R>"?#/C&/
MPCY>BQIXA@2..QC6)$#6%HS *!@9))..Y-)@>S^+/&>A>$XX#XAU**R:X;;&
M'SEOR'2L\?%+P3YTD1\3Z<)4 R"YQ^>*\@M/@]JFN7^DZGXK\4OJL4)67R9+
M?DKU*9W=#7H]E\-_!]I;^7!X>L G7#)N_4G->56S>A2?*FV_+_@FRHR:N=+9
M^/O"]W<PP6^NV4CS$"-02-_;@D8ZUTOF;2<8'X5\T?&C2=+T+6_!D>E6T=D9
MKP(5B7(=0Z$+R>!DD\5](LP RWJ:ZL+B8XBFJD=G?\")P<79C;K48+&UDN+R
M:."",%GD=L #UK!;XA^%%./^$@T[CL9<$5B?&Z$W/PRUR-8S(!!O<#^Z""?T
M!KSCX;_#KP3XE\+C5KC2$N/.N)2DA=U)0-QQFHQ6-CAXN<MD[:#A2<G9'LZ^
M.?#3JKKKEBP/<2<5L:=J=IJ5L+FPN8KFV;(#Q-N!QUKRFX^$'A$V,L-EIPMW
M9"(V\QB$8]\9KSOQ)H'BCX7_  Z^T:;KD2"TF4Y@8@,Q9CG85(YSSS65',J5
M9J,79^:*E1E'5GU*LG!]16!XLO\ 4X+K0++1)K*WN-3OVM6FN[=IUC5;:>8D
M(LB$DF$#[W<U)X5OIK_PUI5W<$&>>UBED/3+,@)_G4'B3_D9_ O_ &&)?_3?
M>5Z,9*2N9$W]C^-/^AB\._\ @AF_^3*/['\:_P#0R>'?I_84W_R9795RMSXU
MM+/6KG3K[3]1MS;E TQ6.16WLRQ[51VD8N5. %+>H%.4U'<UHX>I7NJ2O;^O
MF0#2/&@_YF+PY_X(9_\ Y,H_LCQKG/\ PD7AS_P0S?\ R944GQ$TM=3AB22%
M["0%GN-TBO$!'(QW1F,<YB*[02<YR < VI_B!H,-Y% [W@#Q22M)]CEQ%Y;;
M65UV[E;)Z%>X_O+F/;T_YD=+RO&)I.E+57V_K73;<B;2/&K9SXC\._\ @AG_
M /DRC^Q_&G'_ !47AS_P0S?_ "975VEPEW;1SQ+*J.,@2Q-$P^JL P_$5-6I
MPM.+LSC?['\:?]#'X=_\$4__ ,F4O]C^-,?\C%X<_P#!#-_\F5V-% CC_P"R
M?&O_ $,7AS_P0S__ "91_97C7_H8O#G_ ((9_P#Y,KL** .-_L?QIS_Q4?AW
MG_J S?\ R93?"5_JD]UK]CK,UE/<Z9?K:K-:6[0)(K6T$P)1I'((,Q'WNPKM
M*XGPSQXG\=9_Z#$7_IOLZ .DP3[5#=PK<6TT$PRDB,C>X(Q4P^89%&WUZ9H&
M?/FBZ1XV^%.K7T>D:1_;WAVY<RI'"VUX^>/H<<=\X%6-/\*>*/B'XUM=;\:V
MLNE:/8,LEOI^[ER#D=#Z@9/X#%>^!<9.:-H/3OZT"L>._$[PCK>L?$+POJ6E
M6N^RLRJ2RA^8QYBDG'H *]8GC)A<#KM('Y5:91T'7M32N/3WIW"W4\?^"'AO
M6O#4/B5]6T^6!IIFE@5F!\S&XC%9?PMT#Q)X8T7QGXEU+1W;7K^<S6]DS LZ
MYR!D'_:/ITKW0#+'.:7R\]>M)B22/E7XEMX[\=0:;#J/@NXME@EW(T7))XX/
MS<#I7H/[0.B:IJ_@;0+33K&>ZFCNHVE2'ED C(_+->TA>N* N/:J3'8\=_:-
M9(OA.(YV* W%N#QSPPS6;\6-.U35OA?X+M=&AN+F B#[6D/4H(UP3^M=O\:/
M"&H^,O"2Z;I#6ZW N$E/VAB%*@\C@&NN\.6,FFZ#IMG*5\VWMHXF*GC*J <4
M7T)M[POA^RCT_1["SC38D,"(%/4845H8.?ZUQNG6&JZ_XA\48\4:OIT&GZA'
M:006<-H45#:6\I),D#L26E?OZ5J?\(CJG_0\^)?^_.G_ /R+4E&[P<=<'K2J
M.I-8/_"(:G_T//B3_OSI_P#\BT?\(CJG_0\^)/\ OSI__P BT#.@Y_"E!KGO
M^$2U3_H>?$G_ 'YT_P#^1:/^$2U3_H>?$O\ WYT__P"1:!'1J:0L/6N=_P"$
M2U3_ *'GQ)_WYT__ .1:/^$1U3_H>?$G_?G3_P#Y%H&=%GU[TN<5SG_"):I_
MT//B3_OSI_\ \BTO_"):I_T/7B7_ +\Z?_\ (M CHNK4=!7.?\(EJG_0\^)/
M^_.G_P#R+6+XWT?6]!\%Z_J]GXW\0/<Z?I]Q=Q++!8%&>.-F 8"V!QD<X(H
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M<!:*8?"7B,2B,/MW?N^5P0#_ (UZ!,,P.#Q\IYKS"$RCPKXH$A+$!0IZ J,
M5M3^%KT.>HO?B_4VM-82GPBZ A6CD'/L!7<]JX7P]'-+9>%)(T9HH4E\Q@/N
MYZ5W&<FE5WL@H;7]"3IF@G--S2YK(Z!<XH/O32WI1G/6D%Q2<'B@_K2 CG-)
MG.:8 U)GTHZ<FFMSG&: %R*3JU,SZ?C2[AR!3 <6'Y"E!S@C 'O43'!YHW=?
M:BPR3TQ2$Y I-XXS3-P8T 29]\T;\4WIC/2F[P&.30 YNOI3AWJ%GZ5(OS9
MYH <"2V/SI<#/XTBJ.N:CR".] $K$GC.,4G&!BHVY/>DC.3SVH D!QD]J0G)
MZ4SG<32 9Q0!(O').:7(+=>AI@I4;/I]: %^;<<XQ29ST/0TJ]*3C!Z4 /!X
M]Z1@,Y SVI%Z<<@TA(' H =D;1GZ4TC&,4  8IYP?_UT )D9IO)'3-*<'!QB
ME4C\* $!QG--S\V3W%/;\*:W/0<=* )[/ D./2K=4[-=LS'_ &:N4AA1110
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M<5;3P!IT44*P7,\)CCFA8Q6UJJRI+MW*\8AV'[@_ASZYJ;_A8_@C_H<O#?\
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M*/:@8N*;WI2>1Q2#WH &YQ28!X/6E],FA??]:!"#(/M1CYNO'>I!Z#%(!S0
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M>9=*(O+VX2*>V^T?\>T;&,+)G;\P(FB(&!G<>>*U3\0M,^U75JEK=RW4,T4
MBAD@E,C2.44 K*57YAR'*D9'%:4?@OP_&RLFG*&5+>,-YCYVP8\H9SVP/K@9
MS1;>#-"MK@316;AUD21=US*P0HYD7:"V% 8D[1@<GBN91K]6OZ^1[E2OE,K\
MM.2_X>_\VRU7>VM[F7#\1=-DM9)VLKV +$LRBXDMX=ZF0QDAFE"C#J002,]L
MBHI/B!#>/I(T6UGECNY[59II479"LQ/R'#YWX!Y *^_-;$G@O09!%_H;JT2[
M8WCN949/WAD^5@P(.YB<@YYQTXI8?!F@P36DL-DR-:^7Y06XE"@QDE"5W88C
M<<%@3@XZ<4^6OW7]?(GVV5J[4)7Z=OG[W]/NM#H:***Z3Q HHHH **** .)^
M%.?^%8>#_P#L#6?_ *(2NJQA?>N5^%1Q\+O!_P#V!K/_ -$)74[NK?A0(/6D
MS_C2\\YHQ0 #O^=*<]^E(103SUS0-BC'>C=2#CKS0V>U A>0:13UI<XZTWI0
M [T]Z4=::O/7M2^] "GVHSBC)Q2]_:@!:3//%&<GZ4>M @ ^6EI/SI>U $<G
M^K;Z&O,A&L?A+Q,$602$!F+' //&!7IDO^K;_=KSA%G/A?Q&L[,R*@,6,<+F
MM:>S,:GQ1-737N+3P1IRKF.7;T(YZFH5U.[4GS)3GIP:EAN'N/!VERR_ZQ@,
M\>F16.S=V'<]J]+#PC).ZZGEUY.-FGT-I-6GZ^8<]J7^U9\9,Q^HK$!')Y Q
M3E8L1CTK9T(WV.>->7+N;@U.?C$IX[&F_P!J76#F8@=*S7)&>I)[U&KC>14J
MC%]#3V\K:,UO[1O ,B08Z9]:=_:=QT,O&/6LM3D'&>/S--![^A]*?L8]B76G
MW--M4N1P)3SZU&=6NEZS8].:S3D$D5'UY.<C\135&'8IUII:,TUU6ZW#,N!Z
MT-JLYS^\Z^]9BG@?2FX &0!_A5>QAV'&M.RNS5;4;D@?Z0.3TS2C5+H''F@]
M\DUDL.1WIRD;6WCBE[&'8U]K+N;2ZE.R\OWYYIQU&8;<2<CUK(4[EP!CFI#M
M5@,9^M0Z,+[&BJRMN:9U&YYVR9'?FFKJ-QCYFQZ9/6L\2*&;C'>FM*"""..U
M"I1?0%4DNII_VE-P/- ]:>NHW*,I\T;?0'K65PP7/3TQ3D0 \@<=/>DZ4.P*
MI/N:PU:Y$?WA]?2F#5;G(^8 'N:S&(V<_3%216LSD%54^V.M+V5-+5#=6I>U
MS275+K<?G4G'K0-6N<KC'TQ5-+61<LR1G:,\#I2E6VA0G+C(;'3VJ.2GV17/
M5ZEXZM<!FSCVJ-=4G/)8 9S5"4@LB^C8/O2!1DGI^%-486V)]M4[FE_:5S_S
MVQSZ4Y=0GW %LCG)K+!;Y<'C-.0\Y&<YYH=&'8/;3WN:ZWTV[(<=>E.6^E[$
M9SZUFXPHSU]O6@,P(X_6L_8Q*]M(TEOIPYSS[4GV^<<<9-9I(5AC)SU%(G0D
M$\4>QCV'[65]S6BU"5I4C;N:V #QC/)K!TZ#?(')X!ZUNH?E_&N*M%1E9'92
MDY*['Y]>:,\<8IK=?E-"]#NQ61J.SS[4WZFEQ@4W/K0!9M/]:?I5NJ5E_K3Z
M8/\ 2KM(84444 <K_P )YI'_ #Y^)/\ PG-1_P#C%'_">:1_SY^)/_"<U'_X
MQ7550U#6=,TV:*'4=1LK2:;_ %:3SK&S\XX!//X4FTM65"$IOE@KLQ/^$\TC
M_GS\2?\ A.:C_P#&*/\ A/-(_P"?/Q)_X3FH_P#QBM32O$.F:M]J_LZX:<VH
MS*%B<$<NO (YY1A@9Z>XJY:ZC:74,DL%PA6+'FACM:([0V'4\H<$$A@".])2
MB]4RYT*M-M3BTUOH<_\ \)YI'_/GXD_\)S4?_C%8J^+[ 37#'3_$F&D9E_XI
MW4.03_UQKT&WFBN8(Y[>1)89%#I(C!E=2,@@C@@CO3ZHR:L[,X ^,=/_ .?'
MQ)_X3NH?_&*7_A,=._Y\/$G_ (3NH?\ QBNTTV_MM3LDN[&3S;=RP5]I7)5B
MIX(!Z@U:H3OJARBXMQDK-'F]YXKT^92/[/\ $I.#C'AW4!G_ ,@UY1\8VO?$
M/AVUL]&T'Q/<RB^CED7^P[M,1KSDEHA^0KZ5L;^VOC<BUD\PVTS6\ORD;7 !
M(Y'/4<CBK53I*S&U*'NR5CS.#Q38(3_Q+_$@!_ZE[4.O_?FKVD^)=/U'4TT^
M./4H+QH7G2.]TVYM-Z(55BIEC4-@R)D#GYA7?5Q/B;_DIGAS_L$:E_Z.L:HD
MU0>< '(J0_=SC%-! /T%([\4 -EEC109'1,G +$#-1_:K5%!>Y@7(R"9!R*\
MX^.'A_4M=TO1'TJSDO18:@EU<6\4FV1XA]X+TY(KSS0?AL=,TFWUKQ3H^LZM
M-.LMM#H<)5Q:1,3L#$D'(R,8/!H ]XC\3Z-+KT^C"^A&HPQ+,\18#Y&Z$'O6
MQ')$_P#JY$?(R-K U\OR^#M6U#P9X5MT\*W;:C97,ZW4]PH$Q@0EHEW9.5(8
M+C_9(KHO@-X5U[P_XMGNO$5K?PI<Z?FS0-F&%6D9FC<=F!QCV)H ZS5\_P##
M16A;0?\ D$3?3[RUZSU. ,UY'J7/[1>AXX_XE$W./]I:]:#;L^GK0 ]213N,
M<5&I^;FC/7UH E6N>\5V.IW%QH%]HL-E<7&EW[7307=RT"R*UM/"0'6-R"#,
M#]WL:WE8FD).X@'M2 Q/[;\9X_Y%WP[_ .#V;_Y#I/[<\9\?\4YX>_\ ![-_
M\AUNK]<BF9^8C]*8&(==\9@9_P"$<\/?^#V;_P"0Z5=<\9GIX<\._P#@]F_^
M0ZVS@\'\J;PIP/RH R/[:\:9 _X1SP[S_P!1V;_Y#I#K?C,?\RYX=_\ ![-_
M\AUL\YR>OO0&)/!Y H Q_P"VO&><?\(YX=_\'TW_ ,ATW^W/&>?^1<\/?^#V
M;_Y#K:^I%"ECSVH Q?[<\9]_#GA[_P 'LW_R'1_;OC/_ *%SP]_X/9O_ )#K
M8D(&,XYZTSS ./XLXI 9']O^,N?^*<\/?^#V;_Y#KQ;]H&QU%?AOXFU#6[>R
MM[K4=7@NHX;6X:=8U$,$.-[1H23Y1/W>XZU[V[8R<XYQ7CO[4LT:?"^X61@)
M)+F((">I# \?@*F4M$,P?"GQK\&Z=X8TBQN9K\7-O:QPR!;4D;@N#@YYKH]/
M^,W@_4#Y=G+J,UP3CR%LV,A'J!GI3? /AC04\+Z'*-%T]IC;Q3M(UNK,7*C)
MR1G-;VJ:!H,@#MH^G>9@ G[.H)_$#->+5RZE.33BW?S&L1**N>8^.=4TCQ#X
M^\$ZO9)<B9;EK4B6+8P*G.UU/3[Q(^M>^,=S''J:\.\76&F6/Q8\"6EA8P6[
MK.TLC(F-ZLIVC.><;#],CUKV\$(I)KR,VH*,:<(;)/\ ,Z\//FO)F9XK;;X5
MU8XR?LDIX_W#7DG[/_ANSUCX??;+N?4EFEN9$D\B^EB#A3@ A6 .!Q7I?B?6
M=.?3=9TQ;N%M26PEE-MGY]FP\X]*\:^%&L^)-$^'MY;:-964[VL(U=?.+ O"
MS NO7KC..E:8*C7^JSBGRMM>6@ZDH\Z;U/9/^$#\/;5C:UG:W!+"!KF0PACU
M.S.W)ZYQ7(?%KP;X9T[P!J]VNF0HT$6Y&P3M.1T_.HY/B)XI@\-0^+7T+3F\
M-2Q1OY271-PF?O,>,8]JA^*NM:U>Z.FDRVEC9V&N*R6E[]I+.H"B3YDP,$C'
M>M\/0Q,:L7.6E^_;<B3A9V1Z-\'@%^&N@[5*I]GR![;CBM;QU<7%MH,7]G7<
MMG<3ZA8VGGQ(C.BS7<,3E0ZLN=KMC(->(^"/BCJ^@:'H]AJ6AQ_V;;2P:?<7
M(N,NTDP9T*J!C&W!(]Q7M'CH@Z)IY!SG6-)(_P#!A;U]+!W.4T5\&ZBHP/''
MB3_OSI__ ,BTO_"'ZE_T//B3_OSI_P#\BUU]<EKNO:IIOB-;=H(8M.E@86DC
MPLXN;@*Q\LR*_P"Z[$90Y"M@YP*<IJ"NS;#X>>(DXPWM?^OZ\]D-_P"$0U/_
M *'GQ+_WYT__ .1:/^$0U/\ Z'GQ+_WYT_\ ^1:PM/\ B+=RV>EK?65N)KVW
M5Y)+.64F%GB=TX:+8,[?NER1GHP'-K1_'T\F@C5+O30NFP36]M/<O=!I 9$0
MF0J(PN 9%SC'4\ "LUB:;ZG?/),;"]X_BM;NRMKK=[=33/@_4CU\<^)?^_.G
M_P#R+1_PA^I?]#SXD_[\Z?\ _(M<]#\5I+I(ELO#\\MTP*M#YCL5E'F%H\)$
MS9 13G&/GYP!FM#P?XEU+5?'&H6=S+*MBJ3/';RPJCQX^S[0V!G(\QL@GO["
MA8FG)I1=[A4R3%T8RE5CR\J;W73TN:/_  A^I?\ 0\^)/^_.G_\ R+2#P?J0
MZ>./$G_?G3__ )%KL**W/).0_P"$0U/_ *'GQ+_WYT__ .1:7_A$=3_Z'GQ+
M_P!^=/\ _D6NNHH Y#_A$-3_ .AY\2?]^=/_ /D6J>@C4=/\::QH][K5]JUM
M#I]E=Q->1P*\;R272N 8HT!!$*=0>_K7=UQ<>/\ A:FO9Q_R!M-_]'WU '2#
M^=+GIBF;@3QQ2G[HZY]:!CSCCUIF?P^M*#W-'!ZT"!C\O%&<@4QFPV#GK3L_
MI0 Y3SVI,G=TP*;N'/!ZTN<D 8_&@8^A?4TQ<BESB@!W0\?G1[FFYZ]Z7/IZ
M4".!\*^+=.LM;\9/+;:W+%<:R3%+;:+>7$;^5;6\$F'CB93B6&5>O53VP:Z/
M_A/-(_Y\_$G_ (3FH_\ QBF_##_D6;G_ +#&K?\ IPN*Z6^O+73[5[F_N8;6
MVCQOEFD"(N3@9)X') _&ANVK'&+D[):G.?\ ">:1_P ^?B3_ ,)S4?\ XQ1_
MPGFD?\^?B3_PG-1_^,5T-KJ%G>-MM+NWG;RTFQ%(&.QONMP?NG!P>AJ2.X22
MXEA42AX@I8M&RJ<YQAB,-TYP3COBE=#<))M-;'-?\)YI'_/GXD_\)S4?_C%'
M_">:1_SY^)/_  G-1_\ C%=569KFO:;H4<3ZK<^0LN[8?+9L[5+-]T'L#0VH
MJ['3ISJR4*:;?9:F1_PGFD?\^?B3_P )S4?_ (Q1_P )YI'_ #Y^)/\ PG-1
M_P#C%=513(.5_P"$\TC_ )\_$G_A.:C_ /&*/^$\TC_GS\2?^$YJ/_QBNJHH
M Y7_ (3S2/\ GS\2?^$YJ/\ \8KF?B9XUTN\^'GB2RAM?$ N;W3Y[.W630+^
M,232H8XTW-" "SNJC)ZD5ZA7)?%#_D5[;_L,:5_Z<+>@#888XKYN_:HMC>>(
M_!=H)7B^T7'E[T.&3<P&X>XS7T!KFLZ=HL"SZM>V]G$QVJTS;03CI7SE^T!K
MVD:IXJ\#7]CJ5M<VEO> S2QN&6,!U))[]!4R&C9_X4M/P1XW\1#_ +;4'X*7
M7&WQQX@S_P!=J]-N_%6@V,=V;O5[&/[(H:?=(,QCW'6J[^,_#2:/_:S:W8_V
M;E0;C?E06Z CKD_2OE9XK&IVC?[O^ =?LZ74\>_9\MI-+^('BW3&O)+CR3Y;
MNY^9RKMACZDY/-?07&WFO ?@1>P7WQ0\:SV)66TF<RQ3*,!U+MR,U[YGCW]:
MQS5OZQKO9?D707NZ'C7[5)Q\/+?!Q_IJ?C\K5Z'HOBK0!:VMJ^LV(N%MT=D\
MX9 P.:SOB_H]GK/P_P!8COX1+]GMY+F+D@JZ*2#P:\@^#OPP\+^)_ =MJFM6
MLKWDL\B,R3,HPK8' .*Z\'2AB,*H2OH_S,ZLW3G?N>X7/C[PG#(T4GB'3%=3
M@J9QD5Y?K/B"/4OVC/!\FEWEK<V@@6/?;L&X8N2"?R/TQ5R^^"G@:STBYGNH
M]1A@MT,LEPLY+(HYX!&/TKBM%T;P_8?&+X?W/@N*9=)U%1<(9G)=F#2*20>G
MW<8SVKT\-@X4)\T6]O(QE4<XGT2OB30] ^)VN?V[K.FZ7Y^CZ=Y7VVZC@\S;
M->[MNXC.,C./45O?\+'\$?\ 0Y>&_P#P:0?_ !54=$\6Z/J0UAK&[64:4[)=
MD _NR 2?T!_*M#0]?T_Q#I5OJ.CW N+.<$QR $;L'!KU-#(;_P +'\$?]#EX
M;_\ !I!_\51_PL?P1_T.7AO_ ,&D'_Q5:8D 8 ]37-_\)OI#23)#!KER(9I+
M=Y+;1+V:/S(W*. Z1%6PRL,@D9!I@:/_  L?P1_T.7AO_P &D'_Q5'_"Q_!'
M_0Y>&_\ P:0?_%50_P"$UTWO8^)/_"<U#_XQ2KXVTWO8^)?_  G-0_\ C%("
M]_PL?P1_T.7AO_P:0?\ Q5'_  L?P1_T.7AO_P &D'_Q54_^$VTS_GR\2@8_
MZ%S4/_C%(/&NF9R;'Q+_ .$[J'_QB@"[_P +'\$?]#EX;_\ !I!_\51_PL?P
M1_T.7AO_ ,&D'_Q54O\ A-=+_P"?'Q+_ .$YJ'_QB@>-=-Z_8O$OO_Q3FH?_
M !B@"[_PL?P1_P!#EX;_ /!I!_\ %4?\+'\$?]#EX;_\&D'_ ,55,^-M+(YL
M?$OT_P"$<U#_ .,4#QMIG_/CXD_\)S4/_C% !\*"#\+_  ?_ -@>S_\ 1"5U
M+5RX\;Z6/^7'Q(?^Y<U#_P",4#QMI?>R\2?^$YJ'_P 8H Z=2<\]*7=GBN7'
MCG1A)!'-#K=L)YH[=)+G0[V&/S)'"("[PA5RS*,D@9(KJ!CMB@0?RI(^5H Q
MZ]:<M !_%G--W=2,&@\$8Z4N,=.E "9^0'BD7KSUS2X[4H ' I@+]*!]T]Z!
MU/M2KTXI +VHS@\"D]*<OO0 GUH..U*:,CI0(* >/6@\B@4 0RM^[8^QKA+8
MA]&\2%@J1^4 ,'H,9Y/US^==[)S&W^Z:X2!"?#^OJ[#YH1@J,=OYUK#9F%3X
MD/TX > M.&/X<^F.368>4!ZX/KTK4TX/+X%TY8V ;9TZGJ?6LV:)PF5) !Y'
MO7J86R37F>7B+NUNPP8!]:=D8X&!G(J00MY>0I)Z\TX19 XYSTKIYD<:C)(B
M);/?-19(D+#DDU=$3_Q(P]\@T@MV9CMSTSD__KI*<2G"78C0C&1CIFEW'>O'
M7OGK4B(=O6,G'3-"Q98':W'7D'%+F12YK[$!P>._>HV P,]!5B2%@O!8?\!_
M^O417<HY3(XZTU+J59V=T1*V">A&*3.00#WX%3*F"!M)_&E6 L< 9[ #I5<R
M*46D0;CM^8G(Y^E.Y!PV N2:D:)0I.64#DD$8%"B)F0)*KF0;TPRDL/4 =JE
MSCW+49=AT9X.&YS@>U#$GDXSTS2VB--#OC;,9&0W8^]1M-$C%/M,/MB1?\:5
MTM+FB3?0>2%+=<?RIJL&! R!G\Z<N&9MCJS=\,*D:)]K;HR-N-V>,4KH+.XU
M'^[GD]A4RGY\\-]:8G48 /IAAS3D<(1NQQ[BDY+H4DU83?C@#K[5;TTXN4))
M!],]*J@94EF .>!T-2*S;QM=<CWX'K4RU35QJZ:9:LI52ZD+DD%F')JZES#'
M:YW9=0=I],USIOK6.38]]9AI&PH:9023VZU/YL0==\]NNT\@SIQ^M8.%.74V
MYYIZ(E<@D[!CGOVI,@MDG&/:EENH&F"BYM26/ 60')_.D9%63#S1#)X^<5LI
M(R<7<3<ORXZ \]\U-'@]1@=B*C5X\K&)HB6.%&\<_0=Z=(6C?;@*P/W<XHNF
M)IVV'[Q@8'&>30^-P/<>U&X%1NV GK\W2G%7)&0 0?7&:FZ0G<%3YN3GCK4J
M[0G3GTJ*)6W<[,]2">E3(692-JX^M3)EV+VFSQ*=A."3D5KK['OQ6%8Q-YH)
MC!.>.];JG@9.*\^O;FT.VA?EU'(>3G\!2XY(XI%'?)HY+<YX-8FX[@G%-89;
MYC2XP3CO28W#G&: )[+/G-SD8_PJ[5*R&)6^E7:0T%%%% !7)^(-!O[OQ?IV
MKVB0RPV]LT#QM?S6K9,B-G,:G>,*?D;@YYZ5UE<QXF\6QZ!?RP36K2I'I\E]
MN1\%BLB1A,8[F0<YXQTK.KR\OO[';@/;>UMAU>335O71]4<2OPTU9;OS"VEE
MC,L@N/,?S85$LKE5^3HXD"MR.G>N@\%>"[CP]I^KVSQZ?YEY!&JSQ$[BP@5&
M5OD'R[PS Y.=Q. >MR^\2>(+*_TRTN- L$DOYC!&W]J,5#!"YZ0YQA2/KVQS
M5K4_%+6'B0Z9+98A%LTZ2R2,CW+!23' I39(P^7(+J?F)Q@9KFC3HQ=UT_4]
MBOB\RKP]G*S4E?1IZ1>^CZ-;>NF[.4NO!7B*\LO#UM*NC0_V3#!"LL<N^0F)
MD.\.T&Y<A#\JLN#R6;I3?^%<7\3PR1+I4HRSW=O(S*EZ?M7FJLAV'("<9(."
M ,8YKI!\0=*?[.;>&ZFCGFC@24&)(R[Q+*%W.ZC(5ER,YR< &LVW^*6FJD/]
MJV-S8R2321@-+$P")+Y>_P"^"><Y50S?*V 0 3+C0OJS:%?-N5*%-)7O;J[W
M?>_?T]2IJG@35;GP+IFAPG2C+;F?S?,4,J[R^TQL\3D8W#. I/9AUJ#4/ASJ
M=S]HFCN+%;V>6<RSEFWRQ/;H@C9MN=I=3D=,,3R>*WA\1M/W_-INJK#RWG%8
MMFP3>2S_ .LS@/QC&><@$<UO>&_$%MK\=V]I%+&MM,T#>8T9)8$@_*K$KTZ,
M%/M5JE1F[)_TC&>-S/"Q=244E=W=EO)ZWU[].A4\#:'-H5C?Q3PV=O\ :+R2
MYC@LV+1Q*P4!!E5Z8/8#Z=*Z.BBNJ,5%<J/GZ]:5>HZD]V%<1XG_ .2E^&\Y
M_P"01J7_ *.L:[>N'\49_P"%E>',?] C4O\ T=8U1D;"@$X.:S_$-\VFZ/>W
ML-L]T]O$T@A5@"^T9P":O#VJAK>GP:SI%YI]R\JPW,9A<Q-M8 \'![4 >-6?
MQ_A_LMKG4_#5Y;3LJ201I,L@FC9PF5.!R,],5N'XIZD$U>(>#KXZGI6V2[MO
MM48$<!&1)O/?'\./QJ]?_![PQ>)I*-]NBBTR,10)'-@$!@WS<<G(%:WAWX?Z
M1H-OJR0R7UU-JB>7=7%U+YDCKV&<=!0+0Y"/X[:!)<F&&PU*8R>48%C52\H=
M-QX)'3IU[5T?P_\ B?I_C/4OL-O8WMG,UK]LB\\+B2+>4)&"<892,&L71_@A
MX6TJ]^U*^HW$R1&*(SS@^2,8RN .0*VO"/P[TWPIK U.QO;^YF2S%C&EPX*I
M%G=@8 [\_B:0&1JC#_AHK1L8R-'EXQ_M+^=>M(X[^E>+Z] Y^/\ I&J,R0V=
MAIDCW#R-M&TY4?7EA7>#QQX>;=C5[$_2X3_&F#:6YU;/C[M*C]S@^IKD8_'W
MAMD)&LV'_?\ 7_&A/'/AS;\FM6#'T\]?\:KE9/M(]SL%E%,>4[B,=NM<H?&^
MA*.=2LOPN%_QIO\ PG?AYEXUBQ&?^FR\?K1RL7M8=SK%F..G-+YAX;'-<?I'
MB;6-6TNRU+3_  9KTUE>0I<02>=8KOC=0RG!N01D$'! -7/[6\0[O^1&U_'_
M %\Z?_\ )-26='OQUZYH\WH< &N;.J^(#U\#:]_X$Z?_ /)-(VI^(&'_ "(_
MB ?]O.G_ /R30!TS3#=UZ=O6FF3YOEZ5S3:CKY'_ "(_B#/_ %\:?_\ )5']
MI>(.W@?7_P#P)T__ .2: .E\PCJ*/,(/N>E<W_:?B#_H2/$'_@3I_P#\DT@U
M/Q#NR? ^O_\ @1I__P DT 7_ !#;ZC>Z9+!I%Z+"];B.X,/G;/\ @.1G\Z\.
MU;QEXW\-)XRTG6-2M[B_TRSBOK6\C@"ED+[2"N<<Y_#'>O3O$EOJ_B'27T^^
M\%>)TAD(+&WOK"-^/1A<UP4OPAL99)7F\"^-)&D78Y?5[%BR^A)N.164HZC1
MB:CX\\=^1]JB9;*QOKVRM[*>> -\LJD.5 //S 'FN8^,-[KFI>']9TGQ1?V]
MU?:#=PW$<T,1431R?)R/X2-WO7MU_P"'KN_T32]*N/ GB0VFG3136X6]T\$-
M']W)^T\CFN ^-VC11Z)J-[J?A_5M!N=9FAMVO;N6VEAW1AI0NV&9W!(C;G:1
MG'2IY7=: S=^$VHWUQ\,8KW4+J*$0QR);S^4<"*/(5RO&>GXBN9^'_C_ %/Q
MMH\]I<6[#5X$WR3JFR)E9CL(&<Y/3TXKN_!UI;3?#[2--F=;FU.GI;LR@H)$
MVX. 0",_G1I5M+"L]AX1\)W]U%I;QV4MQ;O:HI(C24)F296;"RKSCJ36;YN:
MZCK^1D_>3L>?^++:^;Q]H(GG>35;EHH+.2W14:S= 6?);.[*/UQCBMK5[S4?
M!>O6%C;>)I=6TW4TO!(+J2,R6\BQEU8,![8P>*N:MX#UF7Q=H.MZ7X%U>W:U
MNYI[Y'O;-C.)$P=O^DG!!SQP,'VK6M? MM;,[1?"S4PS'.3=63'GKUNO>N:O
M&5U[K>CZ(Z:>D;7/$XOMTWP]N?'UWXENXM;>2328QY4;>=&<#9T]"23UP*ZC
MX8>#)/%GAK[=;Z_?66D22&T>R5!ODMXVX0R Y&2.PKT34/"%PWA271;'X:ZD
MD"[Y;>)[FQ"),P(#Y^TDCKUYKE/ ?A/XK^$=#BTNRT!EM]YD<-]CE*LW)P3<
MC(],XHDJ]6E)07*[Z7[#O%/4[&/P'M^%O_"'R:E(Z^6T2W?E $#<2ORY[# Z
MUC?&329K7P-I^HQ7+&[\/!98\QAA,VU4.X9X''ZUI6D7Q5_>B\T"4<GRS'%8
MGCL3F['-<=\0+/XM7?@[7(];T"&'2%MY);B93:[UA0%BW%P3G"YP ?;-<]+!
MXJ-12DU:]_\ /H4ZD6K$G@WX:7NN^$=+E?Q!+;V%Q>+JKV:VR$"8'LQ.> ,#
MFO8_&ORZ+IBYSC6-)!/K_I]O7A_A'XFS:'/HEF8);_P_;:,DEVMA&LDD,Y=O
MO'=@<#H:6#XU1:K?7=GJZ2_8HM9TZZMIH8-WDVT=W#)(9 I))&T8P#DG%>A2
M4XS;EL9.Q];U2_LK3CJ?]H_8+3^T -OVKR5\W&,8WXSTXZUY\OQW^'3HC+KT
MS*Y(0C3+LAB.H'[KFM5?BIX58 K+K!!Z8T*^_P#C-=;L]PC.4;\KM<Z*+PSH
M,,J21:)I<<D8*HRVD8*@DD@''')/YFK*Z/IBV,MDNG68LY<>9;B!?+?  &5Q
M@\*H_ >E<N/B?X9/0ZW_ ."&_P#_ (S3)_BKX5MXFDGFUB*-?O,^AWR@?4F&
MDHQZ(TEB*LM92?WLZ>XT#1[F"2&XTG3Y89)?/='MD97DQC>01RV.,]:FM=+L
M+2<S6EC:P3$%3)%"JL0<9&0/]E?^^1Z5Q#?&7P0I ;4;\$C(!T>]_P#C-+_P
MN3P3_P!!#4/_  3WO_QFCECO83K5&N5R=O4]"HKS\?&#P8>E]J1_[@U[_P#&
M:=_PMWP<>EYJ?_@EO?\ XS57,COJ*X,?%KPB>ESJI_[@E]_\9IP^*WA,])]7
M/_<#OO\ XS2N@.ZKB5./BIKO_8&TW_T??4S_ (6KX5_Y[:Q_X([[_P",UC:1
MXCT[6O'^MZC8M<K9MIEA;K)=6DMKND26[9@HE52<"1,D#'S"BZ [M7':G;_E
MY]:QI-9T^' FOK6,XR TRC^M-_M[2B.=1LC_ -MU_P :.9 ;#. 02<4_?QBL
M.75+(X+7EN PRN95&1[<U=2[B9%99%9<=0V1333 O[L=:0L.E5//X&"3V%+O
MY&0>?SIW07+2, QSZ\9I[$=15+S &PW\Z!,&;J.GK0!<##=QWH,@ ^;\*J&4
M#N!0TXSR1TH"Y:##/)YH+_-C.153SD''!/:HIF=\>7M&.O- 7*_PO_Y%BYQ_
MT&-5_P#3A<5I>+]+?6-'-M# LLHD62,F\>U,3#HZR(K$,#R.,>M9?PIS_P (
MG-NZ_P!K:KG_ ,&%Q77U,HJ2LS2C5E2FJD=U_70\PU3P)K-W>/>2G1KZ]N;2
MVBNI[B) S21L=^T-"Z@,I7YBO\ ^7IA-"^'5[!JVD3:N]A=VEG%"DD;,S[C'
M%*JX!7! +H1G^[["O4**P^JT[W/4_MW%>S=-62:MHK:6MIVLMK'E$GPVU=]4
MRNIP1::)'B5%9RZVZR^=" , ;EDZ\XQWS54?#'5_['2TCFLXY 6+@W&8V8P&
M/<%2!-I)QG.XG RQ/7V&BI^J4S1<0XQ=5]W]?U8****ZCPPHHHH *Y+XH_\
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M5 I().<YZ"I!\S9)QBN8Z"4'/X4I;%,!STZ8I1C'O2 ?GBA6^8BFY/M3A[4
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M1@\@GFNTHJ/84^QUK-<6FFJCTV\O^!J]-CB/^%;:/]NMKKSKD20($4)'!&.
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M&:Y_X.KCX7^%AV_LZ'_T 5T6L3QC3+PHZ,WDMCY@<G%<W\'Y$3X8^%]SH/\
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M2Q_=:?R3_P!NM FC4ZKG/>D;)^[6=_PA>H?]#OXD_P"_.G__ "+1_P (5?\
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MJFH:QK%U>AHB99)ER51@0.!QT[5EW?P3TF#2;^+2+BY\]HY19QW# Q0N_?@
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M_$O3L*D6Y/(/!K#T\C^S[<#GY #S[5<A&YLYK=Q6QYS=G8TO/+M\Q(],4]G
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MUP7:E_B_"C^S\-_(A_6JW\QW?_"X?B'CCQ5/_P" -I_\9I?^%P?$/_H:Y_\
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M<,' 'RD>]+4#&T_X'>%[6]CF:XUF95.?*DOY I_(@UZK$B11+''D+&H4#.>
M.*XYOB1X<\OPX\-U)<IK\C1V+PID$K][=DC;C(%=GG#'&#@\T@$;C&.0:<""
MO!HZC^5"\'T% #\_+@TPC)&,^@IRG'3DT$>_TH FLP1,>?X:N54M#F8_[M6Z
M0PHHHH *YGQ1K5_I&K:9B..'19'"75XT!GV.6 5,*ZE >1OPX!9<@5TU4KK2
MM.N[V"\NK"TGNX,>3/)"K/'@Y^5B,CGTJ)IM6B=&&J4Z=3FJJZU_+^N]NS//
M]*\?W\%JD.HVUO/<RF5[:0RR S!;EHMI2*%B&'& H;(&3CFK4/Q*24Z8RZ<K
M1W<2M(%ED+P.T;N%;]ULP2A ^<-@YV]J["?0-&N(O+GTG3Y8]I78]LC#!;>1
M@CH6^;Z\]:0>'=%$T4HT?3A+$GEQO]E3<B_W0<<#D\>]8JG66G,>I+%Y9.\G
M0=W?9Z>6E_Z]-#$NO$NI1^!H/$GV"WB4*EW-;"4RL;4@%MK80"0*<XY'&.<Y
MKE-0^(FLIX;N));&"TNF::!)X9=[1RI'YN#$RD8"G;G<<D9P 17J;65JUC]B
M:V@-GY?E?9S&#'LQC;MZ8QQBJDN@Z/+<2SRZ5I[SRQ^5)(ULA9TP!M)QDC '
M'L*<Z=1_#(C#8W!4V_:T+ZW6^W1;Z]=[W./N/B-(MG%>0Z3&]JUO+>,7NRKI
M"DPB^Z$/[S+9*9P,$9R*=;_$26XAN)4T:6.'S-EK+,+@).?,9-F5@;Y^ 0J!
MQC.2,&NP;1-*<S%],L6,^[S<VZ'S-Q#-NXYR0"<]2!44OAO0Y6N6ET;37:Z;
M=.6M4)E.<Y;CYCGGGO2Y*W\PUB<M:LZ+W[O:^V_;2YR%K\1;J^^R&QT2)EG%
MJI,UZ4*R3[@HP(SE04.3P<$$#M78>&-6&NZ#9ZDL7D_:$W&/=NVD$@C.!GD'
MG J6'1M,A"B'3K*/:4*[8%&"F=A''\.3CTR<5:M;:"TMT@M(8H($^['$@55[
M\ <5=.-1/WY7.;%U\)4C;#TN5W6MV]+:]>Y+7"^+/^2D^&_^P3J7_HZQKNJX
M3Q:<?$GPWC_H$ZE_Z.L:V/.)I+VU%VML;JV%R1Q$95W^OW<YH:]M%\L-=6^9
M,;!YJC=SCCGGFO(O%'@'7+KQW>ZQ9V5E/!+>PW<<IG*2A8XF5HL=,,2,_2N;
ML_A=XDN/#.JR:K8VYU65#;:?;M=<6J%RYDR.-V=N,'L:0CW_ .WV(EDB>\MA
M(GWD,JY7Z\U,UU;1%%DGB21^%5G +?0=Z\*\)^"9_%&H2-J=O!;6%NUW:W$D
M8:.>;(V( ?0 DY]J[WQSX!M]9\)+9V$,;:I9VZQ:?<S2$/'MZ?-ZTP.RN]0L
MX8V:6[MHPO#;Y54 ^^3UYI/M=M<IY<-S!,P)RL<RL1CKD YXR/SKP5OA1KWB
M'5M;N=:LH=/@G26:W#7?F/\ :65!GY21MW(Q&?[U;?P5^'&J^%=>GOM5A\B-
M;8P+OG$C2R,07<8) 7Y0!GF@#-_:("[5QP1;GD]#R*\XM8V\R/ ;[@_E7I?Q
M^MOM=Q%:Q)YEQ]F>81@_,54C<<>@KE/#'A7Q+K6DP:E8+IX56:)D=F!RN.#Q
M7I9?CH82[J'D9EA*E=ITS NV'F%2>:K;,_\ UJZZ^^'GBZ61F$%@&')PQKBI
M7N;>\N[*_C$=S;RE#MZ5[V#S2CB9*%/<\F6"K48<TD3^4.N?SJ%P!P#FI/,+
M)C%1LN%YKTX/2SW,%>^I>M->UVSM8;:S\1>((+:%%CBABU6X5(T P%4!\  #
M  J7_A)_$I_YFCQ*/^XQ<_\ Q=9:C-2$CR\ >U9K!X?K3C]R.CZU6_G?WLT(
M_$WB5FY\4^)/_!Q<_P#Q=22>)/$888\4^) /^PQ<_P#QRL"9B@RM0O*PY8$T
M_J6&W=./W(T5:O+53?WLZ!O$_B4?\S3XE_\ !O<__%TG_"4^),\^*?$G_@XN
M?_CE8/F/M8M[&@.7+%1T%+ZGAO\ GW'[D/VM;K-_>SH?^$F\2_\ 0T^)/_!Q
M<_\ QRC_ (2;Q)D_\55XD_\ !Q<__'*YV.1B5Z<]:))7QD<@'G%/ZEA[_P .
M/W(/:U[VYW][.A;Q/XE7_F:?$G_@XN?_ (Y3#XI\2@_\C1XEQ_V&+G_XY6"9
MRW('0<T]W(3=Z]*:P6'_ .?<?N0>VK+>;^]FY_PE'B4]/%/B7_P<7/\ \757
M4-6U74TA35=8U>_BB?S4CO+^:=%?!7<%=B,X9AG'<UDF9NF!FD,S[L;1]<TU
M@Z$6I*FKKR0.I6DK.3^\N;@,TA<=JJ&;;NW#D<TJN9 "G'<UT]#+V=B;<!UZ
M4!L57\QLX*J<^]3JW'(&?:A270;C8,_-C%*<T#MTI<T^A(8Z4-R!]:0]N:5^
M*3%U,[6,_93_ +P_G77Z4ZB./J<*#Q7%:[<!+=?3=VKI;;4$AC@"KNW*/QKY
MO-+.KH:5H2=*/JS:+Y).>].A.''.>:PSJZF1D:,CTQ5BSU.*1MI'.*\[D;5S
MBE2DNFAKECYI'/-<]XA!6VG))X%7+W4DCG8CL!WKGM?U(G3;A)%/S'@BER.S
ME<UP]*4IIV['2:1'_H<#%OO(*Z"**,Q KRU9D-OY=C8[2-CPJ1^0J];JQZMT
MYK/1I,RGI-HEEZDKZ]Q4+#( _'I5@PJ%SUYIOD[ACC'K24A26ER'H3D]Z3)(
MQSR>*G,"HQ+'=SQZ4R0*J\*![TKW>@6TN1L,]2>GI34YZYIQY&,KSWI%50PZ
M 9Y-7%$N^Q:3[H'>J?B*1HM!U-XV:.1+>1E93@@A#@@]JF!V\Y_6J/B23/A_
M4QD#_1)>/^ &E):&E)^_%>9],GX,>!CUTV^_\&]Y_P#':/\ A3'@;_H&7W_@
MWO/_ ([7HE<;XRUJYTKQ%HJK?JEE(X26SMY(OM4S,X"D1R*2\>1@["K#<3DX
MKS9U>179]WAL"L34]G!*^OX:F;_PICP-_P! R^_\&]Y_\=I/^%+^!O\ H&7W
M_@WO/_CM8D'Q!U?3_)M[Z\LKR]^WRPRPFU6-E1;@1[=WG##;3N ".<$$\?,;
M^A>+-=GTS6YK2.Q,.E0M/Y4BS2R3?O9LC>TA(^6(XZ\D 8 Q6"QD6[*YZ=3A
MNK3BYM1M>U^F]NJ3WMTMKN71\&? XZ:;?C_N+WO_ ,=J.;X(^ 9EQ-I%W(/1
MM5O#_P"U:R9/B=J\WVEK6PM4MX9 S3R(2JP2NGD2'=(B\J7SEE&0.0.LGA_Q
M#JFJ>/\ 2C=7#1QSQQF2WM[GS("?(N,E=K,N"55L9.,#DD9H6,BVE&^I3X;K
M4X2J5%%<J;Z7T5_R_K4U%^"O@1<;=+O1CIC5[S_X[3Q\&O! Z:=?C_N,7O\
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MNTS1VZ*^,8QN SC  K0KD?\ A+=4_P"A&\2?]_M/_P#DJE_X2W5/^A&\2?\
M?_3_ /Y*II);$3J2F[R=SK:*Y'_A+=4_Z$;Q)_W_ -/_ /DJE_X2W5/^A%\2
M?]_]/_\ DJF3<ZVBN2'BW5#_ ,R+XE_[_:?_ /)5-_X2_4Q_S(WB3_O]I_\
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M>"/0TEC?VU\]TMK)O:UF-O,-I&UP 2.1SPPY''-*Z*=.:O=;;G/_ /"4:O\
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MH^/E '7WIV\,<#'/Z5D:+;4F93R0"2.>#Q59T(4#'&>?>GM*I+<X/K432Y7
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M,GI^\L?_ ))K.<XTW:;MZFL)1FKQ=ST"BO,M8^+MMH]D]WJ/A/Q+#;I]Y_\
M0VQ^ N":RH/C]H5Q&CP^'O$C*XRIV6O/_D>G!JHKPU]!3J0I_&TO4]BHKR/_
M (7II'_0M^)/^^;3_P"2*<?CEI0_YEKQ)TSTM/\ Y(J^5]B/K-'^=?>CUJO"
M/VDAN\1>$,Y_X];_ /\ 0[6MP?'/22<#PUXDS_NVG_R17G?Q/\9P>.-:T.XL
M-+U*QAL(+J.5KWR1N:1H"H7RY'_YYMG..U5"+YEH<^+KTI49)26W<YZ8XLR
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M:\?^)!J&,XV\5MKNXVYXSD^E8.LI)+I5W!#'++),RQ11Q(7=W9@JJJ@$DEB
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M\?O1E/IB-I_V,;0" &8KR0*?INE6^GAVMP%5\ \UIK!J(!_XD?B//_8#O/\
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M@\<DU6^/2K_9/AI\8VZM&-WID'_"O:-+;=!&.#\BXQ]*]7+VWAXBJ?'8O+@
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M)6)]:A+Z&2 "50@\X-<AX=FV:/:HF\A68$X]Z[*>(3V#(6PA!!]ZY(>&)[.
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M GC_ /0J^W=!&[3;=B>L:\_@*^>SI>\CU,ON:^[&#3DY>F+P/PJ51UQQ_6O
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M+L4Z]5JSD_O.NHKD/^%B:%_SQ\0?^$]J'_QBI%\?:.R@K:^)"#T(\.:AS_Y
MJC(ZNBN3;Q]HRC+6OB,#U/AS4!_[0JM-\3O#4"*TYUN-6&Y2^@WX!'J,PT 3
M>.^-<\#?]AJ3_P!-]Y6U@#(//->5_$#XG:+-/X9O-'M=:U)]/U-KB:"/2KF)
MO+-I<19!DC5>&E7C.>:K#XVV8Z^$_$^?^O2F!ZZRXZ5ROCCP78>,+2W2ZN+N
MRO+1_,MKZTD,<T#>JFN3;XQVYCB<^$O% 68[8S]D^\?SK3'Q,;_H3O%>/^O-
M?_BZ 'Z/\+=)T?3[2"WO;Y[B+44U22[E?=+<3*,?.3V-7M>\ Z9K5[J%U<SW
MJ27LMM+*$E(7,!)3 Z8R>:R_^%H+_'X1\5@#O]B7_P"*IR_%.U7.?"_BW'K_
M &>O_P 73 K77P@TR[NM:N+_ %C6;JYU:U-I++-<;VCB,BR;4ST&5QCT)JK_
M ,*S^W^*=9COQ(FB-:V$5K*CYD9H&W8^F0,UH2?%:Q5@)/#/BQ3COIP_^+IW
M_"U=-[Z!XI Q_P! [_[*@1Z!(N(VVC&!@?E7*?";GP-:-ZR3$DG/)E:N;OOC
M%8Q^<D?AGQ/)A/ES9;=S>G4X^M9?@#QIJFE>$K.VE\$>(Y "[!TB3#;G)Z$C
MUH ]GY.,TZ/Y1STS7G(^)-ZB@OX'\4?]^$Y_\>IW_"S)OEW^"?%2CKQ;(?\
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M$<TJHTK9 PH)RQR1P/45;KF/$NBZA>ZWIU]I!BM;B A'O#=.&\HMEXS#L*2
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M.R)2[$#)P.:\ZT_XR:%J=M+/8V&MW$4,7G2M':*Q1-VTDC?GJ#TKM_$LD?\
M8E['-<06XFB:)7FD"+N88 )/J37GWP6^'-YX,TV635;B-[^>![9XHCN1$,A8
M$-ZX/3% B_-\9?"$3/YEQ>",HDD,GV5@MPK'&4/H#P2<5I>'?B9X=U[Q!_9&
MGR71N6W^7))"5CEV'#!6[D&LG0?A9::?J]K=7NH2ZG:6UD]E#9W,(VJC/NZ@
M^O/2E\.?"]=$\91:S_:TL]G;>>UK9&(*(6E;<_S9Y'X4#.6_:51!;:=.L;&4
M07<8<,,8,1R"#R>F<]L>]=%:D#3+8\\PI_Z"*H_&Q["WN]%GO+(W+NS0_>P
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M9/!NFF!/,<W.'&!]W)R:[S%</X;MC-X'TI8)3&?/$A)/WL,<C_/I7<*/SIU
MI7_KYCEH/OS2@?E25B;"_2C%+BCM0,:1@TGKBG'O2>M,!AQUP*,#'8BG'DTT
MGCIQ0 F,C&:;L7/3M3OI1UH CV =!2D 9R.]/X %-/6@!N"&/?TIN"6SD^O6
MI#G=GTI.F/?K3 %R.YY'K2+G=]X]>N:</2D50O0CZ4#(R6SPQZ\FG<@?,3^=
M."]<_7BDQN/TH 3)Z9/TS0%.WJ?SIXP!S^=&0<_TH!C,-N')S]:&!Q@'Z\T_
M'S9I,<<F@0T9X!)X]Z8ZDDY]?6I6Q^-(>2<4 -6G GC)-)T;C&*<O)YZ4 -;
MZFD&3QD]?6I!C_&D_P : $ / !/YTF"6ZGCWI_\ 2F@8H "">&)_.EQC%#9H
M;T/X4 (?:@'U[48 I.@_QH 11M/!X]*&4[O04[C%!&3D@T 2VG^N/^[5NJEG
M_K#Z8JW2&%%%% !6'J6OFRUQM-6T:8C3IK\,L@!;RV5=@!XYW=2>U;E9>HZ#
M8:AJ,%_<I.+N%#$DD5S)%\A(8JP1@&4D#(.1Q4S4K>Z;X:5&,[UE=6>W?IU1
MR-I\0Y-0AT8VFDW$,EW-:K<-*4>.%9LX (<,6*C(.W'(S@\5Z%7,)X#\.H(5
M6REVPA BF[F*C83LR-^"5W$ GH#@<<5T&GVD&GV-M9VB>7;6\2PQ)DG:BC &
M3R>!WK.DJB_B._\ 7H=6/J8.=OJD7'U_SYG_ %^,]%%%;'G!1110 4444 %<
M-XJ_Y*5X;_[!.I?^CK&NYKA?%C!?B3X;+$#_ (E.I=3C_EM8T >%?$SQ%XAT
MKXA:E-;:OK%G8V\MJMO (W,$I8_O.0,!0N??/2LCP=K^LWUU?7_C#7_$%IX:
MM_,@CN[:21/,F9P4"@#<P"ANWIFOIPNAQDH>.Y%#>6PP=A'IQ2$>->%KB/QY
M\'+U/$,FHSR:?-(_GC<L\@B.Z-@<<DX[5Y?'X@\>RG3-.@UK7+G6+^WCN(3%
M<EDB61N#*,<?+BOK91&&QE0/;%4X=$TZ/67UA+2,:B\0A,^/FV#^&@#PKQ'H
M/CSPWX;M+[4/&.M7&HS7RQ2QV6Z1(X23\V,9S@4WX1Z]XGD\<6UC?:IJ]_92
MK=>:E[$P6-5D C.2/O$9/XU]#/M0?-@?6F@H%ZJ,T#/%_P!H*>6"/0C&K.6F
M(V@?[2UJR'?'&6^7Y0<9]JQ?VCGG3^P7MXC)^^VG';YE_*MU8]RQ;B"64$@?
M2O.S+^&EU.>NU=7(2/N^@.*9<\9V\X&:EFCV%<,.N3VQ4$G[Q.P##IFO!DTU
M9EQ>ERK))N8C@"HAP2>O%3% ,@D=,U%*H0  @U@G9:,U7F*%W-Q_.FG:(B<9
M]33W+*. ,FH^67H".M:)Z:C5KD&&'SYP.N*61\\C ^M*1\N!P:B9?XL_A5)Q
MT=QLD;&T9P..E-9P&"J,G%0;<\YZ>G:I/).[=D<C&/2HE9:V)2=AS#YN.3C'
M(IKL>G7M@5)SST]*;@$# S4N321?4 #NXX[=.M2;,MA6'(ZU#(C 9'7'/-26
ML;%RQ V$?C3@W^8*S>@*N>O8TR;@ '^53I&2K,O S@5%,I/##O5Z#81L?)('
M8XS3HV7>IY_*EAC_ '9X[^M")\ZA?;'Y5E.UK,M7L13'+X[]J:(BN,'.#2SQ
MDL2."!UJ(%P 0,G.**6P:(E0*V#MZ]S2.-D?)7KV[T)G. *9<%>^3SFME(.N
M@TO[<GI3(QEB3U[4+^\(*@@=Z6-2K?=YSFM+JPG=D^1MJ%R6#=14I*JO?GT[
M57>0%3P16<DV:+80#Y<C\J5)@<+T:D,H$>,<\]JIY0R#DCZ"JBERV8B[(67N
M.>]12?,3GBG,G9,GOG--=25R02OJ>]*-F+6XUG PH%2@ *-W/?Z5"5W$8Z5+
MPRCO6BVV,WHQR%"O/WJ6/YY%7MW%-484Y4YZ4Z':)%SD+6M-"D[1W.8^(^T7
M&G!3QYX!Q6IIYS 0>N>/:LCXBIMGTM\\>>*TK%_W+<]Z^BP*:H13/G<QE^_5
MS3A)&=IQ]*S=2TS3KV3S;VPM;F7;M#30JQ ZXR1TY-:, R#R<XX/XU"0%(]"
M:[4TSA5XQNM#";P_I'!_LK3L9_Y]D_PI[:!HQDP-(T_W_P!&3_"M*1&V[CZT
MY?O8ZU5EU(]I/?F?WLR!X?T;8?\ B5:>??[,G^%(^@:/M'_$IT\''_/LG^%:
MI8;3U!I"0,<XQQ@TTE8EU)W^)F6- T?YLZ5I_M_HR?X4K>']' !&DZ>><?\
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MHQ7SC^US_P A+P=_UQO_ /T*VKYW6QL_^?6#/_7,?X5/#:V\+9AABC;&"40
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MTK+UG)TF1<YX)S^%:,F#8Y!&:RM<!729,'@J>^.U#T39U4?CBB]\/8]OA"Q
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ML^>?N5VF\<9*X/M3LJ1U7\J(XG%]W^(*%(XO_A6/@[G&BVWX+42_"KP=_P!
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M (/YF:]W?8QOB%XN^&/_  DFH6.L>&)]5OT?;<7%O$5)?TW!@3C@4SX2ZO\
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MI98:;8C:<^0G48[5Z;\!SN\6>+#C'^A:?_Z'=UYOI3C^R=-)^]Y" \>U>F?
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M8QVINW"Y(%/4X;ICCKZTY1F D#]*&O(:(64>N/?%0.1T]*GBSN.[G!]*CN@
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M\MLXW8+QA3SCY^E9MCXZ\065GI4%T;2\N));A);BY,4 G\NX\O8A+QJK;>>
MYY'R]37KU%#HSNVIL4,SPRIQA+#Q;5M>]DUVZMW?RZI,\7O/&FJ3>(H)]\<^
MTB,Z;;22QM"PNPFR0*_S2;0.H .[E2.NI<?$6[M[;1I([[2;^6\\MY8[:#:J
MAFC#1[S<9\Q0YSA&/0E5%>J44E0FK^__ %]Y<LUPLN5/#JR\^G;X?RU[MG._
M#^XFNO"T$MU-)-*9[D%Y&+,0)Y !D^@ 'X5T5%%=$%RQ2/'KU%5JRJ)6NV[=
MKGR-X/&[POH>>UG!C_OVM:MPQ4$C&<\8K,\'''A31<_\^4/_ * M:CC<,$9R
M>AKY>I;FD;P%B;_10<'D9-<[XQN,>$]2" D+%N ]\XS70M\JA%  ]*YSQ0 ?
M"^J;NODG'_?55AG[R?F;/8/!ZQ7O@W3EF0E2A&#QWKI%18+58H!L11P%XK#\
M$(T?A/3_ #L,QC)Y/J>*V+^ZCM(?,E;:0.!FO6FO?9]!A-:4%Y!EWP=Q.#S5
M34M5AMWV;SYQR-OO62MW=ZED0JT,.<;O7WK1MK&&V97V"27'+/SD_C5<L5N=
MW+K9%6.VO-0.Z[E>*'JJ"M2!(X(_+C78 >!BG%R8@&]<?2FXR2Q//\Z"DGU%
MEG^8KV'7 IT4R@'+8QR0W 'OFJLK[,YY!&0/0U0DT^?49/\ 2I2ML#PB\$U-
MNK&XI1%?6_.U 6]G&\RC[TO853\<LX\,3XSDD9S6[#!#9)Y5O&(@!V[UB>-F
M$GAJ<  @,#GWJUHTB'=Q-;26!TC3B,EO(3M[5;\LI</=VU[J=E/(BQR-9W\]
MMYBH6*AA&ZYP7;&?4UGZ6^-+T_<1DPI_*M,R KROTI7:=T9QI1G3C&:NO,/,
MO_\ H/\ B7_P=WG_ ,=IOFZAC_D/^)1S_P!!N\_^.TH(*?-QSV-)O&[E>,<F
MFYR[DK!X>WP+[D*9K\==?\2#_N.7G_QVH9;G4 P":_XD/M_;=Y_\=IXVAL <
M8ZU7D*&0 9QG'UI\TNY:P6'O_#7W(D^TZCNQ_;_B3M_S&[S_ ..THGU+K_PD
M'B7'_8;O/_CM1JWS88 GM4HD!)XXQ@T.<NY3P6'7_+N/W(3S]1[>(?$O3_H-
MW?\ \=I&N-1X \0^)2?^PW=__'*5L#T/IS3-ZA5VCKC/&:7/+N)8+#VO[-?<
MO\B0SZEV\0>).F?^0Y>?_':(Y]1W+N\0>)"#V_MN\Y_\BU'N <9R>,TJLNPM
MCIZT^>7</J>'_P"?<?N1)-+J>X%-?\2@>@UN\(_]&UQ"^'-7L]0>31;J&&W$
M2QQH_.U1P!D\UVH?YN3UX IVZ-@00",8--3EW(J9?0G'EY$O30Y$P^-%(VW6
MGNH''RCG\>M-:/QH"<367()X&!77$Q+@ ;0.!Q1\G."N,<Y%1>^ME]QSK*J"
M[_><QI5IXCN=;T2UUF6+^S;K4[.WN!;R-'(T<EQ&I 92&&0V,@@\U]+GX1>#
MSUM-4/\ W&KW_P"/5XE;[/[9T#:03_;6G $?]?D-?5==-%1E&]CY_,Z*P]50
M@W:WZLX _"'P:>MEJ9_[C5[_ /'J5?A%X.52JVFJ!6Z@:U>X/_D:IM:UO4+7
MQS'86]_#(D\!CMK*&2)V2;8S!KB,KYGEGKN1P!M (YS6/#X[UO4+.WN+*"QM
M8YI)8E^TP.Y#0VWF2\!U_P"6@9!S_"3S4NM33LT7#*<34BIIJS5]]KW_ !T>
MW8T/^%/^#-H'V'4L#H/[9O>/_(U1M\&? [_?TV_;ZZQ>G_VK6*/B;K,D-[/'
M8Z?&L=IYR0RR*LBGRXW5\>;O=6W'I&  0=QP:GUGQ[KVE37T$G]D3W5J\T;V
MRP2(ZJD0=9V'F$^6S':!CN/F)XJ?K-+>WX&W]@8RZAI=^?I_F:2_!?P*K!ET
MN^# 8!&KWF1_Y%J27X.^"I45);#471>BMK-Z0/\ R-4&M>(=?E\.745G=V]O
MJT6MQZ4MS#  C!F0;MCE\??]3TK'C^(&N3WMQJ,$)^PKIDTD=B\0'[Z(Q"1R
M?O;59W&-P&$[=:<J].+U1-+(\35CS1DNV_HUTZK;T=[&R?@GX"( .DWA Z#^
MUKSC_P BTH^"O@0-D:5>@^O]K7G_ ,=K!U[QUJ]SH#1FXT^Q>2.1DN8)0QNM
MLJ +$8YG".%;+#<Y^@.:O:7XZNHK*^^T75C9+:1R21PS))<3W7[V8;TWS*2J
M[!GD@8/*@# L33YK6+>0XI4_:76]M-?RWOY;=;69IM\&O!#,&;3K\L. 3K%[
MG_T;0?@UX(.,Z=?G'3.L7O'_ )%IO@;Q+?>(/$MN]U(H065TK)"V(I"EPBK(
M%#NN=IZAF')P<&O1:UIRC45TCS<9A:F#J>RJ/7_@M?H?+/Q.\.:=X6\?R:;H
MD4\5DVF6UR8YKJ6XQ(TMPI(,C,1D(HP#CBN?$A^48XKJOVB-=T_1?BJG]I/(
MOG:+;!-L>[I/<YS^8K@(?''AQO\ EM,OJ&BZUQ5Z51U'**T*I./)JS8BC,F
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MG=)JSWOMT^?DM[';1?#K088EBBF\0)&HPJ+XAU  #T \^G?\*_T7_GY\1?\
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M3]/]<_\ Z$:WZP!]^?C/[Y\_]]&@3).V:>0,4PG@X'TI>>2: $8?*,@'M05
M!P/>@YQP>,9I-ORG- Q!03A>*!@TF<C':@  )/7M0ZX^Z.*=QMXI"2%/7-(
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MS<@]CQ5^9\QDC''K7):KJL^E>-=$NHX8I9?*,>W=C[V.]94U=GT>;IO"R?\
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MQV=YH]Y-O\BUU.RN)?*C:1O+2YC9B%4%CA5)P 3Q7N0^,7@L]+_4?_!->_\
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M2*4?&K3CT\+^)/RL_P#Y(J^9=SF^IXC_ )]O[F>JT5Y6/C18'IX7\2_E9_\
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M2,W)(I@6K,_O#_NU<JC8_P"M/;CI^57JEC04444 %%%% !1110 5@'F6;O\
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M,HYLG1@$4/'<RQN D?E@!E8$#8=I&>>^::_@?PZ\C.VG#!4H(Q-((UR@C)5
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MSUJ3&2C-@<CH>!6DOA'QF,Y\'ZEG/_/W9?\ R13V\*>,R!_Q1^I<?]/=E_\
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MV\R\?,=H&XC\ZUY<*",YJC>DOXN\"XEP-X.S/)^9N?PIP>J/*SE?[-?S1['
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M,]>U(HP.<9I%!^O/>E;YO:I 3)/04K8'.!GTHZ>E&=S$^W'%, &20:#P?:A
M1S3OX1GUI (%W*,>N:0 9/?ZU*H^7CC%,;&[ [T 6+'_ %A^E7:HV'^M;Z5>
MI#"BBB@ HHHH **** "L <33_P#79_YFM^L!E_>3XS_KG_\ 0C0)DHYS2>]!
M!"TN<+QZ4#&-DY/!H.[G)%(6R>.!BG,<<4 &, <TF1_2E/"C/3-,7H?K2 .,
M^HQ3F.#P*39CID<<4IY[?C0 T#G)S3E)\OKS["DQ\WZ4HYYP>O6F("3QCFFM
MR,=#UIS'[P''O37SVZ8Q2&<+\9@6^'&L*N.47))Q_$*Y;1%QH&GG;PL*J<>F
M*ZSXO1L_P^U?@G"*2!W&X9KS;P'XCL-6TN*"RG_>P(!) XPRXXKCQL7*GH95
M(W2:.CD5%#\9XQS5>5B8P", =_6K-SA8AD[O7':JLP"*-I^]VKP*EXZ20HR;
M15;C<<=..M0G<0,+GL>:L,=PX[]J@<L,  \&N2+Z6+5]V&#NQT/8TU3U##GM
MS2KN&[/ ]33"#P>H K6*;U'?709NP1QQ2M(=R@?K3@PQ]WIQ363+YP>M:*ZT
M9+V!URV>I-1@'=PW)XJ0MTY]@*%(.[()!QQ4STL-/J!5N,_6F*2S<CJ*5Y"
M% _2FABIRP.<=A63ML:)W"0;;@8R>*L-C9D]?2J[?-(&P0 .A%2;SMZ8'KBH
MC$?,R'>-QXX/Z5!*?WH/Y5(Q/F-D?ABF/\W?-=$8V=[$-L<)E"@$8YIWG8
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M .2J7_A(-9_Z$7Q'_P"!&G__ "52&=+GL/QI5]ZYE?$&LC_F1?$?_?\ T_\
M^2JN^&M=&L_VBDFFWNG76GW(M9[>[,1=6,4<H(,3NI!65._K0!N$\<<\4JYZ
MTT8_"G]C2 .O2@?+0#W[T"@ !^M*?UI!P:7'- AC#*UR0"CQY&Q.2T9 XZ$
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MRE\2L<6+P]&C;V-3GWZ6VMYO<*XSPK_R,_CK_L,1?^F^SKLZXWPKSXE\=?\
M89B_]-]G6AQ'3C&.:=BFXI30(#S10/:EQB@09HS2=R:7&: &G[O6N1B9_P#A
M8+KR $W#  S\J]?:NO-<CY[#XA"W$*.ICW%R>5P!5PZF=39&=X;F\O1/$WR!
MC'?2,<=6R1Q7=VIW6L)*[244E?3CI7GGAZ_+Z9XHBV!&ANF;?C!(+_SXKT2V
M.;6(\D[ >3[4Y;"IW_/\R48H8TG6E;@UD;"T8HSUH)XH :..M+WS1WHQS[4
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M+IQKQ=6W+KOZ&.KZ@=O_ !4'B7K@_P#$[O/_ ([1OU#)_P"*@\2GGMK=Y_\
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ME SLZ*X[R/&__0?\-_\ @BG_ /DRE\CQQ_T'_#?_ ((I_P#Y,H ["N-\*_\
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M ".'AS_P9P__ !5*P'1;,-T[TC1#)W#_ .M7/?\ "PO!?!/B_P .G_N)P_\
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M$_\ ( \-?^#V?_Y#J3PSJE[J<FLVNJV%K9WNFW@M'2VNFN(WS!%,&#-&AZ3
M8V]0:5@3/-(O@3H,9'EWVJI&K;U2.?:%;'7&*2Y^"EC+RFN:PIP>?,R*]K"
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M![CI3BV?N\4 -).WM3<9;IQ3N3'VI.G3KZ4#%"X&>YIJL>P-+R<$<T*,K[4
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M^-AM+1J5RC>XKUZBI>%IM6-HY_C(R<[K7R]-NU[:_,\Y\.>!M0TOQ)IE_)-
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M>/3ITI@##YJX_P 1Z>FK^/M!TZ[NM1BLVTR_N'CL[^>TW2)+9JI8Q.I.!(^
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M?JA%\(_!\6KOJL5IJB:I(NQ[Q=:OA,RX P7\[<1P.,]A7>T4U",=4@NSD_\
MA7^B_P#/SXC_ /"BU#_X_5?X;^9_PC<L4D]S<"#4]2MT>YG>:3RX[V=$4NY+
M-A54 DDX KM*XWX<\Z!>?]AK5O\ TX7%4(Z9A]10!3NM- Z#^5 "-]:.AH;K
M10 C=:7M_.@]02*6@!I/J.:4#.<4'K1GGB@!!G-+C.*%/6EH  H_6E[G%(!C
MIVHYH$&:4G\J,"C% "=_6E/Y"C/S4O3 H&)S1C'-+Z4U<XYH$/[<4A/.31MP
M/?-(1DT '?BE7K32.>*5>N!0 ]32TE&.>:0"BDQUH).:6@ ^II/6E]<T=: &
M_2N:U9A;>*+"8QQD2E82QY89ST]N*Z4UQGB.<_\ "::-"9&$9=&VYP,Y:M*>
MYE6=HF;H[(LWC=%.9.3L!'3:W-=IX<_Y .G\D_N5ZGVKA-)C#:YXS;S55?+*
MYVY(R#DX[XKT'1U"Z59JC!U$2@-C&>/2JJ/3[B*?QW]2ZIH/MQ0O&:#6)N Q
M1SVI<4=LT#$ P:0]:.^:7/6@ [4UN*7GM2=>M "#^=(:4>U-]>:8!G'?%*>:
M3;THQW[T '4T#I0.3^-!ZYH&)NZX&:3G//2EY!.?2C!W#.: $/WJ=D'V--'!
M^M'7)]Z %W'TZ4=/:ER.E'6@!I!/3BA0<<TYCCIUIO1>:!"\DC%(HQGD4H8;
M<XI"<'@4  /RTC=Z7/&>*12,X/7K3 7)S^%+CIZTF:.AYI *#36.1[YI>XXS
MGOZ4C=13 3.#SWI2><=J1AD<G-*!GJ2,4 -W8].:4DTTC SU%..* $Y"\]:3
MKCC%. ]3GUIN 1UQ0!/9_P"M;Z5;JG9C$S?2KE(:"BBB@ HHHH **** "L5A
MMEE([R-G\ZVJQ9,[Y/3S&S^= F.Z\=*<N OO28R,@TOW5&?I0,:W3WQ37P"3
MUIV[/3TI&.,YZ4,!0<@<4U<%>?7BCIBC&?SH =RWX4UOO8_6G')']*7&?ZT
M"D8I!V(XHVC%.51@8H$*N?SI^"%XZTUN".]+O]OSH&(I;:0V<TXDDX'YT*<L
M<=>AS0S<9% #<_-CI1_#UY]J;&>F>O\ *I,8'XT"$0'O2L?3MVI.AXH)^;GI
M0,;U[<^M+M(/X4]3\O-)D<YH 8>GU-.QQU]J0?,?2DD('7.*0#CUZ=J&/M1G
M@<4IQV- #1C![4+\H']* ,M_2E[\'C-,!">1BE/!/6DY_7FE;GVH Y;XI?\
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MKE;.W\0:CXRL=6UJQTFQMK*PNK55M-0DN6D::2W;/S01@ " ]S]X5U0/I^E
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M +_Z?_\ )5 '6T5R7_"6:K_T(OB3_O\ Z?\ _)5'_"6:K_T(OB3_ +_Z?_\
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MK&9OWTHZ'>W\Z %'3C/)I2-W2D)XX&*=G"T"&L,H12%1L^7K1C*]<4-PQ-
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M'2CN 33C]WB@!N*3/XTN:.P!H!@HSFC'-&>II?I0 8YYHQ\WM29S^=.QQQ0
MA/\ .@GB@\C@TAH$+[TH^E-W8XIWTH !29]J7I2'U[T +[GK3<\G/2BE ]:
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M,]:!"9!I3QQ^5-(S@"G*"#R:!C<X;ZTO;C.3WI6^]29^7GCF@0J]^:#3>-I
MIWIGKB@!IP.<<>U.7&.E&!P!1CH!0,,Y^\*4$<]:-H'UI>!0 "D."??UI<\\
M>E(5H 7/I2+S[FE_@]*4<4"$Q2YS2=Z7O0,7//>DX]Z,T=N.: $!ZY/>G4FT
M'FE)- "X!'-)VI%^;UQ2KS],T "XQC-+ZX-)CC/84J\4 )GJ*4'TH HSR>*
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MI<YHX !I<T#$ []* >:/;F@<^E  .*49[4G8_6C/I0 N<?6EZX^E)2GN?:@
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M#R:."P%(Q!Q]:1N,?6@!<?-D<4O&[O31R>>*7OC]: %'7F@\C\*3'.:7KTH
M%^5ASQBG=?NTT <9I<X- !G/4TB'G:12J!GM2\#CO0 NW@@=*=G&!S32P4&E
M4\^U "MGCTHVY[TC-1D\]J ' < \8I>W--48X)I<Y%(!,;2,>E(0.2>*", 4
MA8'J* %SGK0P'7FD(&#^=&:8QN2>E.&/\*:OL>*5#ZT"'9]1WH8YS34S^%+U
M./UH 7O2,2.<=Z7N31UZT#&Y^M+G (Z\TA/S?RI,\']10(D^G%+Z9I@8GT&*
M<2>V* &X!8FAAC&*#VH)^[0,% )[\TZDSG&:"WI0 J__ *J#TYHZ-C(I#V&*
M %"C&>M"CC_&D7[HR:.3TH$.R,@BDX+"CC%&1NP ?K0,<3S]*;C:<TUC^>:<
MN3S0 O2A1UI>!SVI,G/M0(<*%H!I.W':@ XX&,9I1^= Q@9I!U.30,7K2\4@
M[]Z<.IH$&.10>O6@GGVI,@M2 *$]#V[TO:D'RTQC_I29Y]:,\9S36..E(0[K
M2'K3<Y%+GKFF XGY32<8YI.N:",G% "@"C'X4"C/% #AWIN:,YZT>E( 8=31
M1WS1GO3 ,C(_04'C\J3^+/M2$DT .4>M&>>E)P.M+Z4 )2'&*7.*;U!H &Z4
M=<4W(!I_TH 7''6DXI,@\#FCV%  .IY/TI5ZF@'(HSB@!1VIPZ4T$T>] "]#
M29QCK129PN30(,9Y_&G''?ZTT9[4I QS0 =A2K24"@ ^E'4>E*.GM2-0 4O?
MGK2 @GK0#G/M0 \#K2 9- .:4<4  )H'!.:3//-&: %/7FEQ28QUH[T@$Q@=
MJY'Q3-;V>O:7/.LDC9Q&J?WB?UKKB/2N(\=0RS:MI8B0MM8,<*20-W/3H*UI
M?$8UM(MHAL9D3XBZ_"<J[VP.X]!A1UKI/" QX?M KB0?-\Z]#\QKE;=#_P +
M+U_/0VA'3_96NJ\'D+X;L@,\*>3]33E\/W$P^/[_ -#:&12CK[TG;-+VK$W#
M%'UH'M2-RM PSD^E'3BD44'GI3 .3TI&I>PI,?E0 BYH/ZTO)%-QS^E !T/O
M0>*.33<$#K0 X&D)R031C'(IN/FH =2>@IV,KVS3 "O04#'#ISZTOL::!C/N
M>:7.#QSF@ XV\TH&&Z$TUESW[T X8Y/'K0 K* >M(I)SWH8[E^7' HY(./2@
M0K<GCTIJG.<]:".?>CW-,8#@]10G/2DQTR.E.4=<&@0<4O7-)P.M*>1BD T'
M I6Z CK0!Z]J:1V'6F C'\J7'RGKS2 <9/\ .ER3SCZ>] #4&.0:<3U!_*@<
M]:0I_.@!._'UI3A?J>M+C\Z0C+<4 2V1S(WTJY52S $I]<5;I#"BBB@ HHHH
M **** "L5N)9N>3(W\ZVJPBW^DRYX_>-_,T"9)U'-"] #TI6Z9S36(P/\* %
M/S<8IK$*#CK2,2!BN \3?$>+1-9N-/'A_6;SR>#-;PY1OH>]5&#F[1!M)79Z
M#NX'&32!L?GFO,5^+MAY<3R>'_$2N20R"S)VCZYYJ4?%S1Q_S"/$(/\ UX'_
M !JO8S["YT>DQ\KGM03T'7UKS<?%W1AC_B5>(<]/^/ _XUI#X@6S*&_L37\8
MR,V8Z?\ ?5+V<NJ%SQ[G;*1U'\Z4<_G7GO\ PLJ'OX9\2>G_ !Z#_P"*JK<?
M%[3;)Q'=Z%XDB<C.#8YR/P-/V,WT#GCW/3QC/T%.!XX].*\I_P"%V^'UZZ9X
MBZ?] ]O\:=_PNWPX,9T[Q"/^X>W^-4J%3L'/'N>J*VU>E*QW=_I7D_\ PO#P
MQT-CKP.>G]GM_C3C\<_"F>;;7!_W#V_QH6'J?RCYT>JX-'L*\TM_C/X3=0S2
M:A&?[KV;@BI?^%Q^$#_R^70/O:O_ (5+I33M8.9'HV?2CVX]:\[C^+W@\L/]
M.N!GI_HK]?RJQ<?%+PU$H8/?R9XPEG(2/TI>SFM&@YD=V#GK[TP=^O%>>/\
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M)IBH5Y&OV!;ZXIZ_!70D;*ZMXA!X_P"8@W:BBCZU6_F8<D>Q:/PFT\N&&O\
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)HHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>image00012.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image00012.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" +(!0T# 2(  A$! Q$!_\0
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M#FF TD<>]*>M&W%+CGD\T (/I32,]:>?KQ3<#ICO0 4C#.#2Y%&.YH =_#0
M>M"\T[/- "8YR* .:!_]>@T !&:0?K2YP*.#TH .IP.M&/E]*7%-)ZXH$+C)
M-'3@4@[\^U+]*  X'6DYP.>:#ZT+ZT .Y-.R=M,[\4HZ>U(!V*7&:;G%.[4
M)TS2FDZTOUH !@4G0YHS0>>E "]:;SSFEI: #%+VYI.12]N: $H^M+C I.]
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MM==Q'S'&0:Y>W#+'G!JP9F*@29;N,5,J:OH:0K-K4Z3[63*<#IU/K3;B]:,
M\X]:P?M<A'!*^]*UR[(0Y9LG%2Z9:K7.BT^[-P?3CKZU>8<&L31KB%9E@:6,
M3.I94+#<P'7 [ULY_'GUK-JSL;1?,KCL<#/:@CN"<T+]W/:EZ<_E290;N<X^
ME(3G%###?6FY.[- #CAL'THSD=>M)U'XT;L@#C- @48YYI>N<GG%"Y[4F>/>
M@8=.&)IV<+^-,_B^;/-.^\.OX4 &[TZTH.<9ZT$ >F?2ACSQ^-  >1UI03V[
MTU2"N<4 YZ4 *1Z4[;SP:C'##/KQ4O!X]Z !1S3L\\4G3.!2@^M( R<\CBEQ
M2-R>O%'?(- "J,?_ %Z#W]10/>C/)H 09QDTWG/:E8Y[4B\-C% !T^M1\[@?
M6G_4TAX.0* #OGUHC.6)I,E@:10>2>,4QDG2ESD9[4F 1CBC&1QQ0 A-&?3F
MD8?C_6E P!B@!22/QHY- //K2Y.[%  <\?SI.OUI6ZT4"$49IW;\::.,XI>>
MY[T *#Q2GI24I'!QS0,3D^U(1\OO1CYOI[TI/_ZZ #V-)GV_&CDM^%(K?-@9
M_*@!Y))XZ4C&CG/O1MYY_*@ 7G)I#G/I2CY> >*7(/2@0$Y(S1Z9S1R>12@=
M,F@8N!36YZ4I]#0.N32 0#'/:G X/:D[G-!(W8H$&,FG_2HU!+<G%29QTH&-
M; Z]J=D8II^]GUH8= ?2@!>F/2CZ4F. /:E08H 4^U&?6C/04C<B@0'VI3P/
M>D&?PI1S0 G:E^M&>*0'UH /SI?I2<_A2B@8ASCI2KVH!HSD\4" T#&[BEY)
MIO0T !Z\4 T4F, T &,MQ1UH'7Z4W=BF I%&:3/YTN>O% !CGVIK9&*7)/6C
MDF@!/IUH!I30!B@!R]*%QGBDZ4M( QE:3'O^- &.*4GM3 3VZXI>G2D_G0V>
M*!#N#UI*!SG-!]* #'I28I,D=_TIQXH 3../QI%*GH<TO)J"62.!=[D =,T+
M43=E<LC!)QBG5%&0X#*>#4F?6BPQ2:!Z_G29Z$TN<T@%H;BD/%(<YY/% "YI
M#US2_6D_7B@!<BE'2LR_U>TL+.6YG<^7&VQL#)W>E68KR)YXX<,))(_- ([<
M?XBG9BYE>Q:'WLT-^5)FESQ2&+_#UI,?-29I3R>* $SFC(]:3 I=HZT &0>1
M3<XH[TTL.:  =<TIZ\4QG4'EA^=(K@]""*=@),>](>_K2 X[_2D&01F@!><4
M$T'GO36;^= QW44W.!R.U&#S]: #G)H ;C/)X]*7[Q/-# <?RI5."<_E3$"\
M+2KQU-)TZY(-*HSZ_C2&(!SG-+ZD>N*7'(R/RH ZXH$-)(HP3QTI3P?7UI*8
M"D8XYR:;C!I<_,*3&<CKWH %SGK2G[WXTJC/6E/&>F12 0= 0..E(Q!7IQFE
M7C ].II#B@!IST'.*5B<'(I>A[>U(Q_.F >E1@#?@Y%/QD=\T#G)H 08_7K2
M _EZYZTNS(ZTV/ &"/QH ",X/IQ6C%_JD_W16=R./>M&+_5)_NBA@.HHHI#"
MBBB@ HHHH I:CUC_ !_I5)N1GWJYJ?\ RR.2.O\ 2J)/J2?2@!K<MP:\R^)&
MCS:1X/UK5].UC54NK:!I8]]P67=GT->G,/FKA/C,O_%L?$I S_HC?S%9U7:W
MJ!2\,^%1J7AK2KV[UK5WN+FUCFD8W!.68 G%:?\ P@\?E,G]NZU\XVY^TG(^
MA[&M7P$@_P"$)T$9S_Q+X?P^05O1X ]:TNR5%=CB9_!%R8?*MO$^J0]2'95D
M<'&/O'FL,_##43G_ (K_ ,3?-R3O6O5!P>G>HG)&!C-+J.R>YYH_PPU-E11\
M0?$:*JX 4(,_7U^M7H_A_JZ1")?&^J, .KVL3-^9YK,NOBY;66H7\%[H>H0P
MVDTEO)<!U9/-2-I-G3J0IQ6QI/Q .IR>39:)=374EDFH0PK,N7A8XSG'!]J+
ML7*MK#!X%UA3N7QMJ!8'O90G%!\#:X"73QS?Y[_Z! :AU7XGPV&DZ;JG]@ZE
M+8WTPME964,LVXJ8ROJ&5A^%7?"'Q(TOQ'JW]GPV.I6<S>:(7N8@$E:)@)%4
M@]5++^=.X[(Q&L]:T#XF^#HKG6VU:WO#<1NLEK%"T8$+'(*]>GZ5U7A?2]7\
M16%WJ$WB_6[3.I7\"06T-EY<:17<L2 ;[=F/RHO)8G.:R_%C;OBUX#4@%=MX
M<@?],7KKOA=_R*]QC_H,:K_Z<+BBX[#/^$/U(_\ ,\^)?^_.G_\ R+2CP?J0
M_P"9Y\2_]^=/_P#D6M?Q9K,F@Z+)?16;W91E#*N[:BD_,[E59@JC))"GI^-8
M#^/XH+VZBGL%>VM[6WN#>6]] 87,N1A7D:,$9! /&<'@<9SE5A%V;.RAE^(K
MP]I3C=>J\N[\T6/^$/U+_H>?$O\ WYT__P"1:/\ A#]2_P"AY\2_]^=/_P#D
M6JVG_$"TO=2MH+2VO;K[;'"]M%% BLF]'9M[-+@X"'. ,8X+9%.D^)>AQN(Y
M$O%EV!RAC7*GSO)93\W53RWH/?BI]O3M>YJ\IQ:ERJF[Z?C_ %^#)_\ A#]2
M_P"AY\2?]^=/_P#D6D_X0[4O^AX\2?\ ?G3_ /Y%KG=8^*D<FGQW'A^*)G!D
M$J76U\ 0F1"#'(1R1@@G(P00*]2JJ=6-1M1Z&6*R^OA(QE7C;FO^!R'_  A^
MI#_F>?$G_?G3_P#Y%H_X0_4O^AX\2?\ ?G3_ /Y%KKZ*T.,Y ^#]2/7QQXD_
M[\Z?_P#(M)_PAVI?]#QXE_[\Z?\ _(M=A10!YSXHTO5_#UC9ZA%XOUR[QJ5A
M;O!<PV7ER1RW<43@[+=6^Z[<A@<XKM,COTK%^*'_ "+%M_V&-)_].%O6RR@K
M@]Z %'3@CVI&)[#-"<*?:E]Z !!W_&EP=V1ZTN0/:ES^7:@ 7/.<>U.- '2C
MO2 ,>]+G#?A31G)SUIV,<T )SG Q0/N\'/O0HR3FEQQQ0 A/&*9@@^]/(IF-
MS\]Z  \YYIHSNXXXIY7%(!\WX4  ]NE.^E-'M2@GM3&&[B@GBG9&, 4Q@=M(
M H/-(5RO%(HP*8#R .!Z4I&*3;R<\4H_&@!",]*!Z?A1CGIFES0(3O10!D>]
M*3_.@88)S@\4HX6D I<'.?0]* $V@'.:'Y VX^M)GGIWH(R#0(4$@^G%*/;K
M30.YP#VIP! &* %Q\PH/6F]#Q1GWH&/'7FD!%(3D^U&>M AV?2E':F=N,4N>
M1DYH ,]QVHYH!)-!; ]Z0PQ@=Z7O2=>IIV13$"GFG-ST%,YR?>GDX/..E(8G
M<8I,>A[4C'YJ.W- "@YI1G-,7[N!TIV,-Z4 .7WI/I2@8%1\_K0(?SW/>@''
M2DZ*<\4G;CD4 ._AHQG\*,X6FYQTH 4^M*O;K3,8QUS3UH #R:*0Y[4O7ZT
M+WS29R>*3H>32CGZ4 (3]:/844F< YH 7&,X_*FMVS^E**:PSWZ4P$0#'2GC
M R?:F*",<9YIQ/M0 AZ#CFER1B@'*\TF>WI0 IYI%//K0>O:DW=A0 _Z4N?_
M *U-_'B@G'.* '<<4@;CFD)&/>DSTSS0(4G]:%XSG%(2*6@!W '-'K2 C=[Y
MH+8R* #^&C/'--'WO:EZ4 -F8@+@=^<5RWC[4FL-*5@2,N/QKJ';IFO*?CM?
MB&PM8$?#D[CSVKLP%/VF(C$X<QJ>SP\Y7/3=$F,^EP.2-S("<5?[5Q_PPO?M
MOA:U?OMQQ779_P#U5CB(>SJRCYFN$J>UHQGY#NW'-.!X&:;FC@^]8G0.8\TG
MUI,^U*6% "FF&C=FC/3% ,X;Q=,K^%=1W'.Z\"1D#H<C_ UT5FR?VK:JXD\\
M6>0V>",KGCUZ5S?C+"^%4V+M!OQP<$_>;/-=!"?^*EA Z?8?7W6MGK&Q@M_Z
M[FZ,=Z5C3,XI0:Q-QR]Z3UI,_GWI,\9I *3ZXJO)=!6VG.15>Y;Y^?7O5/S3
MDKU[=/UK6-.^K.>=5IV1=EOE PI&:K&ZD+')P:JL<?GZ4\C.,'/-:J"1E[6<
MG8'E+YSPWO5FV8%QU/;KUJFRN#E>>>F.E31PR,1@'U'%$DK%P;ZFP!S^%*1W
M!J&W'EJ0W)J4-NXS^5<[.M!G;@?K28X.>M*W!]L4F.O>D,.>W3/6J]U.8(]V
M-V3TJ?)W'/X5G:L/E7C@545J)C&U"?=Q$,>OI1_:<@.6AR,=:T(1F&//I4@1
M:+KL*SMN48=2C=Q&ZE6S5U6R!LY'\ZJWUNC0N< ,!UQ4>D._V?Y^QP*=E:Z"
M[O8T,YQQWIK2+&"3^M+NW#TQS5">7S+Q8SD#'I24;C;L#7Q89CB\P>O:E6ZN
M"Q'DG!YJW'&L8VJ.,4\8'3I3NNB%9]R"&<2$Y&.U3@^U0S (-Z 9%/B?,8/4
MDTF,E4D?>--=@J.S$ #DTHY.:IWWS;8QW.2/6DEJ 1W\<F/+&[TQ3'O6!P87
MZ]N]7(8U51@*,# P*<WS,,4[KL*S((+J.5=N-K]-IJ8@YYYJ&Z4)M*J <]0.
M:F7D<GKR:3&*>!VIJ\YST[4X#K28ZT .  %1'KDT_D\"AUQZT ,P!@CGFM&+
M_5)_NBLX_>':M&+_ %:?04,!U%%%(845RO\ PGFD?\^?B3_PG-1_^,4?\)YI
M'_/GXD_\)S4?_C% '545RO\ PGFD?\^?B3_PG-1_^,4?\)YI'_/GXD_\)S4?
M_C% &]J/_+/\?Z528 +GD^U8E]XVTN79LL_$IQG/_%.:@/\ VA59O&>F_P#/
MAXD_\)W4/_C% C?9N>1BN ^-3&/X8^)B<#_1&_F*VY/&-AGY=/\ $G_A.ZA_
M\9KR3QS>>-?$&A:O8K]I:SN4=$M_^$6U%92N>!N\G:">.<UG.'-8I'KW@8$>
M#=#'&!80=!C^ 5T*\*/RKP_1]=\<6GAC2[**%K:>WMTC<R>'-3<\* %(%OC(
MZ9!(J?4_%WQ"\N-]/LU4A<-$?#VJ-D^N3;C'TJQ'M8/8#.#S4,PWC;CY3G.#
MBO&+GQI\1!% MOI8\Q@ID<Z!J9VG'(Q]G]>>*Z;0[OQ[J.DV^H0W/AB[M+N!
M)[:4">+*N RM@IGD$<'%%P+MW\,_#MSI)TY8[N*W>[>]<K.2S2,I5MS')(VL
M1^-6?"_PZT/PUK?]K:;]L%U]G%J3)-O7RP, 8]NU,L&\=10@7T/AR=\G+)-,
MGTXV5?\ M'BY8(L6.A>9NS*/M4N-OM\G6F 7G@;1;[1;339HI1:6EXU]$%DP
M5D+LYY],L>*HZ)\.M,TC6[34[2\U)VM#,(8)95,2"5MSC&T'D^_85IW%UXG!
MC%M8:.V3\V^YD&![83K4,U[XQ#$0:9H93<<%[N4$C'^YUZT@,7Q6,?&+P)QQ
MY5YS_P!L6KK_ (6_\BO<?]AC5?\ TX7%>=:K<:T_QD\%#5[.SA39=^4UM,T@
M/[ELYR!BNG\&>*;'0=+O-/U.TUU+I-5U&0B+0[V9"LE[-(C!TB*L"K*003UI
M@>@ZC8Q:A;^3.]RB;@V;>XD@;_OI&!Q[9K'F\%Z#*8#]C>(P11PQF"YEB*K&
M24^ZP^8$GYOO<GGDU4_X6!HI_P"7?Q%_X3NH?_&*/^%@:+_S[>(O_"=U#_XQ
M4N$9;HWIXFM25J<VO1M&AIWA'1-.O+:ZLK+RY[=0D3>:YV@*RC@M@\.PY]?I
M4?\ PAGA\ZC]N;38VNOM$ER79V8&20;7."<8([8QWQFJ?_"P-%_Y]O$7_A.Z
MA_\ &*/^%@Z)_P ^_B+_ ,)W4/\ XQ2]G"UK(KZ[B;N7M)7:MN]NWH6I/!6A
M2V<=K/;7,UO%D1I->SR",%2A"[G.T;3C XKHZY+_ (6!HO\ S[^(O_"=U#_X
MQ1_PL'1/^??Q%_X3NH?_ !BG&$8_"C.KB*M:WM)-V[N^YUM%<E_PL#1?^?;Q
M%_X3NH?_ !BC_A8&B_\ /OXB_P#"=U#_ .,51D=;17)?\+ T7_GV\1?^$[J'
M_P 8H_X6!HO_ #[>(O\ PG=0_P#C% !\4./"]M_V&-*_].%O6T<G!QS7$>,?
M%%CK^EV=AIEGKTER^JZ;(!)H=["@6.]AD=F=X@J@*K$DD=*[@GIU%   2#_*
ME _G303S2-T_''6@!^!P.M/ %1*0%QG&*=WZDT@'[A^-"MGK2?Q#Z4[CK0 8
MX-*%XZTTG*\?G24#'CFC@_6FJ?PI6[T"%P*2C/&:3OZT -)/.>E(3ECQVH;Y
MAQUI/XJ8"CH:=@"F\ ]>M!YQCK0,>>!G/:DR,"FX)7G'2EXVT"!LXXI,'UI<
MC!I&XYI +NYIW4TT\TN>G]*8"X^7G-)C@YI23VZ4WZ&@!QZ4F3QCUI%&%/-.
MR,"@8C$@XIQ]130.AQ3J $ Y_&ANAQ3<D'ZT9Z@4"'"@Y!S2*3GD=:7'KQS0
M,-V:.-U YZ<_A29^8T *.N*.3GUH QWI210 G>E [G%)BD"X;I0(>"!2$\>M
M!&!0O"F@ QQP12C'2D ]>E*./RH&+CW.*4]?I3?KZ]*<>32 3.32@TW!S[TN
M>0*8AV,>_>C/)I,X-+CDTAB9]*&^O-'Z4=^E @)ZT=*",\T=* #'R\TF"?04
M[K]*;F@!>X]* >?:E[CZ4GH: %R=U //'K2*<T?RH 1EZ]Z44O/;FD4#/%,
MQQ2=C3C[=*;GK0 4TG/2E)SP*3GVH ,\BCN:3G=1T)- "D'BEZ#)H!SUI&H
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M7H\")!Z 5(,KC]*CB^XO3IQBGXRV?2D DO,;_2L_1&'DO\VXY_2KMPVV)B_
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MUR_EL->L*,+Q3!A\RYYIV<@9Z4W.6]Z4MG/UH <%^;FD9E! S30S<XH<#@T
M/)Z<?G30=O3G-(IRO6ERNT>M "YSDKUQ1G# =<=Z0'&2/2F[OWF10!(ISR:4
M?>^8XI$YSG%(3D8([T +@="3BGJV>G04PGY><_A2+P!@Y% #NN:4$ <TA.5X
M&/>@=.F,T *JA>><FG8]#Q2;N.#3@>E " #]*<Q X/>F,<4'DYZFD _KC-'7
MVI.F.]*?O TP$7'&:7C&*1.>M+D%C[4@#JO/%)U_.G C::9NP..E #2,/SS1
MDYR?3@4YC@&F<M]* 'D@BESCM3 12YQD]Z8#MV<4K#%)G^(T,?>@8?D:&X6D
M_K1U)!':@ (^;^7%"CY>>./RI5[Y_.EXH$)CCU-)TZ4[I3!GG=V- #L_+GI[
M4G3GFE+#I2<YQ^= Q>W-*"*;^M*.M "%>>>@IPP,T'IP:0>_6@!<=\XI6&1G
MM3<'J>]*#TH %P& % ]NU&23G HZM0(0,!GCBG8R?04F.>0/2G< >M  #AL4
MN /QI![T>U QQ/%,-+2YR/6@ 7@9H/8_I29Q2Y]NU ,/QI^.M1 !>]*!Z_G0
M XG%(O6G<=*;G@4"%:G8Q3<]#2KZT#$IWTI,=,4O?VI"&Y-!!(ZT>M!X&>M,
M!>@%! XI-V12CUZ4  &*%'3/%)FG"D, !FD[\=*5?:D8?C0(7--[GFEP.U(.
M^:8!G X_*DVD]_K3L 9IJGF@!<<'%)CUHS24 (!@Y]*=GG/&:1<4G':@!3U]
MJ3;SS^%*N.AI.?7O0 =\?G2BFD9I5X_STH 4=:">>E H(P?>@09YI0<]>*;C
M([XZ4N>QXH 4CBF]*,GGIUIN[!H DXSS^5,'%+CKFD/2F =1WQ5>:98NK8S3
MY'"Y+&LJ^D2<@H 2O7BKA'F9G.:BKE74=2?SIHXSD!,C'K7RIXOE>7Q#>LY^
M;S#_ #KZ/\S-_>VX;D0[O4C)KY_\9://:ZA/+(#RQ.2*^LR2$:<WZ(^8S"NY
MRBWW9T7P6UB:PU"[@B5'60*<'KGVKWJ+5HWN$61Q%(3T)Q7SI\'BW_"6QJJL
MV8SG'X5[YX@T1=1MRHC99%Y1^ZFL<YA36)][J:8-U%"3B]%T.QC(^\&!'K3P
M<]:Y+PUJ(LTCTR[EW7*<[CW%=1R\7RMS7S=6DZ<K=#W:-958WZ]B;(%+GC--
MC&%&>N*?TY[UD;C>AYILAZ_2GYSUIK=Z :/-/$ZX\%@_+G^U"01T^\W6NHA1
MO^$D9\?+]AC[]>1VKFO%J>1X.A5I"Y;421@\+\S<5TUO%M\022X.TV,:_7I6
MZV.9V/*?B]XXU*QU.;2;,FW"J")!U/->-WMY<7,ADNYY)I">2YS7H'QKTZY'
MB8W81C ZXW'G'->:N,=>:^_RBC2CAXRBE?J?+XB;G5?,[ZB!LX)['M4@.3P>
ME0M]*>I^3H0:]9(R:/HKX':^^J:1):7&,VXVC QQ7>ZC& N5& #Q7SS\%]53
M3_$XCFG$:S# &<!J^CKLK+;@+C'45\%F]#V&+;CLSVL#/GHN#W7Y$&GO^^!/
M_P"NMMCD<_2N:#[4QR#GMWK;M&+Q#<>W>O(K1ZGIX:>G*5YS^\8'/7BFMQCL
M<>M37$1+-CD54P57:0:Y&M3M6Q(5.&Y)I\?WP5)/&.M19RG(I=VU0<X]:5AF
MJ.F.^*-N#COU^M,MR3&,G/'-.VMDD' QBM"13\QQ[UF:N.4ZY]/6M!LAA@<=
M*HZP!^[/O^=-;@]B*.>^*D)&NW&0?6AWU+:-H1,D9.*U5X7@<8&!2J,MZ"GS
M>06,LV-Q<Q+]IN203DJ!BM.)1'&JJ  O%2 =.]-Q]*5PL(V.#GC-5PO^DN?<
M5:*C XX'-43_ ,?Y'\/7%$1,O';^E-+XQZT8#<TN,MSVI#*^H'_1N1DTMN<P
MK[=/>ENP##@C-+;\0KP.OI57T%U)<<U"W%V,]<5. 2V1TJ$C]]R#20R;/S#'
M--X///6G8[+T%)QD^]( S\M!.5[5%(^Q0<=.]2*0PX[T "\ YHSTI<8)!'%&
M>F* $3. #3F(#<=:0 4,N6![4 ,Y9@>U:4?^K3Z"LT9)_'%:47^J3_=%#!#J
M***0QDT@BA>0JS!%+$(NXG'H!U-<LGCBT>S@NH].OY(9(7N&:)H)!%$C!6=B
MLI! )Y"DMP>.#752H)8GC8L%92I*L5//H1R#[BN9?P3I;WT,K?:&MXXW5H6N
M96,K,ZL3(Y?,@^7&UL@\>E95.?[!W81X5)_6$_EZ/S76PD/C6QGFOK>"VN)K
MNUF2#[/#+!(\K.S* "LA"_<8D.5( Y%3:9XPT^_\0/HRI)%>HI+(\D1(8 %D
M*JY8$9ZD;3@X)XS*OA'1E695@N!YI4[OM<VZ/:Q9?+._,>"Q^YCJ:MV&AV5A
M>-<VOVI9&7#*UW*R,< ;BA8J6.!EL9)R2<DTDJNEVC6I4P%I<D97MIZV7F]+
MWT_'MIT445L>8%%%% !1110 5YO\+\+\-?")QG.D6GX?N4KTBO./ABV?AKX0
M'7_B46G_ *)2@#I>0>?PKQ7Q3\0KK1;K4X['Q;I-^&MIFAB:V*O!,O*IPQW9
MZ=N:]K9ANP...:@:SMVD!:V@)'.3$N?Y4KB/+K_5O'"6<]P;^PL5\J>\MQ):
M>9YD21HPSA_ER68>M4OAYJ/B5_%VDM#>BZT37+=M7NXYH&WVI**FU7W$8+C(
M'IFO9-B."CJI!!!!&<BG111HJB-%4 ; %&, =!0,\U^(\,O_  LGX=W A0Q"
M\DC,F?F!,;';].,_A7IX?L  *\A^+KZC)\0_ %GIEU%!*\TTD9F0L@<(?F([
M\9'XUTD&E?$%%(;Q'HS').6LCQ^E:1@I+>PI-K9'=+][TI[-Z#FN#:P^(>]!
M_;FANF?G/V1@0/;BJ.H6'Q.6Y1[/6-">-01M-N5S]>*M4DW;F7]?(CG>]F>D
M[N,]* <CC'2O,EC^*Z9_TGPX>O\  W^%,S\6 .'\._D>?TI^P_O+[PY_)GJ&
M/7'%("&Z<>]><7*?%%-ABG\.S$KEAM9=I[CD<U!Y7Q8"@I<^'2<ARNP_]\=/
MUH]BOYE]X<[[,]/"GUXI/XA7%6/_  L F9[IO#I5A^ZB!D&P_P"\!S4<<?Q$
M:WC\V?PXD_5B1(>W3@8]>:CV?FA\VE['=^N?S%&X],_D*\VO)OBC%/BWM_#U
MPF/OAV3/M@C-0+>?%8-DZ9X?/_;<U7L>O,OO!3\F>H!NN*<N"*\L6]^*PZ:1
MH!XZ?::>NH_%48']AZ$?^WOK2]C_ 'E]X<_DSU#Z^GK07XYQS7FYU;XF_-_Q
M3>C'YA@?;NW>K4.K^/O*7SO">G&3'S%=07!/YT>R?=?>'/Y,[W< >V*%8ALD
MY^E<)_;7CK_H4K,C/.-03_&JEWXG\;6ZEO\ A"TDPP!6.]5B/UH]B^Z^]"=1
M+_ACTG?N8XZ4X'Y:\I/CGQF&P? 5R3[7 _QII\>^,^@^']YCKQ,*'1DE?3[T
M'M4>L=>G I<GMUK@+7QOJKP1FY\(ZU%,1\ZJH(4^QILOQ#N+9U2X\)^)-S'C
M9:EQ^8J%!E<Z/0$8 ]<T$_K7GC?$M456;PMXF 8G'^@MGC\*C_X6C <[O#7B
M9?K8/_A5>RDQ<Z/1MP"XXII(!YKS@_%2V2%V7PUXD+#HOV%_F_2FQ_%>S,J*
MWA_Q&H;[S&Q?Y?TH]C/L/G1Z43G..?>DSSZ9XK@_^%G:2J9.GZ[G.-ITZ7./
M7I3F^)>A.H9%U-@1D'[!+S_X[0J4^P<\>YW6.<DTY3FO/Y/B;H*A"[:@NY@@
MS8RC)/0=*C'Q9\+1W;03W5W'( 20UI(,8[=*?L9]A>TCW/1N,"FY'7I7 ?\
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M31DC-!Y![&@"0<=<4G?_ !I@PO7K0&W$#]: '9QS06YQ^M(Y^3(]:3>!QWH
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M;0T7Q*?^9\UW_P  [#_Y'JM\*P%^&WAH+T^Q)[^M=@IR,G!%4)'-#0_$F/\
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M9G5)T:&%HB@1;E8Q(<,Q(!'"@+DBK.H^#M4O+/7+#&E_9]2G:[%S([O+&YC
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M9/MBD"_-3]M(.1'FL_@_QB\LI7Q>8T8@H CG;[<MS4!\'^/$5O*\:(Q"X4/
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M ,8/I3#H\08%?R)-%T6Y*UB\G^K4GDXI_6FQ+LC"'^'@<5)[TC-#, ]10JY
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MLMT70MM8X#%,Y"X(.<YYZ5W$;^;&DB$%& *G'4&JJT)TM9(F%6,_A%.X9Z4
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MQE1@@[<'-'UE=$QK(ZBNYU(JWG=[7[?K^!VG_"N/!'_0F^&__!7!_P#$T?\
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M4%B !G YP!5[)"\U!9W*7-I%-&#LD4.N>N#S4S-QTI#'+SUIRK3%(I^1UYH
M=QUQFD[_ %Z4A;G%+VH$!QGFEQT%-(/K2C_)H <<=J;CO0IR>*7/KZT@$H//
M0"E]Q1G(XI@-(';UYH[4I'-"CB@ 4TOUXI.,TO:@!![#\:.1SP!0,[O:G#IZ
MT )C@4G1J7&6&:,\T "X[#\:3C?[4X?I2>M !QBFTH]:."!C@4 -(R<'CT-*
M!\M.%-[9- ",/>A3GKS]*&_44*3UZ4 &VBES2=N>#0 A.<XI,Y R*=CKZ4O8
M9Y% #1UIV*,8Z4[ZT"(\?-]:55IV!1CWH ;]*!2]_2C '6@!"/SI,>E/84UA
M0!')C(YJ&Z_U+$\U991QD4QE!X(%-/435SYJ^(]C+>^-KD!"P\L8_6N1L_#M
MQ,9@T3\"OHN_\+K/KDUUY8.X  XK9TKPY9VX+>0H8^U?4T\YC0HQBNB/EY97
M6JUI-.R;/CV[MFMYGCE1@48J0>"*^C?@-YI\)1I<@':3L);/RDG\NE7?'/PM
MTS68Y9[%3;WC'<S+_$><U6^$'AC5?#-UJ$%X^;5BOEYYSU_QIXW,J6.P;L[2
M70VH86KA\1%35UW/4(<9P.@J;'2FA0,^II_8'%?*,^A2#%!]Z7TH[9I#$ZU6
MU)<V-Q[H1^E6JJZC\UG, <?+51W%+8\_U:,KX,TE2^6COD)SSGYFXKM[.$KK
M%W,5&)(H@#NSG&>W:N2UP/'X.L!(22+Q-Q#]!O./KQVKK[1D;59PL@9UA0%!
M_#6]3K\SFIO57\OU-''2E/2D SCTIS#\*YCJ$Z"D Y[4X<J:,8]Z!B&D8>AI
M>O6@TP&\FDY[=12KTYH[T -'>AN%]:7%-R=U !GVYH/O1C /]*7^?6@!F<<^
MM(<\\_2G]:9@]^G2F -^M<GXKT:WU;5K)K757TS7[>-I+>2/#,8_X@5/5:ZP
MJ"?:N8\1^'KJ]UFRU;2+];/4;9&BS(F])(V_A(^M;X>2C.[E;?\ I^7<SJJ\
M;6N0>%]4U!M;N](U^WM3JEM DHO+;[L\3$@=>000>#]>]=+=0QW-O-#,FZ*5
M"C*>A!X-8?AW0+NUU2[U76;V.[U*>)(<PQ[(XXUR0 /J2<UTQ&<9^M/$.'/>
M'EMM?R"DI<MI?TCR;X7Z#-:^*M4COYS*-$S9V2GD)&_S9^N.*]548.1SZ5CZ
M)H9TW6M:OC,)/[1E20)C&S"XQ6V%Y%5C*[KU.>_1?EK^-Q4:?LX\OK_7W'!C
M2-5TFXO;_P $WUI>6L\[2RZ9,1M,O1@D@/RDD<@^E=#X4U*VU71+>]LH!;1R
M9)A 'R,#AAQ[UBVOAOQ!HOVV#0M4L193SM-$EQ"2\!<Y8@CKZC-;WAO1(M#T
MBWT^*1I!"#F1NK$G)/YUI7G"4/B3>EN]K=?33\3.G&2EM9?UL9?Q,F6/P#K9
M8G!MF PI/6M;P_@:'I@_Z=8A]/D%0^+]*?7/#>HZ9 X22XB**[= ?>KNFVK6
MFGVENY!:&%(V/8D*!G]*QYX^P4>M_P!$:\K]IS=+'._%:0Q_#W72JELV^T_+
MG@D#^M5_!Q\8+]B_MG^QFTWRP<VY<2 ;>.HQ^M;7C+2)M;\*:GIMJZ+/<Q[%
M9^@Y!K/\-Q>+;:XM8-5BTG^SXTV,T+L7X'&,UO2G'ZLX:7N]]]EL8U(OVR>M
MK=/4Z:8AHW)[*?Y5XQX)N+;PMY>M[2T6HF]CN'9\CSHG9XP?JH;_ ":]K= T
M;#U4UQ6D>"1+X2&C>(=DT:WKW2"%BO!<LN3^//UHPE:%.G*-1Z-J_IK^6C'6
MIRG.+CTO^AC?#>Q>Q\8WOVH(UY?:='>S2[<-N9^GTP5_*O1[^%+BUEAE;$<B
M%&/3 /6LBQT6>'QM=:J3']DDL$M8T'W@58'\L5JZK:)J&G75G+@)/&8V/7&:
MSQ-55:BG?HOZ^15&#A%Q.$4ZGX5T9;36(8M>\+JJQ"YC.)H8L@*'7HZCCD&O
M0863R8_)QLVC;Z8QQ7 QZ-XL7PS%X=\G2_LZQK;?;?,;)B7&&V?WN*[Z"$Q6
MT48YV*$SZX %5BG%ZW3=WMU\VNC)H7O:S2\R17&.G-*QX)SG\*;MY..33E'7
M/-<1TC< =3FF[@<9J0CT':HCV'2F [G/8\UI0_ZE/]T5E]22O&.*U(?]2G^Z
M*3!#Z***0QD\J00R2RG;'&I=CC. !DUA2^,=$C6W;[5+()[>.Z3R;664B-_N
M%@JG;NZ -@D\ 9K:OH/M5E<6^[;YL;1[L9QD8S7+Z#X2NM#N+9K#54$7V6UM
MKI'M=QE\A=H9#N^3<.""&]L'FLIN=URH[<+#"RA)UY-/HN_SY7_7WFC9>*]'
MO-+O-1AGG6RM ?.EEM98@,$@@;E!8@@C"Y.>.I%7(=<TZ2#S7NEM_D\PI= V
M\BIN*AF20!E!88!(&>U9VG>&S8^&KK2A-:W/G332YNK7S(CYDA?:T>X;@-V.
MH]?:N<?P+/#=^&85GDN+:TFD-W)G;&(5998H0C,S; Z1A1EL 'GM4.=5):?\
M.=4:& J2DE4:2;M?K%)OLM6U9>JT.IG\7>'H;J"V?6; SSS&W14F#?O!U4XS
MM/;G') ZD5*?$^@BT^U'6]+%MYAB\[[7'LW@ E=V<9P1Q[BN:;P#+(JA]554
M2\:XCBCA?RXT>-TD1%:5BI.\G(.T$<+U%0Z;\.!:K!YNHQR21(\9D$4I,BF!
MX5SYDSXP'S\N!VP.RYZ]_A1H\/E?+?VLK^F^_EIT[Z^1UH\2:&8A*-9TWRS+
MY ?[4F#)_<SG[WMUK5K@1\/YHIHI+75Q#)']F"RK ZR)Y40C.PK* -P!R&##
MG&#BN^K6FYN_.K'#C*>&AR_5YN7>ZVV\D%%%%:'$%><?"]3_ ,*T\)!3R=(M
M/_1*5Z/7G/PP.WX9>$B2/^01:?A^Y2@#IBG&"1Z5Y(OQ:F35+SS?#TS:+%<2
M6L6HQ3@J9$!^5AC(R1U[5ZA_:5@\+RI?6C11D!W$RE4/H3G KE(_"'A(Q^5#
M]G\I[MKTQK= K)*W!)&>1ST]:0&=H/Q4M-?LH)](T/4[J6;>T<  #R*BJ69<
M]1EL9]0:N>&_B59:_J.E6MEIUXJWYN8GD<8-M-#MW1N,8YW=<U4T_P  >#K&
MVN(K&[DB5E6%I$U'YH4!)"*<_(,YX%=)X-\,:/X5L98-!>0V]S(;@[Y_-W,>
MK ^_>@$<?XZ+'XU?#M?E(VW3 ]_]6W'TKUA0<GK7DGCDY^.7P\(Q_J[L<=?]
M6:]=7(7W- V. P*08&/6@<#K01\HZTQ"GH1ZT#!7VQ1D%?EY]::O&,F@0[T
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M'-+D<4S.31F@1(/TIHQS30>: <YH =Q2-[9HI"<F@!Z].:8WI^=+FFCCKR:
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MXOEU2[UDFUU..WA2WUB[MHXX_L5J^ D4BK]YW.<9RQKLQ[=*Q/ 7_(;\<?\
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MZ2XLK=KDL)8BDJ,I7/<@%?\ @598.DZ,^15&TMUZKH74=U>Q]M0297YN*SO
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MPW_X*X/_ (FC_A7'@C_H3?#?_@K@_P#B:ZJB@#E?^%<>"/\ H3?#?_@K@_\
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M\$,__P F5U]%6<YQ_P#9/C7_ *&+PY_X(9__ ),I?[*\:_\ 0Q>'/_!#/_\
M)E=?10!R']E>-<?\C%X<_P#!#/\ _)E5[*Z\0V'C*QTC6[[2;ZVO-/NKI6L]
M/DMGC:&2W4 EIY P(G/8?=%=O7(:S_R5#P[_ -@;4_\ T?8T =&.![49Q2_I
M2=>*! 6% R>:1@,YQ2CM0  \>E .*&SV%(.E "@9;O\ X4F/\^E(<Y%.7(H
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MMG.:5BDQV\=!BFL2" 32QD< 4A'I2 52"<<?A2'@>^: .O Q0XPN30 $;_\
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M/>.?^PS'_P"F^SKH.#R1]*\RN_%G_"(>*_$L']H^"S]NO8[SR]1\1?8IX?\
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M[5Y'^T?I=I;^'M!DM;.U@8:DB;UB"G:$<[<@9_"O7/B)_P DD\3Y/_,#NO\
MTG:O1P595X>T2MN93BXNS/0ZYWQ-X0T_Q%.\M])<H[6IM087"[ 9$D#C(.&#
M1K@_7BJ__"Q_!'_0Y>&__!I!_P#%4?\ "Q_!'_0Y>&__  :0?_%5U2BI*TBJ
M->IAYJI2=FNI2O\ X::+>6LEN9;N.%I?-V+Y;*O[I8L .A PJC!^\#R"*N?\
M(+IGENGGWF&:9S\Z]981"W\/]U01[^O2E_X6/X(_Z'+PW_X-(/\ XJC_ (6/
MX(_Z'+PW_P"#2#_XJH]A3WL=3S3%M).H]#/7X8:*)YY3/>EI83#DF/<N54;M
MP3<2-BD!B5!Z#!(KIO#^C1Z+!=)'<W-R]S<-<RRW!4LSL #]U5 ''0"LG_A8
M_@C_ *'+PW_X-(/_ (JC_A8_@C_H<O#?_@T@_P#BJ<:4(.\417S#$XB/)5FV
MCJJ*Y7_A8_@C_H<O#?\ X-(/_BJ/^%C^"/\ H<O#?_@T@_\ BJT.,ZJBN5_X
M6/X(_P"AR\-_^#2#_P"*H_X6/X(_Z'+PW_X-(/\ XJ@#JJX_6_\ DJ'AW_L#
MZE_Z/L:F_P"%C^"/^AR\-_\ @T@_^*K%3Q)H?B#XH:)_8.LZ;J?D:-J/F_8K
MI)_+W3V.W=M)QG!QGK@T =P>W:D!YH//X48SG- @//O0/O4O3D]?:COSQ0 O
M7\Z3U^M"]?>D/*^] #L\9%-#^O':EZ=:2@ ]1CZT[&!33[?C2CWH 4?*:7 Z
MTF*7CWH #AA@TI&%&.U&,'B@]J!"<TA'/%.S3>] !FLOQ&H;1KS+!<QXW$9
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MXR",_4&N-NOASI%XDGVVXO9YY)WNGGS'&QE:/8'PB*H*\," #N&3FL:OM/\
MEV>C@?J>OUJ_RWV?RWL[N^UK:MEL^.-'@NKFWOKCRI8I63;'#-)M4;/FD_=@
M)S(H.<@9'/86(O&>@RW\=FEZQGEE\F/,$@61MQ0['*[6&X;=P)&<#/(JA<>
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M$G*F6!X2P]0' ./0XP:YJ#X?:9!"R175^&::&X,A:,DR1N[AL%,<M(Q(QCT
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M;;59+:XC3ST BDB(W$@  [OPH ]CU?XF^%-*M)Y[_5%BCBNWLF_=L3YR ;E
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MF?296F@VD %F7:=WK7DOQIL4G^(7AJP:64V>OSPV]_;@X5Q'(-K#N"-YYK+
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MOY.<4P)PV.*P? W_ "'O'/\ V&H__3?9UK%V!^7TSFL?P"2=:\<;N3_;,?\
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M+>ZO-5O/L:"XN6@C3;#+,6++&YZ0D8V]2.::W$<MXA39X?TF,#:@U-L*H P
MY K=\40QFYM_F.3'C&>:Q]4T#QW?V=C"VG>&T>UN&G#_ -KS'(+$A<?9.,9Q
MFIM8TGQ_J+<:=X8CVC"YU:=B/Q^RBNFG649*39RU,.Y1<4BN;52. V!0;8*%
M)1Q^'2J7_"*_$3&!;^%OK_:=Q_\ (]/?PO\ $%AC[)X4'3IJ,PZ?]NU=OUVG
M;<XE@*FI-CYL'.>M&T!@G*D]JJ#PG\0PV3;>%?3(U.Y!Q[?Z/4%WX4^*;W+M
M:CP6D&[,2375S(R#W81+D_@*7UZF4L!41J+ #DJW0]:<8U /(!]<U@_\(E\8
M!<(Z7?@A8@06BWSD'U&3%D9^M:5UX>^*$GE_9[;P/%APS[KJZ?</0?NN*/KT
M!/ 5;[EF2/Y@=P'T]*39EN2>!D4ZUT'XA":0WFF>#I(2!L2#4;F-D(//S&!L
M@^F*>NA>/2P,FE^$B,\A-4N5X]/^/<\^]'UZG8;P-6Y6,2[C@M],4\Q#!Y:G
M_P#".^/.3_9OA7) Z:K<<>O_ "[?2E;P_P"/1$PBTWPLLF/E+:M<%0>^1]F!
M/YBK^NTNXHX*LB%HUYR<'TS1Y:QJ>3_6K/\ PC_C;_H$^&<D<_\ $XGQG_P%
MIRZ#XV!&=(\,D?\ 88G'_MI2>,I6T9<<-6O[Q7B?=W)VC'-)(H=OO<CJ:I6D
M'BW_ (2#5M(O=.T07%O917<1M[R612)9)5169D3_ )XOG ]/I4BZ7XS&[?H^
MC-Q@'[6]1];I[FWU>9:P%3[V1GUI2HW#KC')JHVF>,Q@C1M%8^GVQZ8EEXY'
M+Z!HA.>-M^PX[57URFB/JE2Y<5"&//'2E^Z!NS@]/SK.^Q>-U9]^@:.,GC;?
MMT]^*5+'QD=N?#^EL/3^T#_A5_7*8OJM1)(TU&X?*"<_I3UR(2,DGG(]*Q;6
MS\?F2077A_0S'CY/*OW5@?<G-275MX[\J-;/P]HPD_C,VH,P/TP!6?UR!7U2
M>YT$;E[.*(8RIX!HCDFCD4+@E#@&L'R_&ZF(/X9TICG]YMU(C/'\/''/KFJT
M<?Q %[&TGAK1C:JS%U746WL,'&"1@<XSQ4_6:>P_JT^IU-P[S8,N21QQ43-N
MX'(KD+[4_'IL7CM/ 2K>!CMD-\&BQGTP#G'O56S\7ZZWB.70KWP-=KJ?D&[B
MBBOEP8<[<DE3SG/2A8JFA?5:AW)4A>%]^E+UP,'K7/W.K>(DC_<>!M6E;L&N
M4'/<9Q3I-7\0I#(8? FK/(& 13<H-P[G..*OZU3[B>&JF_T;D'&>:E4?*,\<
MUQ[>(?%F!_Q;;6..O^FQ_P#Q-+_PD/BG S\-]:'/3[7'_P#$U+Q5/N'U6H=C
M@[^3VYI-[#(*XQ7(IXB\5GS7;X<ZLJ@A4_TI"S#Z8K1BOO$\UNCCP5=Q[N2L
ME_&&'U&RE]9I]RGAZAT4#DS(#Q@@8]:ZQ"-@;VKS5]0\3)$&A\%SM.O1#?IC
MV).VO1+)YI+.)[F+R9F16>/=G8Q'(SWQ7'7FIO0Z:$)05I$RL&Y)Y]J=NP/:
MD4?-@=,4 =N<5@;C1\X_&E(W?YZTJ@!>N*1>5X.><TQ"C 'X]:THO]4G^Z*S
M#ZG%:4)S"A_V128Q]%%%(9Y5_P )M\3O^B1_^7+:_P#Q-'_";?$[_HD?_ERV
MO_Q->J,P12SD*JC)). !7._\)GHS1I)'</Y+,,32H;>-D+ &17EVJZC(R4+=
M1@'(J93C'=FU*A5K?PXMG&_\)M\3O^B1_P#ERVO_ ,31_P )M\3O^B1_^7+:
M_P#Q->B76O:1:1-)=ZK801J5!>2X10"PW+R3W )'J!3K?6M+N;XV5MJ5E->!
M=Q@CG1I /7:#G%'-':XO85;<W*[>AYS_ ,)M\3O^B1_^7+:__$T?\)M\3O\
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MT2[\/QZKIUUIZS2K/=6>W#^60NT$XZ]^W7!KK+'P]\4[BRAN%^(%L@F174/
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MI?A_Q/?7(N$D\E=&O(20#S\S0XJ'0_&GB;1M(LM/B^&WB1[>TA2!"+6Y9R%
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MZ5O$GC,?\Q;P[_X)9O\ Y+H^K5?Y0^M4OYCU:BO*?^$D\9X_Y"OAW_P2S?\
MR72CQ'XQW#.K^'0/7^Q)_P#Y+H^K5?Y1_6:7\QU?Q8_Y)9XR_P"P+>?^B'K#
MN_'WA6*Z%J_B'31/D *+A3^H./UKG_$6H>*M=T#4](N]9T);>_M9;65HM&E#
MJDB%25)NR,X/&0:X8_"7P)U;3KL$CH)ZAT*NRBV'UJDM>8ZSXB^,/#&J^%-5
MTZ'6M/N)Y0L7DB8$O^\48]ZE^#!Q\,=$2-BRQ1O'\AR%(=N*X;5_A5X#CTF_
MEMM/O8YH;:65'^T]&520>GJ!7D?A!-.3P_:M>MJOG31WMRXM;YH41(8PR@*
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M,']::&?7AN(3,L8FC\W?Y>PN,EL9V@9ZXYQUQS3)+ZUCN'@DN+=)U +(95#
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M_A*-!ZC6],SZ?:4_QH \6_:G \[0L\G[+>D#_MBU=WIW&F6Q4<B->GTKSO\
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M/M,+7A1DW."E=-:_G\CQS2_B)J4EOH]M/=6=]+=6RFY*0B%PS1R'(99LY5E
M;;& #D94X%:6C>--77PG)K=TEB=.LIK>":-4E:7RVCC+OO:0DD>8.H)P"22:
M]1HK&-":^W_7WGI5<SPL]L.DFUU\[O:*2NM+VT/'6^)?B%K4,VGV%J\<GV6>
M28;8TN )&*Y>6-0"!%C+9Y;J<"M;P+J]_J'C_44NKB?R#'-(ML;@RQQG_1B
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M_P",4\_$/0P,F#Q"!C.?^$>U#_XQ67'\,4CW;/%&M@L03_HNG=NG_+K5K_A
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M<R;=VV&97...< ]/F7_OH>M7:\U^''A_7],UJ&;6H9%@AL#;1EYUDV?+;X0
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M?#G_ (/I_P#Y#J/0+/6W\4ZMK.NVNFV?VFRM+.&&SO'N?]4]P[,Q:*/&?/
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M7&D:=+%A!L>V1EP@(3@C^$$@>@)Q2'P[HAEDE.CZ;YLJ;)'^RIEUQC!..1@
M8]J.2O\ S?@/ZUE=TW0?IS/R\_7^ML+1/%]U>:^FF7^EPVI::XMA)%=F7]Y"
M%8\&-?E*N,'KD$8[U8\5>(+FV\(ZCJ^B8CDL@SLFH6,R>8%&2 K%&&<CYN1P
M>O;?33K)+@7"6=LLX=I!((E#!F #-G&<D  GO@5+=6\-W;R6]U#'/!(NUXY%
M#*P]"#P16BA/E:;.-XC#>UA4A3LE:ZO=/77>^ZLMSSZ3X@W>GS7%M=V5O?RV
M\,LKSV?G1*?+*%UVNA *HY.%=^5YVYXFO/B(T<$UQ::6L]M%%/=&1KK9YEO'
M*(@Z#8=S,<D*<#&/FYKKQH>DB[FNAI=B+F92DDPMTWNI&"&;&2,<8-$FA:1+
M':1R:78/'9G-LK6Z$0=/N#'R]!T]*SY*VOO'5]:RZ\6Z+\]=^^B:MKM;_@%;
MPGK-QKNGR7LUG':PF:2.$+/YC.$=D)8;1MY4X&36U45M;PVL(BM88X8@20D:
MA5!)))P/4DG\:EK>*:23>IY5:4)5)2IQM'HO(\6T[QK_ ,(II%_+J.B:FVDK
MKFIJ^HP^6\:;M0GY*[M^ 3@_+6I)\389=8U;3M(T#6-5ETN39<-:"(CZ@,X)
M'T%5I?#MUXI^&6O:18SQ03W.L:H%>8$J,:E.><<]JH>&O!/C+PSKFMZEIMSX
M?E;4F4E)1* H7IT'6M5:Q@[W-&?XL6 \'W&OVFE:G,EM<&TN;4JB2V\G'#@M
MQU'3/6M#P7\0;77[NZL;[3[W1=3@B6Y>WO5"@Q,<"16!P5S@5Q%U\-?&=[8^
M(+.>]T%8]:O4O+AD67,>,<+Q["NMN?A\NH^,+O4-6>"XTFXT>+3)+0YW.R.&
MW'MCBD[=!Z]3K]5UFRL-%O=5DE62TM(FFD:(AN%&3CWK@?#7QATK6[JQAGTG
M5].&H[S8S74($=SM&?E8$\D5T-[X-M++P!JWAOPU!%8QW4$T<:C.T.ZD$FO*
MK3P1X\@C\#PW>DZ7);>%F+J(KT;[CY<8.3@=*!H[.W^,6E7-KH$EMIVHS2:P
MUU'#$B*75H!RI&>2W;&>M-M?B]8WGA^+5=-\.>(+Z3[2UK/9VUKNFMW R=XS
M[=JY3X<_#+Q-H^NS^)-8%M]JM))[G3-,6?<BR3'+;W]!TKF+CPQXD\,ZAX9C
MU1$MKS4O$C7*FUEWHA=2%W$>A- 'I_ASXUZ-K>H6-H-*U:UGNM2&F!+A$4QR
M%<Y8;L@#IZUO^-_'\'A&_MXKK1-;O;>2(RR7=C;>;%"N2,,<\'C/T(K%^'/P
MOL=#T:PE\06D-QXAANVOY+H/N/G9X;/L*]!U*T-WI]U;# ,T+QC<,CE2.:!'
M&6/Q5\/7UYX:@M/M4L6NB8VMQY>$5HAEU?)R",CL>M4K7XU^%9K>2;_38T2&
MXGYAR2(2 X&#UYR.W%>8?\*L\<V&@^']+T[3K#[=IMU<W,=^;I=D:R +@+G.
M> WX"M;QE\$]1DTGPNNBF+4)M-MWAOH)K@P"[#'+88=,]*!GKV@^-M(U_6IM
M*L#.US#9PWSETPHCE *C/K@C-<=J%JT?[2ND73%?+GT*50!U^609S_WT*TOA
M1X0U71+C5]5\0QVEO?ZCY:+:6A#1VT4:A40-WP *HZE#(G[1NB2-,&C;0YU2
M/^YB09/XY_2@1ZLFW=E>OJ:D9@%)'/M4:#(YR.XIRG#'/2D##[O3O3AR/F]:
M0$-MR.*#UX/>F [ /3KUKGO%WBK2?"MM!/K<\D*SN4C$<#RL2!D\("<8[UT/
M.X5QOCC2]?OM<\+W.A2A;2SOA+J$1E">;#CD<_>^E)#*B_%?P6^@IK*ZTC:<
M9?(:589&\MST#@+E?JV!79V\D=S#%<0,)(Y$#HPZ,I&0?RKQ3QEX%UNRL_B%
M#H.C1WD'B:2$6ZQ2HGD_*N]V4_[0;IZYKV+PY:RV6A:9:W("S06L43@<X94
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M_,YA)F1I!M*C)P1CO[U[?_PK7Q)_T-.D?^"27_Y*II^&?B//'BC2!]-$E_\
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M/<VGAU#IUR]E<SZA86GVB..-WC6:[AB<J'5ESM=L9!Q2?\(?J.,?\)MXA_\
M ;3O_D6L]#;4BA^)GAN=&:#^W)%7[Q30+\@?E#39/BAX8C(\QM:7=TW:#?C/
M_D&IU\'ZDARGC?Q$IZ9%OIP_]M:'\'ZDY!?QOXB8CH3;Z<?_ &UHT'J1'XF^
M&QC/]N#/3_B07_/_ )!H;XF>'%.&&N ^AT"_'_M&IG\(:G(N'\<>(V'H8-./
M_MK2+X0U)/N^-_$:Y]+?3A_[:T:!J0/\4/#"'#MK2GT.@WX_]HT]_B7X<0,7
M&NJ%&6SH%^,#W_<TK^"[Z1LR>-/$#GIEK;3C_P"VE-_X0>\R3_PF?B'YNO\
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MII[O;70!\Q;B.4J/.2(X$)D#_>)P#DD8QDUUWB#28-=T6\TR[>5(+J,QNT1
M8 ^F01^E8FI>"H-3N+:YOM7U26\MQB*XS"K+B19 <+&%R&0=OKFNJK[6_N$8
M!X%17UI7=W??:VEK>=[_ "T9#'\0=(DU:ULX?.N%NW1('MX978$AR?,4H-G*
M$<%CP<A0":W/[=M1J.IV9CN3)I\44TI2$R;A)NV[57+,?D.1CTZUAZ?\/M,T
M^YMKBUNK];B"9)Q(6C)9E\W.?DQ\WG/GCTQC%6M:\'6VJWFI3OJ&H6Z:C"D%
MS#"8MDBINV_>0D8W'H<'N".*476M>2U_K]2ZL<M=3EI-J-MWWNO+^6_S[#Y/
M'&@1K&7O)5W[\@VDVZ/8^QO,&S,>&(!W8ZCU%+I_BVRU'Q#-IMBLDL<5L\[7
M 1P"4DV$("OSC.?F4D<8&:S8?AOI$5C/:K<7HCF@E@;;Y286219&("H%'*#
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MI/\ Z<+>NRKCOB-_R ++_L,Z3_Z<+>NQK$ZD<UJ'BE;#Q1_9EW!%;6@MS/\
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M'3%,&-QSU]N,T3M^\&/3L*3/S\J>G%:K5&3T8;LY4@?G3<X88_$9ZTY#\O\
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M[9>.0$*"<YSSWKV+_A#_ !OC']G^&<8QC^UI\8]/^/6@^#O&Y7;_ &?X9 '
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M+LY/_A9OAKUUO_P0W_\ \9I#\3_#(ZMK8_[@-_\ _&:ZQ@#Q2% >PHT Y/\
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M_BG]'SGG_08__B:W%&5.23SV-+@ ?XU7,^Y*A'LC$'A+PTR_+X>T;_P!B_\
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M4<LYK1;LEOU?Q>7?E^2?4T/#7BBV\0W^H0V,<GV>U6%UFD1XS()%+#Y'4$#
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MQQ6W\(/O>,/^PTO_ *0VE=<(IO4PQ,W"-X[F9_PC_C?_ *!?AKW_ .)Q/_\
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M)' X^M/Q@)C-#$D2(WS,J8SCI4;<K[],T_;]XY))'>FL2%SR2#VJ1M7!B2P
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M@GHHK'T[X<:387INH[F]:4SQSDMY0RR2&09*H"WS$Y+$G'&>!7/6WCC5=/\
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M;SA]MT=Z.@_AP.<FOKV[>6.WE:W >8(2BGNW85X-)K/QW:5F&DLJDDA5MXB
M/09K-.Q3.T^!7AS5=&T[5]2UNW:TN]7NOM/V9AAHEYP".WWNGM7J8.?I7G_P
MGN?&MQ9W[^/8/L\_F*+="B(=N#N.%_"N_4Y-2QH>N2I[TO4DYQZ5'NY^7\J?
MGOT^E( 4-CKS2$GC&>M*&QVXHSW  -  3D 9H4X.!]*09Z9ZXIXP& H 4FF-
MVYQ3L\\C'I32<T .;CDXI#U! &*/O9&.<4BDGY30 ' X!Z_I6C%_JD_W16:<
M@^IS6E%Q&GT%#!#J***0PHHHH **** *6I8_=Y]_Z528<=#@<U=U$X\O/O\
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M>K*E",H=SR<0DZ[7D>?CX9ZN, >-]4 ' _T:+C]*/^%;ZT!SXZU7KGFVB/\
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MENC#PS.\F/F4--U[_P#+'_.*$\>:@(P3X6N0V>1NF_\ C->W9Z8P#]*4X)Y
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M.<'! YQR#7J<?+'?R0?SKA/'MM'??&;PJ))FCDBAFD5?+#;B!T)SQW_R:[R
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M,6&0/SIY1BO"Y ]ZK1@=1@4]2=O(X]357$XCI(S[9QW-8GCD,)O!8;/_ "%
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M*X\$?]";X;_\%<'_ ,31[#S#^U_[GX_\ \;(&WOQ3& )QM(_&O9_^%<>"/\
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MBF2:'3D2=&!#[R<CCCGZ5M;3D<=^.:=MYP,^_-+VL]KE+"4=^4B8;GR0.3@
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M[F\W=$ZR%R%QR"33L)G:RKMC;'8$U\B"\F\4^)M<F\1?$"70A#=210Q8D;<
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M2G,-RG/%,;[W3\:EKN79-6%C<8(QSFG9R#W)/'%(J+N)VXJ15&W(H0.U]1O
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M49Q2 &!.<=>])_%R/I28(;(Y%.;D'^0H 3IQGGK0P) V^M)L QG.<4YNWI0
MT9)YZ?2EY''KWIV,XSTIKYQQ0,0Y^M&.,GK2*#P3Q3FR"-W2@0U2=WS=*THO
M]4GT%9Y&,$#VXK0B_P!4G^Z*&"'4444AA1110 4444 4]0_Y9_C5)E)&:MZF
MVWR_Q_I55FX'>@0U@0PY_"AA@#'YTI/S9/X>U,9B&]J!@^<\_C2[>A'IBD+9
MR>V*=R,=^* $_B.*'Z#UH4J,D#\31D-CC% ",3P?UQ2_P<TN?E'K1UYP,=J
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M_P"2J#\0;@=?!?B3_OY8?_)5 69W5%<*/B#<'IX+\2?]_+#_ .2J3_A84_\
MT)GB3KC_ %EA_P#)5%PLSNZ*X7_A8-Q_T)GB3_OY8?\ R32?\+!N-N?^$+\2
MX_ZZ6'_R32N@Y7V.[HKA1\0;@]/!GB3_ +^6'_R50?B!<CKX+\2?]_+#_P"2
MJ+H+,[JO+_$40E^*6K!N@T;3^/\ MO>UK_\ "?714D>"_$F!_P!-;#_Y*K"M
M[F[UCQIJFL3Z1?:7:R:?9VD:WCP,[M'+<LY BD<8Q*G4CO0]BH)WN65MU#A"
M%V]:4V\;-A0 ,^E69(UCDW ?F:1EV\CGCKZUDUT.I2U*8MT'I@].*<(N< */
M3Y:GP">PSQBFLN<>F>*5EL:)MZLA\I"PR1T_*A@H&.#S@>M2;<G _&D*@'(S
M[T,J+(9  .M1%<,P]JFDY/TZ5&<@L1@#J,FI9<'W&8^7..>X--D0[L*<\4YL
M%<<?G28^?!Y)K.YK;L(!AN.<]_2GG@#!YIF ,D9Z\TJ<* _ [<TUH+H*-P R
M,?6F]<@=J,DX[=LCO2,H7(/2JN))6$"$C^?%&#QZT@;N*21_1?J :1H##Y>!
M[D4!<L!T[@5'@L#SD_6I"!GGJ!THN-V$*YZ=2<8I67J ,TB@<_[)SQ01\N1W
MJ;MZ#O85<DGIGM36W!>.N<TBCYB><YS3F&!N_(_6K0:7#EB37:_"?_DEG@W_
M + MG_Z(2N(W84D?CBN=;P=X8Y_XIO1>O:QBX_\ ':<)\ICB,.ZUK.UCZ#HK
MYV/@_P ,ACGP]HW'_3C%_P#$T?\ "'>&<#_BG='S_P!>,7_Q-7[9=CG_ +/E
M_,?1-%?.<WA#PT$X\.Z./^W&+_XFO/\ XH^$+"WUC0;C3=+TZ"SPJSQQ6R(&
M/F=3@<\<<TE778RJX1TX\U[GV917B2^$/!CS,D?A[PZ[ D%5L821_P".T'P;
MX.XQX<\/DM]T"QA.['I\M>*^((+3V;&L&_YD>VT5\7QZ'HH\5Z];'2-.,<<N
M$C^S)A!GL,<5;3PYHGEC_B4Z:3T'^C)S^E>PL2G%2MN=M'):E6/,I(^Q:*^/
MH_#FB\;M&T[_ ,!8^/TH'AO0^/\ B3Z<>?\ GU3_  JO;KL;?ZOU/YT>U_M"
MC.B^&!_U&A_Z1W5>4 X/.[VXXK.MM#TRSN8YK73;."="=LL<"H1GCJ!D5<=L
M-\I/IUK*I/G=T>UEV"E@Z3IR=[NX]F^;!!/%3-@JI*MC%5<\@$D_6I$DR.N6
MQZU*/0<;6&3+\QP.@IG.U<K@<XXITS'!V],5$,C ))]:;-%L.P=V2#U].:<_
MW "K#'%,+YDW<XS@<]*1B>QP!2&2-N('4D=\4FTD8&3GJ0*C8GY0,CC.:<I*
MGYNM /34>0-R@ G'.<<T\[E?:<GCL*@WD$<X ZU(SD/CCISWHTOH38?M(0C!
M.?04O+; H/##&13%((' )S@=Z%)>53D=>1BD_(EW1>^$L;1^-O%4C*?+*HN?
M?->O0D8/TKRCX4S!_$.L(WWY(@SG;CD-@<UZOD+QD =Z^9S=_P"TKT1\G-/V
MU1>9X'\<@7^)7A'']X]1Z,M=@H))Z'Z"N,^-[K_PL_PD.-P<Y)'^T*[16X.2
M,^U>W0?^ST_0WR]>_4MY?D.+?,N2?H!0F[/)X)]*8SD$<C'M2C)YQP.^*VN>
MG;34=@\GD<X!/%*VX94XR!Z4F?F^8\$_G3F8[B-P'/%&MA,CW'/(I-XW$#GM
MTI&?G *G-!D!YR.M+4H7=G[W STI)'W/D''X4C2,.AZ<9]*C$F2<[1STJHK4
M"0G##N>O2D8YR/Z4QI"&4\>@H=F."2/Q-5U&M=P P/IZT\.HZ]^:8K9Z#Z\T
MKO\ ,"?RS3N)L<, 8W<?2I-WW<'(JNK\8R,^E2*_RH"!UX.:"9*Z'@XY'KQ@
M4O)(SP<?A0&[']*0L=ON#P#T%.YFM66HS\IQ@<C(]:20%HSGD]L"FQR;@W ]
M<9J:-B"N5^M-$/02;/E+\O.W.*Y_Q^K-IOA1&0[?[95BV>F-N!^/]*WKC/F
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MLTWQ%NLYCT'3C]3-BA4GU:^\.?L<W\6_B]<^#M?BT?3-(6\NF@64R2.<#+'
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M^:$WV-1=<UJ[W-8>&;J,8.UKZ9(@?^ YW?I3/(\87C$O>Z5IJD<B%&F8?]]
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M_6DZ'&?QHVDD4;>P&?>D FW//7TIS8QP/_K4['R\G@#FF@\\4P&@<>U:T/\
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MO2C@KS]*!B X)/7CM21MEB%!QG\Z:N1DD]?:G-DC"Y]^U(&/9L=L9'YTBO\
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M_P A5M>G7BJMBO\ HEOQC]VHY^E6_P"&NMG@(!SZXI5/K01FE^F:0@SV'2E
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MAC--(S@'/7/%*1G&3CUH&19P2 >*7?@'Y3@_G32PR><X/I3>2W P.]("7<O
MY)QS2*V6 -,89/7'THY++ZT 2MCH<"H3R" 1GJ:D;CKG-0[><#.#0V4AS!1&
M,Y84 @@D?A2JH"<C..M,;:..!V)H"_<<3A#G ]J:V#_GI06^5BO3I3 <=.<_
MI2;&EJ4];TL:M8BU-Q/:%9X;B.>WV;XY(I5E1AO5E/S(."",5 T/B%2/^*WU
M[!_Z=K#C_P EJU@/E(Z#;U%02<_=S_A2Z:%<J;U,_P GQ#W\;Z[_ . ]A_\
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M8.H#^#=2./\ I\LO_C]?35%'L(B_MO%]U]Q\PGP'XK_Z$O42=V[F[LNO_?\
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M0_Y^=5_\$E]_\9KR=<\=,]CBE ("^_/UIJNWT%_8\/YF>K_\+:\(?\_6J_\
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MYTW8,GVI[$\9Z9H9:8AC)T[XZ4AP#QZ=JDVYP: JYYYHN!%N#+T)IJC+8 P
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MR/.:O2$2_JZZR8O5B1T)[U%(?E/;BI@<'!SFHIC7B.#OV.I,\@OCC5-0!/\
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M!(&<#C)%7@,XX[5R_P 50?\ A6/BX'MH]Y_Z)>@"7^W=:_Z$;Q'_ -_]/_\
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M>H:!JNDW,]M+=0M=O;.DBQM&K@>5,Y!!F3J!W]*[JN+\1\_$SP[_ -@?4O\
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MT>95$NHV5O,=W[F6[B+@!BN?E8CJ/7O@X/%<O<_#R[E @37G33UNI+A;80R
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MI1@GWII"[LC.<4=6ST&*8#AP>*;D]3@\TJK\Q.:4KG\Z  =S2CC'UI!@<4A
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M\Z!WH&+VYX&*,?-[4=L4H.>: "F8P32]\]OI2D<4 &>*Y;XIY_X5?XPS_P!
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M;Q1[48^;';UI>_M0 T>]*O7WH(YI3P1B@ (Z4X4AYQBEZ#F@!<TH]::.E&*
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M4 %%%% %/43@Q8]ZJ$G'3BK6I?\ +/G'7^E5<@CU'K0(0GYAGO2,2. 1BEW
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M?VIJC H_I0!SOB?/_"3>!L_]!B7_ --]Y7:UQ/B;GQ/X%_[#$O\ Z;[RNVH
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M/SC!>0GG(4XKU6BN589I64F>]+.H3E>="+W_ !M^BL>875_XNTZXNOWFL:A
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M#Z?_ .0ZZ0<T<=.](#F_[3\;?]"[X<_\'T__ ,ATO]I>-O\ H7?#?_@^G_\
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MVD6'SP1DUQ6M0(? .B C:3?@#!Z LW^%=QIY;_A)KM"F(UM(0K_WNM=$WO\
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M:P^6D9?FR.M##CI2AB5/%  !QR!TH(YX%!/KQ2^U  /IQ2#)(]*5>E(O#9H
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MY7U%(2"I]SB@# /H.U "@9X]NU*N <#@4@/I@>M(V6SDX% #P!]30 -Q-(N
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MC-&.:L>4GI^M+Y:^GZT 5CWS0HX-6/*0]J/+3T_6@"#CBC'!JQY:^E'EKZ4
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
FHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>image5.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image5.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %9 G0# 2(  A$! Q$!_\0
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MQ0  $&@^HH_'.!0!G![>E !_GK0"M!&#32,G'0^M #@030>G!I@! YYIPR*
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M:E%)@G- Z'- #B<CZ49XYIHP1U%*<G@8Q2 0$Y]J7.3BF^U+D]N*8"X&<BE
MSU--HR>U(!QI!ZCFC=VI,\4 &#ZFBC\:*8 , 4A&:4'-!.* $48S2[?\YI">
M>*7.5]: %X''>FX]J4?YS0WJ/QQ2&)CG-,9<^H-.'S<C/XT,<#M3$,.!G((-
M?-WB3PC?^(/B#JNGZ:8C=>9+*BR-M#C@X_7]*^D=V1TXKR-1_9_QYDWKA9XL
M+SSEH^O_ ([75AI--V[&55+2_<K>"O&WB+1I=-\/>)="N8D+>0MRT;!O1?9O
MP/2O8=O.">IXINT8#%4)!R.*&+?(P'1LDBL924M2^6QY3\*S_9GBS6=(!'EG
M?L&<']VY X^AKUP9ZUXTC#0OC;'$"%6YN2[#_9DCP.?]_M]*]EYQQQ6N(=Y*
M7=$4E9-=F.SDX-)CK2$CBG#)'6N<U$QC! S3OJ.M)N&W!H&,<4@ X_*CD\TS
M<21D T[)(IA8,#'3]:!C. O2CH<-^=(Q+# ./6D%AXXXQ]*0\4@8C@_I3L\4
M )VSP/44+@\TG'H1FDSSA>M "GV/2CG.>U SZCGTH#<8Q@T!8 /]FEQT],TF
M[GZB@\ '/3I3 7^M)L'7I2;B<>Y_*E&2>30 <;J",?X4#!]B*7 &?2D&@PJ>
MW0]:4< \]*=CG@\TT9'!.3ZTPL.R,8(I.*7.%YJ,_I0 [=R /SHW;NN?I1U7
M_"F#;@CD&@1)GCG'YTX#(!IBGL>U+D=N#2'8?P.0!2<'E:#TSCZBDW # H =
MQC_Z]&T&F_RIP&>: #:/3F@]<"COCO0 *   $4O?I2'UR:/\YH  "3FC&/\
M]=+P.])^5 "]Z.,T'CBD^G6@!>/2CCT%&/Q I.1R:!@ /RI>#1P3@48H$)U-
M'MC.:7W-&,^E !C':C@#FCC@=J0KD$&@ X/3I]:,;> *!QP,4IZ9% #>,4[!
MS3,=NE. /4T *>32!0.1_.E/)XH[8S0 =J/K@4;3FA1SUI   ]J,YZ=C0>G>
MD /KFF [&:,4@;U&*,^WYT@ #&:.,8XH)XZ4W=QTYS3 =CUI/Y4 YI=ISUH
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M,T&Z5[C9Y8"G_9YSSWKVO=N #-V_.LW>Y2O8Y7XC:9>ZSX&U.SL(Q+<,BLJ
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M0 'Z4H'_ .JFJ3G!' I0<GCBD O&.E'.:;DYQ3@3GF@!<]*0D'L:3J<\\4'
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M>$51K=RH&,XA3FI3]Z[*+,NL6/Q>\!:W'%%<V7V.0L@WY+%5++N Z@]Q_A7
M> _B3'X:\/7&E:AIGVRVN'9\@\@LN"'!X*G'\Z]VT+PSI7AN)DTRSBA=E"R2
MJOS28[L>_)-0)X$\,IN(T*P&[D[8  ?PJD[$ZGEWP(TJ235M9UOR(D@=?)3R
MSPI+9*COC 'Z5[H@.,#\JJ:=I]II5FMI86L5K;*21'$FU02<G@>]6EXSALYJ
M-BA>5'0GVI_)Z]/3TI,D=!]*3)SS]<4"%'![?2GY(R6'%1;NI(Y]:5@2.!^
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MI*X _BVDDL<CC.*[30_@WX8T>[^U7$,FHS9X:Y.0..>.ASUYKOR?O<Y]A3E
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MG3\\],TT;0^!DGKS0,9NZ@8IPS@TO49 P*,C&,4 '(X.:0_E2\ ]#DTT@D\
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MW'\7'M3B 5!W<#K2E2>1B@*Q."#D=\4  ^[GOZFD&?;K3STY_G2*W/& >G%
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M+Z_I2YVYX_6D  8/\J4CCCK30WN": 3CZT +@X]?2C..HZ>] )XR1UH)[=:
M'<G!S3?;TZ\TW&">M&X=1VZT .QGWI#C'0"EY_#%-7GM@=J %51@#%*<@X%-
MR<XI<$=3[4"%!'I]:3&[U'-'/4_A[4 XH&.P!VHI.O-% A>#33QTIW /UI/Q
MH&+G ]<TW.T].W44IP0,DTAP%(]*! "I]/<4AVGN,4#&/4TNT<'M0 @ [4G
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MM#>:D"2;AP3CIP%)QQZXS3DFA1?0X'PI\/-4\9ZC%XD\5-,8Y7,CQRCYI>P
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M*!" G&.?RIW.,YP*801G([\49([8STH&+EB1[TX GKG/H:9C!R6I_P V>N*
M%IA#XR3Q[T[<><C!H_B]#Z&D F,GE<^_I0"3D=AQFD);KQ]*.<#%, 5<'.<T
M[Y@,XQ2;ACTHZ\=1]:  DCMFD!8MQ2\],&A0<9Q0 A+9SG)%(&.W/?TIV=QP
M1BE[?+0 @!Q]*3H><?A0V0"#2,"5X(S0(;DY/>G,,C.*3*X.1S[TUWV EMJJ
M!DG- R"XN(X$::65$C7[S.0 /J:\8^(_Q+?7_,\*^&%-RUP-DUS$<[AW11WS
MWIOQ \7R>+M1.@:!-<+9V>]]1F7 1E4C..1D#'XUS.A.+F&\\.^#K(WDU_'Y
M5QJD\15D4@A@H.0BD9.3SR>^,4HW5R6^@Y+C2O L<=IIL:WOBXD MP\-MG'
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M+=B*&[].W:G!B>"!]:0=>I([48^4[<_2D59#@3NVXXIV[:/;O3<$G!!S]:4
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MFW!P,XSWZT"%4#/7\#3R..E1^_ZTX=<YZ\4# C&/2C/...*7 Z'-)@;OYT@
MG!P3SZ4F><T%1G)8YI!@'GO3!"YY':DQCD<YI_&/\:AFD2&%Y7<)&@+,Q.
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M]?QII'H<TJCL /SH 4)SR230/O8)YHQ\N,T<@'G\!2&!ZTPQ\'D_G2A68\@
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/W:@"/)'&3^5%/HI@?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140222162706288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr><th class="th" colspan="2">
<div>Dec. 31, 2023 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">InMode Ltd.<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001742692<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">20-F<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2023<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentRegistrationStatement', window );">Document Registration Statement</a></td>
<td class="text">false<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentShellCompanyReport', window );">Document Shell Company Report</a></td>
<td class="text">false<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39016<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">L3<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">Tavor Building<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Sha&#8217;ar Yokneam<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine3', window );">Entity Address, Address Line Three</a></td>
<td class="text">P.O. Box 533<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Yokneam<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">2069206<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address Country</a></td>
<td class="text">IL<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Ordinary shares, par value NIS 0.01 per ordinary share<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">INMD<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Name of Exchange on which Security is Registered</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="nump">83,982,462<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">Yes<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAccountingStandard', window );">Document Accounting Standard</a></td>
<td class="text">U.S. GAAP<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">Kesselman & Kesselman<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Tel-Aviv, Israel<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm Id</a></td>
<td class="text">1309<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFinStmtErrorCorrectionFlag', window );">Document Financial Statement Error Correction [Flag]</a></td>
<td class="text">false<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember', window );">Business Contact [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ContactPersonnelName', window );">Contact Personnel Name</a></td>
<td class="text">Moshe Mizrahy<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">Tavor Building<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Sha&#8217;ar Yokneam<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine3', window );">Entity Address, Address Line Three</a></td>
<td class="text">P.O. Box 533<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Yokneam<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">2069206<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address Country</a></td>
<td class="text">IL<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">972<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">4-9096313<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">The above number of Ordinary Shares outstanding does not include a total of 1,975,003 Ordinary Shares held at December 31, 2023, as treasury shares, all of which were repurchased by InMode Ltd.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ContactPersonnelName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of contact personnel</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ContactPersonnelName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAccountingStandard">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAccountingStandard</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:accountingStandardItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFinStmtErrorCorrectionFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates whether any of the financial statement period in the filing include a restatement due to error correction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFinStmtErrorCorrectionFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentRegistrationStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a registration statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentRegistrationStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentShellCompanyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentShellCompanyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 3 such as an Office Park</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140222162729456">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>CURRENT ASSETS:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 144,411<span></span>
</td>
<td class="nump">$ 97,540<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable securities (amortized cost of $375,829 and $384,320, as of December 31, 2023 and 2022, respectively)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">373,647<span></span>
</td>
<td class="nump">374,589<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepositsAssetsCurrent', window );">Short-term bank deposits</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">223,547<span></span>
</td>
<td class="nump">75,254<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net of allowance for credit losses of $1,538 and $836, as of December 31, 2023 and 2022, respectively</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">42,362<span></span>
</td>
<td class="nump">26,997<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Prepaid expense and other receivables</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">16,268<span></span>
</td>
<td class="nump">15,094<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">45,095<span></span>
</td>
<td class="nump">39,897<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">TOTAL CURRENT ASSETS</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">845,330<span></span>
</td>
<td class="nump">629,371<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrentAbstract', window );"><strong>NON-CURRENT ASSETS:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetNoncurrent', window );">Accounts receivable net of allowance for credit losses of $716 and $482 as of December 31, 2023 and 2022, respectively</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,670<span></span>
</td>
<td class="nump">3,973<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred income tax assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,506<span></span>
</td>
<td class="nump">3,094<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">9,698<span></span>
</td>
<td class="nump">5,073<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,382<span></span>
</td>
<td class="nump">2,298<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherInvestments', window );">Other investments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">700<span></span>
</td>
<td class="nump">600<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">TOTAL NON-CURRENT ASSETS</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">17,956<span></span>
</td>
<td class="nump">15,038<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">TOTAL ASSETS</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">863,286<span></span>
</td>
<td class="nump">644,409<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>CURRENT LIABILITIES:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">13,966<span></span>
</td>
<td class="nump">16,242<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Contract liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">10,923<span></span>
</td>
<td class="nump">13,798<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">39,247<span></span>
</td>
<td class="nump">51,980<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">TOTAL CURRENT LIABILITIES</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">64,136<span></span>
</td>
<td class="nump">82,020<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>NON-CURRENT LIABILITIES:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Contract liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">3,766<span></span>
</td>
<td class="nump">3,959<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,399<span></span>
</td>
<td class="nump">303<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6,613<span></span>
</td>
<td class="nump">3,509<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">TOTAL NON-CURRENT LIABILITIES</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">11,778<span></span>
</td>
<td class="nump">7,771<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">TOTAL LIABILITIES</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">75,914<span></span>
</td>
<td class="nump">89,791<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>SHAREHOLDERS&#8217; EQUITY:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Ordinary shares, NIS 0.01 par value, authorized 100,000,000 shares at December 31, 2023 and 2022 Issued 85,957,465 and 84,519,994 shares at December 31, 2023 and 2022, respectively Outstanding 83,982,462 and 82,544,991 shares at December 31, 2023 and 2022, respectively</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">245<span></span>
</td>
<td class="nump">241<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">177,820<span></span>
</td>
<td class="nump">148,803<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">693,426<span></span>
</td>
<td class="nump">495,507<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,679)<span></span>
</td>
<td class="num">(7,493)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Less treasury shares, at cost: 1,975,003 and 1,975,003 ordinary shares at December 31, 2023 and 2022, respectively</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(82,440)<span></span>
</td>
<td class="num">(82,440)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">TOTAL SHAREHOLDERS&#8217; EQUITY</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">787,372<span></span>
</td>
<td class="nump">554,618<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">TOTAL LIABILITIES AND SHAREHOLDERS&#8217; EQUITY</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 863,286<span></span>
</td>
<td class="nump">$ 644,409<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">As of December 31, 2022, noncurrent deferred revenue is estimated to be recognized as following: 83% in year 2024 and the rest in year 2025-2026.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 26: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositsAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment within one year or during the operating cycle, if shorter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositsAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-5<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 23: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480842/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481520/505-30-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481549/505-30-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140222163071904">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Marketable securities, amortization</a></td>
<td class="nump">$ 375,829<span></span>
</td>
<td class="nump">$ 384,320<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Accounts receivable, allowance for doubtful accounts</a></td>
<td class="nump">1,538<span></span>
</td>
<td class="nump">836<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableNoncurrent', window );">Accounts receivable net of allowance for credit losses</a></td>
<td class="nump">$ 716<span></span>
</td>
<td class="nump">$ 482<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Ordinary shares, shares authorized</a></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ordinary shares, issued shares</a></td>
<td class="nump">85,957,465<span></span>
</td>
<td class="nump">84,519,994<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ordinary shares, outstanding shares</a></td>
<td class="nump">83,982,462<span></span>
</td>
<td class="nump">82,544,991<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury shares, ordinary shares</a></td>
<td class="nump">1,975,003<span></span>
</td>
<td class="nump">1,975,003<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479344/326-20-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481962/310-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479344/326-20-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481962/310-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140222162597664">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical 2) - &#8362; / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>May 23, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Ordinary shares, par value</a></td>
<td class="nump">&#8362; 0.01<span></span>
</td>
<td class="nump">&#8362; 0.01<span></span>
</td>
<td class="nump">&#8362; 0.01<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140222159823216">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF INCOME - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">REVENUES</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 492,048<span></span>
</td>
<td class="nump">$ 454,271<span></span>
</td>
<td class="nump">$ 357,565<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">COST OF REVENUES</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">80,708<span></span>
</td>
<td class="nump">73,485<span></span>
</td>
<td class="nump">53,592<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">GROSS PROFIT</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">411,340<span></span>
</td>
<td class="nump">380,786<span></span>
</td>
<td class="nump">303,973<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>OPERATING EXPENSES:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">13,410<span></span>
</td>
<td class="nump">12,425<span></span>
</td>
<td class="nump">9,532<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Sales and marketing</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">193,042<span></span>
</td>
<td class="nump">160,576<span></span>
</td>
<td class="nump">119,353<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">9,228<span></span>
</td>
<td class="nump">9,931<span></span>
</td>
<td class="nump">8,411<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_OtherOperatingExpenseIncome', window );">Other income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(800)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">TOTAL OPERATING EXPENSES</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">215,680<span></span>
</td>
<td class="nump">182,932<span></span>
</td>
<td class="nump">136,496<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">OPERATING INCOME</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">195,660<span></span>
</td>
<td class="nump">197,854<span></span>
</td>
<td class="nump">167,477<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNet', window );">Finance income, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">21,607<span></span>
</td>
<td class="nump">3,612<span></span>
</td>
<td class="nump">525<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">INCOME BEFORE INCOME TAXES</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">217,267<span></span>
</td>
<td class="nump">201,466<span></span>
</td>
<td class="nump">168,002<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">INCOME TAXES</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">19,348<span></span>
</td>
<td class="nump">39,946<span></span>
</td>
<td class="nump">2,928<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">NET INCOME</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">197,919<span></span>
</td>
<td class="nump">161,520<span></span>
</td>
<td class="nump">165,074<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Add: Net income attributable to non-controlling interests</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(103)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">NET INCOME ATTRIBUTABLE TO INMODE LTD</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 197,919<span></span>
</td>
<td class="nump">$ 161,520<span></span>
</td>
<td class="nump">$ 164,971<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>EARNINGS PER SHARE:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 2.37<span></span>
</td>
<td class="nump">$ 1.96<span></span>
</td>
<td class="nump">$ 2.03<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 2.3<span></span>
</td>
<td class="nump">$ 1.89<span></span>
</td>
<td class="nump">$ 1.92<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_WeightedAverageNumberOfSharesOutStandingUsedInComputationOfNetIncomePerShareAbstract', window );"><strong>WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING USED IN COMPUTATION OF EARNINGS PER SHARE</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">83,533,593<span></span>
</td>
<td class="nump">82,482,090<span></span>
</td>
<td class="nump">81,444,938<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">85,953,581<span></span>
</td>
<td class="nump">85,403,714<span></span>
</td>
<td class="nump">86,017,203<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Revenues are attributed to geographic areas based on the location of customer. No single customer accounted for 10% or more of Company&#8217;s total revenues, or Company&#8217;s net accounts receivable, in any fiscal year presented.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inmd_OtherOperatingExpenseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other operating income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inmd_OtherOperatingExpenseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inmd_WeightedAverageNumberOfSharesOutStandingUsedInComputationOfNetIncomePerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inmd_WeightedAverageNumberOfSharesOutStandingUsedInComputationOfNetIncomePerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 940<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481913/940-20-25-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(a),(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 33: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-2<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482916/730-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482517/912-730-25-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481283/985-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140222162680992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">NET INCOME</a></td>
<td class="nump">$ 197,919<span></span>
</td>
<td class="nump">$ 161,520<span></span>
</td>
<td class="nump">$ 165,074<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAbstract', window );"><strong>OTHER COMPREHENSIVE INCOME:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Change in net unrealized gains (loss) of marketable securities, net of tax</a></td>
<td class="nump">5,814<span></span>
</td>
<td class="num">(6,174)<span></span>
</td>
<td class="num">(1,675)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">TOTAL COMPREHENSIVE INCOME</a></td>
<td class="nump">203,733<span></span>
</td>
<td class="nump">155,346<span></span>
</td>
<td class="nump">163,399<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Add: Comprehensive income attributable to non-controlling interests</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(103)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">TOTAL COMPREHENSIVE INCOME ATTRIBUTABLE TO INMODE LTD.</a></td>
<td class="nump">$ 203,733<span></span>
</td>
<td class="nump">$ 155,346<span></span>
</td>
<td class="nump">$ 163,296<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-20<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-21<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-9<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 33: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-2<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140222160634400">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Ordinary Shares [Member]</div></th>
<th class="th"><div>Additional paid-in capital [Member]</div></th>
<th class="th"><div>Retained earnings [Member]</div></th>
<th class="th"><div>Accumulated other comprehensive income [Member]</div></th>
<th class="th"><div>Treasury shares [Member]</div></th>
<th class="th"><div>Non-controlling Interest [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Begining Balance at Dec. 31, 2020</a></td>
<td class="nump">$ 216<span></span>
</td>
<td class="nump">$ 101,593<span></span>
</td>
<td class="nump">$ 169,016<span></span>
</td>
<td class="nump">$ 356<span></span>
</td>
<td class="num">$ (17,218)<span></span>
</td>
<td class="nump">$ 1,512<span></span>
</td>
<td class="nump">$ 255,475<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Begining Balance, Shares at Dec. 31, 2020</a></td>
<td class="nump">75,567,554<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">164,971<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">103<span></span>
</td>
<td class="nump">165,074<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive loss, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,675)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,675)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">11,962<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">11,962<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_AcquisitionOfNonControllingInterestInExchangeOfOrdinaryShares', window );">Acquisition of non-controlling interest in exchange of ordinary shares (see note 12b)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(11,165)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">12,780<span></span>
</td>
<td class="num">(1,615)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_ShareValueOfAcquisitionOfNonControllingInterestInExchangeOfOrdinaryShares', window );">Acquisition of non-controlling interest in exchange of ordinary shares (see note 12b) (Shares)</a></td>
<td class="nump">582,826<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_StockRepurchasedOrdinarySharesDuringPeriodValue', window );">Repurchase of ordinary shares</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(35,365)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(35,365)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_StockRepurchasedOrdinarySharesDuringPeriodShares', window );">Repurchase of ordinary shares (Shares)</a></td>
<td class="num">(693,734)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of options</a></td>
<td class="nump">$ 23<span></span>
</td>
<td class="nump">20,308<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">20,331<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of options (Shares)</a></td>
<td class="nump">7,521,469<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance at Dec. 31, 2021</a></td>
<td class="nump">$ 239<span></span>
</td>
<td class="nump">122,698<span></span>
</td>
<td class="nump">333,987<span></span>
</td>
<td class="num">(1,319)<span></span>
</td>
<td class="num">(39,803)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">415,802<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending Balance, shares at Dec. 31, 2021</a></td>
<td class="nump">82,978,115<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">161,520<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">161,520<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive loss, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(6,174)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(6,174)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">24,452<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">24,452<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_StockRepurchasedOrdinarySharesDuringPeriodValue', window );">Repurchase of ordinary shares</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(42,637)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(42,637)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_StockRepurchasedOrdinarySharesDuringPeriodShares', window );">Repurchase of ordinary shares (Shares)</a></td>
<td class="num">(1,077,213)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of options</a></td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">1,653<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,655<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of options (Shares)</a></td>
<td class="nump">644,089<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance at Dec. 31, 2022</a></td>
<td class="nump">$ 241<span></span>
</td>
<td class="nump">148,803<span></span>
</td>
<td class="nump">495,507<span></span>
</td>
<td class="num">(7,493)<span></span>
</td>
<td class="num">(82,440)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 554,618<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending Balance, shares at Dec. 31, 2022</a></td>
<td class="nump">82,544,991<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">82,544,991<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">197,919<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 197,919<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive loss, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,814<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,814<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">23,600<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">23,600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of options</a></td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">5,417<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 5,421<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of options (Shares)</a></td>
<td class="nump">1,437,471<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">915,145<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance at Dec. 31, 2023</a></td>
<td class="nump">$ 245<span></span>
</td>
<td class="nump">$ 177,820<span></span>
</td>
<td class="nump">$ 693,426<span></span>
</td>
<td class="num">$ (1,679)<span></span>
</td>
<td class="num">$ (82,440)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 787,372<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending Balance, shares at Dec. 31, 2023</a></td>
<td class="nump">83,982,462<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">83,982,462<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inmd_AcquisitionOfNonControllingInterestInExchangeOfOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>It represents acquisition of non controlling interest in exchange of ordinary shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inmd_AcquisitionOfNonControllingInterestInExchangeOfOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inmd_ShareValueOfAcquisitionOfNonControllingInterestInExchangeOfOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shares of acquisition of non-controlling interest in exchange of ordinary shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inmd_ShareValueOfAcquisitionOfNonControllingInterestInExchangeOfOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inmd_StockRepurchasedOrdinarySharesDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Repurchase of ordinary shares, shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inmd_StockRepurchasedOrdinarySharesDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inmd_StockRepurchasedOrdinarySharesDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Repurchase of ordinary shares value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inmd_StockRepurchasedOrdinarySharesDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481089/718-20-55-13<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481089/718-20-55-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-17<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-4<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-5<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482739/220-10-55-15<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 33: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-2<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-5<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483550/848-10-65-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-5<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-17<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-3<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 38: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 39: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 40: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 41: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-15<br><br>Reference 42: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-16<br><br>Reference 43: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140222160458208">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>CASH FLOWS FROM OPERATING ACTIVITIES:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 197,919<span></span>
</td>
<td class="nump">$ 161,520<span></span>
</td>
<td class="nump">$ 165,074<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments required to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">623<span></span>
</td>
<td class="nump">680<span></span>
</td>
<td class="nump">517<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">23,600<span></span>
</td>
<td class="nump">24,452<span></span>
</td>
<td class="nump">11,962<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Change in allowance for credit losses of trade receivable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,020<span></span>
</td>
<td class="nump">449<span></span>
</td>
<td class="nump">516<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnInvestments', window );">Loss on marketable securities, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">71<span></span>
</td>
<td class="nump">175<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNet', window );">Finance expense (income), net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(4,714)<span></span>
</td>
<td class="num">(1,210)<span></span>
</td>
<td class="nump">1,223<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxesAndTaxCredits', window );">Deferred income tax assets, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(184)<span></span>
</td>
<td class="nump">84<span></span>
</td>
<td class="num">(770)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Increase in accounts receivable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(16,084)<span></span>
</td>
<td class="num">(10,415)<span></span>
</td>
<td class="num">(10,544)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherReceivables', window );">Increase in other receivables</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(2,224)<span></span>
</td>
<td class="num">(1,787)<span></span>
</td>
<td class="num">(6,400)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Increase in inventories</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(5,198)<span></span>
</td>
<td class="num">(18,871)<span></span>
</td>
<td class="num">(6,043)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Increase (decrease) in accounts payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(2,276)<span></span>
</td>
<td class="nump">7,463<span></span>
</td>
<td class="nump">2,369<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities', window );">Increase (decrease) in other liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(12,588)<span></span>
</td>
<td class="nump">17,941<span></span>
</td>
<td class="nump">14,138<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Increase (decrease) in contract liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(3,068)<span></span>
</td>
<td class="nump">1,201<span></span>
</td>
<td class="nump">2,668<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">176,826<span></span>
</td>
<td class="nump">181,578<span></span>
</td>
<td class="nump">174,885<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>CASH FLOWS FROM INVESTING ACTIVITIES:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_InvestmentInShortTermDeposit', window );">Investment in short-term deposits</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(233,241)<span></span>
</td>
<td class="num">(93,701)<span></span>
</td>
<td class="num">(73,090)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_ProceedsFromInvestmentInShortTermDeposit', window );">Proceeds from short-term deposits</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">85,090<span></span>
</td>
<td class="nump">73,090<span></span>
</td>
<td class="nump">69,180<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of fixed assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(705)<span></span>
</td>
<td class="num">(1,575)<span></span>
</td>
<td class="num">(939)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other investments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(100)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireMarketableSecurities', window );">Purchase of marketable securities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(245,337)<span></span>
</td>
<td class="num">(168,680)<span></span>
</td>
<td class="num">(273,834)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities', window );">Proceeds from sale of marketable securities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,000<span></span>
</td>
<td class="nump">2,303<span></span>
</td>
<td class="nump">93,652<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_ProceedsFromMaturityOfMarketableSecurities', window );">Proceeds from maturity of marketable securities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">253,229<span></span>
</td>
<td class="nump">79,089<span></span>
</td>
<td class="nump">24,925<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(136,064)<span></span>
</td>
<td class="num">(109,474)<span></span>
</td>
<td class="num">(160,106)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>CASH FLOWS FROM FINANCING ACTIVITIES:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchase of ordinary shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="num">(42,637)<span></span>
</td>
<td class="num">(35,365)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Exercise of options</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,504<span></span>
</td>
<td class="nump">1,552<span></span>
</td>
<td class="nump">20,343<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,504<span></span>
</td>
<td class="num">(41,085)<span></span>
</td>
<td class="num">(15,022)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">605<span></span>
</td>
<td class="num">(1,615)<span></span>
</td>
<td class="num">(559)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">46,871<span></span>
</td>
<td class="nump">29,404<span></span>
</td>
<td class="num">(802)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">CASH AND CASH EQUIVALENTS AT BEGINNING OF THE YEAR</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">97,540<span></span>
</td>
<td class="nump">68,136<span></span>
</td>
<td class="nump">68,938<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">CASH AND CASH EQUIVALENTS AT END OF THE YEAR</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">144,411<span></span>
</td>
<td class="nump">97,540<span></span>
</td>
<td class="nump">68,136<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>SUPPLEMENTAL DISCLOSURES OF CASH FLOWS INFORMATION:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income taxes paid</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">31,614<span></span>
</td>
<td class="nump">25,843<span></span>
</td>
<td class="nump">1,658<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_InterestReceived', window );">Interest received</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">14,219<span></span>
</td>
<td class="nump">4,856<span></span>
</td>
<td class="nump">3,358<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>NON-CASH ACTIVITIES</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_OperatingLeaseRightOfUseAssests', window );">Recognition of operating lease right-of-use assets and liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,200<span></span>
</td>
<td class="nump">2,342<span></span>
</td>
<td class="nump">4,315<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_ExerciseOfOptions', window );">Exercise of Options</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">20<span></span>
</td>
<td class="nump">103<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_NonCashAcquisitionOfNoncontrollingInterestInExchangeOfOrdinaryShares', window );">Acquisition of non-controlling interest in exchange of ordinary shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 12,780<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Including, for 2022, payments amounting $12 million for Amendment to the Investments Law and settlements with the Israeli tax authority. See note 13a(2)(b).</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inmd_ExerciseOfOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise of Options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inmd_ExerciseOfOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inmd_InterestReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest received.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inmd_InterestReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inmd_InvestmentInShortTermDeposit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investment in short-term deposit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inmd_InvestmentInShortTermDeposit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inmd_NonCashAcquisitionOfNoncontrollingInterestInExchangeOfOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of non cash Acquisition of noncontrolling interest in exchange of ordinary shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inmd_NonCashAcquisitionOfNoncontrollingInterestInExchangeOfOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inmd_OperatingLeaseRightOfUseAssests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating lease right-of-use assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inmd_OperatingLeaseRightOfUseAssests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inmd_ProceedsFromInvestmentInShortTermDeposit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from short-term deposit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inmd_ProceedsFromInvestmentInShortTermDeposit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inmd_ProceedsFromMaturityOfMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the amount of Proceeds from maturity of marketable securities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inmd_ProceedsFromMaturityOfMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481877/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxesAndTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) and income tax credits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxesAndTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 830<br> -SubTopic 230<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481877/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(c),9(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 912<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482312/912-310-45-11<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in receivables classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount of operating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.10)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for purchase of marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 33: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-2<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140222165988912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfCashFlowsAbstract', window );"><strong>Statement of Cash Flows [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_PaymentsToTaxAuthorities', window );">Payments to tax authorities for Amendment to Investments Law and settlements</a></td>
<td class="nump">$ 12<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inmd_PaymentsToTaxAuthorities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments to tax authorities for Amendment to the Investments Law and settlements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inmd_PaymentsToTaxAuthorities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfCashFlowsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfCashFlowsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140222253389104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GENERAL<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_GeneralAbstract', window );"><strong>General Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock', window );">GENERAL</a></td>
<td class="text">
      <div>
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 1 - GENERAL:</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%">

              <tr style="vertical-align:top">
                <td style="text-align:right;vertical-align:top;width:9pt">
                  <div style="text-align:left;margin-left:49.65pt;line-height:1.25">&#160;</div>
                </td>
                <td style="text-align:left;vertical-align:top;width:auto">
                  <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">InMode Ltd. (separately and together with its subsidiaries, the &#8220;Company&#8221;) was incorporated on January 2, 2008 and commenced operations shortly thereafter. The Company&#8217;s headquarters are located in Israel. The Company is traded in the Nasdaq Global Select Market (the &#8220;Nasdaq&#8221;) since August 2019.</span></span></div>
                  <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
                  <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company designs, develops, manufactures and markets innovative minimally-invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radio frequency technologies. These technologies are used to remodel subdermal adipose or fatty tissue in a variety of procedures including liposuction with simultaneous skin tightening, body and face contouring and ablative skin rejuvenation treatments, as well as, for use in certain women&#8217;s health conditions and procedures. In addition to the minimally-invasive technologies, the Company designs, develops, manufactures and markets non&#8209;invasive medical aesthetic products that target a wide array of procedures including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture and superficial benign vascular and pigmented lesions. The Company also designs, develops, manufactures and markets hands-free medical aesthetic products that target a wide array of procedures such as skin tightening, fat reduction and muscle stimulation.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company has wholly-owned subsidiaries located in the United States and two subsidiaries in Canada (&#8220;North America&#8221;), Hong Kong, Japan, Spain, two subsidiaries in Israel, India, Australia, China, the United Kingdom (&#8220;UK&#8221;), France, Italy and Germany. The Company&#8217;s subsidiaries are referred to collectively herein as the &#8220;Subsidiaries.&#8221; The Company sells its products primarily through its Subsidiaries. See note 12b for an update regarding change in ownership of the UK subsidiary.</span></span></div>
                  </div>
                </td>
              </tr>

          </table>
        </div>
      </div>
    <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inmd_GeneralAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inmd_GeneralAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//235/tableOfContent<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 275<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//275/tableOfContent<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//205/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140222166044160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text">
      <div>
        <div>
          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">NOTE 2 - SIGNIFICANT</span>&#160;<span style="font-weight:bold">ACCOUNTING</span>&#160;<span style="font-weight:bold">POLICIES:</span></span></span></div>
          <div style="line-height:1.25">&#160;</div>

            <div>
              <div style="line-height:1.25">
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:48.4pt">&#160;</td>
                      <td style="width:22.5pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">a.</span></span></td>
                      <td style="width:auto;vertical-align:top">
                        <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Basis of presentation</span></span></span></div>
                        <div style="font-weight:bold">&#160;</div>
                        <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">
                          <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company&#8217;s consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (&#8220;U.S. GAAP&#8221;).</span></span></div>
                        </div>
                      </td>
                    </tr>

                </table>
              </div>
            </div>

          <p style="margin:0pt">&#160;</p>

            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:48.4pt">&#160;</td>
                  <td style="width:22.5pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">b.</span></span></td>
                  <td style="width:auto;vertical-align:top">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Use of estimates</span></span></div>
                    <div style="font-weight:bold">&#160;</div>
                    <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">
                      <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</span></span></div>
                    </div>
                  </td>
                </tr>

            </table>

          <div>
            <div style="line-height:1.25">&#160;</div>
          </div>

            <div>
              <div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:48.4pt">&#160;</td>
                      <td style="width:22.5pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">c.</span></span></td>
                      <td style="width:auto;vertical-align:top">
                        <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Functional currency</span></span></div>
                        <div style="font-weight:bold">&#160;</div>
                        <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:normal">The U.S. dollar (&#8220;U.S. dollar&#8221; or &#8220;$&#8221;) is the currency of the primary economic environment in which the operations of the Company is conducted. Substantial revenues and a substantial portion of the operational costs are denominated in U.S. dollars. Accordingly, the functional currency of the Company is the U.S. dollar (&#8220;primary currency&#8221;).</span></span></span></div>
                        </div>
                      </td>
                    </tr>
                    <tr>
                      <td style="width:48.4pt">&#160;</td>
                      <td style="width:22.5pt;vertical-align:top;font-weight:bold">&#160;</td>
                      <td style="width:auto;vertical-align:top">&#160;</td>
                    </tr>

                </table>
              </div>
              <div></div>
              <div style="line-height:1.25">
                <div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%">

                      <tr style="vertical-align:top">
                        <td style="text-align:right;vertical-align:top;width:70pt">
                          <div style="text-align:left;margin-left:49.65pt;line-height:1.25">&#160;</div>
                        </td>
                        <td style="text-align:left;vertical-align:top;width:auto">
                          <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Transactions and balances originally denominated in U.S. dollars are presented at their original amounts. Balances in non-U.S. dollar currencies are translated into U.S. dollars using historical and current exchange rates for non-monetary and monetary balances, respectively. For non-U.S. dollar transactions and other items in the statements of income (indicated below), the following exchange rates are used: (i) for transactions &#8211; exchange rates at transaction dates or average exchange rates; and (ii) for other items (derived from non-monetary balance sheet items such as depreciation and amortization) &#8211; historical exchange rates. Currency transaction gains and losses are presented in finance income (expenses), as appropriate.</span></span></div>
                          <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
                          <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The functional currency of each of the Subsidiaries is the U.S. dollar.</span></span></div>
                          </div>
                        </td>
                      </tr>

                  </table>
                </div>
              </div>
            </div>

          <div style="line-height:1.25">&#160;</div>

            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:48.4pt">&#160;</td>
                  <td style="width:22.5pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">d.</span></span></td>
                  <td style="width:auto;vertical-align:top">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Principles of consolidation and presentation</span></span></div>
                    <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">&#160;<div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The consolidated financial statements include the accounts of the Company and its Subsidiaries. Intercompany transactions and balances are eliminated in consolidation.</span></span></div>
                    </div>
                  </td>
                </tr>

            </table>

          <div style="line-height:1.25">&#160;</div>

            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:48.4pt">&#160;</td>
                  <td style="width:22.5pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">e.</span></span></td>
                  <td style="width:auto;vertical-align:top">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash and cash equivalents</span></span></div>
                    <div style="font-weight:bold">&#160;</div>
                    <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">
                      <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company considers cash equivalents to be all short-term, highly liquid investments, which include money market instruments, that are not restricted as to withdrawal or use, and short-term bank deposits with original maturities of three months or less from the date of purchase that are not restricted as to withdrawal or use and are readily convertible to known amounts of cash.</span></span></div>
                    </div>
                  </td>
                </tr>

            </table>

          <div style="line-height:1.25">&#160;</div>

            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:48.4pt">&#160;</td>
                  <td style="width:22.5pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">f.</span></span></td>
                  <td style="width:auto;vertical-align:top">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Short-term bank deposits</span></span></div>
                    <div style="font-weight:bold">&#160;</div>
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:normal">Bank deposits with maturities of more than three months but less than one year are included in short-term deposits. Such short-term deposits bear interest at an average annual rate of approximately 4.10%-7.01% in 2023 and 0.50%-5.73% in 2022.</span></span></span></div>
                  </td>
                </tr>

            </table>

          <div style="line-height:1.25">&#160;</div>

            <div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:48.4pt">&#160;</td>
                    <td style="width:22.5pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">g.</span></span></td>
                    <td style="width:auto;vertical-align:top">
                      <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Marketable securities</span></span></div>
                      <div style="font-weight:bold">&#160;</div>
                      <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">
                        <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">AFS Securities</span></span></span></div>
                        <div style="line-height:1.25;font-weight:normal">&#160;</div>
                        <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Marketable securities consist of government bonds, municipal bonds, and corporate debt securities (together &#8220;Debt Securities&#8221;), and certificates of deposit measured at fair value in each reporting period. The fair value of quoted securities is based on current market value.</span></span></div>
                        <div style="line-height:1.25;font-weight:normal">&#160;</div>
                        <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Debt Securities and certificates of deposit are classified as available-for-sale (together &#8220;AFS Securities&#8221;) under current assets in the consolidated balance sheet as they represent the investment of funds available for the Company&#8217;s current operations. Changes in fair value, excluding credit losses and impairments, net of taxes (if applicable), are reflected in other comprehensive income or loss. Realized gains and losses on sales of Debt Securities and certificates of deposit as well as premium or discount amortization are included in the consolidated statements of income as finance income (expenses), net. Fair value is calculated based on publicly available market information. When the estimated fair value of a Debt Security is below its amortized cost, the Debt Security is assessed using the Current Expected Credit Losses model (in accordance with ASU 2016-13) in order to determine what portion of that difference, if any, is caused by expected credit losses. The amortized cost of the Debt Security will be reduced to its fair value if it is more likely than not that the Company is required to sell the impaired security before recovery of its amortized cost basis, or it has the intention to sell the security. If neither of these conditions are met, the Company determines whether the impairment is due to credit losses by comparing the present value of the expected cash flows of the security with its amortized cost basis. The amount of impairment recognized is limited to the excess of the amortized cost over the fair value of the security. An allowance for credit losses for the excess of amortized cost over the expected cash flows is recognized in finance income (expenses), net on the consolidated statements income. </span></span></div>
                      </div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <div style="line-height:1.25">
                <div></div>
              </div>
              <div style="line-height:1.25">
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%">

                    <tr style="vertical-align:top">
                      <td style="text-align:right;vertical-align:top;width:70pt">
                        <div style="text-align:left;margin-left:49.65pt;line-height:1.25">&#160;</div>
                      </td>
                      <td style="text-align:left;vertical-align:top;width:auto">
                        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company classifies investments that are readily convertible to known amounts of cash and have stated maturities of three months or less from the date of purchase as cash equivalents and those with stated maturities of greater than three months as marketable securities.</span></span></div>
                        <div style="line-height:1.25">&#160;</div>
                        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company determines the appropriate classification of its investments in marketable securities at the time of purchase.</span></span></div>
                      </td>
                    </tr>

                </table>
              </div>
            </div>
          &#160;
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:48.4pt">&#160;</td>
                  <td style="width:22.5pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">h.</span></span></td>
                  <td style="width:auto;vertical-align:top">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other Investments</span></span></div>
                    <div style="font-weight:bold">&#160;</div>
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:normal">The Company applies the measurement alternative upon the adoption of ASU 2016-01, and elected to record equity investments without readily determinable fair values at cost for other investments, less impairment, adjusted for subsequent observable price changes. In this measurement alternative method, changes in the carrying value of the equity investments are reflected in current earnings. Changes in the carrying value of the equity investment are required to be made whenever there are observable price changes in orderly transactions for the identical or similar investment of the same issuer.</span></span></span></div>
                  </td>
                </tr>

            </table>

          <div style="line-height:1.25">&#160;</div>
          <div style="line-height:1.25">

              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:48.4pt">&#160;</td>
                    <td style="width:22.5pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">i.</span></span></td>
                    <td style="width:auto;vertical-align:top">
                      <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Inventories</span></span></span></div>
                        <div style="line-height:1.25">&#160;</div>
                        <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Inventories include raw materials and finished products and are valued at the lower of cost or net realizable value. During the year ended December 31, 2022, the Company changed the cost determination method of raw materials from first in, first out (&#8220;FIFO&#8221;) method to a &#8220;moving average&#8221; method. This voluntary change in accounting method was implemented and considered preferable because the Company's ERP system supports automatic calculation of inventory according to the &#8220;moving average&#8221; method and it allows consistency of the cost determination method among the different components of inventory. The change in method was immaterial to all periods presented. The Company regularly evaluates its ability to realize the value of inventory based on a combination of factors including the following: historical usage rates, forecasted sales or usage, estimated current and future market values and new product introductions.</span></span></div>
                      </div>
                    </td>
                  </tr>

              </table>

          </div>

            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:48.4pt">&#160;</td>
                  <td style="width:22.5pt;vertical-align:top;font-weight:bold">&#160;</td>
                  <td style="width:auto;vertical-align:top">&#160;</td>
                </tr>
                <tr>
                  <td style="width:48.4pt">&#160;</td>
                  <td style="width:22.5pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">j.</span></span></td>
                  <td style="width:auto;vertical-align:top">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Leases</span></span></div>
                    <div style="font-weight:bold">&#160;</div>
                    <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">
                      <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company determines if an arrangement is a lease at inception. Balances related to operating leases are included in operating lease right-of-use (&#8220;ROU&#8221;) assets, other current liabilities, and operating lease liabilities in the consolidated balance sheets.</span></span></div>
                      <div style="line-height:1.25;font-weight:normal">&#160;</div>
                      <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company also elected to combine lease and non-lease components and to keep leases with an initial term of 12 months or less off the balance sheet and recognize the associated lease payments in the consolidated statements of income on a straight-line basis over the lease term.</span></span></div>
                      <div style="line-height:1.25;font-weight:normal">&#160;</div>
                      <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">ROU assets represent the Company&#8217;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#8217;s obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized as of the commencement date based on the present value of lease payments over the lease term. The Company&#8217;s lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. The discount rate for the lease is the rate implicit in the lease unless that rate cannot be readily determined. As the Company&#8217;s leases do not provide an implicit rate, the Company&#8217;s uses its estimated incremental borrowing rate based on the information available at the commencement date in determining the present value of lease payments. Lease expense for lease payments is recognized on a straight-line basis over the lease term (see also note 9).</span></span></div>
                    </div>
                  </td>
                </tr>
                <tr>
                  <td style="width:48.4pt">&#160;</td>
                  <td style="width:22.5pt;vertical-align:top;font-weight:bold">&#160;</td>
                  <td style="width:auto;vertical-align:top">&#160;</td>
                </tr>

            </table>

          <div></div>

            <div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:48.4pt">&#160;</td>
                    <td style="width:22.5pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">k.</span></span></td>
                    <td style="width:auto;vertical-align:top">
                      <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Property and equipment</span></span></div>
                      <div style="font-weight:bold">&#160;</div>
                    </td>
                  </tr>

              </table>

                <div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                      <tr>
                        <td style="vertical-align:top;width:70pt">&#160;</td>
                        <td style="vertical-align:top;width:auto">
                          <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:normal">Property and equipment is stated at cost, net of accumulated depreciation and amortization. Depreciation is calculated on a straight-line basis over the following estimated useful lives:</span></span></span></div>
                          </div>
                        </td>
                      </tr>

                  </table>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="margin-left:81pt">
                    <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                        <tr>
                          <td style="vertical-align:top;background-color:rgb(204, 238, 255)">
                            <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Computers</span></span></div>
                          </td>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)">
                            <div style="text-align:center;margin-right:20.45pt;margin-left:13.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3 &#8211; 4 years</span></span></div>
                          </td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom">
                            <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Molds</span></span></div>
                          </td>
                          <td style="vertical-align:bottom">
                            <div style="text-align:center;margin-right:20.45pt;margin-left:13.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4 &#8211; 10 years</span></span></div>
                          </td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)">
                            <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Equipment and furniture</span></span></div>
                          </td>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)">
                            <div style="text-align:center;margin-right:20.45pt;margin-left:13.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10 &#8211; 17 years</span></span></div>
                          </td>
                        </tr>

                    </table>
                  </div>
                </div>

              <div style="line-height:1.25">&#160;</div>
              <div style="line-height:1.25">
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:48.4pt">&#160;</td>
                      <td style="width:22.5pt;vertical-align:top;font-weight:bold">&#160;</td>
                      <td style="width:auto;vertical-align:top;font-weight:normal">
                        <div style="font-family:'Times New Roman',Times,serif">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Leasehold improvements are depreciated using the straight-line method over the shorter of the term of the lease or the estimated useful lives of the improvements.</span></span></div>
                        </div>
                      </td>
                    </tr>

                </table>
              </div>
            </div>


            <table cellpadding="0" cellspacing="0" style="color:#000000;font-family:'Times New Roman',Times,serif;font-size:10pt;text-align:left;width:100%">

                <tr>
                  <td style="width:48.4pt">&#160;</td>
                  <td style="width:22.5pt;vertical-align:top;font-weight:bold">&#160;</td>
                  <td style="width:auto;vertical-align:top">&#160;</td>
                </tr>
                <tr>
                  <td style="width:48.4pt">&#160;</td>
                  <td style="width:22.5pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">l.</span></span></td>
                  <td style="width:auto;vertical-align:top">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Impairment of long-lived assets</span></span></div>
                    <div style="font-weight:bold">&#160;</div>
                    <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:normal">The Company tests long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may no longer be recoverable. Recoverability of long-lived assets is measured by comparing the carrying amount of the long-lived asset to the estimated undiscounted future cash flows expected to be generated by the asset. If the sum of the expected undiscounted cash flow is less than the carrying amount of the asset, the Company recognizes an impairment loss, which is the excess of the carrying amount over the fair value of the asset, using the expected future discounted cash flows.</span></span></span></div>
                      <div style="line-height:1.25">&#160;</div>
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:normal">During the years ended December 31, 2023, 2022 and 2021, the Company did not recognize an impairment loss on its long-lived assets.</span></span></span></div>
                    </div>
                  </td>
                </tr>

            </table>

          <div style="line-height:1.25">&#160;</div>

            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:48.4pt">&#160;</td>
                  <td style="width:22.5pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">m.</span></span></td>
                  <td style="width:auto;vertical-align:top">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Legal and other contingencies</span></span></div>
                    <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">&#160;<div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Certain conditions may exist as of the date of the consolidated financial statements, which may result in a loss to the Company but which will only be resolved when one or more future events occur or fail to occur. The Company&#8217;s management assesses such contingent liabilities, if any, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the Company or unasserted claims that may result in such proceedings, the Company&#8217;s management evaluates the perceived merits of any legal proceedings or unasserted claims as well as the perceived merits of the amount of relief sought or expected to be sought.</span></span></div>
                      <div style="line-height:1.25;font-weight:normal">&#160;</div>
                      <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Management applies the guidance in ASC 450-20, &#8220;Loss Contingencies&#8221; when assessing losses resulting from contingencies. If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be reasonable estimated, then the estimated liability is recorded as accrued expenses in the Company&#8217;s consolidated financial statements.</span></span></div>
                      <div style="margin-left:72pt;line-height:1.25;font-weight:normal">&#160;</div>
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:normal">Legal costs incurred in connection with loss contingencies are expensed as incurred.</span></span></span></div>
                    </div>
                  </td>
                </tr>

            </table>
          <span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;</span></span>

            <div>
              <div style="line-height:1.25">
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:48.4pt">&#160;</td>
                      <td style="width:22.5pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">n.</span></span></td>
                      <td style="width:auto;vertical-align:top">
                        <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Income taxes:</span></span></div>
                      </td>
                    </tr>
                    <tr>
                      <td style="width:48.4pt">&#160;</td>
                      <td style="width:22.5pt;vertical-align:top;font-weight:bold">&#160;</td>
                      <td style="width:auto;vertical-align:top">&#160;</td>
                    </tr>

                </table>
              </div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:72pt">&#160;</td>
                    <td style="width:26.7pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1)</span></span></td>
                    <td style="width:auto;vertical-align:top">
                      <div style="font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company accounts for income taxes in accordance with ASC 740, &#8220;Income Taxes&#8221; (&#8220;ASC 740&#8221;). ASC 740 prescribes the use of the liability method whereby deferred tax asset and liability account balances are determined based on differences between the financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company provides a valuation allowance, if necessary, to reduce deferred tax assets to their estimated realizable value if it is more likely than not that a portion or all of the deferred tax assets will not be realized, based on the weight of available positive and negative evidence. Deferred tax liabilities and assets are classified as non-current in accordance with ASU 2015&#8209;17.</span></span></div>
                    </td>
                  </tr>
                  <tr>
                    <td style="width:72pt">&#160;</td>
                    <td style="width:26.7pt;vertical-align:top">&#160;</td>
                    <td style="width:auto;vertical-align:top">&#160;</td>
                  </tr>

              </table>
              <div></div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:72pt">&#160;</td>
                    <td style="width:26.7pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2)</span></span></td>
                    <td style="width:auto;vertical-align:top">
                      <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company may incur an additional tax liability in the event of an inter-company dividend distribution from Subsidiaries outside of Israel; no additional deferred income tax assets have been provided, since the Company does not expect to distribute inter-company dividends in the foreseeable future that may result in additional tax liability.</span></span></div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:72pt">&#160;</td>
                    <td style="width:26.7pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3)</span></span></td>
                    <td style="width:auto;vertical-align:top">
                      <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Taxes that would apply in the event of disposal of investments in Subsidiaries have not been taken into account in computing the deferred income tax assets, as it is the Company&#8217;s intent and ability to hold these investments.</span></span></div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:72pt">&#160;</td>
                    <td style="width:26.7pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4)</span></span></td>
                    <td style="width:auto;vertical-align:top">
                      <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company accounts for uncertain tax positions in accordance with ASC 740-10. ASC 740&#8209;10 contains a two-step approach to recognizing and measuring uncertain tax positions. The first step is to evaluate the tax position taken or expected to be taken in a tax return by determining if the weight of available evidence indicates that it is more likely than not that, on an evaluation of the technical merits, the tax position will be sustained on audit, including resolution of any related appeals or litigation processes. The second step is to measure the tax benefit of the largest amount that is more than 50% (cumulative probability) likely to be realized upon ultimate settlement.</span></span></div>
                    </td>
                  </tr>

              </table>
            </div>

          <div style="line-height:1.25">&#160;</div>

            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:48.4pt">&#160;</td>
                  <td style="width:22.5pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">o.</span></span></td>
                  <td style="width:auto;vertical-align:top">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Advertising expenses</span></span></div>
                    <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">&#160;<div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Advertising expenses are charged to sales and marketing on the consolidated statement of income as incurred. Advertising expenses for the years ended December 31, 2023, 2022 and 2021 amounted to $15 million, $10 million, and $4 million, respectively.</span></span></div>
                    </div>
                  </td>
                </tr>

            </table>

          <div style="line-height:1.25">&#160;</div>

            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:48.4pt">&#160;</td>
                  <td style="width:22.5pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">p.</span></span></td>
                  <td style="width:auto;vertical-align:top">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based compensation</span></span></div>
                    <div style="font-weight:bold">&#160;</div>
                    <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">
                      <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company grants share options and restricted share units (&#8220;RSU&#8221;) (together &#8220;Share-Based Compensation&#8221;) to its employees, officers, directors and non-employees in consideration for services rendered and for acquiring goods. See note 12(a)(2) for details on outstanding share capital.</span></span></div>
                      <div style="line-height:1.25;font-weight:normal">&#160;</div>
                      <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company accounts for Share-Based Compensation awards classified as equity awards using the grant-date fair value method. The fair value at grant-date of the issued equity award is recognized as an expense on a straight-line basis over the requisite service period. The fair value of each share option granted is estimated using the Binomial Model, and for each RSU granted is based on the Company&#8217;s share price at the close of the last trading day prior to the date of the grant. The Company estimates forfeitures based on historical experience and anticipated future conditions at the time of grant and revises such estimates in subsequent periods if actual forfeitures differ from those estimates.</span></span></div>
                      <div style="line-height:1.25;font-weight:normal">&#160;</div>
                      <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company elected to recognize Share-Based Compensation cost for awards with only service conditions that have a graded vesting schedule using the straight-line method based on the multiple-option award approach. Performance-based Share-Based Compensation expenses are calculated based on the valuation at the grant date, and recognized based on the probability of achieving those targets. The Company assess at what scale can the performance targets be reached at each balance sheet date, and expenses are recognized accordingly.</span></span></div>
                      <div style="line-height:1.25;font-weight:normal">&#160;</div>
                      <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company issues new shares upon option exercise or RSU vesting.</span></span></div>
                    </div>
                  </td>
                </tr>

            </table>

        </div>&#160;<div></div>
        <div>

            <div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="vertical-align:top;font-weight:bold;width:48pt">&#160;</td>
                    <td style="vertical-align:top;font-weight:bold;width:22pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">q.</span></span></td>
                    <td style="vertical-align:top;width:auto">
                      <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenue recognition</span></span></div>
                      <div style="font-weight:bold">&#160;</div>
                      <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">
                        <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company applies ASC 606, &#8220;Revenue from Contracts with Customers&#8221; (&#8220;ASC 606&#8221;). Under ASC 606, an entity recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration that the entity expects to receive in exchange for those goods or services. To determine revenue recognition for arrangements that an entity determines are within the scope of ASC 606, the entity performs the following five steps:</span></span></div>
                      </div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:72pt">&#160;</td>
                    <td style="width:38.05pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(i)</span></span></td>
                    <td style="width:auto;vertical-align:top">
                      <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Identify the contract(s) with a customer;</span></span></div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:72pt">&#160;</td>
                    <td style="width:38.05pt;vertical-align:top;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(ii)</span></span></td>
                    <td style="width:auto;vertical-align:top">
                      <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Identify the performance obligations in the contract. The Company determined that its arrangements are generally comprised of the following elements that are recognized as separate performance obligations: products, consumables and extended warranties;</span></span></div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:72pt">&#160;</td>
                    <td style="width:38.05pt;vertical-align:top;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(iii)</span></span></td>
                    <td style="width:auto;vertical-align:top">
                      <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Determine the transaction price;</span></span></div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:72pt">&#160;</td>
                    <td style="width:38.05pt;vertical-align:top;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(iv)</span></span></td>
                    <td style="width:auto;vertical-align:top">
                      <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Allocate the transaction price to the performance obligations in the contract;</span></span></div>
                      <div style="font-family:'Times New Roman',Times,serif">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company estimates the standalone selling prices of the services to be provided based on actual sales transactions of service contract purchased on a standalone basis and uses the residual approach to estimate the selling price of the products; and</span></span></div>
                      </div>
                    </td>
                  </tr>

              </table>
              <div style="margin-left:106.9pt;line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:72pt">&#160;</td>
                    <td style="width:38.05pt;vertical-align:top;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(v)</span></span></td>
                    <td style="width:auto;vertical-align:top">
                      <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Recognize revenue when (or as) the performance obligation is satisfied. </span></span></div>
                      <div>&#160;</div>
                      <div style="font-family:'Times New Roman',Times,serif">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company only applies the five-step model to contracts when it is probable that the entity will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer, after considering any price concession expected to be provided to the customer, when applicable. At contract inception, the Company assesses the goods or services promised within each contract and determines those that are performance obligations and assesses whether each promised good or service is distinct. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied. </span></span></div>
                        <div style="line-height:1.25">&#160;</div>
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company uses the following practical expedients that are permitted under the rules:</span></span></div>
                        </div>
                      </div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:111pt">&#160;</td>
                    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td>
                    <td style="width:auto;vertical-align:top">
                      <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company recognizes the incremental costs of obtaining contracts as an expense when incurred if the amortization period of the assets that the Company otherwise would have recognized is one year or less. These costs are included in sales and marketing expenses.</span></span></div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:111pt">&#160;</td>
                    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td>
                    <td style="width:auto;vertical-align:top">
                      <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company does not disclose the value of unsatisfied performance obligations for contracts with an original expected length of one year or less.</span></span></div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <div style="line-height:1.25">
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="vertical-align:top;font-weight:bold;width:72pt">&#160;</td>
                      <td style="vertical-align:top;width:auto">
                        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The following is a description of the principal activities from which the Company generates its revenue.</span></span></div>
                        <div style="line-height:1.25">&#160;</div>
                        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Product Revenue, Net</span></span></div>
                        <div style="line-height:1.25">&#160;</div>
                        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenues from product sales are recognized when the customer obtains control over the Company&#8217;s product, typically upon shipment to the customer. Revenues from shipping and handling activities that occur after the customer has obtained control of a good are recognized according to an accounting policy election as a fulfilment cost rather than as an additional promised service. Taxes collected from customers relating to product sales and remitted to governmental authorities are excluded from revenues.</span></span></div>
                      </td>
                    </tr>

                </table>
              </div>
              <p style="margin:0pt">&#160;</p>
              <div></div>
              <div style="line-height:1.25">
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="vertical-align:top;font-weight:bold;width:70pt">&#160;</td>
                      <td style="vertical-align:top;width:auto">
                        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Payment terms and conditions vary by customer. The Company&#8217;s standard terms for end users usually require of payment upon delivery and for distributors require a down payment and payments made within several month from the invoice date. </span></span></div>
                        <div style="line-height:1.25">&#160;</div>
                        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company may enter into installment sales contracts with end users in North America that provide them with long-term (generally up to 60 months) financing for the purchase of the Company&#8217;s products. The interest rate used in these contracts reflects the credit characteristics of the party receiving financing in the contract, as well as any collateral or security provided by the customer. Interest income on these receivables is recognized as finance income and earned over the terms of the contract.</span></span></div>
                        <div style="line-height:1.25">&#160;</div>
                        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Variable consideration includes price concessions related to installment sales contracts. The Company estimates variable consideration using the most likely outcome amount. Amounts included in the transaction price are recognized only when it is probable that a significant reversal of cumulative revenues will not occur.</span></span></div>
                        <div style="line-height:1.25">&#160;</div>
                        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company does not grant a right of return, refund, cancelation or termination. From time to time, the Company participates in its customers&#8217; marketing activities and deducts such amounts from revenue.</span></span></div>
                        <div style="line-height:1.25">&#160;</div>
                        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Service Revenue</span></span></div>
                        <div style="line-height:1.25">&#160;</div>
                        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company also generates revenues from long-term maintenance contracts (&#8220;Extended Warranty&#8221;). Revenue from Extended Warranty is recognized ratably, on a straight-line basis, over the period of the applicable service contract. These maintenance agreements are included in contract liabilities. Revenue from repairs performed in the absence of Extended Warranty is recognized when the related services are performed.</span></span></div>
                        <div style="line-height:1.25">&#160;</div>
                        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company classifies the portion of contract liabilities not expected to be earned in the subsequent 12 months as long-term.</span></span></div>
                      </td>
                    </tr>

                </table>
              </div>
            </div>
          <span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;</span></span>

            <div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="vertical-align:top;font-weight:bold;width:48pt">&#160;</td>
                    <td style="vertical-align:top;width:22pt">
                      <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><strong><span style="font-size:10pt;font-family:Times New Roman, Times, serif">r.</span></strong></p>
                    </td>
                    <td style="vertical-align:top;width:auto">
                      <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Allowance for doubtful accounts and financial instruments &#8211; credit loss</span></span></div>
                      <div style="font-weight:bold">&#160;</div>
                      <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">
                        <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company maintains the allowance for doubtful account resulting from the inability of the Company&#8217;s customers to make required payments.</span></span></div>
                        <div style="line-height:1.25;font-weight:normal">&#160;</div>
                        <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The allowance represents the current estimate of lifetime expected credit losses over the remaining duration of existing accounts receivable. This information includes among other the historic experience, the extent and amount of the account and future expectations.</span></span></div>
                        <div style="line-height:1.25;font-weight:normal">&#160;</div>
                        <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Allowance for credit losses due to the Company&#8217;s accounts receivable amounted to $2,254 and $1,318 as of December 31, 2023 and 2022 respectively. Changes in the allowance for credit losses are recognized in general and administrative expenses. Accounts receivable are written-off against the allowance for credit losses when management deems the accounts are no longer collectible.</span></span></div>
                        <div style="line-height:1.25;font-weight:normal">&#160;</div>
                      </div>
                    </td>
                  </tr>

              </table>

                <div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                      <tr>
                        <td style="vertical-align:top;width:48pt">&#160;</td>
                        <td style="vertical-align:top;width:22pt">&#160;</td>
                        <td style="vertical-align:top;width:auto">
                          <div style="font-family:'Times New Roman',Times,serif">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:normal">The following table sets forth activity in the Company&#8217;s allowance for credit losses for</span> each of the years ended December 31, 2023, 2022 and 2021, respectively:</span></span></div>
                          </div>
                        </td>
                      </tr>

                  </table>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="margin-left:81pt">
                    <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                        <tr>
                          <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:middle;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="text-indent:15.85pt;margin-right:7.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at beginning of year</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,318</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,107</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">672</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:middle;width:64%;vertical-align:bottom">
                            <div style="text-indent:15.85pt;margin-right:7.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Current-period provision</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,020</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">449</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">516</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:middle;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="text-indent:15.85pt;margin-right:7.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Write-offs charged against the</span></span></div>
                            <div style="text-indent:15.85pt;margin-right:7.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">allowance</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(84</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(238</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(81</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                            </div>
                          </td>
                        </tr>
                        <tr>
                          <td style="vertical-align:middle;width:64%;padding-bottom:4px;vertical-align:bottom">
                            <div style="text-indent:15.85pt;margin-right:7.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at end of year</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,254</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,318</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,107</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>

                    </table>
                  </div>
                </div>

            </div>

          <div style="line-height:1.25">&#160;</div>
          <div></div>

            <div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:48pt">&#160;</td>
                    <td style="vertical-align:top;font-weight:bold;width:22pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">s.</span></span></td>
                    <td style="vertical-align:top;width:auto">
                      <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Warranty reserve</span></span></div>
                      <div style="font-weight:bold">&#160;</div>
                      <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">
                        <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company provides a one-year standard warranty for its products. The Company records a provision for the estimated cost to repair or replace products under warranty at the time of sale. Factors that affect the Company&#8217;s warranty reserve include the number of units sold, historical and anticipated rates of warranty repairs, the cost per repair and shipping cost. The Company periodically assesses the adequacy of its recorded warranty liabilities and adjusts the amounts as necessary.</span></span></div>
                        <div style="line-height:1.25;font-weight:normal">&#160;</div>
                      </div>
                    </td>
                  </tr>

              </table>

                <div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                      <tr>
                        <td style="vertical-align:top;width:48pt">&#160;</td>
                        <td style="vertical-align:top;width:22pt">&#160;</td>
                        <td style="vertical-align:top;width:auto">
                          <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">
                            <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The following table sets forth activity in the Company&#8217;s accrued warranty account for each of the years ended December 31, 2023, 2022 and 2021, respectively:</span></span></div>
                          </div>
                        </td>
                      </tr>

                  </table>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="margin-left:81pt">
                    <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                        <tr>
                          <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:middle;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="text-indent:15.85pt;margin-right:7.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at beginning of year</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,418</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,248</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">705</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:middle;width:64%;vertical-align:bottom">
                            <div style="text-indent:15.85pt;margin-right:7.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cost incurred</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2,304</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2,099</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,453</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                        </tr>
                        <tr>
                          <td style="vertical-align:middle;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="text-indent:15.85pt;margin-right:7.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Expense recognized</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,362</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,269</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,996</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:middle;width:64%;padding-bottom:4px;vertical-align:bottom">
                            <div style="text-indent:15.85pt;margin-right:7.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at end of year</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,476</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,418</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,248</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>

                    </table>
                  </div>
                </div>

            </div>

          <div style="line-height:1.25">&#160;</div>

            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:48.4pt">&#160;</td>
                  <td style="width:22.5pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">t.</span></span></td>
                  <td style="width:auto;vertical-align:top">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cost of revenues</span></span></div>
                    <div style="font-weight:bold">&#160;</div>
                    <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">
                      <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cost of revenue consists of products purchased from turnkey sub-contractors which are responsible for the production of most of the Company&#8217;s products under the Company&#8217;s directions and supervision, raw materials for in-house assembly line, shipping and handling costs to customers and to subsidiaries, salary, employee-related expenses and overhead expenses of internal assembly line and service costs associate with warranty.</span></span></div>
                    </div>
                  </td>
                </tr>

            </table>

          <div style="line-height:1.25">&#160;</div>

            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:48.4pt">&#160;</td>
                  <td style="width:22.5pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">u.</span></span></td>
                  <td style="width:auto;vertical-align:top">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Research and development costs</span></span></div>
                    <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">&#160;<div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Research and development costs are expensed as incurred and includes salaries and employee-related expenses, overhead expenses, material and third-party contractor&#8217;s charges related to product development, regulatory affairs and clinical studies.</span></span></div>
                    </div>
                  </td>
                </tr>

            </table>

          <div style="line-height:1.25">&#160;</div>

            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:48.4pt">&#160;</td>
                  <td style="width:22.5pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">v.</span></span></td>
                  <td style="width:auto;vertical-align:top">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Net earnings</span>&#160;<span style="font-weight:bold">per share</span></span></span></div>
                    <div>&#160;</div>
                    <div style="font-family:'Times New Roman',Times,serif">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Basic earnings per share are computed by dividing net income </span></span>attributed to the shareholders of InMode Ltd. by the weighted average number of the Company&#8217;s ordinary shares, par value NIS 0.01 per share (including vested RSUs),<span><span> outstanding for each period, net of treasury shares.</span></span></span></span></div>
                      <div style="line-height:1.25">&#160;</div>
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For the diluted earnings per share calculation, the weighted average number of shares outstanding during the year is adjusted for the average number of shares that are potentially issuable in connection with employee share-based payment, using the treasury stock method.</span></span></div>
                    </div>
                  </td>
                </tr>

            </table>

          <div style="line-height:1.25">&#160;</div>

            <div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:48.4pt">&#160;</td>
                    <td style="width:22.5pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">w.</span></span></td>
                    <td style="width:auto;vertical-align:top">
                      <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair value measurement</span></span></div>
                      <div style="font-weight:bold">&#160;</div>
                      <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">
                        <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company measures fair value and discloses fair value measurements for financial assets and liabilities. Fair value is based on the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. In the absence of active markets for identical assets or liabilities, such measurements involve developing assumptions based on market observable data and, in the absence of such data,</span></span></div>
                        <div style="line-height:1.25;font-weight:normal">&#160;</div>
                        <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">internal information that is consistent with what market participants would use in a hypothetical transaction that occurs at the measurement date. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect the Company&#8217;s market assumptions.</span></span></div>
                      </div>
                    </td>
                  </tr>

              </table><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;</span></span>
              <div></div>
              <div style="line-height:1.25">
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:48.4pt">&#160;</td>
                      <td style="width:22.5pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">w.</span></span></td>
                      <td style="width:auto;vertical-align:top;font-weight:normal">
                        <div style="font-family:'Times New Roman',Times,serif">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The three levels of inputs that may be used to measure fair value are as follows:</span></span></div>
                        </div>
                      </td>
                    </tr>

                </table>
              </div>
              <div>&#160;</div>
              <div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="vertical-align:top;width:106pt;font-weight:bold">&#160;</td>
                      <td style="width:auto;vertical-align:top">
                        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Level 1 &#8211; Quoted prices (unadjusted) in active markets that are accessible at the measurement date for identical assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs.</span></span></div>
                          <div style="line-height:1.25">&#160;</div>
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Level 2 &#8211; Observable prices that are based on identical or similar instruments not quoted on active markets, but corroborated by observable market data, or quoted prices for similar instruments in active markets.</span></span></div>
                          <div style="line-height:1.25">&#160;</div>
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Level 3 &#8211; Unobservable inputs are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level 3 inputs.</span></span></div>
                        </div>
                      </td>
                    </tr>

                </table>
              </div>
              <div>&#160;</div>
              <div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:48.4pt">&#160;</td>
                      <td style="width:22.5pt;vertical-align:top;font-weight:bold">&#160;</td>
                      <td style="width:auto;vertical-align:top;font-weight:normal">
                        <div style="font-family:'Times New Roman',Times,serif">
                          <div style="line-height:1.25">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company maintains policies and procedures to determine the fair value of financial assets and liabilities using what it considers to be the most relevant and reliable market data available.</span></span></div>
                            <div style="line-height:1.25">&#160;</div>
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of December 31, 2023, and 2022, the fair values of the Company's cash, cash equivalents, short term bank deposits, accounts receivable, accounts payable, approximated the carrying values of these instruments presented in the Company's consolidated balance sheets because of their nature.</span></span></div>
                          </div>
                        </div>
                      </td>
                    </tr>

                </table>
              </div>
            </div>

          <div>&#160;</div>

            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:48.4pt">&#160;</td>
                  <td style="width:22.5pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">x.</span></span></td>
                  <td style="width:auto;vertical-align:top">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Segments</span></span></div>
                    <div style="font-family:'Times New Roman',Times,serif;font-weight:normal">&#160;<div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company operates in one segment. Management does not segregate its business for internal reporting. The Company&#8217;s chief operating decision-maker evaluates the performance of its business based on financial data consistent with the presentation in the accompanying financial statements. The Company concluded that its unified business is conducted globally and accordingly represents one operating segment.</span></span></div>
                      <div style="line-height:1.25">&#160;</div>
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Entity-wide disclosures on revenue and long-lived assets are presented in note 14.</span></span></div>
                    </div>
                  </td>
                </tr>

            </table>

          <div style="line-height:1.25">&#160;</div>

            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:48.4pt">&#160;</td>
                  <td style="width:22.5pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">y.</span></span></td>
                  <td style="width:auto;vertical-align:top">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Employee severance benefits</span></span></div>
                    <div style="font-weight:bold">&#160;</div>
                    <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">
                      <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company is required to make severance payments upon dismissal of an Israeli employee or upon termination of employment in certain circumstances.</span></span></div>
                      <div style="line-height:1.25;font-weight:normal">&#160;</div>
                      <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In accordance with the current employment terms with all of its employees (Section 14 of the Israeli Severance Pay Law, 1963) located in Israel, the Company makes regular deposits with certain insurance companies for accounts controlled by each applicable employee in order to secure the employee&#8217;s full retirement benefit and severance obligation. The Company is relieved from any severance pay liability with respect to each such employee after it makes the payments on behalf of the employee. The liability accrued in respect of these employees and the amounts funded, as of the respective agreement dates, are not reflected on the Company&#8217;s consolidated balance sheet, as the amounts funded are not under the control and management of the Company and the pension or severance pay risks have been irrevocably transferred to the applicable insurance companies.</span></span></div>
                      <div style="line-height:1.25;font-weight:normal">&#160;</div>
                      <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The amounts of severance payment expenses were $522, $431 and $405 and for the years ended December 31, 2023, 2022 and 2021, respectively.</span></span></div>
                      <div style="line-height:1.25;font-weight:normal">&#160;</div>
                      <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company expects to contribute approximately $533 in the year ending December 31, 2024 to insurance companies in connection with its expected severance liabilities for the year.</span></span></div>
                    </div>
                  </td>
                </tr>

            </table>

          <div style="line-height:1.25">&#160;</div>

            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:48.4pt">&#160;</td>
                  <td style="width:22.5pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">z.</span></span></td>
                  <td style="width:auto;vertical-align:top">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Treasury Shares</span></span></div>
                    <div style="font-weight:bold">&#160;</div>
                    <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">
                      <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Treasury shares are presented as a reduction of equity, at their cost to the Company.</span></span></div>
                    </div>
                  </td>
                </tr>

            </table>
          &#160;<div></div>

            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:48.4pt">&#160;</td>
                  <td style="width:22.5pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">aa.</span></span></td>
                  <td style="width:auto;vertical-align:top">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Concentration of credit risks</span></span></div>
                    <div style="font-weight:bold">&#160;</div>
                    <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:normal">Most of the cash and cash equivalents were deposited with U.S., European and Israeli banks and financial institutions and were comprised mainly of money market fund. The U.S. market constituted approximately 63% of the revenues in 2023.</span></span></span></div>
                      <div style="line-height:1.25">&#160;</div>
                      <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The exposure of credit risks relating to other trade receivables outside the U.S. is limited, due to the relatively large number of group customers and their wide geographic distribution. The Company performs ongoing credit evaluations of its customers for the purpose of determining the appropriate allowance for Credit Losses and generally does not require collateral and from time to time the Company may choose to purchase trade credit insurance.</span></span></div>
                    </div>
                  </td>
                </tr>

            </table>

          <div style="line-height:1.25">&#160;</div>

            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:48.4pt">&#160;</td>
                  <td style="width:22.5pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">ab.</span></span></td>
                  <td style="width:auto;vertical-align:top">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">War risk situation in Israel</span></span></div>
                    <div style="font-weight:bold">&#160;</div>
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:normal">In October 2023, Israel was attacked by a terrorist organization and entered a state of war. As of the date of these consolidated financial statements, the war is ongoing and continues to evolve. The Company's headquarter, its R&amp;D operations, and certain manufacturing facilities are located in Israel. Currently, such activities in Israel remain largely unaffected. During the year ended December 31, 2023, the impact of this war on the Company&#8217;s results of operations and financial condition was immaterial, but such impact may increase, which could be material, as a result of the continuation, escalation or expansion of such war.</span></span></span></div>
                  </td>
                </tr>

            </table>

          <div style="line-height:1.25">&#160;<div>

                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:48.4pt">&#160;</td>
                      <td style="width:22.5pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">ac.</span></span></td>
                      <td style="width:auto;vertical-align:top">
                        <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">
                          <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Newly issued accounting pronouncements, not yet adopted</span></span></div>
                          <div style="line-height:1.25;font-weight:bold">&#160;</div>
                        </div>
                        <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">
                          <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In December 2023, the FASB issued ASU 2023-09 &#8220;Income Taxes (Topic 740): Improvements to Income Tax Disclosures&#8221;. This guidance is intended to enhance the transparency and decision-usefulness of income tax disclosures. The amendments in ASU 2023-09 address investor requests for enhanced income tax information primarily through changes to disclosure regarding rate reconciliation and income taxes paid both in the U.S. and in foreign jurisdictions. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024 on a prospective basis. Early adoption is permitted, with the option to apply the standard retrospectively. The Company is currently evaluating this guidance to determine the impact it may have on its consolidated financial statements disclosures.</span></span></div>
                          <div style="line-height:1.25;font-weight:normal">&#160;</div>
                          <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In November 2023, the FASB issued ASU 2023-07 &#8220;Segment Reporting: Improvements to Reportable Segment Disclosures&#8221;. This guidance expands public entities&#8217; segment disclosures primarily by requiring disclosure of significant segment expenses that are regularly provided to the chief operating decision maker and included within each reported measure of segment profit or loss, an amount and description of its composition for other segment items, and interim disclosures of a reportable.</span></span></div>
                        </div>
                      </td>
                    </tr>

                </table>

            </div>
          </div>
        </div>
      </div>
    <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//235/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140222166040640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>MARKETABLE SECURITIES AND FAIR VALUE MEASUREMENTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_MarketableSecuritiesAndFairValueMeasurementAbstract', window );"><strong>Marketable Securities and Fair Value Measurement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_MarketableSecuritiesAndFairValueMeasurements', window );">MARKETABLE SECURITIES AND FAIR VALUE MEASUREMENTS</a></td>
<td class="text">
      <div>
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 3 - MARKETABLE SECURITIES AND FAIR VALUE MEASUREMENTS:</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="line-height:1.25">
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:49pt;vertical-align:top;font-weight:bold">&#160;</td>
                <td style="width:auto;vertical-align:top">
                  <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">
                    <div style="line-height:1.25;font-weight:normal">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">AFS securities as of December 31, 2023 and 2022, consisted of government bonds, municipal bonds, corporate debt securities, commercial paper and certificates of deposit. These marketable securities are recorded at fair value.</span></span></div>
                    </div>
                  </div>
                </td>
              </tr>

          </table>
        </div>&#160;<div></div>

          <div>
            <div style="line-height:1.25">
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="vertical-align:top;width:49pt">&#160;</td>
                    <td style="vertical-align:top;width:auto">
                      <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">
                        <div style="line-height:1.25;font-weight:normal">
                          <div style="line-height:1.25">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The following table sets forth the Company&#8217;s marketable securities for the periods indicated:</span></span></div>
                          </div>
                        </div>
                      </div>
                    </td>
                  </tr>

              </table>
            </div>
            <div style="margin-left:49.65pt;line-height:1.25">&#160;</div>
            <div style="margin-left:54pt">
              <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td colspan="1" style="vertical-align:bottom;padding-left:9pt;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:top;padding-left:9pt;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:middle;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Government bonds *</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">353,414</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">339,684</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:middle;width:76%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Municipal bonds</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,319</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,551</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:middle;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Corporate debt securities</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13,234</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">21,252</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:middle;width:76%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Commercial paper</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,195</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:middle;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Certificates of deposit</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,680</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,907</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:middle;width:76%;padding-bottom:4px;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">373,647</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">374,589</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>

              </table>
            </div>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:49pt;vertical-align:top;font-family:'Times New Roman',Times,serif;text-align:center">&#160;</td>
                  <td style="width:auto;vertical-align:top">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">* As of December 31, 2023 and 2022, consists of $0 and $1,502 non-U.S. government bonds, respectively.</span></span></div>
                  </td>
                </tr>

            </table>
          </div>

        <div style="line-height:1.25">&#160;</div>
        <div style="line-height:1.25">
          <div style="line-height:1.25">
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:49pt;vertical-align:top;font-weight:bold">&#160;</td>
                  <td style="width:auto;vertical-align:top">
                    <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">
                      <div style="line-height:1.25;font-weight:normal">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company classifies AFS securities within Level 2 because it uses alternative pricing sources and models utilizing market observable inputs to determine their fair value. See also note 2(w).</span></span></div>
                            <div style="line-height:1.25">&#160;</div>
                          </div>
                        </div>
                      </div>
                    </div>
                  </td>
                </tr>

            </table>
          </div>

            <div>
              <div style="line-height:1.25">
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="vertical-align:top;width:49pt">&#160;</td>
                      <td style="vertical-align:top;width:auto">
                        <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">
                          <div style="line-height:1.25;font-weight:normal">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The following table sets forth the Company&#8217;s financial assets as of December 31, 2023 and 2022, that are measured at fair value on a recurring basis during the period:</span></span></div>
                              </div>
                            </div>
                          </div>
                        </div>
                      </td>
                    </tr>

                </table>
              </div>
              <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;<div style="line-height:1.25">
                  <div>
                    <div style="margin-left:54pt">
                      <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                          <tr>
                            <td rowspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                            <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                            <td colspan="14" rowspan="1" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                              <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">December 31, 2023&#160;</span></span></span></strong></div>
                            </td>
                            <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                              <div style="line-height:1.25">
                                <div style="line-height:1.25;font-weight:bold;text-align:center"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Fair</span></span></span></span></strong></div>
                                <div style="line-height:1.25;font-weight:bold;text-align:center"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>value</span></span></span></span></strong></div>
                              </div>
                            </td>
                            <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;text-align:center">&#160;</td>
                            <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;text-align:center">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                              <div style="line-height:1.25;font-weight:bold;text-align:center"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Cost or</span></span></span></span></strong></div>
                              <div style="line-height:1.25;font-weight:bold;text-align:center"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>amortized</span></span></span></span></strong></div>
                              <div style="line-height:1.25;font-weight:bold;text-align:center"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>cost</span></span></span></span></strong></div>
                            </td>
                            <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;text-align:center">&#160;</td>
                            <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;text-align:center">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                              <div style="line-height:1.25;font-weight:bold;text-align:center"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Gross</span></span></span></span></strong></div>
                              <div style="line-height:1.25;font-weight:bold;text-align:center"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>unrealized</span></span></span></span></strong></div>
                              <div style="line-height:1.25;font-weight:bold;text-align:center"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>holding loss</span></span></span></span></strong></div>
                            </td>
                            <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;text-align:center">&#160;</td>
                            <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;text-align:center">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                              <div style="line-height:1.25;font-weight:bold;text-align:center">
                                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Gross</span></span></strong></p>
                                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">unrealized</span></span></strong></p>
                                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">holding</span></span></strong></p>
                                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">gains</span></span></strong></p>
                              </div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;background-color:rgb(204, 238, 255);vertical-align:bottom">
                              <div style="margin-left:7.1pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Level 2 securities:</span></span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:52%;vertical-align:bottom">
                              <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;margin-left:27pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Government bonds</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">353,414</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">355,382</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2,139</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">171</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                              <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;margin-left:27pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Municipal bonds</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,319</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,363</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(44</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:52%;vertical-align:bottom">
                              <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;margin-left:27pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Corporate debt securities</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13,234</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13,404</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(170</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:52%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                              <div style="line-height:1.25">
                                <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;margin-left:27pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Certificates of deposit</span></span></div>
                              </div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                              <div style="line-height:1.25">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,680</span></span></div>
                              </div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,680</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;width:52%;padding-bottom:4px;vertical-align:bottom">
                              <div style="line-height:1.25">
                                <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
                              </div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                              <div style="line-height:1.25">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">373,647</span></span></div>
                              </div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">375,829</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2,353</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">171</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          </tr>

                      </table>
                    </div>
                    <div>&#160;<div style="margin-left:54pt">
                        <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                            <tr>
                              <td rowspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                              <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                              <td colspan="14" rowspan="1" style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span><span><span style="font-weight:bold">December 31, 2022</span></span></span></strong></span></span></td>
                              <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                                <div style="line-height:1.25">
                                  <div style="line-height:1.25;font-weight:bold;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span><span>Fair</span></span></strong></span></span></div>
                                  <div style="line-height:1.25;font-weight:bold;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span><span>value</span></span></strong></span></span></div>
                                </div>
                              </td>
                              <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;text-align:center">&#160;</td>
                              <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;text-align:center">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                                <div style="line-height:1.25;font-weight:bold;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span><span>Cost or </span></span></strong></span></span></div>
                                <div style="line-height:1.25;font-weight:bold;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span><span>amortized </span></span></strong></span></span></div>
                                <div style="line-height:1.25;font-weight:bold;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span><span>cost</span></span></strong></span></span></div>
                              </td>
                              <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;text-align:center">&#160;</td>
                              <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;text-align:center">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                                <div style="line-height:1.25;font-weight:bold;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span><span>Gross </span></span></strong></span></span></div>
                                <div style="line-height:1.25;font-weight:bold;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span><span>unrealized</span></span></strong></span></span></div>
                                <div style="line-height:1.25;font-weight:bold;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span><span>holding loss</span></span></strong></span></span></div>
                              </td>
                              <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;text-align:center">&#160;</td>
                              <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;text-align:center">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                                <div style="line-height:1.25;font-weight:bold;text-align:center">
                                  <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Gross<br/>unrealized<br/>holding<br/>gains</span></span></p>
                                </div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:middle;background-color:rgb(204, 238, 255);vertical-align:bottom">
                                <div style="margin-left:7.1pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Level 2 securities:</span></span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:middle;width:52%;vertical-align:bottom">
                                <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;margin-left:27pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Government bonds</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">339,684</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">348,687</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(9,003</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:middle;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                                <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;margin-left:27pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Municipal bonds</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,551</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,674</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(123</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:middle;width:52%;vertical-align:bottom">
                                <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;margin-left:27pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Corporate debt securities</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">21,252</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">21,850</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(612</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">14</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:middle;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                                <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;margin-left:27pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Commercial paper</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,195</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,195</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:middle;width:52%;padding-bottom:2px;vertical-align:bottom">
                                <div style="line-height:1.25">
                                  <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;margin-left:27pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Certificates of deposit</span></span></div>
                                </div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                                <div style="line-height:1.25">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,907</span></span></div>
                                </div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,914</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(7</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:top;width:52%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                                <div style="line-height:1.25">
                                  <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
                                </div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                                <div style="line-height:1.25">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">374,589</span></span></div>
                                </div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">384,320</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(9,745</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">14</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                            </tr>

                        </table>
                      </div>
                    </div>
                  </div>
                </div>
              </div>
            </div>

        </div>
        <div style="line-height:1.25">
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:49pt;vertical-align:top;font-family:'Times New Roman',Times,serif;text-align:center">&#160;</td>
                <td style="width:auto;vertical-align:top">&#160;</td>
              </tr>
              <tr>
                <td style="width:49pt;vertical-align:top;font-family:'Times New Roman',Times,serif;text-align:center">&#160;</td>
                <td style="width:auto;vertical-align:top">
                  <div style="font-family:'Times New Roman',Times,serif">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of December 31, 2023 and 2022, the Company considered, based on its evaluation, that the decreases in market value on relevant marketable securities were temporarily impaired and primarily attributable to changes in interest rates, and therefore did not result in an impairment charge in finance income (expenses), net.</span></span></div>
                  </div>
                </td>
              </tr>

          </table>
        </div>&#160;<div style="margin-top:0pt;margin-bottom:0pt"></div>

          <div>
            <div style="line-height:1.25">
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="vertical-align:top;width:49pt">&#160;</td>
                    <td style="vertical-align:top;width:auto">
                      <div style="font-family:'Times New Roman',Times,serif">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of December 31, 2023 and 2022, the Company&#8217;s debt securities and certificates of deposit had the following maturity dates:</span></span></div>
                        </div>
                      </div>
                    </td>
                  </tr>

              </table>
            </div>
            <div style="margin-left:49.65pt;line-height:1.25">&#160;</div>
            <div style="margin-left:54pt">
              <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:middle;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Due within one year</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">308,671</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">243,094</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:middle;width:76%;vertical-align:bottom">
                      <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1 to 2 years</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">49,259</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">124,037</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:middle;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 to 3 years</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">15,717</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7,458</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:middle;width:76%;padding-bottom:4px;vertical-align:bottom">
                      <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">373,647</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">374,589</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>

              </table>
            </div>
          </div>

      </div>
    <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inmd_MarketableSecuritiesAndFairValueMeasurementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inmd_MarketableSecuritiesAndFairValueMeasurementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inmd_MarketableSecuritiesAndFairValueMeasurements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire dislosure for marketable securities and fair value measurements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inmd_MarketableSecuritiesAndFairValueMeasurements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140222166014704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCOUNTS RECEIVABLE<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableGrossAllowanceAndNetAbstract', window );"><strong>Accounts, Notes, Loans and Financing Receivable, Gross, Allowance, and Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock', window );">ACCOUNTS RECEIVABLE</a></td>
<td class="text">
      <div>
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 4 - ACCOUNTS RECEIVABLE:</span></span></div>
        <div style="line-height:1.25">&#160;</div>

          <div>
            <div style="line-height:1.25">
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="vertical-align:top;width:49pt">&#160;</td>
                    <td style="vertical-align:top;width:auto">
                      <div style="font-family:'Times New Roman',Times,serif">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Accounts receivable consist of the following:</span></span></div>
                          </div>
                        </div>
                      </div>
                    </td>
                  </tr>

              </table>
            </div>
            <div style="margin-right:1.95pt;margin-left:49.65pt;line-height:1.25">&#160;</div>
            <div style="margin-left:54pt">
              <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td rowspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="6" rowspan="1" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td rowspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" rowspan="1" style="text-align:center;font-weight:bold;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" rowspan="1" style="vertical-align:top;text-align:center;font-weight:bold;border-bottom:#000000 solid 2px;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></td>
                    <td colspan="1" rowspan="1" style="font-weight:bold;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" rowspan="1" style="text-align:center;font-weight:bold;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" rowspan="1" style="vertical-align:top;text-align:center;font-weight:bold;border-bottom:#000000 solid 2px;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></td>
                    <td colspan="1" rowspan="1" style="font-weight:bold;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">46,646</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">29,859</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Notes receivable</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,640</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,429</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Less - allowance for credit losses</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2,254</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,318</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </div>
                    </td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">46,032</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">30,970</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Less - non-current accounts receivable, net</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(3,670</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(3,973</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </div>
                    </td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total current accounts receivable, net</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">42,362</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">26,997</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>

              </table>
            </div>
          </div>

      </div>
    <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableGrossAllowanceAndNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableGrossAllowanceAndNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//310-10/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140222253414864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PREPAID EXPENSES AND OTHER CURRENT RECEIVABLES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrentAbstract', window );"><strong>Other Receivables, Net, Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_PrepaidExpensesAndOtherCurrentReceivablesTextBlock', window );">PREPAID EXPENSES AND OTHER CURRENT RECIVABLES</a></td>
<td class="text">
      <div>
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 5 - PREPAID EXPENSES AND OTHER CURRENT RECEIVABLES:</span></span></div>
        <div style="line-height:1.25">&#160;</div>

          <div>
            <div style="line-height:1.25">
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="vertical-align:top;width:49pt">&#160;</td>
                    <td style="vertical-align:top;width:auto">
                      <div style="font-family:'Times New Roman',Times,serif">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Prepaid expenses and other current receivables consist of the following:</span></span></div>
                            </div>
                          </div>
                        </div>
                      </div>
                    </td>
                  </tr>

              </table>
            </div>
            <div style="line-height:1.25">&#160;</div>
            <div style="margin-left:54pt">
              <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="6" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Advances to suppliers</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11,960</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11,898</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Prepaid expenses</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,041</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,928</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Government institutions</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">948</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">879</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Income tax</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">66</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">44</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">253</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">345</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total other current receivables</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">16,268</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">15,094</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>

              </table>
            </div>
          </div>

      </div>
    <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inmd_PrepaidExpensesAndOtherCurrentReceivablesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for prepaid expenses and other current receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inmd_PrepaidExpensesAndOtherCurrentReceivablesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140222166053888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">INVENTORIES</a></td>
<td class="text">
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0px;margin-bottom:0pt"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 6 - INVENTORIES:</span></span></strong></p>
    <div>
      <div>
        <div style="line-height:1.25">&#160;</div>

          <div>
            <div style="line-height:1.25">
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="vertical-align:top;width:49pt">&#160;</td>
                    <td style="vertical-align:top;width:auto">
                      <div style="font-family:'Times New Roman',Times,serif">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Inventories consist of the following:</span></span></div>
                              </div>
                            </div>
                          </div>
                        </div>
                      </div>
                    </td>
                  </tr>

              </table>
            </div>
            <div style="margin-right:1.95pt;margin-left:49.65pt;line-height:1.25">&#160;</div>
            <div style="margin-left:54pt">
              <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td rowspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="6" rowspan="1" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td rowspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" rowspan="1" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" rowspan="1" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Raw materials</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,080</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13,686</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Finished products</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">33,015</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">26,211</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total inventories</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">45,095</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">39,897</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>

              </table>
            </div>
          </div>

      </div>
    </div>
  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//330/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140222261436928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT, NET<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">PROPERTY AND EQUIPMENT, NET</a></td>
<td class="text">
      <div>
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 7 - PROPERTY AND EQUIPMENT, NET:</span></span></div>
        <div style="line-height:1.25">&#160;</div>

          <div>
            <div style="line-height:1.25">
              <div style="line-height:1.25">
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:49pt;vertical-align:top;font-family:'Times New Roman',Times,serif;text-align:center">&#160;</td>
                      <td style="width:auto;vertical-align:top">
                        <div style="font-family:'Times New Roman',Times,serif">
                          <div style="line-height:1.25">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25">
                                <div style="line-height:1.25">
                                  <div style="line-height:1.25">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Composition of property and equipment grouped by major classifications is as follows:</span></span></div>
                                  </div>
                                </div>
                              </div>
                            </div>
                          </div>
                        </div>
                      </td>
                    </tr>

                </table>
              </div>
            </div>
            <div style="line-height:1.25">&#160;</div>
            <div style="margin-left:54pt">
              <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td rowspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="6" rowspan="1" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td rowspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" rowspan="1" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" rowspan="1" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="margin-right:7.2pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Computers</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,334</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,191</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;vertical-align:bottom">
                      <div style="margin-right:7.2pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Office furniture and equipment</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">670</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">562</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="margin-right:7.2pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Molds</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,592</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,550</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
                      <div style="margin-right:7.2pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Leasehold improvements</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,243</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">829</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,839</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,132</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;padding-bottom:2px;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Less: accumulated depreciation</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(3,457</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2,834</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </div>
                    </td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="margin-right:7.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total property and equipment, net</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,382</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,298</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>

              </table>
            </div>
          </div>

        <div style="line-height:1.25">&#160;</div>
        <div style="line-height:1.25">
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:49pt;vertical-align:top;font-family:'Times New Roman',Times,serif;text-align:center">&#160;</td>
                <td style="width:auto;vertical-align:top">
                  <div style="font-family:'Times New Roman',Times,serif">
                    <div style="line-height:1.25">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total depreciation and amortization in respect of property and equipment were $623, $680 and $517 for the years ended December 31, 2023, 2022 and 2021, respectively.</span></span></div>
                              </div>
                            </div>
                          </div>
                        </div>
                      </div>
                    </div>
                  </div>
                </td>
              </tr>

          </table>
        </div>
      </div>
    <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//360/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140222165773824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER INVESTMENTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTextBlock', window );">OTHER INVESTMENTS</a></td>
<td class="text">
    <div>
      <div>
        <div style="line-height:1.25;font-weight:bold">
          <p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">NOTE 8 - OTHER INVESTMENTS:</span></span></p>
          <p style="margin:0pt">&#160;</p>
        </div>
        <div style="line-height:1.25;margin-top:0pt">
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%">

              <tr style="vertical-align:top">
                <td style="text-align:right;vertical-align:top;width:9pt">
                  <div style="margin-left:49.65pt;line-height:1.25;text-align:justify">&#160;</div>
                </td>
                <td style="text-align:left;vertical-align:top;width:auto">
                  <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">
                    <div>
                      <div style="line-height:1.25">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25">
                                <div style="line-height:1.25">
                                  <div style="line-height:1.25">
                                    <div style="line-height:1.25">
                                      <p><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>In November 2019, the Company signed a Share Purchase and Shareholders Agreement (the &#8220;SPA&#8221;) with (BY) Medimor Ltd., one of the Company&#8217;s turnkey manufacturing subcontractors (&#8220;Medimor&#8221;). Pursuant to the SPA, the Company has invested (in December 2019 and July 2020) an aggregate amount of $600 in consideration for 1,369,863 ordinary shares of Medimor (which reflected at the signing date a 14.78% ownership interest on an as-issued basis and 10.34% ownership interest on a fully diluted basis.</span></span></span></span></p>
                                    </div>
                                    <div style="line-height:1.25">&#160;<p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>In November 2023, the Company signed an additional SPA with Medimor and invested $100 in consideration for 117,440 ordinary shares of Medimor.</span></span></span></span></p>
                                    </div>
                                    <div style="line-height:1.25">&#160;</div>
                                    <div style="line-height:1.25">
                                      <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The SPAs together reflected as of December 31, 2023 a 14.78% ownership interest on an as-issued basis and 11.23% ownership interest on a fully diluted basis.</span></span></span></span></p>
                                    </div>
                                    <div style="line-height:1.25">&#160;</div>
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>The Company&#8217;s investment in Medimor is measured at cost, less impairment and adjusted for subsequent observable price changes if any. As of December 31, 2023, 2022 and 2021, the Company did not recognize an impairment or adjustment on its other investments.</span></span></span></span></span></span></div>
                                  </div>
                                </div>
                              </div>
                            </div>
                          </div>
                        </div>
                      </div>
                    </div>
                  </div>
                </td>
              </tr>

          </table>
        </div>
      </div>
    </div>
  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//320/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Topic 321<br> -Publisher FASB<br> -URI https://asc.fasb.org//321/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Topic 325<br> -Publisher FASB<br> -URI https://asc.fasb.org//325/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140222160007472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">LEASES</a></td>
<td class="text">
    <div>
      <div>
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 9 - LEASES:</span></span></div>
        <div>
          <div>
            <div style="line-height:1.25">&#160;</div>
            <div style="line-height:1.25">
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%">

                  <tr style="vertical-align:top">
                    <td style="text-align:right;vertical-align:top;width:49pt">
                      <div style="text-align:left;line-height:1.25">&#160;</div>
                    </td>
                    <td style="text-align:left;vertical-align:top;width:auto">
                      <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">
                        <div>
                          <div style="line-height:1.25">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25">
                                <div style="line-height:1.25">
                                  <div style="line-height:1.25">
                                    <div style="line-height:1.25">
                                      <div style="line-height:1.25">
                                        <div style="line-height:1.25">
                                          <div>
                                            <div style="line-height:1.25">
                                              <div style="line-height:1.25">
                                                <div style="line-height:1.25">
                                                  <div style="line-height:1.25">
                                                    <div style="line-height:1.25">
                                                      <div style="line-height:1.25">
                                                        <div style="line-height:1.25">
                                                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company&#8217;s main leasing properties are located in Israel, USA and Canada as detailed below:</span></span></div>
                                                        </div>
                                                      </div>
                                                    </div>
                                                  </div>
                                                </div>
                                              </div>
                                            </div>
                                          </div>
                                        </div>
                                      </div>
                                    </div>
                                  </div>
                                </div>
                              </div>
                            </div>
                          </div>
                        </div>
                      </div>
                    </td>
                  </tr>

              </table>
            </div>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:49.65pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">a.</span></span></td>
                  <td style="width:auto;vertical-align:top">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In May 2018, the Company signed a lease agreement for its headquarters in Israel. In January 2019, February 2020, March 2021, March 2023 and May 2023 the Company signed supplement lease agreements, further expanding its headquarters in Israel (collectively, the &#8220;Lease Agreement&#8221;). The Lease Agreement will expire in December 2027. The current monthly rent payment under the Lease Agreement is approximately $64.5.</span></span></div>
                    <div>&#160;</div>
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The costs under the Lease Agreement in Israel are linked to the Israeli Consumer Price Index. For purposes of ensuring the Company&#8217;s obligation towards the lessor, the Company has provided the lessor with a bank guarantee of NIS 966 thousand (approximately $266).</span></span></div>
                  </td>
                </tr>

            </table>
            <p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left">&#160;</p>
            <div></div>
            <div style="line-height:1.25">
              <div style="line-height:1.25">
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:48.4pt">&#160;</td>
                      <td style="width:22.5pt;vertical-align:top;font-family:'Times New Roman',Times,serif;text-align:center">&#160;</td>
                      <td style="width:auto;vertical-align:top">
                        <div style="font-family:'Times New Roman',Times,serif">
                          <div style="line-height:1.25">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25">
                                <div style="line-height:1.25">
                                  <div style="line-height:1.25">
                                    <div style="line-height:1.25">
                                      <div style="line-height:1.25">
                                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company also leases warehouse outside the company's offices. The Lease Agreement will expire in august 2027. The current monthly rent payment under the Lease Agreement is approximately $7.</span></span></div>
                                        <div style="line-height:1.25">&#160;</div>
                                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company also leases vehicles for several employees in Israel for a period of three years.</span></span></div>
                                      </div>
                                    </div>
                                  </div>
                                </div>
                              </div>
                            </div>
                          </div>
                        </div>
                      </td>
                    </tr>

                </table>
              </div>
              <div style="line-height:1.25">&#160;</div>
            </div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:48.4pt">&#160;</td>
                  <td style="width:22.5pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">b.</span></span></td>
                  <td style="width:auto;vertical-align:top">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In August 2020, the Company&#8217;s U.S. subsidiary, has signed a new lease agreement, for additional lease agreement of property and for its offices (&#8220;U.S Lease&#8221;). The U.S. Lease is for <span style="-sec-ix-hidden:Fxbrl_20240205133500283">7 years and 4 months</span> which began in the middle of April of 2021. The current monthly rent payment is approximately $27.</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:48.4pt">&#160;</td>
                  <td style="width:22.5pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">c.</span></span></td>
                  <td style="width:auto;vertical-align:top">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company&#8217;s Canadian subsidiary has signed a new lease agreement in April 2022 for property and for its offices (&#8220;Canadian Lease&#8221;). The Canadian Lease is for 3 years which began in July 2022. The current monthly rent payment is approximately $17.</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="width:48.4pt">&#160;</td>
                  <td style="width:22.5pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold">&#160;</td>
                  <td style="width:auto;vertical-align:top">&#160;</td>
                </tr>
                <tr>
                  <td style="width:48.4pt">&#160;</td>
                  <td style="width:22.5pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold">&#160;</td>
                  <td style="width:auto;vertical-align:top">
                    <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">From time to time the Company also leases small properties, mainly for offices for Subsidiaries around the world which range for periods of up to 3 years.</span></p>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
          </div>
        </div>
      </div>
    </div>
    <div>
      <div>

          <div>
            <div style="line-height:1.25">
              <div style="line-height:1.25">
                <table cellpadding="0" cellspacing="0" style="width:100%">

                    <tr>
                      <td style="vertical-align:top;width:auto">
                        <div style="font-family:'Times New Roman',Times,serif">
                          <div style="line-height:1.25;margin-left:70pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The lease cost was as follows:</span></span></div>
                        </div>
                      </td>
                    </tr>

                </table>
                <p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left">&#160;</p>
              </div>
            </div>
            <div style="margin-left:81pt">
              <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td colspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td style="padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="10" rowspan="1" style="padding-bottom:2px;vertical-align:bottom;border-bottom:2px solid black">
                      <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:1pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended</span></span></div>
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td style="padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" rowspan="1" style="padding-bottom:2px;vertical-align:bottom;border-bottom:2px solid black">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="2" rowspan="1" style="padding-bottom:2px;vertical-align:bottom;border-bottom:2px solid black">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="2" rowspan="1" style="padding-bottom:2px;vertical-align:bottom;border-bottom:2px solid black">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:top;padding-left:9pt;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Operating lease cost</span></span></div>
                    </td>
                    <td style="width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,348</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,628</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,297</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>

              </table>
            </div>
          </div>

        <div style="line-height:1.25">&#160;</div>

          <div>
            <div style="line-height:1.25">
              <div style="line-height:1.25">
                <div style="line-height:1.25">
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                      <tr>
                        <td style="vertical-align:top;margin-top:0pt;margin-bottom:0pt;width:auto">
                          <div style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">
                            <div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt">
                              <div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt;margin-left:70pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Supplemental cash flow information related to leases was as follows:</span></span></div>
                            </div>
                          </div>
                        </td>
                      </tr>

                  </table>
                </div>
              </div>
            </div>
            <p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left">&#160;</p>
            <div>
              <div>
                <div style="margin-left:81pt">
                  <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                      <tr>
                        <td colspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="10" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:1pt">Year ended</div>
                          <div style="line-height:1.25">
                            <div style="text-align:center;line-height:1.25;font-weight:bold">December 31</div>
                          </div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td colspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                          <div style="line-height:1.25">
                            <div style="text-align:center;line-height:1.25;font-weight:bold">2023</div>
                          </div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                          <div style="line-height:1.25">
                            <div style="text-align:center;line-height:1.25;font-weight:bold">2022</div>
                          </div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                          <div style="line-height:1.25">
                            <div style="text-align:center;line-height:1.25;font-weight:bold">2021</div>
                          </div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td colspan="1" style="vertical-align:top;padding-left:9pt;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25">Operating cash flows from operating leases</div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25">
                            <div style="line-height:1.25">2,530</div>
                          </div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25">
                            <div style="line-height:1.25">1,881</div>
                          </div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25">
                            <div style="line-height:1.25">1,328</div>
                          </div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>

                  </table>
                </div>
              </div>
            </div>
          </div>

        <p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left">&#160;</p>

          <div>
            <div style="line-height:1.25">
              <div style="line-height:1.25">
                <div style="line-height:1.25">
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                      <tr>
                        <td style="vertical-align:top;width:auto">
                          <div style="font-family:'Times New Roman',Times,serif">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25;margin-left:70pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Supplemental balance sheet information related to leases was as follows:</span></span></div>
                            </div>
                          </div>
                        </td>
                      </tr>

                  </table>
                </div>
              </div>
            </div>
            <p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left">&#160;</p>
            <div style="margin-left:81pt">
              <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="6" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:1pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:1pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:1pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Operating Leases</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;padding-bottom:2px;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Operating lease right-of-use assets</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9,698</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,073</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other current liabilities</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,404</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,453</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;padding-bottom:2px;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Operating lease liabilities</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,613</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,509</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total operating lease liabilities</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9,017</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,962</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted Average Remaining Lease Term</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Operating leases</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.90 years</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.30 years</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted Average Discount Rate</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Operating leases</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.00%-7.84</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.00%-5.80</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                      </div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>

        <div style="line-height:1.25">&#160;</div>
        <div></div>

          <div>
            <div style="line-height:1.25">
              <div style="line-height:1.25">
                <div style="line-height:1.25">
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                      <tr>
                        <td style="vertical-align:top;width:auto">
                          <div style="font-family:'Times New Roman',Times,serif">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25">
                                <div style="line-height:1.25;margin-left:70pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of December 31, 2023, the maturities of lease liabilities were as follows:</span></span></div>
                              </div>
                            </div>
                          </div>
                        </td>
                      </tr>

                  </table>
                </div>
              </div>
              <div style="margin-left:49.65pt;line-height:1.25">&#160;</div>
            </div>
            <div style="margin-left:81pt">
              <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;</span></span></td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" rowspan="1" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:1pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Operating Leases</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year Ending December 31,</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:88%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,745</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2025</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,491</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:88%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2026</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,001</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2027</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,733</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:88%;padding-bottom:2px;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2028 and beyond</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">902</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total lease payments</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9,872</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:88%;padding-bottom:2px;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Less imputed interests</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(855</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </div>
                    </td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:88%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9,017</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>

              </table>
            </div>
          </div>

      </div>
    </div>
  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//842-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140222166109456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER CURRENT LIABILITIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock', window );">OTHER CURRENT LIABILITIES</a></td>
<td class="text">
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">NOTE 10 -</span><span>&#160;</span><span style="font-weight:bold">OTHER CURRENT LIABILITIES:</span></p>

      <div>
        <div>
          <div style="line-height:1.25">&#160;</div>
          <div style="line-height:1.25">
            <div style="line-height:1.25">
              <div style="line-height:1.25">
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="vertical-align:top;width:49pt;font-weight:bold">&#160;</td>
                      <td style="width:auto;vertical-align:top">
                        <div style="font-family:'Times New Roman',Times,serif">
                          <div style="line-height:1.25">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other current liabilities consist of the following:</span></span></div>
                              </div>
                            </div>
                          </div>
                        </div>
                      </td>
                    </tr>

                </table>
              </div>
            </div>
            <div style="margin-left:49.65pt;line-height:1.25">&#160;</div>
          </div>
          <div style="margin-left:54pt">
            <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                <tr>
                  <td colspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="6" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                    <div style="line-height:1.25">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31</span></span></div>
                    </div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                    <div style="line-height:1.25">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                    </div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="2" rowspan="1" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                    <div style="line-height:1.25">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                    </div>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Employees and related expenses</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">21,040</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">19,439</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:top;width:76%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Government institutions</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,932</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,052</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Income tax payable</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,918</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">19,241</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:top;width:76%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Warranty reserve</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,476</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,418</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Operating lease liabilities</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,404</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,453</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:top;width:76%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Contractor liability</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,656</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,003</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,821</span></span></div>
                    </div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,374</span></span></div>
                    </div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total other current liabilities</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">39,247</span></span></div>
                    </div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">51,980</span></span></div>
                    </div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>

            </table>
          </div>
        </div>
      </div>

  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140222162698336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGECIES</a></td>
<td class="text">
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">NOTE 11 -</span><span style="padding-left:0pt">&#160;</span><span style="font-weight:bold">COMMITMENTS AND CONTINGENCIES:</span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt;margin-left:49.65pt">&#160;</p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt;margin-left:49.65pt"><span style="font-weight:bold">Subcontracting Agreements</span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt;margin-left:49.65pt">&#160;</p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt;margin-left:49.65pt"><span style="font-size:10pt;font-family:Times New Roman, serif">The Company has an existing turnkey manufacturing agreements with three of its major subcontractors in Israel in connection with manufacturing and assembling the Company&#8217;s products.</span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt;margin-left:49.65pt">&#160;</p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt;margin-left:49.65pt"><span style="font-size:10pt;font-family:Times New Roman, serif">The Company has agreements with two of the subcontractors which are renewed automatically every year for an additional one-year period, unless either the Company or the turnkey manufacturer gives written notice three months prior to the expiration of the term of its decision not to renew the agreement. Additionally, the Company or the turnkey manufacturer has the ability to terminate the contract at any time and for any reason with a prior written notice of four months.</span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt;margin-left:49.65pt">&#160;</p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt;margin-left:49.65pt"><span style="font-size:10pt;font-family:Times New Roman, serif">In addition, </span>in October 2019, the Company entered into a turnkey manufacturing agreement with another of its major subcontractors in Israel, Medimor (See also note 8). The agreement is for three years and renewed automatically every year afterwards for an additional one-year period, unless either the Company or Medimor gives written notice three months prior to the expiration of the term of its decision not to renew the agreement. Additionally, the Company or Medimor has the ability to terminate the agreement at any time and for any reason with a prior written notice of six months.</p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt;margin-left:49.65pt">&#160;</p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt;margin-left:49.65pt"><span style="font-size:10pt;font-family:Times New Roman, serif">According to the agreements above, the Company does not have a minimum order obligation, but the Company provides the subcontractors a six-month rolling forecast with the projected demand for products. In case of termination of the agreement with each subcontractor, the Company has to compensate that subcontractor for non-returnable inventory, materials in orders that cannot be cancelled and finished products inventory. As of December 31, 2023, the subcontractors&#8217; finished goods inventory, raw materials and open orders amounted to approximately $41,561. In order to secure these obligations, the Company gave its subcontractors advances in the amount of $9,914.</span></p>
  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//450/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480327/954-440-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140222165883552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHAREHOLDERS' EQUITY<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">SHAREHOLDERS' EQUITY</a></td>
<td class="text">
    <div>
      <div>
        <div>
          <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 12 - SHAREHOLDERS&#8217; EQUITY:</span></span></div>
        </div>
      </div>
      <div>
        <div>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:49pt">&#160;</td>
                <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:18pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">a.</span></span></td>
                <td style="vertical-align:top;text-align:justify;width:auto">
                  <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share Capital:</span></span></div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:49pt">&#160;</td>
                <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:18pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1)</span></span></td>
                <td style="vertical-align:top;text-align:justify;width:auto">
                  <div style="text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Ordinary shares</span></span></div>
                  <div>&#160;</div>
                  <div>
                    <div style="line-height:1.25;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Each holder of the Company&#8217;s ordinary shares is entitled to one vote. The holders of ordinary shares are also entitled to receive dividends whenever funds are legally available, when and if declared by the Company&#8217;s Board of Directors. Since inception, the Company has not declared any dividends.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="line-height:1.25;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In September 2020, the Company approved a share repurchase program of up to two million ordinary shares, to be purchased out of the Company&#8217;s cash reserve and to be paid solely from the Company&#8217;s IPO proceeds. In February 2022, the Company approved that the share repurchase program could also be funded from the proceeds of exercised options. In March 2022, the Company approved an additional repurchase program of up to one million ordinary shares, to be purchased out of its cash reserve and to be paid from the Company&#8217;s remaining IPO proceeds and from the proceeds of exercised options.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="line-height:1.25;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">During 2021, the Company purchased 693,734 shares in the amount of $35.4 million. In addition, during 2022, the Company purchased 1,077,213 shares in the amount of $42.6 million. During 2023 the company did not purchase any shares. As of December 31, 2023, the Company purchased 2,557,829 shares in the amount of $95.2 million under these repurchase programs.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="line-height:1.25;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On September 30, 2021, the Company executed a 1-for-2 share split (&#8220;2021 Share Split&#8221;) of the Company&#8217;s shares by way of an issuance of bonus shares. Upon the effectiveness of the 2021 Share Split, (i) one bonus share was issued for each outstanding share, (ii) the number of ordinary shares into&#160;</span></span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">which each outstanding option to purchase ordinary shares is exercisable was adjusted through proportional increase, (iii) the exercise price of each exercisable share under such outstanding options to purchase ordinary shares was adjusted through proportional decrease, (iv) the number of outstanding RSUs was adjusted through proportional increase, and (v) the number of shares reserved under the Company&#8217;s options plans was proportionally adjusted to accommodate the adjustment to the number of exercisable options under the Company&#8217;s respective option plans.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="line-height:1.25;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Unless otherwise indicated, and except for authorized capital, all of the share numbers, number of RSUs, number of options to purchase ordinary shares, net income per share amounts, share prices and option exercise prices in these financial statements have been adjusted, on a retroactive basis, to reflect the 2021 Share Split.</span></span></div>
                  </div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:49pt">&#160;</td>
                <td style="vertical-align:top;width:18pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2)</span></span></td>
                <td style="vertical-align:top;text-align:justify;width:auto">
                  <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based compensation</span></span></div>
                  <div>&#160;</div>
                  <div>
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On January 30, 2008, the Company&#8217;s Board of Directors adopted two share option plans as follows (collectively, the &#8220;2008 Plans&#8221;):</span></span></div>
                  </div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:67pt">&#160;</td>
                <td style="vertical-align:top;width:22pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">a)</span></span></td>
                <td style="vertical-align:top;width:auto">
                  <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2008 Israeli Option Plan (&#8220;2008 Israeli Plan&#8221;) allowing the Company to grant ordinary shares and options to purchase ordinary shares to Israeli employees, officers, directors, consultants and service providers. Each option under the 2008 Israeli Plan grants the right to exercise such option into one ordinary share of the Company.</span></span></div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:67pt">&#160;</td>
                <td style="vertical-align:top;width:21pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">b)</span></span></td>
                <td style="vertical-align:top;width:auto">
                  <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2008 ROW Option Plan (&#8220;2008 ROW Plan&#8221;) allowing the Company to grant ordinary shares and options to purchase ordinary shares to non-Israeli employees, officers, directors, consultants and service providers. Each option under the 2008 ROW Plan grants the right to exercise such option into one ordinary share of the Company.</span></span></div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <div style="clear:both;margin-top:0pt;margin-bottom:0pt">
            <div style="width:100%">
              <div></div>
            </div>
          </div>
          <div style="line-height:1.25">
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:67pt">&#160;</td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div>
                      <div style="line-height:1.25;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In June 2018, the Company&#8217;s Board of Directors adopted a new incentive plan (&#8220;2018 Incentive Plan&#8221;), allowing the Company to grant ordinary shares, options to purchase ordinary shares, restricted shares and restricted share unit (&#8220;RSUs&#8221;) (together, &#8220;Awards&#8221;) to Israeli and other non-U.S. employees, officers, directors, consultants and service providers of the Company and its Subsidiaries. The 2018 Incentive Plan also includes as an appendix a sub-plan allowing the Company to grant awards to U.S. employees, officers, consultants and service providers of the Company and its Subsidiaries. Each option award under 2018 Incentive Plan grants the right to exercise such option into one ordinary share of the Company. The Company&#8217;s subsidiary in U.S. may recognize under U.S. corporate tax laws, a tax benefit for RSU and options exercised for U.S. employees and U.S. service providers for tax purposes.</span></span></div>
                      <div style="line-height:1.25">&#160;</div>
                      <div style="line-height:1.25;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The grant of awards to Israeli employees, officers and directors under the 2008 Israeli Plan and the 2018 Incentive Plan is subject to the terms stipulated by Sections 102 and 102A of the Israeli Income Tax Ordinance. Each award grant is subject to the track chosen by the Company, either Section 102 or Section 102A of the Israeli Income Tax Ordinance, and pursuant to the terms thereof, the Company is not allowed to claim as an expense for tax purposes the amounts credited to employees as benefits, including amounts recorded as salary benefits in the Company&#8217;s accounts, in respect of options granted to employees under the 2008 Israeli Plan, with the exception of the work-income benefit component, if any, determined on grant date. For consultants and service providers, grants under the 2008 Israeli Plan and the 2018 Incentive Plan are subject to Section 3(i) of the Israeli Income Tax Ordinance.</span></span></div>
                      <div style="line-height:1.25">&#160;</div>
                      <div style="line-height:1.25;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Upon the adoption of the 2018 Incentive Plan, the then-current pool of awards available for future grants under the 2008 Plans was canceled and returned to the Company&#8217;s authorized and un-issued share capital. In addition, any shares returning to the free pool of options under the 2008 Plans, due to options expirations or otherwise, are automatically returning to the Company&#8217;s authorized and un-issued share capital.</span></span></div>
                      <div style="line-height:1.25">&#160;</div>
                      <div style="line-height:1.25;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Upon adoption of the 2018 Incentive Plan, the Board and the shareholders resolved to approve an evergreen mechanism with respect to the 2018 Incentive Plan, under which the number of reserved, authorized and unissued ordinary shares of the Company available for issuance of awards pursuant to&#160;</span></span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">the 2018 Incentive Plan shall automatically increase on an annual basis, by such number of ordinary shares as follows: on the first business day of each calendar year beginning in 2019, the number of awards equal to the lesser of (i) 800,000 ordinary shares, (ii) three percent of the number of shares outstanding as of such date or (iii) a lesser number of ordinary shares as shall be determined by the Company&#8217;s board of directors. </span></span></div>
                      <div style="line-height:1.25;text-align:left">&#160;</div>
                      <div style="line-height:1.25;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As</span></span>&#160;of December 31, 2023, the total awards under 2018 Incentive Plan that have been authorized to be issued as ordinary shares were 8,378,000 of which&#160;1,902,431 awards were available for grant under the 2018 Incentive Plan.</div>
                    </div>
                  </td>
                </tr>

            </table>
          </div>
          <div style="line-height:1.25">&#160;</div>
          <div style="clear:both;margin-top:0pt;margin-bottom:0pt">
            <div style="width:100%">
              <div></div>
            </div>
          </div>
        </div>
        <div style="line-height:1.25">
          <div>
            <table cellpadding="0" cellspacing="0" style="color:#000000;font-family:'Times New Roman',Times,serif;font-size:10pt;text-align:left;width:100%">

                <tr>
                  <td style="width:58.5pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top;font-family:'Times New Roman',Times,serif">&#160;</td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div>
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of December 31, 2023, 1,902,431 awards were available for grant under the 2018 Incentive Plan.</span></span></div>
                        <div style="line-height:1.25">&#160;</div>
                        <div style="line-height:1.25"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Share Options</span></span></span></strong></div>
                        <div style="line-height:1.25;font-weight:bold">&#160;</div>
                      </div>
                    </div>
                  </td>
                </tr>

            </table>
          </div>

            <div>
              <div style="line-height:1.25">
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:auto;vertical-align:top;text-align:justify">
                        <div>
                          <div style="line-height:1.25">
                            <div style="line-height:1.25;margin-left:75.5pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The following tables is a summary of stock option activity for the year ended on December 31, 2023<span style="font-weight:bold">&#160;</span>:</span></span></div>
                          </div>
                        </div>
                      </td>
                    </tr>

                </table>
              </div>
              <div style="line-height:1.25">&#160;</div>
              <div style="margin-left:81pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="6" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year&#160;ended&#160;December&#160;31</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="6" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Number</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Average</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">of</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercise</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Price*</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Outstanding at beginning of year</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,553,640</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5.30</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Changes during the year:</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="margin-left:8.8pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Granted</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;vertical-align:bottom">
                        <div style="margin-left:8.8pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercised</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(915,145</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5.92</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="margin-left:8.8pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Forfeited</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom">
                        <div style="margin-left:8.8pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Expired</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Outstanding at end of year</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,638,495</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.96</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercisable at end of year</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,638,495</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.96</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="width:76%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="8" style="vertical-align:top;vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">* In U.S. dollars per Ordinary Share</span></span></div>
                      </td>
                    </tr>

                </table>
              </div>
            </div>

          <div style="line-height:1.25">&#160;</div>
          <div style="line-height:1.25">
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:58.5pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top;font-family:'Times New Roman',Times,serif">&#160;</td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div>
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of December 31, 2023, the weighted-average remaining contractual life of exercisable options were 1.90 years. The total intrinsic value of options exercised during 2023, 2022 and 2021 were approximately $24,819, $10,549 and $277,978, respectively.</span></span></div>
                        <div style="line-height:1.25">&#160;</div>
                      </div>
                    </div>
                  </td>
                </tr>

            </table>
          </div>

            <div>
              <div style="line-height:1.25">
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:auto;vertical-align:top;text-align:justify">
                        <div>
                          <div style="line-height:1.25">
                            <div style="line-height:1.25;margin-left:75.5pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The following tables summarize information concerning outstanding and exercisable options as of December 31, 2023:</span></span></div>
                          </div>
                        </div>
                      </td>
                    </tr>

                </table>
              </div>&#160;<div style="margin-left:81pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td colspan="10" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25;text-align:center"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options outstanding and exercisable</span></span></strong></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="2" rowspan="5" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercise</span></span></div>
                        <div style="line-height:1.25">
                          <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Prices *</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center">&#160;</td>
                      <td colspan="2" rowspan="5" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Number of</span></span></div>
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">options</span></span></div>
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Outstanding and exercisable</span></span></div>
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">at end of</span></span></div>
                        <div style="line-height:1.25">
                          <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">year</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
                      <td colspan="1" rowspan="5" style="vertical-align:bottom;padding-bottom:2px;text-align:center">&#160;</td>
                      <td colspan="2" rowspan="5" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted</span></span></div>
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">average</span></span></div>
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">remaining</span></span></div>
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">contractual</span></span></div>
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">life</span></span></div>
                      </td>
                      <td colspan="1" rowspan="5" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">0.28</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">361,993</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">0.42</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">0.29</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">203,438</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">0.42</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.16</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">149,948</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.71</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.75</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">211,173</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.02</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5.11</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">70,756</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.26</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7.00</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">41,000</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.61</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9.85</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">565,129</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.18</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12.16</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">28,558</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.35</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">21.62</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,500</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.86</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>

                </table>
              </div>
              <div style="line-height:1.25">&#160;</div>
              <div style="line-height:1.25">
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:58.5pt">&#160;</td>
                      <td style="width:18pt;vertical-align:top;font-family:'Times New Roman',Times,serif">&#160;</td>
                      <td style="width:auto;vertical-align:top;text-align:justify">
                        <div>
                          <div style="line-height:1.25">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">* In U.S. dollars per Ordinary Share.</span></span></div>
                            </div>
                          </div>
                        </div>
                      </td>
                    </tr>

                </table>
              </div>
            </div>

          <div style="line-height:1.25">
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div>
                      <div style="line-height:1.25">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25;margin-left:77pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The aggregate intrinsic value of total exercisable options as of December 31, 2023 is $28,315.</span></span></div>
                        </div>
                      </div>
                    </div>
                  </td>
                </tr>

            </table>
          </div>
          <p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left">&#160;</p>
          <div></div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:58.5pt">&#160;</td>
                <td style="width:18pt;vertical-align:top;font-family:'Times New Roman',Times,serif">&#160;</td>
                <td style="width:auto;vertical-align:top;text-align:justify">
                  <div>
                    <div style="line-height:1.25">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Restricted Share Units</span></span></span></div>
                        <div style="line-height:1.25">&#160;</div>
                      </div>
                    </div>
                  </div>
                </td>
              </tr>

          </table>

            <div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:auto;vertical-align:top;text-align:justify">
                      <div>
                        <div style="line-height:1.25">
                          <div style="line-height:1.25">
                            <div style="line-height:1.25;margin-left:76pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The following tables summarize information concerning RSUs as of December 31, 2023<span style="font-weight:bold">&#160;</span>:</span></span></div>
                          </div>
                        </div>
                      </div>
                    </td>
                  </tr>

              </table><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;</span></span>
              <div style="margin-left:81pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="6" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year&#160;ended&#160;December&#160;31</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="6" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Number</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Average</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">of</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Grant&#160;Date</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">RSUs</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair Value</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Outstanding at beginning of year</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">804,575</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">45.74</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Changes during the year:</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="margin-left:8.8pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Granted</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">706,560</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">34.44</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;vertical-align:bottom">
                        <div style="margin-left:8.8pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Vested</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(522,326</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">43.33</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="margin-left:8.8pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Forfeited</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(52,760</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">37.21</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Outstanding at end of year *</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">936,049</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">39.04</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>

                </table>
              </div>
              <div style="line-height:1.25">&#160;</div>
              <div style="line-height:1.25">
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:58.5pt">&#160;</td>
                      <td style="width:18pt;vertical-align:top;font-family:'Times New Roman',Times,serif">&#160;</td>
                      <td style="width:auto;vertical-align:top;text-align:justify">
                        <div>
                          <div style="line-height:1.25">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">* As of December 31, 2023, 275,249 RSUs were vested and were settled by issuance of respective shares at the beginning of January 2024.</span></span></div>
                            </div>
                          </div>
                        </div>
                      </td>
                    </tr>

                </table>
              </div>
            </div>

          <div style="margin-left:113.4pt;line-height:1.25">&#160;</div>
          <div style="line-height:1.25">
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%">

                <tr style="vertical-align:top">
                  <td style="text-align:right;vertical-align:top;width:58pt">&#160;</td>
                  <td style="text-align:right;vertical-align:top;width:18pt">
                    <div style="text-align:left;line-height:1.25">&#160;</div>
                  </td>
                  <td style="text-align:left;vertical-align:top;width:auto">
                    <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">
                      <div>
                        <div style="line-height:1.25">
                          <div style="line-height:1.25">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25">
                                <div style="line-height:1.25">
                                  <div style="line-height:1.25">
                                    <div style="line-height:1.25">
                                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Each RSU represents the right to receive one ordinary share of the Company upon the vesting thereof. The fair value of an RSU is identical to the value of the underlying share at the close of the last trading day prior to the day of grant. The weighted average fair value of each RSU granted in 2023 was 34.44, and in 2022 was 49.35 and in 2021 35.44 based on the Company&#8217;s share price at closing of trading day prior to the day of grant.</span></span></div>
                                      <div style="line-height:1.25">&#160;</div>
                                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The total fair value of RSUs granted during the year ended December 31, 2023, 2022 and 2021, was $24,334, $30,817, and $19,279 respectively.</span></span></div>
                                      <div style="line-height:1.25">&#160;</div>
                                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of December 31, 2023, the Company had 660,800 unvested RSUs. The total unrecognized compensation cost of employee RSUs as of December 31, 2023 is $12,517, which is expected to be recognized over a weighted average period of 1.10 years.</span></span></div>
                                      <div style="line-height:1.25">&#160;</div>
                                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The total vesting-date value of equity classified RSUs vested during, 2023 is $6,122.&#160;</span></span><span style="font-size:10pt;font-family:Times New Roman, Times, serif">The following table illustrates the effect of share-based compensation on the consolidated statements of income:</span></div>
                                      <div style="line-height:1.25">&#160;</div>
                                    </div>
                                  </div>
                                </div>
                              </div>
                            </div>
                          </div>
                        </div>
                      </div>
                    </div>
                  </td>
                </tr>

            </table>
          </div>

            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;</span></span>
              <div style="margin-left:76pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="10" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended December 31</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cost of sales</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,046</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,917</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,108</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                        <div style="text-indent:-12.6pt;margin-left:12.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Research and development expenses</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,652</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,166</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,554</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-12.6pt;margin-left:12.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Selling and marketing expenses</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">17,167</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">17,302</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8,274</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;padding-bottom:2px;vertical-align:bottom">
                        <div style="text-indent:-12.6pt;margin-left:12.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">General and administrative expenses</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,735</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,067</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,026</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23,600</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">24,452</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11,962</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>

                </table>
              </div>
            </div>

          <div style="line-height:1.25">&#160;</div>
          <div style="clear:both;margin-top:0pt;margin-bottom:0pt">
            <div style="width:100%">
              <div></div>
            </div>
          </div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:49pt">&#160;</td>
                <td style="vertical-align:top;font-weight:bold;width:18pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">b.</span></span></td>
                <td style="vertical-align:top;text-align:justify;width:auto">
                  <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-Controlling Interests:</span></span></div>
                  <div style="font-weight:bold">&#160;</div>
                  <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:normal">On April 23, 2021, the Company, Dilazar Limited (&#8220;Dilazar&#8221;), Wigmore and Invasix UK (the UK subsidiary) entered into a share exchange agreement (the &#8220;UK Exchange Agreement&#8221;) whereby, Dilazar (which owned 49% of the Invasix UK&#8217;s shares immediately prior to the UK Exchange Agreement, which shares were previously transferred to Dilazar from its wholly-owned subsidiary Wigmore) sold to the Company all of its outstanding share capital in Invasix UK and Wigmore sold to the Company all of its rights pursuant to the Founders Memorandum of Understanding, dated March 4, 2014, by and between Wigmore and the Company, in exchange for the issuance at closing to Dilazar by the Company in a private placement of 457,912 of the Company&#8217;s ordinary shares, par value NIS 0.01. Upon closing, in May 2021, 457,912 of the Company&#8217;s ordinary shares were issued to Dilazar from the Company&#8217;s treasury shares.</span></span></span></div>
                </td>
              </tr>

          </table>
        </div>
      </div>
    </div>
  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480237/815-40-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//505/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-16<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140222167293472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text">
      <div>
        <div>
          <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 13 - INCOME TAXES:</span></span></div>
          <div style="line-height:1.25;font-weight:bold">&#160;</div>
          <div style="line-height:1.25">
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:49pt">&#160;</td>
                  <td style="vertical-align:top;font-weight:bold;width:18pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">a.</span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">InMode Ltd.</span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company is taxed according to Israeli tax laws:</span></span></div>
                  </td>
                </tr>

            </table>
          </div>
        </div>
        <div>&#160;<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:67pt">&#160;</td>
                <td style="vertical-align:top;width:21pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1)</span></span></td>
                <td style="vertical-align:top;width:auto">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Measurement of results for tax purposes</span></span></div>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company as a &#8220;foreign-investment company&#8221; measures its results for tax purposes in dollar based on Income Tax Regulations (Bookkeeping Principles of Foreign Invested Companies and of Certain Partnerships and the Determination of Their Taxable Income), 1986.</span></span></div>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">These consolidated financial statements are presented in U.S. dollars. The changes in the exchange rate of the dollar, both on an annual and a cumulative basis, cause a difference between taxable income and income reflected in these consolidated financial statements. ASC 740-10-25 prohibits the recognition of deferred tax liabilities or assets that arise from differences between the financial reporting and tax bases of assets and liabilities that are re-measured from the local currency into dollars using historical exchange rates, and that result from changes in exchange rates or indexing for tax purposes. Consequently, the above-mentioned differences were not reflected in the computation of deferred tax assets and liabilities.</span></span></div>
                </td>
              </tr>

          </table>&#160;<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:67pt">&#160;</td>
                <td style="vertical-align:top;width:21pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2)</span></span></td>
                <td style="vertical-align:top;width:auto">
                  <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Basis of taxation</span></span></div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:67pt">&#160;</td>
                <td style="vertical-align:top;font-weight:bold;width:21pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">a)</span></span></td>
                <td style="vertical-align:top;width:auto">
                  <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Incentives Applicable until 2020</span></span></div>
                  <div style="font-weight:bold">&#160;</div>
                  <div style="font-weight:bold">
                    <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Under the Encouragement of Capital Investments Law, including Amendment No. 60 thereof as published in April 2005, by virtue of the &#8220;Approved Enterprise&#8221; or &#8220;Benefited Enterprise&#8221; status, the Israeli Company was tax exempt from 2012 to 2020 for income derived from the Benefited Enterprise. See also note 13a(2)(b).</span></span></div>
                  </div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:67pt">&#160;</td>
                <td style="vertical-align:top;font-weight:bold;width:21pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">b)</span></span></td>
                <td style="vertical-align:top;width:auto">
                  <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Incentives Applicable starting 2021 - The New Technological Enterprise and Preferred Enterprise Incentives Regime &#8211; Amendment 73 to the Investment Law</span></span></div>
                  <div style="font-weight:bold">&#160;</div>
                  <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:normal">On June 14, 2017, the Encouragement of Capital Investments Regulations (Preferred Technology Income and Capital Profits for a Technological Enterprise), 2017 (the &#8220;Regulations&#8221;) were published, which adopted Action 5 under the base erosion and profit shifting (&#8220;BEPS&#8221;) regulations. The Regulations describe, inter alia, the mechanism used to determine the calculation of the benefits under the PTE (Preferred technological enterprise) or PE (Preferred enterprise) and under the SPTE (Special Preferred Technology Enterprise) regime and determine certain requirements relating to documentation of intellectual property for the purpose of the PTE or PE. According to these provisions, a company that complies with the terms under the PTE or PE</span> regime may be entitled to certain tax benefits with respect to income generated during the company&#8217;s regular course of business and derived from the preferred intangible asset (as determined in the Investments Law) and income attributed to production activity (different tax rate), Excluding income derived from intangible assets used for marketing.</span></span></div>
                  <div style="font-weight:bold">&#160;</div>
                </td>
              </tr>

          </table>
        </div>
        <div></div>
        <div>
          <div style="line-height:1.25">
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:67pt">&#160;</td>
                  <td style="vertical-align:top;font-weight:bold;width:21pt">&#160;</td>
                  <td style="vertical-align:top;width:auto">
                    <div style="font-weight:bold">
                      <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In the event that intangible assets used for marketing purposes generate over 10% of the PTE&#8217;s or PE&#8217;s income, the relevant portion, calculated using a transfer pricing study, would be subject to regular corporate income tax. If such income does not exceed 10%, the PTE or PE will not be required to exclude the marketing income from the PTE&#8217;s or PE&#8217;s total income. The Regulations set a presumption of direct production expenses plus 10% with respect to income related to production, which can be countered by the results of a supporting transfer pricing study. Tax rates applicable to such production income expenses will be similar to the tax rates under the Preferred Enterprise regime, to the extent such income would be considered as eligible. In order to calculate the preferred income, the PTE and PE is required to take into account the income and the research and development expenses that are attributed to each single preferred intangible asset.</span></span></div>
                      <div style="line-height:1.25;font-weight:normal">&#160;</div>
                      <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The company reviews every year whether it meets the conditions of the PTE or PE. The difference for the company is immaterial since it located in development area A.</span></span></div>
                      <div style="line-height:1.25;font-weight:normal">&#160;</div>
                      <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Under the Regulations the Company&#8217;s tax rate is expected to be approximately 7.5%.</span></span></div>
                      <div style="line-height:1.25;font-weight:normal">&#160;</div>
                      <div style="line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Amendment 74 to the Investment Law</span></span></div>
                      <div style="line-height:1.25;font-weight:normal">&#160;</div>
                      <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Pursuant to the amendment to the Investments Law which became effective on November 15, 2021, a company that elects by November 15, 2022 to pay a reduced corporate tax rate as set forth in that amendment (rather than the regular corporate tax rate applicable to Approved Enterprise income) with respect to undistributed exempt income accumulated by the company until December 31, 2020 will be entitled to distribute a dividend from such income or to be used for any other reason found by the company, without being required to pay additional corporate tax.</span></span></div>
                      <div style="line-height:1.25;font-weight:normal">&#160;</div>
                      <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company elected to take advantage of the amendment, and during November 2022 has paid NIS 42.5 million ($12.0 million) as a one-time payment, and as a result NIS 591 million (approximately $165.7 million) of the Company&#8217;s undistributed exempt income for years 2012 until 2020 are entitled to be distributed as dividend or to be used for any other reason found by the Company without being required to pay additional corporate tax. As a result, the Company is required to invest NIS 32 million (approximately $9 million) in its industrial enterprises in Israel over a five year period. Such investment may be in the form of the acquisition of industrial assets (excluding real estate assets), investment in R&amp;D in Israel, or payroll payments to new employees to be hired by the enterprise.<sup style="vertical-align:text-top;line-height:1;font-size:smaller">&#160;</sup>All the amount that was required to invest was invested in 2022.</span></span></div>
                    </div>
                  </td>
                </tr>

            </table>
          </div>&#160;<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:67pt">&#160;</td>
                <td style="vertical-align:top;width:21pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3)</span></span></td>
                <td style="vertical-align:top;width:auto">
                  <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Corporate tax rate in Israel</span></span></div>
                  <div>&#160;</div>
                  <div>
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The income of Israeli companies, other than preferred income, is taxed in accordance with Israeli tax laws at the regular corporate tax rates. The corporate tax rate is 23% for 2018 and thereafter. Capital gain is subject to capital gain tax according to the corporate tax rate in the year the assets are sold.</span></span></div>
                  </div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <div style="line-height:1.25">
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:49pt">&#160;</td>
                  <td style="vertical-align:top;font-weight:bold;width:18pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">b.</span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div style="font-weight:bold">
                      <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Subsidiaries outside of Israel</span></span></div>
                    </div>
                    <div style="font-weight:bold">&#160;</div>
                    <div style="font-weight:bold">
                      <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Subsidiaries that are incorporated outside of Israel are assessed for taxes under the tax laws in their countries of residence.</span></span></div>
                      <div style="line-height:1.25;font-weight:normal">&#160;</div>
                      <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The corporate tax rates of Subsidiaries outside of Israel for the year ended on December 31, 2023 is between 21% to 26.5%.</span></span></div>
                    </div>
                  </td>
                </tr>

            </table>
          </div>&#160;<div></div>
          <div style="line-height:1.25">
            <div style="line-height:1.25">
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:49pt">&#160;</td>
                    <td style="vertical-align:top;font-weight:bold;width:18pt">&#160;</td>
                    <td style="vertical-align:top;text-align:justify;width:auto">
                      <div style="font-weight:bold">
                        <div style="font-weight:bold">
                          <div style="line-height:1.25">
                            <div style="line-height:1.25;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:normal">In March 2020, the Coronavirus Aid, Relief, and Economic Security Act (&#8220;CARES Act&#8221;) was enacted in the US, which provides among others, tax relief measures for businesses including a five-year net operating loss (&#8220;NOL&#8221;) carry back. As a result, the Company recognized in its consolidated financial statements a receivable tax asset in the amount of $2,894, under current other receivables. During 2022, the Company fully received the tax refund as part of the CARES Act.</span></span></span></div>
                            <div style="line-height:1.25;text-align:left">&#160;</div>
                          </div>
                          <div style="line-height:1.25;font-weight:normal;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of December 31, 2023, the Company&#8217;s subsidiary in U.S has an accumulated tax loss carryforward of approximately $217 million derived mainly from exercises of options by employees which provided the Company tax deductions in excess of the actual compensation expenses (recognized in loss), under the Tax Cuts and Jobs Act of 2017 (&#8220;TCJA&#8221;).</span></span></div>
                          <div style="line-height:1.25;font-weight:normal;text-align:left">&#160;</div>
                          <div style="line-height:1.25;font-weight:normal;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Under U.S. tax laws, subject to certain limitations, carryforward tax losses originating in tax years beginning after January 1, 2018, have no expiration date, but they are limited to 80% of the company's<span style="font-weight:normal"> taxable income in any given tax year. However, the 80% limitation was temporarily removed by the CARES Act, for tax years beginning before January 1, 2021. A full valuation allowance was created against the Company&#8217;s subsidiary in the U.S against the deferred tax assets. Management currently believes that it is more likely than not that the deferred taxes generated in U.S will not be realized in the foreseeable future.</span></span></span></div>
                        </div>
                      </div>
                    </td>
                  </tr>
                  <tr>
                    <td style="width:49pt">&#160;</td>
                    <td style="vertical-align:top;font-weight:bold;width:18pt">&#160;</td>
                    <td style="vertical-align:top;text-align:justify;width:auto">&#160;</td>
                  </tr>

              </table>
            </div>
          </div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:49.65pt">&#160;</td>
                <td style="width:18pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">c.</span></span></td>
                <td style="width:auto;vertical-align:top">
                  <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred income tax assets</span></span></div>
                  <div style="font-weight:bold">&#160;</div>
                </td>
              </tr>

          </table>

            <div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="vertical-align:top;width:49pt">&#160;</td>
                    <td style="vertical-align:top;width:18pt">&#160;</td>
                    <td style="vertical-align:top;width:auto">
                      <div style="font-weight:bold">
                        <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred income tax assets reflect the net tax effects of loss and credit carryforwards and temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The components of the Company&#8217;s net deferred tax assets (liabilities) at December 31, 2023 and 2022 were as follows:</span></span></div>
                      </div>
                    </td>
                  </tr>

              </table>
              <div style="margin-left:67.5pt;line-height:1.25">&#160;</div>
              <div style="margin-left:72pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="6" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)">
                        <div style="margin-left:0.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred tax assets in respect of:</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="width:76%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                        <div style="text-indent:9pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Subsidiaries carryforward losses</span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">58,075</span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">60,229</span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="width:76%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
                        <div style="text-indent:9pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other temporary differences</span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,112</span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,369</span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="width:76%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                        <div style="text-indent:9pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based compensation</span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,194</span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,073</span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="vertical-align:bottom;width:76%;background-color:rgb(255, 255, 255)">
                        <div style="line-height:1.25;margin-left:9pt"><span style="line-height:1.25;text-indent:9pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred</span></span></span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"> tax asset in respect to other comprehensive loss</span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">502</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,238</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="width:76%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                        <div style="text-indent:-12.15pt;margin-left:21.25pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total deferred tax assets before valuation allowance</span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">65,883</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">69,909</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="width:76%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">
                        <div style="text-indent:9pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Valuation allowance</span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(64,377</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(66,815</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </div>
                      </td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="width:76%;padding-bottom:4px;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total deferred tax assets</span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,506</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,094</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
                    </tr>

                </table>
              </div>
            </div>

          <div style="line-height:1.25">&#160;</div>
          <div style="line-height:1.25">
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:49.65pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top;font-weight:bold">&#160;</td>
                  <td style="width:auto;vertical-align:top">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred taxes are computed using the tax rates expected to be in effect when those differences reverse.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company records net deferred tax assets to the extent it believes these assets will more likely than not be realized in the foreseeable future. As of each reporting date, management considers new evidence, both positive and negative, that could impact management&#8217;s view with regard to the future realization of deferred tax assets for each jurisdiction.</span></span></div>
                  </td>
                </tr>

            </table>
          </div>&#160;<div></div>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:49.65pt">&#160;</td>
                <td style="width:18pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">d.</span></span></td>
                <td style="width:auto;vertical-align:top">
                  <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Reconciliation of theoretical tax expense to actual tax expense</span></span></div>
                  <div style="font-weight:bold">&#160;</div>
                </td>
              </tr>

          </table>

            <div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="vertical-align:top;width:49pt">&#160;</td>
                    <td style="vertical-align:top;width:18pt">&#160;</td>
                    <td style="vertical-align:top;width:auto">
                      <div style="font-weight:bold">
                        <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Following is a reconciliation of the theoretical provision for income tax, assuming all income is taxed at the statutory corporate tax rate applicable to Israeli corporations, and the actual tax on income:</span></span></div>
                      </div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <div style="margin-left:72pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td colspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="10" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended December 31</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="1" style="vertical-align:top;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Income before taxes on income</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25">217,267</div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25">201,466</div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25">168,002</div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="1" style="vertical-align:top;width:64%;vertical-align:bottom">
                        <div style="text-indent:-13.55pt;margin-left:13.55pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>Theoretical tax expenses at the statutory rate of InMode&#160;Ltd.</span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                      </td>
                    </tr>
                    <tr>
                      <td colspan="1" style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">49,971</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">46,337</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">38,640</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="1" style="vertical-align:top;width:64%;vertical-align:bottom">
                        <div style="text-indent:-13.55pt;margin-left:13.55pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Increase (decrease) in taxes on income due to:</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="1" style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:0.75pt;margin-left:13.55pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Benefits to the Benefited Enterprise</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(31,739</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(29,429</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(37,478</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                    </tr>
                    <tr>
                      <td colspan="1" style="vertical-align:top;width:64%;vertical-align:bottom">
                        <div style="text-indent:-7.05pt;margin-left:21.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Different effective tax rates applicable to the Subsidiaries</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,956</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,453</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2,033</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                    </tr>
                    <tr>
                      <td colspan="1" style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="margin-left:13.55pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Valuation allowance</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">126</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">130</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">40</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="1" style="vertical-align:top;width:64%;vertical-align:bottom">
                        <div style="margin-left:13.55pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Uncertain tax positions</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,096</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">303</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,921</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="1" style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-9.4pt;margin-left:22.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-deductible expenses and other permanent differences, mainly share based compensation expenses</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,850</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,842</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,838</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="1" style="vertical-align:top;padding-left:9pt;width:64%;vertical-align:bottom">
                        <div style="text-indent:-9.4pt;margin-left:22.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Amendment to the Investments Law payment - see also note 13a(2)(b)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,017</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="1" style="vertical-align:top;padding-left:9pt;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="margin-left:13.55pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Settlements with the Israeli tax authority net of decrease of related uncertain tax&#160;provision</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10,199</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="1" style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">19,348</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">39,946</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,928</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>

                </table>
              </div>
            </div>

          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:49pt">&#160;</td>
                <td style="vertical-align:top;font-weight:bold;width:18pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">e.</span></span></td>
                <td style="vertical-align:top;width:auto">
                  <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Tax assessments</span></span></div>
                  <div style="font-weight:bold">&#160;</div>
                  <div style="font-weight:bold">
                    <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In February 2022, the Israeli Company settled the 2017-2020 income tax assessment with the Israeli tax authority, paying $1.3 million. also see Note 13a(2)(b).</span></span></div>
                    <div style="line-height:1.25;font-weight:normal">&#160;</div>
                    <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In December 2022 the Company reached an agreement with the Israeli Tax Authority under which the Company paid on January 2023 NIS 50.2 million (approximately $14.3 million).</span></span></div>
                    <div style="line-height:1.25;font-weight:normal">&#160;</div>
                    <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of December 31, 2023, tax assessments of the Israeli Company through tax year 2021 are considered final. In addition, all tax assessments of one of the Company&#8217;s subsidiaries in Israel through tax year 2018 are considered final. Another Israeli subsidiary was established in 2022 and therefore does not have any tax year that considered final.</span></span></div>
                    <div style="line-height:1.25;font-weight:normal">&#160;</div>
                    <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of December 31, 2023, all tax assessments on the Company&#8217;s subsidiary in the United States, through tax year 2019, are considered final.</span></span></div>
                    <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The </span></span>other Subsidiaries' open tax years range from 2018-2023.</div>
                  </div>
                </td>
              </tr>

          </table>
        </div>&#160;<div></div>
        <div>

            <div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:49.65pt">&#160;</td>
                    <td style="width:18pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">f.</span></span></td>
                    <td style="width:auto;vertical-align:top">
                      <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Income before income taxes is composed of the following:</span></span></div>
                    </td>
                  </tr>
                  <tr>
                    <td style="width:49.65pt">&#160;</td>
                    <td style="width:18pt;vertical-align:top;font-weight:bold">&#160;</td>
                    <td style="width:auto;vertical-align:top">&#160;</td>
                  </tr>

              </table>
              <div style="margin-left:72pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="10" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended December 31</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">InMode Ltd. and Israeli subsidiaries</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">211,137</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">196,354</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">163,370</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Subsidiaries outside of Israel</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,130</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,112</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,632</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">217,267</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">201,466</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">168,002</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>

                </table>
              </div>
            </div>

          <div style="line-height:1.25">&#160;</div>

            <div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:49.65pt">&#160;</td>
                    <td style="width:18pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">g.</span></span></td>
                    <td style="width:auto;vertical-align:top">
                      <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Tax expenses (tax benefit):</span></span></div>
                    </td>
                  </tr>

              </table>
              <div style="margin-left:72pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="10" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended December 31</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Current:</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;vertical-align:bottom">
                        <div style="margin-left:8.55pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Israel</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">17,633</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">38,248</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,829</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="margin-left:8.55pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Subsidiaries</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,864</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,614</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(131</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </div>
                      </td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">19,497</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">39,862</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,698</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred:</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;vertical-align:bottom">
                        <div style="margin-left:8.55pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Israel</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(149</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">84</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(770</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="margin-left:8.55pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Subsidiaries</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(149</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">84</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(770</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </div>
                      </td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total taxes on income</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">19,348</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">39,946</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,928</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>

                </table>
              </div>
            </div>

          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:49.65pt">&#160;</td>
                <td style="width:18pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">h.</span></span></td>
                <td style="width:auto;vertical-align:top">
                  <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Uncertain tax positions:</span></span></div>
                  <div style="font-weight:bold">&#160;</div>
                  <div style="font-weight:bold">
                    <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">ASC No. 740, Income Taxes, requires significant judgment in determining what constitutes an individual tax position as well as assessing the outcome of each tax position. Changes in judgment as to recognition or measurement of tax positions can materially affect the estimate of the effective tax rate and consequently, affect the operating results of the Company. </span></span><br/><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:normal">&#160;</span></span></span></div>
                  </div>
                </td>
              </tr>

          </table>

            <div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="vertical-align:top;width:49pt">&#160;</td>
                    <td style="vertical-align:top;width:18pt">&#160;</td>
                    <td style="vertical-align:top;width:auto">
                      <div style="font-weight:bold">
                        <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The following table summarizes the activity of the Company&#8217;s unrecognized tax benefits:</span></span></div>
                      </div>
                    </td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:49pt">&#160;</td>
                    <td style="vertical-align:top;width:18pt">&#160;</td>
                    <td style="vertical-align:top;width:auto">&#160;</td>
                  </tr>

              </table>
              <div style="margin-left:72pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year&#160;ended&#160;December&#160;31</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="margin-left:16.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at January 1</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">303</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,831</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:76%;vertical-align:bottom">
                        <div style="margin-left:16.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Decrease in uncertain tax positions for the previous years</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4,831</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="margin-left:16.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Increase in uncertain tax positions for the current year, net</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,096</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">303</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:76%;padding-bottom:4px;vertical-align:bottom">
                        <div style="margin-left:16.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at December 31</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,399</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">303</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>

                </table>
              </div>
            </div>

          <div style="line-height:1.25">&#160;</div>
          <div style="line-height:1.25">
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:49.65pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top;font-weight:bold">&#160;</td>
                  <td style="width:auto;vertical-align:top">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company does not expect uncertain tax positions to change significantly over the next 12 months.</span></span></div>
                  </td>
                </tr>

            </table>
          </div>
        </div>
      </div>
    <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//740/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-21<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482526/740-270-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-17<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140222167183536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ENTITY-WIDE DISCLOSURE<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">ENTITY-WIDE DISCLOSURE</a></td>
<td class="text">
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 14 - ENTITY-WIDE DISCLOSURE:</span></span></strong></p>
    <div>
      <div>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:49.65pt">&#160;</td>
              <td style="width:18pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">a.</span></span></td>
              <td style="width:auto;vertical-align:top">
                <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenue</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>

          <div>
            <div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:67pt">&#160;</td>
                    <td style="vertical-align:top;width:21pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1)</span></span></td>
                    <td style="vertical-align:top;width:auto">
                      <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenues by geographic area were as follows:</span></span></div>
                    </td>
                  </tr>

              </table>
              <p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left">&#160;</p>
              <div style="margin-left:93pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="10" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended December 31</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">United States</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">307,818</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">298,612</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">237,263</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:64%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Europe</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">62,532</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">49,274</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">36,588</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">121,698</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">106,385</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">83,714</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:64%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">492,048</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">*</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">454,271</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">*</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">357,565</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">*</span></span></div>
                        </div>
                      </td>
                    </tr>

                </table>
              </div>
            </div>
            <div style="line-height:1.25">&#160;</div>
            <div style="line-height:1.25">
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:71pt">&#160;</td>
                    <td style="vertical-align:top;width:18pt">&#160;</td>
                    <td style="vertical-align:top;width:auto">
                      <div>
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">*Revenues are attributed to geographic areas based on the location of customer. No single customer accounted for 10% or more of Company&#8217;s total revenues, or Company&#8217;s net accounts receivable, in any fiscal year presented.</span></span></div>
                      </div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>

        <p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left">&#160;</p>

          <div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:67pt">&#160;</td>
                  <td style="vertical-align:top;width:21pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2)</span></span></td>
                  <td style="vertical-align:top;width:auto">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenues based on products' category were as follows:</span></span></div>
                  </td>
                </tr>

            </table>
            <p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left">&#160;</p>
            <div style="margin-left:93pt">
              <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="10" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended December 31</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:middle;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Capital Equipment revenues</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">412,089</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">394,212</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">319,239</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:middle;width:64%;padding-bottom:2px;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Consumables and service revenues</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">79,959</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">60,059</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">38,326</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:middle;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">492,048</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">454,271</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">357,565</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>

              </table>
            </div>
          </div>

        <div style="line-height:1.25">&#160;</div>

          <div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:67pt">&#160;</td>
                  <td style="vertical-align:top;width:21pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3)</span></span></td>
                  <td style="vertical-align:top;width:auto">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenues based on products' technology were as follows:</span></span></div>
                  </td>
                </tr>

            </table>
            <p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left">&#160;</p>
            <div style="margin-left:93pt">
              <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="10" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended December 31</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="10" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:middle;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Minimal-Invasive</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">83</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">81</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">72</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:middle;width:64%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Hands-Free</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">20</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:middle;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-Invasive</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:middle;width:64%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>

              </table>
            </div>
          </div>

        <div style="line-height:1.25">&#160;</div>

          <div>
            <div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:67pt">&#160;</td>
                    <td style="vertical-align:top;width:21pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4)</span></span></td>
                    <td style="vertical-align:top;width:auto">
                      <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The changes in contract liabilities are as follows:</span></span></div>
                    </td>
                  </tr>

              </table>
              <p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left">&#160;</p>
              <div style="margin-left:93pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td rowspan="1" style="vertical-align:middle;width:76%;background-color:rgb(255, 255, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="6" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year&#160;ended&#160;December&#160;31</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td rowspan="1" style="vertical-align:middle;width:76%;background-color:rgb(255, 255, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" rowspan="1" style="text-align:center;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255);font-weight:bold;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></td>
                      <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-15.95pt;margin-left:15.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of January 1</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">17,757</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">16,556</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:76%;vertical-align:bottom">
                        <div style="text-indent:-15.95pt;margin-left:15.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Increases due to issuance of new contracts, excluding amounts recognized as revenue during the period</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,498</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">14,987</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-15.95pt;margin-left:15.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenue recognized that was included in the contract liability balance at the beginning of the period</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(15,566</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(13,786</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </div>
                      </td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:76%;padding-bottom:4px;vertical-align:bottom">
                        <div style="text-indent:-15.95pt;margin-left:15.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">14,689</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">17,757</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-15.95pt;margin-left:15.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Contract liability presented in non-current liabilities (1)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,766</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,959</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:76%;padding-bottom:4px;vertical-align:bottom">
                        <div style="text-indent:-15.95pt;margin-left:15.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Contract liability presented in current liabilities</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10,923</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13,798</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>

                </table>
              </div>
            </div>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:67pt">&#160;</td>
                  <td style="vertical-align:top;width:21pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1)</span></span></td>
                  <td style="vertical-align:top;width:auto">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of December 31, 2023, non-current deferred revenue is estimated to be recognized as following: 83% in year 2025 and the rest in year 2026-2027.</span></span></div>
                  </td>
                </tr>

            </table>
          </div>

        <div style="line-height:1.25">&#160;</div>
        <div></div>

          <div>
            <div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:49.65pt">&#160;</td>
                    <td style="width:18pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">b.</span></span></td>
                    <td style="width:auto;vertical-align:top">
                      <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Long-Lived Assets</span></span></div>
                    </td>
                  </tr>

              </table>
              <p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left">&#160;</p>
              <div style="margin-left:72pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="6" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-15.95pt;margin-left:15.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Israel</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,704</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,263</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:76%;vertical-align:bottom">
                        <div style="text-indent:-15.95pt;margin-left:15.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">United States</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,789</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,097</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-15.95pt;margin-left:15.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,587</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,011</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:76%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,080</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7,371</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-15.95pt;margin-left:15.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other long-term assets*</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,370</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,573</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:76%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">16,450</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11,944</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>

                </table>
              </div>
            </div>
            <div style="line-height:1.25">&#160;</div>
            <div style="line-height:1.25">
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:49.65pt">&#160;</td>
                    <td style="width:18pt;vertical-align:top;font-weight:bold">&#160;</td>
                    <td style="width:auto;vertical-align:top">
                      <div style="font-weight:normal">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">*Consists of non-current accounts receivable, net and other investments</span></span></div>
                      </div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>

      </div>
    </div>
  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//280/tableOfContent<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-26<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 34<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-34<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-21<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-21<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140222167293472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">RELATED PARTIES</a></td>
<td class="text">
      <div>
        <div>
          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">NOTE 15 - RELATED PARTIES</span>:</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:49.5pt">&#160;</td>
                <td style="width:18pt;font-weight:bold;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">a.</span></span></td>
                <td style="width:auto;vertical-align:top">
                  <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company receives and provides certain services from and to Home Skinovations Ltd., a related party as part of a service agreement between them. The services include an office sublease in Israel, use of certain computer hardware and switchboard infrastructure, certain software licenses, joint purchases of employee&#8217;s welfare products and services from third parties and limited manpower services. The Chairman of the Board and Chief Executive Officer of the Company is also a substantial shareholder and board member of Home Skinovations Ltd. and one of the Company&#8217;s directors, serves on the board of directors of Home Skinovations Ltd. The Company recorded expenses related to services received and provided from Home Skinovations Ltd. of $99, $332 and $239 for the years ended December 31, 2023, 2022 and 2021, respectively.</span></span></div>
                  <div>&#160;</div>
                  <div>
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In addition, the balance of the <span style="-sec-ix-hidden:Fxbrl_20240208192647081"><span style="-sec-ix-hidden:Fxbrl_20240208181011420">accounts payable</span></span> as of December 31, 2023, 2022 was $0.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In February 2022 the Company have entered into an Asset Purchase Agreement with Home Skinovations, whereby Home Skinovations Ltd. sold and assigned to the Company all of Home Skinovations Ltd.&#8217;s right, title and interest in and to Home Skinovations Ltd.&#8217;s Spa segment assets (including molds, tooling, inventory and trademarks) and further granted the Company an exclusive license to certain IP rights of Home Skinovations Ltd., all the foregoing in consideration for an aggregate amount of $497.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company&#8217;s subsidiary in Canada receives and provides certain services from and to a subsidiary of Home Skinovations Ltd. in Canada as part of a service agreement between them. The services include mobile phone services, an office sublease, use of certain computer hardware and switchboard infrastructure, certain software licenses, joint purchases of employee&#8217;s welfare products and services from third parties and limited manpower services. In relation to these services received and provided, the Company recorded expenses (income) in the amount of $(30), $123 and $433 for the years ended December 31, 2023, 2022 and 2021, respectively. In addition, the balance of the <span style="-sec-ix-hidden:Fxbrl_20240208192657231"><span style="-sec-ix-hidden:Fxbrl_20240208190452680">accounts receivable</span></span> as of December 31, 2023, 2022 was $0.</span></span></div>
                  </div>
                </td>
              </tr>

          </table>&#160;<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:67.65pt">&#160;</td>
                <td style="width:18pt;vertical-align:top;font-weight:normal">1)</td>
                <td style="width:auto;vertical-align:top">
                  <div>
                    <div style="line-height:1.25">The Company&#8217;s subsidiaries in North America received marketing services from SpaMedica International SRL, which was amalgamated with an affiliate company into the Company&#8217;s major shareholder BoomerangFX International SRL during 2021. Dr. Stephan Mulholland is a beneficiary owner of 100% of the Company's major shareholder BoomerangFX. The Company recorded expenses related to those services in the amount of $172 for the year ended December 31, 2021. Starting from 2022 calendar year, Dr. Stephen Mulholland provides the Company and its subsidiaries certain marketing services as an independent contractor. The Company recorded expenses related to those services in the amount of $636, $723 for the years ended December 31, 2023 and 2022, respectively.</div>
                  </div>
                  <div>&#160;</div>
                  <div>
                    <div style="line-height:1.25">During 2023 Dr. Stephen Mulholland ceased to be a related party.</div>
                  </div>
                </td>
              </tr>

          </table>
        </div>&#160;<div></div>
        <div>
          <div>
            <div style="line-height:1.25">
              <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;color:rgb(0, 0, 0)">

                  <tr>
                    <td style="width:67.65pt">&#160;</td>
                    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span>2)</span></span></td>
                    <td style="width:auto;vertical-align:top">
                      <div>
                        <div style="line-height:1.25"><span style="font-size:10pt"><span>The Company receives certain investment portfolio management services from Himalaya Family Office Consulting Ltd., with respect to part of its investment portfolio. The Chairman of the Board and Chief Executive Officer of the Company, is a minor shareholder and a board member of Himalaya Family Office Consulting Ltd. In relation to these services, the Company recorded expenses in the amount of $193, $100 and $90 for the years ended December 31, 2023, 2022 and 2021, respectively.</span></span></div>
                      </div>
                      <div>&#160;</div>
                      <div>
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span>In addition, the balance of the <span style="-sec-ix-hidden:Fxbrl_20240208192704302"><span style="-sec-ix-hidden:Fxbrl_20240208173003815">accounts payable</span></span> as of December 31, 2023, 2022, was $86, $28, respectively.</span></span></div>
                        </div>
                      </div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
      </div>
    <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//850/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-6<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140222160609472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of presentation</a></td>
<td class="text">
            <div>
              <div style="line-height:1.25">
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:48.4pt">&#160;</td>
                      <td style="width:22.5pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">a.</span></span></td>
                      <td style="width:auto;vertical-align:top">
                        <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Basis of presentation</span></span></span></div>
                        <div style="font-weight:bold">&#160;</div>
                        <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">
                          <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company&#8217;s consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (&#8220;U.S. GAAP&#8221;).</span></span></div>
                        </div>
                      </td>
                    </tr>

                </table>
              </div>
            </div>
          <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of estimates</a></td>
<td class="text">
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:48.4pt">&#160;</td>
                  <td style="width:22.5pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">b.</span></span></td>
                  <td style="width:auto;vertical-align:top">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Use of estimates</span></span></div>
                    <div style="font-weight:bold">&#160;</div>
                    <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">
                      <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</span></span></div>
                    </div>
                  </td>
                </tr>

            </table>
          <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Functional currency</a></td>
<td class="text">
            <div>
              <div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:48.4pt">&#160;</td>
                      <td style="width:22.5pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">c.</span></span></td>
                      <td style="width:auto;vertical-align:top">
                        <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Functional currency</span></span></div>
                        <div style="font-weight:bold">&#160;</div>
                        <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:normal">The U.S. dollar (&#8220;U.S. dollar&#8221; or &#8220;$&#8221;) is the currency of the primary economic environment in which the operations of the Company is conducted. Substantial revenues and a substantial portion of the operational costs are denominated in U.S. dollars. Accordingly, the functional currency of the Company is the U.S. dollar (&#8220;primary currency&#8221;).</span></span></span></div>
                        </div>
                      </td>
                    </tr>
                    <tr>
                      <td style="width:48.4pt">&#160;</td>
                      <td style="width:22.5pt;vertical-align:top;font-weight:bold">&#160;</td>
                      <td style="width:auto;vertical-align:top">&#160;</td>
                    </tr>

                </table>
              </div>
              <div></div>
              <div style="line-height:1.25">
                <div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%">

                      <tr style="vertical-align:top">
                        <td style="text-align:right;vertical-align:top;width:70pt">
                          <div style="text-align:left;margin-left:49.65pt;line-height:1.25">&#160;</div>
                        </td>
                        <td style="text-align:left;vertical-align:top;width:auto">
                          <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Transactions and balances originally denominated in U.S. dollars are presented at their original amounts. Balances in non-U.S. dollar currencies are translated into U.S. dollars using historical and current exchange rates for non-monetary and monetary balances, respectively. For non-U.S. dollar transactions and other items in the statements of income (indicated below), the following exchange rates are used: (i) for transactions &#8211; exchange rates at transaction dates or average exchange rates; and (ii) for other items (derived from non-monetary balance sheet items such as depreciation and amortization) &#8211; historical exchange rates. Currency transaction gains and losses are presented in finance income (expenses), as appropriate.</span></span></div>
                          <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
                          <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The functional currency of each of the Subsidiaries is the U.S. dollar.</span></span></div>
                          </div>
                        </td>
                      </tr>

                  </table>
                </div>
              </div>
            </div>
          <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of consolidation and presentation</a></td>
<td class="text">
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:48.4pt">&#160;</td>
                  <td style="width:22.5pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">d.</span></span></td>
                  <td style="width:auto;vertical-align:top">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Principles of consolidation and presentation</span></span></div>
                    <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">&#160;<div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The consolidated financial statements include the accounts of the Company and its Subsidiaries. Intercompany transactions and balances are eliminated in consolidation.</span></span></div>
                    </div>
                  </td>
                </tr>

            </table>
          <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and cash equivalents</a></td>
<td class="text">
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:48.4pt">&#160;</td>
                  <td style="width:22.5pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">e.</span></span></td>
                  <td style="width:auto;vertical-align:top">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash and cash equivalents</span></span></div>
                    <div style="font-weight:bold">&#160;</div>
                    <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">
                      <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company considers cash equivalents to be all short-term, highly liquid investments, which include money market instruments, that are not restricted as to withdrawal or use, and short-term bank deposits with original maturities of three months or less from the date of purchase that are not restricted as to withdrawal or use and are readily convertible to known amounts of cash.</span></span></div>
                    </div>
                  </td>
                </tr>

            </table>
          <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_ShortTermBankDepositsPolicyTextBlock', window );">Short-term bank deposits</a></td>
<td class="text">
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:48.4pt">&#160;</td>
                  <td style="width:22.5pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">f.</span></span></td>
                  <td style="width:auto;vertical-align:top">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Short-term bank deposits</span></span></div>
                    <div style="font-weight:bold">&#160;</div>
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:normal">Bank deposits with maturities of more than three months but less than one year are included in short-term deposits. Such short-term deposits bear interest at an average annual rate of approximately 4.10%-7.01% in 2023 and 0.50%-5.73% in 2022.</span></span></span></div>
                  </td>
                </tr>

            </table>
          <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesPolicy', window );">Marketable securities</a></td>
<td class="text">
            <div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:48.4pt">&#160;</td>
                    <td style="width:22.5pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">g.</span></span></td>
                    <td style="width:auto;vertical-align:top">
                      <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Marketable securities</span></span></div>
                      <div style="font-weight:bold">&#160;</div>
                      <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">
                        <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">AFS Securities</span></span></span></div>
                        <div style="line-height:1.25;font-weight:normal">&#160;</div>
                        <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Marketable securities consist of government bonds, municipal bonds, and corporate debt securities (together &#8220;Debt Securities&#8221;), and certificates of deposit measured at fair value in each reporting period. The fair value of quoted securities is based on current market value.</span></span></div>
                        <div style="line-height:1.25;font-weight:normal">&#160;</div>
                        <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Debt Securities and certificates of deposit are classified as available-for-sale (together &#8220;AFS Securities&#8221;) under current assets in the consolidated balance sheet as they represent the investment of funds available for the Company&#8217;s current operations. Changes in fair value, excluding credit losses and impairments, net of taxes (if applicable), are reflected in other comprehensive income or loss. Realized gains and losses on sales of Debt Securities and certificates of deposit as well as premium or discount amortization are included in the consolidated statements of income as finance income (expenses), net. Fair value is calculated based on publicly available market information. When the estimated fair value of a Debt Security is below its amortized cost, the Debt Security is assessed using the Current Expected Credit Losses model (in accordance with ASU 2016-13) in order to determine what portion of that difference, if any, is caused by expected credit losses. The amortized cost of the Debt Security will be reduced to its fair value if it is more likely than not that the Company is required to sell the impaired security before recovery of its amortized cost basis, or it has the intention to sell the security. If neither of these conditions are met, the Company determines whether the impairment is due to credit losses by comparing the present value of the expected cash flows of the security with its amortized cost basis. The amount of impairment recognized is limited to the excess of the amortized cost over the fair value of the security. An allowance for credit losses for the excess of amortized cost over the expected cash flows is recognized in finance income (expenses), net on the consolidated statements income. </span></span></div>
                      </div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <div style="line-height:1.25">
                <div></div>
              </div>
              <div style="line-height:1.25">
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%">

                    <tr style="vertical-align:top">
                      <td style="text-align:right;vertical-align:top;width:70pt">
                        <div style="text-align:left;margin-left:49.65pt;line-height:1.25">&#160;</div>
                      </td>
                      <td style="text-align:left;vertical-align:top;width:auto">
                        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company classifies investments that are readily convertible to known amounts of cash and have stated maturities of three months or less from the date of purchase as cash equivalents and those with stated maturities of greater than three months as marketable securities.</span></span></div>
                        <div style="line-height:1.25">&#160;</div>
                        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company determines the appropriate classification of its investments in marketable securities at the time of purchase.</span></span></div>
                      </td>
                    </tr>

                </table>
              </div>
            </div>
          <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">Other Investments</a></td>
<td class="text">
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:48.4pt">&#160;</td>
                  <td style="width:22.5pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">h.</span></span></td>
                  <td style="width:auto;vertical-align:top">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other Investments</span></span></div>
                    <div style="font-weight:bold">&#160;</div>
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:normal">The Company applies the measurement alternative upon the adoption of ASU 2016-01, and elected to record equity investments without readily determinable fair values at cost for other investments, less impairment, adjusted for subsequent observable price changes. In this measurement alternative method, changes in the carrying value of the equity investments are reflected in current earnings. Changes in the carrying value of the equity investment are required to be made whenever there are observable price changes in orderly transactions for the identical or similar investment of the same issuer.</span></span></span></div>
                  </td>
                </tr>

            </table>
          <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventories</a></td>
<td class="text">
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:48.4pt">&#160;</td>
                    <td style="width:22.5pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">i.</span></span></td>
                    <td style="width:auto;vertical-align:top">
                      <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Inventories</span></span></span></div>
                        <div style="line-height:1.25">&#160;</div>
                        <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Inventories include raw materials and finished products and are valued at the lower of cost or net realizable value. During the year ended December 31, 2022, the Company changed the cost determination method of raw materials from first in, first out (&#8220;FIFO&#8221;) method to a &#8220;moving average&#8221; method. This voluntary change in accounting method was implemented and considered preferable because the Company's ERP system supports automatic calculation of inventory according to the &#8220;moving average&#8221; method and it allows consistency of the cost determination method among the different components of inventory. The change in method was immaterial to all periods presented. The Company regularly evaluates its ability to realize the value of inventory based on a combination of factors including the following: historical usage rates, forecasted sales or usage, estimated current and future market values and new product introductions.</span></span></div>
                      </div>
                    </td>
                  </tr>

              </table>
            <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text">
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:48.4pt">&#160;</td>
                  <td style="width:22.5pt;vertical-align:top;font-weight:bold">&#160;</td>
                  <td style="width:auto;vertical-align:top">&#160;</td>
                </tr>
                <tr>
                  <td style="width:48.4pt">&#160;</td>
                  <td style="width:22.5pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">j.</span></span></td>
                  <td style="width:auto;vertical-align:top">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Leases</span></span></div>
                    <div style="font-weight:bold">&#160;</div>
                    <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">
                      <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company determines if an arrangement is a lease at inception. Balances related to operating leases are included in operating lease right-of-use (&#8220;ROU&#8221;) assets, other current liabilities, and operating lease liabilities in the consolidated balance sheets.</span></span></div>
                      <div style="line-height:1.25;font-weight:normal">&#160;</div>
                      <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company also elected to combine lease and non-lease components and to keep leases with an initial term of 12 months or less off the balance sheet and recognize the associated lease payments in the consolidated statements of income on a straight-line basis over the lease term.</span></span></div>
                      <div style="line-height:1.25;font-weight:normal">&#160;</div>
                      <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">ROU assets represent the Company&#8217;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#8217;s obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized as of the commencement date based on the present value of lease payments over the lease term. The Company&#8217;s lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. The discount rate for the lease is the rate implicit in the lease unless that rate cannot be readily determined. As the Company&#8217;s leases do not provide an implicit rate, the Company&#8217;s uses its estimated incremental borrowing rate based on the information available at the commencement date in determining the present value of lease payments. Lease expense for lease payments is recognized on a straight-line basis over the lease term (see also note 9).</span></span></div>
                    </div>
                  </td>
                </tr>
                <tr>
                  <td style="width:48.4pt">&#160;</td>
                  <td style="width:22.5pt;vertical-align:top;font-weight:bold">&#160;</td>
                  <td style="width:auto;vertical-align:top">&#160;</td>
                </tr>

            </table>
          <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and equipment</a></td>
<td class="text">
            <div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:48.4pt">&#160;</td>
                    <td style="width:22.5pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">k.</span></span></td>
                    <td style="width:auto;vertical-align:top">
                      <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Property and equipment</span></span></div>
                      <div style="font-weight:bold">&#160;</div>
                    </td>
                  </tr>

              </table>

                <div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                      <tr>
                        <td style="vertical-align:top;width:70pt">&#160;</td>
                        <td style="vertical-align:top;width:auto">
                          <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:normal">Property and equipment is stated at cost, net of accumulated depreciation and amortization. Depreciation is calculated on a straight-line basis over the following estimated useful lives:</span></span></span></div>
                          </div>
                        </td>
                      </tr>

                  </table>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="margin-left:81pt">
                    <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                        <tr>
                          <td style="vertical-align:top;background-color:rgb(204, 238, 255)">
                            <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Computers</span></span></div>
                          </td>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)">
                            <div style="text-align:center;margin-right:20.45pt;margin-left:13.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3 &#8211; 4 years</span></span></div>
                          </td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom">
                            <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Molds</span></span></div>
                          </td>
                          <td style="vertical-align:bottom">
                            <div style="text-align:center;margin-right:20.45pt;margin-left:13.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4 &#8211; 10 years</span></span></div>
                          </td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)">
                            <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Equipment and furniture</span></span></div>
                          </td>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)">
                            <div style="text-align:center;margin-right:20.45pt;margin-left:13.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10 &#8211; 17 years</span></span></div>
                          </td>
                        </tr>

                    </table>
                  </div>
                </div>

              <div style="line-height:1.25">&#160;</div>
              <div style="line-height:1.25">
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:48.4pt">&#160;</td>
                      <td style="width:22.5pt;vertical-align:top;font-weight:bold">&#160;</td>
                      <td style="width:auto;vertical-align:top;font-weight:normal">
                        <div style="font-family:'Times New Roman',Times,serif">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Leasehold improvements are depreciated using the straight-line method over the shorter of the term of the lease or the estimated useful lives of the improvements.</span></span></div>
                        </div>
                      </td>
                    </tr>

                </table>
              </div>
            </div>
          <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment of long-lived assets</a></td>
<td class="text">
            <table cellpadding="0" cellspacing="0" style="color:#000000;font-family:'Times New Roman',Times,serif;font-size:10pt;text-align:left;width:100%">

                <tr>
                  <td style="width:48.4pt">&#160;</td>
                  <td style="width:22.5pt;vertical-align:top;font-weight:bold">&#160;</td>
                  <td style="width:auto;vertical-align:top">&#160;</td>
                </tr>
                <tr>
                  <td style="width:48.4pt">&#160;</td>
                  <td style="width:22.5pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">l.</span></span></td>
                  <td style="width:auto;vertical-align:top">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Impairment of long-lived assets</span></span></div>
                    <div style="font-weight:bold">&#160;</div>
                    <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:normal">The Company tests long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may no longer be recoverable. Recoverability of long-lived assets is measured by comparing the carrying amount of the long-lived asset to the estimated undiscounted future cash flows expected to be generated by the asset. If the sum of the expected undiscounted cash flow is less than the carrying amount of the asset, the Company recognizes an impairment loss, which is the excess of the carrying amount over the fair value of the asset, using the expected future discounted cash flows.</span></span></span></div>
                      <div style="line-height:1.25">&#160;</div>
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:normal">During the years ended December 31, 2023, 2022 and 2021, the Company did not recognize an impairment loss on its long-lived assets.</span></span></span></div>
                    </div>
                  </td>
                </tr>

            </table>
          <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock', window );">Legal and other contingencies</a></td>
<td class="text">
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:48.4pt">&#160;</td>
                  <td style="width:22.5pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">m.</span></span></td>
                  <td style="width:auto;vertical-align:top">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Legal and other contingencies</span></span></div>
                    <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">&#160;<div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Certain conditions may exist as of the date of the consolidated financial statements, which may result in a loss to the Company but which will only be resolved when one or more future events occur or fail to occur. The Company&#8217;s management assesses such contingent liabilities, if any, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the Company or unasserted claims that may result in such proceedings, the Company&#8217;s management evaluates the perceived merits of any legal proceedings or unasserted claims as well as the perceived merits of the amount of relief sought or expected to be sought.</span></span></div>
                      <div style="line-height:1.25;font-weight:normal">&#160;</div>
                      <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Management applies the guidance in ASC 450-20, &#8220;Loss Contingencies&#8221; when assessing losses resulting from contingencies. If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be reasonable estimated, then the estimated liability is recorded as accrued expenses in the Company&#8217;s consolidated financial statements.</span></span></div>
                      <div style="margin-left:72pt;line-height:1.25;font-weight:normal">&#160;</div>
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:normal">Legal costs incurred in connection with loss contingencies are expensed as incurred.</span></span></span></div>
                    </div>
                  </td>
                </tr>

            </table>
          <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income taxes</a></td>
<td class="text">
            <div>
              <div style="line-height:1.25">
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:48.4pt">&#160;</td>
                      <td style="width:22.5pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">n.</span></span></td>
                      <td style="width:auto;vertical-align:top">
                        <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Income taxes:</span></span></div>
                      </td>
                    </tr>
                    <tr>
                      <td style="width:48.4pt">&#160;</td>
                      <td style="width:22.5pt;vertical-align:top;font-weight:bold">&#160;</td>
                      <td style="width:auto;vertical-align:top">&#160;</td>
                    </tr>

                </table>
              </div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:72pt">&#160;</td>
                    <td style="width:26.7pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1)</span></span></td>
                    <td style="width:auto;vertical-align:top">
                      <div style="font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company accounts for income taxes in accordance with ASC 740, &#8220;Income Taxes&#8221; (&#8220;ASC 740&#8221;). ASC 740 prescribes the use of the liability method whereby deferred tax asset and liability account balances are determined based on differences between the financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company provides a valuation allowance, if necessary, to reduce deferred tax assets to their estimated realizable value if it is more likely than not that a portion or all of the deferred tax assets will not be realized, based on the weight of available positive and negative evidence. Deferred tax liabilities and assets are classified as non-current in accordance with ASU 2015&#8209;17.</span></span></div>
                    </td>
                  </tr>
                  <tr>
                    <td style="width:72pt">&#160;</td>
                    <td style="width:26.7pt;vertical-align:top">&#160;</td>
                    <td style="width:auto;vertical-align:top">&#160;</td>
                  </tr>

              </table>
              <div></div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:72pt">&#160;</td>
                    <td style="width:26.7pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2)</span></span></td>
                    <td style="width:auto;vertical-align:top">
                      <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company may incur an additional tax liability in the event of an inter-company dividend distribution from Subsidiaries outside of Israel; no additional deferred income tax assets have been provided, since the Company does not expect to distribute inter-company dividends in the foreseeable future that may result in additional tax liability.</span></span></div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:72pt">&#160;</td>
                    <td style="width:26.7pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3)</span></span></td>
                    <td style="width:auto;vertical-align:top">
                      <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Taxes that would apply in the event of disposal of investments in Subsidiaries have not been taken into account in computing the deferred income tax assets, as it is the Company&#8217;s intent and ability to hold these investments.</span></span></div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:72pt">&#160;</td>
                    <td style="width:26.7pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4)</span></span></td>
                    <td style="width:auto;vertical-align:top">
                      <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company accounts for uncertain tax positions in accordance with ASC 740-10. ASC 740&#8209;10 contains a two-step approach to recognizing and measuring uncertain tax positions. The first step is to evaluate the tax position taken or expected to be taken in a tax return by determining if the weight of available evidence indicates that it is more likely than not that, on an evaluation of the technical merits, the tax position will be sustained on audit, including resolution of any related appeals or litigation processes. The second step is to measure the tax benefit of the largest amount that is more than 50% (cumulative probability) likely to be realized upon ultimate settlement.</span></span></div>
                    </td>
                  </tr>

              </table>
            </div>
          <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdvertisingCostsPolicyTextBlock', window );">Advertising expenses</a></td>
<td class="text">
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:48.4pt">&#160;</td>
                  <td style="width:22.5pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">o.</span></span></td>
                  <td style="width:auto;vertical-align:top">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Advertising expenses</span></span></div>
                    <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">&#160;<div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Advertising expenses are charged to sales and marketing on the consolidated statement of income as incurred. Advertising expenses for the years ended December 31, 2023, 2022 and 2021 amounted to $15 million, $10 million, and $4 million, respectively.</span></span></div>
                    </div>
                  </td>
                </tr>

            </table>
          <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Share-based compensation</a></td>
<td class="text">
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:48.4pt">&#160;</td>
                  <td style="width:22.5pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">p.</span></span></td>
                  <td style="width:auto;vertical-align:top">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based compensation</span></span></div>
                    <div style="font-weight:bold">&#160;</div>
                    <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">
                      <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company grants share options and restricted share units (&#8220;RSU&#8221;) (together &#8220;Share-Based Compensation&#8221;) to its employees, officers, directors and non-employees in consideration for services rendered and for acquiring goods. See note 12(a)(2) for details on outstanding share capital.</span></span></div>
                      <div style="line-height:1.25;font-weight:normal">&#160;</div>
                      <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company accounts for Share-Based Compensation awards classified as equity awards using the grant-date fair value method. The fair value at grant-date of the issued equity award is recognized as an expense on a straight-line basis over the requisite service period. The fair value of each share option granted is estimated using the Binomial Model, and for each RSU granted is based on the Company&#8217;s share price at the close of the last trading day prior to the date of the grant. The Company estimates forfeitures based on historical experience and anticipated future conditions at the time of grant and revises such estimates in subsequent periods if actual forfeitures differ from those estimates.</span></span></div>
                      <div style="line-height:1.25;font-weight:normal">&#160;</div>
                      <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company elected to recognize Share-Based Compensation cost for awards with only service conditions that have a graded vesting schedule using the straight-line method based on the multiple-option award approach. Performance-based Share-Based Compensation expenses are calculated based on the valuation at the grant date, and recognized based on the probability of achieving those targets. The Company assess at what scale can the performance targets be reached at each balance sheet date, and expenses are recognized accordingly.</span></span></div>
                      <div style="line-height:1.25;font-weight:normal">&#160;</div>
                      <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company issues new shares upon option exercise or RSU vesting.</span></span></div>
                    </div>
                  </td>
                </tr>

            </table>
          <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue recognition</a></td>
<td class="text">
            <div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="vertical-align:top;font-weight:bold;width:48pt">&#160;</td>
                    <td style="vertical-align:top;font-weight:bold;width:22pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">q.</span></span></td>
                    <td style="vertical-align:top;width:auto">
                      <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenue recognition</span></span></div>
                      <div style="font-weight:bold">&#160;</div>
                      <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">
                        <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company applies ASC 606, &#8220;Revenue from Contracts with Customers&#8221; (&#8220;ASC 606&#8221;). Under ASC 606, an entity recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration that the entity expects to receive in exchange for those goods or services. To determine revenue recognition for arrangements that an entity determines are within the scope of ASC 606, the entity performs the following five steps:</span></span></div>
                      </div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:72pt">&#160;</td>
                    <td style="width:38.05pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(i)</span></span></td>
                    <td style="width:auto;vertical-align:top">
                      <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Identify the contract(s) with a customer;</span></span></div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:72pt">&#160;</td>
                    <td style="width:38.05pt;vertical-align:top;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(ii)</span></span></td>
                    <td style="width:auto;vertical-align:top">
                      <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Identify the performance obligations in the contract. The Company determined that its arrangements are generally comprised of the following elements that are recognized as separate performance obligations: products, consumables and extended warranties;</span></span></div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:72pt">&#160;</td>
                    <td style="width:38.05pt;vertical-align:top;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(iii)</span></span></td>
                    <td style="width:auto;vertical-align:top">
                      <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Determine the transaction price;</span></span></div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:72pt">&#160;</td>
                    <td style="width:38.05pt;vertical-align:top;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(iv)</span></span></td>
                    <td style="width:auto;vertical-align:top">
                      <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Allocate the transaction price to the performance obligations in the contract;</span></span></div>
                      <div style="font-family:'Times New Roman',Times,serif">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company estimates the standalone selling prices of the services to be provided based on actual sales transactions of service contract purchased on a standalone basis and uses the residual approach to estimate the selling price of the products; and</span></span></div>
                      </div>
                    </td>
                  </tr>

              </table>
              <div style="margin-left:106.9pt;line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:72pt">&#160;</td>
                    <td style="width:38.05pt;vertical-align:top;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(v)</span></span></td>
                    <td style="width:auto;vertical-align:top">
                      <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Recognize revenue when (or as) the performance obligation is satisfied. </span></span></div>
                      <div>&#160;</div>
                      <div style="font-family:'Times New Roman',Times,serif">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company only applies the five-step model to contracts when it is probable that the entity will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer, after considering any price concession expected to be provided to the customer, when applicable. At contract inception, the Company assesses the goods or services promised within each contract and determines those that are performance obligations and assesses whether each promised good or service is distinct. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied. </span></span></div>
                        <div style="line-height:1.25">&#160;</div>
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company uses the following practical expedients that are permitted under the rules:</span></span></div>
                        </div>
                      </div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:111pt">&#160;</td>
                    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td>
                    <td style="width:auto;vertical-align:top">
                      <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company recognizes the incremental costs of obtaining contracts as an expense when incurred if the amortization period of the assets that the Company otherwise would have recognized is one year or less. These costs are included in sales and marketing expenses.</span></span></div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:111pt">&#160;</td>
                    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td>
                    <td style="width:auto;vertical-align:top">
                      <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company does not disclose the value of unsatisfied performance obligations for contracts with an original expected length of one year or less.</span></span></div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <div style="line-height:1.25">
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="vertical-align:top;font-weight:bold;width:72pt">&#160;</td>
                      <td style="vertical-align:top;width:auto">
                        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The following is a description of the principal activities from which the Company generates its revenue.</span></span></div>
                        <div style="line-height:1.25">&#160;</div>
                        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Product Revenue, Net</span></span></div>
                        <div style="line-height:1.25">&#160;</div>
                        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenues from product sales are recognized when the customer obtains control over the Company&#8217;s product, typically upon shipment to the customer. Revenues from shipping and handling activities that occur after the customer has obtained control of a good are recognized according to an accounting policy election as a fulfilment cost rather than as an additional promised service. Taxes collected from customers relating to product sales and remitted to governmental authorities are excluded from revenues.</span></span></div>
                      </td>
                    </tr>

                </table>
              </div>
              <p style="margin:0pt">&#160;</p>
              <div></div>
              <div style="line-height:1.25">
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="vertical-align:top;font-weight:bold;width:70pt">&#160;</td>
                      <td style="vertical-align:top;width:auto">
                        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Payment terms and conditions vary by customer. The Company&#8217;s standard terms for end users usually require of payment upon delivery and for distributors require a down payment and payments made within several month from the invoice date. </span></span></div>
                        <div style="line-height:1.25">&#160;</div>
                        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company may enter into installment sales contracts with end users in North America that provide them with long-term (generally up to 60 months) financing for the purchase of the Company&#8217;s products. The interest rate used in these contracts reflects the credit characteristics of the party receiving financing in the contract, as well as any collateral or security provided by the customer. Interest income on these receivables is recognized as finance income and earned over the terms of the contract.</span></span></div>
                        <div style="line-height:1.25">&#160;</div>
                        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Variable consideration includes price concessions related to installment sales contracts. The Company estimates variable consideration using the most likely outcome amount. Amounts included in the transaction price are recognized only when it is probable that a significant reversal of cumulative revenues will not occur.</span></span></div>
                        <div style="line-height:1.25">&#160;</div>
                        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company does not grant a right of return, refund, cancelation or termination. From time to time, the Company participates in its customers&#8217; marketing activities and deducts such amounts from revenue.</span></span></div>
                        <div style="line-height:1.25">&#160;</div>
                        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Service Revenue</span></span></div>
                        <div style="line-height:1.25">&#160;</div>
                        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company also generates revenues from long-term maintenance contracts (&#8220;Extended Warranty&#8221;). Revenue from Extended Warranty is recognized ratably, on a straight-line basis, over the period of the applicable service contract. These maintenance agreements are included in contract liabilities. Revenue from repairs performed in the absence of Extended Warranty is recognized when the related services are performed.</span></span></div>
                        <div style="line-height:1.25">&#160;</div>
                        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company classifies the portion of contract liabilities not expected to be earned in the subsequent 12 months as long-term.</span></span></div>
                      </td>
                    </tr>

                </table>
              </div>
            </div>
          <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy', window );">Allowance for doubtful accounts and financial instruments - credit loss</a></td>
<td class="text">
            <div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="vertical-align:top;font-weight:bold;width:48pt">&#160;</td>
                    <td style="vertical-align:top;width:22pt">
                      <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><strong><span style="font-size:10pt;font-family:Times New Roman, Times, serif">r.</span></strong></p>
                    </td>
                    <td style="vertical-align:top;width:auto">
                      <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Allowance for doubtful accounts and financial instruments &#8211; credit loss</span></span></div>
                      <div style="font-weight:bold">&#160;</div>
                      <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">
                        <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company maintains the allowance for doubtful account resulting from the inability of the Company&#8217;s customers to make required payments.</span></span></div>
                        <div style="line-height:1.25;font-weight:normal">&#160;</div>
                        <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The allowance represents the current estimate of lifetime expected credit losses over the remaining duration of existing accounts receivable. This information includes among other the historic experience, the extent and amount of the account and future expectations.</span></span></div>
                        <div style="line-height:1.25;font-weight:normal">&#160;</div>
                        <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Allowance for credit losses due to the Company&#8217;s accounts receivable amounted to $2,254 and $1,318 as of December 31, 2023 and 2022 respectively. Changes in the allowance for credit losses are recognized in general and administrative expenses. Accounts receivable are written-off against the allowance for credit losses when management deems the accounts are no longer collectible.</span></span></div>
                        <div style="line-height:1.25;font-weight:normal">&#160;</div>
                      </div>
                    </td>
                  </tr>

              </table>

                <div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                      <tr>
                        <td style="vertical-align:top;width:48pt">&#160;</td>
                        <td style="vertical-align:top;width:22pt">&#160;</td>
                        <td style="vertical-align:top;width:auto">
                          <div style="font-family:'Times New Roman',Times,serif">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:normal">The following table sets forth activity in the Company&#8217;s allowance for credit losses for</span> each of the years ended December 31, 2023, 2022 and 2021, respectively:</span></span></div>
                          </div>
                        </td>
                      </tr>

                  </table>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="margin-left:81pt">
                    <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                        <tr>
                          <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:middle;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="text-indent:15.85pt;margin-right:7.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at beginning of year</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,318</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,107</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">672</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:middle;width:64%;vertical-align:bottom">
                            <div style="text-indent:15.85pt;margin-right:7.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Current-period provision</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,020</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">449</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">516</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:middle;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="text-indent:15.85pt;margin-right:7.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Write-offs charged against the</span></span></div>
                            <div style="text-indent:15.85pt;margin-right:7.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">allowance</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(84</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(238</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(81</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                            </div>
                          </td>
                        </tr>
                        <tr>
                          <td style="vertical-align:middle;width:64%;padding-bottom:4px;vertical-align:bottom">
                            <div style="text-indent:15.85pt;margin-right:7.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at end of year</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,254</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,318</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,107</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>

                    </table>
                  </div>
                </div>

            </div>
          <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyPolicy', window );">Warranty reserve</a></td>
<td class="text">
            <div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:48pt">&#160;</td>
                    <td style="vertical-align:top;font-weight:bold;width:22pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">s.</span></span></td>
                    <td style="vertical-align:top;width:auto">
                      <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Warranty reserve</span></span></div>
                      <div style="font-weight:bold">&#160;</div>
                      <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">
                        <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company provides a one-year standard warranty for its products. The Company records a provision for the estimated cost to repair or replace products under warranty at the time of sale. Factors that affect the Company&#8217;s warranty reserve include the number of units sold, historical and anticipated rates of warranty repairs, the cost per repair and shipping cost. The Company periodically assesses the adequacy of its recorded warranty liabilities and adjusts the amounts as necessary.</span></span></div>
                        <div style="line-height:1.25;font-weight:normal">&#160;</div>
                      </div>
                    </td>
                  </tr>

              </table>

                <div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                      <tr>
                        <td style="vertical-align:top;width:48pt">&#160;</td>
                        <td style="vertical-align:top;width:22pt">&#160;</td>
                        <td style="vertical-align:top;width:auto">
                          <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">
                            <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The following table sets forth activity in the Company&#8217;s accrued warranty account for each of the years ended December 31, 2023, 2022 and 2021, respectively:</span></span></div>
                          </div>
                        </td>
                      </tr>

                  </table>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="margin-left:81pt">
                    <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                        <tr>
                          <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:middle;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="text-indent:15.85pt;margin-right:7.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at beginning of year</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,418</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,248</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">705</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:middle;width:64%;vertical-align:bottom">
                            <div style="text-indent:15.85pt;margin-right:7.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cost incurred</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2,304</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2,099</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,453</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                        </tr>
                        <tr>
                          <td style="vertical-align:middle;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="text-indent:15.85pt;margin-right:7.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Expense recognized</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,362</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,269</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,996</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:middle;width:64%;padding-bottom:4px;vertical-align:bottom">
                            <div style="text-indent:15.85pt;margin-right:7.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at end of year</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,476</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,418</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,248</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>

                    </table>
                  </div>
                </div>

            </div>
          <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfSalesPolicyTextBlock', window );">Cost of revenues</a></td>
<td class="text">
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:48.4pt">&#160;</td>
                  <td style="width:22.5pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">t.</span></span></td>
                  <td style="width:auto;vertical-align:top">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cost of revenues</span></span></div>
                    <div style="font-weight:bold">&#160;</div>
                    <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">
                      <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cost of revenue consists of products purchased from turnkey sub-contractors which are responsible for the production of most of the Company&#8217;s products under the Company&#8217;s directions and supervision, raw materials for in-house assembly line, shipping and handling costs to customers and to subsidiaries, salary, employee-related expenses and overhead expenses of internal assembly line and service costs associate with warranty.</span></span></div>
                    </div>
                  </td>
                </tr>

            </table>
          <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and development costs</a></td>
<td class="text">
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:48.4pt">&#160;</td>
                  <td style="width:22.5pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">u.</span></span></td>
                  <td style="width:auto;vertical-align:top">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Research and development costs</span></span></div>
                    <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">&#160;<div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Research and development costs are expensed as incurred and includes salaries and employee-related expenses, overhead expenses, material and third-party contractor&#8217;s charges related to product development, regulatory affairs and clinical studies.</span></span></div>
                    </div>
                  </td>
                </tr>

            </table>
          <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net earnings per share</a></td>
<td class="text">
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:48.4pt">&#160;</td>
                  <td style="width:22.5pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">v.</span></span></td>
                  <td style="width:auto;vertical-align:top">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Net earnings</span>&#160;<span style="font-weight:bold">per share</span></span></span></div>
                    <div>&#160;</div>
                    <div style="font-family:'Times New Roman',Times,serif">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Basic earnings per share are computed by dividing net income </span></span>attributed to the shareholders of InMode Ltd. by the weighted average number of the Company&#8217;s ordinary shares, par value NIS 0.01 per share (including vested RSUs),<span><span> outstanding for each period, net of treasury shares.</span></span></span></span></div>
                      <div style="line-height:1.25">&#160;</div>
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For the diluted earnings per share calculation, the weighted average number of shares outstanding during the year is adjusted for the average number of shares that are potentially issuable in connection with employee share-based payment, using the treasury stock method.</span></span></div>
                    </div>
                  </td>
                </tr>

            </table>
          <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair value measurement</a></td>
<td class="text">
            <div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:48.4pt">&#160;</td>
                    <td style="width:22.5pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">w.</span></span></td>
                    <td style="width:auto;vertical-align:top">
                      <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair value measurement</span></span></div>
                      <div style="font-weight:bold">&#160;</div>
                      <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">
                        <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company measures fair value and discloses fair value measurements for financial assets and liabilities. Fair value is based on the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. In the absence of active markets for identical assets or liabilities, such measurements involve developing assumptions based on market observable data and, in the absence of such data,</span></span></div>
                        <div style="line-height:1.25;font-weight:normal">&#160;</div>
                        <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">internal information that is consistent with what market participants would use in a hypothetical transaction that occurs at the measurement date. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect the Company&#8217;s market assumptions.</span></span></div>
                      </div>
                    </td>
                  </tr>

              </table><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;</span></span>
              <div></div>
              <div style="line-height:1.25">
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:48.4pt">&#160;</td>
                      <td style="width:22.5pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">w.</span></span></td>
                      <td style="width:auto;vertical-align:top;font-weight:normal">
                        <div style="font-family:'Times New Roman',Times,serif">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The three levels of inputs that may be used to measure fair value are as follows:</span></span></div>
                        </div>
                      </td>
                    </tr>

                </table>
              </div>
              <div>&#160;</div>
              <div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="vertical-align:top;width:106pt;font-weight:bold">&#160;</td>
                      <td style="width:auto;vertical-align:top">
                        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Level 1 &#8211; Quoted prices (unadjusted) in active markets that are accessible at the measurement date for identical assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs.</span></span></div>
                          <div style="line-height:1.25">&#160;</div>
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Level 2 &#8211; Observable prices that are based on identical or similar instruments not quoted on active markets, but corroborated by observable market data, or quoted prices for similar instruments in active markets.</span></span></div>
                          <div style="line-height:1.25">&#160;</div>
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Level 3 &#8211; Unobservable inputs are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level 3 inputs.</span></span></div>
                        </div>
                      </td>
                    </tr>

                </table>
              </div>
              <div>&#160;</div>
              <div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:48.4pt">&#160;</td>
                      <td style="width:22.5pt;vertical-align:top;font-weight:bold">&#160;</td>
                      <td style="width:auto;vertical-align:top;font-weight:normal">
                        <div style="font-family:'Times New Roman',Times,serif">
                          <div style="line-height:1.25">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company maintains policies and procedures to determine the fair value of financial assets and liabilities using what it considers to be the most relevant and reliable market data available.</span></span></div>
                            <div style="line-height:1.25">&#160;</div>
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of December 31, 2023, and 2022, the fair values of the Company's cash, cash equivalents, short term bank deposits, accounts receivable, accounts payable, approximated the carrying values of these instruments presented in the Company's consolidated balance sheets because of their nature.</span></span></div>
                          </div>
                        </div>
                      </td>
                    </tr>

                </table>
              </div>
            </div>
          <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segments</a></td>
<td class="text">
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:48.4pt">&#160;</td>
                  <td style="width:22.5pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">x.</span></span></td>
                  <td style="width:auto;vertical-align:top">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Segments</span></span></div>
                    <div style="font-family:'Times New Roman',Times,serif;font-weight:normal">&#160;<div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company operates in one segment. Management does not segregate its business for internal reporting. The Company&#8217;s chief operating decision-maker evaluates the performance of its business based on financial data consistent with the presentation in the accompanying financial statements. The Company concluded that its unified business is conducted globally and accordingly represents one operating segment.</span></span></div>
                      <div style="line-height:1.25">&#160;</div>
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Entity-wide disclosures on revenue and long-lived assets are presented in note 14.</span></span></div>
                    </div>
                  </td>
                </tr>

            </table>
          <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_EmployeeSeveranceBenefitsPolicyTextBlock', window );">Employee severance benefits</a></td>
<td class="text">
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:48.4pt">&#160;</td>
                  <td style="width:22.5pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">y.</span></span></td>
                  <td style="width:auto;vertical-align:top">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Employee severance benefits</span></span></div>
                    <div style="font-weight:bold">&#160;</div>
                    <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">
                      <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company is required to make severance payments upon dismissal of an Israeli employee or upon termination of employment in certain circumstances.</span></span></div>
                      <div style="line-height:1.25;font-weight:normal">&#160;</div>
                      <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In accordance with the current employment terms with all of its employees (Section 14 of the Israeli Severance Pay Law, 1963) located in Israel, the Company makes regular deposits with certain insurance companies for accounts controlled by each applicable employee in order to secure the employee&#8217;s full retirement benefit and severance obligation. The Company is relieved from any severance pay liability with respect to each such employee after it makes the payments on behalf of the employee. The liability accrued in respect of these employees and the amounts funded, as of the respective agreement dates, are not reflected on the Company&#8217;s consolidated balance sheet, as the amounts funded are not under the control and management of the Company and the pension or severance pay risks have been irrevocably transferred to the applicable insurance companies.</span></span></div>
                      <div style="line-height:1.25;font-weight:normal">&#160;</div>
                      <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The amounts of severance payment expenses were $522, $431 and $405 and for the years ended December 31, 2023, 2022 and 2021, respectively.</span></span></div>
                      <div style="line-height:1.25;font-weight:normal">&#160;</div>
                      <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company expects to contribute approximately $533 in the year ending December 31, 2024 to insurance companies in connection with its expected severance liabilities for the year.</span></span></div>
                    </div>
                  </td>
                </tr>

            </table>
          <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_TreasurySharesPolicyTextBlock', window );">Treasury Shares</a></td>
<td class="text">
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:48.4pt">&#160;</td>
                  <td style="width:22.5pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">z.</span></span></td>
                  <td style="width:auto;vertical-align:top">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Treasury Shares</span></span></div>
                    <div style="font-weight:bold">&#160;</div>
                    <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">
                      <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Treasury shares are presented as a reduction of equity, at their cost to the Company.</span></span></div>
                    </div>
                  </td>
                </tr>

            </table>
          <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of credit risks</a></td>
<td class="text">
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:48.4pt">&#160;</td>
                  <td style="width:22.5pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">aa.</span></span></td>
                  <td style="width:auto;vertical-align:top">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Concentration of credit risks</span></span></div>
                    <div style="font-weight:bold">&#160;</div>
                    <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:normal">Most of the cash and cash equivalents were deposited with U.S., European and Israeli banks and financial institutions and were comprised mainly of money market fund. The U.S. market constituted approximately 63% of the revenues in 2023.</span></span></span></div>
                      <div style="line-height:1.25">&#160;</div>
                      <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The exposure of credit risks relating to other trade receivables outside the U.S. is limited, due to the relatively large number of group customers and their wide geographic distribution. The Company performs ongoing credit evaluations of its customers for the purpose of determining the appropriate allowance for Credit Losses and generally does not require collateral and from time to time the Company may choose to purchase trade credit insurance.</span></span></div>
                    </div>
                  </td>
                </tr>

            </table>
          <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_WarRiskSituationInIsraelPolicyTextBlock', window );">War risk situation in Israel</a></td>
<td class="text">
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:48.4pt">&#160;</td>
                  <td style="width:22.5pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">ab.</span></span></td>
                  <td style="width:auto;vertical-align:top">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">War risk situation in Israel</span></span></div>
                    <div style="font-weight:bold">&#160;</div>
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:normal">In October 2023, Israel was attacked by a terrorist organization and entered a state of war. As of the date of these consolidated financial statements, the war is ongoing and continues to evolve. The Company's headquarter, its R&amp;D operations, and certain manufacturing facilities are located in Israel. Currently, such activities in Israel remain largely unaffected. During the year ended December 31, 2023, the impact of this war on the Company&#8217;s results of operations and financial condition was immaterial, but such impact may increase, which could be material, as a result of the continuation, escalation or expansion of such war.</span></span></span></div>
                  </td>
                </tr>

            </table>
          <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Newly issued accounting pronouncements, not yet adopted</a></td>
<td class="text">
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:48.4pt">&#160;</td>
                      <td style="width:22.5pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">ac.</span></span></td>
                      <td style="width:auto;vertical-align:top">
                        <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">
                          <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Newly issued accounting pronouncements, not yet adopted</span></span></div>
                          <div style="line-height:1.25;font-weight:bold">&#160;</div>
                        </div>
                        <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">
                          <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In December 2023, the FASB issued ASU 2023-09 &#8220;Income Taxes (Topic 740): Improvements to Income Tax Disclosures&#8221;. This guidance is intended to enhance the transparency and decision-usefulness of income tax disclosures. The amendments in ASU 2023-09 address investor requests for enhanced income tax information primarily through changes to disclosure regarding rate reconciliation and income taxes paid both in the U.S. and in foreign jurisdictions. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024 on a prospective basis. Early adoption is permitted, with the option to apply the standard retrospectively. The Company is currently evaluating this guidance to determine the impact it may have on its consolidated financial statements disclosures.</span></span></div>
                          <div style="line-height:1.25;font-weight:normal">&#160;</div>
                          <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In November 2023, the FASB issued ASU 2023-07 &#8220;Segment Reporting: Improvements to Reportable Segment Disclosures&#8221;. This guidance expands public entities&#8217; segment disclosures primarily by requiring disclosure of significant segment expenses that are regularly provided to the chief operating decision maker and included within each reported measure of segment profit or loss, an amount and description of its composition for other segment items, and interim disclosures of a reportable.</span></span></div>
                        </div>
                      </td>
                    </tr>

                </table>
              <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inmd_EmployeeSeveranceBenefitsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Employee severance benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inmd_EmployeeSeveranceBenefitsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inmd_ShortTermBankDepositsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for short-term bank deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inmd_ShortTermBankDepositsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inmd_TreasurySharesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy treasury shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inmd_TreasurySharesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inmd_WarRiskSituationInIsraelPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for war risk situation in Israel.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inmd_WarRiskSituationInIsraelPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for advertising cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -SubTopic 35<br> -Topic 720<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483406/720-35-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 450<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480598/954-450-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482425/460-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480981/942-825-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfSalesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cost of product sold and service rendered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Topic 705<br> -Publisher FASB<br> -URI https://asc.fasb.org//705/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfSalesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//830/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480091/360-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 4<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482338/360-10-05-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-17<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-25<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-19<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483489/210-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 912<br> -SubTopic 330<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482105/912-330-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//330/tableOfContent<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483080/330-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483080/330-10-50-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 270<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482989/270-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(f)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(f)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(f)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 12<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-12<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 19<br> -Subparagraph (2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-19<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment classified as marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480832/942-320-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the allowance for doubtful accounts for trade and other accounts receivable balances, and when impairments, charge-offs or recoveries are recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481962/310-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483044/730-10-05-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482785/280-10-55-47<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.C.Q3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.1.Q5)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.3.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//718/tableOfContent<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for standard warranties including the methodology for measuring the liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482425/460-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140222167569248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock', window );">Schedule of Property and Equipment Estimated Useful Lives</a></td>
<td class="text">
                <div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                      <tr>
                        <td style="vertical-align:top;width:70pt">&#160;</td>
                        <td style="vertical-align:top;width:auto">
                          <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:normal">Property and equipment is stated at cost, net of accumulated depreciation and amortization. Depreciation is calculated on a straight-line basis over the following estimated useful lives:</span></span></span></div>
                          </div>
                        </td>
                      </tr>

                  </table>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="margin-left:81pt">
                    <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                        <tr>
                          <td style="vertical-align:top;background-color:rgb(204, 238, 255)">
                            <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Computers</span></span></div>
                          </td>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)">
                            <div style="text-align:center;margin-right:20.45pt;margin-left:13.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3 &#8211; 4 years</span></span></div>
                          </td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom">
                            <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Molds</span></span></div>
                          </td>
                          <td style="vertical-align:bottom">
                            <div style="text-align:center;margin-right:20.45pt;margin-left:13.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4 &#8211; 10 years</span></span></div>
                          </td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)">
                            <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Equipment and furniture</span></span></div>
                          </td>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)">
                            <div style="text-align:center;margin-right:20.45pt;margin-left:13.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10 &#8211; 17 years</span></span></div>
                          </td>
                        </tr>

                    </table>
                  </div>
                </div>
              <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock', window );">Schedule Of Allowance For Credit Losses</a></td>
<td class="text">
                <div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                      <tr>
                        <td style="vertical-align:top;width:48pt">&#160;</td>
                        <td style="vertical-align:top;width:22pt">&#160;</td>
                        <td style="vertical-align:top;width:auto">
                          <div style="font-family:'Times New Roman',Times,serif">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:normal">The following table sets forth activity in the Company&#8217;s allowance for credit losses for</span> each of the years ended December 31, 2023, 2022 and 2021, respectively:</span></span></div>
                          </div>
                        </td>
                      </tr>

                  </table>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="margin-left:81pt">
                    <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                        <tr>
                          <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:middle;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="text-indent:15.85pt;margin-right:7.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at beginning of year</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,318</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,107</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">672</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:middle;width:64%;vertical-align:bottom">
                            <div style="text-indent:15.85pt;margin-right:7.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Current-period provision</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,020</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">449</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">516</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:middle;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="text-indent:15.85pt;margin-right:7.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Write-offs charged against the</span></span></div>
                            <div style="text-indent:15.85pt;margin-right:7.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">allowance</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(84</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(238</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(81</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                            </div>
                          </td>
                        </tr>
                        <tr>
                          <td style="vertical-align:middle;width:64%;padding-bottom:4px;vertical-align:bottom">
                            <div style="text-indent:15.85pt;margin-right:7.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at end of year</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,254</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,318</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,107</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>

                    </table>
                  </div>
                </div>
              <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock', window );">Schedule of Accrued Warranty</a></td>
<td class="text">
                <div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                      <tr>
                        <td style="vertical-align:top;width:48pt">&#160;</td>
                        <td style="vertical-align:top;width:22pt">&#160;</td>
                        <td style="vertical-align:top;width:auto">
                          <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">
                            <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The following table sets forth activity in the Company&#8217;s accrued warranty account for each of the years ended December 31, 2023, 2022 and 2021, respectively:</span></span></div>
                          </div>
                        </td>
                      </tr>

                  </table>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="margin-left:81pt">
                    <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                        <tr>
                          <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:middle;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="text-indent:15.85pt;margin-right:7.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at beginning of year</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,418</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,248</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">705</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:middle;width:64%;vertical-align:bottom">
                            <div style="text-indent:15.85pt;margin-right:7.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cost incurred</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2,304</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2,099</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,453</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                        </tr>
                        <tr>
                          <td style="vertical-align:middle;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="text-indent:15.85pt;margin-right:7.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Expense recognized</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,362</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,269</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,996</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:middle;width:64%;padding-bottom:4px;vertical-align:bottom">
                            <div style="text-indent:15.85pt;margin-right:7.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at end of year</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,476</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,418</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,248</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>

                    </table>
                  </div>
                </div>
              <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inmd_ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of property and equipment estimated useful lives.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inmd_ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482425/460-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140222162560624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>MARKETABLE SECURITIES AND FAIR VALUE MEASUREMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_MarketableSecuritiesAndFairValueMeasurementAbstract', window );"><strong>Marketable Securities and Fair Value Measurement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesTextBlock', window );">Schedule of Marketable Securities</a></td>
<td class="text">
          <div>
            <div style="line-height:1.25">
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="vertical-align:top;width:49pt">&#160;</td>
                    <td style="vertical-align:top;width:auto">
                      <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">
                        <div style="line-height:1.25;font-weight:normal">
                          <div style="line-height:1.25">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The following table sets forth the Company&#8217;s marketable securities for the periods indicated:</span></span></div>
                          </div>
                        </div>
                      </div>
                    </td>
                  </tr>

              </table>
            </div>
            <div style="margin-left:49.65pt;line-height:1.25">&#160;</div>
            <div style="margin-left:54pt">
              <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td colspan="1" style="vertical-align:bottom;padding-left:9pt;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:top;padding-left:9pt;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:middle;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Government bonds *</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">353,414</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">339,684</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:middle;width:76%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Municipal bonds</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,319</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,551</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:middle;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Corporate debt securities</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13,234</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">21,252</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:middle;width:76%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Commercial paper</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,195</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:middle;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Certificates of deposit</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,680</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,907</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:middle;width:76%;padding-bottom:4px;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">373,647</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">374,589</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>

              </table>
            </div>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:49pt;vertical-align:top;font-family:'Times New Roman',Times,serif;text-align:center">&#160;</td>
                  <td style="width:auto;vertical-align:top">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">* As of December 31, 2023 and 2022, consists of $0 and $1,502 non-U.S. government bonds, respectively.</span></span></div>
                  </td>
                </tr>

            </table>
          </div>
        <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock', window );">Schedule of Financial Assets Measured at Fair Value on Recurring Basis</a></td>
<td class="text">
            <div>
              <div style="line-height:1.25">
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="vertical-align:top;width:49pt">&#160;</td>
                      <td style="vertical-align:top;width:auto">
                        <div style="font-family:'Times New Roman',Times,serif;font-weight:bold">
                          <div style="line-height:1.25;font-weight:normal">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The following table sets forth the Company&#8217;s financial assets as of December 31, 2023 and 2022, that are measured at fair value on a recurring basis during the period:</span></span></div>
                              </div>
                            </div>
                          </div>
                        </div>
                      </td>
                    </tr>

                </table>
              </div>
              <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;<div style="line-height:1.25">
                  <div>
                    <div style="margin-left:54pt">
                      <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                          <tr>
                            <td rowspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                            <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                            <td colspan="14" rowspan="1" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                              <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">December 31, 2023&#160;</span></span></span></strong></div>
                            </td>
                            <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                              <div style="line-height:1.25">
                                <div style="line-height:1.25;font-weight:bold;text-align:center"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Fair</span></span></span></span></strong></div>
                                <div style="line-height:1.25;font-weight:bold;text-align:center"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>value</span></span></span></span></strong></div>
                              </div>
                            </td>
                            <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;text-align:center">&#160;</td>
                            <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;text-align:center">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                              <div style="line-height:1.25;font-weight:bold;text-align:center"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Cost or</span></span></span></span></strong></div>
                              <div style="line-height:1.25;font-weight:bold;text-align:center"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>amortized</span></span></span></span></strong></div>
                              <div style="line-height:1.25;font-weight:bold;text-align:center"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>cost</span></span></span></span></strong></div>
                            </td>
                            <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;text-align:center">&#160;</td>
                            <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;text-align:center">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                              <div style="line-height:1.25;font-weight:bold;text-align:center"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Gross</span></span></span></span></strong></div>
                              <div style="line-height:1.25;font-weight:bold;text-align:center"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>unrealized</span></span></span></span></strong></div>
                              <div style="line-height:1.25;font-weight:bold;text-align:center"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>holding loss</span></span></span></span></strong></div>
                            </td>
                            <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;text-align:center">&#160;</td>
                            <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;text-align:center">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                              <div style="line-height:1.25;font-weight:bold;text-align:center">
                                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Gross</span></span></strong></p>
                                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">unrealized</span></span></strong></p>
                                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">holding</span></span></strong></p>
                                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">gains</span></span></strong></p>
                              </div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;background-color:rgb(204, 238, 255);vertical-align:bottom">
                              <div style="margin-left:7.1pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Level 2 securities:</span></span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:52%;vertical-align:bottom">
                              <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;margin-left:27pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Government bonds</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">353,414</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">355,382</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2,139</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">171</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                              <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;margin-left:27pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Municipal bonds</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,319</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,363</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(44</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:52%;vertical-align:bottom">
                              <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;margin-left:27pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Corporate debt securities</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13,234</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13,404</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(170</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:52%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                              <div style="line-height:1.25">
                                <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;margin-left:27pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Certificates of deposit</span></span></div>
                              </div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                              <div style="line-height:1.25">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,680</span></span></div>
                              </div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,680</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;width:52%;padding-bottom:4px;vertical-align:bottom">
                              <div style="line-height:1.25">
                                <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
                              </div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                              <div style="line-height:1.25">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">373,647</span></span></div>
                              </div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">375,829</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2,353</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">171</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          </tr>

                      </table>
                    </div>
                    <div>&#160;<div style="margin-left:54pt">
                        <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                            <tr>
                              <td rowspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                              <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                              <td colspan="14" rowspan="1" style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span><span><span style="font-weight:bold">December 31, 2022</span></span></span></strong></span></span></td>
                              <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                                <div style="line-height:1.25">
                                  <div style="line-height:1.25;font-weight:bold;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span><span>Fair</span></span></strong></span></span></div>
                                  <div style="line-height:1.25;font-weight:bold;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span><span>value</span></span></strong></span></span></div>
                                </div>
                              </td>
                              <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;text-align:center">&#160;</td>
                              <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;text-align:center">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                                <div style="line-height:1.25;font-weight:bold;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span><span>Cost or </span></span></strong></span></span></div>
                                <div style="line-height:1.25;font-weight:bold;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span><span>amortized </span></span></strong></span></span></div>
                                <div style="line-height:1.25;font-weight:bold;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span><span>cost</span></span></strong></span></span></div>
                              </td>
                              <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;text-align:center">&#160;</td>
                              <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;text-align:center">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                                <div style="line-height:1.25;font-weight:bold;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span><span>Gross </span></span></strong></span></span></div>
                                <div style="line-height:1.25;font-weight:bold;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span><span>unrealized</span></span></strong></span></span></div>
                                <div style="line-height:1.25;font-weight:bold;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span><span>holding loss</span></span></strong></span></span></div>
                              </td>
                              <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;text-align:center">&#160;</td>
                              <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;text-align:center">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                                <div style="line-height:1.25;font-weight:bold;text-align:center">
                                  <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Gross<br/>unrealized<br/>holding<br/>gains</span></span></p>
                                </div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:middle;background-color:rgb(204, 238, 255);vertical-align:bottom">
                                <div style="margin-left:7.1pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Level 2 securities:</span></span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:middle;width:52%;vertical-align:bottom">
                                <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;margin-left:27pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Government bonds</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">339,684</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">348,687</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(9,003</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:middle;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                                <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;margin-left:27pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Municipal bonds</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,551</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,674</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(123</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:middle;width:52%;vertical-align:bottom">
                                <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;margin-left:27pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Corporate debt securities</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">21,252</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">21,850</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(612</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">14</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:middle;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                                <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;margin-left:27pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Commercial paper</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,195</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,195</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:middle;width:52%;padding-bottom:2px;vertical-align:bottom">
                                <div style="line-height:1.25">
                                  <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;margin-left:27pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Certificates of deposit</span></span></div>
                                </div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                                <div style="line-height:1.25">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,907</span></span></div>
                                </div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,914</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(7</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:top;width:52%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                                <div style="line-height:1.25">
                                  <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
                                </div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                                <div style="line-height:1.25">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">374,589</span></span></div>
                                </div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">384,320</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(9,745</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">14</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                            </tr>

                        </table>
                      </div>
                    </div>
                  </div>
                </div>
              </div>
            </div>
          <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock', window );">Schedule of Debt Securities on Maturity</a></td>
<td class="text">
          <div>
            <div style="line-height:1.25">
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="vertical-align:top;width:49pt">&#160;</td>
                    <td style="vertical-align:top;width:auto">
                      <div style="font-family:'Times New Roman',Times,serif">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of December 31, 2023 and 2022, the Company&#8217;s debt securities and certificates of deposit had the following maturity dates:</span></span></div>
                        </div>
                      </div>
                    </td>
                  </tr>

              </table>
            </div>
            <div style="margin-left:49.65pt;line-height:1.25">&#160;</div>
            <div style="margin-left:54pt">
              <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:middle;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Due within one year</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">308,671</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">243,094</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:middle;width:76%;vertical-align:bottom">
                      <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1 to 2 years</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">49,259</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">124,037</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:middle;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 to 3 years</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">15,717</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7,458</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:middle;width:76%;padding-bottom:4px;vertical-align:bottom">
                      <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">373,647</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">374,589</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>

              </table>
            </div>
          </div>
        <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inmd_MarketableSecuritiesAndFairValueMeasurementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inmd_MarketableSecuritiesAndFairValueMeasurementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-9<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aaa)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140222165988384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCOUNTS RECEIVABLE (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableGrossAllowanceAndNetAbstract', window );"><strong>Accounts, Notes, Loans and Financing Receivable, Gross, Allowance, and Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock', window );">Schedule of Accounts Receivable</a></td>
<td class="text">
          <div>
            <div style="line-height:1.25">
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="vertical-align:top;width:49pt">&#160;</td>
                    <td style="vertical-align:top;width:auto">
                      <div style="font-family:'Times New Roman',Times,serif">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Accounts receivable consist of the following:</span></span></div>
                          </div>
                        </div>
                      </div>
                    </td>
                  </tr>

              </table>
            </div>
            <div style="margin-right:1.95pt;margin-left:49.65pt;line-height:1.25">&#160;</div>
            <div style="margin-left:54pt">
              <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td rowspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="6" rowspan="1" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td rowspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" rowspan="1" style="text-align:center;font-weight:bold;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" rowspan="1" style="vertical-align:top;text-align:center;font-weight:bold;border-bottom:#000000 solid 2px;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></td>
                    <td colspan="1" rowspan="1" style="font-weight:bold;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" rowspan="1" style="text-align:center;font-weight:bold;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" rowspan="1" style="vertical-align:top;text-align:center;font-weight:bold;border-bottom:#000000 solid 2px;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></td>
                    <td colspan="1" rowspan="1" style="font-weight:bold;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">46,646</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">29,859</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Notes receivable</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,640</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,429</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Less - allowance for credit losses</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2,254</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,318</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </div>
                    </td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">46,032</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">30,970</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Less - non-current accounts receivable, net</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(3,670</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(3,973</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </div>
                    </td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total current accounts receivable, net</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">42,362</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">26,997</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>

              </table>
            </div>
          </div>
        <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableGrossAllowanceAndNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableGrossAllowanceAndNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3,4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140222166797632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PREPAID EXPENSES AND OTHER CURRENT RECEIVABLES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrentAbstract', window );"><strong>Other Receivables, Net, Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_ScheduleOfPrepaidExpensesAndOtherCurrentRecivablesTableTextBlock', window );">Schedule Of Prepaid Expenses And Other Current Receivables</a></td>
<td class="text">
          <div>
            <div style="line-height:1.25">
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="vertical-align:top;width:49pt">&#160;</td>
                    <td style="vertical-align:top;width:auto">
                      <div style="font-family:'Times New Roman',Times,serif">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Prepaid expenses and other current receivables consist of the following:</span></span></div>
                            </div>
                          </div>
                        </div>
                      </div>
                    </td>
                  </tr>

              </table>
            </div>
            <div style="line-height:1.25">&#160;</div>
            <div style="margin-left:54pt">
              <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="6" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Advances to suppliers</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11,960</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11,898</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Prepaid expenses</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,041</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,928</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Government institutions</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">948</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">879</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Income tax</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">66</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">44</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">253</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">345</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total other current receivables</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">16,268</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">15,094</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>

              </table>
            </div>
          </div>
        <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inmd_ScheduleOfPrepaidExpensesAndOtherCurrentRecivablesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of prepaid expenses and other current receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inmd_ScheduleOfPrepaidExpensesAndOtherCurrentRecivablesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140222166033264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventories</a></td>
<td class="text">
          <div>
            <div style="line-height:1.25">
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="vertical-align:top;width:49pt">&#160;</td>
                    <td style="vertical-align:top;width:auto">
                      <div style="font-family:'Times New Roman',Times,serif">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Inventories consist of the following:</span></span></div>
                              </div>
                            </div>
                          </div>
                        </div>
                      </div>
                    </td>
                  </tr>

              </table>
            </div>
            <div style="margin-right:1.95pt;margin-left:49.65pt;line-height:1.25">&#160;</div>
            <div style="margin-left:54pt">
              <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td rowspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="6" rowspan="1" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td rowspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" rowspan="1" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" rowspan="1" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Raw materials</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,080</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13,686</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Finished products</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">33,015</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">26,211</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total inventories</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">45,095</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">39,897</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>

              </table>
            </div>
          </div>
        <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483489/210-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140222166030352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT, NET (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property and Equipment</a></td>
<td class="text">
          <div>
            <div style="line-height:1.25">
              <div style="line-height:1.25">
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:49pt;vertical-align:top;font-family:'Times New Roman',Times,serif;text-align:center">&#160;</td>
                      <td style="width:auto;vertical-align:top">
                        <div style="font-family:'Times New Roman',Times,serif">
                          <div style="line-height:1.25">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25">
                                <div style="line-height:1.25">
                                  <div style="line-height:1.25">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Composition of property and equipment grouped by major classifications is as follows:</span></span></div>
                                  </div>
                                </div>
                              </div>
                            </div>
                          </div>
                        </div>
                      </td>
                    </tr>

                </table>
              </div>
            </div>
            <div style="line-height:1.25">&#160;</div>
            <div style="margin-left:54pt">
              <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td rowspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="6" rowspan="1" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td rowspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" rowspan="1" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" rowspan="1" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="margin-right:7.2pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Computers</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,334</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,191</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;vertical-align:bottom">
                      <div style="margin-right:7.2pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Office furniture and equipment</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">670</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">562</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="margin-right:7.2pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Molds</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,592</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,550</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
                      <div style="margin-right:7.2pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Leasehold improvements</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,243</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">829</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,839</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,132</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;padding-bottom:2px;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Less: accumulated depreciation</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(3,457</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2,834</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </div>
                    </td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="margin-right:7.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total property and equipment, net</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,382</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,298</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>

              </table>
            </div>
          </div>
        <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140222160032752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Schedule of Lease Expense</a></td>
<td class="text">
          <div>
            <div style="line-height:1.25">
              <div style="line-height:1.25">
                <table cellpadding="0" cellspacing="0" style="width:100%">

                    <tr>
                      <td style="vertical-align:top;width:auto">
                        <div style="font-family:'Times New Roman',Times,serif">
                          <div style="line-height:1.25;margin-left:70pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The lease cost was as follows:</span></span></div>
                        </div>
                      </td>
                    </tr>

                </table>
                <p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left">&#160;</p>
              </div>
            </div>
            <div style="margin-left:81pt">
              <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td colspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td style="padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="10" rowspan="1" style="padding-bottom:2px;vertical-align:bottom;border-bottom:2px solid black">
                      <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:1pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended</span></span></div>
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td style="padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" rowspan="1" style="padding-bottom:2px;vertical-align:bottom;border-bottom:2px solid black">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="2" rowspan="1" style="padding-bottom:2px;vertical-align:bottom;border-bottom:2px solid black">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="2" rowspan="1" style="padding-bottom:2px;vertical-align:bottom;border-bottom:2px solid black">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td colspan="1" style="vertical-align:top;padding-left:9pt;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Operating lease cost</span></span></div>
                    </td>
                    <td style="width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,348</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,628</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,297</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>

              </table>
            </div>
          </div>
        <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_ScheduleOfSupplementalCashFlowInformationRelatedToLeases', window );">Schedule of Supplemental Cash Flow Information Related to Leases</a></td>
<td class="text">
          <div>
            <div style="line-height:1.25">
              <div style="line-height:1.25">
                <div style="line-height:1.25">
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                      <tr>
                        <td style="vertical-align:top;margin-top:0pt;margin-bottom:0pt;width:auto">
                          <div style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">
                            <div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt">
                              <div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt;margin-left:70pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Supplemental cash flow information related to leases was as follows:</span></span></div>
                            </div>
                          </div>
                        </td>
                      </tr>

                  </table>
                </div>
              </div>
            </div>
            <p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left">&#160;</p>
            <div>
              <div>
                <div style="margin-left:81pt">
                  <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                      <tr>
                        <td colspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="10" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:1pt">Year ended</div>
                          <div style="line-height:1.25">
                            <div style="text-align:center;line-height:1.25;font-weight:bold">December 31</div>
                          </div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td colspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                          <div style="line-height:1.25">
                            <div style="text-align:center;line-height:1.25;font-weight:bold">2023</div>
                          </div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                          <div style="line-height:1.25">
                            <div style="text-align:center;line-height:1.25;font-weight:bold">2022</div>
                          </div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                          <div style="line-height:1.25">
                            <div style="text-align:center;line-height:1.25;font-weight:bold">2021</div>
                          </div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td colspan="1" style="vertical-align:top;padding-left:9pt;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25">Operating cash flows from operating leases</div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25">
                            <div style="line-height:1.25">2,530</div>
                          </div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25">
                            <div style="line-height:1.25">1,881</div>
                          </div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25">
                            <div style="line-height:1.25">1,328</div>
                          </div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>

                  </table>
                </div>
              </div>
            </div>
          </div>
        <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_ScheduleOfSupplementalBalanceSheetInformationRelatedToLeases', window );">Schedule of Supplemental Balance Sheet Information Related to Leases</a></td>
<td class="text">
          <div>
            <div style="line-height:1.25">
              <div style="line-height:1.25">
                <div style="line-height:1.25">
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                      <tr>
                        <td style="vertical-align:top;width:auto">
                          <div style="font-family:'Times New Roman',Times,serif">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25;margin-left:70pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Supplemental balance sheet information related to leases was as follows:</span></span></div>
                            </div>
                          </div>
                        </td>
                      </tr>

                  </table>
                </div>
              </div>
            </div>
            <p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left">&#160;</p>
            <div style="margin-left:81pt">
              <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="6" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:1pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:1pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:1pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Operating Leases</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;padding-bottom:2px;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Operating lease right-of-use assets</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9,698</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,073</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other current liabilities</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,404</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,453</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;padding-bottom:2px;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Operating lease liabilities</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,613</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,509</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total operating lease liabilities</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9,017</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,962</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted Average Remaining Lease Term</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Operating leases</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.90 years</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.30 years</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted Average Discount Rate</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Operating leases</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.00%-7.84</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.00%-5.80</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                      </div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Maturities of Lease Liabilities</a></td>
<td class="text">
          <div>
            <div style="line-height:1.25">
              <div style="line-height:1.25">
                <div style="line-height:1.25">
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                      <tr>
                        <td style="vertical-align:top;width:auto">
                          <div style="font-family:'Times New Roman',Times,serif">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25">
                                <div style="line-height:1.25;margin-left:70pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of December 31, 2023, the maturities of lease liabilities were as follows:</span></span></div>
                              </div>
                            </div>
                          </div>
                        </td>
                      </tr>

                  </table>
                </div>
              </div>
              <div style="margin-left:49.65pt;line-height:1.25">&#160;</div>
            </div>
            <div style="margin-left:81pt">
              <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;</span></span></td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" rowspan="1" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:1pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Operating Leases</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year Ending December 31,</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:88%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,745</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2025</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,491</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:88%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2026</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,001</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2027</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,733</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:88%;padding-bottom:2px;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2028 and beyond</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">902</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total lease payments</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9,872</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:88%;padding-bottom:2px;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Less imputed interests</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(855</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </div>
                    </td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:88%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9,017</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>

              </table>
            </div>
          </div>
        <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inmd_ScheduleOfSupplementalBalanceSheetInformationRelatedToLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of supplemental balance sheet information related to leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inmd_ScheduleOfSupplementalBalanceSheetInformationRelatedToLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inmd_ScheduleOfSupplementalCashFlowInformationRelatedToLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of supplemental cash flow information related to leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inmd_ScheduleOfSupplementalCashFlowInformationRelatedToLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140222166037472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER CURRENT LIABILITIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCurrentLiabilitiesTableTextBlock', window );">Schedule of Other Current Liabilities</a></td>
<td class="text">
      <div>
        <div>
          <div style="line-height:1.25">&#160;</div>
          <div style="line-height:1.25">
            <div style="line-height:1.25">
              <div style="line-height:1.25">
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="vertical-align:top;width:49pt;font-weight:bold">&#160;</td>
                      <td style="width:auto;vertical-align:top">
                        <div style="font-family:'Times New Roman',Times,serif">
                          <div style="line-height:1.25">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other current liabilities consist of the following:</span></span></div>
                              </div>
                            </div>
                          </div>
                        </div>
                      </td>
                    </tr>

                </table>
              </div>
            </div>
            <div style="margin-left:49.65pt;line-height:1.25">&#160;</div>
          </div>
          <div style="margin-left:54pt">
            <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                <tr>
                  <td colspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="6" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                    <div style="line-height:1.25">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31</span></span></div>
                    </div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                    <div style="line-height:1.25">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                    </div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="2" rowspan="1" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                    <div style="line-height:1.25">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                    </div>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Employees and related expenses</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">21,040</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">19,439</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:top;width:76%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Government institutions</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,932</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,052</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Income tax payable</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,918</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">19,241</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:top;width:76%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Warranty reserve</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,476</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,418</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Operating lease liabilities</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,404</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,453</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:top;width:76%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Contractor liability</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,656</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,003</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,821</span></span></div>
                    </div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,374</span></span></div>
                    </div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total other current liabilities</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">39,247</span></span></div>
                    </div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">51,980</span></span></div>
                    </div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>

            </table>
          </div>
        </div>
      </div>
    <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCurrentLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of other current liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCurrentLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140222162596832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHAREHOLDERS' EQUITY (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Options Granted</a></td>
<td class="text">
            <div>
              <div style="line-height:1.25">
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:auto;vertical-align:top;text-align:justify">
                        <div>
                          <div style="line-height:1.25">
                            <div style="line-height:1.25;margin-left:75.5pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The following tables is a summary of stock option activity for the year ended on December 31, 2023<span style="font-weight:bold">&#160;</span>:</span></span></div>
                          </div>
                        </div>
                      </td>
                    </tr>

                </table>
              </div>
              <div style="line-height:1.25">&#160;</div>
              <div style="margin-left:81pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="6" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year&#160;ended&#160;December&#160;31</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="6" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Number</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Average</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">of</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercise</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Price*</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Outstanding at beginning of year</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,553,640</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5.30</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Changes during the year:</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="margin-left:8.8pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Granted</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;vertical-align:bottom">
                        <div style="margin-left:8.8pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercised</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(915,145</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5.92</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="margin-left:8.8pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Forfeited</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom">
                        <div style="margin-left:8.8pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Expired</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Outstanding at end of year</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,638,495</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.96</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercisable at end of year</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,638,495</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.96</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="width:76%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="8" style="vertical-align:top;vertical-align:bottom">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">* In U.S. dollars per Ordinary Share</span></span></div>
                      </td>
                    </tr>

                </table>
              </div>
            </div>
          <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock', window );">Schedule of Outstanding and Exercisable Options</a></td>
<td class="text">
            <div>
              <div style="line-height:1.25">
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:auto;vertical-align:top;text-align:justify">
                        <div>
                          <div style="line-height:1.25">
                            <div style="line-height:1.25;margin-left:75.5pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The following tables summarize information concerning outstanding and exercisable options as of December 31, 2023:</span></span></div>
                          </div>
                        </div>
                      </td>
                    </tr>

                </table>
              </div>&#160;<div style="margin-left:81pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td colspan="10" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25;text-align:center"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options outstanding and exercisable</span></span></strong></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="2" rowspan="5" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercise</span></span></div>
                        <div style="line-height:1.25">
                          <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Prices *</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center">&#160;</td>
                      <td colspan="2" rowspan="5" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Number of</span></span></div>
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">options</span></span></div>
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Outstanding and exercisable</span></span></div>
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">at end of</span></span></div>
                        <div style="line-height:1.25">
                          <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">year</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
                      <td colspan="1" rowspan="5" style="vertical-align:bottom;padding-bottom:2px;text-align:center">&#160;</td>
                      <td colspan="2" rowspan="5" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted</span></span></div>
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">average</span></span></div>
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">remaining</span></span></div>
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">contractual</span></span></div>
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">life</span></span></div>
                      </td>
                      <td colspan="1" rowspan="5" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">0.28</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">361,993</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">0.42</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">0.29</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">203,438</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">0.42</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.16</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">149,948</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.71</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.75</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">211,173</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.02</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5.11</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">70,756</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.26</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7.00</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">41,000</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.61</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9.85</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">565,129</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.18</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12.16</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">28,558</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.35</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">21.62</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,500</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.86</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>

                </table>
              </div>
              <div style="line-height:1.25">&#160;</div>
              <div style="line-height:1.25">
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:58.5pt">&#160;</td>
                      <td style="width:18pt;vertical-align:top;font-family:'Times New Roman',Times,serif">&#160;</td>
                      <td style="width:auto;vertical-align:top;text-align:justify">
                        <div>
                          <div style="line-height:1.25">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">* In U.S. dollars per Ordinary Share.</span></span></div>
                            </div>
                          </div>
                        </div>
                      </td>
                    </tr>

                </table>
              </div>
            </div>
          <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of Share Based Compensation Expense</a></td>
<td class="text">
            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;</span></span>
              <div style="margin-left:76pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="10" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended December 31</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cost of sales</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,046</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,917</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,108</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                        <div style="text-indent:-12.6pt;margin-left:12.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Research and development expenses</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,652</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,166</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,554</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-12.6pt;margin-left:12.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Selling and marketing expenses</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">17,167</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">17,302</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8,274</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;padding-bottom:2px;vertical-align:bottom">
                        <div style="text-indent:-12.6pt;margin-left:12.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">General and administrative expenses</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,735</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,067</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,026</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23,600</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">24,452</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11,962</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>

                </table>
              </div>
            </div>
          <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Options Granted</a></td>
<td class="text">
            <div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:auto;vertical-align:top;text-align:justify">
                      <div>
                        <div style="line-height:1.25">
                          <div style="line-height:1.25">
                            <div style="line-height:1.25;margin-left:76pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The following tables summarize information concerning RSUs as of December 31, 2023<span style="font-weight:bold">&#160;</span>:</span></span></div>
                          </div>
                        </div>
                      </div>
                    </td>
                  </tr>

              </table><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;</span></span>
              <div style="margin-left:81pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="6" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year&#160;ended&#160;December&#160;31</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="6" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Number</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Average</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">of</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Grant&#160;Date</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">RSUs</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair Value</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Outstanding at beginning of year</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">804,575</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">45.74</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Changes during the year:</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="margin-left:8.8pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Granted</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">706,560</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">34.44</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;vertical-align:bottom">
                        <div style="margin-left:8.8pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Vested</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(522,326</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">43.33</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="margin-left:8.8pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Forfeited</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(52,760</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">37.21</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Outstanding at end of year *</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">936,049</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">39.04</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>

                </table>
              </div>
              <div style="line-height:1.25">&#160;</div>
              <div style="line-height:1.25">
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:58.5pt">&#160;</td>
                      <td style="width:18pt;vertical-align:top;font-family:'Times New Roman',Times,serif">&#160;</td>
                      <td style="width:auto;vertical-align:top;text-align:justify">
                        <div>
                          <div style="line-height:1.25">
                            <div style="line-height:1.25">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">* As of December 31, 2023, 275,249 RSUs were vested and were settled by issuance of respective shares at the beginning of January 2024.</span></span></div>
                            </div>
                          </div>
                        </div>
                      </td>
                    </tr>

                </table>
              </div>
            </div>
          <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140222162601696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Tax Assets (liabilities)</a></td>
<td class="text">
            <div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="vertical-align:top;width:49pt">&#160;</td>
                    <td style="vertical-align:top;width:18pt">&#160;</td>
                    <td style="vertical-align:top;width:auto">
                      <div style="font-weight:bold">
                        <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred income tax assets reflect the net tax effects of loss and credit carryforwards and temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The components of the Company&#8217;s net deferred tax assets (liabilities) at December 31, 2023 and 2022 were as follows:</span></span></div>
                      </div>
                    </td>
                  </tr>

              </table>
              <div style="margin-left:67.5pt;line-height:1.25">&#160;</div>
              <div style="margin-left:72pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="6" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)">
                        <div style="margin-left:0.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred tax assets in respect of:</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="width:76%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                        <div style="text-indent:9pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Subsidiaries carryforward losses</span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">58,075</span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">60,229</span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="width:76%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
                        <div style="text-indent:9pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other temporary differences</span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,112</span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,369</span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="width:76%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                        <div style="text-indent:9pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based compensation</span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,194</span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,073</span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="vertical-align:bottom;width:76%;background-color:rgb(255, 255, 255)">
                        <div style="line-height:1.25;margin-left:9pt"><span style="line-height:1.25;text-indent:9pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred</span></span></span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"> tax asset in respect to other comprehensive loss</span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">502</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,238</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="width:76%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                        <div style="text-indent:-12.15pt;margin-left:21.25pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total deferred tax assets before valuation allowance</span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">65,883</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">69,909</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="width:76%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">
                        <div style="text-indent:9pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Valuation allowance</span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(64,377</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(66,815</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </div>
                      </td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="width:76%;padding-bottom:4px;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total deferred tax assets</span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,506</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,094</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
                    </tr>

                </table>
              </div>
            </div>
          <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Reconciliation of Theoretical Provision For Income Tax</a></td>
<td class="text">
            <div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="vertical-align:top;width:49pt">&#160;</td>
                    <td style="vertical-align:top;width:18pt">&#160;</td>
                    <td style="vertical-align:top;width:auto">
                      <div style="font-weight:bold">
                        <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Following is a reconciliation of the theoretical provision for income tax, assuming all income is taxed at the statutory corporate tax rate applicable to Israeli corporations, and the actual tax on income:</span></span></div>
                      </div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <div style="margin-left:72pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td colspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="10" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended December 31</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="1" style="vertical-align:top;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Income before taxes on income</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25">217,267</div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25">201,466</div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25">168,002</div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="1" style="vertical-align:top;width:64%;vertical-align:bottom">
                        <div style="text-indent:-13.55pt;margin-left:13.55pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>Theoretical tax expenses at the statutory rate of InMode&#160;Ltd.</span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                      </td>
                    </tr>
                    <tr>
                      <td colspan="1" style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">49,971</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">46,337</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">38,640</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="1" style="vertical-align:top;width:64%;vertical-align:bottom">
                        <div style="text-indent:-13.55pt;margin-left:13.55pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Increase (decrease) in taxes on income due to:</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="1" style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:0.75pt;margin-left:13.55pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Benefits to the Benefited Enterprise</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(31,739</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(29,429</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(37,478</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                    </tr>
                    <tr>
                      <td colspan="1" style="vertical-align:top;width:64%;vertical-align:bottom">
                        <div style="text-indent:-7.05pt;margin-left:21.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Different effective tax rates applicable to the Subsidiaries</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,956</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,453</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2,033</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                    </tr>
                    <tr>
                      <td colspan="1" style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="margin-left:13.55pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Valuation allowance</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">126</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">130</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">40</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="1" style="vertical-align:top;width:64%;vertical-align:bottom">
                        <div style="margin-left:13.55pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Uncertain tax positions</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,096</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">303</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,921</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="1" style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-9.4pt;margin-left:22.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-deductible expenses and other permanent differences, mainly share based compensation expenses</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,850</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,842</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,838</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="1" style="vertical-align:top;padding-left:9pt;width:64%;vertical-align:bottom">
                        <div style="text-indent:-9.4pt;margin-left:22.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Amendment to the Investments Law payment - see also note 13a(2)(b)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,017</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="1" style="vertical-align:top;padding-left:9pt;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="margin-left:13.55pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Settlements with the Israeli tax authority net of decrease of related uncertain tax&#160;provision</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10,199</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="1" style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">19,348</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">39,946</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,928</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>

                </table>
              </div>
            </div>
          <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Schedule of Income Before Income Taxes</a></td>
<td class="text">
            <div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:49.65pt">&#160;</td>
                    <td style="width:18pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">f.</span></span></td>
                    <td style="width:auto;vertical-align:top">
                      <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Income before income taxes is composed of the following:</span></span></div>
                    </td>
                  </tr>
                  <tr>
                    <td style="width:49.65pt">&#160;</td>
                    <td style="width:18pt;vertical-align:top;font-weight:bold">&#160;</td>
                    <td style="width:auto;vertical-align:top">&#160;</td>
                  </tr>

              </table>
              <div style="margin-left:72pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="10" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended December 31</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">InMode Ltd. and Israeli subsidiaries</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">211,137</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">196,354</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">163,370</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Subsidiaries outside of Israel</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,130</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,112</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,632</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">217,267</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">201,466</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">168,002</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>

                </table>
              </div>
            </div>
          <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of Tax Expenses (Tax Benefit)</a></td>
<td class="text">
            <div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:49.65pt">&#160;</td>
                    <td style="width:18pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">g.</span></span></td>
                    <td style="width:auto;vertical-align:top">
                      <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Tax expenses (tax benefit):</span></span></div>
                    </td>
                  </tr>

              </table>
              <div style="margin-left:72pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="10" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended December 31</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Current:</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;vertical-align:bottom">
                        <div style="margin-left:8.55pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Israel</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">17,633</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">38,248</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,829</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="margin-left:8.55pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Subsidiaries</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,864</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,614</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(131</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </div>
                      </td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">19,497</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">39,862</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,698</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred:</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;vertical-align:bottom">
                        <div style="margin-left:8.55pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Israel</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(149</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">84</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(770</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="margin-left:8.55pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Subsidiaries</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(149</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">84</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(770</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </div>
                      </td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total taxes on income</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">19,348</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">39,946</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,928</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>

                </table>
              </div>
            </div>
          <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock', window );">Schedule of Unrecognized Tax Benefits</a></td>
<td class="text">
            <div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="vertical-align:top;width:49pt">&#160;</td>
                    <td style="vertical-align:top;width:18pt">&#160;</td>
                    <td style="vertical-align:top;width:auto">
                      <div style="font-weight:bold">
                        <div style="line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The following table summarizes the activity of the Company&#8217;s unrecognized tax benefits:</span></span></div>
                      </div>
                    </td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:49pt">&#160;</td>
                    <td style="vertical-align:top;width:18pt">&#160;</td>
                    <td style="vertical-align:top;width:auto">&#160;</td>
                  </tr>

              </table>
              <div style="margin-left:72pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year&#160;ended&#160;December&#160;31</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="margin-left:16.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at January 1</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">303</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,831</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:76%;vertical-align:bottom">
                        <div style="margin-left:16.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Decrease in uncertain tax positions for the previous years</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4,831</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="margin-left:16.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Increase in uncertain tax positions for the current year, net</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,096</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">303</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:76%;padding-bottom:4px;vertical-align:bottom">
                        <div style="margin-left:16.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at December 31</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,399</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">303</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>

                </table>
              </div>
            </div>
          <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Paragraph 9<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Paragraph 12<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140222163030304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ENTITY-WIDE DISCLOSURE (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock', window );">Schedule of Net Sales by Geographic Area</a></td>
<td class="text">
          <div>
            <div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:67pt">&#160;</td>
                    <td style="vertical-align:top;width:21pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1)</span></span></td>
                    <td style="vertical-align:top;width:auto">
                      <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenues by geographic area were as follows:</span></span></div>
                    </td>
                  </tr>

              </table>
              <p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left">&#160;</p>
              <div style="margin-left:93pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="10" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended December 31</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">United States</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">307,818</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">298,612</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">237,263</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:64%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Europe</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">62,532</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">49,274</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">36,588</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">121,698</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">106,385</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">83,714</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:64%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">492,048</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">*</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">454,271</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">*</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">357,565</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">*</span></span></div>
                        </div>
                      </td>
                    </tr>

                </table>
              </div>
            </div>
            <div style="line-height:1.25">&#160;</div>
            <div style="line-height:1.25">
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:71pt">&#160;</td>
                    <td style="vertical-align:top;width:18pt">&#160;</td>
                    <td style="vertical-align:top;width:auto">
                      <div>
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">*Revenues are attributed to geographic areas based on the location of customer. No single customer accounted for 10% or more of Company&#8217;s total revenues, or Company&#8217;s net accounts receivable, in any fiscal year presented.</span></span></div>
                      </div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock', window );">Revenue from External Customers by Products and Services</a></td>
<td class="text">
          <div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:67pt">&#160;</td>
                  <td style="vertical-align:top;width:21pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2)</span></span></td>
                  <td style="vertical-align:top;width:auto">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenues based on products' category were as follows:</span></span></div>
                  </td>
                </tr>

            </table>
            <p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left">&#160;</p>
            <div style="margin-left:93pt">
              <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="10" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended December 31</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:middle;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Capital Equipment revenues</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">412,089</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">394,212</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">319,239</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:middle;width:64%;padding-bottom:2px;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Consumables and service revenues</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">79,959</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">60,059</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">38,326</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:middle;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">492,048</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">454,271</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">357,565</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>

              </table>
            </div>
          </div>
        <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock', window );">Schedule of Net Sales by Technology</a></td>
<td class="text">
          <div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:67pt">&#160;</td>
                  <td style="vertical-align:top;width:21pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3)</span></span></td>
                  <td style="vertical-align:top;width:auto">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenues based on products' technology were as follows:</span></span></div>
                  </td>
                </tr>

            </table>
            <p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left">&#160;</p>
            <div style="margin-left:93pt">
              <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="10" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended December 31</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="10" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:middle;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Minimal-Invasive</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">83</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">81</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">72</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:middle;width:64%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Hands-Free</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">20</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:middle;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-Invasive</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:middle;width:64%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>

              </table>
            </div>
          </div>
        <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock', window );">Schedule of Changes in Contract Liabilities</a></td>
<td class="text">
          <div>
            <div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:67pt">&#160;</td>
                    <td style="vertical-align:top;width:21pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4)</span></span></td>
                    <td style="vertical-align:top;width:auto">
                      <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The changes in contract liabilities are as follows:</span></span></div>
                    </td>
                  </tr>

              </table>
              <p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left">&#160;</p>
              <div style="margin-left:93pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td rowspan="1" style="vertical-align:middle;width:76%;background-color:rgb(255, 255, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="6" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year&#160;ended&#160;December&#160;31</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td rowspan="1" style="vertical-align:middle;width:76%;background-color:rgb(255, 255, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" rowspan="1" style="text-align:center;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255);font-weight:bold;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></td>
                      <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-15.95pt;margin-left:15.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of January 1</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">17,757</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">16,556</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:76%;vertical-align:bottom">
                        <div style="text-indent:-15.95pt;margin-left:15.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Increases due to issuance of new contracts, excluding amounts recognized as revenue during the period</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,498</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">14,987</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-15.95pt;margin-left:15.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenue recognized that was included in the contract liability balance at the beginning of the period</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(15,566</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(13,786</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </div>
                      </td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:76%;padding-bottom:4px;vertical-align:bottom">
                        <div style="text-indent:-15.95pt;margin-left:15.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">14,689</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">17,757</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-15.95pt;margin-left:15.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Contract liability presented in non-current liabilities (1)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,766</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,959</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:76%;padding-bottom:4px;vertical-align:bottom">
                        <div style="text-indent:-15.95pt;margin-left:15.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Contract liability presented in current liabilities</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10,923</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13,798</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>

                </table>
              </div>
            </div>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:67pt">&#160;</td>
                  <td style="vertical-align:top;width:21pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1)</span></span></td>
                  <td style="vertical-align:top;width:auto">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of December 31, 2023, non-current deferred revenue is estimated to be recognized as following: 83% in year 2025 and the rest in year 2026-2027.</span></span></div>
                  </td>
                </tr>

            </table>
          </div>
        <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfLongLivedAssetsHeldForSaleTextBlock', window );">Schedule of Long-Lived Assets</a></td>
<td class="text">
          <div>
            <div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:49.65pt">&#160;</td>
                    <td style="width:18pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">b.</span></span></td>
                    <td style="width:auto;vertical-align:top">
                      <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Long-Lived Assets</span></span></div>
                    </td>
                  </tr>

              </table>
              <p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left">&#160;</p>
              <div style="margin-left:72pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="6" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-15.95pt;margin-left:15.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Israel</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,704</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,263</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:76%;vertical-align:bottom">
                        <div style="text-indent:-15.95pt;margin-left:15.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">United States</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,789</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,097</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-15.95pt;margin-left:15.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,587</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,011</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:76%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,080</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7,371</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-indent:-15.95pt;margin-left:15.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other long-term assets*</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,370</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,573</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:76%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">16,450</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11,944</span></span></div>
                        </div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>

                </table>
              </div>
            </div>
            <div style="line-height:1.25">&#160;</div>
            <div style="line-height:1.25">
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:49.65pt">&#160;</td>
                    <td style="width:18pt;vertical-align:top;font-weight:bold">&#160;</td>
                    <td style="width:auto;vertical-align:top">
                      <div style="font-weight:normal">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">*Consists of non-current accounts receivable, net and other investments</span></span></div>
                      </div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfLongLivedAssetsHeldForSaleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long lived assets held for sale. Disclosure may include the description of the facts and circumstances leading to the expected disposal, manner and timing of disposal, the carrying value of the assets held for sale, the gain (loss) recognized in the income statement and the income statement caption that includes that gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfLongLivedAssetsHeldForSaleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph a<br> -SubTopic 10<br> -Topic 280<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-21<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-18<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-20<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-16<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-21<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140222159023664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
<th class="th" colspan="2"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>Segment</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>&#8362; / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>&#8362; / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 23, 2021 </div>
<div>&#8362; / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_AccountingPoliciesLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdvertisingExpense', window );">Advertising expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="nump">$ 4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Par or Stated Value Per Share | &#8362; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Amounts of severance payment expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 522<span></span>
</td>
<td class="nump">$ 431<span></span>
</td>
<td class="nump">405<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Allowance for credit losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,107<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,254<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,318<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 672<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of Operating Segments | Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember', window );">Forecast [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_AccountingPoliciesLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Amounts of severance payment expenses</a></td>
<td class="nump">$ 533<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_AccountingPoliciesLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_ShortTermDepositsAnnualInterestRate', window );">Short Term Deposits Annual Interest Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.10%<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_AccountingPoliciesLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_ShortTermDepositsAnnualInterestRate', window );">Short Term Deposits Annual Interest Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.01%<span></span>
</td>
<td class="nump">5.73%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inmd_AccountingPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inmd_AccountingPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inmd_ShortTermDepositsAnnualInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Short-term deposits annual interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inmd_ShortTermDepositsAnnualInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 720<br> -SubTopic 35<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483406/720-35-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479344/326-20-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481962/310-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeveranceCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeveranceCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140222160573808">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Schedule of Property and Equipment Estimated Useful Lives) (Details)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computers [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computers [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="text">4 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ToolsDiesAndMoldsMember', window );">Molds [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="text">4 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ToolsDiesAndMoldsMember', window );">Molds [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Equipment and furniture [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Equipment and furniture [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="text">17 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ToolsDiesAndMoldsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ToolsDiesAndMoldsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140222162495792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Schedule of Allowance For Credit Losses) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Balance at beginning of year</a></td>
<td class="nump">$ 1,318<span></span>
</td>
<td class="nump">$ 1,107<span></span>
</td>
<td class="nump">$ 672<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Current-period provision</a></td>
<td class="nump">1,020<span></span>
</td>
<td class="nump">449<span></span>
</td>
<td class="nump">516<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs', window );">Write-offs charged against the allowance</a></td>
<td class="num">(84)<span></span>
</td>
<td class="num">(238)<span></span>
</td>
<td class="num">(81)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Balance at end of year</a></td>
<td class="nump">$ 2,254<span></span>
</td>
<td class="nump">$ 1,318<span></span>
</td>
<td class="nump">$ 1,107<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479344/326-20-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481962/310-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of direct write-downs of accounts receivable charged against the allowance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140222160065616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Schedule of Accrued Warranty) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyAccrual', window );">Balance at beginning of year</a></td>
<td class="nump">$ 1,418<span></span>
</td>
<td class="nump">$ 1,248<span></span>
</td>
<td class="nump">$ 705<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyAccrualPayments', window );">Cost incurred</a></td>
<td class="num">(2,304)<span></span>
</td>
<td class="num">(2,099)<span></span>
</td>
<td class="num">(1,453)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued', window );">Expense recognized</a></td>
<td class="nump">2,362<span></span>
</td>
<td class="nump">2,269<span></span>
</td>
<td class="nump">1,996<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyAccrual', window );">Balance at end of year</a></td>
<td class="nump">$ 1,476<span></span>
</td>
<td class="nump">$ 1,418<span></span>
</td>
<td class="nump">$ 1,248<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyAccrual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount as of the balance sheet date of the aggregate standard product warranty liability. Does not include the balance for the extended product warranty liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482425/460-10-50-8<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)(5)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482425/460-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyAccrual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyAccrualPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in the standard product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard product warranty. Excludes extended product warranties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482425/460-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyAccrualPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in the standard product warranty accrual from warranties issued. Excludes extended product warranties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482425/460-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyAccrualWarrantiesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140222161386896">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>MARKETABLE SECURITIES AND FAIR VALUE MEASUREMENTS (Narrative) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesLineItems', window );"><strong>Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable securities</a></td>
<td class="nump">$ 373,647<span></span>
</td>
<td class="nump">$ 374,589<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=inmd_NonUsGovernmentAgenciesDebtSecuritiesMember', window );">Non Us Government Agencies Debt Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesLineItems', window );"><strong>Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable securities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,502<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=inmd_NonUsGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=inmd_NonUsGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140222160337568">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>MARKETABLE SECURITIES AND FAIR VALUE MEASUREMENTS (Schedule Of Marketable Securities) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesLineItems', window );"><strong>Marketable Securities [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable securities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 373,647<span></span>
</td>
<td class="nump">$ 374,589<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">Government bonds [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesLineItems', window );"><strong>Marketable Securities [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable securities</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">353,414<span></span>
</td>
<td class="nump">339,684<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MunicipalBondsMember', window );">Municipal bonds [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesLineItems', window );"><strong>Marketable Securities [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable securities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,319<span></span>
</td>
<td class="nump">2,551<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt securities [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesLineItems', window );"><strong>Marketable Securities [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable securities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">13,234<span></span>
</td>
<td class="nump">21,252<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial Paper [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesLineItems', window );"><strong>Marketable Securities [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable securities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,195<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember', window );">Certificates of deposit [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesLineItems', window );"><strong>Marketable Securities [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable securities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 4,680<span></span>
</td>
<td class="nump">$ 6,907<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">As of December 31, 2023 and 2022, consists of $0 and $1,502 non-U.S. government bonds, respectively.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MunicipalBondsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MunicipalBondsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140222160498080">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>MARKETABLE SECURITIES AND FAIR VALUE MEASUREMENTS (Schedule of Financial Assets Measured at Fair Value) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesLineItems', window );"><strong>Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Cost or amortized cost</a></td>
<td class="nump">$ 375,829<span></span>
</td>
<td class="nump">$ 384,320<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesLineItems', window );"><strong>Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">373,647<span></span>
</td>
<td class="nump">374,589<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Cost or amortized cost</a></td>
<td class="nump">375,829<span></span>
</td>
<td class="nump">384,320<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized holding loss</a></td>
<td class="num">(2,353)<span></span>
</td>
<td class="num">(9,745)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized holding gains</a></td>
<td class="nump">171<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 Securities [Member] | Government bonds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesLineItems', window );"><strong>Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">353,414<span></span>
</td>
<td class="nump">339,684<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Cost or amortized cost</a></td>
<td class="nump">355,382<span></span>
</td>
<td class="nump">348,687<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized holding loss</a></td>
<td class="num">(2,139)<span></span>
</td>
<td class="num">(9,003)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized holding gains</a></td>
<td class="nump">171<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 Securities [Member] | Municipal bonds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesLineItems', window );"><strong>Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">2,319<span></span>
</td>
<td class="nump">2,551<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Cost or amortized cost</a></td>
<td class="nump">2,363<span></span>
</td>
<td class="nump">2,674<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized holding loss</a></td>
<td class="num">(44)<span></span>
</td>
<td class="num">(123)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized holding gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 Securities [Member] | Corporate debt securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesLineItems', window );"><strong>Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">13,234<span></span>
</td>
<td class="nump">21,252<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Cost or amortized cost</a></td>
<td class="nump">13,404<span></span>
</td>
<td class="nump">21,850<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized holding loss</a></td>
<td class="num">(170)<span></span>
</td>
<td class="num">(612)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized holding gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 Securities [Member] | Commercial Paper [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesLineItems', window );"><strong>Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,195<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Cost or amortized cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,195<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized holding loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized holding gains</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 Securities [Member] | Certificates of deposit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesLineItems', window );"><strong>Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">4,680<span></span>
</td>
<td class="nump">6,907<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Cost or amortized cost</a></td>
<td class="nump">4,680<span></span>
</td>
<td class="nump">6,914<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized holding loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized holding gains</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MunicipalBondsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MunicipalBondsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140222162494560">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>MARKETABLE SECURITIES AND FAIR VALUE MEASUREMENTS (Schedule of Debt Securities on Maturity) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_MarketableSecuritiesAndFairValueMeasurementAbstract', window );"><strong>Marketable Securities and Fair Value Measurement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Due within one year</a></td>
<td class="nump">$ 308,671<span></span>
</td>
<td class="nump">$ 243,094<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInOneToTwoYearsFairValue', window );">1 to 2 years</a></td>
<td class="nump">49,259<span></span>
</td>
<td class="nump">124,037<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInTwoToThreeYearsFairValue', window );">2 to 3 years</a></td>
<td class="nump">15,717<span></span>
</td>
<td class="nump">7,458<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate', window );">Total</a></td>
<td class="nump">$ 373,647<span></span>
</td>
<td class="nump">$ 374,589<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInOneToTwoYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt securities, available for sale maturity, within one to two years, fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInOneToTwoYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInTwoToThreeYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt securities, available for sale maturity, within two to three years, fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInTwoToThreeYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inmd_MarketableSecuritiesAndFairValueMeasurementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inmd_MarketableSecuritiesAndFairValueMeasurementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480832/942-320-50-3A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480832/942-320-50-3A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140222160241584">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ACCOUNTS RECEIVABLE (Schedule of Accounts Receivable) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableGrossAllowanceAndNetAbstract', window );"><strong>Accounts, Notes, Loans and Financing Receivable, Gross, Allowance, and Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableGross', window );">Trade</a></td>
<td class="nump">$ 46,646<span></span>
</td>
<td class="nump">$ 29,859<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesReceivableGross', window );">Notes receivable</a></td>
<td class="nump">1,640<span></span>
</td>
<td class="nump">2,429<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Less - allowance for credit losses</a></td>
<td class="num">(2,254)<span></span>
</td>
<td class="num">(1,318)<span></span>
</td>
<td class="num">$ (1,107)<span></span>
</td>
<td class="num">$ (672)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsAndNotesReceivableNet', window );">Notes And Loans Receivable Net</a></td>
<td class="nump">46,032<span></span>
</td>
<td class="nump">30,970<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetNoncurrent', window );">Less - non-current accounts receivable</a></td>
<td class="num">(3,670)<span></span>
</td>
<td class="num">(3,973)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Total current accounts receivable</a></td>
<td class="nump">$ 42,362<span></span>
</td>
<td class="nump">$ 26,997<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsAndNotesReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of accounts and financing receivable. Includes, but is not limited to, notes and loan receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsAndNotesReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableGrossAllowanceAndNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableGrossAllowanceAndNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479344/326-20-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481962/310-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesReceivableGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost, before allowance for credit loss, of financing receivable. Excludes financing receivable covered under loss sharing agreement and net investment in lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 80<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479294/326-20-55-80<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 79<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479294/326-20-55-79<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479344/326-20-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1405<br> -Paragraph (a)<br> -Subparagraph (1)<br> -Publisher SEC<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1405<br> -Paragraph (a)<br> -Subparagraph (2)<br> -Publisher SEC<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1404<br> -Paragraph (a)<br> -Publisher SEC<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-14<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -SubTopic 10<br> -Topic 310<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481962/310-10-50-7A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesReceivableGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140222156103184">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>PREPAID EXPENSES AND OTHER CURRENT RECEIVABLES (Schedule of Prepaid expenses and other current receivables) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrentAbstract', window );"><strong>Other Receivables, Net, Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_OtherAdvancesToSuppliersCurrent', window );">Advances to suppliers</a></td>
<td class="nump">$ 11,960<span></span>
</td>
<td class="nump">$ 11,898<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_OtherPrepaidExpensesReceivablesCurrent', window );">Prepaid expenses</a></td>
<td class="nump">3,041<span></span>
</td>
<td class="nump">1,928<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_OtherGovernmentInstitutionsReceivablesCurrent', window );">Government institutions</a></td>
<td class="nump">948<span></span>
</td>
<td class="nump">879<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_OtherIncomeTaxReceivablesCurrent', window );">Income tax</a></td>
<td class="nump">66<span></span>
</td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivablesGrossCurrent', window );">Other</a></td>
<td class="nump">253<span></span>
</td>
<td class="nump">345<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Total other current receivables</a></td>
<td class="nump">$ 16,268<span></span>
</td>
<td class="nump">$ 15,094<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inmd_OtherAdvancesToSuppliersCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, advances to suppliers of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inmd_OtherAdvancesToSuppliersCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inmd_OtherGovernmentInstitutionsReceivablesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, government institution of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inmd_OtherGovernmentInstitutionsReceivablesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inmd_OtherIncomeTaxReceivablesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, income tax of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inmd_OtherIncomeTaxReceivablesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inmd_OtherPrepaidExpensesReceivablesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, prepaid expenses of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inmd_OtherPrepaidExpensesReceivablesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesGrossCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesGrossCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140222156096528">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INVENTORIES (Schedule of Inventories) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRawMaterials', window );">Raw materials</a></td>
<td class="nump">$ 12,080<span></span>
</td>
<td class="nump">$ 13,686<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoods', window );">Finished products</a></td>
<td class="nump">33,015<span></span>
</td>
<td class="nump">26,211<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total inventories</a></td>
<td class="nump">$ 45,095<span></span>
</td>
<td class="nump">$ 39,897<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterials">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterials</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140222162621680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT, NET (Schedule of Property and Equipment) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">$ 5,839<span></span>
</td>
<td class="nump">$ 5,132<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: accumulated depreciation</a></td>
<td class="num">(3,457)<span></span>
</td>
<td class="num">(2,834)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Total property and equipment, net</a></td>
<td class="nump">2,382<span></span>
</td>
<td class="nump">2,298<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">623<span></span>
</td>
<td class="nump">680<span></span>
</td>
<td class="nump">$ 517<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">1,334<span></span>
</td>
<td class="nump">1,191<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember', window );">Office furniture and equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">670<span></span>
</td>
<td class="nump">562<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ToolsDiesAndMoldsMember', window );">Molds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">2,592<span></span>
</td>
<td class="nump">2,550<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">$ 1,243<span></span>
</td>
<td class="nump">$ 829<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480842/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ToolsDiesAndMoldsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ToolsDiesAndMoldsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140222159190224">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>OTHER INVESTMENTS (Narrative) (Details) - Medimor [Member] - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Nov. 30, 2023</div></th>
<th class="th"><div>Nov. 30, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=inmd_SharePurchaseAndShareholdersAgreementMember', window );">Share purchase and shareholders agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems', window );"><strong>Net Investment Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Investments', window );">Investment Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="nump">$ 600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">117,440<span></span>
</td>
<td class="nump">1,369,863<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14.78%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=inmd_SharePurchaseAndShareholdersAgreementMember', window );">Share purchase and shareholders agreement [Member] | Fully diluted basis [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems', window );"><strong>Net Investment Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.34%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=inmd_TwoPurchaseAndShareholdersAgreementsMember', window );">Two purchase and shareholders agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems', window );"><strong>Net Investment Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest</a></td>
<td class="nump">14.78%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=inmd_TwoPurchaseAndShareholdersAgreementsMember', window );">Two purchase and shareholders agreements [Member] | Fully diluted basis [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems', window );"><strong>Net Investment Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest</a></td>
<td class="nump">11.23%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Investments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(h))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Investments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=inmd_SharePurchaseAndShareholdersAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=inmd_SharePurchaseAndShareholdersAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=inmd_MedimorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=inmd_MedimorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=inmd_FullyDilutedBasisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=inmd_FullyDilutedBasisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=inmd_TwoPurchaseAndShareholdersAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=inmd_TwoPurchaseAndShareholdersAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140222160358992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES (Narrative) (Details) - Lease agreement [Member]<br> &#8362; in Thousands</strong></div></th>
<th class="th" colspan="4">1 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jul. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 31, 2018 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th"><div>Jul. 01, 2022</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_LeaseExpires', window );">Lease expiration date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">December 2027<span></span>
</td>
<td class="text">December 2027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_BankGuarantee', window );">Bank guarantee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 266,000<span></span>
</td>
<td class="nump">&#8362; 966<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_CurrentMonthlyRentPayment', window );">Current monthly rent payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 64,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=inmd_LeaseAgreementMember', window );">Vehicles [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Term of contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=inmd_LeaseAgreementMember', window );">Warehouse [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_LeaseExpires', window );">Lease expiration date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">august 2027<span></span>
</td>
<td class="text">august 2027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_CurrentMonthlyRentPayment', window );">Current monthly rent payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=inmd_LeaseAgreementMember', window );">Office Building [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_CurrentMonthlyRentPayment', window );">Current monthly rent payment</a></td>
<td class="nump">$ 17,000<span></span>
</td>
<td class="nump">$ 27,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Term of contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years 4 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inmd_BankGuarantee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Bank guarantee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inmd_BankGuarantee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inmd_CurrentMonthlyRentPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Current monthly rent payment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inmd_CurrentMonthlyRentPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inmd_LeaseExpires">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease expires period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inmd_LeaseExpires</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=inmd_LeaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=inmd_LeaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=srt_WarehouseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=srt_WarehouseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=srt_OfficeBuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=srt_OfficeBuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140222168457568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES (Schedule of Lease Expense) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="nump">$ 2,348<span></span>
</td>
<td class="nump">$ 1,628<span></span>
</td>
<td class="nump">$ 1,297<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140222166019072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES (Schedule of Supplemental Cash Flow Information Related to Leases) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash flows from operating leases</a></td>
<td class="nump">$ 2,530<span></span>
</td>
<td class="nump">$ 1,881<span></span>
</td>
<td class="nump">$ 1,328<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140222162497648">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LEASES (Schedule of Supplemental Balance Sheet Information Related to Leases) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesOperatingAbstract', window );"><strong>Operating Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">$ 9,698<span></span>
</td>
<td class="nump">$ 5,073<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_OtherCurrentLeaseLiabilities', window );">Other current liabilities</a></td>
<td class="nump">2,404<span></span>
</td>
<td class="nump">1,453<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities</a></td>
<td class="nump">6,613<span></span>
</td>
<td class="nump">3,509<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="nump">$ 9,017<span></span>
</td>
<td class="nump">$ 4,962<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted Average Remaining Lease Term, Operating leases</a></td>
<td class="text">2 years 10 months 24 days<span></span>
</td>
<td class="text">4 years 3 months 18 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesOperatingAbstract', window );"><strong>Operating Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted Average Discount Rate, Operating leases</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesOperatingAbstract', window );"><strong>Operating Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted Average Discount Rate, Operating leases</a></td>
<td class="nump">7.84%<span></span>
</td>
<td class="nump">5.80%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inmd_OtherCurrentLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other lease liabilities classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inmd_OtherCurrentLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesOperatingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesOperatingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140222160273968">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LEASES (Schedule of Maturities of Lease Liabilities) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2024</a></td>
<td class="nump">$ 2,745<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2025</a></td>
<td class="nump">2,491<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2026</a></td>
<td class="nump">2,001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2027</a></td>
<td class="nump">1,733<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">2028 and beyond</a></td>
<td class="nump">902<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">9,872<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less imputed interests</a></td>
<td class="num">(855)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="nump">$ 9,017<span></span>
</td>
<td class="nump">$ 4,962<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140222159834336">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>OTHER CURRENT LIABILITIES (Schedule Of Other Liabilities) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_OtherCurrentLiabilitiesLineItems', window );"><strong>Other Current Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Employees and related expenses</a></td>
<td class="nump">$ 21,040<span></span>
</td>
<td class="nump">$ 19,439<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_GovernmentInstitutions', window );">Government institutions</a></td>
<td class="nump">3,932<span></span>
</td>
<td class="nump">4,052<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Income tax payable</a></td>
<td class="nump">1,918<span></span>
</td>
<td class="nump">19,241<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_WarrantyReserveLiabilityCurrent', window );">Warranty reserve</a></td>
<td class="nump">1,476<span></span>
</td>
<td class="nump">1,418<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_OtherCurrentLeaseLiabilities', window );">Other current liabilities</a></td>
<td class="nump">2,404<span></span>
</td>
<td class="nump">1,453<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_ContractorLiability', window );">Contractor Liability</a></td>
<td class="nump">5,656<span></span>
</td>
<td class="nump">4,003<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">2,821<span></span>
</td>
<td class="nump">2,374<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Total other current liabilities</a></td>
<td class="nump">$ 39,247<span></span>
</td>
<td class="nump">$ 51,980<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inmd_ContractorLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of contractor liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inmd_ContractorLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inmd_GovernmentInstitutions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Government institutions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inmd_GovernmentInstitutions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inmd_OtherCurrentLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other lease liabilities classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inmd_OtherCurrentLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inmd_OtherCurrentLiabilitiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inmd_OtherCurrentLiabilitiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inmd_WarrantyReserveLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warranty reserve liability current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inmd_WarrantyReserveLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140222162660688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES (Narrative) (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantSupplyCommitmentRemainingMinimumAmountCommitted', window );">Supply and open orders commitment</a></td>
<td class="nump">$ 41,561<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForAdvanceToAffiliate', window );">Subcontractors advances</a></td>
<td class="nump">$ 9,914<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForAdvanceToAffiliate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow from advancing money to an affiliate (an entity that is related but not strictly controlled by the entity).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForAdvanceToAffiliate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantSupplyCommitmentRemainingMinimumAmountCommitted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The floor amount as of the balance sheet date that the entity must expend to satisfy the terms of disclosed arrangements (excluding long-term commitments) in which the entity must commit resources to supply goods or services to one or more customers.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantSupplyCommitmentRemainingMinimumAmountCommitted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140222156179984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHAREHOLDERS' EQUITY (Narrative) (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>&#8362; / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>&#8362; / shares</div>
</th>
<th class="th">
<div>May 23, 2021 </div>
<div>&#8362; / shares</div>
</th>
<th class="th">
<div>Apr. 23, 2021 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Ordinary shares, par value | &#8362; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 0.01<span></span>
</td>
<td class="nump">&#8362; 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteStockSplit', window );">Stock split</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1-for-2 share split<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_StockRepurchasedDuringPeriodValueOne', window );">Repurchase of ordinary shares | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 42,600<span></span>
</td>
<td class="nump">$ 35,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of ordinary shares, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,077,213<span></span>
</td>
<td class="nump">693,734<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_FairValueOfRestrictedOptionsGranted', window );">Fair value of RSUs granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,334<span></span>
</td>
<td class="nump">30,817<span></span>
</td>
<td class="nump">19,279<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1', window );">Vested options | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,122<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Unvested options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">660,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized compensation expense | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,517<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized compensation cost, recognition period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 1 month 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue', window );">Fair value of RSU granted, per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34.44<span></span>
</td>
<td class="nump">$ 49.35<span></span>
</td>
<td class="nump">$ 35.44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonVestedVested', window );">Number of RSUs vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">275,249<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=srt_SubsidiariesMember', window );">Invasix UK [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">457,912<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=srt_SubsidiariesMember', window );">Invasix UK [Member] | Dilazar Limited [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Ownership interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=inmd_TwoThousandsEighteenIncentivePlanMember', window );">2018 Incentive Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized to be issued as ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,378,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of options available for grant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,902,431<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Aggregate intrinsic value | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 28,315<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=inmd_TwoThousandsEighteenIncentivePlanMember', window );">2018 Incentive Plan [Member] | Employees [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted average remaining contractual life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Total intrinsic value of options exercised | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24,819<span></span>
</td>
<td class="nump">$ 10,549<span></span>
</td>
<td class="nump">$ 277,978<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=inmd_ShareRepurchaseProgramMember', window );">Share Repurchase Program [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_StockRepurchasedDuringPeriodValueOne', window );">Repurchase of ordinary shares | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 95,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of ordinary shares, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,557,829<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of ordinary shares, shares</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inmd_FairValueOfRestrictedOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of restricted options granted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inmd_FairValueOfRestrictedOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonVestedVested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of restricted stock units vested at the end of the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonVestedVested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inmd_StockRepurchasedDuringPeriodValueOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Repurchase of ordinary shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inmd_StockRepurchasedDuringPeriodValueOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average intrinsic value of award granted under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of non-vested options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteStockSplit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of the stock split arrangement. Also provide the retroactive effect given by a stock split that occurs after the balance date but before the release of financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB Topic 4.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteStockSplit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=srt_SubsidiariesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=srt_SubsidiariesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=inmd_DilazarLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=inmd_DilazarLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=inmd_TwoThousandsEighteenIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=inmd_TwoThousandsEighteenIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=inmd_EmployeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=inmd_EmployeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=inmd_ShareRepurchaseProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=inmd_ShareRepurchaseProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140222159009744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHAREHOLDERS' EQUITY (Schedule Of Options Granted) (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr><th class="th" colspan="2">
<div>Dec. 31, 2023 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of options</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at beginning of year | shares</a></td>
<td class="nump">2,553,640<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_OptionsChangesDuringYear', window );"><strong>Changes during the year:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Granted | shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised | shares</a></td>
<td class="num">(915,145)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Forfeited | shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Expired | shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at end of year | shares</a></td>
<td class="nump">1,638,495<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable at end of year | shares</a></td>
<td class="nump">1,638,495<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted average exercise price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at beginning of year | $ / shares</a></td>
<td class="nump">$ 5.3<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_WeightedAverageExercisePriceChangesDuringYearAbstract', window );"><strong>Changes during the year:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted | $ / shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised | $ / shares</a></td>
<td class="nump">5.92<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Forfeited | $ / shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice', window );">Expired | $ / shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at end of year | $ / shares</a></td>
<td class="nump">4.96<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Exercisable at end of year | $ / shares</a></td>
<td class="nump">$ 4.96<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">In U.S. dollars per Ordinary Share</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inmd_OptionsChangesDuringYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inmd_OptionsChangesDuringYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inmd_WeightedAverageExercisePriceChangesDuringYearAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inmd_WeightedAverageExercisePriceChangesDuringYearAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140222159132176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHAREHOLDERS' EQUITY (Schedule Of Outstanding and Exercisable Options) (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr><th class="th" colspan="2">
<div>Dec. 31, 2023 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=inmd_ExercisePriceRangeOneMember', window );">$0.28 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice', window );">Exercise prices | $ / shares</a></td>
<td class="nump">$ 0.28<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number of options Outstanding and exercisable at end of year | shares</a></td>
<td class="nump">361,993<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted average remaining contractual life of outstanding options</a></td>
<td class="text">5 months 1 day<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=inmd_ExercisePriceRangeTwoMember', window );">$0.29 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice', window );">Exercise prices | $ / shares</a></td>
<td class="nump">$ 0.29<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number of options Outstanding and exercisable at end of year | shares</a></td>
<td class="nump">203,438<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted average remaining contractual life of outstanding options</a></td>
<td class="text">5 months 1 day<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=inmd_ExercisePriceRangeThreeMember', window );">$3.16 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice', window );">Exercise prices | $ / shares</a></td>
<td class="nump">$ 3.16<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number of options Outstanding and exercisable at end of year | shares</a></td>
<td class="nump">149,948<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted average remaining contractual life of outstanding options</a></td>
<td class="text">1 year 8 months 15 days<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=inmd_ExercisePriceRangeFourMember', window );">$3.75 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice', window );">Exercise prices | $ / shares</a></td>
<td class="nump">$ 3.75<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number of options Outstanding and exercisable at end of year | shares</a></td>
<td class="nump">211,173<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted average remaining contractual life of outstanding options</a></td>
<td class="text">2 years 7 days<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=inmd_ExercisePriceRangeFiveMember', window );">$5.11 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice', window );">Exercise prices | $ / shares</a></td>
<td class="nump">$ 5.11<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number of options Outstanding and exercisable at end of year | shares</a></td>
<td class="nump">70,756<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted average remaining contractual life of outstanding options</a></td>
<td class="text">2 years 3 months 3 days<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=inmd_ExercisePriceRangeSixMember', window );">$7.00 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice', window );">Exercise prices | $ / shares</a></td>
<td class="nump">$ 7<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number of options Outstanding and exercisable at end of year | shares</a></td>
<td class="nump">41,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted average remaining contractual life of outstanding options</a></td>
<td class="text">2 years 7 months 9 days<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=inmd_ExercisePriceRangeSevenMember', window );">$9.85 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice', window );">Exercise prices | $ / shares</a></td>
<td class="nump">$ 9.85<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number of options Outstanding and exercisable at end of year | shares</a></td>
<td class="nump">565,129<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted average remaining contractual life of outstanding options</a></td>
<td class="text">3 years 2 months 4 days<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=inmd_ExercisePriceRangeEightMember', window );">$12.16 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice', window );">Exercise prices | $ / shares</a></td>
<td class="nump">$ 12.16<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number of options Outstanding and exercisable at end of year | shares</a></td>
<td class="nump">28,558<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted average remaining contractual life of outstanding options</a></td>
<td class="text">3 years 4 months 6 days<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=inmd_ExercisePriceRangeNineMember', window );">$21.62 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice', window );">Exercise prices | $ / shares</a></td>
<td class="nump">$ 21.62<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number of options Outstanding and exercisable at end of year | shares</a></td>
<td class="nump">6,500<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted average remaining contractual life of outstanding options</a></td>
<td class="text">3 years 10 months 9 days<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">In U.S. dollars per Ordinary Share</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inmd_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The floor of a range of exercise prices for purposes of disclosing shares potentially issuable under outstanding and exercisable stock option awards on all stock option plans and other required information pertaining to awards in the range.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inmd_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=inmd_ExercisePriceRangeOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=inmd_ExercisePriceRangeOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=inmd_ExercisePriceRangeTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=inmd_ExercisePriceRangeTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=inmd_ExercisePriceRangeThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=inmd_ExercisePriceRangeThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=inmd_ExercisePriceRangeFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=inmd_ExercisePriceRangeFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=inmd_ExercisePriceRangeFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=inmd_ExercisePriceRangeFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=inmd_ExercisePriceRangeSixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=inmd_ExercisePriceRangeSixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=inmd_ExercisePriceRangeSevenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=inmd_ExercisePriceRangeSevenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=inmd_ExercisePriceRangeEightMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=inmd_ExercisePriceRangeEightMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=inmd_ExercisePriceRangeNineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=inmd_ExercisePriceRangeNineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140222160574224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHAREHOLDERS' EQUITY (Schedule of Options Granted Resticted Share Unit) (Details) - Restricted Stock Units (RSUs) [Member]<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr><th class="th" colspan="2">
<div>Dec. 31, 2023 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward', window );"><strong>Number of RSUs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding at beginning of year | shares</a></td>
<td class="nump">804,575<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_UnitsChangesDuringYearAbstract', window );"><strong>Changes during the year:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted | shares</a></td>
<td class="nump">706,560<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested | shares</a></td>
<td class="num">(522,326)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited | shares</a></td>
<td class="num">(52,760)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding at end of year | shares</a></td>
<td class="nump">936,049<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted Average Grant Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding at beginning of year | $ / shares</a></td>
<td class="nump">$ 45.74<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_WeightedAverageGrantDateChangesDuringYearAbstract', window );"><strong>Changes during the year:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted | $ / shares</a></td>
<td class="nump">34.44<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue', window );">Vested | $ / shares</a></td>
<td class="nump">43.33<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited | $ / shares</a></td>
<td class="nump">37.21<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding at end of year | $ / shares</a></td>
<td class="nump">$ 39.04<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">As of December 31, 2023, 275,249 RSUs were vested and were settled by issuance of respective shares at the beginning of January 2024.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were vested.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inmd_UnitsChangesDuringYearAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inmd_UnitsChangesDuringYearAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inmd_WeightedAverageGrantDateChangesDuringYearAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inmd_WeightedAverageGrantDateChangesDuringYearAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140222159173504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHAREHOLDERS' EQUITY (Schedule Of Share Based Compensation Expense) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Equity-based compensation income</a></td>
<td class="nump">$ 23,600<span></span>
</td>
<td class="nump">$ 24,452<span></span>
</td>
<td class="nump">$ 11,962<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of Sales [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Equity-based compensation income</a></td>
<td class="nump">2,046<span></span>
</td>
<td class="nump">1,917<span></span>
</td>
<td class="nump">1,108<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and Development Expenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Equity-based compensation income</a></td>
<td class="nump">2,652<span></span>
</td>
<td class="nump">3,166<span></span>
</td>
<td class="nump">1,554<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember', window );">Selling and Marketing Expenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Equity-based compensation income</a></td>
<td class="nump">17,167<span></span>
</td>
<td class="nump">17,302<span></span>
</td>
<td class="nump">8,274<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and Administrative Expenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Equity-based compensation income</a></td>
<td class="nump">$ 1,735<span></span>
</td>
<td class="nump">$ 2,067<span></span>
</td>
<td class="nump">$ 1,026<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140222162827120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Narrative) (Details)<br> $ in Thousands, &#8362; in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th">
<div>Nov. 15, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 15, 2021 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Statutory rate</a></td>
<td class="nump">23.00%<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesReceivable', window );">Tax asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,894<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Accumulated tax loss carryforward</a></td>
<td class="nump">$ 217,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_OneTimePayment', window );">One-time payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,000<span></span>
</td>
<td class="nump">&#8362; 42.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_UndistributedExemptIncome', window );">Undistributed exempt income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">165,700<span></span>
</td>
<td class="nump">591.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions', window );">Payment of income tax assessment with tax authorities</a></td>
<td class="nump">$ 1,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=inmd_AmendmentAdvantageExemptionMember', window );">Amendment Advantage Exemption [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_OneTimePayment', window );">One-time payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,000<span></span>
</td>
<td class="nump">&#8362; 32.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityNameAxis=inmd_IsraeliTaxAuthorityMember', window );">Israeli Tax Authority [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_UndistributedExemptIncome', window );">Undistributed exempt income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 50.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityNameAxis=inmd_SubsidiariesOutsideIsraelMember', window );">Subsidiaries outside Israel [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_CorporateTax', window );">Corporate tax</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityNameAxis=inmd_SubsidiariesOutsideIsraelMember', window );">Subsidiaries outside Israel [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_CorporateTax', window );">Corporate tax</a></td>
<td class="nump">26.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=inmd_RegulationsMember', window );">Regulations [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_CorporateTax', window );">Corporate tax</a></td>
<td class="nump">7.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inmd_CorporateTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Corporate tax rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inmd_CorporateTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inmd_OneTimePayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>One-time payment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inmd_OneTimePayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inmd_UndistributedExemptIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Undistributed exempt income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inmd_UndistributedExemptIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxContingencyLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxContingencyLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.10)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) to previously recorded tax expense. Includes, but is not limited to, significant settlements of income tax disputes, and unusual tax positions or infrequent actions taken by the entity, including tax assessment reversal, and IRS tax settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482620/740-10-25-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482620/740-10-25-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CumulativeEffectPeriodOfAdoptionAxis=inmd_AmendmentAdvantageExemptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CumulativeEffectPeriodOfAdoptionAxis=inmd_AmendmentAdvantageExemptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=inmd_IsraeliTaxAuthorityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=inmd_IsraeliTaxAuthorityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=inmd_SubsidiariesOutsideIsraelMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=inmd_SubsidiariesOutsideIsraelMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=inmd_RegulationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=inmd_RegulationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140222162602480">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INCOME TAXES (Schedule of Deferred Tax Assets (liabilities)) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNetAbstract', window );"><strong>Deferred tax assets in respect of:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Subsidiaries carryforward losses</a></td>
<td class="nump">$ 58,075<span></span>
</td>
<td class="nump">$ 60,229<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other temporary differences</a></td>
<td class="nump">3,112<span></span>
</td>
<td class="nump">2,369<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Share-based compensation</a></td>
<td class="nump">4,194<span></span>
</td>
<td class="nump">5,073<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOtherComprehensiveLoss', window );">Deferred tax asset in respect to other comprehensive loss</a></td>
<td class="nump">502<span></span>
</td>
<td class="nump">2,238<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total deferred tax assets before valuation allowance</a></td>
<td class="nump">65,883<span></span>
</td>
<td class="nump">69,909<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(64,377)<span></span>
</td>
<td class="num">(66,815)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Total deferred tax assets</a></td>
<td class="nump">$ 1,506<span></span>
</td>
<td class="nump">$ 3,094<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOtherComprehensiveLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from unrealized losses in other comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOtherComprehensiveLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140222160187600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Schedule of Reconciliation of Theoretical Provision For Income Tax) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before taxes on income</a></td>
<td class="nump">$ 217,267<span></span>
</td>
<td class="nump">$ 201,466<span></span>
</td>
<td class="nump">$ 168,002<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Theoretical tax expenses at the statutory rate of InMode Ltd.</a></td>
<td class="nump">23.00%<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Theoretical tax benefit</a></td>
<td class="nump">$ 49,971<span></span>
</td>
<td class="nump">$ 46,337<span></span>
</td>
<td class="nump">$ 38,640<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract', window );"><strong>Increase (decrease) in taxes on income due to:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_IncomeTaxReconciliationBenefitsToBenefitedEnterprise', window );">Benefits to the Benefited Enterprise</a></td>
<td class="num">(31,739)<span></span>
</td>
<td class="num">(29,429)<span></span>
</td>
<td class="num">(37,478)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_IncomeTaxReconciliationDifferentEffectiveTaxRatesApplicableToSubsidiaries', window );">Different effective tax rates applicable to the Subsidiaries</a></td>
<td class="num">(1,956)<span></span>
</td>
<td class="num">(1,453)<span></span>
</td>
<td class="num">(2,033)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="nump">126<span></span>
</td>
<td class="nump">130<span></span>
</td>
<td class="nump">40<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_IncomeTaxReconciliationUncertainTaxPosition', window );">Uncertain tax positions</a></td>
<td class="nump">1,096<span></span>
</td>
<td class="nump">303<span></span>
</td>
<td class="nump">1,921<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_IncomeTaxReconciliationNonDeductibleExpenses', window );">Non-deductible expenses and other permanent differences, mainly share based compensation expenses</a></td>
<td class="nump">1,850<span></span>
</td>
<td class="nump">1,842<span></span>
</td>
<td class="nump">1,838<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_IncomeTaxReconciliationAmendmentToInvestmentsLawPayment', window );">Amendment to the Investments Law payment - see also note 13a(2)(b)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">12,017<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_IncomeTaxReconciliationSettlementsWithIsraeliTaxAuthorityNetOfDecreaseOfRelatedUncertainTax', window );">Settlements with the Israeli tax authority net of decrease of related uncertain tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">10,199<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total taxes on income</a></td>
<td class="nump">$ 19,348<span></span>
</td>
<td class="nump">$ 39,946<span></span>
</td>
<td class="nump">$ 2,928<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inmd_IncomeTaxReconciliationAmendmentToInvestmentsLawPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of income tax reconciliation amendment to the investments law payment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inmd_IncomeTaxReconciliationAmendmentToInvestmentsLawPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inmd_IncomeTaxReconciliationBenefitsToBenefitedEnterprise">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Benefits to the Benefited Enterprise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inmd_IncomeTaxReconciliationBenefitsToBenefitedEnterprise</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inmd_IncomeTaxReconciliationDifferentEffectiveTaxRatesApplicableToSubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to Different effective tax rates applicable to the subsidiaries.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inmd_IncomeTaxReconciliationDifferentEffectiveTaxRatesApplicableToSubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inmd_IncomeTaxReconciliationNonDeductibleExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to Non-deductible expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inmd_IncomeTaxReconciliationNonDeductibleExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inmd_IncomeTaxReconciliationSettlementsWithIsraeliTaxAuthorityNetOfDecreaseOfRelatedUncertainTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of Income tax reconciliation settlements with israeli tax authority net of decrease of related uncertain tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inmd_IncomeTaxReconciliationSettlementsWithIsraeliTaxAuthorityNetOfDecreaseOfRelatedUncertainTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inmd_IncomeTaxReconciliationUncertainTaxPosition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to uncertain tax position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inmd_IncomeTaxReconciliationUncertainTaxPosition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 940<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481913/940-20-25-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140222159820672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Schedule of Income Before Income Taxes) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_IncomeTaxNoteLineItems', window );"><strong>Income Tax Note [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before taxes on income</a></td>
<td class="nump">$ 217,267<span></span>
</td>
<td class="nump">$ 201,466<span></span>
</td>
<td class="nump">$ 168,002<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityNameAxis=inmd_InmodeLtdAndIsreaeliSubsidiariesMember', window );">InMode Ltd. and Israeli subsidiaries [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_IncomeTaxNoteLineItems', window );"><strong>Income Tax Note [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before taxes on income</a></td>
<td class="nump">211,137<span></span>
</td>
<td class="nump">196,354<span></span>
</td>
<td class="nump">163,370<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityNameAxis=inmd_SubsidiariesOutsideIsraelMember', window );">Subsidiaries outside of Israel [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_IncomeTaxNoteLineItems', window );"><strong>Income Tax Note [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before taxes on income</a></td>
<td class="nump">$ 6,130<span></span>
</td>
<td class="nump">$ 5,112<span></span>
</td>
<td class="nump">$ 4,632<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inmd_IncomeTaxNoteLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inmd_IncomeTaxNoteLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 940<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481913/940-20-25-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=inmd_InmodeLtdAndIsreaeliSubsidiariesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=inmd_InmodeLtdAndIsreaeliSubsidiariesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=inmd_SubsidiariesOutsideIsraelMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=inmd_SubsidiariesOutsideIsraelMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140222155147472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Schedule of Tax Expenses (Tax Benefit)) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_IncomeTaxNoteLineItems', window );"><strong>Income Tax Note [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Current</a></td>
<td class="nump">$ 19,497<span></span>
</td>
<td class="nump">$ 39,862<span></span>
</td>
<td class="nump">$ 3,698<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred</a></td>
<td class="num">(149)<span></span>
</td>
<td class="nump">84<span></span>
</td>
<td class="num">(770)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total taxes on income</a></td>
<td class="nump">19,348<span></span>
</td>
<td class="nump">39,946<span></span>
</td>
<td class="nump">2,928<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityNameAxis=country_IL', window );">Israel [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_IncomeTaxNoteLineItems', window );"><strong>Income Tax Note [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Current</a></td>
<td class="nump">17,633<span></span>
</td>
<td class="nump">38,248<span></span>
</td>
<td class="nump">3,829<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred</a></td>
<td class="num">(149)<span></span>
</td>
<td class="nump">84<span></span>
</td>
<td class="num">(770)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityNameAxis=inmd_SubsidiariesOutsideIsraelMember', window );">Subsidiaries outside Israel [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_IncomeTaxNoteLineItems', window );"><strong>Income Tax Note [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Current</a></td>
<td class="nump">1,864<span></span>
</td>
<td class="nump">1,614<span></span>
</td>
<td class="num">(131)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inmd_IncomeTaxNoteLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inmd_IncomeTaxNoteLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=country_IL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=country_IL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=inmd_SubsidiariesOutsideIsraelMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=inmd_SubsidiariesOutsideIsraelMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140222163051632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Schedule of Unrecognized Tax Benefits) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Balance at January 1</a></td>
<td class="nump">$ 303<span></span>
</td>
<td class="nump">$ 4,831<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions', window );">Decrease in uncertain tax positions for the previous years</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(4,831)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Increase in uncertain tax positions for the current year, net</a></td>
<td class="nump">1,096<span></span>
</td>
<td class="nump">303<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Balance at December 31</a></td>
<td class="nump">$ 1,399<span></span>
</td>
<td class="nump">$ 303<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-10B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140222166796080">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ENTITY-WIDE DISCLOSURE (Narrative) (Details)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_PercentageOfNonCurrentDeferredRevenue', window );">Percentage of non- current deferred revenue</a></td>
<td class="nump">83.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inmd_PercentageOfNonCurrentDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of non- current deferred revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inmd_PercentageOfNonCurrentDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingRevenueReconcilingItemLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140222162770560">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>ENTITY-WIDE DISCLOSURE (Schedule Of Net Sales By Geographical Area) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">REVENUES</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 492,048<span></span>
</td>
<td class="nump">$ 454,271<span></span>
</td>
<td class="nump">$ 357,565<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">REVENUES</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">307,818<span></span>
</td>
<td class="nump">298,612<span></span>
</td>
<td class="nump">237,263<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">REVENUES</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">62,532<span></span>
</td>
<td class="nump">49,274<span></span>
</td>
<td class="nump">36,588<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=inmd_OtherCountryMember', window );">Other Country [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">REVENUES</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 121,698<span></span>
</td>
<td class="nump">$ 106,385<span></span>
</td>
<td class="nump">$ 83,714<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Revenues are attributed to geographic areas based on the location of customer. No single customer accounted for 10% or more of Company&#8217;s total revenues, or Company&#8217;s net accounts receivable, in any fiscal year presented.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingRevenueReconcilingItemLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=inmd_OtherCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=inmd_OtherCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140222160115584">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>ENTITY-WIDE DISCLOSURE (Schedule of revenues based on products' category) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 492,048<span></span>
</td>
<td class="nump">$ 454,271<span></span>
</td>
<td class="nump">$ 357,565<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=inmd_CapitalEquipmentMember', window );">Capital Equipment [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">412,089<span></span>
</td>
<td class="nump">394,212<span></span>
</td>
<td class="nump">319,239<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=inmd_ConsumablesAndServiceRevenuesMember', window );">Consumables And Service Revenues [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 79,959<span></span>
</td>
<td class="nump">$ 60,059<span></span>
</td>
<td class="nump">$ 38,326<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Revenues are attributed to geographic areas based on the location of customer. No single customer accounted for 10% or more of Company&#8217;s total revenues, or Company&#8217;s net accounts receivable, in any fiscal year presented.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=inmd_CapitalEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=inmd_CapitalEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=inmd_ConsumablesAndServiceRevenuesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=inmd_ConsumablesAndServiceRevenuesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140222159769024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ENTITY-WIDE DISCLOSURE (Schedule of Net Sales by Techonology) (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_PercentageOfNetSalesBasedOnProductsTechnology', window );">Percentage of net sales based on products technology</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=inmd_MinimalInvasiveMember', window );">Minimal-Invasive [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_PercentageOfNetSalesBasedOnProductsTechnology', window );">Percentage of net sales based on products technology</a></td>
<td class="nump">83.00%<span></span>
</td>
<td class="nump">81.00%<span></span>
</td>
<td class="nump">72.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=inmd_HandsFreeMember', window );">Hands-Free [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_PercentageOfNetSalesBasedOnProductsTechnology', window );">Percentage of net sales based on products technology</a></td>
<td class="nump">8.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=inmd_NonInvasiveMember', window );">Non-Invasive [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_PercentageOfNetSalesBasedOnProductsTechnology', window );">Percentage of net sales based on products technology</a></td>
<td class="nump">9.00%<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inmd_PercentageOfNetSalesBasedOnProductsTechnology">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of net sales based on products technology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inmd_PercentageOfNetSalesBasedOnProductsTechnology</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481027/954-310-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=inmd_MinimalInvasiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=inmd_MinimalInvasiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=inmd_HandsFreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=inmd_HandsFreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=inmd_NonInvasiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=inmd_NonInvasiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140222166996768">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>ENTITY-WIDE DISCLOSURE (Schedule Of Changes In Contract Liabilities) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Balance as of January 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 17,757<span></span>
</td>
<td class="nump">$ 16,556<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_IncreasesDueToIssuanceOfNewContractsExcludingAmountsRecognizedAsRevenueDuringPeriod', window );">Increases due to issuance of new contracts, excluding amounts recognized as revenue during the period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">12,498<span></span>
</td>
<td class="nump">14,987<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized that was included in the contract liability balance at the beginning of the period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(15,566)<span></span>
</td>
<td class="num">(13,786)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Balance as of December 31</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">14,689<span></span>
</td>
<td class="nump">17,757<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Contract liability presented in non-current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">3,766<span></span>
</td>
<td class="nump">3,959<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Contract liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 10,923<span></span>
</td>
<td class="nump">$ 13,798<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">As of December 31, 2022, noncurrent deferred revenue is estimated to be recognized as following: 83% in year 2024 and the rest in year 2025-2026.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inmd_IncreasesDueToIssuanceOfNewContractsExcludingAmountsRecognizedAsRevenueDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increases due to issuance of new contracts, excluding amounts recognized as revenue during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inmd_IncreasesDueToIssuanceOfNewContractsExcludingAmountsRecognizedAsRevenueDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140222159770832">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>ENTITY-WIDE DISCLOSURE (Schedule Of Long-Lived Assets) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_TotalLongLivedAssetsByGeographicalArea', window );">Total long-lived assets by geographical area</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 12,080<span></span>
</td>
<td class="nump">$ 7,371<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other long-term assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">4,370<span></span>
</td>
<td class="nump">4,573<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Total Long-Lived Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">16,450<span></span>
</td>
<td class="nump">11,944<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IL', window );">Israel [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_TotalLongLivedAssetsByGeographicalArea', window );">Total long-lived assets by geographical area</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6,704<span></span>
</td>
<td class="nump">3,263<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_TotalLongLivedAssetsByGeographicalArea', window );">Total long-lived assets by geographical area</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,789<span></span>
</td>
<td class="nump">2,097<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=inmd_OtherCountryMember', window );">Other [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_TotalLongLivedAssetsByGeographicalArea', window );">Total long-lived assets by geographical area</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 3,587<span></span>
</td>
<td class="nump">$ 2,011<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Consists of non-current accounts receivable, net and other investments</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inmd_TotalLongLivedAssetsByGeographicalArea">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of long lived assets by geographical area.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inmd_TotalLongLivedAssetsByGeographicalArea</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=inmd_OtherCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=inmd_OtherCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140222162827728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTIES (Narrative) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts paybale</a></td>
<td class="nump">$ 13,966<span></span>
</td>
<td class="nump">$ 16,242<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=inmd_HomeSkinnovationsLtdMember', window );">Home Skinnovations Ltd [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Payment for services received</a></td>
<td class="nump">99<span></span>
</td>
<td class="nump">332<span></span>
</td>
<td class="nump">$ 239<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_inmd_RelatedPartyConsiderationForAggregateAmount', window );">Related party consideration for aggregate amount</a></td>
<td class="nump">497<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts paybale</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableRelatedAndNonrelatedPartyStatusExtensibleEnumeration', window );">Accounts Payable, Related and Nonrelated Party Status [Extensible Enumeration]</a></td>
<td class="text">Accounts paybale<span></span>
</td>
<td class="text">Accounts paybale<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=inmd_SubsidiaryOfHomeSkinnovationsLtdMember', window );">Subsidiary of Home Skinnovations Ltd [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNet', window );">Accounts receivable</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableAfterAllowanceForCreditLossRelatedAndNonrelatedPartyStatusExtensibleEnumeration', window );">Accounts Receivable, after Allowance for Credit Loss, Related and Nonrelated Party Status [Extensible Enumeration]</a></td>
<td class="text">Accounts Receivable, after Allowance for Credit Loss, Current<span></span>
</td>
<td class="text">Accounts Receivable, after Allowance for Credit Loss, Current<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=inmd_SubsidiaryOfHomeSkinnovationsLtdMember', window );">Subsidiary of Home Skinnovations Ltd [Member] | Expenses (Income) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Payment for services received</a></td>
<td class="num">$ (30)<span></span>
</td>
<td class="nump">$ 123<span></span>
</td>
<td class="nump">433<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=inmd_SpaMedicalInternationalLsrlMember', window );">Spa Medical International Lsrl [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Payment for services received</a></td>
<td class="nump">172<span></span>
</td>
<td class="nump">636<span></span>
</td>
<td class="nump">723<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=inmd_HimalayaFamilyOfficeConsultingLtdMember', window );">Himalaya Family Office Consulting Ltd. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Payment for services received</a></td>
<td class="nump">193<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="nump">$ 90<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts paybale</a></td>
<td class="nump">$ 86<span></span>
</td>
<td class="nump">$ 28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableRelatedAndNonrelatedPartyStatusExtensibleEnumeration', window );">Accounts Payable, Related and Nonrelated Party Status [Extensible Enumeration]</a></td>
<td class="text">Accounts paybale<span></span>
</td>
<td class="text">Accounts paybale<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_inmd_RelatedPartyConsiderationForAggregateAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>It represents related party consideration for aggregate amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">inmd_RelatedPartyConsiderationForAggregateAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>inmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableRelatedAndNonrelatedPartyStatusExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates related and nonrelated party status for accounts payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableRelatedAndNonrelatedPartyStatusExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableAfterAllowanceForCreditLossRelatedAndNonrelatedPartyStatusExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates related and nonrelated party status for accounts receivable, after allowance for credit loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(3)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableAfterAllowanceForCreditLossRelatedAndNonrelatedPartyStatusExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480833/946-310-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(5)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481058/954-310-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transactions with related party during the financial reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAmountsOfTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=inmd_HomeSkinnovationsLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=inmd_HomeSkinnovationsLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=inmd_SubsidiaryOfHomeSkinnovationsLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=inmd_SubsidiaryOfHomeSkinnovationsLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=inmd_ExpensesIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=inmd_ExpensesIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=inmd_SpaMedicalInternationalLsrlMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=inmd_SpaMedicalInternationalLsrlMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=inmd_HimalayaFamilyOfficeConsultingLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=inmd_HimalayaFamilyOfficeConsultingLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>104
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MY/9YV=A'>'7J[5\B+ YJ%@?=6,RX2J6=KS&!6=](J 5I,Z?*2850.ZRI':*
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M#*P;\:L&5R37R&&);+=%'L^.@M$1#0\@LWK<>G+2PN&'_S?6%N=$M),3?8/
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M8=?ZS63=)RD[L94>;*5MV@<C)M<(5@V%^1?^YS;:L9BGRKB*I2JW4)5'C-T
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MXBWO(K95ZTP4)Y/8LKI6^;?O@IAJ*7311,HM]/.=;N!X7=MUBB;?[@*==X/
M/DO+:;F,9ELE%;3E4<JGW< GH)B4BDG7L6U0C/\/Q<;5UA,18M>/B8Q"#;Y(
MJUR%MN<JP^4RRF^,6(SRT[=>E**0;2+%8B-00Q4.H8W4RS"3G.W[3<Q!CT[?
MVROQ)ZX8O(**EHD4EL9\[*Y7U&Y ;5*G7X.<'3A0?#>@K'(+VIX40+J_3;8Q
M4_S'$6:8)>!:Z_R";\>+$QTC<#T?Z&'7JY.R2<RS@Z;)K?(&VIXWW',ID1)
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M -I76:9^/.0#''XH,?@?4$L#!!0    ( %PX35C.ZZ!]2@,  (0)   8
M>&PO=V]R:W-H965T<R]S:&5E=#,N>&ULK99M;]LV$,>_"J$50PMTT;,L9;8
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M<8DW159O3370HK35-Q4::]EV,WR>09H 7)\+H;<#4]"[!S]^ U!+ P04
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MJJN-ZG:V&S8+Y/DVMCRP:;/&4 74!0,J(S .7&$FGX \(8B(0$0,(A+(VUY
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M+1XWW%_S5 +$[_>)X%Z]R \<[BL/_P]02P,$%     @ 7#A-6#F*[#EL @
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M.^@)17/9FOC-+3_0*IZ7K*]P)J2_8IGOCE_W1-&&Z.J5,#RHM<V_\N<*AX[
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M\#$2"GB#*4CH%D38X/&7=(*34C8(CW)2 &_?H_A _HUP)^A*V;;DQTT/'*1
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MK*:5=?"F5Z0.Z&8$;>E6*S3\2'^N%*A/X*<>KX$ET]CR(EGF'X2E/O<-DET
M&L@N=&]!5=5./PIKT5M9.H#U01"1+/(*;%'XD,E;W:NR0MR>@1(Y,R !QMB(
M[\,9;#UXDJT#2@Q<T:*1J(QUCB)I?$!\L("E%[P\(7,?U@Y@8PTZY=[(YM[T
M QU$&HD@\<B=H:H";D#TYW!'@ NKC% <PZIE*T(*%"5)$/4%*:,D$@=_%.%
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M+Z 1RB+YIPY.3\C5L)T*6%N2<<47[0(S3"B8L:!223#<T LL7"G>0+R75F.
ME2DF)IN_@8BGVQZFO?R;8F^UA>1I\[S%R)6KZ1/K]KL+/M'46[L:-G<0ECJU
M5&63TSC!&U1^PA 05/;U+*DQ3D>^'25.7R3STTC1NVH8TNS!DU/5ID@>3R\]
M;<C*'_!Y2Q7649=G73&<?9E,WKPMET)^O='CZ[$1'!0?2_0 5IJP 9")8@Z]
M,G>*N!['^PW>:O>I/J28;J_EIOV-^'( HB'8<$F^Q=$"4Q?#=-9&H 1KQ8P(
MR[2NL+52>R%NFQC$6@0N;MU;V@LAM=?K8^Z@B-%M#6]2O!X,R; X(EO;9I1(
M4 ,9 =NI%LL>&\E&3B#7ZA_0\9X#AN'7;TE9*I]J;2GX9A7EQ):$"N_Y45Y^
M%KM;>VH:H)MPSA:EW3&$S]&M-<?S-6("3HVN1;#5Z-;D0D?5%QC$L?&DXXGF
M*R3N\^<OYT^S9!&SE?CEH';1HBW8:L H3P#%P<H*4M-B_5)USUGN#!LZ"-;]
M8NT3V &(3!*L425=TW<8_\4U;DVK=/42C>=@7X=QS^+V]&&A.5$0H-U@+"\V
ML1IMZ'J8#BFK;F'21Z!VPA#CE^!K<N*'39,)M7L,35ER <@EF<1,0Y70J,+&
M& 28@")494.R038M0A@=FJD-^4U](N6!(6*1)"1WT6VTK'P<@U0,R:PP)?DY
MC<[TYH/(Y"UVE#,/X,R2RP?$<U^[& ULSI2/MNAQ27TV/W>"UQ+K.>D.+GA)
MNWUS9CJ]X^0DED-)2@_-:"L$6;#A;T<@D)(IRHG0:B5'H<0L8B\V>$$0/C95
M[$4@9"@R-=!*G2X/4=RD7!V5!I;OIXV(HX)J1F&&V@(<5)=W.M_4%)!GZVLV
M/HN5X:8WB!F)6?1 R[,@TD^V>F^79K>,[5G O,8,$X9V8$6)7Y*9Z*M,#);9
M%R%R1=LX>);@:JY*;^JH=DU%@FP ,19,4*UX=?YC>B(1&A29;&$1?9XZ)#6A
M-.;<,!IWJ!$ I*[C)%26-%ER75!6WW#5M1A#DW\D<;M!^+AXA3(:1&>4KL!G
M'RP_B(NAG*DSO9F-1WZ/<RE(8_!^F%^E6[ABN)09_'+N?\''?[CTOT=U[LD.
MBTKAJ&>LPE"8 $2CCJ!TW2KD;[.A%.[.UQ8'Y:[\85^C^>\2(7<^$3*J#.2=
M7]'.-\'.[@VI0-+;7=4<-/IQS6I5 G/#3T4) H 253:?X1ZSA<V8:V0ZI12\
M;N]+SO;4G(2DD!GJ_!PSUW@AZZ8IL+15:PXVSA<GZO1DP37RP-W P>2BHR;K
M%/MP?.Q<[<I.58,\3"@7CYTV57O5@A:*=;ODV.4S;ZO119R1#Q^$-WR"-OHS
M<%/PO(VX86Z\B#88A&>5^+\<S?UZ;),R_R!GM,7Q S6J5,P:DA%#R-5*8:C0
M'OA5B8TG(-I^QXJZF;LT6@C(*WP_LL.&&HXWY9H#&]JKFL"N5X8Z*.A2"X6F
M:MFT-L@18I!VC&_:]X0!;"M-0=@ GJCI 9%#XI^4+=8TE#L5!NJ"ZK2XBH8V
M%K:[+UW0PV].80%7:6*3R!C\X#:M$+B'FK3BL\5E-!RZ.DK-KD9&2)?K[#$6
M9(DC.!\)?+)R%!X.Q1Y:&<16^08L_TI_+1X=W?D6Y?ZNTF="6TS=UFK(TG>Z
MI5P(8%\DWM%SQ(I@HCK5)M:%B3M/&D0LLSCW60S3;$Z/<19B4^I[/B?>1(=Z
M9Y35I7 $[D3UH2;'<NM< JT[?S+[MFA%Q".^1 P39V<]G-%I0U'@F]!B8$B*
M&,K4$V,9UKN"=Q\[:XE'Y5*SY'.6O)<>0]EEI&ILU <-PB?G3YP;;]\C@L50
M#[;V"GW=4%,UZ(4I_QX6\?[]1RH[=VNCG ,.[*+XL^V"E RDD9YMS'4LV21%
MV[1M*FZB!?&$-TNZ(PT4S8Q,Q#HR;J3\RCC#P>LHEW 0@-CH-,)VFBO#?<\4
MFPQ(+*.-X:;":N)VC'!F4%\C84.3#AM!0052!"+9=KCES4YSN9W@,(!9J- ,
M4EZKDFHD]<Z\2$[*T^262KE6!XL%NLH3<RKE!@[?+Q-L4(L?#PG=9]+#Z@%:
M[4B-8V$M;1,?'P_INY2I'I\N521^D+VK(H2-LNR&&X^/POG"597-Z/[[+;H$
M1IBP8]-O3[!A ( P "CXU=TFZ8.@/XX4&CYV?YI< Y2Y<V6&#UE5]HT8?)E,
M*SB6Q "OJC"8CR77TL6=^[2>,[;8.+<^>U!VQ J)S>JHW@]6"#0%@>+*1UVF
MU6W/I@ABCS+D;(X 5^'BH;=HX1?H IA]JS#?"W5&)B> SO=.VT42X01Y!XCU
M."XIWPP_&;3FXOICTH1A8!MY@YU;;AF@<ATGW'P-1!Q;#GB./+L<"-1VG<=B
MA=^F9RM6XF,I,B%#\#VZEA4V^0GE6+X$N;GJ./]$.[$+?K %G0V& XU5HH'C
M[,A@M!Y'Z5VK#+A)G;]]5[(5Y]-<YF?Z $XPB_ B_>?61(J)*I^;L)'O&(O8
M<!QM:UL#:.%(#01P4*= B=IO*),H?A]F/;WB&><$)IA9?&4E/.^0ZAV\8]3Y
MUZG8\9H7C#M$J[-PBS(6DCM$=">98^LV@'4'"H%T\Y-8V@1H(9<EJ'3AS .@
MA74QM60Y?HD]%^8>EZ.(FAXD?D$6<I0=-NFHM(B2K7LT9SBH1P9KW&?A6B>E
M'(ZNVNB@US_JIYP()E@++)M$B MLRHB(05UG7[N+.DJ[U*P1FTW8\VD[8!VK
M5KI>=]0*/3H4]T^[*Z?"RH+R)*X(GR4IM4:C!$8ZY$@VF6U^W((++$CM 1<W
M"0. H2[5GV+TS=(_M/M%UK(%HH+,6!.[!,5QT\UZKT,_4=8%67/8(3V#O";3
MUFRDTF8@O+(!7/C<S@8E0<H6I&H"3'!M&F6[68Q&<&*6D&&E>(RS,Q5+EF/V
M.14.1X78.YR#(]X;>2AX6ZN^6I75ELN4#16<;6SO"#-/$-]V,DUD6<8Y-*ML
MM$P(L*!+\EN &5P/^4(B N!3WW2+5-*#^&U]W2(W6]KE[9"-+'G'U6125"@5
MY=:5O*?Y!(?@6J8*!]AR )^0UZ!  ML.-%:BI^N63@:R[F5+H@!0SR6UI]D8
MA,LM-*UK=4.6P%XA^R;- K!E<-P4P?K(8'H,0[981^M+/;$$ >4[^F:QPJ!B
M#DQA< X "P< 7-J$D3S@;G\PV.T/D'J;]!KCP[EB$K0%B+#KUN9LZS4W<Y]X
M8[C?X84].9>"WU.;A42[7JP'U\,4#RL8LI3XLZXUG.QDZEYDT]/HX BQI\1-
M9AB/Q51EBPHU=\8F6-SLP(&3Q.Z&!7!@TL["L@4>8U"A5]]*4XGMO?/FZF'
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M&\J( Q2SV@XSRFU\S[\FDI::_(,B++@B"<]J;+=R]4 @393H7 EW(9TD*L<
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MTZM'7 9J?^F:'7VU+G \F%#T(ZIBW>(#\/FJ:3K["V[@OFOYE_\#4$L#!!0
M   ( %PX35B:MJ.NQ04  "<.   9    >&PO=V]R:W-H965T<R]S:&5E=#$R
M+GAM;*U7;6_;-A#^SE]Q<(O!+11;HB3+3I, 3N)TP9JNB)/NP[ /M$3;1"51
M(ZFXZ:_?D5(<)[6==B@,6!)Y;WSN[B%YM)+JBUYR;N!KD9?ZN+,TICKL]W6Z
MY 73/5GQ$F?F4A7,X*=:]'6E.,N<4I'WJ>\/^@439>?DR(U]4B='LC:Y*/DG
M!;HN"J;N3WDN5\>=H/,P<"T62V,'^B='%5OP*3>WU2>%7_VUE4P4O-1"EJ#X
M_+@S#@Y/(ROO!#X+OM(;[V!7,I/RB_VXS(X[O@V(YSPUU@+#QQT_XWEN#6$8
M_[8V.VN75G'S_<'ZA5L[KF7&-#^3^5\B,\OCSK #&9^S.C?7<O4[;]<36WNI
MS+7[AU4C._ [D-;:R*)5Q@@*439/]K7%84-AN$N!M@K4Q=TX<E&>,\-.CI1<
M@;+2:,V^N*4Z;0Q.E#8I4Z-P5J">.;D:7_\QN1F??IC =')V>WUY<SF9POCC
M.5R,+Z_A\_C#[02N)N/I[?7D:O+Q9GK4-^C6*O?3UL5IXX+N<!%0N)*E66J8
ME!G/GAKH8[SKH.E#T*=TK\5SGO8@##R@/@WWV O7((3.7KP+!*:^<,-F.8<I
M3VLEC. :6)G!!1,*/K.\YG#%F:X5QX(T\/=XIHW"BOIG&QR-LW"[,]MEA[IB
M*3_N8!MIKNYXY^2W5\' ?[=G*=%Z*=$^Z[\FGWM=;%_ QS]O)A#" ?QT (=D
M?#$%O8&[!CD'S#$O9ERM\^SR@2_4@U0B*6C#,RNXD'=<E2XM,UEFVH.B+D4J
M*I8_#*1255(QP[%?9V;#EYTJ"JY2@<(5J]"=]9)R9<1<I*CA8LEX);4P/;A9
MXGJQ_=;ELAFVXLA2Z IK')B!N2V=.ULZ/8)Z,)<Y,J H%_"@:C0.*K,$@]-G
MLJA8>?_;JR$-DG=ZAQ.4=](8J9"9!E%F+LSLD&P 1BQ>]H^2]\_0@;<DC$,O
M"B(2AB-O,(S(U5.X"/7"8(3_<1R0LUW(D2#T:!@1&G@TIBCW%$9R0"(O&,7D
M;#N4.#L8^F3@C?R$W$C#<A(FH3>($GQ&7CP<D;<P_M%"<'*O?3?Q.O!BGT(I
MRX/;WK2WI3RP9BON-H/\ODE-BSVD.=,:H\50G]7D2IBE*.$#1R6@,.,IJ[$2
MA %\8.YS@TZ8M0F50C0QRUK6*FUII) 9SS741N3BFYULL@MR9MO')5F458T+
M,1(A0F-(]=QF&FMHHY"0GC@ZTQ+7ASFAW=6;_U5<<U&RTF4+%VQ%7^XYL\2:
MMC5>-#SXK,;![K"V_FNE;!BX4PH-6>T^'BOV29DV/LC%V@B6D490L D+#%U\
M0R<ICI#W2FI$K\131^Y&ES+/K.$<QW?/+O!,HLE#SAZS>?A=5SSV1!Q[X9"2
M+O6"<$3>D" )=C9(. A)-XI0ZN#E1L%'Y$>D&R1^H["W,9K_ _P];X[8&]*1
MC0]#;N-[#BG]-9#^('(MBX31$)\)Z8X\WP_=$K_'S5(*]0:)Q8&&+P#74@L^
MAK%/NH. VO5&WW--PS3-_\$>:!NVP7\TTDV<]P=T&\H)AY$74M^N(8GBQMO+
M)&0V&<024L:Q/3QW6,QL7PAL,&ZSP>Q!M&TEJY7Q%/&W!(+<TE+"NIL4GESO
M&.*\?2=8H1,PO+#@*9'?@\ (A.M+C Q)J&B&F3%*S.I&']DE7;)RT7@4)1(-
MQ_*P\",Q6D4,"X_%$FUG(K,L8^D23[A6GI6M$Y=^-*06EK=:-K&ON)MRZ/*O
M>&7 5;WQH.2F]W,0KCGJ63GLVYAAR5SD&S2(YW6K> ^9E=VU.YXCU"VU2^3;
M>\X4"7TL9.PJ&H6>/\+&M:A1-Z=)-,*:')& 1IX?)H3:N;"="V(O"1*2>%$\
MW+ZGP;8#7G_C\(YUO7!7%(V55)>F.<>O1]>WH'%S^'\4;ZY0>(Y=(.5!SN>H
MZO<2//"JYEK2?!A9N:O 3!J\6+C7)=[DN+(".#^7N*VT'];!^FYX\A]02P,$
M%     @ 7#A-6$P],"O8 @  * 8  !D   !X;"]W;W)K<VAE971S+W-H965T
M,3,N>&ULC551;]HP$'[WK[ R:>JDM$F< (4!$E"Z56II16GW,.W!) >)FMC,
M-J7[]SLG(>LTROH2GWUWG[^[\UWZ.ZF>= I@Z$N1"SUP4F,V/<_3<0H%UV=R
M P(U*ZD*;G"KUI[>*.!)Z53D'O/]ME?P3#C#?GEVIX9]N35Y)N!.4;TM"JY^
MC2&7NX$3./N#>;9.C3WPAOT-7\,]F(?-G<*=UZ D60%"9U)0!:N!,PIZX\C:
MEP:/&>ST*YG:2)92/MG-53)P?$L(<HB-1>"X/,,$\MP"(8V?-:;37&D=7\M[
M],LR=HQER35,9/XM2TPZ<,X=FL"*;W,SE[NO4,?3LGBQS'7YI;O:UG=HO-5&
M%K4S,B@R4:W\I<[#>QQ8[<!*WM5%)<L+;OBPK^2.*FN-:%8H0RV]D5PF;%'N
MC4)MAGYF.)I,;A]FBWLZGTZF5X^C\?6T[QD$MFHOKD'&%0A[ R1@]$8*DVHZ
M%0DD?P-XR*BAQ?:TQNPHX@7$9S0,7,I\%A[!"YLPPQ*O]5:8<2RWPFB7SJ0!
M7*XE%YIRD=#+3' 19V)-YQ!#]LR7.;CTBY(:S48YOEI4XXFUG6&7?!\MM5'X
MFGX<2E1%(SQ,PW983V]X# ,'6TB#>@9G^/%#T/8_'PDR:H*,CJ&_MY9'00Y3
MG-TNIC2BI_3 %3VR3RXVZ3Z!-);8M]I0N:(F!;J2-I&8Y![!TD*Q!(7E);:Z
MML2,+!1/@$1MMQVU">NZYZTN*4OU"I0$J/4)<R/6)=>@-1+B^P+A%8K&"I+,
MT!QK!YJ<,)>U(O*)G 1N&)RC@/A^R$CHN]V.OX<04IS&6Z5 &!P2_X3B4@&&
MG(1N&UT^6:';"5%82,-S^E_'B+EAFQ'6=KO=#CU49>]5]Q:@UN6,TK3$JQJY
M.6W&X*CJ_C_FU0R]X6J=X;O.886N_ED'^T%5<ZG:&+DI9\%2&IPLI9CB* =E
M#5"_DICS>F,O:'X.P]]02P,$%     @ 7#A-6.],R(;5 @  +P8  !D   !X
M;"]W;W)K<VAE971S+W-H965T,30N>&ULE57;CMHP$'WW5XQ2J4]T<X4%"DA<
MTBY2ET6!W5:J^F"2 :)-[-0VE_Y][018J@)J7^+;G.,S'ONDL^/B5:X1%>SS
MC,FNM5:J:-NVC->84WG'"V1Z9<E%3I4>BI4M"X$T*4%Y9GN.T[!SFC*KURGG
MIJ+7X1N5I0RG N0FSZGX-<",[[J6:QTGHG2U5F;"[G4*NL(9JN=B*O3(/K$D
M:8Y,IIR!P&77ZKOM06#BRX"7%'?RK \FDP7GKV8P3KJ68P1AAK$R#%0W6QQB
MEADB+>/G@=,Z;6F Y_TC^Z<R=YW+@DH<\NQKFJAUUVI:D."2;C(5\=T#'O*I
M&[Z89[+\PJZ*#>XMB#=2\?P U@KRE%4MW1_.X0S0=*X O / *W57&Y4J1U31
M7D?P'0@3K=E,ITRU1&MQ*3-%F2FA5U.-4[UI%$[[XQ&$WZ;A9!;.H#\9P=/\
M(8Q@^!Q%X60.43@,QR_]P9=PUK&5WM,@[?C /ZCXO2O\K@>/G*FUA) EF/Q)
M8&NQ)\7>4?' N\DXPO@.?+<&GN/Y-_C\TPGX)5_]"M^36J. "&-,MW21H:S!
M!%4-AALAD"GXWE]()?3M^7$I^XK;O\QM7E1;%C3&KJ6?C$2Q1:OW_IW;<#[>
M4!Z<E >WV/^Q=C=*=Y/^LOC)TSR$.GR _[LX;3(56- T =QK/Y$H@;($>'GV
M\>&DQ5L-(.;ZW4L%? DZ!I8\T_:1LE6;Z/ICOM PWR7F"IB/1_K)EK)8 Q77
M!E,468I"$M>MM1J.:9JMYE\2B%]S I?H&*])/O,M"I8;'2F3*E4;XQJ2M((F
M:=ZWR)C%/$=0=$\:#1($I+PWQ*O[Q _J9,X5S:[G0]Q&S6LTB5NO.:T +A7?
M/GO$.8I5:57F(#9,5>_Y-'MRPWYE F_AE94^4K'224"&2PUU[N[UW1>5/54#
MQ8O2$A9<:8,INVOMZ"A,@%Y?<JZ. [/!Z1_1^PU02P,$%     @ 7#A-6'4W
M&@5V @  1P4  !D   !X;"]W;W)K<VAE971S+W-H965T,34N>&ULA51-;]LP
M#+W[5P@>L%-6VW*2IEEBH&E3K(=^(.VZP["#8M.Q4%GR)+IN_WTE.W$S(,TN
MMDCQ/3V*I&:-TL^F $#R6@IIYGZ!6$V#P*0%E,R<J JDW<F5+AE:4V\"4VE@
M60LJ14##<!R4C$L_F;6^>YW,5(V"2[C7Q-1ER?3; H1JYG[D[QPKOBG0.8)D
M5K$-/ #^K.ZUM8*>)>,E2,.5)!KRN7\>31=#%]\&/'%HS-Z:N$S62CT[XSJ;
M^Z$3! )2= S,_E[@ H1P1%;&WRVGWQ_I@/OK'?M5F[O-9<T,7"CQBV=8S/V)
M3S+(62UPI9H?L,UGY/A2)4S[)4T7&U.?I+5!56[!5D')9?=GK]M[V -,PD\
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MA88GI[9M=#>VG8&J:D=EK= .7KLL[$L'V@78_5PIW!GN@/[M3-X!4$L#!!0
M   ( %PX35A2/DD/*@,  +\&   9    >&PO=V]R:W-H965T<R]S:&5E=#$V
M+GAM;)55;6_;-A#^KE]Q4(NA [1(HOP6SS:0%Q<KL"1>ZFX8AGV@I9/%51)5
MDHKK_?H>*45S@<3 OIS(XSW/O9!W6ARD^JP+1 -?J[+62[\PIIF'H4X+K+B^
MD W6=))+57%#6[4/=:.09PY4E2&+HDE8<5'[JX73;=1J(5M3BAHW"G1;55P=
MK[&4AZ4?^\^*1[$OC%6$JT7#]_@1S:=FHV@7#BR9J+#60M:@,%_Z5_'\>F3M
MG<'O @_Z9 TVDYV4G^WF0[;T(QL0EI@:R\#I\X0W6):6B,+XTG/Z@TL+/%T_
ML[]WN5,N.Z[Q1I9_B,P42W_F0X8Y;TOS* ^_8)_/V/*ELM1.PJ&S'9''M-5&
M5CV8]I6HNR__VM?A!#"+7@&P'L!<W)TC%^4M-WRU4/( REH3FUVX5!V:@A.U
MO92/1M&I()Q9;1X?-NO'[9]P=7\+Z]\^?=C<K>^W =ROMXO0D -K%J8]V75'
MQEXABQG<R=H4&M9UAMGW!"%%-H3'GL.[9F<9;S&]@"0.@$4L.<.7#.DFCF_\
M6KJ*GK,RQP V):\-\#J#]9=6-/3.#/QUM=-&T4/Y^Z7<.^;D96;;/'/=\!27
M/G6'1O6$_NJ'-_$D^OE,W*,A[M$Y]O][3>?)[A^V:YC"3W"&=>[=R*J16KC>
MD3DT?>5<R7 HV5[)ML$,=D=ZE?](!6G)M1:Y2+E%:A :N(9<EM3^>N[1A6*U
M0T67ZMD[M8(Y7ZU!I;TX2)(1R?@R]AYRHD'(6U4+TRK\WK4WF4;>>,*\.UEF
MVF/!^))9.8Z\7Y'ZM" UB(KB?D)K;[G9*/%F[-(;![/$RCAA9*SUG*9#VE9M
MR0WEDB'=8"I< MZ[)!B-I]Z/WCM&H!$MMM+P\I5Z!%"CH2B2F8V%7<YZZU-*
MA^"55$;\VRF$G6^ZH4%UIM('I J\G; D(#F+W.G;<3REVBHP!<(1N=* MO/@
MI,Q=[SC)'(@6I.P=TD@LCQ<OO=#P9*A4J/9N=&I(95N;;KX,VF$Z7W5#Z3_S
M;K3?<;47]!9*S D:74RI/54W+KN-D8T;43MI:."Y94%_&%36@,YS*<WSQCH8
M_EFK;U!+ P04    " !<.$U8WH"YSND#  #E"   &0   'AL+W=O<FMS:&5E
M=',O<VAE970Q-RYX;6R=5FUOVS80_MY?<5"[(@%<O;J)F]@&[-1#,RQI$'L=
MAF$?:.DL<9%(EZ3B9K^^1\I2'-0VMGVQ^7;//??<\:CA1JH'72 :^%:50H^\
MPICU11#HM,"*:5^N4=#.2JJ*&9JJ/-!KA2QS1E49Q&%X%E2,"V\\=&MW:CR4
MM2FYP#L%NJXJIIZF6,K-R(N\=N&>YX6Q"\%XN&8YSM'\MKY3- LZE(Q7*#27
M A2N1MXDNICV[7EWX O'C=X9@XUD*>6#G5QG(R^TA+#$U%@$1G^/>(5E:8&(
MQM<MIM>YM(:[XQ;]9Q<[Q;)D&J]D^3O/3#'R!AYDN&)U:>[EYA-NXWEO\5)9
M:O<+F^9LG'B0UMK(:FM,#"HNFG_V;:O#CL$@/& 0;PUBQ[MQY%A^9(:-ATIN
M0-G3A&8'+E1G3>2XL$F9&T6[G.S,^//BT^P>KF^_S.:+F]GM8CX,#,':S2#=
M0DP;B/@ 1!3#C12FT# 3&68O 0+BTY&*6U+3^"CB1TQ]2*(>Q&&<',%+NB 3
MA_?^ -ZU>$1MJ)2,AC\G2VT4%<-?^R)M<)+]./:"7.@U2W'DT0W0J![1&[]]
M'9V%ET=8]CN6_6/H_RX5QR%N/R]F,(!W\ /6Q:MK ;?R$:LE*M(U^M #4R!<
MR6K-Q!-HG@O,@,&\8 KAKE9I0<4.3&3-4B'+#)6&2:X0K91P8NW?OA[$<7@Y
MOYNX471Y2@5L"CB9_G$*-T@76"KXU61^#Z1 D*M=K]8D.K_48&HE'O")"EO4
M*\I-K;C(J5$L4RHLFRQ)GD^VOK:HK3_?DM4U(T9&.G0B\S(XB@2XJP$*\80+
MH )[%L+%^$M=/MER"T]I"BRG*'-F*/Y*UH1,O-^<A2&A %'2G*1@KJM06X2H
MEYQ]Z W.$I JXX)Z&V@KF;9FK08GFX*GA>UCMB%9J8WC:(6WP6;.&T1]_WSP
M$\B-(+$+OB:/!@F** C'3+_C6M=D3[V(:\<]"OVD?] &5G5)L66\K$UKYL/+
M:HB3_=5 YEG&;:"LM+(VN6U#LKX[6=]$!^6)SGO]?GA$'/_5HDD;58+,D9BH
M7:'<T2YE;5_XOV)%?IS\1[$6>TJ6=SW%1MU*0DXJ9+I638)3J4T/2M1TGLRY
M<N<M#9;]73O=K$)4Z!J_UG9/+FU;8<L28:UXBD#74.2D%E^1W9,/D_UJN-_8
M0=,@>IG.C&<@I"%-4TG5]H^]UKN$;"X=GV9&>]0HI4O#<YC:W]?C@IVGIT*5
MNP=64^!T:YI7J%OMWO!)\W0]'V\^ &Z8RKG0)->*3$/_G-JY:A[59F+DVCUD
M2VGH673#@KY#4-D#M+^2TK03ZZ#[LAE_!U!+ P04    " !<.$U82D:U[2,&
M   ?#P  &0   'AL+W=O<FMS:&5E=',O<VAE970Q."YX;6RU5UMOVS84?M>O
M(-RU2P%%UL77W  W3;$4O01QNF(8]D!+M$U$$E62BN-_OX^DK#B.DW48]B*1
MTKE\Y\K#DY60MVK)F";W15ZJT\Y2Z^JHVU7IDA54!:)B)?[,A2RHQE8NNJJ2
MC&:6J<B[<1@.N@7E9>?LQ'Z[DF<GHM8Y+]F5)*HN"BK7[U@N5J>=J+/Y<,T7
M2VT^=,].*KI@4Z:_55<2NVXK)>,%*Q47)9%L?MJ91$?O>H;>$OS.V4IMK8FQ
M9";$K=E<9J>=T !B.4NUD4#QNF/G+,^-(,#XT<CLM"H-X_9Z(_V#M1VVS*AB
MYR+_SC.]/.V,.B1C<UKG^EJL?F.-/7TC+Q6YLD^R<K01B--::5$TS$!0\-*]
MZ7WCARV&4?@,0]PPQ!:W4V11OJ>:GIU(L2+24$.:65A3+3? \=($9:HE_G+P
MZ;-/%Y/IQ?2DJR'+?.FF#=\[QQ<_PQ?%Y+,H]5*1BS)CV6,!78!HD<0;)._B
M%R6^9VE DL@G<1@G+\A+6LL2*Z__G&4,P5+DS\E,:8G@_[7/2"<BV2_"%,21
MJFC*3CO(>,7D'>N<O7D5#<+C%P#V6H"]EZ2_X/H7^?:C^O+UYH*,R2%Q4H^\
MFR4CYZ*H:+E^\VH41\-C14R1DAQ^X>6"5!*5+36'CZAD)!<IU2PCH+A4DK+<
M)]^F$T++C)S3DF:44(5TUY3GH)J9:C[R:.!=EN0S72-HT<@G^D$I47Q1@I):
MA8S0A60,U:P).@GA6I$E>LB/FDK-I'I0&Q!(_$A+_+!2QS[YP&:RV<:A#W4R
M79IUM+5.+%*'!)L]0%1=5;E#L(-(^61>2[!(PN[!DAGW/(^0'*#H;%>Y8_G:
M&6U<'(?'-N?(9"/8?HV.WP;$1&/G)PH]SXU"#N]#./*?%3-@@ %#QY'64AK*
MPE1:OB9V4]&U9:]1=](JWQ7,$=$*X;WGZ%J 2'X9]()^(U(H&/8";VNE30I>
MWL)U6EA:]X/#L25Z. 1<29[B,X3=!P1-DE2UK(2I.C$G:-RU-)[4>S)1S'*^
MH+8O:[&B,E.6+&=*"?DXCY;(.QASQS.#I"6"^_02V36CY2U9($BTU(P9Q5\N
MIV0\&(!6U,IDQ<&.-^+!X&VP72"$YDJXK% $:)CAA*Q:*VBU2E-'^:LQ;0ZK
MU4_%E-8+M/#_(Z*-O'T&W+$E3^$D6VB*W3%)@:FH<K%F;#N/S7]*T 2XR(SC
M]!+ZR)I1J0)O9DM[TAH0^GL#^2V8!BBM&1S%4:*^#5=;^B5.Y9UB\YW:+.,F
M^D"VVQX I&E-:UO3FW;1^)T<-+4&S<Y/CZO, G+^X\X%0V>2%=9SGE=>&NSM
MD+;5<5INF?2/%AF/3BK)<^.FV*K\*0-:77NL>/QO8TG26+)"@)?HP0L00/G'
M.K=M+_Z)''N:2=$P\#Y(41"-8<N6NGT_DURJH,CPA[/#MX<*Y!A\&PO->KIQ
MH#M@!)+;"L60EF>-!:C9!7,.LTEH^T9=&1#))@]O;,4;)YC6A>I4YB":HP.+
ME3KR_@ 56@UZ@]<VT"3RS"%@'K%Y1-Y7R$>W03-Z$.7%?M(;>9$_B,TS'@^]
M:7M$("]3JI9D#BUPL1M^W1R:VV-2;_6+_X:HU0,9)@SB,58%G/TD!,+1*,(S
M =I'.&<TIR7:L)OA_QW6+8#^%L('<&Z(>N(_:6;=0S$_-&V2*L6T\L;^8#SR
M^GXX3+RO]C#=)&+.Z8SGW*0+C.F%/9C1ZR=/I&[3#?Q!E'B)WP_'WHTP=HH7
MJ,=^& V]GC\>Q-YW.XC#[(GI?,BO:V92M+6&W#!9[.H&L& <NISS>D&R63X1
M]IZK%+FLR35<NT]*&+X^' :CGO>ZV?2#48C-Q";WML/MI.*Z*@*&L]+.8B!Z
M8A]9,<D>!>Y)A&S67;C193>J/7A]V.N;9=\$8&RS<8!E&-KE$ $9)C;X(]NR
M9FPMRLP;AW'C? >I:2+&WZ-A['W"04QX4=5N;L24Q#!<> >C?M][ZQA=9,B^
M:;F[=6G!,+&P5S-%K'?=_:7]VM[^)N[2\T#NKHZ8 A>\5$ Y!VL8#'$GD.XZ
MYC9:5/8*-!,:%RJ[-+,=DX8 _^="Z,W&*&COQ&=_ U!+ P04    " !<.$U8
M@+IA=^\"   \!@  &0   'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6R554UO
M&C$0O?M76%NIIVWV$P(4D""A#5(^$"'-H>K![ Y@Q6MO;1/"O^]XEVRI%)!Z
M\7KL-\]OQI[9_D[I%[,!L/2M$-(,O(VU92\(3+:!@ID+58+$G972!;-HZG5@
M2@TLKYP*$<1AV X*QJ4W[%=K,SWLJZT57,),4[,M"J;W8Q!J-_ B[WUASM<;
MZQ:"8;]D:W@$^U3.-%I!PY+S J3A2E(-JX$WBGKCU.$KP \..W,TIRZ2I5(O
MSICF R]T@D! 9AT#P\\K7($0C@AE_#YP>LV1SO%X_L[^K8H=8UDR U=*///<
M;@9>QZ,YK-A6V+G:W< AGI;CRY0PU4AW-39)/)IMC57%P1D5%%S67_9VR,.1
M0R<\X1 ?'.)*=WU0I?*:63;L:[6CVJ&1S4VJ4"MO%,>ENY1'JW&7HY\=/BQN
M)G-Z]32?3^X7]'8Z&D]OIXOIY+$?6*1WH" [4(UKJO@$5133.R7MQM")S"'_
MER! 78VX^%W<.#[+> W9!4TBG\9AG)SA2YI@DXJO=8)OQO9L*<!0)G,ZRC*]
M9<+0GZ.EL1J?QZ^/8JX9DX\97<GT3,DR&'A8$P;T*WC#SY^B=OCUC-ZTT9N>
M8_^_RSE+];'0^X?%A$8A_4)/GM0C#W8#&I^BUB M%9PMN>"68Q8SA;5I+%4K
MBABZ4@)+G,MUC^#%0;%$MR0B[N[<$)-)40JUAT/^-0AF(:?PA@W&@"%QY(=I
M2**NGR9=\EV]@I:%.Y-+8[G=NBHV)/&[24Q2/VS%9"HS50"U[(V6]=62R.]&
M'<<1IQ%Y9EHS:??T$#'NII=M-R+FH03-+,JE K"LCR,CL9^&J<.U$G*%;]J]
M#J4;R)ZT_':K[52$29T@=.G$&*R?7*9DH2P35)U*'$F<O$O20K&=D'[T4(*C
MBBY KZN^Y3*^E;8N[F:U:8VCNB/\A==]]8[I-680HURA:WAQB=6AZUY5&U:5
M57]8*HO=IIINL+V#=@#<7REEWPUW0//#&/X!4$L#!!0    ( %PX35B!%,7P
M=00  $,*   9    >&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;(U6VW+;-A#]
ME1TFDR=9$N5+'$?2C"R[C1XL>V*W?>CT 217(A(08 %0E[_O+DA1DF-K.N.Q
M"!)[]IRSB\MP;>Q/ER-ZV!1*NU&4>U_>]'HNS;$0KFM*U/1E86PA/ WMLN=*
MBR(+087J#?K]JUXAI([&P_#NR8Z'IO)*:GRRX*JB$'9[B\JL1U$<[5Y\E\O<
M\XO>>%B*)3ZC_Z-\LC3JM2B9+% [:3187(RB27QS>\'SPX0_):[=P3.PDL28
MGSR89:.HSX108>H90=#/"J>H% ,1C7\;S*A-R8&'SSOTWX)VTI((AU.C_I*9
MST?1=009+D2E_'>S_H:-GDO&2XURX3^LZ[F7@PC2RGE3-,'$H)"Z_A6;QH>#
M@.O^.P&#)F 0>->) LL[X<5X:,T:+,\F-'X(4D,TD9.:B_+L+7V5%.?'T\>'
MA]G+P_W\Y1DF\SN8/LY?9O/?[^?3V?WSL.<I!4_LI0W<;0TW> <N'L"#T3YW
M<*\SS(X!>L2M)3C8$;P=G$2\P[0+YW$'!OW!^0F\\U;P><"[?$^P*0KIJ:V\
M Z$SF!)=J9>H4XD.[J1+E7&51?A[DCAOJ6O^><N&.LGYVTEX)=VX4J0XBFBI
M.+0KC,:?/L17_:\G)%RT$BY.H;];L_=*=AIM_OAR#W$,9W"R%V[@N4I2,HLM
M(<-@LK2(M8\O.9*/12GT%G+!O@)NI O3?&7U3]Q2S^IJ0:&5Y;=B'[R6/@>?
MTQC, B2]*<0/P_M&F\Y8!U+#S%F!BI_H@VZ6=0A_!4YE%<YAD:C 8,_NTX?K
M0?SYJX/2FJQ*:3O[E?MK9FO#O!CD%:-U+M,<!+6*18UKI*05+5?A92J4V@*N
MT&YAB\(";9YLBL@RR:2% J/Q+'PJT4J3=:#2"IT#I)QH#SF#J8>_&DGSEK2E
M$1,KO4<-VE!N;,PLZG58$CP!F("!FU):$7QK-'FTQ<[W#%,9-EO"X8@@*\QJ
M3>G"I-6@MIW_S9.=#4")5-)O Q_*++7P&#[LC 5!?P3F:></A:RMVQ(9X7;E
M%HVJ5[I)QL)4ME'>A=G>\0Y,TM38+/2#.=9$-4_,"H_%9(9\91]RL:*YO/7*
MHB*K;$9R#'764M3 2>6/(JFU5C)#]U;+"'!R<Q;X@34JM"<)Q%0XOUL(R @_
MJ+NIH3(Z@1L/]AU+LFA^D+OS\*"@K:P:#P7UZ!&+8YVA,(;L+^B8=W4UJ 1'
M$2&_-OK,(A=7) II$:XHA['4 ]3QU,-"A34:_'$U2"HT.Y@@/Z5T\/(283GD
M)9U86:MICT;]Y5@)[?JT?,GIW<[?></.9C7O\9;&9.Z0FA7K WJ<FV\S.Y*B
M,)5FF\D 41*9C>3)M'0_7L2=RZLX>%U7G*8X3/E<(!YL?ML![MC0)?<+KZ;7
MI<]6;$(P*=0I)&>M'[]TOL07W;<.AM[!P5Z@78;KBZ-J46A]QK=OVQO2I+X8
M[*?7UZL'89=2.U"XH-!^]S,=D+:^LM0#;\IP34B,IUTL/.9TRT/+$^C[PAB_
M&W""]MXX_@]02P,$%     @ 7#A-6)T.)\^/#P  #2X  !D   !X;"]W;W)K
M<VAE971S+W-H965T,C$N>&ULO5I9<]PV$G[GKT IVJR4HBA><\E'E7PERL:6
MU[+C2FWM X;$S"#F$!."U$CY]=O= #B<4[(WE8HCB030Z./K1G<33Y>J^J)G
M0M3L;EZ4^MG1K*X7%^?G.IN).=>!6H@21B:JFO,:'JOIN5Y4@N>T:%Z<QV'8
M/Y]S61X]?TKOWE?/GZJF+F0IWE=,-_,YK^Y?B$(MGQU%1^[%!SF=U?CB_/G3
M!9^*&U%_6KROX.F\I9++N2BU5"6KQ.39T65T\2+%^33A5RF6NO,W0TG&2GW!
MAZO\V5&(#(E"9#52X/#K5KP418&$@(T_+,VC=DM<V/W;47]#LH,L8Z[%2U5\
MEGD]>W8T/&*YF/"FJ#^HY4_"RM-#>IDJ-/UD2S,W&1RQK-&UFMO%P,%<EN8W
MO[-ZZ"P8AGL6Q'9!3'R;C8C+5[SFSY]6:LDJG W4\ \2E58#<[)$H]S4%8Q*
M6%<_O_GI\L/KGZY_>?7ZP\T_V>M_?[KZ^-O3\QHHX_AY9JF\,%3B/52BF+U5
M93W3['69BWR=P#FPU/(5.[Y>Q <IOA)9P)+(9W$8)P?H):V<"='K[9.S5MF7
MF2IR46F0\X]&UO?LG:H%^\_E6-<5H.._N^0V5)/=5-%C+O2"9^+9$;B$%M6M
M.'K^_7=1/WQR@.>TY3D]1/W1MCE,Y=WUQ]<,#'3&NO2^_VX81X,GENJ%QP/O
M9L8KP5[RA:QY<>%%I]YUE<L27)5I'-+>:Y[-F%$B4Q-6SV"ZFB]X>6_)::;6
MES"IF2AK61<B9[5BJA3L%K0>L(^PV-H#:6VN0U9XH=7:ZDID GR8Y?)6YJ+,
M-5O.1"EN@9U)@X^XJA!37A3WC-]R6?!Q(7R:Q7B9,SD!C\T*F):S\?U. 5XH
M7N7(T2L)V]6JT@&[D64F&/Y88"CQNPO9C&M6JGI%&%^V' ;LJF0WL$[,Q\ F
MH#E<7\X7BTK=XC(C.@BY:*H,J H&(].*SY&;9H$*J)<*@D!18#S;T)B/XV-8
M8Q>##$V]STH9US-F 4N*L6NYS)E6A0#U32HUW[GVZOTU,I8)8:5[(\95@XR
M</$>X>H9KVEDKXR9:HK<F!PX07/"LI8)MR$*).Y$E4F2D,QAN'C+@> A%CA
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M**5V NX_%O42.RQ=@*Q!3)8KX[LJLSWL.Z=%1Y'K5392X&BT6XQ+BX)G!C_
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M7CZ))QP,NRLJ3=#8 *&5+7>AFR0U[O<<@(B@5XX[Q(K;OBW=;*"SD@OLE-:
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M!F4-\/U<2K.[L0'ZD_K9?U!+ P04    " !<.$U8%;3Q75X&  !&$@  &0
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M\RQ7-6)CGZ;&6.DSQTJ?C7+!#U[^L\01X6&!]RV%9WST;#;YD0F23]\EP&#
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MTN)@T3]<J<4P'ZP"_00='N%)BKV,SCSFB&08V9 PR0K 9*!\56/R>R7I! /
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MW1<VN[^93J;7#^SDD<\EV$^#AL/5R*>1;)$O2^3X'>0H9K=:N:5EURJ%]"U
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M TH[H1=%+1S#7NC<IT@#)"U5SDVIX'UHIW,5..T.=692)-JA7KM'[=@.G&^
M9;K!9<(SU/T"UM]RTU;D=&G/:7O=R(YA1-%9ZSXVA[C,2L$,YI( GD+,JP2<
MB\AKM:^<3\X%15 +)TMIF#AQ'A[)P:"*J&NUT%Z7'+MR_Z!<,U#KJBEI$LLR
M-W7E-JM-WQO7Y?[?O6Z:,Z;6'(]90(K0X/(*W[NJ&U%M&%E4Q;^2!EM)-=U@
M[P9E'7 _E=+L#1N@^1N,_@%02P,$%     @ 7#A-6)M7_S[U P  F0H  !D
M  !X;"]W;W)K<VAE971S+W-H965T,S(N>&ULI59M;]LV$/ZN7T%HR- "BB7K
MW9EMP'DI5B!!@SA=,0S[0$MG6R@E:B05)_]^1\I6E,91VPTP:)+B/??<PR-Y
MTQT77^460)''DE5R9F^5JL]<5V9;**D<\1HJ_++FHJ0*AV+CREH S8U1R5S?
M\V*WI$5ESZ=F[E;,I[Q1K*C@5A#9E"453^? ^&YFC^W#Q%VQV2H]X<ZG-=W
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M7;*X:5$4^\!(9UN(WD;2<;)?OR-E*V[F*$6Q83 @\^WNGN,]=R0/5HVXD0L
M1>^JLI:'UD*I=G\TDMD"*BZ=IH4:9V:-J+C"KIB/9"N YT:H*D?,=:-1Q8O:
M&A^8L0LQ/FB6JBQJN!!4+JN*B_LC*)O5H>59FX'+8KY0>F T/FCY'*:@KMH+
M@;U1KR4O*JAET=14P.S0FGC[1ZE>;Q9\+& EM]I4>W+=-#>Z<Y8?6JX&!"5D
M2FO@^'<+QU"66A'"^'.MT^I-:L'M]D;[:^,[^G+-)1PWY:<B5XM#*[%H#C.^
M+-5ELWH+:W]"K2]K2FF^=-6MC5.+9DNIFFHMC BJHN[^^=UZ'[8$$O<) ;86
M8 9W9\B@/.&*CP]$LZ)"KT9MNF%<-=((KJAU4*9*X&R!<FH\?3NY/'U[_N[D
M]'+Z,SW]_>KLPV?ZX@._+D'N'8P4FM +1]E:W5&GCCVASF/T?5.KA:2G=0[Y
MUPI&B*T'R#8 C]B@QA/('.I[-F4N\P?T^;W#OM$7/N7P@@MX=82!S.EQ4R&Y
M)3?\F C!ZSD@X12]OJ?;ZR[XO1F>K+C(Z9=WJ)*>*:CD'[MVJ+/O[[:ODVQ?
MMCR#0PNS2(*X!6O\TP]>Y/XRX%W0>Q<,:1]/,6GS90FTF='S5OLEZ1OT2SV.
M10=U6-F'!=!94V+>%O6<*L,)6DC*-RFLK2!#LQO:M \Y5JA[%!-4H?@]<$%!
M4X'B-,82JFL0?3S)YX?YK4EBYCZ9C(*<_+;4XV1R"P+K!&EFY/0.1%9((&L?
MR84H,GA)SI=**E[G&B_',,*\J&O=0: :"F%V&/IV%+CD1Q(ZODN.%SKHDN9+
M89Q<8]XGZUTCK_"W,9>3%ZD7VEX0DCT43QG!RC"#XF%=6XAU^Q$4]+$'X=F1
MG]A!&B*(P$FCC7Z]P<^N?4G/:GKE3!V:8VBXD+3%/3L7:$A'Q-!V@$AA3Z3P
MVXFT[0IBVX:[#L N<@T;V$FNCE?%7T"+NCMP-*NRILY ='%\! 6VH#1KOG.I
M0?^#:_L;L@PI>6"6892D+]?LTRHW!A[O!^P*'S'AVW"8\HZ\>([IDU)+HE=*
M8,(L>4G+8@888-=A"?$CSTY3'SL!Z\92S ??#OQD,^8[7D2\(+73("&>$WMF
M+ X)\SS;BWW"')<9AGL>B5T[#B,<8A$.Q8[KDL"S7?QC3J0E4R<)21@AK]$2
MJDYPS&/:!$LP71"1XVOZ,<^)&(GL$$5])_DV*CH#7(QZ+D;?S$6CE.XHWYA[
MV(9=1!S4OKL@#]4E_##]\<AQ(Y6I@1S)B[7%#3 L=NK%^/7<A%RB.BZRA6%)
M#K=X!6K-00(=6"T3A8SXMA=IR3 ,R!0O*!MB82[<@-*]7L"+<6VL_WP,<6*S
M."!OH$9RE4:$YWA)*"0R2]]VMN3L&(.($+6P[2(7&-9!38+ #A "$B>-&!V(
M5MQ'*QZ,%CJM,'<TZ:?F;+BJ"R7IB\OIE=RC7]Z;S=QY< [J_<Z#,^E1)__S
MM2#Y#[Q+>^_2?_-:,*SL^RJW#O]3I?E[KP'&!8KW7B!:/7G-"T$_\G()S]\$
M$C>P0RR90>A@"CU[#8A=+'P1%K[ "0+R$3FN;P,A8[:/N;1' BR2_M9U *?L
M&-?O$3]VL%0\?1W (R;U(ZP=6'Q3QPVPK$YV;Q-^X]!F0=IMY@JP$MX:)";U
M35^"4B4.(%4+*9<<]U_K0DJU8!Y 5&H&2PU">_G5QOS*ZZ6NW&@LV%FX1UL/
MC0K$W#RG)(9Y6:ONS=&/]B^V2?=0>5C>/??><X&6)2UAAJ(NGEX6%=T3JNNH
MIC7/ENM&X2/(-!?XZ@2A%^#\K&G4IJ,-]._8\=]02P,$%     @ 7#A-6*I)
M0$WN!@  O!$  !D   !X;"]W;W)K<VAE971S+W-H965T,S4N>&ULE5AK;^LV
M$OW.7T&XV,(!E%@ORU*:!,BKV!2][<5-;K?%8C_0TC@F*HE:DHIO^NMWAI(5
M)56,+ (HE,0Y\SY#^6RG])]F"V#YMZJLS?EL:VUSNEB8? N5,">J@1K?;)2N
MA,5;_;@PC091.*&J7(2^GRPJ(>O9Q9E[]EE?G*G6EK*&SYJ;MJJ$?KZ"4NW.
M9\%L_^"+?-Q:>K"X.&O$(]R#_=I\UGBW&% *64%MI*JYALWY[#(XO4IIO]OP
MFX2=&:TY>;)6ZD^ZN2O.9SX9!"7DEA $_GN":RA+ D(S_MMCS@:5)#A>[]%_
M=+ZC+VMAX%J5_Y*%W9[/TADO8"/:TGY1NW]"[\^2\')5&G?ENVYOLIKQO#56
M5;TP6E#)NOLOOO5Q& FD_CL"82\0.KL[1<[*&V'%Q9E6.ZYI-Z+1PKGJI-$X
M65-2[JW&MQ+E[,7=+]>_?KKE#Y>_W][S^8-8EV".SA86H6G#(N]AKCJ8\!V8
M(.2?5&VWAM_6!12O 19HTV!8N#?L*CR(> /Y"8\"CX=^&!W BP9'(X>W?,_1
M.E<5\ ?QC=](DY?*M!KXOR_7QFHLC?],^=PA1M.(U"ZGIA$YG,^P'PSH)YA=
M?/]=D/@_'+ W'NR-#Z%?W&/[%6T)7&WX#6Q :RB<]9?&@#5\7DJQEJ6T\IV$
M'82?-G[0([M@650G.G78*]1(W&Z!U\@5] HV&WQDR$(,I^&B+GB.XM+R7&C]
MC)2Q$[KH7EBH&J6Q[WDA44Y#G8/A:[ [@-K!.AE9/W)1J;;N<'OM!##RER,R
MW\A:U+D4)=J&R)8DFU8WRD"O$3'W4*U!KTAJY-E^\PE_(.T*[:NAUTNRU_A$
MU,_??Y>&P>H'X]PN]A$:A>95)KBPF*X<JC7HH7R=.;@(^0X=1SDTI40Z-*=L
MM)?15KJ$[&9"C202- TE06U.V7V[-K*00E,\QN%VN0##EJGGKY8L\;TPS-BO
MZ)&>3@*+O" (6>A%2<;NMT+#,?%<X4*"]"N(/EGL!5G,EH@939@WMLXJKIPV
MDM>P)09_ F<66_JD*(Q2]J LIFXJGFM 3X _B;(5'7-3K##7P)*EEZ812S(O
M\S/VV\2.>1)[T6K%CG"5>&FPQ-6[JEC@+?T$_?>SF!_HV>70L\L/]^P7R!66
M)]:&LQ"?8)6A7U;F:,QGK9ZD&VPX6_@+-TTU\D&=TXW\HRLOZ@B)O8"9>6L+
MU;<=V=,,]KQN$H\BU5:N*\MR_P)!\1V&4G2$8*RPK5585KG25&"VZS"W$$U3
MH@X<+%09=T8+*.6P$54:[Z5=<]NB-22+IG3:3MD?(#0'FBM\NEWP$K ^B'WU
MD'WF!81A"WMALL*M@1<G"0L2; \LQG%2'*=]HY(G!GGKFG,&0W=7?U(%\)]M
M<<+0@'^,+C'6Y2I@<>)%T8I%J9?$/MF%IR4#?%Y MSJB;GEC("]:BL\INX(:
M-A+; (-%!O3WZ/MM;4$W6AJL<F265911E8>9%X=N%:V\>)7BZJ;O;=LS-'7?
M/AWF33Y(Q9A*V#SPLF5">!BH9>14>'Y$BZE^"T*,9>0S=/0KWFLK.M\X4JMT
MV<4F\S-L,C_"58:)^D75QYC+%@TC(UXBCD70$4<#>-XB+A[3E,?IC%D^<T,4
MQ?].40,2ZDF7/EWCD*[(-I=XCBPJ0NQ]OJN?P-C*\?W/8L<;\>Q>'W,#6(>E
M4;Q6F/ @$O/P:+X^8L?HJ^<'*US@4=66T GOI-UVB'UE.WII[59I:9_=T,"B
MV:>>UAI*0?EL7\=KWX&DR$>RS6B1>5&<L@CK*DZ0.+,P/<13R<!3R8=YJF^;
MJZYM7I@(S!07'<2=YJ+-R9O6?&$73#I2B9N\E,R>ES9[\OIXYP\=Z8IHGPDS
MKNLP"+P NS+(L#N7,1) A(/"?SU'\:L%;[JX.!"6>%3=2S<A8R^)PO>8Y%!>
M5D->5A_."QWU;O>M,:>[G@DF#WL'<:?S\GC"'L:$-Z<J7/<Z/AKZZU83T9RR
M/EP8FP2Y JDOI+KU4J2F5_2"[9A@\+TDB)%A$/"(BCS.5E3D:1*B3)*EPPEC
M )X',9%<BE(KS-K1:]1C]_>W/=W@?SL*_L^F2H?DI1].WM>:1NYC+?_J#^U[
M5I_*W4'8Z=P]C-L$'20>[3ZK4:/9CU+Y1 STSFFV'9LX2KWY0.JO1$GD3S/R
M)U&W=)X,',''2+8!G6D[LD-J:Z>'@CMFD%GHTY-4K>'/J)02.>\PCE[FY@=0
M\JX,'8A'G#L:.B-CQ]X$7H04BQLF<[\8?5%7H!_=[P9$5?@UT7U<#T^'GR8N
MNR_RE^W=[QJ?A'Z4:&L)&Q3U3U9XGM/=;P7=C56-^SY?*XM?^VZY!5& I@WX
M?J-P$/4WI&#XP>;B?U!+ P04    " !<.$U8?.S< \@%  !"#@  &0   'AL
M+W=O<FMS:&5E=',O<VAE970S-BYX;6R=5UM/&SD4?O>OL%*U6ZJ!S"5S"04D
M"'3+BE($=*MJM0_.Q$FLSMBI[1#87[^?/<D0:)KM5HB)QW/.=^[GV <+I;^:
M*>>6WM>5-(>=J;6S_6[7E%->,[.G9ESBRUCIFEF\ZDG7S#1G(\]45]TX#+-N
MS83L'!WXO2M]=*#FMA*27VEJYG7-],,)K]3BL!-U5AO78C*U;J-[=#!C$W[#
M[:?9E<9;MT49B9I+(Y2DFH\/.\?1_DGAZ#W!GX(OS-J:.DN&2GUU+^>CPT[H
M%.(5+ZU#8/BYXP->50X(:GQ;8G9:D8YQ?;U"?^=MARU#9OA 59_%R$X/.T6'
MCOB8S2M[K1;O^=*>U.&5JC+^21<-;9IW:#DW5M5+9FA0"]G\LONE']88BO '
M#/&2(?9Z-X*\EJ?,LJ,#K194.VJ@N84WU7-#.2%=4&ZLQE<!/GMT=GE[?OME
M]_/YZ1D]/;\97'R\^71]1E_?LF'%S<Y!UT*((^V62\"3!C#^ 6 4TP]*VJFA
M9W+$1T\!NM"N53%>J7@2;T4\Y>4>3:* QF&<;,%+6I,3CY?^ .^&3Y!5EE[S
MF=)6R G]ZWAHK$:"_+W)W@8MV8SFBF;?S%C)#SNH"L/U'>\<O7H19>';+;KV
M6EU[V]"/;E"$HWG%J1K32Y3H#4-4Z/"!_L[51+/95)3T&,6X2>_MR-$.N>9W
M7,X;O,DC'@,>77#-*3-TK"K4K=DG7SC3E+N04@2$UT.N$13B8N(>L7M$Y),4
M%A0WEEEN2!+F01$5).X701:!),F#.$O(V5RCJY L#M(D)KU^$.<]DF1!6A3D
MHYUR3:(X"K)^0:(P"Y(B)442Y%$/I'$0]@KRAO32'K@BK)(T#](LQ>I-:Q!S
MRENKQ7#NU+'JN7W&E_*(HB] 'JU4R7R3@)N;HN-ZCUXJ:I >\/YJ#TVD5'/I
M,-$/:12^I/BIE?8!&JAZQN3#JQ=%'.5O#<1:5J%S-4H%CO0YB41,EY@&E"47
M=Z[P BK0L.0#'0M3 N/!.=^GEY.]MR6QTC:QTJWA7[J*CK6JZ=F]Y5I"SF!I
MIT^)*ZU&\Q)Z,8F((K%%R<VF1-LJ:7.!Q.O9MXK$;"GP-XIH\(G2#[^:A@,V
M$\[W9]_F8N:+?14%THN00D6?)'TD$'(RB9!^29\,E,1@\EW/&VP:@Q\9\W[0
M3_LD"X,0/TD1)''6)N0J'9?)2+=$*&LCE/U:Z=_R<BI5I28/FX*Q%71S,)+M
MP;"MO%\-QTOR04A1LVKW7-XQ@S&,@B9%1/*8O(>SS>X[S;&'<@<#N53RD;"/
M/_<A7/UO\VW>^C;_:=\.IDQ.8#DJ#CG@QP"]$&PH*F'%YH3?#M[;(;?H*>4C
M;KG"K1YQFQ[U?UQYPBHF2\\$M?]@<HY3%(U(E =YFI,(_3/-R+DL77^#@!'*
M&YU/&#/W?&"2."6ME$%#XO=E-1^Y"<CJM@6IB13_0 EF5KD/).V(7*><<2W4
M"/TYZ+GVW OZ1;[*GG5N.V66+I@SW\G CFA:[7>^>$#.+0VSGF+()T)*)Q :
MK\E\':6HK8SL8(5Q4+C54Y^L^PVJ92CSI7,&WTMMVZG33"+ERKG6KE6L!^DU
MQB1D06KBJ_^_<#9@(&>#/F+H=(;+'.+Q<VV;LTWP1 T<+3E6HS8*PE!N+,IH
M.=*&_%FXFE2"X_9ID;QTZOBY >C4MS3G2RAKU[]DNWCDVR9*T=94\=,U=:'D
M9/<"Y3NBQ\9PN[&*ML,-]\AW*&1S89P;S7A%LB /<8SP)XRGYY (V=(GZ-3]
M?'F^2'#6R-U.%!$_$$*2!PD:N/^,\P D8R;6<*L3C/,&OH9XIGGB*JV7HA=%
M0;_7(V_<Y!#&^IBN!W#C7/<#'[%07HZ0=XB'&U!F4P2Z:^=Z3.6)O[T8ZF&;
M(WZ[VUZ0CIM[P2-Y<[OZP#2JRM"*C\$:[N48VKJYL30O5LW\+6&H+(X ?CG%
M)8]K1X#O8Z7LZL4):*^-1_\"4$L#!!0    ( %PX35CW^2Y=+ 8  )(X   9
M    >&PO=V]R:W-H965T<R]S:&5E=#,W+GAM;+6;VV[;.!"&7X5PBZ(%BE@'
MGY(F!A+KK"8-ZK1[4>R%8C.Q4$ET13I)@7WXI0ZQ+5O6RKO_WB02S?F&E.:G
M1B)Y_LS2GWQ!J2 O<93PB\Y"B.59M\MG"QH'_(0M:2)_>6!I' AYFCYV^3*E
MP3PWBJ.NIBB#;AR$26=\GI?=IN-SMA)1F-#;E/!5' ?I[RL:L>>+CMIY+?@:
M/BY$5M =GR^#1SJEXMOR-I5GW35E'L8TX2%+2$H?+CJ7ZIFO#C.#O,;WD#[S
MK6.2=>6>L9_9B3N_Z"A9BVA$9R)#!/+?$YW0*,I(LAV_2FAG[3,SW#Y^I5MY
MYV5G[@-.)RSZ(YR+Q45GU"%S^A"L(O&5/3NT[% _X\U8Q/._Y+FH.SCMD-F*
M"Q:7QK(%<9@4_X.7\D)L&6C: 0.M--!V#'3E@(%>&NAM/?1*@UY;@WYIT-\U
MZ!\P&)0&@[8>AJ7!L*V'46DP:NOAM#0XW37H';IQRNN=4]KZ4-<WNPBZ(DKR
M$#,"$8S/4_9,TJR^Y&4'>9SF]C*RPB23U%2D\M=0VHGQU+5O7,N=7-[<D<O)
MY,NWFSOWQB:W7SZ[$]><DO<W09H&6=A_(.\-*H(PXA_(6Q(FY&[!5CQ(YOR\
M*V1+,EYW5GJ]*KQJ![RJ&KEFB5AP8B9S.J\"NK(+ZWYHK_VXTAJ)!IV=$%W]
M2#1%ZY%O4X.\?_NAIF&3]AC]%4.F]%&.(J(&9[3':0VM,MMCU :,=4SGWKT9
MZ0/M$^D2O@A26G<7[7]QL6HPSC$7J46S7,Q%]YHQU\%OHNGE-6_1*K]]JY3Z
M5E4"7U\+6,^Y_0/<R]F,K1(1)H_DED7A+*2<_/@L*Q%7T)C_62?.@JC7$[.'
M^!E?!C-ZT9%/:4[3)]H9OWNC#I1/=8)"P@PDS$3"+"3,1L(<),Q%PCPDS ?!
M*B+KK476:Z*/+^=/-!4ASU1&7V0ZRVN'@*M&RK'"*F"#')9EQD]CM:\HRGGW
M:5LQ-;64O5KF?JW>7B4+V7H;"7.0,!<)\Y P'P2KA'A_'>+]QA"?L#B6KSA3
MP68_/Y+;("4LE6>!H'/R/8A6E-Q269 ]_<A?;9Z'5XW^CA4#$F8@82829A6P
MX99.E1-%K>K41GITVGATD1Z]-AY]D,>*% 9K*0R:1_LXRZ@X80^$4SGP!\F,
MDF7P.WL':!S^&[''1OQ@;\CN:]K.X+]?IZ?O7$FSJ-.K#/W]G9$?V7 ;"7.0
M,!<)\Y P'P2KA/MP'>[#YG"/(O:<Q_B#'/)G*9V'@D2,'PCR1MBQ08Z$&4B8
M.=S/JU1EN*,;I$=[WZ.F]7M5CP[2HUO31UT=53UZ2(_^OL?!<#.H5<)WM [?
M46/XWJSB>YF9R,'ZRY)FGZIDCEY^L.$R4SG\[>:JD7ML)(_VAMF=@=A NC.1
M, L)LY$P!PESD3 /"?-!L(I^3M?Z.6W4C\52.@NX(#^N:::DVB]&C8ACI8*$
M&4B8B8192)B-A#E(F(N$>4B8#X)55*4JFXD5!?YAMD2"= :E&5":":594)H-
MI3E0F@NE>5":CZ)5!;<UDZG^/Z_M);?RJJWKU>QMTNS\:#$A:2:49D%I-I3F
M0&DNE.9!:3Z*5A63MA&3UBBFZS )XU7<F!0V(XY^6B%I!I1F0FD6E&9#:0Z4
MYD)I'I3FHVA5@6VF[57\O+T*G;B'T@PHS832+"C-AM(<*,V%TCPHS4?1JH+;
M3.&KS7/XTP5+!;FC:4P,NF0\E*GB99*L@HBXB:#2I2!? T%KA0>=V"]I6;J\
M/076V_U@>*#>[NR-"6V=!:794)H#I;E0F@>E^2A:52R;Q0!J\VJ Z^#EG],_
MZ 0_E&9 :2:49D%I-I3F0&DNE.9!:3Z*5A789HF!.L"G?]#U!5": :694)H%
MI=E0F@.EN5":!Z7Y*%I5<)M%#FKS*H?_E/Y!USR4M-VT;KB[!LHX4+$_U'<3
M0&3[+"C-AM(<*,V%TCPHS4?1"KETMW8(Q31]S#>Q<9(_@XIET.O2]4:YRWQ[
MV$[YE7IFJC7EEGIFUY4[ZIE;[%3:N"UVZUT'Z6.8<!+1!]D$Y60H'Y5IL0&N
M.!%LF>];NF="L#@_7-!@3M.L@OS]@3'Q>I(Y6&]#'/\-4$L#!!0    ( %PX
M35A1$I I(0,  %X/   9    >&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;+57
MVV[B,!#]%2LKK5IIU<2AW+J U-++(A6*2KO[4.V#(1.PZL2I[916VH]?.T!"
MI6(N:EX@=CS'9\;'.9K6G(MG.0-0Z"UBL6P[,Z62,]>5DQE$1)[P!&+])N0B
M(DH/Q=25B0 29$$1<WW/J[D1H;'3:65S0]%I\50Q&L-0()E&$1'O%\#XO.U@
M9S5Q3Z<S92;<3BLA4QB!>DR&0H_<'"6@$<22\A@)"-O..3Z[P$T3D*WX36$N
MUYZ1267,^;,9](*VXQE&P&"B# 31?Z_0!<8,DN;QL@1U\CU-X/KS"OTZ2UXG
M,R82NIS]H8&:M9V&@P((2<K4/9__@F5"58,WX4QFOVB^7.LY:))*Q:-EL&80
MT7CQ3]Z6A5@+P*<; OQE@)_Q7FR4L;PDBG1:@L^1,*LUFGG(4LVB-3D:FU,9
M*:'?4AVG.J/>S:!WW>N>#Q[0>;=[]SAXZ UNT/#NMM?M78W0T4CK($@9(!ZB
MH=!J$.H=D3A 5R\I3?3Y*'0E%=7U@0 ]2@A3AFYUH>4Q.KH$12B3QRU7::IF
M0W>RI'6QH.5OH'4)DQ-4P3^0[_F5C^&NSC!/T\_3]#.\R@:\+H^25(&0Z*D/
MT1C$7_0/]6E,HS3*ISZC:84U5^9,)F0";4??"0GB%9S.]V^XYOVTD*[DI"L9
M>G4#Z56Y?Z A([K.'ZO^=*N7HYZ"2'[*O%("\].<^:FUW(4BTH4BF%'$9RSM
M.!7T#D1("Z-JSJAZ@ #(VU8!6&$/+&,M)UTK40"U$IC7<^;U+Q* '>=TJP :
M.:.&%:G/6;#W[;="'EC"9DZX6>+A-TM@CKW"5+PO.OXM0-O/'Z\Y'=Y3 3M<
M?SOFH84L; O[)8H E^%>N+ O;/68?51@!\+>=AD4UH2W>%->/E/,,!4Q5:F
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M2)EYJ/;!! -6DSAC&YCY]^LX:4@@1$4*+VWLW'MRS_7!.G;O0-D;WV(LP*_
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M:YRI\)Q+C2MC#EZ?9!B8"ASP_\HH)IA6.6;\&^_R"'FXK\D?,<=LC[7!GW_
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M![9N(=-:'4]=:,46'#T/K/045\BT?79RLIOM,Z6>1S4[1NN"4F-K4CP4'YV
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M'ZXI65*>&:C?5XS)'R?9UP+EUR&C_P!02P,$%     @ 7#A-6% )Q+_5 @
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MI;SQW16]ZTBV+F^Y&9/JSBR;*_570ZX#U/R",?G>T1=G_9\,_P)02P,$%
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M_2M7K)I::2M?:19U!"D)K5:IU:IFW1ZF/3AP":C&9K9)NG\_VQ"6=J3J0U_
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MB6*#3OS^G3_V/@_)\Y9DR1N1/9%NU$LW>HD]_EJCT+W,UI":#L]UATO(!:^
M]SO4RCND:<L]MMS&63=Q<!9ZD;O9U^K_('\R\9\&)0-!83#I@]K:W+T/O$*Q
MMD8I(>4-4VWO]ZN]%\^L!3U;GVN/;BWU'TUK\#=$K$LF=<VYIO1./^F>$ZUI
MMA/%:VLC*ZZT*=EAH?\S*$R WL\Y5[N).:#_<\5_ 5!+ P04    " !<.$U8
M&S+K1H0#  "+#0  &0   'AL+W=O<FMS:&5E=',O<VAE970U,RYX;6RM5VUO
MTS 0_BM60&A(;'E/V]%6VEH02$Q,ZX /B ]N<FTLG#C83KO]>^PDRY(VS:CH
ME]9.[AX_S_E\OHRWC/\6,8!$#PE-Q<2(I<PN35.$,2187+ ,4O5FQ7B"I9KR
MM2DR#C@JG!)J.I85F DFJ3$=%\]N^73,<DE)"K<<B3Q),'^\!LJV$\,VGA[<
MD74L]0-S.L[P&A8@OV6W7,W,&B4B":2"L!1Q6$V,*_MR9KO:H;#X3F K&F.D
MI2P9^ZTGGZ.)86E&0"&4&@*KOPW,@%*-I'C\J4"->DWMV!P_H7\LQ"LQ2RQ@
MQN@/$LEX8@P-%,$*YU3>L>TGJ 3Y&B]D5!2_:%O96@8*<R%94CDK!@E)RW_\
M4 6BX> $!QR<RL'9=? /.+B50Q$YLV16R)ICB:=CSK:(:VN%I@=%; IOI8:D
M>AL7DJNW1/G)Z9</5XL/"W2V4/D1Y1006Z%%GF44U%Y)3-$UIC@- 2V*I/J<
MEIFC=^ .*)80(<G0%U"1%&_1V1PD)E2-SM&WQ1R=O7Z+7B.2HON8Y0*GD1B;
M4K'6:YMAQ?"Z9.@<8#B'\ *Y]COD6([;X3[[=W>G[6ZJ6-4!<^J .06>?P#O
M:P9<Z4_7E>@N026"VXV@#^:ER' ($T.=/ %\ \;TS2L[L-YWR3L16$NL6XMU
M^] ;8JD6B[@^%.=L=9ZK"18"9*?^$C0H0'4=V4Q'P6@X-C=-7?M&OC5P:Z,6
M7Z_FZ_7SE3%P=6PX5\F+*,%+0HDDW;M40GD- HYG>3LL]XULSS_ TJ]9^D=%
M]06>_AZ%(+#='9[[1JYOC;IY!C7/H)?G/=,%@!W'-MC?>\L>[+#=-_)&@=/-
M=E"S'?2R_5%4;%6/KC:*\!I4?=+76'U2T3WPY!W:"7ZGAOZ%'/0(F MD6RAA
MJ8P%<CP4X<<NJ%D_E%=!N4](]K #J16.81V.82_TC9*>Y GZ>0/)$OBO+IV]
M",?6J1.!M<2.:K&C_R[*HU.*/1%82ZQM/=_9UG&I/B<B9+DJ>7?J1OZW'*^6
ML)W&(;0N+&?GI+YHUI;0:#OL_O3$#R^F9S_$L5MV*K2VX.>VP?[_OL$^:>-P
M*K2VX.?6P>[O'4Z2I.42.@F;V3<8[E[3!PS]X4Z>FHU.67^FW&"^)JE0%%;*
MS[H8J.WC9>=?3B3+BN9YR:1JQ8MAK+Z6@&L#]7[%F'R:Z'Z\_OZ:_@502P,$
M%     @ 7#A-6%ME;ZGX @  8 H  !D   !X;"]W;W)K<VAE971S+W-H965T
M-30N>&ULK99=3]LP%(;_BI6A":1!OI.6M9&@,&U2D1"%[6+:A=N<MA9.G-E.
M"_]^MA-":4.*JMTTMN/W^'F/&_L,UHP_BB6 1$\9S<706DI9G-NVF"TAP^*,
M%9"K-W/&,RQ5ER]L47# J1%EU/8<)[(S3'(K&9BQ6YX,6"DIR>&6(U%F&>;/
MET#9>FBYULO '5DLI1ZPDT&!%S !^5#<<M6SFR@IR2 7A.6(PWQH7;CG(]?1
M C/C)X&UV&@C;67*V*/N_$B'EJ.)@,),ZA!8/58P DIU),7QMPYJ-6MJX6;[
M)?HW8UZ9F6(!(T9_D50NAU;/0BG,<4GE'5M_A]I0J./-&!7F%ZWKN8Z%9J60
M+*O%BB C>?7$3W4B-@1N\([ JP7>1P5^+?"-T8K,V+K"$B<#SM:(Z]DJFFZ8
MW!BU<D-RO8T3R=5;HG0R&5]?3*XGZ'BB_A]I20&Q.;K!LN1$$A"Z-P:5)30F
M>$JH&3Q!QU<@,:&J=8H>)E?H^.@$'2&2H_LE*P7.4S&PI8+32]BS&N2R O'>
M ;F"V1GRW2_(<SR_13[ZN-Q[*[=52IJ\>$U>/!,O?"\OVK5 OR^F0G+U7_O3
MYJ@*X;>'T!_@N2CP#(:6^L($\!58R>=/;N1\;?/WGX*]<>LW;OVNZ(E*6M!F
ML%)%1J4/A%7BQ4$XL%>;X)VA#P0/&O!@'WC8!EZI@DWPH.]N@7>&/A \;,##
M?>!1&WBX"^XXV^"=H0\$CQKP:!]XW 8>[8"[L>]O@7>&/A \;L#C?> ]I,XF
M-(5GEJ=M'N(=#WW'V[+0N<B!%GJ-A5ZGA7LF,474',@%?E:WJ6P]:7N[/GKQ
MMI'.I0XTTF^,]#N-C$$(1+*BE)"J>T."6J+=2G_'RFDOW#Z!.A<[T(KKO-Z@
MS@=V1156'$N2+^K]H:\79NMEZ.P<K7W'C;>,M<P*^M'K3E;$]L;UKVNO&\P7
M)!<*9*YDSEFLS@M>E3-51[+"5 13)E5]89I+50("UQ/4^SEC\J6CBXRFJ$S^
M 5!+ P04    " !<.$U8<4*6-#H#  "F"0  &0   'AL+W=O<FMS:&5E=',O
M<VAE970U-2YX;6RMEEUOVC 4AO^*E4U3)VV-\PET$&FEW8;4K170]6+:A0F'
M8LV),]M ^?>SDS0%XK).V@VQD_.^?LXQ_NAON/@EEP */60LEP-GJ51QYKHR
M74)&Y"DO(-=?%EQD1.FNN'=E(8#,2U'&7!_CV,T(S9VD7[Z[$4F?KQ2C.=P(
M)%=91L3V'!C?#!S/>7PQIO=+95ZX2;\@]S !=5O<"-US&Y<YS2"7E.=(P&+@
M?/3.AAXV@C+B.X6-W&DCD\J,\U^F,YH/'&R(@$&JC 71CS4,@3'CI#E^UZ9.
M,Z81[K8?W3^5R>MD9D3"D+,[.E?+@=-UT!P69,74F&^^0)U09/Q2SF3YBS9U
M+'90NI**9[58$V0TKY[DH2[$CL +GQ'XM<!_J2"H!4&9:$56IG5!%$GZ@F^0
M,-':S33*VI1JG0W-S31.E-!?J=:IY'KZY7*,AK?C\>6W*;H:?3P?78VFH\L)
M.IGHO\Q\Q0!=+]"U6H) 5Y3,**.*@GR+3BY $<ITZSVZG5R@D]=OT6M$<S1=
M\I4D^5SV7:4)S3AN6M.<5S3^,S07D)ZBP'N'?.P'%OGPY7)_7^[JNC3%\9OB
M^*5?]%QQRJR'*R$@5[O9HQ]7.A2-%&3RIRW-RC>P^YJE>28+DL+ T6M/@EB#
MD[QYY<7X@RWI_V2V5X*@*4%PS#VYS K&MZ!3UC.JURTC"N8('O0V(L$ZPY5?
M7/J9362=^!X.<=]=[^;4CO)Z8=!KHO9@PP8V/ K[F:]!Y)F9+)I+1=7*;!56
MRLHHW!D_Z 7^ 60[*,21;V>,&L;H*.,H3WD&2)$'5) MF3&PX46MD;V>USW
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ME>X(\]=(-^T@S +]?<VY.@P,0/5O@-F_4$L#!!0    ( %PX35CF5ZA3I@4
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MT72+5L&I%<8=_V!52*J9)]6L36I$N4!42IW$P-'W>TAFP"HW12W.>S>%2;#
M$%B!/S_GS_]@,?HF>3<)%A@"*_#>RGEO&1?C'K%Q+#.GX9>T>&J$.[A5DF*%
M$7;:U4ILYQFU:S.:2(X(FZ^0_&JB +;R7+;6VR3[V-:KLQ;[O;O$)%A@"*S
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MJBV9VV0+VV+;E?FYA">-]6MSMCDOZCMB$[^[_U]69V?Y3N#MY]M+N\#I$/=
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M7!NH^2EC\JFC%ZBNL@;_ U!+ P04    " !<.$U8U\:LN@\$  !@#P  &0
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M2?)$S?CV3R@#:AN^B"?2_J)M:>LY*,JEXFD)UAZDE!57\JT48@_@!R\ < G
MQX#."X"@! 3'@-8+@%8):+T6T"X!-G2WB-T*-R&*C :";Y$PUIK-W%CU+5KK
M19E)E+D2>I=JG!J%G^ZG]_^\_SR=A&@RG8\__C5_F(7H;*XS,LX30'RI\V$#
M+ =I_Y$8Z;\W$SS.(R5_1Q%1L.+BZ1R=34 1FLAS]!X]S"?H[.TY>HLH0_=K
MGDO"8CEPE?;8G.M&I7?CPCO\@G<^1K><J;5$(8LA/B1P=:A5O'@7[QB?9)Q
M=(D"_P)A#P<U#DU>#\<U\/#U</]$-$'U[P66K_T"WQQ6NF@5FD'&A:)LA::L
M>'F8(GS\J,W15$$J_ZW3ON .ZKG-&^I*9B2"H:-?01+$!IS1NS=^Q_M0IUN3
M9&%#9 >:MBI-6Z?81[,RVVO\NCF-?/1K92Y '0LR[^W-J-7'7JLW<#?[ M:8
MM5NXZQ^:A=^;!>UNN].NS Z";E=!MT^Z/B89521!X=><9C:E'F\A78"HC>@D
MUX\F3I-D84-D!QIV*@T[O[ 8.TUJVB19V!#9@:;=2M/NSQ;CN$"V]@O&QUZO
M?U17WYL%_1;V\5%=U9CY?1STZ^NJ5_G?.UU7G.D6C"P2_?6\9C&::WUH!&@7
MU\DR.TG]HRG1)%G8$-F!I/U*TOXO++-^DYHV218V1':@J>\]MX'>3Q=:"=W_
MYG3[_?9QH=68=3SOV"RL,0MZ >[4%YIO&MG#%?P<$_Z_[W%59T0 (DH)NLB5
M[F$51RO@*T&R-8W,)MGK;M4:4,*C(J%T_UNTX2 NT2>.I,XXW1;OUO2D$_&<
M&4Z=A,CW?D/ZDG)A.^<Q3S/"GMZ]Z6&_^T'J8\U'=M=/7QC38Q.FA\.24VK+
M".C&O#XN3">M[="2RDAS/ $1R&:".?NR+@?<O:E >[JRXYA$EKIHAZK5:N2[
ML8/.T?K8C((UZ]>^?S7QZW>PWK%<[O/1Q>QY2\2*,HD26&HWO,NN+G11C'/%
M@^*9G5<67&F)[>U:C\ @C('>7W*N=@_F@&JH'OT'4$L#!!0    ( %PX35A*
MA-K ? ,  "@1   9    >&PO=V]R:W-H965T<R]S:&5E=#<Q+GAM;+U8:T_;
M,!3]*U8F32 -\BI]L#82;4!4 H8H#$UH']SDMHU([,YV6_CWLY,0FBS-BF31
M#TWLW'/L>W*/$Z>_H>R9+P $>DEBP@?&0HCEJ6GR8 $)YL=T"41>F5&68"&;
M;&[R)0,<IJ D-AW+:IL)CHCA]=.^6^;UZ4K$$8%;AO@J23!['4),-P/#-MXZ
M[J+Y0J@.T^LO\1PF(!Z6MTRVS((EC!(@/*($,9@-C#/[U+==!4@C?D:PX5OG
M2*4RI?19-<;AP+#4C""&0"@*+ ]K&$$<*R8YCS\YJ5&,J8#;YV_L%VGR,IDI
MYC"B\6,4BL7 Z!HHA!E>Q>*.;BXA3^A$\04TYND_VF2Q'<= P8H+FN1@.8,D
M(MD1O^1"; 'L]@Z DP.<*J"U ^#F '=?0"L'M%)ELE12'7PLL-=G=(.8BI9L
MZB05,T7+]".B[OM$,'DUDCCAG=_<C^]_'3V._7/DCR>CJQ^3A[MS=#"1!1:N
M8D!TAFYD^4UP#!Q-7]$]! M*:$SGKX?HP >!HY@?]DTA)Z,HS2 ?>)@-[.P8
MV';0-25BP=$Y"2$L$Y@RBR(5YRV5H=/(Z$-PC%S[&W(LQZV9T&A_N%,#]_>'
MVPW9N,6-<5.^DQU\(TH"((+AU!YW$7]&3U<R!HT%)/QWG> 9H5M/J!:04[[$
M 0P,N4)P8&LPO*]?[+;UO4XLG62^)K*2D*U"R%83NW<+3 DI%S%5RT36,L]J
M6:X6(9+:+AD-5X'@2,C2SBJ[3MUL%#N[_VHY77OR/J^W-?M_B-\84LKOI,CO
MI#&_ZXA$"8Z/QF2-N5Q#T=,U)%-@M2722/71$M%)YFLB*TG8+B1LZ_9:6Z>0
M.LE\360E(3N%D)U/\5KG7Y=8QUVW8K?Z*-O:_E7]5XOI./46[!9I=QO3OL0D
MY$<7#)K-UTCRT9K12>9K(BN)URO$Z^DV7T^GD#K)?$UD)2%MZ_U=SOH4^^7#
M5%QB=2O^JP^K.JX^:H?C[*WW5KLQUQM*]GOD-?-\M%JTLOFZV,H:.N\:.KJM
MES/J4E,GFZ^+K:SF^PN[W?@:J\]];JW[>E7W[17F[PCK5OQG;FTA$V#S="O.
M44!71&1;L**WV.Z?I9O<2O]0?09(MZ;O--DWA&O,YA'A*(:9I)1/75F6+-N6
M9PU!E^E&=4J%W/:FIPO (3 5(*_/*!5O#35 \7'$^PM02P,$%     @ 7#A-
M6/2<=3O_ P  5PL  !D   !X;"]W;W)K<VAE971S+W-H965T-S(N>&ULK59M
MC^(V$/XK5GJM]J1E0Q)(8 M(NV&K4MW+"G9[JD[]8)*!6)?8G.TLN_WU-TY"
M#EA#>U*_@%]FQL\S]CR9T5;(+RH#T.2YR+D:.YG6FVO754D&!5578@,<=U9"
M%E3C5*Y=M9% T\JIR%V_VPW=@C+N3$;5VKV<C$2I<\;A7A)5%@65+[>0B^W8
M\9S=PIRM,VT6W,EH0]>P /VXN9<X<]LH*2N *R8XD; :.S?>]=2K'"J+/QEL
MU=Z8&"I+(;Z8R2P=.UV#"')(M E!\>\)8LAS$PEQ?&V".NV9QG%_O(O^6T4>
MR2RI@ECDGUBJL[$S<$@**UKF>BZVOT-#J&_B)2)7U2_9-K9=AR2ETJ)HG!%!
MP7C]3Y^;1.PY>,$)![]Q\(\=PA,.0>,0'#OT3CCT&H=>E9F:2I6'*=5T,I)B
M2Z2QQFAF4"6S\D;ZC)M[7VB)NPS]].3NP\/LX:_.I]GTCDQGB_C=Q\7C_(Y<
M+/"!I64.Y..*Q!GE:U!DQDDLN)9X5^0=HTN6,\U O2474]"4Y3CJD,?%E%R\
M>4O>$,;)0R9*17FJ1JY&L.9(-VF Q34P_P0PSR?O\;!,D3N>0GH8P$66+55_
M1S7VST:<0G)% N^2^%T_L ":_G=W_PR<H,U\4,7KGXBW@#76CR9SV BI&5^3
MSS=+567W;UNZZFB!/9J1AVNUH0F,':Q_!?()G,DO/WEA]U<;U?\IV 'Q7DN\
M=R[ZY);FE"= J")B1?Z@O$3!(9Z-<QTHK (9!7N:>%'4CT;NTSX9BU78[X>M
MU0'*?HNR?Q;EC">HHPJ??5H"T8(PI<H*-X+FJ&=)4PKJDL!SDI>IN4):B))K
MA8J8B#5G_T!J:$IX HY1TE(:(YT!V8!D(K5QKF'U]MGXO>'@B+/%"HTB.^>P
MY1R>Y3QO<.ZAUQG59(L<&#<<<07+VA#8T2=YHP0OJ+_-Q>K*8@EKQKDAC!D[
MSSE\Q:;CX0V&1Z1M9D$T.''34<LZ^H'WB&4.Q1(DEKH-:63)>S@8'@&U6!V\
MVP.<@Q;GX"S.^'7&J^KDNKX5+G@G*:4THI)_EV<+B]OS!WWVK (T>$4JB%Y=
MD<5HV!_:B0];XL,?(VYG%0]?ZT!W:*3^ *'%*HCVZNL HF>ZE,.5O2^K]V]I
MO#E^4O77X]+<U>ZJL$D!'*6M2C!%0&F&/8VI/X%U="0G*Y%CNX:%=4T&P<_F
MZE^ 2A.Y1_!C6]4:/@R]O]/OX$]X99-O=Z][*$"NJRY,88&CDM6JWJZVG=YM
MU=\<K<>F [2LWWC=ZQ@S:=OQ<*?N\;X?7;><[ZE$_5 DAQ7"Z%Y%*'FR[N+J
MB1:;JJ]9"HU=4C7,L/,%:0QP?R6$WDW, 6TO/?D&4$L#!!0    ( %PX35C#
M &49[0,  (@0   9    >&PO=V]R:W-H965T<R]S:&5E=#<S+GAM;,58;6_B
M.!#^*U9N=>I*VR;.*_0 :0L]'5+W6I7V5J?J/I@P0+2)S=D&NO_^;"<-A(2H
MU5'U"SCVS.-G'H_##+TMXS_$$D"BYRREHF\MI5Q=VK:(EY 1<<%60-7*G/&,
M2/7(%[98<2 SXY2EMNLXH9V1A%J#GIF[XX,>6\LTH7#'D5AG&>$_KR!EV[Z%
MK9>)^V2QE'K"'O169 $3D(^K.ZZ>[!)EEF1 1<(HXC#O6U_QY0B'VL%8_)7
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MPS ,0'_%T)XP!] AB#-E\18$^0%6H@_8$@6*19V_K]JE<9 +&7D]/!+<'FE
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MS3[+;+G/S]TB61]>W#_\T\'UOU!+ P04    " !<.$U8Q]=S3T<"  #5*P
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M#?4V KT-]38"O0WU-@*];?*RFT!O0[V-0&]#O8U ;T.]C4!O0[V-0&]#O8U
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M>I:];8?7?#;]H?7F&5!+ 0(4 Q0    ( %PX35@'04UB@0   +$    0
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M965T,RYX;6Q02P$"% ,4    " !<.$U8BZQ07%H"  #\!0  &
M    @(%*&P  >&PO=V]R:W-H965T<R]S:&5E=#0N>&UL4$L! A0#%     @
M7#A-6- (\HFH!@  MQH  !@              ("!VAT  'AL+W=O<FMS:&5E
M=',O<VAE970U+GAM;%!+ 0(4 Q0    ( %PX35C$G-7EH ,  )0+   8
M          " @;@D  !X;"]W;W)K<VAE971S+W-H965T-BYX;6Q02P$"% ,4
M    " !<.$U8\8,C<Q\(  #3-P  &               @(&.*   >&PO=V]R
M:W-H965T<R]S:&5E=#<N>&UL4$L! A0#%     @ 7#A-6 U%2/>T"0  NRP
M !@              ("!XS   'AL+W=O<FMS:&5E=',O<VAE970X+GAM;%!+
M 0(4 Q0    ( %PX35@YBNPY; (  /H$   8              " @<TZ  !X
M;"]W;W)K<VAE971S+W-H965T.2YX;6Q02P$"% ,4    " !<.$U8^E$P#%D%
M   P#   &0              @(%O/0  >&PO=V]R:W-H965T<R]S:&5E=#$P
M+GAM;%!+ 0(4 Q0    ( %PX35@8_0L#=R<  '=Y   9              "
M@?]"  !X;"]W;W)K<VAE971S+W-H965T,3$N>&UL4$L! A0#%     @ 7#A-
M6)JVHZ[%!0  )PX  !D              ("!K6H  'AL+W=O<FMS:&5E=',O
M<VAE970Q,BYX;6Q02P$"% ,4    " !<.$U83#TP*]@"   H!@  &0
M        @(&I<   >&PO=V]R:W-H965T<R]S:&5E=#$S+GAM;%!+ 0(4 Q0
M   ( %PX35CO3,B&U0(  "\&   9              " @;AS  !X;"]W;W)K
M<VAE971S+W-H965T,30N>&UL4$L! A0#%     @ 7#A-6'4W&@5V @  1P4
M !D              ("!Q'8  'AL+W=O<FMS:&5E=',O<VAE970Q-2YX;6Q0
M2P$"% ,4    " !<.$U84CY)#RH#  "_!@  &0              @(%Q>0
M>&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;%!+ 0(4 Q0    ( %PX35C>@+G.
MZ0,  .4(   9              " @=)\  !X;"]W;W)K<VAE971S+W-H965T
M,3<N>&UL4$L! A0#%     @ 7#A-6$I&M>TC!@  'P\  !D
M ("!\H   'AL+W=O<FMS:&5E=',O<VAE970Q."YX;6Q02P$"% ,4    " !<
M.$U8@+IA=^\"   \!@  &0              @(%,AP  >&PO=V]R:W-H965T
M<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0    ( %PX35B!%,7P=00  $,*   9
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M970R-"YX;6Q02P$"% ,4    " !<.$U814KL,(0I   7B0  &0
M    @('/O0  >&PO=V]R:W-H965T<R]S:&5E=#(U+GAM;%!+ 0(4 Q0    (
M %PX35B@&#YN)P0  +X)   9              " @8KG  !X;"]W;W)K<VAE
M971S+W-H965T,C8N>&UL4$L! A0#%     @ 7#A-6*8D$_3C!   : P  !D
M             ("!Z.L  'AL+W=O<FMS:&5E=',O<VAE970R-RYX;6Q02P$"
M% ,4    " !<.$U8-+29CMX"   ?!@  &0              @($"\0  >&PO
M=V]R:W-H965T<R]S:&5E=#(X+GAM;%!+ 0(4 Q0    ( %PX35CU0!)(X0(
M  P&   9              " @1?T  !X;"]W;W)K<VAE971S+W-H965T,CDN
M>&UL4$L! A0#%     @ 7#A-6# /;6-\ @  1@4  !D              ("!
M+_<  'AL+W=O<FMS:&5E=',O<VAE970S,"YX;6Q02P$"% ,4    " !<.$U8
M%]DZR^L"   9!@  &0              @('B^0  >&PO=V]R:W-H965T<R]S
M:&5E=#,Q+GAM;%!+ 0(4 Q0    ( %PX35B;5_\^]0,  )D*   9
M      " @03]  !X;"]W;W)K<VAE971S+W-H965T,S(N>&UL4$L! A0#%
M  @ 7#A-6-_:A-SW @  + 8  !D              ("!, $! 'AL+W=O<FMS
M:&5E=',O<VAE970S,RYX;6Q02P$"% ,4    " !<.$U8!-3L%7T%  #3#@
M&0              @(%>! $ >&PO=V]R:W-H965T<R]S:&5E=#,T+GAM;%!+
M 0(4 Q0    ( %PX35BJ24!-[@8  +P1   9              " @1(* 0!X
M;"]W;W)K<VAE971S+W-H965T,S4N>&UL4$L! A0#%     @ 7#A-6'SLW /(
M!0  0@X  !D              ("!-Q$! 'AL+W=O<FMS:&5E=',O<VAE970S
M-BYX;6Q02P$"% ,4    " !<.$U8]_DN72P&  "2.   &0
M@($V%P$ >&PO=V]R:W-H965T<R]S:&5E=#,W+GAM;%!+ 0(4 Q0    ( %PX
M35A1$I I(0,  %X/   9              " @9D= 0!X;"]W;W)K<VAE971S
M+W-H965T,S@N>&UL4$L! A0#%     @ 7#A-6!NQI$$O P  *PD  !D
M         ("!\2 ! 'AL+W=O<FMS:&5E=',O<VAE970S.2YX;6Q02P$"% ,4
M    " !<.$U8N=!?>1D#   &"0  &0              @(%7) $ >&PO=V]R
M:W-H965T<R]S:&5E=#0P+GAM;%!+ 0(4 Q0    ( %PX35AM\^N*I (  . '
M   9              " @:<G 0!X;"]W;W)K<VAE971S+W-H965T-#$N>&UL
M4$L! A0#%     @ 7#A-6'[O),@\!   !Q0  !D              ("!@BH!
M 'AL+W=O<FMS:&5E=',O<VAE970T,BYX;6Q02P$"% ,4    " !<.$U8-HB#
M'\0%   I(@  &0              @('U+@$ >&PO=V]R:W-H965T<R]S:&5E
M=#0S+GAM;%!+ 0(4 Q0    ( %PX35A0"<2_U0(  #,'   9
M  " @? T 0!X;"]W;W)K<VAE971S+W-H965T-#0N>&UL4$L! A0#%     @
M7#A-6%!&4<"  P  <@T  !D              ("!_#<! 'AL+W=O<FMS:&5E
M=',O<VAE970T-2YX;6Q02P$"% ,4    " !<.$U8(L6L @H#  !V"   &0
M            @(&S.P$ >&PO=V]R:W-H965T<R]S:&5E=#0V+GAM;%!+ 0(4
M Q0    ( %PX35C'Z/HS?P(  $T&   9              " @?0^ 0!X;"]W
M;W)K<VAE971S+W-H965T-#<N>&UL4$L! A0#%     @ 7#A-6'#2]\MG!
M/A@  !D              ("!JD$! 'AL+W=O<FMS:&5E=',O<VAE970T."YX
M;6Q02P$"% ,4    " !<.$U8$; YC+H#   >%0  &0              @(%(
M1@$ >&PO=V]R:W-H965T<R]S:&5E=#0Y+GAM;%!+ 0(4 Q0    ( %PX35CK
M0#8D'P0  ),8   9              " @3E* 0!X;"]W;W)K<VAE971S+W-H
M965T-3 N>&UL4$L! A0#%     @ 7#A-6,,Y)UE\ @  B 8  !D
M     ("!CTX! 'AL+W=O<FMS:&5E=',O<VAE970U,2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( %PX35A$:D44? (  & %   9              "
M@7!> 0!X;"]W;W)K<VAE971S+W-H965T-38N>&UL4$L! A0#%     @ 7#A-
M6.E<@+1S"@  \'@  !D              ("!(V$! 'AL+W=O<FMS:&5E=',O
M<VAE970U-RYX;6Q02P$"% ,4    " !<.$U80F;L"_T#   2$   &0
M        @('-:P$ >&PO=V]R:W-H965T<R]S:&5E=#4X+GAM;%!+ 0(4 Q0
M   ( %PX35CF5ZA3I@4  %PF   9              " @0%P 0!X;"]W;W)K
M<VAE971S+W-H965T-3DN>&UL4$L! A0#%     @ 7#A-6*"AZ6T-!   H T
M !D              ("!WG4! 'AL+W=O<FMS:&5E=',O<VAE970V,"YX;6Q0
M2P$"% ,4    " !<.$U8V4+CYAL$  !^%0  &0              @($B>@$
M>&PO=V]R:W-H965T<R]S:&5E=#8Q+GAM;%!+ 0(4 Q0    ( %PX35CE/<9!
M=@8  " [   9              " @71^ 0!X;"]W;W)K<VAE971S+W-H965T
M-C(N>&UL4$L! A0#%     @ 7#A-6-XM]TPT P  60D  !D
M ("!(84! 'AL+W=O<FMS:&5E=',O<VAE970V,RYX;6Q02P$"% ,4    " !<
M.$U80SZ]?@4%   K$0  &0              @(&,B $ >&PO=V]R:W-H965T
M<R]S:&5E=#8T+GAM;%!+ 0(4 Q0    ( %PX35CDXTXV4@,  ),-   9
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M970V.2YX;6Q02P$"% ,4    " !<.$U8U\:LN@\$  !@#P  &0
M    @(%OGP$ >&PO=V]R:W-H965T<R]S:&5E=#<P+GAM;%!+ 0(4 Q0    (
M %PX35A*A-K ? ,  "@1   9              " @;6C 0!X;"]W;W)K<VAE
M971S+W-H965T-S$N>&UL4$L! A0#%     @ 7#A-6/2<=3O_ P  5PL  !D
M             ("!:*<! 'AL+W=O<FMS:&5E=',O<VAE970W,BYX;6Q02P$"
M% ,4    " !<.$U8PP!E&>T#  "($   &0              @(&>JP$ >&PO
M=V]R:W-H965T<R]S:&5E=#<S+GAM;%!+ 0(4 Q0    ( %PX35@JGL#[3P4
M  \@   9              " @<*O 0!X;"]W;W)K<VAE971S+W-H965T-S0N
M>&UL4$L! A0#%     @ 7#A-6(\/=8QI P  [A4   T              ( !
M2+4! 'AL+W-T>6QE<RYX;6Q02P$"% ,4    " !<.$U8EXJ[',     3 @
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8;6Q02P4&     %( 4@!U%@  *<0!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>217</ContextCount>
  <ElementCount>353</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>70</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>7</UnitCount>
  <MyReports>
    <Report instance="zk2430873.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://inmodemd.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="zk2430873.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0002 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://inmodemd.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="zk2430873.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://inmodemd.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="zk2430873.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0004 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://inmodemd.com/role/CONSOLIDATEDBALANCESHEETSParentheticals2</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical 2)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="zk2430873.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0005 - Statement - CONSOLIDATED STATEMENTS OF INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://inmodemd.com/role/ConsolidatedStatementsOfIncome</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF INCOME</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="zk2430873.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0006 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://inmodemd.com/role/ConsolidatedStatementsOfComprehensiveIncome</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="zk2430873.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0007 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://inmodemd.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="zk2430873.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://inmodemd.com/role/ConsolidatedStatementsOfCashFlows</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="zk2430873.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0009 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://inmodemd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParentheticals</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="zk2430873.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0010 - Disclosure - GENERAL</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://inmodemd.com/role/General</Role>
      <ShortName>GENERAL</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="zk2430873.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0011 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://inmodemd.com/role/SignificantAccountingPolicies</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="zk2430873.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0012 - Disclosure - MARKETABLE SECURITIES AND FAIR VALUE MEASUREMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurements</Role>
      <ShortName>MARKETABLE SECURITIES AND FAIR VALUE MEASUREMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="zk2430873.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0013 - Disclosure - ACCOUNTS RECEIVABLE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://inmodemd.com/role/AccountsReceivable</Role>
      <ShortName>ACCOUNTS RECEIVABLE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="zk2430873.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0014 - Disclosure - PREPAID EXPENSES AND OTHER CURRENT RECEIVABLES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://inmodemd.com/role/OtherCurrentReceivables</Role>
      <ShortName>PREPAID EXPENSES AND OTHER CURRENT RECEIVABLES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="zk2430873.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0015 - Disclosure - INVENTORIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://inmodemd.com/role/Inventories</Role>
      <ShortName>INVENTORIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="zk2430873.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0016 - Disclosure - PROPERTY AND EQUIPMENT, NET</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://inmodemd.com/role/PropertyAndEquipmentNet</Role>
      <ShortName>PROPERTY AND EQUIPMENT, NET</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="zk2430873.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0017 - Disclosure - OTHER INVESTMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://inmodemd.com/role/OtherInvestments</Role>
      <ShortName>OTHER INVESTMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="zk2430873.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0018 - Disclosure - LEASES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://inmodemd.com/role/Leases</Role>
      <ShortName>LEASES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="zk2430873.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0019 - Disclosure - OTHER CURRENT LIABILITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://inmodemd.com/role/OtherCurrentLiabilities</Role>
      <ShortName>OTHER CURRENT LIABILITIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="zk2430873.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0020 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://inmodemd.com/role/CommitmentsAndContingentLiabilities</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="zk2430873.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0021 - Disclosure - SHAREHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://inmodemd.com/role/ShareholdersEquity</Role>
      <ShortName>SHAREHOLDERS' EQUITY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="zk2430873.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0022 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://inmodemd.com/role/TaxesOnIncome</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="zk2430873.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0023 - Disclosure - ENTITY-WIDE DISCLOSURE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://inmodemd.com/role/Entity-wideDisclosure</Role>
      <ShortName>ENTITY-WIDE DISCLOSURE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="zk2430873.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0024 - Disclosure - RELATED PARTIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://inmodemd.com/role/RelatedParties</Role>
      <ShortName>RELATED PARTIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="zk2430873.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0025 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://inmodemd.com/role/SignificantAccountingPoliciesPolicies</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="zk2430873.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0026 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://inmodemd.com/role/SignificantAccountingPoliciesTables</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://inmodemd.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="zk2430873.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0027 - Disclosure - MARKETABLE SECURITIES AND FAIR VALUE MEASUREMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsTables</Role>
      <ShortName>MARKETABLE SECURITIES AND FAIR VALUE MEASUREMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurements</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="zk2430873.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0028 - Disclosure - ACCOUNTS RECEIVABLE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://inmodemd.com/role/AccountsReceivableTables</Role>
      <ShortName>ACCOUNTS RECEIVABLE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://inmodemd.com/role/AccountsReceivable</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="zk2430873.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0029 - Disclosure - PREPAID EXPENSES AND OTHER CURRENT RECEIVABLES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://inmodemd.com/role/OtherCurrentReceivablesTables</Role>
      <ShortName>PREPAID EXPENSES AND OTHER CURRENT RECEIVABLES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://inmodemd.com/role/OtherCurrentReceivables</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="zk2430873.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0030 - Disclosure - INVENTORIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://inmodemd.com/role/InventoriesTables</Role>
      <ShortName>INVENTORIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://inmodemd.com/role/Inventories</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="zk2430873.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0031 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://inmodemd.com/role/PropertyAndEquipmentNetTables</Role>
      <ShortName>PROPERTY AND EQUIPMENT, NET (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://inmodemd.com/role/PropertyAndEquipmentNet</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="zk2430873.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0032 - Disclosure - LEASES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://inmodemd.com/role/LeasesTables</Role>
      <ShortName>LEASES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://inmodemd.com/role/Leases</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="zk2430873.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>0033 - Disclosure - OTHER CURRENT LIABILITIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://inmodemd.com/role/OtherCurrentLiabilitiesTables</Role>
      <ShortName>OTHER CURRENT LIABILITIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://inmodemd.com/role/OtherCurrentLiabilities</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="zk2430873.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>0034 - Disclosure - SHAREHOLDERS' EQUITY (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://inmodemd.com/role/ShareholdersEquityTables</Role>
      <ShortName>SHAREHOLDERS' EQUITY (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://inmodemd.com/role/ShareholdersEquity</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="zk2430873.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>0035 - Disclosure - INCOME TAXES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://inmodemd.com/role/TaxesOnIncomeTables</Role>
      <ShortName>INCOME TAXES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://inmodemd.com/role/TaxesOnIncome</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="zk2430873.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0036 - Disclosure - ENTITY-WIDE DISCLOSURE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://inmodemd.com/role/Entity-wideDisclosureTables</Role>
      <ShortName>ENTITY-WIDE DISCLOSURE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://inmodemd.com/role/Entity-wideDisclosure</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="zk2430873.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>0037 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://inmodemd.com/role/SignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://inmodemd.com/role/SignificantAccountingPoliciesTables</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="zk2430873.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>0038 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Schedule of Property and Equipment Estimated Useful Lives) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://inmodemd.com/role/SignificantAccountingPoliciesScheduleOfPropertyAndEquipmentEstimatedUsefulLivesDetails</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Schedule of Property and Equipment Estimated Useful Lives) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://inmodemd.com/role/SignificantAccountingPoliciesTables</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="zk2430873.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>0039 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Schedule of Allowance For Credit Losses) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://inmodemd.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleOfAllowanceForCreditLossesDetails</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Schedule of Allowance For Credit Losses) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://inmodemd.com/role/SignificantAccountingPoliciesTables</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="zk2430873.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>0040 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Schedule of Accrued Warranty) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://inmodemd.com/role/SignificantAccountingPoliciesScheduleOfAccruedWarrantyDetails</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Schedule of Accrued Warranty) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://inmodemd.com/role/SignificantAccountingPoliciesTables</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="zk2430873.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>0041 - Disclosure - MARKETABLE SECURITIES AND FAIR VALUE MEASUREMENTS (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsNarrativeDetails</Role>
      <ShortName>MARKETABLE SECURITIES AND FAIR VALUE MEASUREMENTS (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsTables</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="zk2430873.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>0042 - Disclosure - MARKETABLE SECURITIES AND FAIR VALUE MEASUREMENTS (Schedule Of Marketable Securities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsScheduleOfMarketableSecuritiesDetails</Role>
      <ShortName>MARKETABLE SECURITIES AND FAIR VALUE MEASUREMENTS (Schedule Of Marketable Securities) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="zk2430873.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>0043 - Disclosure - MARKETABLE SECURITIES AND FAIR VALUE MEASUREMENTS (Schedule of Financial Assets Measured at Fair Value) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsScheduleOfFinancialAssetsMeasuredAtFairValueDetails</Role>
      <ShortName>MARKETABLE SECURITIES AND FAIR VALUE MEASUREMENTS (Schedule of Financial Assets Measured at Fair Value) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="zk2430873.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>0044 - Disclosure - MARKETABLE SECURITIES AND FAIR VALUE MEASUREMENTS (Schedule of Debt Securities on Maturity) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsScheduleOfDebtSecuritiesOnMaturityDetails</Role>
      <ShortName>MARKETABLE SECURITIES AND FAIR VALUE MEASUREMENTS (Schedule of Debt Securities on Maturity) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="zk2430873.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>0045 - Disclosure - ACCOUNTS RECEIVABLE (Schedule of Accounts Receivable) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://inmodemd.com/role/AccountsReceivableScheduleOfAccountsReceivableDetails</Role>
      <ShortName>ACCOUNTS RECEIVABLE (Schedule of Accounts Receivable) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://inmodemd.com/role/AccountsReceivableTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="zk2430873.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>0046 - Disclosure - PREPAID EXPENSES AND OTHER CURRENT RECEIVABLES (Schedule of Prepaid expenses and other current receivables) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://inmodemd.com/role/OtherCurrentReceivablesScheduleOfOtherCurrentReceivablesDetails</Role>
      <ShortName>PREPAID EXPENSES AND OTHER CURRENT RECEIVABLES (Schedule of Prepaid expenses and other current receivables) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://inmodemd.com/role/OtherCurrentReceivablesTables</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="zk2430873.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>0047 - Disclosure - INVENTORIES (Schedule of Inventories) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://inmodemd.com/role/InventoriesScheduleOfInventoriesDetails</Role>
      <ShortName>INVENTORIES (Schedule of Inventories) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://inmodemd.com/role/InventoriesTables</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="zk2430873.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>0048 - Disclosure - PROPERTY AND EQUIPMENT, NET (Schedule of Property and Equipment) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://inmodemd.com/role/PropertyAndEquipmentNetScheduleOfPropertyAndEquipmentDetails</Role>
      <ShortName>PROPERTY AND EQUIPMENT, NET (Schedule of Property and Equipment) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://inmodemd.com/role/PropertyAndEquipmentNetTables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="zk2430873.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>0049 - Disclosure - OTHER INVESTMENTS (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://inmodemd.com/role/OtherInvestmentsDetails</Role>
      <ShortName>OTHER INVESTMENTS (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://inmodemd.com/role/OtherInvestments</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="zk2430873.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>0050 - Disclosure - LEASES (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://inmodemd.com/role/LeasesNarrativeDetails</Role>
      <ShortName>LEASES (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://inmodemd.com/role/LeasesTables</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="zk2430873.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>0051 - Disclosure - LEASES (Schedule of Lease Expense) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://inmodemd.com/role/LeasesScheduleOfLeaseExpenseDetails</Role>
      <ShortName>LEASES (Schedule of Lease Expense) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://inmodemd.com/role/LeasesTables</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="zk2430873.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>0052 - Disclosure - LEASES (Schedule of Supplemental Cash Flow Information Related to Leases) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://inmodemd.com/role/LeasesScheduleOfSupplementalCashFlowInformationRelatedToLeasesDetails</Role>
      <ShortName>LEASES (Schedule of Supplemental Cash Flow Information Related to Leases) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://inmodemd.com/role/LeasesTables</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="zk2430873.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>0053 - Disclosure - LEASES (Schedule of Supplemental Balance Sheet Information Related to Leases) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://inmodemd.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails</Role>
      <ShortName>LEASES (Schedule of Supplemental Balance Sheet Information Related to Leases) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://inmodemd.com/role/LeasesTables</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="zk2430873.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>0054 - Disclosure - LEASES (Schedule of Maturities of Lease Liabilities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://inmodemd.com/role/LeasesScheduleOfMaturitiesOfLeaseLiabilitiesDetails</Role>
      <ShortName>LEASES (Schedule of Maturities of Lease Liabilities) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://inmodemd.com/role/LeasesTables</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="zk2430873.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>0055 - Disclosure - OTHER CURRENT LIABILITIES (Schedule Of Other Liabilities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://inmodemd.com/role/OtherCurrentLiabilitiesScheduleOfOtherLiabilitiesDetails</Role>
      <ShortName>OTHER CURRENT LIABILITIES (Schedule Of Other Liabilities) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://inmodemd.com/role/OtherCurrentLiabilitiesTables</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="zk2430873.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>0056 - Disclosure - COMMITMENTS AND CONTINGENCIES (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://inmodemd.com/role/CommitmentsAndContingentLiabilitiesDetails</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://inmodemd.com/role/CommitmentsAndContingentLiabilities</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="zk2430873.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>0057 - Disclosure - SHAREHOLDERS' EQUITY (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://inmodemd.com/role/ShareholdersEquityNarrativeDetails</Role>
      <ShortName>SHAREHOLDERS' EQUITY (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://inmodemd.com/role/ShareholdersEquityTables</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="zk2430873.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>0059 - Disclosure - SHAREHOLDERS' EQUITY (Schedule Of Options Granted) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://inmodemd.com/role/ShareholdersEquityScheduleOfOptionsGrantedDetails</Role>
      <ShortName>SHAREHOLDERS' EQUITY (Schedule Of Options Granted) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://inmodemd.com/role/ShareholdersEquityTables</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="zk2430873.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>0060 - Disclosure - SHAREHOLDERS' EQUITY (Schedule Of Outstanding and Exercisable Options) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://inmodemd.com/role/ShareholdersEquityScheduleOfOutstandingAndExercisableOptionsDetails</Role>
      <ShortName>SHAREHOLDERS' EQUITY (Schedule Of Outstanding and Exercisable Options) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://inmodemd.com/role/ShareholdersEquityTables</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="zk2430873.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>0061 - Disclosure - SHAREHOLDERS' EQUITY (Schedule of Options Granted Resticted Share Unit) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://inmodemd.com/role/ShareholdersEquityScheduleOfOptionsGrantedRestictedShareUnitDetails</Role>
      <ShortName>SHAREHOLDERS' EQUITY (Schedule of Options Granted Resticted Share Unit) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://inmodemd.com/role/ShareholdersEquityTables</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="zk2430873.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>0062 - Disclosure - SHAREHOLDERS' EQUITY (Schedule Of Share Based Compensation Expense) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://inmodemd.com/role/ShareholdersEquityScheduleOfShareBasedCompensationExpenseDetails</Role>
      <ShortName>SHAREHOLDERS' EQUITY (Schedule Of Share Based Compensation Expense) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://inmodemd.com/role/ShareholdersEquityTables</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="zk2430873.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>0063 - Disclosure - INCOME TAXES (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://inmodemd.com/role/TaxesOnIncomeNarrativeDetails</Role>
      <ShortName>INCOME TAXES (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://inmodemd.com/role/TaxesOnIncomeTables</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="zk2430873.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>0064 - Disclosure - INCOME TAXES (Schedule of Deferred Tax Assets (liabilities)) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://inmodemd.com/role/TaxesOnIncomeScheduleOfDeferredTaxAssetsLiabilitiesDetails</Role>
      <ShortName>INCOME TAXES (Schedule of Deferred Tax Assets (liabilities)) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://inmodemd.com/role/TaxesOnIncomeTables</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="zk2430873.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>0065 - Disclosure - INCOME TAXES (Schedule of Reconciliation of Theoretical Provision For Income Tax) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://inmodemd.com/role/TaxesOnIncomeScheduleOfReconciliationOfTheoreticalProvisionForIncomeTaxDetails</Role>
      <ShortName>INCOME TAXES (Schedule of Reconciliation of Theoretical Provision For Income Tax) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://inmodemd.com/role/TaxesOnIncomeTables</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="zk2430873.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>0066 - Disclosure - INCOME TAXES (Schedule of Income Before Income Taxes) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://inmodemd.com/role/TaxesOnIncomeScheduleOfIncomeBeforeIncomeTaxesDetails</Role>
      <ShortName>INCOME TAXES (Schedule of Income Before Income Taxes) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://inmodemd.com/role/TaxesOnIncomeTables</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="zk2430873.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>0067 - Disclosure - INCOME TAXES (Schedule of Tax Expenses (Tax Benefit)) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://inmodemd.com/role/TaxesOnIncomeScheduleOfTaxExpensesTaxBenefitDetails</Role>
      <ShortName>INCOME TAXES (Schedule of Tax Expenses (Tax Benefit)) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://inmodemd.com/role/TaxesOnIncomeTables</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="zk2430873.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>0068 - Disclosure - INCOME TAXES (Schedule of Unrecognized Tax Benefits) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://inmodemd.com/role/TaxesOnIncomeScheduleOfUnrecognizedTaxBenefitsDetails</Role>
      <ShortName>INCOME TAXES (Schedule of Unrecognized Tax Benefits) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://inmodemd.com/role/TaxesOnIncomeTables</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="zk2430873.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>0069 - Disclosure - ENTITY-WIDE DISCLOSURE (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://inmodemd.com/role/Entity-wideDisclosureNarrativeDetails</Role>
      <ShortName>ENTITY-WIDE DISCLOSURE (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://inmodemd.com/role/Entity-wideDisclosureTables</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="zk2430873.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>0070 - Disclosure - ENTITY-WIDE DISCLOSURE (Schedule Of Net Sales By Geographical Area) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://inmodemd.com/role/Entity-wideDisclosureScheduleOfNetSalesByGeographicalAreaDetails</Role>
      <ShortName>ENTITY-WIDE DISCLOSURE (Schedule Of Net Sales By Geographical Area) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://inmodemd.com/role/Entity-wideDisclosureTables</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="zk2430873.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>0071 - Disclosure - ENTITY-WIDE DISCLOSURE (Schedule of revenues based on products' category) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://inmodemd.com/role/ENTITYWIDEDISCLOSUREDisclosureOfRevenuesBasedOnProductsCategory</Role>
      <ShortName>ENTITY-WIDE DISCLOSURE (Schedule of revenues based on products' category) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://inmodemd.com/role/Entity-wideDisclosureTables</ParentRole>
      <Position>70</Position>
    </Report>
    <Report instance="zk2430873.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>0072 - Disclosure - ENTITY-WIDE DISCLOSURE (Schedule of Net Sales by Techonology) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://inmodemd.com/role/Entity-wideDisclosureScheduleOfNetSalesByTechonologyDetails</Role>
      <ShortName>ENTITY-WIDE DISCLOSURE (Schedule of Net Sales by Techonology) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://inmodemd.com/role/Entity-wideDisclosureTables</ParentRole>
      <Position>71</Position>
    </Report>
    <Report instance="zk2430873.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>0073 - Disclosure - ENTITY-WIDE DISCLOSURE (Schedule Of Changes In Contract Liabilities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://inmodemd.com/role/Entity-wideDisclosureScheduleOfChangesInContractLiabilitiesDetails</Role>
      <ShortName>ENTITY-WIDE DISCLOSURE (Schedule Of Changes In Contract Liabilities) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://inmodemd.com/role/Entity-wideDisclosureTables</ParentRole>
      <Position>72</Position>
    </Report>
    <Report instance="zk2430873.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>0074 - Disclosure - ENTITY-WIDE DISCLOSURE (Schedule Of Long-Lived Assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://inmodemd.com/role/Entity-wideDisclosureScheduleOfLong-livedAssetsDetails</Role>
      <ShortName>ENTITY-WIDE DISCLOSURE (Schedule Of Long-Lived Assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://inmodemd.com/role/Entity-wideDisclosureTables</ParentRole>
      <Position>73</Position>
    </Report>
    <Report instance="zk2430873.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>0075 - Disclosure - RELATED PARTIES (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://inmodemd.com/role/RelatedPartiesDetails</Role>
      <ShortName>RELATED PARTIES (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://inmodemd.com/role/RelatedParties</ParentRole>
      <Position>74</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>inmd-20231231.xsd</File>
    <File>inmd-20231231_cal.xml</File>
    <File>inmd-20231231_def.xml</File>
    <File>inmd-20231231_lab.xml</File>
    <File>inmd-20231231_pre.xml</File>
    <File doctype="20-F" isDefinitelyFs="true" isUsgaap="true" original="zk2430873.htm">zk2430873.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>image00001.jpg</File>
    <File>image1.jpg</File>
    <File>image2.jpg</File>
    <File>inmd_img01.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="807">http://fasb.org/us-gaap/2023</BaseTaxonomy>
    <BaseTaxonomy items="46">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>111
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "zk2430873.htm": {
   "nsprefix": "inmd",
   "nsuri": "http://inmodemd.com/20231231",
   "dts": {
    "schema": {
     "local": [
      "inmd-20231231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/currency/2023/currency-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd",
      "https://xbrl.sec.gov/exch/2023/exch-2023.xsd",
      "https://xbrl.sec.gov/naics/2023/naics-2023.xsd",
      "https://xbrl.sec.gov/sic/2023/sic-2023.xsd",
      "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "inmd-20231231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "inmd-20231231_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "inmd-20231231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "inmd-20231231_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "zk2430873.htm"
     ]
    }
   },
   "keyStandard": 297,
   "keyCustom": 56,
   "axisStandard": 26,
   "axisCustom": 0,
   "memberStandard": 34,
   "memberCustom": 35,
   "hidden": {
    "total": 11,
    "http://fasb.org/us-gaap/2023": 7,
    "http://xbrl.sec.gov/dei/2023": 4
   },
   "contextCount": 217,
   "entityCount": 1,
   "segmentCount": 70,
   "elementCount": 613,
   "unitCount": 7,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2023": 807,
    "http://xbrl.sec.gov/dei/2023": 46
   },
   "report": {
    "R1": {
     "role": "http://inmodemd.com/role/DocumentAndEntityInformation",
     "longName": "0001 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "span",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "span",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://inmodemd.com/role/ConsolidatedBalanceSheets",
     "longName": "0002 - Statement - CONSOLIDATED BALANCE SHEETS",
     "shortName": "CONSOLIDATED BALANCE SHEETS",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "C_20231231",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20231231",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://inmodemd.com/role/ConsolidatedBalanceSheetsParenthetical",
     "longName": "0003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "C_20231231",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20231231",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "unique": true
     }
    },
    "R4": {
     "role": "http://inmodemd.com/role/CONSOLIDATEDBALANCESHEETSParentheticals2",
     "longName": "0004 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical 2)",
     "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical 2)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "C_20231231",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "ILS_per_Share",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "us-gaap:CommonStockParOrStatedValuePerShare",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R5": {
     "role": "http://inmodemd.com/role/ConsolidatedStatementsOfIncome",
     "longName": "0005 - Statement - CONSOLIDATED STATEMENTS OF INCOME",
     "shortName": "CONSOLIDATED STATEMENTS OF INCOME",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:Revenues",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:CostOfRevenue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "unique": true
     }
    },
    "R6": {
     "role": "http://inmodemd.com/role/ConsolidatedStatementsOfComprehensiveIncome",
     "longName": "0006 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME",
     "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:ProfitLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "unique": true
     }
    },
    "R7": {
     "role": "http://inmodemd.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity",
     "longName": "0007 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY",
     "shortName": "CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "7",
     "firstAnchor": {
      "contextRef": "C_20201231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20201231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     }
    },
    "R8": {
     "role": "http://inmodemd.com/role/ConsolidatedStatementsOfCashFlows",
     "longName": "0008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "8",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:ProfitLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:ShareBasedCompensation",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "unique": true
     }
    },
    "R9": {
     "role": "http://inmodemd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParentheticals",
     "longName": "0009 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "9",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "inmd:PaymentsToTaxAuthorities",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "inmd:PaymentsToTaxAuthorities",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://inmodemd.com/role/General",
     "longName": "0010 - Disclosure - GENERAL",
     "shortName": "GENERAL",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://inmodemd.com/role/SignificantAccountingPolicies",
     "longName": "0011 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurements",
     "longName": "0012 - Disclosure - MARKETABLE SECURITIES AND FAIR VALUE MEASUREMENTS",
     "shortName": "MARKETABLE SECURITIES AND FAIR VALUE MEASUREMENTS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "inmd:MarketableSecuritiesAndFairValueMeasurements",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "inmd:MarketableSecuritiesAndFairValueMeasurements",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://inmodemd.com/role/AccountsReceivable",
     "longName": "0013 - Disclosure - ACCOUNTS RECEIVABLE",
     "shortName": "ACCOUNTS RECEIVABLE",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://inmodemd.com/role/OtherCurrentReceivables",
     "longName": "0014 - Disclosure - PREPAID EXPENSES AND OTHER CURRENT RECEIVABLES",
     "shortName": "PREPAID EXPENSES AND OTHER CURRENT RECEIVABLES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "inmd:PrepaidExpensesAndOtherCurrentReceivablesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "inmd:PrepaidExpensesAndOtherCurrentReceivablesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://inmodemd.com/role/Inventories",
     "longName": "0015 - Disclosure - INVENTORIES",
     "shortName": "INVENTORIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://inmodemd.com/role/PropertyAndEquipmentNet",
     "longName": "0016 - Disclosure - PROPERTY AND EQUIPMENT, NET",
     "shortName": "PROPERTY AND EQUIPMENT, NET",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://inmodemd.com/role/OtherInvestments",
     "longName": "0017 - Disclosure - OTHER INVESTMENTS",
     "shortName": "OTHER INVESTMENTS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:InvestmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:InvestmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://inmodemd.com/role/Leases",
     "longName": "0018 - Disclosure - LEASES",
     "shortName": "LEASES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://inmodemd.com/role/OtherCurrentLiabilities",
     "longName": "0019 - Disclosure - OTHER CURRENT LIABILITIES",
     "shortName": "OTHER CURRENT LIABILITIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://inmodemd.com/role/CommitmentsAndContingentLiabilities",
     "longName": "0020 - Disclosure - COMMITMENTS AND CONTINGENCIES",
     "shortName": "COMMITMENTS AND CONTINGENCIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://inmodemd.com/role/ShareholdersEquity",
     "longName": "0021 - Disclosure - SHAREHOLDERS' EQUITY",
     "shortName": "SHAREHOLDERS' EQUITY",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://inmodemd.com/role/TaxesOnIncome",
     "longName": "0022 - Disclosure - INCOME TAXES",
     "shortName": "INCOME TAXES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://inmodemd.com/role/Entity-wideDisclosure",
     "longName": "0023 - Disclosure - ENTITY-WIDE DISCLOSURE",
     "shortName": "ENTITY-WIDE DISCLOSURE",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://inmodemd.com/role/RelatedParties",
     "longName": "0024 - Disclosure - RELATED PARTIES",
     "shortName": "RELATED PARTIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "24",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://inmodemd.com/role/SignificantAccountingPoliciesPolicies",
     "longName": "0025 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "25",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://inmodemd.com/role/SignificantAccountingPoliciesTables",
     "longName": "0026 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "26",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "inmd:ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "div",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "inmd:ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "div",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsTables",
     "longName": "0027 - Disclosure - MARKETABLE SECURITIES AND FAIR VALUE MEASUREMENTS (Tables)",
     "shortName": "MARKETABLE SECURITIES AND FAIR VALUE MEASUREMENTS (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "27",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:MarketableSecuritiesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "inmd:MarketableSecuritiesAndFairValueMeasurements",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:MarketableSecuritiesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "inmd:MarketableSecuritiesAndFairValueMeasurements",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://inmodemd.com/role/AccountsReceivableTables",
     "longName": "0028 - Disclosure - ACCOUNTS RECEIVABLE (Tables)",
     "shortName": "ACCOUNTS RECEIVABLE (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "28",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://inmodemd.com/role/OtherCurrentReceivablesTables",
     "longName": "0029 - Disclosure - PREPAID EXPENSES AND OTHER CURRENT RECEIVABLES (Tables)",
     "shortName": "PREPAID EXPENSES AND OTHER CURRENT RECEIVABLES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "29",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "inmd:ScheduleOfPrepaidExpensesAndOtherCurrentRecivablesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "inmd:PrepaidExpensesAndOtherCurrentReceivablesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "inmd:ScheduleOfPrepaidExpensesAndOtherCurrentRecivablesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "inmd:PrepaidExpensesAndOtherCurrentReceivablesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://inmodemd.com/role/InventoriesTables",
     "longName": "0030 - Disclosure - INVENTORIES (Tables)",
     "shortName": "INVENTORIES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "30",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "us-gaap:InventoryDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "us-gaap:InventoryDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://inmodemd.com/role/PropertyAndEquipmentNetTables",
     "longName": "0031 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables)",
     "shortName": "PROPERTY AND EQUIPMENT, NET (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "31",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://inmodemd.com/role/LeasesTables",
     "longName": "0032 - Disclosure - LEASES (Tables)",
     "shortName": "LEASES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "32",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://inmodemd.com/role/OtherCurrentLiabilitiesTables",
     "longName": "0033 - Disclosure - OTHER CURRENT LIABILITIES (Tables)",
     "shortName": "OTHER CURRENT LIABILITIES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "33",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:OtherCurrentLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:OtherCurrentLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://inmodemd.com/role/ShareholdersEquityTables",
     "longName": "0034 - Disclosure - SHAREHOLDERS' EQUITY (Tables)",
     "shortName": "SHAREHOLDERS' EQUITY (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "34",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://inmodemd.com/role/TaxesOnIncomeTables",
     "longName": "0035 - Disclosure - INCOME TAXES (Tables)",
     "shortName": "INCOME TAXES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "35",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://inmodemd.com/role/Entity-wideDisclosureTables",
     "longName": "0036 - Disclosure - ENTITY-WIDE DISCLOSURE (Tables)",
     "shortName": "ENTITY-WIDE DISCLOSURE (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "36",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://inmodemd.com/role/SignificantAccountingPoliciesNarrativeDetails",
     "longName": "0037 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details)",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "37",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:AdvertisingExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "td",
       "tr",
       "table",
       "us-gaap:AdvertisingCostsPolicyTextBlock",
       "div",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:AdvertisingExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "td",
       "tr",
       "table",
       "us-gaap:AdvertisingCostsPolicyTextBlock",
       "div",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://inmodemd.com/role/SignificantAccountingPoliciesScheduleOfPropertyAndEquipmentEstimatedUsefulLivesDetails",
     "longName": "0038 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Schedule of Property and Equipment Estimated Useful Lives) (Details)",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Schedule of Property and Equipment Estimated Useful Lives) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "38",
     "firstAnchor": {
      "contextRef": "C_20231231_srtRangeAxis_srtMinimumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapComputerEquipmentMember",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "inmd:ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock",
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "div",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20231231_srtRangeAxis_srtMinimumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapComputerEquipmentMember",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "inmd:ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock",
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "div",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://inmodemd.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleOfAllowanceForCreditLossesDetails",
     "longName": "0039 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Schedule of Allowance For Credit Losses) (Details)",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Schedule of Allowance For Credit Losses) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "39",
     "firstAnchor": {
      "contextRef": "C_20221231",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy",
       "div",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock",
       "div",
       "us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy",
       "div",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "unique": true
     }
    },
    "R40": {
     "role": "http://inmodemd.com/role/SignificantAccountingPoliciesScheduleOfAccruedWarrantyDetails",
     "longName": "0040 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Schedule of Accrued Warranty) (Details)",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Schedule of Accrued Warranty) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "40",
     "firstAnchor": {
      "contextRef": "C_20221231",
      "name": "us-gaap:StandardProductWarrantyAccrual",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock",
       "div",
       "us-gaap:StandardProductWarrantyPolicy",
       "div",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20201231",
      "name": "us-gaap:StandardProductWarrantyAccrual",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock",
       "div",
       "us-gaap:StandardProductWarrantyPolicy",
       "div",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "unique": true
     }
    },
    "R41": {
     "role": "http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsNarrativeDetails",
     "longName": "0041 - Disclosure - MARKETABLE SECURITIES AND FAIR VALUE MEASUREMENTS (Narrative) (Details)",
     "shortName": "MARKETABLE SECURITIES AND FAIR VALUE MEASUREMENTS (Narrative) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "41",
     "firstAnchor": {
      "contextRef": "C_20231231",
      "name": "us-gaap:MarketableSecuritiesCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20231231_usgaapFinancialInstrumentAxis_inmdNonUsGovernmentAgenciesDebtSecuritiesMember",
      "name": "us-gaap:MarketableSecuritiesCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:MarketableSecuritiesTextBlock",
       "div",
       "inmd:MarketableSecuritiesAndFairValueMeasurements",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "unique": true
     }
    },
    "R42": {
     "role": "http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsScheduleOfMarketableSecuritiesDetails",
     "longName": "0042 - Disclosure - MARKETABLE SECURITIES AND FAIR VALUE MEASUREMENTS (Schedule Of Marketable Securities) (Details)",
     "shortName": "MARKETABLE SECURITIES AND FAIR VALUE MEASUREMENTS (Schedule Of Marketable Securities) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "42",
     "firstAnchor": {
      "contextRef": "C_20231231",
      "name": "us-gaap:MarketableSecuritiesCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20231231_usgaapFinancialInstrumentAxis_usgaapUSGovernmentAgenciesDebtSecuritiesMember",
      "name": "us-gaap:MarketableSecuritiesCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:MarketableSecuritiesTextBlock",
       "div",
       "inmd:MarketableSecuritiesAndFairValueMeasurements",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "unique": true
     }
    },
    "R43": {
     "role": "http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsScheduleOfFinancialAssetsMeasuredAtFairValueDetails",
     "longName": "0043 - Disclosure - MARKETABLE SECURITIES AND FAIR VALUE MEASUREMENTS (Schedule of Financial Assets Measured at Fair Value) (Details)",
     "shortName": "MARKETABLE SECURITIES AND FAIR VALUE MEASUREMENTS (Schedule of Financial Assets Measured at Fair Value) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "43",
     "firstAnchor": {
      "contextRef": "C_20231231",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20231231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecurities",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "div",
       "div",
       "inmd:MarketableSecuritiesAndFairValueMeasurements",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "unique": true
     }
    },
    "R44": {
     "role": "http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsScheduleOfDebtSecuritiesOnMaturityDetails",
     "longName": "0044 - Disclosure - MARKETABLE SECURITIES AND FAIR VALUE MEASUREMENTS (Schedule of Debt Securities on Maturity) (Details)",
     "shortName": "MARKETABLE SECURITIES AND FAIR VALUE MEASUREMENTS (Schedule of Debt Securities on Maturity) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "44",
     "firstAnchor": {
      "contextRef": "C_20231231",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "div",
       "inmd:MarketableSecuritiesAndFairValueMeasurements",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20231231",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "div",
       "inmd:MarketableSecuritiesAndFairValueMeasurements",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     }
    },
    "R45": {
     "role": "http://inmodemd.com/role/AccountsReceivableScheduleOfAccountsReceivableDetails",
     "longName": "0045 - Disclosure - ACCOUNTS RECEIVABLE (Schedule of Accounts Receivable) (Details)",
     "shortName": "ACCOUNTS RECEIVABLE (Schedule of Accounts Receivable) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "45",
     "firstAnchor": {
      "contextRef": "C_20231231",
      "name": "us-gaap:AccountsReceivableGross",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
       "div",
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20231231",
      "name": "us-gaap:AccountsReceivableGross",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
       "div",
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     }
    },
    "R46": {
     "role": "http://inmodemd.com/role/OtherCurrentReceivablesScheduleOfOtherCurrentReceivablesDetails",
     "longName": "0046 - Disclosure - PREPAID EXPENSES AND OTHER CURRENT RECEIVABLES (Schedule of Prepaid expenses and other current receivables) (Details)",
     "shortName": "PREPAID EXPENSES AND OTHER CURRENT RECEIVABLES (Schedule of Prepaid expenses and other current receivables) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "C_20231231",
      "name": "inmd:OtherAdvancesToSuppliersCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "inmd:ScheduleOfPrepaidExpensesAndOtherCurrentRecivablesTableTextBlock",
       "div",
       "inmd:PrepaidExpensesAndOtherCurrentReceivablesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20231231",
      "name": "inmd:OtherAdvancesToSuppliersCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "inmd:ScheduleOfPrepaidExpensesAndOtherCurrentRecivablesTableTextBlock",
       "div",
       "inmd:PrepaidExpensesAndOtherCurrentReceivablesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     }
    },
    "R47": {
     "role": "http://inmodemd.com/role/InventoriesScheduleOfInventoriesDetails",
     "longName": "0047 - Disclosure - INVENTORIES (Schedule of Inventories) (Details)",
     "shortName": "INVENTORIES (Schedule of Inventories) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "C_20231231",
      "name": "us-gaap:InventoryRawMaterials",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "div",
       "div",
       "us-gaap:InventoryDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20231231",
      "name": "us-gaap:InventoryRawMaterials",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "div",
       "div",
       "us-gaap:InventoryDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     }
    },
    "R48": {
     "role": "http://inmodemd.com/role/PropertyAndEquipmentNetScheduleOfPropertyAndEquipmentDetails",
     "longName": "0048 - Disclosure - PROPERTY AND EQUIPMENT, NET (Schedule of Property and Equipment) (Details)",
     "shortName": "PROPERTY AND EQUIPMENT, NET (Schedule of Property and Equipment) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "C_20231231",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "div",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20231231",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "div",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     }
    },
    "R49": {
     "role": "http://inmodemd.com/role/OtherInvestmentsDetails",
     "longName": "0049 - Disclosure - OTHER INVESTMENTS (Narrative) (Details)",
     "shortName": "OTHER INVESTMENTS (Narrative) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "C_20231130_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_inmdMedimorMember_usgaapTypeOfArrangementAxis_inmdSharePurchaseAndShareholdersAgreementMember",
      "name": "us-gaap:Investments",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "p",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "us-gaap:InvestmentTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20231130_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_inmdMedimorMember_usgaapTypeOfArrangementAxis_inmdSharePurchaseAndShareholdersAgreementMember",
      "name": "us-gaap:Investments",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "p",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "us-gaap:InvestmentTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     }
    },
    "R50": {
     "role": "http://inmodemd.com/role/LeasesNarrativeDetails",
     "longName": "0050 - Disclosure - LEASES (Narrative) (Details)",
     "shortName": "LEASES (Narrative) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "C_20180501to20180531_usgaapTypeOfArrangementAxis_inmdLeaseAgreementMember",
      "name": "inmd:LeaseExpires",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20180501to20180531_usgaapTypeOfArrangementAxis_inmdLeaseAgreementMember",
      "name": "inmd:BankGuarantee",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "unique": true
     }
    },
    "R51": {
     "role": "http://inmodemd.com/role/LeasesScheduleOfLeaseExpenseDetails",
     "longName": "0051 - Disclosure - LEASES (Schedule of Lease Expense) (Details)",
     "shortName": "LEASES (Schedule of Lease Expense) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:OperatingLeaseCost",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "div",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:OperatingLeaseCost",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "div",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     }
    },
    "R52": {
     "role": "http://inmodemd.com/role/LeasesScheduleOfSupplementalCashFlowInformationRelatedToLeasesDetails",
     "longName": "0052 - Disclosure - LEASES (Schedule of Supplemental Cash Flow Information Related to Leases) (Details)",
     "shortName": "LEASES (Schedule of Supplemental Cash Flow Information Related to Leases) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:OperatingLeasePayments",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "div",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "inmd:ScheduleOfSupplementalCashFlowInformationRelatedToLeases",
       "div",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:OperatingLeasePayments",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "div",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "inmd:ScheduleOfSupplementalCashFlowInformationRelatedToLeases",
       "div",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     }
    },
    "R53": {
     "role": "http://inmodemd.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails",
     "longName": "0053 - Disclosure - LEASES (Schedule of Supplemental Balance Sheet Information Related to Leases) (Details)",
     "shortName": "LEASES (Schedule of Supplemental Balance Sheet Information Related to Leases) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "C_20231231",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20231231",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "inmd:ScheduleOfSupplementalBalanceSheetInformationRelatedToLeases",
       "div",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "unique": true
     }
    },
    "R54": {
     "role": "http://inmodemd.com/role/LeasesScheduleOfMaturitiesOfLeaseLiabilitiesDetails",
     "longName": "0054 - Disclosure - LEASES (Schedule of Maturities of Lease Liabilities) (Details)",
     "shortName": "LEASES (Schedule of Maturities of Lease Liabilities) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "C_20231231",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "div",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20231231",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "div",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     }
    },
    "R55": {
     "role": "http://inmodemd.com/role/OtherCurrentLiabilitiesScheduleOfOtherLiabilitiesDetails",
     "longName": "0055 - Disclosure - OTHER CURRENT LIABILITIES (Schedule Of Other Liabilities) (Details)",
     "shortName": "OTHER CURRENT LIABILITIES (Schedule Of Other Liabilities) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "C_20231231",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "us-gaap:OtherCurrentLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20231231",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "us-gaap:OtherCurrentLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     }
    },
    "R56": {
     "role": "http://inmodemd.com/role/CommitmentsAndContingentLiabilitiesDetails",
     "longName": "0056 - Disclosure - COMMITMENTS AND CONTINGENCIES (Narrative) (Details)",
     "shortName": "COMMITMENTS AND CONTINGENCIES (Narrative) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "C_20231231",
      "name": "us-gaap:SignificantSupplyCommitmentRemainingMinimumAmountCommitted",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20231231",
      "name": "us-gaap:SignificantSupplyCommitmentRemainingMinimumAmountCommitted",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     }
    },
    "R57": {
     "role": "http://inmodemd.com/role/ShareholdersEquityNarrativeDetails",
     "longName": "0057 - Disclosure - SHAREHOLDERS' EQUITY (Narrative) (Details)",
     "shortName": "SHAREHOLDERS' EQUITY (Narrative) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "C_20231231",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "ILS_per_Share",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "us-gaap:CommonStockParOrStatedValuePerShare",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:StockholdersEquityNoteStockSplit",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "unique": true
     }
    },
    "R58": {
     "role": "http://inmodemd.com/role/ShareholdersEquityScheduleOfOptionsGrantedDetails",
     "longName": "0059 - Disclosure - SHAREHOLDERS' EQUITY (Schedule Of Options Granted) (Details)",
     "shortName": "SHAREHOLDERS' EQUITY (Schedule Of Options Granted) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "C_20221231",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "div",
       "div",
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20221231",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "div",
       "div",
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     }
    },
    "R59": {
     "role": "http://inmodemd.com/role/ShareholdersEquityScheduleOfOutstandingAndExercisableOptionsDetails",
     "longName": "0060 - Disclosure - SHAREHOLDERS' EQUITY (Schedule Of Outstanding and Exercisable Options) (Details)",
     "shortName": "SHAREHOLDERS' EQUITY (Schedule Of Outstanding and Exercisable Options) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeOneMember",
      "name": "inmd:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice",
      "unitRef": "USD_Per_Share",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
       "div",
       "div",
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeOneMember",
      "name": "inmd:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice",
      "unitRef": "USD_Per_Share",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
       "div",
       "div",
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     }
    },
    "R60": {
     "role": "http://inmodemd.com/role/ShareholdersEquityScheduleOfOptionsGrantedRestictedShareUnitDetails",
     "longName": "0061 - Disclosure - SHAREHOLDERS' EQUITY (Schedule of Options Granted Resticted Share Unit) (Details)",
     "shortName": "SHAREHOLDERS' EQUITY (Schedule of Options Granted Resticted Share Unit) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "C_20221231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "div",
       "div",
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20221231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "div",
       "div",
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     }
    },
    "R61": {
     "role": "http://inmodemd.com/role/ShareholdersEquityScheduleOfShareBasedCompensationExpenseDetails",
     "longName": "0062 - Disclosure - SHAREHOLDERS' EQUITY (Schedule Of Share Based Compensation Expense) (Details)",
     "shortName": "SHAREHOLDERS' EQUITY (Schedule Of Share Based Compensation Expense) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "div",
       "div",
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "div",
       "div",
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     }
    },
    "R62": {
     "role": "http://inmodemd.com/role/TaxesOnIncomeNarrativeDetails",
     "longName": "0063 - Disclosure - INCOME TAXES (Narrative) (Details)",
     "shortName": "INCOME TAXES (Narrative) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "div",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20200331",
      "name": "us-gaap:IncomeTaxesReceivable",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "span",
       "div",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "unique": true
     }
    },
    "R63": {
     "role": "http://inmodemd.com/role/TaxesOnIncomeScheduleOfDeferredTaxAssetsLiabilitiesDetails",
     "longName": "0064 - Disclosure - INCOME TAXES (Schedule of Deferred Tax Assets (liabilities)) (Details)",
     "shortName": "INCOME TAXES (Schedule of Deferred Tax Assets (liabilities)) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "C_20231231",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "div",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20231231",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "div",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     }
    },
    "R64": {
     "role": "http://inmodemd.com/role/TaxesOnIncomeScheduleOfReconciliationOfTheoreticalProvisionForIncomeTaxDetails",
     "longName": "0065 - Disclosure - INCOME TAXES (Schedule of Reconciliation of Theoretical Provision For Income Tax) (Details)",
     "shortName": "INCOME TAXES (Schedule of Reconciliation of Theoretical Provision For Income Tax) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "64",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "div",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "unique": true
     }
    },
    "R65": {
     "role": "http://inmodemd.com/role/TaxesOnIncomeScheduleOfIncomeBeforeIncomeTaxesDetails",
     "longName": "0066 - Disclosure - INCOME TAXES (Schedule of Income Before Income Taxes) (Details)",
     "shortName": "INCOME TAXES (Schedule of Income Before Income Taxes) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "65",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231_usgaapIncomeTaxAuthorityNameAxis_inmdInmodeLtdAndIsreaeliSubsidiariesMember",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "div",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "unique": true
     }
    },
    "R66": {
     "role": "http://inmodemd.com/role/TaxesOnIncomeScheduleOfTaxExpensesTaxBenefitDetails",
     "longName": "0067 - Disclosure - INCOME TAXES (Schedule of Tax Expenses (Tax Benefit)) (Details)",
     "shortName": "INCOME TAXES (Schedule of Tax Expenses (Tax Benefit)) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "66",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:CurrentIncomeTaxExpenseBenefit",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "div",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:CurrentIncomeTaxExpenseBenefit",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "div",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     }
    },
    "R67": {
     "role": "http://inmodemd.com/role/TaxesOnIncomeScheduleOfUnrecognizedTaxBenefitsDetails",
     "longName": "0068 - Disclosure - INCOME TAXES (Schedule of Unrecognized Tax Benefits) (Details)",
     "shortName": "INCOME TAXES (Schedule of Unrecognized Tax Benefits) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "67",
     "firstAnchor": {
      "contextRef": "C_20221231",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "div",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20211231",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "div",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "unique": true
     }
    },
    "R68": {
     "role": "http://inmodemd.com/role/Entity-wideDisclosureNarrativeDetails",
     "longName": "0069 - Disclosure - ENTITY-WIDE DISCLOSURE (Narrative) (Details)",
     "shortName": "ENTITY-WIDE DISCLOSURE (Narrative) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "68",
     "firstAnchor": {
      "contextRef": "C_20231231",
      "name": "inmd:PercentageOfNonCurrentDeferredRevenue",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "div",
       "div",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20231231",
      "name": "inmd:PercentageOfNonCurrentDeferredRevenue",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "div",
       "div",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     }
    },
    "R69": {
     "role": "http://inmodemd.com/role/Entity-wideDisclosureScheduleOfNetSalesByGeographicalAreaDetails",
     "longName": "0070 - Disclosure - ENTITY-WIDE DISCLOSURE (Schedule Of Net Sales By Geographical Area) (Details)",
     "shortName": "ENTITY-WIDE DISCLOSURE (Schedule Of Net Sales By Geographical Area) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "69",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:Revenues",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231_srtStatementGeographicalAxis_countryUS",
      "name": "us-gaap:Revenues",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
       "div",
       "div",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "unique": true
     }
    },
    "R70": {
     "role": "http://inmodemd.com/role/ENTITYWIDEDISCLOSUREDisclosureOfRevenuesBasedOnProductsCategory",
     "longName": "0071 - Disclosure - ENTITY-WIDE DISCLOSURE (Schedule of revenues based on products' category) (Details)",
     "shortName": "ENTITY-WIDE DISCLOSURE (Schedule of revenues based on products' category) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "70",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:Revenues",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231_srtProductOrServiceAxis_inmdCapitalEquipmentMember",
      "name": "us-gaap:Revenues",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
       "div",
       "div",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "unique": true
     }
    },
    "R71": {
     "role": "http://inmodemd.com/role/Entity-wideDisclosureScheduleOfNetSalesByTechonologyDetails",
     "longName": "0072 - Disclosure - ENTITY-WIDE DISCLOSURE (Schedule of Net Sales by Techonology) (Details)",
     "shortName": "ENTITY-WIDE DISCLOSURE (Schedule of Net Sales by Techonology) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "71",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "inmd:PercentageOfNetSalesBasedOnProductsTechnology",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
       "div",
       "div",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "inmd:PercentageOfNetSalesBasedOnProductsTechnology",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
       "div",
       "div",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     }
    },
    "R72": {
     "role": "http://inmodemd.com/role/Entity-wideDisclosureScheduleOfChangesInContractLiabilitiesDetails",
     "longName": "0073 - Disclosure - ENTITY-WIDE DISCLOSURE (Schedule Of Changes In Contract Liabilities) (Details)",
     "shortName": "ENTITY-WIDE DISCLOSURE (Schedule Of Changes In Contract Liabilities) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "72",
     "firstAnchor": {
      "contextRef": "C_20221231",
      "name": "us-gaap:ContractWithCustomerLiability",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "div",
       "div",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20211231",
      "name": "us-gaap:ContractWithCustomerLiability",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "div",
       "div",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "unique": true
     }
    },
    "R73": {
     "role": "http://inmodemd.com/role/Entity-wideDisclosureScheduleOfLong-livedAssetsDetails",
     "longName": "0074 - Disclosure - ENTITY-WIDE DISCLOSURE (Schedule Of Long-Lived Assets) (Details)",
     "shortName": "ENTITY-WIDE DISCLOSURE (Schedule Of Long-Lived Assets) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "73",
     "firstAnchor": {
      "contextRef": "C_20231231",
      "name": "inmd:TotalLongLivedAssetsByGeographicalArea",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "us-gaap:DisclosureOfLongLivedAssetsHeldForSaleTextBlock",
       "div",
       "div",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20231231",
      "name": "inmd:TotalLongLivedAssetsByGeographicalArea",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "us-gaap:DisclosureOfLongLivedAssetsHeldForSaleTextBlock",
       "div",
       "div",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true,
      "unique": true
     }
    },
    "R74": {
     "role": "http://inmodemd.com/role/RelatedPartiesDetails",
     "longName": "0075 - Disclosure - RELATED PARTIES (Narrative) (Details)",
     "shortName": "RELATED PARTIES (Narrative) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "74",
     "firstAnchor": {
      "contextRef": "C_20231231",
      "name": "us-gaap:AccountsPayableCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdHomeSkinnovationsLtdMember",
      "name": "us-gaap:RelatedPartyTransactionAmountsOfTransaction",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2430873.htm",
      "unique": true
     }
    }
   },
   "tag": {
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "inmd_AccountingPoliciesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "AccountingPoliciesLineItems",
     "presentation": [
      "http://inmodemd.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accounting Policies [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "inmd_AccountingPoliciesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "AccountingPoliciesTable",
     "presentation": [
      "http://inmodemd.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table of accounting policies.",
        "label": "Accounting Policies [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsAndNotesReceivableNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsAndNotesReceivableNet",
     "crdr": "debit",
     "calculation": {
      "http://inmodemd.com/role/AccountsReceivableScheduleOfAccountsReceivableDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://inmodemd.com/role/AccountsReceivableScheduleOfAccountsReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts and Financing Receivable, after Allowance for Credit Loss",
        "totalLabel": "Notes And Loans Receivable Net",
        "documentation": "Amount, after allowance for credit loss, of accounts and financing receivable. Includes, but is not limited to, notes and loan receivable."
       }
      }
     },
     "auth_ref": [
      "r281",
      "r933"
     ]
    },
    "us-gaap_AccountsNotesLoansAndFinancingReceivableGrossAllowanceAndNetAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsNotesLoansAndFinancingReceivableGrossAllowanceAndNetAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts, Notes, Loans and Financing Receivable, Gross, Allowance, and Net [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
     "presentation": [
      "http://inmodemd.com/role/OtherCurrentLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "OTHER CURRENT LIABILITIES",
        "documentation": "The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://inmodemd.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedBalanceSheets",
      "http://inmodemd.com/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable",
        "totalLabel": "Accounts Payable, Current, Total",
        "positiveLabel": "Accounts receivable, net of allowance for credit losses of $1,538 and $836, as of December 31, 2023 and 2022, respectively",
        "verboseLabel": "Accounts receivable, net of allowance for credit losses of $836 and $1,107, as of December 31, 2022 and 2021, respectively",
        "positiveTerseLabel": "Accounts paybale",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r768"
     ]
    },
    "us-gaap_AccountsPayableRelatedAndNonrelatedPartyStatusExtensibleEnumeration": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsPayableRelatedAndNonrelatedPartyStatusExtensibleEnumeration",
     "presentation": [
      "http://inmodemd.com/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Payable, Related and Nonrelated Party Status [Extensible Enumeration]",
        "documentation": "Indicates related and nonrelated party status for accounts payable."
       }
      }
     },
     "auth_ref": [
      "r826",
      "r868",
      "r927",
      "r928",
      "r931"
     ]
    },
    "us-gaap_AccountsReceivableAfterAllowanceForCreditLossRelatedAndNonrelatedPartyStatusExtensibleEnumeration": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsReceivableAfterAllowanceForCreditLossRelatedAndNonrelatedPartyStatusExtensibleEnumeration",
     "presentation": [
      "http://inmodemd.com/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Receivable, after Allowance for Credit Loss, Related and Nonrelated Party Status [Extensible Enumeration]",
        "documentation": "Indicates related and nonrelated party status for accounts receivable, after allowance for credit loss."
       }
      }
     },
     "auth_ref": [
      "r826",
      "r868",
      "r926",
      "r932"
     ]
    },
    "us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsReceivableAllowanceForCreditLossTableTextBlock",
     "presentation": [
      "http://inmodemd.com/role/SignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Receivable, Allowance for Credit Loss [Table Text Block]",
        "verboseLabel": "Schedule Of Allowance For Credit Losses",
        "documentation": "Tabular disclosure of allowance for credit loss on accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r854"
     ]
    },
    "us-gaap_AccountsReceivableGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsReceivableGross",
     "crdr": "debit",
     "calculation": {
      "http://inmodemd.com/role/AccountsReceivableScheduleOfAccountsReceivableDetails": {
       "parentTag": "us-gaap_AccountsAndNotesReceivableNet",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/AccountsReceivableScheduleOfAccountsReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trade",
        "documentation": "Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business."
       }
      }
     },
     "auth_ref": [
      "r191",
      "r281",
      "r933"
     ]
    },
    "us-gaap_AccountsReceivableNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsReceivableNet",
     "crdr": "debit",
     "presentation": [
      "http://inmodemd.com/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Receivable, after Allowance for Credit Loss",
        "totalLabel": "Accounts Receivable, after Allowance for Credit Loss, Total",
        "terseLabel": "Accounts receivable",
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business."
       }
      }
     },
     "auth_ref": [
      "r652",
      "r719",
      "r774",
      "r933"
     ]
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsReceivableNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://inmodemd.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/AccountsReceivableScheduleOfAccountsReceivableDetails",
      "http://inmodemd.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "positiveLabel": "Accounts receivable, net of allowance for credit losses of $1,538 and $836, as of December 31, 2023 and 2022, respectively",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Total current accounts receivable",
        "totalLabel": "Accounts Receivable, after Allowance for Credit Loss, Current, Total",
        "verboseLabel": "Accounts receivable, net of allowance for credit losses of $836 and $1,107, as of December 31, 2022 and 2021, respectively",
        "positiveTerseLabel": "Accounts paybale",
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current."
       }
      }
     },
     "auth_ref": [
      "r281",
      "r282"
     ]
    },
    "us-gaap_AccountsReceivableNetNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsReceivableNetNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://inmodemd.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/AccountsReceivableScheduleOfAccountsReceivableDetails",
      "http://inmodemd.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less - non-current accounts receivable",
        "label": "Accounts receivable",
        "terseLabel": "Accounts receivable net of allowance for credit losses of $482 and $0 as of December 31, 2022 and 2021, respectively",
        "verboseLabel": "Accounts receivable net of allowance for credit losses of $716 and $482 as of December 31, 2023 and 2022, respectively",
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r281",
      "r565"
     ]
    },
    "us-gaap_AccruedIncomeTaxesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccruedIncomeTaxesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://inmodemd.com/role/OtherCurrentLiabilitiesScheduleOfOtherLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/OtherCurrentLiabilitiesScheduleOfOtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Income Taxes, Current",
        "verboseLabel": "Income tax payable",
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations."
       }
      }
     },
     "auth_ref": [
      "r106",
      "r159"
     ]
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://inmodemd.com/role/PropertyAndEquipmentNetScheduleOfPropertyAndEquipmentDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/PropertyAndEquipmentNetScheduleOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less: accumulated depreciation",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services."
       }
      }
     },
     "auth_ref": [
      "r64",
      "r188",
      "r583"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://inmodemd.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated other comprehensive income (loss)",
        "terseLabel": "Accumulated other comprehensive loss",
        "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r37",
      "r118",
      "r194",
      "r579",
      "r608",
      "r609"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated other comprehensive income [Member]",
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r17",
      "r37",
      "r474",
      "r477",
      "r509",
      "r604",
      "r605",
      "r819",
      "r820",
      "r821",
      "r827",
      "r828",
      "r829"
     ]
    },
    "inmd_AcquisitionOfNonControllingInterestInExchangeOfOrdinaryShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "AcquisitionOfNonControllingInterestInExchangeOfOrdinaryShares",
     "crdr": "debit",
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents acquisition of non controlling interest in exchange of ordinary shares.",
        "label": "Acquisition Of Non Controlling Interest In Exchange Of Ordinary Shares",
        "verboseLabel": "Acquisition of non-controlling interest in exchange of ordinary shares (see note 12b)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdditionalPaidInCapitalCommonStock",
     "crdr": "credit",
     "calculation": {
      "http://inmodemd.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional paid-in capital",
        "terseLabel": "Additional paid-in capital",
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital."
       }
      }
     },
     "auth_ref": [
      "r110"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional paid-in capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r422",
      "r423",
      "r424",
      "r624",
      "r827",
      "r828",
      "r829",
      "r906",
      "r937"
     ]
    },
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://inmodemd.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "crdr": "credit",
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Share-based compensation expenses",
        "totalLabel": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition, Total",
        "verboseLabel": "Share-based compensation",
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r75",
      "r76",
      "r389"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments required to reconcile net income to net cash provided by operating activities:",
        "terseLabel": "Adjustments required to reconcile net income to net cash provided by operating activities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdvertisingCostsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdvertisingCostsPolicyTextBlock",
     "presentation": [
      "http://inmodemd.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Advertising Cost [Policy Text Block]",
        "terseLabel": "Advertising expenses",
        "documentation": "Disclosure of accounting policy for advertising cost."
       }
      }
     },
     "auth_ref": [
      "r166"
     ]
    },
    "us-gaap_AdvertisingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdvertisingExpense",
     "crdr": "debit",
     "presentation": [
      "http://inmodemd.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Advertising Expense",
        "terseLabel": "Advertising expenses",
        "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line."
       }
      }
     },
     "auth_ref": [
      "r430"
     ]
    },
    "currency_AllCurrenciesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/currency/2023",
     "localname": "AllCurrenciesDomain",
     "presentation": [
      "http://inmodemd.com/role/TaxesOnIncomeNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Currencies [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AllocatedShareBasedCompensationExpense",
     "crdr": "debit",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityScheduleOfShareBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement, Expense",
        "terseLabel": "Equity-based compensation income",
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized."
       }
      }
     },
     "auth_ref": [
      "r420",
      "r429"
     ]
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AllowanceForDoubtfulAccountsReceivable",
     "crdr": "credit",
     "calculation": {
      "http://inmodemd.com/role/AccountsReceivableScheduleOfAccountsReceivableDetails": {
       "parentTag": "us-gaap_AccountsAndNotesReceivableNet",
       "weight": -1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/AccountsReceivableScheduleOfAccountsReceivableDetails",
      "http://inmodemd.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleOfAllowanceForCreditLossesDetails",
      "http://inmodemd.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less - allowance for credit losses",
        "periodEndLabel": "Balance at end of year",
        "periodStartLabel": "Balance at beginning of year",
        "label": "Accounts Receivable, Allowance for Credit Loss",
        "verboseLabel": "Allowance for credit losses",
        "documentation": "Amount of allowance for credit loss on accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r195",
      "r283",
      "r321",
      "r324",
      "r327",
      "r933"
     ]
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "crdr": "credit",
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts receivable, allowance for doubtful accounts",
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r195",
      "r283",
      "r321"
     ]
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AllowanceForDoubtfulAccountsReceivableNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Receivable, Allowance for Credit Loss, Noncurrent",
        "terseLabel": "Accounts receivable net of allowance for credit losses",
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r283",
      "r321"
     ]
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AllowanceForDoubtfulAccountsReceivableWriteOffs",
     "crdr": "debit",
     "presentation": [
      "http://inmodemd.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleOfAllowanceForCreditLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Write-offs charged against the allowance",
        "label": "Accounts Receivable, Allowance for Credit Loss, Writeoff",
        "verboseLabel": "Write-offs charged against the allowance",
        "documentation": "Amount of direct write-downs of accounts receivable charged against the allowance."
       }
      }
     },
     "auth_ref": [
      "r326"
     ]
    },
    "inmd_AmendmentAdvantageExemptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "AmendmentAdvantageExemptionMember",
     "presentation": [
      "http://inmodemd.com/role/TaxesOnIncomeNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment Advantage Exemption [Member]",
        "label": "Amendment Advantage Exemption [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://inmodemd.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "presentation": [
      "http://inmodemd.com/role/LeasesNarrativeDetails",
      "http://inmodemd.com/role/OtherInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r465"
     ]
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://inmodemd.com/role/ConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Default Label]",
        "totalLabel": "TOTAL ASSETS",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r158",
      "r190",
      "r222",
      "r253",
      "r267",
      "r272",
      "r318",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r467",
      "r471",
      "r488",
      "r576",
      "r657",
      "r768",
      "r781",
      "r865",
      "r866",
      "r917"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://inmodemd.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current",
        "totalLabel": "TOTAL CURRENT ASSETS",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r183",
      "r198",
      "r222",
      "r318",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r467",
      "r471",
      "r488",
      "r768",
      "r865",
      "r866",
      "r917"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CURRENT ASSETS:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://inmodemd.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Noncurrent",
        "totalLabel": "TOTAL NON-CURRENT ASSETS",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r222",
      "r318",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r467",
      "r471",
      "r488",
      "r865",
      "r866",
      "r917"
     ]
    },
    "us-gaap_AssetsNoncurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsNoncurrentAbstract",
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "NON-CURRENT ASSETS:",
        "terseLabel": "NON-CURRENT ASSETS:"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://inmodemd.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Firm Id",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r788",
      "r789",
      "r790"
     ]
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorLocation",
     "presentation": [
      "http://inmodemd.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r788",
      "r789",
      "r790"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorName",
     "presentation": [
      "http://inmodemd.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r788",
      "r789",
      "r790"
     ]
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "crdr": "credit",
     "presentation": [
      "http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsScheduleOfFinancialAssetsMeasuredAtFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gross unrealized holding gains",
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r288"
     ]
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "crdr": "debit",
     "presentation": [
      "http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsScheduleOfFinancialAssetsMeasuredAtFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Gross unrealized holding loss",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax",
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r289"
     ]
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "crdr": "debit",
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsScheduleOfFinancialAssetsMeasuredAtFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Marketable securities, amortization",
        "verboseLabel": "Cost or amortized cost",
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r285",
      "r332",
      "r575"
     ]
    },
    "inmd_AvailableForSaleSecuritiesDebtMaturitiesMoreThanFiveYearsFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesMoreThanFiveYearsFairValue",
     "crdr": "debit",
     "calculation": {
      "http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsScheduleOfDebtSecuritiesOnMaturityDetails": {
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate",
       "weight": 1.0,
       "order": 50.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsScheduleOfDebtSecuritiesOnMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities, available for sale maturity, more than five years, fair value.",
        "label": "Available For Sale Securities Debt Maturities More Than Five Years Fair Value",
        "verboseLabel": "More than 5 years"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate",
     "crdr": "debit",
     "calculation": {
      "http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsScheduleOfDebtSecuritiesOnMaturityDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsScheduleOfDebtSecuritiesOnMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value",
        "totalLabel": "Total",
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date."
       }
      }
     },
     "auth_ref": [
      "r842",
      "r843",
      "r930"
     ]
    },
    "inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInFourToFiveYearsFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithInFourToFiveYearsFairValue",
     "crdr": "debit",
     "calculation": {
      "http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsScheduleOfDebtSecuritiesOnMaturityDetails": {
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate",
       "weight": 1.0,
       "order": 40.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsScheduleOfDebtSecuritiesOnMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities, available for sale maturity, within four to five years, fair value.",
        "label": "Available For Sale Securities Debt Maturities With In Four To Five Years Fair Value",
        "verboseLabel": "4 to 5 years"
       }
      }
     },
     "auth_ref": []
    },
    "inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInOneToTwoYearsFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithInOneToTwoYearsFairValue",
     "crdr": "debit",
     "calculation": {
      "http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsScheduleOfDebtSecuritiesOnMaturityDetails": {
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsScheduleOfDebtSecuritiesOnMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities, available for sale maturity, within one to two years, fair value.",
        "label": "Available For Sale Securities Debt Maturities With In One To Two Years Fair Value",
        "verboseLabel": "1 to 2 years"
       }
      }
     },
     "auth_ref": []
    },
    "inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInThreeToFourYearsFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithInThreeToFourYearsFairValue",
     "crdr": "debit",
     "calculation": {
      "http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsScheduleOfDebtSecuritiesOnMaturityDetails": {
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsScheduleOfDebtSecuritiesOnMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities, available for sale maturity, within three to four years, fair value.",
        "label": "Available For Sale Securities Debt Maturities With In Three To Four Years Fair Value",
        "verboseLabel": "3 to 4 years"
       }
      }
     },
     "auth_ref": []
    },
    "inmd_AvailableForSaleSecuritiesDebtMaturitiesWithInTwoToThreeYearsFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithInTwoToThreeYearsFairValue",
     "crdr": "debit",
     "calculation": {
      "http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsScheduleOfDebtSecuritiesOnMaturityDetails": {
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsScheduleOfDebtSecuritiesOnMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities, available for sale maturity, within two to three years, fair value.",
        "label": "Available For Sale Securities Debt Maturities With In Two To Three Years Fair Value",
        "verboseLabel": "2 to 3 years"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
     "crdr": "debit",
     "calculation": {
      "http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsScheduleOfDebtSecuritiesOnMaturityDetails": {
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsScheduleOfDebtSecuritiesOnMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Due within one year",
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r292",
      "r572"
     ]
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "crdr": "debit",
     "presentation": [
      "http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsScheduleOfFinancialAssetsMeasuredAtFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value",
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r286",
      "r332",
      "r564",
      "r835"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityNarrativeDetails",
      "http://inmodemd.com/role/ShareholdersEquityScheduleOfOptionsGrantedRestictedShareUnitDetails",
      "http://inmodemd.com/role/ShareholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r391",
      "r392",
      "r393",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419"
     ]
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BalanceSheetLocationAxis",
     "presentation": [
      "http://inmodemd.com/role/OtherCurrentLiabilitiesScheduleOfOtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Balance Sheet Location [Axis]",
        "documentation": "Information by location on balance sheet (statement of financial position)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BalanceSheetLocationDomain",
     "presentation": [
      "http://inmodemd.com/role/OtherCurrentLiabilitiesScheduleOfOtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position)."
       }
      }
     },
     "auth_ref": [
      "r90",
      "r91"
     ]
    },
    "inmd_BankGuarantee": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "BankGuarantee",
     "crdr": "credit",
     "presentation": [
      "http://inmodemd.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bank guarantee.",
        "label": "Bank guarantee"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "presentation": [
      "http://inmodemd.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basis of presentation",
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": []
    },
    "srt_BoardOfDirectorsChairmanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "BoardOfDirectorsChairmanMember",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Board of Director [Member]"
       }
      }
     },
     "auth_ref": [
      "r833"
     ]
    },
    "us-gaap_BondsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BondsMember",
     "presentation": [
      "http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "US Government Bonds [Member]",
        "documentation": "Debt security, in which the authorized issuer owes the holder a debt and is obliged to repay the principal and interest (the coupon)."
       }
      }
     },
     "auth_ref": []
    },
    "inmd_BonusShareIssuesPerOutstandingShare": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "BonusShareIssuesPerOutstandingShare",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bonus share issues per outstanding share.",
        "label": "Bonus Share Issues Per Outstanding Share"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionAcquireeDomain",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree."
       }
      }
     },
     "auth_ref": [
      "r463",
      "r760",
      "r761"
     ]
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionAxis",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition [Axis]",
        "documentation": "Information by business combination or series of individually immaterial business combinations."
       }
      }
     },
     "auth_ref": [
      "r80",
      "r82",
      "r463",
      "r760",
      "r761"
     ]
    },
    "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition, Percentage of Voting Interests Acquired",
        "verboseLabel": "Ownership interest",
        "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination."
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationConsiderationTransferred1",
     "crdr": "credit",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchase consideration",
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r3",
      "r13"
     ]
    },
    "dei_BusinessContactMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "BusinessContactMember",
     "presentation": [
      "http://inmodemd.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Contact [Member]",
        "documentation": "Business contact for the entity"
       }
      }
     },
     "auth_ref": [
      "r789",
      "r790"
     ]
    },
    "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock",
     "presentation": [
      "http://inmodemd.com/role/General"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "GENERAL",
        "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": [
      "r102",
      "r133",
      "r134"
     ]
    },
    "inmd_CapitalEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "CapitalEquipmentMember",
     "presentation": [
      "http://inmodemd.com/role/ENTITYWIDEDISCLOSUREDisclosureOfRevenuesBasedOnProductsCategory"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member is stand for capital equipment.",
        "label": "Capital Equipment [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://inmodemd.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "CASH AND CASH EQUIVALENTS AT END OF THE YEAR",
        "periodStartLabel": "CASH AND CASH EQUIVALENTS AT BEGINNING OF THE YEAR",
        "label": "Cash and cash equivalents",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r43",
      "r186",
      "r738"
     ]
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "presentation": [
      "http://inmodemd.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "verboseLabel": "Cash and cash equivalents",
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value."
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "CASH AND CASH EQUIVALENTS AT END OF THE YEAR",
        "periodStartLabel": "CASH AND CASH EQUIVALENTS AT BEGINNING OF THE YEAR",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "totalLabel": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Total",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r43",
      "r130",
      "r219"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://inmodemd.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS",
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r130"
     ]
    },
    "us-gaap_CertificatesOfDepositMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CertificatesOfDepositMember",
     "presentation": [
      "http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsScheduleOfFinancialAssetsMeasuredAtFairValueDetails",
      "http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsScheduleOfMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Certificates of deposit [Member]",
        "documentation": "Short to medium-term investment available at banks and savings and loan institutions where a customer agrees to lend money to the institution for a certain amount of time and is paid a predetermined rate of interest. Certificates of deposit (CD) are typically Federal Deposit Insurance Corporation (FDIC) insured."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r775",
      "r776",
      "r777",
      "r778"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://inmodemd.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommercialPaperMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommercialPaperMember",
     "presentation": [
      "http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsScheduleOfFinancialAssetsMeasuredAtFairValueDetails",
      "http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsScheduleOfMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commercial Paper [Member]",
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds."
       }
      }
     },
     "auth_ref": [
      "r140",
      "r775",
      "r776",
      "r777",
      "r778"
     ]
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "calculation": {
      "http://inmodemd.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "COMMITMENTS AND CONTINGENCIES (note 12)",
        "terseLabel": "COMMITMENTS AND CONTINGENCIES",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r32",
      "r98",
      "r577",
      "r643"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://inmodemd.com/role/CommitmentsAndContingentLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "COMMITMENTS AND CONTINGENT LIABILITIES",
        "terseLabel": "COMMITMENTS AND CONTINGECIES",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r139",
      "r341",
      "r342",
      "r721",
      "r856"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingenciesPolicyTextBlock",
     "presentation": [
      "http://inmodemd.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal and other contingencies",
        "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies."
       }
      }
     },
     "auth_ref": [
      "r65",
      "r722"
     ]
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockMember",
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ordinary Shares [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r771",
      "r772",
      "r773",
      "r775",
      "r776",
      "r777",
      "r778",
      "r827",
      "r828",
      "r906",
      "r936",
      "r937"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://inmodemd.com/role/CONSOLIDATEDBALANCESHEETSParentheticals2",
      "http://inmodemd.com/role/ShareholdersEquityNarrativeDetails",
      "http://inmodemd.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Ordinary shares, par value",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r109"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ordinary shares, shares authorized",
        "verboseLabel": "Shares authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r109",
      "r644"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ordinary shares, issued shares",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r109"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://inmodemd.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Ending Balance, shares",
        "periodStartLabel": "Begining Balance, Shares",
        "label": "Ordinary shares, outstanding shares",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r109",
      "r644",
      "r663",
      "r937",
      "r938"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://inmodemd.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Ordinary shares, NIS 0.01 par value, authorized 100,000,000 shares at December 31, 2023 and 2022 Issued 85,957,465 and 84,519,994 shares at December 31, 2023 and 2022, respectively Outstanding 83,982,462 and 82,544,991 shares at December 31, 2023 and 2022, respectively",
        "verboseLabel": "Ordinary shares, NIS 0.01 par value, authorized 100,000,000 shares at December 31, 2022 and 2021. Issued 84,519,994 and 83,875,905 shares at December 31, 2022 and 2021, respectively. Outstanding 82,544,991 and 82,978,115 shares at December 31, 2022 and 2021, respectively.",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r109",
      "r578",
      "r768"
     ]
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComprehensiveIncomeNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://inmodemd.com/role/ConsolidatedStatementsOfComprehensiveIncome": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "TOTAL COMPREHENSIVE INCOME ATTRIBUTABLE TO INMODE LTD.",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r38",
      "r203",
      "r205",
      "r214",
      "r569",
      "r593"
     ]
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComprehensiveIncomeNetOfTaxAbstract",
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "OTHER COMPREHENSIVE INCOME:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "crdr": "debit",
     "calculation": {
      "http://inmodemd.com/role/ConsolidatedStatementsOfComprehensiveIncome": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Add: Comprehensive income attributable to non-controlling interests",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r85",
      "r89",
      "r203",
      "r205",
      "r213",
      "r568",
      "r592"
     ]
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://inmodemd.com/role/ConsolidatedStatementsOfComprehensiveIncome": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "TOTAL COMPREHENSIVE INCOME",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r89",
      "r154",
      "r203",
      "r205",
      "r212",
      "r567",
      "r591"
     ]
    },
    "us-gaap_ComputerEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComputerEquipmentMember",
     "presentation": [
      "http://inmodemd.com/role/PropertyAndEquipmentNetScheduleOfPropertyAndEquipmentDetails",
      "http://inmodemd.com/role/SignificantAccountingPoliciesScheduleOfPropertyAndEquipmentEstimatedUsefulLivesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Computers [Member]",
        "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskByTypeAxis",
     "presentation": [
      "http://inmodemd.com/role/Entity-wideDisclosureScheduleOfNetSalesByTechonologyDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk Type [Axis]",
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender."
       }
      }
     },
     "auth_ref": [
      "r49",
      "r50",
      "r93",
      "r94",
      "r280",
      "r720",
      "r800"
     ]
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskCreditRisk",
     "presentation": [
      "http://inmodemd.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "verboseLabel": "Concentration of credit risks",
        "documentation": "Disclosure of accounting policy for credit risk."
       }
      }
     },
     "auth_ref": [
      "r100",
      "r169"
     ]
    },
    "us-gaap_ConcentrationRiskLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskLineItems",
     "presentation": [
      "http://inmodemd.com/role/Entity-wideDisclosureScheduleOfNetSalesByTechonologyDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r720"
     ]
    },
    "us-gaap_ConcentrationRiskTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskTable",
     "presentation": [
      "http://inmodemd.com/role/Entity-wideDisclosureScheduleOfNetSalesByTechonologyDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk [Table]",
        "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark."
       }
      }
     },
     "auth_ref": [
      "r48",
      "r49",
      "r50",
      "r51",
      "r93",
      "r157",
      "r720"
     ]
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskTypeDomain",
     "presentation": [
      "http://inmodemd.com/role/Entity-wideDisclosureScheduleOfNetSalesByTechonologyDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk Type [Domain]",
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration."
       }
      }
     },
     "auth_ref": [
      "r49",
      "r50",
      "r93",
      "r94",
      "r280",
      "r720"
     ]
    },
    "srt_ConsolidatedEntitiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ConsolidatedEntitiesAxis",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Axis]"
       }
      }
     },
     "auth_ref": [
      "r224",
      "r467",
      "r468",
      "r471",
      "r472",
      "r516",
      "r732",
      "r864",
      "r867",
      "r869"
     ]
    },
    "srt_ConsolidatedEntitiesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ConsolidatedEntitiesDomain",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "auth_ref": [
      "r224",
      "r467",
      "r468",
      "r471",
      "r472",
      "r516",
      "r732",
      "r864",
      "r867",
      "r869"
     ]
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConsolidationPolicyTextBlock",
     "presentation": [
      "http://inmodemd.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Principles of consolidation and presentation",
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary."
       }
      }
     },
     "auth_ref": [
      "r86",
      "r740"
     ]
    },
    "inmd_ConsumablesAndServiceRevenuesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "ConsumablesAndServiceRevenuesMember",
     "presentation": [
      "http://inmodemd.com/role/ENTITYWIDEDISCLOSUREDisclosureOfRevenuesBasedOnProductsCategory"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stand for consumables and service revenues.",
        "label": "Consumables And Service Revenues [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContactPersonnelEmailAddress": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ContactPersonnelEmailAddress",
     "presentation": [
      "http://inmodemd.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Email Address",
        "documentation": "Email address of contact personnel."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContactPersonnelFaxNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ContactPersonnelFaxNumber",
     "presentation": [
      "http://inmodemd.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Fax Number",
        "documentation": "Fax Number of contact personnel."
       }
      }
     },
     "auth_ref": [
      "r789"
     ]
    },
    "dei_ContactPersonnelName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ContactPersonnelName",
     "presentation": [
      "http://inmodemd.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Name",
        "documentation": "Name of contact personnel"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock",
     "presentation": [
      "http://inmodemd.com/role/Entity-wideDisclosureTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Changes in Contract Liabilities",
        "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability."
       }
      }
     },
     "auth_ref": [
      "r871"
     ]
    },
    "us-gaap_ContractWithCustomerLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ContractWithCustomerLiability",
     "crdr": "credit",
     "presentation": [
      "http://inmodemd.com/role/Entity-wideDisclosureScheduleOfChangesInContractLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Balance as of December 31",
        "periodStartLabel": "Balance as of January 1",
        "label": "Contract with Customer, Liability",
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r373",
      "r374",
      "r375"
     ]
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ContractWithCustomerLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://inmodemd.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedBalanceSheets",
      "http://inmodemd.com/role/Entity-wideDisclosureScheduleOfChangesInContractLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contract liabilities",
        "verboseLabel": "Contract liabilities",
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r373",
      "r374",
      "r375"
     ]
    },
    "us-gaap_ContractWithCustomerLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ContractWithCustomerLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://inmodemd.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedBalanceSheets",
      "http://inmodemd.com/role/Entity-wideDisclosureScheduleOfChangesInContractLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contract liability presented in non-current liabilities",
        "verboseLabel": "Contract liabilities",
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r373",
      "r374",
      "r375"
     ]
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "crdr": "credit",
     "presentation": [
      "http://inmodemd.com/role/Entity-wideDisclosureScheduleOfChangesInContractLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue recognized that was included in the contract liability balance at the beginning of the period",
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due."
       }
      }
     },
     "auth_ref": [
      "r376"
     ]
    },
    "inmd_ContractorLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "ContractorLiability",
     "crdr": "credit",
     "calculation": {
      "http://inmodemd.com/role/OtherCurrentLiabilitiesScheduleOfOtherLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 50.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/OtherCurrentLiabilitiesScheduleOfOtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of contractor liability.",
        "label": "Contractor Liability"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CorporateDebtSecuritiesMember",
     "presentation": [
      "http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsScheduleOfFinancialAssetsMeasuredAtFairValueDetails",
      "http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsScheduleOfMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Corporate debt securities [Member]",
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment."
       }
      }
     },
     "auth_ref": [
      "r757",
      "r759",
      "r935"
     ]
    },
    "inmd_CorporateTax": {
     "xbrltype": "percentItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "CorporateTax",
     "presentation": [
      "http://inmodemd.com/role/TaxesOnIncomeNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate tax rate.",
        "label": "Corporate tax"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CostOfRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CostOfRevenue",
     "crdr": "debit",
     "calculation": {
      "http://inmodemd.com/role/ConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "COST OF REVENUES",
        "verboseLabel": "COST OF REVENUES",
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r124",
      "r222",
      "r318",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r488",
      "r865"
     ]
    },
    "us-gaap_CostOfSalesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CostOfSalesMember",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityScheduleOfShareBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost of Sales [Member]",
        "documentation": "Primary financial statement caption encompassing cost of sales."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CostOfSalesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CostOfSalesPolicyTextBlock",
     "presentation": [
      "http://inmodemd.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost of revenues",
        "documentation": "Disclosure of accounting policy for cost of product sold and service rendered."
       }
      }
     },
     "auth_ref": [
      "r804"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "presentation": [
      "http://inmodemd.com/role/TaxesOnIncomeNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Axis]"
       }
      }
     },
     "auth_ref": [
      "r180",
      "r228",
      "r233",
      "r239",
      "r319",
      "r320",
      "r422",
      "r423",
      "r424",
      "r453",
      "r454",
      "r473",
      "r474",
      "r475",
      "r477",
      "r478",
      "r479",
      "r482",
      "r483",
      "r484",
      "r485",
      "r508"
     ]
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "presentation": [
      "http://inmodemd.com/role/TaxesOnIncomeNarrativeDetails"
     ],
     "auth_ref": [
      "r180",
      "r228",
      "r233",
      "r239",
      "r319",
      "r320",
      "r422",
      "r423",
      "r424",
      "r453",
      "r454",
      "r473",
      "r474",
      "r475",
      "r477",
      "r478",
      "r479",
      "r482",
      "r483",
      "r484",
      "r485",
      "r508"
     ]
    },
    "srt_CurrencyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "CurrencyAxis",
     "presentation": [
      "http://inmodemd.com/role/TaxesOnIncomeNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Currency [Axis]"
       }
      }
     },
     "auth_ref": [
      "r909"
     ]
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://inmodemd.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "presentation": [
      "http://inmodemd.com/role/TaxesOnIncomeScheduleOfTaxExpensesTaxBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current",
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r153",
      "r452",
      "r458",
      "r825"
     ]
    },
    "inmd_CurrentMonthlyRentPayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "CurrentMonthlyRentPayment",
     "crdr": "debit",
     "presentation": [
      "http://inmodemd.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Current monthly rent payment.",
        "label": "Current monthly rent payment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtSecuritiesAvailableForSaleTableTextBlock",
     "presentation": [
      "http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Debt Securities on Maturity",
        "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r837",
      "r838",
      "r839",
      "r840",
      "r841",
      "r842",
      "r843",
      "r844",
      "r845",
      "r846",
      "r847",
      "r848"
     ]
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredIncomeTaxAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://inmodemd.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred income taxes, net",
        "terseLabel": "Deferred income tax assets",
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r437",
      "r438"
     ]
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "presentation": [
      "http://inmodemd.com/role/TaxesOnIncomeScheduleOfTaxExpensesTaxBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred",
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r153",
      "r176",
      "r457",
      "r458",
      "r825"
     ]
    },
    "us-gaap_DeferredIncomeTaxesAndTaxCredits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredIncomeTaxesAndTaxCredits",
     "crdr": "debit",
     "calculation": {
      "http://inmodemd.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 60.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Income Taxes and Tax Credits",
        "verboseLabel": "Deferred income tax assets, net",
        "documentation": "Amount of deferred income tax expense (benefit) and income tax credits."
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsGross",
     "crdr": "debit",
     "calculation": {
      "http://inmodemd.com/role/TaxesOnIncomeScheduleOfDeferredTaxAssetsLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/TaxesOnIncomeScheduleOfDeferredTaxAssetsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Total deferred tax assets before valuation allowance",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r447"
     ]
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://inmodemd.com/role/TaxesOnIncomeScheduleOfDeferredTaxAssetsLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://inmodemd.com/role/TaxesOnIncomeScheduleOfDeferredTaxAssetsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "totalLabel": "Total deferred tax assets",
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r903"
     ]
    },
    "us-gaap_DeferredTaxAssetsNetAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsNetAbstract",
     "presentation": [
      "http://inmodemd.com/role/TaxesOnIncomeScheduleOfDeferredTaxAssetsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred tax assets in respect of:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "crdr": "debit",
     "calculation": {
      "http://inmodemd.com/role/TaxesOnIncomeScheduleOfDeferredTaxAssetsLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/TaxesOnIncomeScheduleOfDeferredTaxAssetsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsidiaries carryforward losses",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r78",
      "r904"
     ]
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsOther",
     "crdr": "debit",
     "calculation": {
      "http://inmodemd.com/role/TaxesOnIncomeScheduleOfDeferredTaxAssetsLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/TaxesOnIncomeScheduleOfDeferredTaxAssetsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other temporary differences",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other."
       }
      }
     },
     "auth_ref": [
      "r78",
      "r904"
     ]
    },
    "us-gaap_DeferredTaxAssetsOtherComprehensiveLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsOtherComprehensiveLoss",
     "crdr": "debit",
     "calculation": {
      "http://inmodemd.com/role/TaxesOnIncomeScheduleOfDeferredTaxAssetsLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/TaxesOnIncomeScheduleOfDeferredTaxAssetsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred tax asset in respect to other comprehensive loss",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from unrealized losses in other comprehensive income."
       }
      }
     },
     "auth_ref": [
      "r78",
      "r904"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "crdr": "debit",
     "calculation": {
      "http://inmodemd.com/role/TaxesOnIncomeScheduleOfDeferredTaxAssetsLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/TaxesOnIncomeScheduleOfDeferredTaxAssetsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost",
        "verboseLabel": "Share-based compensation",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation."
       }
      }
     },
     "auth_ref": [
      "r78",
      "r904"
     ]
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsValuationAllowance",
     "crdr": "credit",
     "calculation": {
      "http://inmodemd.com/role/TaxesOnIncomeScheduleOfDeferredTaxAssetsLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/TaxesOnIncomeScheduleOfDeferredTaxAssetsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Valuation allowance",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized."
       }
      }
     },
     "auth_ref": [
      "r448"
     ]
    },
    "us-gaap_DepositsAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DepositsAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://inmodemd.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-term bank deposits",
        "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment within one year or during the operating cycle, if shorter."
       }
      }
     },
     "auth_ref": [
      "r818"
     ]
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DepreciationDepletionAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://inmodemd.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfCashFlows",
      "http://inmodemd.com/role/PropertyAndEquipmentNetScheduleOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation and amortization",
        "terseLabel": "Depreciation and amortization",
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r256"
     ]
    },
    "inmd_DevelopmentZoneAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "DevelopmentZoneAMember",
     "presentation": [
      "http://inmodemd.com/role/TaxesOnIncomeNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Development Zone A [Member]",
        "label": "Development Zone A [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "inmd_DilazarLimitedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "DilazarLimitedMember",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Dilazar Limited [Member]",
        "label": "Dilazar Limited [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisclosureOfLongLivedAssetsHeldForSaleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisclosureOfLongLivedAssetsHeldForSaleTextBlock",
     "presentation": [
      "http://inmodemd.com/role/Entity-wideDisclosureTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Long-Lived Assets",
        "documentation": "Tabular disclosure of long lived assets held for sale. Disclosure may include the description of the facts and circumstances leading to the expected disposal, manner and timing of disposal, the carrying value of the assets held for sale, the gain (loss) recognized in the income statement and the income statement caption that includes that gain (loss)."
       }
      }
     },
     "auth_ref": [
      "r22"
     ]
    },
    "us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Awards Authorized to be Issued",
        "documentation": "Tabular disclosure of share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r68"
     ]
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://inmodemd.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r789"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://inmodemd.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r788",
      "r789",
      "r790"
     ]
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://inmodemd.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r788",
      "r789",
      "r790",
      "r792"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://inmodemd.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://inmodemd.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://inmodemd.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://inmodemd.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r782"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://inmodemd.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r789"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://inmodemd.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r791"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://inmodemd.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareAbstract",
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "NET INCOME PER SHARE:",
        "terseLabel": "EARNINGS PER SHARE:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic",
        "verboseLabel": "Basic",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r215",
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r240",
      "r242",
      "r244",
      "r245",
      "r246",
      "r247",
      "r485",
      "r486",
      "r570",
      "r594",
      "r744"
     ]
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Diluted",
        "terseLabel": "Diluted",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r215",
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r242",
      "r244",
      "r245",
      "r246",
      "r247",
      "r485",
      "r486",
      "r570",
      "r594",
      "r744"
     ]
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerSharePolicyTextBlock",
     "presentation": [
      "http://inmodemd.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net income per share",
        "verboseLabel": "Net earnings per share",
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements."
       }
      }
     },
     "auth_ref": [
      "r46",
      "r47"
     ]
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "crdr": "debit",
     "calculation": {
      "http://inmodemd.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effect of Exchange Rate on Cash and Cash Equivalents",
        "terseLabel": "EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS",
        "totalLabel": "Effect of Exchange Rate on Cash and Cash Equivalents, Total",
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r908"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "presentation": [
      "http://inmodemd.com/role/TaxesOnIncomeNarrativeDetails",
      "http://inmodemd.com/role/TaxesOnIncomeScheduleOfReconciliationOfTheoreticalProvisionForIncomeTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statutory rate",
        "verboseLabel": "Theoretical tax expenses at the statutory rate of InMode Ltd.",
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss)."
       }
      }
     },
     "auth_ref": [
      "r223",
      "r440",
      "r459"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsDividends": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationDeductionsDividends",
     "presentation": [
      "http://inmodemd.com/role/TaxesOnIncomeNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tax rate after divdend",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to deduction for dividend."
       }
      }
     },
     "auth_ref": [
      "r901",
      "r905"
     ]
    },
    "inmd_EffectiveIncomeTaxRateReconciliationDeductionsDividendsForNonIsraeliResidents": {
     "xbrltype": "percentItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "EffectiveIncomeTaxRateReconciliationDeductionsDividendsForNonIsraeliResidents",
     "presentation": [
      "http://inmodemd.com/role/TaxesOnIncomeNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax rate for dividend distributed to a corporate shareholder who is not an Israeli resident.",
        "label": "Effective Income Tax Rate Reconciliation Deductions Dividends For Non Israeli Residents"
       }
      }
     },
     "auth_ref": []
    },
    "inmd_ElsewhereMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "ElsewhereMember",
     "presentation": [
      "http://inmodemd.com/role/TaxesOnIncomeNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Elsewhere [Member]",
        "label": "Elsewhere [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://inmodemd.com/role/OtherCurrentLiabilitiesScheduleOfOtherLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/OtherCurrentLiabilitiesScheduleOfOtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employees and related expenses",
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r29"
     ]
    },
    "inmd_EmployeeRelatedSeveranceLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "EmployeeRelatedSeveranceLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://inmodemd.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Related Severance Liabilities.",
        "label": "Employee Related Severance Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unrecognized compensation cost, recognition period",
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r421"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "crdr": "debit",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unrecognized compensation expense",
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r900"
     ]
    },
    "inmd_EmployeeSeveranceBenefitsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "EmployeeSeveranceBenefitsPolicyTextBlock",
     "presentation": [
      "http://inmodemd.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee severance benefits.",
        "label": "Employee Severance Benefits Policy Text Block",
        "terseLabel": "Employee severance benefits"
       }
      }
     },
     "auth_ref": []
    },
    "inmd_EmployeesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "EmployeesMember",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employees [Member]",
        "label": "Employees [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://inmodemd.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://inmodemd.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://inmodemd.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://inmodemd.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://inmodemd.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://inmodemd.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://inmodemd.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses, Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://inmodemd.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r784"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://inmodemd.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://inmodemd.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://inmodemd.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r784"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://inmodemd.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r795"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://inmodemd.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://inmodemd.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r784"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://inmodemd.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://inmodemd.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r793"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://inmodemd.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r784"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://inmodemd.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r784"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://inmodemd.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://inmodemd.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r794"
     ]
    },
    "us-gaap_EquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquipmentMember",
     "presentation": [
      "http://inmodemd.com/role/SignificantAccountingPoliciesScheduleOfPropertyAndEquipmentEstimatedUsefulLivesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equipment and furniture [Member]",
        "documentation": "Tangible personal property used to produce goods and services."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r180",
      "r207",
      "r208",
      "r209",
      "r225",
      "r226",
      "r227",
      "r230",
      "r236",
      "r238",
      "r248",
      "r319",
      "r320",
      "r372",
      "r422",
      "r423",
      "r424",
      "r453",
      "r454",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r479",
      "r484",
      "r490",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r509",
      "r604",
      "r605",
      "r606",
      "r624",
      "r687"
     ]
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "EquityMethodInvesteeNameDomain",
     "presentation": [
      "http://inmodemd.com/role/OtherInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Domain]"
       }
      }
     },
     "auth_ref": [
      "r315",
      "r316",
      "r317"
     ]
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "presentation": [
      "http://inmodemd.com/role/OtherInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership interest",
        "verboseLabel": "Ownership interest",
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting."
       }
      }
     },
     "auth_ref": [
      "r315"
     ]
    },
    "srt_EuropeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "EuropeMember",
     "presentation": [
      "http://inmodemd.com/role/Entity-wideDisclosureScheduleOfNetSalesByGeographicalAreaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Europe [Member]",
        "verboseLabel": "Europe [Member]"
       }
      }
     },
     "auth_ref": [
      "r939",
      "r940",
      "r941",
      "r942"
     ]
    },
    "inmd_ExerciseOfOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "ExerciseOfOptions",
     "crdr": "debit",
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise of Options.",
        "label": "Exercise of Options"
       }
      }
     },
     "auth_ref": []
    },
    "inmd_ExercisePriceRangeEightMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "ExercisePriceRangeEightMember",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityScheduleOfOutstandingAndExercisableOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "$12.16 [Member]",
        "label": "Exercise Price Range Eight [Member]",
        "terseLabel": "$12.16 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "inmd_ExercisePriceRangeFiveMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "ExercisePriceRangeFiveMember",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityScheduleOfOutstandingAndExercisableOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "$5.11 [Member]",
        "label": "Exercise Price Range Five [Member]",
        "terseLabel": "$5.11 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "inmd_ExercisePriceRangeFourMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "ExercisePriceRangeFourMember",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityScheduleOfOutstandingAndExercisableOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "$3.75 [Member]",
        "label": "Exercise Price Range Four [Member]",
        "terseLabel": "$3.75 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "inmd_ExercisePriceRangeNineMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "ExercisePriceRangeNineMember",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityScheduleOfOutstandingAndExercisableOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "$21.62 [Member]",
        "label": "Exercise Price Range Nine [Member]",
        "terseLabel": "$21.62 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "inmd_ExercisePriceRangeOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "ExercisePriceRangeOneMember",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityScheduleOfOutstandingAndExercisableOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "$0.28 [Member]",
        "label": "Exercise Price Range One Member",
        "terseLabel": "$0.28 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "inmd_ExercisePriceRangeSevenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "ExercisePriceRangeSevenMember",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityScheduleOfOutstandingAndExercisableOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "$9.85 [Member]",
        "label": "Exercise Price Range Seven [Member]",
        "terseLabel": "$9.85 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "inmd_ExercisePriceRangeSixMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "ExercisePriceRangeSixMember",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityScheduleOfOutstandingAndExercisableOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "$7.00 [Member]",
        "label": "Exercise Price Range Six [Member]",
        "terseLabel": "$7.00 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "inmd_ExercisePriceRangeThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "ExercisePriceRangeThreeMember",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityScheduleOfOutstandingAndExercisableOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "$3.16 [Member]",
        "label": "Exercise Price Range Three [Member]",
        "terseLabel": "$3.16 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "inmd_ExercisePriceRangeTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "ExercisePriceRangeTwoMember",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityScheduleOfOutstandingAndExercisableOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "$0.29 [Member]",
        "label": "Exercise Price Range Two [Member]",
        "terseLabel": "$0.29 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "inmd_ExpensesIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "ExpensesIncomeMember",
     "presentation": [
      "http://inmodemd.com/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expenses (Income) [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock",
     "presentation": [
      "http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Financial Assets Measured at Fair Value on Recurring Basis",
        "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)."
       }
      }
     },
     "auth_ref": [
      "r92",
      "r156"
     ]
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsScheduleOfFinancialAssetsMeasuredAtFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r357",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r487",
      "r521",
      "r522",
      "r523",
      "r752",
      "r753",
      "r757",
      "r758",
      "r759"
     ]
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueInputsLevel2Member",
     "presentation": [
      "http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsScheduleOfFinancialAssetsMeasuredAtFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Level 2 Securities [Member]",
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets."
       }
      }
     },
     "auth_ref": [
      "r357",
      "r378",
      "r383",
      "r487",
      "r522",
      "r752",
      "r753",
      "r757",
      "r758",
      "r759"
     ]
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "presentation": [
      "http://inmodemd.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair value measurement",
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsScheduleOfFinancialAssetsMeasuredAtFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "auth_ref": [
      "r357",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r521",
      "r522",
      "r523",
      "r752",
      "r753",
      "r757",
      "r758",
      "r759"
     ]
    },
    "inmd_FairValueOfOptionsGranted": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "FairValueOfOptionsGranted",
     "crdr": "debit",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of options granted.",
        "label": "Fair value of options granted"
       }
      }
     },
     "auth_ref": []
    },
    "inmd_FairValueOfRestrictedOptionsGranted": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "FairValueOfRestrictedOptionsGranted",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of restricted options granted.",
        "label": "Fair Value Of Restricted Options Granted",
        "terseLabel": "Fair value of RSUs granted"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinancialInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinancialInstrumentAxis",
     "presentation": [
      "http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsNarrativeDetails",
      "http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsScheduleOfFinancialAssetsMeasuredAtFairValueDetails",
      "http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsScheduleOfMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instrument [Axis]",
        "documentation": "Information by type of financial instrument."
       }
      }
     },
     "auth_ref": [
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r322",
      "r323",
      "r328",
      "r329",
      "r330",
      "r333",
      "r334",
      "r335",
      "r358",
      "r370",
      "r480",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r590",
      "r751",
      "r805",
      "r806",
      "r807",
      "r808",
      "r809",
      "r810",
      "r811",
      "r848",
      "r849",
      "r850",
      "r851"
     ]
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "presentation": [
      "http://inmodemd.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Functional currency",
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy."
       }
      }
     },
     "auth_ref": [
      "r489"
     ]
    },
    "inmd_FullyDilutedBasisMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "FullyDilutedBasisMember",
     "presentation": [
      "http://inmodemd.com/role/OtherInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fully diluted basis [Member]",
        "label": "Fully diluted basis [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "inmd_GIBFAndJVCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "GIBFAndJVCMember",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "GIBF and JVC [Member]",
        "label": "G I B F And J V C [Member]",
        "terseLabel": "GIBF and JVC [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GainLossOnInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GainLossOnInvestments",
     "crdr": "credit",
     "calculation": {
      "http://inmodemd.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 40.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Loss on marketable securities, net",
        "label": "Gain (Loss) on Investments",
        "documentation": "Amount of realized and unrealized gain (loss) on investment."
       }
      }
     },
     "auth_ref": [
      "r127",
      "r796"
     ]
    },
    "inmd_GeneralAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "GeneralAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "General Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://inmodemd.com/role/ConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General and administrative",
        "verboseLabel": "General and administrative",
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line."
       }
      }
     },
     "auth_ref": [
      "r125",
      "r667"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GeneralAndAdministrativeExpenseMember",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityScheduleOfShareBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General and Administrative Expenses [Member]",
        "documentation": "Primary financial statement caption encompassing general and administrative expense."
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "inmd_GovernmentInstitutions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "GovernmentInstitutions",
     "crdr": "credit",
     "calculation": {
      "http://inmodemd.com/role/OtherCurrentLiabilitiesScheduleOfOtherLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/OtherCurrentLiabilitiesScheduleOfOtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Government institutions.",
        "label": "Government Institutions",
        "verboseLabel": "Government institutions"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GranteeStatusAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GranteeStatusAxis",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityScheduleOfOptionsGrantedDetails",
      "http://inmodemd.com/role/ShareholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Grantee Status [Axis]",
        "documentation": "Information by status of recipient to whom award is granted."
       }
      }
     },
     "auth_ref": [
      "r388",
      "r390",
      "r391",
      "r392",
      "r393",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419"
     ]
    },
    "us-gaap_GranteeStatusDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GranteeStatusDomain",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityScheduleOfOptionsGrantedDetails",
      "http://inmodemd.com/role/ShareholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Status of recipient to whom award is granted."
       }
      }
     },
     "auth_ref": [
      "r388",
      "r390",
      "r391",
      "r392",
      "r393",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419"
     ]
    },
    "us-gaap_GrossProfit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GrossProfit",
     "crdr": "credit",
     "calculation": {
      "http://inmodemd.com/role/ConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gross Profit",
        "totalLabel": "GROSS PROFIT",
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity."
       }
      }
     },
     "auth_ref": [
      "r123",
      "r222",
      "r253",
      "r266",
      "r271",
      "r274",
      "r318",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r488",
      "r746",
      "r865"
     ]
    },
    "inmd_HandsFreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "HandsFreeMember",
     "presentation": [
      "http://inmodemd.com/role/Entity-wideDisclosureScheduleOfNetSalesByTechonologyDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hands-Free [Member]",
        "label": "Hands-Free [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "inmd_HimalayaFamilyOfficeConsultingLtdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "HimalayaFamilyOfficeConsultingLtdMember",
     "presentation": [
      "http://inmodemd.com/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Himalaya Family Office Consulting Ltd. [Member]",
        "label": "Himalaya Family Office Consulting Ltd. [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "inmd_HomeSkinnovationsLtdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "HomeSkinnovationsLtdMember",
     "presentation": [
      "http://inmodemd.com/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Home Skinnovations Ltd [Member]",
        "label": "Home Skinnovations Ltd [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "country_IL": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2023",
     "localname": "IL",
     "presentation": [
      "http://inmodemd.com/role/Entity-wideDisclosureScheduleOfLong-livedAssetsDetails",
      "http://inmodemd.com/role/TaxesOnIncomeScheduleOfTaxExpensesTaxBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Israel [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "currency_ILS": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/currency/2023",
     "localname": "ILS",
     "presentation": [
      "http://inmodemd.com/role/TaxesOnIncomeNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "NIS [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IPOMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IPOMember",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "IPO [Member]",
        "documentation": "First sale of stock by a private company to the public."
       }
      }
     },
     "auth_ref": []
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://inmodemd.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r788",
      "r789",
      "r790"
     ]
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "presentation": [
      "http://inmodemd.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Impairment of long-lived assets",
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r138"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://inmodemd.com/role/ConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfIncome",
      "http://inmodemd.com/role/TaxesOnIncomeScheduleOfIncomeBeforeIncomeTaxesDetails",
      "http://inmodemd.com/role/TaxesOnIncomeScheduleOfReconciliationOfTheoreticalProvisionForIncomeTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income before taxes on income",
        "totalLabel": "INCOME BEFORE INCOME TAXES",
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r120",
      "r161",
      "r253",
      "r266",
      "r271",
      "r274",
      "r571",
      "r585",
      "r746"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementLocationAxis",
     "presentation": [
      "http://inmodemd.com/role/RelatedPartiesDetails",
      "http://inmodemd.com/role/ShareholdersEquityScheduleOfShareBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement Location [Axis]",
        "documentation": "Information by location in the income statement."
       }
      }
     },
     "auth_ref": [
      "r339",
      "r340",
      "r672"
     ]
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementLocationDomain",
     "presentation": [
      "http://inmodemd.com/role/RelatedPartiesDetails",
      "http://inmodemd.com/role/ShareholdersEquityScheduleOfShareBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement Location [Domain]",
        "documentation": "Location in the income statement."
       }
      }
     },
     "auth_ref": [
      "r340",
      "r672"
     ]
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxAuthorityAxis",
     "presentation": [
      "http://inmodemd.com/role/TaxesOnIncomeNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Authority [Axis]",
        "verboseLabel": "Income Tax Authority, Name [Axis]",
        "documentation": "Information by tax jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxAuthorityDomain",
     "presentation": [
      "http://inmodemd.com/role/TaxesOnIncomeNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxAuthorityNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxAuthorityNameAxis",
     "presentation": [
      "http://inmodemd.com/role/TaxesOnIncomeNarrativeDetails",
      "http://inmodemd.com/role/TaxesOnIncomeScheduleOfIncomeBeforeIncomeTaxesDetails",
      "http://inmodemd.com/role/TaxesOnIncomeScheduleOfTaxExpensesTaxBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Authority, Name [Axis]",
        "documentation": "Information by name of taxing authority."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "us-gaap_IncomeTaxAuthorityNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxAuthorityNameDomain",
     "presentation": [
      "http://inmodemd.com/role/TaxesOnIncomeNarrativeDetails",
      "http://inmodemd.com/role/TaxesOnIncomeScheduleOfIncomeBeforeIncomeTaxesDetails",
      "http://inmodemd.com/role/TaxesOnIncomeScheduleOfTaxExpensesTaxBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Named agency, division or body that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxContingencyLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxContingencyLineItems",
     "presentation": [
      "http://inmodemd.com/role/TaxesOnIncomeNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Contingency [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxContingencyTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxContingencyTable",
     "presentation": [
      "http://inmodemd.com/role/TaxesOnIncomeNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Contingency [Table]",
        "documentation": "Disclosure of information about tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r79",
      "r151",
      "r152"
     ]
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://inmodemd.com/role/TaxesOnIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "TAXES ON INCOME",
        "terseLabel": "INCOME TAXES",
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information."
       }
      }
     },
     "auth_ref": [
      "r223",
      "r433",
      "r441",
      "r445",
      "r450",
      "r455",
      "r460",
      "r461",
      "r462",
      "r618"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://inmodemd.com/role/ConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0,
       "order": 10.0
      },
      "http://inmodemd.com/role/TaxesOnIncomeScheduleOfReconciliationOfTheoreticalProvisionForIncomeTaxDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfIncome",
      "http://inmodemd.com/role/TaxesOnIncomeScheduleOfReconciliationOfTheoreticalProvisionForIncomeTaxDetails",
      "http://inmodemd.com/role/TaxesOnIncomeScheduleOfTaxExpensesTaxBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "INCOME TAXES",
        "terseLabel": "Total taxes on income",
        "totalLabel": "Total taxes on income",
        "verboseLabel": "INCOME TAXES",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r164",
      "r177",
      "r237",
      "r238",
      "r257",
      "r439",
      "r456",
      "r596"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract",
     "presentation": [
      "http://inmodemd.com/role/TaxesOnIncomeScheduleOfReconciliationOfTheoreticalProvisionForIncomeTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (decrease) in taxes on income due to:"
       }
      }
     },
     "auth_ref": []
    },
    "inmd_IncomeTaxNoteLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "IncomeTaxNoteLineItems",
     "presentation": [
      "http://inmodemd.com/role/TaxesOnIncomeScheduleOfIncomeBeforeIncomeTaxesDetails",
      "http://inmodemd.com/role/TaxesOnIncomeScheduleOfTaxExpensesTaxBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Tax Note [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "inmd_IncomeTaxNoteTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "IncomeTaxNoteTable",
     "presentation": [
      "http://inmodemd.com/role/TaxesOnIncomeScheduleOfIncomeBeforeIncomeTaxesDetails",
      "http://inmodemd.com/role/TaxesOnIncomeScheduleOfTaxExpensesTaxBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table of income taxes.",
        "label": "Income Tax Note [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxPolicyTextBlock",
     "presentation": [
      "http://inmodemd.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income taxes",
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements."
       }
      }
     },
     "auth_ref": [
      "r206",
      "r435",
      "r436",
      "r445",
      "r446",
      "r449",
      "r451",
      "r614"
     ]
    },
    "inmd_IncomeTaxReconciliationAmendmentToInvestmentsLawPayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "IncomeTaxReconciliationAmendmentToInvestmentsLawPayment",
     "crdr": "debit",
     "calculation": {
      "http://inmodemd.com/role/TaxesOnIncomeScheduleOfReconciliationOfTheoreticalProvisionForIncomeTaxDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 70.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/TaxesOnIncomeScheduleOfReconciliationOfTheoreticalProvisionForIncomeTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of income tax reconciliation amendment to the investments law payment.",
        "label": "Income Tax Reconciliation Amendment To Investments Law Payment",
        "verboseLabel": "Amendment to the Investments Law payment - see also note 13a(2)(b)"
       }
      }
     },
     "auth_ref": []
    },
    "inmd_IncomeTaxReconciliationBenefitsToBenefitedEnterprise": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "IncomeTaxReconciliationBenefitsToBenefitedEnterprise",
     "crdr": "credit",
     "calculation": {
      "http://inmodemd.com/role/TaxesOnIncomeScheduleOfReconciliationOfTheoreticalProvisionForIncomeTaxDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/TaxesOnIncomeScheduleOfReconciliationOfTheoreticalProvisionForIncomeTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Benefits to the Benefited Enterprise.",
        "label": "Income Tax Reconciliation Benefits To Benefited Enterprise",
        "terseLabel": "Benefits to the Benefited Enterprise",
        "negatedLabel": "Benefits to the Benefited Enterprise"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "crdr": "debit",
     "calculation": {
      "http://inmodemd.com/role/TaxesOnIncomeScheduleOfReconciliationOfTheoreticalProvisionForIncomeTaxDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/TaxesOnIncomeScheduleOfReconciliationOfTheoreticalProvisionForIncomeTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Valuation allowance",
        "terseLabel": "Valuation allowance",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r901"
     ]
    },
    "inmd_IncomeTaxReconciliationDifferentEffectiveTaxRatesApplicableToOperatingLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "IncomeTaxReconciliationDifferentEffectiveTaxRatesApplicableToOperatingLoss",
     "crdr": "debit",
     "calculation": {
      "http://inmodemd.com/role/TaxesOnIncomeScheduleOfReconciliationOfTheoreticalProvisionForIncomeTaxDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 90.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/TaxesOnIncomeScheduleOfReconciliationOfTheoreticalProvisionForIncomeTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by operating losses.",
        "label": "Income Tax Reconciliation Different Effective Tax Rates Applicable To Operating Loss",
        "terseLabel": "NOL carry back as part of the CARES Act relief"
       }
      }
     },
     "auth_ref": []
    },
    "inmd_IncomeTaxReconciliationDifferentEffectiveTaxRatesApplicableToSubsidiaries": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "IncomeTaxReconciliationDifferentEffectiveTaxRatesApplicableToSubsidiaries",
     "crdr": "credit",
     "calculation": {
      "http://inmodemd.com/role/TaxesOnIncomeScheduleOfReconciliationOfTheoreticalProvisionForIncomeTaxDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/TaxesOnIncomeScheduleOfReconciliationOfTheoreticalProvisionForIncomeTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to Different effective tax rates applicable to the subsidiaries.",
        "label": "Income Tax Reconciliation Different Effective Tax Rates Applicable To Subsidiaries",
        "terseLabel": "Different effective tax rates applicable to the Subsidiaries",
        "negatedLabel": "Different effective tax rates applicable to the Subsidiaries"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "crdr": "debit",
     "calculation": {
      "http://inmodemd.com/role/TaxesOnIncomeScheduleOfReconciliationOfTheoreticalProvisionForIncomeTaxDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/TaxesOnIncomeScheduleOfReconciliationOfTheoreticalProvisionForIncomeTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Theoretical tax benefit",
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r440"
     ]
    },
    "inmd_IncomeTaxReconciliationNonDeductibleExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "IncomeTaxReconciliationNonDeductibleExpenses",
     "crdr": "debit",
     "calculation": {
      "http://inmodemd.com/role/TaxesOnIncomeScheduleOfReconciliationOfTheoreticalProvisionForIncomeTaxDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 50.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/TaxesOnIncomeScheduleOfReconciliationOfTheoreticalProvisionForIncomeTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to Non-deductible expenses.",
        "label": "Income Tax Reconciliation Non Deductible Expenses",
        "verboseLabel": "Non-deductible expenses and other permanent differences, mainly share based compensation expenses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationPriorYearIncomeTaxes",
     "crdr": "debit",
     "calculation": {
      "http://inmodemd.com/role/TaxesOnIncomeScheduleOfReconciliationOfTheoreticalProvisionForIncomeTaxDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 60.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/TaxesOnIncomeScheduleOfReconciliationOfTheoreticalProvisionForIncomeTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Previous years",
        "verboseLabel": "Previous year",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r901"
     ]
    },
    "inmd_IncomeTaxReconciliationSettlementsWithIsraeliTaxAuthorityNetOfDecreaseOfRelatedUncertainTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "IncomeTaxReconciliationSettlementsWithIsraeliTaxAuthorityNetOfDecreaseOfRelatedUncertainTax",
     "crdr": "debit",
     "calculation": {
      "http://inmodemd.com/role/TaxesOnIncomeScheduleOfReconciliationOfTheoreticalProvisionForIncomeTaxDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 80.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/TaxesOnIncomeScheduleOfReconciliationOfTheoreticalProvisionForIncomeTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of Income tax reconciliation settlements with israeli tax authority net of decrease of related uncertain tax.",
        "label": "Income Tax Reconciliation Settlements With Israeli Tax Authority Net Of Decrease Of Related Uncertain Tax",
        "terseLabel": "Settlements with the Israeli tax authority net of decrease of related uncertain tax"
       }
      }
     },
     "auth_ref": []
    },
    "inmd_IncomeTaxReconciliationUncertainTaxPosition": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "IncomeTaxReconciliationUncertainTaxPosition",
     "crdr": "debit",
     "calculation": {
      "http://inmodemd.com/role/TaxesOnIncomeScheduleOfReconciliationOfTheoreticalProvisionForIncomeTaxDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 40.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/TaxesOnIncomeScheduleOfReconciliationOfTheoreticalProvisionForIncomeTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to uncertain tax position.",
        "label": "Income Tax Reconciliation Uncertain Tax Position",
        "verboseLabel": "Uncertain tax positions"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxesPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income taxes paid",
        "terseLabel": "Income taxes paid *",
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes."
       }
      }
     },
     "auth_ref": [
      "r45"
     ]
    },
    "us-gaap_IncomeTaxesReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxesReceivable",
     "crdr": "debit",
     "presentation": [
      "http://inmodemd.com/role/TaxesOnIncomeNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tax asset",
        "documentation": "Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes."
       }
      }
     },
     "auth_ref": [
      "r97",
      "r815"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccountsPayable",
     "crdr": "debit",
     "calculation": {
      "http://inmodemd.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 100.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase in accounts payable",
        "terseLabel": "Increase (decrease) in accounts payable",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "crdr": "credit",
     "calculation": {
      "http://inmodemd.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 70.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Increase in accounts receivable",
        "label": "Increase (Decrease) in Accounts Receivable",
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://inmodemd.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 130.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "crdr": "debit",
     "calculation": {
      "http://inmodemd.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 120.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (decrease) in contract liabilities",
        "terseLabel": "Increase (decrease) in contract liabilities",
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r549",
      "r823"
     ]
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInInventories",
     "crdr": "credit",
     "calculation": {
      "http://inmodemd.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 90.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Increase in inventories",
        "label": "Increase (Decrease) in Inventories",
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes in operating assets and liabilities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOtherOperatingLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://inmodemd.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 110.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase in other liabilities",
        "terseLabel": "Increase (decrease) in other liabilities",
        "documentation": "Amount of increase (decrease) in operating liabilities classified as other."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_IncreaseDecreaseInOtherReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOtherReceivables",
     "crdr": "credit",
     "calculation": {
      "http://inmodemd.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 80.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Increase in other receivables",
        "label": "Increase (Decrease) in Other Receivables",
        "documentation": "Amount of increase (decrease) in receivables classified as other."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "inmd_IncreasesDueToIssuanceOfNewContractsExcludingAmountsRecognizedAsRevenueDuringPeriod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "IncreasesDueToIssuanceOfNewContractsExcludingAmountsRecognizedAsRevenueDuringPeriod",
     "crdr": "credit",
     "presentation": [
      "http://inmodemd.com/role/Entity-wideDisclosureScheduleOfChangesInContractLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increases due to issuance of new contracts, excluding amounts recognized as revenue during the period.",
        "label": "Increases due to issuance of new contracts, excluding amounts recognized as revenue during the period"
       }
      }
     },
     "auth_ref": []
    },
    "inmd_InmodeLtdAndIsreaeliSubsidiariesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "InmodeLtdAndIsreaeliSubsidiariesMember",
     "presentation": [
      "http://inmodemd.com/role/TaxesOnIncomeScheduleOfIncomeBeforeIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "InMode Ltd. and Isreaeli subsidiaries[member]",
        "label": "Inmode Ltd And Isreaeli Subsidiaries [Member]",
        "verboseLabel": "InMode Ltd. and Israeli subsidiaries [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestIncomeExpenseNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestIncomeExpenseNet",
     "crdr": "credit",
     "calculation": {
      "http://inmodemd.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 50.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Income (Expense), Net",
        "totalLabel": "Interest Income (Expense), Net, Total",
        "negatedLabel": "Finance expense (income), net",
        "documentation": "The net amount of operating interest income (expense)."
       }
      }
     },
     "auth_ref": [
      "r163"
     ]
    },
    "inmd_InterestReceived": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "InterestReceived",
     "crdr": "debit",
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest received.",
        "label": "Interest received"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryDisclosureTextBlock",
     "presentation": [
      "http://inmodemd.com/role/Inventories"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "INVENTORIES",
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory."
       }
      }
     },
     "auth_ref": [
      "r336"
     ]
    },
    "us-gaap_InventoryFinishedGoods": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryFinishedGoods",
     "crdr": "debit",
     "calculation": {
      "http://inmodemd.com/role/InventoriesScheduleOfInventoriesDetails": {
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/InventoriesScheduleOfInventoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finished products",
        "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r816"
     ]
    },
    "us-gaap_InventoryNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryNet",
     "crdr": "debit",
     "calculation": {
      "http://inmodemd.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 50.0
      },
      "http://inmodemd.com/role/InventoriesScheduleOfInventoriesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedBalanceSheets",
      "http://inmodemd.com/role/InventoriesScheduleOfInventoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventories",
        "totalLabel": "Total inventories",
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r197",
      "r739",
      "r768"
     ]
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryPolicyTextBlock",
     "presentation": [
      "http://inmodemd.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory, Policy [Policy Text Block]",
        "verboseLabel": "Inventories",
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost."
       }
      }
     },
     "auth_ref": [
      "r165",
      "r185",
      "r196",
      "r336",
      "r337",
      "r338",
      "r550",
      "r741"
     ]
    },
    "us-gaap_InventoryRawMaterials": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryRawMaterials",
     "crdr": "debit",
     "calculation": {
      "http://inmodemd.com/role/InventoriesScheduleOfInventoriesDetails": {
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/InventoriesScheduleOfInventoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Raw materials",
        "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r817"
     ]
    },
    "inmd_InvestmentInShortTermDeposit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "InvestmentInShortTermDeposit",
     "crdr": "credit",
     "calculation": {
      "http://inmodemd.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment in short-term deposit.",
        "negatedLabel": "Investment in short-term deposits",
        "label": "Investment In Short Term Deposit"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentIncomeNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentIncomeNet",
     "crdr": "credit",
     "calculation": {
      "http://inmodemd.com/role/ConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance income, net",
        "verboseLabel": "Finance income, net",
        "documentation": "Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities."
       }
      }
     },
     "auth_ref": [
      "r126",
      "r128"
     ]
    },
    "us-gaap_InvestmentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentPolicyTextBlock",
     "presentation": [
      "http://inmodemd.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Policy [Policy Text Block]",
        "verboseLabel": "Other Investments",
        "documentation": "Disclosure of accounting policy for investment in financial asset."
       }
      }
     },
     "auth_ref": [
      "r595",
      "r610",
      "r611",
      "r612",
      "r613",
      "r698",
      "r699"
     ]
    },
    "us-gaap_InvestmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentTextBlock",
     "presentation": [
      "http://inmodemd.com/role/OtherInvestments"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "OTHER INVESTMENTS",
        "documentation": "The entire disclosure for investment."
       }
      }
     },
     "auth_ref": [
      "r802",
      "r803",
      "r834"
     ]
    },
    "us-gaap_InvestmentTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentTypeAxis",
     "presentation": [
      "http://inmodemd.com/role/OtherInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Type [Axis]",
        "documentation": "Information by type of investments."
       }
      }
     },
     "auth_ref": [
      "r626",
      "r628",
      "r629",
      "r631",
      "r633",
      "r695",
      "r697",
      "r701",
      "r704",
      "r705",
      "r706",
      "r707",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r773"
     ]
    },
    "us-gaap_InvestmentTypeCategorizationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentTypeCategorizationMember",
     "presentation": [
      "http://inmodemd.com/role/OtherInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments [Domain]",
        "documentation": "Asset obtained to generate income or appreciate in value."
       }
      }
     },
     "auth_ref": [
      "r626",
      "r628",
      "r629",
      "r631",
      "r633",
      "r695",
      "r697",
      "r701",
      "r704",
      "r705",
      "r706",
      "r707",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r773"
     ]
    },
    "us-gaap_Investments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Investments",
     "crdr": "debit",
     "presentation": [
      "http://inmodemd.com/role/OtherInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Amount",
        "verboseLabel": "Investment Amount",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all investments."
       }
      }
     },
     "auth_ref": [
      "r574"
     ]
    },
    "us-gaap_InvestmentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "inmd_IsraeliTaxAuthorityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "IsraeliTaxAuthorityMember",
     "presentation": [
      "http://inmodemd.com/role/TaxesOnIncomeNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member is stand for Israeli Tax Authority.",
        "label": "Israeli Tax Authority [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "inmd_JointVentureAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "JointVentureAgreementMember",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Guangzhou Sino Israel Bio Industry Investment Fund LLP [Member]",
        "label": "Joint Venture Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "inmd_LeaseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "LeaseAgreementMember",
     "presentation": [
      "http://inmodemd.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease agreement [Member]",
        "label": "Lease Agreement [Member]",
        "verboseLabel": "Lease agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeaseCostTableTextBlock",
     "presentation": [
      "http://inmodemd.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Lease Expense",
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income."
       }
      }
     },
     "auth_ref": [
      "r911"
     ]
    },
    "inmd_LeaseExpires": {
     "xbrltype": "stringItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "LeaseExpires",
     "presentation": [
      "http://inmodemd.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease expires period.",
        "label": "Lease expires",
        "verboseLabel": "Lease expiration date"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeaseholdImprovementsMember",
     "presentation": [
      "http://inmodemd.com/role/PropertyAndEquipmentNetScheduleOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leasehold Improvements [Member]",
        "documentation": "Additions or improvements to assets held under a lease arrangement."
       }
      }
     },
     "auth_ref": [
      "r137"
     ]
    },
    "us-gaap_LeasesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeasesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "inmd_LeasesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "LeasesLineItems",
     "presentation": [
      "http://inmodemd.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Leases [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeasesOperatingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeasesOperatingAbstract",
     "presentation": [
      "http://inmodemd.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Leases"
       }
      }
     },
     "auth_ref": []
    },
    "inmd_LeasesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "LeasesTable",
     "presentation": [
      "http://inmodemd.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table of leases.",
        "label": "Leases [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeLeasesPolicyTextBlock",
     "presentation": [
      "http://inmodemd.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases",
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee."
       }
      }
     },
     "auth_ref": [
      "r502"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "presentation": [
      "http://inmodemd.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Maturities of Lease Liabilities",
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r912"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "crdr": "credit",
     "calculation": {
      "http://inmodemd.com/role/LeasesScheduleOfMaturitiesOfLeaseLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://inmodemd.com/role/LeasesScheduleOfMaturitiesOfLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total lease payments",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease."
       }
      }
     },
     "auth_ref": [
      "r507"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "crdr": "credit",
     "calculation": {
      "http://inmodemd.com/role/LeasesScheduleOfMaturitiesOfLeaseLiabilitiesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 40.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/LeasesScheduleOfMaturitiesOfLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "2028 and beyond",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r507"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "calculation": {
      "http://inmodemd.com/role/LeasesScheduleOfMaturitiesOfLeaseLiabilitiesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/LeasesScheduleOfMaturitiesOfLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2024",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r507"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "crdr": "credit",
     "calculation": {
      "http://inmodemd.com/role/LeasesScheduleOfMaturitiesOfLeaseLiabilitiesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/LeasesScheduleOfMaturitiesOfLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "verboseLabel": "2027",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r507"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "calculation": {
      "http://inmodemd.com/role/LeasesScheduleOfMaturitiesOfLeaseLiabilitiesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/LeasesScheduleOfMaturitiesOfLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2026",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r507"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://inmodemd.com/role/LeasesScheduleOfMaturitiesOfLeaseLiabilitiesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/LeasesScheduleOfMaturitiesOfLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2025",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r507"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "crdr": "credit",
     "presentation": [
      "http://inmodemd.com/role/LeasesScheduleOfMaturitiesOfLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less imputed interests",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "terseLabel": "Less imputed interests",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease."
       }
      }
     },
     "auth_ref": [
      "r507"
     ]
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseTermOfContract",
     "presentation": [
      "http://inmodemd.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Term of Contract",
        "verboseLabel": "Term of contract",
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r910"
     ]
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeasesTextBlock",
     "presentation": [
      "http://inmodemd.com/role/Leases"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "LEASES",
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r498"
     ]
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://inmodemd.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities",
        "totalLabel": "TOTAL LIABILITIES",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r222",
      "r318",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r468",
      "r471",
      "r472",
      "r488",
      "r642",
      "r745",
      "r781",
      "r865",
      "r917",
      "r918"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://inmodemd.com/role/ConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity",
        "totalLabel": "TOTAL LIABILITIES AND SHAREHOLDERS\u2019 EQUITY",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r114",
      "r160",
      "r581",
      "r768",
      "r824",
      "r852",
      "r907"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and shareholders' equity",
        "terseLabel": "Liabilities and shareholders\u2019 equity"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://inmodemd.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current",
        "totalLabel": "TOTAL CURRENT LIABILITIES",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r184",
      "r222",
      "r318",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r468",
      "r471",
      "r472",
      "r488",
      "r768",
      "r865",
      "r917",
      "r918"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CURRENT LIABILITIES:",
        "terseLabel": "CURRENT LIABILITIES:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://inmodemd.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Noncurrent",
        "totalLabel": "TOTAL NON-CURRENT LIABILITIES",
        "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r103",
      "r104",
      "r105",
      "r107",
      "r222",
      "r318",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r468",
      "r471",
      "r472",
      "r488",
      "r865",
      "r917",
      "r918"
     ]
    },
    "us-gaap_LiabilitiesNoncurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesNoncurrentAbstract",
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "NON-CURRENT LIABILITIES:",
        "terseLabel": "NON-CURRENT LIABILITIES:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
     "presentation": [
      "http://inmodemd.com/role/AccountsReceivable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ACCOUNTS RECEIVABLE",
        "documentation": "The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses."
       }
      }
     },
     "auth_ref": [
      "r832"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://inmodemd.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "inmd_MarketableSecuritiesAndFairValueMeasurementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "MarketableSecuritiesAndFairValueMeasurementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Marketable Securities and Fair Value Measurement [Abstract]",
        "terseLabel": "Marketable Securities And Fair Value Measurements Schedule Of Debt Securities On Maturity",
        "verboseLabel": "Marketable Securities And Fair Value Measurements"
       }
      }
     },
     "auth_ref": []
    },
    "inmd_MarketableSecuritiesAndFairValueMeasurements": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "MarketableSecuritiesAndFairValueMeasurements",
     "presentation": [
      "http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire dislosure for marketable securities and fair value measurements.",
        "label": "Marketable Securities And Fair Value Measurements",
        "verboseLabel": "MARKETABLE SECURITIES AND FAIR VALUE MEASUREMENTS"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MarketableSecuritiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MarketableSecuritiesCurrent",
     "crdr": "debit",
     "calculation": {
      "http://inmodemd.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedBalanceSheets",
      "http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsNarrativeDetails",
      "http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsScheduleOfMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "positiveLabel": "Marketable securities (amortized cost of $375,829 and $384,320, as of December 31, 2023 and 2022, respectively)",
        "label": "Marketable Securities, Current",
        "terseLabel": "Marketable securities",
        "verboseLabel": "Marketable securities (amortized cost of $384,320 and $296,243, as of December 31, 2022 and 2021, respectively)",
        "documentation": "Amount of investment in marketable security, classified as current."
       }
      }
     },
     "auth_ref": [
      "r814"
     ]
    },
    "us-gaap_MarketableSecuritiesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MarketableSecuritiesLineItems",
     "presentation": [
      "http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsNarrativeDetails",
      "http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsScheduleOfFinancialAssetsMeasuredAtFairValueDetails",
      "http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsScheduleOfMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Marketable Securities [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MarketableSecuritiesPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MarketableSecuritiesPolicy",
     "presentation": [
      "http://inmodemd.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Marketable securities",
        "documentation": "Disclosure of accounting policy for investment classified as marketable security."
       }
      }
     },
     "auth_ref": [
      "r99"
     ]
    },
    "us-gaap_MarketableSecuritiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MarketableSecuritiesTable",
     "presentation": [
      "http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsNarrativeDetails",
      "http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsScheduleOfFinancialAssetsMeasuredAtFairValueDetails",
      "http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsScheduleOfMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Marketable Securities [Table]",
        "documentation": "Disclosure of information about investment in marketable security."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MarketableSecuritiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MarketableSecuritiesTextBlock",
     "presentation": [
      "http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Marketable Securities",
        "documentation": "Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets."
       }
      }
     },
     "auth_ref": []
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MaximumMember",
     "presentation": [
      "http://inmodemd.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails",
      "http://inmodemd.com/role/SignificantAccountingPoliciesNarrativeDetails",
      "http://inmodemd.com/role/SignificantAccountingPoliciesScheduleOfPropertyAndEquipmentEstimatedUsefulLivesDetails",
      "http://inmodemd.com/role/TaxesOnIncomeNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "verboseLabel": "Maximum [Member]"
       }
      }
     },
     "auth_ref": [
      "r343",
      "r344",
      "r345",
      "r346",
      "r385",
      "r548",
      "r603",
      "r634",
      "r635",
      "r696",
      "r700",
      "r702",
      "r703",
      "r708",
      "r733",
      "r734",
      "r748",
      "r754",
      "r762",
      "r770",
      "r870",
      "r919",
      "r920",
      "r921",
      "r922",
      "r923",
      "r924"
     ]
    },
    "inmd_MedimorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "MedimorMember",
     "presentation": [
      "http://inmodemd.com/role/OtherInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medimor [Member]",
        "label": "Medimor [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "inmd_MinimalInvasiveMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "MinimalInvasiveMember",
     "presentation": [
      "http://inmodemd.com/role/Entity-wideDisclosureScheduleOfNetSalesByTechonologyDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimal-Invasive [Member]",
        "label": "Minimal-Invasive [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MinimumMember",
     "presentation": [
      "http://inmodemd.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails",
      "http://inmodemd.com/role/ShareholdersEquityNarrativeDetails",
      "http://inmodemd.com/role/SignificantAccountingPoliciesNarrativeDetails",
      "http://inmodemd.com/role/SignificantAccountingPoliciesScheduleOfPropertyAndEquipmentEstimatedUsefulLivesDetails",
      "http://inmodemd.com/role/TaxesOnIncomeNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "verboseLabel": "Minimum [Member]"
       }
      }
     },
     "auth_ref": [
      "r343",
      "r344",
      "r345",
      "r346",
      "r385",
      "r548",
      "r603",
      "r634",
      "r635",
      "r696",
      "r700",
      "r702",
      "r703",
      "r708",
      "r733",
      "r734",
      "r748",
      "r754",
      "r762",
      "r770",
      "r870",
      "r919",
      "r920",
      "r921",
      "r922",
      "r923",
      "r924"
     ]
    },
    "inmd_MinorityInterestDecreaseFromRedemptionsOne": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "MinorityInterestDecreaseFromRedemptionsOne",
     "crdr": "debit",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Waiver of redeemable non controlling interest.",
        "label": "Minority Interest Decrease From Redemptions One",
        "terseLabel": "Waiver of redeemable non controlling interest"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis",
     "presentation": [
      "http://inmodemd.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Real Estate, Type of Property [Axis]"
       }
      }
     },
     "auth_ref": [
      "r718",
      "r723",
      "r724",
      "r725",
      "r726",
      "r727",
      "r728",
      "r729",
      "r730",
      "r731"
     ]
    },
    "srt_MortgageLoansOnRealEstateNamePropertyTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MortgageLoansOnRealEstateNamePropertyTypeDomain",
     "presentation": [
      "http://inmodemd.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Real Estate [Domain]"
       }
      }
     },
     "auth_ref": [
      "r723",
      "r724",
      "r725",
      "r726",
      "r727",
      "r728",
      "r729",
      "r730",
      "r731"
     ]
    },
    "us-gaap_MunicipalBondsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MunicipalBondsMember",
     "presentation": [
      "http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsScheduleOfFinancialAssetsMeasuredAtFairValueDetails",
      "http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsScheduleOfMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Municipal bonds [Member]",
        "documentation": "Long-term debt securities issued by state, city or local governments or the agencies operated by state, city or local governments."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://inmodemd.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used in financing activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r218"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CASH FLOWS FROM FINANCING ACTIVITIES:",
        "terseLabel": "CASH FLOWS FROM FINANCING ACTIVITIES:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://inmodemd.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r218"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CASH FLOWS FROM INVESTING ACTIVITIES:",
        "terseLabel": "CASH FLOWS FROM INVESTING ACTIVITIES:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://inmodemd.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r130",
      "r131",
      "r132"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CASH FLOWS FROM OPERATING ACTIVITIES:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://inmodemd.com/role/ConsolidatedStatementsOfIncome": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss) Attributable to Parent",
        "totalLabel": "NET INCOME ATTRIBUTABLE TO INMODE LTD",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r121",
      "r132",
      "r162",
      "r182",
      "r201",
      "r204",
      "r209",
      "r222",
      "r229",
      "r231",
      "r232",
      "r233",
      "r234",
      "r237",
      "r238",
      "r243",
      "r253",
      "r266",
      "r271",
      "r274",
      "r318",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r486",
      "r488",
      "r588",
      "r665",
      "r685",
      "r686",
      "r746",
      "r779",
      "r865"
     ]
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "crdr": "debit",
     "calculation": {
      "http://inmodemd.com/role/ConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Add: Net income attributable to non-controlling interests",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r88",
      "r155",
      "r201",
      "r204",
      "r237",
      "r238",
      "r587",
      "r821"
     ]
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://inmodemd.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Newly issued and recently adopted accounting pronouncements",
        "verboseLabel": "Newly issued accounting pronouncements, not yet adopted",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "inmd_NoAmendmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "NoAmendmentMember",
     "presentation": [
      "http://inmodemd.com/role/TaxesOnIncomeNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "No Amendment [Member]",
        "label": "No Amendment [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "inmd_NonCashAcquisitionOfNoncontrollingInterestInExchangeOfOrdinaryShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "NonCashAcquisitionOfNoncontrollingInterestInExchangeOfOrdinaryShares",
     "crdr": "debit",
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of non cash Acquisition of noncontrolling interest in exchange of ordinary shares.",
        "label": "Non Cash Acquisition Of Noncontrolling Interest In Exchange Of Ordinary Shares",
        "verboseLabel": "Acquisition of non-controlling interest in exchange of ordinary shares"
       }
      }
     },
     "auth_ref": []
    },
    "inmd_NonInvasiveMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "NonInvasiveMember",
     "presentation": [
      "http://inmodemd.com/role/Entity-wideDisclosureScheduleOfNetSalesByTechonologyDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-Invasive [Member]",
        "label": "Non-Invasive [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "inmd_NonIsraeliPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "NonIsraeliPlanMember",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-Israeli [Member]",
        "label": "Non Israeli Plan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "inmd_NonUsGovernmentAgenciesDebtSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "NonUsGovernmentAgenciesDebtSecuritiesMember",
     "presentation": [
      "http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non US Government Securities [Member]",
        "label": "Non Us Government Agencies Debt Securities [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "NON-CASH ACTIVITIES"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NoncontrollingInterestMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NoncontrollingInterestMember",
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-controlling Interest [Member]",
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest."
       }
      }
     },
     "auth_ref": [
      "r83",
      "r372",
      "r827",
      "r828",
      "r829",
      "r937"
     ]
    },
    "us-gaap_NoncurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NoncurrentAssets",
     "crdr": "debit",
     "presentation": [
      "http://inmodemd.com/role/Entity-wideDisclosureScheduleOfLong-livedAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncurrent Assets",
        "terseLabel": "Total Long-Lived Assets",
        "documentation": "Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r279"
     ]
    },
    "us-gaap_NotesReceivableGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NotesReceivableGross",
     "crdr": "debit",
     "calculation": {
      "http://inmodemd.com/role/AccountsReceivableScheduleOfAccountsReceivableDetails": {
       "parentTag": "us-gaap_AccountsAndNotesReceivableNet",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/AccountsReceivableScheduleOfAccountsReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Notes receivable",
        "documentation": "Amortized cost, before allowance for credit loss, of financing receivable. Excludes financing receivable covered under loss sharing agreement and net investment in lease."
       }
      }
     },
     "auth_ref": [
      "r175",
      "r178",
      "r179",
      "r193",
      "r328",
      "r331",
      "r749",
      "r750",
      "r812",
      "r853"
     ]
    },
    "us-gaap_NumberOfOperatingSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NumberOfOperatingSegments",
     "presentation": [
      "http://inmodemd.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of Operating Segments",
        "verboseLabel": "Number of operating segment",
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues."
       }
      }
     },
     "auth_ref": [
      "r831"
     ]
    },
    "srt_OfficeBuildingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "OfficeBuildingMember",
     "presentation": [
      "http://inmodemd.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Office Building [Member]"
       }
      }
     },
     "auth_ref": [
      "r943",
      "r944"
     ]
    },
    "us-gaap_OfficeEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OfficeEquipmentMember",
     "presentation": [
      "http://inmodemd.com/role/PropertyAndEquipmentNetScheduleOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Office furniture and equipment [Member]",
        "documentation": "Tangible personal property used in an office setting. Examples include, but are not limited to, computers, copiers and fax machine."
       }
      }
     },
     "auth_ref": []
    },
    "inmd_OneTimePayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "OneTimePayment",
     "crdr": "credit",
     "presentation": [
      "http://inmodemd.com/role/TaxesOnIncomeNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "One-time payment.",
        "label": "One Time Payment",
        "terseLabel": "One-time payment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingExpenses",
     "crdr": "debit",
     "calculation": {
      "http://inmodemd.com/role/ConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses",
        "totalLabel": "TOTAL OPERATING EXPENSES",
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingExpensesAbstract",
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "OPERATING EXPENSES:",
        "verboseLabel": "OPERATING EXPENSES:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://inmodemd.com/role/ConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Income (Loss)",
        "totalLabel": "OPERATING INCOME",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r253",
      "r266",
      "r271",
      "r274",
      "r746"
     ]
    },
    "us-gaap_OperatingLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseCost",
     "crdr": "debit",
     "presentation": [
      "http://inmodemd.com/role/LeasesScheduleOfLeaseExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating lease cost",
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability."
       }
      }
     },
     "auth_ref": [
      "r503",
      "r767"
     ]
    },
    "us-gaap_OperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiability",
     "crdr": "credit",
     "calculation": {
      "http://inmodemd.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://inmodemd.com/role/LeasesScheduleOfMaturitiesOfLeaseLiabilitiesDetails",
      "http://inmodemd.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Liability",
        "terseLabel": "Total operating lease liabilities",
        "totalLabel": "Total operating lease liabilities",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease."
       }
      }
     },
     "auth_ref": [
      "r500"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://inmodemd.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails": {
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0,
       "order": 0.0
      },
      "http://inmodemd.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedBalanceSheets",
      "http://inmodemd.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating lease liabilities",
        "terseLabel": "Operating lease liabilities",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r500"
     ]
    },
    "us-gaap_OperatingLeasePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeasePayments",
     "crdr": "credit",
     "presentation": [
      "http://inmodemd.com/role/LeasesScheduleOfSupplementalCashFlowInformationRelatedToLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating cash flows from operating leases",
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use."
       }
      }
     },
     "auth_ref": [
      "r501",
      "r504"
     ]
    },
    "inmd_OperatingLeaseRightOfUseAssests": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "OperatingLeaseRightOfUseAssests",
     "crdr": "debit",
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating lease right-of-use assets.",
        "label": "Operating Lease Right Of Use Assests",
        "verboseLabel": "Recognition of operating lease right-of-use assets and liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://inmodemd.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedBalanceSheets",
      "http://inmodemd.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating lease right-of-use assets",
        "terseLabel": "Operating lease right-of-use assets",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r499"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "presentation": [
      "http://inmodemd.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Discount Rate Operating leases",
        "terseLabel": "Weighted Average Discount Rate, Operating leases",
        "documentation": "Weighted average discount rate for operating lease calculated at point in time."
       }
      }
     },
     "auth_ref": [
      "r506",
      "r767"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "presentation": [
      "http://inmodemd.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Remaining Lease Term Operating leases",
        "verboseLabel": "Weighted Average Remaining Lease Term, Operating leases",
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r505",
      "r767"
     ]
    },
    "us-gaap_OperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLossCarryforwards",
     "crdr": "debit",
     "presentation": [
      "http://inmodemd.com/role/TaxesOnIncomeNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated tax loss carryforward",
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "inmd_OptionsChangesDuringYear": {
     "xbrltype": "stringItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "OptionsChangesDuringYear",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityScheduleOfOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options Changes During Year",
        "terseLabel": "Changes during the year:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherAccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://inmodemd.com/role/OtherCurrentLiabilitiesScheduleOfOtherLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 60.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/OtherCurrentLiabilitiesScheduleOfOtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Accrued Liabilities, Current",
        "verboseLabel": "Other",
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r29"
     ]
    },
    "inmd_OtherAdvancesToSuppliersCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "OtherAdvancesToSuppliersCurrent",
     "crdr": "debit",
     "calculation": {
      "http://inmodemd.com/role/OtherCurrentReceivablesScheduleOfOtherCurrentReceivablesDetails": {
       "parentTag": "us-gaap_OtherReceivablesNetCurrent",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/OtherCurrentReceivablesScheduleOfOtherCurrentReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, advances to suppliers of receivables classified as other, due within one year or the operating cycle, if longer.",
        "label": "Other Advances To Suppliers Current",
        "terseLabel": "Advances to suppliers"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherAssetsNoncurrent",
     "crdr": "debit",
     "presentation": [
      "http://inmodemd.com/role/Entity-wideDisclosureScheduleOfLong-livedAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Assets, Noncurrent",
        "verboseLabel": "Other long-term assets",
        "documentation": "Amount of noncurrent assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r189"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent",
     "crdr": "credit",
     "calculation": {
      "http://inmodemd.com/role/ConsolidatedStatementsOfComprehensiveIncome": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, on foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r16",
      "r154"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other comprehensive income (loss), net",
        "terseLabel": "Other comprehensive income, net",
        "verboseLabel": "Other comprehensive loss, net",
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r24",
      "r202",
      "r205",
      "r211",
      "r490",
      "r491",
      "r496",
      "r566",
      "r589",
      "r819",
      "r820"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://inmodemd.com/role/ConsolidatedStatementsOfComprehensiveIncome": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in net unrealized gains (loss) of marketable securities, net of tax",
        "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale."
       }
      }
     },
     "auth_ref": [
      "r199",
      "r200",
      "r314"
     ]
    },
    "inmd_OtherCountryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "OtherCountryMember",
     "presentation": [
      "http://inmodemd.com/role/Entity-wideDisclosureScheduleOfLong-livedAssetsDetails",
      "http://inmodemd.com/role/Entity-wideDisclosureScheduleOfNetSalesByGeographicalAreaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other [Member]",
        "label": "Other Country [Member]",
        "verboseLabel": "Other [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "inmd_OtherCurrentLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "OtherCurrentLeaseLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://inmodemd.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails": {
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0,
       "order": 10.0
      },
      "http://inmodemd.com/role/OtherCurrentLiabilitiesScheduleOfOtherLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 40.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails",
      "http://inmodemd.com/role/OtherCurrentLiabilitiesScheduleOfOtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other lease liabilities classified as current.",
        "label": "Other Current Lease Liabilities",
        "terseLabel": "Other current liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "inmd_OtherCurrentLiabilitiesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "OtherCurrentLiabilitiesLineItems",
     "presentation": [
      "http://inmodemd.com/role/OtherCurrentLiabilitiesScheduleOfOtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Other Current Liabilities [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherCurrentLiabilitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherCurrentLiabilitiesMember",
     "presentation": [
      "http://inmodemd.com/role/OtherCurrentLiabilitiesScheduleOfOtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Current Liabilities [Member]",
        "documentation": "Primary financial statement caption encompassing other current liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "inmd_OtherCurrentLiabilitiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "OtherCurrentLiabilitiesTable",
     "presentation": [
      "http://inmodemd.com/role/OtherCurrentLiabilitiesScheduleOfOtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table of other current liabilities.",
        "label": "Other Current Liabilities [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherCurrentLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherCurrentLiabilitiesTableTextBlock",
     "presentation": [
      "http://inmodemd.com/role/OtherCurrentLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Other Current Liabilities",
        "documentation": "Tabular disclosure of other current liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "inmd_OtherGovernmentInstitutionsReceivablesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "OtherGovernmentInstitutionsReceivablesCurrent",
     "crdr": "debit",
     "calculation": {
      "http://inmodemd.com/role/OtherCurrentReceivablesScheduleOfOtherCurrentReceivablesDetails": {
       "parentTag": "us-gaap_OtherReceivablesNetCurrent",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/OtherCurrentReceivablesScheduleOfOtherCurrentReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, government institution of receivables classified as other, due within one year or the operating cycle, if longer.",
        "label": "Other Government Institutions Receivables Current",
        "terseLabel": "Government institutions"
       }
      }
     },
     "auth_ref": []
    },
    "inmd_OtherIncomeTaxReceivablesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "OtherIncomeTaxReceivablesCurrent",
     "crdr": "debit",
     "calculation": {
      "http://inmodemd.com/role/OtherCurrentReceivablesScheduleOfOtherCurrentReceivablesDetails": {
       "parentTag": "us-gaap_OtherReceivablesNetCurrent",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/OtherCurrentReceivablesScheduleOfOtherCurrentReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, income tax of receivables classified as other, due within one year or the operating cycle, if longer.",
        "label": "Other Income Tax Receivables Current",
        "terseLabel": "Income tax"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherInvestments",
     "crdr": "debit",
     "calculation": {
      "http://inmodemd.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 40.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Investments",
        "terseLabel": "Other investments",
        "documentation": "Amount of investments classified as other."
       }
      }
     },
     "auth_ref": [
      "r813"
     ]
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://inmodemd.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 20.0
      },
      "http://inmodemd.com/role/OtherCurrentLiabilitiesScheduleOfOtherLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedBalanceSheets",
      "http://inmodemd.com/role/OtherCurrentLiabilitiesScheduleOfOtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other liabilities",
        "terseLabel": "Other liabilities",
        "totalLabel": "Total other current liabilities",
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r29",
      "r768"
     ]
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherLiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://inmodemd.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Liabilities, Noncurrent",
        "verboseLabel": "Other liabilities",
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r31"
     ]
    },
    "inmd_OtherOperatingExpenseIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "OtherOperatingExpenseIncome",
     "crdr": "credit",
     "calculation": {
      "http://inmodemd.com/role/ConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": -1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other operating income.",
        "negatedLabel": "Other income",
        "label": "Other Operating Expense Income"
       }
      }
     },
     "auth_ref": []
    },
    "inmd_OtherPrepaidExpensesReceivablesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "OtherPrepaidExpensesReceivablesCurrent",
     "crdr": "debit",
     "calculation": {
      "http://inmodemd.com/role/OtherCurrentReceivablesScheduleOfOtherCurrentReceivablesDetails": {
       "parentTag": "us-gaap_OtherReceivablesNetCurrent",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/OtherCurrentReceivablesScheduleOfOtherCurrentReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, prepaid expenses of receivables classified as other, due within one year or the operating cycle, if longer.",
        "label": "Other Prepaid Expenses Receivables Current",
        "terseLabel": "Prepaid expenses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherReceivablesGrossCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherReceivablesGrossCurrent",
     "crdr": "debit",
     "calculation": {
      "http://inmodemd.com/role/OtherCurrentReceivablesScheduleOfOtherCurrentReceivablesDetails": {
       "parentTag": "us-gaap_OtherReceivablesNetCurrent",
       "weight": 1.0,
       "order": 40.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/OtherCurrentReceivablesScheduleOfOtherCurrentReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other",
        "terseLabel": "Other",
        "documentation": "Amount, before allowance, of receivables classified as other, due within one year or the operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r192"
     ]
    },
    "us-gaap_OtherReceivablesNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherReceivablesNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://inmodemd.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 40.0
      },
      "http://inmodemd.com/role/OtherCurrentReceivablesScheduleOfOtherCurrentReceivablesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedBalanceSheets",
      "http://inmodemd.com/role/OtherCurrentReceivablesScheduleOfOtherCurrentReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other receivables",
        "terseLabel": "Prepaid expense and other receivables",
        "totalLabel": "Total other current receivables",
        "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherReceivablesNetCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherReceivablesNetCurrentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Receivables, Net, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://inmodemd.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r789"
     ]
    },
    "inmd_OwnershipInterestExchange": {
     "xbrltype": "percentItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "OwnershipInterestExchange",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ownership interest exchange for voting interest acquired.",
        "label": "Ownership interest exchange"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PayablesAndAccrualsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables and Accruals [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsForAdvanceToAffiliate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsForAdvanceToAffiliate",
     "crdr": "credit",
     "presentation": [
      "http://inmodemd.com/role/CommitmentsAndContingentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments for Advance to Affiliate",
        "terseLabel": "Subcontractors advances",
        "documentation": "The cash outflow from advancing money to an affiliate (an entity that is related but not strictly controlled by the entity)."
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "crdr": "credit",
     "calculation": {
      "http://inmodemd.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other investments",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other."
       }
      }
     },
     "auth_ref": [
      "r799",
      "r822"
     ]
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "crdr": "credit",
     "calculation": {
      "http://inmodemd.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Repurchase of ordinary shares",
        "label": "Payments for Repurchase of Common Stock",
        "documentation": "The cash outflow to reacquire common stock during the period."
       }
      }
     },
     "auth_ref": [
      "r42"
     ]
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsOfStockIssuanceCosts",
     "crdr": "credit",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "IPO expenses",
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security."
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquireBusinessesGross",
     "crdr": "credit",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payment to purchase licence",
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price."
       }
      }
     },
     "auth_ref": [
      "r40",
      "r464"
     ]
    },
    "us-gaap_PaymentsToAcquireMarketableSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquireMarketableSecurities",
     "crdr": "credit",
     "calculation": {
      "http://inmodemd.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 40.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchase of marketable securities",
        "label": "Payments to Acquire Marketable Securities",
        "documentation": "Amount of cash outflow for purchase of marketable security."
       }
      }
     },
     "auth_ref": [
      "r836"
     ]
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://inmodemd.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchase of fixed assets",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "inmd_PaymentsToTaxAuthorities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "PaymentsToTaxAuthorities",
     "crdr": "credit",
     "presentation": [
      "http://inmodemd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments to tax authorities for Amendment to the Investments Law and settlements.",
        "label": "Payments To Tax Authorities",
        "terseLabel": "Payments to tax authorities for Amendment to Investments Law and settlements"
       }
      }
     },
     "auth_ref": []
    },
    "inmd_PercentageOfNetSalesBasedOnProductsTechnology": {
     "xbrltype": "percentItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "PercentageOfNetSalesBasedOnProductsTechnology",
     "presentation": [
      "http://inmodemd.com/role/Entity-wideDisclosureScheduleOfNetSalesByTechonologyDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of net sales based on products technology.",
        "label": "Percentage of net sales based on products technology"
       }
      }
     },
     "auth_ref": []
    },
    "inmd_PercentageOfNonCurrentDeferredRevenue": {
     "xbrltype": "percentItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "PercentageOfNonCurrentDeferredRevenue",
     "presentation": [
      "http://inmodemd.com/role/Entity-wideDisclosureNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of non- current deferred revenue.",
        "label": "Percentage of non- current deferred revenue"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PlanNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PlanNameAxis",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Plan Name [Axis]",
        "documentation": "Information by plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r874",
      "r875",
      "r876",
      "r877",
      "r878",
      "r879",
      "r880",
      "r881",
      "r882",
      "r883",
      "r884",
      "r885",
      "r886",
      "r887",
      "r888",
      "r889",
      "r890",
      "r891",
      "r892",
      "r893",
      "r894",
      "r895",
      "r896",
      "r897",
      "r898",
      "r899"
     ]
    },
    "us-gaap_PlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PlanNameDomain",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r874",
      "r875",
      "r876",
      "r877",
      "r878",
      "r879",
      "r880",
      "r881",
      "r882",
      "r883",
      "r884",
      "r885",
      "r886",
      "r887",
      "r888",
      "r889",
      "r890",
      "r891",
      "r892",
      "r893",
      "r894",
      "r895",
      "r896",
      "r897",
      "r898",
      "r899"
     ]
    },
    "inmd_PrepaidExpensesAndOtherCurrentReceivablesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "PrepaidExpensesAndOtherCurrentReceivablesTextBlock",
     "presentation": [
      "http://inmodemd.com/role/OtherCurrentReceivables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for prepaid expenses and other current receivables.",
        "label": "Prepaid Expenses And Other Current Receivables [Text Block]",
        "terseLabel": "PREPAID EXPENSES AND OTHER CURRENT RECIVABLES"
       }
      }
     },
     "auth_ref": []
    },
    "inmd_ProceedsFromInvestmentInShortTermDeposit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "ProceedsFromInvestmentInShortTermDeposit",
     "crdr": "debit",
     "calculation": {
      "http://inmodemd.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from short-term deposit.",
        "label": "Proceeds From Investment In Short Term Deposit",
        "terseLabel": "Proceeds from short-term deposits"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromIssuanceInitialPublicOffering": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromIssuanceInitialPublicOffering",
     "crdr": "debit",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from initial public offering of ordinary shares, net of offering costs",
        "verboseLabel": "Proceeds from initial public offering",
        "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "inmd_ProceedsFromMaturityOfMarketableSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "ProceedsFromMaturityOfMarketableSecurities",
     "crdr": "debit",
     "calculation": {
      "http://inmodemd.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 60.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represent the amount of Proceeds from maturity of marketable securities",
        "label": "Proceeds From Maturity Of Marketable Securities",
        "terseLabel": "Proceeds from maturity of marketable securities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromSaleAndMaturityOfMarketableSecurities",
     "crdr": "debit",
     "calculation": {
      "http://inmodemd.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 50.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from sale of marketable securities",
        "terseLabel": "Proceeds from sale of marketable securities",
        "documentation": "The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromStockOptionsExercised",
     "crdr": "debit",
     "calculation": {
      "http://inmodemd.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from Stock Options Exercised",
        "verboseLabel": "Exercise of options",
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r21"
     ]
    },
    "srt_ProductOrServiceAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ProductOrServiceAxis",
     "presentation": [
      "http://inmodemd.com/role/ENTITYWIDEDISCLOSUREDisclosureOfRevenuesBasedOnProductsCategory"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]"
       }
      }
     },
     "auth_ref": [
      "r276",
      "r551",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r736",
      "r755",
      "r769",
      "r801",
      "r857",
      "r858",
      "r872",
      "r934"
     ]
    },
    "srt_ProductsAndServicesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ProductsAndServicesDomain",
     "presentation": [
      "http://inmodemd.com/role/ENTITYWIDEDISCLOSUREDisclosureOfRevenuesBasedOnProductsCategory"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]"
       }
      }
     },
     "auth_ref": [
      "r276",
      "r551",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r736",
      "r755",
      "r769",
      "r801",
      "r857",
      "r858",
      "r872",
      "r934"
     ]
    },
    "us-gaap_ProfitLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProfitLoss",
     "crdr": "credit",
     "calculation": {
      "http://inmodemd.com/role/ConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 0.0
      },
      "http://inmodemd.com/role/ConsolidatedStatementsOfComprehensiveIncome": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 0.0
      },
      "http://inmodemd.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfCashFlows",
      "http://inmodemd.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity",
      "http://inmodemd.com/role/ConsolidatedStatementsOfComprehensiveIncome",
      "http://inmodemd.com/role/ConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "NET INCOME",
        "terseLabel": "Net income",
        "totalLabel": "NET INCOME",
        "verboseLabel": "NET INCOME",
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r182",
      "r201",
      "r204",
      "r217",
      "r222",
      "r229",
      "r237",
      "r238",
      "r253",
      "r266",
      "r271",
      "r274",
      "r318",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r466",
      "r469",
      "r470",
      "r486",
      "r488",
      "r571",
      "r586",
      "r623",
      "r665",
      "r685",
      "r686",
      "r746",
      "r765",
      "r766",
      "r780",
      "r821",
      "r865"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "presentation": [
      "http://inmodemd.com/role/LeasesNarrativeDetails",
      "http://inmodemd.com/role/PropertyAndEquipmentNetScheduleOfPropertyAndEquipmentDetails",
      "http://inmodemd.com/role/SignificantAccountingPoliciesScheduleOfPropertyAndEquipmentEstimatedUsefulLivesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Lived Tangible Asset [Axis]",
        "verboseLabel": "Long-Lived Tangible Asset [Axis]",
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "presentation": [
      "http://inmodemd.com/role/PropertyAndEquipmentNet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PROPERTY AND EQUIPMENT, NET",
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r136",
      "r170",
      "r173",
      "r174"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentGross",
     "crdr": "debit",
     "calculation": {
      "http://inmodemd.com/role/PropertyAndEquipmentNetScheduleOfPropertyAndEquipmentDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/PropertyAndEquipmentNetScheduleOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property plant and equipment gross",
        "terseLabel": "Property, plant and equipment, gross",
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r137",
      "r187",
      "r584"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentLineItems",
     "presentation": [
      "http://inmodemd.com/role/PropertyAndEquipmentNetScheduleOfPropertyAndEquipmentDetails",
      "http://inmodemd.com/role/SignificantAccountingPoliciesScheduleOfPropertyAndEquipmentEstimatedUsefulLivesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "calculation": {
      "http://inmodemd.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 20.0
      },
      "http://inmodemd.com/role/PropertyAndEquipmentNetScheduleOfPropertyAndEquipmentDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedBalanceSheets",
      "http://inmodemd.com/role/PropertyAndEquipmentNetScheduleOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property and equipment, net",
        "terseLabel": "Property and equipment, net",
        "totalLabel": "Total property and equipment, net",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r573",
      "r584",
      "r768"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "presentation": [
      "http://inmodemd.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property and equipment",
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r170",
      "r173",
      "r582"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "presentation": [
      "http://inmodemd.com/role/PropertyAndEquipmentNetTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Property and Equipment",
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "presentation": [
      "http://inmodemd.com/role/LeasesNarrativeDetails",
      "http://inmodemd.com/role/PropertyAndEquipmentNetScheduleOfPropertyAndEquipmentDetails",
      "http://inmodemd.com/role/SignificantAccountingPoliciesScheduleOfPropertyAndEquipmentEstimatedUsefulLivesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Lived Tangible Asset [Domain]",
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "auth_ref": [
      "r137"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "presentation": [
      "http://inmodemd.com/role/SignificantAccountingPoliciesScheduleOfPropertyAndEquipmentEstimatedUsefulLivesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment, Useful Life",
        "verboseLabel": "Estimated useful lives",
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProvisionForDoubtfulAccounts",
     "crdr": "debit",
     "calculation": {
      "http://inmodemd.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfCashFlows",
      "http://inmodemd.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleOfAllowanceForCreditLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "terseLabel": "Change in allowance for credit losses of trade receivable",
        "verboseLabel": "Current-period provision",
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r216",
      "r325"
     ]
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RangeAxis",
     "presentation": [
      "http://inmodemd.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails",
      "http://inmodemd.com/role/ShareholdersEquityNarrativeDetails",
      "http://inmodemd.com/role/SignificantAccountingPoliciesNarrativeDetails",
      "http://inmodemd.com/role/SignificantAccountingPoliciesScheduleOfPropertyAndEquipmentEstimatedUsefulLivesDetails",
      "http://inmodemd.com/role/TaxesOnIncomeNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r343",
      "r344",
      "r345",
      "r346",
      "r377",
      "r385",
      "r416",
      "r417",
      "r418",
      "r524",
      "r548",
      "r603",
      "r634",
      "r635",
      "r696",
      "r700",
      "r702",
      "r703",
      "r708",
      "r733",
      "r734",
      "r748",
      "r754",
      "r762",
      "r770",
      "r773",
      "r855",
      "r870",
      "r920",
      "r921",
      "r922",
      "r923",
      "r924"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RangeMember",
     "presentation": [
      "http://inmodemd.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails",
      "http://inmodemd.com/role/ShareholdersEquityNarrativeDetails",
      "http://inmodemd.com/role/SignificantAccountingPoliciesNarrativeDetails",
      "http://inmodemd.com/role/SignificantAccountingPoliciesScheduleOfPropertyAndEquipmentEstimatedUsefulLivesDetails",
      "http://inmodemd.com/role/TaxesOnIncomeNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]"
       }
      }
     },
     "auth_ref": [
      "r343",
      "r344",
      "r345",
      "r346",
      "r377",
      "r385",
      "r416",
      "r417",
      "r418",
      "r524",
      "r548",
      "r603",
      "r634",
      "r635",
      "r696",
      "r700",
      "r702",
      "r703",
      "r708",
      "r733",
      "r734",
      "r748",
      "r754",
      "r762",
      "r770",
      "r773",
      "r855",
      "r870",
      "r920",
      "r921",
      "r922",
      "r923",
      "r924"
     ]
    },
    "us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy",
     "presentation": [
      "http://inmodemd.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Allowance for doubtful accounts and financial instruments - credit loss",
        "documentation": "Disclosure of accounting policy for determining the allowance for doubtful accounts for trade and other accounts receivable balances, and when impairments, charge-offs or recoveries are recognized."
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ReconciliationOfRevenueFromSegmentsToConsolidatedTable",
     "presentation": [
      "http://inmodemd.com/role/Entity-wideDisclosureNarrativeDetails",
      "http://inmodemd.com/role/Entity-wideDisclosureScheduleOfNetSalesByGeographicalAreaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reconciliation of Revenue from Segments to Consolidated [Table]",
        "documentation": "Identification, description, and amounts of all significant reconciling items in the reconciliation of total revenues from reportable segments to the entity's consolidated revenues."
       }
      }
     },
     "auth_ref": [
      "r58",
      "r59"
     ]
    },
    "inmd_RegulationsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "RegulationsMember",
     "presentation": [
      "http://inmodemd.com/role/TaxesOnIncomeNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Regulations [Member]",
        "label": "Regulations [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "inmd_RelatedPartyConsiderationForAggregateAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "RelatedPartyConsiderationForAggregateAmount",
     "crdr": "credit",
     "presentation": [
      "http://inmodemd.com/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents related party consideration for aggregate amount.",
        "label": "Related Party Consideration For Aggregate Amount",
        "verboseLabel": "Related party consideration for aggregate amount"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyDomain",
     "presentation": [
      "http://inmodemd.com/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests."
       }
      }
     },
     "auth_ref": [
      "r384",
      "r513",
      "r514",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r662",
      "r664",
      "r694"
     ]
    },
    "us-gaap_RelatedPartyTransactionAmountsOfTransaction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionAmountsOfTransaction",
     "crdr": "debit",
     "presentation": [
      "http://inmodemd.com/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payment for services received",
        "documentation": "Amount of transactions with related party during the financial reporting period."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r513"
     ]
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionLineItems",
     "presentation": [
      "http://inmodemd.com/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transaction [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r668",
      "r669",
      "r672"
     ]
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "presentation": [
      "http://inmodemd.com/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party [Axis]",
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests."
       }
      }
     },
     "auth_ref": [
      "r384",
      "r513",
      "r514",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r662",
      "r664",
      "r694",
      "r916"
     ]
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "presentation": [
      "http://inmodemd.com/role/RelatedParties"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "RELATED PARTIES",
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
       }
      }
     },
     "auth_ref": [
      "r510",
      "r511",
      "r512",
      "r514",
      "r515",
      "r619",
      "r620",
      "r621",
      "r670",
      "r671",
      "r672",
      "r691",
      "r693"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://inmodemd.com/role/ConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and development",
        "terseLabel": "Research and development",
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use."
       }
      }
     },
     "auth_ref": [
      "r101",
      "r432",
      "r925"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ResearchAndDevelopmentExpenseMember",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityScheduleOfShareBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and Development Expenses [Member]",
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "presentation": [
      "http://inmodemd.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and development costs",
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process."
       }
      }
     },
     "auth_ref": [
      "r431"
     ]
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestrictedStockUnitsRSUMember",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityNarrativeDetails",
      "http://inmodemd.com/role/ShareholdersEquityScheduleOfOptionsGrantedRestictedShareUnitDetails",
      "http://inmodemd.com/role/ShareholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted Stock Units (RSUs) [Member]",
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://inmodemd.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retained earnings",
        "verboseLabel": "Retained earnings",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r111",
      "r142",
      "r580",
      "r607",
      "r609",
      "r617",
      "r645",
      "r768"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retained earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r180",
      "r225",
      "r226",
      "r227",
      "r230",
      "r236",
      "r238",
      "r319",
      "r320",
      "r422",
      "r423",
      "r424",
      "r453",
      "r454",
      "r473",
      "r475",
      "r476",
      "r479",
      "r484",
      "r604",
      "r606",
      "r624",
      "r937"
     ]
    },
    "us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
     "presentation": [
      "http://inmodemd.com/role/Entity-wideDisclosureTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Net Sales by Geographic Area",
        "documentation": "Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue."
       }
      }
     },
     "auth_ref": [
      "r23"
     ]
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueRecognitionPolicyTextBlock",
     "presentation": [
      "http://inmodemd.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue recognition",
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources."
       }
      }
     },
     "auth_ref": [
      "r666",
      "r735",
      "r742"
     ]
    },
    "us-gaap_Revenues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Revenues",
     "crdr": "credit",
     "calculation": {
      "http://inmodemd.com/role/ConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfIncome",
      "http://inmodemd.com/role/ENTITYWIDEDISCLOSUREDisclosureOfRevenuesBasedOnProductsCategory",
      "http://inmodemd.com/role/Entity-wideDisclosureScheduleOfNetSalesByGeographicalAreaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues",
        "verboseLabel": "REVENUES",
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)."
       }
      }
     },
     "auth_ref": [
      "r210",
      "r222",
      "r254",
      "r255",
      "r265",
      "r269",
      "r270",
      "r276",
      "r278",
      "r280",
      "r318",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r488",
      "r571",
      "r865"
     ]
    },
    "us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenuesFromExternalCustomersAndLongLivedAssetsLineItems",
     "presentation": [
      "http://inmodemd.com/role/Entity-wideDisclosureScheduleOfLong-livedAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues from External Customers and Long-Lived Assets [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SaleOfStockNameOfTransactionDomain",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement."
       }
      }
     },
     "auth_ref": []
    },
    "srt_ScenarioForecastMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ScenarioForecastMember",
     "presentation": [
      "http://inmodemd.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forecast [Member]"
       }
      }
     },
     "auth_ref": [
      "r386",
      "r830"
     ]
    },
    "srt_ScenarioUnspecifiedDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ScenarioUnspecifiedDomain",
     "presentation": [
      "http://inmodemd.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "auth_ref": [
      "r239",
      "r386",
      "r797",
      "r830"
     ]
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
     "presentation": [
      "http://inmodemd.com/role/AccountsReceivableTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Accounts Receivable",
        "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables."
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "presentation": [
      "http://inmodemd.com/role/TaxesOnIncomeTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Tax Expenses (Tax Benefit)",
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years."
       }
      }
     },
     "auth_ref": [
      "r148"
     ]
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "presentation": [
      "http://inmodemd.com/role/TaxesOnIncomeTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Deferred Tax Assets (liabilities)",
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "presentation": [
      "http://inmodemd.com/role/TaxesOnIncomeTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Reconciliation of Theoretical Provision For Income Tax",
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r146"
     ]
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Share Based Compensation Expense",
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement."
       }
      }
     },
     "auth_ref": [
      "r74"
     ]
    },
    "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
     "presentation": [
      "http://inmodemd.com/role/Entity-wideDisclosureTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from External Customers by Products and Services [Table Text Block]",
        "terseLabel": "Revenue from External Customers by Products and Services",
        "verboseLabel": "Schedule of revenues based on products' category",
        "documentation": "Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information."
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "presentation": [
      "http://inmodemd.com/role/OtherInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Axis]"
       }
      }
     },
     "auth_ref": [
      "r315",
      "r316",
      "r317"
     ]
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "presentation": [
      "http://inmodemd.com/role/TaxesOnIncomeTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Income Before Income Taxes",
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions."
       }
      }
     },
     "auth_ref": [
      "r825"
     ]
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "presentation": [
      "http://inmodemd.com/role/InventoriesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Inventories",
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r115",
      "r116",
      "r117"
     ]
    },
    "us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems",
     "presentation": [
      "http://inmodemd.com/role/OtherInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Investment Income [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r590"
     ]
    },
    "us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable",
     "presentation": [
      "http://inmodemd.com/role/OtherInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Income [Table]",
        "documentation": "Disclosure of information about investment income, including, but not limited to, interest and dividend income and amortization of discount (premium) derived from debt and equity securities. Excludes realized and unrealized gain (loss) on investments."
       }
      }
     },
     "auth_ref": [
      "r126",
      "r128",
      "r590"
     ]
    },
    "inmd_ScheduleOfPrepaidExpensesAndOtherCurrentRecivablesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "ScheduleOfPrepaidExpensesAndOtherCurrentRecivablesTableTextBlock",
     "presentation": [
      "http://inmodemd.com/role/OtherCurrentReceivablesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of prepaid expenses and other current receivables.",
        "label": "Schedule Of Prepaid Expenses And Other Current Recivables [Table Text Block]",
        "terseLabel": "Schedule of prepaid expenses and other current receivables",
        "verboseLabel": "Schedule Of Prepaid Expenses And Other Current Receivables"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfProductWarrantyLiabilityTableTextBlock",
     "presentation": [
      "http://inmodemd.com/role/SignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Accrued Warranty",
        "documentation": "Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability."
       }
      }
     },
     "auth_ref": [
      "r347"
     ]
    },
    "inmd_ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock",
     "presentation": [
      "http://inmodemd.com/role/SignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of property and equipment estimated useful lives.",
        "label": "Schedule Of Property And Equipment Estimated Useful Lives [Table Text Block]",
        "terseLabel": "Schedule of Property and Equipment Estimated Useful Lives"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "presentation": [
      "http://inmodemd.com/role/PropertyAndEquipmentNetScheduleOfPropertyAndEquipmentDetails",
      "http://inmodemd.com/role/SignificantAccountingPoliciesScheduleOfPropertyAndEquipmentEstimatedUsefulLivesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Table]",
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "presentation": [
      "http://inmodemd.com/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Related Party Transactions, by Related Party [Table]",
        "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
       }
      }
     },
     "auth_ref": [
      "r95",
      "r96",
      "r668",
      "r669",
      "r672"
     ]
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable",
     "presentation": [
      "http://inmodemd.com/role/Entity-wideDisclosureScheduleOfLong-livedAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]",
        "documentation": "Schedule of material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries."
       }
      }
     },
     "auth_ref": [
      "r61",
      "r119"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "presentation": [
      "http://inmodemd.com/role/ENTITYWIDEDISCLOSUREDisclosureOfRevenuesBasedOnProductsCategory"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r56",
      "r57",
      "r63"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityNarrativeDetails",
      "http://inmodemd.com/role/ShareholdersEquityScheduleOfOptionsGrantedDetails",
      "http://inmodemd.com/role/ShareholdersEquityScheduleOfOptionsGrantedRestictedShareUnitDetails",
      "http://inmodemd.com/role/ShareholdersEquityScheduleOfOutstandingAndExercisableOptionsDetails",
      "http://inmodemd.com/role/ShareholdersEquityScheduleOfShareBasedCompensationExpenseDetails",
      "http://inmodemd.com/role/ShareholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "documentation": "Disclosure of information about share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r388",
      "r390",
      "r391",
      "r392",
      "r393",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Outstanding and Exercisable Options",
        "documentation": "Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms."
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Options Granted",
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r20",
      "r69"
     ]
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Assumptions Used to Calculate Fair Value of Options Granted",
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions."
       }
      }
     },
     "auth_ref": [
      "r145"
     ]
    },
    "inmd_ScheduleOfSupplementalBalanceSheetInformationRelatedToLeases": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "ScheduleOfSupplementalBalanceSheetInformationRelatedToLeases",
     "presentation": [
      "http://inmodemd.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of supplemental balance sheet information related to leases.",
        "label": "Schedule of Supplemental Balance Sheet Information Related to Leases"
       }
      }
     },
     "auth_ref": []
    },
    "inmd_ScheduleOfSupplementalCashFlowInformationRelatedToLeases": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "ScheduleOfSupplementalCashFlowInformationRelatedToLeases",
     "presentation": [
      "http://inmodemd.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of supplemental cash flow information related to leases.",
        "label": "Schedule of Supplemental Cash Flow Information Related to Leases"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
     "presentation": [
      "http://inmodemd.com/role/TaxesOnIncomeTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Unrecognized Tax Benefits",
        "documentation": "Tabular disclosure of the change in unrecognized tax benefits."
       }
      }
     },
     "auth_ref": [
      "r764",
      "r902"
     ]
    },
    "us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
     "presentation": [
      "http://inmodemd.com/role/Entity-wideDisclosureTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Net Sales by Technology",
        "documentation": "Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark."
       }
      }
     },
     "auth_ref": [
      "r48",
      "r49",
      "r50",
      "r51",
      "r93",
      "r157"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://inmodemd.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r783"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12gTitle",
     "presentation": [
      "http://inmodemd.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12g Title",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r786"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://inmodemd.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name of Exchange on which Security is Registered",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r785"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://inmodemd.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r787"
     ]
    },
    "srt_SegmentGeographicalDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "SegmentGeographicalDomain",
     "presentation": [
      "http://inmodemd.com/role/Entity-wideDisclosureScheduleOfLong-livedAssetsDetails",
      "http://inmodemd.com/role/Entity-wideDisclosureScheduleOfNetSalesByGeographicalAreaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]"
       }
      }
     },
     "auth_ref": [
      "r278",
      "r279",
      "r627",
      "r630",
      "r632",
      "r697",
      "r701",
      "r705",
      "r709",
      "r723",
      "r724",
      "r725",
      "r726",
      "r727",
      "r728",
      "r729",
      "r730",
      "r731",
      "r737",
      "r756",
      "r773",
      "r872",
      "r934"
     ]
    },
    "us-gaap_SegmentReportingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SegmentReportingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SegmentReportingDisclosureTextBlock",
     "presentation": [
      "http://inmodemd.com/role/Entity-wideDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ENTITY-WIDE DISCLOSURE",
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments."
       }
      }
     },
     "auth_ref": [
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r258",
      "r268",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r280"
     ]
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SegmentReportingInformationLineItems",
     "presentation": [
      "http://inmodemd.com/role/ENTITYWIDEDISCLOSUREDisclosureOfRevenuesBasedOnProductsCategory"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "presentation": [
      "http://inmodemd.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segments",
        "documentation": "Disclosure of accounting policy for segment reporting."
       }
      }
     },
     "auth_ref": [
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r278",
      "r747"
     ]
    },
    "us-gaap_SegmentReportingRevenueReconcilingItemLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SegmentReportingRevenueReconcilingItemLineItems",
     "presentation": [
      "http://inmodemd.com/role/Entity-wideDisclosureNarrativeDetails",
      "http://inmodemd.com/role/Entity-wideDisclosureScheduleOfNetSalesByGeographicalAreaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting, Revenue Reconciling Item [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SellingAndMarketingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SellingAndMarketingExpense",
     "crdr": "debit",
     "calculation": {
      "http://inmodemd.com/role/ConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sales and marketing",
        "terseLabel": "Sales and marketing",
        "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SellingAndMarketingExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SellingAndMarketingExpenseMember",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityScheduleOfShareBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Selling and Marketing Expenses [Member]",
        "documentation": "Primary financial statement caption encompassing selling and marketing expense."
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "us-gaap_SeveranceCosts1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SeveranceCosts1",
     "crdr": "debit",
     "presentation": [
      "http://inmodemd.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amounts of severance payment expenses",
        "documentation": "Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://inmodemd.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based compensation",
        "terseLabel": "Share-based compensation expenses",
        "verboseLabel": "Share-based compensation",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityScheduleOfOptionsGrantedRestictedShareUnitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Forfeited",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r408"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityScheduleOfOptionsGrantedRestictedShareUnitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "verboseLabel": "Forfeited",
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event."
       }
      }
     },
     "auth_ref": [
      "r408"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityScheduleOfOptionsGrantedRestictedShareUnitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "verboseLabel": "Granted",
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r406"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair value of RSU granted, per share",
        "terseLabel": "Fair value of RSU granted, per share",
        "documentation": "Per share or unit weighted-average intrinsic value of award granted under share-based payment arrangement. Excludes share and unit options."
       }
      }
     },
     "auth_ref": [
      "r406"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityScheduleOfOptionsGrantedRestictedShareUnitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "verboseLabel": "Granted",
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r406"
     ]
    },
    "inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonVestedVested": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonVestedVested",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of restricted stock units vested at the end of the year.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Non Vested Vested",
        "terseLabel": "Number of RSUs vested"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityScheduleOfOptionsGrantedRestictedShareUnitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Outstanding at end of year",
        "periodStartLabel": "Outstanding at beginning of year",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "terseLabel": "Unvested RSUs",
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r403",
      "r404"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityScheduleOfOptionsGrantedRestictedShareUnitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Outstanding at end of year",
        "periodStartLabel": "Outstanding at beginning of year",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options."
       }
      }
     },
     "auth_ref": [
      "r403",
      "r404"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityScheduleOfOptionsGrantedRestictedShareUnitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Grant Date Fair Value"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityScheduleOfOptionsGrantedRestictedShareUnitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Vested",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r407"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
     "crdr": "debit",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value",
        "terseLabel": "Fair value of RSUs granted",
        "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash."
       }
      }
     },
     "auth_ref": [
      "r410"
     ]
    },
    "inmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityScheduleOfOptionsGrantedRestictedShareUnitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were vested.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award, Equity Instruments Other Than Options, Vested, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityNarrativeDetails",
      "http://inmodemd.com/role/ShareholdersEquityScheduleOfOptionsGrantedDetails",
      "http://inmodemd.com/role/ShareholdersEquityScheduleOfOptionsGrantedRestictedShareUnitDetails",
      "http://inmodemd.com/role/ShareholdersEquityScheduleOfOutstandingAndExercisableOptionsDetails",
      "http://inmodemd.com/role/ShareholdersEquityScheduleOfShareBasedCompensationExpenseDetails",
      "http://inmodemd.com/role/ShareholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r388",
      "r390",
      "r391",
      "r392",
      "r393",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityScheduleOfOptionsGrantedRestictedShareUnitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of RSUs",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized",
        "totalLabel": "Total",
        "verboseLabel": "Number of shares authorized to be issued as ordinary shares",
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r763"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of options available for grant",
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable."
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityScheduleOfOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercisable at end of year",
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan."
       }
      }
     },
     "auth_ref": [
      "r397"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityScheduleOfOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "verboseLabel": "Exercisable at end of year",
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r397"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total intrinsic value of options exercised",
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares."
       }
      }
     },
     "auth_ref": [
      "r410"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityScheduleOfOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Expired",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period",
        "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements."
       }
      }
     },
     "auth_ref": [
      "r402"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityScheduleOfOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Forfeited",
        "label": "Stock options cancelled",
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r401"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityScheduleOfOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock options granted",
        "verboseLabel": "Granted",
        "documentation": "Net number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r881"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityScheduleOfOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Outstanding at end of year",
        "periodStartLabel": "Outstanding at beginning of year",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "documentation": "Number of options outstanding, including both vested and non-vested options."
       }
      }
     },
     "auth_ref": [
      "r395",
      "r396"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityScheduleOfOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of options",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityScheduleOfOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Outstanding at end of year",
        "periodStartLabel": "Outstanding at beginning of year",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r395",
      "r396"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityScheduleOfOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average exercise price"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate intrinsic value",
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r411"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityNarrativeDetails",
      "http://inmodemd.com/role/ShareholdersEquityScheduleOfOptionsGrantedRestictedShareUnitDetails",
      "http://inmodemd.com/role/ShareholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r391",
      "r392",
      "r393",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityScheduleOfOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercised",
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares."
       }
      }
     },
     "auth_ref": [
      "r400"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityScheduleOfOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expired",
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired."
       }
      }
     },
     "auth_ref": [
      "r402"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityScheduleOfOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forfeited",
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated."
       }
      }
     },
     "auth_ref": [
      "r401"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityScheduleOfOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Granted",
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options."
       }
      }
     },
     "auth_ref": [
      "r399"
     ]
    },
    "inmd_ShareBasedCompensationAwardTrancheFourMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "ShareBasedCompensationAwardTrancheFourMember",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Third portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.",
        "label": "Share Based Compensation Award Tranche Four [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationAwardTrancheOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationAwardTrancheOneMember",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement, Tranche One [Member]",
        "documentation": "First portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationAwardTrancheThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationAwardTrancheThreeMember",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement, Tranche Three [Member]",
        "documentation": "Third portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationAwardTrancheTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationAwardTrancheTwoMember",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement, Tranche Two [Member]",
        "documentation": "Second portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "presentation": [
      "http://inmodemd.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement [Policy Text Block]",
        "verboseLabel": "Share-based compensation",
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost."
       }
      }
     },
     "auth_ref": [
      "r387",
      "r394",
      "r413",
      "r414",
      "r415",
      "r416",
      "r419",
      "r425",
      "r426",
      "r427",
      "r428"
     ]
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityScheduleOfOutstandingAndExercisableOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price Range [Axis]",
        "documentation": "Information by range of option prices pertaining to options granted."
       }
      }
     },
     "auth_ref": [
      "r72"
     ]
    },
    "inmd_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityNarrativeDetails",
      "http://inmodemd.com/role/ShareholdersEquityScheduleOfOutstandingAndExercisableOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The floor of a range of exercise prices for purposes of disclosing shares potentially issuable under outstanding and exercisable stock option awards on all stock option plans and other required information pertaining to awards in the range.",
        "label": "Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price",
        "verboseLabel": "Exercise prices"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityScheduleOfOutstandingAndExercisableOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices."
       }
      }
     },
     "auth_ref": [
      "r73"
     ]
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityScheduleOfOutstandingAndExercisableOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of options exercisable at end of year",
        "documentation": "The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied."
       }
      }
     },
     "auth_ref": [
      "r71"
     ]
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityScheduleOfOutstandingAndExercisableOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of options Outstanding and exercisable at end of year",
        "documentation": "The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices."
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "us-gaap_ShareBasedPaymentArrangementEmployeeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedPaymentArrangementEmployeeMember",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityScheduleOfOptionsGrantedDetails",
      "http://inmodemd.com/role/ShareholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employees, officers and directors [Member]",
        "documentation": "Recipient, of award granted under share-based payment arrangement, over whom grantor exercises or has right to exercise sufficient control to establish employer-employee relationship based on law of pertinent jurisdiction. Includes, but is not limited to, nonemployee director treated as employee when acting as member of board of directors, if elected by grantor's shareholders or appointed to board position to be filled by shareholder election when existing term expires."
       }
      }
     },
     "auth_ref": [
      "r390",
      "r391",
      "r392",
      "r393",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419"
     ]
    },
    "inmd_SharePurchaseAndShareholdersAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "SharePurchaseAndShareholdersAgreementMember",
     "presentation": [
      "http://inmodemd.com/role/OtherInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share Purchase and Shareholders Agreement [Member]",
        "label": "Share Purchase And Shareholders Agreement [Member]",
        "verboseLabel": "Share purchase and shareholders agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "inmd_ShareRepurchaseProgramMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "ShareRepurchaseProgramMember",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Repurchase Program [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "inmd_ShareValueOfAcquisitionOfNonControllingInterestInExchangeOfOrdinaryShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "ShareValueOfAcquisitionOfNonControllingInterestInExchangeOfOrdinaryShares",
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of acquisition of non-controlling interest in exchange of ordinary shares.",
        "label": "Share Value Of Acquisition Of Non Controlling Interest In Exchange Of Ordinary Shares",
        "terseLabel": "Acquisition of non-controlling interest in exchange of ordinary shares (see note 12b) (Shares)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityNarrativeDetails",
      "http://inmodemd.com/role/ShareholdersEquityScheduleOfOutstandingAndExercisableOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average remaining contractual life",
        "verboseLabel": "Weighted average remaining contractual life of exercisable options",
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unvested options",
        "documentation": "Number of non-vested options outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityScheduleOfOutstandingAndExercisableOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average remaining contractual life of outstanding options",
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r144"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1",
     "crdr": "credit",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vested options",
        "documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock."
       }
      }
     },
     "auth_ref": [
      "r410"
     ]
    },
    "inmd_SharesAuthorizedAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "SharesAuthorizedAmount",
     "crdr": "credit",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares authorized amount.",
        "label": "Shares authorized amount"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharesIssued",
     "presentation": [
      "http://inmodemd.com/role/OtherInvestmentsDetails",
      "http://inmodemd.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ordinary shares of Medimor",
        "verboseLabel": "Ordinary shares",
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharesIssuedPricePerShare",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Price per share",
        "documentation": "Per share or per unit amount of equity securities issued."
       }
      }
     },
     "auth_ref": []
    },
    "inmd_ShortTermBankDepositsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "ShortTermBankDepositsPolicyTextBlock",
     "presentation": [
      "http://inmodemd.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for short-term bank deposits.",
        "label": "Short Term Bank Deposits Policy Text Block",
        "verboseLabel": "Short-term bank deposits"
       }
      }
     },
     "auth_ref": []
    },
    "inmd_ShortTermDepositsAnnualInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "ShortTermDepositsAnnualInterestRate",
     "presentation": [
      "http://inmodemd.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short-term deposits annual interest rate.",
        "label": "Short Term Deposits Annual Interest Rate"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://inmodemd.com/role/SignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SIGNIFICANT ACCOUNTING POLICIES",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r133",
      "r220"
     ]
    },
    "us-gaap_SignificantSupplyCommitmentRemainingMinimumAmountCommitted": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SignificantSupplyCommitmentRemainingMinimumAmountCommitted",
     "crdr": "credit",
     "presentation": [
      "http://inmodemd.com/role/CommitmentsAndContingentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supply and open orders commitment",
        "documentation": "The floor amount as of the balance sheet date that the entity must expend to satisfy the terms of disclosed arrangements (excluding long-term commitments) in which the entity must commit resources to supply goods or services to one or more customers."
       }
      }
     },
     "auth_ref": [
      "r32",
      "r98"
     ]
    },
    "inmd_SpaMedicalInternationalLsrlMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "SpaMedicalInternationalLsrlMember",
     "presentation": [
      "http://inmodemd.com/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Spa MedicaI International SRL [Member]",
        "label": "Spa Medical International Lsrl [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "inmd_SpecialPreferredEnterpriseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "SpecialPreferredEnterpriseMember",
     "presentation": [
      "http://inmodemd.com/role/TaxesOnIncomeNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Special Preferred Enterprise [Member]",
        "label": "Special Preferred Enterprise [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StandardProductWarrantyAccrual": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StandardProductWarrantyAccrual",
     "crdr": "credit",
     "presentation": [
      "http://inmodemd.com/role/SignificantAccountingPoliciesScheduleOfAccruedWarrantyDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Balance at end of year",
        "periodStartLabel": "Balance at beginning of year",
        "label": "Standard Product Warranty Accrual",
        "documentation": "Amount as of the balance sheet date of the aggregate standard product warranty liability. Does not include the balance for the extended product warranty liability."
       }
      }
     },
     "auth_ref": [
      "r860",
      "r863"
     ]
    },
    "us-gaap_StandardProductWarrantyAccrualPayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StandardProductWarrantyAccrualPayments",
     "crdr": "debit",
     "presentation": [
      "http://inmodemd.com/role/SignificantAccountingPoliciesScheduleOfAccruedWarrantyDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Cost incurred",
        "label": "Standard Product Warranty Accrual, Decrease for Payments",
        "documentation": "Amount of decrease in the standard product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard product warranty. Excludes extended product warranties."
       }
      }
     },
     "auth_ref": [
      "r861"
     ]
    },
    "us-gaap_StandardProductWarrantyAccrualWarrantiesIssued": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StandardProductWarrantyAccrualWarrantiesIssued",
     "crdr": "credit",
     "presentation": [
      "http://inmodemd.com/role/SignificantAccountingPoliciesScheduleOfAccruedWarrantyDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense recognized",
        "documentation": "Amount of increase in the standard product warranty accrual from warranties issued. Excludes extended product warranties."
       }
      }
     },
     "auth_ref": [
      "r862"
     ]
    },
    "us-gaap_StandardProductWarrantyPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StandardProductWarrantyPolicy",
     "presentation": [
      "http://inmodemd.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warranty reserve",
        "documentation": "Disclosure of accounting policy for standard warranties including the methodology for measuring the liability."
       }
      }
     },
     "auth_ref": [
      "r859"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r34",
      "r180",
      "r207",
      "r208",
      "r209",
      "r225",
      "r226",
      "r227",
      "r230",
      "r236",
      "r238",
      "r248",
      "r319",
      "r320",
      "r372",
      "r422",
      "r423",
      "r424",
      "r453",
      "r454",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r479",
      "r484",
      "r490",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r509",
      "r604",
      "r605",
      "r606",
      "r624",
      "r687"
     ]
    },
    "srt_StatementGeographicalAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "StatementGeographicalAxis",
     "presentation": [
      "http://inmodemd.com/role/Entity-wideDisclosureScheduleOfLong-livedAssetsDetails",
      "http://inmodemd.com/role/Entity-wideDisclosureScheduleOfNetSalesByGeographicalAreaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]"
       }
      }
     },
     "auth_ref": [
      "r278",
      "r279",
      "r627",
      "r630",
      "r632",
      "r697",
      "r701",
      "r705",
      "r709",
      "r718",
      "r723",
      "r724",
      "r725",
      "r726",
      "r727",
      "r728",
      "r729",
      "r730",
      "r731",
      "r737",
      "r756",
      "r773",
      "r872",
      "r934"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementLineItems",
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity",
      "http://inmodemd.com/role/DocumentAndEntityInformation",
      "http://inmodemd.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r225",
      "r226",
      "r227",
      "r248",
      "r551",
      "r610",
      "r625",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r644",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r653",
      "r654",
      "r655",
      "r656",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r664",
      "r666",
      "r667",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r687",
      "r774"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfStockholdersEquityAbstract",
     "auth_ref": []
    },
    "srt_StatementScenarioAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "StatementScenarioAxis",
     "presentation": [
      "http://inmodemd.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]"
       }
      }
     },
     "auth_ref": [
      "r239",
      "r386",
      "r797",
      "r798",
      "r830"
     ]
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementTable",
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity",
      "http://inmodemd.com/role/DocumentAndEntityInformation",
      "http://inmodemd.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]",
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed."
       }
      }
     },
     "auth_ref": [
      "r225",
      "r226",
      "r227",
      "r248",
      "r551",
      "r610",
      "r625",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r644",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r653",
      "r654",
      "r655",
      "r656",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r664",
      "r666",
      "r667",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r687",
      "r774"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Initial public offering of ordinary shares, net of offering costs, shares",
        "verboseLabel": "Issuance of shares",
        "documentation": "Number of new stock issued during the period."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r108",
      "r109",
      "r142",
      "r615",
      "r687",
      "r714"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity",
      "http://inmodemd.com/role/ShareholdersEquityScheduleOfOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Exercised",
        "label": "Exercise of options, shares",
        "terseLabel": "Exercise of options (Shares)",
        "documentation": "Number of share options (or share units) exercised during the current period."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r108",
      "r109",
      "r142",
      "r400"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "crdr": "credit",
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise of options",
        "terseLabel": "Exercise of options",
        "documentation": "Value of stock issued as a result of the exercise of stock options."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r34",
      "r142"
     ]
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockRepurchasedDuringPeriodShares",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Repurchased During Period, Shares",
        "verboseLabel": "Repurchase of ordinary shares, shares",
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r108",
      "r109",
      "r142",
      "r616",
      "r687",
      "r715"
     ]
    },
    "inmd_StockRepurchasedDuringPeriodValueOne": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "StockRepurchasedDuringPeriodValueOne",
     "crdr": "debit",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Repurchase of ordinary shares.",
        "label": "Stock Repurchased During Period Value One",
        "verboseLabel": "Repurchase of ordinary shares"
       }
      }
     },
     "auth_ref": []
    },
    "inmd_StockRepurchasedOrdinarySharesDuringPeriodShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "StockRepurchasedOrdinarySharesDuringPeriodShares",
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Repurchase of ordinary shares, shares.",
        "label": "Stock Repurchased Ordinary Shares During Period Shares",
        "terseLabel": "Repurchase of ordinary shares (Shares)"
       }
      }
     },
     "auth_ref": []
    },
    "inmd_StockRepurchasedOrdinarySharesDuringPeriodValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "StockRepurchasedOrdinarySharesDuringPeriodValue",
     "crdr": "debit",
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Repurchase of ordinary shares value.",
        "label": "Stock Repurchased Ordinary Shares During Period Value",
        "terseLabel": "Repurchase of ordinary shares"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://inmodemd.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "TOTAL SHAREHOLDERS\u2019 EQUITY",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r109",
      "r112",
      "r113",
      "r135",
      "r646",
      "r663",
      "r688",
      "r689",
      "r768",
      "r781",
      "r824",
      "r852",
      "r907",
      "r937"
     ]
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "InMode Ltd. shareholders' equity:",
        "terseLabel": "SHAREHOLDERS\u2019 EQUITY:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "crdr": "credit",
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Ending Balance",
        "periodStartLabel": "Begining Balance",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "TOTAL SHAREHOLDERS' EQUITY",
        "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity."
       }
      }
     },
     "auth_ref": [
      "r83",
      "r84",
      "r87",
      "r180",
      "r181",
      "r208",
      "r225",
      "r226",
      "r227",
      "r230",
      "r236",
      "r319",
      "r320",
      "r372",
      "r422",
      "r423",
      "r424",
      "r453",
      "r454",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r479",
      "r484",
      "r490",
      "r492",
      "r496",
      "r509",
      "r605",
      "r606",
      "r622",
      "r646",
      "r663",
      "r688",
      "r689",
      "r716",
      "r780",
      "r824",
      "r852",
      "r907",
      "r937"
     ]
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityNoteAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Note [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SHAREHOLDERS' EQUITY",
        "documentation": "The entire disclosure for equity."
       }
      }
     },
     "auth_ref": [
      "r141",
      "r221",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r371",
      "r372",
      "r481",
      "r690",
      "r692",
      "r717"
     ]
    },
    "us-gaap_StockholdersEquityNoteStockSplit": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityNoteStockSplit",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock split",
        "documentation": "Description of the stock split arrangement. Also provide the retroactive effect given by a stock split that occurs after the balance date but before the release of financial statements."
       }
      }
     },
     "auth_ref": [
      "r143"
     ]
    },
    "us-gaap_SubsequentEventMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventMember",
     "presentation": [
      "http://inmodemd.com/role/Entity-wideDisclosureNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Member]",
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r497",
      "r517"
     ]
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventTypeAxis",
     "presentation": [
      "http://inmodemd.com/role/Entity-wideDisclosureNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event Type [Axis]",
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r497",
      "r517"
     ]
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventTypeDomain",
     "presentation": [
      "http://inmodemd.com/role/Entity-wideDisclosureNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r497",
      "r517"
     ]
    },
    "srt_SubsidiariesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "SubsidiariesMember",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Invasix UK [Member]"
       }
      }
     },
     "auth_ref": [
      "r873",
      "r913",
      "r914",
      "r916"
     ]
    },
    "inmd_SubsidiariesOutsideIsraelMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "SubsidiariesOutsideIsraelMember",
     "presentation": [
      "http://inmodemd.com/role/TaxesOnIncomeNarrativeDetails",
      "http://inmodemd.com/role/TaxesOnIncomeScheduleOfIncomeBeforeIncomeTaxesDetails",
      "http://inmodemd.com/role/TaxesOnIncomeScheduleOfTaxExpensesTaxBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Subsidiaries outside Israel [Member]",
        "label": "Subsidiaries outside Israel [Member]",
        "terseLabel": "Subsidiaries outside of Israel [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "inmd_SubsidiaryOfHomeSkinnovationsLtdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "SubsidiaryOfHomeSkinnovationsLtdMember",
     "presentation": [
      "http://inmodemd.com/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Subsidiary Of Home Skinnovations Ltd [Member]",
        "label": "Subsidiary of Home Skinnovations Ltd [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsidiarySaleOfStockAxis",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of Stock [Axis]",
        "documentation": "Information by type of sale of the entity's stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SupplementalCashFlowElementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SupplementalCashFlowElementsAbstract",
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SUPPLEMENTAL DISCLOSURES OF CASH FLOWS INFORMATION:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TaxAdjustmentsSettlementsAndUnusualProvisions",
     "crdr": "debit",
     "presentation": [
      "http://inmodemd.com/role/TaxesOnIncomeNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tax Adjustments, Settlements, and Unusual Provisions",
        "verboseLabel": "Payment of income tax assessment with tax authorities",
        "documentation": "Amount of increase (decrease) to previously recorded tax expense. Includes, but is not limited to, significant settlements of income tax disputes, and unusual tax positions or infrequent actions taken by the entity, including tax assessment reversal, and IRS tax settlement."
       }
      }
     },
     "auth_ref": [
      "r149",
      "r150"
     ]
    },
    "inmd_TaxBenefitYear": {
     "xbrltype": "durationItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "TaxBenefitYear",
     "presentation": [
      "http://inmodemd.com/role/TaxesOnIncomeNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax benefit in years.",
        "label": "Tax benefit year"
       }
      }
     },
     "auth_ref": []
    },
    "inmd_TaxRateForRecipientForDividendsDistributedByPreferredCompany": {
     "xbrltype": "percentItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "TaxRateForRecipientForDividendsDistributedByPreferredCompany",
     "presentation": [
      "http://inmodemd.com/role/TaxesOnIncomeNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax rate for recipient for dividends distributed by Preferred Company from income derived from its PTE or SPTE.",
        "label": "Tax Rate For Recipient For Dividends Distributed By Preferred Company"
       }
      }
     },
     "auth_ref": []
    },
    "srt_TitleOfIndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "TitleOfIndividualAxis",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r833",
      "r915"
     ]
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ToolsDiesAndMoldsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ToolsDiesAndMoldsMember",
     "presentation": [
      "http://inmodemd.com/role/PropertyAndEquipmentNetScheduleOfPropertyAndEquipmentDetails",
      "http://inmodemd.com/role/SignificantAccountingPoliciesScheduleOfPropertyAndEquipmentEstimatedUsefulLivesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Molds [Member]",
        "documentation": "Equipment commonly used to cut, shape, and form metal and other materials into goods for sale."
       }
      }
     },
     "auth_ref": []
    },
    "inmd_TotalLongLivedAssetsByGeographicalArea": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "TotalLongLivedAssetsByGeographicalArea",
     "crdr": "debit",
     "presentation": [
      "http://inmodemd.com/role/Entity-wideDisclosureScheduleOfLong-livedAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of long lived assets by geographical area.",
        "label": "Total Long Lived Assets By Geographical Area",
        "verboseLabel": "Total long-lived assets by geographical area"
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://inmodemd.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "presentation": [
      "http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsNarrativeDetails",
      "http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsScheduleOfFinancialAssetsMeasuredAtFairValueDetails",
      "http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsScheduleOfMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instruments [Domain]",
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms."
       }
      }
     },
     "auth_ref": [
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r358",
      "r370",
      "r480",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r590",
      "r805",
      "r806",
      "r807",
      "r808",
      "r809",
      "r810",
      "r811",
      "r848",
      "r849",
      "r850",
      "r851"
     ]
    },
    "inmd_TreasurySharesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "TreasurySharesPolicyTextBlock",
     "presentation": [
      "http://inmodemd.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy treasury shares.",
        "label": "Treasury Shares Policy Text Block",
        "terseLabel": "Treasury Shares"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TreasuryStockCommonMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TreasuryStockCommonMember",
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Treasury shares [Member]",
        "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r66"
     ]
    },
    "us-gaap_TreasuryStockCommonShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TreasuryStockCommonShares",
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Treasury shares, ordinary shares",
        "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r66"
     ]
    },
    "us-gaap_TreasuryStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TreasuryStockValue",
     "crdr": "debit",
     "calculation": {
      "http://inmodemd.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0,
       "order": 40.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less treasury shares, at cost: 1,975,003 and 1,975,003 ordinary shares at December 31, 2023 and 2022, respectively",
        "label": "Treasury Stock, Value",
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury."
       }
      }
     },
     "auth_ref": [
      "r33",
      "r66",
      "r67"
     ]
    },
    "inmd_TwoPurchaseAndShareholdersAgreementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "TwoPurchaseAndShareholdersAgreementsMember",
     "presentation": [
      "http://inmodemd.com/role/OtherInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two Purchase And Shareholders Agreements [Member]",
        "label": "Two Purchase And Shareholders Agreements [Member]",
        "verboseLabel": "Two purchase and shareholders agreements [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "inmd_TwoThousandsEighteenIncentivePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "TwoThousandsEighteenIncentivePlanMember",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2018 Incentive Plan [Member]",
        "label": "Two Thousands Eighteen Incentive Plan [Member]",
        "terseLabel": "2018 Incentive Plan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TypeOfArrangementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TypeOfArrangementAxis",
     "presentation": [
      "http://inmodemd.com/role/LeasesNarrativeDetails",
      "http://inmodemd.com/role/OtherInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r465"
     ]
    },
    "country_US": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2023",
     "localname": "US",
     "presentation": [
      "http://inmodemd.com/role/Entity-wideDisclosureScheduleOfLong-livedAssetsDetails",
      "http://inmodemd.com/role/Entity-wideDisclosureScheduleOfNetSalesByGeographicalAreaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "United States [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_USGovernmentAgenciesDebtSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "USGovernmentAgenciesDebtSecuritiesMember",
     "presentation": [
      "http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsScheduleOfFinancialAssetsMeasuredAtFairValueDetails",
      "http://inmodemd.com/role/MarketableSecuritiesAndFairValueMeasurementsScheduleOfMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Government bonds [Member]",
        "documentation": "Debentures, notes, and other debt securities issued by US government agencies, for example, but not limited to, Government National Mortgage Association (GNMA or Ginnie Mae). Excludes US treasury securities and debt issued by government-sponsored Enterprises (GSEs), for example, but is not limited to, Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac), Federal National Mortgage Association (FNMA or Fannie Mae), and the Federal Home Loan Bank (FHLB)."
       }
      }
     },
     "auth_ref": [
      "r743",
      "r757",
      "r929"
     ]
    },
    "inmd_UndistributedExemptIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "UndistributedExemptIncome",
     "crdr": "credit",
     "presentation": [
      "http://inmodemd.com/role/TaxesOnIncomeNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Undistributed exempt income.",
        "label": "Undistributed exempt income"
       }
      }
     },
     "auth_ref": []
    },
    "inmd_UnitsChangesDuringYearAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "UnitsChangesDuringYearAbstract",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityScheduleOfOptionsGrantedRestictedShareUnitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Changes during the year:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnrecognizedTaxBenefits",
     "crdr": "credit",
     "presentation": [
      "http://inmodemd.com/role/TaxesOnIncomeScheduleOfUnrecognizedTaxBenefitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Balance at December 31",
        "periodStartLabel": "Balance at January 1",
        "label": "Unrecognized Tax Benefits",
        "documentation": "Amount of unrecognized tax benefits."
       }
      }
     },
     "auth_ref": [
      "r434",
      "r442"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions",
     "crdr": "debit",
     "presentation": [
      "http://inmodemd.com/role/TaxesOnIncomeScheduleOfUnrecognizedTaxBenefitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Decrease in uncertain tax positions for the previous years",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions",
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns."
       }
      }
     },
     "auth_ref": [
      "r443"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "crdr": "credit",
     "presentation": [
      "http://inmodemd.com/role/TaxesOnIncomeScheduleOfUnrecognizedTaxBenefitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase in uncertain tax positions for the current year",
        "verboseLabel": "Increase in uncertain tax positions for the current year, net",
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return."
       }
      }
     },
     "auth_ref": [
      "r444"
     ]
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://inmodemd.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Use of estimates",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r52",
      "r53",
      "r54",
      "r167",
      "r168",
      "r171",
      "r172"
     ]
    },
    "us-gaap_VehiclesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VehiclesMember",
     "presentation": [
      "http://inmodemd.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vehicles [Member]",
        "documentation": "Equipment used primarily for road transportation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_VestingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VestingAxis",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting [Axis]",
        "documentation": "Information by vesting schedule of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r874",
      "r875",
      "r876",
      "r877",
      "r878",
      "r879",
      "r880",
      "r881",
      "r882",
      "r883",
      "r884",
      "r885",
      "r886",
      "r887",
      "r888",
      "r889",
      "r890",
      "r891",
      "r892",
      "r893",
      "r894",
      "r895",
      "r896",
      "r897",
      "r898",
      "r899"
     ]
    },
    "us-gaap_VestingDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VestingDomain",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vesting schedule of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r874",
      "r875",
      "r876",
      "r877",
      "r878",
      "r879",
      "r880",
      "r881",
      "r882",
      "r883",
      "r884",
      "r885",
      "r886",
      "r887",
      "r888",
      "r889",
      "r890",
      "r891",
      "r892",
      "r893",
      "r894",
      "r895",
      "r896",
      "r897",
      "r898",
      "r899"
     ]
    },
    "inmd_WarRiskSituationInIsraelPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "WarRiskSituationInIsraelPolicyTextBlock",
     "presentation": [
      "http://inmodemd.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for war risk situation in Israel.",
        "label": "War Risk Situation In Israel [Policy Text Block]",
        "verboseLabel": "War risk situation in Israel"
       }
      }
     },
     "auth_ref": []
    },
    "srt_WarehouseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "WarehouseMember",
     "presentation": [
      "http://inmodemd.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warehouse [Member]"
       }
      }
     },
     "auth_ref": [
      "r943",
      "r944"
     ]
    },
    "inmd_WarrantyReserveLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "WarrantyReserveLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://inmodemd.com/role/OtherCurrentLiabilitiesScheduleOfOtherLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://inmodemd.com/role/OtherCurrentLiabilitiesScheduleOfOtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warranty reserve liability current.",
        "label": "Warranty Reserve Liability Current",
        "verboseLabel": "Warranty reserve"
       }
      }
     },
     "auth_ref": []
    },
    "inmd_WeightedAverageExercisePriceChangesDuringYearAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "WeightedAverageExercisePriceChangesDuringYearAbstract",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityScheduleOfOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Exercise Price Changes During Year Abstract",
        "terseLabel": "Changes during the year:"
       }
      }
     },
     "auth_ref": []
    },
    "inmd_WeightedAverageGrantDateChangesDuringYearAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "WeightedAverageGrantDateChangesDuringYearAbstract",
     "presentation": [
      "http://inmodemd.com/role/ShareholdersEquityScheduleOfOptionsGrantedRestictedShareUnitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Changes during the year:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "verboseLabel": "Diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r241",
      "r246"
     ]
    },
    "inmd_WeightedAverageNumberOfSharesOutStandingUsedInComputationOfNetIncomePerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://inmodemd.com/20231231",
     "localname": "WeightedAverageNumberOfSharesOutStandingUsedInComputationOfNetIncomePerShareAbstract",
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number Of Shares Out Standing Used In Computation Of Net Income Per Share Abstract",
        "terseLabel": "WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING USED IN COMPUTATION OF EARNINGS PER SHARE"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "presentation": [
      "http://inmodemd.com/role/ConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "verboseLabel": "Basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r240",
      "r246"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "4",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482338/360-10-05-4"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "SubTopic": "20",
   "Topic": "940",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "7",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-7"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "8",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-8"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-20"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-1"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "405",
   "Topic": "942",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481047/942-405-50-1"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(3)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c),(3)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2A"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "a",
   "SubTopic": "10",
   "Topic": "280",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482739/220-10-55-15"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.20)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.21)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.24)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.25)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.3,4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-5"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-16"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-20"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-21"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "310",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-9"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "460",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481549/505-30-45-1"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481520/505-30-50-4"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-12"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-13"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-8"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "217",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482663/740-10-55-217"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-3"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-15"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-16"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-21"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4I"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "820",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-20"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03.10)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03.17)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "320",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-5"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "825",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480981/942-825-50-1"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "985",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1"
  },
  "r102": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//205/tableOfContent"
  },
  "r103": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 201.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r104": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 201.5-02(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r105": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 201.5-02(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r106": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r107": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r108": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r109": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r110": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r111": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r112": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r113": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r114": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r115": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r116": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r117": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r118": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11"
  },
  "r119": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r120": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r121": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r122": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r123": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r124": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r125": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r126": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.7(a),(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r127": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.7(c),9(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r128": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.8)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r129": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r130": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
  },
  "r131": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r132": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r133": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//235/tableOfContent"
  },
  "r134": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "275",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//275/tableOfContent"
  },
  "r135": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2"
  },
  "r136": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//360/tableOfContent"
  },
  "r137": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r138": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480091/360-10-S99-2"
  },
  "r139": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//440/tableOfContent"
  },
  "r140": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481573/470-10-45-12A"
  },
  "r141": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//505/tableOfContent"
  },
  "r142": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r143": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SAB Topic 4.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-4"
  },
  "r144": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r145": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r146": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12"
  },
  "r147": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r148": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r149": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482620/740-10-25-10"
  },
  "r150": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482620/740-10-25-8"
  },
  "r151": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15"
  },
  "r152": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A"
  },
  "r153": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r154": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19"
  },
  "r155": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r156": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r157": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21"
  },
  "r158": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r159": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r160": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r161": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r162": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r163": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04.10)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "270",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482989/270-10-45-6"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "SubTopic": "35",
   "Topic": "720",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483406/720-35-50-1"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-1"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-6"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-7"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "SubTopic": "10",
   "Topic": "310",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-7A"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1405",
   "Paragraph": "(a)",
   "Subparagraph": "(1)",
   "Publisher": "SEC"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1405",
   "Paragraph": "(a)",
   "Subparagraph": "(2)",
   "Publisher": "SEC"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(3)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-1"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-2"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-6"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480530/250-10-S99-5"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//280/tableOfContent"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-15"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-26"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-34"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-4"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479344/326-20-45-1"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-11"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-14"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-16"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-5"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-5"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479130/326-30-45-1"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-7"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-9"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//330/tableOfContent"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-1"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-4"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-1"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-2"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-8"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-8"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//718/tableOfContent"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-2"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.C.Q3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.1.Q5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.3.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "35",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483406/720-35-50-1"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483044/730-10-05-1"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482916/730-10-50-1"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//740/tableOfContent"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-10B"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-25"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-28"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-4"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-6"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-20"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "808",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//830/tableOfContent"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//842-20/tableOfContent"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-1"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//850/tableOfContent"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-6"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481435/852-10-45-14"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481444/860-30-45-1"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-7"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(4)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "912",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482312/912-310-45-11"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "912",
   "SubTopic": "330",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482105/912-330-50-1"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "33",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "33",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "35A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "35A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-3A"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1)(h))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(f)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(f)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(f)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-2"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-5"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-6"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-2"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(5)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "12",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-12"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "19",
   "Subparagraph": "(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-19"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5D",
   "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5D"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5D",
   "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5D"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-3"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481058/954-310-45-1"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481027/954-310-50-2"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "450",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480598/954-450-50-1"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r731": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r732": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r733": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1"
  },
  "r734": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1"
  },
  "r735": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r736": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(a)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H"
  },
  "r737": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(b)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H"
  },
  "r738": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r739": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r740": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r741": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r742": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r743": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r744": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52"
  },
  "r745": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r746": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31"
  },
  "r747": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482785/280-10-55-47"
  },
  "r748": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A"
  },
  "r749": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "79",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479294/326-20-55-79"
  },
  "r750": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "80",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479294/326-20-55-80"
  },
  "r751": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479081/326-30-55-8"
  },
  "r752": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B"
  },
  "r753": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C"
  },
  "r754": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r755": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r756": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r757": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r758": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r759": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17"
  },
  "r760": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11"
  },
  "r761": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6"
  },
  "r762": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8"
  },
  "r763": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r764": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "217",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482663/740-10-55-217"
  },
  "r765": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J"
  },
  "r766": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K"
  },
  "r767": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53"
  },
  "r768": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10"
  },
  "r769": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479401/944-30-55-2"
  },
  "r770": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F"
  },
  "r771": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r772": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r773": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1"
  },
  "r774": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1"
  },
  "r775": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r776": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r777": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r778": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r779": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10"
  },
  "r780": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11"
  },
  "r781": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12"
  },
  "r782": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r783": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r784": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r785": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r786": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r787": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r788": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r789": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r790": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r791": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r792": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r793": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r794": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r795": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r796": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r797": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-10"
  },
  "r798": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-3"
  },
  "r799": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12"
  },
  "r800": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "SubTopic": "825",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B"
  },
  "r801": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4H",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H"
  },
  "r802": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Topic": "321",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//321/tableOfContent"
  },
  "r803": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Topic": "325",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//325/tableOfContent"
  },
  "r804": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Topic": "705",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//705/tableOfContent"
  },
  "r805": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(a)",
   "Publisher": "SEC"
  },
  "r806": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(b)",
   "Subparagraph": "(1)",
   "Publisher": "SEC"
  },
  "r807": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(b)",
   "Subparagraph": "(2)",
   "Publisher": "SEC"
  },
  "r808": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(b)",
   "Subparagraph": "(3)",
   "Publisher": "SEC"
  },
  "r809": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(c)",
   "Subparagraph": "(2)(i)",
   "Publisher": "SEC"
  },
  "r810": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(c)",
   "Subparagraph": "(2)(ii)",
   "Publisher": "SEC"
  },
  "r811": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(c)",
   "Subparagraph": "(2)(iii)",
   "Publisher": "SEC"
  },
  "r812": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1404",
   "Paragraph": "(a)",
   "Publisher": "SEC"
  },
  "r813": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r814": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r815": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r816": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r817": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r818": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r819": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4"
  },
  "r820": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5"
  },
  "r821": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
  },
  "r822": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r823": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r824": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r825": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r826": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r827": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
  },
  "r828": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
  },
  "r829": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
  },
  "r830": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4"
  },
  "r831": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-18"
  },
  "r832": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//310-10/tableOfContent"
  },
  "r833": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-13"
  },
  "r834": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//320/tableOfContent"
  },
  "r835": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-1"
  },
  "r836": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-11"
  },
  "r837": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r838": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r839": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r840": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r841": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r842": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r843": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r844": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r845": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r846": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r847": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r848": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9"
  },
  "r849": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3"
  },
  "r850": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3"
  },
  "r851": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3"
  },
  "r852": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r853": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479344/326-20-45-1"
  },
  "r854": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13"
  },
  "r855": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10"
  },
  "r856": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//450/tableOfContent"
  },
  "r857": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9"
  },
  "r858": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r859": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8"
  },
  "r860": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8"
  },
  "r861": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8"
  },
  "r862": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8"
  },
  "r863": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8"
  },
  "r864": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r865": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r866": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r867": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r868": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r869": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r870": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r871": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-10"
  },
  "r872": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5"
  },
  "r873": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r874": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r875": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r876": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r877": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r878": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r879": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r880": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r881": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r882": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r883": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r884": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r885": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r886": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r887": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r888": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r889": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r890": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r891": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r892": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r893": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r894": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r895": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r896": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r897": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r898": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r899": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r900": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r901": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12"
  },
  "r902": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A"
  },
  "r903": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r904": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-6"
  },
  "r905": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r906": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r907": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r908": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "830",
   "SubTopic": "230",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1"
  },
  "r909": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479424/830-30-S99-1"
  },
  "r910": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3"
  },
  "r911": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r912": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6"
  },
  "r913": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r914": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r915": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2"
  },
  "r916": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3"
  },
  "r917": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
  },
  "r918": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
  },
  "r919": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r920": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r921": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r922": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r923": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r924": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r925": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "912",
   "SubTopic": "730",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482517/912-730-25-1"
  },
  "r926": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(10)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r927": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r928": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r929": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-2"
  },
  "r930": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-3A"
  },
  "r931": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r932": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r933": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r934": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B"
  },
  "r935": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480109/944-80-50-1"
  },
  "r936": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
  },
  "r937": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r938": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r939": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r940": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r941": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r942": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r943": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1"
  },
  "r944": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>112
<FILENAME>0001178913-24-000490-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001178913-24-000490-xbrl.zip
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M.$U8<M_K>',)   X,@  $    &5X:&EB:71?,3(M,BYH=&WM6VUOVS@2_G[
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M$$D%8)0J*$NCH$_#YPG*^%F 4A*UXK9UF'<!D2 .U7:C7A<*<R9/Y9 'Y)6
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MCVP]XR-9)W[KNN73Y3G^-PO_T/Q_D?\ 4$L#!!0    ( %PX35AZPP6,\@0
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M/_-2E1D_)4LAJS$\?2N6O( _^1W<J"7)GG; 43I0<"W2";C1A?C(QQ &N9F
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M'54UV!490S^/(3[)=T+'.V\9O,<]'>L?TO@G;PW_(I=TX%4'_B9"PVLB*>G
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MM84##)1SS7TF*AQ$E <\?$S;U],Z_$FGBH)R &]8E/1V^B'=%02@@WVFKQ]
M?4G@H\Q'R.EE/5][@OMP[OO$]YIEA?M.I*KV_C7#/X<((R]O&NH$:JFYHCO*
M';6>6LEUBB,I$Z2&F1:=EG$)]=45CSBU];=MK*+NO%=^V-O@U7>B8S>Q%3AV
MQPVQ8066AW8C)&;U.V&K[;GXLSOQ%H5YON&;4YBFBJ%XS=7[Y'WRLF"K%\&W
MU_P0J+*_<)G97:'^V_WUR15U__[ZY'+[4^ZO+W C?/05,9$R2^!PE_;O%/@P
M] ]QNI,KJ5_//MQRH?P"_1=02P,$%     @ 7#A-6"$FT1+*W0  2?<) !
M  !E>&AI8FET7S0M,3,N:'1M[+U[<YQ(MB_Z_XVXWX&C';W'WE$J\TA>=K<C
MU+9GVN?8W8ZVSYXS<>-&1P*)1)N"&J DJ^^7O[GR 0D%]2Z9DLHQT[9*%&0F
MF>OY6[_UXTTU2U__W_^7IOUX0W#$_D7_72552E[_^(+_+3[\'Y>7VH<D)%E)
M(JW*7VIA/IOC[)[_FOUYFX>+&<DJ+2P(KNAEBS+)KK6?BQQ'11)=$^W3[[_%
M24HTTYKZ4V-J&ZZG?/]-/K\ODNN;2C-\W]8N-5,WD?KURTL^V!=BM#\&>72O
M!==AGN;%3Q?_$;,_%UI9W:?DIXLXSZK+&,^2]/ZE]K<OR8R4VJ_D3OL]G^'L
M;Q.-?3+12E(D\2N-75TF?Y&7FJ'/JU=:1;Y5ESA-KK.76DIB^@E[SDOM/W3V
MY]4%'PU=&3&O3_B:_+J8!:3XG92D^H'^^P?CATOM!^WR!SKV'^$1&PZ.CXT/
M[>(UG3)<SY\7);?RI=!_:F&*R_*GBY]___1W>/XO=&E(<?%:KBN[1CQ3G1%;
MZ%=:FF3D\H; #W3>4],6"['IR'Y<]$SK3MPOR-,(KN&#__'%XG7SMG^\*30V
ME)\NZ*:JZ)#E+8*\H#-XJ65Y1EYI_*?+(*^J?$:'./^FE7F:1%J0XO!K_?LJ
MG[_44/>7]<3T^;?F]?%M0K]*K[DN\D46779_I:X4']XK;8:+ZR2[A*WP4L.+
M*J\_*OA3V&>;+<F[;S=)D%0:FAJ6LCP_!D7SXEXT+[K]&O=^9T$Q?*N+W@&T
M_CVPH^0Z[3<\K7<'+5[_/5\4U8UV%44DBQ8S*H*T_YW-B[PB(8B:#P271+NZ
M+@AA(BAB NCO)"@6N+C73&]"I8GAL44>F,N^R_J?_V$X^JOOO%*_D#32<!9I
M)7T278$DT_X0?[2<_MNG?\7:C'[SAGYDL<^IF+4><%$J'% 5$)(T+><XI!KB
MIPO]@OT\QU$D?SZ,#+]+HNH&?M!_V$2@2V'Z]O.GOW](RNH+#/5"2Z*?+OZR
M]3 *0]L(72-&V+9\UT8QT3WDQ80$@=4<'$7(584B\N#G2$Y,C,S5ISX,])84
M51+B5(Z/RK/]-\//I+HC)'M)57FT9AQ<GNT[BHO64]H[J6^ GV\P+K1_Y5\S
M@F<:&!BS!,[M)UQ4&2G*FV3>%H.;W;9]]68;NG,+903:K_GTI6;;NFX@QW'Z
M!K3=([*\F.&4/N3BMY@4VF=JS=2+<$'EE*?]@K\F$9YA[7,UG<A?'?#!SVY(
M09(,QQ4HVHL/I"SSXN)Y[UHO?=;93?3'HK/UZ4=P<.2!KY7:&ENDI6 ]>ZK;
M\[TME"%U\ENL53=$BY.BK+0Y?=FOCJD:-M*XCT%(&I:.G3C60XL>ED#'@6_%
MQ#%C-\8^]F)_A$+R*HO&*R#?9[,\(MJ'*II^+T'XALH^ ^FNY8#YM$X$J=OG
MST59)?']\!%>DDL_W\,ZW^0%W9W<A,%57MQ/M(_%5/N8E_3$?DS^*O!-,M'>
MOWVIZ;;AF505.Q/M[B;7DE+].K40X0Y@]@3D!J<Q6#YPZ-]PSY6924%"_Y-4
M$]7R;O[0FU*KDAZX@DI(.N:"?7^^*.;T\Y+?CSZT-DJ3LO\^%U_P+16P6K!(
M4CB\D[;0GVB??M-^SK]IMF4]D+@GI%_<TR<,^B[U_;3:97G,NJ$D84XWQUDY
M'$PY^%84^'Y@V;:%=$1P9.NQC1PK='2$4#A"Y?#/7][]_N[J\W[ZH5<F[JDT
M7E.IMN3=3JA(TQ:*5YPRK_@.E](=#+A'H'&+CTE +@VH $VH>YU45(3.YU2:
M)2$=$/P>5Q4.;\"I+K6.(%D;YJ"2F)Y:G/*!"*EQ\9R.L]3HHM#'$.:MOH"Q
MS/B/<9%3[YY.'P0X^_L9/8U=*=6^,[WTFM"K"F460B;3K9UD8;J 8]&6UF+*
M.$WAN"?%BHG3XW$#UP5$4U9 *PBUWPNN:NA!2.FB)[<$7NCZI?G06I%7\,0#
MB-.SY]XC=UQD6L1&MNW[&/D6#DP]"LW8BR(OC"T2G^7.%G)G00\I-X/H"9B5
MTJ9BVWDBA D_E"4_RK6HT7!!,%SO.8Y6_GNF71<YM:K2/&2Q.BK0%*T;ISG]
M$KT8UT:3]C7+[S(0'1<_DZ32A$VUK4SBH\A:#Y+GD)W[];>0(Y)?FU!)4,[E
MZ7\^42=K3)!E#D^72J1"F2U\5,]WUYDI]VR+W#MZ4N%ORP6KYBL\ PXR*;O2
M==LGM^^F/I0^,*&+P;)%*?FFO,.>V =<"BL0)M4]K(8,#+'A;#P8\:AZ%$Q_
M:,WBM/?81.O1+NK%ZAN"[<$\@-9\#Z\<R#<JPN !["#=T _K'4I'L<OWV92:
M_4I? %MHT)TS?-^=?T#.&NF8&BF*?1<A"Q'/I*YU:/NNB8GN1K83HL@WR%DC
M;:&1N,[YS_^@:^F^*J5!2)63%"=]IR$,\X*;A'FCO^@KIN>8?)LG!8'C_Y:$
M!+*YFF5,6#+Z?"B.>"B<2 \\W7;\T$?(C!TO<$TS"+%#W,@@R#@?BJT/!;@T
M:<)UD+##((C%7*\RH3M<F!P;G9D (F8Y\[(^--<K9@7<&BZ'KXD;PWZKZ(.D
MHP8W8MHG(G'"'=(TOP,7C3EM5Y^U]Y_IRE$+"?3RH@3?K1"W;+1XW!IB5WFI
M#V+Z.BF9#2*&(D_\\@S9P$I2P43 ,0SR6W(^\4<\\=@+/81C/]+-$.GTL)N.
M:UC(M4-L& X:8[9@W">>'D!JV98 +ZC//"%_*[D<H(X'W?\E['*(:M!_$W%&
MI)G.M"+.0B)"(X C6 1_4M-5GIIYD=\F);N-ZOG5EK'B%*J!\=;!8F?^U>@/
M50^XZF<J?KY>T?_4ARFDTJ. W5'=U$%JAD7BAT5\4J.7X,,.-JOS"(X?:SVC
M!SIR(2!&O5]N!M<^B[W9 7' X0M*A/]2,[3+WBC_X++43YW33RX#^.A2^&PX
MO</W96O; OPKRZGC%-%OB']T$&"7XB!Q[-;R.G.\%_MM2R;)76"JF"^Y!#V8
MKQK-MPG@:=]]IF8\MD *L<^2C)XF^MA+TYM:]KR;%:D_/4)6Y'W%HLB@_ D]
MQ/2\ ]**2@\JO.:+E$4T0 1$A&X-<'JIL2 <Y2HA);<.4GKLRY=GI-$ZM4CB
MV(BQ&?BN;Z+011[]?^C8!J86L1]@<S>U6&^/H^A%8SH^E;@2D[IX_8F*J!EL
M$*8!Z]A_-]4W2MUTHCM;]W&H.QCKINXA.XZP[A+#,#T2^2[R/7?/G;UMVG75
M&S[J$8+S8HSOP+S^PBP\<2R8Q0=&7 VJ57R]3J(0K,XJJ185G"9J2E;DNJ ^
M'XA_KC0@DI^Q*"2#7(#?)6*0!2DK,!CACLQZ[$&ZG$_?(4Y?[!BZ';@8Q;:#
M=(0\77<,;%FZ%3B.9]E/Z?29(]17KS]#CB#/M!M6PU&RTP)!E;Q(Z/%CWAL[
M1?2TW9*,?A:J8*0LY9 FGHW(\@HR$@M>KL..9$&/=M5VS,YG[5@1?E^/',>B
M[]'0$281)H9#W,!W+-TAEKYC,/,TSYHUQK-V!; /%JR ,T.^S0'BQ\,C5*WA
M C04BX6J80Q^M&[P+6&J:T9PQC69@-<P5<=.FYH47V0IP ?%,^@I90'.2&.Q
MU+ND).=3>*13:&(+NYYE>-2C0ECW? OYH:E'R#<#%-D[YME.\Q2B,9["+QWX
M[++UJ$89S^?D6,A,VPM(9&(O"A$]%\A'NA.0 'E8#[%.HJ=T3NPQGI-/!;E-
M\D6I106.JYX >V/T,>T$\'8>\0!=1.W%3)B6+*X/!ZHV"+E9V0WFOV!8]U8(
MGT?XDZ*.^8&VG&J?%^&-'!;+GPO+$T>SA.I%. ^06J #^G-!G<6$'FQZ[W\O
M<)E<UI_,BSPD! [(^8P?"P5IASIV Q12IP]%D1_$EN'[)(@,T[$CO&/]XG&C
MBF/TTM9$%:]Z,M[GD.+QMK7GXB#&9AP$R$*N$0:ABWT]]%V3F$[L[KNM3TAU
MF=,Q!N%??VXGD.-%&B<I"R<*G<.],"61M.1V"9#(>J*)Q6O,=./_Q!DKC."P
M+8N?/Y;,Y-C<YHQ*0(EIJYADIL>8#HMX^&0(1D:_/6D!1;M@E'YDK\2Y<J0J
MA\DR4,P,%V&=3(,X:=BL"/U^NB!SZIE6HC8!KBLW6I8K'JK]IETI:]%$>.5"
MJ[A?[7(3R'%[)6O,[?BU^+J:Q59JU7:F[OZ9U8O7'_."Y/3H;;.7/](M<=.[
MDY'V+,X7Q7-U/W>0R>V-S#>J7/0BS^,UF/-MWO\ !GSZ@/G>[_).O[1A;DR@
M2#3,\(LY.&2\>51SQI;0XT_B90S(Z4Z-6-7SVM:^%%QN\BKJYS9O0A6.3_4E
MK%S_YK(#O80/3W+O=[;\LV1*IKL?B.<0D3,GMHV$740MI(=<QA-U22P=!;8>
M8SO0=81<QR..3KT1WPD-WR,Q>DHNR3$\^+5>N1S>&_K%H$CH2\=9>=GSY@T&
MQ]R5EV]Y$PU9WVN<DH,-X.+UI%>Q;>S/9(K\C0#U$2U'X17/1V*'5R&#&_@(
MOS- D>_K3!FDMSGZN&(5YO2.71=*JW/<]$7"T''%]0'+?ZNI-N59]-87[=%>
MR+!F\_F%&%(R$T/:751.Z%=#,F?AUH+PX"@,8D8]-4CEL^\5Y!H740F?W]TD
MU*K'6I3$;":53 \NSQX7!<ZN^;1X*7N/CSP]'"7'":K&<1WT(8_MF,=\I=^W
M^L#W[N9UDJ!]BS4RH-E]&XJ O4\\5 .:QJM-SO=ZMV"M-[?)X6_68!,IL/NA
M?^)E"^:Y;.%LG*\RSGWB8M^UO0!A"QDA\4(GC$GHAI&)S!#AIV2<CQ*8]7?!
MLH9O\X37HE%5$N6+H)IH204>*928)#$K:P7-T.8<Z8WKY"FA"J##WP;WI>(6
M9Y&L+AVR_D !]'Q9@7BUZMOZ%=3X0^(G>J*]P*+G-K:);G@H-@W/B'S7T;TP
M\+!'B/Z43O1(05ZM(PEV#OU+L2[3A Y&K5AMUX,#60O[LC!+<1+)+]US2U<M
M/X ?XH0:!,P*"^[E+9FL&(PZWM 3'  SFC*:!LS9+8S=R-;E?YCQF+/9\'0?
M'6-)QU;&.*P!W6QL5+A%.5U:P,_ AS68ID;TE(N$V\?@QM(3D<SJGR!UF$5E
M!^TC2B_HNEWCA"Z1POO&*->R^SQC3!=P7TZ2>193QZJ^B/4P].TH<.P(F8[K
MF3:)B!5@T]6);XZRJF^,!L*:I&F'#>8N+[XN,;>R<J,VL<0@8](9N7,T0)J.
ML0%52)&G(\_'@6T$Q-!=RPQ,>E2>4#F2-4[DCE"<H$. ^Z4L%W 'K,74#06V
M3M#BC ZPPE\9J3%38[T('&:Z<U6-"_IQOJ#6/--Y].J[C/'G44V:!$D*W&^B
M) .:#4WJX!(_RE2UT6'!K7L.M51]4),!8:FH-NV[+D$G)-;5VCT. ([PO%IQ
M.S85!G6B]@./8F6$1&6-[L%S,!EX;?QZ/3SAG#6WS.C@:"#MKDC8")XQ:AK.
M7PW0J,WRH8(*A"WC"0%U3E2Z><0C@1V91-<QLFT/!Q;V=3U$?N1Y9N@\)>DV
M1ABOE&Y2@+'001U-D.=DV;.7-9I49G.&*(4;F'PCX4*B]Z2USX+9Y0)G&W/H
M@*5>+$).UI-0L=MRC3:4'C7U598O"3=<,0I7O$0A;5I+$,!H/?*H$K*7S5<4
M$_2980HO*'A15 ?(F5 /A\OL^QY- '-,$RP^X-'S6@X#&0ES",6%<U+$$ T6
M<:/V,+H+P34*O&%6D'>6A<<J+\+$MF+D.X9GH0@%@1V:*/9U'P4&0=8H2P_&
M&$E9X_I\J26)RN37&^XX&=]FJW3Q@1B0&-T1U"(RCJ,F<*2LK;0] :6[:GUE
M>&HV8ZE+*AL[AC&/+3/*>WA,Q(1I=H<;)#G7+F%><,E89W.7WW0?H^$ZW=,#
MLV>8L456)>D2 :J[-3,T\\BWW)),2X@,[H/BAT]5O#IVB /')[9M(L?U@L!
MGF-$=J@;],=]JS>/(E['6&6Y@7A-VR)@!?S]+%NWDJWI.MFZO+X=V=I"W0R+
MU?(P<G7#I, #B-?MMN19MFX9I/1,SS9L9-D.E:VF[KFAJP=8CV,<Q [>%\M[
M%-GJG)YL[;B+<WS/&PY)6="-MT6+0KJ C\WB/=&#XE$Q%Q W=*S(1RYQ_"@.
M=,-%KJV[NDV>#.'1P(D<(=O?!N8.@R0.G,'S83K>80HC(XYM8F'=C! .'>QB
M:N3[3DA<W:3:9[?#)-'4QSY+MC&U#A,ZIN?F**FQTZH@Z2T?&3 AT3&PYCVA
M\AQTM C?3H9$Q$3#O-5\>L]%"9W&6I/VU_>?Z4Z5)>K/XB2N[K4R^:9E=,3E
M#?E*TO(YQ'F;FK2>;A/,YIW4X.YNY%?C)CN5.%_Q-6GPUPE.2_9I@YI_0XWY
MQ8P^[E.14%/_/5V$;]JS:Y(1X*@"3NYO=#B+($W*&UYC31<C@[96O^:W_-T8
M-GLWYH0#Q%FK,!CS;V&5P^_A=UN;_@$NDY _7PFLS]-%J?WWU1=($Z3X[F3*
M0DY44#M$#]S(-$W?<A$R"#;-.,0VMD(2NJZ_8VO!TQ34YU*_/D%M#_GZWT%0
M]\EI(2C;@II^'A.RN;CV.N*:,X_M(+"7Y72[/*=?8 M)K4C$TQ6$3[M\QSJ7
M[YRZ2HQ,!YHWF5&@T_]Z"#LVPI$7Z7'H&X&[(\[U-%7B&/&S(@#?*:)A=,:J
MJ3ZD*AJTRQQ@%R+D1I],[6$6=:<&,(3;&:X":AG#(@D:"JMNU68#YQ QO_K!
MRU'W,S[C6+$[9#N^;INVK0<H)M@GL1.'7A1$R O"<%]H^LG$[N#0CA*K]N/B
M]3\*'#80L0O^XR?ZE3RZ.(?BCHE=0K;N4V<N1#8B@8U=VP@BW=!M;!"+!.-6
M9\B<V@<\&J.$J?^:5^ ;E)52R5GC I=K1AF66\D^"Y^))9-9#PT.Y)S-*YE
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M9JU*?-8/GA=.@@G(0L=P84B*K(DPUUUW6=LOZ?QE)*0W@0;QU&43(2C.?L(
M7=FU##4MA;-ZXD'P%>@N2;U/WJI(B_)PP2@ 7FE?9#$I#S3!>O,NF*R'&+5G
MN66\T=I]I%*#:!^3OPKJ5283Y2UH[]^^W.P>NFUXIFWY3NOK=S<Y6\\%'5!!
M;3^6R0=(0$-P(B9:3^ A"S:/?B!8([N,3I6N!-UX](6\YR@+?CX>LIKK@'>O
M-=AF[@)70NR?O$!+#W7#P+!9(D1"+[ <$MNV@WTCLEW#/)2#T=58JFY3-6C;
M4EYJ,K5D.]O]#DN?,=W/+?1Z^41MNO1O<47G)^V)'6^C#1UB?VI!JR]+.<*[
M#[6/H4G3>DVA7CM^>/$/OJKK)9S:YTY3559+W('*6C%!.4ZPR=ET?KHP3/="
MV%D_7=CV1<=6M[FMWK.,_1/NV!_-*/G0>M\(_/GPJV:[KH.&K^C7KRLGJ_5H
MCDW?R%;[I.7Q->>YX_4=21@J3&1GIZ=V>@S][/6L,S,8VNE8?L?5? X='+]I
M5^-P,H[K9?V<+LB\2'A;F:L&)7K50[IZN/GW!6F& R^&<=S 2^N$;?4&VKJZ
MY[SN\#Z[FN@&XT+[5_XU(WC6UC+MGSX(:K!/N*"&<U'>)/,-!<CA!.OQ1>MV
MENU>@M@8$,0'$\7C%\:K]O2Q3T-?.-@PER7!^:2=_$DSSR>M8_B,Q@CZ^6]/
MP@K"V5?M'PO,(/GD@6<\YM0Q"SO%IA&%MN69ID>0'H6![F'7=#PS</38(SL6
MI;!@T/YYV^64Z9:!R8O77_*UJ=&3GT#'TS^EU_-'WQ_M0[5!X?6CG=@)OTY#
MNPH"K+T+2*;]G-Z>_%O<?CZ'>WD'F$![O=[0+P1%0A4(SLK+'BUB,"N4JLP]
M0^B-3KIX_0LI_DJ3>ZP]@^H1DZK'=>%9GAL6-B/[DO'J>6U";E#&?AJK?+@E
MIB],KC*LS^8K_;$&^?=%M]]PW/_0BS@6WNA@:4;5KWM+#7[M<U*\^(@C/)L\
M%I/WXO7O9-J7BM[,"EYZDR>>6+XJ68?-/LU;EZX]@XQSD@EW\F+MTE%G*:4R
M(ZO$<ET\9Y2C JHRT>Z(QL$3VK5<7$[2F)3A#74M18^Z&EN!9]1?K$2Q#&'E
M,O4C -1WGR^*DJ3Q1%O,98%_N9C)QN"]5L6V<_I4)%F8S*'"F(VFGMIC0AE\
M81CD]D1YF4) 6!-54A,H\'X*C!TB"8EHG_I,,*=H[^''YU _/5\$:5+> $,G
M1U^^(8"O3K6?%P7!"WA'GQFG M4RO$CB';UU/DM"[7=24A$$)18UL5APSPLV
M&"]%'L=)F##6>EZ_!<"6AM8RJ;9^R6S8C_+-KI_[SZP-;FL%ZE</[XV_X>9U
M2BIXUAU(GC%9XG\/ND,<-.70S?,DJZ#ZA>&3.#&I?+7P-7%9@$ORQ%8?OMI>
M^[K1%:\9@H-"S; 0J!08%U=O2^.Z2HF_&<:+ &H3NC?5;TZ\R2)ISA4]U%2&
MUIU0%!+]6OT]IO?Q/M8$YJVBG\/2SGAC!;QR"1C[8D#"'&[. J)-)X:,/HLO
M+(#YJ @%:C2ZV*P2M&CDIM)M6M9\"'G;T7;R[#6W$@*T$%3&\A>R&*49P8IG
M/K*WV)XW?5=I?L=>&\ZZ,]>@X?"_%YC!*PM2Y<P.X:R9F-D0[=<AWT/":PAJ
M1L[Z]?!*'U9/R\^B?(&M(_F8%GR]&*N/2L=*TB[[%W=%=W9<%VPS7.IC6L=_
M*GU>9"L^V'^PE\3"P(^B.!QVFNSP (DV>=ZO.VNM)3.H%V5=MWCM"]C%@@#G
MKDBJBF3BGKS^-,LUUCQ&')>[6A4'BS)A4-,(WPM."\ZA?E_7C:KWD4>AH,<K
M8:V!V&'*Z94!\-Y6"9-8G$B,\%&)N:E?AR\%!+[.;\3E%Q^^N)QQBRW-FPVP
M=@@>TT9Y)PJ,86FD/H#S4:5\<<2RL 58E+7N&MP@HE<$6!;UETO6]99CQA?#
M7YZ(?0#Z4C':DAEG!N;T*ZR*LFD\P>JCZ^YJK9NRV10$>(KAZX2>_+!2B=K*
M1GFELOE=_[A8T60D&6<4WP],(66SE:Q;$I MW\()B7+"R6+(MY!S*2_?_#'M
M)58WUTRPMA1KCCTZWR1M.<M@)!GF2UW7YM/9E%-.E$G=XB2[EWN(:51N,<WH
M>'F9? H\&GR?+LJNL)'E!K7.I+][=*O=:$/@)2+7.96$D-J4G"'TER75>/#9
MT>9>9]-W0]B;V(]09'@8^2YR/=/S',.WXACI.K%CQQT_PG[:O86X%)9[>6/4
MO]X30=Z/LSYF5+,=WQJ"7V\0!LB^K@:>GS2.>@<$>1=N\_<\IR^L'R4YB-J2
M('W#;T#Z3@ND;P\BN<[ J8V!4]89.+4&.-59@E\('?[ 9CY*1?L ('(\ *\W
M3P'?]3XK%P4SJ^6\SQBO3>A!W-AP8V1984 <A&SBZ0[!'C9,/= ]"^W+YW,<
M!OX1LGBL2;S6V_,D*/C7^1+'Z63YSR6B<^ZAU[TE.WUMU<:X-6&1PA76VST>
M%P5KTLNXSZ&G$/?7Q=NI(]9E$[)A06KZC+HM9LU^5'^-$[! )J-0>VE6/%EW
M;K.[5@K%NFVY7A#$9NPB.XRQ'3J182/=M&TSPF-G%3N8N /9-D;IQLZF&L?*
M S@XK$\C*5@WG9Q%762_+AG@ZF_G.ZD;7MVV*-99.Z^DE#=I"-:;=EKT--*G
MP)/$\699/T8CF"409]?R,%S,Z?-K%D2E%Y=@#!6$[A#Y4UJ_?ZC[<2TU3^@1
M)3#F^MDL1E<)'E46TV439^DU3HHHQ [G8@M%Y[)&@(AY9I@G[R0GJKP<.E_R
MT&:@?#11*%L'^%HGLE.G2LK,^I)K0)O(N6?%PY>DH/PCKN1@%[IZ%0YO9"ZN
M)7Q9\)O'354&VHQ11EX#1H)QS5:"[X'+X (P&)N EQJ#UE +R[>%1-3J1.[-
M@5EWYEV#*$3W#4SWU35.4TB6A="+*E)>IV3+I2O[OBPP27<<90U8ZHRU']$Q
M2EOB1#52%%$E%)M>8+@^BAS/]QP=F[&M^VX<>Q@_)8TTRBX=NUJ+RQR7BLDH
M(2JBQ2-5#KCJ[:>^A74)H(@B7UR#R(@6&\J+25LBEP,BN4=XCT]:FT/26G+W
MLO35)D+Q<VMJRQT)P!;!&>>0ZDA*-ORMQ>Z*&SY_I5U)U=K-\D$B:D97GA3L
M%M)4ZO:L9F/J/!&V,FL*T^<\M Z MAP1'[RV+Z*_*L([I".5$?^M=W7JI*[Z
MFEM9RH+$I!!9-.IF;?U*EEY$_PJ=U>)1U*(=QU& X] V=!?Y$<*>3F(K1'X8
M4_?-&WOWJH.JQ5$VK?FGPM><$8%J51+;_3T?!OL]#.@Y@5#8Q/]83I-' NY'
M+Z&7AD1%>'!YDR_YBY@>#4D.282H[6E;4S=1)L+_; 13XS(J8DTVP9FMTY.U
MAF28RH.K2&M015YN("$[.D0P<75%M[* BB_#R?;  .*4BO1J4DSE6X\(="B1
M[J[HU'W'610%-"5>%%E2WH@^AJT5[G\X2'U85ZK"P7P!1LEY02Y9O*U,*B+5
M9">2(.,#94\/@.YFR:*U&WL9??0,FBT"?$;T-2+1<[[5>9!"K BS,<706/=S
M/L^E^(8( ZCSAMYQ<'^Q8O21_?&#^AR<G;LC:3$SUD.+1"2R@@CY/O:09:(H
M(@[Q39>88^^]=E M-LKN2%>5Z!?R[P4I]U%4XJRIBJKONP*1:G-\*#^#22&?
MWU4_8-F7E6+1MU3.*O-XTJMSEL39]U!!:/^8VD9NTX#&^2YNSE7KM7;55]?O
MZ7-W:M!AVZUM7!S5]]FL8*M'998/Z.NL3_C9SM0]1+[O3 [9!_A!9W+(<ZYT
M9>/8V U]/_0)]<.121S/C6WD.A8F!)FQ\Z0BTZ-LQ\9;.XIFCBI[/O2$!0=
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M/]KA+_7Z6ANGZ/KB21AZ8S=QJHTF-QT"BB2\)Q\K--SH3LSE3/&B)&K9=+J
MJK Z^BD[^XJ8$4,3\WI&*GM%M_$JOV-9*>X 3^J?VUYT=P%DD(P%=L4WZ,^L
M_7 FG.. 4+$:U^)XTK=J8H!< #/MPH0P"%=\FQ>\/R%]=V7.E)T6PHPC$26&
M&@(ZQC0)DWQ1IO?3VHL'7;7K$J<)%AGA9K&[T^=.:43W%0/DU*'";]3)C_BF
M%V]C*P0.=&Q>!']"72!L1"TL0.4W ^(OO$TF(3*T[11O4LJFK?0"UC,E@):.
MM?(J";46>-DLA+U9U6)"W?S;)%IP=A&8WEFW'4FW>9@@)W:LR/$]9!M.@%#L
MNY9!=,?S8L=X2KK-':%JZ]4+BSG+2[4/&B^:+6M<B&(NDA)V)X_CMPYLR6W/
MDIFV</9W,,[5RF11DDS_49 X9<*#I5VH3+K%Z:*N(Y:B19SN'ITF*EK/Y_Y(
MYQZ[$?'U$.'8-*@KCK'KNP8R/"H$(L=SK*=T[KWQGGON,RHFT0J]/63T8/ 7
MP:GDEA2G[TK9#>E>HV8"YK10]!;,+"LUR L"'D@D ()%DC*)\:SY+B'-=]E7
M^:\Z-U@7<EZVY13T#2XW"4+W/5?%OW(?(%/0=%BF*NI.TKUCYZ&,AO"L_IIV
M#77E$HG=^UWQ8V?]F*&<%QSLUP<):"($2=G8T*I9#$!K)G ;2PSDO3! X9_<
M!N/I;Y6M FAX9ID"ME/U0$=?U,89!R)VXA];N42301W3$X[9RF>2V/IZPG?Y
M D#W9.6T6>0DX<ESJ2GI(B_H&*EP[$&:SW,PZDGY?"B8PUX',^6;=[*I$[&T
M_U?Z%&==>"2@F.-$H6[$AF-A%)(HH-9O8/LV)E&$0]M[2KK0'Z$N/&:&?>C[
MVV79UXFJ))/X82E F7]>"C$'R676J9;*CJY(X)@XKF64R!3#=>=U91+<A;G.
MM=^O%/S1E<TY@)=^F,>XX*9 *VO/%(Y@ CH+FF,9W19Q7(P\Y.L><K"/73=P
MJ9_M$M=%6$=/2= 8^@@E#:/\8KYL?9P%Z(/^#3B8<CU8CZGX\(8%;NE5(9S!
M-*U-&G%)^_[,[!H06@6YE''@=AJ(6^PD*4OJ6 ^ 3I<A/SUFER)6(#H)V#\\
MXU(D!Y%WFP-$!SZ%B"D,8J)9.I>,+5B@1,MR.&&]!' ';GZ=)<NQ3!C=]6/D
MZH818A3$KH<=SS!\W_2LR+?UIU64;(Q0LOQ=" SJ!221Q E'^2*H)L)9 _0R
M]SS8*8QQDBX*HIHM[7B?BKE2^#JI%J\]+F-J3>A_$/S'9^("Y"[G?IOP5 'X
M**(LK5.3)J40W?-E+W_!1+BHW+-MN"2[XF5>D#_I54T^[9KSE(.C)*RA=BIF
MPH1DS:?((<[,*YX!&3,K#)#.L (-Z-IZ:9RDK+P)S*O>V2B5=5.-0R'(-SK<
MLH3P0P<4L5+HRT#'TMRAXKRJ]H-L=TL,N$P-27++BMIS^DU>U*X *U^P\$55
MY-2U92!,>A&+2/05=L'%^9QDG+B];"A(ETK:ZSM#_7HEKZ\+P=; W;5HP38!
M?&=@?W>2<NHF'[_R>.)P0/L,!SQU.\*+=.(:D1WI+D+$]'S7,I%-K0M=-SP+
M/:EJ \,<H1W1A"Y>#&LC*'I2@Z#D&WU@UDT8M@R(IM GN)?*"*L$09O;%2I:
M#_AH9T"T#</B'@&+K#/_@L?@:_(B%@B!Y["CW),=P!&>LU#0#";5P'UJ Z%<
M&G+;8AFH%5L;#JJ+!3ALA865>31GE4D&29%"&!J),N4VOE L6DV(S&T<:>(P
MHZ-/I_8YGL5 "DC0Y,O@]!V=<YFS2#9=H3#/,A'?9YC)CH^I3FDB[IKABFIN
MGHPJ0VHXL+G* ):TZ?KR">WD<Z?HK!3V%:Q54!*.+,J6DL/U2K7,UO84EPS%
M-01<XS<M3E2?^+X+L$D;NY:![( $4>#8,;9L.FA+=\F3TB?62/7)DN\$$B6]
MY_*@(6'JGNLZ-=:<[UIW3%A;A<[EU+!/@.]>,N'+&F^&&8$?"(NUJ3CTH7@Z
MJ(V,W)%H&7X"XI5*-/IU@-"QJ'=9\ZSW1=<5$I6&-.4L$8X%IG913(U+QS<"
MA PC\)S <OS0TPW=P[$?/RF)@$8H$=9'JD3[0#5 TI@"+2(#5H !:>PZ4L2[
MJ#!ATJCK9:NMBS!896=!*81&[=MDMIA):Y+GM+I6P)+]MV1A\MK5. %Y)WD$
M)*1V7N0W29!44N@4."EY?2N#PR8S:97+O@PM.#/O^]$':%8-N-4 YMX6'9LM
M>R4;V+27?FD!9!SQ+/^.)/^",+2"V ELDX1(=V-?-UR#6 ACXKIF]*2*20Q[
MA/)O,SJ1M1%A!G4'-Z4VK:# H>'QI<[THF#N4B$P9/4G,VJ%+.#17?P=AZ35
M2+:&0:25UR?07D<K\PE')=5A?FA85W%/O'&9NP* /J*1RVWDF0R1QXN"C9=\
M@Z9/294NJP+&N5,RCUQ8C="-)4HP_> #OM-LUW0O#=]Q^>@AA,R+^\%;[(*G
MA*^_TD,_BZLCB:O0MV/;](AOA $R4!P@SXQTI$>>KT?8>UJ)16>$XNI]7_)P
ME;DT2!XU$5!*(0 3$5GCETH6K5Y&C DSPB!G!0U2>1(2H*Y9F)3\<SJF/.,E
MK6VR\M8XV5EF#F4=)XKHI0P0#)*D+Q#V)I\)3N>FNNP-GB<53K6/0"Y"Y_6^
M!9GXC"%O5DIL\#(QU')@JC_F5+NHT8()RY;?+&"I:EZVDGVWU#FS.BH>+90P
MCQ9NC"]%'^EO[9ZW3.6RGH%:H)?)EL' 6"UZVDI//8D5?[F^Z0U)YVVKDL-6
M,Y*"6<K2A )@SJ*\9;6(N+L-OCT+P?%"-CX8Q2XOQ=J4-Q*P&S#.T4I:M,!9
MDW4AP+V@%:#_$B7L4&?7.06*5I2A9]BG,QS5B/#6]MIO/S6V<\UUW=<UD+?(
M7AF+[Q[1[M2; "9G=TXK4F089C%PQP-IQ_[>3LJ_CIW_''7VT^G-?AXD]SGN
MS.?J#;#I^SD;8:NRLEZ("/WCDPB9L>7K-C7$+#T(@X#^ZVGYC&.MTJ3R?A."
M;6IT<"QW59(T!G_K-L&#,/2Z1*7#[JT8;9U<6Q-(8X0B=0< 1N=-U^4F+^@F
M74GH?7:FCA7[\4T["ET;F[Z)"#:P9_N1$^F&&?A>Y.Y(AR0YSHY]C)$YM0]X
MC,?9/*8Q[>A) QZCVC!LHC!W69/JHN?SF1+<;GJ_B*N?3VK^(4::U!3K"2P<
M, O3<PU,1+P$0Q9PQ$E!5!N^>0K\AN[76?Z5_I7"N<H8!A,",GG)BK*I_J]N
M_KW <$59,0)'*H6N<0KU@VF>1TL\$FE"#?1(#@ZN#A;0_'N>S.%T)-F?"^H>
MT%G?$FJ]I^W/<%*$!;5>)G0>.123EE61?(5KZOJU^LY--2I]P'4*3@?_U53[
ML@P [+"U2RJ+FG&DC71O2$947A%1C=FIH^PN@*SNXRUQ#DL&LCZGTH\[[4%$
M=OD<&69$K@ID(N@!$#2<K'^0H!>9@$,&'> %\*$[^Z8>B7PCX:+B.UQB0S.9
M@&C I4I;(P6,U%L-R[H!+0WV+LDBZG*3- )7G/Z0W]%_, HNWJ-,('I@W[(/
MHYP5+'=S( WI"'/#6RYK"L$$]@4%TL1\M&5WLI_F:Q5/:-OQ/FO-HV%(#!/%
MD8,MW4%8MW%H>,A EAUCQ\:V_K2TYB@;W+Q9P0XH(V$9SVEP+1@#?J/J<AS'
MA%[P+&& M>=200IY*B6L(%S?5C.WDB:-=I8/X9Q4H()[N?FXO<*#=UW)\:P.
MF9%O(9E+*UTJM^<34<(I2]&IC!(5F?0J$VE4^U<W)5=^2FV74FVU5O5MP*TE
M-->B4%NV04D"SQ'Q&]2IHI:V6[34W5(4LM%^&Y6L+X>2FL-T(*KD?E++E=FZ
M+F)VF/JRW:5!W<TX[=W/N!T"5KMSLO,L$: 2%:52: J;I+L &L-PMH/+RDU]
MP27)N_EUJ"17FA0W..+T7#Q?"<TYALDE^][86>,=)-[C8!TCWS<=QT2NBWW?
MTO7(0JX>F'X4AD\JWC-&=IY!":.0KDPTAAN@9Q2(<:.D# O"+?%^'DHEAL,4
M$J1H!I41%QJKB];826?/$7FMEG9I :Z6;]WC(O2/5<EZ*-Y25&OJ!DVP 6\#
M%3[W.6OUUA5OR\CM_E1<\[B>(K\&\*T]X\H:AM^LGH+*[Z4+)AE3VLNB]MS;
M\G@\9=CPL8-LXD=(1[$7^GZL$SO6D>6YZ&F)PC&2LX@CK1*5$6[--"EBB?1N
M@@B#\>XVMU6;-Z6!)VQERW4IH!K!T%>BTDJY\]B!..]+>5CI%?#ZI]J4TYY!
MZI?EMAN^TU4#$FO%[?GOQ%#%2%Y7!;2ZDS\I8JKOTC/DU[R"[4-U6%:[H J#
M1JNM.(NKM8 ?81*Q#+^$D3!,;TW)II3BL3UXV7$FV%5RP<.D"!<S& ?L](8S
MK0'ZP+Y(!XJD1'1/MIT57Q+0!BSBFHQ[5![L)H8LPX+,31);:C&OZ4+J7<TV
M(3T.[)]=8KJ.MR*W^W3H#3_&PN[CPQ?<<_'V,383M1E6A2J.^?#V^^_M3?]2
M@3*U"RZ:\'Z[KSOOO/6@!V^5X-[WD:HTZ\O7LW0*<S,Z32*%]&:<ZTI$35[.
M,A7E(FC]O GM' AF>6I$Q*_L8L5N\)RU:ZZ[J_!P3Q/L!-5>)W2Z"$0F/^_5
M?")6LHYLXD#K*DCF6D'*K7NMJ7?C04^5FK7&+\H*%E",M=*2-2P\9Q03231U
M\?/[+Q?P.MC86=6Q<-=$&6!KL1B9E;#M7IX;-JUSMRPCMMS8-)TXL)"-21!Y
MMN?[KNE8./2<?=VM0WA!(_2!WO 3J1F7BCRM-[ TXIG\G(B]FA0J+;J2J)A!
M ^($IZ6$7*L)C4&GY_D0RD"&YA>%-$%[B2&5WR^?V7:2O>L(<*(EV1A9)6/H
M81?H/H"S!>\C5H16$E)%KA"$VV#]6=1)+(4P)_DC5T]XQ:IUI\^_L3K%SRQJ
M(;8;J;X6PS"8S%EJE#+@"&]("B[NMB&Y]S)NXIADX2U&<(4Y_*4&=HE)I>X>
M!.'L%L:KYVV6\)YN8CT\X0/+L,3Q+5^RRN@-E1&DR'9\XT2V6:-Z^R"DY%DW
M5J $8)11*^"7[N0E>UF=$>O*'YFVE4N[BGB]#QA%%58>)LR,87*D]6JDD07]
M8D13]J)M[7!A#*O3@E?MV!!H20*N@@3UP8$@U2O%@:RF:\1"5E?6P3\P1^4T
M,J+6*_# Z$\,".IF8:5Q67\0$,DCQRJAF?[!HC,>*PCF;^?7]Y\UR]8GU$(8
M?SCG1(TK%!DA,@W3\JAQ%7E&X)G8B"P7NP0%[MZU=/L;5^/$EHB#8FJ7VH?E
MAEBUX0,@ZJ2(6.;\OBX XIB3^FLB^].&E@CA%.01J\95A10CHN1G&H+<$,2]
M'[)KE@R+KJ75TKJ]SUXR+NIC77MQ*PV72<>66#:U!'(/TPLQGU5RG62<RG'E
MT 4A^EKZ!N:+]D(Y^PP@Z"IV.<A&(%3GH7N,];07:XEDI;"9+7K9Y%,;@*_R
M3&7;R1<V?AFZ54B\EC%[QUOJ3<,VTDO0.W\L_8%-UX3 &2G'@I66BL8PW0BQ
M>''/_NOY0P>%'WX%5QVLDAL,G;9_K,"5FM'Y'5^R>1*6#QD*^3[K=#75/BL&
M-"-HJ1&#OV(!9&C<=?HO*MP7%1G<0@\X^)^GVL]YE#!K\T\JE0ED!\M%RL0T
M9[RBLP#92"<T(U#="LJ8*B@Z&"(LW7\ODOFLE4/"VBRO1/V/@/$/P*FSFGP1
MJ&PP_9*J<E62'9:Y69&-><!5>S-5#(1>]&AS#)H"">Z1WA% O F@3 SY A[$
MJ!4?5A0>DUUP(5C-!MC,\'_X2:Z:*L#&L#14-#(55X]<H8,41<K@3?(T'GV[
M="\)I\!C4ZO8[3FBB&!YC!1MF&GEOV<"40J057&KQGEJN+$A(@ :-6/W1V+Q
M.(&XN!C .?1UL=_7R[N;4CB:1M@^LW.B;HMMV,2U CN* @\19'L>]B+3(<BP
MS B9P7=W6ZPQNRT6=5O>S>9I?D_=B+_UM?3E_^+<:&I3MT#1 )PF* P7<ZFY
MZ%')Q$$"BEUP])5@"^%/I&,6_XIX;1F4]M1A)^D0+'L)PA-@ <22.0N@?)HV
M2"P9UK@+R\4TW1"SXO=L'FE>&EA=S#H@BDV])2R8SL=0([NCZ* B,U$K&1J2
M7HG%[\Z<+E15)-PQ5/#YL%ST-7$1P9<5N$3FU<V$__(F7T#L,,")B)#.\Z1D
MZF=%1E$&>^@+:=ZWLM2=+C#L$AFGGR49O<.ZL#7I<]I:X<JE!=B]L?<NG;RW
MBMNMK]T3[F"S5QX5RFEOC;=XW2Y2:=6E=-P,H(Q]^<C0 E]J A\15N:U_G-H
MQA'Q!DNP\W@Q?1V?ZI#C-NSM@@!IZ 34^['@6[H<8IJ46ZY]WNG^+X0]RQ_[
MMW(U;;S:C(H*!M&?HP8WU!6E]8E4 )X]I,%\B>A-.7NPH-:,DCHW>)U3@1]3
MB7<SU(NF3H>4"GA<F4/].[D" \NY$@3*Q]D;L1)O&;0K-V'K9E@9*ZVE+[L$
M!<+9A59G61<9LWNI^"R@(4P&=TQD["I-.+AO$ZH[V#;T34-+KX(#-JBPKQKC
M&I>5YHCN7."W1+?\A<JWF,+;8P3*D*(J&?P.S(TYON\9O.1LEDGL_A5BY>+4
MI2J7T*K; OOHB_@'! 6UC%P#^1@,HJFK8\-F;Z!Q-9K=+[N,*:*_M9W$:6JS
M^9=*OX+Z-VH6N]DI3;#@C40%?0!(I.TBX]+P/>,,23PH)-$[0Q(?3K>/&:=H
MOMRZ&O^161YK<8I]K/Q=A. 0Y&XOK%T#5E2R,6?$W<;1%3-"'B&&'KDQ0B:.
M?6R3P'!]WPWIQ]Z^/6'[ AY2=&^V%FN/JB&%](XWO7@]K<7\V,(XJX!%%^\D
MEN3O20&OLWT$[T_>7SQ.*/J]2,JSZ (GJRF7 LH3YERL9H41?# "Y2:P1 WN
MI<TI6M]9KK=T(_(V:BW@D3:U5DW(7@6C6:=6)IPYEK=#BI-O%9L9X[M9\+S(
M\V: W$MH$_&PWXFZVJ6A-E0\?* !:9'S-%BP#A]K(H,E#<*T9J&J_81>,BIJ
MHE-+FPG2!R>D6L= 15\H<!+PK3"1E[4(J9K/!@FIFK16EY>*/X]Q=G!G4/@V
MRWC-57B$QEG?'+VI1,/D/JP-G1[_[_])8E[-Q_HZT[EM"Y_]6-^SD47BYC60
M]O_=* JW.XKTJ<)&1X,354,FQX:+/CP^=$!HO=)^$8!/=?J'B1^O8;\Y6[]]
MUB^)W="WHLBRB(Z\T ULV\).X%D1LLS8W9?9=M_<8J^].T:4Y"I)U@>:E/'K
MO V;/)NLPR8K2.$>FA&!*.U-V#88SUJP]:=KU\-/Y9JW4*A=D[FW70RCH%D4
M+. D^AZLAG+6_ (*E%/:0CS]237.GZS[:<YSPSTI3^66!6^3Q50%MQ05NQ :
M/H1@^\45TRZ++,UQ))//XM]R\A&YA0XQU-"C&IUI=ZVDWZ^ 0S2F4H\^+X%?
M\^2IT%;W%>OK<(.+&;6'F1B'Q .\'OI.OTK34+!4+BKJ<6233BI>M856)62?
MB7>64AV3/N_+S\*($JHCRK;Q1+T(ECH2,+4Z^R&!:G(%^O!JG1=4JSXEZW&_
M05JAS;7!A]W:&$PAWV6D4&C.BC[739E8W.XGI&Q^I3D;\][876:U(P(L'(RO
M)Q?=&.H#$"O&35\N:M+>GAV(\0Z88CJ-&];B836JF&#&<K@,+;Y:@BMP<!1_
M.(/ :AM@8.O"V)70!;X/G@02]O_;&=-FH*U!;5G>QJW)M]&@_^!0T*MF.6\1
MEO4A4K; H(ALV-F$7&="QL0)[,BS<:"'""$+^X:I$\,U(L>-B6^,/X!J/=$
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MHKPO(/]"^;U@9N*M@RM)SK3UQMS>!'G0E=Y?G^[U/CY3>;Y@R[W%T3^N5'V
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M&XJ0/O ZP-?-2X R4Y^1HYEK"//0]3;T7MD0>SQ HK;?^EX5"4Z_[^H:;M.
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M=>9]T>^U Y'\OLMC5#>L#%**:TD%($NZ&(D2RVPMW-T-KF#5RXJ%N0:N$ZC
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M5$65?4<AGJD[;D"^ 0\O/3Y\ WY9M_P+T>)'\J4E2]O+$R14:LNMN#;=+^2
MRVQ70SFW<%/96UEBH%"%9TU$N(=+<VPM7M$VOFV'&]*TX672K>8\CJ9X+U,L
MNTCS-<?19$O7#<5V':SYAF\B3YW9Z# IF)>$!(<W/CHMY;Q0JYX4%MDM$CW
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MH29.5U15QU@Q;0?TS[%M*[:CNB9&EFF8A\D:G-G$R:>32U:&VX3PB%YKQ5Z
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M)E)MI)I-U0/YQ<.:H\HY#W1_R@*R3!,<TE7.$:=,<3!.%%Y ?CD]]LR:4^M
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MOFY^?D)_H<2#CFR_P%E.((ZA[^=X ;>42K?2'W#4,Y'>!^DR3GF^],M(M-J
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M=7=1W=R*Y63YT)& _%'70 \J*J8V\K@(*&J1\(0>0=&J>5PI'N/$Z1U('K$
MO(CX?TV?*YX>0O/APZDZ=GHWLU7A$QR*OQD*GB5![>&C><T+]8X@)F+(DIJV
M^R&03/%IERBDY'W&\8:MW\E6S'A;OIC'HP!_T[\;,8\I:%K[I:,Z>SC,$X\[
M9\X3U8BU_?KTE_KYC=.RCQX3N<KZ3U1CV6J/F_OL_/IF +W3T_[EZ<<+&%S!
MR=7ES<?W@][ER2?H_7+=[U_T+P>YB5^FT3YG4K%P\B566T$]3JJ> NLE%EO]
M=H,1DW#&A%30"P*:!%D,;]6(3O&Y,?EK8\&H%#%V-Z_%:I%,SE:?F 042!)
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M]7I[W[4+W-;A$U'W[!XU1?T&-*I!;\S&%?!,&#,"3$F=PU)(!4[)4@3Q]A;
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M*J%IJ2_HF.DS#\A$.2_A6R94%!HN)7]#P9&<8GSM431YD J64Y9))-7B/][
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M8$PG)#*--R6)C0/.8;DSUL[^,P,.&N'W:WM+<[=1UN5OYS$V648A&['*(^G
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M4ME+*W%OJ;V]K93Z7;5TLY3Z79WU?4JIZV2L6OV&*Y3[QK+J_Q=02P,$%
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M7,(3]D.UHZNI 5^_X1M'FW*+A_6U_UK^?@SK#A0/*Q<N]P?HID@#?B\F2N;
MD"YT/0;I5TWA;*$( #T >'E5@P6,@H#WN1X#CR<AGRF4;B-=P9D2,R7+2DRA
MY=(*)KB2:6#]P.LW]19=2J$I^G!B59''^WN/#BL@8Y#,>&<*DC>IBQ*&(\W5
M! 5D72LU %T"[AF![5YN5EMXK,=%"21*(KR67Y2HFF0L)+,&/3(-V.\56'J!
MJ63D?#J 'O(D:U)DRM #F/Q5D<.JS8!\BR9+Q5B>*W=3BNL@ZW :V+1M#8<R
M+=54E@IF$"P?-KVIPX60T&93UJA?G369A%GS#.&&$IC]&1R=63A)P@AX@:JH
M^WE=[AB-XG4N4,31*D1D:61)>3;<W!T(_&\+Z,_L'XBX>O%VPXHEI1Y:CJ!P
M%(E"60I\$&R)/%%,-)X0#?7! [SB1&0U:!(5#V_*/V_2$@,M-AG,=506$UPM
M5E9,7VT2"D:V1:1,NB?H,1,8$2Q(%@(\ ;N"Y:T6D_4AS*LXU[3UX^)"@2!!
MZNR.>JCJ"Z5ROWJIG%F5J3U<6*IS#9ISV), +8TU4F2HNO0M:%B%'/A%>#,M
M$8ZXU!4NI!T%W)X#/T*JV-L7$]CN<24NB)"'$2-(%5!)2F38,VU8HA*5S6F!
MK9M9=#9RQW'U#G/_Z=GT\!NQZ1/+X *>[/>)F#,M?F19.:YHM^:%9:&GEH6V
M2&_G-NY1\LWV"$Z]2L/C\_(2+*]:GZN.*!6H],PY]V"LE2@-\)BCF02L7MF&
MK'"KR&A+X426$U@.9T*>>$D(S$TF"=C6$I@L2VZ\HV/L4C^!Z6JYBU?2R(YO
MCX#['U'GT)5O8#/=VA&O4,B/ UXBSPO-(T$17C1#HRQHW%D-+4K;D\S[.Y/"
MK+!?5F) )%4B)N3T3J-<&DD"Z@:(_F[;%^,"Q;,="700&M"O05"*ASO'V/0K
M-%KW=[=?W<J#DJYU4+H=MPP4>Y+,RC9'+P/HZ-A 1R<!@UM!/Z4=[Y*-1N:8
MY\9 I(=D5X^5DZ+):P;0$/B$)[=?R*HU"D2[%/P4',%V=R2&U66B5%KY$W&%
M+J@!4OHN0) ;24TJYQ"5"3>"L82S6//%D#=0BT5NL"N:)@KR',ZC!EGNYEW=
M2KI6WT@ M+8P% 0+R99D022Y-YEC$> KJS&<D+PA[F95?[JJ;7\,K%;A8Z@S
M W=6)5*B,C =/JJ*$6*/P.//@1 4*Y--;KZ@A5(;H+8:"-]>,25K?4#D4^H$
M;P;F6AJHLGT56@1]=."7 !1/%&4D /P==N#81/<._G&+=?O0F(%ED&#'#2L-
M:GO9UI_YM !#/P/MNT:-'%35'/\/SYEY\HD QH_V$YH H*#+LA;-U)P26==2
MYVR4@4@2K]QA^:BF14D2]"U8@4VIK EE1%XDZ?P"&)&W\)BGA2(#U DLF><-
MGD^9P30',8U8,-T=;J.B6RDJD D:<>:T?J#Y<YVPF;RX-5C>?R-_!.JJK*8P
M@(\EL(HSG2#EXN39'BZ@!VH'!NM^\'-O\DQ52.95X3NXR@HOX4I)!CN,<J0>
M.S\H.6$9#3-7G-N6L"J+S[[X^.'5!WFF7H!-_^48_O'07MC%%&[9'N(]VW)4
MHTM89A=R5LUI*,0'T;N<%T#2*;1C/K0<S-L&A637<'<V[$ZF7R/HU_+ _="E
M;%#?/I>R X2CE0P__V-[V\0MX%S>->B& \&HZE_A\Z_[O_[ZJXE+N 5R8?2-
MY(*C[% B=(@\=#H)9'_V(#$_PRN!2">."3\BAI+.4_7Q&J@7V,FT!)ZB@3]X
M?);Q(,8W^K"2KG; <@-9;-_82E)!NCR5V#>A;CVLP4L8YODPSD09EUN-G>-5
M:!(=A*6JFS+?Z66TEK\NY",B!PV,&.Q0Q:L7K,!O_7/G&3&\1^L-=V78MEOM
M3R]/;J7Z=/:-CDF@?R] .60>DG49@J?]UG3O9J8-@5\3N%#B3WF1D_C4_@ A
MF?MG2T=+@>\7!!LYKA&*4_ )^_"NUDQ>1"H4-N@@X#ES@#'!,49PALQ@,("0
MZ@(URD""&0+*53-'BW<:D)N?P6M7>YQ$.C7!A@9CK$STKD5T2+MA:UYZ'N\%
M*)EV%OYT65##ZB(E^2IA!9?<>?N.U$)GYO[.FEX[.^-K,N+I')OHCY?GYBB;
M(>^(U[&BOHI/A$SQ?#G:U6MY.R;0Y*#"U%EHE"W4Q"\TF&1#9;5@'!T8)R.E
M00*I@8/(YG=HNKMR+Q@ZTTQYXL'ER'W:YR;]N8_$V@[/SR$4Z7>2?7EVQ:T$
M6;YGY*TF_R<^KJ=:K0#B&"89/;"\NSG )VI=:.K"(H$P<UI<:$0;3HL0*6I?
MJU&^-68_!R JSA8%&H*AJP)AO6-&PPGH'0R:G!V 9(Q6<\!=KVVBJ0]\@J*M
MR<%7L3":?_P4R/)B1IN*G*0)!7'HWJVM)$>)1\S%P="^B0$HEZ0URM&(SF./
MED%AMY4]P3 LL0R];$5IN>6^?0)O;3]9=+H-I J+.E3VJ*O4GW2T4? , T&A
M8@1[N6RGE@F?'?$Y_,K-4ZP!AQ6@7Q;(O$*H*B"05;H.(PVF8$=-:_C@'=/2
M3SOTZ8O?$>AK <Q+N^+@AU#J@+(W5O /AD3AL&668! "057D0<3!6'!.Y\1Y
M;$PG7IJ'J$^ L'!W/!;DYPE:)% =JIF6/RH^=>9;%"Z1QVBZM^!"8Y+"3?IM
M2<;[+L8Z&:_&BAVDR#CB "Q<3;1EY+UGGU[+(7*82)TCW@6LA/-&')]A5UN+
M^9C8ANZ:L-U/H08MKAXW#+O'D;#AB#PQK$1[[#PSYC+PV28) $(?AT(N"4L;
M=+K(!W.&ON:Z&+"<DI=P_FFQYGI)VKX;#M2A(=].O\1ZCFF4X)XZ(G]HD6<S
MK\,L(GIC2B+I.^F^B39>RP-EU5US\"7(:X/+H!F;&2"9'1*2'-]3R>+9D ,L
MI :B!I:\9?29@<&0+$44HWF!0JR-]PS33_\[C-?J7S@BX"A9%,6V2DS5F-0@
M0I,9JO=(@JYJRRASB[,'ORL;I$V.$7M'B#8&-T/S!1C\[(EBNRQP8,QQI"]Q
M7#!9#96-%P*JZO%.!NMD@HBF-M(KX,%]F(L!#@.7AMTX3PQSO6]M(<>.!_(+
M@8&*:CEQFL6Z>^4XO1$!1ILE 96S;P5;B2:VL\*NAZ+":9/%$)B-8^1685B>
M2L$2/%5317PI$I "9XI'=ZQ6< 03IHMN@%7#M[Z##Z8G$:G3!'LLN(V^U7?>
MD0B\R%%SR6Q$,S[@KLWI8>-HOS=8^3;ZC'YJ.;P0C;M_\]&XUY-IB69(8E*\
M0CRN1UEE3FXY#EY9JB9:[V[N'/%)D:<VNE_5:(358XJYR22%,6S*K8$ FX_B
MG9,M3_;F>6_@V!AAXQ"K&1,@3NN2S&S<*N8CV:EF:IG1UN<SZPF"ZT3+V45[
M5_@1./'GT$P]N@/IKOQO%"_(!B:H-DAHBJ4O 6Z@E8!A@9Y%1N"J"K8(=U.A
M 9JPAN'!*Z8.#KX*;5#&!\P6JO2P)[7=" (-MJ-.8'HVQ-OFL9/..<1,-A?Z
MS[VC\Z7NH\LL%.=X8)Q%YB>^]+P%T5PP33Y3?*3JSD&>$ H16I*@_:C)M X'
M0L=I.0AB#4Q[_-I-4KY%RSR=9Y4>WL;3L1[(9;E-VZ@YUP7:W6)<3) ,@9R
M(V7R A6]TL0>TM<@W]0EX;A,Z_W'E&J]_Z//P5(Z]-/O/P?#WG-0# E\ >.N
MF.K<@"S1BN'_*Y4-4"BH*6>".G(=6$ F$CG>+TJDSAO!>&&>FHZCPV#[]L<
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M>?>]\=\WQEL9>XR,K#6_E6^N^<TUYR9\(RP"%^ZI::H!)"0DP"/B!R#, '<
M*@H*2@IR*DI*2FIJ*AI:QO.TY\[1LEUBH&?DN,S%R7$9#+["*\I_A5N8!PP6
MD+LN+"XA+2W-Q:^@+"^I)"HE+?D+A(2:FIKV'"WK^?.LDE?!5R7_ZT%H!2Y2
M =E /8B$&R"]2 *Z2$+H!+@ @(2<Y/<!_'.0D(+(R"DHJ:AISA$75%\ 2$E
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M_96%QK:&F[P) ,]P$&0+ASA@L'QSB].:'YOZ>!G_D/CO;X4VWVQJUST5W2(
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M4:=HK5,5@"9B3TQ4"J ]"0&0H;(14E'&1W03C05$_?SZH;F%U;MK  LI4I"
M4#L3U=@H'WL3O8"-O4E)O,N(U<M7;;_SOL<Q!&#%=Q>"@];B@UR^.H*^\!*
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M]2SPD+)6!\;!A.0S)964Z%+D_ B[*5K",>7<4%#^M'#I0%)ZT&]!K_.)UOW
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MLT/1NT74LHHJHQ[)?_%0$J;^%U!+ P04    " !=.$U8<76?HHX3  !2%@
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MMJL.UPHF=1]N,,]%<1MIT*QQ[2:V[377=F1I/K?^($>4D+;2#O6LGFJY+JI
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M 7CU$M;" ?5"3!."V!_7@]%@TKOI9)K)=!HLHF#.]"R*>QX/:@?1XHX9+2]
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M>(2+;2L)146990C"A6HN7>Y>5.?M>>'=<9I[%JA'M>^NHLP^U+. Q1WC5,F
M7&R7 65CO*=E DUO@2(ONX2F]*14G)G7LHWA1SZN06@8NC&M8!F;"8QJUR9
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M&=S'?T]A_Q%<VR1VLT@UR@SR7;:!U"R;(S7_S<3W[HQZ2[1R?_L_4$L#!!0
M   ( %TX35B:UB#M4A(  &0# 0 5    :6YM9"TR,#(S,3(S,5]C86PN>&UL
M[1W9<MLX\GV^PNM]=APY<R2I9*;D*^LJ.W))RL[L$XLF(0L[%*$%2-F:KY\&
M#Y&B"!"0*%!0]B6Q)#30W0#Z!!J??GN=!2<+1!DFX>?3WINWIR<H](B/P^?/
MIW$T.7M_^MNO/WP*</CGD\O0"30/V>?3:13-/YZ?O[R\O'E]HL$;0I_/+]Z^
M?7>>-SQ-6WY\97BM]<N[O&WO_(^'^Y$W13/W#(<L<D.O@.+=U,'U/GSX<)[\
M"DT9_L@2^'OBN5%"0"->)\(6_--9WNR,?W76NSA[UWOSROS37W\X.?GTC[.S
MD[NOXYLO=W^</"U/;OXZ^^-R>']R=I;\2DF AFARDF#W,5K.T>=3AF?S@%.5
M?#>E:/+Y%(<S'[J_>->[2#O_YQ4)&0FP[T;(OW0#SHC1%*&(G9[P3K\-[U:$
M 3#QT<Q_XY'9.?_Q7 Q\WB):HPC^G:$P8H/)':R/&=+%K::'?2%X169SBJ8H
M9'B!=L>VKKN]H>ZRZ6U 7K2GOKZ37=%\<.F?*'*? C1"7DQQA!'KA_ZMB^F_
MW2!&#\AE,4W'Y5O9CP,TF%RCIZAH/P@?W(C_O;R&KG"@1-I^!MZ5'7W/(S&,
M.$0>PHL$N]78F[]ID+M=Q[N2,XBFB%[%E (7B]Y+_!0TT"!LUR%V)?$N7$#'
MA.+RF*4O-4A1[6I7E!\IF2,:+6&YW_POQG.^QK^BJ!BSKH$&'3OUORMQ][!O
MR_P;Q7. XB.X05E[W8430F>)4A^B@ NX,4EA-2AM;["VR<X$$Q=2D^2W>^P^
MX2#Y9@<"5;IM4VB4NJ_LZ.WHV;KO78D:NZ]<7Z3*O:Q/)@B0\>'G/F-@4VU'
MU@Z][XDPD+0D]&"L9-$/)N,I(A1%V',#V/T+S+V!6T)3,.AC=V*W'3%E +3R
MXB !O0=RUQB!7B,4^LC/6<&QV,I>YB/!6 'QUOH/N'-!Z#JG>?<,^D]<B(G+
MGA(_(F9GSZX[/^=3<(Z"B.7?)).23$CVA9/.>-YIX#ZA(!G*66_@O$TY8!BO
M; \VHI>U<WJ&L>06+J@G_A]740LWX(9@/[IR*5V"ZYK8B!+LE>"-4U5G]#;/
MA 3*N3!,P36:$X:!DXJKJ+:]\\[TFM^PL,$>4M@"$C#G1\,T))JQ9$ K42 &
M<GXRC']N2"\!!PG&Y6;.SYW(QJ^@QQ3%8]'4>7\(:UH-=3FD<4IR,VEE&F2\
ME:X3,9#SP3#^N3OU"+9&5'&Z)!3(P)R>:;-@ +B ^14^)V[%$#]/H\'D&T,)
M6V421@;G]$QKV$3@<1G"HB1TU"0;2TV=GFEE6G('8/Y'$?'^G)+ 1Y3QM1 M
M)<@W@3H]T_I)"_TZA$TKI"LRFY$PP:31FJPT-8]LW_<Q=X[ F7(Q"+TK=XXC
M-R@A)A/XC<!.S[2J'7+W+T3^C4M#D!X,E%(\BY/8#(AV[&&9T&D&=GJ_F-?'
M.0YIE&,SJ7!/&%=0X!N[KW+]K-.3TS.ML,<T"<XOE?;.9F.G9UI#EZ2EFDQU
M+DPKKM+@S6;]9F/S".=6Y*.[Y":DNC>U#F >\2L21M3UHM]Q-+V*603;:15Q
M7#:3H0+N7)@V):IQ4T77L&XAF7;.2S@HN2^U[9T+\^:#9!TH$:+8@WG2JDM#
MB1HQD'-AVKA8=TKT9J41UKDP;5IP0PVG3@J/:<*R ?10Z,G5F03*>5>XEZ7(
M>Y^N4^-2+^\?_EP+NV^>KLE:G+-XEF;:SG"$9CG\A)*9(/R=#TGD\><30L%;
M^'P* #$#1,@\-6E/3UX0]SH_G_8.A*82SO6DJ0:GCXAD>0P[)[1W!)2*(MXY
MC1='0&-#8#PG]=T1D"J-H.>$_G@$A%8"[SEI/QT^:4TZ9"VT;9&H6<=;8R?6
M$GP<]$K#_D<VMTT) HLTB@JYC9D$B]2*$KTU^0<K%(I*[D% <WW<WP81)<!<
M8.#7Y N.CDBUK((5,EF+;K7D@Q7"66^^]=,25DAL+2;49S,4Q/99]X3N(+<K
MJ1$K-G45YT;*2AD)&X2U '.YG["9?#DZ4E43-+8MXF;*)2D=*]21]HY=3Y+8
M-J$5[+=8S?7T'Q/Y\JS24<ZX4@+*MOVL:W T)*_4R?]T7KE:LL_K)C57H(TF
M"K_RJVZY(2Y)#:ZU,WX#Y9&2"8X:4"P:&;^E4;#F%I9TNO9B6'[9QH3YOD03
M0M$J!HG8S2L(:5B3.'3I\@[60++5N>@F :#V?!=&B"(F/_B^MU&-<W EPI16
M8TUKXQA_H3!JNN8DF)9:&<=PB!8HC*49_[R)^=M:A$7\!F RO/1(0JF=\;M+
MJW5V\SI'(9.R<J.M\?L^0\00*%Q^4. :&!:0)/2?H2-=!!(XXU2,4"*) )GT
M!$#!40D)8B#CMY:^H! 60@"H]/T9#C&+^+)8H&8B&B!U[S9MWOSEWZ3V<76Q
MYA51-G!K G%,GVPJTA\I LUWPRJMS5^46>G?C'.7,,]RK2& ,'_?9,WLZT<1
MQ4]Q<B9G3+3-%>V^RC=2NG)(JG:O./%:V)XV>-7K"-<3M5_[T@8N[9D##=[\
MFG%K [L$F->3N6X9VT!>!6-1KF]E41\-354C7"&(=@#)*ZW56&>]6T9F&7/1
MVI0;^C8L6 URI4Z!%8%@#6*;G0<K L *%"NX) JG" Y@YW9B70@\(BNV@[K1
M6NLZV2'/%3V.K;PI#0YTE@6I*ZUJ^NY4%0&%*]@2*./I$@DN\"F(>27G1T*3
MI;V;3]_R2,;#T(>>6!(=F[L%M8"?P_2XAK<<4S=DKI>P.?233YGD\O\;I](^
M524P+[73\>BJW-4TAHCY0+^ O&\A16Z _T+^OTC %_,7%X=\)0S"4A%BBAG\
M= T?8;4CBHFO(##V-:3Q4FD2&; _Z:(D37[J7)G+M8+X)$/+0M4&QVX/5!])
MK-889XP+>2N\CL[9WX)&L,+W;UM8*NH(*YRBU?,-QFOJ5FH.#(%I%'N 7U:3
M8/V+4LMT$<*4\ L0Z!JE_Z^VS,VK-W7#9S0$*F\F$^1)+0&CB!AWV/@5<< Y
MJ7H-B^5R^8WQ"ZNK^%8?A.VBJ1B5>B?_=[,V:Q13Y*5UR.'O &6ZK3_C<OVO
MY'L)YBK@QEV:T12T["4L=)^+2)"/3534 QAW)\JEWZ])_!1-XB"_BR)?/4(P
MXV>8"@6M5EBTMGT']993G9AJT2Q^VG2^IA[$>!WFC5O^R0%R^/\*OL12YC>!
M=G#$J:JI-FLVR \/-8(;K]B\B52U3(H6155@XQ6<-U$J/?NC14H)KI.C:8*U
MDEW[VVJ=9;#F:SD+%DIQ/T:IJJ=&+^9/Y&TB)[WOI46FM">G9]H2J%U@-$;^
MMM.X"6Z^Z+7 2D_U_HZF?DTGVF6:!:>&RVGCT13,VC&BLZQPF>C8L RF+;R
M!1Y"?I)!WP9'57CSU:%!B"9FX)CT/?!E*1(6]Y%9Q<J=F*\)G>,&!GMY%DI%
M;E2W@V9/YJM);TQ#77%#G6FL@W<N.KB6MV+VR U0<M(J?5Z3/SRG1Z)N7]IE
MH!4DB#;VFCV8K_(LT!2W.'1#;T=U4].)<V%:GY;V_A#-8^I-0=4GIT@4GCEH
M!NZ H/)&X"@,DG TNWE%U,.L""4W;:(Z6/.5H=.(ZF!2CK(.PIWBN:O([35F
MH)S=X LE\9P?:L7,2T_1(;\X1"?A5_?(E4M#=Y9W,1U<%Z1RM +8-B1N]0@Z
MDFQU&T0K!M2M2!^WP0]A:-Z*O&Y+VT 6WK>B;%P;?!!E"NRH)]<&!R0I!X4*
MU$?"!(6<1<Z,GX]]2RCF.W)^_'+TBT,I79*SX_UWR(Y*RB5GQ8?OD!4U*9O"
MJOK^)(<TT;-BS-';FUNDAE;,.7I35#6OM.+(01NE!^[\"U):-GM^(I+6^:*4
M06N.!QRNXM)@@TZ2[OA7QG:Y/85(@>UK98=TH!T7QO>S;$2Y1*M#"IH\V2;Y
M:,5[5^T*W^;LIA51AP.W>01Y59MCO2*2&@6X)"UKL_&CR0^5M*X5AL^A[+S#
M2/RJ9RWV?O&L3IX#[K<NILF;-0_)(S;I=;21-T5^',".O$9/4=%^$.;ZX9H_
M>!08OJS67\"8G (0&UR)%XAQ-#/4X-,(YBA *U1AYB4G!+;OU/@E,E54>0@'
MAX,0_0>Y=#7!+?"@OF/=RUR"8UHZ2-QQ),9D_$(X)DQ&8VM]Z][O:H5,P )0
M@0[1/@@5]:Y[):P=4CD>8W)+8KH76D7=Z]X=:X58C@8@@Q=[F5=1[[H7SG8D
M]8%7" #MVSZ9XIY+]](Z>^YS%XTB,&=VEM V'"QJDW%MBGTK#.^.F2=1)5:X
MM5VS3Z*=K#CZU#'_)!K/BO>3.V.?5).J!T#W[KYNGO@IG-3-W[IQ3S,TP*O^
M2B)40D=^Q5X*9][)W&!F4D%< ?\*A/$:'Q7F-:%=U]QX#8]^$) 7-_10S:E7
MI5H :AV4'+K.)%S#*A<9OL+%985%NQW1@J5IAQVZY3RKKF.--/?>E5):SRU]
M@;-T^++03((&G:BGZA%1GKA(,9.(%S&0KF*2/5;5]Q=\ZMF8C.+Y/,"(,C%J
M*F MA22341XIFKO8S\O5EYBA@F,C=$MAQ62P+V2!:)@>G6$1CN(D$:&)L6HG
M+04)LT,;V2EW35PE<,9+0E6W2B*U]7=8&>P ZMM*!4"=X]&\,VU0W-N1K;+9
MK5#BVY&O(3FLB EMQP6Y3+(BF*-#N*(<4X_"[-UJ*UT.*2RUTI>=6&?Y^,OF
MYR[S9L9# ZO!A^[+@QLABMU 7I^IIGT'3W=G6-SR1Y-@OK\0XBNAO090LM.Z
M>TYH;?(%&U'$=1O4KB:%U0E2UZU[%S+Y4>WR*6T@JA X=0TZD3S"0^5R220#
M,RZ9A,@T!0'E@,9E5=_SXAE?@<A7J9"P3<&PMH8X 'G8L 0%TJ-QRFT0E-N1
MWN+<'U)-_7M^2K1DRR4^9W*2T0TNW8![HJ,IXL^I30A-V3M$"1?&)(7M)B"W
MNH7*<5 IZ"F ,"YN!7CP!QB:XQU-L&W&[C+_8VTH29TW&<P!R#OQ](M\,@5>
MVR#ME E7F<4#,A*K@JM(RP\F5<P[$5'WB#&$!.S/+W%<2\\6JW9A7(BI(O85
M)G7\@H(%>B!A-)59D]MV:=S.5$64GP@9OY 62,YZ,IY@U\*/'\)JBU;>E_&G
M-70PY$>F6B*6=V4\WZ**8'\2H>10'3_BU +!:_T=0(9&0\ *S(0=Q)8-UH,Y
M!A5"SHHLCV'&9!+1BM2/6=9D\M.*W) YSE0%[0&ED-9<C,)&KQS\Z=IZKR*A
M>!AA$\*X;7XSFP=DB5 6IM&BH1&VI0!#?;9;%%JH;VW^O&E:R*I45;*9H4*8
MEDX _>Y2ZH;1<H@8HHM"%#0< &H :^E:7^MAI':NX.75VHCT(2!14^./MZ6'
M@C:*J"D*)"&@TWUI=;'$%&@_%?%D@U6M3+A<_%EA*&M/LDQD6F'_ZLUNLRBV
MPK35([I!REMQ[4R/XGI-8D65+.T=W*AXU.M@[=T;200,KQ?/I4VY=DM:0IP_
ME X>5\2Z]D<V$)*?,*EK;MP3V4"BZ41)/4 '#UY7T"C\;7XN$P3V<D+HBTNE
M1^$T>CD "OF6U2*& QAWP3;0@#_R[[*3X^4W0/JA?XE"-,$1JW\DY(HPK5W4
MPG#&\QKU4\?1HF@*F&$P.C2W97T/QK,8&WCQN]?I3.0WXG2HVH0^@((H D$N
MT+Q" 6J#5R1&7I%8J8#]/CB0264K/,.=J6U'&EOA4[:S,NI$MA7>Y8Y2L%:R
M'](I3($7,D0>"3UP.Y)!!I/Q%!&*(@PCEY_\6H5*.KI]DXV>[<%LTTDTKP"B
M@SLYQ6VS$I\%Z/6C6P0+Q@U&D1O%_ I% 2\OD]GJ."UE8 0XY1)S3+*_0+3R
M)\7F%#-AY;EM^FKIZK9@Z&L\ 1& PB@M90O2+N,>Z_,KM1Z_9<?OUSXQ[&.7
M2O(1K0U@W.X78'Z5E/2]"W<SGG?OO*4<DP"1;S "!6$8PB^/_/4+^$YSBNNZ
M:"D#)1CQ*[].X,>PG&#UY!>A-;&N[<-XSDJ W"/%)#F54 KNZR^RNEY*V:P]
M3$Q_!LJ<)V#&I/2PY+W[DIVXT)RCINZ<]_LD9H2B*+WAD=9_8]1% >8[-8ZF
MA)=& ^.*1T#3"N+<"DFR;>7]H$EP&T,Z'[I7&&L.YEXTQMH(_/F]KBUOL:TF
M,+[;-G9L\-N5F;2+N:3AK]C.BJVL*SO><&IK/^E96E8X^:TL'8'59D5&N14&
MB Q *U+-;>T.@8EHQ?M+K:P"!1-3X<GG(V%&2^:GPJ/01\*P+6U5A:>BQ0'5
M3^<<O2?@_Z]_ U!+ P04    " !=.$U8,SM<]/$T  !:E@, %0   &EN;60M
M,C R,S$R,S%?9&5F+GAM;.U=67?C-I9^GU]14_-<<;Q4)963]!QYJ]&,R_*1
M[*1[7GAH$9(Y19%JD+2M_O4#D!07$2L)@J"DE\1E \1W+X"+N^'B]_]\7WD?
M7@$,W<#_X^/I3S]__ #\>>"X_O*/CW&T^/3KQ__\V[_][KG^CV<[!!]0<S_\
MX^-+%*U_.SEY>WO[Z?T9>C\%<'ER]O//YR?;AA_3EK^]AVZE]=OYMNWIR=^_
MW\WF+V!E?W+],++]>=$+?X;4[_3KUZ\GR5]1T]#]+4SZWP5S.TH(X.+Z0&V!
M__5IV^P3_M6GT[-/YZ<_O8=.C@NU<:)\F/('/I^D?_SXMW_[\.'W?__TZ</X
M_O'FV_CO'YXW'V[^]>GOE].[#Y\^)7^%@0>F8/$A(>2W:+,&?WP,W=7:PPQ(
M?O<"P>*/CZZ_<A"2L_/3LQ3'?UP'\W@%_&CD.S=^Y$:;L;\(X"JA_N,'_-VG
MZ3C'A_H'#E@Y/\V#U0G^XPFS_TE+<%>!'P:>Z]@1<&81^B\>*9PLKEYL?PG"
ML3][L2%X"3P'K;>;?\9H>!',33[;EI3Z)Q_M9P^$(GBI?5N#<I>^NW#G-IJ_
M^3R(T03ZRP?$FKD+PGL;0C2-K^ :1+;KB2&5^F"G\+$@<&(/3!8/,%@#&&WP
M$D7<6^/9O@DC=X7G_RD$B]B[0ZA"570V'[DM0[[;\ ?Z%%H;,S"/H1LA-&CL
M6]N%?]I>#+X#.XQANMR;3&^K[^LDKI@"4J^.*!8;M!\VW+H^.@Y=VQN%(8C"
MK)$SBO)^G3-%'$);%I&VW3V(V/M2@OY6WV]+W"1Z 7#L(ZD1)0R6P$WKVA;2
M'9K*9N<%I:<:0,5\S.(UZH5IMKU+V\.*X>P%@*BDJTR!AX7R8Y#VE:9!Q6!*
MEL95#"$:^\ZUGUTOV9H%M*1!Z2^R:Z?)M]4K3HT4$_Y7U ,M,6>-ISW\!I'"
M )Q6N'D?[92,.,)F%;;EL&A[!W#NAO@<R*"H(DQP&'TS-D4BTYUC<P%W>?)=
MF>-"Q3!=DIK\[1()(N<J6*V!'R8RZN8=_]ANCTF.T9;(1_L=A!-_["-(H(F4
M8'] *;R"->F_+P$Z'4#Z<]*P*6SA#W=$#OIU-JTA^O$2^& AM5N:?+8M*:GG
MXM.;ZX!K-YQ[ =9,FRP@L0]U K=@%59%;0^$EYMO(%A">_V"#%5O!('=EA*9
M,;01^0CF+X$?>,%RTP5]A,]W3-I=X"\_>6B].*FEI(XJVI?;$I3ILP\VE-0J
MR1U;\_?^<?SXC[_&US?7X]G5W63V-+TIV#%93,$K\&,TN?@\FOC(6G/B>11>
M(2C+  JY$-L.425Q=[R%'3XG;N X_+2T[74Z)@#.ZN3F/4)"T$7*T(T?KP!,
MSM$[-XS"CUQ.X:^'6R]S;0S,PA/@12'^#1XP3+B:<!0/G6&VX7P+._NQC#QW
M8+M^=.*XJY.LS8GM>6( ":[TK2<<^] _)WCPUUK!03]C-@;^)P<L[-B+%(*K
M?UL5U&!ENWXW2--/MP.:?./3"JR> 52)LO+=5A!?$!HXCY_!IYQTA4!)7V\%
MUP^BD=)]DWTP!856IXM,C$1^^#\J@P L91S@;(?!:)H&@?!8:#0OF%>&\'"(
M+8"-)13^32&@LE]8>3@'D03&Z,=<+'KV,_"282UZ8^OGE#?Z\281'1&L24/K
MM 7.$,Q_6@:O)PYP4XCHAP(9^H>53N+(<2! >D*8_?"(OC]Z=TD<Y7?J&'%I
MM.N*E-P!66O7,:[+.$1K*PRO C^RY]'WBFS<P49L:RS?KLMG6Z?K< J62+_!
M'I)[>T7:([2FUA<-Z*[0GH2V-T;B\OU_P(8);Z>M]4NG^+92&4\:!5:YB?6K
M%C0/ +H!.B:<:R30.+ J;:VOG>++?-NW2(FWO7\ &[(ATII;IVV.$'$V%@/?
MHM_09#*EM77:K52I#IO.HCC,4GOK]*Q;\8=&=9*1/7M)$WWE-M;IN1;.;049
MUJ#RHY_#/6(?Z_1""^"1[\>V-P7K /)PEIM:IY_UR$!T)H1N&GL3@+C;W#KM
M]BC9CCM[ 9Z'/>2VOQ$"6N]@G79[JJ0GV:WK@?N8H<SL-K-.NSU>,J4)R8XP
M\'W@,50%4E/KM-O396L6S0.()JG8HE<X=PANKI!!Q60DLZ=UUNV94]'LL_]A
MD^E4Q!(HM[?.--HMI8'/)(&>66?=GCNT@<\E@9Y;9]V>1Y6!K]"/$_@8O-&L
M!$IKZZS;,Z@R[$,01K;WO^Z:NZ=(':RS;L^C*H?2+2S$S+2I==;M.83G# =Q
M&+PK-['.NCUK<!JV]_ 2^.RS9K>9=:;WK+FUWYGXJ.VMLXYMFIV!;Y#E[F4K
M2A!KN8MUWNTYDV43;D[/GA_=B.@.(S6SSKL]59 RB%-19IO5<^!1,%7:6.?=
MGAY;!MR\SY.,=8:N0VIJG7=[9A3SLQ2;QF4VC=V>$MOQ4C493=;DV7.7V44'
M)D)"#^M<QSF!%/L55O>"^8\D@28L94:Q'4V,CM:Y#K?87\@N^1\?'?XS8"-)
M IQQ&,8<:X'2QSK78='\&7CHB+5A8K- MI-[IZUUWNUYD\UIZG'*%R.V J@>
M%587ZUR/K1,!B$X2G/=B1W8&A6/DD+I8%SJLFV0FBPP CDV;M[0N=%@T-RL
MEVC^OL'@+7K)S'TF2&(/ZT*'57/S7GA/4E<>&VFMN76AQ\=6W-R98=%H0QI0
M>@?KHMLS*TFJ+F_?9%0<JF0JG+QNUH6.TZOLFV(N@7)#ZZ+;TVD\7\!1[+CH
M.Z,H NA0Q N/X?ZE=[ NNCV7LE$9VEVIA771[1F4#76778QE ]JVLBZZ/6FR
MX6Y=N!K3-F^EC?595W0&*5^KZ ;" %X%Z!B;<U89OZ/UN3AIBLR-$:P28</Y
M=H0LB40J-6L!@Y5 CL1VR("3H_ A@ Z ?WQ$/>(0(0F2;'<;#Y<DIOR&\^6
M\\?'",:@^"4R0<%[=)->HOGC8PB62?2C&^H9*4$,;N045CE1\]N0\B"H7.F&
M0%K^6$&=&.HZI:1D"MW$D7+.JI014=:)H65?]#=;U<3$+J9KF\.QI?'4C%F3
MD3T%,VJY'WM!53UE9$O6V3#)VDDYV5)S/FQJ=C-5MF1=#),L5G;+EK3/PR2-
MD1*SI>S+/E"VDT6SI>V78=)62\+9TO/K,.GAYNQLZ?LZ;/IV<WV*,WG8=)$2
MA'+:!JIPL'.*<NH&JG>0$I)RF@:J?= RF7*Z!JI^".8\Y60.5!5AYDGEQ U4
M&V'F5N7$#50=8>9CY<0-5#=A9''EI U4+6$G?A66]1Y05\H8R^D:J&*RFW*6
MTS-05824KY;3M">J2"7'+2=NH/H(+RDNIV^@B@@IHRZG::#Z1RTC+R=HH#H'
M+94OIVN@Z@8I#S"G::!Z!B=SL'!Z#Y,\L23#G,J!JAW<I,2<P('J(=1DQIRP
M@2HCO.S'G+Z!ZB.\=,F<OH'J(Y1$RYRL@:HDG-3,G+R!*BBL?,Z<MH$J*>P4
MT)RZ@:HK(OFB141[F#224TUSJ@:JH["S4W/J!JJ@[.2WYN0,5"TA9,?F) U4
M$ZEEU^8$#53U$$O$S:FD:"*_GU2+JRFNM];D 9MC&3;#RK"UPIE.*C[(D$F*
MYIY2ETVHGW8J=D!0"X\QVVM'77)W4,NX4=MJ1SMR'#>52 ^VZXS]*WOM1K;'
M1<[L9[6Y/]:$BBFN".P#Y\:&/M),0RY\<@>KS86R1MR?HU,D3FH;IP]GH+6+
M!#+.['[-:K'S9T+T&U:;.VA-J'N$R=L]FV1]ITN=2PVUC]7F*EH3]/>!CV^8
MH(,4?769.%&0WLPE@-6M5:'!_B1H^Q*.S<XPM (JN@E:S%[L)"^HP40MC"+H
M/L?)"U./ 9GQS,-.Q0#M:N2U/&!$;ON+=&M7/Z\)$0\P6+C174 L,%)OU*Z>
M7A. -%F*T=R#*'EI@@%=I'N[FGO-3OO_B[-'O1X#RA&>+([GW2=8I@#MD-"-
MP S 5W<.4I?=%,R#96JK)"^S,16&;H>6KA!8?P\ _P8=I^EHZ+N3!=KR5_4M
M/_:WL=7)8@+1_K'1>95L*0+][3\J75200EGRM817DT4G5"H;0+HV(8UB+.RF
M8!U#- Y^8*$RRG4,L:A/5A-M]3;YC'0)P];H.=,B^9UV-0X;'_5)O-2I<3/Y
M6_;\5?;$%R#=X6[\K795$162FW)?$;V,CY6K*QYOB!MZ0US4(V/<)7%AX&1Z
M:3X<L^Z+<]&2B2.Y>_:",)XWR- KUI)44IU&AEZUEIU$"4>2H=>Q)2EF.9L,
MO9DM22''&Z7]CC:_:D4GY\<>%+!0[[7: V;P?%J&"F89$JL^,$/EK@Q!HIXQ
M0P6P#*DZ?%X#+K.AQC4VX&H<ZKUF R[?T=35-N *'XW=<P.N^M'*3S?DLB#M
M'':\HB$=9Y+5$\42OU6H.5T,H[C</2M'$&)QB-E_N2F:/-B;)!/[S8;.G4AZ
M6>N/:T]'*[\DS84?TO _HK5PB0#^8#!'\4CZ$^+RM\W)Z,O[;H2ORFQ7N AS
MVG]<>\(4"7)YILJ0L4A.IQ@)K57ZNU:\:3Z0]@0M[M0F4GL41R\!=/\%G"<D
M4V&)I@?/]M%VV(KR!XAT^2G>)TK65>O!M:>$%23=K-9>L %; X<B5#PO2X*?
M+#+C!]&9'IA708C,*BDV*AY3>TH:;T$(R6!>YK*J,;0GNWW#-5W1Y";7-SF)
MSK6V_:+E)N816FM'7)_K8BEL=Q8W/5+\(P.<D7X2)=,MMZ$^NDYLU^[]X4Z4
M=ZHX*8#[#C[3\#TO[OQT,9Q^IDU!&*%C.[F_@TZ<)V3-A=/9DT!^.Z/?<>Z;
MS/WNYN['T:#"2*4X)M3;>&;F-G3)0R6FH*F!.<U\:V4FFAKYZW/MJ3 730U
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M^E<8O0YDGOKQD*CS^Q^]8'SM1#>/=/K]==.FPN^ONZID-WY_)1=<M?O]E5R
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MKW [UB;7"\3ZHOL2?.-3M+KQ"LV[BQ.;-I;UI1=_E0(27FW7P]H=FO_DR-3
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M!07H'U9>=9( M?)W17<C1>!0YW^GA1Y(WY$:O8I73%"5-II@V>]\6.4VBMY
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M4Z/$E")J*1.9>V(%1=?O)WB49SL$?_M_4$L#!!0    ( %TX35@7.KSD@=X
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MZWWPPTCPL +=2*?U_6*S[[KU-N-D1:)JU,"V+D<)64MA-HG-ONO6&TW(/(W
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M8&W31R@#&[?'-:[ ZFK>/Q%65[/^B;"ZFO-QO=1PATHJ!-"ZFO4U0.MJWM<
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M.]^0((GQ)Z8KIB?X879%\7;-XL:/R!QJQ"#'C]:2%4*ST.R[M@GSCD*.SW+
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M%V#F:DI0J0FX6HA8K'&U$-$T(:P]L=&Z#N!G/,KQ/)^G('YP?;QJY6[\Q T
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M%;MS=EV[^1M(NYJ J_$(B+T4(:/ "@ RXQ&,,C+C$0AK6&57;J<@(#4>43
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M[GN/&(]TUYN ;@G,J.Q]C?P<F4\4=I<:98&/\>@WPS0AT8N/Z<1%2^U[&KY
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MHPWS#$U'(^K@CK=:267 V'3\8I^QZ4BG!F1YX/H$*Q94 @Q-QSGF&?8D)A*
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M^:HD#[R,QWA[N"K?GMF7 _Y2ZS$=UU 3<#4>KQ'V:BM+68")"LJ7Z:2TZH2
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MTW4CFOD^%T;P/;> WH^)7_UD-0IO <24=C(N<'<0EJ,+: &=P;D-C@;]G#Y
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M_8!2N'8NWEU\^V.=?BYS_5QTKY_<@*8G#.#O&P;PLVO7?>["90%;.&\Q<_8
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MO,C"F&6<O<E+;T:'*<MZ2F%*=VFK?LM2R #J/[+QXEL"+C2*^6*+9;DLE;+
M&IG("E+6!IXEZ_/J"KVJ1D(ZMF,3Z*;E)HQY6):GM.E%LGP(8]&+(>=,&)3!
M6L2^[X+Q!7%PJ@\67I0IB>>J&"44)0'!( [*,>Y6&:;,(]N7X<UP,K@FO6(
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M,,R"*HY-V>K^!^VT^(4/33E?^\".88:.MF4I3Q8C'&?%+<K;-,$NK,JTC+(
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M0WKA+I==M^^"/LBJ' )[FX9)^@?S4V761T(?LN<P*3)OS0M3AGSH T3G?!M
MB"RQE0QQ,)\G!21+]->F19L<O/F([9?E.4D4 I3C0P<4A.?JYJ&#HNIWJHKC
MZF#$6BNEM8Q;[J9@,9OI4C53)>U-'(/5/Q@HXHBMZ'('"JJW8Q?K'RJ4"N=+
M.QV<\<=\IL5R>*J]+6S*NN&.JO(]NM?(-1QUZ(\+?Q7RM9TY96<3+#BIY*JP
M)G#*KG@:U0)C&Q[$OVC"FS3Z=7J<C)SAYAB!H^HQ/AP6X$L'!P&QF8-L[=5,
MQJ[TKVT</08+&:AF0@U)'CY+XETNFO!-65FX3DI2EI=Y20AWN! ,>F.8,!SB
M=4S?OH* T>W7R;N:K'K4X/TD=X'^1G8CL)H U]9G065YEXZ"6A ZMK)NO@UO
M9N,)43+D6M\KN +WQ((O28(\\*Q*>*LT@2>A1"-.J2\^RAR41%D.*8J2^!X_
M.6\MM;3;<2T+.YK/!@6C'\7=:/B)__TK']73T(_T78X7\)95"2I5Y57K.M^6
MX=I_E9WN8!-(#V?8UEKG!Z^DM7TCV_9$6=KAKJB'HWT5)W@L\97^K@<4S=^]
MP1*VP)QH7FR]\ JZ]FC03@97EG. N$E-S-U/)A\%UC:=?3U46($>RJX-R?44
M5X!RI-?M5(4O^)3V",''Q/&-X97&AGM07CF]'9NTO!V3OA6YADV!:FNX\*,9
M2Y>&6[VBN*>4]T" M'U+!%G>,\V!A#*D>Y0O%'A*HF"TY*NB9_GJT_CXMBSO
MJ0+TWF,>I641X@%:*E%O;)HS1-<;T%**1M\L8TQ^WX;746O:;!F#(O6I4I4V
MI&?/+,5"F2Y1]M,#IPY\$<PREF9VB>0WDL(GWI9G*6GK3LHXFK>'NFYJL_-@
MC1'?E8B$K59E69<--8! 8W#OXRI\WH?53LK095"E=W6@)ZU6ISJ[M8#.IF>_
MG'T2QV\/;)W0A&.S!7/#!Y?9=Q8]LZ^<FSPA3]E[6E38<AR[;\H6>L2:[UTV
MH7!%_O7]F0YJ(UQL]P:.6.VCZU:;/:5L/V.H,)NHSOD^UP!'S/:K\V;[GNS1
M:-^3XS 9!XT8[ /AV:L1PET<0&3& G+1#G_,>5&Y.8=:SPN7JT(FKI5'NNY1
M,123SC@V'JE6Z,D:#[B'^7*_1!M =]KNME$[ KY=#P=3F@-JG;*P7S5>5#M8
M_09 L=<%N>U+:<?(Q18T[3*M1# _(().JW1<ECOP4M]N+=QQ]6TVG@VNO>O1
MX'QT/9H1W;]0E!S$,C(I; _RH4D&F^QJ7;&VDT5=:&@]!JO6%S&;15:,W\;7
ME\/)]+_]ET]GIQ__APCA//O#1>.8-TVWC"3"^9?B_^2QPYG,:EJS1::=R@W(
M*J,=#E\/HYD"0RO%3KP#IGWNVX,JG?$^<W$WF0QO9@Z-7*7.YNOA;:WITO88
M=-?FBW\EW7LT.02!LO7NIJP+#JYHCOOXS?CF9_?\O%'=G*)*K[P3[JZ!H$U&
M\XH0.@V0^#'7.^=KE-0/&)^OMN_-V]ZU'5Q<C.]N9E-O,KP8CKX-SJ\/$GI%
M9"Z$S*P=P+[6X5B;6,RF*>NK+GRK]U.9E4^$JL]$Q+__^N[CAY-/9Y_%[/Q?
MWWUZ?_+N[)<3SQ=G<9>\W>"PV7MW>N*=_7+V3I3B_S@[J9+#<MVC]=\H;&UJ
M$IV?*DTR52+:'G(^M^EP)ABZO0&M90E7IB;]==$S>GBF=$;IF6>??STY>_\.
M\\RSRC-/'?7,:V/ ,*UODL<+T^&0UQ/LQQQ7],;CG"%M3Q?F3*M^C]L4&C@D
M,,)8Q.^KWAEI<E^<KV]]= IKB@&L:A<4WK-E2MYX$F1%',[#E1^=)W%@NL)5
M%_0>H"3IW:T;ED.&IMLT@<QLP?GZ+F/!*"Z#\,>/ Q@Q\5TZ2#DH,CQ5%7@/
M:^\GJ(-;Y&]>78W7U$.V@N@!%<NN. >HA43G+6IP_D'![<^$YN4U)#N[NA[_
M/O6N)N.OWM7H9G!S,;KYX@TN9J-OQ N0'4!JU^%4('<THKR^_.)^6%?C<#_4
M0;7JAV$-SLE^J,'5JQ_*AP*.]T,32)M^^&H@=S1B<VGX1?VP.4MTMQ_JH!K[
MX4J!JL3M<+$O:K#UZHOCV^%DX(B;-ID 4$^L0@S(O#>#/$_#AT(N O+$DR2;
MTOT4"%H/&\ZJC .#V6PR.K^;P8:;-QOS7W\=7PZ]Z]DEX76=#01JZ\Z2'GDF
M!D'P+YZ2?=S?,E.<Q#\K==%>_.@/&1LZS+ZY69DW(DQW>,.^EU'+N"9\0(GY
M/^?RU8U]ECE>2;3VPBPK((>*R",+JUC^.S](5G"?QZ^_ 0.J\A'"3;S>T/7&
M5J%C*$^XG^?>FCM&V2 DIN9>QV>-ALS$0;W $/MMW8<V(G5T/3=0@6CW0\-V
MQ,W6 %-'J"'=EVA.F40 ,$SSLE"9.92.%F^KB[^.@6Q,/XMT3 =4NKMY<S5
MN\AKA30Q+T@<A/*F #<<+VKV-F6/^$M[61HV!QNV70E0CJ4H".V@68-H&'4F
M!2@L,%XLPCFSR1\M2RJ)HV&R8W52:<HAI6[Y*CU?Q\//X0%3O%LQY+;"^'6'
M9F4R_+?;X0W15=N6QN8WMBV=#[*6LNR@N.[:H".OH[MU@W>L!ANOWN#=]*[=
ML01LFOEP>6ZLV[B.,=#1Q/+]*QQ8TZMKCF&,/Z4@8U*8^CBA2K8:_M!!57OY
M]Q8*/.G)*Z/8T8LZ+@UN]P$7XMMV(]$./"Z;HWK-UF$#L3N[B)+OF;=(D^6V
MBSD 9!(^/N7CQ5W&Q%+(RJ=2D/DY6?Q<\!\.EXYV!]_:1F/C5Z^$II]9?F>@
M%0L&G#KYC^RR?*(&F4K*ZQ=:2U5B7BGG58(>2'KC5W"_':QF 59G2#/8DU=!
M^R*K3A@$:U)?C9W:6;46+(.RB-=DKP&W+Y&W16UE7AUJUZS,6?2%GZ;K19)^
M]U,D".]@/B^6100''"*M4 1YU>>*& D&N(_--4L+%E@^OY%A'TL9[[4>X]CZ
MH!D/&L:2KNW%U--%[V23BZ*'?A32JZ&WE<?#A(I4]CF,6(23+6ARD2Q7*7MB
M<18^LV85?,,X@YCY/PSM/U<EJU/#GZ ;'R[NNMV\:H,+-XT.%W4<8"M(ND6=
M#A*8B"Q$,(;D+DZ9'\$5^]^2*."SR!<^S0&\<=Q<%!ZD8<;_=,E_C!\Y*PJ3
MP.BH,I,+7,[B:+VB_H3WR"O/2F>%W>VE[G*X:"/X*Y^>Z)I*#B7*X&W:]1;6
M+D74N8AVPUN/HV<</A0;&:2N6,NO$A#:?D3L"K<LU0UIXU<+)7HQ+R?V=A"M
M#?._"YN#B-:&S4$YFY1]D'HO:DM]*]+XBL^)^TSM]J^*7\5]K)I>>;8JSNT[
MNRIM]\34=6\-I&@*]T<[??K V<!V:F)%<21_[<H/@SIA$YS.OTIJ,_N!40_&
M=FPDSM"&(S"?A&^G8BN3@56LBS9N=IF.%^*\B"T-/S*?ZU?EA7=5$O08!+>Z
M2M)!\ PY6V;)8+$0":#U#T K"6^1I%XI U=3:RFR/F_&HNOVT^*ABO65I-PN
M4HHR):."X39-YHP%V56:+!7"W/W8P@GBW!>(=E167>VGJAIQ:/<W3UW-'/#E
MR,[FF[ 5_\B3GS&(.K=<)K$(!J7/1E67%5?;TB",_70MPS]16P_#T6FP35!2
MU!.RE(C&"Z'"*,L*Z.MP;05)\7([KN@ J0GX&#;_>Q&F[+S(PA@"&V;XM=12
M",;CNO&C<,XX4@=Z10U%]V9?CT?Q(.V>F!.6T<(Q]@^8+Z7L*T0@>*&Q^+B[
M8FF^ON50<LYUZNNNG19;A#_@;0/9@4(/*+;6JFHX\40=)W64R!75'630X\9?
MXKFJH( ')0BS5*D4H!IZ1S%W=3^Z+1[X"#5>+!ALHNL1J#,_)S9"C@]P(,C]
M3$IJ9LYZP[PN Y</*<_@[=M!OTJU: =J\T[]""*)5=EMQ@O[P7X#7N9'KSOL
MVZTQ>B/M-N2K(^UE3F!+XQ6DD\N&/U@Z#S,66)A/R'FEH%=+.M+W]*ATIJK^
M*M^<" $BDRS"''_57#\)INP9E8;8VU9Y=DVVC:9HJ-LV.VP;VCMII:,N'-QA
M=;1P0CU],F][;5*F3<9$O?V%(3I?S]:&_)_*8\49_WT(8[:X;7- CF7O09V0
MM+&G"2#M;![;N*2W$W@I,_M#A$"'<.>WD%GVQ./]R"D\AA5]*>*MZL[3/!M\
M!#'*$=^$!B$^Y5B@@7-R.#P[&^;:&(BR8VB[I@U(B8+"<LW7OK9E%LK+<T80
M)A=[+1"6S ,'@1_AK5X7RL[^9!/I0V\6IV#8W_W: $.[^X."X9\TI:K&9WO"
M;-4HFKN,+8KH.EP@9Y*F<?C$D](>B+M(S!1PVA5HEH=+\2RAD#@B;C:J6?(Y
MS/@2^"I)+Y/B(>?:E(%PT#<5XH_*$?Z)=Y&R(,P]6.-4L02\GR:,MV+F1X=Y
M>FTYT>#@M+'ZZLN\?A0EW\4Y.)Q[S24^N,LK<S3G$%S_P+%"['T0!ZF;B,J;
M%C^OQ.5F&=,.Y"G<3[D'LI&OH +0_'U0&40#TQ"2>[!AQZ 4K((SR7L;971;
M/CN',5^X%O*$X&?5ZD1MDW"UX*H#M\YX ?TI+IC8ZRH#JLR2BR3../H !A,\
MPO=F5># 967EQEY9'9R*J!52Q@"?,/%NZ];GPRMWC3B#*(M)+',&9N.%\COC
ML2F8/6/I<SBO@_O01-Q" )E7(Z60)Z0\18Q\)8+ ,5^70N%0WYG"T)ROU;^@
M>T>;N.@V5S 8MGLKD^'U8#:\]&X'$ZJ8;A.6,3^=/_&9X)*/45$B^%1)*I#&
MEQ)B+ \:&3+:88:@XQVO">%%!C \#-K H$C6P:5('P@941GX V:9PQT[6R#)
MTW#.N[DX\;J+0TZ3IG=FRY02Y1&>D.$$?7J7_8W8*CE?E[)@Z*?PWCQ3'FQ?
MLD4X#[%I1(IYK)0CI-\6$/0]_A4@]&U^HP]MZ4OL-S45'O[@8W+L1Q=%EB=+
M/CR?K[^PY#'U5T_A?) RO^\C0#C5A&L &03Y;JKRH"Y"K$#A'^%Z2!+;[,U5
M_#YMQ B5QUB3_"-I[RWUT_;1X;?AS1T5#9**:5V<3V*PV2?V^F1 @*Y5A*Q,
MKO:JZKRZ/C&YM8*UDB\QJEXY7E0+?1&B5:0X5.,5-YL$]KU<LXU%"Q'>JR>Q
MO,XLGZO/_!\E/SEG,9]*\IX#&9=ON-=/\%-9#TE*N 8IGQ99FL)VQ0_I:.#.
M.[_9KFH3<$O'_4EYNT@,=KA8R$Q\M4TA9M+F?DQ/Q.W-G-D32U*6AW/>J>OM
M0.\J2:L0F#.:Z )*,RQ74;)F;"IW8J9PE_/<SU@ ;L\]5$"!O;IYO=DEYJU_
M\,6LV*84E_KMVTA\P!-?\-1/5!V"N#7B/,S7OX<!]XI%DBZ%:F9.P\T:%'/1
M5\HV[&B-C0T^S9#/R4U5IQC^JUK+/3\/:O=$]0<9^ZT6TH=K,3TEWZW%".G+
MX1I(=W"@=K"THA0/HH_QGK4JJ_LGC_=A]IBD) GMFQ:10]\YXZW1#+Z7_#\9
M'RB!/O#?AX]]!]]R0)75*L,KS>F=BI;;(^>-7I[N](8EQ8EN)V_BD$\<9=M.
MV"I)(::=W/<_7U^4SF5FO#+M2E5592=W"*TU3/Q,1P./[K2F05:.*K_[:>K'
M^;H.0MO3(:M@=U4]Y*"0*QFH>3KND;E@*KM##QSB)BG%3G9.8.+<.B!Q WVO
M%;9M,^RVTG:A0<I38#D4B7CU-9$X7Y=_M&N%LK!75^4I=0E_J$JX 5R_&H&!
MYU&F;.+XZS+EP?( XH=:-@?(_JQ9C*B?$*VB%*S.K\5W7&XG\=ML4.1/G#[P
M]=I='+!4>8P#PQ]OP.K1S6W*B>8$8/>(RU;D6<Y[CDBV"..HK$NL4\9T#W@Z
M6T9YD52&,N@[#5:/K;[ )$AS;T&'4NT#*LIO?E3(SI-EQ5+^KN_$WTAZ(IDH
MW$GQH[DX4O&N_##UX"ONM0Y$EZSV+/B"H-QKRR9)%%W):,,]6T*MT%.V[TA]
M/8.=RAA"A:?53DV8_<D9 ___*Q%S9<>3EAF;/\5)E#S24+VMN<]XBZ4]O=%>
M7ME6WO:VQ_!F-IK]\?/OH\NA=SF:7ER/IW<3DE=H!NIA7N<9F0;]>F\+EGT2
MS4-F<>NKM7( *;:=98+(GG8YJ6\<*O4(TSA@)9$,4CS[AM?:35XL/32_BO>U
MK(K3;9#BJFMC8[V.ZKLWN.$"0BDDM*_%W+A;-(6+[G7D(7UJB7)C!Z:]K"KN
MK4J.3QF32$]=]280RQ.YX3M7"M.YOUYWK>LCNA^T[6UW\?4PM%OPKVB"W3Q'
M6=-BJV;Q?]]DC#=YNJ?O,V413SY4((/XT WQ81LB[/3EZU'SG$"\:I@]^7&U
M'GQ\3$7PIA%GTF&<A7.QJE%6NH8N:-Y*,.XDG'A2-4_1K8R[EW/MJB75B5<K
MZ-4:RH77B;H<I^WZ5);1#3!B9?I<K4SA:J7W>(!E:;_ 7SMWT<Y6XDO:!0NY
M"J-8=F&MN]:ECFI\V@%\UY33W5<?7M!7:WW@Y=HM[6AYR ;G*]IL*\F5V/JY
MY'T!^I_HJ)W4Y55L48A89:W46D)=[W)S*\LYZO'J)M,.J&]S[!#H,^.H^7K.
M*I4Y[*A![HE;+:[S-<H-Y%?"O<EF]+/U-H6I&,P)4' 9@-&QM=[!V\F*ZKU2
M.[GB2JY/P=NCVE]Z'NYKNE<>'N7:?A@3+F5N$G&3B@4W!9[U3#V!SCT&N406
MWIKY!TGA(AMEFOMI[DZS:)/8;#;+ WL,X[@,W'NHQJ$;!;=;!-^@>XT-FEH;
M_D^ASQN<FK=;7!<_\ZXL(O9<WOH0M=O4^U<>O7:;\?ZB UMW8W4=2AR6V2EC
M'AVE.P8[*;>.[#+='[[U7-FY_B9:T+@!(XN\+=_9@HUO6+\&=Y'*O-7=ZLVF
M%G$_;9;&% U_<N"QDI@_&BU!>(IW\./G'ZM0WL\TC')-H:/J?K4!E9O"< T(
MXMM<AL]AP.GM!,MT6!7PUB&+CLNF)MPSEB[U=R@NRER(A1]YO#,NWXRIOR41
MKP9>EJ'&KHIZSW79HX<O[EFG#"XG,*YLCH*'@C\O>$D^V,NB7GJ@3)X':X".
M.Z8OG37I;Y[NVC!\(2!GN/8,V"Q<N]8 <D^EFN>."[]0O7R1HKP].A2[:II*
M?M%K/DD6@'[_C:<C1((S'>/!"(I2FR>HMJ_,,N?Y=7EX?_3 !U$^!(O$ARZD
M<MU7HSS[801ODO@H(=;_'<-$F2O+\RLY$5Q7\..C:H7-)&$ Q'#RH[XU//S>
MZ2MBWMI#VGB?>:@#W'H=JNBAV<JK$[0)98YQ].G9W(8L=2XYWB[+ELZ6F##(
M3<'YBK)4P=<SM:_XI:^DE;@W5Y8Z$6U>"(K6TOE0C]8"YV**RQ$F1MQ3KV/9
MQL:/Q04HF:(GK.^[UQM!U<S'#I+S\I5VQNO6J;9]S+<01;DCVP4W0#S0#6UE
M1JN_>:!][==U$^7^[AN\XF\ J744$3:[&@7F\'@OBHX3LLW]XPVT!]S_?B46
M=@07@%_ %;;NR%2+.ZUEZ[LR!YS=#W]=I@2N;'7]I6[NH?#?_$46%/F!;J74
MD[ORQ4/>MGO%AK/?''YC0T7O;8^_P@#2>W/BC0\KQO9XU<&&8&_,D7:&$6IA
M<X6MVMNH%N?>BK1E7D#E\);!MGW.7KI))D9XI3,?\;:/O.P#T5FK6Q$)_$II
M5.1IOSY@2QW_8&L_Z!@=:_,>5'VO  ^[<=@EPHL] 0W(B>T ]I[UAP?9Z7L]
M_*T-L!U:P-W]OR[\FGV=WOC=WMCJ:@'CL[]N\-3[(6WH(H FA,UZ8N/8&"A,
M1[&:ACOQREH\7@UMV+!.H+.GE.T%JJC(=;#?D[U _9XX"%3V2LY-1B)V:OC,
M1%AD0^+)#L#>?TC90^=I>=$6K1EUGS!M[EAR^SZ1=;AK-'GPYHK.$X4)<PB_
M '8;=+4GK1QHEQ.4Y5TCYMXMB'VWC;) Z=<VVV'1'6RKUIIEQ[9JMY&)TIQ7
MVU'G?@1G=?IUCO:^ISJER"^=>+H.2K]-\X(P>41&,-QR*C=M/-'ZM#V[(M.-
M)U3)ZPSTI"J2G? NM^!(RE0? 5]"05!TX@"UPMXC<855O\>]>:<5AHVO+ B7
MR4%&CCZ<HM):NPGMR$W<4D?A]7R])7Z'Y 0"'Z>-$10^QB%W4,AC)%.@5G')
MPZZ,@M/1EYO1U>AB<#/S!A<7X[N;V>CFBW<[OAY=C&BRY"IHIL5J%:WY*+<,
M15*L>L?T*___9;&4 9CEWW/LI8"H0W3<A ^6<-4;.O*\KI3V$ S&7KY>VLJP
M)3)E^9$64#GT.G9N9<:AZ^D*#C>.FLP0M"=$I4B50[+.;.:54I1WQ8QPR@E1
MSTHAY+D7QG/(.DBS762GN_Y65X=)3KQ+-H<4\O*E0U69>S#+'T/C)%_&RO>:
MK#(. 3'LA-16X>JP])EFVLQY/Q)<4#RX:Y)UXZMZ^2"_*4FYI*^TOS8_J*R*
MT3^,K#09+R[\[.DJ2KYGYI0\M>I\5@ 13\A0)^9I8)3)ZOF(E&2AV!6SAE.+
M>I6L.[!DYM%!+):7*7OB TR=Z[R'P53A.INI&Q@-*?Z:[D*8G0]6[4])!$15
M#CGXE=ZRV#]5P4(&>9Z&#T4N-HSR!))S'HCCVCUH;4/1OD@=SP;7WO2WP63X
MV_CZ<CB9_K?_\NGL]./_\(;_^VXT^\,-*QB=?Q1_30+F7>?!/\N58&T9)H3_
MA6Z_" >B95"H%0X"H<=2:1L&'U2B(A!KW50,OXKOSY*;)!878Q*18ZB*K:"?
MU^5^:[DB(5]*[06G=LD%ZZP#(^W?K7:"IU^.M0?$$Z^NWBOK;XV1FY_PJF\X
M-&CNU$2ZP)KM@?:?G!IB;Y*\BV-H)CV0(N<6.BBV61O=-HCX[705A0:3>!G\
MG4QGN42^+-(Z_93<Q;UAW\6?](NC4<RI-^?@J^*!KU1AEY^EY2[45D2($R]F
M@M;69>:0%^[D@-O4MCOJ=O!UTP'\26S!U3$R2/>K##C4?,3U+3X'[_CUQV \
M/VO.A0_I:/8DLA\TW12M@>;])"OYFT,6$S=I^SO=@9_6O,10!D26+DAFG@E;
M\7J?X!RW[7J&&4F1\Z1@'2!SZL2H;0:F,TLCH9VC",],BX>,KW-A,_6Y>T^R
M+NR)TO1;DYO:FZXLME2GO *PJ7;';NJ6YN3[J%O*=Q#DN_,II\7#FYDW_,;_
MG^9D>E-EPRYBRTL(-Q.WE.8?0L\W6GI#:<HS#JY/&(1\B(,LU^.%&#5Q[?U(
M#(MR]*?4>K6*Q":R'U4G'4/YBXXN>G=[>SW\RMV;K]$O1].+Z_'T;C*<>N,K
M[V(P_<V[NA[_/O5&-U?CR=?!;#2^.<B.7!>^F?]C$/QGD8G;$]F4Y7D%+@[N
MXB*#(]HT>0XS]-HCK\%3JN#S<5/)B;BJ4=;C-1413M;] .OF[>HJ(O?.4)Z$
MY+P)_"QC62;^\#W,G^3OY 4^./8EL6V21-DE_S@D<D^B(#/,A>+OI!,@O _(
M^'H<M)VR]#F<PS7&YEQ.B:$*(UFF_]-E K>*].^%ZF,Z-0C[?T@)(LC,SPH^
M(,(@!S>?DMA@HJIT=0>0UE@MS0T4?DOSDX.&Z.RW4[$!!']L>LW[MI=OP_!S
ML7/T+][IR>>/'TYXZXGQKOEI"R<(7+*Y,)OW[O3$._OE3(KP?YR=P/T)>!@;
M/K.()!"VIC&T!WQ5.XAR)W2)7& <&"^4B\ HG;A((BZ8P)/+9[;Q3 =:7_U9
M2<JP*70X#F)]:G87-U>#^#QVSF*V")%[7\J-/,7EB(_#,  =5PK_U8\+Z$4'
M4;_+R3"==3MB:ED/B%%5FG"$0_2O+LYE$Y85$5PRODJ3Y2TW95K&9/1_5-=9
M]!Y67[T+8Z_@EDIS/H\*WK.JY,2M/-ZAO%7*GL.DR,2%4!(RM)=FT/DI:G/E
M<F)=N;?@M7NB^G+_2HC47W"H94:QKF4NX!YIG%NZ2%6'C8O,9<T'NS)LN3[8
M4VMHCVAV; UQ7D7B&1F?7H=9'B[Y0(,$K).[EZPJ1*+F]$O"K1L+!O#(8G@I
M<<D>\BGCK2A67P96W8AZ#TE,O ;ZQI[">634MRI"K&<&70"E6^7?"?=MMAZ^
M54\Y+\.HX+^5:Q7EN9Q=#KY6EHF-)X9EW81C5U_0ND'J@"AVM%E+[W,_"^?[
ML)BHR#U[(8#U)%F/8)#.-T#XZ;S2@_^S T)9XK_/$SY)K?*?-^P&!(:C2.;W
MXG%:NKX?70O5Y-<2B5#YVR__[W^GTNQN*EBZ5C/^-PK-Q+0^7]\/HDB2!S%9
MR4VK=RU=3:4IM1]=3^_?H]K"7PFT"UAX/^ 3>0"3^57D/]Y_V%:Q781*SR((
M\R2]"M/E*+C_5:OG1A%:/:^3N7B7?O_1H&E=B%;7&W_)[C\9]!0%B'0\+[(P
M9ED&40+]>74X_5FGK;XHD=X7<-&<+UXNDH#=G_ZBTW>C")6:LJWX>BQ+XIA%
M0SY21H,@X-,I7Y*U9JE.$4=@7/D_J@C2K?G,7-X1 *++G;;F-[0HE=IRT7T5
M9G,_^H.OO(=Q !FW[T];DYVQ.)'ZE\E<'&HU<0.JMYSWI]JIT"! #2&."S^:
ML%62YO>GVOE16Y18[:LPGN;+?)BF27J1I!!:A$^(@FB<:J=."T%R2.#=95Q2
M_CL^CFHG5[R\$P"@>Y;J:V=;K#2Q\K?5T9 85\ZT$Z^^++'B$_88PNT8$<VH
M>H=Y?Z:=@LTRQ$"F3XPOOI+ERH_7Y2!SIIV$#0+$$,3-"K&_7 '0SL1H<6KU
M^5?NS[0S\$81(C6'?.+DS%<RQO(_UYRYG]Z?:2==O+QC ,[NS[03+U[>,0#O
M[L^TDRY>W@4 L(X:I[/D>WQ_IIUIL=).*%_NKIUI)UEM41?49I4;U#=JWVFG
MV@XA%Z#<)EGN1_\>KL0Z_)UVPC4(D$*X8)#[(!K% ?OQO]CZ_IUVHM67I55<
MWH 33RM;IRSOM+.MA2 M)+FXE11 K@QSSH??:>=AHP@IC.&2I8]<ER]I\CU_
M*FG9_3O#S*R7H 7QH^%D98Z\=X:I65.<5/VKL$[@_<XP(2O%R-5-+_CRXS'A
MT],[PQR\69)4:8C)DZX29?%4SJ]R&C!,QV9)8E Y@P<6X3/C:UJ_'%_NWQOF
M9D2$%$:UKHUSL;GYWC G;Q4E55M=R-Z_-TS%&P5)5?Z61-QU_53VS.S^O6'J
MW2Y+JOCOO 7_5\Q9_)3Y61*S0#SZ3>_?&Z9;3(8(R&B^2,L3MD&>,\YBZBW,
M]]KIUB! ! %.,*/;)]Z6Y3ST7CO+MHH1J2NNJJML2VS=P\O;2GWM;-LI1@2G
MO*ZW/CU[F(5YQ =*[=3;*D:N[F.IKG:2;14C5G?X8_XDDAO _/)!.Y-JBQ*K
M7?OK^"$*'^4]@P_:B=0D002"TW%8T$W7RX<DNO^@G4HWRQ H&L;+X+X=<ORZ
M?OW_H369=HHX":,UI7:*G#H#0SY3_]":3XW%W;%"J7YK5C46IVO]OQ>A7$6/
M%S=)?-$.RS:*JS%RO*B2'93O(#^TYMX]5$IGR1<U16L>WT.E1^H5+8ZPATK/
MJ)JB?D<_2R8L8$L16TB\!ATOX!=L"1U8C^?^UQ;WV$.E9!WD94W1(C)[J)2L
M@U3W:P?!L\\7V"+KD%2]O,/X:XL 60J26;<;$L*-.@7IK 1S+<0'?V;2Q^Y_
M18A1NR2='=I*(U2H7=*EED8(4+LDV= N5+GUPV"6W,4![$E"B%H62/^5$>#O
M?T4XCI4PK1-U0D,XBY4PK:MU0D,XB)4PF4,6>;+DB_AY]8AVL%JER3,+SM?G
MB9\&Y?;S*+[_B/ *ZPK('-,>(L(7K"L@<]!G/XR LUPE*43X:E[HPGO=KWY>
MO==-4C;C9/<J?&9P%S.[\L-4!B3YB)"'E]=,9O<]- I"/UY>\S%["L)G7EXS
MV2!HJ?KO8?XTBJ^2(ITENH9!.--^:G>]&W4U#L+-]E.[Z]VIJW$0PK>?VH^C
M6XUC-DMFWY/MID$(XS[J/HXNA34,0C?W4?=Q="=$^4\(4=U'W<?1E69/*>/J
MPX"PW38(P]U3]<?1H0S-\S(2W%7]<70K0_.\C YW57\DG>M[PD<& +'=.B_C
MQ1VU'TG70AMG']P8K?U(.A;:./O@QFCM5-WJW(___%+X<.F2<8QZBKM9B,K)
MMU354\[-0E0N=Y[$128.*&72HEN6*F\;Q!_N/^FIH8THF04L=/NL)W8VHF36
M*H.-7+)LGH;B@.JZOO[R64_&C#)D]C$"T=,FHXQ#%I'783[KR0U:WB%+E #T
M_ ,M3V6!"W\5YGX$J?-6RR:3S&<]0T!*4[4^IKQ^!D=*D[5\$F>%N-O0) -@
M$_;,XJ*.C?E9/T_;B)+9Q :6?DZW$26TEDB#DJ37H?\01I 7^K-^9M<5);1&
M2Y?37_13M[8LF=[RM1:;^3^XPOJY>:,070MO:*J??#<+D6GZ' 8W(1#FN,FG
M_8M^IM46IFMCK>;Z*59?V '-FWQAI[\@TZNVM NMKNJ.S*[ZTH[ICLVGNM)4
M2_7R.>=7/AP_1>L)!#V2R9BX_LC$B4J0^8X! S)KXA)$&"XY\X@2017_/8G9
MH&(@[<B0IN)4%D"UU\^E6'$J[</(_X?/B<@RS%E0ZZZ?7;6%R=I=K[E^EM47
M)M)\N%C(O$SR%ARG*A/.6"8,9#D;%(_++EE0B*A]V67(QTP6!]E5DMXD\2A+
M?1:%$Y;!;R';33N<Y &^0F7E?;>5G@_L^2M4;15E[/L32UG=&?0,8KL<F6U;
M^NI90ZL<E;[+592L&?>+"%(E31D$VN=BU2HNA(=$[7B6UK)D=K#"I6<35K+$
MN&JEJO0[XD7@6J&K[5"8_2J@MIP%0CT;L:_ ?81ZSF)= =4JI%*PWGAKQ]/4
MEJ/VN49?A']LEZ/6=[Q8A'.6\ND; B(G:59N?(H$O8%,%2MV1J/<Y]-X#0^A
M#"^KEMQZN[8&0BE>6"U5:_Q@Z3R$O&3C59EIK1WD$RE)9D&-S@CG:)<DUODV
MA8,&>'8\A%Q%M5,AW,(H1=W^")9VJ$\;*4>Q(*3!*$4VC[:T@DOA-12$'9B$
MW/&P#20(/3 *N8D$(0XF(8>\*RG2&@G"$4Q"#GF7B@29WXU";B(Q3^1:(7>\
MZR:,FWYBGMZU0NYXUP82VXE>%7(223MJ:+>0.]XU5H#8SO%C!WU+Q6$[P8\=
M]"P5A^WT/G;0KV"3I8Y%THXV:B'ECF]M8K&=X#>D',5B.\6K4@[Y6/BC1F([
MQ3<R#OF7@L-V@E=DG,1A.[TW,N[XE7A$4B%IAS*UD'+'MS:QV,[P&U*.8K&=
MY54IAWSL>U(CL9WG&QF'_$O!83O+*S).XK"=X1L9.K]:L3ACF;RL4 / IG5-
M82I/JI_GC1><OFX$GN0 ]+.Y2<9-'/K9W"CC  YY1/!%//2#%*_ZN1R7<,$6
M6QB0H* &"7H,$P:ATN9<FQ8:_3QN(^N ;0RX]'.ZE:S3N/0SO(TLU<QRQ1[2
M@H]*L&D%+ZN?DB+SXR";?6=QOE9V*9#HGK;R9/YHC4_/!JSEG<>G)PNV\H[X
MY[^S%*+5*"P.B2':)>>(/VKP(%RB2\Y9/ BKZ)"C]C>Q$R8>K;0Z184,"11J
M7P.U#]I@1!B(?0U4&,,%Z/65RSP9X"%$Q$:8S'IVR! J8B5,ABR&ZYI5$&0D
M_N9F*3HK;.J*L(?-4H[HBC"!C5)DXV\11>O+,(+ T>=^%M;W!9'0D5AY,K]
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M=J_U"/P"8@"&\3AFD*KFR@_3\OY1.X#RGFIVUC^:GSAZG"':UD&)\[N?!N"
M,L)E.SJSOB"UQA#\O-08YW@;!0DU/O<CV(Z;/C&67\-)?Y4-Y4,[;'.G#"D.
M/H&-%UO!*->M*T+MV,X]:Z#$F,1!M47X:SN$LZX8I;9%%L8LXV13WM:LG.37
M=ESF+A&W4-RR%-(A^X]LO/B6@*>,XIRE+,MEJ90%'"3*27:L\1C; .4B.]9(
MR$,JC2^2Y4,8BR$/$F2%01E!2>SB+UC*U3SER%'6T:L>!VRNI#(9Q$$Y1MYR
MLX"MA,+UR/AK.P3U"VHCQ X7?;EZ\!]X#?G,Z1$<W.07?IJNN6-* OAK.SIU
MOPJ. "'*7^PJ(.ROM@A1DF-7 >'YI%[!;;KR*Q[IVJX"Y[RTA1"/?&U7 ;&7
M;FDW89 _?IZSH-1^\Q=*28X<95(OJYC8YB]I$91VO:SB(_81E(2]K&+BD>\E
M+8*2LY=53'BG\D6*R^=SHWB>,C]CETS^E_\<%8%XJC$7J: G?EYF3^5-B#*]
M5];D6$>J7=K<2#=?41/*L1#>#RU">)#"%PZ7;)7PQ6.U(X*')3>)47I0LEQ"
MEGEX]+IB:8T#YZ1: 6($85[=:^,+65BWLQB2P' <./,TB+F*!@]4;A*C["NX
M6DW:A_I"Q:]XW/)^%;EIOT919>& !ROO6=,Q8<;I8+^:W/3LUN(0CQ+>HQ9B
M^Y8A<*KY 0_ZW2[LAN:W?CI.1>*_0&R;<,XAGI-R+#BIL1!W'AW.2"S$B7M8
MJ9[0)1L4^5.2PFT1CLK(3S Q-VRE06-D*9B82[8995D!2/"PX)B(2S89%WF6
M^S&L.3@4(QE!Y=S%8V0:J)Q+7K:)Q\@B4#G*/:-&KW+K'X\"WBKKAE]5>MM,
M__3G+VV];:9Z^E.5=N#(.DCFKWC\;I,8K?<8T)CF<52,UJ<PM9IU+!ZWVT;<
M35L-\CP-'XI<Q-1(X#D$7ZWPNB/EEL3]KWA0[Y=6?=2M8J(2+ZK:S9Y0[]S>
MPO7N)+9L)1-!V>NGW/2E'5O-1(/V^BEB7RNX&G5@\&H? @]!CHF0VCZ&ZV7R
MDM4DS/X\7]?7;W_%HX>;Q%Q"(P,RP;\X&@/1PL6<16/@7+@8:7_94NLZC-DH
M9TMP- /E0J5<LHP(Z\5Q&$B65L(I#/R3E\G2#^/[7_'8W28Q6C19$H6!S-VP
MO=N-1]TVRM'B$<P;7ME<%%G.)\I4O/H=Q'7N\O56,+E?\2#8NU3G&/I:38[3
MP"],@@XC,G &DR#M>&Y$9.(.!D'2/0Z#8E6,C%_Q:,E6\J[Z8(//1"RZY5WU
M2"5HQ:]X/&3;*ERUX@9*$QFQJL)56T[8,XL+5D:V%\=5>'3EGC616C9=)9Q8
M;3U(K]:5>,!ELR IHHPO[LM&Y@@,_$0MZ)#&!J:A%B3M*: (O%5N/,7 )K8+
MD[>U4*;%V/&HPP8I2BQRR*S3#Y8!P,]9S!8A'XSQ",,=DH28MN)B;+V,WUY\
MX/&%>]5#BE<^,*Q-48998F _E#(8I%S%@A(#@Q3A"-?2BL'--/Y?N;&5W?^*
M!PKNE'7)1FU<Z)3?*>N2O;8'0SS4;Y>H ]:J>X4($<7!H!0!D7 1 TH8$ D'
MO&MS3,-#ZVK+NV0#J3_*#[3E'6O_YIH!'A_7*.>2/>K<51#T33QK7B0IQ*6!
MCM)) VRJ<0HMI(7EP#HYP9:$<Q@VCI:OQ;"&1^JUK<(EE/P?U>_*65'-. 1Q
M(^0DF>E3$L&ZB3=))Z/8Z_?>7OMU4I>]?L^E<1[N($K5JV#UO#GLR8]&W"7O
MT**SIT4:<5+;B:><V69X[U_QP,AZ 5+[\)%X'HHFY?^.6-EGRNB<XO<<D($U
M6<B[C\_ IBSD*3VP?AHW7EPGG 3Q&360WO4;BX)J[Z?9/L*C&O>MBM*JBJKZ
M45U->7&^;LK<^FOXG8Q_J+0*3LOV_"G"5AOZ:<QY<E:]\&I6$WCL8E3&31PH
MZT)E"/ONMDX0CVS.0:#41R_@D"4J!"A;T0LX9(/+,"IR..C$ _=B(@[9H4&!
M,A%,Q"%;M ZK\ B\7:(.V::-"B4?7:*4MA*Q6.K+Y9R?0X26*G6YY$N#_(I!
M7,D(7A<7>9*N-PISY"@7V4?UE#;?2^N@G&0?U3ON.Y<L*&1.LLL0,M['07;_
M$8\YO&N5Y#XR7J@1CL;QBV(IU4\[.&GEZTP_^I(FQ8I+ (D5 28*%I3[I;P9
M>(/B?(E>N[^Z;7 :2*\=^>A!;!N<X-)K1WBS=[A<1<F:\8%7)/>IKO^%K-[J
M^HB'INX6IAP12N6F+'T.(?> ;B?@)HF?N159(-;\V2S)_6A[J_DFR?]@>7,1
M4L:_NTK2\E=0[I0W$T[<7U>3M]CFXJG_>%5U9GQ5\2H*4+;PU@/)CWC$;8?>
M4H(J^?HKRY\@<"0T/N@U_AZS-'L*5TTD?XX'7V%85W(D2/'5@G4EA+-ZG=A(
M;CA_93YLN0;C> (7&E,^^XEH_<W:]R,>=KMW7806KG4]7]?__"WD<WDZ?UI?
MLV>N#;SU_8B'VK:LP06,HWA5Y)G0Z:P:<?"(V28Q%]"4?@6=29^JYR,>^]J^
M$L>09FT?*Q^E?L3C6O>KB!)Q&/LQQ+<=Q9R,%^+X1G8_E(YA(I0HDI2%C[%D
MS=R7E 3O<'<5?HSD6J'ML2@7VKU2PI: E+1POV@<-Q,?6!-E.7H!!Q&@O$8O
M0#BS?V$Q;$/"F7FP#.,P$V_:GUEY5X=C09E+ERBE7;I0X?&:NT3=M54U9^.Q
MFNTJH+0;'ZAROJ*#3?%,CNUX&.9V85+->:^^31.XGO\1#Z.L%G-&6Y09J,4(
M_7ZT7'$V(I9%:;7+UKH$TYHL\4#(.]5':"UY:@+3QA7_VX7<5.3KI&9742;E
M5E[!#'_PKIVD :<_Z5H$BD%"1WW$8RP?\K-OMC51[G+(SU+V3:&N"% MR'5U
M<><C'@<:$R'WB5JE:S5M[4<\!K1)S#TTU4H0CP1M%B1'!->,99#M?"U-@T>"
M1B1<Q( 2'$2"O+>K&MWX2U;B0$F/0<H%>US4R1W6UW58M8]X &BSH&.(9("U
MCWA8:%S(!22:%#(?\5#1)C&WT"@\%0\;;91S%T_'Q(_(N3"JL>S6#P-X6?H1
M#Q2M*>V"+13=\5#/FM)NM/N$S5GX+,<J/":S7L"%UM]ZH/\1CYCLX)M^'$7W
ME+XEXH(WM5!TS^1;(H1W=' 4W3/XE@AAQE%$)=VJM[D2NGE!MI[N\8#%>_R*
M"[VOM8.%!S=&95S L=G$%^*BW2BV>2OZ$8^ O(?:C[UMNAG)[K6[,&YO:H]T
M[JZ+\Q_QF,W[_9![WG2;ADGZ!_-3A2;Q]NAF4Q;5' W:;MYE40UM;]A*M3R8
MSY,"4C'[:\F/\;C/W<*T=NQ$9F)J'<).VDQ=UN"AH*WDG;3<!CX33^N6=\I^
M%\;@W!_QX-!]JW+*JEVH3>2L5U5.V1HNXL1\?@_%_&$B609!I^RX@0@/"6T6
M=,I&=12Q"W\5YG[4K [Q<- ]:G'*>B(&5Q,VK7EGP\&:V(UU-4>#M@?/P:MQ
MRX]!S6;2 Y ]*$]+VCU+;F+KP7A:TJ1VD_<JY)*@7!:*G74\?C4J0VHC%(>!
MP" R;MK#0$D0&=*]73F]KG6GFG@X:I,8J7>UU%+V+O%8U$8Y%_!<P<W8)Q9\
M21((:X!'GT8D7, @>@<>8'JCG#OZ&B9\I1SI2%3JT=JKQV-'HS(NM'L;AV'.
M1F1<L,?$__[5YR-^Z$?090W3M$Z V!+R&<BHR@/+]3=,S^WBSFEOF)3;Q8F]
M1ZK3[@;&V5@OY(0=6DCPZ,^XD!,VX?T8#]/LR/NO36V-TZT#;[T4-1K>B<<N
MUA5WHJU5[S9.N]O%W=!^76:(_H@'(M:4=D;W"SYM/B9I&5VW>G2&QR"VD*;$
M=CNN(>"S;EV(4--KV"BI]M4+/YJQ=%E=Z<?#!ANDZ+%D^5;:JX]XI%],A!K%
M4Q(%H^4J39[EP_G*F_"@O28Q:C3*Q(!'Z]TJ2:YSO>^K*(_.Q9@(*8HL8TPJ
MUN)O>+1>DQ@YFF8O'O2KC_[XF@L2X&TGV?Z(Q_/=I3I7T9<QQ[/+@G'(Z.QO
M7<=QX$29@74=A)S95L?!(F?B'M%5^ R@42ZQ6X5'8.GM%C!0DETJ/ (?N.$#
MT.P[BY[95TZXGCC#QX,$[USG$7A"2^=/>&C@G>L\ G\0OIL4*<=OX%(]ZSH"
M^RNX#32L9UU'8N_94\H8!][!VOI4=B06KY#OQN2TE1V+S;\G'/>+Z5Q5U;'8
M6Z!^,;FKJG+5UG=Q (&<BSB'!'9S7G2PA)\X]MTX'EJAJW8WM,!N' ^M\ A]
M8#>"AU9(>#M%I[ 2A?43'M&U0](QOX8=T/&BVA+EN'IQLRUIU['UXE];TI2]
M4;G ^0F/T^K(K=9-;7'^X\:M5$6-02QCG<-F-$LS&8J:0\"I3)>L&U; <.%D
MI4O687O5.]B?\,"IUG4X;#\%)TX[;.MPPYY5YHQ/>)!5M_)LZ'3'0ZEJ2CO5
M[HU'X2%3#5).V4'!@L_YN)0;=H'PAK5;V<SZBH ;UMA 8,,$% '7;*"XE TA
MT BZ9A,%D0T5T A2VBCQ8ZY2SI=6J1\P/K]MOYG17:C_A$<DW:U"0IM^]=,_
M60Z:32%5R-8TA)("DYBS:%!"8!(C]$XC&CSBJ$F,<"_$C 8E"R8QPFA,.K6N
MZX"5G_  I&9!Q_J.O +#X:#$P2#E&!89@/,3'H,4%W(-23,3X3%(S8*4B,)8
MQ*NM7A-JTG*=KV_]<EQ .46?:BC1%G$X#U=^=)[$074C\1,>GU1;GE#_&Y9#
M<L[;-($$PL'Y^BYCP2@N<P#%CP/(05QNT^%12GO4<BQ843+1HQ9";F&O94/P
M\1BH.]1V%'96L*,$98?:W+.[?%"PY>-XP-4>M;AG9SU6E.'TJ.4H[*KX-$J%
M=JCM*.RL8$>)TPZUN6?WYBZ^ZN,HF>I1BWMVUF-%&5:/6H["KHI/]^5?IMIH
M[=QD]N&P3%1+*>B.QGB\U,V"M/[5*#+(\S1\*,1J<98@"9$^X5%/^U?FBJTL
MD9N(4,_*2&W^O0P2R17B8T',_SF73^7TF7@_X6%1>]=%:O'>N W,J&==E/;F
MQ?BHWS"7.*A7)6*[L9DZ\$"J]I506EC;UZK=%CR*JE&.&$]Y2B:BBW,,.)_9
M+NN6WC@GV2Y+VE-R-?V)R-')=<>)AZX\9;L7X+'C14WHINQ1AL;XA,<JQ84<
M18+S#U2(T*?&BT4X9W!':@6Z5(,1'F]4+T!HB[HYRU!_8 .4$+0+.Z8Y.J6W
M"U-ZS;8RS1R-A_[$A5RR@8($G9!Q(1=LHJ[Q\'"?NN(NV&%#>W1:UA5WH>WK
M6"5<>71>UI1VH>4W'ZK<?\(#>6(B3J) YV-,Q!D_4E'@\S$B0GB'!E%)O2&)
M!_SL%G;/RS:0=<_@J+ SGE>]TN1PNJ?S30EGK#,)'Y_R\>(N8V+EQJ%TS^=:
M08<1=<_N6D%G_.QW!IJQ8/#,?_O(+LNGD9!FJ[P@PT%VDP#;NIRQI!5N2_Y@
M49>K]IXP"$>G/D(\O?^$ARWM79>K]M;CMB0J%G4Y86].R2_\-%TODO2[GP9\
M+L'#I!JD*&T(E^('\WE:L$#W_@D/H-HAZ3(FG+Z8)2E]3F@FMF=5)H8'6=4+
MD%NEC0!G+%H!:AM<),M5RIY8G(7/K%F9WS!./F;^#PX()RPV\M06ZL:'<Q4;
M>??MAW,2&WG*-2FBWUV<,C\*_\&"WY(HX#/0%SZ;@M+CN+F1/DC#C/_IDO\8
M/W)2%29!TR9XN->#?9.\'\CQ1ID%JG,#/'2L6= ]1%N!13_A<67M*J!&J$:B
M_X2'EFV5=4MO,SMQ)-J^T$5'KO# KY@(=>MK49A9B8/<4(O"3$4T(M2S%_+8
M' ^W:I!RR*\VL)CYA7.OY[>?38LK%I6_?,9CGQKEJ&V#XS%/[IB<0_:!&\8U
M&O.$KI=RR#8;6,SSN5[*5;N8YWB]%/78K-6JOA7P&0\1:B%-Z'.W_EIH-8@#
ML?/C1YD""N4!)C%:-((;7B7I('CVN<PL&2P6?$;Q<\;QH(S +.@P(I0:F 4)
M1P9%L=LTF3,69%>\D$+O-Q^_?,;C</:MR@T[VJ'&0W+VK<H-6T_8JDCG3W[&
M( SE<IG$(H0;!XIR#@MI-RR*8T,9B(6T W8;+X0JHRPK8 2!BTS@FB@7,<HY
M8"L^!,[_7H0I.R^R,(8PJ9+(<DPH)^F4=0F7+MH&!X>2$[L*C@"AB:E85.!
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M0/^#J[N_VB[ [1^B*SL(#DA^B7MN,; 0FJ\=*U(3,7KRG, LJTV*4A,,KI$
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M"#WB5D4><*9VX"$N#I&8N=_NXZY9UV -5Y#%1OS)[>HR-A2L,QB2]M3^=A>
M%^"%\#5M+XF;-"$M/&[6R):X959J5]6Q":K+ #U1^^ @=';J@]O5<E1S5TG=
M4>UJ.7:A0[?0G<N%%/MV8;/=GD=.[:I=H^3 ,[7H2AU0%D)UQZ39>!'@):,G
MZK&DHML\$&$P-&)[0NG5=R1)$[LLT2-R.T 2T1RNQI;RD<2/XY.E%_;Y0#S
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MF5#:9Q&AAYC"+R""*X3(J:)0V]#X5QNZV(I^XP<+VP77X#DJXAPG6URY[T^
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M"W"^XZ0#+SJ<K+Z-.K?8GF,'3IJPE=$R[93#LO4R)^I/ F:"DU:^8M;G%UI
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MY'UQ,>YHGJ*2 >6.B_$VM]!^ABZ,(-UMSII3:EG6!W$S2 Y"W;2Y<[57YZ5
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MT?[N,J!*:,F[:YB3K2^]V#6>^?+<\[$\ESR[V9.+(S5H%4^ST..][?+:+O0
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MV3C?(T=B2Q[,B>?@+M>KN%4J_E7)>C/9;(*X?IPV*;(Q3-;/NN5U0DA#VI(
MZ17S]>\^]J@A( 'BEBA,HQU8Y[G9@M;/VF-04W/%TD]AR  '2%[U0Q%+!VVJ
M];,:T7O^YH$ A^YEY)J^(]T:L2!-]*9.L'Z6%+TI$-U!#UVRT2%;_QJL IR5
MC*U8C\ !VX3_&98/\16L7_H*#4*'_AEZZ2.-SJ83%W+TO3CT/,DJ8DD',LM8
MOPS&@998[G'MAV"?&/IPLNP2\5=9S<L5Y^XOVU8 6;\HM$AV CV2'Y-W)/FO
MI+M6/0#6+X,10[FH5;7L6#3/5>U>6)4%D/5+(=#VE,_)S?'+ #E.;E68*&=J
MKJM2'*MD%.Z1.J2"%J?&JNT;JPX)<PWG)-^"D?-H7/DQ(: I>(HD11I[7PH!
M3T:\G%9I+'[=\_E1\B:]L%C?=3Z/X&1CDR=YFOIEZX!6$9),#QU?TR A E&R
M5(V]GX60XN2Z*BO]-_:7G)F*2Z\*V*-01X=6 #-^CJYI=V%3- AGAI 3/$YL
MQ=**C;T .S[NK.QE>GW+'AF""; 8?D6ZLXD<SX&8<)0YV=.#1Y*>=_T13RW#
MU9?E=--KK_9=Q)T!LSB6M:1OTSA<#GC"B29EEH]/86E,'DZVN[&W0F.$:?GT
M)\U&\M*LI?K3ZR_W3(PZI!1K9$?I_*;>J9WA2R8OMUZ L73J_C =E26@U^CN
MF13'<#*Q*>H7F/IEZX!*W0RT6@;C1[=2U\!8(4$AOM42!\8Z*G@8-RJ,H*R)
MR4<1C=247\C(_JMI3*8(/3+M! LYC$^%ZY2JQR4F1M7JJE,**J]V,:KN67J8
M5Z#LAG$NM>Z94K#4AW&N!WT\(U0Q1%EWK8]S'ED53(RU G5*$JDJ*,HZ<'T8
MCN.59/E8HC*G)DQ&C*\?B!B"96@*L?=T]&0>4FXYG)RP)X5"ZA757T4G_U+&
MV:ZZI[:&>CHY>3^0(B)8Q"<GS0B:_&HE:KWZ4$Y*X\)2C+XR636)<I)^+,6E
MPU)%.46-\V)V2E%M-8MR^GX,K:>_FD4YH3^&1M5I0:/"^GU2%#1_!U*)I/QS
M&.>[-Y.D*NHBY33_6!I8\WI*.<%:!R!\F#M#I+)33M:/X1GB%Y;*"?(QM*H&
M9:QR"M65I),*S[KT1$MHY03^6#I3=_6(>*6S<H+7E:@31XM&#G93HRO_-'6U
MZ_1I])XB7E6O(OI&]:?Z^^?RET)4^"/^[?$O*]\/O$? <XI*<Y4OB/C81\^:
M\]/*WR9;QC2IA!<5(:)5T^LUB) .%?YH0+^BK&19MIEPMZ)2K3/-1?!4Q=VR
M4%88VZN7.@F' 1SMNJ>UR*:.[1=:;CM+PFCM$->_=<$*F451HA4B;Y$>\3.S
MG>!@2IFG-W[)E//HN^Z-'^ _=D$CYH9#IEMB?M1#LF0O66K1RE4GRU_%AH$P
M"7CY)["IC49IXZVAE:"O*DL=?KGJ1OKIQ H.+KO9LJ@/)BVD%[.&ULL*749K
M '&) !W,0=C-TEU4OWVXT XF%AX=%"/L9AG247L@#X<AS;EEP]&PJM(YM6I[
M66>]M/!2\\&/8B4KZ5E8\%KKE/0$@<%5U49)\/ZI+$U:BLS(VJ,F&#*,-\T7
ML\Z,TQ6H-A:B&-@5HZB#8H DKL4M]T5E*4"L,^-4)QY^!*FU+U)+@H++! Z,
MV 2!MS^^E@(%EUHTC-CC><J'IO/04WATD580 NOL:^^>TU/G'CIMNB]I0_(Y
MF4H.(JP":.6NJ4$@5D#+BP80<%:9BO$PBC69W)1'"7:**<=S>1G+C9TAW#F!
M<P>9JL)9N\3+$=E!-.S(*LEOP_/X*:NLU7_0&A?5;KBVYAQ4Q;(F1/\WI6D3
M)V-[5OR:$,Z+,UF<01*N$V=D^QIN)\J2G9;M:XV>*$MR;]*KP#5Z]Z?>AZ0L
MT15J;(N0@<C^$D[0\:E9[<C1Z[<I?Y"3-M'!]VSG"QZ;(M*<$ U/B5J_L6DV
M#3-I*NTE-NY%,).N#5S"QO4X,).R#?R_QM6J[H>RZKR^8U1N3/L<$I[B#BMJ
M]YT.6BKP@HN_Y"1)B71*$#TEB&J--4D,P)P6%)>'JM*!,>2DF':PVY H5L>
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MMR\4;5#[(\4$2R0)NI&R)4/U9ZNHFJ3GZ^4+\ ,0P57)5'/C!X40<[)?-,<
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M]@"?M!3&<.E?H>/EN]#!UPS-:=-N0>UR(39-@'_M<;;0*PZ"1EMQ'#N4&29
MSG7I4.?T#3W5R\(<KQ_JH^.:,G7.Z]X&Z]XL#TW#E115U$&OY0K$#<7FZWO?
M2]_0S/"1PD#S*PE-[E_D95RIE$>R\55EFMFK/4)D M&O/%,IP(!8&$7CG0M,
MF(70Y >JC8V3I:]=XVR^+5 A>"Y$+_7>0ZV(\GYAY[T'T<)V07AY^ ;\36#O
M7G 1TPE2'$^JP$=6!<(@*N&,?BKPQ0U+<7F5.!>OPC5D!8 Y7@^T";7*>U-%
M?N9XC>%;3PM&^-;30@O=IOO WP&JCG$\1%'45EJ!/<:4'456'ZG=YMV?9J,[
M"BJ%AX5"-J0$FR&/_$F9:2P"\JYOT_#GPDM CW'?JW+=N'W:PKE(5FE2>6:,
M_+[BN! >J5$5UY,D!_W=-+8P7M^ZK('Q2RU0H;U^^<O=7>Z=2=KN$JQ>?,]W
M_<WAI.C*9B@@YD* )(EHCS#\@Z?(DB=H]T+4P$!LP/=;,6;UCX&0]XHQ2U$6
MT!WTX-9V9]ZKC3MFL;4VXF!%@/QF>TYX$P ."$?#%"FN][@LK0@%:@.UJZTU
MEA#14.F39)51$3=;=E7C'G9S[R'P<>6X$-_;R;4MY&[C+3)$395ZFYHFJ?,!
M%D2P<N,.!LLJU*+?4LB!-B3=4Q!5@II">R@&PP%<#.OOD+&JACQRI%?.6"6S
M]1TU"'V1#37/S2GPF)KN[DSJ*X<S#Y?4P,_L+;2?D:(<P9Z*^PU<#XPWQN4X
MK_9AY&]!D-&3))X)S5-6E2X-?K[>@Z4_"\,]KIF-F?@MVSZ<OJ_<O8,IN,6V
ML/ Q#_F=A*E!Y'H?H+\GP=(T@;.#K;2GM# _2<FJE,#<]-O6%NI#[^F 926#
M#+O% E?]2:)1FN)3K*"_^ 4+KJMV:*73!ZKR,6_,L>87B5.JPYO86&E.,1^1
M;F=CY7759ZCCQ)[1$*KR-M"[8XP+Z>+EZ+!51?_*T:WO;3ZY2%UWDIXS)X5(
M%O:<E)D_%3NII^@C!8A%,K8*)^AJ0*2^+2C-<Z"U6_@4$3J*B%#%!?TZC$W]
M@'&@DN=2Q-W6=$E%SKAEW(RCND<]2X#V2<1F:P]BC3DE@49(3R:.EVU9WAKJ
M8NL$% ; QT-+G<H'(XNU?NU,=1"U1ZQ*L%-H[O#=HPU#<XTL==@\S-A *XN&
MP-H!AAMW=94I$'J,XR 5.!&83%BT&F,7#76TY(EXH\H2Z(Y\!(%SR.4PTZ:1
M#W;06TA "83#,K"]$ G+N$"7@"6,-[57BQ@9M,M#Y2\2AC#A];2':8O!QHD[
M%U^D5_RXT>?UP:IBO7'!VC^@Y_FO24N<V\CAA'U39ZCNAG&8K^7!$YNMR+JV
MV-EWP,'20MP8R+.3*_HV#'BM.W@396UOM,^+8S_M@WUC;Z&+*+*&*X"SO))2
MAOQO+39=>^Q&6F@YTX)O\298!A#IBD.<I=T:18%%L"\.99XL%A2FR=I')7NQ
M.80T5CLQ*;>\F'V8/16W?->+S&2URF(J 'S%3^\]8(DKQ/$F@#U9HYMMXKK^
M&PX@N?&#*R2RP@CW8TNICF1E)/D&I4^ &7N/N[ AIH)HC:FWWZ;-VJ1(H'AO
MW(?>")9.XVWFZ]+OY+F;M KNZJ[B\BAOB9\*Z*0T1!]ALMD$<9W@! #:G2*Q
M!.Z<W@^?/Z!G$3$)/YR./,$ZT_UF'L'1T1%LL;IUUGO;8 '53\#=(J-3F69]
M;HT/S2(IH8>92A,Y)/B$,+[&(QE8@C65J1,.'CMAE=)@X[DHJ@)ZJ;'AK.+L
M*JS6TN-9QW4_LU5C959\(W)H.;A*$2C7NT?A1A=&EG"F*(: 4=%%CU!4L3T,
MXK*E D_&FVJQ4,4LQRZOD5"I Z/&N&[V%M26M)2,Z5@VL;DHR_,QRZ_?^K#6
MC3ST]![9C*BXQ]0K6([I<FMI+E*6252ZOC3$1US-[Q?SV]GU9#F]OIS<3NZO
MIHO?IM/EXB&F^PN(L 86GFM.&LKDO?GZ!GKHB8&VFS4V$TD@$IC>0W6%[=;W
M%I&_^@/1=A[$0#J_V^X>/(!@\8+HS4!)8';)Y]V74"I&=\I!%$.Q*\%,\UE;
M+-%_[Z;WR\7\YFJR^.WF=O[]Z,SU=N2N[/#E!HEV(A%*K&FR1XQ61<X^I$5A
M2\W6(;%P.7.\4>>#1"R2,,1 9L G83'[=C^[F5U-[I>3JZOYT_UR=O_M 9V-
MJ]ET4:BV9 6CIS"^5$[ E01\%Z[0-Q X'O1)VM^?,C&O_?USM-Z[=<6.A8O0
M MJ#UQX"_Q6&B7IP#!8#&]8T[>5ZQ$C['1U]="K6++0D5]*>5ZF+"WMOO\<\
M^3151/2$C;4^3!.B<0[R*,/^NV.N\LW0/N[?P([<'9[+$3231H+8\I_?9]?3
MZ]GBZG:^>'J<%I5%BMRPHY*15^CK;OS@<*HL(I]'<0S2S%O[P3;^FI>'](_B
M613"JVFIRI'R!U+E0? *5[3*_+2A.F'$R5+IUB&S<@AUO**4@RM[!R/;G?YK
M#W?X:[%CGLFC58&"XQ"VF%M*V&97  <N_E3M0C;C;-PVZ.=&FJZ]OJ),$[?>
M0QK;5(Z0N=A,C?)JB$V5-(S+<A0!#BS\J)0@WL9C(P<928+-D/HH?%R*"#U'
MXXI 4'+;2#Y^QD:=BL)/B\C(G] .CA!)K_O[9PS(,U*S_N/_ U!+ P04
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M=!UEFLE,U=1VAX'OAZ3_H@@#RT,>,.!/@ %!'=(;\L?@R0?$^^.R6>#W0\+
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M?UE)%7NF?\%*R')8U^O4P@:K083.$C^L4JE<=@L,#/-Q,;EAX+A2W7=K_&4
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M8\>-<8.F^-HBWWYU;BM=9TKRR<T1V]>^99MN.XA*\:+])1H0HT3EAG2;[\+
MM"@:"G).R7(>%&+&XOEAH%L%9 $M7-6YOXOI .,?HWP.]VD*TD6R.HE)9&S
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MB6M]O6W:MLU'18CAB0J=M;']YI6SMWN5)2%LX6YNTZY/+]\%ZHYG$SSMNC<
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M6AY'I#/HY8F%_'<9T(&4U3XGDCXXRV^ID-G<$YVB:[+HP^<G-8M-X3\3GJ6
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M&X]@VU8B'U=$/MX<D6$00*73GX\PZ>3BZ&?8M1? @D71@4OI .2=D^/?671
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M5*)S #_D+9F0?\!-R6W<['Z'Z_9GG-P"Q[JF90EH 3L87ME^4VP%^G(<-5O
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ME"NAZP\(:\'2441%3+!\HE\_D*.WH8LPW02'SAA"=2160P1R#-MMQH?L"<V
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MY_*N#(UN/:N52&L<IZ :E5X>T:=B6.WE,ME]T([]*@/8FJ737JS1*.LVSTW
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MXUKKBEX8_X@QG_['YR. -'&%#="/5S@,$+>>#@9Q],HQP*!X&Q2$Z;33B,T
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M%\I12$O-6;L )#P8'"-4T-1>D#=S,[E:V%14DB!J?%G#FTV))KBAOB8=-HA
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M1/X=^O=AD*RV[4:Q)15B(%I/A @*?,0*YO:?MHNO)N=[D$$?)RS7Z9>+V>0
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M;P@3*,8V&3O*,%M14:IH<GOV)@&<Z>;8^RXPQS":1==J@X)(B4RP2_OG2!U
M^Z;RJC0"AE1&,JQY<Q,7V!909MCF%OL54Y)B,,A=V#\-DGJ5]:8E#UJ_/W23
M:#4A"1 _U>/Q[HA?3,?;T&1=AO"S RI8##U?AHR@5A],#J,Q?='G.?V9$"".
M<+&,A'*-]PCO[Y!I;]\PNA/VTMVV[E;+:@0#\#<58BI%DV*F+)3U0X+J^50'
M3S1Y45BS2=QDY1T/-$4*(--T$*:(:5J1>CBZ>YB"A%$(^*<@7T8NHNA8J 6\
M&&2#=!W=VCYT)JM;&EW6AUMHD(&-,VPN^M"+Y#>C='LK:ETJ:BW?BEICXY>
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MTBQNRLVC181_?2+5+]E]\O9O;<)#C#48SLCWF@Z,@][&)-:AT[X6M@KXG5'
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M5_6LHC"_4\HP4XT3&3H AUC;]:!,\BHA0._'0S?)MZ'P?KX'=J(I3S=MJ<F
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MM>C<46AN^GEYHS.5;MCIC^[I^<W%P"@S"I 2\.96 #-80@@U6\^GB/PR/X:
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MLN%,>-0,WDNPU/7J*XA^JMO(\+\>UL:ERV*QJ:IT5LS3=.&V>3K;5+/5?+F
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M_$_K4, 3&1Q ?1RMLC++!.#$0&3[/45DFH(TU#%8!P>:'>Y]N/>RA_,MY15
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MA!%==OTI)*')\SI3,>6TH<GL26Z;U.J57SR4)[,4(O,9Y,^\;WZ7L=O=67;
M6%G30SK;5C_E$H=7E3YNKH\<]_KHKU!&.O@!E=CJ1+!VWWA-0$.=_BU[1%+&
MQ52(@R]\AC+E-M]"GHFARY,"!,9L_ J9Z_Q?GNI"6! M<6D<-FLI4#05$EEQ
M4"MAAWF;R9\HY,42TA\Y[_7CI3< =@0D@/#GVYW>0<G_8_3\1"Q3U?3& P56
M2[%QY!?P*QZ;XSM9DKUGVM<71_:1RN?R:Z?D7 ED>#!I[>\[ -Z@/ 9Z_\*J
MK3TELH&.&%2Y.CCP?2-<(!8-]&Y%NU$U8]SKIF"KDDZI5)A Q2G5'M*27^!\
MI.>[:"H8%E'VFGP.U6OZDH1PILT]:G\&EG9N9#F8*]_;%)0D'.1+XZ0HU=S)
M$V<.+1/BFE3E:Q:2OZZ[]GS/07[@+@L6+B1C5=ZD4I8#:1IF%)/N#K(CMZ2J
M;O=-'NB8O#/GY5A1L'>UC+RJ(W_S#C(0Y)2@X'QT%.K[&W57WYL%>37>-<<C
MB$?$+\9T)HGM,Z%BI&N9'17N%+*+R90"*??9[+O-X/$PPCBT&F(T7HO-/5.>
M,CTXM"I(#1A<9A?UWL@$#G+[!7D*OID[82]P-80J&2'(S^4MM&5 [8,.WQ^3
MWPQP^)X_33TXIKV#M#QKE"<Q)><.V=-@:)[@OY%,;&KT'OFN/-2/.\6]NP>\
MY[=.WOZ$O0Y]$DF_%=7>;\(9O7QV (XG'F5FKV2$E$G,^\M+@]:Z>$%XH D!
M%/RS<;A3&<TZM B5KE]TAY<[!6;23H+[I 9]!/1$Z'_[=ZE+GB7.S?>@BU]*
M!#^I.W0_@DZ$X6@:]@3# +8 A)2M(G@TN9PE,;/]/F8""G\ZLO]R7Q][()ZQ
M^5$]SND'TDT !#PE0J:/XA$-]/!_LUQ-2G C<Z_^CT<NJWSMET44H0MAHD9'
M\.;#C5TH4-="G^0$&R7E:UAFC6]CDD7AW01BI0 <E.L[XG>KSNT>HQZ8(X<2
MA-AG@:--U-KI[X,@OJ8=@JZD/M4##E@:S4N<&O2) ON23!+A6M=+%1ZD3P(]
ME6'TV#5[1_,JPDIO)G]L'MT#&17@&2/T(;+8@65,!@.!'AUW2A*'TPF?'LA0
M+S 5LJY!8DCV5KO[C-UI^>[@.QL&Y,#!R3A8N(!0;Y395F9(--S$Z""8Q28P
MBG7G>["_'98#X!Y8<IK17)%IF>%TE>$;F6)E(Q!5C&7KP..3%X,U345_H$!)
M[Y QGM&GJ6@0OQ2X;P@OBQ(1W<\A/S&4)G87L!1O-P&)?6):E+<RQ<4R1?H/
M7Z:(U>@/F(3\ >9S4044@*)_!EYE,)4??"SBNE<>''7?UF$F="-+ZW!IDM=X
MP&E>>Z8L?&K.9 ^:SNN"O:+1X2%/#0(=8,P36-:7]+Z??1&P\,;51&77^2=]
M9(-@>:'U<S?)C\IYQH^7.E#_^:&ET"_+/U)V3.>7ZD,M,1OX0#V(S.2(=V]B
M''_ +9CQ560/GAIN:M(^.W6'?GN6H'26;M=NFQ6[I4O31;FMTE5>KN;+F2NV
ML[1\ZX&^H@=:)()K()8HC2@^"$G-PR.'OZCX^&E&JQ>45^-@6.7S^68S*UVQ
M6Z>S:I4MYN6JW&;I.MNMMNOB31RN:8D/#@EF=#OO7F%)4^C J-S< <@6AV:T
MS2-,'$6OQ8X=\+("B)'SL7Y5OJCY=KU:;->I6ZU7Z:9<9+--GLV+S7I>+MPZ
M?],1OT H9%"*\TJ_.=0%*/WRC!GQD)LW?+NO=_BS;#Y?KEV1NBJ=+;;Y+)MM
MW2+?Y:M=7F;5V^%?<?B:=9KJ@3-]J_\Y#E(Z>D>"PZ:0%I<>+8YZ%-D./FAW
MXD^]^V-V@+IYUKZ:C+C-8E;M9LMLM]VE>;[;I?/%LEAO=O-RL\PVZS<9N4)&
M&-LCD^!Q6CL498"V&B<L"8>&YA->[;RW&W^VJ\4J75>KM)I[7>!U0YD#PV2Q
M2V>;M_.^BOFK:,\UEWJA:@F!%S<41$G]U[O6>;K=%KF/$/)YNEU4_O<;'RLL
MMX6_[NEZ^W;,5QPS)L0L-K='V#; $$0=^_\58H)=ODBS:E:5FYT/"+=N-]LL
MENMROEB7FVQ9IF]B<*488#54Q0 .^%0PJL0,C0D@:\*U'!^:_8,P!(K;J,XB
M-&]"FNS5 L;*9?.56VQ<N4@WJ=L5\\IO6C&KYHN52]_<PVN$ _3!2'9ZPJ4[
M3&/?0[V7?UPI>^/HG\5S>FU-[O5,"1"#%D6V<=Y#7"P765HN5K-E7N3E-B_+
MM[S"SPPA';48=2&Y,.5<K6%-\QX$( $(\P;].:!^2A82& D)C=)4;<J.V?[_
ML?>FW6U;V=K@=_P*=+KJ;;N;4CB*9'*KUG(\)*Z*$Z_8-=R/( "*B$F A4$R
M\^M[CV< 08FR9<DNZZY;599$ F?89Y\]//O9NZHV]XY#Y1#%JRPE##%_1)YN
MAK8_E'N3LD4R24?3Z6PY&@W&Z32-QI-Y,AG,DV$\&$3+AT#%,5+F0"E,,%.O
MFS9+8-NP<?&NJ+E<YZ7G9D(1H!;_I\FJS$BC,7K,<#X'XV>2)LE@FJ;I<@+2
ME$X7X_ET&$V2:+:838;)XD&DCA IQ!,RU9$IW/?RR^T4C(#-D4](>N)U?.I>
MJ6/!#HZ6@V@4C<\6H&26L^%T/ET,DR0]6RY'_?1!+(ZTB>N2FVAA>>?F4,[O
MGOEDVRWL$.83O^,T8L7D 3GBIB[7X+4W"["]2'5)X2P5P>I/VNZ,<2.!,#48
M:Y[P1A9/GU M4^BEEYAU95FGN=/4#?&Y)C'M)YE<QC7*/Q15:@<DY)*!]PI)
M%4>U4K7TI"<;8\^8"P9Y,0HOE"W@5!/@3/.+K"P$/Z:13#_.*;!X++W/BC(0
M:Y5K?M>ZE@3^9G+I\$ES#BN%^*^Y=A.\C+ V2#\L@?-#R5WIT!9Q;;Y\1V60
MOQL<^JY3"%;!(*CB!4G(8%SR/'FY--.)LG*OP!V[#8=QM,5,/IM@C(QVAF>_
M';2^33<F!HAH&]2FIU9@;/$;K\$+&EI^>7T+=:"FIK<1%Q,SP^A2V30IRD@Y
M<D<L N8"8(()(57; P#6[2S[E0?Z7I 2+R3[=M4%I-7;! >K6XB$X-8G<Y,"
MRH6\UKD<W?YP<%";O#XT,5,H8EV#0#MK5[HF!V@NE%#KED3 H=CKEG;_K"AE
M+%>GK9EVQ98(8M%)W?)HDO;I\\^/5<ID?,H9:6_N_F&YH]U^0GMH4*^C :)>
MAR/5>@@=F8UZ\]FP-SX;[BTN%F,@XQ[.ZA$J+5NX$RGQY#(<].;32:_?'^V#
M;-)UPLACQ"<2J+"B/J!58S[T^#0T-;TB/X>$+&P+67!0R+)<KA63 K4<7L>*
M%A+EE5AWXM94[E,T4LV.4]C" *C6HYPJ8.*VTY;<2$7)0D=N2EY)2<]:89%4
MS8J(XIZW.EHDL"Q3/#15L4Y")>GRKK!FBV2.\$J\NN^Y3299&H3%C#+J/PK'
M(4^\PB5S=_''=O9306N'M15=F<+/6/WNH,Q,]2WB2:TY<Q&MFT]WEQQ-XL?+
M@!!CI-Q9:Z=W6I0XJE;.R@A;9I?2TT6R;#H!?=GR&%WW%%W0 FL@4NY>*51$
M;YF?T7#%<M.I:YY'] ()D1@%\A&-ZAPFB/2M$/J5,?V,)<'ECJ"$&BID(( ]
M%2@@D2D&)@OD3Z<Q(HF+LBRIQH73N4ZQFL[4?Q4Y54<;'B)G;@W:Q>B?] ??
MA^2G]+_?EL4RJZL>_0B_CIAD*;<5S9;B!@L-)<&*STR,T@J\!<VT][%A1#1.
M+:+(.^V^9;->9H)A=U4S'P7;&--K-ELQ3XXP[R5->AJ\=$F.NE:A=Q7V<XW[
MA$>))&8A?/N1<Q!;F$\6#%IRT=6DZ8.K[_7MMDRIVO\!7GT87CWYZN'51UT\
MA\KHK7]+J%O/Z]Z)?@Q:1>)J$=J^V7B6_1X<%X4/ZV5EI?QQS,Z_B8C6ZPX-
MP;T)7I(7OW?R2KPXJ]JV+]^G2W!8583,'08A+"$>H\@YE83PZK "]Z, 2"UZ
MSD$ 4Y*,I8[,HTIU%VM%-$OW;UO<$G')S1:;*)9IP+W!UZG;$"(Q!#U,FZ4%
M5C 3:8O18D>I.[ID5"0NXJG05AH"%#('?:+&8*_NVFW*HMVEVWT:?'K8JDL@
MN=3?>_)6:HVD&I;BX3!AK(.Q%ZZ=;:^;&,P2/A>JM\TX%KM##"!<'R3)(H/_
MQZ59XBU" :F@$\/<,X&<*Z\ :5.?(C-\NF]WP]MJX7)/2Z)R% 2LBC<5I](X
M ^K/K+<Y6%S81B:.P2HHN6 *I*;4R]W6"Q)2KNT[]4VA/JL5//2N9G'T ILH
MY*!6M7!'HN]D: S\SML>7[,C?WXB5B:Q-WQKG=CD2NS+=@2_K8DN H%_7.3O
MO0DVXHV09(_[XT>+QXHU?A.5BP@,M)-?WZ_!F'C")5/#?G]XSRY%AS!;Y]W"
M(;3@%(ZRI3.JBP"I,?/$"2+ N-+2W43#JHF+EM^EZ_[2>D4]I_<S*S<)&).+
M)Z4E$@SUCE6DAT&G$3C+(_ZU0U>\!-6RC"X*YIO/TTO*(- 7=B:/PEP]%#K.
MA.L?9)",#J4IM0MO. ]UK.*"<>L-.Q:'_479FKU@LI :BA7+:!:]H)! >[=M
M 6"H(!V\@K6 (2F<S4@9TA[<X$$, ^>F7L.WU@XGDG_5[TN#+?1AT<'CJ !;
MPWBO&L[RY:/1K/%4_6W@](' IA2Z$!XO)$[9@?E(&P2W]3RS1+HJ21D8[[F$
MF(JL[8TALOI4M'7L=%@S4Z^C]]P#^S]-2H17F:$UB>&2 '$#J4%."+XN003Q
M8"OED>."R#&X0R\?"8C3"\L6BKSRS)AUQ#CIJG_]XN73'N4@<.4"[;N';;<V
MO#3;IF0N:$TVP"_IZ&)!?,B]6SMB?W*8Q %DOS/DBGXZQMSF@Y84QV#XO,24
M"O3I*,#MQX]5K72%%4QE-1= M[I:7ZY2L@EE@^7E&1/V<.[7^TZPB1("#S04
M1EY$TE]$6./H2]HRO8R;#9YQ;2%8KYHVKP/C8I2MC@,&8=FL4^4#XE?3;2HC
M161580P^&7 D-[;P)KM=!)6L%E5'B08;^5 ^6Q+U03(JRPRDIF8)RN!H6')L
MO1_5)I9$N=S#3)9IHJ>APG,0N;Q%[LQY*&>;J8S;$:*[Y0##]3&LNHF(I"ZK
MK3$/$^85DO)'9F_XB:ZG\)&-S6#$4*REE]AQ<M!_[I)L@D%IVE.<O(4YTS]>
M*?<Y/?2%G+F7?.;@4Z"OG# ^J5KG]9788(_IMJ3@5*#A;(I:N4/=MUW<I,@!
M#>AB9YS,!3VW0T,8\EWRCO W8"RV6A,0W_:=K50@*W7R6K2@$@V^M%I0[P3_
M":=JX+H+SJXH'(#\'%:M <L^D?)=JJ!E&B.<-RQH5A7,(@.6GW^$7794EK?[
M[\BJ)'3&+T8O6XG?PHJ[J%*7%=]-Y@Z!UOUSND;Z/*3J4:C+2!T!N*D68O><
M!YC*4^%P A,'? D0$5NKW//SB7R;4T&XYQ"V'NVP1K&KZP[6H8C98\LU'J1F
MW3]MGO@X)?;<[$[GGH0=>T)Q8(]EA\TWB1ZC_L^(0K#]W4I6_SB?UC2*H@9\
M&=W)B*-"&,4ZJU:6S,_2#'>&7P('?<=7"9X:XOMH1\4L53E:XVI+XR)BAH#]
M7<L&Q]L/$\#$,SG?&=.RL;,*_^K)]WE4@1G5P:7E%)OCT%[OS9+=Y7S#82D]
M//C@P.!;84$S$8X7J:SDXJ"XD[M>;,#RPY0>/4[&&QSKLA\1PC0;USFLZ]8\
M<%:P1[>V P3.D,AIPRLH+T2,)T:>-D2&EIC7]+AEX1+<F(9[&8 6P24FD6'_
M(2OM$UV7B+(2 1\FHTE3(0/M[-#3BC"1L2'==2FUW^-60PEWOM+!4U]C+,'A
M$<58:Q5;LDIG;T(QK]#;I-N\=I]_X[-Q:#C<W.,B;3>A8=T;W& OF7R:3+)T
M8\PQTQSF,HW>,7+(8[#69@78A6@KZI J"^!M G 2!+H"M;HBE20/N!#9<J=D
M99@K([6U;$K^C7'"K?00R0@:+!@FZ1)=QV-F&;$>*;8[W@MA.@)#6E7'ZC0W
M:S.[>ZWB#,50?OU]%7ST??7?GO Z>TAX'1,6]>+=&F8 D;O % 0!4(QI@"J$
M1!;[,8+X@YH.W$2$U0)$)L[6'P6X"NZ,1M9X D9_5;L&G(,.O=O^B%'8/6%.
MDXL'WN)S)*;R?=Y^S"IIXU("TOASY><:H/F;YT]/PW\H>VKX_#WK.;QZVTDS
M>\>V+J%0^A*Z'7$X(M"C) :%,Q/D[%P+:Q']9EGJC<)$\T=OC<^N*(-T>MDP
M&H$02_]I(E"!Y7H7:"J-'(+B_<[5V[1N;ILLCF(<3&<<,T16]QN*;$1JC[&E
MX1:LP5@VS?H\,E1]^\@,N30-?W0K(2II3U'5OT15$OVG9XUG)\7+9T4;6%GD
M5B :?4E 7DS["/^3^1 ^'RT:0EV24X<]0L#8Q_C6(JHR:A4(]I@]CWZPIG)R
MK9'AIY:QR:8'5Z^H4LPSX2J9@J!&5HBTJ679,"V"%8+8NWX)(Q&633*G,,=*
MT!0*O:FQ:'8;SH&>M: M2O3=O92L%6!.8N).;FLFP[JI@-!]*@O<LX"@0.#(
M.8)DUKZSBKN;OD<V?1N[]Y6![;I41K")VG0)4\E(K'Q274HSC&5&9.'<U]9,
M'!2$&H*#,S707?V ?@9VY(VJZ]1VK^72=2BS=DKO-W-&PA?/PD<O$"7[S C7
MXP/GQA_><XX=>OT:W%:"X'8J=LD]_-ZK%<'(2TU@<%9@N=JH#E1:!"+FI'L5
M%]N]EK*"LJJU;5=T 5I1]0IRTI$]#E)29A5W7)6>69X"BHXX,'=W@5V:N FK
MD>Z;3#+;V*Z1=OAO39Z&HSXQ8V,J)5ICA69))S9 3M'?N;^EFIL.=LP!?1!:
MEQNO@36$0DMG#_Y,EKB4/>P]S6+NZ"JASJ.4(10EAX^F)8[!L_HCS:706!_*
M_0<]%\WKF.?(L@V4X+Y=%!FM%*W E0O5[D 3:#6- # XV\?M9/D T,3=3#+6
M1]/A[+( 3"37:[Z"BI]:NB\%K="YI8$WTIX;B-S3FP;7XF)9O%8 K@/5;:W@
M^S>5IZR5NQHWBA )GGUA+QNQ+5)YA'?<#AE=/N-^:U(;F RX=SY1;D#$X5E'
MOTTB)(=O,D\S[=P64X!4/]5N#M1IJ9V&;ZB!3I%C<%UU" W#U+W0ZDN".7 D
MD81D'X72.K!>&TH,2*/5:!6>WS8"CAGL(RZ6,R5?>_,F!EPJEK[7VFUCE'N;
MT+T%]YKS?7+C"\W2+=.,,+(8Z(*MBHTVU=EUKYX5",0F8"="Y8&G'@2.ZE<K
MA:V\5FLD]N<YG$%Y!,RZ8XK>WC=\'# [&:.Z%$O9Q!)8CW#ZT+]PC%!R/ORV
M]N@&,,"/W8^P:S^"X_=#_!.S*T8G6.MC+<04O(#P'=DFRL1V+B!Y,E08B#W
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M0'J4 X:P^TR#C<G"2I3PWL9;71O-KRE<1YREUZQR+G>&Z"F?.C_51;8US+3
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MT:@<,FR1CF<*5KBFT?2I>='L["F.@&1^L*T](I?#?I+IR6)W@O]KV>5,M^W
MQ9DNRVB3@G'VS@/#"**!NT/O##$TF$["MVM*AIWG.CX./Y_,-L/4UO.W+5A%
M/-\=%;P8_O\"I--H'C2[FS5O/YA:,=4,D0 0=[$5)>Q^(/TJ5&3P*UX+"/<@
M.EK"=,F1C1!][ B(<PPT:H/!+-&Y6.2X 6^@Q#H$8H+#, ^^CM%PIL,%/9[,
MCO;%Y%U%+G9#%ACK1!#0?(30=AS,:F6ZU6A8'):>F+06*?DAV,"S9,5M,"$!
M@94)<HI18-W3%CFVG8G%NR1[EL)!$\SPD.J.DS<O!XH6)MB;,]$IX\?)K6FI
M*#I1'6NP2'=%+H\44C "3F#PFT+=(,+4[;-MPS>YG-UZ)ZI5I1P52^<%@Y&T
M*-YQ")'WG/A#NM? $/03.DG,VP1D2$M[G1DRU[3=\4#5(AFZ=KI2N>.TD#!^
M*[_ =D-JTW-M*3#D4+$=LK$%8Z/M803QB <V]6QJ^.4B9> 1O4"LZ;0U',?R
MW@_BW9*%_=^>-)]_-4GSC\LB[5>QN?$9R^&]G\W$"/HZ6B!T,E>R(RD2NB/'
M[T>Y:TWU4!G2[5V!G.)N^KUB;"2.N -[K=IYY1:D6#A:=A9/9:'@;M;%I%,S
M@=8V.2V+Y+QY:>!NW#8UX^<)_WS=D-V81K"? ^T"/DO5AI\>]2')'04Z)K9B
ME)=;4./<,65T&6CR0OC[N A4P<H=E3QN+N&ZFHR[3#0<?33^MVCL3K0Z,"@X
M5RAJ?F^2<TX32]J]J7J4TNFB LT3A^?(C853_S\$T$6;U+;U>\($P[^9;A0O
M$.XZ[)^\< *C8NRUV_1654HTKD$GEZ=<KMY3Z%IFNR<F:$#ND0EWC+X6/EL>
M^YTK "$\QW9/PD3D5"$;'("E*5JE42(LWH=H28)7 ELX:@>9Q=7%VG3M!,%M
MKXCE"-F;">/2CX'#@K='-$MAAFZF69V2CFEO0*2*M$]:9,676?W0(#9R'$KB
MFN>U4?77FI^C:O+4)CC( :$"'=.#RT59ZUJY?;M:0MISFC6!HT;A+BKQ[!J'
M"0A+?IK/J8DY67\,/##'#R,<A"*2S%IDU8'O!_1]\FW4_0$K,9)!F9<(&NDT
M?%ES(,=4B+LE!T12I>5GQBB&A7$.()\P+5GW)A[(Q!G]QN>]B[C7.>L%V-D9
MH65C+>4Q#4Q=:AZOGCRKNX<?60A7+Y#>+M++BH;+<4UX_*['8"W"MW&PWN%<
M<%R&3DWE$@ZYFUA)Y<&R81#=BKF>:;).+\3<>(Q84&1 ])VOPI1?D9O" X6S
ML6^."T^$]D2-"#XBSF5)E'Y9+D8[AB<PI!EPNH@'TTHU(KZ$Q*XEE.PP5CH5
M_;99?QNP<@;'KA>*/@Z1)D7LGB[GJI1IF\$LO<\MT>"4N(K]3D]BQ'DM$72'
M!\U\FX@)%PRQP.BC-JHDMY[N!-QA;I&C>3N)$T6M-N)B,5"3<9%^RU4A7'3F
M9"2F)8"2*G,2U<6XT<*(JL-I@OJI8>R+C%S)@,)!S(.JV\R8M20I4X$:F1;U
ML/157&8+U(T+>)-'!J&*S)R-W1YTR#49K(HQ;!G!3HR-5ELZT7ATKA1A$EUR
M;!M7...4.>]'88FU6<7=>9&JV]6>#Y)W-V#B$R=(&3]R?WO<18]@1DQ704BE
M)@U$ GHV+8?T?[FV=#9K:'I:1S4!0&PW>65--1]EQ!.(*'<!%45*;4]XE_DF
MJ)I,65L#]X]N0)!^O]7*,"P;E5:P"[I4N6:U%"QKMFARPNS8LM7VN3?-+>3*
MZ;B0$#"5M<8?<8&%)*!)?TE#6Z7"4!Y->:XFP_2A3@FC4:F/G/1B^A[YQ@7V
M >>E>DQJGH92>0^E\T6@(RY-)] HFQX58=-@+O6.34Q!X763GMVGR?_:LTV.
MX:SU2%\1$N#J9%;9ZPC)[:1I)-9L8"F?O4;!,4K+<V%OZG&#-)<8&%YB0L7,
M(.P&A_2Y#L=Q*!S'5)K/I8$UU>@B8;W&O1S"8S(9;<=S26:*X>SW",D3@<FP
MY2@$>^FV5#K<3]31JTL=#0>GHZL(OC5/Z'D&#MDG'I9N">QH5!38,Z*.!-TM
MG;_6+@OHR=/65CV-*2)?&?,A(_,LYX':)- MUF*^;S0B#"8?QB(J:JWK/%8C
MP,K9+ RZ+JVUK;@T3D3/^@T.9[?KIK3WW\XM\$AB+2QWX39L5G(8[$W/R^V,
MJ&44W?BXH9QC%LGQ*,PH#E3Y4G4^,YDW#J+'Z?C-(&_[R%9G'1/ND9;$MC-O
M8%YKL:+>^C?(CY9&:V&T:=1JKQ#2H;1:+2KGRC+M4E.22EKRF>R8Q%9P.#6&
MJ':!"SXZ1[9K>A_\'=NHIDM3:^*]BD(Z[MR\GI#_:MGH1JK=;Y 1BFQ'C#?!
M7R4I"#DW8[;]'KP<%%H$N&:L/<SG<6=AV*0PM5YQO80[4N^O'"%VS'1A,\C&
MT"#Z,EQ6LO'0_29*;%M^39)X63#GI^UWE(@:('7I*$BOU;8Y):;,% -\A7.
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M49[-X3\]D]-&!/MVA<@)6X98= T"=$;P_\VGPY/QR;P_/QL-1CQ:T/QPK'
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MD6&Q#[;&.P%;'@XE7@11[MXQ [M^;?^G=M*OM$Q;-9_X)+2_0 PI.6&MRT@
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M[A,C#<A4:L%&%F<H/A%Q5Y1@SCT:A*]^^N,QGS^);P<F-[=$2PXM[=P\37O
M&FR/E[,5TE$;23=O9NA.%>*&8P;0Y4IS[#\5Q@I,*@(P!IJ,%U03)^5!)@U.
MSDT[/Y(,X&/JY052G_=$K_F?(]AGI0H3F0E8EX0>;%.""MDY<BP$D6EZATSR
MA+<SWHB-L9P@5>(E T,L5$*#9GZ\PNTK^/80<,H!3;%&#O">W%/UAW%:"T<L
MVJ$]%RQPW=MQ7[$K4<X\NH%"N! >$B.,TPUH,5%DP9PY_J)R>VGZ+*S[(RD/
M!14C #A]?10NTTLWGHC?')V,R8237ST^#5RI/X2DM):ODIN!U&X89)!FA!+8
MXDD.967Y0)$,\>\WU-^9_XW$:QJ^WY;I28(CV2")(UWQ=I41Y$[V-\T.[LHM
M/]+1WQOI&WTP4 $*&.W5LMEZ: >9$&%?*RI04^-=K^H #(I-Q40;8*9$!,FL
MG [$MG.==Y_LR8J8 ?9*<:X1HY=9>5MX @7G?'LC4_EML8W86\*^8IFF"3D?
M,EUK?_@<<E;@E N2^-.92[TB[ 1&8"VS7J @GWB'"-6U,BM@.-CDV!Z1MVI:
M%0@E.[$^/PYEBYT[_5$+L]ZNH7HL^4AR@4F"=)4#>) ZO1T;0.PG:)X1V\JO
M'4E0R_?.B_E(W;@;1>W4O&GSK]PL9[@7G'PL8;MK+!U_"L'-ID &6L>;;1M<
MM;@XTM=E."U3EM'V"@=71J(^:N5M3+=[T=P00'!D\*9C'.W8PZ%U8:F4=1 T
M+V6X<]_J(OTFK2CY>C/1U]%>]/6(R*N-?S!"[#@;(V@UU_&OLKN)8>X%78=7
MY4L'0R_H.NQ_7D'7T7=AAQUK]=!G%G3]Q0W2O9*BD2<&8OW6Z6=[/UTQV[F8
M:UO(NJT1!=X<.&C):SK%.L\RY>2?GMPGFJ;383Q<1J/D;#R=31:C43)>).-!
MNH!'#L</U8U'5#=>>U%XL6!/#J[IZ:MM!-M,YWO!<#.@JX+BQ\;$]T+\[9BX
M:?-\"$SJ% 9K_/]M.R[%\:7TB!#WC2/<X5/3EXJ)M#.G5-D)R6BSM&LW4#MF
MMI%<-P/5O?BW ^.R(G2MF4%IABXPUWT5\)_%8(K/X^EHVA^/!\,H7L[BT7BZ
MF(^3LW3T4!)]*TKC6:NL_ZK*?:,GT/CE$L 3,@=[>^P ZA[ XVQ-]('''M'@
ME3O(FH:PFF<D8\^^M5*G70^.QW<1<T]DRT^6;:A0@BK ER'&,Y*H3+AV0X-3
M6FFQ8:R*^RXGY$TU(LA^;AQ&5K/D2GIJ]68S-6.57"0IVQ?/GIQ0&@?U[=&[
M<'#UN]38AZDO'KH9\[.FN%D _6?4&S>"H/(;;_ZF9U'YKKW$GTKC?0T9S;/_
M[HSF#2ZMQ=E@>C:.1H/)-!DGX^&B/YX/4K!\A]&@/UD^6+JW<FG]!!M[PA5Y
M+W-D-TK9*<6R5*M#^)Y:.9]]_3-3)I#@F>!"RRS5K*P9$P-6"<)(;!Z5E ":
M7$.N)(+T!BW[1<4I.8M)OX^/.(/_R:.\H' T 5YSN**8 \?!A!M*.E3;8$M3
MO-QK+;?-SC&0"?-EI"B&BBGA0=<5)5E-^RTOL]JBV<'4"U=K2DMD+NNO,'=X
M[<U@1G3\#2$@OP^W;W]N-FD<1U99F_;M?%:-&-VUL=I?1-/9-!E$$9SZ_BB:
M+Y+%:#(<3I:+R6*9#!_._6V<^Z<V!>>$9S'"SC'C4PV1MAS9^-#WKO5P8>@G
M4?)[P]%]SZG6+"&?*<4Z.T_$XTM(#2(:EZI#<3KA>1L!/>\[K91NE*"S&=!^
MA7OH,F[)\Q&><2 EY\,QF"N5"6HTW4GY<^%7T)2YEJ-75$QM>2V=G/SM69 *
M @[_6=391=0+U2/NA<\OBG<F;7!<812WXO8,/.GWT,8%'^&!M)N''^P9?LRS
M!*K<-D&/FA9#FWV]]SE12/G$A32GIUBWG:Z$C.LU]M-Z0RT)WC#QY;WU!7/B
MIITATHX>8'MMOX+;Z>A%[1RJ.-NNJ<.?-ADT/B3EF^PH(J<!F333PE0'DG,(
M  ;E_%W*?*(%^GW5IX_SS@?C:-R?3;$1ZWB>]N?#<7+63]-9.I@D8-)\IK?@
M['1RY#TXP$\>N,NRTUNY!)^$J!QJRG)QTV1+)5<H)(&*IY#] JW;]8X[ 5()
M_9:X9V-+7\6$$)GPT#C-XN!GO#J$<B%<$TMRB[W8EEK"%[Z_-T[LT72V&"2C
M =A4XWAX%DVC:3)*DNE\L(B'P\_5N+HEL;IEN9(,J"=9Y@KCSO L$-ILU';H
M#?.F9-S+_C>CJK+T7MA254QZMJ.2R+H+/O,F^CWYB2C3[U&OW9>41?WA>+J<
M+**SL_YX 0[[=-0?SJ<1/.]LM%A^KK3%MR5EMR1F"+X.5P7:@=A9N5H56\3A
MGD<YN:4+M&Z%:$Z<8U_'@7F=(:*/@J_@O>/E*V3_U#(JX@[/+&[PJ8U^"IXF
M?7_?9?$[2UQ<(^0L/]?FOWL=@PG/!@\FCD*W"T:5QICP]AI<V%Z:>UW=S!3N
MN?6SDU]V#!AMP(E:'L'1T8:HWGCXIIVP-.R"Z3#18+'@:G?F1@0=@,4V6>Z
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M6<,G,AGT'[U[;$&9\)#_-!EWDG' 37#AQV!Q,+J!\M5/\AQ9<']+Z5:&8XP
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M.J=+VH*/DC;;#<T#&=*+NR_KBAQO_QXV^QD<%!C-\\)>@V(]+Z,-[1\J21.
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MD@RNS<><W\9,+64=67<8[07:)2O!$D!,"]B;QSHW9O1FU)R&Y*\;*%F&+PS
MX\!<*UE_%!<JV"^V^9E'6TPD8#X8= !G>$"7UH\I;3!Z_=3Y;,^ZM3B1R'I
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M!Z@.?JZ/1L\'OD7'(.>ONW2V86I"1T0('$QN%-4;,I"J>J CE/A(19*:P$/
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M.$5/ZJ4>(KSWPW8IHFOI[W.8RK7\H*_V7I$-0.<JD!NCPY5SYF&?,72BA-?
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M^UOX5Q@6QD_XKF[P=#J!]KP)[@_L+,>:F.!1_0/SX,UEZ+_/LXL<M'(0AQ=
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MXT?:_0HO*Q>A\71@:FA%N$*U/E@;6%7=AZNT.>=4%H@(1A,O^AI>:&FL#?7
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M.8@,8ZTL!%)[RP 16,T2H!]2%<AV3<HG!L_!K&H*1JMJ>75V<F60-9V;QNJ
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M5HW7SB44E,&+!QLA8(.75+1P0R54T4T9YHB>EV#R1?2U=+0@%R1G_9/VS91
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M?J_%G\!/^7RM[XP2'AXD1QW?X]_2,>)OGR!E:[LZN#Z_L;2'S,+?]PJ_W+#
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MLP<ON#-$@;.G^\(>*/(K/)7__*']PR/HX0^/5G"W]5VC%MQE?0\)6G#'!3_
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M@"3LR8+MP3RG@5:N['S+PL5<269F^U!P9U!RI7G $U18.$(NYX,PK#B>,+1
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M^P]6ZF%-73#)"/<%C+DL2DIM3"Z2^(JFPF6I7]&29J<0?L-M?(17E&>BL5Q
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MWRP'.24@-O#/?^>^8+N@$ F+5M,D]ZQRHX4MM/EG$#G^@ J:E6E%5Y"S+\Q
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M'_%2_;29<%#66%<@\D5];Z&Z$07=)2("XNH<DOLCI;=+N\IP<)Y+,&65"M8
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MBE'OEC!@OYLD@V@5/+7O-@@V#!(D<W%:*4."QMDN/R]S@X9S9FGW?^6C"\D
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M<QS[R?"\#=8.4D$M9Z[SLC6N0ZWQ\RR^#7NK>8$-KK)NGE:>R=%T%L;4VE"
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MJ8U2[FN^!"0.[M\TX>YMKMK-YOX#36(U%H(*FA^13.TT4:@U]SVZ6H,8.]O
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MP 9I<D]Y1_((CC?EV.&(+P*JL8L2C-NBU4@VN.!PT=1E $8 S4!&JIQ508#
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MG;?K6J<^ DP-"%&U1?TB%>UB.(FQO?(XB:?2<Y<EF1\"?T.+^Q+Y7L;-P6"
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M\Y<=K'/K;W@)A2C]YI"^(*,I7+%.;#B[NA26ZGXC5&=!4.3_%)O8W\)__^-
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M)G)K!VZE)BHL>2RN'*BA)#X]T'" 'XL+R[H&[=N=+I,4S!D\/%:UY=0<*\Y
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MQ1ID7J2,HR#O\K!($_,5]_0Q6:<#LOJZ)3FG%SZ4ST*2XWD1DQ8;!65_E?S
MX:O_'F )&0@<4B9!Q>=04@)*Y>_[Z@++[F#G+<W[&J)WM&;261M04=I+80SL
M%*-$59.R'66<0&X2ZSK8%5).A]YV;?X(>V@+DDA>!=AY3\<+S_P?*#*Q&"]W
M$,-R_)@6Q8 W%T(I1;O?^52<S($6BD[IQ%"$#OEY&SA.CNIUM2]W0+ ZV].F
M::8CGQNV0T$*H2?S15!487*;*T#R(8./Z%J\#/E>0'3VU9\)C\*GJDKL68\
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M6),AQFY,A%$& ,5]V^@*-["Z%#-SIM1NP2=@<X!AW9W%6NQ;PLJ/8)CI$!=
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M5T&6LR)>\2*N V$PK8H\K)9%F.7E,C^2\GU)&;0<Z(X.%"N1C &A!/5A,D^
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M==GH0ZZ:'BT]\:/UO"H?5YV,Q8&#:@8JGV#(H(IL09:L.0.0Q;XI/PHF?H.
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MNS,G4N-/2KVQZ+UMRB <[Y^[<]<$Y\/D$Q,?B<W[*6FWW=+[:73O5:=92)]
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MO: ^CZ0T6#V_-V)*/;0";=>HV$ _5;'P[@:[9.\Z5G%!O1][:B]>[SMT!%Q
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MP[J1#V$>=!M(/X9/>LW6@)GB8NC[>AQ@#$+,"':ZU'FN>KZDG5#.C>P)#):
MLPH*5*-3;QF^2/^'+2@.)16V5MO2 /(Y;7?Y.S"&&$E]U07*N$O2;,9CXK53
M*Z(3'XA#"T%G?8-]IWJI0$CV+;%HC?R5](Z-,:C;!SCP,;3UGVR+C4*H,.5
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M#_!NNX-^K=EO(*D ".Z^&H%$A@&8R/'\(X-S@Y%,;V!Z860[G49B<($%@@O
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MR?Y79_];/TSV?^/AYZPT:E71F9+<"A%?K93ZA#AR*%#!LR_WO'T]$J1',SK
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M-0%D.KCLUM-DW%.8:LGM'"\>*FRG6/@GZVUAE8HE?)R8(XG"V8/267![]LD
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MH"9H'(FS3!,0T A98X50R.K/8=44#XDOP*=ABV:0F>.P%6 ]SGH+ML8)95.
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M.%A-U>]!R1LE=HS";U.7&FPY#_,9'I44TJ5D-&",8UU1_FC,X)K: <?A2G:
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M*Y07;^2M\185]%R,%HG$+@,C!KIZ,S!)'+AXO"TA]<2RZ+0"\6OI*DWOD%B
M"E99C%0[1T0#V<]*":=/V!%)^^&J.SBNXF;$3OQK']IF3.?JOS(GP8[ ^%.$
M<;K;",S]3)?'T9-,A#7\;9K,A*TGC4)%O1"B])=^?0L[82NC@N3*%&0)0CN
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M^C>M@8?G@,%W9P5\FV3E;6TT;.:#FJ&;!S$:O&\XYB/^L^4U.NH&K7ZW9U)
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M4;XPWH3?"A4[GR'VBJ%W8<E1&P\,X/2K[=XM*7UG!MA:J\N0!TJX&#4,.3-
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M62#2Z-I]E.;("D@;7ORX,^_AC+38K7"/!6?AY)P%CCV7R.(U$<5;,K#)P_<
M45@K=4OORYT^4/>%T@5!AG%:*LFQY?*J9'%6ABDKX+T7?;Q=7X(@Z:H;OM(S
M E*3>T%:@]."#.#!GXX'PY'68KFXF5MN.'#M82P:9?OPFJQG'&TUP(<13SQ!
M W)H '?<FU,#"LS E[6Z3%XQ]LX,0GRK''N:?^^X/U$0/E?6_Z+82:T\1T=8
M7Z/DP;<BUZ?+40*H#HQ6*E N&TC)S0"H,ME'W#@#8 9@1FV8P3$6]L", EG\
MIXX9 E4QJ#-GD$\ @((&@B)FJ]&0YUNS$^5J6)1J5^Z;N9D550*B, 82J.DI
MJRE?Q_%M-2VVKE)&:>'6J&E)-HE14H"I3KNE/EOER-DL#RCQP"3;6Y)TJ :Z
MB26,OAV0RQ="IY!;;J&%CBYK/6$-HJ-4L&JC"? "\*)*O.![7V[#BP*C2:3M
MLY*[(5J[\*+,Q)AFG):+>" O3BZ_>),)ZU6Z/I>Q':7F=(9=;N1SY_K5>&+7
MCG7OS%G?:4*O"YXL'SWAIR$_^,\_]C2U^XE2[D)(Q1?!?&KX] #K'.1'9(KT
M<0G.U7@-W+?6MHCX'/!Z-/@RNAY-1\,XP 9%P=ILZ(@WF;!>S35,'=?&1NG'
M,U4_[Q#.:9J&JO7.]>KKA"VL5U+_ XS01AL1HC+KNUPV:2QX-TSN*FD!I<O]
M3DVE(<"B%WH8IZ6,7![IWLI8($VA(VM&33E>+76/UBT+\[R_85CHRKE:E5UQ
M@2\D:RK-5_$O\(].)I.NR^62Q@+Q=R=\NE@&>/3(CV.CKY7L_HK<UVI*60?7
M\X15@4LJ/5 5"MQ[=;E[4MFEZ_MJ1:FE(FW'+-VTZKT84L<@=:PNV.UEIYNF
MCF.K,#KT/O9RA.XR)VY@ M #T*,V],A./-T+/0HLLJ7*_1ZDH-9_T%Q'@TK^
M@!D")^WW%GM<CF?%%DO'D%4=ZF<WY1'M$7PN:[+BS;:GR8I64Y<8 ;;(YIYS
M[>9KI6LWU,79$L5M$=4C:?CTP!$]R,]IG"JKQKD&)\@B/Z(]]B"7TKWSV*RR
M3H+=NAADX!R=L#)P^<J'*T.A'?S,W.G,(BB#L Y377MM/<?#3;?;Q#5KA<4Q
MOJG0QK%*5;7L9+U?$W2!FRGT,$Y+'_F.0GGTL4!30H%F0CDI:XVQ+39:& I
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MZV7'V+UU>J9P[!<H6 8%R^K;XE6.B+.FNN53<0C7SCBAGN$-DINWC(9&+ )
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M -H.@B1,:[3$R6J04 (*%HJ"13&0VHN"^]&+#%/O9].+1(#$DV0:@1<)!I,
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M <ZZL>6NJXJ.+1&UUU'^N>DD<*F+0K@&FJG+FG8 259J87EA$88+  0 5"@
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M:N\\Y.L4JMNE9F 8JJST&I"O"\QE,%  Q>HX[5051>GCOQ2*:>6F8Y@RQDK
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MK78"(F]S9^'-7_%?Z !LA!9$4["SC1^*KV>Q*/SCY@U"-'MRL3__B-6)BFJ
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M%#-!/QD3WT_7+IDY_FSY'(0LJ<EQ;5I_?D633TJIK,I7DU0IFM= Z/FN1T>
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M-#@?!8Y-;I[.*HS''XTN->9XR+$Y\XG<K1G!@;6>MTKGO)_9]!80N46(W )
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M-/[M(YE^-[+S,6H^X2TZ7'57C.QG>OL(.?)E#%?<SRM?R?-\?4L@FR\[F\^
M;#[(YH-L/LCF:VHVWR;00W:>V/U&P,,^U,-6P,/&0FZ],O<!D30;@D"I&BT_
M+?^55,Y>.173#->$\7A\.[H'K5'$F#P^*>"TI,X*+97DTXC9(GHD]5]L-'?P
MM+XFY8V2/B >-=W9M[#;[_URDV]2H&0_!]*S92<)10%I0TD*;>/7?XHK_-#&
M !XY B5%3\0ZEQ0@OI)N,D.W.]:_ 7NEV MB3AGSEC8BF*LUQA,_]GQ2,9YF
M!5O,EXS.[LD"/,=MZ_\_>V_:W;9RY ^_GT^!X\F=L>=0"@#N=L;GZ%IR1O.W
M)8\E)T]>Y4!D4T0, 0P62\JG?ZJZ&R! + 1( &R0?2<C2R267JI^77O9CV=(
M),K;=7![L$+-:Z2R/?/>A8U/,<V+QQJ$<6.AO2='-^8U<VCW&,*T2-K,=<[#
M_SP2FT(R<<XE0/*T^BYV1W71_3Z+HN!6ALOR^8CYBV6?A0/<""ND_2N> 4J9
MTOI*55(8!%(D=?"#<DVSVJ(XNM<-G?TZ'#LOY.N$ V=O9['YJ9IE;$ DJOZ+
ML?N&2ZO(A^8$QII\0E%2@N2$Z)%_,5R3'8W)8!CF-/-2D2I>5'N_F%?RJJ7]
MRG[?NN+5$QI"> U])_#9SE+!\!SXC%77B[OTLH,^-@PS-)@H-T;(4#PXULP%
ML+#M\Y:^K -,K,9_:/A8M\>E1B-)2UN\1[R$G>*&'2=88PHL:+P(['D/RWG-
MJ*6*-2=FD4;TSW/E,SW)S"<6Z S_)@.;$*%X,3V*QO$<8X_#9,S3&[/ZL:@F
MBIZLI![7/1)&KH[N;4OF\3L>M\7MK=U<J^:S\"W/B3E?W(1Q>BT8/!FTRQ,]
MSM:'=9A]?Q5FI/V59:2]KO/P$]G\J>LVSDP8 Z#>:R^WQ&=O?7)N1&A$$8>I
M\/8PXB(^!>/1);&4OCA>1X&%L1;@&]-PR<HP0;[B;N4USAL/'JVC"8/:-M7(
MY1 >5U&X8RQLD<P[RN*-DVU4FY8)BE'S^$7F_L5:&D8AK%P2"ZL=K(N4:CH7
M>5&$BSA 6'_"UB8YC823,$K*L;64*D8T&*KIS@;?U^+T/=8>O;#GM^ARNN!U
MB]??8][1,_+R9\>]=(('?Q%8X57UE,X_K5BF=NL6Q<L4Y3'1*IMFRUMY/VPS
MER/Y^RYP>!&/5+$JQZ5M_N LDR*=WA%53HIXD1F*.#>NBXU3$Q)3SD%M0:7,
M#=CA2V5@[4.HZ%N.5[[]T+:)RII+6;8DD[<'I.)*X;[QGKW4LK(VV,4J)&>9
M?-;>?6QC9_PDH:EP;1BL3Z39M6RQ./NRW@&0*;%[LAU:OC T&?8@2JR$];;,
M!:&Z9B3)Q-B&),K?/_$ Z'G@1BT/R8OI<363\^7:>(4RLHDJ*FO_D["P@.:)
M+:YXY >)2L?'"L?SVE OZSZPB9R7D* H#K"2\FP*+ Q3$D06C";W=AY$N=2;
M+)>QG14Z@E%Y3%-U?3#5IX-4IZD"*6LMBV5)6@4]I_J)GE/]+3VG])X^S.@[
MM;V'5C2SX7C8G]0VLZ(>8=5FIO7ZVB1C9M0>G&KZ%K9[TY.=MI1/-/\O2J4W
M"HAHP^@(=W!S/^/9.?9@1:6;VA.CM /E(HO L%B<BP%:]IFS6(!"C:>*OW4(
M5.T%RC=811U8+L*KR*VE!1>[O5#-BV8FTN@Q$T'JX#C1=GCW-CU* ]90)[JJ
MI:B[4%_Z1+?D"^S(/7Y55Z77<-4SEZ$#FE/&QJR'G^OC+B>PEU.:RCY-+QF$
M7HN3O/Z\[<UG'C:4)>3_9$R[SVV)K%<2)H8PX_QK"+2I8[@ ]> 3#EHLQYC+
M156:?"8;+%9+*=V25%JDC.:;K+(M#=E MGW#MX!O7EF.B99K0>"(P\(/([ I
M 3Z,*2;J;TG V&+\+ 2E5(QFSEH7L'$!_FSC<C[GT/"AKUXV(_'8-^40A;T-
ME@8I[[_?:&]RWLR>V>S+];R7X[1YX"E_,=]%'LM;,(P]4*OPUN3-Z5C&0AFE
M,=,-(DU%+-F*)L5XDMK$NBCHP_/2] F-4"8 ZL^NL9(4?9(4K4N*EA1]5!2M
MG3I%YTNA;*P[BD=/YGQN$:X'C0:_?7@P9C\?7="=YSQCQ7U\>*NK Y#&^Q/X
M,1R^VYLH*5V9-E8K?J\-SR?#M6^*!B&]'Y_KF:7F&J"MWWGS0<-7'@B,@%J-
M03U!U:2RCE$C07$U?J\-:0 I!1U6#*DH!?%Q3MNAYW;4]Q*F7FTR&(\&@[]K
M_<Y8>[O-8VT)*(*RG:##DFB01(-4E-'.:*#5B ::.I9H<$QL)^BP)!HDT4!+
M.\MVA0.U-C@8C74)!M$\6M'TCDF+^\2BA<YX3#S-8_.J]2_D2]\ "1T @45
MUZ-#3CVE57T+Z2P#.,O$$M0B1\$@Q81.,60DR7U'PGTI+:8B]^D1]]5GTQ@,
MII+W1& $R7N-\EY:9ZC(?%K$?/69$(;:Z!28KRU](,.%=6K.H+^ZN$7.8N'1
MDAN/6,5B'==;W04IZ#2C2#TAN*5>NFO4KI5PUL- N:,>1Z?V%/S?.\'&7F#\
M:G@R[80HM,(O;ZN<E?T=?6\4>VX!>EI2'"?IG!+!8RP:08S,8_F(:#?5S^T4
M-E4> _(8./0QL*/3M>@8:,*" 1LHSP%Y#ASGILIS0)X#ASX'=G6W%QT$35C3
M)IH\!^0Y4/^F'LA\.:@A>4(DFUTL3AWK&XL4H5Y^Y=L[C6$0M)Z/19(GF'A'
M;<61'A$453E&!_5%M#==F:6CIV8NV[;N-99X(O&D<3RI+R9>L P9B2<23R2>
MM(XG-4;5"Y9D<[R 4J2:9GY<5-TGIV%9;O.L6('J?RN\H^#JG4H*%;?3C#]R
M9H&*B8N\+%%)>'..L>?D-CLL\9SDDV1SS^SFGD/9W%,V]Y3-/65SS^XV]RS3
MV:'XQ"M5[CX7J'>ZN[8J_ 4,5^+^F[W:D)9XP2Y]2DL\=N=&II6:F&9+5+G-
M2TLT[QBBUC\:;DK\=[S?Y#?6]B]L?".[<6P.>WLWCOHZ;>0T\6 59!L0W-+5
MW(^GST74R@DK];N_JL2/RU8555M5\&:<GF(H#HP&W7U*U-'V.=P)/,>QJUZR
MU6CX#"QV[L[Q$5%*=-2\-.RL@*HY)C@XO*T7]OB#WT"W(-%3E< &,7?]5H,5
M.J?-&)P%;2UYKGPV9K0W+FO9N%B0F9]9*/AY@XK"3@OT8CN@18#AH6C_\% [
MF?>BE@MAI78X)5A70=HRC=""\;''TNYD/=Y2%.:&X@V?'-[N+<W5"NM\X9?)
M!6,)Y/@B"V:)M8L]WF'+F)-_!L:,-OXP62UXE/UC6Q'OM\7JR?\C\'@[B[![
MH>$I-L%.G8;[*LNY9Y5S'TRT=%NLN]F2S .+W"XVSM8O?,U?92'WXBU9#U\6
M<F_P$-E\R2$/DGUJN<]FP!4Q; L[V- >ZK*"NZS@7LENSB8C*[AGO%Q6!Y85
MW%MWC4N*SKQ9((J6%=PE11\71<L*[K*"NZS@?O@4,$&'=:I56M%H^O>!5M:7
M=(&*N6$U'(8ZD(7:CXN[!!W6B3/]:&^FKS-45!](IC\J[A)T6"?.]&G?5E6F
MKZ_J^E@=2I:/YB&KKE<D\T_H6S?M&19?GPM!-[+@K+B@F%TV@Z/BI!HJ?C->
MGTA[1=;U7E_=.]'WT+5FQ:*&JG4HNLZ\$B]JQ8MI;7C12%&UGCKM?&%XL:A!
MXH7$B]WQ0E=KPXLF:F]IO<&P+_%"7+R0-?A;4RJO7E;$]@B-KWZTX6EB:):R
M+*4 M2AD6<K=C(YZJCA%\?''_S2)=^UY 9FWIV:/]FX#V7;<2'M5*%NLD2/A
M3<);T:V"P9M>.[PU8Q701WM;!22\'7KP$MXDO+4+;ZG:IWO#6S-&C.ET[X9\
MIPUOLE:VK)7=_B$C:U%V^W@8[!U15&<[\L'X: X!6<)6PD9J@$<#&T>7<B!A
M0\*&A(VF8>/HDA:.%S9.M+YUF?J-?91Z-RD9XYEO%W= B!ZKV5A7/2GQ:T:E
M-S:;=#)*-)X/MI=P2MVFZUA[.J-F;COYZ'[)(HVI<6.%J<Q*O]G\U':!1AJ1
M[RP4E_PB=D"\TE"X9WG&ANMJB5!1:V-I$1 \$\O[P6=1F<15X,Z6AD?FRL)U
MGA0_<.V?Y%7Q@H<S!!"75T@$0)\M%2R^C!6Q\$$(#V%A1OXT/'CAV4_\O5EE
MNC;*,V9=,C==0I_%:A)ZP8JXK!!D3W&-9P4K0+HF'+>LDJ1]AI6B"2U]^/1@
M85%#F_36%1/Q&4OX887E$STL'#D+/#BGB,O> 1_ A#US;AJN2:'*L SWM:>0
MIY7EO!)RYA*+UFXD+-:'W>8 6RV)$?L4*RUBT0H;RS[&!\2F@A.9$3X*^-Z9
MF?!4Y=GTEU'ALO(U%O,+=V5B0];9NG'.I<[2PYQTPV'ZI/M./&( J5[8\TN@
M9\M98;@C#[VJIUZQ//+$.O*"(SWR0E*FF#!?$S/#A=T/P!U/,$X4 AQ8Q0M#
M3Q^.M',L2QOF\='+>45>CT%W6- V%[][:?#N12<+.Q.6ICL_6QFN_ZJL3\+H
ME()#TWTD6%27/1B.$'ZVQ4>.!20? [C"<5^QP#!6^:5/G\$:(W7"&@5S&*U$
M_8$^GJ10_\IPL3B.]XVX=]CZ02HY1XWXO]I#_,8[(*47[(;X"N$$7;XIQ9N/
M6 N<-C[):9E4>$(TI GMI/@TUW:*__S=\ !?PC56HH6C1\<,](P H?KA%72,
M7R;RNV(3F@\.JH"27%;#]UWS(>#0CGH*?=(2=@2U!A#TK^VOSIPH7_SY.3X2
M+V';AB<2T*+Q&*\-GZ7I."Z, ?0,]F@ #SAME%^&!;K:S?6=HIZK6FP.;]D1
MAZ/^13Q\R_>[']Z[7GP!%"?P:<5]O"JJ?,Q*Q/?H9'$H+C&\('IMBN=*VR+W
MJBY\$&+YS!76N6G1K<T@%0"0&9[85-_<LJEL 1.+/@]<6K^:5YI63(]7U4<-
MF[\]]T&L#P$,8N7X(#V8M*:_Z7D!/:=,&X\[FRG'3&D,Y1OV@+,'JLBO6"I8
M3PF\<"CK+??AV%2>B+]TYE+F&.KC:<H[\!F$M+\@$WZE:T9P+9G<4;/T<9K]
M<<K()>)))L^[],C9138Y@#Z*!,^/G:<UR<M..0UVRN'K["F+]=I3I=?T9I;C
M);^(;0JS>2Y :K!G)K<Q^DRCC/5RP<8VT=UP +%CP;&YK19-D/2D>78""\0A
MFKE(S%],U/$ :^"![-'866=EF$P&<@W;6V#;O>A=M!L#7$N=T'!4T4NX!_:!
M^,^$V*!4NS_A0:A(TPXXM*<,:[,3FY@R!RWZ'&0J=D ^> 3#(>%DI'T?"'\*
M-_EBR"95GOGTX;/8[ 'Q A!Z$JMFVK\<"Q[#57-J%X9C]6G%[,S1 O'!.@]H
MJJ50#.,R<'U[8>.)V-CH>_""WL'[XHA!XI'MV[29%]RD1 ?;#53(W0^XV<S@
MC9]G40<C2[3I(W4IRU>0AI:$[7B<PNB#G=DL< LHZG:]E:8-\C]:;!86-GKB
MKZ8;[#SX!JP9=X)@4/"*T,A@Q7,"=X9$];PTX1F![>0^,$O$YR^)$5N5'DI-
M=SMJ@ 1"6HW/<?/M\Z)VSINTG!K67#90Q@;*(]E 6390E@V4*\SQ1C90%JN!
M\J&LA04FVKW:$N_6=7B/IL)T":LT%F:'?UX 7&Z#X>U;E>&H$-^2D1=3F!^#
MN+,]H\L6C?(VC4P]HY3&LK_C8?.)K< )ZO3^TB5$L5"SY % 5"OPF7KSBOIU
MX#'=FJLG":T?X=CCG0^]:BT&M^@.N1:JG"#;+#MN9E/4/'@HPOKLYJ1'CQ(9
M/!(.910>\)G6LOV9<2]S6/=8\0LRH*(I5/76/BC_%SCH<Z'F+D]Y&]BA&^8=
M-2LDS4J1X\688:MC&MR88U(H8X)B'9IC7+XTB8N1+:_*([R6-5A>PGH0;/7L
MFHZ+MC0 B' 2#$.JM5NNP1]WP(W3HXV+66SXYD6[$]GIUNN/,JT)+T%7F^WY
M;L ,?K;C*_]D%.!L[G9/>0@PILAU'=#E#.X2CMEU8I:A'K[@GPE26N2\,D55
MI[1]_6C[?F18R'#OZ!GXO"0V,(KOPW>PC+:3L,*AK_27 0O[@,W92[ 0')G9
M'-3?B8/D>2K\>=JJU%W?62RV8%QPXX%DZLA/9I@V6N8]986^]S"L<^4Z,S*G
M#C1@^3GQB?N$0?9^$C) &-_F*N,Q$M078?K,1T$#?."Y#^R!-)W!)2#@&R "
MX/WPA[EY4,20JWHV7QW ?X"=NJ#Z3D83==X_7>]M[(BW$0GUGYXR,[QEC_Y4
MR#\#$R[#PQ3S-QP7!##86#CU[9^PR2O',_$;WMC=XUY+7/+8AROCE7^R BIY
M,9]8=.X2 WM<]Y5&3\6'0KU,ZT-\!32%IKCY1I_Y_V3^*[2;,X&!%VSQE@2I
MZH',#'18L6?"=&W#!_*L+ %TY7RJFA*Y3Y2.IDU'XW0Y4/*(._8=R + UGYL
M)$)'^-/TQ.*#7XXT(X03<YNY'QNQ!8<\Y)T502V,:E"9>?P)1-!4?3S$_]M$
MA!L:37F[N*6/ ^8,5[52+6!^4Y3>K\;3^]5$=O^91V:8X?_LN',X--Y\=&R2
M2NT'AJ<//%>^&K;QR.T(#F$J*GSIDD>T*IAXBJ P0KPPL9''4K@AQ#&5:#/"
M8 :*T8*O(0U A=%BLN39D_$3#F6"IQU=71K\0UPZ 1[ DGAII%RO928JV&S&
M;; @(GI,L@"/,#!F-F-#H[''T3,\N(I%X23&CX^EWH8Y#Q"A.:'FPL3#-1P2
MBQK!I!KX]-%R'FA +$H7^#*,GGZ$OV&!V'#@3 <A<+T4X=(?=4CSE>V#ZHM.
M:Q*&CU'!&#8F3/RE,J]C/YY9-,@KE(1=DA1W@"")H@U./BQ8TP?]=0*J:3_-
MWU_Q..L[@J';P#V_$YLL@&:EP''4 D<Z&_LX!(ZK*&\@)&A081A%RP(,C0@Y
M)NJKH."ZW!,(AW-L\7G*!AR!*\!M@/$GT_/0NKW \-IKSS6(9:ZS/4 \H!<R
MNX<1%EY@WU,) W-%@/H,_-=T9\$3)JC,JN29-A.G*L*V7-M<?*!+'\DT-)D8
MEBZVBKB^'KL")(]08@JWP5/>WO%D'&T06C;"O8I."N6;\:I\,9Y["NBQ_7=P
M$,\,?N"R:WMQ.P,E#(]G#;N1U8.-(=Q1TX8CGCZ;25PF]TI$1A":K^Q8%O-L
MT!PP8[6"DXH>+Q$9F3QRFX5]S] SC4,)OX]$S$5@H1CJF]P-QJ&"U[0(Y^D\
M ,I16DP*>I3R+9/\"L-K\<,$Z<?BR>D\L<0(#:AUV-AIG'4T:AJCB,8ZME14
M' W9A\:=+PUK$6Y'>!<;TOH]!M;Z8KL0OBVR!ZWWE^6!DS!."A;"!H&UAPY[
M_GQ^,WI]#!#EUVY"-%3!>J*0S^.#UR'X*1$^U[)$7Y4>0?3H=145ON5TR$]K
M32-I;XLFA!GO%#3<C9UP3>^GIRR-7W@@$" UX(E?#M+-:Y0 X*YS(F-4E4&4
M$FS8&1!N'J8,;$+^NG;,,X%-_4-!(;M^NOYE^#0L]>-I+36]&>KIEC>]XI&G
M2_!M'7D3_2P&?2VMH"-/% X^W?]\Z^";J%8_R&A]3@<?II5BOJF']<.!/S.,
M\KB2H65>Z\60RZI0<^BX&36$2>3)&2\4A;A*$\'C'@5 PT*223>'WDHR@XAD
M!D@R?_=<_RXTG=S-B&VXIG/Q8GKT"_[W9\<E,\/SO]*]KH>Y^^FVCJ&%AR8T
M$Y;GO$E@ URL+,$D(VN9"E%TB4E<@(B[Y>(T+0T2?74X&B<,$O<\H9M619%6
MB..V0OSK2*T0(1$KC(JEY:'^E>6%)9*V7M I##C_8R4;T3+AO_9XS*/ITHI;
MH9#/3T6A87CMQLK/+*P4!"-3$+>G((YE"J),090IB#(%L:LIB%D?R8S$?3(2
M*V4C9D>1Y68AEE.5QI-T&<E/CHW4[5+K]'?3^_D)I!]0E>$WJ2M%'Q^%KF08
M1ZHL)6@89?89I6%FL3\!U:E=\ UULZ^Q6O8T2)D6[]V(5F:F>^ZKPRP7-'+A
M8=A3K@+761$LIP3WA;Y!#&AFSJ5UF!0&(9M^L*Y[3Y^)9C388#*GD?#6*RNO
M;Y/7,/0<_4',MT4/7_XI.I3HTU#92U@M1_W?UJXKUG$!3VK$NKPZD(>*EFK3
M\$M>5C1L:I.O6'EG6D714; *D8M>L#F)Q9ZS\H\8?>6'NV!ZBF4^(2GTE'E
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M]9$Z3957/3JK:%VP6U-3S8@F1..WCIA'C]_T&77$!F)\\&-I#\+0F'2$=?(
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ML)#<X^_W0!R_6PX<@6G31U_55,UW\#<T@KQ1B#<S5BB0N %YLRGSY,LO6\-
M1%<Z\;\LF33/KE F8@Z5M.TVC#)/0F4KUWQ7IW95>5_+WWAHU>P__GVB:^,/
MWF;G%7KU+#NY6ED:5"."8\"RG&>@4E#&?+SQ59GCM2D,*;3'%7Y=:&O*)IYL
MLU=:5TJ;N+(,3^D3BB:T#Z;G(Y!_/Z1W-/>4RGO4<)"EMS!D8!)B! HE0(*Q
MQD3]+<G86VP@A>"1.D?WQHC21M7Z,@5$>.UHRVN3K@Z^<US%JEX18D?$*E;
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M:6?J^^0F/(HBC,J2'EM!6Y;T"!$YU?1G$Y%;*NNCC7KZJ*.])&19'XD!7<:
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M8[0-OUL$?P'DO7AR8)W^13_/1>5F2XSW!L..EGZKI@QVG/3>=7M+)%Y*O-S
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M-MI3]I4B[I&W:2CU",2JQOJC\9_7MG*#Z08HSH"8..U1:0=KG1GVJ^(!0X#
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M_85X*.39($:MR Q^O7?PHY@@>!'.\#J<X%]P?ENT4Y3;;F"DD9AV_^S<+YW
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M0.=PT"DNX'M?=;=*24=6#XII."[0J5@#;FCWWG:,4O08/OD>PSY@%Q=XGZK
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MM0%J2BO_)6@IO-KB>!].D MF,PIS\*B9:+J9N85!3RO_RZ^4M?*D+P9(%O
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MRH:>081_'S,GZ?7FSD- 3#?0//&,B/I2PR.!XZSA< \PWSY6! )UV#$59K_
MFY@Z*G&=-I-]Z"=DIQAH<+P"1-(,K.%Y&63+;U0Z>>VO@:)IBII0.G?T7X'R
M^0,SVX.J<]\,RY@M9K'ZG&GOUBV\+]1)HW._XU/GTRZR6J>:MEK]@E)#SF4:
M#(9:H<NDO]6R3%L;)?4/\PM6K1-N"%L78>J%AZF/1)BZ"%,78>HB3/UHPM1%
M%'KFLFSN6K&+[6&G([CQAHH,4\5:8\6>YHJ##!:'/7H?J\*>"O'>7]N1I/)_
M-2T#U)&B?FWYY>W11QPX7QW;TE\,9^&2<V,BD1_4-.@3CR6X CRP9\:8W-/Q
M E4&3 0/$[LOSG_ Z0-75DGD&+!LZ=$R83_O@Q!NEF@\P<CKF6T]<W,QEAI!
M196]<U6L$'$]2.9E;KO C\8]=F=,4;6H1S#QF6=)F[;KAB.[O;L)QS36'6=)
ML$7@!M>S7U+N/WS<Z$',488/OT6-%QZ?%50]"^;M^\= R<YVT/+VD,-4;?90
M3:/NC_#Q&2J@+&M%=:^5AJ-N2BN3?"L,+UGGA?$ P9#<#KGDL4+HUHNOYM/"
M-)?^O72R"I2G3PL>H#+7'2^,=PBH:.>ROOOQ70YK#GOHUAMV,_E4 @#GS-J3
M,MQ(F8$ED8X=O(8DB_/2K5B (#/ (6LQ-@(Z>M4=5LLS3Q""3^.])(W?!5Q[
M T^^B#S8S;)U;&AVNEO< $Q[?51%D(<_TPT+)L3B&.D;=<:&7_:1ASJPP-"5
M\SV&;+&.(&SE)M3/)PG*-&)Q@C!\@!5O&$=ZOZY2*][' 0EWX(,4L8MB&LO%
MPB^Q^'?[T67 #$_FM3Y\&'RX^/MY@(.[6$@+(>^\?-9 -N+Q_DS]" S04LQ3
MZ)>R,+'M#P^>E^(,$K -J\9I/+.JMBSUBGW"0[8>*5RWV*F&-@KR=]U:(#,R
MIE6&$K#C"];>1*HP'$X@>!Q)<#0R!^F2V<]-OSD4C&NXRFSSPVC_Y&Z5"9*E
M6]%!"^3[#-RP&FV'_,U^Q=04#B7XHM7D>64P8 K;T1V#(?^,!2H' 6,!PDMA
M.=+D"CQ2+&4<7P)5@0.;G26LUPM_E6Z:]BMW'<-+QPYE**6CS];U<L <$TD
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M:R7'8K>RFJ[7,$CBVJ8Q:7O3Z^(GLN<YL_9K33V@NLI(UM2DS'BX3A?A]G\
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M<7$H2S%"(OMMX2+MAC+3RMP,#SU_,]S?\+D9YNAO;'DB-&J8[IXTVI,[Z1S
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M"YG;KH$8XN:M_;-YO&OH.=^7L]EW __$B,!"W#1+6;+S^PMR:W?(H O')3\
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M2"?,^:F*/ALX/Y$^4R7GJZ.AU%=4P?EM9K,&#NF$.3]5S68#YR?Z;U7*^=I
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M$Q8$#TJ+%_VD?P8_!IV<$)E-)EDPDP"-%+R467F4$1T\CR=1QE\;>=S8A#5
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M];4_'^W)$OZ9>C/S\_\'4$L! A0#%     @ 7#A-6$E>DS!R"0  DS(  !
M             ( !     &5X:&EB:71?,3(M,2YH=&U02P$"% ,4    " !<
M.$U8<M_K>',)   X,@  $               @ &@"0  97AH:6)I=%\Q,BTR
M+FAT;5!+ 0(4 Q0    ( %PX35AZPP6,\@0  "X4   0              "
M 4$3  !E>&AI8FET7S$S+3$N:'1M4$L! A0#%     @ 7#A-6 Z56V;5!
M'!0  !               ( !81@  &5X:&EB:71?,3,M,BYH=&U02P$"% ,4
M    " !<.$U8JN^C_!($  "*#@  $               @ %D'0  97AH:6)I
M=%\Q-2TQ+FAT;5!+ 0(4 Q0    ( %PX35@A)M$2RMT  $GW"0 0
M      "  :0A  !E>&AI8FET7S0M,3,N:'1M4$L! A0#%     @ 7#A-6%Z2
M3^@Y!P  H2D   \              ( !G/\  &5X:&EB:71?-"TW+FAT;5!+
M 0(4 Q0    ( %PX35B/K'/+6 <  &PL   /              "  0(' 0!E
M>&AI8FET7S0M."YH=&U02P$"% ,4    " !=.$U8#;(8.3$$  #^'P  #P
M            @ &'#@$ 97AH:6)I=%\X+3$N:'1M4$L! A0#%     @ 73A-
M6 @9DHQ '@  -JT   X              ( !Y1(! &5X:&EB:71?.3<N:'1M
M4$L! A0#%     @ 73A-6(>O$?]-$P  2A8   X              ( !43$!
M &EM86=E,# P,#$N:G!G4$L! A0#%     @ 73A-6#R5$JG]&0  $1T   H
M             ( !RD0! &EM86=E,2YJ<&=02P$"% ,4    " !=.$U8<76?
MHHX3  !2%@  "@              @ 'O7@$ :6UA9V4R+FIP9U!+ 0(4 Q0
M   ( %TX35C5*$UXQ!H  (0S 0 1              "  :5R 0!I;FUD+3(P
M,C,Q,C,Q+GAS9%!+ 0(4 Q0    ( %TX35B:UB#M4A(  &0# 0 5
M      "  9B- 0!I;FUD+3(P,C,Q,C,Q7V-A;"YX;6Q02P$"% ,4    " !=
M.$U8,SM<]/$T  !:E@, %0              @ $=H $ :6YM9"TR,#(S,3(S
M,5]D968N>&UL4$L! A0#%     @ 73A-6!<ZO.2!W@  9X\+ !4
M     ( !0=4! &EN;60M,C R,S$R,S%?;&%B+GAM;%!+ 0(4 Q0    ( %TX
M35AJ 7YBP5<  'C\!0 5              "  ?6S @!I;FUD+3(P,C,Q,C,Q
M7W!R92YX;6Q02P$"% ,4    " !=.$U82H)02H$I   X4P  #@
M    @ 'I"P, :6YM9%]I;6<P,2YJ<&=02P$"% ,4    " !=.$U8"]X3*7]&
M! !UGRD #0              @ &6-0, >FLR-#,P.#<S+FAT;5!+!08
..%  4 -4$  ! ? <    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>zk2430873_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2023"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:inmd="http://inmodemd.com/20231231"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2023"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="inmd-20231231.xsd" xlink:type="simple"/>
    <context id="C_20230101to20231231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdHomeSkinnovationsLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inmd:HomeSkinnovationsLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdHomeSkinnovationsLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inmd:HomeSkinnovationsLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdHomeSkinnovationsLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inmd:HomeSkinnovationsLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_usgaapIncomeStatementLocationAxis_inmdExpensesIncomeMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdSubsidiaryOfHomeSkinnovationsLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">inmd:ExpensesIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inmd:SubsidiaryOfHomeSkinnovationsLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapIncomeStatementLocationAxis_inmdExpensesIncomeMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdSubsidiaryOfHomeSkinnovationsLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">inmd:ExpensesIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inmd:SubsidiaryOfHomeSkinnovationsLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_usgaapIncomeStatementLocationAxis_inmdExpensesIncomeMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdSubsidiaryOfHomeSkinnovationsLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">inmd:ExpensesIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inmd:SubsidiaryOfHomeSkinnovationsLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdSpaMedicalInternationalLsrlMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inmd:SpaMedicalInternationalLsrlMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdSpaMedicalInternationalLsrlMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inmd:SpaMedicalInternationalLsrlMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdSpaMedicalInternationalLsrlMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inmd:SpaMedicalInternationalLsrlMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdHimalayaFamilyOfficeConsultingLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inmd:HimalayaFamilyOfficeConsultingLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdHimalayaFamilyOfficeConsultingLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inmd:HimalayaFamilyOfficeConsultingLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdHimalayaFamilyOfficeConsultingLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inmd:HimalayaFamilyOfficeConsultingLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdHomeSkinnovationsLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inmd:HomeSkinnovationsLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdHomeSkinnovationsLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inmd:HomeSkinnovationsLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdHimalayaFamilyOfficeConsultingLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inmd:HimalayaFamilyOfficeConsultingLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdHimalayaFamilyOfficeConsultingLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inmd:HimalayaFamilyOfficeConsultingLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdSubsidiaryOfHomeSkinnovationsLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inmd:SubsidiaryOfHomeSkinnovationsLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdSubsidiaryOfHomeSkinnovationsLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">inmd:SubsidiaryOfHomeSkinnovationsLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20220101to20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_usgaapIncomeTaxAuthorityNameAxis_inmdInmodeLtdAndIsreaeliSubsidiariesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">inmd:InmodeLtdAndIsreaeliSubsidiariesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapIncomeTaxAuthorityNameAxis_inmdInmodeLtdAndIsreaeliSubsidiariesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">inmd:InmodeLtdAndIsreaeliSubsidiariesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_usgaapIncomeTaxAuthorityNameAxis_inmdInmodeLtdAndIsreaeliSubsidiariesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">inmd:InmodeLtdAndIsreaeliSubsidiariesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_usgaapIncomeTaxAuthorityNameAxis_inmdSubsidiariesOutsideIsraelMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">inmd:SubsidiariesOutsideIsraelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapIncomeTaxAuthorityNameAxis_inmdSubsidiariesOutsideIsraelMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">inmd:SubsidiariesOutsideIsraelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_usgaapIncomeTaxAuthorityNameAxis_inmdSubsidiariesOutsideIsraelMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">inmd:SubsidiariesOutsideIsraelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_usgaapIncomeTaxAuthorityNameAxis_countryIL">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">country:IL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapIncomeTaxAuthorityNameAxis_countryIL">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">country:IL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_usgaapIncomeTaxAuthorityNameAxis_countryIL">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">country:IL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_usgaapIncomeTaxAuthorityAxis_inmdRegulationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">inmd:RegulationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20211115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
        </entity>
        <period>
            <instant>2021-11-15</instant>
        </period>
    </context>
    <context id="C_20211115_srtCumulativeEffectPeriodOfAdoptionAxis_inmdAmendmentAdvantageExemptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">inmd:AmendmentAdvantageExemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-11-15</instant>
        </period>
    </context>
    <context id="C_20221231_usgaapIncomeTaxAuthorityNameAxis_inmdIsraeliTaxAuthorityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">inmd:IsraeliTaxAuthorityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_srtRangeAxis_srtMinimumMember_usgaapIncomeTaxAuthorityNameAxis_inmdSubsidiariesOutsideIsraelMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">inmd:SubsidiariesOutsideIsraelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_srtRangeAxis_srtMaximumMember_usgaapIncomeTaxAuthorityNameAxis_inmdSubsidiariesOutsideIsraelMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">inmd:SubsidiariesOutsideIsraelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20191130_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_inmdMedimorMember_usgaapTypeOfArrangementAxis_inmdSharePurchaseAndShareholdersAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inmd:MedimorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">inmd:SharePurchaseAndShareholdersAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-11-30</instant>
        </period>
    </context>
    <context id="C_20191130_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_inmdMedimorMember_usgaapInvestmentTypeAxis_inmdFullyDilutedBasisMember_usgaapTypeOfArrangementAxis_inmdSharePurchaseAndShareholdersAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inmd:MedimorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">inmd:FullyDilutedBasisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">inmd:SharePurchaseAndShareholdersAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-11-30</instant>
        </period>
    </context>
    <context id="C_20231130_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_inmdMedimorMember_usgaapTypeOfArrangementAxis_inmdSharePurchaseAndShareholdersAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inmd:MedimorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">inmd:SharePurchaseAndShareholdersAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-30</instant>
        </period>
    </context>
    <context id="C_20231231_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_inmdMedimorMember_usgaapTypeOfArrangementAxis_inmdTwoPurchaseAndShareholdersAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inmd:MedimorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">inmd:TwoPurchaseAndShareholdersAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_inmdMedimorMember_usgaapInvestmentTypeAxis_inmdFullyDilutedBasisMember_usgaapTypeOfArrangementAxis_inmdTwoPurchaseAndShareholdersAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">inmd:MedimorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">inmd:FullyDilutedBasisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">inmd:TwoPurchaseAndShareholdersAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20180501to20180531_usgaapTypeOfArrangementAxis_inmdLeaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">inmd:LeaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-05-01</startDate>
            <endDate>2018-05-31</endDate>
        </period>
    </context>
    <context id="C_20231231_srtRangeAxis_srtMinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_srtRangeAxis_srtMaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_srtRangeAxis_srtMinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_srtRangeAxis_srtMaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20180501to20180531_srtMortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_srtWarehouseMember_usgaapTypeOfArrangementAxis_inmdLeaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:WarehouseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">inmd:LeaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-05-01</startDate>
            <endDate>2018-05-31</endDate>
        </period>
    </context>
    <context id="C_20200801to20200831_srtMortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_srtOfficeBuildingMember_usgaapTypeOfArrangementAxis_inmdLeaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OfficeBuildingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">inmd:LeaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="C_20220701to20220731_srtMortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_srtOfficeBuildingMember_usgaapTypeOfArrangementAxis_inmdLeaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OfficeBuildingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">inmd:LeaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-07-31</endDate>
        </period>
    </context>
    <context id="C_20180531_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapVehiclesMember_usgaapTypeOfArrangementAxis_inmdLeaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">inmd:LeaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-05-31</instant>
        </period>
    </context>
    <context id="C_20200831_srtMortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_srtOfficeBuildingMember_usgaapTypeOfArrangementAxis_inmdLeaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OfficeBuildingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">inmd:LeaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="C_20220701_srtMortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_srtOfficeBuildingMember_usgaapTypeOfArrangementAxis_inmdLeaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OfficeBuildingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">inmd:LeaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-01</instant>
        </period>
    </context>
    <context id="C_20231231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapOfficeEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapOfficeEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapToolsDiesAndMoldsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ToolsDiesAndMoldsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapToolsDiesAndMoldsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ToolsDiesAndMoldsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_usgaapFinancialInstrumentAxis_usgaapUSGovernmentAgenciesDebtSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_usgaapFinancialInstrumentAxis_usgaapUSGovernmentAgenciesDebtSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_usgaapFinancialInstrumentAxis_usgaapMunicipalBondsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_usgaapFinancialInstrumentAxis_usgaapCorporateDebtSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_usgaapFinancialInstrumentAxis_usgaapCorporateDebtSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_usgaapFinancialInstrumentAxis_usgaapCertificatesOfDepositMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_usgaapFinancialInstrumentAxis_usgaapCertificatesOfDepositMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_usgaapFinancialInstrumentAxis_inmdNonUsGovernmentAgenciesDebtSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inmd:NonUsGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_usgaapFinancialInstrumentAxis_inmdNonUsGovernmentAgenciesDebtSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">inmd:NonUsGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapUSGovernmentAgenciesDebtSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapMunicipalBondsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapCorporateDebtSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapCertificatesOfDepositMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapUSGovernmentAgenciesDebtSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapCorporateDebtSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapCertificatesOfDepositMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_usgaapFinancialInstrumentAxis_usgaapMunicipalBondsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapCommercialPaperMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapMunicipalBondsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_usgaapFinancialInstrumentAxis_usgaapCommercialPaperMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_usgaapFinancialInstrumentAxis_usgaapCommercialPaperMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20201231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20201231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20201231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20201231_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20201231_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20201231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20211231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20221231_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_srtStatementGeographicalAxis_countryUS">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_srtStatementGeographicalAxis_countryUS">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_srtStatementGeographicalAxis_countryUS">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_srtStatementGeographicalAxis_inmdOtherCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">inmd:OtherCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_srtStatementGeographicalAxis_inmdOtherCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">inmd:OtherCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_srtStatementGeographicalAxis_inmdOtherCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">inmd:OtherCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_usgaapConcentrationRiskByTypeAxis_inmdMinimalInvasiveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">inmd:MinimalInvasiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapConcentrationRiskByTypeAxis_inmdMinimalInvasiveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">inmd:MinimalInvasiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_usgaapConcentrationRiskByTypeAxis_inmdMinimalInvasiveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">inmd:MinimalInvasiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_usgaapConcentrationRiskByTypeAxis_inmdHandsFreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">inmd:HandsFreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapConcentrationRiskByTypeAxis_inmdHandsFreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">inmd:HandsFreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_usgaapConcentrationRiskByTypeAxis_inmdHandsFreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">inmd:HandsFreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_usgaapConcentrationRiskByTypeAxis_inmdNonInvasiveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">inmd:NonInvasiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapConcentrationRiskByTypeAxis_inmdNonInvasiveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">inmd:NonInvasiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_usgaapConcentrationRiskByTypeAxis_inmdNonInvasiveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">inmd:NonInvasiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_srtStatementGeographicalAxis_countryIL">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_srtStatementGeographicalAxis_countryIL">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_srtStatementGeographicalAxis_countryUS">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_srtStatementGeographicalAxis_countryUS">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_srtStatementGeographicalAxis_inmdOtherCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">inmd:OtherCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_srtStatementGeographicalAxis_inmdOtherCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">inmd:OtherCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20210101to20211231_srtStatementGeographicalAxis_srtEuropeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_srtStatementGeographicalAxis_srtEuropeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_srtStatementGeographicalAxis_srtEuropeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_srtProductOrServiceAxis_inmdCapitalEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inmd:CapitalEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_srtProductOrServiceAxis_inmdCapitalEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inmd:CapitalEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_srtProductOrServiceAxis_inmdCapitalEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inmd:CapitalEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_srtProductOrServiceAxis_inmdConsumablesAndServiceRevenuesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inmd:ConsumablesAndServiceRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_srtProductOrServiceAxis_inmdConsumablesAndServiceRevenuesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inmd:ConsumablesAndServiceRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_srtProductOrServiceAxis_inmdConsumablesAndServiceRevenuesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">inmd:ConsumablesAndServiceRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_srtRangeAxis_srtMinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_srtRangeAxis_srtMaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_srtRangeAxis_srtMinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_srtRangeAxis_srtMaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_srtStatementScenarioAxis_srtScenarioForecastMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_srtRangeAxis_srtMinimumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_srtRangeAxis_srtMaximumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_srtRangeAxis_srtMinimumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapToolsDiesAndMoldsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ToolsDiesAndMoldsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_srtRangeAxis_srtMinimumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_srtRangeAxis_srtMaximumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapToolsDiesAndMoldsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ToolsDiesAndMoldsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_srtRangeAxis_srtMaximumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_usgaapPlanNameAxis_inmdTwoThousandsEighteenIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">inmd:TwoThousandsEighteenIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">inmd:ExercisePriceRangeOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">inmd:ExercisePriceRangeOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">inmd:ExercisePriceRangeTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">inmd:ExercisePriceRangeTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">inmd:ExercisePriceRangeThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">inmd:ExercisePriceRangeThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeFourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">inmd:ExercisePriceRangeFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeFourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">inmd:ExercisePriceRangeFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeFiveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">inmd:ExercisePriceRangeFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeFiveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">inmd:ExercisePriceRangeFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeSixMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">inmd:ExercisePriceRangeSixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeSixMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">inmd:ExercisePriceRangeSixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeSevenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">inmd:ExercisePriceRangeSevenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeSevenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">inmd:ExercisePriceRangeSevenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeEightMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">inmd:ExercisePriceRangeEightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeEightMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">inmd:ExercisePriceRangeEightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeNineMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">inmd:ExercisePriceRangeNineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeNineMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">inmd:ExercisePriceRangeNineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_usgaapIncomeStatementLocationAxis_usgaapCostOfSalesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapIncomeStatementLocationAxis_usgaapCostOfSalesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_usgaapIncomeStatementLocationAxis_usgaapCostOfSalesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_usgaapIncomeStatementLocationAxis_usgaapSellingAndMarketingExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapIncomeStatementLocationAxis_usgaapSellingAndMarketingExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_usgaapIncomeStatementLocationAxis_usgaapSellingAndMarketingExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_usgaapIncomeStatementLocationAxis_usgaapGeneralAndAdministrativeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapIncomeStatementLocationAxis_usgaapGeneralAndAdministrativeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_usgaapIncomeStatementLocationAxis_usgaapGeneralAndAdministrativeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_srtTitleOfIndividualAxis_inmdEmployeesMember_usgaapPlanNameAxis_inmdTwoThousandsEighteenIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">inmd:EmployeesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">inmd:TwoThousandsEighteenIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_srtTitleOfIndividualAxis_inmdEmployeesMember_usgaapPlanNameAxis_inmdTwoThousandsEighteenIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">inmd:EmployeesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">inmd:TwoThousandsEighteenIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_srtTitleOfIndividualAxis_inmdEmployeesMember_usgaapPlanNameAxis_inmdTwoThousandsEighteenIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">inmd:EmployeesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">inmd:TwoThousandsEighteenIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20221231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_usgaapPlanNameAxis_inmdTwoThousandsEighteenIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">inmd:TwoThousandsEighteenIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20210523">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
        </entity>
        <period>
            <instant>2021-05-23</instant>
        </period>
    </context>
    <context id="C_20210423_srtConsolidatedEntitiesAxis_srtSubsidiariesMember_usgaapBusinessAcquisitionAxis_inmdDilazarLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">inmd:DilazarLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-23</instant>
        </period>
    </context>
    <context id="C_20210423_srtConsolidatedEntitiesAxis_srtSubsidiariesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-23</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_usgaapPlanNameAxis_inmdShareRepurchaseProgramMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">inmd:ShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20200901to20200930_usgaapSubsidiarySaleOfStockAxis_usgaapIPOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001742692</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <unit id="ILS_per_Share">
        <divide>
            <unitNumerator>
                <measure>iso4217:ILS</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <unit id="Segment">
        <measure>inmd:Segment</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="USD_Per_Share">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="ils">
        <measure>iso4217:ILS</measure>
    </unit>
    <us-gaap:AccountsPayableRelatedAndNonrelatedPartyStatusExtensibleEnumeration
      contextRef="C_20231231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdHimalayaFamilyOfficeConsultingLtdMember"
      id="Fxbrl_20240208173003815">http://fasb.org/us-gaap/2023#AccountsPayableCurrent</us-gaap:AccountsPayableRelatedAndNonrelatedPartyStatusExtensibleEnumeration>
    <us-gaap:AccountsPayableRelatedAndNonrelatedPartyStatusExtensibleEnumeration
      contextRef="C_20221231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdHimalayaFamilyOfficeConsultingLtdMember"
      id="Fxbrl_20240208192704302">http://fasb.org/us-gaap/2023#AccountsPayableCurrent</us-gaap:AccountsPayableRelatedAndNonrelatedPartyStatusExtensibleEnumeration>
    <us-gaap:AccountsPayableRelatedAndNonrelatedPartyStatusExtensibleEnumeration
      contextRef="C_20231231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdHomeSkinnovationsLtdMember"
      id="Fxbrl_20240208181011420">http://fasb.org/us-gaap/2023#AccountsPayableCurrent</us-gaap:AccountsPayableRelatedAndNonrelatedPartyStatusExtensibleEnumeration>
    <us-gaap:AccountsPayableRelatedAndNonrelatedPartyStatusExtensibleEnumeration
      contextRef="C_20221231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdHomeSkinnovationsLtdMember"
      id="Fxbrl_20240208192647081">http://fasb.org/us-gaap/2023#AccountsPayableCurrent</us-gaap:AccountsPayableRelatedAndNonrelatedPartyStatusExtensibleEnumeration>
    <us-gaap:AccountsReceivableAfterAllowanceForCreditLossRelatedAndNonrelatedPartyStatusExtensibleEnumeration
      contextRef="C_20231231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdSubsidiaryOfHomeSkinnovationsLtdMember"
      id="Fxbrl_20240208190452680">http://fasb.org/us-gaap/2023#AccountsReceivableNetCurrent</us-gaap:AccountsReceivableAfterAllowanceForCreditLossRelatedAndNonrelatedPartyStatusExtensibleEnumeration>
    <us-gaap:AccountsReceivableAfterAllowanceForCreditLossRelatedAndNonrelatedPartyStatusExtensibleEnumeration
      contextRef="C_20221231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdSubsidiaryOfHomeSkinnovationsLtdMember"
      id="Fxbrl_20240208192657231">http://fasb.org/us-gaap/2023#AccountsReceivableNetCurrent</us-gaap:AccountsReceivableAfterAllowanceForCreditLossRelatedAndNonrelatedPartyStatusExtensibleEnumeration>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="C_20200831_srtMortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_srtOfficeBuildingMember_usgaapTypeOfArrangementAxis_inmdLeaseAgreementMember"
      id="Fxbrl_20240205133500283">P7Y4M</us-gaap:LesseeOperatingLeaseTermOfContract>
    <dei:AmendmentFlag contextRef="C_20230101to20231231" id="FFact_1054">false</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus contextRef="C_20230101to20231231" id="FFact_1055">FY</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentFiscalYearFocus contextRef="C_20230101to20231231" id="FFact_1056">2023</dei:DocumentFiscalYearFocus>
    <dei:EntityCentralIndexKey contextRef="C_20230101to20231231" id="FFact_1057">0001742692</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="C_20230101to20231231" id="F20230120134654274_0">20-F</dei:DocumentType>
    <dei:DocumentRegistrationStatement contextRef="C_20230101to20231231" id="F20230120134654277_1">false</dei:DocumentRegistrationStatement>
    <dei:DocumentAnnualReport contextRef="C_20230101to20231231" id="F20230120134654278_2">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="C_20230101to20231231" id="F20230120134654282_3">2023-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate contextRef="C_20230101to20231231" id="F20230120134654283_4">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport contextRef="C_20230101to20231231" id="F20230120134654283_5">false</dei:DocumentTransitionReport>
    <dei:DocumentShellCompanyReport contextRef="C_20230101to20231231" id="F20230120134654284_6">false</dei:DocumentShellCompanyReport>
    <dei:EntityFileNumber contextRef="C_20230101to20231231" id="F20230120134654284_7">001-39016</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="C_20230101to20231231" id="F20230120134654286_8">InMode Ltd.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="C_20230101to20231231"
      id="Fxbrl_20230120195503335">L3</dei:EntityIncorporationStateCountryCode>
    <dei:EntityAddressAddressLine1
      contextRef="C_20230101to20231231"
      id="F20230120134654274_01">Tavor Building</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="C_20230101to20231231"
      id="F20230120134654274_02">Sha&#x2019;ar Yokneam</dei:EntityAddressAddressLine2>
    <dei:EntityAddressAddressLine3
      contextRef="C_20230101to20231231"
      id="F20230120134654274_03">P.O. Box 533</dei:EntityAddressAddressLine3>
    <dei:EntityAddressCityOrTown
      contextRef="C_20230101to20231231"
      id="F20230120134654274_04">Yokneam</dei:EntityAddressCityOrTown>
    <dei:EntityAddressPostalZipCode
      contextRef="C_20230101to20231231"
      id="F20230120134654274_05">2069206</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCountry
      contextRef="C_20230101to20231231"
      id="F20230120134654274_06">IL</dei:EntityAddressCountry>
    <dei:ContactPersonnelName
      contextRef="C_20230101to20231231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember"
      id="F20230120134654274_07">Moshe Mizrahy</dei:ContactPersonnelName>
    <dei:CityAreaCode
      contextRef="C_20230101to20231231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember"
      id="Fxbrl_20230120195755807">972</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="C_20230101to20231231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember"
      id="F20230120134654274_09">4-9096313</dei:LocalPhoneNumber>
    <dei:EntityAddressAddressLine1
      contextRef="C_20230101to20231231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember"
      id="F20230120134654277_10">Tavor Building</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="C_20230101to20231231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember"
      id="F20230120134654277_11">Sha&#x2019;ar Yokneam</dei:EntityAddressAddressLine2>
    <dei:EntityAddressAddressLine3
      contextRef="C_20230101to20231231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember"
      id="F20230120134654277_12">P.O. Box 533</dei:EntityAddressAddressLine3>
    <dei:EntityAddressCityOrTown
      contextRef="C_20230101to20231231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember"
      id="F20230120134654277_13">Yokneam</dei:EntityAddressCityOrTown>
    <dei:EntityAddressPostalZipCode
      contextRef="C_20230101to20231231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember"
      id="F20230120134654277_14">2069206</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCountry
      contextRef="C_20230101to20231231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember"
      id="F20230120134654277_15">IL</dei:EntityAddressCountry>
    <dei:Security12bTitle
      contextRef="C_20230101to20231231"
      id="F20230120134654277_16">Ordinary shares, par value NIS 0.01 per ordinary share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_20230101to20231231"
      id="F20230120134654277_17">INMD</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="C_20230101to20231231"
      id="F20230120134654277_18">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="C_20231231"
      decimals="INF"
      id="Fxbrl_20230120221255665"
      unitRef="Shares">83982462</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="C_20230101to20231231"
      id="F20230120134654278_20">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="C_20230101to20231231"
      id="F20230120134654278_21">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="C_20230101to20231231"
      id="F20230120134654278_22">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="C_20230101to20231231"
      id="F20230120134654278_23">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="C_20230101to20231231"
      id="F20230120134654278_24">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntityEmergingGrowthCompany
      contextRef="C_20230101to20231231"
      id="F20230120134654278_25">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag
      contextRef="C_20230101to20231231"
      id="F20230120134654278_26">true</dei:IcfrAuditorAttestationFlag>
    <dei:DocumentFinStmtErrorCorrectionFlag
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240205164757032">false</dei:DocumentFinStmtErrorCorrectionFlag>
    <dei:DocumentAccountingStandard
      contextRef="C_20230101to20231231"
      id="F20230120134654278_27">U.S. GAAP</dei:DocumentAccountingStandard>
    <dei:EntityShellCompany
      contextRef="C_20230101to20231231"
      id="F20230120134654278_28">false</dei:EntityShellCompany>
    <dei:AuditorFirmId
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240205135253296">1309</dei:AuditorFirmId>
    <dei:AuditorName
      contextRef="C_20230101to20231231"
      id="Fxbrl_20230214000712999">Kesselman &amp; Kesselman</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="C_20230101to20231231"
      id="Fxbrl_20220610114750884">Tel-Aviv, Israel</dei:AuditorLocation>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_42"
      unitRef="USD">144411000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_43"
      unitRef="USD">97540000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_44"
      unitRef="USD">375829000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_45"
      unitRef="USD">384320000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_46"
      unitRef="USD">373647000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_47"
      unitRef="USD">374589000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:DepositsAssetsCurrent
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_48"
      unitRef="USD">223547000</us-gaap:DepositsAssetsCurrent>
    <us-gaap:DepositsAssetsCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_49"
      unitRef="USD">75254000</us-gaap:DepositsAssetsCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20230210021911691"
      unitRef="USD">1538000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20230210021933434"
      unitRef="USD">836000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_52"
      unitRef="USD">42362000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_53"
      unitRef="USD">26997000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_54"
      unitRef="USD">16268000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_55"
      unitRef="USD">15094000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:InventoryNet
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_56"
      unitRef="USD">45095000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_57"
      unitRef="USD">39897000</us-gaap:InventoryNet>
    <us-gaap:AssetsCurrent
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_58"
      unitRef="USD">845330000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_59"
      unitRef="USD">629371000</us-gaap:AssetsCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableNoncurrent
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20230210023555792"
      unitRef="USD">716000</us-gaap:AllowanceForDoubtfulAccountsReceivableNoncurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableNoncurrent
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20230210023633859"
      unitRef="USD">482000</us-gaap:AllowanceForDoubtfulAccountsReceivableNoncurrent>
    <us-gaap:AccountsReceivableNetNoncurrent
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_60"
      unitRef="USD">3670000</us-gaap:AccountsReceivableNetNoncurrent>
    <us-gaap:AccountsReceivableNetNoncurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_61"
      unitRef="USD">3973000</us-gaap:AccountsReceivableNetNoncurrent>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_64"
      unitRef="USD">1506000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_65"
      unitRef="USD">3094000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_66"
      unitRef="USD">9698000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_67"
      unitRef="USD">5073000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_68"
      unitRef="USD">2382000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_69"
      unitRef="USD">2298000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OtherInvestments
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_70"
      unitRef="USD">700000</us-gaap:OtherInvestments>
    <us-gaap:OtherInvestments
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_71"
      unitRef="USD">600000</us-gaap:OtherInvestments>
    <us-gaap:AssetsNoncurrent
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_72"
      unitRef="USD">17956000</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_73"
      unitRef="USD">15038000</us-gaap:AssetsNoncurrent>
    <us-gaap:Assets
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_74"
      unitRef="USD">863286000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_75"
      unitRef="USD">644409000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_76"
      unitRef="USD">13966000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_77"
      unitRef="USD">16242000</us-gaap:AccountsPayableCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_78"
      unitRef="USD">10923000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_79"
      unitRef="USD">13798000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_80"
      unitRef="USD">39247000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_81"
      unitRef="USD">51980000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_82"
      unitRef="USD">64136000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_83"
      unitRef="USD">82020000</us-gaap:LiabilitiesCurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_84"
      unitRef="USD">3766000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_85"
      unitRef="USD">3959000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_86"
      unitRef="USD">1399000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_87"
      unitRef="USD">303000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_88"
      unitRef="USD">6613000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_89"
      unitRef="USD">3509000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_90"
      unitRef="USD">11778000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_91"
      unitRef="USD">7771000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_92"
      unitRef="USD">75914000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_93"
      unitRef="USD">89791000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="C_20231231"
      id="Fxbrl_20240205172103830"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="C_20221231"
      id="Fxbrl_20240205172223101"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_20221231"
      decimals="2"
      id="Fxbrl_20230120140150676"
      unitRef="ILS_per_Share">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_20231231"
      decimals="2"
      id="Fxbrl_20230120140145108"
      unitRef="ILS_per_Share">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_20221231"
      decimals="INF"
      id="Fxbrl_20230119233138679"
      unitRef="Shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_20231231"
      decimals="INF"
      id="FFact_97"
      unitRef="Shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_20231231"
      decimals="INF"
      id="FFact_98"
      unitRef="Shares">85957465</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_20221231"
      decimals="INF"
      id="FFact_99"
      unitRef="Shares">84519994</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_20231231"
      decimals="INF"
      id="FFact_100"
      unitRef="Shares">83982462</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_20221231"
      decimals="INF"
      id="FFact_101"
      unitRef="Shares">82544991</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_102"
      unitRef="USD">245000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_103"
      unitRef="USD">241000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_104"
      unitRef="USD">177820000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_105"
      unitRef="USD">148803000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_106"
      unitRef="USD">693426000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_107"
      unitRef="USD">495507000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_108"
      unitRef="USD">-1679000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_109"
      unitRef="USD">-7493000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TreasuryStockCommonShares
      contextRef="C_20231231"
      decimals="INF"
      id="FFact_110"
      unitRef="Shares">1975003</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonShares
      contextRef="C_20221231"
      decimals="INF"
      id="FFact_111"
      unitRef="Shares">1975003</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockValue
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_112"
      unitRef="USD">82440000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_113"
      unitRef="USD">82440000</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquity
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_118"
      unitRef="USD">787372000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_119"
      unitRef="USD">554618000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_120"
      unitRef="USD">863286000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_121"
      unitRef="USD">644409000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:Revenues
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_122"
      unitRef="USD">492048000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_123"
      unitRef="USD">454271000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_124"
      unitRef="USD">357565000</us-gaap:Revenues>
    <us-gaap:CostOfRevenue
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_125"
      unitRef="USD">80708000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_126"
      unitRef="USD">73485000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_127"
      unitRef="USD">53592000</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_128"
      unitRef="USD">411340000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_129"
      unitRef="USD">380786000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_130"
      unitRef="USD">303973000</us-gaap:GrossProfit>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_131"
      unitRef="USD">13410000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_132"
      unitRef="USD">12425000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_133"
      unitRef="USD">9532000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_134"
      unitRef="USD">193042000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_135"
      unitRef="USD">160576000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_136"
      unitRef="USD">119353000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_137"
      unitRef="USD">9228000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_138"
      unitRef="USD">9931000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_139"
      unitRef="USD">8411000</us-gaap:GeneralAndAdministrativeExpense>
    <inmd:OtherOperatingExpenseIncome
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_140"
      unitRef="USD">0</inmd:OtherOperatingExpenseIncome>
    <inmd:OtherOperatingExpenseIncome
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230120000300565"
      unitRef="USD">0</inmd:OtherOperatingExpenseIncome>
    <inmd:OtherOperatingExpenseIncome
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20230120000318213"
      unitRef="USD">800000</inmd:OtherOperatingExpenseIncome>
    <us-gaap:OperatingExpenses
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_143"
      unitRef="USD">215680000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_144"
      unitRef="USD">182932000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_145"
      unitRef="USD">136496000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_146"
      unitRef="USD">195660000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_147"
      unitRef="USD">197854000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_148"
      unitRef="USD">167477000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeNet
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_149"
      unitRef="USD">21607000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_150"
      unitRef="USD">3612000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_151"
      unitRef="USD">525000</us-gaap:InvestmentIncomeNet>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_152"
      unitRef="USD">217267000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_153"
      unitRef="USD">201466000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_154"
      unitRef="USD">168002000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_155"
      unitRef="USD">19348000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_156"
      unitRef="USD">39946000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_157"
      unitRef="USD">2928000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_158"
      unitRef="USD">197919000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_159"
      unitRef="USD">161520000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_160"
      unitRef="USD">165074000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_161"
      unitRef="USD">0</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230120000407581"
      unitRef="USD">0</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_163"
      unitRef="USD">103000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_164"
      unitRef="USD">197919000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_165"
      unitRef="USD">161520000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20240205093752570"
      unitRef="USD">164971000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_20230101to20231231"
      decimals="INF"
      id="FFact_167"
      unitRef="USD_Per_Share">2.37</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_20220101to20221231"
      decimals="INF"
      id="FFact_168"
      unitRef="USD_Per_Share">1.96</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_20210101to20211231"
      decimals="INF"
      id="FFact_169"
      unitRef="USD_Per_Share">2.03</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_20230101to20231231"
      decimals="INF"
      id="FFact_170"
      unitRef="USD_Per_Share">2.3</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_20220101to20221231"
      decimals="INF"
      id="FFact_171"
      unitRef="USD_Per_Share">1.89</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_20210101to20211231"
      decimals="INF"
      id="FFact_172"
      unitRef="USD_Per_Share">1.92</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_20230101to20231231"
      decimals="INF"
      id="FFact_173"
      unitRef="Shares">83533593</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_20220101to20221231"
      decimals="INF"
      id="FFact_174"
      unitRef="Shares">82482090</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_20210101to20211231"
      decimals="INF"
      id="FFact_175"
      unitRef="Shares">81444938</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_20230101to20231231"
      decimals="INF"
      id="FFact_176"
      unitRef="Shares">85953581</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_20220101to20221231"
      decimals="INF"
      id="FFact_177"
      unitRef="Shares">85403714</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_20210101to20211231"
      decimals="INF"
      id="FFact_178"
      unitRef="Shares">86017203</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ProfitLoss
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_179"
      unitRef="USD">197919000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_180"
      unitRef="USD">161520000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_181"
      unitRef="USD">165074000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_185"
      unitRef="USD">5814000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230120001613434"
      unitRef="USD">-6174000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_187"
      unitRef="USD">-1675000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_188"
      unitRef="USD">203733000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_189"
      unitRef="USD">155346000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_190"
      unitRef="USD">163399000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_191"
      unitRef="USD">0</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230120001759442"
      unitRef="USD">0</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_193"
      unitRef="USD">103000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_194"
      unitRef="USD">203733000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_195"
      unitRef="USD">155346000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_196"
      unitRef="USD">163296000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_20201231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="FFact_197"
      unitRef="Shares">75567554</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20201231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="FFact_198"
      unitRef="USD">216000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20201231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="FFact_199"
      unitRef="USD">101593000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20201231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="FFact_200"
      unitRef="USD">169016000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20201231_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="FFact_201"
      unitRef="USD">356000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20201231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember"
      decimals="-3"
      id="Fxbrl_20230120014100242"
      unitRef="USD">-17218000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20201231_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember"
      decimals="-3"
      id="FFact_202"
      unitRef="USD">1512000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20201231"
      decimals="-3"
      id="FFact_203"
      unitRef="USD">255475000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20230120014141233"
      unitRef="USD">0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20230120014146795"
      unitRef="USD">0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="FFact_204"
      unitRef="USD">164971000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fxbrl_20230120014200921"
      unitRef="USD">0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember"
      decimals="-3"
      id="Fxbrl_20230120014207753"
      unitRef="USD">0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember"
      decimals="-3"
      id="Fxbrl_20230120014122241"
      unitRef="USD">103000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_206"
      unitRef="USD">165074000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20230120014409521"
      unitRef="USD">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20230120014405384"
      unitRef="USD">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20230120014401640"
      unitRef="USD">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="FFact_207"
      unitRef="USD">-1675000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember"
      decimals="-3"
      id="Fxbrl_20230120014413889"
      unitRef="USD">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember"
      decimals="-3"
      id="Fxbrl_20230210171619966"
      unitRef="USD">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_209"
      unitRef="USD">-1675000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20230120014625593"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="FFact_210"
      unitRef="USD">11962000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20230120014617369"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fxbrl_20230120014610681"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember"
      decimals="-3"
      id="Fxbrl_20230120014605432"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember"
      decimals="-3"
      id="Fxbrl_20230120014602448"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_211"
      unitRef="USD">11962000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <inmd:ShareValueOfAcquisitionOfNonControllingInterestInExchangeOfOrdinaryShares
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20240205100449992"
      unitRef="Shares">582826</inmd:ShareValueOfAcquisitionOfNonControllingInterestInExchangeOfOrdinaryShares>
    <inmd:AcquisitionOfNonControllingInterestInExchangeOfOrdinaryShares
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20230120014900537"
      unitRef="USD">0</inmd:AcquisitionOfNonControllingInterestInExchangeOfOrdinaryShares>
    <inmd:AcquisitionOfNonControllingInterestInExchangeOfOrdinaryShares
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20230120013012498"
      unitRef="USD">-11165000</inmd:AcquisitionOfNonControllingInterestInExchangeOfOrdinaryShares>
    <inmd:AcquisitionOfNonControllingInterestInExchangeOfOrdinaryShares
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20230120015037489"
      unitRef="USD">0</inmd:AcquisitionOfNonControllingInterestInExchangeOfOrdinaryShares>
    <inmd:AcquisitionOfNonControllingInterestInExchangeOfOrdinaryShares
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fxbrl_20230120015330833"
      unitRef="USD">0</inmd:AcquisitionOfNonControllingInterestInExchangeOfOrdinaryShares>
    <inmd:AcquisitionOfNonControllingInterestInExchangeOfOrdinaryShares
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember"
      decimals="-3"
      id="Fxbrl_20230120015322551"
      unitRef="USD">12780000</inmd:AcquisitionOfNonControllingInterestInExchangeOfOrdinaryShares>
    <inmd:AcquisitionOfNonControllingInterestInExchangeOfOrdinaryShares
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember"
      decimals="-3"
      id="Fxbrl_20230120013041324"
      unitRef="USD">-1615000</inmd:AcquisitionOfNonControllingInterestInExchangeOfOrdinaryShares>
    <inmd:AcquisitionOfNonControllingInterestInExchangeOfOrdinaryShares
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20230120015103976"
      unitRef="USD">0</inmd:AcquisitionOfNonControllingInterestInExchangeOfOrdinaryShares>
    <inmd:StockRepurchasedOrdinarySharesDuringPeriodShares
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20230120015415168"
      unitRef="Shares">-693734</inmd:StockRepurchasedOrdinarySharesDuringPeriodShares>
    <inmd:StockRepurchasedOrdinarySharesDuringPeriodValue
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20230120015635296"
      unitRef="USD">0</inmd:StockRepurchasedOrdinarySharesDuringPeriodValue>
    <inmd:StockRepurchasedOrdinarySharesDuringPeriodValue
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20230120015631911"
      unitRef="USD">0</inmd:StockRepurchasedOrdinarySharesDuringPeriodValue>
    <inmd:StockRepurchasedOrdinarySharesDuringPeriodValue
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20230120015628399"
      unitRef="USD">0</inmd:StockRepurchasedOrdinarySharesDuringPeriodValue>
    <inmd:StockRepurchasedOrdinarySharesDuringPeriodValue
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fxbrl_20230120015624551"
      unitRef="USD">0</inmd:StockRepurchasedOrdinarySharesDuringPeriodValue>
    <inmd:StockRepurchasedOrdinarySharesDuringPeriodValue
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember"
      decimals="-3"
      id="Fxbrl_20230120015442888"
      unitRef="USD">-35365000</inmd:StockRepurchasedOrdinarySharesDuringPeriodValue>
    <inmd:StockRepurchasedOrdinarySharesDuringPeriodValue
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember"
      decimals="-3"
      id="Fxbrl_20230120015448736"
      unitRef="USD">0</inmd:StockRepurchasedOrdinarySharesDuringPeriodValue>
    <inmd:StockRepurchasedOrdinarySharesDuringPeriodValue
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20230120011840595"
      unitRef="USD">-35365000</inmd:StockRepurchasedOrdinarySharesDuringPeriodValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="FFact_220"
      unitRef="Shares">7521469</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="FFact_221"
      unitRef="USD">23000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="FFact_222"
      unitRef="USD">20308000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20230120015811910"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fxbrl_20230120015808495"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember"
      decimals="-3"
      id="Fxbrl_20230120015805017"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember"
      decimals="-3"
      id="Fxbrl_20230120015747415"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_223"
      unitRef="USD">20331000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20240205110327660"
      unitRef="Shares">82978115</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="FFact_225"
      unitRef="USD">239000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="FFact_226"
      unitRef="USD">122698000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="FFact_227"
      unitRef="USD">333987000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="FFact_228"
      unitRef="USD">-1319000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember"
      decimals="-3"
      id="Fxbrl_20230120015939639"
      unitRef="USD">-39803000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember"
      decimals="-3"
      id="FFact_229"
      unitRef="USD">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_230"
      unitRef="USD">415802000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20230120020053357"
      unitRef="USD">0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20230120020031391"
      unitRef="USD">0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="FFact_231"
      unitRef="USD">161520000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fxbrl_20230120020026566"
      unitRef="USD">0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember"
      decimals="-3"
      id="Fxbrl_20230120020023182"
      unitRef="USD">0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember"
      decimals="-3"
      id="FFact_232"
      unitRef="USD">0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_233"
      unitRef="USD">161520000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20230120020216727"
      unitRef="USD">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20230120020210846"
      unitRef="USD">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20230120020203406"
      unitRef="USD">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fxbrl_20230120020231054"
      unitRef="USD">-6174000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember"
      decimals="-3"
      id="Fxbrl_20230120020144286"
      unitRef="USD">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember"
      decimals="-3"
      id="Fxbrl_20230120020139912"
      unitRef="USD">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230120022444363"
      unitRef="USD">-6174000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20230120020427958"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="FFact_236"
      unitRef="USD">24452000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20230120020424800"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fxbrl_20230120020421119"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember"
      decimals="-3"
      id="Fxbrl_20230120020418199"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember"
      decimals="-3"
      id="Fxbrl_20230120020408670"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_237"
      unitRef="USD">24452000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <inmd:StockRepurchasedOrdinarySharesDuringPeriodShares
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="FFact_240"
      unitRef="Shares">-1077213</inmd:StockRepurchasedOrdinarySharesDuringPeriodShares>
    <inmd:StockRepurchasedOrdinarySharesDuringPeriodValue
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20230120020841599"
      unitRef="USD">0</inmd:StockRepurchasedOrdinarySharesDuringPeriodValue>
    <inmd:StockRepurchasedOrdinarySharesDuringPeriodValue
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20230120020837238"
      unitRef="USD">0</inmd:StockRepurchasedOrdinarySharesDuringPeriodValue>
    <inmd:StockRepurchasedOrdinarySharesDuringPeriodValue
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20230120020831126"
      unitRef="USD">0</inmd:StockRepurchasedOrdinarySharesDuringPeriodValue>
    <inmd:StockRepurchasedOrdinarySharesDuringPeriodValue
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fxbrl_20230120020825313"
      unitRef="USD">0</inmd:StockRepurchasedOrdinarySharesDuringPeriodValue>
    <inmd:StockRepurchasedOrdinarySharesDuringPeriodValue
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember"
      decimals="-3"
      id="FFact_241"
      unitRef="USD">-42637000</inmd:StockRepurchasedOrdinarySharesDuringPeriodValue>
    <inmd:StockRepurchasedOrdinarySharesDuringPeriodValue
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember"
      decimals="-3"
      id="Fxbrl_20230120020813735"
      unitRef="USD">0</inmd:StockRepurchasedOrdinarySharesDuringPeriodValue>
    <inmd:StockRepurchasedOrdinarySharesDuringPeriodValue
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_242"
      unitRef="USD">-42637000</inmd:StockRepurchasedOrdinarySharesDuringPeriodValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="FFact_243"
      unitRef="Shares">644089</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="FFact_244"
      unitRef="USD">2000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="FFact_245"
      unitRef="USD">1653000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20230120021056973"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fxbrl_20230120021036974"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember"
      decimals="-3"
      id="Fxbrl_20230120021023181"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember"
      decimals="-3"
      id="Fxbrl_20230120021008854"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_246"
      unitRef="USD">1655000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="FFact_247"
      unitRef="Shares">82544991</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="FFact_248"
      unitRef="USD">241000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20221231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="FFact_249"
      unitRef="USD">148803000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20221231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="FFact_250"
      unitRef="USD">495507000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20221231_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fxbrl_20230120022215604"
      unitRef="USD">-7493000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20221231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember"
      decimals="-3"
      id="FFact_252"
      unitRef="USD">-82440000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20221231_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember"
      decimals="-3"
      id="FFact_253"
      unitRef="USD">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_254"
      unitRef="USD">554618000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20230120022017693"
      unitRef="USD">0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20230120022005948"
      unitRef="USD">0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="FFact_255"
      unitRef="USD">197919000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fxbrl_20230120022129700"
      unitRef="USD">0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember"
      decimals="-3"
      id="Fxbrl_20230120022146284"
      unitRef="USD">0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember"
      decimals="-3"
      id="FFact_256"
      unitRef="USD">0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_257"
      unitRef="USD">197919000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20230120021820981"
      unitRef="USD">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20230120021815325"
      unitRef="USD">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20230120021811246"
      unitRef="USD">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="FFact_258"
      unitRef="USD">5814000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember"
      decimals="-3"
      id="Fxbrl_20230120021805421"
      unitRef="USD">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember"
      decimals="-3"
      id="Fxbrl_20230120021802101"
      unitRef="USD">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_259"
      unitRef="USD">5814000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20230120021731694"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20240205100930808"
      unitRef="USD">23600000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20230120021717053"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fxbrl_20230120021655621"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember"
      decimals="-3"
      id="Fxbrl_20230120021639134"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember"
      decimals="-3"
      id="Fxbrl_20230120021628245"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_261"
      unitRef="USD">23600000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="FFact_269"
      unitRef="Shares">1437471</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="FFact_270"
      unitRef="USD">4000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="FFact_271"
      unitRef="USD">5417000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20230120021305510"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fxbrl_20230120021249174"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember"
      decimals="-3"
      id="Fxbrl_20230120021219749"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember"
      decimals="-3"
      id="Fxbrl_20230120021159981"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_272"
      unitRef="USD">5421000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_20231231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="FFact_273"
      unitRef="Shares">83982462</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20231231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="FFact_274"
      unitRef="USD">245000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20231231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="FFact_275"
      unitRef="USD">177820000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20231231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="FFact_276"
      unitRef="USD">693426000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20231231_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="FFact_277"
      unitRef="USD">-1679000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20231231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember"
      decimals="-3"
      id="FFact_278"
      unitRef="USD">-82440000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20231231_usgaapStatementEquityComponentsAxis_usgaapNoncontrollingInterestMember"
      decimals="-3"
      id="Fxbrl_20230120021145391"
      unitRef="USD">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_279"
      unitRef="USD">787372000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_280"
      unitRef="USD">197919000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_281"
      unitRef="USD">161520000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_282"
      unitRef="USD">165074000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_283"
      unitRef="USD">623000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_284"
      unitRef="USD">680000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_285"
      unitRef="USD">517000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ShareBasedCompensation
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_286"
      unitRef="USD">23600000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_287"
      unitRef="USD">24452000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_288"
      unitRef="USD">11962000</us-gaap:ShareBasedCompensation>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_289"
      unitRef="USD">1020000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_290"
      unitRef="USD">449000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_291"
      unitRef="USD">516000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:GainLossOnInvestments
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_292"
      unitRef="USD">0</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_293"
      unitRef="USD">-71000</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_294"
      unitRef="USD">-175000</us-gaap:GainLossOnInvestments>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20230120005516002"
      unitRef="USD">4714000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_296"
      unitRef="USD">1210000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20230120005526885"
      unitRef="USD">-1223000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_298"
      unitRef="USD">-184000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230120005647758"
      unitRef="USD">84000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_300"
      unitRef="USD">-770000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_301"
      unitRef="USD">16084000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_302"
      unitRef="USD">10415000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20230120005541533"
      unitRef="USD">10544000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInOtherReceivables
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_304"
      unitRef="USD">2224000</us-gaap:IncreaseDecreaseInOtherReceivables>
    <us-gaap:IncreaseDecreaseInOtherReceivables
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_305"
      unitRef="USD">1787000</us-gaap:IncreaseDecreaseInOtherReceivables>
    <us-gaap:IncreaseDecreaseInOtherReceivables
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_306"
      unitRef="USD">6400000</us-gaap:IncreaseDecreaseInOtherReceivables>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_307"
      unitRef="USD">5198000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_308"
      unitRef="USD">18871000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_309"
      unitRef="USD">6043000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_310"
      unitRef="USD">-2276000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_311"
      unitRef="USD">7463000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_312"
      unitRef="USD">2369000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_313"
      unitRef="USD">-12588000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_314"
      unitRef="USD">17941000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_315"
      unitRef="USD">14138000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_316"
      unitRef="USD">-3068000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_317"
      unitRef="USD">1201000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20230120005559413"
      unitRef="USD">2668000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_322"
      unitRef="USD">176826000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_323"
      unitRef="USD">181578000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_324"
      unitRef="USD">174885000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <inmd:InvestmentInShortTermDeposit
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_325"
      unitRef="USD">233241000</inmd:InvestmentInShortTermDeposit>
    <inmd:InvestmentInShortTermDeposit
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_326"
      unitRef="USD">93701000</inmd:InvestmentInShortTermDeposit>
    <inmd:InvestmentInShortTermDeposit
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_327"
      unitRef="USD">73090000</inmd:InvestmentInShortTermDeposit>
    <inmd:ProceedsFromInvestmentInShortTermDeposit
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_328"
      unitRef="USD">85090000</inmd:ProceedsFromInvestmentInShortTermDeposit>
    <inmd:ProceedsFromInvestmentInShortTermDeposit
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_329"
      unitRef="USD">73090000</inmd:ProceedsFromInvestmentInShortTermDeposit>
    <inmd:ProceedsFromInvestmentInShortTermDeposit
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_330"
      unitRef="USD">69180000</inmd:ProceedsFromInvestmentInShortTermDeposit>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_331"
      unitRef="USD">705000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_332"
      unitRef="USD">1575000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_333"
      unitRef="USD">939000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20240205101624969"
      unitRef="USD">100000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20240205101650280"
      unitRef="USD">0</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20240205101704557"
      unitRef="USD">0</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_337"
      unitRef="USD">245337000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_338"
      unitRef="USD">168680000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_339"
      unitRef="USD">273834000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_340"
      unitRef="USD">5000000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_341"
      unitRef="USD">2303000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_342"
      unitRef="USD">93652000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <inmd:ProceedsFromMaturityOfMarketableSecurities
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20230131032211860_Fact_340"
      unitRef="USD">253229000</inmd:ProceedsFromMaturityOfMarketableSecurities>
    <inmd:ProceedsFromMaturityOfMarketableSecurities
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230131032211860_Fact_341"
      unitRef="USD">79089000</inmd:ProceedsFromMaturityOfMarketableSecurities>
    <inmd:ProceedsFromMaturityOfMarketableSecurities
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20230131032211860_Fact_342"
      unitRef="USD">24925000</inmd:ProceedsFromMaturityOfMarketableSecurities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_343"
      unitRef="USD">-136064000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_344"
      unitRef="USD">-109474000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_345"
      unitRef="USD">-160106000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_349"
      unitRef="USD">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_350"
      unitRef="USD">42637000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20230120005856887"
      unitRef="USD">35365000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_352"
      unitRef="USD">5504000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_353"
      unitRef="USD">1552000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_354"
      unitRef="USD">20343000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_355"
      unitRef="USD">5504000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_356"
      unitRef="USD">-41085000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20230120010009023"
      unitRef="USD">-15022000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_358"
      unitRef="USD">605000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230120142003953"
      unitRef="USD">-1615000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_360"
      unitRef="USD">-559000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_361"
      unitRef="USD">46871000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230120005631534"
      unitRef="USD">29404000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_363"
      unitRef="USD">-802000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_364"
      unitRef="USD">97540000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_365"
      unitRef="USD">68136000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_20201231"
      decimals="-3"
      id="FFact_366"
      unitRef="USD">68938000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_367"
      unitRef="USD">144411000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_368"
      unitRef="USD">97540000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_369"
      unitRef="USD">68136000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_370"
      unitRef="USD">31614000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_371"
      unitRef="USD">25843000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_372"
      unitRef="USD">1658000</us-gaap:IncomeTaxesPaidNet>
    <inmd:InterestReceived
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_373"
      unitRef="USD">14219000</inmd:InterestReceived>
    <inmd:InterestReceived
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_374"
      unitRef="USD">4856000</inmd:InterestReceived>
    <inmd:InterestReceived
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_375"
      unitRef="USD">3358000</inmd:InterestReceived>
    <inmd:OperatingLeaseRightOfUseAssests
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_376"
      unitRef="USD">5200000</inmd:OperatingLeaseRightOfUseAssests>
    <inmd:OperatingLeaseRightOfUseAssests
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_377"
      unitRef="USD">2342000</inmd:OperatingLeaseRightOfUseAssests>
    <inmd:OperatingLeaseRightOfUseAssests
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_378"
      unitRef="USD">4315000</inmd:OperatingLeaseRightOfUseAssests>
    <inmd:ExerciseOfOptions
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20240205100151108"
      unitRef="USD">20000</inmd:ExerciseOfOptions>
    <inmd:ExerciseOfOptions
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20240205100248190"
      unitRef="USD">103000</inmd:ExerciseOfOptions>
    <inmd:ExerciseOfOptions
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20240205100306825"
      unitRef="USD">0</inmd:ExerciseOfOptions>
    <inmd:NonCashAcquisitionOfNoncontrollingInterestInExchangeOfOrdinaryShares
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_382"
      unitRef="USD">0</inmd:NonCashAcquisitionOfNoncontrollingInterestInExchangeOfOrdinaryShares>
    <inmd:NonCashAcquisitionOfNoncontrollingInterestInExchangeOfOrdinaryShares
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230120004200376"
      unitRef="USD">0</inmd:NonCashAcquisitionOfNoncontrollingInterestInExchangeOfOrdinaryShares>
    <inmd:NonCashAcquisitionOfNoncontrollingInterestInExchangeOfOrdinaryShares
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20230120004204888"
      unitRef="USD">12780000</inmd:NonCashAcquisitionOfNoncontrollingInterestInExchangeOfOrdinaryShares>
    <inmd:PaymentsToTaxAuthorities
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20240205165813930"
      unitRef="USD">12000</inmd:PaymentsToTaxAuthorities>
    <us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240205092101211">
      &lt;div&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;NOTE 1 - GENERAL:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%"&gt;

              &lt;tr style="vertical-align:top"&gt;
                &lt;td style="text-align:right;vertical-align:top;width:9pt"&gt;
                  &lt;div style="text-align:left;margin-left:49.65pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td style="text-align:left;vertical-align:top;width:auto"&gt;
                  &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;InMode Ltd. (separately and together with its subsidiaries, the &#x201c;Company&#x201d;) was incorporated on January 2, 2008 and commenced operations shortly thereafter. The Company&#x2019;s headquarters are located in Israel. The Company is traded in the Nasdaq Global Select Market (the &#x201c;Nasdaq&#x201d;) since August 2019.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&#160;&lt;/div&gt;
                  &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company designs, develops, manufactures and markets innovative minimally-invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radio frequency technologies. These technologies are used to remodel subdermal adipose or fatty tissue in a variety of procedures including liposuction with simultaneous skin tightening, body and face contouring and ablative skin rejuvenation treatments, as well as, for use in certain women&#x2019;s health conditions and procedures. In addition to the minimally-invasive technologies, the Company designs, develops, manufactures and markets non&#x2011;invasive medical aesthetic products that target a wide array of procedures including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture and superficial benign vascular and pigmented lesions. The Company also designs, develops, manufactures and markets hands-free medical aesthetic products that target a wide array of procedures such as skin tightening, fat reduction and muscle stimulation.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company has wholly-owned subsidiaries located in the United States and two subsidiaries in Canada (&#x201c;North America&#x201d;), Hong Kong, Japan, Spain, two subsidiaries in Israel, India, Australia, China, the United Kingdom (&#x201c;UK&#x201d;), France, Italy and Germany. The Company&#x2019;s subsidiaries are referred to collectively herein as the &#x201c;Subsidiaries.&#x201d; The Company sells its products primarily through its Subsidiaries. See note 12b for an update regarding change in ownership of the UK subsidiary.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
        &lt;/div&gt;
      &lt;/div&gt;
    </us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240205094425028">
      &lt;div&gt;
        &lt;div&gt;
          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;NOTE 2 - SIGNIFICANT&lt;/span&gt;&#160;&lt;span style="font-weight:bold"&gt;ACCOUNTING&lt;/span&gt;&#160;&lt;span style="font-weight:bold"&gt;POLICIES:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

            &lt;div&gt;
              &lt;div style="line-height:1.25"&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:48.4pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="width:22.5pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;a.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="width:auto;vertical-align:top"&gt;
                        &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;Basis of presentation&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="font-weight:bold"&gt;&#160;&lt;/div&gt;
                        &lt;div style="font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;
                          &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company&#x2019;s consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (&#x201c;U.S. GAAP&#x201d;).&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
            &lt;/div&gt;

          &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;

            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:48.4pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:22.5pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;b.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top"&gt;
                    &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Use of estimates&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="font-weight:bold"&gt;&#160;&lt;/div&gt;
                    &lt;div style="font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;
                      &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;

          &lt;div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;/div&gt;

            &lt;div&gt;
              &lt;div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:48.4pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="width:22.5pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;c.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="width:auto;vertical-align:top"&gt;
                        &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Functional currency&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="font-weight:bold"&gt;&#160;&lt;/div&gt;
                        &lt;div style="font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:normal"&gt;The U.S. dollar (&#x201c;U.S. dollar&#x201d; or &#x201c;$&#x201d;) is the currency of the primary economic environment in which the operations of the Company is conducted. Substantial revenues and a substantial portion of the operational costs are denominated in U.S. dollars. Accordingly, the functional currency of the Company is the U.S. dollar (&#x201c;primary currency&#x201d;).&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="width:48.4pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="width:22.5pt;vertical-align:top;font-weight:bold"&gt;&#160;&lt;/td&gt;
                      &lt;td style="width:auto;vertical-align:top"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
              &lt;div&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;
                &lt;div&gt;
                  &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%"&gt;

                      &lt;tr style="vertical-align:top"&gt;
                        &lt;td style="text-align:right;vertical-align:top;width:70pt"&gt;
                          &lt;div style="text-align:left;margin-left:49.65pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="text-align:left;vertical-align:top;width:auto"&gt;
                          &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Transactions and balances originally denominated in U.S. dollars are presented at their original amounts. Balances in non-U.S. dollar currencies are translated into U.S. dollars using historical and current exchange rates for non-monetary and monetary balances, respectively. For non-U.S. dollar transactions and other items in the statements of income (indicated below), the following exchange rates are used: (i) for transactions &#x2013; exchange rates at transaction dates or average exchange rates; and (ii) for other items (derived from non-monetary balance sheet items such as depreciation and amortization) &#x2013; historical exchange rates. Currency transaction gains and losses are presented in finance income (expenses), as appropriate.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&#160;&lt;/div&gt;
                          &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The functional currency of each of the Subsidiaries is the U.S. dollar.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
              &lt;/div&gt;
            &lt;/div&gt;

          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:48.4pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:22.5pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;d.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top"&gt;
                    &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Principles of consolidation and presentation&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&#160;&lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The consolidated financial statements include the accounts of the Company and its Subsidiaries. Intercompany transactions and balances are eliminated in consolidation.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;

          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:48.4pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:22.5pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;e.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top"&gt;
                    &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="font-weight:bold"&gt;&#160;&lt;/div&gt;
                    &lt;div style="font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;
                      &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company considers cash equivalents to be all short-term, highly liquid investments, which include money market instruments, that are not restricted as to withdrawal or use, and short-term bank deposits with original maturities of three months or less from the date of purchase that are not restricted as to withdrawal or use and are readily convertible to known amounts of cash.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;

          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:48.4pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:22.5pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;f.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top"&gt;
                    &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Short-term bank deposits&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="font-weight:bold"&gt;&#160;&lt;/div&gt;
                    &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:normal"&gt;Bank deposits with maturities of more than three months but less than one year are included in short-term deposits. Such short-term deposits bear interest at an average annual rate of approximately 4.10%-7.01% in 2023 and 0.50%-5.73% in 2022.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;

          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

            &lt;div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:48.4pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:22.5pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;g.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:auto;vertical-align:top"&gt;
                      &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Marketable securities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="font-weight:bold"&gt;&#160;&lt;/div&gt;
                      &lt;div style="font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;
                        &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="text-decoration:underline"&gt;AFS Securities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="line-height:1.25;font-weight:normal"&gt;&#160;&lt;/div&gt;
                        &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Marketable securities consist of government bonds, municipal bonds, and corporate debt securities (together &#x201c;Debt Securities&#x201d;), and certificates of deposit measured at fair value in each reporting period. The fair value of quoted securities is based on current market value.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="line-height:1.25;font-weight:normal"&gt;&#160;&lt;/div&gt;
                        &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Debt Securities and certificates of deposit are classified as available-for-sale (together &#x201c;AFS Securities&#x201d;) under current assets in the consolidated balance sheet as they represent the investment of funds available for the Company&#x2019;s current operations. Changes in fair value, excluding credit losses and impairments, net of taxes (if applicable), are reflected in other comprehensive income or loss. Realized gains and losses on sales of Debt Securities and certificates of deposit as well as premium or discount amortization are included in the consolidated statements of income as finance income (expenses), net. Fair value is calculated based on publicly available market information. When the estimated fair value of a Debt Security is below its amortized cost, the Debt Security is assessed using the Current Expected Credit Losses model (in accordance with ASU 2016-13) in order to determine what portion of that difference, if any, is caused by expected credit losses. The amortized cost of the Debt Security will be reduced to its fair value if it is more likely than not that the Company is required to sell the impaired security before recovery of its amortized cost basis, or it has the intention to sell the security. If neither of these conditions are met, the Company determines whether the impairment is due to credit losses by comparing the present value of the expected cash flows of the security with its amortized cost basis. The amount of impairment recognized is limited to the excess of the amortized cost over the fair value of the security. An allowance for credit losses for the excess of amortized cost over the expected cash flows is recognized in finance income (expenses), net on the consolidated statements income. &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;
                &lt;div&gt;&lt;/div&gt;
              &lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%"&gt;

                    &lt;tr style="vertical-align:top"&gt;
                      &lt;td style="text-align:right;vertical-align:top;width:70pt"&gt;
                        &lt;div style="text-align:left;margin-left:49.65pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:top;width:auto"&gt;
                        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company classifies investments that are readily convertible to known amounts of cash and have stated maturities of three months or less from the date of purchase as cash equivalents and those with stated maturities of greater than three months as marketable securities.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company determines the appropriate classification of its investments in marketable securities at the time of purchase.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &#160;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:48.4pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:22.5pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;h.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top"&gt;
                    &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other Investments&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="font-weight:bold"&gt;&#160;&lt;/div&gt;
                    &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:normal"&gt;The Company applies the measurement alternative upon the adoption of ASU 2016-01, and elected to record equity investments without readily determinable fair values at cost for other investments, less impairment, adjusted for subsequent observable price changes. In this measurement alternative method, changes in the carrying value of the equity investments are reflected in current earnings. Changes in the carrying value of the equity investment are required to be made whenever there are observable price changes in orderly transactions for the identical or similar investment of the same issuer.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;

          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;

              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:48.4pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:22.5pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;i.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:auto;vertical-align:top"&gt;
                      &lt;div style="font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;Inventories&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Inventories include raw materials and finished products and are valued at the lower of cost or net realizable value. During the year ended December 31, 2022, the Company changed the cost determination method of raw materials from first in, first out (&#x201c;FIFO&#x201d;) method to a &#x201c;moving average&#x201d; method. This voluntary change in accounting method was implemented and considered preferable because the Company's ERP system supports automatic calculation of inventory according to the &#x201c;moving average&#x201d; method and it allows consistency of the cost determination method among the different components of inventory. The change in method was immaterial to all periods presented. The Company regularly evaluates its ability to realize the value of inventory based on a combination of factors including the following: historical usage rates, forecasted sales or usage, estimated current and future market values and new product introductions.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;

          &lt;/div&gt;

            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:48.4pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:22.5pt;vertical-align:top;font-weight:bold"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="width:48.4pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:22.5pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;j.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top"&gt;
                    &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Leases&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="font-weight:bold"&gt;&#160;&lt;/div&gt;
                    &lt;div style="font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;
                      &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company determines if an arrangement is a lease at inception. Balances related to operating leases are included in operating lease right-of-use (&#x201c;ROU&#x201d;) assets, other current liabilities, and operating lease liabilities in the consolidated balance sheets.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="line-height:1.25;font-weight:normal"&gt;&#160;&lt;/div&gt;
                      &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company also elected to combine lease and non-lease components and to keep leases with an initial term of 12 months or less off the balance sheet and recognize the associated lease payments in the consolidated statements of income on a straight-line basis over the lease term.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="line-height:1.25;font-weight:normal"&gt;&#160;&lt;/div&gt;
                      &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;ROU assets represent the Company&#x2019;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#x2019;s obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized as of the commencement date based on the present value of lease payments over the lease term. The Company&#x2019;s lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. The discount rate for the lease is the rate implicit in the lease unless that rate cannot be readily determined. As the Company&#x2019;s leases do not provide an implicit rate, the Company&#x2019;s uses its estimated incremental borrowing rate based on the information available at the commencement date in determining the present value of lease payments. Lease expense for lease payments is recognized on a straight-line basis over the lease term (see also note 9).&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="width:48.4pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:22.5pt;vertical-align:top;font-weight:bold"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;

          &lt;div&gt;&lt;/div&gt;

            &lt;div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:48.4pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:22.5pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;k.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:auto;vertical-align:top"&gt;
                      &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Property and equipment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="font-weight:bold"&gt;&#160;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;

                &lt;div&gt;
                  &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:70pt"&gt;&#160;&lt;/td&gt;
                        &lt;td style="vertical-align:top;width:auto"&gt;
                          &lt;div style="font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:normal"&gt;Property and equipment is stated at cost, net of accumulated depreciation and amortization. Depreciation is calculated on a straight-line basis over the following estimated useful lives:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;div style="margin-left:81pt"&gt;
                    &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255)"&gt;
                            &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Computers&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                            &lt;div style="text-align:center;margin-right:20.45pt;margin-left:13.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3 &#x2013; 4 years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Molds&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom"&gt;
                            &lt;div style="text-align:center;margin-right:20.45pt;margin-left:13.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4 &#x2013; 10 years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                            &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Equipment and furniture&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                            &lt;div style="text-align:center;margin-right:20.45pt;margin-left:13.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10 &#x2013; 17 years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                  &lt;/div&gt;
                &lt;/div&gt;

              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:48.4pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="width:22.5pt;vertical-align:top;font-weight:bold"&gt;&#160;&lt;/td&gt;
                      &lt;td style="width:auto;vertical-align:top;font-weight:normal"&gt;
                        &lt;div style="font-family:'Times New Roman',Times,serif"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Leasehold improvements are depreciated using the straight-line method over the shorter of the term of the lease or the estimated useful lives of the improvements.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
            &lt;/div&gt;


            &lt;table cellpadding="0" cellspacing="0" style="color:#000000;font-family:'Times New Roman',Times,serif;font-size:10pt;text-align:left;width:100%"&gt;

                &lt;tr&gt;
                  &lt;td style="width:48.4pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:22.5pt;vertical-align:top;font-weight:bold"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="width:48.4pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:22.5pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;l.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top"&gt;
                    &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Impairment of long-lived assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="font-weight:bold"&gt;&#160;&lt;/div&gt;
                    &lt;div style="font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:normal"&gt;The Company tests long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may no longer be recoverable. Recoverability of long-lived assets is measured by comparing the carrying amount of the long-lived asset to the estimated undiscounted future cash flows expected to be generated by the asset. If the sum of the expected undiscounted cash flow is less than the carrying amount of the asset, the Company recognizes an impairment loss, which is the excess of the carrying amount over the fair value of the asset, using the expected future discounted cash flows.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:normal"&gt;During the years ended December 31, 2023, 2022 and 2021, the Company did not recognize an impairment loss on its long-lived assets.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;

          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:48.4pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:22.5pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;m.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top"&gt;
                    &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Legal and other contingencies&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&#160;&lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Certain conditions may exist as of the date of the consolidated financial statements, which may result in a loss to the Company but which will only be resolved when one or more future events occur or fail to occur. The Company&#x2019;s management assesses such contingent liabilities, if any, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the Company or unasserted claims that may result in such proceedings, the Company&#x2019;s management evaluates the perceived merits of any legal proceedings or unasserted claims as well as the perceived merits of the amount of relief sought or expected to be sought.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="line-height:1.25;font-weight:normal"&gt;&#160;&lt;/div&gt;
                      &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Management applies the guidance in ASC 450-20, &#x201c;Loss Contingencies&#x201d; when assessing losses resulting from contingencies. If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be reasonable estimated, then the estimated liability is recorded as accrued expenses in the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="margin-left:72pt;line-height:1.25;font-weight:normal"&gt;&#160;&lt;/div&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:normal"&gt;Legal costs incurred in connection with loss contingencies are expensed as incurred.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          &lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;

            &lt;div&gt;
              &lt;div style="line-height:1.25"&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:48.4pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="width:22.5pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;n.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="width:auto;vertical-align:top"&gt;
                        &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Income taxes:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="width:48.4pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="width:22.5pt;vertical-align:top;font-weight:bold"&gt;&#160;&lt;/td&gt;
                      &lt;td style="width:auto;vertical-align:top"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:72pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:26.7pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:auto;vertical-align:top"&gt;
                      &lt;div style="font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company accounts for income taxes in accordance with ASC 740, &#x201c;Income Taxes&#x201d; (&#x201c;ASC 740&#x201d;). ASC 740 prescribes the use of the liability method whereby deferred tax asset and liability account balances are determined based on differences between the financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company provides a valuation allowance, if necessary, to reduce deferred tax assets to their estimated realizable value if it is more likely than not that a portion or all of the deferred tax assets will not be realized, based on the weight of available positive and negative evidence. Deferred tax liabilities and assets are classified as non-current in accordance with ASU 2015&#x2011;17.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="width:72pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:26.7pt;vertical-align:top"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:auto;vertical-align:top"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;div&gt;&lt;/div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:72pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:26.7pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:auto;vertical-align:top"&gt;
                      &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company may incur an additional tax liability in the event of an inter-company dividend distribution from Subsidiaries outside of Israel; no additional deferred income tax assets have been provided, since the Company does not expect to distribute inter-company dividends in the foreseeable future that may result in additional tax liability.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:72pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:26.7pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:auto;vertical-align:top"&gt;
                      &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Taxes that would apply in the event of disposal of investments in Subsidiaries have not been taken into account in computing the deferred income tax assets, as it is the Company&#x2019;s intent and ability to hold these investments.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:72pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:26.7pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:auto;vertical-align:top"&gt;
                      &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company accounts for uncertain tax positions in accordance with ASC 740-10. ASC 740&#x2011;10 contains a two-step approach to recognizing and measuring uncertain tax positions. The first step is to evaluate the tax position taken or expected to be taken in a tax return by determining if the weight of available evidence indicates that it is more likely than not that, on an evaluation of the technical merits, the tax position will be sustained on audit, including resolution of any related appeals or litigation processes. The second step is to measure the tax benefit of the largest amount that is more than 50% (cumulative probability) likely to be realized upon ultimate settlement.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;

          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:48.4pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:22.5pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;o.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top"&gt;
                    &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Advertising expenses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&#160;&lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Advertising expenses are charged to sales and marketing on the consolidated statement of income as incurred. Advertising expenses for the years ended December 31, 2023, 2022 and 2021 amounted to $15 million, $10 million, and $4 million, respectively.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;

          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:48.4pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:22.5pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;p.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top"&gt;
                    &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Share-based compensation&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="font-weight:bold"&gt;&#160;&lt;/div&gt;
                    &lt;div style="font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;
                      &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company grants share options and restricted share units (&#x201c;RSU&#x201d;) (together &#x201c;Share-Based Compensation&#x201d;) to its employees, officers, directors and non-employees in consideration for services rendered and for acquiring goods. See note 12(a)(2) for details on outstanding share capital.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="line-height:1.25;font-weight:normal"&gt;&#160;&lt;/div&gt;
                      &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company accounts for Share-Based Compensation awards classified as equity awards using the grant-date fair value method. The fair value at grant-date of the issued equity award is recognized as an expense on a straight-line basis over the requisite service period. The fair value of each share option granted is estimated using the Binomial Model, and for each RSU granted is based on the Company&#x2019;s share price at the close of the last trading day prior to the date of the grant. The Company estimates forfeitures based on historical experience and anticipated future conditions at the time of grant and revises such estimates in subsequent periods if actual forfeitures differ from those estimates.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="line-height:1.25;font-weight:normal"&gt;&#160;&lt;/div&gt;
                      &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company elected to recognize Share-Based Compensation cost for awards with only service conditions that have a graded vesting schedule using the straight-line method based on the multiple-option award approach. Performance-based Share-Based Compensation expenses are calculated based on the valuation at the grant date, and recognized based on the probability of achieving those targets. The Company assess at what scale can the performance targets be reached at each balance sheet date, and expenses are recognized accordingly.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="line-height:1.25;font-weight:normal"&gt;&#160;&lt;/div&gt;
                      &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company issues new shares upon option exercise or RSU vesting.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;

        &lt;/div&gt;&#160;&lt;div&gt;&lt;/div&gt;
        &lt;div&gt;

            &lt;div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;font-weight:bold;width:48pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;font-weight:bold;width:22pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;q.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:auto"&gt;
                      &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenue recognition&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="font-weight:bold"&gt;&#160;&lt;/div&gt;
                      &lt;div style="font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;
                        &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company applies ASC 606, &#x201c;Revenue from Contracts with Customers&#x201d; (&#x201c;ASC 606&#x201d;). Under ASC 606, an entity recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration that the entity expects to receive in exchange for those goods or services. To determine revenue recognition for arrangements that an entity determines are within the scope of ASC 606, the entity performs the following five steps:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:72pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:38.05pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(i)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:auto;vertical-align:top"&gt;
                      &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Identify the contract(s) with a customer;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:72pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:38.05pt;vertical-align:top;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(ii)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:auto;vertical-align:top"&gt;
                      &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Identify the performance obligations in the contract. The Company determined that its arrangements are generally comprised of the following elements that are recognized as separate performance obligations: products, consumables and extended warranties;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:72pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:38.05pt;vertical-align:top;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(iii)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:auto;vertical-align:top"&gt;
                      &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Determine the transaction price;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:72pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:38.05pt;vertical-align:top;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(iv)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:auto;vertical-align:top"&gt;
                      &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Allocate the transaction price to the performance obligations in the contract;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="font-family:'Times New Roman',Times,serif"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company estimates the standalone selling prices of the services to be provided based on actual sales transactions of service contract purchased on a standalone basis and uses the residual approach to estimate the selling price of the products; and&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;div style="margin-left:106.9pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:72pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:38.05pt;vertical-align:top;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(v)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:auto;vertical-align:top"&gt;
                      &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Recognize revenue when (or as) the performance obligation is satisfied. &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div&gt;&#160;&lt;/div&gt;
                      &lt;div style="font-family:'Times New Roman',Times,serif"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company only applies the five-step model to contracts when it is probable that the entity will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer, after considering any price concession expected to be provided to the customer, when applicable. At contract inception, the Company assesses the goods or services promised within each contract and determines those that are performance obligations and assesses whether each promised good or service is distinct. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied. &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company uses the following practical expedients that are permitted under the rules:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:111pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#x2022;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:auto;vertical-align:top"&gt;
                      &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company recognizes the incremental costs of obtaining contracts as an expense when incurred if the amortization period of the assets that the Company otherwise would have recognized is one year or less. These costs are included in sales and marketing expenses.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:111pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#x2022;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:auto;vertical-align:top"&gt;
                      &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company does not disclose the value of unsatisfied performance obligations for contracts with an original expected length of one year or less.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;font-weight:bold;width:72pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:top;width:auto"&gt;
                        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The following is a description of the principal activities from which the Company generates its revenue.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Product Revenue, Net&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenues from product sales are recognized when the customer obtains control over the Company&#x2019;s product, typically upon shipment to the customer. Revenues from shipping and handling activities that occur after the customer has obtained control of a good are recognized according to an accounting policy election as a fulfilment cost rather than as an additional promised service. Taxes collected from customers relating to product sales and remitted to governmental authorities are excluded from revenues.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
              &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;
              &lt;div&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;font-weight:bold;width:70pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:top;width:auto"&gt;
                        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Payment terms and conditions vary by customer. The Company&#x2019;s standard terms for end users usually require of payment upon delivery and for distributors require a down payment and payments made within several month from the invoice date. &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company may enter into installment sales contracts with end users in North America that provide them with long-term (generally up to 60 months) financing for the purchase of the Company&#x2019;s products. The interest rate used in these contracts reflects the credit characteristics of the party receiving financing in the contract, as well as any collateral or security provided by the customer. Interest income on these receivables is recognized as finance income and earned over the terms of the contract.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Variable consideration includes price concessions related to installment sales contracts. The Company estimates variable consideration using the most likely outcome amount. Amounts included in the transaction price are recognized only when it is probable that a significant reversal of cumulative revenues will not occur.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company does not grant a right of return, refund, cancelation or termination. From time to time, the Company participates in its customers&#x2019; marketing activities and deducts such amounts from revenue.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Service Revenue&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company also generates revenues from long-term maintenance contracts (&#x201c;Extended Warranty&#x201d;). Revenue from Extended Warranty is recognized ratably, on a straight-line basis, over the period of the applicable service contract. These maintenance agreements are included in contract liabilities. Revenue from repairs performed in the absence of Extended Warranty is recognized when the related services are performed.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company classifies the portion of contract liabilities not expected to be earned in the subsequent 12 months as long-term.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;

            &lt;div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;font-weight:bold;width:48pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:22pt"&gt;
                      &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;r.&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;
                    &lt;/td&gt;
                    &lt;td style="vertical-align:top;width:auto"&gt;
                      &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Allowance for doubtful accounts and financial instruments &#x2013; credit loss&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="font-weight:bold"&gt;&#160;&lt;/div&gt;
                      &lt;div style="font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;
                        &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company maintains the allowance for doubtful account resulting from the inability of the Company&#x2019;s customers to make required payments.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="line-height:1.25;font-weight:normal"&gt;&#160;&lt;/div&gt;
                        &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The allowance represents the current estimate of lifetime expected credit losses over the remaining duration of existing accounts receivable. This information includes among other the historic experience, the extent and amount of the account and future expectations.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="line-height:1.25;font-weight:normal"&gt;&#160;&lt;/div&gt;
                        &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Allowance for credit losses due to the Company&#x2019;s accounts receivable amounted to $2,254 and $1,318 as of December 31, 2023 and 2022 respectively. Changes in the allowance for credit losses are recognized in general and administrative expenses. Accounts receivable are written-off against the allowance for credit losses when management deems the accounts are no longer collectible.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="line-height:1.25;font-weight:normal"&gt;&#160;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;

                &lt;div&gt;
                  &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:48pt"&gt;&#160;&lt;/td&gt;
                        &lt;td style="vertical-align:top;width:22pt"&gt;&#160;&lt;/td&gt;
                        &lt;td style="vertical-align:top;width:auto"&gt;
                          &lt;div style="font-family:'Times New Roman',Times,serif"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:normal"&gt;The following table sets forth activity in the Company&#x2019;s allowance for credit losses for&lt;/span&gt; each of the years ended December 31, 2023, 2022 and 2021, respectively:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;div style="margin-left:81pt"&gt;
                    &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:middle;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="text-indent:15.85pt;margin-right:7.2pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance at beginning of year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,318&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,107&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;672&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:middle;width:64%;vertical-align:bottom"&gt;
                            &lt;div style="text-indent:15.85pt;margin-right:7.2pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Current-period provision&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;449&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;516&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:middle;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="text-indent:15.85pt;margin-right:7.2pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Write-offs charged against the&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;div style="text-indent:15.85pt;margin-right:7.2pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;allowance&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(84&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(238&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(81&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:middle;width:64%;padding-bottom:4px;vertical-align:bottom"&gt;
                            &lt;div style="text-indent:15.85pt;margin-right:7.2pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance at end of year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,254&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,318&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,107&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                  &lt;/div&gt;
                &lt;/div&gt;

            &lt;/div&gt;

          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div&gt;&lt;/div&gt;

            &lt;div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:48pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;font-weight:bold;width:22pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;s.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:auto"&gt;
                      &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Warranty reserve&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="font-weight:bold"&gt;&#160;&lt;/div&gt;
                      &lt;div style="font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;
                        &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company provides a one-year standard warranty for its products. The Company records a provision for the estimated cost to repair or replace products under warranty at the time of sale. Factors that affect the Company&#x2019;s warranty reserve include the number of units sold, historical and anticipated rates of warranty repairs, the cost per repair and shipping cost. The Company periodically assesses the adequacy of its recorded warranty liabilities and adjusts the amounts as necessary.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="line-height:1.25;font-weight:normal"&gt;&#160;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;

                &lt;div&gt;
                  &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:48pt"&gt;&#160;&lt;/td&gt;
                        &lt;td style="vertical-align:top;width:22pt"&gt;&#160;&lt;/td&gt;
                        &lt;td style="vertical-align:top;width:auto"&gt;
                          &lt;div style="font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;
                            &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The following table sets forth activity in the Company&#x2019;s accrued warranty account for each of the years ended December 31, 2023, 2022 and 2021, respectively:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;div style="margin-left:81pt"&gt;
                    &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:middle;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="text-indent:15.85pt;margin-right:7.2pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance at beginning of year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,418&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,248&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;705&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:middle;width:64%;vertical-align:bottom"&gt;
                            &lt;div style="text-indent:15.85pt;margin-right:7.2pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cost incurred&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,304&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,099&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,453&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:middle;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="text-indent:15.85pt;margin-right:7.2pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Expense recognized&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,362&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,269&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,996&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:middle;width:64%;padding-bottom:4px;vertical-align:bottom"&gt;
                            &lt;div style="text-indent:15.85pt;margin-right:7.2pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance at end of year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,476&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,418&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,248&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                  &lt;/div&gt;
                &lt;/div&gt;

            &lt;/div&gt;

          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:48.4pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:22.5pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;t.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top"&gt;
                    &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cost of revenues&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="font-weight:bold"&gt;&#160;&lt;/div&gt;
                    &lt;div style="font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;
                      &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cost of revenue consists of products purchased from turnkey sub-contractors which are responsible for the production of most of the Company&#x2019;s products under the Company&#x2019;s directions and supervision, raw materials for in-house assembly line, shipping and handling costs to customers and to subsidiaries, salary, employee-related expenses and overhead expenses of internal assembly line and service costs associate with warranty.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;

          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:48.4pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:22.5pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;u.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top"&gt;
                    &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Research and development costs&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&#160;&lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Research and development costs are expensed as incurred and includes salaries and employee-related expenses, overhead expenses, material and third-party contractor&#x2019;s charges related to product development, regulatory affairs and clinical studies.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;

          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:48.4pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:22.5pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;v.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;Net earnings&lt;/span&gt;&#160;&lt;span style="font-weight:bold"&gt;per share&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div&gt;&#160;&lt;/div&gt;
                    &lt;div style="font-family:'Times New Roman',Times,serif"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Basic earnings per share are computed by dividing net income &lt;/span&gt;&lt;/span&gt;attributed to the shareholders of InMode Ltd. by the weighted average number of the Company&#x2019;s ordinary shares, par value NIS 0.01 per share (including vested RSUs),&lt;span&gt;&lt;span&gt; outstanding for each period, net of treasury shares.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;For the diluted earnings per share calculation, the weighted average number of shares outstanding during the year is adjusted for the average number of shares that are potentially issuable in connection with employee share-based payment, using the treasury stock method.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;

          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

            &lt;div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:48.4pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:22.5pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;w.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:auto;vertical-align:top"&gt;
                      &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fair value measurement&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="font-weight:bold"&gt;&#160;&lt;/div&gt;
                      &lt;div style="font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;
                        &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company measures fair value and discloses fair value measurements for financial assets and liabilities. Fair value is based on the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. In the absence of active markets for identical assets or liabilities, such measurements involve developing assumptions based on market observable data and, in the absence of such data,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="line-height:1.25;font-weight:normal"&gt;&#160;&lt;/div&gt;
                        &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;internal information that is consistent with what market participants would use in a hypothetical transaction that occurs at the measurement date. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect the Company&#x2019;s market assumptions.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;
              &lt;div&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:48.4pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="width:22.5pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;w.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="width:auto;vertical-align:top;font-weight:normal"&gt;
                        &lt;div style="font-family:'Times New Roman',Times,serif"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The three levels of inputs that may be used to measure fair value are as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
              &lt;div&gt;&#160;&lt;/div&gt;
              &lt;div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:106pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
                      &lt;td style="width:auto;vertical-align:top"&gt;
                        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Level 1 &#x2013; Quoted prices (unadjusted) in active markets that are accessible at the measurement date for identical assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Level 2 &#x2013; Observable prices that are based on identical or similar instruments not quoted on active markets, but corroborated by observable market data, or quoted prices for similar instruments in active markets.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Level 3 &#x2013; Unobservable inputs are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level 3 inputs.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
              &lt;div&gt;&#160;&lt;/div&gt;
              &lt;div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:48.4pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="width:22.5pt;vertical-align:top;font-weight:bold"&gt;&#160;&lt;/td&gt;
                      &lt;td style="width:auto;vertical-align:top;font-weight:normal"&gt;
                        &lt;div style="font-family:'Times New Roman',Times,serif"&gt;
                          &lt;div style="line-height:1.25"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company maintains policies and procedures to determine the fair value of financial assets and liabilities using what it considers to be the most relevant and reliable market data available.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As of December 31, 2023, and 2022, the fair values of the Company's cash, cash equivalents, short term bank deposits, accounts receivable, accounts payable, approximated the carrying values of these instruments presented in the Company's consolidated balance sheets because of their nature.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
            &lt;/div&gt;

          &lt;div&gt;&#160;&lt;/div&gt;

            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:48.4pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:22.5pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;x.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top"&gt;
                    &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Segments&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="font-family:'Times New Roman',Times,serif;font-weight:normal"&gt;&#160;&lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company operates in one segment. Management does not segregate its business for internal reporting. The Company&#x2019;s chief operating decision-maker evaluates the performance of its business based on financial data consistent with the presentation in the accompanying financial statements. The Company concluded that its unified business is conducted globally and accordingly represents one operating segment.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Entity-wide disclosures on revenue and long-lived assets are presented in note 14.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;

          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:48.4pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:22.5pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;y.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top"&gt;
                    &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Employee severance benefits&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="font-weight:bold"&gt;&#160;&lt;/div&gt;
                    &lt;div style="font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;
                      &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company is required to make severance payments upon dismissal of an Israeli employee or upon termination of employment in certain circumstances.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="line-height:1.25;font-weight:normal"&gt;&#160;&lt;/div&gt;
                      &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In accordance with the current employment terms with all of its employees (Section 14 of the Israeli Severance Pay Law, 1963) located in Israel, the Company makes regular deposits with certain insurance companies for accounts controlled by each applicable employee in order to secure the employee&#x2019;s full retirement benefit and severance obligation. The Company is relieved from any severance pay liability with respect to each such employee after it makes the payments on behalf of the employee. The liability accrued in respect of these employees and the amounts funded, as of the respective agreement dates, are not reflected on the Company&#x2019;s consolidated balance sheet, as the amounts funded are not under the control and management of the Company and the pension or severance pay risks have been irrevocably transferred to the applicable insurance companies.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="line-height:1.25;font-weight:normal"&gt;&#160;&lt;/div&gt;
                      &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The amounts of severance payment expenses were $522, $431 and $405 and for the years ended December 31, 2023, 2022 and 2021, respectively.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="line-height:1.25;font-weight:normal"&gt;&#160;&lt;/div&gt;
                      &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company expects to contribute approximately $533 in the year ending December 31, 2024 to insurance companies in connection with its expected severance liabilities for the year.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;

          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:48.4pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:22.5pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;z.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top"&gt;
                    &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Treasury Shares&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="font-weight:bold"&gt;&#160;&lt;/div&gt;
                    &lt;div style="font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;
                      &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Treasury shares are presented as a reduction of equity, at their cost to the Company.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          &#160;&lt;div&gt;&lt;/div&gt;

            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:48.4pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:22.5pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;aa.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top"&gt;
                    &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Concentration of credit risks&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="font-weight:bold"&gt;&#160;&lt;/div&gt;
                    &lt;div style="font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:normal"&gt;Most of the cash and cash equivalents were deposited with U.S., European and Israeli banks and financial institutions and were comprised mainly of money market fund. The U.S. market constituted approximately 63% of the revenues in 2023.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The exposure of credit risks relating to other trade receivables outside the U.S. is limited, due to the relatively large number of group customers and their wide geographic distribution. The Company performs ongoing credit evaluations of its customers for the purpose of determining the appropriate allowance for Credit Losses and generally does not require collateral and from time to time the Company may choose to purchase trade credit insurance.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;

          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:48.4pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:22.5pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;ab.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top"&gt;
                    &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;War risk situation in Israel&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="font-weight:bold"&gt;&#160;&lt;/div&gt;
                    &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:normal"&gt;In October 2023, Israel was attacked by a terrorist organization and entered a state of war. As of the date of these consolidated financial statements, the war is ongoing and continues to evolve. The Company's headquarter, its R&amp;amp;D operations, and certain manufacturing facilities are located in Israel. Currently, such activities in Israel remain largely unaffected. During the year ended December 31, 2023, the impact of this war on the Company&#x2019;s results of operations and financial condition was immaterial, but such impact may increase, which could be material, as a result of the continuation, escalation or expansion of such war.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;

          &lt;div style="line-height:1.25"&gt;&#160;&lt;div&gt;

                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:48.4pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="width:22.5pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;ac.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="width:auto;vertical-align:top"&gt;
                        &lt;div style="font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;
                          &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Newly issued accounting pronouncements, not yet adopted&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;div style="line-height:1.25;font-weight:bold"&gt;&#160;&lt;/div&gt;
                        &lt;/div&gt;
                        &lt;div style="font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;
                          &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In December 2023, the FASB issued ASU 2023-09 &#x201c;Income Taxes (Topic 740): Improvements to Income Tax Disclosures&#x201d;. This guidance is intended to enhance the transparency and decision-usefulness of income tax disclosures. The amendments in ASU 2023-09 address investor requests for enhanced income tax information primarily through changes to disclosure regarding rate reconciliation and income taxes paid both in the U.S. and in foreign jurisdictions. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024 on a prospective basis. Early adoption is permitted, with the option to apply the standard retrospectively. The Company is currently evaluating this guidance to determine the impact it may have on its consolidated financial statements disclosures.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;div style="line-height:1.25;font-weight:normal"&gt;&#160;&lt;/div&gt;
                          &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In November 2023, the FASB issued ASU 2023-07 &#x201c;Segment Reporting: Improvements to Reportable Segment Disclosures&#x201d;. This guidance expands public entities&#x2019; segment disclosures primarily by requiring disclosure of significant segment expenses that are regularly provided to the chief operating decision maker and included within each reported measure of segment profit or loss, an amount and description of its composition for other segment items, and interim disclosures of a reportable.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;

            &lt;/div&gt;
          &lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;
    </us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240205094636406">
            &lt;div&gt;
              &lt;div style="line-height:1.25"&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:48.4pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="width:22.5pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;a.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="width:auto;vertical-align:top"&gt;
                        &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;Basis of presentation&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="font-weight:bold"&gt;&#160;&lt;/div&gt;
                        &lt;div style="font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;
                          &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company&#x2019;s consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (&#x201c;U.S. GAAP&#x201d;).&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          </us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240205094651732">
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:48.4pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:22.5pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;b.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top"&gt;
                    &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Use of estimates&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="font-weight:bold"&gt;&#160;&lt;/div&gt;
                    &lt;div style="font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;
                      &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          </us-gaap:UseOfEstimates>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240205094720859">
            &lt;div&gt;
              &lt;div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:48.4pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="width:22.5pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;c.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="width:auto;vertical-align:top"&gt;
                        &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Functional currency&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="font-weight:bold"&gt;&#160;&lt;/div&gt;
                        &lt;div style="font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:normal"&gt;The U.S. dollar (&#x201c;U.S. dollar&#x201d; or &#x201c;$&#x201d;) is the currency of the primary economic environment in which the operations of the Company is conducted. Substantial revenues and a substantial portion of the operational costs are denominated in U.S. dollars. Accordingly, the functional currency of the Company is the U.S. dollar (&#x201c;primary currency&#x201d;).&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="width:48.4pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="width:22.5pt;vertical-align:top;font-weight:bold"&gt;&#160;&lt;/td&gt;
                      &lt;td style="width:auto;vertical-align:top"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
              &lt;div&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;
                &lt;div&gt;
                  &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%"&gt;

                      &lt;tr style="vertical-align:top"&gt;
                        &lt;td style="text-align:right;vertical-align:top;width:70pt"&gt;
                          &lt;div style="text-align:left;margin-left:49.65pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="text-align:left;vertical-align:top;width:auto"&gt;
                          &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Transactions and balances originally denominated in U.S. dollars are presented at their original amounts. Balances in non-U.S. dollar currencies are translated into U.S. dollars using historical and current exchange rates for non-monetary and monetary balances, respectively. For non-U.S. dollar transactions and other items in the statements of income (indicated below), the following exchange rates are used: (i) for transactions &#x2013; exchange rates at transaction dates or average exchange rates; and (ii) for other items (derived from non-monetary balance sheet items such as depreciation and amortization) &#x2013; historical exchange rates. Currency transaction gains and losses are presented in finance income (expenses), as appropriate.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&#160;&lt;/div&gt;
                          &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The functional currency of each of the Subsidiaries is the U.S. dollar.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          </us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240205094726621">
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:48.4pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:22.5pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;d.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top"&gt;
                    &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Principles of consolidation and presentation&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&#160;&lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The consolidated financial statements include the accounts of the Company and its Subsidiaries. Intercompany transactions and balances are eliminated in consolidation.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          </us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240205094731221">
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:48.4pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:22.5pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;e.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top"&gt;
                    &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="font-weight:bold"&gt;&#160;&lt;/div&gt;
                    &lt;div style="font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;
                      &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company considers cash equivalents to be all short-term, highly liquid investments, which include money market instruments, that are not restricted as to withdrawal or use, and short-term bank deposits with original maturities of three months or less from the date of purchase that are not restricted as to withdrawal or use and are readily convertible to known amounts of cash.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          </us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <inmd:ShortTermBankDepositsPolicyTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240205094735405">
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:48.4pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:22.5pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;f.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top"&gt;
                    &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Short-term bank deposits&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="font-weight:bold"&gt;&#160;&lt;/div&gt;
                    &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:normal"&gt;Bank deposits with maturities of more than three months but less than one year are included in short-term deposits. Such short-term deposits bear interest at an average annual rate of approximately 4.10%-7.01% in 2023 and 0.50%-5.73% in 2022.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          </inmd:ShortTermBankDepositsPolicyTextBlock>
    <inmd:ShortTermDepositsAnnualInterestRate
      contextRef="C_20230101to20231231_srtRangeAxis_srtMinimumMember"
      decimals="4"
      id="FFact_395"
      unitRef="Pure">0.041</inmd:ShortTermDepositsAnnualInterestRate>
    <inmd:ShortTermDepositsAnnualInterestRate
      contextRef="C_20230101to20231231_srtRangeAxis_srtMaximumMember"
      decimals="4"
      id="FFact_396"
      unitRef="Pure">0.0701</inmd:ShortTermDepositsAnnualInterestRate>
    <inmd:ShortTermDepositsAnnualInterestRate
      contextRef="C_20220101to20221231_srtRangeAxis_srtMinimumMember"
      decimals="4"
      id="FFact_397"
      unitRef="Pure">0.005</inmd:ShortTermDepositsAnnualInterestRate>
    <inmd:ShortTermDepositsAnnualInterestRate
      contextRef="C_20220101to20221231_srtRangeAxis_srtMaximumMember"
      decimals="4"
      id="FFact_398"
      unitRef="Pure">0.0573</inmd:ShortTermDepositsAnnualInterestRate>
    <us-gaap:MarketableSecuritiesPolicy
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240205094742982">
            &lt;div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:48.4pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:22.5pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;g.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:auto;vertical-align:top"&gt;
                      &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Marketable securities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="font-weight:bold"&gt;&#160;&lt;/div&gt;
                      &lt;div style="font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;
                        &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="text-decoration:underline"&gt;AFS Securities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="line-height:1.25;font-weight:normal"&gt;&#160;&lt;/div&gt;
                        &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Marketable securities consist of government bonds, municipal bonds, and corporate debt securities (together &#x201c;Debt Securities&#x201d;), and certificates of deposit measured at fair value in each reporting period. The fair value of quoted securities is based on current market value.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="line-height:1.25;font-weight:normal"&gt;&#160;&lt;/div&gt;
                        &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Debt Securities and certificates of deposit are classified as available-for-sale (together &#x201c;AFS Securities&#x201d;) under current assets in the consolidated balance sheet as they represent the investment of funds available for the Company&#x2019;s current operations. Changes in fair value, excluding credit losses and impairments, net of taxes (if applicable), are reflected in other comprehensive income or loss. Realized gains and losses on sales of Debt Securities and certificates of deposit as well as premium or discount amortization are included in the consolidated statements of income as finance income (expenses), net. Fair value is calculated based on publicly available market information. When the estimated fair value of a Debt Security is below its amortized cost, the Debt Security is assessed using the Current Expected Credit Losses model (in accordance with ASU 2016-13) in order to determine what portion of that difference, if any, is caused by expected credit losses. The amortized cost of the Debt Security will be reduced to its fair value if it is more likely than not that the Company is required to sell the impaired security before recovery of its amortized cost basis, or it has the intention to sell the security. If neither of these conditions are met, the Company determines whether the impairment is due to credit losses by comparing the present value of the expected cash flows of the security with its amortized cost basis. The amount of impairment recognized is limited to the excess of the amortized cost over the fair value of the security. An allowance for credit losses for the excess of amortized cost over the expected cash flows is recognized in finance income (expenses), net on the consolidated statements income. &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;
                &lt;div&gt;&lt;/div&gt;
              &lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%"&gt;

                    &lt;tr style="vertical-align:top"&gt;
                      &lt;td style="text-align:right;vertical-align:top;width:70pt"&gt;
                        &lt;div style="text-align:left;margin-left:49.65pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:top;width:auto"&gt;
                        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company classifies investments that are readily convertible to known amounts of cash and have stated maturities of three months or less from the date of purchase as cash equivalents and those with stated maturities of greater than three months as marketable securities.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company determines the appropriate classification of its investments in marketable securities at the time of purchase.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          </us-gaap:MarketableSecuritiesPolicy>
    <us-gaap:InvestmentPolicyTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240205094750582">
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:48.4pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:22.5pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;h.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top"&gt;
                    &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other Investments&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="font-weight:bold"&gt;&#160;&lt;/div&gt;
                    &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:normal"&gt;The Company applies the measurement alternative upon the adoption of ASU 2016-01, and elected to record equity investments without readily determinable fair values at cost for other investments, less impairment, adjusted for subsequent observable price changes. In this measurement alternative method, changes in the carrying value of the equity investments are reflected in current earnings. Changes in the carrying value of the equity investment are required to be made whenever there are observable price changes in orderly transactions for the identical or similar investment of the same issuer.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          </us-gaap:InvestmentPolicyTextBlock>
    <us-gaap:InventoryPolicyTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240205094757029">
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:48.4pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:22.5pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;i.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:auto;vertical-align:top"&gt;
                      &lt;div style="font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;Inventories&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Inventories include raw materials and finished products and are valued at the lower of cost or net realizable value. During the year ended December 31, 2022, the Company changed the cost determination method of raw materials from first in, first out (&#x201c;FIFO&#x201d;) method to a &#x201c;moving average&#x201d; method. This voluntary change in accounting method was implemented and considered preferable because the Company's ERP system supports automatic calculation of inventory according to the &#x201c;moving average&#x201d; method and it allows consistency of the cost determination method among the different components of inventory. The change in method was immaterial to all periods presented. The Company regularly evaluates its ability to realize the value of inventory based on a combination of factors including the following: historical usage rates, forecasted sales or usage, estimated current and future market values and new product introductions.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            </us-gaap:InventoryPolicyTextBlock>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240205094801432">
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:48.4pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:22.5pt;vertical-align:top;font-weight:bold"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="width:48.4pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:22.5pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;j.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top"&gt;
                    &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Leases&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="font-weight:bold"&gt;&#160;&lt;/div&gt;
                    &lt;div style="font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;
                      &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company determines if an arrangement is a lease at inception. Balances related to operating leases are included in operating lease right-of-use (&#x201c;ROU&#x201d;) assets, other current liabilities, and operating lease liabilities in the consolidated balance sheets.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="line-height:1.25;font-weight:normal"&gt;&#160;&lt;/div&gt;
                      &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company also elected to combine lease and non-lease components and to keep leases with an initial term of 12 months or less off the balance sheet and recognize the associated lease payments in the consolidated statements of income on a straight-line basis over the lease term.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="line-height:1.25;font-weight:normal"&gt;&#160;&lt;/div&gt;
                      &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;ROU assets represent the Company&#x2019;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#x2019;s obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized as of the commencement date based on the present value of lease payments over the lease term. The Company&#x2019;s lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. The discount rate for the lease is the rate implicit in the lease unless that rate cannot be readily determined. As the Company&#x2019;s leases do not provide an implicit rate, the Company&#x2019;s uses its estimated incremental borrowing rate based on the information available at the commencement date in determining the present value of lease payments. Lease expense for lease payments is recognized on a straight-line basis over the lease term (see also note 9).&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="width:48.4pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:22.5pt;vertical-align:top;font-weight:bold"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          </us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240205094808566">
            &lt;div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:48.4pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:22.5pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;k.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:auto;vertical-align:top"&gt;
                      &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Property and equipment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="font-weight:bold"&gt;&#160;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;

                &lt;div&gt;
                  &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:70pt"&gt;&#160;&lt;/td&gt;
                        &lt;td style="vertical-align:top;width:auto"&gt;
                          &lt;div style="font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:normal"&gt;Property and equipment is stated at cost, net of accumulated depreciation and amortization. Depreciation is calculated on a straight-line basis over the following estimated useful lives:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;div style="margin-left:81pt"&gt;
                    &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255)"&gt;
                            &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Computers&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                            &lt;div style="text-align:center;margin-right:20.45pt;margin-left:13.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3 &#x2013; 4 years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Molds&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom"&gt;
                            &lt;div style="text-align:center;margin-right:20.45pt;margin-left:13.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4 &#x2013; 10 years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                            &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Equipment and furniture&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                            &lt;div style="text-align:center;margin-right:20.45pt;margin-left:13.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10 &#x2013; 17 years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                  &lt;/div&gt;
                &lt;/div&gt;

              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:48.4pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="width:22.5pt;vertical-align:top;font-weight:bold"&gt;&#160;&lt;/td&gt;
                      &lt;td style="width:auto;vertical-align:top;font-weight:normal"&gt;
                        &lt;div style="font-family:'Times New Roman',Times,serif"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Leasehold improvements are depreciated using the straight-line method over the shorter of the term of the lease or the estimated useful lives of the improvements.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          </us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <inmd:ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240205125323201">
                &lt;div&gt;
                  &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:70pt"&gt;&#160;&lt;/td&gt;
                        &lt;td style="vertical-align:top;width:auto"&gt;
                          &lt;div style="font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:normal"&gt;Property and equipment is stated at cost, net of accumulated depreciation and amortization. Depreciation is calculated on a straight-line basis over the following estimated useful lives:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;div style="margin-left:81pt"&gt;
                    &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255)"&gt;
                            &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Computers&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                            &lt;div style="text-align:center;margin-right:20.45pt;margin-left:13.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3 &#x2013; 4 years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Molds&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom"&gt;
                            &lt;div style="text-align:center;margin-right:20.45pt;margin-left:13.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4 &#x2013; 10 years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                            &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Equipment and furniture&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                            &lt;div style="text-align:center;margin-right:20.45pt;margin-left:13.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10 &#x2013; 17 years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                  &lt;/div&gt;
                &lt;/div&gt;
              </inmd:ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_20231231_srtRangeAxis_srtMinimumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapComputerEquipmentMember"
      id="Fxbrl_20240205125741538">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_20231231_srtRangeAxis_srtMaximumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapComputerEquipmentMember"
      id="Fxbrl_20240205125814667">P4Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_20231231_srtRangeAxis_srtMinimumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapToolsDiesAndMoldsMember"
      id="Fxbrl_20240205125836674">P4Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_20231231_srtRangeAxis_srtMaximumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapToolsDiesAndMoldsMember"
      id="Fxbrl_20240205125850370">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_20231231_srtRangeAxis_srtMinimumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapEquipmentMember"
      id="Fxbrl_20240205125840699">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_20231231_srtRangeAxis_srtMaximumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapEquipmentMember"
      id="Fxbrl_20240205125854844">P17Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240205094813029">
            &lt;table cellpadding="0" cellspacing="0" style="color:#000000;font-family:'Times New Roman',Times,serif;font-size:10pt;text-align:left;width:100%"&gt;

                &lt;tr&gt;
                  &lt;td style="width:48.4pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:22.5pt;vertical-align:top;font-weight:bold"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="width:48.4pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:22.5pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;l.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top"&gt;
                    &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Impairment of long-lived assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="font-weight:bold"&gt;&#160;&lt;/div&gt;
                    &lt;div style="font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:normal"&gt;The Company tests long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may no longer be recoverable. Recoverability of long-lived assets is measured by comparing the carrying amount of the long-lived asset to the estimated undiscounted future cash flows expected to be generated by the asset. If the sum of the expected undiscounted cash flow is less than the carrying amount of the asset, the Company recognizes an impairment loss, which is the excess of the carrying amount over the fair value of the asset, using the expected future discounted cash flows.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:normal"&gt;During the years ended December 31, 2023, 2022 and 2021, the Company did not recognize an impairment loss on its long-lived assets.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          </us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:CommitmentsAndContingenciesPolicyTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240205094822105">
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:48.4pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:22.5pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;m.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top"&gt;
                    &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Legal and other contingencies&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&#160;&lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Certain conditions may exist as of the date of the consolidated financial statements, which may result in a loss to the Company but which will only be resolved when one or more future events occur or fail to occur. The Company&#x2019;s management assesses such contingent liabilities, if any, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the Company or unasserted claims that may result in such proceedings, the Company&#x2019;s management evaluates the perceived merits of any legal proceedings or unasserted claims as well as the perceived merits of the amount of relief sought or expected to be sought.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="line-height:1.25;font-weight:normal"&gt;&#160;&lt;/div&gt;
                      &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Management applies the guidance in ASC 450-20, &#x201c;Loss Contingencies&#x201d; when assessing losses resulting from contingencies. If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be reasonable estimated, then the estimated liability is recorded as accrued expenses in the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="margin-left:72pt;line-height:1.25;font-weight:normal"&gt;&#160;&lt;/div&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:normal"&gt;Legal costs incurred in connection with loss contingencies are expensed as incurred.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          </us-gaap:CommitmentsAndContingenciesPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240205094831103">
            &lt;div&gt;
              &lt;div style="line-height:1.25"&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:48.4pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="width:22.5pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;n.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="width:auto;vertical-align:top"&gt;
                        &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Income taxes:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="width:48.4pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="width:22.5pt;vertical-align:top;font-weight:bold"&gt;&#160;&lt;/td&gt;
                      &lt;td style="width:auto;vertical-align:top"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:72pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:26.7pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:auto;vertical-align:top"&gt;
                      &lt;div style="font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company accounts for income taxes in accordance with ASC 740, &#x201c;Income Taxes&#x201d; (&#x201c;ASC 740&#x201d;). ASC 740 prescribes the use of the liability method whereby deferred tax asset and liability account balances are determined based on differences between the financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company provides a valuation allowance, if necessary, to reduce deferred tax assets to their estimated realizable value if it is more likely than not that a portion or all of the deferred tax assets will not be realized, based on the weight of available positive and negative evidence. Deferred tax liabilities and assets are classified as non-current in accordance with ASU 2015&#x2011;17.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="width:72pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:26.7pt;vertical-align:top"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:auto;vertical-align:top"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;div&gt;&lt;/div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:72pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:26.7pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:auto;vertical-align:top"&gt;
                      &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company may incur an additional tax liability in the event of an inter-company dividend distribution from Subsidiaries outside of Israel; no additional deferred income tax assets have been provided, since the Company does not expect to distribute inter-company dividends in the foreseeable future that may result in additional tax liability.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:72pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:26.7pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:auto;vertical-align:top"&gt;
                      &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Taxes that would apply in the event of disposal of investments in Subsidiaries have not been taken into account in computing the deferred income tax assets, as it is the Company&#x2019;s intent and ability to hold these investments.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:72pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:26.7pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:auto;vertical-align:top"&gt;
                      &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company accounts for uncertain tax positions in accordance with ASC 740-10. ASC 740&#x2011;10 contains a two-step approach to recognizing and measuring uncertain tax positions. The first step is to evaluate the tax position taken or expected to be taken in a tax return by determining if the weight of available evidence indicates that it is more likely than not that, on an evaluation of the technical merits, the tax position will be sustained on audit, including resolution of any related appeals or litigation processes. The second step is to measure the tax benefit of the largest amount that is more than 50% (cumulative probability) likely to be realized upon ultimate settlement.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
          </us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:AdvertisingCostsPolicyTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240205094845770">
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:48.4pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:22.5pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;o.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top"&gt;
                    &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Advertising expenses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&#160;&lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Advertising expenses are charged to sales and marketing on the consolidated statement of income as incurred. Advertising expenses for the years ended December 31, 2023, 2022 and 2021 amounted to $15 million, $10 million, and $4 million, respectively.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          </us-gaap:AdvertisingCostsPolicyTextBlock>
    <us-gaap:AdvertisingExpense
      contextRef="C_20230101to20231231"
      decimals="-6"
      id="Fxbrl_20230214001207012"
      unitRef="USD">15000000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="C_20220101to20221231"
      decimals="-6"
      id="Fxbrl_20230214001212815"
      unitRef="USD">10000000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="C_20210101to20211231"
      decimals="-6"
      id="Fxbrl_20230214001219487"
      unitRef="USD">4000000</us-gaap:AdvertisingExpense>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240205094856192">
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:48.4pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:22.5pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;p.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top"&gt;
                    &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Share-based compensation&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="font-weight:bold"&gt;&#160;&lt;/div&gt;
                    &lt;div style="font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;
                      &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company grants share options and restricted share units (&#x201c;RSU&#x201d;) (together &#x201c;Share-Based Compensation&#x201d;) to its employees, officers, directors and non-employees in consideration for services rendered and for acquiring goods. See note 12(a)(2) for details on outstanding share capital.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="line-height:1.25;font-weight:normal"&gt;&#160;&lt;/div&gt;
                      &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company accounts for Share-Based Compensation awards classified as equity awards using the grant-date fair value method. The fair value at grant-date of the issued equity award is recognized as an expense on a straight-line basis over the requisite service period. The fair value of each share option granted is estimated using the Binomial Model, and for each RSU granted is based on the Company&#x2019;s share price at the close of the last trading day prior to the date of the grant. The Company estimates forfeitures based on historical experience and anticipated future conditions at the time of grant and revises such estimates in subsequent periods if actual forfeitures differ from those estimates.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="line-height:1.25;font-weight:normal"&gt;&#160;&lt;/div&gt;
                      &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company elected to recognize Share-Based Compensation cost for awards with only service conditions that have a graded vesting schedule using the straight-line method based on the multiple-option award approach. Performance-based Share-Based Compensation expenses are calculated based on the valuation at the grant date, and recognized based on the probability of achieving those targets. The Company assess at what scale can the performance targets be reached at each balance sheet date, and expenses are recognized accordingly.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="line-height:1.25;font-weight:normal"&gt;&#160;&lt;/div&gt;
                      &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company issues new shares upon option exercise or RSU vesting.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          </us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:RevenueRecognitionPolicyTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240205094933327">
            &lt;div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;font-weight:bold;width:48pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;font-weight:bold;width:22pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;q.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:auto"&gt;
                      &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenue recognition&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="font-weight:bold"&gt;&#160;&lt;/div&gt;
                      &lt;div style="font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;
                        &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company applies ASC 606, &#x201c;Revenue from Contracts with Customers&#x201d; (&#x201c;ASC 606&#x201d;). Under ASC 606, an entity recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration that the entity expects to receive in exchange for those goods or services. To determine revenue recognition for arrangements that an entity determines are within the scope of ASC 606, the entity performs the following five steps:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:72pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:38.05pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(i)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:auto;vertical-align:top"&gt;
                      &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Identify the contract(s) with a customer;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:72pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:38.05pt;vertical-align:top;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(ii)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:auto;vertical-align:top"&gt;
                      &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Identify the performance obligations in the contract. The Company determined that its arrangements are generally comprised of the following elements that are recognized as separate performance obligations: products, consumables and extended warranties;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:72pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:38.05pt;vertical-align:top;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(iii)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:auto;vertical-align:top"&gt;
                      &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Determine the transaction price;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:72pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:38.05pt;vertical-align:top;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(iv)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:auto;vertical-align:top"&gt;
                      &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Allocate the transaction price to the performance obligations in the contract;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="font-family:'Times New Roman',Times,serif"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company estimates the standalone selling prices of the services to be provided based on actual sales transactions of service contract purchased on a standalone basis and uses the residual approach to estimate the selling price of the products; and&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;div style="margin-left:106.9pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:72pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:38.05pt;vertical-align:top;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(v)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:auto;vertical-align:top"&gt;
                      &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Recognize revenue when (or as) the performance obligation is satisfied. &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div&gt;&#160;&lt;/div&gt;
                      &lt;div style="font-family:'Times New Roman',Times,serif"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company only applies the five-step model to contracts when it is probable that the entity will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer, after considering any price concession expected to be provided to the customer, when applicable. At contract inception, the Company assesses the goods or services promised within each contract and determines those that are performance obligations and assesses whether each promised good or service is distinct. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied. &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company uses the following practical expedients that are permitted under the rules:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:111pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#x2022;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:auto;vertical-align:top"&gt;
                      &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company recognizes the incremental costs of obtaining contracts as an expense when incurred if the amortization period of the assets that the Company otherwise would have recognized is one year or less. These costs are included in sales and marketing expenses.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:111pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#x2022;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:auto;vertical-align:top"&gt;
                      &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company does not disclose the value of unsatisfied performance obligations for contracts with an original expected length of one year or less.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;font-weight:bold;width:72pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:top;width:auto"&gt;
                        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The following is a description of the principal activities from which the Company generates its revenue.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Product Revenue, Net&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenues from product sales are recognized when the customer obtains control over the Company&#x2019;s product, typically upon shipment to the customer. Revenues from shipping and handling activities that occur after the customer has obtained control of a good are recognized according to an accounting policy election as a fulfilment cost rather than as an additional promised service. Taxes collected from customers relating to product sales and remitted to governmental authorities are excluded from revenues.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
              &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;
              &lt;div&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;font-weight:bold;width:70pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:top;width:auto"&gt;
                        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Payment terms and conditions vary by customer. The Company&#x2019;s standard terms for end users usually require of payment upon delivery and for distributors require a down payment and payments made within several month from the invoice date. &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company may enter into installment sales contracts with end users in North America that provide them with long-term (generally up to 60 months) financing for the purchase of the Company&#x2019;s products. The interest rate used in these contracts reflects the credit characteristics of the party receiving financing in the contract, as well as any collateral or security provided by the customer. Interest income on these receivables is recognized as finance income and earned over the terms of the contract.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Variable consideration includes price concessions related to installment sales contracts. The Company estimates variable consideration using the most likely outcome amount. Amounts included in the transaction price are recognized only when it is probable that a significant reversal of cumulative revenues will not occur.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company does not grant a right of return, refund, cancelation or termination. From time to time, the Company participates in its customers&#x2019; marketing activities and deducts such amounts from revenue.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Service Revenue&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company also generates revenues from long-term maintenance contracts (&#x201c;Extended Warranty&#x201d;). Revenue from Extended Warranty is recognized ratably, on a straight-line basis, over the period of the applicable service contract. These maintenance agreements are included in contract liabilities. Revenue from repairs performed in the absence of Extended Warranty is recognized when the related services are performed.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company classifies the portion of contract liabilities not expected to be earned in the subsequent 12 months as long-term.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          </us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240205094945087">
            &lt;div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;font-weight:bold;width:48pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:22pt"&gt;
                      &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;r.&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;
                    &lt;/td&gt;
                    &lt;td style="vertical-align:top;width:auto"&gt;
                      &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Allowance for doubtful accounts and financial instruments &#x2013; credit loss&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="font-weight:bold"&gt;&#160;&lt;/div&gt;
                      &lt;div style="font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;
                        &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company maintains the allowance for doubtful account resulting from the inability of the Company&#x2019;s customers to make required payments.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="line-height:1.25;font-weight:normal"&gt;&#160;&lt;/div&gt;
                        &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The allowance represents the current estimate of lifetime expected credit losses over the remaining duration of existing accounts receivable. This information includes among other the historic experience, the extent and amount of the account and future expectations.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="line-height:1.25;font-weight:normal"&gt;&#160;&lt;/div&gt;
                        &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Allowance for credit losses due to the Company&#x2019;s accounts receivable amounted to $2,254 and $1,318 as of December 31, 2023 and 2022 respectively. Changes in the allowance for credit losses are recognized in general and administrative expenses. Accounts receivable are written-off against the allowance for credit losses when management deems the accounts are no longer collectible.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="line-height:1.25;font-weight:normal"&gt;&#160;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;

                &lt;div&gt;
                  &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:48pt"&gt;&#160;&lt;/td&gt;
                        &lt;td style="vertical-align:top;width:22pt"&gt;&#160;&lt;/td&gt;
                        &lt;td style="vertical-align:top;width:auto"&gt;
                          &lt;div style="font-family:'Times New Roman',Times,serif"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:normal"&gt;The following table sets forth activity in the Company&#x2019;s allowance for credit losses for&lt;/span&gt; each of the years ended December 31, 2023, 2022 and 2021, respectively:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;div style="margin-left:81pt"&gt;
                    &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:middle;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="text-indent:15.85pt;margin-right:7.2pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance at beginning of year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,318&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,107&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;672&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:middle;width:64%;vertical-align:bottom"&gt;
                            &lt;div style="text-indent:15.85pt;margin-right:7.2pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Current-period provision&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;449&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;516&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:middle;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="text-indent:15.85pt;margin-right:7.2pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Write-offs charged against the&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;div style="text-indent:15.85pt;margin-right:7.2pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;allowance&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(84&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(238&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(81&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:middle;width:64%;padding-bottom:4px;vertical-align:bottom"&gt;
                            &lt;div style="text-indent:15.85pt;margin-right:7.2pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance at end of year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,254&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,318&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,107&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                  &lt;/div&gt;
                &lt;/div&gt;

            &lt;/div&gt;
          </us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20240205102249294"
      unitRef="USD">2254000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20240205102257538"
      unitRef="USD">1318000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240205125408201">
                &lt;div&gt;
                  &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:48pt"&gt;&#160;&lt;/td&gt;
                        &lt;td style="vertical-align:top;width:22pt"&gt;&#160;&lt;/td&gt;
                        &lt;td style="vertical-align:top;width:auto"&gt;
                          &lt;div style="font-family:'Times New Roman',Times,serif"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:normal"&gt;The following table sets forth activity in the Company&#x2019;s allowance for credit losses for&lt;/span&gt; each of the years ended December 31, 2023, 2022 and 2021, respectively:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;div style="margin-left:81pt"&gt;
                    &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:middle;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="text-indent:15.85pt;margin-right:7.2pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance at beginning of year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,318&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,107&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;672&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:middle;width:64%;vertical-align:bottom"&gt;
                            &lt;div style="text-indent:15.85pt;margin-right:7.2pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Current-period provision&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;449&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;516&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:middle;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="text-indent:15.85pt;margin-right:7.2pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Write-offs charged against the&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;div style="text-indent:15.85pt;margin-right:7.2pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;allowance&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(84&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(238&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(81&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:middle;width:64%;padding-bottom:4px;vertical-align:bottom"&gt;
                            &lt;div style="text-indent:15.85pt;margin-right:7.2pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance at end of year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,254&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,318&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,107&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                  &lt;/div&gt;
                &lt;/div&gt;
              </us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20240205101847644_13"
      unitRef="USD">1318000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20240205101847644_17"
      unitRef="USD">1107000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="C_20201231"
      decimals="-3"
      id="Fxbrl_20240205101847644_111"
      unitRef="USD">672000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20240205101847644_23"
      unitRef="USD">1020000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20240205101847644_27"
      unitRef="USD">449000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20240205101847644_211"
      unitRef="USD">516000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20240205101847644_33"
      unitRef="USD">84000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20240205101847644_37"
      unitRef="USD">238000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20240205101847644_311"
      unitRef="USD">81000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20240205101847644_43"
      unitRef="USD">2254000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20240205101847644_47"
      unitRef="USD">1318000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20240205101847644_411"
      unitRef="USD">1107000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:StandardProductWarrantyPolicy
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240205095022165">
            &lt;div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:48pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;font-weight:bold;width:22pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;s.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:auto"&gt;
                      &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Warranty reserve&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="font-weight:bold"&gt;&#160;&lt;/div&gt;
                      &lt;div style="font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;
                        &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company provides a one-year standard warranty for its products. The Company records a provision for the estimated cost to repair or replace products under warranty at the time of sale. Factors that affect the Company&#x2019;s warranty reserve include the number of units sold, historical and anticipated rates of warranty repairs, the cost per repair and shipping cost. The Company periodically assesses the adequacy of its recorded warranty liabilities and adjusts the amounts as necessary.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="line-height:1.25;font-weight:normal"&gt;&#160;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;

                &lt;div&gt;
                  &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:48pt"&gt;&#160;&lt;/td&gt;
                        &lt;td style="vertical-align:top;width:22pt"&gt;&#160;&lt;/td&gt;
                        &lt;td style="vertical-align:top;width:auto"&gt;
                          &lt;div style="font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;
                            &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The following table sets forth activity in the Company&#x2019;s accrued warranty account for each of the years ended December 31, 2023, 2022 and 2021, respectively:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;div style="margin-left:81pt"&gt;
                    &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:middle;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="text-indent:15.85pt;margin-right:7.2pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance at beginning of year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,418&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,248&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;705&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:middle;width:64%;vertical-align:bottom"&gt;
                            &lt;div style="text-indent:15.85pt;margin-right:7.2pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cost incurred&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,304&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,099&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,453&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:middle;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="text-indent:15.85pt;margin-right:7.2pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Expense recognized&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,362&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,269&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,996&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:middle;width:64%;padding-bottom:4px;vertical-align:bottom"&gt;
                            &lt;div style="text-indent:15.85pt;margin-right:7.2pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance at end of year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,476&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,418&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,248&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                  &lt;/div&gt;
                &lt;/div&gt;

            &lt;/div&gt;
          </us-gaap:StandardProductWarrantyPolicy>
    <us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240205125448187">
                &lt;div&gt;
                  &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:48pt"&gt;&#160;&lt;/td&gt;
                        &lt;td style="vertical-align:top;width:22pt"&gt;&#160;&lt;/td&gt;
                        &lt;td style="vertical-align:top;width:auto"&gt;
                          &lt;div style="font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;
                            &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The following table sets forth activity in the Company&#x2019;s accrued warranty account for each of the years ended December 31, 2023, 2022 and 2021, respectively:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;div style="margin-left:81pt"&gt;
                    &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:middle;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="text-indent:15.85pt;margin-right:7.2pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance at beginning of year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,418&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,248&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;705&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:middle;width:64%;vertical-align:bottom"&gt;
                            &lt;div style="text-indent:15.85pt;margin-right:7.2pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cost incurred&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,304&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,099&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,453&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:middle;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="text-indent:15.85pt;margin-right:7.2pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Expense recognized&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,362&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,269&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,996&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:middle;width:64%;padding-bottom:4px;vertical-align:bottom"&gt;
                            &lt;div style="text-indent:15.85pt;margin-right:7.2pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance at end of year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,476&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,418&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,248&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                  &lt;/div&gt;
                &lt;/div&gt;
              </us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock>
    <us-gaap:StandardProductWarrantyAccrual
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_415"
      unitRef="USD">1418000</us-gaap:StandardProductWarrantyAccrual>
    <us-gaap:StandardProductWarrantyAccrual
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_416"
      unitRef="USD">1248000</us-gaap:StandardProductWarrantyAccrual>
    <us-gaap:StandardProductWarrantyAccrual
      contextRef="C_20201231"
      decimals="-3"
      id="FFact_417"
      unitRef="USD">705000</us-gaap:StandardProductWarrantyAccrual>
    <us-gaap:StandardProductWarrantyAccrualPayments
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_418"
      unitRef="USD">2304000</us-gaap:StandardProductWarrantyAccrualPayments>
    <us-gaap:StandardProductWarrantyAccrualPayments
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_419"
      unitRef="USD">2099000</us-gaap:StandardProductWarrantyAccrualPayments>
    <us-gaap:StandardProductWarrantyAccrualPayments
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_420"
      unitRef="USD">1453000</us-gaap:StandardProductWarrantyAccrualPayments>
    <us-gaap:StandardProductWarrantyAccrualWarrantiesIssued
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_421"
      unitRef="USD">2362000</us-gaap:StandardProductWarrantyAccrualWarrantiesIssued>
    <us-gaap:StandardProductWarrantyAccrualWarrantiesIssued
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_422"
      unitRef="USD">2269000</us-gaap:StandardProductWarrantyAccrualWarrantiesIssued>
    <us-gaap:StandardProductWarrantyAccrualWarrantiesIssued
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_423"
      unitRef="USD">1996000</us-gaap:StandardProductWarrantyAccrualWarrantiesIssued>
    <us-gaap:StandardProductWarrantyAccrual
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_424"
      unitRef="USD">1476000</us-gaap:StandardProductWarrantyAccrual>
    <us-gaap:StandardProductWarrantyAccrual
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_425"
      unitRef="USD">1418000</us-gaap:StandardProductWarrantyAccrual>
    <us-gaap:StandardProductWarrantyAccrual
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_426"
      unitRef="USD">1248000</us-gaap:StandardProductWarrantyAccrual>
    <us-gaap:CostOfSalesPolicyTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240205095032023">
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:48.4pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:22.5pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;t.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top"&gt;
                    &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cost of revenues&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="font-weight:bold"&gt;&#160;&lt;/div&gt;
                    &lt;div style="font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;
                      &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cost of revenue consists of products purchased from turnkey sub-contractors which are responsible for the production of most of the Company&#x2019;s products under the Company&#x2019;s directions and supervision, raw materials for in-house assembly line, shipping and handling costs to customers and to subsidiaries, salary, employee-related expenses and overhead expenses of internal assembly line and service costs associate with warranty.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          </us-gaap:CostOfSalesPolicyTextBlock>
    <us-gaap:ResearchAndDevelopmentExpensePolicy
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240205095035523">
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:48.4pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:22.5pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;u.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top"&gt;
                    &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Research and development costs&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&#160;&lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Research and development costs are expensed as incurred and includes salaries and employee-related expenses, overhead expenses, material and third-party contractor&#x2019;s charges related to product development, regulatory affairs and clinical studies.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          </us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240205095042783">
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:48.4pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:22.5pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;v.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;Net earnings&lt;/span&gt;&#160;&lt;span style="font-weight:bold"&gt;per share&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div&gt;&#160;&lt;/div&gt;
                    &lt;div style="font-family:'Times New Roman',Times,serif"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Basic earnings per share are computed by dividing net income &lt;/span&gt;&lt;/span&gt;attributed to the shareholders of InMode Ltd. by the weighted average number of the Company&#x2019;s ordinary shares, par value NIS 0.01 per share (including vested RSUs),&lt;span&gt;&lt;span&gt; outstanding for each period, net of treasury shares.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;For the diluted earnings per share calculation, the weighted average number of shares outstanding during the year is adjusted for the average number of shares that are potentially issuable in connection with employee share-based payment, using the treasury stock method.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          </us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240205095052796">
            &lt;div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:48.4pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:22.5pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;w.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:auto;vertical-align:top"&gt;
                      &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fair value measurement&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="font-weight:bold"&gt;&#160;&lt;/div&gt;
                      &lt;div style="font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;
                        &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company measures fair value and discloses fair value measurements for financial assets and liabilities. Fair value is based on the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. In the absence of active markets for identical assets or liabilities, such measurements involve developing assumptions based on market observable data and, in the absence of such data,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="line-height:1.25;font-weight:normal"&gt;&#160;&lt;/div&gt;
                        &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;internal information that is consistent with what market participants would use in a hypothetical transaction that occurs at the measurement date. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect the Company&#x2019;s market assumptions.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;
              &lt;div&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:48.4pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="width:22.5pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;w.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="width:auto;vertical-align:top;font-weight:normal"&gt;
                        &lt;div style="font-family:'Times New Roman',Times,serif"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The three levels of inputs that may be used to measure fair value are as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
              &lt;div&gt;&#160;&lt;/div&gt;
              &lt;div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:106pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
                      &lt;td style="width:auto;vertical-align:top"&gt;
                        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Level 1 &#x2013; Quoted prices (unadjusted) in active markets that are accessible at the measurement date for identical assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Level 2 &#x2013; Observable prices that are based on identical or similar instruments not quoted on active markets, but corroborated by observable market data, or quoted prices for similar instruments in active markets.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Level 3 &#x2013; Unobservable inputs are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level 3 inputs.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
              &lt;div&gt;&#160;&lt;/div&gt;
              &lt;div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:48.4pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="width:22.5pt;vertical-align:top;font-weight:bold"&gt;&#160;&lt;/td&gt;
                      &lt;td style="width:auto;vertical-align:top;font-weight:normal"&gt;
                        &lt;div style="font-family:'Times New Roman',Times,serif"&gt;
                          &lt;div style="line-height:1.25"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company maintains policies and procedures to determine the fair value of financial assets and liabilities using what it considers to be the most relevant and reliable market data available.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As of December 31, 2023, and 2022, the fair values of the Company's cash, cash equivalents, short term bank deposits, accounts receivable, accounts payable, approximated the carrying values of these instruments presented in the Company's consolidated balance sheets because of their nature.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          </us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240205095119671">
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:48.4pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:22.5pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;x.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top"&gt;
                    &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Segments&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="font-family:'Times New Roman',Times,serif;font-weight:normal"&gt;&#160;&lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company operates in one segment. Management does not segregate its business for internal reporting. The Company&#x2019;s chief operating decision-maker evaluates the performance of its business based on financial data consistent with the presentation in the accompanying financial statements. The Company concluded that its unified business is conducted globally and accordingly represents one operating segment.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Entity-wide disclosures on revenue and long-lived assets are presented in note 14.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          </us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="C_20230101to20231231"
      decimals="0"
      id="Fxbrl_20240205102757575"
      unitRef="Segment">1</us-gaap:NumberOfOperatingSegments>
    <inmd:EmployeeSeveranceBenefitsPolicyTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240205095124323">
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:48.4pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:22.5pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;y.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top"&gt;
                    &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Employee severance benefits&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="font-weight:bold"&gt;&#160;&lt;/div&gt;
                    &lt;div style="font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;
                      &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company is required to make severance payments upon dismissal of an Israeli employee or upon termination of employment in certain circumstances.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="line-height:1.25;font-weight:normal"&gt;&#160;&lt;/div&gt;
                      &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In accordance with the current employment terms with all of its employees (Section 14 of the Israeli Severance Pay Law, 1963) located in Israel, the Company makes regular deposits with certain insurance companies for accounts controlled by each applicable employee in order to secure the employee&#x2019;s full retirement benefit and severance obligation. The Company is relieved from any severance pay liability with respect to each such employee after it makes the payments on behalf of the employee. The liability accrued in respect of these employees and the amounts funded, as of the respective agreement dates, are not reflected on the Company&#x2019;s consolidated balance sheet, as the amounts funded are not under the control and management of the Company and the pension or severance pay risks have been irrevocably transferred to the applicable insurance companies.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="line-height:1.25;font-weight:normal"&gt;&#160;&lt;/div&gt;
                      &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The amounts of severance payment expenses were $522, $431 and $405 and for the years ended December 31, 2023, 2022 and 2021, respectively.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="line-height:1.25;font-weight:normal"&gt;&#160;&lt;/div&gt;
                      &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company expects to contribute approximately $533 in the year ending December 31, 2024 to insurance companies in connection with its expected severance liabilities for the year.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          </inmd:EmployeeSeveranceBenefitsPolicyTextBlock>
    <us-gaap:SeveranceCosts1
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_435"
      unitRef="USD">522000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_436"
      unitRef="USD">431000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_437"
      unitRef="USD">405000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="C_20240101to20241231_srtStatementScenarioAxis_srtScenarioForecastMember"
      decimals="-3"
      id="FFact_438"
      unitRef="USD">533000</us-gaap:SeveranceCosts1>
    <inmd:TreasurySharesPolicyTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240205095130567">
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:48.4pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:22.5pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;z.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top"&gt;
                    &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Treasury Shares&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="font-weight:bold"&gt;&#160;&lt;/div&gt;
                    &lt;div style="font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;
                      &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Treasury shares are presented as a reduction of equity, at their cost to the Company.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          </inmd:TreasurySharesPolicyTextBlock>
    <us-gaap:ConcentrationRiskCreditRisk
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240205095137883">
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:48.4pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:22.5pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;aa.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top"&gt;
                    &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Concentration of credit risks&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="font-weight:bold"&gt;&#160;&lt;/div&gt;
                    &lt;div style="font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:normal"&gt;Most of the cash and cash equivalents were deposited with U.S., European and Israeli banks and financial institutions and were comprised mainly of money market fund. The U.S. market constituted approximately 63% of the revenues in 2023.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The exposure of credit risks relating to other trade receivables outside the U.S. is limited, due to the relatively large number of group customers and their wide geographic distribution. The Company performs ongoing credit evaluations of its customers for the purpose of determining the appropriate allowance for Credit Losses and generally does not require collateral and from time to time the Company may choose to purchase trade credit insurance.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          </us-gaap:ConcentrationRiskCreditRisk>
    <inmd:WarRiskSituationInIsraelPolicyTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240205095148046">
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:48.4pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:22.5pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;ab.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top"&gt;
                    &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;War risk situation in Israel&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="font-weight:bold"&gt;&#160;&lt;/div&gt;
                    &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:normal"&gt;In October 2023, Israel was attacked by a terrorist organization and entered a state of war. As of the date of these consolidated financial statements, the war is ongoing and continues to evolve. The Company's headquarter, its R&amp;amp;D operations, and certain manufacturing facilities are located in Israel. Currently, such activities in Israel remain largely unaffected. During the year ended December 31, 2023, the impact of this war on the Company&#x2019;s results of operations and financial condition was immaterial, but such impact may increase, which could be material, as a result of the continuation, escalation or expansion of such war.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          </inmd:WarRiskSituationInIsraelPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240205095154190">
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:48.4pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="width:22.5pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;ac.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="width:auto;vertical-align:top"&gt;
                        &lt;div style="font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;
                          &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Newly issued accounting pronouncements, not yet adopted&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;div style="line-height:1.25;font-weight:bold"&gt;&#160;&lt;/div&gt;
                        &lt;/div&gt;
                        &lt;div style="font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;
                          &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In December 2023, the FASB issued ASU 2023-09 &#x201c;Income Taxes (Topic 740): Improvements to Income Tax Disclosures&#x201d;. This guidance is intended to enhance the transparency and decision-usefulness of income tax disclosures. The amendments in ASU 2023-09 address investor requests for enhanced income tax information primarily through changes to disclosure regarding rate reconciliation and income taxes paid both in the U.S. and in foreign jurisdictions. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024 on a prospective basis. Early adoption is permitted, with the option to apply the standard retrospectively. The Company is currently evaluating this guidance to determine the impact it may have on its consolidated financial statements disclosures.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;div style="line-height:1.25;font-weight:normal"&gt;&#160;&lt;/div&gt;
                          &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In November 2023, the FASB issued ASU 2023-07 &#x201c;Segment Reporting: Improvements to Reportable Segment Disclosures&#x201d;. This guidance expands public entities&#x2019; segment disclosures primarily by requiring disclosure of significant segment expenses that are regularly provided to the chief operating decision maker and included within each reported measure of segment profit or loss, an amount and description of its composition for other segment items, and interim disclosures of a reportable.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              </us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <inmd:MarketableSecuritiesAndFairValueMeasurements
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240205112729720">
      &lt;div&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;NOTE 3 - MARKETABLE SECURITIES AND FAIR VALUE MEASUREMENTS:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

              &lt;tr&gt;
                &lt;td style="width:49pt;vertical-align:top;font-weight:bold"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:auto;vertical-align:top"&gt;
                  &lt;div style="font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;
                    &lt;div style="line-height:1.25;font-weight:normal"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;AFS securities as of December 31, 2023 and 2022, consisted of government bonds, municipal bonds, corporate debt securities, commercial paper and certificates of deposit. These marketable securities are recorded at fair value.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
        &lt;/div&gt;&#160;&lt;div&gt;&lt;/div&gt;

          &lt;div&gt;
            &lt;div style="line-height:1.25"&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:49pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:auto"&gt;
                      &lt;div style="font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;
                        &lt;div style="line-height:1.25;font-weight:normal"&gt;
                          &lt;div style="line-height:1.25"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The following table sets forth the Company&#x2019;s marketable securities for the periods indicated:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
            &lt;div style="margin-left:49.65pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="margin-left:54pt"&gt;
              &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-left:9pt;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:top;padding-left:9pt;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:middle;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Government bonds *&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;353,414&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;339,684&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:middle;width:76%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Municipal bonds&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,319&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,551&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:middle;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Corporate debt securities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13,234&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;21,252&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:middle;width:76%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Commercial paper&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,195&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:middle;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Certificates of deposit&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,680&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,907&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:middle;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;373,647&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;374,589&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:49pt;vertical-align:top;font-family:'Times New Roman',Times,serif;text-align:center"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;* As of December 31, 2023 and 2022, consists of $0 and $1,502 non-U.S. government bonds, respectively.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          &lt;/div&gt;

        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;
          &lt;div style="line-height:1.25"&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:49pt;vertical-align:top;font-weight:bold"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top"&gt;
                    &lt;div style="font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;
                      &lt;div style="line-height:1.25;font-weight:normal"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company classifies AFS securities within Level 2 because it uses alternative pricing sources and models utilizing market observable inputs to determine their fair value. See also note 2(w).&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          &lt;/div&gt;

            &lt;div&gt;
              &lt;div style="line-height:1.25"&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:49pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:top;width:auto"&gt;
                        &lt;div style="font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;
                          &lt;div style="line-height:1.25;font-weight:normal"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="line-height:1.25"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The following table sets forth the Company&#x2019;s financial assets as of December 31, 2023 and 2022, that are measured at fair value on a recurring basis during the period:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
              &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&#160;&lt;div style="line-height:1.25"&gt;
                  &lt;div&gt;
                    &lt;div style="margin-left:54pt"&gt;
                      &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                          &lt;tr&gt;
                            &lt;td rowspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="14" rowspan="1" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;December 31, 2023&#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;
                                &lt;div style="line-height:1.25;font-weight:bold;text-align:center"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Fair&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;
                                &lt;div style="line-height:1.25;font-weight:bold;text-align:center"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;value&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;
                              &lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="padding-bottom:2px;vertical-align:bottom;text-align:center"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                              &lt;div style="line-height:1.25;font-weight:bold;text-align:center"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Cost or&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;
                              &lt;div style="line-height:1.25;font-weight:bold;text-align:center"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;amortized&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;
                              &lt;div style="line-height:1.25;font-weight:bold;text-align:center"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;cost&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="padding-bottom:2px;vertical-align:bottom;text-align:center"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                              &lt;div style="line-height:1.25;font-weight:bold;text-align:center"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Gross&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;
                              &lt;div style="line-height:1.25;font-weight:bold;text-align:center"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;unrealized&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;
                              &lt;div style="line-height:1.25;font-weight:bold;text-align:center"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;holding loss&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="padding-bottom:2px;vertical-align:bottom;text-align:center"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                              &lt;div style="line-height:1.25;font-weight:bold;text-align:center"&gt;
                                &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Gross&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;
                                &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;unrealized&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;
                                &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;holding&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;
                                &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;gains&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;
                              &lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:middle;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                              &lt;div style="margin-left:7.1pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="text-decoration:underline"&gt;Level 2 securities:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:middle;width:52%;vertical-align:bottom"&gt;
                              &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;margin-left:27pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Government bonds&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;353,414&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;355,382&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,139&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;171&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:middle;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                              &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;margin-left:27pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Municipal bonds&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,319&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,363&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(44&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:middle;width:52%;vertical-align:bottom"&gt;
                              &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;margin-left:27pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Corporate debt securities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13,234&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13,404&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(170&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:middle;width:52%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;
                                &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;margin-left:27pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Certificates of deposit&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,680&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,680&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:top;width:52%;padding-bottom:4px;vertical-align:bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;
                                &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;373,647&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;375,829&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,353&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;171&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;

                      &lt;/table&gt;
                    &lt;/div&gt;
                    &lt;div&gt;&#160;&lt;div style="margin-left:54pt"&gt;
                        &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                            &lt;tr&gt;
                              &lt;td rowspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="14" rowspan="1" style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-weight:bold"&gt;December 31, 2022&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                              &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;
                                  &lt;div style="line-height:1.25;font-weight:bold;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&lt;span&gt;&lt;span&gt;Fair&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;div style="line-height:1.25;font-weight:bold;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&lt;span&gt;&lt;span&gt;value&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="padding-bottom:2px;vertical-align:bottom;text-align:center"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                                &lt;div style="line-height:1.25;font-weight:bold;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&lt;span&gt;&lt;span&gt;Cost or &lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;div style="line-height:1.25;font-weight:bold;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&lt;span&gt;&lt;span&gt;amortized &lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;div style="line-height:1.25;font-weight:bold;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&lt;span&gt;&lt;span&gt;cost&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="padding-bottom:2px;vertical-align:bottom;text-align:center"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                                &lt;div style="line-height:1.25;font-weight:bold;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&lt;span&gt;&lt;span&gt;Gross &lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;div style="line-height:1.25;font-weight:bold;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&lt;span&gt;&lt;span&gt;unrealized&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;div style="line-height:1.25;font-weight:bold;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&lt;span&gt;&lt;span&gt;holding loss&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="padding-bottom:2px;vertical-align:bottom;text-align:center"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                                &lt;div style="line-height:1.25;font-weight:bold;text-align:center"&gt;
                                  &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Gross&lt;br/&gt;unrealized&lt;br/&gt;holding&lt;br/&gt;gains&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                                &lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:middle;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                                &lt;div style="margin-left:7.1pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="text-decoration:underline"&gt;Level 2 securities:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:middle;width:52%;vertical-align:bottom"&gt;
                                &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;margin-left:27pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Government bonds&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;339,684&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;348,687&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(9,003&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:middle;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                                &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;margin-left:27pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Municipal bonds&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,551&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,674&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(123&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:middle;width:52%;vertical-align:bottom"&gt;
                                &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;margin-left:27pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Corporate debt securities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;21,252&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;21,850&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(612&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;14&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:middle;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                                &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;margin-left:27pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Commercial paper&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,195&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,195&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:middle;width:52%;padding-bottom:2px;vertical-align:bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;
                                  &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;margin-left:27pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Certificates of deposit&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,907&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,914&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:top;width:52%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;
                                  &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;374,589&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;384,320&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(9,745&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;14&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;

                        &lt;/table&gt;
                      &lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/div&gt;
                &lt;/div&gt;
              &lt;/div&gt;
            &lt;/div&gt;

        &lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

              &lt;tr&gt;
                &lt;td style="width:49pt;vertical-align:top;font-family:'Times New Roman',Times,serif;text-align:center"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:auto;vertical-align:top"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="width:49pt;vertical-align:top;font-family:'Times New Roman',Times,serif;text-align:center"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:auto;vertical-align:top"&gt;
                  &lt;div style="font-family:'Times New Roman',Times,serif"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As of December 31, 2023 and 2022, the Company considered, based on its evaluation, that the decreases in market value on relevant marketable securities were temporarily impaired and primarily attributable to changes in interest rates, and therefore did not result in an impairment charge in finance income (expenses), net.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
        &lt;/div&gt;&#160;&lt;div style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;/div&gt;

          &lt;div&gt;
            &lt;div style="line-height:1.25"&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:49pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:auto"&gt;
                      &lt;div style="font-family:'Times New Roman',Times,serif"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As of December 31, 2023 and 2022, the Company&#x2019;s debt securities and certificates of deposit had the following maturity dates:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
            &lt;div style="margin-left:49.65pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="margin-left:54pt"&gt;
              &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:middle;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Due within one year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;308,671&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;243,094&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:middle;width:76%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1 to 2 years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;49,259&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;124,037&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:middle;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2 to 3 years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;15,717&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7,458&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:middle;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;373,647&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;374,589&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
          &lt;/div&gt;

      &lt;/div&gt;
    </inmd:MarketableSecuritiesAndFairValueMeasurements>
    <us-gaap:MarketableSecuritiesTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240205112634685">
          &lt;div&gt;
            &lt;div style="line-height:1.25"&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:49pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:auto"&gt;
                      &lt;div style="font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;
                        &lt;div style="line-height:1.25;font-weight:normal"&gt;
                          &lt;div style="line-height:1.25"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The following table sets forth the Company&#x2019;s marketable securities for the periods indicated:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
            &lt;div style="margin-left:49.65pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="margin-left:54pt"&gt;
              &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-left:9pt;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:top;padding-left:9pt;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:middle;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Government bonds *&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;353,414&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;339,684&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:middle;width:76%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Municipal bonds&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,319&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,551&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:middle;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Corporate debt securities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13,234&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;21,252&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:middle;width:76%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Commercial paper&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,195&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:middle;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Certificates of deposit&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,680&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,907&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:middle;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;373,647&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;374,589&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:49pt;vertical-align:top;font-family:'Times New Roman',Times,serif;text-align:center"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;* As of December 31, 2023 and 2022, consists of $0 and $1,502 non-U.S. government bonds, respectively.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          &lt;/div&gt;
        </us-gaap:MarketableSecuritiesTextBlock>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="C_20231231_usgaapFinancialInstrumentAxis_usgaapUSGovernmentAgenciesDebtSecuritiesMember"
      decimals="-3"
      id="FFact_444"
      unitRef="USD">353414000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="C_20221231_usgaapFinancialInstrumentAxis_usgaapUSGovernmentAgenciesDebtSecuritiesMember"
      decimals="-3"
      id="FFact_445"
      unitRef="USD">339684000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="C_20231231_usgaapFinancialInstrumentAxis_usgaapMunicipalBondsMember"
      decimals="-3"
      id="FFact_446"
      unitRef="USD">2319000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="C_20221231_usgaapFinancialInstrumentAxis_usgaapMunicipalBondsMember"
      decimals="-3"
      id="Fxbrl_20230120021708616"
      unitRef="USD">2551000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="C_20231231_usgaapFinancialInstrumentAxis_usgaapCorporateDebtSecuritiesMember"
      decimals="-3"
      id="FFact_448"
      unitRef="USD">13234000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="C_20221231_usgaapFinancialInstrumentAxis_usgaapCorporateDebtSecuritiesMember"
      decimals="-3"
      id="FFact_449"
      unitRef="USD">21252000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="C_20231231_usgaapFinancialInstrumentAxis_usgaapCommercialPaperMember"
      decimals="-3"
      id="Fxbrl_20230120032254671"
      unitRef="USD">0</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="C_20221231_usgaapFinancialInstrumentAxis_usgaapCommercialPaperMember"
      decimals="-3"
      id="Fxbrl_20230120032335072"
      unitRef="USD">4195000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="C_20231231_usgaapFinancialInstrumentAxis_usgaapCertificatesOfDepositMember"
      decimals="-3"
      id="FFact_450"
      unitRef="USD">4680000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="C_20221231_usgaapFinancialInstrumentAxis_usgaapCertificatesOfDepositMember"
      decimals="-3"
      id="FFact_451"
      unitRef="USD">6907000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_452"
      unitRef="USD">373647000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_453"
      unitRef="USD">374589000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="C_20231231_usgaapFinancialInstrumentAxis_inmdNonUsGovernmentAgenciesDebtSecuritiesMember"
      decimals="-3"
      id="FFact_454"
      unitRef="USD">0</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="C_20221231_usgaapFinancialInstrumentAxis_inmdNonUsGovernmentAgenciesDebtSecuritiesMember"
      decimals="-3"
      id="FFact_455"
      unitRef="USD">1502000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240205112651050">
            &lt;div&gt;
              &lt;div style="line-height:1.25"&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:49pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:top;width:auto"&gt;
                        &lt;div style="font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;
                          &lt;div style="line-height:1.25;font-weight:normal"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="line-height:1.25"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The following table sets forth the Company&#x2019;s financial assets as of December 31, 2023 and 2022, that are measured at fair value on a recurring basis during the period:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
              &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&#160;&lt;div style="line-height:1.25"&gt;
                  &lt;div&gt;
                    &lt;div style="margin-left:54pt"&gt;
                      &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                          &lt;tr&gt;
                            &lt;td rowspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="14" rowspan="1" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;December 31, 2023&#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;
                                &lt;div style="line-height:1.25;font-weight:bold;text-align:center"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Fair&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;
                                &lt;div style="line-height:1.25;font-weight:bold;text-align:center"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;value&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;
                              &lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="padding-bottom:2px;vertical-align:bottom;text-align:center"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                              &lt;div style="line-height:1.25;font-weight:bold;text-align:center"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Cost or&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;
                              &lt;div style="line-height:1.25;font-weight:bold;text-align:center"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;amortized&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;
                              &lt;div style="line-height:1.25;font-weight:bold;text-align:center"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;cost&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="padding-bottom:2px;vertical-align:bottom;text-align:center"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                              &lt;div style="line-height:1.25;font-weight:bold;text-align:center"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Gross&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;
                              &lt;div style="line-height:1.25;font-weight:bold;text-align:center"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;unrealized&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;
                              &lt;div style="line-height:1.25;font-weight:bold;text-align:center"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;holding loss&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="padding-bottom:2px;vertical-align:bottom;text-align:center"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                              &lt;div style="line-height:1.25;font-weight:bold;text-align:center"&gt;
                                &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Gross&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;
                                &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;unrealized&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;
                                &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;holding&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;
                                &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;gains&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;
                              &lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:middle;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                              &lt;div style="margin-left:7.1pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="text-decoration:underline"&gt;Level 2 securities:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:middle;width:52%;vertical-align:bottom"&gt;
                              &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;margin-left:27pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Government bonds&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;353,414&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;355,382&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,139&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;171&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:middle;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                              &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;margin-left:27pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Municipal bonds&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,319&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,363&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(44&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:middle;width:52%;vertical-align:bottom"&gt;
                              &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;margin-left:27pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Corporate debt securities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13,234&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13,404&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(170&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:middle;width:52%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;
                                &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;margin-left:27pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Certificates of deposit&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,680&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,680&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:top;width:52%;padding-bottom:4px;vertical-align:bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;
                                &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;373,647&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;375,829&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,353&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;171&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;

                      &lt;/table&gt;
                    &lt;/div&gt;
                    &lt;div&gt;&#160;&lt;div style="margin-left:54pt"&gt;
                        &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                            &lt;tr&gt;
                              &lt;td rowspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="14" rowspan="1" style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-weight:bold"&gt;December 31, 2022&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                              &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;
                                  &lt;div style="line-height:1.25;font-weight:bold;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&lt;span&gt;&lt;span&gt;Fair&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;div style="line-height:1.25;font-weight:bold;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&lt;span&gt;&lt;span&gt;value&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="padding-bottom:2px;vertical-align:bottom;text-align:center"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                                &lt;div style="line-height:1.25;font-weight:bold;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&lt;span&gt;&lt;span&gt;Cost or &lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;div style="line-height:1.25;font-weight:bold;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&lt;span&gt;&lt;span&gt;amortized &lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;div style="line-height:1.25;font-weight:bold;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&lt;span&gt;&lt;span&gt;cost&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="padding-bottom:2px;vertical-align:bottom;text-align:center"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                                &lt;div style="line-height:1.25;font-weight:bold;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&lt;span&gt;&lt;span&gt;Gross &lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;div style="line-height:1.25;font-weight:bold;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&lt;span&gt;&lt;span&gt;unrealized&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;div style="line-height:1.25;font-weight:bold;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&lt;span&gt;&lt;span&gt;holding loss&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="padding-bottom:2px;vertical-align:bottom;text-align:center"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                                &lt;div style="line-height:1.25;font-weight:bold;text-align:center"&gt;
                                  &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Gross&lt;br/&gt;unrealized&lt;br/&gt;holding&lt;br/&gt;gains&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                                &lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:middle;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                                &lt;div style="margin-left:7.1pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="text-decoration:underline"&gt;Level 2 securities:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:middle;width:52%;vertical-align:bottom"&gt;
                                &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;margin-left:27pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Government bonds&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;339,684&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;348,687&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(9,003&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:middle;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                                &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;margin-left:27pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Municipal bonds&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,551&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,674&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(123&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:middle;width:52%;vertical-align:bottom"&gt;
                                &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;margin-left:27pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Corporate debt securities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;21,252&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;21,850&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(612&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;14&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:middle;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                                &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;margin-left:27pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Commercial paper&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,195&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,195&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:middle;width:52%;padding-bottom:2px;vertical-align:bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;
                                  &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;margin-left:27pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Certificates of deposit&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,907&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,914&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:top;width:52%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;
                                  &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;374,589&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;384,320&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(9,745&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;14&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;

                        &lt;/table&gt;
                      &lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/div&gt;
                &lt;/div&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          </us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_20231231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapUSGovernmentAgenciesDebtSecuritiesMember"
      decimals="-3"
      id="FFact_457"
      unitRef="USD">353414000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_20231231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapUSGovernmentAgenciesDebtSecuritiesMember"
      decimals="-3"
      id="FFact_458"
      unitRef="USD">355382000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_20231231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapUSGovernmentAgenciesDebtSecuritiesMember"
      decimals="-3"
      id="FFact_459"
      unitRef="USD">2139000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_20231231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapUSGovernmentAgenciesDebtSecuritiesMember"
      decimals="-3"
      id="FFact_460"
      unitRef="USD">171000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_20231231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapMunicipalBondsMember"
      decimals="-3"
      id="FFact_461"
      unitRef="USD">2319000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_20231231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapMunicipalBondsMember"
      decimals="-3"
      id="FFact_462"
      unitRef="USD">2363000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_20231231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapMunicipalBondsMember"
      decimals="-3"
      id="FFact_463"
      unitRef="USD">44000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_20231231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapMunicipalBondsMember"
      decimals="-3"
      id="Fxbrl_20240205143326095"
      unitRef="USD">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_20231231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapCorporateDebtSecuritiesMember"
      decimals="-3"
      id="FFact_465"
      unitRef="USD">13234000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_20231231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapCorporateDebtSecuritiesMember"
      decimals="-3"
      id="FFact_466"
      unitRef="USD">13404000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_20231231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapCorporateDebtSecuritiesMember"
      decimals="-3"
      id="FFact_467"
      unitRef="USD">170000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_20231231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapCorporateDebtSecuritiesMember"
      decimals="-3"
      id="FFact_468"
      unitRef="USD">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_20231231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapCertificatesOfDepositMember"
      decimals="-3"
      id="FFact_469"
      unitRef="USD">4680000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_20231231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapCertificatesOfDepositMember"
      decimals="-3"
      id="FFact_470"
      unitRef="USD">4680000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_20231231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapCertificatesOfDepositMember"
      decimals="-3"
      id="FFact_471"
      unitRef="USD">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_20231231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapCertificatesOfDepositMember"
      decimals="-3"
      id="FFact_472"
      unitRef="USD">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_20231231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member"
      decimals="-3"
      id="FFact_473"
      unitRef="USD">373647000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_20231231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member"
      decimals="-3"
      id="FFact_474"
      unitRef="USD">375829000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_20231231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member"
      decimals="-3"
      id="FFact_475"
      unitRef="USD">2353000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_20231231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member"
      decimals="-3"
      id="FFact_476"
      unitRef="USD">171000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_20221231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapUSGovernmentAgenciesDebtSecuritiesMember"
      decimals="-3"
      id="FFact_477"
      unitRef="USD">339684000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_20221231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapUSGovernmentAgenciesDebtSecuritiesMember"
      decimals="-3"
      id="FFact_478"
      unitRef="USD">348687000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_20221231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapUSGovernmentAgenciesDebtSecuritiesMember"
      decimals="-3"
      id="FFact_479"
      unitRef="USD">9003000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_20221231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapUSGovernmentAgenciesDebtSecuritiesMember"
      decimals="-3"
      id="FFact_480"
      unitRef="USD">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_20221231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapMunicipalBondsMember"
      decimals="-3"
      id="Fxbrl_20230120031549545"
      unitRef="USD">2551000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_20221231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapMunicipalBondsMember"
      decimals="-3"
      id="Fxbrl_20230120031616068"
      unitRef="USD">2674000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_20221231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapMunicipalBondsMember"
      decimals="-3"
      id="Fxbrl_20230120031655473"
      unitRef="USD">123000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_20221231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapMunicipalBondsMember"
      decimals="-3"
      id="Fxbrl_20230120031731450"
      unitRef="USD">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_20221231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapCorporateDebtSecuritiesMember"
      decimals="-3"
      id="FFact_481"
      unitRef="USD">21252000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_20221231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapCorporateDebtSecuritiesMember"
      decimals="-3"
      id="FFact_482"
      unitRef="USD">21850000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_20221231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapCorporateDebtSecuritiesMember"
      decimals="-3"
      id="FFact_483"
      unitRef="USD">612000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_20221231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapCorporateDebtSecuritiesMember"
      decimals="-3"
      id="FFact_484"
      unitRef="USD">14000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_20221231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapCommercialPaperMember"
      decimals="-3"
      id="Fxbrl_20230120031159247"
      unitRef="USD">4195000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_20221231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapCommercialPaperMember"
      decimals="-3"
      id="Fxbrl_20230120031250775"
      unitRef="USD">4195000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_20221231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapCommercialPaperMember"
      decimals="-3"
      id="Fxbrl_20230120031416602"
      unitRef="USD">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_20221231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapCommercialPaperMember"
      decimals="-3"
      id="Fxbrl_20230120031449159"
      unitRef="USD">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_20221231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapCertificatesOfDepositMember"
      decimals="-3"
      id="FFact_485"
      unitRef="USD">6907000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_20221231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapCertificatesOfDepositMember"
      decimals="-3"
      id="FFact_486"
      unitRef="USD">6914000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_20221231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapCertificatesOfDepositMember"
      decimals="-3"
      id="Fxbrl_20230120204142744"
      unitRef="USD">7000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_20221231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFinancialInstrumentAxis_usgaapCertificatesOfDepositMember"
      decimals="-3"
      id="FFact_488"
      unitRef="USD">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_20221231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member"
      decimals="-3"
      id="FFact_489"
      unitRef="USD">374589000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_20221231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member"
      decimals="-3"
      id="FFact_490"
      unitRef="USD">384320000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_20221231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member"
      decimals="-3"
      id="FFact_491"
      unitRef="USD">9745000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_20221231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member"
      decimals="-3"
      id="FFact_492"
      unitRef="USD">14000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240205112710072">
          &lt;div&gt;
            &lt;div style="line-height:1.25"&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:49pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:auto"&gt;
                      &lt;div style="font-family:'Times New Roman',Times,serif"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As of December 31, 2023 and 2022, the Company&#x2019;s debt securities and certificates of deposit had the following maturity dates:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
            &lt;div style="margin-left:49.65pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="margin-left:54pt"&gt;
              &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:middle;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Due within one year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;308,671&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;243,094&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:middle;width:76%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1 to 2 years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;49,259&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;124,037&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:middle;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2 to 3 years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;15,717&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7,458&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:middle;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;373,647&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;374,589&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
          &lt;/div&gt;
        </us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_494"
      unitRef="USD">308671000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_495"
      unitRef="USD">243094000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <inmd:AvailableForSaleSecuritiesDebtMaturitiesWithInOneToTwoYearsFairValue
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_496"
      unitRef="USD">49259000</inmd:AvailableForSaleSecuritiesDebtMaturitiesWithInOneToTwoYearsFairValue>
    <inmd:AvailableForSaleSecuritiesDebtMaturitiesWithInOneToTwoYearsFairValue
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_497"
      unitRef="USD">124037000</inmd:AvailableForSaleSecuritiesDebtMaturitiesWithInOneToTwoYearsFairValue>
    <inmd:AvailableForSaleSecuritiesDebtMaturitiesWithInTwoToThreeYearsFairValue
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_498"
      unitRef="USD">15717000</inmd:AvailableForSaleSecuritiesDebtMaturitiesWithInTwoToThreeYearsFairValue>
    <inmd:AvailableForSaleSecuritiesDebtMaturitiesWithInTwoToThreeYearsFairValue
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_499"
      unitRef="USD">7458000</inmd:AvailableForSaleSecuritiesDebtMaturitiesWithInTwoToThreeYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_500"
      unitRef="USD">373647000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_501"
      unitRef="USD">374589000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate>
    <us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240205111114115">
      &lt;div&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;NOTE 4 - ACCOUNTS RECEIVABLE:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

          &lt;div&gt;
            &lt;div style="line-height:1.25"&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:49pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:auto"&gt;
                      &lt;div style="font-family:'Times New Roman',Times,serif"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Accounts receivable consist of the following:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
            &lt;div style="margin-right:1.95pt;margin-left:49.65pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="margin-left:54pt"&gt;
              &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                  &lt;tr&gt;
                    &lt;td rowspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="6" rowspan="1" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td rowspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" rowspan="1" style="text-align:center;font-weight:bold;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" rowspan="1" style="vertical-align:top;text-align:center;font-weight:bold;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td colspan="1" rowspan="1" style="font-weight:bold;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" rowspan="1" style="text-align:center;font-weight:bold;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" rowspan="1" style="vertical-align:top;text-align:center;font-weight:bold;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td colspan="1" rowspan="1" style="font-weight:bold;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trade&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;46,646&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;29,859&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Notes receivable&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,640&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,429&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Less - allowance for credit losses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,254&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,318&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;46,032&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;30,970&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Less - non-current accounts receivable, net&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(3,670&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(3,973&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total current accounts receivable, net&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;42,362&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;26,997&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
          &lt;/div&gt;

      &lt;/div&gt;
    </us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240205111100218">
          &lt;div&gt;
            &lt;div style="line-height:1.25"&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:49pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:auto"&gt;
                      &lt;div style="font-family:'Times New Roman',Times,serif"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Accounts receivable consist of the following:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
            &lt;div style="margin-right:1.95pt;margin-left:49.65pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="margin-left:54pt"&gt;
              &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                  &lt;tr&gt;
                    &lt;td rowspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="6" rowspan="1" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td rowspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" rowspan="1" style="text-align:center;font-weight:bold;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" rowspan="1" style="vertical-align:top;text-align:center;font-weight:bold;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td colspan="1" rowspan="1" style="font-weight:bold;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" rowspan="1" style="text-align:center;font-weight:bold;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" rowspan="1" style="vertical-align:top;text-align:center;font-weight:bold;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td colspan="1" rowspan="1" style="font-weight:bold;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trade&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;46,646&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;29,859&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Notes receivable&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,640&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,429&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Less - allowance for credit losses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,254&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,318&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;46,032&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;30,970&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Less - non-current accounts receivable, net&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(3,670&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(3,973&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total current accounts receivable, net&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;42,362&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;26,997&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
          &lt;/div&gt;
        </us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock>
    <us-gaap:AccountsReceivableGross
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_504"
      unitRef="USD">46646000</us-gaap:AccountsReceivableGross>
    <us-gaap:AccountsReceivableGross
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_505"
      unitRef="USD">29859000</us-gaap:AccountsReceivableGross>
    <us-gaap:NotesReceivableGross
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_506"
      unitRef="USD">1640000</us-gaap:NotesReceivableGross>
    <us-gaap:NotesReceivableGross
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_507"
      unitRef="USD">2429000</us-gaap:NotesReceivableGross>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_508"
      unitRef="USD">2254000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_509"
      unitRef="USD">1318000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AccountsAndNotesReceivableNet
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_510"
      unitRef="USD">46032000</us-gaap:AccountsAndNotesReceivableNet>
    <us-gaap:AccountsAndNotesReceivableNet
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_511"
      unitRef="USD">30970000</us-gaap:AccountsAndNotesReceivableNet>
    <us-gaap:AccountsReceivableNetNoncurrent
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_512"
      unitRef="USD">3670000</us-gaap:AccountsReceivableNetNoncurrent>
    <us-gaap:AccountsReceivableNetNoncurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_513"
      unitRef="USD">3973000</us-gaap:AccountsReceivableNetNoncurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_514"
      unitRef="USD">42362000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_515"
      unitRef="USD">26997000</us-gaap:AccountsReceivableNetCurrent>
    <inmd:PrepaidExpensesAndOtherCurrentReceivablesTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240205111947187">
      &lt;div&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;NOTE 5 - PREPAID EXPENSES AND OTHER CURRENT RECEIVABLES:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

          &lt;div&gt;
            &lt;div style="line-height:1.25"&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:49pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:auto"&gt;
                      &lt;div style="font-family:'Times New Roman',Times,serif"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Prepaid expenses and other current receivables consist of the following:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="margin-left:54pt"&gt;
              &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="6" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Advances to suppliers&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11,960&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11,898&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Prepaid expenses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,041&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,928&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Government institutions&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;948&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;879&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Income tax&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;66&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;44&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;253&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;345&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total other current receivables&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;16,268&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;15,094&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
          &lt;/div&gt;

      &lt;/div&gt;
    </inmd:PrepaidExpensesAndOtherCurrentReceivablesTextBlock>
    <inmd:ScheduleOfPrepaidExpensesAndOtherCurrentRecivablesTableTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240205111933156">
          &lt;div&gt;
            &lt;div style="line-height:1.25"&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:49pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:auto"&gt;
                      &lt;div style="font-family:'Times New Roman',Times,serif"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Prepaid expenses and other current receivables consist of the following:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="margin-left:54pt"&gt;
              &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="6" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Advances to suppliers&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11,960&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11,898&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Prepaid expenses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,041&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,928&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Government institutions&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;948&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;879&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Income tax&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;66&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;44&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;253&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;345&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total other current receivables&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;16,268&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;15,094&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
          &lt;/div&gt;
        </inmd:ScheduleOfPrepaidExpensesAndOtherCurrentRecivablesTableTextBlock>
    <inmd:OtherAdvancesToSuppliersCurrent
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_518"
      unitRef="USD">11960000</inmd:OtherAdvancesToSuppliersCurrent>
    <inmd:OtherAdvancesToSuppliersCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_519"
      unitRef="USD">11898000</inmd:OtherAdvancesToSuppliersCurrent>
    <inmd:OtherPrepaidExpensesReceivablesCurrent
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_520"
      unitRef="USD">3041000</inmd:OtherPrepaidExpensesReceivablesCurrent>
    <inmd:OtherPrepaidExpensesReceivablesCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_521"
      unitRef="USD">1928000</inmd:OtherPrepaidExpensesReceivablesCurrent>
    <inmd:OtherGovernmentInstitutionsReceivablesCurrent
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_522"
      unitRef="USD">948000</inmd:OtherGovernmentInstitutionsReceivablesCurrent>
    <inmd:OtherGovernmentInstitutionsReceivablesCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_523"
      unitRef="USD">879000</inmd:OtherGovernmentInstitutionsReceivablesCurrent>
    <inmd:OtherIncomeTaxReceivablesCurrent
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_524"
      unitRef="USD">66000</inmd:OtherIncomeTaxReceivablesCurrent>
    <inmd:OtherIncomeTaxReceivablesCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_525"
      unitRef="USD">44000</inmd:OtherIncomeTaxReceivablesCurrent>
    <us-gaap:OtherReceivablesGrossCurrent
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_526"
      unitRef="USD">253000</us-gaap:OtherReceivablesGrossCurrent>
    <us-gaap:OtherReceivablesGrossCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_527"
      unitRef="USD">345000</us-gaap:OtherReceivablesGrossCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_528"
      unitRef="USD">16268000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_529"
      unitRef="USD">15094000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:InventoryDisclosureTextBlock contextRef="C_20230101to20231231" id="FFact_539">
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0px;margin-bottom:0pt"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;NOTE 6 - INVENTORIES:&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;
    &lt;div&gt;
      &lt;div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

          &lt;div&gt;
            &lt;div style="line-height:1.25"&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:49pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:auto"&gt;
                      &lt;div style="font-family:'Times New Roman',Times,serif"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="line-height:1.25"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Inventories consist of the following:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
            &lt;div style="margin-right:1.95pt;margin-left:49.65pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="margin-left:54pt"&gt;
              &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                  &lt;tr&gt;
                    &lt;td rowspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="6" rowspan="1" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td rowspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" rowspan="1" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" rowspan="1" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Raw materials&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,080&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13,686&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Finished products&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;33,015&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;26,211&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total inventories&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;45,095&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;39,897&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
          &lt;/div&gt;

      &lt;/div&gt;
    &lt;/div&gt;
  </us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240205113625734">
          &lt;div&gt;
            &lt;div style="line-height:1.25"&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:49pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:auto"&gt;
                      &lt;div style="font-family:'Times New Roman',Times,serif"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="line-height:1.25"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Inventories consist of the following:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
            &lt;div style="margin-right:1.95pt;margin-left:49.65pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="margin-left:54pt"&gt;
              &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                  &lt;tr&gt;
                    &lt;td rowspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="6" rowspan="1" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td rowspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" rowspan="1" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" rowspan="1" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Raw materials&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,080&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13,686&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Finished products&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;33,015&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;26,211&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total inventories&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;45,095&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;39,897&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
          &lt;/div&gt;
        </us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterials
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_532"
      unitRef="USD">12080000</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryRawMaterials
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_533"
      unitRef="USD">13686000</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryFinishedGoods
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_534"
      unitRef="USD">33015000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryFinishedGoods
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_535"
      unitRef="USD">26211000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryNet
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_536"
      unitRef="USD">45095000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_537"
      unitRef="USD">39897000</us-gaap:InventoryNet>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240205113706519">
      &lt;div&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;NOTE 7 - PROPERTY AND EQUIPMENT, NET:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

          &lt;div&gt;
            &lt;div style="line-height:1.25"&gt;
              &lt;div style="line-height:1.25"&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:49pt;vertical-align:top;font-family:'Times New Roman',Times,serif;text-align:center"&gt;&#160;&lt;/td&gt;
                      &lt;td style="width:auto;vertical-align:top"&gt;
                        &lt;div style="font-family:'Times New Roman',Times,serif"&gt;
                          &lt;div style="line-height:1.25"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="line-height:1.25"&gt;
                                &lt;div style="line-height:1.25"&gt;
                                  &lt;div style="line-height:1.25"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Composition of property and equipment grouped by major classifications is as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/div&gt;
                                &lt;/div&gt;
                              &lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
            &lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="margin-left:54pt"&gt;
              &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                  &lt;tr&gt;
                    &lt;td rowspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="6" rowspan="1" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td rowspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" rowspan="1" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" rowspan="1" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="margin-right:7.2pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Computers&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,334&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,191&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
                      &lt;div style="margin-right:7.2pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Office furniture and equipment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;670&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;562&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="margin-right:7.2pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Molds&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,592&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,550&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom"&gt;
                      &lt;div style="margin-right:7.2pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Leasehold improvements&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,243&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;829&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,839&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,132&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:76%;padding-bottom:2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Less: accumulated depreciation&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(3,457&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,834&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="margin-right:7.2pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total property and equipment, net&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,382&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,298&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
          &lt;/div&gt;

        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

              &lt;tr&gt;
                &lt;td style="width:49pt;vertical-align:top;font-family:'Times New Roman',Times,serif;text-align:center"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:auto;vertical-align:top"&gt;
                  &lt;div style="font-family:'Times New Roman',Times,serif"&gt;
                    &lt;div style="line-height:1.25"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="line-height:1.25"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total depreciation and amortization in respect of property and equipment were $623, $680 and $517 for the years ended December 31, 2023, 2022 and 2021, respectively.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
        &lt;/div&gt;
      &lt;/div&gt;
    </us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240205113728326">
          &lt;div&gt;
            &lt;div style="line-height:1.25"&gt;
              &lt;div style="line-height:1.25"&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:49pt;vertical-align:top;font-family:'Times New Roman',Times,serif;text-align:center"&gt;&#160;&lt;/td&gt;
                      &lt;td style="width:auto;vertical-align:top"&gt;
                        &lt;div style="font-family:'Times New Roman',Times,serif"&gt;
                          &lt;div style="line-height:1.25"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="line-height:1.25"&gt;
                                &lt;div style="line-height:1.25"&gt;
                                  &lt;div style="line-height:1.25"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Composition of property and equipment grouped by major classifications is as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/div&gt;
                                &lt;/div&gt;
                              &lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
            &lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="margin-left:54pt"&gt;
              &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                  &lt;tr&gt;
                    &lt;td rowspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="6" rowspan="1" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td rowspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" rowspan="1" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" rowspan="1" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="margin-right:7.2pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Computers&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,334&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,191&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
                      &lt;div style="margin-right:7.2pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Office furniture and equipment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;670&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;562&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="margin-right:7.2pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Molds&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,592&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,550&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom"&gt;
                      &lt;div style="margin-right:7.2pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Leasehold improvements&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,243&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;829&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,839&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,132&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:76%;padding-bottom:2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Less: accumulated depreciation&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(3,457&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,834&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="margin-right:7.2pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total property and equipment, net&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,382&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,298&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
          &lt;/div&gt;
        </us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_20231231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapComputerEquipmentMember"
      decimals="-3"
      id="FFact_540"
      unitRef="USD">1334000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapComputerEquipmentMember"
      decimals="-3"
      id="FFact_541"
      unitRef="USD">1191000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_20231231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapOfficeEquipmentMember"
      decimals="-3"
      id="FFact_542"
      unitRef="USD">670000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapOfficeEquipmentMember"
      decimals="-3"
      id="FFact_543"
      unitRef="USD">562000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_20231231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapToolsDiesAndMoldsMember"
      decimals="-3"
      id="FFact_544"
      unitRef="USD">2592000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapToolsDiesAndMoldsMember"
      decimals="-3"
      id="FFact_545"
      unitRef="USD">2550000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_20231231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdImprovementsMember"
      decimals="-3"
      id="FFact_546"
      unitRef="USD">1243000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdImprovementsMember"
      decimals="-3"
      id="FFact_547"
      unitRef="USD">829000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20240205113856622"
      unitRef="USD">5839000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20240205113909598"
      unitRef="USD">5132000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_550"
      unitRef="USD">3457000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_551"
      unitRef="USD">2834000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_552"
      unitRef="USD">2382000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_553"
      unitRef="USD">2298000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_555"
      unitRef="USD">623000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_556"
      unitRef="USD">680000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_557"
      unitRef="USD">517000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:InvestmentTextBlock contextRef="C_20230101to20231231" id="FFact_565">
    &lt;div&gt;
      &lt;div&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;
          &lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;NOTE 8 - OTHER INVESTMENTS:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;
        &lt;/div&gt;
        &lt;div style="line-height:1.25;margin-top:0pt"&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%"&gt;

              &lt;tr style="vertical-align:top"&gt;
                &lt;td style="text-align:right;vertical-align:top;width:9pt"&gt;
                  &lt;div style="margin-left:49.65pt;line-height:1.25;text-align:justify"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td style="text-align:left;vertical-align:top;width:auto"&gt;
                  &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;
                    &lt;div&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="line-height:1.25"&gt;
                                &lt;div style="line-height:1.25"&gt;
                                  &lt;div style="line-height:1.25"&gt;
                                    &lt;div style="line-height:1.25"&gt;
                                      &lt;p&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;In November 2019, the Company signed a Share Purchase and Shareholders Agreement (the &#x201c;SPA&#x201d;) with (BY) Medimor Ltd., one of the Company&#x2019;s turnkey manufacturing subcontractors (&#x201c;Medimor&#x201d;). Pursuant to the SPA, the Company has invested (in December 2019 and July 2020) an aggregate amount of $600 in consideration for 1,369,863 ordinary shares of Medimor (which reflected at the signing date a 14.78% ownership interest on an as-issued basis and 10.34% ownership interest on a fully diluted basis.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                                    &lt;/div&gt;
                                    &lt;div style="line-height:1.25"&gt;&#160;&lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;In November 2023, the Company signed an additional SPA with Medimor and invested $100 in consideration for 117,440 ordinary shares of Medimor.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                                    &lt;/div&gt;
                                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                                    &lt;div style="line-height:1.25"&gt;
                                      &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The SPAs together reflected as of December 31, 2023 a 14.78% ownership interest on an as-issued basis and 11.23% ownership interest on a fully diluted basis.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                                    &lt;/div&gt;
                                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The Company&#x2019;s investment in Medimor is measured at cost, less impairment and adjusted for subsequent observable price changes if any. As of December 31, 2023, 2022 and 2021, the Company did not recognize an impairment or adjustment on its other investments.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/div&gt;
                                &lt;/div&gt;
                              &lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
        &lt;/div&gt;
      &lt;/div&gt;
    &lt;/div&gt;
  </us-gaap:InvestmentTextBlock>
    <us-gaap:Investments
      contextRef="C_20191130_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_inmdMedimorMember_usgaapTypeOfArrangementAxis_inmdSharePurchaseAndShareholdersAgreementMember"
      decimals="-3"
      id="Fxbrl_20240208193843203"
      unitRef="USD">600000</us-gaap:Investments>
    <us-gaap:SharesIssued
      contextRef="C_20191130_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_inmdMedimorMember_usgaapTypeOfArrangementAxis_inmdSharePurchaseAndShareholdersAgreementMember"
      decimals="INF"
      id="Fxbrl_20240208193850619"
      unitRef="Shares">1369863</us-gaap:SharesIssued>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="C_20191130_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_inmdMedimorMember_usgaapTypeOfArrangementAxis_inmdSharePurchaseAndShareholdersAgreementMember"
      decimals="4"
      id="Fxbrl_20240208193856514"
      unitRef="Pure">0.1478</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="C_20191130_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_inmdMedimorMember_usgaapInvestmentTypeAxis_inmdFullyDilutedBasisMember_usgaapTypeOfArrangementAxis_inmdSharePurchaseAndShareholdersAgreementMember"
      decimals="4"
      id="Fxbrl_20240208193906181"
      unitRef="Pure">0.1034</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:Investments
      contextRef="C_20231130_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_inmdMedimorMember_usgaapTypeOfArrangementAxis_inmdSharePurchaseAndShareholdersAgreementMember"
      decimals="-3"
      id="Fxbrl_20240208193935557"
      unitRef="USD">100000</us-gaap:Investments>
    <us-gaap:SharesIssued
      contextRef="C_20231130_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_inmdMedimorMember_usgaapTypeOfArrangementAxis_inmdSharePurchaseAndShareholdersAgreementMember"
      decimals="INF"
      id="Fxbrl_20240208193943493"
      unitRef="Shares">117440</us-gaap:SharesIssued>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="C_20231231_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_inmdMedimorMember_usgaapTypeOfArrangementAxis_inmdTwoPurchaseAndShareholdersAgreementsMember"
      decimals="4"
      id="Fxbrl_20240208194001093"
      unitRef="Pure">0.1478</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="C_20231231_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_inmdMedimorMember_usgaapInvestmentTypeAxis_inmdFullyDilutedBasisMember_usgaapTypeOfArrangementAxis_inmdTwoPurchaseAndShareholdersAgreementsMember"
      decimals="4"
      id="Fxbrl_20240208194018300"
      unitRef="Pure">0.1123</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="C_20230101to20231231" id="FFact_602">
    &lt;div&gt;
      &lt;div&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;NOTE 9 - LEASES:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div&gt;
          &lt;div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%"&gt;

                  &lt;tr style="vertical-align:top"&gt;
                    &lt;td style="text-align:right;vertical-align:top;width:49pt"&gt;
                      &lt;div style="text-align:left;line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td style="text-align:left;vertical-align:top;width:auto"&gt;
                      &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;
                        &lt;div&gt;
                          &lt;div style="line-height:1.25"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="line-height:1.25"&gt;
                                &lt;div style="line-height:1.25"&gt;
                                  &lt;div style="line-height:1.25"&gt;
                                    &lt;div style="line-height:1.25"&gt;
                                      &lt;div style="line-height:1.25"&gt;
                                        &lt;div style="line-height:1.25"&gt;
                                          &lt;div&gt;
                                            &lt;div style="line-height:1.25"&gt;
                                              &lt;div style="line-height:1.25"&gt;
                                                &lt;div style="line-height:1.25"&gt;
                                                  &lt;div style="line-height:1.25"&gt;
                                                    &lt;div style="line-height:1.25"&gt;
                                                      &lt;div style="line-height:1.25"&gt;
                                                        &lt;div style="line-height:1.25"&gt;
                                                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company&#x2019;s main leasing properties are located in Israel, USA and Canada as detailed below:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                                        &lt;/div&gt;
                                                      &lt;/div&gt;
                                                    &lt;/div&gt;
                                                  &lt;/div&gt;
                                                &lt;/div&gt;
                                              &lt;/div&gt;
                                            &lt;/div&gt;
                                          &lt;/div&gt;
                                        &lt;/div&gt;
                                      &lt;/div&gt;
                                    &lt;/div&gt;
                                  &lt;/div&gt;
                                &lt;/div&gt;
                              &lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:49.65pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:18pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;a.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In May 2018, the Company signed a lease agreement for its headquarters in Israel. In January 2019, February 2020, March 2021, March 2023 and May 2023 the Company signed supplement lease agreements, further expanding its headquarters in Israel (collectively, the &#x201c;Lease Agreement&#x201d;). The Lease Agreement will expire in December 2027. The current monthly rent payment under the Lease Agreement is approximately $64.5.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div&gt;&#160;&lt;/div&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The costs under the Lease Agreement in Israel are linked to the Israeli Consumer Price Index. For purposes of ensuring the Company&#x2019;s obligation towards the lessor, the Company has provided the lessor with a bank guarantee of NIS 966 thousand (approximately $266).&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left"&gt;&#160;&lt;/p&gt;
            &lt;div&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;
              &lt;div style="line-height:1.25"&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:48.4pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="width:22.5pt;vertical-align:top;font-family:'Times New Roman',Times,serif;text-align:center"&gt;&#160;&lt;/td&gt;
                      &lt;td style="width:auto;vertical-align:top"&gt;
                        &lt;div style="font-family:'Times New Roman',Times,serif"&gt;
                          &lt;div style="line-height:1.25"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="line-height:1.25"&gt;
                                &lt;div style="line-height:1.25"&gt;
                                  &lt;div style="line-height:1.25"&gt;
                                    &lt;div style="line-height:1.25"&gt;
                                      &lt;div style="line-height:1.25"&gt;
                                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company also leases warehouse outside the company's offices. The Lease Agreement will expire in august 2027. The current monthly rent payment under the Lease Agreement is approximately $7.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company also leases vehicles for several employees in Israel for a period of three years.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                      &lt;/div&gt;
                                    &lt;/div&gt;
                                  &lt;/div&gt;
                                &lt;/div&gt;
                              &lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:48.4pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:22.5pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;b.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In August 2020, the Company&#x2019;s U.S. subsidiary, has signed a new lease agreement, for additional lease agreement of property and for its offices (&#x201c;U.S Lease&#x201d;). The U.S. Lease is for &lt;span style="-sec-ix-hidden:Fxbrl_20240205133500283"&gt;7 years and 4 months&lt;/span&gt; which began in the middle of April of 2021. The current monthly rent payment is approximately $27.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:48.4pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:22.5pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;c.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company&#x2019;s Canadian subsidiary has signed a new lease agreement in April 2022 for property and for its offices (&#x201c;Canadian Lease&#x201d;). The Canadian Lease is for 3 years which began in July 2022. The current monthly rent payment is approximately $17.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="width:48.4pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:22.5pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="width:48.4pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:22.5pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top"&gt;
                    &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;From time to time the Company also leases small properties, mainly for offices for Subsidiaries around the world which range for periods of up to 3 years.&lt;/span&gt;&lt;/p&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;
    &lt;/div&gt;
    &lt;div&gt;
      &lt;div&gt;

          &lt;div&gt;
            &lt;div style="line-height:1.25"&gt;
              &lt;div style="line-height:1.25"&gt;
                &lt;table cellpadding="0" cellspacing="0" style="width:100%"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:auto"&gt;
                        &lt;div style="font-family:'Times New Roman',Times,serif"&gt;
                          &lt;div style="line-height:1.25;margin-left:70pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The lease cost was as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
                &lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left"&gt;&#160;&lt;/p&gt;
              &lt;/div&gt;
            &lt;/div&gt;
            &lt;div style="margin-left:81pt"&gt;
              &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td style="padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="10" rowspan="1" style="padding-bottom:2px;vertical-align:bottom;border-bottom:2px solid black"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:1pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year ended&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td style="padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" rowspan="1" style="padding-bottom:2px;vertical-align:bottom;border-bottom:2px solid black"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" rowspan="1" style="padding-bottom:2px;vertical-align:bottom;border-bottom:2px solid black"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" rowspan="1" style="padding-bottom:2px;vertical-align:bottom;border-bottom:2px solid black"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:top;padding-left:9pt;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Operating lease cost&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td style="width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,348&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,628&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,297&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
          &lt;/div&gt;

        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

          &lt;div&gt;
            &lt;div style="line-height:1.25"&gt;
              &lt;div style="line-height:1.25"&gt;
                &lt;div style="line-height:1.25"&gt;
                  &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;margin-top:0pt;margin-bottom:0pt;width:auto"&gt;
                          &lt;div style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;
                            &lt;div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt"&gt;
                              &lt;div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt;margin-left:70pt"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Supplemental cash flow information related to leases was as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
              &lt;/div&gt;
            &lt;/div&gt;
            &lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left"&gt;&#160;&lt;/p&gt;
            &lt;div&gt;
              &lt;div&gt;
                &lt;div style="margin-left:81pt"&gt;
                  &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                      &lt;tr&gt;
                        &lt;td colspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="10" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:1pt"&gt;Year ended&lt;/div&gt;
                          &lt;div style="line-height:1.25"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;December 31&lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td colspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;2023&lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;2022&lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;2021&lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td colspan="1" style="vertical-align:top;padding-left:9pt;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;Operating cash flows from operating leases&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;
                            &lt;div style="line-height:1.25"&gt;2,530&lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;
                            &lt;div style="line-height:1.25"&gt;1,881&lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;
                            &lt;div style="line-height:1.25"&gt;1,328&lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/div&gt;

        &lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left"&gt;&#160;&lt;/p&gt;

          &lt;div&gt;
            &lt;div style="line-height:1.25"&gt;
              &lt;div style="line-height:1.25"&gt;
                &lt;div style="line-height:1.25"&gt;
                  &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:auto"&gt;
                          &lt;div style="font-family:'Times New Roman',Times,serif"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="line-height:1.25;margin-left:70pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Supplemental balance sheet information related to leases was as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
              &lt;/div&gt;
            &lt;/div&gt;
            &lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left"&gt;&#160;&lt;/p&gt;
            &lt;div style="margin-left:81pt"&gt;
              &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="6" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:1pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:1pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:1pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Operating Leases&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:76%;padding-bottom:2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9,698&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,073&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other current liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,404&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,453&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:76%;padding-bottom:2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Operating lease liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,613&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,509&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9,017&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,962&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted Average Remaining Lease Term&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Operating leases&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.90 years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.30 years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted Average Discount Rate&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Operating leases&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.00%-7.84&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.00%-5.80&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
          &lt;/div&gt;

        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div&gt;&lt;/div&gt;

          &lt;div&gt;
            &lt;div style="line-height:1.25"&gt;
              &lt;div style="line-height:1.25"&gt;
                &lt;div style="line-height:1.25"&gt;
                  &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:auto"&gt;
                          &lt;div style="font-family:'Times New Roman',Times,serif"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="line-height:1.25"&gt;
                                &lt;div style="line-height:1.25;margin-left:70pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As of December 31, 2023, the maturities of lease liabilities were as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
              &lt;/div&gt;
              &lt;div style="margin-left:49.65pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;/div&gt;
            &lt;div style="margin-left:81pt"&gt;
              &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                  &lt;tr&gt;
                    &lt;td rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" rowspan="1" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:1pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Operating Leases&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year Ending December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:88%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,745&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2025&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,491&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:88%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2026&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,001&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2027&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,733&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:88%;padding-bottom:2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2028 and beyond&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;902&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total lease payments&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9,872&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:88%;padding-bottom:2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Less imputed interests&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(855&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:88%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9,017&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
          &lt;/div&gt;

      &lt;/div&gt;
    &lt;/div&gt;
  </us-gaap:LesseeOperatingLeasesTextBlock>
    <inmd:LeaseExpires
      contextRef="C_20180501to20180531_usgaapTypeOfArrangementAxis_inmdLeaseAgreementMember"
      id="FFact_566">December 2027</inmd:LeaseExpires>
    <inmd:CurrentMonthlyRentPayment
      contextRef="C_20180501to20180531_usgaapTypeOfArrangementAxis_inmdLeaseAgreementMember"
      decimals="-2"
      id="FFact_567"
      unitRef="USD">64500</inmd:CurrentMonthlyRentPayment>
    <inmd:BankGuarantee
      contextRef="C_20180501to20180531_usgaapTypeOfArrangementAxis_inmdLeaseAgreementMember"
      decimals="-3"
      id="FFact_568"
      unitRef="ils">966000</inmd:BankGuarantee>
    <inmd:BankGuarantee
      contextRef="C_20180501to20180531_usgaapTypeOfArrangementAxis_inmdLeaseAgreementMember"
      decimals="-3"
      id="FFact_569"
      unitRef="USD">266000</inmd:BankGuarantee>
    <inmd:LeaseExpires
      contextRef="C_20180501to20180531_srtMortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_srtWarehouseMember_usgaapTypeOfArrangementAxis_inmdLeaseAgreementMember"
      id="Fxbrl_20230131042821333">august 2027</inmd:LeaseExpires>
    <inmd:CurrentMonthlyRentPayment
      contextRef="C_20180501to20180531_srtMortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_srtWarehouseMember_usgaapTypeOfArrangementAxis_inmdLeaseAgreementMember"
      decimals="-3"
      id="Fxbrl_20240205132710680"
      unitRef="USD">7000</inmd:CurrentMonthlyRentPayment>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="C_20180531_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapVehiclesMember_usgaapTypeOfArrangementAxis_inmdLeaseAgreementMember"
      id="Fxbrl_20240205133417664">P3Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <inmd:CurrentMonthlyRentPayment
      contextRef="C_20200801to20200831_srtMortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_srtOfficeBuildingMember_usgaapTypeOfArrangementAxis_inmdLeaseAgreementMember"
      decimals="-3"
      id="Fxbrl_20230131042856469"
      unitRef="USD">27000</inmd:CurrentMonthlyRentPayment>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="C_20220701_srtMortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_srtOfficeBuildingMember_usgaapTypeOfArrangementAxis_inmdLeaseAgreementMember"
      id="Fxbrl_20240205135622575">P3Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <inmd:CurrentMonthlyRentPayment
      contextRef="C_20220701to20220731_srtMortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_srtOfficeBuildingMember_usgaapTypeOfArrangementAxis_inmdLeaseAgreementMember"
      decimals="-3"
      id="Fxbrl_20230131044202294"
      unitRef="USD">17000</inmd:CurrentMonthlyRentPayment>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240205122007603">
          &lt;div&gt;
            &lt;div style="line-height:1.25"&gt;
              &lt;div style="line-height:1.25"&gt;
                &lt;table cellpadding="0" cellspacing="0" style="width:100%"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:auto"&gt;
                        &lt;div style="font-family:'Times New Roman',Times,serif"&gt;
                          &lt;div style="line-height:1.25;margin-left:70pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The lease cost was as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
                &lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left"&gt;&#160;&lt;/p&gt;
              &lt;/div&gt;
            &lt;/div&gt;
            &lt;div style="margin-left:81pt"&gt;
              &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td style="padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="10" rowspan="1" style="padding-bottom:2px;vertical-align:bottom;border-bottom:2px solid black"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:1pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year ended&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td style="padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" rowspan="1" style="padding-bottom:2px;vertical-align:bottom;border-bottom:2px solid black"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" rowspan="1" style="padding-bottom:2px;vertical-align:bottom;border-bottom:2px solid black"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" rowspan="1" style="padding-bottom:2px;vertical-align:bottom;border-bottom:2px solid black"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td colspan="1" style="vertical-align:top;padding-left:9pt;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Operating lease cost&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td style="width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,348&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,628&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,297&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
          &lt;/div&gt;
        </us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20240205095310852"
      unitRef="USD">2348000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_574"
      unitRef="USD">1628000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_575"
      unitRef="USD">1297000</us-gaap:OperatingLeaseCost>
    <inmd:ScheduleOfSupplementalCashFlowInformationRelatedToLeases
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240205122018185">
          &lt;div&gt;
            &lt;div style="line-height:1.25"&gt;
              &lt;div style="line-height:1.25"&gt;
                &lt;div style="line-height:1.25"&gt;
                  &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;margin-top:0pt;margin-bottom:0pt;width:auto"&gt;
                          &lt;div style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;
                            &lt;div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt"&gt;
                              &lt;div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt;margin-left:70pt"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Supplemental cash flow information related to leases was as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
              &lt;/div&gt;
            &lt;/div&gt;
            &lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left"&gt;&#160;&lt;/p&gt;
            &lt;div&gt;
              &lt;div&gt;
                &lt;div style="margin-left:81pt"&gt;
                  &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                      &lt;tr&gt;
                        &lt;td colspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="10" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:1pt"&gt;Year ended&lt;/div&gt;
                          &lt;div style="line-height:1.25"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;December 31&lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td colspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;2023&lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;2022&lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;2021&lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td colspan="1" style="vertical-align:top;padding-left:9pt;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;Operating cash flows from operating leases&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;
                            &lt;div style="line-height:1.25"&gt;2,530&lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;
                            &lt;div style="line-height:1.25"&gt;1,881&lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;
                            &lt;div style="line-height:1.25"&gt;1,328&lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/div&gt;
        </inmd:ScheduleOfSupplementalCashFlowInformationRelatedToLeases>
    <us-gaap:OperatingLeasePayments
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20240205124932194_xbrl_20240205095310852"
      unitRef="USD">2530000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20240205124932194_Fact_574"
      unitRef="USD">1881000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20240205124932194_Fact_575"
      unitRef="USD">1328000</us-gaap:OperatingLeasePayments>
    <inmd:ScheduleOfSupplementalBalanceSheetInformationRelatedToLeases
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240205122027420">
          &lt;div&gt;
            &lt;div style="line-height:1.25"&gt;
              &lt;div style="line-height:1.25"&gt;
                &lt;div style="line-height:1.25"&gt;
                  &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:auto"&gt;
                          &lt;div style="font-family:'Times New Roman',Times,serif"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="line-height:1.25;margin-left:70pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Supplemental balance sheet information related to leases was as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
              &lt;/div&gt;
            &lt;/div&gt;
            &lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left"&gt;&#160;&lt;/p&gt;
            &lt;div style="margin-left:81pt"&gt;
              &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="6" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:1pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:1pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:1pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Operating Leases&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:76%;padding-bottom:2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9,698&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,073&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other current liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,404&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,453&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:76%;padding-bottom:2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Operating lease liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,613&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,509&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9,017&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,962&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted Average Remaining Lease Term&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Operating leases&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.90 years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.30 years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted Average Discount Rate&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Operating leases&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.00%-7.84&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.00%-5.80&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
          &lt;/div&gt;
        </inmd:ScheduleOfSupplementalBalanceSheetInformationRelatedToLeases>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_580"
      unitRef="USD">9698000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_581"
      unitRef="USD">5073000</us-gaap:OperatingLeaseRightOfUseAsset>
    <inmd:OtherCurrentLeaseLiabilities
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_582"
      unitRef="USD">2404000</inmd:OtherCurrentLeaseLiabilities>
    <inmd:OtherCurrentLeaseLiabilities
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_583"
      unitRef="USD">1453000</inmd:OtherCurrentLeaseLiabilities>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_584"
      unitRef="USD">6613000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_585"
      unitRef="USD">3509000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiability
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_586"
      unitRef="USD">9017000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_587"
      unitRef="USD">4962000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="C_20231231" id="FFact_588">P2Y10M24D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="C_20221231" id="FFact_589">P4Y3M18D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="C_20231231_srtRangeAxis_srtMinimumMember"
      decimals="4"
      id="FFact_590"
      unitRef="Pure">0.02</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="C_20231231_srtRangeAxis_srtMaximumMember"
      decimals="4"
      id="FFact_591"
      unitRef="Pure">0.0784</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="C_20221231_srtRangeAxis_srtMinimumMember"
      decimals="4"
      id="Fxbrl_20230120042952079"
      unitRef="Pure">0.02</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="C_20221231_srtRangeAxis_srtMaximumMember"
      decimals="4"
      id="Fxbrl_20230120043000440"
      unitRef="Pure">0.058</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240205122038009">
          &lt;div&gt;
            &lt;div style="line-height:1.25"&gt;
              &lt;div style="line-height:1.25"&gt;
                &lt;div style="line-height:1.25"&gt;
                  &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:auto"&gt;
                          &lt;div style="font-family:'Times New Roman',Times,serif"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="line-height:1.25"&gt;
                                &lt;div style="line-height:1.25;margin-left:70pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As of December 31, 2023, the maturities of lease liabilities were as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
              &lt;/div&gt;
              &lt;div style="margin-left:49.65pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;/div&gt;
            &lt;div style="margin-left:81pt"&gt;
              &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                  &lt;tr&gt;
                    &lt;td rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" rowspan="1" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:1pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Operating Leases&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year Ending December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:88%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,745&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2025&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,491&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:88%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2026&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,001&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2027&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,733&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:88%;padding-bottom:2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2028 and beyond&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;902&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total lease payments&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9,872&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:88%;padding-bottom:2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Less imputed interests&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(855&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:88%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9,017&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
          &lt;/div&gt;
        </us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_594"
      unitRef="USD">2745000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_595"
      unitRef="USD">2491000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_596"
      unitRef="USD">2001000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20240205101509151"
      unitRef="USD">1733000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20240205101515348"
      unitRef="USD">902000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_598"
      unitRef="USD">9872000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_599"
      unitRef="USD">855000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_600"
      unitRef="USD">9017000</us-gaap:OperatingLeaseLiability>
    <us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock contextRef="C_20230101to20231231" id="FFact_618">
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;NOTE 10 -&lt;/span&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;span style="font-weight:bold"&gt;OTHER CURRENT LIABILITIES:&lt;/span&gt;&lt;/p&gt;

      &lt;div&gt;
        &lt;div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;
            &lt;div style="line-height:1.25"&gt;
              &lt;div style="line-height:1.25"&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:49pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
                      &lt;td style="width:auto;vertical-align:top"&gt;
                        &lt;div style="font-family:'Times New Roman',Times,serif"&gt;
                          &lt;div style="line-height:1.25"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="line-height:1.25"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other current liabilities consist of the following:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
            &lt;/div&gt;
            &lt;div style="margin-left:49.65pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;/div&gt;
          &lt;div style="margin-left:54pt"&gt;
            &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                &lt;tr&gt;
                  &lt;td colspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="6" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td colspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" rowspan="1" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td colspan="1" style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Employees and related expenses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;21,040&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;19,439&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td colspan="1" style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Government institutions&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,932&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,052&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td colspan="1" style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Income tax payable&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,918&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;19,241&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td colspan="1" style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Warranty reserve&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,476&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,418&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td colspan="1" style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Operating lease liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,404&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,453&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td colspan="1" style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Contractor liability&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,656&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,003&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td colspan="1" style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,821&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,374&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td colspan="1" style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total other current liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;39,247&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;51,980&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          &lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;

  </us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock>
    <us-gaap:OtherCurrentLiabilitiesTableTextBlock contextRef="C_20230101to20231231" id="FFact_617">
      &lt;div&gt;
        &lt;div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;
            &lt;div style="line-height:1.25"&gt;
              &lt;div style="line-height:1.25"&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:49pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
                      &lt;td style="width:auto;vertical-align:top"&gt;
                        &lt;div style="font-family:'Times New Roman',Times,serif"&gt;
                          &lt;div style="line-height:1.25"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="line-height:1.25"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other current liabilities consist of the following:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
            &lt;/div&gt;
            &lt;div style="margin-left:49.65pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;/div&gt;
          &lt;div style="margin-left:54pt"&gt;
            &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                &lt;tr&gt;
                  &lt;td colspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="6" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td colspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" rowspan="1" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td colspan="1" style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Employees and related expenses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;21,040&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;19,439&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td colspan="1" style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Government institutions&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,932&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,052&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td colspan="1" style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Income tax payable&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,918&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;19,241&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td colspan="1" style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Warranty reserve&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,476&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,418&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td colspan="1" style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Operating lease liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,404&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,453&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td colspan="1" style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Contractor liability&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,656&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,003&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td colspan="1" style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,821&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,374&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td colspan="1" style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total other current liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;39,247&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;51,980&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          &lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;
    </us-gaap:OtherCurrentLiabilitiesTableTextBlock>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_603"
      unitRef="USD">21040000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_604"
      unitRef="USD">19439000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <inmd:GovernmentInstitutions
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_605"
      unitRef="USD">3932000</inmd:GovernmentInstitutions>
    <inmd:GovernmentInstitutions
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_606"
      unitRef="USD">4052000</inmd:GovernmentInstitutions>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_607"
      unitRef="USD">1918000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_608"
      unitRef="USD">19241000</us-gaap:AccruedIncomeTaxesCurrent>
    <inmd:WarrantyReserveLiabilityCurrent
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_609"
      unitRef="USD">1476000</inmd:WarrantyReserveLiabilityCurrent>
    <inmd:WarrantyReserveLiabilityCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_610"
      unitRef="USD">1418000</inmd:WarrantyReserveLiabilityCurrent>
    <inmd:OtherCurrentLeaseLiabilities
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_611"
      unitRef="USD">2404000</inmd:OtherCurrentLeaseLiabilities>
    <inmd:OtherCurrentLeaseLiabilities
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_612"
      unitRef="USD">1453000</inmd:OtherCurrentLeaseLiabilities>
    <inmd:ContractorLiability
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20240205112207940_Fact_611"
      unitRef="USD">5656000</inmd:ContractorLiability>
    <inmd:ContractorLiability
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20240205112207940_Fact_612"
      unitRef="USD">4003000</inmd:ContractorLiability>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_613"
      unitRef="USD">2821000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_614"
      unitRef="USD">2374000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_615"
      unitRef="USD">39247000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_616"
      unitRef="USD">51980000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="C_20230101to20231231" id="FFact_620">
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;NOTE 11 -&lt;/span&gt;&lt;span style="padding-left:0pt"&gt;&#160;&lt;/span&gt;&lt;span style="font-weight:bold"&gt;COMMITMENTS AND CONTINGENCIES:&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt;margin-left:49.65pt"&gt;&#160;&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt;margin-left:49.65pt"&gt;&lt;span style="font-weight:bold"&gt;Subcontracting Agreements&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt;margin-left:49.65pt"&gt;&#160;&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt;margin-left:49.65pt"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, serif"&gt;The Company has an existing turnkey manufacturing agreements with three of its major subcontractors in Israel in connection with manufacturing and assembling the Company&#x2019;s products.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt;margin-left:49.65pt"&gt;&#160;&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt;margin-left:49.65pt"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, serif"&gt;The Company has agreements with two of the subcontractors which are renewed automatically every year for an additional one-year period, unless either the Company or the turnkey manufacturer gives written notice three months prior to the expiration of the term of its decision not to renew the agreement. Additionally, the Company or the turnkey manufacturer has the ability to terminate the contract at any time and for any reason with a prior written notice of four months.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt;margin-left:49.65pt"&gt;&#160;&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt;margin-left:49.65pt"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, serif"&gt;In addition, &lt;/span&gt;in October 2019, the Company entered into a turnkey manufacturing agreement with another of its major subcontractors in Israel, Medimor (See also note 8). The agreement is for three years and renewed automatically every year afterwards for an additional one-year period, unless either the Company or Medimor gives written notice three months prior to the expiration of the term of its decision not to renew the agreement. Additionally, the Company or Medimor has the ability to terminate the agreement at any time and for any reason with a prior written notice of six months.&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt;margin-left:49.65pt"&gt;&#160;&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt;margin-left:49.65pt"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, serif"&gt;According to the agreements above, the Company does not have a minimum order obligation, but the Company provides the subcontractors a six-month rolling forecast with the projected demand for products. In case of termination of the agreement with each subcontractor, the Company has to compensate that subcontractor for non-returnable inventory, materials in orders that cannot be cancelled and finished products inventory. As of December 31, 2023, the subcontractors&#x2019; finished goods inventory, raw materials and open orders amounted to approximately $41,561. In order to secure these obligations, the Company gave its subcontractors advances in the amount of $9,914.&lt;/span&gt;&lt;/p&gt;
  </us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:SignificantSupplyCommitmentRemainingMinimumAmountCommitted
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20240205134443827"
      unitRef="USD">41561000</us-gaap:SignificantSupplyCommitmentRemainingMinimumAmountCommitted>
    <us-gaap:PaymentsForAdvanceToAffiliate
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20230120012921515"
      unitRef="USD">9914000</us-gaap:PaymentsForAdvanceToAffiliate>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20220609132952308">
    &lt;div&gt;
      &lt;div&gt;
        &lt;div&gt;
          &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;NOTE 12 - SHAREHOLDERS&#x2019; EQUITY:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;
      &lt;div&gt;
        &lt;div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

              &lt;tr&gt;
                &lt;td style="width:49pt"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:18pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;a.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                  &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Share Capital:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

              &lt;tr&gt;
                &lt;td style="width:49pt"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:18pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                  &lt;div style="text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Ordinary shares&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;div&gt;&#160;&lt;/div&gt;
                  &lt;div&gt;
                    &lt;div style="line-height:1.25;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Each holder of the Company&#x2019;s ordinary shares is entitled to one vote. The holders of ordinary shares are also entitled to receive dividends whenever funds are legally available, when and if declared by the Company&#x2019;s Board of Directors. Since inception, the Company has not declared any dividends.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="line-height:1.25;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In September 2020, the Company approved a share repurchase program of up to two million ordinary shares, to be purchased out of the Company&#x2019;s cash reserve and to be paid solely from the Company&#x2019;s IPO proceeds. In February 2022, the Company approved that the share repurchase program could also be funded from the proceeds of exercised options. In March 2022, the Company approved an additional repurchase program of up to one million ordinary shares, to be purchased out of its cash reserve and to be paid from the Company&#x2019;s remaining IPO proceeds and from the proceeds of exercised options.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="line-height:1.25;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;During 2021, the Company purchased 693,734 shares in the amount of $35.4 million. In addition, during 2022, the Company purchased 1,077,213 shares in the amount of $42.6 million. During 2023 the company did not purchase any shares. As of December 31, 2023, the Company purchased 2,557,829 shares in the amount of $95.2 million under these repurchase programs.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="line-height:1.25;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On September 30, 2021, the Company executed a 1-for-2 share split (&#x201c;2021 Share Split&#x201d;) of the Company&#x2019;s shares by way of an issuance of bonus shares. Upon the effectiveness of the 2021 Share Split, (i) one bonus share was issued for each outstanding share, (ii) the number of ordinary shares into&#160;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;which each outstanding option to purchase ordinary shares is exercisable was adjusted through proportional increase, (iii) the exercise price of each exercisable share under such outstanding options to purchase ordinary shares was adjusted through proportional decrease, (iv) the number of outstanding RSUs was adjusted through proportional increase, and (v) the number of shares reserved under the Company&#x2019;s options plans was proportionally adjusted to accommodate the adjustment to the number of exercisable options under the Company&#x2019;s respective option plans.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="line-height:1.25;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Unless otherwise indicated, and except for authorized capital, all of the share numbers, number of RSUs, number of options to purchase ordinary shares, net income per share amounts, share prices and option exercise prices in these financial statements have been adjusted, on a retroactive basis, to reflect the 2021 Share Split.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

              &lt;tr&gt;
                &lt;td style="width:49pt"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:top;width:18pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                  &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Share-based compensation&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;div&gt;&#160;&lt;/div&gt;
                  &lt;div&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On January 30, 2008, the Company&#x2019;s Board of Directors adopted two share option plans as follows (collectively, the &#x201c;2008 Plans&#x201d;):&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

              &lt;tr&gt;
                &lt;td style="width:67pt"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:top;width:22pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;a)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:top;width:auto"&gt;
                  &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2008 Israeli Option Plan (&#x201c;2008 Israeli Plan&#x201d;) allowing the Company to grant ordinary shares and options to purchase ordinary shares to Israeli employees, officers, directors, consultants and service providers. Each option under the 2008 Israeli Plan grants the right to exercise such option into one ordinary share of the Company.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

              &lt;tr&gt;
                &lt;td style="width:67pt"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:top;width:21pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;b)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:top;width:auto"&gt;
                  &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2008 ROW Option Plan (&#x201c;2008 ROW Plan&#x201d;) allowing the Company to grant ordinary shares and options to purchase ordinary shares to non-Israeli employees, officers, directors, consultants and service providers. Each option under the 2008 ROW Plan grants the right to exercise such option into one ordinary share of the Company.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="clear:both;margin-top:0pt;margin-bottom:0pt"&gt;
            &lt;div style="width:100%"&gt;
              &lt;div&gt;&lt;/div&gt;
            &lt;/div&gt;
          &lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:67pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                    &lt;div&gt;
                      &lt;div style="line-height:1.25;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In June 2018, the Company&#x2019;s Board of Directors adopted a new incentive plan (&#x201c;2018 Incentive Plan&#x201d;), allowing the Company to grant ordinary shares, options to purchase ordinary shares, restricted shares and restricted share unit (&#x201c;RSUs&#x201d;) (together, &#x201c;Awards&#x201d;) to Israeli and other non-U.S. employees, officers, directors, consultants and service providers of the Company and its Subsidiaries. The 2018 Incentive Plan also includes as an appendix a sub-plan allowing the Company to grant awards to U.S. employees, officers, consultants and service providers of the Company and its Subsidiaries. Each option award under 2018 Incentive Plan grants the right to exercise such option into one ordinary share of the Company. The Company&#x2019;s subsidiary in U.S. may recognize under U.S. corporate tax laws, a tax benefit for RSU and options exercised for U.S. employees and U.S. service providers for tax purposes.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;div style="line-height:1.25;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The grant of awards to Israeli employees, officers and directors under the 2008 Israeli Plan and the 2018 Incentive Plan is subject to the terms stipulated by Sections 102 and 102A of the Israeli Income Tax Ordinance. Each award grant is subject to the track chosen by the Company, either Section 102 or Section 102A of the Israeli Income Tax Ordinance, and pursuant to the terms thereof, the Company is not allowed to claim as an expense for tax purposes the amounts credited to employees as benefits, including amounts recorded as salary benefits in the Company&#x2019;s accounts, in respect of options granted to employees under the 2008 Israeli Plan, with the exception of the work-income benefit component, if any, determined on grant date. For consultants and service providers, grants under the 2008 Israeli Plan and the 2018 Incentive Plan are subject to Section 3(i) of the Israeli Income Tax Ordinance.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;div style="line-height:1.25;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Upon the adoption of the 2018 Incentive Plan, the then-current pool of awards available for future grants under the 2008 Plans was canceled and returned to the Company&#x2019;s authorized and un-issued share capital. In addition, any shares returning to the free pool of options under the 2008 Plans, due to options expirations or otherwise, are automatically returning to the Company&#x2019;s authorized and un-issued share capital.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;div style="line-height:1.25;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Upon adoption of the 2018 Incentive Plan, the Board and the shareholders resolved to approve an evergreen mechanism with respect to the 2018 Incentive Plan, under which the number of reserved, authorized and unissued ordinary shares of the Company available for issuance of awards pursuant to&#160;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;the 2018 Incentive Plan shall automatically increase on an annual basis, by such number of ordinary shares as follows: on the first business day of each calendar year beginning in 2019, the number of awards equal to the lesser of (i) 800,000 ordinary shares, (ii) three percent of the number of shares outstanding as of such date or (iii) a lesser number of ordinary shares as shall be determined by the Company&#x2019;s board of directors. &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="line-height:1.25;text-align:left"&gt;&#160;&lt;/div&gt;
                      &lt;div style="line-height:1.25;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As&lt;/span&gt;&lt;/span&gt;&#160;of December 31, 2023, the total awards under 2018 Incentive Plan that have been authorized to be issued as ordinary shares were 8,378,000 of which&#160;1,902,431 awards were available for grant under the 2018 Incentive Plan.&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          &lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="clear:both;margin-top:0pt;margin-bottom:0pt"&gt;
            &lt;div style="width:100%"&gt;
              &lt;div&gt;&lt;/div&gt;
            &lt;/div&gt;
          &lt;/div&gt;
        &lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;
          &lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="color:#000000;font-family:'Times New Roman',Times,serif;font-size:10pt;text-align:left;width:100%"&gt;

                &lt;tr&gt;
                  &lt;td style="width:58.5pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:18pt;vertical-align:top;font-family:'Times New Roman',Times,serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As of December 31, 2023, 1,902,431 awards were available for grant under the 2018 Incentive Plan.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="text-decoration:underline"&gt;Share Options&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&#160;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          &lt;/div&gt;

            &lt;div&gt;
              &lt;div style="line-height:1.25"&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                        &lt;div&gt;
                          &lt;div style="line-height:1.25"&gt;
                            &lt;div style="line-height:1.25;margin-left:75.5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The following tables is a summary of stock option activity for the year ended on December 31, 2023&lt;span style="font-weight:bold"&gt;&#160;&lt;/span&gt;:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="margin-left:81pt"&gt;
                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="6" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year&#160;ended&#160;December&#160;31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="6" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Number&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Average&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;of&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exercise&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Options&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Price*&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Outstanding at beginning of year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,553,640&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5.30&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Changes during the year:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="margin-left:8.8pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Granted&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
                        &lt;div style="margin-left:8.8pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exercised&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(915,145&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5.92&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="margin-left:8.8pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Forfeited&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;
                        &lt;div style="margin-left:8.8pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Expired&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Outstanding at end of year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,638,495&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.96&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exercisable at end of year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,638,495&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.96&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="width:76%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td colspan="8" style="vertical-align:top;vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;* In U.S. dollars per Ordinary Share&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
            &lt;/div&gt;

          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:58.5pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:18pt;vertical-align:top;font-family:'Times New Roman',Times,serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As of December 31, 2023, the weighted-average remaining contractual life of exercisable options were 1.90 years. The total intrinsic value of options exercised during 2023, 2022 and 2021 were approximately $24,819, $10,549 and $277,978, respectively.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          &lt;/div&gt;

            &lt;div&gt;
              &lt;div style="line-height:1.25"&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                        &lt;div&gt;
                          &lt;div style="line-height:1.25"&gt;
                            &lt;div style="line-height:1.25;margin-left:75.5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The following tables summarize information concerning outstanding and exercisable options as of December 31, 2023:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;&#160;&lt;div style="margin-left:81pt"&gt;
                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                    &lt;tr&gt;
                      &lt;td colspan="10" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25;text-align:center"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Options outstanding and exercisable&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td colspan="2" rowspan="5" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exercise&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Prices *&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" rowspan="5" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Number of&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;options&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Outstanding and exercisable&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;at end of&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" rowspan="5" style="vertical-align:bottom;padding-bottom:2px;text-align:center"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" rowspan="5" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;average&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;remaining&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;contractual&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;life&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" rowspan="5" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.28&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;361,993&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.42&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.29&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;203,438&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.42&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.16&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;149,948&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.71&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.75&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;211,173&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.02&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5.11&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;70,756&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.26&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7.00&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;41,000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.61&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9.85&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;565,129&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.18&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12.16&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;28,558&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.35&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;21.62&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,500&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.86&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:58.5pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="width:18pt;vertical-align:top;font-family:'Times New Roman',Times,serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                        &lt;div&gt;
                          &lt;div style="line-height:1.25"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;* In U.S. dollars per Ordinary Share.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
            &lt;/div&gt;

          &lt;div style="line-height:1.25"&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25;margin-left:77pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The aggregate intrinsic value of total exercisable options as of December 31, 2023 is $28,315.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          &lt;/div&gt;
          &lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left"&gt;&#160;&lt;/p&gt;
          &lt;div&gt;&lt;/div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

              &lt;tr&gt;
                &lt;td style="width:58.5pt"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:18pt;vertical-align:top;font-family:'Times New Roman',Times,serif"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                  &lt;div&gt;
                    &lt;div style="line-height:1.25"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="text-decoration:underline"&gt;Restricted Share Units&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;

            &lt;div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                      &lt;div&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;
                            &lt;div style="line-height:1.25;margin-left:76pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The following tables summarize information concerning RSUs as of December 31, 2023&lt;span style="font-weight:bold"&gt;&#160;&lt;/span&gt;:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;
              &lt;div style="margin-left:81pt"&gt;
                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="6" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year&#160;ended&#160;December&#160;31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="6" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Number&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Average&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;of&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Grant&#160;Date&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;RSUs&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fair Value&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Outstanding at beginning of year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;804,575&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;45.74&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Changes during the year:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="margin-left:8.8pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Granted&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;706,560&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;34.44&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
                        &lt;div style="margin-left:8.8pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Vested&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(522,326&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;43.33&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="margin-left:8.8pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Forfeited&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(52,760&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;37.21&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Outstanding at end of year *&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;936,049&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;39.04&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:58.5pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="width:18pt;vertical-align:top;font-family:'Times New Roman',Times,serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                        &lt;div&gt;
                          &lt;div style="line-height:1.25"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;* As of December 31, 2023, 275,249 RSUs were vested and were settled by issuance of respective shares at the beginning of January 2024.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
            &lt;/div&gt;

          &lt;div style="margin-left:113.4pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%"&gt;

                &lt;tr style="vertical-align:top"&gt;
                  &lt;td style="text-align:right;vertical-align:top;width:58pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:top;width:18pt"&gt;
                    &lt;div style="text-align:left;line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="text-align:left;vertical-align:top;width:auto"&gt;
                    &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;
                      &lt;div&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="line-height:1.25"&gt;
                                &lt;div style="line-height:1.25"&gt;
                                  &lt;div style="line-height:1.25"&gt;
                                    &lt;div style="line-height:1.25"&gt;
                                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Each RSU represents the right to receive one ordinary share of the Company upon the vesting thereof. The fair value of an RSU is identical to the value of the underlying share at the close of the last trading day prior to the day of grant. The weighted average fair value of each RSU granted in 2023 was 34.44, and in 2022 was 49.35 and in 2021 35.44 based on the Company&#x2019;s share price at closing of trading day prior to the day of grant.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The total fair value of RSUs granted during the year ended December 31, 2023, 2022 and 2021, was $24,334, $30,817, and $19,279 respectively.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As of December 31, 2023, the Company had 660,800 unvested RSUs. The total unrecognized compensation cost of employee RSUs as of December 31, 2023 is $12,517, which is expected to be recognized over a weighted average period of 1.10 years.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The total vesting-date value of equity classified RSUs vested during, 2023 is $6,122.&#160;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;The following table illustrates the effect of share-based compensation on the consolidated statements of income:&lt;/span&gt;&lt;/div&gt;
                                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                                    &lt;/div&gt;
                                  &lt;/div&gt;
                                &lt;/div&gt;
                              &lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          &lt;/div&gt;

            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;
              &lt;div style="margin-left:76pt"&gt;
                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="10" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year ended December 31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cost of sales&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,046&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,917&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,108&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-12.6pt;margin-left:12.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Research and development expenses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,652&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,166&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,554&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-12.6pt;margin-left:12.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Selling and marketing expenses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;17,167&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;17,302&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8,274&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-12.6pt;margin-left:12.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;General and administrative expenses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,735&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,067&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,026&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;23,600&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;24,452&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11,962&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
            &lt;/div&gt;

          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="clear:both;margin-top:0pt;margin-bottom:0pt"&gt;
            &lt;div style="width:100%"&gt;
              &lt;div&gt;&lt;/div&gt;
            &lt;/div&gt;
          &lt;/div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

              &lt;tr&gt;
                &lt;td style="width:49pt"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:top;font-weight:bold;width:18pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;b.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                  &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Non-Controlling Interests:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;div style="font-weight:bold"&gt;&#160;&lt;/div&gt;
                  &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:normal"&gt;On April 23, 2021, the Company, Dilazar Limited (&#x201c;Dilazar&#x201d;), Wigmore and Invasix UK (the UK subsidiary) entered into a share exchange agreement (the &#x201c;UK Exchange Agreement&#x201d;) whereby, Dilazar (which owned 49% of the Invasix UK&#x2019;s shares immediately prior to the UK Exchange Agreement, which shares were previously transferred to Dilazar from its wholly-owned subsidiary Wigmore) sold to the Company all of its outstanding share capital in Invasix UK and Wigmore sold to the Company all of its rights pursuant to the Founders Memorandum of Understanding, dated March 4, 2014, by and between Wigmore and the Company, in exchange for the issuance at closing to Dilazar by the Company in a private placement of 457,912 of the Company&#x2019;s ordinary shares, par value NIS 0.01. Upon closing, in May 2021, 457,912 of the Company&#x2019;s ordinary shares were issued to Dilazar from the Company&#x2019;s treasury shares.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
        &lt;/div&gt;
      &lt;/div&gt;
    &lt;/div&gt;
  </us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="C_20200901to20200930_usgaapSubsidiarySaleOfStockAxis_usgaapIPOMember"
      decimals="INF"
      id="Fxbrl_20230210152949131"
      unitRef="Shares">2</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="C_20210101to20211231"
      decimals="INF"
      id="Fxbrl_20230120042241251"
      unitRef="Shares">693734</us-gaap:StockRepurchasedDuringPeriodShares>
    <inmd:StockRepurchasedDuringPeriodValueOne
      contextRef="C_20210101to20211231"
      decimals="-4"
      id="Fxbrl_20230120042257792"
      unitRef="USD">35400000</inmd:StockRepurchasedDuringPeriodValueOne>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="C_20220101to20221231"
      decimals="INF"
      id="Fxbrl_20230120042143068"
      unitRef="Shares">1077213</us-gaap:StockRepurchasedDuringPeriodShares>
    <inmd:StockRepurchasedDuringPeriodValueOne
      contextRef="C_20220101to20221231"
      decimals="-4"
      id="Fxbrl_20230120042202495"
      unitRef="USD">42600000</inmd:StockRepurchasedDuringPeriodValueOne>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="C_20230101to20231231_usgaapPlanNameAxis_inmdShareRepurchaseProgramMember"
      decimals="INF"
      id="Fxbrl_20230210121053657"
      unitRef="Shares">2557829</us-gaap:StockRepurchasedDuringPeriodShares>
    <inmd:StockRepurchasedDuringPeriodValueOne
      contextRef="C_20230101to20231231_usgaapPlanNameAxis_inmdShareRepurchaseProgramMember"
      decimals="-4"
      id="Fxbrl_20230210121101407"
      unitRef="USD">95200000</inmd:StockRepurchasedDuringPeriodValueOne>
    <us-gaap:StockholdersEquityNoteStockSplit
      contextRef="C_20230101to20231231"
      id="Fxbrl_20230131051015427">1-for-2 share split</us-gaap:StockholdersEquityNoteStockSplit>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_20230101to20231231_usgaapPlanNameAxis_inmdTwoThousandsEighteenIncentivePlanMember"
      decimals="INF"
      id="Fxbrl_20230131051259236"
      unitRef="Shares">800000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="C_20231231_usgaapPlanNameAxis_inmdTwoThousandsEighteenIncentivePlanMember"
      decimals="INF"
      id="Fxbrl_20240208201751065"
      unitRef="Shares">8378000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="C_20231231_usgaapPlanNameAxis_inmdTwoThousandsEighteenIncentivePlanMember"
      decimals="INF"
      id="FFact_642"
      unitRef="Shares">1902431</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240205105026367">
            &lt;div&gt;
              &lt;div style="line-height:1.25"&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                        &lt;div&gt;
                          &lt;div style="line-height:1.25"&gt;
                            &lt;div style="line-height:1.25;margin-left:75.5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The following tables is a summary of stock option activity for the year ended on December 31, 2023&lt;span style="font-weight:bold"&gt;&#160;&lt;/span&gt;:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="margin-left:81pt"&gt;
                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="6" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year&#160;ended&#160;December&#160;31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="6" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Number&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Average&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;of&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exercise&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Options&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Price*&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Outstanding at beginning of year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,553,640&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5.30&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Changes during the year:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="margin-left:8.8pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Granted&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
                        &lt;div style="margin-left:8.8pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exercised&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(915,145&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5.92&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="margin-left:8.8pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Forfeited&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;
                        &lt;div style="margin-left:8.8pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Expired&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Outstanding at end of year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,638,495&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.96&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exercisable at end of year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,638,495&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.96&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="width:76%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td colspan="8" style="vertical-align:top;vertical-align:bottom"&gt;
                        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;* In U.S. dollars per Ordinary Share&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          </us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_20221231"
      decimals="INF"
      id="FFact_695"
      unitRef="Shares">2553640</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_20221231"
      decimals="INF"
      id="FFact_696"
      unitRef="USD_Per_Share">5.3</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="C_20230101to20231231"
      decimals="INF"
      id="Fxbrl_20230120101724042"
      unitRef="Shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="C_20230101to20231231"
      decimals="INF"
      id="Fxbrl_20230120101707941"
      unitRef="USD_Per_Share">0</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_20230101to20231231"
      decimals="INF"
      id="FFact_707"
      unitRef="Shares">915145</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="C_20230101to20231231"
      decimals="INF"
      id="FFact_708"
      unitRef="USD_Per_Share">5.92</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="C_20230101to20231231"
      decimals="INF"
      id="FFact_711"
      unitRef="Shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="C_20230101to20231231"
      decimals="INF"
      id="FFact_712"
      unitRef="USD_Per_Share">0</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
      contextRef="C_20230101to20231231"
      decimals="INF"
      id="Fxbrl_20230120062156531"
      unitRef="Shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="C_20230101to20231231"
      decimals="INF"
      id="Fxbrl_20230120062219955"
      unitRef="USD_Per_Share">0</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_20231231"
      decimals="INF"
      id="FFact_719"
      unitRef="Shares">1638495</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_20231231"
      decimals="INF"
      id="FFact_720"
      unitRef="USD_Per_Share">4.96</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="C_20231231"
      decimals="INF"
      id="FFact_723"
      unitRef="Shares">1638495</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="C_20231231"
      decimals="INF"
      id="FFact_724"
      unitRef="USD_Per_Share">4.96</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="C_20230101to20231231_srtTitleOfIndividualAxis_inmdEmployeesMember_usgaapPlanNameAxis_inmdTwoThousandsEighteenIncentivePlanMember"
      id="Fxbrl_20230120053845922">P1Y10M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="C_20230101to20231231_srtTitleOfIndividualAxis_inmdEmployeesMember_usgaapPlanNameAxis_inmdTwoThousandsEighteenIncentivePlanMember"
      decimals="-3"
      id="Fxbrl_20230120053852098"
      unitRef="USD">24819000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="C_20220101to20221231_srtTitleOfIndividualAxis_inmdEmployeesMember_usgaapPlanNameAxis_inmdTwoThousandsEighteenIncentivePlanMember"
      decimals="-3"
      id="Fxbrl_20230120053858497"
      unitRef="USD">10549000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="C_20210101to20211231_srtTitleOfIndividualAxis_inmdEmployeesMember_usgaapPlanNameAxis_inmdTwoThousandsEighteenIncentivePlanMember"
      decimals="-3"
      id="Fxbrl_20230120053906154"
      unitRef="USD">277978000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240205105125046">
            &lt;div&gt;
              &lt;div style="line-height:1.25"&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                        &lt;div&gt;
                          &lt;div style="line-height:1.25"&gt;
                            &lt;div style="line-height:1.25;margin-left:75.5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The following tables summarize information concerning outstanding and exercisable options as of December 31, 2023:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;&#160;&lt;div style="margin-left:81pt"&gt;
                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                    &lt;tr&gt;
                      &lt;td colspan="10" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25;text-align:center"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Options outstanding and exercisable&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td colspan="2" rowspan="5" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exercise&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Prices *&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" rowspan="5" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Number of&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;options&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Outstanding and exercisable&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;at end of&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" rowspan="5" style="vertical-align:bottom;padding-bottom:2px;text-align:center"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" rowspan="5" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center"&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;average&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;remaining&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;contractual&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;life&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" rowspan="5" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.28&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;361,993&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.42&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.29&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;203,438&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.42&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.16&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;149,948&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.71&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.75&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;211,173&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.02&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5.11&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;70,756&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.26&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7.00&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;41,000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.61&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9.85&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;565,129&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.18&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12.16&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;28,558&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.35&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;21.62&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,500&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.86&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:58.5pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="width:18pt;vertical-align:top;font-family:'Times New Roman',Times,serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                        &lt;div&gt;
                          &lt;div style="line-height:1.25"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;* In U.S. dollars per Ordinary Share.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          </us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock>
    <inmd:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice
      contextRef="C_20230101to20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeOneMember"
      decimals="INF"
      id="FFact_760"
      unitRef="USD_Per_Share">0.28</inmd:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="C_20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeOneMember"
      decimals="INF"
      id="FFact_761"
      unitRef="Shares">361993</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="C_20230101to20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeOneMember"
      id="FFact_762">P0Y5M1D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <inmd:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice
      contextRef="C_20230101to20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeTwoMember"
      decimals="INF"
      id="FFact_765"
      unitRef="USD_Per_Share">0.29</inmd:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="C_20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeTwoMember"
      decimals="INF"
      id="FFact_766"
      unitRef="Shares">203438</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="C_20230101to20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeTwoMember"
      id="FFact_767">P0Y5M1D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <inmd:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice
      contextRef="C_20230101to20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeThreeMember"
      decimals="INF"
      id="FFact_770"
      unitRef="USD_Per_Share">3.16</inmd:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="C_20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeThreeMember"
      decimals="INF"
      id="FFact_771"
      unitRef="Shares">149948</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="C_20230101to20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeThreeMember"
      id="FFact_772">P1Y8M15D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <inmd:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice
      contextRef="C_20230101to20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeFourMember"
      decimals="INF"
      id="FFact_775"
      unitRef="USD_Per_Share">3.75</inmd:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="C_20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeFourMember"
      decimals="INF"
      id="FFact_776"
      unitRef="Shares">211173</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="C_20230101to20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeFourMember"
      id="FFact_777">P2Y7D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <inmd:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice
      contextRef="C_20230101to20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeFiveMember"
      decimals="INF"
      id="FFact_780"
      unitRef="USD_Per_Share">5.11</inmd:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="C_20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeFiveMember"
      decimals="INF"
      id="FFact_781"
      unitRef="Shares">70756</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="C_20230101to20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeFiveMember"
      id="FFact_782">P2Y3M3D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <inmd:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice
      contextRef="C_20230101to20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeSixMember"
      decimals="INF"
      id="FFact_785"
      unitRef="USD_Per_Share">7</inmd:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="C_20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeSixMember"
      decimals="INF"
      id="FFact_786"
      unitRef="Shares">41000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="C_20230101to20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeSixMember"
      id="FFact_787">P2Y7M9D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <inmd:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice
      contextRef="C_20230101to20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeSevenMember"
      decimals="INF"
      id="FFact_790"
      unitRef="USD_Per_Share">9.85</inmd:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="C_20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeSevenMember"
      decimals="INF"
      id="FFact_791"
      unitRef="Shares">565129</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="C_20230101to20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeSevenMember"
      id="FFact_792">P3Y2M4D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <inmd:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice
      contextRef="C_20230101to20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeEightMember"
      decimals="INF"
      id="FFact_795"
      unitRef="USD_Per_Share">12.16</inmd:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="C_20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeEightMember"
      decimals="INF"
      id="FFact_796"
      unitRef="Shares">28558</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="C_20230101to20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeEightMember"
      id="FFact_797">P3Y4M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <inmd:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice
      contextRef="C_20230101to20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeNineMember"
      decimals="INF"
      id="FFact_800"
      unitRef="USD_Per_Share">21.62</inmd:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="C_20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeNineMember"
      decimals="INF"
      id="FFact_801"
      unitRef="Shares">6500</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="C_20230101to20231231_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_inmdExercisePriceRangeNineMember"
      id="FFact_802">P3Y10M9D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="C_20231231_usgaapPlanNameAxis_inmdTwoThousandsEighteenIncentivePlanMember"
      decimals="-3"
      id="FFact_806"
      unitRef="USD">28315000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="C_20230101to20231231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      id="Fxbrl_20240205105227621">
            &lt;div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                      &lt;div&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;
                            &lt;div style="line-height:1.25;margin-left:76pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The following tables summarize information concerning RSUs as of December 31, 2023&lt;span style="font-weight:bold"&gt;&#160;&lt;/span&gt;:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;
              &lt;div style="margin-left:81pt"&gt;
                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="6" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year&#160;ended&#160;December&#160;31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="6" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Number&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Average&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;of&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Grant&#160;Date&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;RSUs&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fair Value&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Outstanding at beginning of year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;804,575&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;45.74&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Changes during the year:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="margin-left:8.8pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Granted&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;706,560&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;34.44&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
                        &lt;div style="margin-left:8.8pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Vested&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(522,326&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;43.33&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="margin-left:8.8pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Forfeited&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(52,760&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;37.21&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Outstanding at end of year *&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;936,049&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;39.04&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:58.5pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="width:18pt;vertical-align:top;font-family:'Times New Roman',Times,serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                        &lt;div&gt;
                          &lt;div style="line-height:1.25"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;* As of December 31, 2023, 275,249 RSUs were vested and were settled by issuance of respective shares at the beginning of January 2024.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          </us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="C_20221231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="INF"
      id="Fxbrl_20230120064100124"
      unitRef="Shares">804575</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="C_20221231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="INF"
      id="Fxbrl_20230120064106675"
      unitRef="USD_Per_Share">45.74</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="C_20230101to20231231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="INF"
      id="Fxbrl_20230120063737867"
      unitRef="Shares">706560</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_20230101to20231231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="2"
      id="Fxbrl_20230120063858688"
      unitRef="USD_Per_Share">34.44</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="C_20230101to20231231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="INF"
      id="Fxbrl_20230120063912503"
      unitRef="Shares">522326</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <inmd:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="C_20230101to20231231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="2"
      id="Fxbrl_20230120064001573"
      unitRef="USD_Per_Share">43.33</inmd:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="C_20230101to20231231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="INF"
      id="Fxbrl_20230120063751848"
      unitRef="Shares">52760</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="C_20230101to20231231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="INF"
      id="Fxbrl_20230120063958765"
      unitRef="USD_Per_Share">37.21</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="C_20231231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="INF"
      id="Fxbrl_20230120063922997"
      unitRef="Shares">936049</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="C_20231231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="INF"
      id="Fxbrl_20230120063944773"
      unitRef="USD_Per_Share">39.04</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <inmd:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonVestedVested
      contextRef="C_20231231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="INF"
      id="FFact_815"
      unitRef="Shares">275249</inmd:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonVestedVested>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue
      contextRef="C_20230101to20231231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="INF"
      id="Fxbrl_20230120050330070"
      unitRef="USD_Per_Share">34.44</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue
      contextRef="C_20220101to20221231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="INF"
      id="Fxbrl_20230120050336934"
      unitRef="USD_Per_Share">49.35</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue
      contextRef="C_20210101to20211231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="INF"
      id="Fxbrl_20230120050358608"
      unitRef="USD_Per_Share">35.44</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue>
    <inmd:FairValueOfRestrictedOptionsGranted
      contextRef="C_20230101to20231231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="INF"
      id="Fxbrl_20230210121250399"
      unitRef="Shares">24334</inmd:FairValueOfRestrictedOptionsGranted>
    <inmd:FairValueOfRestrictedOptionsGranted
      contextRef="C_20220101to20221231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="INF"
      id="Fxbrl_20230210121257313"
      unitRef="Shares">30817</inmd:FairValueOfRestrictedOptionsGranted>
    <inmd:FairValueOfRestrictedOptionsGranted
      contextRef="C_20210101to20211231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="INF"
      id="Fxbrl_20240205101856695"
      unitRef="Shares">19279</inmd:FairValueOfRestrictedOptionsGranted>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="C_20231231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="INF"
      id="Fxbrl_20230120050220206"
      unitRef="Shares">660800</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="C_20231231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="-3"
      id="Fxbrl_20230120050228579"
      unitRef="USD">12517000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="C_20230101to20231231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      id="Fxbrl_20230120050234748">P1Y1M6D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="C_20230101to20231231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="-3"
      id="Fxbrl_20240205102630753"
      unitRef="USD">6122000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240205105323519">
            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;
              &lt;div style="margin-left:76pt"&gt;
                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="10" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year ended December 31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cost of sales&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,046&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,917&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,108&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-12.6pt;margin-left:12.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Research and development expenses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,652&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,166&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,554&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-12.6pt;margin-left:12.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Selling and marketing expenses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;17,167&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;17,302&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8,274&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-12.6pt;margin-left:12.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;General and administrative expenses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,735&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,067&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,026&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;23,600&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;24,452&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11,962&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          </us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_20230101to20231231_usgaapIncomeStatementLocationAxis_usgaapCostOfSalesMember"
      decimals="-3"
      id="FFact_825"
      unitRef="USD">2046000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_20220101to20221231_usgaapIncomeStatementLocationAxis_usgaapCostOfSalesMember"
      decimals="-3"
      id="FFact_826"
      unitRef="USD">1917000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_20210101to20211231_usgaapIncomeStatementLocationAxis_usgaapCostOfSalesMember"
      decimals="-3"
      id="FFact_827"
      unitRef="USD">1108000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_20230101to20231231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember"
      decimals="-3"
      id="FFact_828"
      unitRef="USD">2652000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_20220101to20221231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember"
      decimals="-3"
      id="FFact_829"
      unitRef="USD">3166000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_20210101to20211231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember"
      decimals="-3"
      id="FFact_830"
      unitRef="USD">1554000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_20230101to20231231_usgaapIncomeStatementLocationAxis_usgaapSellingAndMarketingExpenseMember"
      decimals="-3"
      id="FFact_831"
      unitRef="USD">17167000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_20220101to20221231_usgaapIncomeStatementLocationAxis_usgaapSellingAndMarketingExpenseMember"
      decimals="-3"
      id="FFact_832"
      unitRef="USD">17302000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_20210101to20211231_usgaapIncomeStatementLocationAxis_usgaapSellingAndMarketingExpenseMember"
      decimals="-3"
      id="FFact_833"
      unitRef="USD">8274000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_20230101to20231231_usgaapIncomeStatementLocationAxis_usgaapGeneralAndAdministrativeExpenseMember"
      decimals="-3"
      id="FFact_834"
      unitRef="USD">1735000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_20220101to20221231_usgaapIncomeStatementLocationAxis_usgaapGeneralAndAdministrativeExpenseMember"
      decimals="-3"
      id="FFact_835"
      unitRef="USD">2067000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_20210101to20211231_usgaapIncomeStatementLocationAxis_usgaapGeneralAndAdministrativeExpenseMember"
      decimals="-3"
      id="FFact_836"
      unitRef="USD">1026000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_837"
      unitRef="USD">23600000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_838"
      unitRef="USD">24452000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_839"
      unitRef="USD">11962000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="C_20210423_srtConsolidatedEntitiesAxis_srtSubsidiariesMember_usgaapBusinessAcquisitionAxis_inmdDilazarLimitedMember"
      decimals="2"
      id="Fxbrl_20230131055505729"
      unitRef="Pure">0.49</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:SharesIssued
      contextRef="C_20210423_srtConsolidatedEntitiesAxis_srtSubsidiariesMember"
      decimals="INF"
      id="Fxbrl_20230131055523443"
      unitRef="Shares">457912</us-gaap:SharesIssued>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_20210523"
      decimals="2"
      id="Fxbrl_20230131054917619"
      unitRef="ILS_per_Share">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:SharesIssued
      contextRef="C_20210423_srtConsolidatedEntitiesAxis_srtSubsidiariesMember"
      decimals="INF"
      id="Fxbrl_20230131055634764"
      unitRef="Shares">457912</us-gaap:SharesIssued>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240205110851898">
      &lt;div&gt;
        &lt;div&gt;
          &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;NOTE 13 - INCOME TAXES:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25;font-weight:bold"&gt;&#160;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:49pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:top;font-weight:bold;width:18pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;a.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;InMode Ltd.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company is taxed according to Israeli tax laws:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          &lt;/div&gt;
        &lt;/div&gt;
        &lt;div&gt;&#160;&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

              &lt;tr&gt;
                &lt;td style="width:67pt"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:top;width:21pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:top;width:auto"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Measurement of results for tax purposes&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company as a &#x201c;foreign-investment company&#x201d; measures its results for tax purposes in dollar based on Income Tax Regulations (Bookkeeping Principles of Foreign Invested Companies and of Certain Partnerships and the Determination of Their Taxable Income), 1986.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;These consolidated financial statements are presented in U.S. dollars. The changes in the exchange rate of the dollar, both on an annual and a cumulative basis, cause a difference between taxable income and income reflected in these consolidated financial statements. ASC 740-10-25 prohibits the recognition of deferred tax liabilities or assets that arise from differences between the financial reporting and tax bases of assets and liabilities that are re-measured from the local currency into dollars using historical exchange rates, and that result from changes in exchange rates or indexing for tax purposes. Consequently, the above-mentioned differences were not reflected in the computation of deferred tax assets and liabilities.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;&#160;&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

              &lt;tr&gt;
                &lt;td style="width:67pt"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:top;width:21pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:top;width:auto"&gt;
                  &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Basis of taxation&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

              &lt;tr&gt;
                &lt;td style="width:67pt"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:top;font-weight:bold;width:21pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;a)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:top;width:auto"&gt;
                  &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Incentives Applicable until 2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;div style="font-weight:bold"&gt;&#160;&lt;/div&gt;
                  &lt;div style="font-weight:bold"&gt;
                    &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Under the Encouragement of Capital Investments Law, including Amendment No. 60 thereof as published in April 2005, by virtue of the &#x201c;Approved Enterprise&#x201d; or &#x201c;Benefited Enterprise&#x201d; status, the Israeli Company was tax exempt from 2012 to 2020 for income derived from the Benefited Enterprise. See also note 13a(2)(b).&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

              &lt;tr&gt;
                &lt;td style="width:67pt"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:top;font-weight:bold;width:21pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;b)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:top;width:auto"&gt;
                  &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Incentives Applicable starting 2021 - The New Technological Enterprise and Preferred Enterprise Incentives Regime &#x2013; Amendment 73 to the Investment Law&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;div style="font-weight:bold"&gt;&#160;&lt;/div&gt;
                  &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:normal"&gt;On June 14, 2017, the Encouragement of Capital Investments Regulations (Preferred Technology Income and Capital Profits for a Technological Enterprise), 2017 (the &#x201c;Regulations&#x201d;) were published, which adopted Action 5 under the base erosion and profit shifting (&#x201c;BEPS&#x201d;) regulations. The Regulations describe, inter alia, the mechanism used to determine the calculation of the benefits under the PTE (Preferred technological enterprise) or PE (Preferred enterprise) and under the SPTE (Special Preferred Technology Enterprise) regime and determine certain requirements relating to documentation of intellectual property for the purpose of the PTE or PE. According to these provisions, a company that complies with the terms under the PTE or PE&lt;/span&gt; regime may be entitled to certain tax benefits with respect to income generated during the company&#x2019;s regular course of business and derived from the preferred intangible asset (as determined in the Investments Law) and income attributed to production activity (different tax rate), Excluding income derived from intangible assets used for marketing.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;div style="font-weight:bold"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
        &lt;/div&gt;
        &lt;div&gt;&lt;/div&gt;
        &lt;div&gt;
          &lt;div style="line-height:1.25"&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:67pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:top;font-weight:bold;width:21pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:top;width:auto"&gt;
                    &lt;div style="font-weight:bold"&gt;
                      &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In the event that intangible assets used for marketing purposes generate over 10% of the PTE&#x2019;s or PE&#x2019;s income, the relevant portion, calculated using a transfer pricing study, would be subject to regular corporate income tax. If such income does not exceed 10%, the PTE or PE will not be required to exclude the marketing income from the PTE&#x2019;s or PE&#x2019;s total income. The Regulations set a presumption of direct production expenses plus 10% with respect to income related to production, which can be countered by the results of a supporting transfer pricing study. Tax rates applicable to such production income expenses will be similar to the tax rates under the Preferred Enterprise regime, to the extent such income would be considered as eligible. In order to calculate the preferred income, the PTE and PE is required to take into account the income and the research and development expenses that are attributed to each single preferred intangible asset.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="line-height:1.25;font-weight:normal"&gt;&#160;&lt;/div&gt;
                      &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The company reviews every year whether it meets the conditions of the PTE or PE. The difference for the company is immaterial since it located in development area A.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="line-height:1.25;font-weight:normal"&gt;&#160;&lt;/div&gt;
                      &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Under the Regulations the Company&#x2019;s tax rate is expected to be approximately 7.5%.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="line-height:1.25;font-weight:normal"&gt;&#160;&lt;/div&gt;
                      &lt;div style="line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Amendment 74 to the Investment Law&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="line-height:1.25;font-weight:normal"&gt;&#160;&lt;/div&gt;
                      &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Pursuant to the amendment to the Investments Law which became effective on November 15, 2021, a company that elects by November 15, 2022 to pay a reduced corporate tax rate as set forth in that amendment (rather than the regular corporate tax rate applicable to Approved Enterprise income) with respect to undistributed exempt income accumulated by the company until December 31, 2020 will be entitled to distribute a dividend from such income or to be used for any other reason found by the company, without being required to pay additional corporate tax.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="line-height:1.25;font-weight:normal"&gt;&#160;&lt;/div&gt;
                      &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company elected to take advantage of the amendment, and during November 2022 has paid NIS 42.5 million ($12.0 million) as a one-time payment, and as a result NIS 591 million (approximately $165.7 million) of the Company&#x2019;s undistributed exempt income for years 2012 until 2020 are entitled to be distributed as dividend or to be used for any other reason found by the Company without being required to pay additional corporate tax. As a result, the Company is required to invest NIS 32 million (approximately $9 million) in its industrial enterprises in Israel over a five year period. Such investment may be in the form of the acquisition of industrial assets (excluding real estate assets), investment in R&amp;amp;D in Israel, or payroll payments to new employees to be hired by the enterprise.&lt;sup style="vertical-align:text-top;line-height:1;font-size:smaller"&gt;&#160;&lt;/sup&gt;All the amount that was required to invest was invested in 2022.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          &lt;/div&gt;&#160;&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

              &lt;tr&gt;
                &lt;td style="width:67pt"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:top;width:21pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:top;width:auto"&gt;
                  &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Corporate tax rate in Israel&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;div&gt;&#160;&lt;/div&gt;
                  &lt;div&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The income of Israeli companies, other than preferred income, is taxed in accordance with Israeli tax laws at the regular corporate tax rates. The corporate tax rate is 23% for 2018 and thereafter. Capital gain is subject to capital gain tax according to the corporate tax rate in the year the assets are sold.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:49pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:top;font-weight:bold;width:18pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;b.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                    &lt;div style="font-weight:bold"&gt;
                      &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Subsidiaries outside of Israel&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                    &lt;div style="font-weight:bold"&gt;&#160;&lt;/div&gt;
                    &lt;div style="font-weight:bold"&gt;
                      &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Subsidiaries that are incorporated outside of Israel are assessed for taxes under the tax laws in their countries of residence.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="line-height:1.25;font-weight:normal"&gt;&#160;&lt;/div&gt;
                      &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The corporate tax rates of Subsidiaries outside of Israel for the year ended on December 31, 2023 is between 21% to 26.5%.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          &lt;/div&gt;&#160;&lt;div&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;
            &lt;div style="line-height:1.25"&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:49pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;font-weight:bold;width:18pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                      &lt;div style="font-weight:bold"&gt;
                        &lt;div style="font-weight:bold"&gt;
                          &lt;div style="line-height:1.25"&gt;
                            &lt;div style="line-height:1.25;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:normal"&gt;In March 2020, the Coronavirus Aid, Relief, and Economic Security Act (&#x201c;CARES Act&#x201d;) was enacted in the US, which provides among others, tax relief measures for businesses including a five-year net operating loss (&#x201c;NOL&#x201d;) carry back. As a result, the Company recognized in its consolidated financial statements a receivable tax asset in the amount of $2,894, under current other receivables. During 2022, the Company fully received the tax refund as part of the CARES Act.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;div style="line-height:1.25;text-align:left"&gt;&#160;&lt;/div&gt;
                          &lt;/div&gt;
                          &lt;div style="line-height:1.25;font-weight:normal;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As of December 31, 2023, the Company&#x2019;s subsidiary in U.S has an accumulated tax loss carryforward of approximately $217 million derived mainly from exercises of options by employees which provided the Company tax deductions in excess of the actual compensation expenses (recognized in loss), under the Tax Cuts and Jobs Act of 2017 (&#x201c;TCJA&#x201d;).&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;div style="line-height:1.25;font-weight:normal;text-align:left"&gt;&#160;&lt;/div&gt;
                          &lt;div style="line-height:1.25;font-weight:normal;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Under U.S. tax laws, subject to certain limitations, carryforward tax losses originating in tax years beginning after January 1, 2018, have no expiration date, but they are limited to 80% of the company's&lt;span style="font-weight:normal"&gt; taxable income in any given tax year. However, the 80% limitation was temporarily removed by the CARES Act, for tax years beginning before January 1, 2021. A full valuation allowance was created against the Company&#x2019;s subsidiary in the U.S against the deferred tax assets. Management currently believes that it is more likely than not that the deferred taxes generated in U.S will not be realized in the foreseeable future.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="width:49pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;font-weight:bold;width:18pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
          &lt;/div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

              &lt;tr&gt;
                &lt;td style="width:49.65pt"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:18pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;c.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="width:auto;vertical-align:top"&gt;
                  &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Deferred income tax assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;div style="font-weight:bold"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;

            &lt;div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:49pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:18pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:auto"&gt;
                      &lt;div style="font-weight:bold"&gt;
                        &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Deferred income tax assets reflect the net tax effects of loss and credit carryforwards and temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The components of the Company&#x2019;s net deferred tax assets (liabilities) at December 31, 2023 and 2022 were as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;div style="margin-left:67.5pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="margin-left:72pt"&gt;
                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="6" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                      &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                        &lt;div style="margin-left:0.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Deferred tax assets in respect of:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                      &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                      &lt;td style="width:76%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                        &lt;div style="text-indent:9pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Subsidiaries carryforward losses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;58,075&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;60,229&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                      &lt;td style="width:76%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
                        &lt;div style="text-indent:9pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other temporary differences&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,112&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,369&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                      &lt;td style="width:76%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                        &lt;div style="text-indent:9pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Share-based compensation&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,194&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,073&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                      &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(255, 255, 255)"&gt;
                        &lt;div style="line-height:1.25;margin-left:9pt"&gt;&lt;span style="line-height:1.25;text-indent:9pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Deferred&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt; tax asset in respect to other comprehensive loss&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;502&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,238&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                      &lt;td style="width:76%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                        &lt;div style="text-indent:-12.15pt;margin-left:21.25pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total deferred tax assets before valuation allowance&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;65,883&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;69,909&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                      &lt;td style="width:76%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
                        &lt;div style="text-indent:9pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Valuation allowance&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(64,377&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(66,815&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                      &lt;td style="width:76%;padding-bottom:4px;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total deferred tax assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,506&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,094&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
            &lt;/div&gt;

          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:49.65pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:18pt;vertical-align:top;font-weight:bold"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Deferred taxes are computed using the tax rates expected to be in effect when those differences reverse.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company records net deferred tax assets to the extent it believes these assets will more likely than not be realized in the foreseeable future. As of each reporting date, management considers new evidence, both positive and negative, that could impact management&#x2019;s view with regard to the future realization of deferred tax assets for each jurisdiction.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          &lt;/div&gt;&#160;&lt;div&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

              &lt;tr&gt;
                &lt;td style="width:49.65pt"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:18pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;d.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="width:auto;vertical-align:top"&gt;
                  &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Reconciliation of theoretical tax expense to actual tax expense&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;div style="font-weight:bold"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;

            &lt;div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:49pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:18pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:auto"&gt;
                      &lt;div style="font-weight:bold"&gt;
                        &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Following is a reconciliation of the theoretical provision for income tax, assuming all income is taxed at the statutory corporate tax rate applicable to Israeli corporations, and the actual tax on income:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="margin-left:72pt"&gt;
                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                    &lt;tr&gt;
                      &lt;td colspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="10" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year ended December 31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td colspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td colspan="1" style="vertical-align:top;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Income before taxes on income&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;217,267&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;201,466&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;168,002&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td colspan="1" style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-13.55pt;margin-left:13.55pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;Theoretical tax expenses at the statutory rate of InMode&#160;Ltd.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;23&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;23&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;23&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td colspan="1" style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;49,971&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;46,337&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;38,640&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td colspan="1" style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-13.55pt;margin-left:13.55pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Increase (decrease) in taxes on income due to:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td colspan="1" style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-indent:0.75pt;margin-left:13.55pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Benefits to the Benefited Enterprise&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(31,739&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(29,429&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(37,478&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td colspan="1" style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-7.05pt;margin-left:21.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Different effective tax rates applicable to the Subsidiaries&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,956&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,453&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,033&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td colspan="1" style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="margin-left:13.55pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Valuation allowance&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;126&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;130&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;40&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td colspan="1" style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
                        &lt;div style="margin-left:13.55pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Uncertain tax positions&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,096&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;303&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,921&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td colspan="1" style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-9.4pt;margin-left:22.95pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Non-deductible expenses and other permanent differences, mainly share based compensation expenses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,850&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,842&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,838&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td colspan="1" style="vertical-align:top;padding-left:9pt;width:64%;vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-9.4pt;margin-left:22.95pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Amendment to the Investments Law payment - see also note 13a(2)(b)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,017&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td colspan="1" style="vertical-align:top;padding-left:9pt;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="margin-left:13.55pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Settlements with the Israeli tax authority net of decrease of related uncertain tax&#160;provision&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10,199&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td colspan="1" style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;19,348&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;39,946&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,928&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
            &lt;/div&gt;

          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

              &lt;tr&gt;
                &lt;td style="width:49pt"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:top;font-weight:bold;width:18pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;e.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:top;width:auto"&gt;
                  &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Tax assessments&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;div style="font-weight:bold"&gt;&#160;&lt;/div&gt;
                  &lt;div style="font-weight:bold"&gt;
                    &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In February 2022, the Israeli Company settled the 2017-2020 income tax assessment with the Israeli tax authority, paying $1.3 million. also see Note 13a(2)(b).&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25;font-weight:normal"&gt;&#160;&lt;/div&gt;
                    &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In December 2022 the Company reached an agreement with the Israeli Tax Authority under which the Company paid on January 2023 NIS 50.2 million (approximately $14.3 million).&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25;font-weight:normal"&gt;&#160;&lt;/div&gt;
                    &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As of December 31, 2023, tax assessments of the Israeli Company through tax year 2021 are considered final. In addition, all tax assessments of one of the Company&#x2019;s subsidiaries in Israel through tax year 2018 are considered final. Another Israeli subsidiary was established in 2022 and therefore does not have any tax year that considered final.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25;font-weight:normal"&gt;&#160;&lt;/div&gt;
                    &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As of December 31, 2023, all tax assessments on the Company&#x2019;s subsidiary in the United States, through tax year 2019, are considered final.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The &lt;/span&gt;&lt;/span&gt;other Subsidiaries' open tax years range from 2018-2023.&lt;/div&gt;
                  &lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
        &lt;/div&gt;&#160;&lt;div&gt;&lt;/div&gt;
        &lt;div&gt;

            &lt;div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:49.65pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:18pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;f.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:auto;vertical-align:top"&gt;
                      &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Income before income taxes is composed of the following:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="width:49.65pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:18pt;vertical-align:top;font-weight:bold"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:auto;vertical-align:top"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;div style="margin-left:72pt"&gt;
                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="10" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year ended December 31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;InMode Ltd. and Israeli subsidiaries&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;211,137&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;196,354&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;163,370&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Subsidiaries outside of Israel&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,130&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,112&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,632&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;217,267&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;201,466&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;168,002&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
            &lt;/div&gt;

          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

            &lt;div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:49.65pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:18pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;g.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:auto;vertical-align:top"&gt;
                      &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Tax expenses (tax benefit):&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;div style="margin-left:72pt"&gt;
                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="10" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year ended December 31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Current:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
                        &lt;div style="margin-left:8.55pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Israel&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;17,633&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;38,248&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,829&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="margin-left:8.55pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Subsidiaries&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,864&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,614&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(131&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;19,497&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;39,862&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,698&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Deferred:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
                        &lt;div style="margin-left:8.55pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Israel&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(149&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;84&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(770&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="margin-left:8.55pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Subsidiaries&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(149&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;84&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(770&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total taxes on income&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;19,348&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;39,946&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,928&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
            &lt;/div&gt;

          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

              &lt;tr&gt;
                &lt;td style="width:49.65pt"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:18pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;h.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="width:auto;vertical-align:top"&gt;
                  &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Uncertain tax positions:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;div style="font-weight:bold"&gt;&#160;&lt;/div&gt;
                  &lt;div style="font-weight:bold"&gt;
                    &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;ASC No. 740, Income Taxes, requires significant judgment in determining what constitutes an individual tax position as well as assessing the outcome of each tax position. Changes in judgment as to recognition or measurement of tax positions can materially affect the estimate of the effective tax rate and consequently, affect the operating results of the Company. &lt;/span&gt;&lt;/span&gt;&lt;br/&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:normal"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;

            &lt;div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:49pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:18pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:auto"&gt;
                      &lt;div style="font-weight:bold"&gt;
                        &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The following table summarizes the activity of the Company&#x2019;s unrecognized tax benefits:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:49pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:18pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:auto"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;div style="margin-left:72pt"&gt;
                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year&#160;ended&#160;December&#160;31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:middle;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="margin-left:16.85pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance at January 1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;303&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,831&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:middle;width:76%;vertical-align:bottom"&gt;
                        &lt;div style="margin-left:16.85pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Decrease in uncertain tax positions for the previous years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4,831&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:middle;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="margin-left:16.85pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Increase in uncertain tax positions for the current year, net&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,096&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;303&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:middle;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;
                        &lt;div style="margin-left:16.85pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance at December 31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,399&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;303&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
            &lt;/div&gt;

          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:49.65pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:18pt;vertical-align:top;font-weight:bold"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company does not expect uncertain tax positions to change significantly over the next 12 months.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          &lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;
    </us-gaap:IncomeTaxDisclosureTextBlock>
    <inmd:CorporateTax
      contextRef="C_20230101to20231231_usgaapIncomeTaxAuthorityAxis_inmdRegulationsMember"
      decimals="3"
      id="Fxbrl_20230131113531818"
      unitRef="Pure">0.075</inmd:CorporateTax>
    <inmd:OneTimePayment
      contextRef="C_20211115"
      decimals="-5"
      id="Fxbrl_20230131113833491"
      unitRef="ils">42500000</inmd:OneTimePayment>
    <inmd:OneTimePayment
      contextRef="C_20211115"
      decimals="-5"
      id="Fxbrl_20230131113847356"
      unitRef="USD">12000000</inmd:OneTimePayment>
    <inmd:UndistributedExemptIncome
      contextRef="C_20211115"
      decimals="-6"
      id="Fxbrl_20230131113902097"
      unitRef="ils">591000000</inmd:UndistributedExemptIncome>
    <inmd:UndistributedExemptIncome
      contextRef="C_20211115"
      decimals="-5"
      id="Fxbrl_20230131113913325"
      unitRef="USD">165700000</inmd:UndistributedExemptIncome>
    <inmd:OneTimePayment
      contextRef="C_20211115_srtCumulativeEffectPeriodOfAdoptionAxis_inmdAmendmentAdvantageExemptionMember"
      decimals="-6"
      id="Fxbrl_20230131113931115"
      unitRef="ils">32000000</inmd:OneTimePayment>
    <inmd:OneTimePayment
      contextRef="C_20211115_srtCumulativeEffectPeriodOfAdoptionAxis_inmdAmendmentAdvantageExemptionMember"
      decimals="-6"
      id="Fxbrl_20230131113943020"
      unitRef="USD">9000000</inmd:OneTimePayment>
    <inmd:CorporateTax
      contextRef="C_20230101to20231231_srtRangeAxis_srtMinimumMember_usgaapIncomeTaxAuthorityNameAxis_inmdSubsidiariesOutsideIsraelMember"
      decimals="2"
      id="Fxbrl_20240205171331220"
      unitRef="Pure">0.21</inmd:CorporateTax>
    <inmd:CorporateTax
      contextRef="C_20230101to20231231_srtRangeAxis_srtMaximumMember_usgaapIncomeTaxAuthorityNameAxis_inmdSubsidiariesOutsideIsraelMember"
      decimals="3"
      id="Fxbrl_20240205171337783"
      unitRef="Pure">0.265</inmd:CorporateTax>
    <us-gaap:IncomeTaxesReceivable
      contextRef="C_20200331"
      decimals="-3"
      id="FFact_884"
      unitRef="USD">2894000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:OperatingLossCarryforwards
      contextRef="C_20231231"
      decimals="-6"
      id="FFact_885"
      unitRef="USD">217000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240205113145487">
            &lt;div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:49pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:18pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:auto"&gt;
                      &lt;div style="font-weight:bold"&gt;
                        &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Deferred income tax assets reflect the net tax effects of loss and credit carryforwards and temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The components of the Company&#x2019;s net deferred tax assets (liabilities) at December 31, 2023 and 2022 were as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;div style="margin-left:67.5pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="margin-left:72pt"&gt;
                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="6" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                      &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                        &lt;div style="margin-left:0.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Deferred tax assets in respect of:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                      &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                      &lt;td style="width:76%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                        &lt;div style="text-indent:9pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Subsidiaries carryforward losses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;58,075&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;60,229&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                      &lt;td style="width:76%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
                        &lt;div style="text-indent:9pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other temporary differences&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,112&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,369&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                      &lt;td style="width:76%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                        &lt;div style="text-indent:9pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Share-based compensation&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,194&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,073&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                      &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(255, 255, 255)"&gt;
                        &lt;div style="line-height:1.25;margin-left:9pt"&gt;&lt;span style="line-height:1.25;text-indent:9pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Deferred&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt; tax asset in respect to other comprehensive loss&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;502&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,238&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                      &lt;td style="width:76%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                        &lt;div style="text-indent:-12.15pt;margin-left:21.25pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total deferred tax assets before valuation allowance&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;65,883&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;69,909&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                      &lt;td style="width:76%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
                        &lt;div style="text-indent:9pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Valuation allowance&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(64,377&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(66,815&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                      &lt;td style="width:76%;padding-bottom:4px;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total deferred tax assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,506&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,094&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          </us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_886"
      unitRef="USD">58075000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_887"
      unitRef="USD">60229000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_888"
      unitRef="USD">3112000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_889"
      unitRef="USD">2369000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_890"
      unitRef="USD">4194000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_891"
      unitRef="USD">5073000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsOtherComprehensiveLoss
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20230120111952311_Fact_890"
      unitRef="USD">502000</us-gaap:DeferredTaxAssetsOtherComprehensiveLoss>
    <us-gaap:DeferredTaxAssetsOtherComprehensiveLoss
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20230120111952311_Fact_891"
      unitRef="USD">2238000</us-gaap:DeferredTaxAssetsOtherComprehensiveLoss>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20230120102325108_Fact_898"
      unitRef="USD">65883000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20230120102325108_Fact_899"
      unitRef="USD">69909000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_896"
      unitRef="USD">64377000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_897"
      unitRef="USD">66815000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_898"
      unitRef="USD">1506000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_899"
      unitRef="USD">3094000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240205113210208">
            &lt;div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:49pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:18pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:auto"&gt;
                      &lt;div style="font-weight:bold"&gt;
                        &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Following is a reconciliation of the theoretical provision for income tax, assuming all income is taxed at the statutory corporate tax rate applicable to Israeli corporations, and the actual tax on income:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="margin-left:72pt"&gt;
                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                    &lt;tr&gt;
                      &lt;td colspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="10" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year ended December 31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td colspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td colspan="1" style="vertical-align:top;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Income before taxes on income&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;217,267&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;201,466&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;168,002&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td colspan="1" style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-13.55pt;margin-left:13.55pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;Theoretical tax expenses at the statutory rate of InMode&#160;Ltd.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;23&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;23&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;23&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td colspan="1" style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;49,971&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;46,337&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;38,640&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td colspan="1" style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-13.55pt;margin-left:13.55pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Increase (decrease) in taxes on income due to:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td colspan="1" style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-indent:0.75pt;margin-left:13.55pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Benefits to the Benefited Enterprise&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(31,739&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(29,429&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(37,478&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td colspan="1" style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-7.05pt;margin-left:21.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Different effective tax rates applicable to the Subsidiaries&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,956&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,453&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,033&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td colspan="1" style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="margin-left:13.55pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Valuation allowance&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;126&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;130&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;40&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td colspan="1" style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
                        &lt;div style="margin-left:13.55pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Uncertain tax positions&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,096&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;303&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,921&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td colspan="1" style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-9.4pt;margin-left:22.95pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Non-deductible expenses and other permanent differences, mainly share based compensation expenses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,850&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,842&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,838&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td colspan="1" style="vertical-align:top;padding-left:9pt;width:64%;vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-9.4pt;margin-left:22.95pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Amendment to the Investments Law payment - see also note 13a(2)(b)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,017&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td colspan="1" style="vertical-align:top;padding-left:9pt;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="margin-left:13.55pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Settlements with the Israeli tax authority net of decrease of related uncertain tax&#160;provision&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10,199&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td colspan="1" style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;19,348&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;39,946&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,928&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          </us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_907"
      unitRef="USD">217267000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_908"
      unitRef="USD">201466000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_909"
      unitRef="USD">168002000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="C_20230101to20231231"
      decimals="2"
      id="FFact_910"
      unitRef="Pure">0.23</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="C_20220101to20221231"
      decimals="2"
      id="FFact_911"
      unitRef="Pure">0.23</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="C_20210101to20211231"
      decimals="2"
      id="FFact_912"
      unitRef="Pure">0.23</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_913"
      unitRef="USD">49971000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_914"
      unitRef="USD">46337000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_915"
      unitRef="USD">38640000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <inmd:IncomeTaxReconciliationBenefitsToBenefitedEnterprise
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_916"
      unitRef="USD">31739000</inmd:IncomeTaxReconciliationBenefitsToBenefitedEnterprise>
    <inmd:IncomeTaxReconciliationBenefitsToBenefitedEnterprise
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_917"
      unitRef="USD">29429000</inmd:IncomeTaxReconciliationBenefitsToBenefitedEnterprise>
    <inmd:IncomeTaxReconciliationBenefitsToBenefitedEnterprise
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_918"
      unitRef="USD">37478000</inmd:IncomeTaxReconciliationBenefitsToBenefitedEnterprise>
    <inmd:IncomeTaxReconciliationDifferentEffectiveTaxRatesApplicableToSubsidiaries
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_919"
      unitRef="USD">1956000</inmd:IncomeTaxReconciliationDifferentEffectiveTaxRatesApplicableToSubsidiaries>
    <inmd:IncomeTaxReconciliationDifferentEffectiveTaxRatesApplicableToSubsidiaries
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230120112420029"
      unitRef="USD">1453000</inmd:IncomeTaxReconciliationDifferentEffectiveTaxRatesApplicableToSubsidiaries>
    <inmd:IncomeTaxReconciliationDifferentEffectiveTaxRatesApplicableToSubsidiaries
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20230120112427832"
      unitRef="USD">2033000</inmd:IncomeTaxReconciliationDifferentEffectiveTaxRatesApplicableToSubsidiaries>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_925"
      unitRef="USD">126000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_926"
      unitRef="USD">130000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_927"
      unitRef="USD">40000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <inmd:IncomeTaxReconciliationUncertainTaxPosition
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20230120112828521"
      unitRef="USD">1096000</inmd:IncomeTaxReconciliationUncertainTaxPosition>
    <inmd:IncomeTaxReconciliationUncertainTaxPosition
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_929"
      unitRef="USD">303000</inmd:IncomeTaxReconciliationUncertainTaxPosition>
    <inmd:IncomeTaxReconciliationUncertainTaxPosition
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_930"
      unitRef="USD">1921000</inmd:IncomeTaxReconciliationUncertainTaxPosition>
    <inmd:IncomeTaxReconciliationNonDeductibleExpenses
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_931"
      unitRef="USD">1850000</inmd:IncomeTaxReconciliationNonDeductibleExpenses>
    <inmd:IncomeTaxReconciliationNonDeductibleExpenses
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_932"
      unitRef="USD">1842000</inmd:IncomeTaxReconciliationNonDeductibleExpenses>
    <inmd:IncomeTaxReconciliationNonDeductibleExpenses
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_933"
      unitRef="USD">1838000</inmd:IncomeTaxReconciliationNonDeductibleExpenses>
    <inmd:IncomeTaxReconciliationAmendmentToInvestmentsLawPayment
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20230210104355513_xbrl_20230210103120152"
      unitRef="USD">0</inmd:IncomeTaxReconciliationAmendmentToInvestmentsLawPayment>
    <inmd:IncomeTaxReconciliationAmendmentToInvestmentsLawPayment
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230210104355513_xbrl_20230210103132889"
      unitRef="USD">12017000</inmd:IncomeTaxReconciliationAmendmentToInvestmentsLawPayment>
    <inmd:IncomeTaxReconciliationAmendmentToInvestmentsLawPayment
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20230210104355513_xbrl_20230120102708186_Fact_933"
      unitRef="USD">0</inmd:IncomeTaxReconciliationAmendmentToInvestmentsLawPayment>
    <inmd:IncomeTaxReconciliationSettlementsWithIsraeliTaxAuthorityNetOfDecreaseOfRelatedUncertainTax
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20230210104419032_xbrl_20230210104355513_xbrl_20230210103120152"
      unitRef="USD">0</inmd:IncomeTaxReconciliationSettlementsWithIsraeliTaxAuthorityNetOfDecreaseOfRelatedUncertainTax>
    <inmd:IncomeTaxReconciliationSettlementsWithIsraeliTaxAuthorityNetOfDecreaseOfRelatedUncertainTax
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230210104419032_xbrl_20230210104355513_xbrl_20230210103132889"
      unitRef="USD">10199000</inmd:IncomeTaxReconciliationSettlementsWithIsraeliTaxAuthorityNetOfDecreaseOfRelatedUncertainTax>
    <inmd:IncomeTaxReconciliationSettlementsWithIsraeliTaxAuthorityNetOfDecreaseOfRelatedUncertainTax
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20230210104419032_xbrl_20230210104355513_xbrl_20230120102708186_Fact_933"
      unitRef="USD">0</inmd:IncomeTaxReconciliationSettlementsWithIsraeliTaxAuthorityNetOfDecreaseOfRelatedUncertainTax>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_937"
      unitRef="USD">19348000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_938"
      unitRef="USD">39946000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_939"
      unitRef="USD">2928000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:TaxAdjustmentsSettlementsAndUnusualProvisions
      contextRef="C_20230101to20231231"
      decimals="-5"
      id="Fxbrl_20230131150049364"
      unitRef="USD">1300000</us-gaap:TaxAdjustmentsSettlementsAndUnusualProvisions>
    <inmd:UndistributedExemptIncome
      contextRef="C_20221231_usgaapIncomeTaxAuthorityNameAxis_inmdIsraeliTaxAuthorityMember"
      decimals="-5"
      id="Fxbrl_20230210140458012"
      unitRef="ils">50200000</inmd:UndistributedExemptIncome>
    <inmd:UndistributedExemptIncome
      contextRef="C_20221231_usgaapIncomeTaxAuthorityNameAxis_inmdIsraeliTaxAuthorityMember"
      decimals="-5"
      id="Fxbrl_20230210140523646"
      unitRef="USD">14300000</inmd:UndistributedExemptIncome>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240205113231928">
            &lt;div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:49.65pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:18pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;f.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:auto;vertical-align:top"&gt;
                      &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Income before income taxes is composed of the following:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="width:49.65pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:18pt;vertical-align:top;font-weight:bold"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:auto;vertical-align:top"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;div style="margin-left:72pt"&gt;
                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="10" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year ended December 31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;InMode Ltd. and Israeli subsidiaries&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;211,137&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;196,354&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;163,370&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Subsidiaries outside of Israel&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,130&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,112&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,632&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;217,267&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;201,466&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;168,002&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          </us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_20230101to20231231_usgaapIncomeTaxAuthorityNameAxis_inmdInmodeLtdAndIsreaeliSubsidiariesMember"
      decimals="-3"
      id="FFact_941"
      unitRef="USD">211137000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_20220101to20221231_usgaapIncomeTaxAuthorityNameAxis_inmdInmodeLtdAndIsreaeliSubsidiariesMember"
      decimals="-3"
      id="FFact_942"
      unitRef="USD">196354000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_20210101to20211231_usgaapIncomeTaxAuthorityNameAxis_inmdInmodeLtdAndIsreaeliSubsidiariesMember"
      decimals="-3"
      id="FFact_943"
      unitRef="USD">163370000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_20230101to20231231_usgaapIncomeTaxAuthorityNameAxis_inmdSubsidiariesOutsideIsraelMember"
      decimals="-3"
      id="FFact_944"
      unitRef="USD">6130000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_20220101to20221231_usgaapIncomeTaxAuthorityNameAxis_inmdSubsidiariesOutsideIsraelMember"
      decimals="-3"
      id="FFact_945"
      unitRef="USD">5112000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_20210101to20211231_usgaapIncomeTaxAuthorityNameAxis_inmdSubsidiariesOutsideIsraelMember"
      decimals="-3"
      id="FFact_946"
      unitRef="USD">4632000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_947"
      unitRef="USD">217267000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_948"
      unitRef="USD">201466000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_949"
      unitRef="USD">168002000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240205113248427">
            &lt;div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:49.65pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:18pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;g.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:auto;vertical-align:top"&gt;
                      &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Tax expenses (tax benefit):&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;div style="margin-left:72pt"&gt;
                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="10" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year ended December 31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Current:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
                        &lt;div style="margin-left:8.55pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Israel&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;17,633&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;38,248&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,829&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="margin-left:8.55pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Subsidiaries&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,864&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,614&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(131&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;19,497&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;39,862&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,698&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Deferred:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
                        &lt;div style="margin-left:8.55pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Israel&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(149&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;84&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(770&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="margin-left:8.55pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Subsidiaries&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(149&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;84&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(770&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total taxes on income&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;19,348&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;39,946&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,928&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          </us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="C_20230101to20231231_usgaapIncomeTaxAuthorityNameAxis_countryIL"
      decimals="-3"
      id="FFact_951"
      unitRef="USD">17633000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="C_20220101to20221231_usgaapIncomeTaxAuthorityNameAxis_countryIL"
      decimals="-3"
      id="FFact_952"
      unitRef="USD">38248000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="C_20210101to20211231_usgaapIncomeTaxAuthorityNameAxis_countryIL"
      decimals="-3"
      id="FFact_953"
      unitRef="USD">3829000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="C_20230101to20231231_usgaapIncomeTaxAuthorityNameAxis_inmdSubsidiariesOutsideIsraelMember"
      decimals="-3"
      id="Fxbrl_20230120114248879_Fact_957"
      unitRef="USD">1864000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="C_20220101to20221231_usgaapIncomeTaxAuthorityNameAxis_inmdSubsidiariesOutsideIsraelMember"
      decimals="-3"
      id="Fxbrl_20230120114248879_Fact_958"
      unitRef="USD">1614000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="C_20210101to20211231_usgaapIncomeTaxAuthorityNameAxis_inmdSubsidiariesOutsideIsraelMember"
      decimals="-3"
      id="Fxbrl_20230120114248879_Fact_959"
      unitRef="USD">-131000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20230210105713218_xbrl_20230120114248879_Fact_957"
      unitRef="USD">19497000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230210105713218_xbrl_20230120114248879_Fact_958"
      unitRef="USD">39862000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20230210105713218_xbrl_20230120114248879_Fact_959"
      unitRef="USD">3698000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="C_20230101to20231231_usgaapIncomeTaxAuthorityNameAxis_countryIL"
      decimals="-3"
      id="Fxbrl_20230120113838966_Fact_978"
      unitRef="USD">-149000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="C_20220101to20221231_usgaapIncomeTaxAuthorityNameAxis_countryIL"
      decimals="-3"
      id="Fxbrl_20230120113838966_Fact_979"
      unitRef="USD">84000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="C_20210101to20211231_usgaapIncomeTaxAuthorityNameAxis_countryIL"
      decimals="-3"
      id="Fxbrl_20230120113838966_Fact_980"
      unitRef="USD">-770000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="C_20230101to20231231_usgaapIncomeTaxAuthorityNameAxis_inmdSubsidiariesOutsideIsraelMember"
      decimals="-3"
      id="Fxbrl_20230120103603322_xbrl_20230120103544203"
      unitRef="USD">0</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="C_20220101to20221231_usgaapIncomeTaxAuthorityNameAxis_inmdSubsidiariesOutsideIsraelMember"
      decimals="-3"
      id="Fxbrl_20230120103603322_Fact_967"
      unitRef="USD">0</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="C_20210101to20211231_usgaapIncomeTaxAuthorityNameAxis_inmdSubsidiariesOutsideIsraelMember"
      decimals="-3"
      id="Fxbrl_20230120103603322_Fact_968"
      unitRef="USD">0</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20230120113854852_Fact_978"
      unitRef="USD">-149000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230120113854852_Fact_979"
      unitRef="USD">84000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20230120113854852_Fact_980"
      unitRef="USD">-770000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_978"
      unitRef="USD">19348000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_979"
      unitRef="USD">39946000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_980"
      unitRef="USD">2928000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240205113307909">
            &lt;div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:49pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:18pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:auto"&gt;
                      &lt;div style="font-weight:bold"&gt;
                        &lt;div style="line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The following table summarizes the activity of the Company&#x2019;s unrecognized tax benefits:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:49pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:18pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:auto"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;div style="margin-left:72pt"&gt;
                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year&#160;ended&#160;December&#160;31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:middle;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="margin-left:16.85pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance at January 1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;303&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,831&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:middle;width:76%;vertical-align:bottom"&gt;
                        &lt;div style="margin-left:16.85pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Decrease in uncertain tax positions for the previous years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4,831&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:middle;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="margin-left:16.85pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Increase in uncertain tax positions for the current year, net&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,096&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;303&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:middle;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;
                        &lt;div style="margin-left:16.85pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance at December 31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,399&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;303&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          </us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_982"
      unitRef="USD">303000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_983"
      unitRef="USD">4831000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_984"
      unitRef="USD">0</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230120104011627"
      unitRef="USD">4831000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_986"
      unitRef="USD">1096000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_987"
      unitRef="USD">303000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_988"
      unitRef="USD">1399000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_989"
      unitRef="USD">303000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="C_20230101to20231231" id="FFact_1038">
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;NOTE 14 - ENTITY-WIDE DISCLOSURE:&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;
    &lt;div&gt;
      &lt;div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:49.65pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:18pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;a.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top"&gt;
                &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenue&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

          &lt;div&gt;
            &lt;div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:67pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:21pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:auto"&gt;
                      &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenues by geographic area were as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left"&gt;&#160;&lt;/p&gt;
              &lt;div style="margin-left:93pt"&gt;
                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="10" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year ended December 31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:middle;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;United States&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;307,818&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;298,612&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;237,263&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:middle;width:64%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Europe&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;62,532&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;49,274&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;36,588&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:middle;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;121,698&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;106,385&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;83,714&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:middle;width:64%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;492,048&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;*&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;454,271&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;*&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;357,565&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;*&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
            &lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:71pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:18pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:auto"&gt;
                      &lt;div&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;*Revenues are attributed to geographic areas based on the location of customer. No single customer accounted for 10% or more of Company&#x2019;s total revenues, or Company&#x2019;s net accounts receivable, in any fiscal year presented.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
          &lt;/div&gt;

        &lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left"&gt;&#160;&lt;/p&gt;

          &lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:67pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:top;width:21pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:top;width:auto"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenues based on products' category were as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left"&gt;&#160;&lt;/p&gt;
            &lt;div style="margin-left:93pt"&gt;
              &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="10" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year ended December 31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:middle;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Capital Equipment revenues&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;412,089&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;394,212&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;319,239&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:middle;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Consumables and service revenues&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;79,959&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;60,059&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;38,326&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:middle;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;492,048&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;454,271&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;357,565&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
          &lt;/div&gt;

        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

          &lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:67pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:top;width:21pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:top;width:auto"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenues based on products' technology were as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left"&gt;&#160;&lt;/p&gt;
            &lt;div style="margin-left:93pt"&gt;
              &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="10" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year ended December 31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="10" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:middle;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Minimal-Invasive&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;83&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;81&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;72&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:middle;width:64%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Hands-Free&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;20&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:middle;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Non-Invasive&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:middle;width:64%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
          &lt;/div&gt;

        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

          &lt;div&gt;
            &lt;div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:67pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:21pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:auto"&gt;
                      &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The changes in contract liabilities are as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left"&gt;&#160;&lt;/p&gt;
              &lt;div style="margin-left:93pt"&gt;
                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                    &lt;tr&gt;
                      &lt;td rowspan="1" style="vertical-align:middle;width:76%;background-color:rgb(255, 255, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="6" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year&#160;ended&#160;December&#160;31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td rowspan="1" style="vertical-align:middle;width:76%;background-color:rgb(255, 255, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" rowspan="1" style="text-align:center;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255);font-weight:bold;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:middle;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-15.95pt;margin-left:15.95pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as of January 1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;17,757&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;16,556&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:middle;width:76%;vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-15.95pt;margin-left:15.95pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Increases due to issuance of new contracts, excluding amounts recognized as revenue during the period&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,498&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;14,987&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:middle;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-15.95pt;margin-left:15.95pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenue recognized that was included in the contract liability balance at the beginning of the period&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(15,566&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(13,786&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:middle;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-15.95pt;margin-left:15.95pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as of December 31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;14,689&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;17,757&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:middle;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-15.95pt;margin-left:15.95pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Contract liability presented in non-current liabilities (1)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,766&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,959&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:middle;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-15.95pt;margin-left:15.95pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Contract liability presented in current liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10,923&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13,798&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
            &lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:67pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:top;width:21pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:top;width:auto"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As of December 31, 2023, non-current deferred revenue is estimated to be recognized as following: 83% in year 2025 and the rest in year 2026-2027.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          &lt;/div&gt;

        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div&gt;&lt;/div&gt;

          &lt;div&gt;
            &lt;div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:49.65pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:18pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;b.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:auto;vertical-align:top"&gt;
                      &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Long-Lived Assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left"&gt;&#160;&lt;/p&gt;
              &lt;div style="margin-left:72pt"&gt;
                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="6" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:middle;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-15.95pt;margin-left:15.95pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Israel&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,704&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,263&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:middle;width:76%;vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-15.95pt;margin-left:15.95pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;United States&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,789&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,097&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:middle;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-15.95pt;margin-left:15.95pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,587&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,011&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:middle;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,080&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7,371&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:middle;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-15.95pt;margin-left:15.95pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other long-term assets*&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,370&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,573&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:middle;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;16,450&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11,944&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
            &lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:49.65pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:18pt;vertical-align:top;font-weight:bold"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:auto;vertical-align:top"&gt;
                      &lt;div style="font-weight:normal"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;*Consists of non-current accounts receivable, net and other investments&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
          &lt;/div&gt;

      &lt;/div&gt;
    &lt;/div&gt;
  </us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240205141121811">
          &lt;div&gt;
            &lt;div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:67pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:21pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:auto"&gt;
                      &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenues by geographic area were as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left"&gt;&#160;&lt;/p&gt;
              &lt;div style="margin-left:93pt"&gt;
                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="10" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year ended December 31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:middle;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;United States&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;307,818&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;298,612&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;237,263&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:middle;width:64%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Europe&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;62,532&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;49,274&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;36,588&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:middle;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;121,698&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;106,385&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;83,714&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:middle;width:64%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;492,048&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;*&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;454,271&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;*&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;357,565&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;*&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
            &lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:71pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:18pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:auto"&gt;
                      &lt;div&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;*Revenues are attributed to geographic areas based on the location of customer. No single customer accounted for 10% or more of Company&#x2019;s total revenues, or Company&#x2019;s net accounts receivable, in any fiscal year presented.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
          &lt;/div&gt;
        </us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock>
    <us-gaap:Revenues
      contextRef="C_20230101to20231231_srtStatementGeographicalAxis_countryUS"
      decimals="-3"
      id="FFact_992"
      unitRef="USD">307818000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_20220101to20221231_srtStatementGeographicalAxis_countryUS"
      decimals="-3"
      id="FFact_993"
      unitRef="USD">298612000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_20210101to20211231_srtStatementGeographicalAxis_countryUS"
      decimals="-3"
      id="FFact_994"
      unitRef="USD">237263000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_20230101to20231231_srtStatementGeographicalAxis_srtEuropeMember"
      decimals="-3"
      id="Fxbrl_20230131122327862_Fact_992"
      unitRef="USD">62532000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_20220101to20221231_srtStatementGeographicalAxis_srtEuropeMember"
      decimals="-3"
      id="Fxbrl_20230131122327862_Fact_993"
      unitRef="USD">49274000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_20210101to20211231_srtStatementGeographicalAxis_srtEuropeMember"
      decimals="-3"
      id="Fxbrl_20230131122327862_Fact_994"
      unitRef="USD">36588000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_20230101to20231231_srtStatementGeographicalAxis_inmdOtherCountryMember"
      decimals="-3"
      id="FFact_995"
      unitRef="USD">121698000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_20220101to20221231_srtStatementGeographicalAxis_inmdOtherCountryMember"
      decimals="-3"
      id="FFact_996"
      unitRef="USD">106385000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_20210101to20211231_srtStatementGeographicalAxis_inmdOtherCountryMember"
      decimals="-3"
      id="FFact_997"
      unitRef="USD">83714000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_998"
      unitRef="USD">492048000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_999"
      unitRef="USD">454271000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_1000"
      unitRef="USD">357565000</us-gaap:Revenues>
    <us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240205135644068">
          &lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:67pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:top;width:21pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:top;width:auto"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenues based on products' category were as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left"&gt;&#160;&lt;/p&gt;
            &lt;div style="margin-left:93pt"&gt;
              &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="10" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year ended December 31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:middle;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Capital Equipment revenues&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;412,089&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;394,212&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;319,239&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:middle;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Consumables and service revenues&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;79,959&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;60,059&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;38,326&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:middle;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;492,048&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;454,271&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;357,565&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
          &lt;/div&gt;
        </us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock>
    <us-gaap:Revenues
      contextRef="C_20230101to20231231_srtProductOrServiceAxis_inmdCapitalEquipmentMember"
      decimals="-3"
      id="Fxbrl_20240205124122989"
      unitRef="USD">412089000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_20220101to20221231_srtProductOrServiceAxis_inmdCapitalEquipmentMember"
      decimals="-3"
      id="Fxbrl_20240205124131321"
      unitRef="USD">394212000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_20210101to20211231_srtProductOrServiceAxis_inmdCapitalEquipmentMember"
      decimals="-3"
      id="Fxbrl_20240205124134328"
      unitRef="USD">319239000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_20230101to20231231_srtProductOrServiceAxis_inmdConsumablesAndServiceRevenuesMember"
      decimals="-3"
      id="Fxbrl_20240205124304562_xbrl_20240205124122989"
      unitRef="USD">79959000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_20220101to20221231_srtProductOrServiceAxis_inmdConsumablesAndServiceRevenuesMember"
      decimals="-3"
      id="Fxbrl_20240205124304562_xbrl_20240205124131321"
      unitRef="USD">60059000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_20210101to20211231_srtProductOrServiceAxis_inmdConsumablesAndServiceRevenuesMember"
      decimals="-3"
      id="Fxbrl_20240205124304562_xbrl_20240205124134328"
      unitRef="USD">38326000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20240205124305915_xbrl_20240205124122989"
      unitRef="USD">492048000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20240205124305915_xbrl_20240205124131321"
      unitRef="USD">454271000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20240205124305915_xbrl_20240205124134328"
      unitRef="USD">357565000</us-gaap:Revenues>
    <us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240205135415381">
          &lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:67pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:top;width:21pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:top;width:auto"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenues based on products' technology were as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left"&gt;&#160;&lt;/p&gt;
            &lt;div style="margin-left:93pt"&gt;
              &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="10" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year ended December 31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="10" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:middle;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Minimal-Invasive&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;83&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;81&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;72&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:middle;width:64%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Hands-Free&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;20&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:middle;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Non-Invasive&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:middle;width:64%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
          &lt;/div&gt;
        </us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock>
    <inmd:PercentageOfNetSalesBasedOnProductsTechnology
      contextRef="C_20230101to20231231_usgaapConcentrationRiskByTypeAxis_inmdMinimalInvasiveMember"
      decimals="2"
      id="FFact_1002"
      unitRef="Pure">0.83</inmd:PercentageOfNetSalesBasedOnProductsTechnology>
    <inmd:PercentageOfNetSalesBasedOnProductsTechnology
      contextRef="C_20220101to20221231_usgaapConcentrationRiskByTypeAxis_inmdMinimalInvasiveMember"
      decimals="2"
      id="FFact_1003"
      unitRef="Pure">0.81</inmd:PercentageOfNetSalesBasedOnProductsTechnology>
    <inmd:PercentageOfNetSalesBasedOnProductsTechnology
      contextRef="C_20210101to20211231_usgaapConcentrationRiskByTypeAxis_inmdMinimalInvasiveMember"
      decimals="2"
      id="FFact_1004"
      unitRef="Pure">0.72</inmd:PercentageOfNetSalesBasedOnProductsTechnology>
    <inmd:PercentageOfNetSalesBasedOnProductsTechnology
      contextRef="C_20230101to20231231_usgaapConcentrationRiskByTypeAxis_inmdHandsFreeMember"
      decimals="2"
      id="FFact_1005"
      unitRef="Pure">0.08</inmd:PercentageOfNetSalesBasedOnProductsTechnology>
    <inmd:PercentageOfNetSalesBasedOnProductsTechnology
      contextRef="C_20220101to20221231_usgaapConcentrationRiskByTypeAxis_inmdHandsFreeMember"
      decimals="2"
      id="FFact_1006"
      unitRef="Pure">0.10</inmd:PercentageOfNetSalesBasedOnProductsTechnology>
    <inmd:PercentageOfNetSalesBasedOnProductsTechnology
      contextRef="C_20210101to20211231_usgaapConcentrationRiskByTypeAxis_inmdHandsFreeMember"
      decimals="2"
      id="FFact_1007"
      unitRef="Pure">0.20</inmd:PercentageOfNetSalesBasedOnProductsTechnology>
    <inmd:PercentageOfNetSalesBasedOnProductsTechnology
      contextRef="C_20230101to20231231_usgaapConcentrationRiskByTypeAxis_inmdNonInvasiveMember"
      decimals="2"
      id="FFact_1008"
      unitRef="Pure">0.09</inmd:PercentageOfNetSalesBasedOnProductsTechnology>
    <inmd:PercentageOfNetSalesBasedOnProductsTechnology
      contextRef="C_20220101to20221231_usgaapConcentrationRiskByTypeAxis_inmdNonInvasiveMember"
      decimals="2"
      id="FFact_1009"
      unitRef="Pure">0.09</inmd:PercentageOfNetSalesBasedOnProductsTechnology>
    <inmd:PercentageOfNetSalesBasedOnProductsTechnology
      contextRef="C_20210101to20211231_usgaapConcentrationRiskByTypeAxis_inmdNonInvasiveMember"
      decimals="2"
      id="FFact_1010"
      unitRef="Pure">0.08</inmd:PercentageOfNetSalesBasedOnProductsTechnology>
    <inmd:PercentageOfNetSalesBasedOnProductsTechnology
      contextRef="C_20230101to20231231"
      decimals="2"
      id="FFact_1011"
      unitRef="Pure">1</inmd:PercentageOfNetSalesBasedOnProductsTechnology>
    <inmd:PercentageOfNetSalesBasedOnProductsTechnology
      contextRef="C_20220101to20221231"
      decimals="2"
      id="FFact_1012"
      unitRef="Pure">1</inmd:PercentageOfNetSalesBasedOnProductsTechnology>
    <inmd:PercentageOfNetSalesBasedOnProductsTechnology
      contextRef="C_20210101to20211231"
      decimals="2"
      id="FFact_1013"
      unitRef="Pure">1</inmd:PercentageOfNetSalesBasedOnProductsTechnology>
    <us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240205141050251">
          &lt;div&gt;
            &lt;div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:67pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:21pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:auto"&gt;
                      &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The changes in contract liabilities are as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left"&gt;&#160;&lt;/p&gt;
              &lt;div style="margin-left:93pt"&gt;
                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                    &lt;tr&gt;
                      &lt;td rowspan="1" style="vertical-align:middle;width:76%;background-color:rgb(255, 255, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="6" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year&#160;ended&#160;December&#160;31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td rowspan="1" style="vertical-align:middle;width:76%;background-color:rgb(255, 255, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" rowspan="1" style="text-align:center;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255);font-weight:bold;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:middle;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-15.95pt;margin-left:15.95pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as of January 1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;17,757&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;16,556&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:middle;width:76%;vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-15.95pt;margin-left:15.95pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Increases due to issuance of new contracts, excluding amounts recognized as revenue during the period&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,498&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;14,987&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:middle;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-15.95pt;margin-left:15.95pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenue recognized that was included in the contract liability balance at the beginning of the period&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(15,566&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(13,786&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:middle;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-15.95pt;margin-left:15.95pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as of December 31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;14,689&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;17,757&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:middle;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-15.95pt;margin-left:15.95pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Contract liability presented in non-current liabilities (1)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,766&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,959&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:middle;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-15.95pt;margin-left:15.95pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Contract liability presented in current liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10,923&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13,798&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
            &lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:67pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:top;width:21pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:top;width:auto"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As of December 31, 2023, non-current deferred revenue is estimated to be recognized as following: 83% in year 2025 and the rest in year 2026-2027.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          &lt;/div&gt;
        </us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock>
    <us-gaap:ContractWithCustomerLiability
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_1015"
      unitRef="USD">17757000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_1016"
      unitRef="USD">16556000</us-gaap:ContractWithCustomerLiability>
    <inmd:IncreasesDueToIssuanceOfNewContractsExcludingAmountsRecognizedAsRevenueDuringPeriod
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_1017"
      unitRef="USD">12498000</inmd:IncreasesDueToIssuanceOfNewContractsExcludingAmountsRecognizedAsRevenueDuringPeriod>
    <inmd:IncreasesDueToIssuanceOfNewContractsExcludingAmountsRecognizedAsRevenueDuringPeriod
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_1018"
      unitRef="USD">14987000</inmd:IncreasesDueToIssuanceOfNewContractsExcludingAmountsRecognizedAsRevenueDuringPeriod>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_1019"
      unitRef="USD">-15566000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_1020"
      unitRef="USD">-13786000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiability
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_1021"
      unitRef="USD">14689000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_1022"
      unitRef="USD">17757000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_1023"
      unitRef="USD">3766000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_1024"
      unitRef="USD">3959000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_1025"
      unitRef="USD">10923000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_1026"
      unitRef="USD">13798000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <inmd:PercentageOfNonCurrentDeferredRevenue
      contextRef="C_20231231"
      decimals="2"
      id="FFact_1027"
      unitRef="Pure">0.83</inmd:PercentageOfNonCurrentDeferredRevenue>
    <us-gaap:DisclosureOfLongLivedAssetsHeldForSaleTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240205141110581">
          &lt;div&gt;
            &lt;div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:49.65pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:18pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;b.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:auto;vertical-align:top"&gt;
                      &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Long-Lived Assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left"&gt;&#160;&lt;/p&gt;
              &lt;div style="margin-left:72pt"&gt;
                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="6" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:middle;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-15.95pt;margin-left:15.95pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Israel&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,704&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,263&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:middle;width:76%;vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-15.95pt;margin-left:15.95pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;United States&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,789&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,097&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:middle;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-15.95pt;margin-left:15.95pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,587&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,011&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:middle;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,080&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7,371&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:middle;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-indent:-15.95pt;margin-left:15.95pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other long-term assets*&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,370&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,573&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:middle;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;16,450&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11,944&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
            &lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:49.65pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:18pt;vertical-align:top;font-weight:bold"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:auto;vertical-align:top"&gt;
                      &lt;div style="font-weight:normal"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;*Consists of non-current accounts receivable, net and other investments&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
          &lt;/div&gt;
        </us-gaap:DisclosureOfLongLivedAssetsHeldForSaleTextBlock>
    <inmd:TotalLongLivedAssetsByGeographicalArea
      contextRef="C_20231231_srtStatementGeographicalAxis_countryIL"
      decimals="-3"
      id="FFact_1029"
      unitRef="USD">6704000</inmd:TotalLongLivedAssetsByGeographicalArea>
    <inmd:TotalLongLivedAssetsByGeographicalArea
      contextRef="C_20221231_srtStatementGeographicalAxis_countryIL"
      decimals="-3"
      id="FFact_1030"
      unitRef="USD">3263000</inmd:TotalLongLivedAssetsByGeographicalArea>
    <inmd:TotalLongLivedAssetsByGeographicalArea
      contextRef="C_20231231_srtStatementGeographicalAxis_countryUS"
      decimals="-3"
      id="FFact_1031"
      unitRef="USD">1789000</inmd:TotalLongLivedAssetsByGeographicalArea>
    <inmd:TotalLongLivedAssetsByGeographicalArea
      contextRef="C_20221231_srtStatementGeographicalAxis_countryUS"
      decimals="-3"
      id="FFact_1032"
      unitRef="USD">2097000</inmd:TotalLongLivedAssetsByGeographicalArea>
    <inmd:TotalLongLivedAssetsByGeographicalArea
      contextRef="C_20231231_srtStatementGeographicalAxis_inmdOtherCountryMember"
      decimals="-3"
      id="FFact_1033"
      unitRef="USD">3587000</inmd:TotalLongLivedAssetsByGeographicalArea>
    <inmd:TotalLongLivedAssetsByGeographicalArea
      contextRef="C_20221231_srtStatementGeographicalAxis_inmdOtherCountryMember"
      decimals="-3"
      id="FFact_1034"
      unitRef="USD">2011000</inmd:TotalLongLivedAssetsByGeographicalArea>
    <inmd:TotalLongLivedAssetsByGeographicalArea
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20240205140957808_Fact_1035"
      unitRef="USD">12080000</inmd:TotalLongLivedAssetsByGeographicalArea>
    <inmd:TotalLongLivedAssetsByGeographicalArea
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20240205140957808_Fact_1036"
      unitRef="USD">7371000</inmd:TotalLongLivedAssetsByGeographicalArea>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20240205132505564_Fact_1035"
      unitRef="USD">4370000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20240205132505564_Fact_1036"
      unitRef="USD">4573000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:NoncurrentAssets
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_1035"
      unitRef="USD">16450000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_1036"
      unitRef="USD">11944000</us-gaap:NoncurrentAssets>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240208204236302">
      &lt;div&gt;
        &lt;div&gt;
          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;NOTE 15 - RELATED PARTIES&lt;/span&gt;:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

              &lt;tr&gt;
                &lt;td style="width:49.5pt"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:18pt;font-weight:bold;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;a.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="width:auto;vertical-align:top"&gt;
                  &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company receives and provides certain services from and to Home Skinovations Ltd., a related party as part of a service agreement between them. The services include an office sublease in Israel, use of certain computer hardware and switchboard infrastructure, certain software licenses, joint purchases of employee&#x2019;s welfare products and services from third parties and limited manpower services. The Chairman of the Board and Chief Executive Officer of the Company is also a substantial shareholder and board member of Home Skinovations Ltd. and one of the Company&#x2019;s directors, serves on the board of directors of Home Skinovations Ltd. The Company recorded expenses related to services received and provided from Home Skinovations Ltd. of $99, $332 and $239 for the years ended December 31, 2023, 2022 and 2021, respectively.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;div&gt;&#160;&lt;/div&gt;
                  &lt;div&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In addition, the balance of the &lt;span style="-sec-ix-hidden:Fxbrl_20240208192647081"&gt;&lt;span style="-sec-ix-hidden:Fxbrl_20240208181011420"&gt;accounts payable&lt;/span&gt;&lt;/span&gt; as of December 31, 2023, 2022 was $0.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In February 2022 the Company have entered into an Asset Purchase Agreement with Home Skinovations, whereby Home Skinovations Ltd. sold and assigned to the Company all of Home Skinovations Ltd.&#x2019;s right, title and interest in and to Home Skinovations Ltd.&#x2019;s Spa segment assets (including molds, tooling, inventory and trademarks) and further granted the Company an exclusive license to certain IP rights of Home Skinovations Ltd., all the foregoing in consideration for an aggregate amount of $497.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company&#x2019;s subsidiary in Canada receives and provides certain services from and to a subsidiary of Home Skinovations Ltd. in Canada as part of a service agreement between them. The services include mobile phone services, an office sublease, use of certain computer hardware and switchboard infrastructure, certain software licenses, joint purchases of employee&#x2019;s welfare products and services from third parties and limited manpower services. In relation to these services received and provided, the Company recorded expenses (income) in the amount of $(30), $123 and $433 for the years ended December 31, 2023, 2022 and 2021, respectively. In addition, the balance of the &lt;span style="-sec-ix-hidden:Fxbrl_20240208192657231"&gt;&lt;span style="-sec-ix-hidden:Fxbrl_20240208190452680"&gt;accounts receivable&lt;/span&gt;&lt;/span&gt; as of December 31, 2023, 2022 was $0.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;&#160;&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

              &lt;tr&gt;
                &lt;td style="width:67.65pt"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:18pt;vertical-align:top;font-weight:normal"&gt;1)&lt;/td&gt;
                &lt;td style="width:auto;vertical-align:top"&gt;
                  &lt;div&gt;
                    &lt;div style="line-height:1.25"&gt;The Company&#x2019;s subsidiaries in North America received marketing services from SpaMedica International SRL, which was amalgamated with an affiliate company into the Company&#x2019;s major shareholder BoomerangFX International SRL during 2021. Dr. Stephan Mulholland is a beneficiary owner of 100% of the Company's major shareholder BoomerangFX. The Company recorded expenses related to those services in the amount of $172 for the year ended December 31, 2021. Starting from 2022 calendar year, Dr. Stephen Mulholland provides the Company and its subsidiaries certain marketing services as an independent contractor. The Company recorded expenses related to those services in the amount of $636, $723 for the years ended December 31, 2023 and 2022, respectively.&lt;/div&gt;
                  &lt;/div&gt;
                  &lt;div&gt;&#160;&lt;/div&gt;
                  &lt;div&gt;
                    &lt;div style="line-height:1.25"&gt;During 2023 Dr. Stephen Mulholland ceased to be a related party.&lt;/div&gt;
                  &lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
        &lt;/div&gt;&#160;&lt;div&gt;&lt;/div&gt;
        &lt;div&gt;
          &lt;div&gt;
            &lt;div style="line-height:1.25"&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;color:rgb(0, 0, 0)"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:67.65pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;2)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:auto;vertical-align:top"&gt;
                      &lt;div&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;The Company receives certain investment portfolio management services from Himalaya Family Office Consulting Ltd., with respect to part of its investment portfolio. The Chairman of the Board and Chief Executive Officer of the Company, is a minor shareholder and a board member of Himalaya Family Office Consulting Ltd. In relation to these services, the Company recorded expenses in the amount of $193, $100 and $90 for the years ended December 31, 2023, 2022 and 2021, respectively.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                      &lt;div&gt;&#160;&lt;/div&gt;
                      &lt;div&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;In addition, the balance of the &lt;span style="-sec-ix-hidden:Fxbrl_20240208192704302"&gt;&lt;span style="-sec-ix-hidden:Fxbrl_20240208173003815"&gt;accounts payable&lt;/span&gt;&lt;/span&gt; as of December 31, 2023, 2022, was $86, $28, respectively.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
          &lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;
    </us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="C_20230101to20231231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdHomeSkinnovationsLtdMember"
      decimals="-3"
      id="Fxbrl_20230131123034237"
      unitRef="USD">99000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="C_20220101to20221231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdHomeSkinnovationsLtdMember"
      decimals="-3"
      id="Fxbrl_20230131123041448"
      unitRef="USD">332000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="C_20210101to20211231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdHomeSkinnovationsLtdMember"
      decimals="-3"
      id="Fxbrl_20230131123046934"
      unitRef="USD">239000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:AccountsPayableCurrent
      contextRef="C_20221231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdHomeSkinnovationsLtdMember"
      decimals="-3"
      id="Fxbrl_20240205122456326"
      unitRef="USD">0</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="C_20231231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdHomeSkinnovationsLtdMember"
      decimals="-3"
      id="Fxbrl_20240205122431219"
      unitRef="USD">0</us-gaap:AccountsPayableCurrent>
    <inmd:RelatedPartyConsiderationForAggregateAmount
      contextRef="C_20230101to20231231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdHomeSkinnovationsLtdMember"
      decimals="-3"
      id="Fxbrl_20230131123529781"
      unitRef="USD">497000</inmd:RelatedPartyConsiderationForAggregateAmount>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="C_20230101to20231231_usgaapIncomeStatementLocationAxis_inmdExpensesIncomeMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdSubsidiaryOfHomeSkinnovationsLtdMember"
      decimals="-3"
      id="Fxbrl_20230131124342928"
      unitRef="USD">-30000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="C_20220101to20221231_usgaapIncomeStatementLocationAxis_inmdExpensesIncomeMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdSubsidiaryOfHomeSkinnovationsLtdMember"
      decimals="-3"
      id="Fxbrl_20230131124352840"
      unitRef="USD">123000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="C_20210101to20211231_usgaapIncomeStatementLocationAxis_inmdExpensesIncomeMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdSubsidiaryOfHomeSkinnovationsLtdMember"
      decimals="-3"
      id="Fxbrl_20230131124359791"
      unitRef="USD">433000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:AccountsReceivableNet
      contextRef="C_20221231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdSubsidiaryOfHomeSkinnovationsLtdMember"
      decimals="-3"
      id="Fxbrl_20240208190552555"
      unitRef="USD">0</us-gaap:AccountsReceivableNet>
    <us-gaap:AccountsReceivableNet
      contextRef="C_20231231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdSubsidiaryOfHomeSkinnovationsLtdMember"
      decimals="-3"
      id="Fxbrl_20240208184557538"
      unitRef="USD">0</us-gaap:AccountsReceivableNet>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="C_20230101to20231231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdSpaMedicalInternationalLsrlMember"
      decimals="-3"
      id="Fxbrl_20230131124619385"
      unitRef="USD">172000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="C_20220101to20221231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdSpaMedicalInternationalLsrlMember"
      decimals="-3"
      id="Fxbrl_20230131124631373"
      unitRef="USD">636000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="C_20210101to20211231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdSpaMedicalInternationalLsrlMember"
      decimals="-3"
      id="Fxbrl_20230131124637719"
      unitRef="USD">723000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="C_20230101to20231231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdHimalayaFamilyOfficeConsultingLtdMember"
      decimals="-3"
      id="Fxbrl_20230131125250358"
      unitRef="USD">193000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="C_20220101to20221231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdHimalayaFamilyOfficeConsultingLtdMember"
      decimals="-3"
      id="Fxbrl_20230131125300232"
      unitRef="USD">100000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="C_20210101to20211231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdHimalayaFamilyOfficeConsultingLtdMember"
      decimals="-3"
      id="Fxbrl_20230131125306335"
      unitRef="USD">90000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:AccountsPayableCurrent
      contextRef="C_20231231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdHimalayaFamilyOfficeConsultingLtdMember"
      decimals="-3"
      id="Fxbrl_20240205122557345"
      unitRef="USD">86000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="C_20221231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_inmdHimalayaFamilyOfficeConsultingLtdMember"
      decimals="-3"
      id="Fxbrl_20240205122600617"
      unitRef="USD">28000</us-gaap:AccountsPayableCurrent>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#FFact_370"
          xlink:label="FFact_370"
          xlink:type="locator"/>
        <link:footnote id="FN20240205164156889" xlink:label="FN20240205164156889" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Including, for 2022, payments amounting $12 million for Amendment to the Investments Law and settlements with the Israeli tax authority. See note 13a(2)(b).</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_370"
          xlink:to="FN20240205164156889"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_371"
          xlink:label="FFact_371"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_371"
          xlink:to="FN20240205164156889"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_372"
          xlink:label="FFact_372"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_372"
          xlink:to="FN20240205164156889"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_444"
          xlink:label="FFact_444"
          xlink:type="locator"/>
        <link:footnote id="FN20240205142459908" xlink:label="FN20240205142459908" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">As of December 31, 2023 and 2022, consists of $0 and $1,502 non-U.S. government bonds, respectively.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_444"
          xlink:to="FN20240205142459908"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_445"
          xlink:label="FFact_445"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_445"
          xlink:to="FN20240205142459908"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_998"
          xlink:label="FFact_998"
          xlink:type="locator"/>
        <link:footnote id="FN20240205114132415" xlink:label="FN20240205114132415" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Revenues are attributed to geographic areas based on the location of customer. No single customer accounted for 10% or more of Company&#x2019;s total revenues, or Company&#x2019;s net accounts receivable, in any fiscal year presented.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_998"
          xlink:to="FN20240205114132415"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_999"
          xlink:label="FFact_999"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_999"
          xlink:to="FN20240205114132415"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_1000"
          xlink:label="FFact_1000"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_1000"
          xlink:to="FN20240205114132415"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_1023"
          xlink:label="FFact_1023"
          xlink:type="locator"/>
        <link:footnote id="FN20230120225247000" xlink:label="FN20230120225247000" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">As of December 31, 2022, noncurrent deferred revenue is estimated to be recognized as following: 83% in year 2024 and the rest in year 2025-2026.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_1023"
          xlink:to="FN20230120225247000"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_1024"
          xlink:label="FFact_1024"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_1024"
          xlink:to="FN20230120225247000"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20240205132505564_Fact_1036"
          xlink:label="Fxbrl_20240205132505564_Fact_1036"
          xlink:type="locator"/>
        <link:footnote id="FN20240205164435993" xlink:label="FN20240205164435993" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Consists of non-current accounts receivable, net and other investments</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20240205132505564_Fact_1036"
          xlink:to="FN20240205164435993"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20240205132505564_Fact_1035"
          xlink:label="Fxbrl_20240205132505564_Fact_1035"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20240205132505564_Fact_1035"
          xlink:to="FN20240205164435993"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20230120221255665"
          xlink:label="Fxbrl_20230120221255665"
          xlink:type="locator"/>
        <link:footnote id="FN20240205135838393" xlink:label="FN20240205135838393" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The above number of Ordinary Shares outstanding does not include a total of 1,975,003 Ordinary Shares held at December 31, 2023, as treasury shares, all of which were repurchased by InMode Ltd.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20230120221255665"
          xlink:to="FN20240205135838393"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_696"
          xlink:label="FFact_696"
          xlink:type="locator"/>
        <link:footnote id="FN20230131142645552" xlink:label="FN20230131142645552" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">In U.S. dollars per Ordinary Share</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_696"
          xlink:to="FN20230131142645552"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_708"
          xlink:label="FFact_708"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_708"
          xlink:to="FN20230131142645552"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_712"
          xlink:label="FFact_712"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_712"
          xlink:to="FN20230131142645552"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_720"
          xlink:label="FFact_720"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_720"
          xlink:to="FN20230131142645552"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_724"
          xlink:label="FFact_724"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_724"
          xlink:to="FN20230131142645552"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_760"
          xlink:label="FFact_760"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_760"
          xlink:to="FN20230131142645552"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_765"
          xlink:label="FFact_765"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_765"
          xlink:to="FN20230131142645552"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_770"
          xlink:label="FFact_770"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_770"
          xlink:to="FN20230131142645552"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_775"
          xlink:label="FFact_775"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_775"
          xlink:to="FN20230131142645552"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_780"
          xlink:label="FFact_780"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_780"
          xlink:to="FN20230131142645552"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_785"
          xlink:label="FFact_785"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_785"
          xlink:to="FN20230131142645552"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_790"
          xlink:label="FFact_790"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_790"
          xlink:to="FN20230131142645552"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_795"
          xlink:label="FFact_795"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_795"
          xlink:to="FN20230131142645552"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_800"
          xlink:label="FFact_800"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_800"
          xlink:to="FN20230131142645552"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20230120062219955"
          xlink:label="Fxbrl_20230120062219955"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20230120062219955"
          xlink:to="FN20230131142645552"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20230120063922997"
          xlink:label="Fxbrl_20230120063922997"
          xlink:type="locator"/>
        <link:footnote id="FN20240205110132274" xlink:label="FN20240205110132274" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">As of December 31, 2023, 275,249 RSUs were vested and were settled by issuance of respective shares at the beginning of January 2024.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20230120063922997"
          xlink:to="FN20240205110132274"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20230120063944773"
          xlink:label="Fxbrl_20230120063944773"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20230120063944773"
          xlink:to="FN20240205110132274"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20230120101707941"
          xlink:label="Fxbrl_20230120101707941"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20230120101707941"
          xlink:to="FN20230131142645552"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
